act_id,struct_id,target_id,target_name,target_class,accession,gene,swissprot,act_value,act_unit,act_type,act_comment,act_source,relation,moa,moa_source,act_source_url,moa_source_url,action_type,first_in_class,tdl,act_ref_id,moa_ref_id,organism
218475,5375,1366,Nuclear factor NF-kappa-B p105 subunit,Cytosolic other,P19838,NFKB1,NFKB1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/31132753,INHIBITOR,,Tclin,,2750,Homo sapiens
218476,5375,755,5'-AMP-activated protein kinase catalytic subunit alpha-1,Kinase,Q13131,PRKAA1,AAPK1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/31132753,INHIBITOR,,Tclin,,2750,Homo sapiens
218477,5375,4392,SARS-CoV-2,Virus,,,,6,,EC50,Vero E6 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/32149769,,INHIBITOR,,,2751,,
218478,1893,4392,SARS-CoV-2,Virus,,,,5.53,,EC50,Activity determined against Vero E6 cells,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.26434/chemrxiv.12039888.v1,,INHIBITOR,,,2752,,
218479,3972,4392,SARS-CoV-2,Virus,,,,5.69,,IC50,Activity determined against Vero/hSLAM cell,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/32251768,,INHIBITOR,,,2753,,
218480,1912,4392,SARS-CoV-2,Virus,,,,6.55,,IC50,,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1101/2020.03.20.999730,,INHIBITOR,,,2754,,
218481,276,4392,SARS-CoV-2,Virus,,,,5.67,,EC50,in vitro inhibition of SAR-CoV2 replication,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1101/2020.04.03.023846,,INHIBITOR,,,2755,,
218482,1395,4392,SARS-CoV-2,Virus,,,,5.35,,EC50,Activity determined against Vero E6 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/32194981,,INHIBITOR,,,2756,,
218483,1001,4392,SARS-CoV-2,Virus,,,,6.34,,EC50,Activity determined against Vero E6 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/32251767,,INHIBITOR,,,2757,,
218484,4677,4392,SARS-CoV-2,Virus,,,,5.59,,EC50,Activity determined against Vero E6 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/32251767,,INHIBITOR,,,2757,,
218485,607,4392,SARS-CoV-2,Virus,,,,5.95,,EC50,Activity determined against Vero E6 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/32020029,,INHIBITOR,,,2758,,
218487,924,4393,Main protease (M-PRO),Enzyme,P0DTD1,REP,R1AB_SARS2,6.26,,IC50,,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1101/2020.03.23.004580,,INHIBITOR,,,2760,,Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
218490,5377,4392,SARS-CoV-2,Virus,,,,6.52,,IC50,Activity determined against Vero E6 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/32253226,,INHIBITOR,,,2762,,
218491,5378,4392,SARS-CoV-2,Virus,,,,5.29,,EC50,Activity determined against Vero E6 cells,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1101/2020.03.11.986836,,INHIBITOR,,,2763,,
218492,633,4392,SARS-CoV-2,Virus,,,,5.36,,IC50,Activity determined against Vero E6 cells. Possible target viral NSP15 (uridylate-specific endoribonuclease),SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1101/2020.03.11.987016,,INHIBITOR,,,2759,,
218493,2580,749,Cathepsin L1,Enzyme,P07711,CTSL,CATL1_HUMAN,5.78,,IC50,Teicoplanin potently prevents the entrance of 2019-nCoV-Spike-pseudoviruses into the cytoplasm,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://dx.doi.org/10.1101/2020.02.05.935387,http://dx.doi.org/10.1101/2020.02.05.935387,INHIBITOR,,Tclin,2761,2761,Homo sapiens
218494,5379,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,9.62,,IC50,PDGFRA D842V (exon 18) mutant,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29093181,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf,INHIBITOR,,Tclin,2765,2764,Homo sapiens
218495,5379,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,9.57,,IC50,KIT D816V (exon 17),SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29093181,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf,INHIBITOR,,Tclin,2765,2764,Homo sapiens
218497,5379,4396,Mast/stem cell growth factor receptor Kit,Kinase,P05532,Kit,KIT_MOUSE,7.66,,IC50,Inhibition of KIT D816Y mutant autophosphorylation in P815 cell line,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/29093181,,INHIBITOR,,Tclin,2765,,Mus musculus
218499,5380,4397,Histone-lysine N-methyltransferase EZH2,Enzyme,Q15910,EZH2,EZH2_HUMAN,7.96,,IC50,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211723s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211723s000lbl.pdf,INHIBITOR,,Tclin,2766,2766,Homo sapiens
217428,5277,4111,Ileal sodium/bile acid cotransporter,Transporter,Q12908,SLC10A2,NTCP2_HUMAN,9.275724,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://dx.doi.org/10.1016/S0016-5085(10)61017-7,http://dx.doi.org/10.1016/S0016-5085(10)61017-7,INHIBITOR,,Tclin,2004,2004,Homo sapiens
217429,5276,1047,Cystic fibrosis transmembrane conductance regulator,Ion channel,P13569,CFTR,CFTR_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210491lbl.pdf,PHARMACOLOGICAL CHAPERONE,,Tclin,,2005,Homo sapiens
217430,5275,258,Somatostatin receptor type 2,GPCR,P30874,SSTR2,SSR2_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208700s000lbl.pdf,AGONIST,,Tclin,,2006,Homo sapiens
217431,5271,3193,Growth hormone secretagogue receptor type 1,GPCR,Q92847,GHSR,GHSR_HUMAN,7.81,,IC50,"In a radioligand displacement assay using <sup>125</sup>I-labeled ghrelin as the probe, and human pituitary gland samples.",IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9745,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205598s000lbl.pdf,AGONIST,,Tclin,2008,2007,Homo sapiens
217432,2717,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,6.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=213,,ANTAGONIST,,,,,Rattus norvegicus
217433,2781,1970,5-hydroxytryptamine receptor 3A,Ion channel,P23979,Htr3a,5HT3A_MOUSE,7.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2294,,ANTAGONIST,,,,,Mus musculus
217434,897,1970,5-hydroxytryptamine receptor 3A,Ion channel,P23979,Htr3a,5HT3A_MOUSE,5.26,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2298,,BLOCKER,,,,,Mus musculus
217435,2162,1970,5-hydroxytryptamine receptor 3A,Ion channel,P23979,Htr3a,5HT3A_MOUSE,4.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4051,,BLOCKER,,,,,Mus musculus
217436,660,1855,5-hydroxytryptamine receptor 4,GPCR,Q62758,Htr4,5HT4R_RAT,8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=240,,AGONIST,,,,,Rattus norvegicus
217437,1043,4017,5-hydroxytryptamine receptor 5A,Unclassified,P30966,Htr5a,5HT5A_MOUSE,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,ANTAGONIST,,,,,Mus musculus
215569,2601,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.41,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
217438,1775,4017,5-hydroxytryptamine receptor 5A,Unclassified,P30966,Htr5a,5HT5A_MOUSE,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,,,,Mus musculus
217439,3659,4017,5-hydroxytryptamine receptor 5A,Unclassified,P30966,Htr5a,5HT5A_MOUSE,6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,,,,Mus musculus
217440,1043,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,8.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,AGONIST,,,,,Rattus norvegicus
217441,1621,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,8.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=17,,AGONIST,,,,,Rattus norvegicus
217442,1588,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43,,AGONIST,,,,,Rattus norvegicus
217443,180,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200,,ANTAGONIST,,,,,Rattus norvegicus
217444,191,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,8.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=201,,ANTAGONIST,,,,,Rattus norvegicus
217445,888,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121,,ANTAGONIST,,,,,Rattus norvegicus
217446,1723,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,7.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133,,ANTAGONIST,,,,,Rattus norvegicus
217447,1775,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,6.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,,,,Rattus norvegicus
217448,1796,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,,ANTAGONIST,,,,,Rattus norvegicus
217449,722,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,,ANTAGONIST,,,,,Rattus norvegicus
217450,1613,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,7.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=205,,ANTAGONIST,,,,,Rattus norvegicus
217451,1982,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,8.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=47,,ANTAGONIST,,,,,Rattus norvegicus
217452,2389,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=96,,ANTAGONIST,,,,,Rattus norvegicus
217453,403,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35,,AGONIST,,,,,Rattus norvegicus
217454,1588,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,9.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43,,AGONIST,,,,,Rattus norvegicus
217455,2105,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=48,,AGONIST,,,,,Rattus norvegicus
217456,180,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200,,ANTAGONIST,,,,,Rattus norvegicus
217457,1524,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,6.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,,,,Rattus norvegicus
217458,1982,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=47,,ANTAGONIST,,,,,Rattus norvegicus
217459,2543,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,6.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=54,,ANTAGONIST,,,,,Rattus norvegicus
217460,1499,3933,Beta-3 adrenergic receptor,Unclassified,P25962,Adrb3,ADRB3_MOUSE,5.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=536,,AGONIST,,,,,Mus musculus
217461,431,3933,Beta-3 adrenergic receptor,Unclassified,P25962,Adrb3,ADRB3_MOUSE,6.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=570,,ANTAGONIST,,,,,Mus musculus
217462,2303,3933,Beta-3 adrenergic receptor,Unclassified,P25962,Adrb3,ADRB3_MOUSE,6.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=564,,ANTAGONIST,,,,,Mus musculus
217464,4186,4116,B1 bradykinin receptor,GPCR,P97583,Bdkrb1,BKRB1_RAT,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=667,,ANTAGONIST,,,,,Rattus norvegicus
217465,2780,505,Extracellular calcium-sensing receptor,GPCR,P41180,CASR,CASR_HUMAN,4.4,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=717,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
217466,1942,4102,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q01815,Cacna1c,CAC1C_MOUSE,8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2524,,GATING INHIBITOR,,,,,Mus musculus
217467,1937,1882,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,P27732,Cacna1d,CAC1D_RAT,6.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2523,,GATING INHIBITOR,,,,,Rattus norvegicus
217468,1942,4117,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q99246,Cacna1d,CAC1D_MOUSE,7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2524,,GATING INHIBITOR,,,,,Mus musculus
217469,2878,3945,Voltage-dependent N-type calcium channel subunit alpha-1B,Unclassified,Q02294,Cacna1b,CAC1B_RAT,10.3,,IC50,,IUPHAR,=,,,,,BLOCKER,,,,,Rattus norvegicus
217470,992,4054,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O54898,Cacna1g,CAC1G_RAT,7,,IC50,,IUPHAR,=,,,,,BLOCKER,,,,,Rattus norvegicus
217341,5256,2142,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,P42336,PIK3CA,PK3CA_HUMAN,9.301030158996582,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24170767,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209936s000lbl.pdf,INHIBITOR,,Tclin,690,691,Homo sapiens
215570,4115,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,8.408935393,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
217342,5256,704,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,9.154901504516602,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24170767,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209936s000lbl.pdf,INHIBITOR,,Tclin,690,691,Homo sapiens
217343,5256,2313,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Kinase,P42338,PIK3CB,PK3CB_HUMAN,8.431797981262207,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24170767,,INHIBITOR,,Tchem,690,,Homo sapiens
217344,5256,2314,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Kinase,P48736,PIK3CG,PK3CG_HUMAN,8.193819999694824,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24170767,,INHIBITOR,,Tclin,690,,Homo sapiens
217345,5257,397,Potassium channel subfamily K member 2,Ion channel,O95069,KCNK2,KCNK2_HUMAN,7.221848964691162,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21293470,,BLOCKER,,Tclin,692,,Homo sapiens
217346,1407,953,Acid-sensing ion channel 1,Ion channel,P78348,ASIC1,ASIC1_HUMAN,3.53,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/28949138,,BLOCKER,,Tchem,693,,Homo sapiens
217347,5259,2322,Cyclin-dependent kinase 4,Kinase,P11802,CDK4,CDK4_HUMAN,9.22184875,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24919854,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208716Orig1s000lbl.pdf,INHIBITOR,,Tclin,794,793,Homo sapiens
217348,5259,1950,Cyclin-dependent kinase 6,Kinase,Q00534,CDK6,CDK6_HUMAN,8.619788758,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24919854,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208716Orig1s000lbl.pdf,INHIBITOR,,Tclin,794,793,Homo sapiens
217349,5261,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,8.6,,Ki,Value based on agonist activity of latanoprost.,IUPHAR,~,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9635,http://www.ncbi.nlm.nih.gov/pubmed/21396362,AGONIST,,Tclin,,894,Homo sapiens
217350,5262,4109,DNA terminase complex,Enzyme,F5HC79|F5HCU8|F5HGI9,TRM1|TRM2|TRM3,TRM1_HCMVM|TRM2_HCMVM|TRM3_HCMVM,8.677780705,,EC50,,DRUG LABEL,=,1,DRUG LABEL,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209939Orig1s000,209940Orig1s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209939Orig1s000,209940Orig1s000lbl.pdf",INHIBITOR,,Tclin,994,994,Human cytomegalovirus (strain Merlin)
217352,5263,4110,Interleukin-5 receptor subunit alpha,Membrane receptor,Q01344,IL5RA,IL5RA_HUMAN,10.95860731,,Kd,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761070s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761070s000lbl.pdf,ANTIBODY BINDING,,Tclin,995,995,Homo sapiens
217353,5014,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.795880017,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,AGONIST,,Tclin,391,,Homo sapiens
217355,5014,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.200659451,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,AGONIST,,Tchem,391,,Homo sapiens
217357,5014,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.494850022,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,,,Tclin,391,,Homo sapiens
217358,5014,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.468521083,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,,,Tclin,391,,Homo sapiens
217359,5014,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.853871964,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,,,Tchem,391,,Homo sapiens
217360,5014,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.236572006,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,,,Tchem,391,,Homo sapiens
217361,5014,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.420216403,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,,,Tclin,391,,Homo sapiens
217362,5014,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.823908741,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,,,Tclin,391,,Homo sapiens
217363,5014,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.769551079,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,,,Tclin,391,,Homo sapiens
217364,5014,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,7.229147988,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,,,Tclin,391,,Homo sapiens
217365,5014,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.173925197,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,,,Tclin,391,,Homo sapiens
217366,5014,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.537602002,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,INHIBITOR,,Tclin,391,,Homo sapiens
217367,5014,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.8569852,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,INHIBITOR,,Tclin,391,,Homo sapiens
217368,5014,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.024568191,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,INHIBITOR,,Tclin,391,,Homo sapiens
217369,5267,1700,Glucagon-like peptide 1 receptor,GPCR,P43220,GLP1R,GLP1R_HUMAN,9.420216403,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26308095,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209637lbl.pdf,AGONIST,,Tclin,996,1096,Homo sapiens
217370,5269,713,Rho-associated protein kinase 2,Kinase,O75116,ROCK2,ROCK2_HUMAN,8.376751,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/27072905,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208254lbl.pdf,INHIBITOR,,Tclin,1097,1197,Homo sapiens
216941,1900,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.522878646850586,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22711801,,,,Tclin,659,,Homo sapiens
216942,331,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.864867210388184,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22711801,,,,Tclin,659,,Homo sapiens
216944,331,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.160521984100342,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22711801,,,,Tclin,659,,Homo sapiens
216945,331,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.263603687286377,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22711801,,,,Tclin,659,,Homo sapiens
216946,6,150,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,O15554,KCNN4,KCNN4_HUMAN,7.6,,IC50,,IUPHAR,=,,,,,BLOCKER,,Tchem,,,Homo sapiens
216947,6,907,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,O60840,CACNA1F,CAC1F_HUMAN,6,,IC50,,IUPHAR,~,,,,,GATING INHIBITOR,,Tclin,,,Homo sapiens
216948,6,1853,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,6,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,,,,Rattus norvegicus
216949,6,1960,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q02485,Cacna1s,CAC1S_RAT,6,,IC50,,IUPHAR,=,,,,,GATING INHIBITOR,,,,,Rattus norvegicus
216950,91,3939,P2X purinoceptor 2,Unclassified,P49653,P2rx2,P2RX2_RAT,5.85,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,AGONIST,,,,,Rattus norvegicus
216951,91,580,P2X purinoceptor 1,Ion channel,P51575,P2RX1,P2RX1_HUMAN,7.25,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,AGONIST,,Tchem,,,Homo sapiens
216952,91,4096,P2X purinoceptor 5,Unclassified,P51578,P2rx5,P2RX5_RAT,6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,AGONIST,,,,,Rattus norvegicus
216953,91,4095,P2X purinoceptor 6,Unclassified,P51579,P2rx6,P2RX6_RAT,6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,AGONIST,,,,,Rattus norvegicus
216954,91,3915,Transient receptor potential cation channel subfamily M member 4,Unclassified,Q7TN37,Trpm4,TRPM4_MOUSE,6.1,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,BLOCKER,,,,,Mus musculus
216955,91,2607,P2X purinoceptor 4,Ion channel,Q99571,P2RX4,P2RX4_HUMAN,6.3,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,AGONIST,,Tchem,,,Homo sapiens
216956,91,3977,P2X purinoceptor 4,Unclassified,Q9JJX6,P2rx4,P2RX4_MOUSE,6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,AGONIST,,,,,Mus musculus
216957,138,4068,Prostaglandin E2 receptor EP3 subtype,Unclassified,P34980,Ptger3,PE2R3_RAT,9.35,,EC50,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
216958,138,2152,Prostaglandin E2 receptor EP4 subtype,GPCR,P43114,Ptger4,PE2R4_RAT,9.2,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
216959,138,3975,Prostacyclin receptor,Unclassified,P43252,Ptgir,PI2R_MOUSE,7.5,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Mus musculus
216960,138,4093,Prostaglandin E2 receptor EP1 subtype,Unclassified,P70597,Ptger1,PE2R1_RAT,7,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
216961,138,2151,Prostaglandin E2 receptor EP2 subtype,GPCR,Q62928,Ptger2,PE2R2_RAT,8,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
216962,138,3273,Cation channel sperm-associated protein 4,Ion channel,Q7RTX7,CATSPER4,CTSR4_HUMAN,6.3,,EC50,Patch clamp electrophysiology.,IUPHAR,=,,,,,ACTIVATOR,,Tchem,,,Homo sapiens
216963,138,3272,Cation channel sperm-associated protein 3,Ion channel,Q86XQ3,CATSPER3,CTSR3_HUMAN,6.3,,EC50,Patch clamp electrophysiology.,IUPHAR,=,,,,,ACTIVATOR,,Tchem,,,Homo sapiens
216964,138,3270,Cation channel sperm-associated protein 1,Ion channel,Q8NEC5,CATSPER1,CTSR1_HUMAN,6.3,,EC50,Patch clamp electrophysiology,IUPHAR,=,,,,,ACTIVATOR,,Tchem,,,Homo sapiens
216965,138,3271,Cation channel sperm-associated protein 2,Ion channel,Q96P56,CATSPER2,CTSR2_HUMAN,6.3,,EC50,Patch clamp electrophysiology.,IUPHAR,=,,,,,ACTIVATOR,,Tchem,,,Homo sapiens
216966,158,4064,Sodium/hydrogen exchanger 5,Unclassified,Q14940,SLC9A5,SL9A5_HUMAN,4.68,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2421,,INHIBITOR,,,,,Homo sapiens
216967,176,4072,Sodium channel protein type 5 subunit alpha,Unclassified,P15389,Scn5a,SCN5A_RAT,5.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2566,,BLOCKER,,,,,Rattus norvegicus
216968,179,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=963,,ANTAGONIST,,,,,Rattus norvegicus
216969,180,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,8.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200,,ANTAGONIST,,,,,Rattus norvegicus
216970,180,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200,,ANTAGONIST,,,,,Rattus norvegicus
216971,180,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200,,ANTAGONIST,,,,,Mus musculus
216972,180,3990,G protein-activated inward rectifier potassium channel 2,Ion channel,P48542,Kcnj6,KCNJ6_MOUSE,4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=200,,BLOCKER,,,,,Mus musculus
216973,191,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,8.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=201,,ANTAGONIST,,,,,Rattus norvegicus
216974,191,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=201,,ANTAGONIST,,,,,Rattus norvegicus
216975,191,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=201,,ANTAGONIST,,,,,Rattus norvegicus
216976,242,1878,D(4) dopamine receptor,GPCR,P30729,Drd4,DRD4_RAT,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=34,,ANTAGONIST,,,,,Rattus norvegicus
216977,242,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=34,,AGONIST,,,,,Rattus norvegicus
216978,242,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=34,,AGONIST,,,,,Rattus norvegicus
216979,274,4091,Potassium voltage-gated channel subfamily KQT member 1,Unclassified,P97414,Kcnq1,KCNQ1_MOUSE,5.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2588,,BLOCKER,,,,,Mus musculus
216980,333,3963,Sodium-dependent neutral amino acid transporter B(0)AT1,Unclassified,Q695T7,SLC6A19,S6A19_HUMAN,4.36,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7601,,INHIBITOR,,,,,Homo sapiens
216981,343,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,5.14,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1967,,AGONIST,,Tclin,,,Homo sapiens
215867,5203,699,Poly [ADP-ribose] polymerase 1,Enzyme,P09874,PARP1,PARP1_HUMAN,8.5,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://dx.doi.org/10.1021/acs.jmedchem.6b00990,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209115s000lbl.pdf,INHIBITOR,,Tclin,629,628,Homo sapiens
215868,5203,34,Poly [ADP-ribose] polymerase 2,Enzyme,Q9UGN5,PARP2,PARP2_HUMAN,7.550000190734863,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://dx.doi.org/10.1021/acs.jmedchem.6b00990,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209115s000lbl.pdf,INHIBITOR,,Tclin,629,628,Homo sapiens
215869,5203,3508,Poly [ADP-ribose] polymerase 3,Enzyme,Q9Y6F1,PARP3,PARP3_HUMAN,6.389999866485596,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://dx.doi.org/10.1021/acs.jmedchem.6b00990,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209115s000lbl.pdf,INHIBITOR,,Tclin,629,628,Homo sapiens
215870,5203,3727,Poly [ADP-ribose] polymerase 4,Enzyme,Q9UKK3,PARP4,PARP4_HUMAN,6.079999923706055,,IC50,,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1021/acs.jmedchem.6b00990,,INHIBITOR,,,629,,Homo sapiens
215871,5203,2537,Tankyrase-1,Enzyme,O95271,TNKS,TNKS1_HUMAN,6.840000152587891,,IC50,,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1021/acs.jmedchem.6b00990,,INHIBITOR,,Tchem,629,,Homo sapiens
215872,5203,2365,Tankyrase-2,Enzyme,Q9H2K2,TNKS2,TNKS2_HUMAN,6.050000190734863,,IC50,,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1021/acs.jmedchem.6b00990,,INHIBITOR,,Tchem,629,,Homo sapiens
215874,5203,3728,Poly [ADP-ribose] polymerase 10,Enzyme,Q53GL7,PARP10,PAR10_HUMAN,6.25,,IC50,,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1021/acs.jmedchem.6b00990,,INHIBITOR,,,629,,Homo sapiens
215875,5203,3729,Poly [ADP-ribose] polymerase 12,Enzyme,Q9H0J9,PARP12,PAR12_HUMAN,5.179999828338623,,IC50,,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1021/acs.jmedchem.6b00990,,INHIBITOR,,,629,,Homo sapiens
215876,5203,3730,Poly [ADP-ribose] polymerase 14,Enzyme,Q460N5,PARP14,PAR14_HUMAN,5.050000190734863,,IC50,,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1021/acs.jmedchem.6b00990,,INHIBITOR,,,629,,Homo sapiens
215878,5203,3731,Poly [ADP-ribose] polymerase 15,Enzyme,Q460N3,PARP15,PAR15_HUMAN,4.489999771118164,,IC50,,SCIENTIFIC LITERATURE,=,,,http://dx.doi.org/10.1021/acs.jmedchem.6b00990,,INHIBITOR,,,629,,Homo sapiens
215879,5201,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,6.3098039627075195,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/20188549,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207695s000lbl.pdf,INHIBITOR,,Tclin|Tclin|Tclin|Tclin,630,631,Homo sapiens
215880,5202,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,8.229147911071777,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/20363976,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004085/WC500223723.pdf,INHIBITOR,,Tclin,632,648,Homo sapiens
215881,5202,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,8.244125366210938,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/20363976,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004085/WC500223723.pdf,INHIBITOR,,Tclin,632,648,Homo sapiens
215882,5202,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,7.275723934173584,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20363976,,INHIBITOR,,Tclin,632,,Homo sapiens
215883,5209,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,8.698969841003418,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22959248,http://www.ncbi.nlm.nih.gov/pubmed/22088449,INHIBITOR,,Tclin,633,634,Homo sapiens
215884,5210,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,8.036211967468262,,IC50,HCC827 cells expressing EGFR(DEL19),SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/27357069,http://www.ncbi.nlm.nih.gov/pubmed/27357069,INHIBITOR,,Tclin,635,635,Homo sapiens
215887,5208,36,Heat-stable enterotoxin receptor,Enzyme,P25092,GUCY2C,GUC2C_HUMAN,6.721246242523193,,EC50,Stimulation of cGMP synthesis in T84 cells,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26558155,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208745lbl.pdf,AGONIST,,Tclin,637,636,Homo sapiens
215890,4299,3496,Cytochrome P450 3A,Enzyme,P08684|P20815|P24462|Q9HB55,CYP3A4|CYP3A43|CYP3A5|CYP3A7,CP343_HUMAN|CP3A4_HUMAN|CP3A5_HUMAN|CP3A7_HUMAN,6.027334213256836,,Ki,Inactivation of Human Hepatic Microsomal CYP3A-Dependent Midazolam 1'-Hydroxylase Activity,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24900196,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203094s005lbl.pdf,INHIBITOR,,Tclin|Tclin|Tclin|Tclin,638,639,Homo sapiens
215891,5188,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,7.514278411865234,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/25676420,http://www.ncbi.nlm.nih.gov/pubmed/25676420,INHIBITOR,,Tclin,640,640,Homo sapiens
215892,5211,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,9,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21443688,http://www.ncbi.nlm.nih.gov/pubmed/21443688,INHIBITOR,,Tclin,641,641,Homo sapiens
215893,5211,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,6.367542743682861,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21443688,,INHIBITOR,,Tclin,641,,Homo sapiens
215894,5211,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7.886056423187256,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21443688,,INHIBITOR,,Tclin,641,,Homo sapiens
215895,5211,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.275723934173584,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21443688,,INHIBITOR,,Tclin,641,,Homo sapiens
215896,1736,2857,Muscarinic acetylcholine receptor,GPCR,P08172|P08173|P08912|P11229|P20309,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,ACM1_HUMAN|ACM2_HUMAN|ACM3_HUMAN|ACM4_HUMAN|ACM5_HUMAN,,,,,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D00721,http://www.kegg.jp/entry/D00721,ANTAGONIST,,Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
215897,2815,437,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q13698,CACNA1S,CAC1S_HUMAN,,,,,UNKNOWN,,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2406,BLOCKER,,Tclin,,,Homo sapiens
215898,1545,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D01847,http://www.kegg.jp/entry/D01847,ANTAGONIST,,Tclin,,,Homo sapiens
215899,2165,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D08374,http://www.kegg.jp/entry/D08374,INHIBITOR,,Tclin,,,Homo sapiens
215900,2165,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D08374,http://www.kegg.jp/entry/D08374,INHIBITOR,,Tclin,,,Homo sapiens
215863,5186,3726,Toxin B,Enzyme,P18177,toxB,TOXB_CLODI,9,,Kd,,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf,ANTIBODY BINDING,,,625,625,Clostridioides difficile
215865,5183,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,10.4,,Kd,BIAcore assay,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9172,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761038lbl.pdf,ANTIBODY BINDING,,Tclin,,624,Homo sapiens
215866,5179,2990,Interleukin-17 receptor,Membrane receptor,Q8NAC3|Q96F46,IL17RA|IL17RC,I17RA_HUMAN|I17RC_HUMAN,9.199999809265137,,Kd,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7540,http://www.ncbi.nlm.nih.gov/pubmed/22455412,ANTIBODY BINDING,,Tclin|Tclin,,626,Homo sapiens
215857,2370,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.835647106170654,,Kd,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9537821,,,,Tclin,623,,Homo sapiens
215858,616,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.97469425201416,,Kd,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9537821,,,,Tclin,623,,Homo sapiens
215859,616,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.84163761138916,,Kd,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9537821,,,,Tclin,623,,Homo sapiens
215860,916,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.4202165603637695,,Kd,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9537821,,,,Tclin,623,,Homo sapiens
215861,916,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.6575775146484375,,Kd,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9537821,,,,Tclin,623,,Homo sapiens
215538,5174,3022,Integrin alpha-L/beta-2,Adhesion,P05107|P20701,ITGAL|ITGB2,ITAL_HUMAN|ITB2_HUMAN,8.045757293701172,,IC50,inhibition of ICAM-1 binding to LFA-1 in HuT 78 cell line,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24900456,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208073s000lbl.pdf,ANTAGONIST,,Tclin|Tclin,615,616,Homo sapiens
215539,5001,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,7.259637355804443,,Ki,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206940s000lbl.pdf,,AGONIST,,,331,,Cavia porcellus
215540,4374,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.886056423187256,,Ki,,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208524s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208524s000lbl.pdf,AGONIST,,Tclin,617,617,Homo sapiens
215542,4374,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.8326826095581055,,Ki,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208524s000lbl.pdf,,,,Tclin,617,,Homo sapiens
215544,4374,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.036211967468262,,Ki,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208524s000lbl.pdf,,,,Tclin,617,,Homo sapiens
215545,5176,3652,uric acid,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125293s085lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125293s085lbl.pdf,OXIDATIVE ENZYME,,,619,619,
215546,5177,2940,T-cell surface glycoprotein CD3,Surface antigen,P04234|P07766|P09693,CD3D|CD3E|CD3G,CD3D_HUMAN|CD3E_HUMAN|CD3G_HUMAN,,,,Mechanism of Action,UNKNOWN,,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6889,ANTIBODY BINDING,,Tclin|Tclin|Tclin,,,Homo sapiens
215547,3325,2478,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,8.793173789978027,,EC50,GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24113750,,AGONIST,,Tchem,620,,Homo sapiens
215548,1889,2478,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,6.013228416442871,,EC50,GPR35a–beta-arrestin-2 interaction assays performed using a CHO–K1 cell line stably expressing human GPR35 and beta-arrestin-2,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24113750,,AGONIST,,Tchem,620,,Homo sapiens
215550,4353,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.193819999694824,,Ki,inhibition of [3H]-pyrilamine binding to human recombinant histamine H1-receptors,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/16274260,http://www.ncbi.nlm.nih.gov/pubmed/16274260,ANTAGONIST,,Tclin,118,118,Homo sapiens
215551,1005,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,4.3,,IC50,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6322,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6322,INHIBITOR,,Tclin,,,Homo sapiens
215553,1006,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,7.5,,IC50,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6332,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6332,INHIBITOR,,Tclin,,,Homo sapiens
215555,2741,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.698970004,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215556,621,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,9.552841969,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215557,1626,378,Melatonin receptor type 1A,GPCR,P48039,MTNR1A,MTR1A_HUMAN,9.537602002,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215558,2741,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,9.455931956,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215559,623,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.366531544,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215560,623,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,9.193820026,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215561,1211,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.065501549,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215562,403,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,8.86,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215563,820,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.853871964,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215564,1211,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.795880017,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215565,2332,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.721246399,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215566,820,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.698970004,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215567,3201,1208,"Glutamate receptor ionotropic, kainate 4",Ion channel,Q16099,GRIK4,GRIK4_HUMAN,8.640164518,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215568,2741,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.455931956,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215571,1707,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.27572413,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215572,2723,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8.270025714,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215573,1707,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.251811973,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215574,751,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.22184875,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215575,4115,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8.187086643,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215576,2346,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.124938737,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215577,1707,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.958607315,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215107,4399,2683,Thrombopoietin receptor,Membrane receptor,P40238,MPL,TPOR_HUMAN,7.42,,EC50,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6961,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6961,AGONIST,,Tclin,,,Homo sapiens
215118,5137,3024,Interferon alpha/beta receptor,Membrane receptor,P17181|P48551,IFNAR1|IFNAR2,INAR1_HUMAN|INAR2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125499s009lbl.pdf,AGONIST,,Tclin|Tclin,,586,Homo sapiens
215119,5139,3024,Interferon alpha/beta receptor,Membrane receptor,P17181|P48551,IFNAR1|IFNAR2,INAR1_HUMAN|INAR2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103628s5258lbl.pdf,AGONIST,,Tclin|Tclin,,587,Homo sapiens
215120,5140,3024,Interferon alpha/beta receptor,Membrane receptor,P17181|P48551,IFNAR1|IFNAR2,INAR1_HUMAN|INAR2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103471s5188lbl.pdf,AGONIST,,Tclin|Tclin,,588,Homo sapiens
215121,5141,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103172s5203lbl.pdf,ACTIVATOR,,Tclin,,589,Homo sapiens
215122,5142,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.300000190734863,,Ki,1 nM [3H]ketanserin binding in cell membranes,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/16469866,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207318lbl.pdf,INVERSE AGONIST,,Tclin,590,591,Homo sapiens
215123,5142,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.800000190734863,,Ki,3 nM [3H]mesulergine binding in cell membranes,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/16469866,,INVERSE AGONIST,,Tclin,590,,Homo sapiens
215124,5143,632,Catechol O-methyltransferase,Enzyme,P21964,COMT,COMT_HUMAN,9,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/24847974,http://www.ncbi.nlm.nih.gov/pubmed/24847974,INHIBITOR,,Tclin,592,592,Homo sapiens
215128,5149,337,Lutropin-choriogonadotropic hormone receptor,GPCR,P22888,LHCGR,LSHR_HUMAN,,,,,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201464,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201464,AGONIST,,Tclin,,,Homo sapiens
215129,1867,3702,Serine protease hepsin,Enzyme,P05981,HPN,HEPS_HUMAN,9.279999732971191,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264,,,,Tchem,,,Homo sapiens
215130,1867,3708,Hepatocyte growth factor activator,Enzyme,Q04756,HGFAC,HGFA_HUMAN,7.599999904632568,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264,,,,Tchem,,,Homo sapiens
215134,1996,3715,Monoacylglycerol lipase ABHD6,Enzyme,Q9BV23,ABHD6,ABHD6_HUMAN,7.320000171661377,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247,,,,Tchem,,,Homo sapiens
215136,2073,3711,Folate receptor alpha,Membrane receptor,P15328,FOLR1,FOLR1_HUMAN,7.380000114440918,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,Tchem,,,Homo sapiens
215139,2172,3716,Ubiquitin carboxyl-terminal hydrolase 1,Enzyme,O94782,USP1,UBP1_HUMAN,5.699999809265137,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,,,,Tchem,,,Homo sapiens
215140,2353,3711,Folate receptor alpha,Membrane receptor,P15328,FOLR1,FOLR1_HUMAN,7.820000171661377,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071,,,,Tchem,,,Homo sapiens
215141,2448,3717,Dipeptidyl peptidase 2,Enzyme,Q9UHL4,DPP7,DPP2_HUMAN,4.21999979019165,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1422,,,,Tchem,,,Homo sapiens
215142,2452,3718,Myeloblastin,Unclassified,P24158,PRTN3,PRTN3_HUMAN,6.46999979019165,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76688,,,,Tchem,,,Homo sapiens
215143,2697,3707,Krueppel-like factor 10,Unclassified,Q13118,KLF10,KLF10_HUMAN,4.300000190734863,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1324,,,,Tbio,,,Homo sapiens
215144,5110,3719,Alpha-galactosidase A,Enzyme,P06280,GLA,AGAL_HUMAN,7.150000095367432,,IC50,,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004059/WC500208434.pdf,PHARMACOLOGICAL CHAPERONE,,Tclin,,598,Homo sapiens
215098,5133,525,Apoptosis regulator Bcl-2,Cytosolic other,P10415,BCL2,BCL2_HUMAN,11,,Ki,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/23291630,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208573s000lbl.pdf,INHIBITOR,,Tclin,583,584,Homo sapiens
215099,5133,861,Bcl-2-like protein 1,Cytosolic other,Q07817,BCL2L1,B2CL1_HUMAN,7.318758964538574,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/23291630,,INHIBITOR,,Tchem,583,,Homo sapiens
215100,5133,3486,Apoptosis regulator Bcl-W,Cytosolic other,Q92843,BCL2L2,B2CL2_HUMAN,6.610834121704102,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/23291630,,INHIBITOR,,Tchem,583,,Homo sapiens
215102,2407,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941,,AGONIST,,Tclin,,,Homo sapiens
215104,2407,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,10.22,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941,AGONIST,,Tclin,,,Homo sapiens
215105,2407,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941,,AGONIST,,Tclin,,,Homo sapiens
215106,5135,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103532s5175lbl.pdf,HYDROLYTIC ENZYME,,,,585,
189280,1892,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021877s005lbl.pdf,OTHER,,,,452,
215031,5082,3690,aspargine,Amino acid,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103411s5180lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103411s5180lbl.pdf,HYDROLYTIC ENZYME,,,531,531,
215032,5080,2544,Genome polyprotein,Polyprotein,P27958,,POLG_HCVH,11.397939682006836,,EC50,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,INHIBITOR,,,532,532,Hepatitis C virus genotype 1a (isolate H)
215033,5080,2536,Genome polyprotein,Polyprotein,P26663,,POLG_HCVBK,11.522878646850586,,EC50,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,INHIBITOR,,,532,532,Hepatitis C virus genotype 1b (isolate BK)
215034,5080,3694,Genome polyprotein,Polyprotein,O39929,,POLG_HCVED,12.522878646850586,,EC50,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,INHIBITOR,,,532,532,Hepatitis C virus genotype 4a (isolate ED43)
215035,5081,2544,Genome polyprotein,Polyprotein,P27958,,POLG_HCVH,12.397939682006836,,EC50,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,INHIBITOR,,,532,532,Hepatitis C virus genotype 1a (isolate H)
215036,5081,2536,Genome polyprotein,Polyprotein,P26663,,POLG_HCVBK,12.301030158996582,,EC50,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,INHIBITOR,,,532,532,Hepatitis C virus genotype 1b (isolate BK)
215037,5081,3694,Genome polyprotein,Polyprotein,O39929,,POLG_HCVED,12.522878646850586,,EC50,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208261Orig1s000lbl.pdf,INHIBITOR,,,532,532,Hepatitis C virus genotype 4a (isolate ED43)
215038,2345,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D05679,http://www.kegg.jp/entry/D05679,AGONIST,,Tclin,,,Homo sapiens
215040,4867,2752,Potassium-transporting ATPase,Transporter,P20648|P51164,ATP4A|ATP4B,ATP4A_HUMAN|ATP4B_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2154989,http://www.ncbi.nlm.nih.gov/pubmed/2154989,INHIBITOR,,Tclin|Tclin,536,536,Homo sapiens
215042,3961,2752,Potassium-transporting ATPase,Transporter,P20648|P51164,ATP4A|ATP4B,ATP4A_HUMAN|ATP4B_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/11304936,http://www.ncbi.nlm.nih.gov/pubmed/11304936,INHIBITOR,,Tclin|Tclin,537,537,Homo sapiens
215044,642,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/9298526,http://www.ncbi.nlm.nih.gov/pubmed/9298526,BLOCKER,,Tclin|Tclin,539,539,Homo sapiens
215046,727,16,bile acids,Metabolite,,,,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/4859983,http://www.ncbi.nlm.nih.gov/pubmed/4859983,CHELATING AGENT,,,541,541,
215047,837,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2547493,http://www.ncbi.nlm.nih.gov/pubmed/2547493,BLOCKER,,Tclin|Tclin,543,543,Homo sapiens
215048,927,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D01228,http://www.kegg.jp/entry/D01228,INHIBITOR,,Tclin,,,Homo sapiens
215049,1631,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/8287905,BLOCKER,,Tclin|Tclin,,544,Homo sapiens
215051,1934,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/7898101,BLOCKER,,Tclin|Tclin,,545,Homo sapiens
215052,2960,3695,Nucleotide-binding oligomerization domain-containing protein 2,Cytosolic other,Q9HC29,NOD2,NOD2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000802/WC500026565.pdf,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000802/WC500026565.pdf,ACTIVATOR,,Tclin,546,546,Homo sapiens
215054,1763,2,iron,Inorganic material,,,,,,,Mechanism of Action (Fe3+ >> Fe2+),SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/10533013,http://www.ncbi.nlm.nih.gov/pubmed/10533013,OTHER,,,548,548,
215063,4099,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17213004,http://www.ncbi.nlm.nih.gov/pubmed/17213004,BLOCKER,,Tclin|Tclin,552,552,Homo sapiens
214976,5066,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/UCM200875.pdf,ACTIVATOR,,Tclin,,477,Homo sapiens
214977,5067,2484,Proteasome subunit beta type-5,Enzyme,P28074,PSMB5,PSB5_HUMAN,8.468521118164062,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/20160034,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208462lbl.pdf,INHIBITOR,,Tclin,479,478,Homo sapiens
214978,5067,2483,Proteasome subunit beta type-2,Enzyme,P49721,PSMB2,PSB2_HUMAN,5.455932140350342,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20160034,,INHIBITOR,,Tclin,479,,Homo sapiens
214979,5067,2482,Proteasome subunit beta type-1,Enzyme,P20618,PSMB1,PSB1_HUMAN,7.508638381958008,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20160034,,INHIBITOR,,Tclin,479,,Homo sapiens
214980,5068,1364,Synaptic vesicle glycoprotein 2A,Transporter,Q7L0J3,SV2A,SV2A_HUMAN,7.099999904632568,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/18500360,http://www.ncbi.nlm.nih.gov/pubmed/18500360,MODULATOR,,Tclin,480,480,Homo sapiens
189242,5031,1720,C-C chemokine receptor type 4,GPCR,P51679,CCR4,CCR4_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/22686619,ANTIBODY BINDING,,Tclin,,435,Homo sapiens
214981,5063,3575,Lymphocyte differentiation antigen CD38,Tumour-associated antigen,P28907,CD38,CD38_HUMAN,8.22,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7395,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/761036Orig1s000lbledt.pdf,ANTIBODY BINDING,,Tclin,,481,Homo sapiens
214982,5070,3690,aspargine,Amino acid,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/101063s5169lbl.pdf,HYDROLYTIC ENZYME,,,,482,
214983,5071,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125547s000lbl.pdf,ANTIBODY BINDING,,Tclin,,483,Homo sapiens
214984,2437,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/1982751,ANTAGONIST,,Tclin,,485,Homo sapiens
214985,3579,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/13499132,ANTAGONIST,,Tclin,,487,Homo sapiens
214986,1852,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/13757612,ANTAGONIST,,Tclin,,488,Homo sapiens
214987,2131,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/17404836,INHIBITOR,,Tclin,,489,Homo sapiens
214988,2131,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/17404836,INHIBITOR,,Tclin,,489,Homo sapiens
214990,4865,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/5889715,INHIBITOR,,Tclin,,490,Homo sapiens
214992,4865,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/5889715,INHIBITOR,,Tclin,,490,Homo sapiens
214993,2152,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,BLOCKER,,Tclin,,,Homo sapiens
214994,2152,139,Sodium channel protein type 3 subunit alpha,Ion channel,Q9NY46,SCN3A,SCN3A_HUMAN,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,BLOCKER,,Tclin,,,Homo sapiens
214995,2152,141,Sodium channel protein type 8 subunit alpha,Ion channel,Q9UQD0,SCN8A,SCN8A_HUMAN,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,BLOCKER,,Tclin,,,Homo sapiens
214996,2152,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,BLOCKER,,Tclin,,,Homo sapiens
214997,5072,3691,SLAM family member 7,Membrane receptor,Q9NQ25,SLAMF7,SLAF7_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/761035s000lbl.pdf,ANTIBODY BINDING,,Tclin,,493,Homo sapiens
214998,934,2311,Transient receptor potential cation channel subfamily M member 8,Ion channel,Q7Z2W7,TRPM8,TRPM8_HUMAN,4.6,,EC50,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2430,http://www.ncbi.nlm.nih.gov/pubmed/15306801,ACTIVATOR,,Tclin,,494,Homo sapiens
215000,2291,445,Potassium voltage-gated channel subfamily A member 5,Ion channel,P22460,KCNA5,KCNA5_HUMAN,4.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2561,,BLOCKER,,Tclin,,,Homo sapiens
215001,839,2,iron,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020212s017lbl.pdf,CHELATING AGENT,,,,500,
215002,4937,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.318758964538574,,IC50,time-resolved fluorescence resonance energy transfer assay to examine each compound’s ability to phosphorylate substrate peptide Biotin-EGPWLEEEEEAYGWMDF in the presence of the drug and 30 umol/L ATP,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25349307,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208434s000lbl.pdf,INHIBITOR,,Tclin,504,503,Homo sapiens
215003,5077,341,Prostacyclin receptor,GPCR,P43119,PTGIR,PI2R_HUMAN,7.698969841003418,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26291199,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207947s000lbl.pdf,AGONIST,,Tclin,506,507,Homo sapiens
189273,2206,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,7.408935546875,,Ki,Monoamine oxidase A (human liver form) inhibitor induced spectral changes,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/12781338,http://www.ncbi.nlm.nih.gov/pubmed/9368911,INHIBITOR,,Tclin,445,444,Homo sapiens
189274,5046,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,9.045757293701172,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/24900486,http://www.ncbi.nlm.nih.gov/pubmed/22084396,INHIBITOR,,Tclin,446,456,Homo sapiens
189275,5047,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,9.187087059020996,,EC50,PPRE-luc transactivation assay in HepG2 cells transfected with hPPAR-alpha and hPPAR-gamma receptors,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/26171220,http://www.ncbi.nlm.nih.gov/pubmed/26171220,AGONIST,,Tclin,448,448,Homo sapiens
189276,5047,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,8.522878646850586,,EC50,PPRE-luc transactivation assay in HepG2 cells transfected with hPPAR-alpha and hPPAR-gamma receptors,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/26171220,http://www.ncbi.nlm.nih.gov/pubmed/26171220,AGONIST,,Tclin,448,448,Homo sapiens
189277,5048,788,Histamine H3 receptor,GPCR,Q9Y5N1,HRH3,HRH3_HUMAN,9.795880317687988,,Ki,[35S]GTP-gamma-S binding in HEK-293 cells stably expressing the human H3,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17005916,http://www.ncbi.nlm.nih.gov/pubmed/21615387,INVERSE AGONIST,,Tclin,449,450,Homo sapiens
189278,5051,3668,collagen,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125338s085s087s088lbl.pdf,HYDROLYTIC ENZYME,,,,451,
189281,5052,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.468521118164062,,Ki,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,PARTIAL AGONIST,,Tclin,454,454,Homo sapiens
189282,5052,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.769551277160645,,Ki,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,PARTIAL AGONIST,,Tclin,454,454,Homo sapiens
189284,5052,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.468521118164062,,Ki,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,ANTAGONIST,,Tclin,454,454,Homo sapiens
189285,5052,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.09691047668457,,Ki,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,,,,Tclin,454,,Homo sapiens
189286,5052,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.3565473556518555,,Ki,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,,,,Tchem,454,,Homo sapiens
189287,5052,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.823908805847168,,Ki,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,,,,Tclin,454,,Homo sapiens
189289,5052,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.408935546875,,Ki,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,,,,Tclin,454,,Homo sapiens
189290,5052,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.214670181274414,,Ki,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,,,,Tclin,454,,Homo sapiens
189292,999,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.886056900024414,,Ki,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20706slr011_emadine_lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20706slr011_emadine_lbl.pdf,ANTAGONIST,,Tclin,457,457,Homo sapiens
189294,5054,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,9.09691047668457,,Ki,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/24660890,http://www.ncbi.nlm.nih.gov/pubmed/24660890,INHIBITOR,,Tclin,458,458,Homo sapiens
189295,5056,3669,potassium,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205739s000lbl.pdf,CHELATING AGENT,,,,459,
189296,5057,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021629s030lbl.pdf,AGONIST,,Tclin,,462,Homo sapiens
189222,5022,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,9,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/12177684,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022526lbl.pdf,AGONIST,,Tclin,416,417,Homo sapiens
189223,5022,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.3098039627075195,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/12177684,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022526lbl.pdf,ANTAGONIST,,Tclin,416,417,Homo sapiens
189224,5022,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.397939682006836,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/12177684,,ANTAGONIST,,Tchem,416,,Homo sapiens
189225,5022,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.515700340270996,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/12177684,,,,Tclin,416,,Homo sapiens
189227,5022,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.43889856338501,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/12177684,,,,Tclin,416,,Homo sapiens
189230,5022,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.0491485595703125,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20840530,,ANTAGONIST,,Tclin,418,,Homo sapiens
189231,5022,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.054039478302002,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20840530,,ANTAGONIST,,Tclin,418,,Homo sapiens
189232,5022,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.092588424682617,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20840530,,,,Tchem,418,,Homo sapiens
189233,4496,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.34,,Ki,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986,INVERSE AGONIST,,Tclin,,,Homo sapiens
189235,626,221,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,4.522878646850586,,EC50,Chlorzoxazone-stimulated activity of BK(Ca) channels in neuroblastoma IMR-32 cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/12480161,http://www.ncbi.nlm.nih.gov/pubmed/12480161,OPENER,,Tclin,423,423,Homo sapiens
189236,5026,3005,Interleukin-11 receptor,Membrane receptor,P40189|Q14626,IL11RA|IL6ST,I11RA_HUMAN|IL6RB_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103694s1008lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103694s1008lbl.pdf,AGONIST,,Tclin|Tclin,425,425,Homo sapiens
189237,5027,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,9.180456161499023,,Ki,CHO cells expressing the human NK1 receptor,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/22497992,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206500s000lbl.pdf,ANTAGONIST,,Tclin,430,431,Homo sapiens
189238,5028,3660,Triglycerides,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004004/WC500192715.pdf,HYDROLYTIC ENZYME,,,,432,
189239,5028,3659,Cholesteryl esters,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004004/WC500192715.pdf,HYDROLYTIC ENZYME,,,,432,
189240,5025,3003,Granulocyte macrophage colony-stimulating factor receptor,Membrane receptor,P15509|P32927,CSF2RA|CSF2RB,CSF2R_HUMAN|IL3RB_HUMAN,8.301030158996582,,Kd,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2001448,http://www.ncbi.nlm.nih.gov/pubmed/2001448,AGONIST,,Tclin|Tclin,433,433,Homo sapiens
189241,5030,3662,glycogen,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125141s219lbl.pdf,HYDROLYTIC ENZYME,,,,434,
189243,5033,3663,hyaluronic acid,Metabolite,,,,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021665s005lbl.pdf,HYDROLYTIC ENZYME,,,,436,
189244,4731,2760,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,P18507|P47869|P47870,GABRA2|GABRB2|GABRG2,GBRA2_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,6.886056423187256,,IC50,inhibition of GABA-induced Cl- current in human GABAA receptor expressed in Xenopus oocytes,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/17234181,,NEGATIVE MODULATOR,,Tclin|Tclin|Tclin,437,,Homo sapiens
189245,4731,2804,GABA A receptor alpha-1/beta-1/gamma-2,Ion channel,P14867|P18505|P18507,GABRA1|GABRB1|GABRG2,GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN,6.823908805847168,,IC50,inhibition of GABA-induced Cl- current in human GABAA receptor expressed in Xenopus oocytes,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/17234181,,NEGATIVE MODULATOR,,Tclin|Tclin|Tclin,437,,Homo sapiens
189246,4731,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,6.698969841003418,,IC50,inhibition of GABA-induced Cl- current in human GABAA receptor expressed in Xenopus oocytes,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/17234181,,NEGATIVE MODULATOR,,Tclin|Tclin|Tclin,437,,Homo sapiens
189247,1739,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,4.409999847412109,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26056160,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,438,,Homo sapiens
189248,1739,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,4.519999980926514,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26056160,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,438,,Homo sapiens
189249,1739,2760,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,P18507|P47869|P47870,GABRA2|GABRB2|GABRG2,GBRA2_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,4.610000133514404,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26056160,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,438,,Homo sapiens
189250,1739,2793,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,P18507|P34903|P47870,GABRA3|GABRB2|GABRG2,GBRA3_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,4.309999942779541,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26056160,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,438,,Homo sapiens
189251,1739,2796,GABA A receptor alpha-4/beta-2/delta,Ion channel,O14764|P47870|P48169,GABRA4|GABRB2|GABRD,GBRA4_HUMAN|GBRB2_HUMAN|GBRD_HUMAN,4.170000076293945,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26056160,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,438,,Homo sapiens
189252,1739,3664,GABA A receptor alpha-4/beta-3/delta,Ion channel,O14764|P28472|P48169,GABRA4|GABRB3|GABRD,GBRA4_HUMAN|GBRB3_HUMAN|GBRD_HUMAN,3.9100000858306885,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26056160,,AGONIST,,Tclin|Tclin|Tclin,438,,Homo sapiens
189208,2738,3,copper,Inorganic material,,,,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/6121964,http://www.ncbi.nlm.nih.gov/pubmed/6121964,CHELATING AGENT,,,398,398,
189209,5016,3654,Proprotein convertase subtilisin/kexin type 9,Enzyme,Q8NBP7,PCSK9,PCSK9_HUMAN,9.42,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6744,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125559Orig1s000lbl.pdf,INHIBITOR,,Tclin,,403,Homo sapiens
189210,5017,3011,"Interleukin-1 receptor, type I",Membrane receptor,P14778|Q9NPH3,IL1R1|IL1RAP,IL1AP_HUMAN|IL1R1_HUMAN,7.820000171661377,,Kd,Mechanism of Action,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6972,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103950s5150lbl.pdf,ANTAGONIST,,Tclin|Tclin,,402,Homo sapiens
189211,5018,3658,globotriaosylceramide (GL-3),Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103979s5135lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/103979s5135lbl.pdf,HYDROLYTIC ENZYME,,,405,405,
189213,4002,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,"CAROPPO, R, EFFECT OF NIPEROTIDINE ON HYDROGEN-ION SECRETION AND ELECTRICAL PARAMETERS OF ISOLATED ASTRIC-MUCOSA, Curr. Ther. Res.-Clin. Exp., 1990, 48, 1, 20-29","CAROPPO, R, EFFECT OF NIPEROTIDINE ON HYDROGEN-ION SECRETION AND ELECTRICAL PARAMETERS OF ISOLATED ASTRIC-MUCOSA, Curr. Ther. Res.-Clin. Exp., 1990, 48, 1, 20-29",ANTAGONIST,,Tclin,406,406,Homo sapiens
189214,4945,607,Gastrin/cholecystokinin type B receptor,GPCR,P32239,CCKBR,GASR_HUMAN,8.8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3551,,AGONIST,,Tclin,,,Homo sapiens
189216,5021,3658,globotriaosylceramide (GL-3),Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000369/WC500053612.pdf,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000369/WC500053612.pdf,HYDROLYTIC ENZYME,,,407,407,
189217,1394,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,5.528708457946777,,EC50,(S) enantiomer activation of hTAAR1 in RD-HGA16 cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22037049,http://www.ncbi.nlm.nih.gov/pubmed/22037049,AGONIST,,Tclin,409,409,Homo sapiens
189219,195,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,6.221848964691162,,EC50,(S) enantiomer activation of hTAAR1 in RD-HGA16 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22037049,,AGONIST,,Tclin,409,,Homo sapiens
189221,2105,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.46999979019165,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/20600305,"http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19385slr030,031,035_permax_lbl.pdf",AGONIST,,Tclin,395,413,Homo sapiens
189187,5012,384,Neprilysin,Enzyme,P08473,MME,NEP_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207620Orig1s000lbl.pdf,INHIBITOR,,Tclin,,384,Homo sapiens
189188,5013,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,8.397939682006836,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21186796,http://www.ncbi.nlm.nih.gov/pubmed/26115728,INHIBITOR,,Tclin,386,387,Homo sapiens
189190,2697,632,Catechol O-methyltransferase,Enzyme,P21964,COMT,COMT_HUMAN,9.568635940551758,,Ki,,SCIENTIFIC LITERATURE,=,1,CHEMBL,http://www.ncbi.nlm.nih.gov/pubmed/7703232,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1324,INHIBITOR,,Tclin,389,,Homo sapiens
189192,1018,632,Catechol O-methyltransferase,Enzyme,P21964,COMT,COMT_HUMAN,9.522878646850586,,Ki,,SCIENTIFIC LITERATURE,=,1,CHEMBL,http://www.ncbi.nlm.nih.gov/pubmed/7703232,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL953,INHIBITOR,,Tclin,389,,Homo sapiens
189193,1431,344,Farnesyl pyrophosphate synthase,Enzyme,P14324,FDPS,FPPS_HUMAN,7.522878646850586,,IC50,inhibition of human recombinant FPP synthase,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/11160603,http://www.ncbi.nlm.nih.gov/pubmed/11160603,INHIBITOR,,Tclin,390,390,Homo sapiens
189194,5014,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.522878646850586,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24947465,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf,AGONIST,,Tclin,391,392,Homo sapiens
189195,5014,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.95860767364502,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,AGONIST,,Tclin,391,,Homo sapiens
189196,5014,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,9.920818328857422,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24947465,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf,AGONIST,,Tclin,391,392,Homo sapiens
189198,5014,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.327901840209961,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24947465,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205422s000lbl.pdf,ANTAGONIST,,Tclin,391,392,Homo sapiens
189199,5014,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.721246719360352,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,ANTAGONIST,,Tclin,391,,Homo sapiens
189200,5014,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,9.769551277160645,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,ANTAGONIST,,Tclin,391,,Homo sapiens
189201,5014,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,9.229147911071777,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,ANTAGONIST,,Tclin,391,,Homo sapiens
189202,5014,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.721246242523193,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,ANTAGONIST,,Tclin,391,,Homo sapiens
189204,5014,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,8.431797981262207,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,ANTAGONIST,,Tclin,391,,Homo sapiens
189205,5014,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.585026741027832,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24947465,,ANTAGONIST,,Tclin,391,,Homo sapiens
189206,5015,2710,Growth hormone receptor,GPCR,P10912,GHR,GHR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021106s036lbl.pdf,ANTAGONIST,,Tclin,,393,Homo sapiens
189118,1293,719,Dihydropyrimidine dehydrogenase [NADP(+)],Enzyme,Q12882,DPYD,DPYD_HUMAN,6.638272285461426,,Ki,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/3114201,http://www.ncbi.nlm.nih.gov/pubmed/21668582,INHIBITOR,,Tclin,280,279,Homo sapiens
189119,2002,3650,Uridine 5'-monophosphate synthase,Enzyme,P11172,UMPS,UMPS_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/8862723,http://www.ncbi.nlm.nih.gov/pubmed/8862723,INHIBITOR,,Tclin,281,281,Homo sapiens
189120,4172,2926,"Hepatitis C virus serine protease, NS3/NS4A",Enzyme,A3EZI9|D2K2A8,NS3|NS4A,A3EZI9_9HEPC|D2K2A8_9HEPC,8.95860767364502,,Ki,Inhibition of HCV 1a NS3/4A protease,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394,INHIBITOR,,,,,Hepatitis C virus
189121,4220,652,Protein P,Polyprotein,Q9IF40,P,Q9IF40_HBV,5.886056423187256,,EC50,first strand synthesis,DRUG LABEL,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022011s013lbl.pdf,INHIBITOR,,,8,290,Hepatitis B virus
189122,237,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/8723169,http://www.ncbi.nlm.nih.gov/pubmed/8723169,AGONIST,,Tclin,291,291,Homo sapiens
189123,4988,3651,Cell membrane,Cell membrane,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206333Orig1s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206333Orig1s000lbl.pdf,OTHER,,,294,294,
189124,2484,3261,Taste receptor type 2 member 46,GPCR,P59540,TAS2R46,T2R46_HUMAN,6.3665313720703125,,EC50,calcium imaging in ransfected human embryonic kidney (HEK)-293T,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20022913,,AGONIST,,Tbio,276,,Homo sapiens
189125,4989,3404,glucocerebroside,Metabolite,,,,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022575s012lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022575s012lbl.pdf,HYDROLYTIC ENZYME,,,295,295,
189126,4990,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,,,,microtubule destabilizing agent maytansine derivative,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125427s033lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125427s033lbl.pdf,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,296,296,Homo sapiens
189127,4990,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,,,,binding to sub-domain IV of the HER2 receptor,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125427s033lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125427s033lbl.pdf,ANTIBODY BINDING,,Tclin,296,296,Homo sapiens
189128,4991,3648,Granulocyte colony-stimulating factor receptor,Membrane receptor,Q99062,CSF3R,CSF3R_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002556/WC500148380.pdf,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002556/WC500148380.pdf,ACTIVATOR,,Tclin,299,299,Homo sapiens
189129,4993,2752,Potassium-transporting ATPase,Transporter,P20648|P51164,ATP4A|ATP4B,ATP4A_HUMAN|ATP4B_HUMAN,8,,Ki,[14C]TAK-438 binding,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21828261,http://www.ncbi.nlm.nih.gov/pubmed/21828261,INHIBITOR,,Tclin|Tclin,301,301,Homo sapiens
189130,4994,3652,uric acid,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103946s5083lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/103946s5083lbl.pdf,OXIDATIVE ENZYME,,,302,302,
180664,4973,619,Histone deacetylase 3,Enzyme,O15379,HDAC3,HDAC3_HUMAN,7.173925399780273,,IC50,HDAC enzyme inhibition assay using BSA substrate,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22080169,http://www.ncbi.nlm.nih.gov/pubmed/22080169,INHIBITOR,,Tclin,243,243,Homo sapiens
189131,81,2857,Muscarinic acetylcholine receptor,GPCR,P08172|P08173|P08912|P11229|P20309,CHRM1|CHRM2|CHRM3|CHRM4|CHRM5,ACM1_HUMAN|ACM2_HUMAN|ACM3_HUMAN|ACM4_HUMAN|ACM5_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/1696381,http://www.ncbi.nlm.nih.gov/pubmed/1696381,AGONIST,,Tclin|Tclin|Tclin|Tclin|Tclin,307,307,Homo sapiens
189132,6,236,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,8.4,,IC50,Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells,IUPHAR,=,1,IUPHAR,,,GATING INHIBITOR,,Tclin,,,Homo sapiens
189133,4918,3653,glycosaminoglycans,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125151s0184lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125151s0184lbl.pdf,HYDROLYTIC ENZYME,,,321,321,
189136,4995,3397,Erythropoietin receptor,Membrane receptor,P19235,EPOR,EPOR_HUMAN,11.15,,IC50,Assay performed using recombinant human EPO,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4921,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103234s5323lbl.pdf,AGONIST,,Tclin,,322,Homo sapiens
189138,1112,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,7.3,,IC50,Note: enzyme subunit is not specified in the referenced article,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6815,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL44657,INHIBITOR,,Tclin,,,Homo sapiens
189139,4996,2683,Thrombopoietin receptor,Membrane receptor,P40238,MPL,TPOR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125268s141lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125268s141lbl.pdf,AGONIST,,Tclin,323,323,Homo sapiens
189140,4997,3653,glycosaminoglycans,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125058s220lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125058s220lbl.pdf,HYDROLYTIC ENZYME,,,324,324,
189141,4999,3653,glycosaminoglycans,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125460s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125460s000lbl.pdf,HYDROLYTIC ENZYME,,,326,326,
189142,5001,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,8.769551277160645,,Ki,Recombinantly expressed human mu OR,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/22671931,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206940s000lbl.pdf,AGONIST,,Tclin,328,331,Homo sapiens
189143,5001,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,7.259637355804443,,Ki,Recombinantly expressed human kappa OR,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22671931,,AGONIST,,Tclin,328,,Homo sapiens
189145,5001,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,8.886056900024414,,Ki,equivalent to DPDPE in human SK-N-BE cells,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/22671931,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206940s000lbl.pdf,ANTAGONIST,,Tclin,328,331,Homo sapiens
189146,1819,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022572s003lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022572s003lbl.pdf,OTHER,,,329,329,
189147,5002,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020563s124lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020563s124lbl.pdf,AGONIST,,Tclin,330,330,Homo sapiens
189148,5003,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018780s150lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018780s150lbl.pdf,AGONIST,,Tclin,332,332,Homo sapiens
189112,2063,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,8.301030158996582,,IC50,recombinant human cyclooxygenase,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/10794682,http://www.ncbi.nlm.nih.gov/pubmed/10794682,INHIBITOR,,Tclin,271,271,Homo sapiens
189113,2063,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,3.853872060775757,,IC50,recombinant human cyclooxygenase,SCIENTIFIC LITERATURE,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
189114,4189,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,7.663540363311768,,IC50,human recombinant PR-B isoform in Sf9 cells,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/18060946,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021945s005lbl.pdf,AGONIST,,Tclin,272,273,Homo sapiens
189115,4986,3648,Granulocyte colony-stimulating factor receptor,Membrane receptor,Q99062,CSF3R,CSF3R_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/125031s082lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/125031s082lbl.pdf,ACTIVATOR,,Tclin,274,274,Homo sapiens
189116,4987,3648,Granulocyte colony-stimulating factor receptor,Membrane receptor,Q99062,CSF3R,CSF3R_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103353s5184lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103353s5184lbl.pdf,ACTIVATOR,,Tclin,275,275,Homo sapiens
189117,1193,3250,Taste receptor type 2 member 14,GPCR,Q9NYV8,TAS2R14,T2R14_HUMAN,6.863279342651367,,EC50,calcium imaging in ransfected human embryonic kidney (HEK)-293T,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20022913,,AGONIST,,Tbio,276,,Homo sapiens
180685,4976,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016466s046lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016466s046lbl.pdf,AGONIST,,Tclin,254,254,Homo sapiens
180689,4112,445,Potassium voltage-gated channel subfamily A member 5,Ion channel,P22460,KCNA5,KCNA5_HUMAN,5.63,,IC50,Inhibition of human Kv1.5 channel expressed in HEK293 cells by whole cell patch clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL184412,,,,Tclin,,,Homo sapiens
180690,4112,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.5,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL184412,,,,Tclin,,,Homo sapiens
180691,1948,2827,Soluble guanylate cyclase,Enzyme,O75343|P33402|Q02108|Q02153,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,GCYA2_HUMAN|GCYA3_HUMAN|GCYB1_HUMAN|GCYB2_HUMAN,,,,Mechanism of Action; CHEMBL2111348; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200689,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200689,ACTIVATOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
180692,1344,3412,Voltage-gated potassium channel,Ion channel,O43525|O43526|O95259|P16389|P17658|P22001|P22459|P22460|P48547|P51787|P56696|Q03721|Q09470|Q12809|Q14003|Q14721|Q16322|Q6PIU1|Q8NCM2|Q8TAE7|Q8TDN1|Q8TDN2|Q92953|Q96KK3|Q96L42|Q96PR1|Q96RP8|Q9BQ31|Q9H252|Q9H3M0|Q9NR82|Q9NS40|Q9NSA2|Q9NZV8|Q9UIX4|Q9UJ96|Q9UK17|Q9ULD8|Q9ULS6|Q9UQ05,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,KCA10_HUMAN|KCNA1_HUMAN|KCNA2_HUMAN|KCNA3_HUMAN|KCNA4_HUMAN|KCNA5_HUMAN|KCNA6_HUMAN|KCNA7_HUMAN|KCNB1_HUMAN|KCNB2_HUMAN|KCNC1_HUMAN|KCNC2_HUMAN|KCNC3_HUMAN|KCNC4_HUMAN|KCND1_HUMAN|KCND2_HUMAN|KCND3_HUMAN|KCNF1_HUMAN|KCNG1_HUMAN|KCNG2_HUMAN|KCNG3_HUMAN|KCNG4_HUMAN|KCNH1_HUMAN|KCNH2_HUMAN|KCNH3_HUMAN|KCNH4_HUMAN|KCNH5_HUMAN|KCNH6_HUMAN|KCNH7_HUMAN|KCNH8_HUMAN|KCNQ1_HUMAN|KCNQ2_HUMAN|KCNQ3_HUMAN|KCNQ4_HUMAN|KCNQ5_HUMAN|KCNS1_HUMAN|KCNS2_HUMAN|KCNS3_HUMAN|KCNV1_HUMAN|KCNV2_HUMAN,,,,Mechanism of Action; CHEMBL2362996; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL821,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL821,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
180693,1319,1537,Sodium- and chloride-dependent glycine transporter 1,Transporter,P48067,SLC6A9,SC6A9_HUMAN,4.5,,IC50,Inhibition of GlyT1 (unknown origin) assessed as inhibition of [14C]glycine uptake,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL773,,,,Tchem,,,Homo sapiens
180694,1319,1372,"Glutamate receptor ionotropic, NMDA 1",Ion channel,P35439,Grin1,NMDZ1_RAT,6.6,,IC50,In vitro inhibitory activity to inhibit [3H]glycine binding to NMDA receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL773,,,,,,,Rattus norvegicus
180695,1319,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,6.77,,Ki,"Affinity for the glycine binding site of NMDA receptor by inhibition of [3H]5,7-dichlorokynurenic acid ([3H]DCKA) binding to rat brain synaptic membrane",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL773,,,,,,,Rattus norvegicus
180696,58,3413,Urease,Enzyme,P07374,,UREA_CANEN,4.76,,IC50,Inhibition of jack bean urease,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL734,,,,,,,Canavalia ensiformis
180697,58,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,4.33,,IC50,Inhibitory activity against carbonic anhydrase II,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL734,,,,Tclin,,,Homo sapiens
180698,58,2747,Bacterial urease,Enzyme,Q03282|Q03283|Q03284,ureA|ureB|ureC,URE1_ECOLX|URE2_ECOLX|URE3_ECOLX,,,,Mechanism of Action; CHEMBL2364683; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL734,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL734,INHIBITOR,,,,,Escherichia coli
180699,1399,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,4.51,,Ki,Inhibition of human CA5a,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL467,,,,Tclin,,,Homo sapiens
180700,1399,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,4.64,,Ki,Inhibition of human CA9,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL467,,,,Tclin,,,Homo sapiens
180701,1399,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,4.55,,Ki,Inhibition of human CA2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL467,,,,Tclin,,,Homo sapiens
180702,1233,2889,Alcohol dehydrogenase,Enzyme,P00327|P00328,,ADH1E_HORSE|ADH1S_HORSE,7.89,,Kd,Inhibition of horse liver alcohol dehydrogenase using ethanol as substrate assessed as dissociation constant by spectrophotometric titration in presence of 1 mM NAD+,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1308,,,,,,,Equus caballus
180703,1233,2743,Alcohol dehydrogenase,Enzyme,P00325|P00326|P07327,ADH1A|ADH1B|ADH1C,ADH1A_HUMAN|ADH1B_HUMAN|ADH1G_HUMAN,,,,Mechanism of Action; CHEMBL2363044; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1308,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1308,INHIBITOR,,Tclin|Tclin|Tclin,,,Homo sapiens
180706,759,1372,"Glutamate receptor ionotropic, NMDA 1",Ion channel,P35439,Grin1,NMDZ1_RAT,5.13,,IC50,In vitro inhibitory activity to inhibit [3H]glycine binding to NMDA receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771,,,,,,,Rattus norvegicus
180707,759,1839,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,Q00961,Grin2c,NMDE3_RAT,4.74,,EC50,Compound was evaluated for in vitro inhibition of [3H]TCP at NMDA receptor.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771,,,,,,,Rattus norvegicus
180657,342,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/1281221,http://www.ncbi.nlm.nih.gov/pubmed/1281221,BLOCKER,,Tclin,240,240,Homo sapiens
180658,342,236,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/1281221,http://www.ncbi.nlm.nih.gov/pubmed/1281221,BLOCKER,,Tclin,240,240,Homo sapiens
180659,4177,215,Voltage-dependent calcium channel subunit alpha-2/delta-1,Ion channel,P54289,CACNA2D1,CA2D1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21651903,http://www.ncbi.nlm.nih.gov/pubmed/21651903,MODULATOR,,Tclin,60,60,Homo sapiens
180660,4177,1030,Voltage-dependent calcium channel subunit alpha-2/delta-2,Ion channel,Q9NY47,CACNA2D2,CA2D2_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21651903,http://www.ncbi.nlm.nih.gov/pubmed/21651903,MODULATOR,,Tclin,60,60,Homo sapiens
180661,4483,2484,Proteasome subunit beta type-5,Enzyme,P28074,PSMB5,PSB5_HUMAN,8.221848487854004,,IC50,fluorogenic peptide substrate hydrolysis,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17616698,http://www.ncbi.nlm.nih.gov/pubmed/17616698,INHIBITOR,,Tclin,242,242,Homo sapiens
180662,4973,606,Histone deacetylase 1,Enzyme,Q13547,HDAC1,HDAC1_HUMAN,7.022276401519775,,IC50,HDAC enzyme inhibition assay using BSA substrate,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22080169,http://www.ncbi.nlm.nih.gov/pubmed/22080169,INHIBITOR,,Tclin,243,243,Homo sapiens
180663,4973,598,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,6.79587984085083,,IC50,HDAC enzyme inhibition assay using BSA substrate,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22080169,http://www.ncbi.nlm.nih.gov/pubmed/22080169,INHIBITOR,,Tclin,243,243,Homo sapiens
134526,269,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/18506437,OTHER,,,,447,
180665,4973,917,Histone deacetylase 10,Enzyme,Q969S8,HDAC10,HDA10_HUMAN,7.107905387878418,,IC50,HDAC enzyme inhibition assay using BSA substrate,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22080169,http://www.ncbi.nlm.nih.gov/pubmed/22080169,INHIBITOR,,Tclin,243,243,Homo sapiens
180666,4973,717,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,6.1348958015441895,,IC50,HDAC enzyme inhibition assay using BSA substrate,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22080169,,INHIBITOR,,Tclin,243,,Homo sapiens
180667,4973,2307,Histone deacetylase 11,Enzyme,Q96DB2,HDAC11,HDA11_HUMAN,6.364516258239746,,IC50,HDAC enzyme inhibition assay using BSA substrate,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22080169,,INHIBITOR,,Tclin,243,,Homo sapiens
180669,939,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,6.698999881744385,,ID50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL92,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
180670,2044,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,8.05,,EC50,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2770,http://www.ncbi.nlm.nih.gov/pubmed/11309480,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,244,244,Homo sapiens
180672,4964,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,,,,microtubule disrupting agent auristatin E,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125388_S056S078lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125388_S056S078lbl.pdf,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,226,226,Homo sapiens
180674,4171,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,8.229999542236328,,IC50,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6813,http://www.ncbi.nlm.nih.gov/pubmed/19010832,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,245,Homo sapiens
180675,2823,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,9,,IC50,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6851,http://www.ncbi.nlm.nih.gov/pubmed/19010832,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,245,Homo sapiens
180676,2827,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19010832,http://www.ncbi.nlm.nih.gov/pubmed/19010832,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,245,245,Homo sapiens
180677,2825,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19010832,http://www.ncbi.nlm.nih.gov/pubmed/19010832,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,245,245,Homo sapiens
180678,1517,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19010832,http://www.ncbi.nlm.nih.gov/pubmed/19010832,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,245,245,Homo sapiens
180679,3644,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19010832,http://www.ncbi.nlm.nih.gov/pubmed/19010832,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,245,245,Homo sapiens
180680,3880,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,6.843148231506348,,IC50,HEK-293 cells stably expressing hCav3.2 T-type Ca2+ channels,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21466810,,BLOCKER,,Tclin,246,,Homo sapiens
180681,992,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,6.621057510375977,,IC50,HEK-293 cells stably expressing hCav3.2 T-type Ca2+ channels,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21466810,,BLOCKER,,Tclin,246,,Homo sapiens
172501,4941,2322,Cyclin-dependent kinase 4,Kinase,P11802,CDK4,CDK4_HUMAN,7.958607196807861,,IC50,Cdk4/cyclin D1,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/15542782,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207103s000lbl.pdf,INHIBITOR,,Tclin,171,170,Homo sapiens
172502,4941,1950,Cyclin-dependent kinase 6,Kinase,Q00534,CDK6,CDK6_HUMAN,7.823908805847168,,IC50,Cdk6/cyclin D2,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/15542782,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207103s000lbl.pdf,INHIBITOR,,Tclin,171,170,Homo sapiens
172503,4941,2327,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,Q13627,DYRK1A,DYR1A_HUMAN,5.698969841003418,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/15542782,,INHIBITOR,,Tchem,171,,Homo sapiens
172505,4941,2283,Ribosomal protein S6 kinase alpha-1,Kinase,Q15418,RPS6KA1,KS6A1_HUMAN,5.096909999847412,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/15542782,,INHIBITOR,,Tchem,171,,Homo sapiens
172506,4942,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,7.6575775146484375,,IC50,in vitro kinase activity at 1uM ATP,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/17943726,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf,INHIBITOR,,Tclin,173,172,Homo sapiens
172507,4942,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,8.397939682006836,,IC50,in vitro kinase activity at 1uM ATP,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/17943726,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf,INHIBITOR,,Tclin,173,172,Homo sapiens
172508,4942,543,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,8.28399658203125,,IC50,in vitro kinase activity at 1uM ATP,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/17943726,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf,INHIBITOR,,Tclin,173,172,Homo sapiens
172509,4942,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,7.337242126464844,,IC50,in vitro kinase activity at 1uM ATP,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/17943726,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf,INHIBITOR,,Tclin,173,172,Homo sapiens
172510,4942,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,7.2924299240112305,,IC50,in vitro kinase activity at 1uM ATP,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/17943726,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf,INHIBITOR,,Tclin,173,172,Homo sapiens
172511,4942,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.408935546875,,IC50,in vitro kinase activity at 1uM ATP,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/17943726,,INHIBITOR,,Tclin,173,,Homo sapiens
172512,4942,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7,,IC50,in vitro kinase activity at 1uM ATP,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/17943726,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf,INHIBITOR,,Tclin,173,172,Homo sapiens
172513,4942,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.187086582183838,,IC50,in vitro kinase activity at 1uM ATP,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/17943726,,INHIBITOR,,Tclin,173,,Homo sapiens
172514,4942,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.82,,Ki,Inhibition of RET (unknown origin),CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289601,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206947s000lbl.pdf,INHIBITOR,,Tclin,,172,Homo sapiens
170515,2166,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.019999980926514,,EC50,calcium response in CHO cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24558448,,AGONIST,,Tclin,117,,Homo sapiens
170517,2166,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.949999809265137,,EC50,calcium response in CHO cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24558448,,AGONIST,,Tclin,117,,Homo sapiens
170520,2166,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.96999979019165,,EC50,calcium response in CHO cells,SCIENTIFIC LITERATURE,=,1,IUPHAR,http://www.ncbi.nlm.nih.gov/pubmed/24558448,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=305,AGONIST,,Tclin,117,,Homo sapiens
170522,2166,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.150000095367432,,EC50,calcium response in CHO cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24558448,,AGONIST,,Tclin,117,,Homo sapiens
170524,2166,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7,,EC50,calcium response in CHO cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24558448,,AGONIST,,Tclin,117,,Homo sapiens
170527,4920,3393,Pseudomonas aeruginosa,Bacteria,,,,5.299278259277344,,MIC90,Pseudomonas aeruginosa ATCC 27853 ciprofloxacin susceptible at pH 5.8-6.2,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21709094,http://www.ncbi.nlm.nih.gov/pubmed/21709094,MINIMUM INHIBITORY CONCENTRATION,,,121,121,
170528,4920,25,Staphylococcus aureus subsp. aureus,Bacteria,,,,6.503398418426514,,MIC90,methicillin-resistant S. aureus [MRSA] ATCC 33591 ciprofloxacin susceptible at pH 5.8-6.2,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21709094,http://www.ncbi.nlm.nih.gov/pubmed/21709094,MINIMUM INHIBITORY CONCENTRATION,,,121,121,
170529,1859,526,Inosine-5'-monophosphate dehydrogenase 2,Enzyme,P12268,IMPDH2,IMDH2_HUMAN,8.154901504516602,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/10878285,http://www.ncbi.nlm.nih.gov/pubmed/10878285,INHIBITOR,,Tclin,124,124,Homo sapiens
170531,1859,282,Inosine-5'-monophosphate dehydrogenase 1,Enzyme,P20839,IMPDH1,IMDH1_HUMAN,7.481485843658447,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/10878285,http://www.ncbi.nlm.nih.gov/pubmed/10878285,INHIBITOR,,Tclin,124,124,Homo sapiens
170532,4921,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,6.346787452697754,,Ki,human recombinant MAO B,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17915852,http://www.ncbi.nlm.nih.gov/pubmed/17030736,INHIBITOR,,Tclin,125,126,Homo sapiens
170534,4923,3394,Programmed cell death protein 1,Membrane receptor,Q15116,PDCD1,PDCD1_HUMAN,9.14,,Kd,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7335,http://www.ncbi.nlm.nih.gov/pubmed/24872026,ANTIBODY BINDING,,Tclin,129,129,Homo sapiens
170536,4302,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.6899995803833,,Ki,,SCIENTIFIC LITERATURE,=,1,CHEMBL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201027,ANTAGONIST,,Tclin,130,,Homo sapiens
170538,4302,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,9.25,,Ki,,SCIENTIFIC LITERATURE,=,1,IUPHAR,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7459,ANTAGONIST,,Tclin,130,,Homo sapiens
170539,4302,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.640000343322754,,Ki,,SCIENTIFIC LITERATURE,=,1,CHEMBL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201027,ANTAGONIST,,Tclin,130,,Homo sapiens
170540,4302,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,9.0600004196167,,Ki,,SCIENTIFIC LITERATURE,=,1,IUPHAR,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7459,ANTAGONIST,,Tclin,130,,Homo sapiens
134541,4168,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.00261402130127,,Ki,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/200603s015lbl.pdf,ANTAGONIST,,Tclin,,180,Homo sapiens
170542,4302,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.90999984741211,,Ki,,SCIENTIFIC LITERATURE,=,1,IUPHAR,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002430/WC500133771.pdf,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7459,ANTAGONIST,,Tclin,130,,Homo sapiens
170543,4342,57,Transient receptor potential cation channel subfamily V member 1,Ion channel,Q8NER1,TRPV1,TRPV1_HUMAN,7.710000038146973,,EC50,increases in intracellular (HEK-293 cells) Ca2+ using Fluo-3 dye,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/14599363,http://www.ncbi.nlm.nih.gov/pubmed/25171227,OPENER,,Tclin,131,340,Homo sapiens
169805,4915,2939,B-lymphocyte antigen CD19,Surface antigen,P15391,CD19,CD19_HUMAN,9,,Kd,Binding of the single-chain Fv portion of blinatumomab to CD19.,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7384,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125557lbl.pdf,ANTIBODY BINDING,,Tclin,,102,Homo sapiens
169806,4915,2940,T-cell surface glycoprotein CD3,Surface antigen,P04234|P07766|P09693,CD3D|CD3E|CD3G,CD3D_HUMAN|CD3E_HUMAN|CD3G_HUMAN,7,,Kd,Binding of the single-chain Fv portion of blinatumomab to CD3.,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7384,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125557lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin|Tclin,,102,Homo sapiens
169807,2368,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/10364735,AGONIST,,Tclin,,103,Homo sapiens
169793,1101,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/4396765,http://www.ncbi.nlm.nih.gov/pubmed/4396765,AGONIST,,Tclin,89,89,Homo sapiens
169794,4824,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/4396765,http://www.ncbi.nlm.nih.gov/pubmed/4396765,AGONIST,,Tclin,89,89,Homo sapiens
169795,648,343,Cysteinyl leukotriene receptor 1,GPCR,Q9Y271,CYSLTR1,CLTR1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/23859232,ANTAGONIST,,Tclin,,90,Homo sapiens
169796,2237,343,Cysteinyl leukotriene receptor 1,GPCR,Q9Y271,CYSLTR1,CLTR1_HUMAN,10,,IC50,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3634,http://www.ncbi.nlm.nih.gov/pubmed/23859232,ANTAGONIST,,Tclin,,90,Homo sapiens
169798,2847,1648,Vitamin K epoxide reductase complex subunit 1-like protein 1,Enzyme,Q8N0U8,VKORC1L1,VKORL_HUMAN,4.28399658203125,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/23928358,,,,Tbio,91,,Homo sapiens
169800,4516,2685,Adrenocorticotropic hormone receptor,GPCR,Q01718,MC2R,ACTHR_HUMAN,8.267605781555176,,Ki,125I-ACTH binding in OS3 cells expressing hMC2R wild type,SCIENTIFIC LITERATURE,=,1,CHEMBL,http://www.ncbi.nlm.nih.gov/pubmed/17877367,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103784,AGONIST,,Tclin,92,,Homo sapiens
169801,4821,2685,Adrenocorticotropic hormone receptor,GPCR,Q01718,MC2R,ACTHR_HUMAN,8.008773803710938,,Ki,125I-ACTH binding in OS3 cells expressing hMC2R wild type,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17877367,http://www.ncbi.nlm.nih.gov/pubmed/17877367,AGONIST,,Tclin,92,92,Homo sapiens
169802,1384,30,Ryanodine receptor 2,Ion channel,Q92736,RYR2,RYR2_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23319593,http://www.ncbi.nlm.nih.gov/pubmed/23319593,BLOCKER,,Tclin,93,93,Homo sapiens
169803,1384,31,Ryanodine receptor 2,Ion channel,B0LPN4,Ryr2,RYR2_RAT,7.151810646057129,,IC50,sarcoplasmic reticulum diastolic Ca2+ leakage,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/23319593,,,,,93,,Rattus norvegicus
169804,4156,11,reactive chemical species,Reactive chemical species,,,,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19466525,http://www.ncbi.nlm.nih.gov/pubmed/19466525,OTHER,,,94,94,
169782,323,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,3.494849920272827,,ED50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19661462,http://www.ncbi.nlm.nih.gov/pubmed/12173241,BLOCKER,,Tclin,4,517,Homo sapiens
169783,323,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/12173241,BLOCKER,,Tclin,,517,Homo sapiens
169785,323,138,Sodium channel protein type 2 subunit alpha,Ion channel,Q99250,SCN2A,SCN2A_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/12173241,BLOCKER,,Tclin,,517,Homo sapiens
169786,323,139,Sodium channel protein type 3 subunit alpha,Ion channel,Q9NY46,SCN3A,SCN3A_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/12173241,BLOCKER,,Tclin,,517,Homo sapiens
169787,323,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/12173241,BLOCKER,,Tclin,,517,Homo sapiens
169788,323,473,Sodium channel protein type 7 subunit alpha,Ion channel,Q01118,SCN7A,SCN7A_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/12173241,BLOCKER,,Tclin,,517,Homo sapiens
169789,323,141,Sodium channel protein type 8 subunit alpha,Ion channel,Q9UQD0,SCN8A,SCN8A_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/12173241,BLOCKER,,Tclin,,517,Homo sapiens
169790,323,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/12173241,BLOCKER,,Tclin,,517,Homo sapiens
169791,323,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/12173241,BLOCKER,,Tclin,,517,Homo sapiens
169792,323,175,Sodium channel protein type 11 subunit alpha,Ion channel,Q9UI33,SCN11A,SCNBA_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/12173241,BLOCKER,,Tclin,,517,Homo sapiens
134540,990,35,Ornithine decarboxylase,Enzyme,Q9TZZ6,,Q9TZZ6_TRYBG,,,,Mechanism of Action,DRUG LABEL,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/3924048,INHIBITOR,,,,284,Trypanosoma brucei gambiense
28205,1436,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
134542,4168,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.327901840209961,,Ki,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/200603s015lbl.pdf,ANTAGONIST,,Tclin,,180,Homo sapiens
134543,4168,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,9.305395126342773,,Ki,,DRUG LABEL,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
134544,4168,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.966576099395752,,Ki,antagonist with moderate affinity,DRUG LABEL,=,,,,,,,Tclin,,,Homo sapiens
134545,4168,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.195178985595703,,Ki,partial agonist,DRUG LABEL,=,,,,,,,Tclin,,,Homo sapiens
134546,4168,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.390405654907227,,Ki,antagonist,DRUG LABEL,=,,,,,,,Tclin,,,Homo sapiens
134547,4885,1700,Glucagon-like peptide 1 receptor,GPCR,P43220,GLP1R,GLP1R_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/125469Orig1s000Lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/125469Orig1s000Lbl.pdf,AGONIST,,Tclin,252,252,Homo sapiens
134548,1770,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/011757s103lbl.pdf,AGONIST,,Tclin,,181,Homo sapiens
134549,302,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022249Orig1s019lbl.pdf,OTHER,,,,286,
134550,43,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/11556519,INHIBITOR,,Tclin,,429,Homo sapiens
134551,1751,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,8.92,,Ki,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4815,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205776s000lbl.pdf,INHIBITOR,,Tclin,,185,Homo sapiens
134552,2782,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/15212190,AGONIST,,Tclin,,99,Homo sapiens
134553,1987,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/9726653,INHIBITOR,,Tclin|Tclin,,288,Homo sapiens
134554,4886,481,Pancreatic triacylglycerol lipase,Enzyme,P16233,PNLIP,LIPP_HUMAN,8.225482940673828,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/18500680,http://www.ncbi.nlm.nih.gov/pubmed/18500680,INHIBITOR,,Tclin,5,5,Homo sapiens
134559,4888,304,Xanthine dehydrogenase/oxidase,Enzyme,P47989,XDH,XDH_HUMAN,8.275724411010742,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19783139,http://www.ncbi.nlm.nih.gov/pubmed/19783139,INHIBITOR,,Tclin,7,7,Homo sapiens
134560,4890,51,Sodium/glucose cotransporter 2,Transporter,P31639,SLC5A2,SC5A2_HUMAN,8.131943702697754,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22139434,http://www.ncbi.nlm.nih.gov/pubmed/22139434,INHIBITOR,,Tclin,8,8,Homo sapiens
134561,4890,2059,Sodium/glucose cotransporter 1,Transporter,P13866,SLC5A1,SC5A1_HUMAN,5.726767063140869,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22139434,,,,Tclin,8,,Homo sapiens
134562,4891,51,Sodium/glucose cotransporter 2,Transporter,P31639,SLC5A2,SC5A2_HUMAN,8.645891189575195,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20302302,http://www.ncbi.nlm.nih.gov/pubmed/20302302,INHIBITOR,,Tclin,9,9,Homo sapiens
134563,4891,2059,Sodium/glucose cotransporter 1,Transporter,P13866,SLC5A1,SC5A1_HUMAN,5.399026870727539,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20302302,,,,Tclin,9,,Homo sapiens
134564,4892,51,Sodium/glucose cotransporter 2,Transporter,P31639,SLC5A2,SC5A2_HUMAN,8.537602424621582,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22889351,http://www.ncbi.nlm.nih.gov/pubmed/22889351,INHIBITOR,,Tclin,10,10,Homo sapiens
134565,4892,2059,Sodium/glucose cotransporter 1,Transporter,P13866,SLC5A1,SC5A1_HUMAN,5.073451995849609,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22889351,,,,Tclin,10,,Homo sapiens
134566,4893,700,Thymidine phosphorylase,Enzyme,P19971,TYMP,TYPH_HUMAN,7.698969841003418,,IC50,spectrophotometric assay; 5-nitro-2'-deoxyuridine substrate,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/12519058,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207981s000lbl.pdf,INHIBITOR,,Tclin,11,442,Homo sapiens
134567,4895,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,9.431797981262207,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22959556,http://www.ncbi.nlm.nih.gov/pubmed/22959556,INHIBITOR,,Tclin,12,12,Homo sapiens
134568,4895,844,Dipeptidyl peptidase 8,Enzyme,Q6V1X1,DPP8,DPP8_HUMAN,6.585026741027832,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22959556,,,,Tchem,12,,Homo sapiens
134569,4895,880,Dipeptidyl peptidase 9,Enzyme,Q86TI2,DPP9,DPP9_HUMAN,6.267606258392334,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22959556,,,,Tchem,12,,Homo sapiens
134570,4896,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,8.42021656036377,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22019046,http://www.ncbi.nlm.nih.gov/pubmed/22019046,INHIBITOR,,Tclin,13,13,Homo sapiens
134571,4896,844,Dipeptidyl peptidase 8,Enzyme,Q6V1X1,DPP8,DPP8_HUMAN,7.1674909591674805,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22019046,,,,Tchem,13,,Homo sapiens
134572,4896,880,Dipeptidyl peptidase 9,Enzyme,Q86TI2,DPP9,DPP9_HUMAN,7.221848964691162,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22019046,,,,Tchem,13,,Homo sapiens
134521,24,8,glutamine,Amino acid,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,"http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020572s016,020573s015lbl.pdf",OTHER,,,,427,
134522,4797,5,heme iron,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/201444s000lbl.pdf,OTHER,,,,518,
134523,30,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/09048slr037_methoxsalen_lbl.pdf,CROSS-LINKING AGENT,,,,428,
134524,141,6,DNA,DNA,,,,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/7763301,OTHER,,,,519,
134525,156,11,reactive chemical species,Reactive chemical species,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020221s024lbl.pdf,OTHER,,,,563,
134527,269,7,RNA,RNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/18506437,OTHER,,,,447,
134528,512,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020637s026lbl.pdf,OTHER,,,,282,
134529,347,9,homocysteine,Unnatural amino acid,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020576s010lbl.pdf,OTHER,,,,505,
134530,438,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020954s014lbl.pdf,OTHER,,,,564,
134532,636,10,trivalent metal,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21022s004lbl.pdf,CHELATING AGENT,,,,367,
134533,4133,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020452s005lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020452s005lbl.pdf,CROSS-LINKING AGENT,,,561,561,
134534,774,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050682s029s030lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050682s029s030lbl.pdf,OTHER,,,562,562,
134537,2081,3,copper,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,"http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19853s012,014lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19853s012,014lbl.pdf",CHELATING AGENT,,,397,397,
126959,4622,36,Heat-stable enterotoxin receptor,Enzyme,P25092,GUCY2C,GUC2C_HUMAN,8.906578063964844,,Ki,competitive radioligand binding assay with [125I]-STa,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20863829,http://www.ncbi.nlm.nih.gov/pubmed/20863829,AGONIST,,Tclin,14,14,Homo sapiens
126960,4678,25,Staphylococcus aureus subsp. aureus,Bacteria,,,,7.469350814819336,,MIC,as determined by broth microdilution with 0.002% polysorbate-80 during oritavancin dissolution and dilution and in the final assay,DRUG LABEL,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206334s000lbl.pdf,MINIMUM INHIBITORY CONCENTRATION,,,,289,
126961,4678,23,Streptococcus pneumoniae,Bacteria,,,,8.900714874267578,,MIC,as determined by broth microdilution with 0.002% polysorbate-80 during oritavancin dissolution and dilution and in the final assay,DRUG LABEL,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206334s000lbl.pdf,MINIMUM INHIBITORY CONCENTRATION,,,,289,
126962,4678,24,Enterococcus faecalis ATCC 29212,Bacteria,,,,8.019901275634766,,MIC,as determined by broth microdilution with 0.002% polysorbate-80 during oritavancin dissolution and dilution and in the final assay,DRUG LABEL,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206334s000lbl.pdf,MINIMUM INHIBITORY CONCENTRATION,,,,289,
126964,4881,38,Orexin receptor type 1,GPCR,O43613,HCRTR1,OX1R_HUMAN,9.259636878967285,,Ki,radioligand-displacement binding assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20565075,http://www.ncbi.nlm.nih.gov/pubmed/20565075,ANTAGONIST,,Tclin,15,15,Homo sapiens
126965,4881,2577,Orexin receptor type 2,GPCR,O43614,HCRTR2,OX2R_HUMAN,9.455931663513184,,Ki,radioligand-displacement binding assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20565075,http://www.ncbi.nlm.nih.gov/pubmed/20565075,ANTAGONIST,,Tclin,15,15,Homo sapiens
126966,2616,2576,Protein cereblon,Cytosolic other,Q96SW2,CRBN,CRBN_HUMAN,6.392973899841309,,EC50,competitive titration of thalidomide with human DDB1-human CRBN (50 nM) and Cy5-thalidomide (20 nM),SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/25043012,http://www.ncbi.nlm.nih.gov/pubmed/26131937,MODULATOR,,Tclin,16,383,Homo sapiens
126967,3317,2576,Protein cereblon,Cytosolic other,Q96SW2,CRBN,CRBN_HUMAN,6.527390003204346,,EC50,competitive titration of thalidomide with human DDB1-human CRBN (50 nM) and Cy5-thalidomide (20 nM),SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/25043012,http://www.ncbi.nlm.nih.gov/pubmed/26131937,MODULATOR,,Tclin,16,383,Homo sapiens
126968,4746,2576,Protein cereblon,Cytosolic other,Q96SW2,CRBN,CRBN_HUMAN,6.57708215713501,,EC50,competitive titration of thalidomide with human DDB1-human CRBN (50 nM) and Cy5-thalidomide (20 nM),SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/25043012,http://www.ncbi.nlm.nih.gov/pubmed/26131937,MODULATOR,,Tclin,16,383,Homo sapiens
97500,4873,25,Staphylococcus aureus subsp. aureus,Bacteria,,,,5.9545488357543945,,MIC,MIC for S. aureus ATCC 29213,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21502615,http://www.ncbi.nlm.nih.gov/pubmed/21502615,MINIMUM INHIBITORY CONCENTRATION,,,17,17,
97501,4874,27,Trichophyton rubrum,Fungi,,,,6.445156097412109,,MIC,80% inhibition,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/11302816,http://www.ncbi.nlm.nih.gov/pubmed/11302816,MINIMUM INHIBITORY CONCENTRATION,,,18,18,
97502,4874,26,Trichophyton mentagrophytes,Fungi,,,,6.144125938415527,,MIC,80% inhibition,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/11302816,http://www.ncbi.nlm.nih.gov/pubmed/11302816,MINIMUM INHIBITORY CONCENTRATION,,,18,18,
97503,4875,2544,Genome polyprotein,Polyprotein,P27958,,POLG_HCVH,10.301030158996582,,EC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20410884,http://www.ncbi.nlm.nih.gov/pubmed/20410884,INHIBITOR,,,19,19,Hepatitis C virus genotype 1a (isolate H)
97504,4875,2536,Genome polyprotein,Polyprotein,P26663,,POLG_HCVBK,11.045757293701172,,EC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20410884,http://www.ncbi.nlm.nih.gov/pubmed/20410884,INHIBITOR,,,19,19,Hepatitis C virus genotype 1b (isolate BK)
97493,4382,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,7.649752140045166,,EC50,cAMP accumulation in CHO cells expressing human beta-3 adrenergic receptor,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17293563,http://www.ncbi.nlm.nih.gov/pubmed/17293563,AGONIST,,Tclin,20,20,Homo sapiens
97495,4866,609,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,8.09691047668457,,IC50,in vitro enzymatic activity,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/23742252,,,,Tclin,21,,Homo sapiens
97496,4866,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,8.154901504516602,,IC50,in vitro enzymatic activity,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/23742252,,AGONIST,,Tclin,21,,Homo sapiens
97497,4866,925,Testis-specific serine/threonine-protein kinase 1,Kinase,Q9BXA7,TSSK1B,TSSK1_HUMAN,7.638272285461426,,IC50,in vitro enzymatic activity,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/23742252,,,,Tchem,21,,Homo sapiens
162409,1820,443,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1670,INHIBITOR,,Tclin,,,Homo sapiens
97498,4866,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,9.698969841003418,,IC50,in vitro enzymatic activity,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23742252,http://www.ncbi.nlm.nih.gov/pubmed/23742252,INHIBITOR,,Tclin,21,21,Homo sapiens
97499,4870,43,Proteinase-activated receptor 1,GPCR,P25116,F2R,PAR1_HUMAN,8.091514587402344,,Ki,antagonist,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/18447380,http://www.ncbi.nlm.nih.gov/pubmed/18447380,ANTAGONIST,,Tclin,22,22,Homo sapiens
97488,4833,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,7.79587984085083,,IC50,fluorometric assay with Gly-Pro-AMC substrate,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://professional.diabetes.org/Content/Posters/2008/p502-P.pdf,http://professional.diabetes.org/Content/Posters/2008/p502-P.pdf,INHIBITOR,,Tclin,95,95,Homo sapiens
97489,4833,880,Dipeptidyl peptidase 9,Enzyme,Q86TI2,DPP9,DPP9_HUMAN,4.327902317047119,,IC50,fluorometric assay with Gly-Pro-AMC substrate,SCIENTIFIC LITERATURE,=,,,http://professional.diabetes.org/Content/Posters/2008/p502-P.pdf,,,,Tchem,95,,Homo sapiens
97490,4834,524,Ceramide glucosyltransferase,Enzyme,Q16739,UGCG,CEGT_HUMAN,6.826813697814941,,IC50,inhibition of GlcCer synthesis in disrupted wild-type MDCK cell preparations,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22058426,http://www.ncbi.nlm.nih.gov/pubmed/22058426,INHIBITOR,,Tclin,23,23,Homo sapiens
97491,4864,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.95078182220459,,Ki,radioligand binding in HEK-293 cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23499664,http://www.ncbi.nlm.nih.gov/pubmed/23499664,INHIBITOR,,Tclin,24,24,Homo sapiens
97492,4864,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.035269260406494,,Ki,radioligand binding in HEK-293 cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23499664,http://www.ncbi.nlm.nih.gov/pubmed/23499664,INHIBITOR,,Tclin,24,24,Homo sapiens
97481,4829,559,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,Q08499,PDE4D,PDE4D_HUMAN,7.130768299102783,,IC50,PDE4 enzyme isolated from U937 cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19256507,http://www.ncbi.nlm.nih.gov/pubmed/19256507,INHIBITOR,,Tclin,25,25,Homo sapiens
97483,4830,2059,Sodium/glucose cotransporter 1,Transporter,P13866,SLC5A1,SC5A1_HUMAN,5.0809221267700195,,IC50,uptake of [14C] alpha-methyl glucopyranoside,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21985634,,,,Tclin,26,,Homo sapiens
97484,4830,44,Sodium/glucose cotransporter 4,Transporter,Q2M3M2,SLC5A9,SC5A9_HUMAN,4.958607196807861,,IC50,uptake of [14C] alpha-methyl glucopyranoside,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21985634,,,,Tdark,26,,Homo sapiens
97485,4830,45,Sodium/glucose cotransporter 5,Transporter,A0PJK1,SLC5A10,SC5AA_HUMAN,5.958607196807861,,IC50,uptake of [14C] mannose,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21985634,,,,Tdark,26,,Homo sapiens
97486,4830,2432,Sodium/myo-inositol cotransporter 2,Transporter,Q8WWX8,SLC5A11,SC5AB_HUMAN,5.698969841003418,,IC50,uptake of [14C] myo-inositol,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21985634,,,,Tchem,26,,Homo sapiens
97487,4830,51,Sodium/glucose cotransporter 2,Transporter,P31639,SLC5A2,SC5A2_HUMAN,7.2441253662109375,,Kd,[3H]-empagliflozin kinetic binding experiment,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21985634,http://www.ncbi.nlm.nih.gov/pubmed/21985634,INHIBITOR,,Tclin,26,26,Homo sapiens
97477,2054,2729,Potassium-transporting ATPase,Enzyme,P18597|P27112,ATP4A|ATP4B,ATP4A_RABIT|ATP4B_RABIT,6,,IC50,[14C]AP accumulation as an indicator of acid secretion in rabbit isolated fundic glands,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/2164086,,,,,27,,Oryctolagus cuniculus
97478,1990,2729,Potassium-transporting ATPase,Enzyme,P18597|P27112,ATP4A|ATP4B,ATP4A_RABIT|ATP4B_RABIT,6.15490198135376,,IC50,[14C]AP accumulation as an indicator of acid secretion in rabbit isolated fundic glands,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/2164086,,,,,27,,Oryctolagus cuniculus
97479,2716,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,7.28399658203125,,Ki,inhibition of [3H]AL-5848 binding to prostaglandin FP receptor,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/10454045,http://www.ncbi.nlm.nih.gov/pubmed/10454045,AGONIST,,Tclin,28,28,Homo sapiens
97480,2716,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,5.455807685852051,,Ki,inhibition of [3H]AL-5848 binding to prostaglandin EP3 receptor,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/10454045,,,,Tclin,28,,Homo sapiens
97474,4820,378,Melatonin receptor type 1A,GPCR,P48039,MTNR1A,MTR1A_HUMAN,9.449999809265137,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22640220,http://www.ncbi.nlm.nih.gov/pubmed/22640220,AGONIST,,Tclin,29,29,Homo sapiens
97475,4820,379,Melatonin receptor type 1B,GPCR,P49286,MTNR1B,MTR1B_HUMAN,9.800000190734863,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22640220,http://www.ncbi.nlm.nih.gov/pubmed/22640220,AGONIST,,Tclin,29,29,Homo sapiens
97466,4814,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,7.329999923706055,,Ki,competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20371707,,,,Tclin,30,,Homo sapiens
97467,4814,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.140000343322754,,Ki,competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20371707,http://www.ncbi.nlm.nih.gov/pubmed/20371707,ANTAGONIST,,Tclin,30,30,Homo sapiens
97468,4814,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.260000228881836,,Ki,competitive binding experiments against [3H]CGP 12177 in the presence of 5'-guanylyl-imidodiphosphate,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20371707,,,,Tclin,30,,Homo sapiens
97469,4815,1700,Glucagon-like peptide 1 receptor,GPCR,P43220,GLP1R,GLP1R_HUMAN,8.844663619995117,,IC50,CHO cells transfected with the human GLP-1 receptor binding affinity,SCIENTIFIC LITERATURE,=,1,IUPHAR,http://www.ncbi.nlm.nih.gov/pubmed/18417092,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7387,AGONIST,,Tclin,31,,Homo sapiens
97471,4816,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,10.221848487854004,,Ki,"radioligand binding assays in CHO cells expressing human M1, M2, or M3 receptors in a scintillation proximity assay with 0.5 nM [3H]-N-methyl scopolamine as the ligand",SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19317446,http://www.ncbi.nlm.nih.gov/pubmed/19317446,ANTAGONIST,,Tclin,32,32,Homo sapiens
97472,4816,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,9.823908805847168,,Ki,"radioligand binding assays in CHO cells expressing human M1, M2, or M3 receptors in a scintillation proximity assay with 0.5 nM [3H]-N-methyl scopolamine as the ligand",SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/19317446,,,,Tclin,32,,Homo sapiens
97473,4816,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.795880317687988,,Ki,"radioligand binding assays in CHO cells expressing human M1, M2, or M3 receptors in a scintillation proximity assay with 0.5 nM [3H]-N-methyl scopolamine as the ligand",SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/19317446,,,,Tclin,32,,Homo sapiens
93397,4806,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,8.431797981262207,,Ki,antagonist,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22171087,http://www.ncbi.nlm.nih.gov/pubmed/21486038,ANTAGONIST,,Tclin,33,138,Homo sapiens
93398,4806,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.721246242523193,,Ki,antagonist,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22171087,http://www.ncbi.nlm.nih.gov/pubmed/21486038,ANTAGONIST,,Tclin,33,138,Homo sapiens
93399,4806,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.481485843658447,,Ki,partial agonist,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22171087,http://www.ncbi.nlm.nih.gov/pubmed/21486038,AGONIST,,Tclin,33,138,Homo sapiens
93400,4806,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.823908805847168,,Ki,agonist,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22171087,http://www.ncbi.nlm.nih.gov/pubmed/21486038,AGONIST,,Tclin,33,138,Homo sapiens
93401,4806,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.795880317687988,,Ki,inhibitor,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22171087,http://www.ncbi.nlm.nih.gov/pubmed/21486038,INHIBITOR,,Tclin,33,138,Homo sapiens
93402,4806,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,6.698969841003418,,Ki,antagonist,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22171087,,,,,33,,Rattus norvegicus
93403,4807,46,Guanylate cyclase soluble subunit beta-1,Enzyme,Q02153,GUCY1B3,GCYB1_HUMAN,7.522878646850586,,MEC,minimal effective concentration to achieve threefold stimulation of cGMP formation in a recombinant sGC-overexpressing cell line,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19263460,http://www.ncbi.nlm.nih.gov/pubmed/19263460,POSITIVE ALLOSTERIC MODULATOR,,Tclin,34,34,Homo sapiens
93404,4807,831,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",Enzyme,Q9NP56,PDE7B,PDE7B_HUMAN,5.537601947784424,,IC50,radioligand binding,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/19263460,,,,Tclin,34,,Homo sapiens
93405,4808,1791,Acetylcholinesterase,Enzyme,P37136,Ache,ACES_RAT,6.568636417388916,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/11256231,,,,,35,,Rattus norvegicus
93406,4808,1774,Butyrylcholinesterase; Protein Bche,Enzyme,Q9JKC1,Bche,Q9JKC1_RAT,6.6575775146484375,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/11256231,,,,,35,,Rattus norvegicus
93407,4809,457,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,9.301030158996582,,IC50,IC50 value as determined in binding assays using membranes of Chinese hamster ovary (CHO) cells containing recombinant ETA,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22862294,http://www.ncbi.nlm.nih.gov/pubmed/22862294,ANTAGONIST,,Tclin,36,36,Homo sapiens
93408,4809,458,Endothelin B receptor,GPCR,P24530,EDNRB,EDNRB_HUMAN,6.407823085784912,,IC50,IC50 value as determined in binding assays using membranes of Chinese hamster ovary (CHO) cells containing recombinant ETB,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22862294,http://www.ncbi.nlm.nih.gov/pubmed/22862294,ANTAGONIST,,Tclin,36,36,Homo sapiens
93389,4305,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,8.28399658203125,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1963681,INHIBITOR,,Tclin,,,Homo sapiens
93390,4305,770,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",Enzyme,P51160,PDE6C,PDE6C_HUMAN,6.200659275054932,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
28187,4283,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,7.017728805541992,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201776,AGONIST,,Tclin,,,Homo sapiens
28188,4283,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.318758964538574,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201776,INHIBITOR,,Tclin,,,Homo sapiens
28189,4713,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,8.481486320495605,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
28190,4647,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.346799850463867,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201064,AGONIST,,Tclin,,,Homo sapiens
28191,4715,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,10.455931663513184,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf,INHIBITOR,,Tclin,,560,Homo sapiens
28192,4715,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,8.886056900024414,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf,INHIBITOR,,Tclin,,560,Homo sapiens
28193,4715,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.28399658203125,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf,INHIBITOR,,Tclin,,560,Homo sapiens
28194,4715,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,7.844664096832275,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf,INHIBITOR,,Tclin,,560,Homo sapiens
28195,4715,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,7.946921348571777,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf,INHIBITOR,,Tclin,,560,Homo sapiens
28196,4715,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,8.337242126464844,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203756lbl.pdf,INHIBITOR,,Tclin,,560,Homo sapiens
28197,4715,53,Macrophage-stimulating protein receptor,Kinase,Q04912,MST1R,RON_HUMAN,6.906578540802002,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,,Tchem,,,Homo sapiens
28198,4621,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
28204,1436,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
28206,4716,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,9.431797981262207,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1171837,INHIBITOR,,Tclin,,,Homo sapiens
28207,4716,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,8.267605781555176,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,,Tchem,,,Homo sapiens
28208,4716,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,9.619789123535156,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
28209,4716,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.903090000152588,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
28210,4716,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,8.823908805847168,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
28211,4716,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,8.657577514648438,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
28212,4716,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,8.95860767364502,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
28214,4744,1047,Cystic fibrosis transmembrane conductance regulator,Ion channel,P13569,CFTR,CFTR_HUMAN,5.15490198135376,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202292s000lbl.pdf,INHIBITOR,,Tclin,,236,Homo sapiens
28215,4744,1705,Anoctamin-1,Ion channel,Q5XXA6,ANO1,ANO1_HUMAN,5.187086582183838,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202292s000lbl.pdf,INHIBITOR,,Tclin,,236,Homo sapiens
2978,85,71,DNA polymerase catalytic subunit,Enzyme,P09252,,DPOL_VZVD,,,,,WOMBAT-PK,,,,,,,,,,,Varicella-zoster virus (strain Dumas)
2979,85,72,Thymidine kinase,Kinase,Q9QNF7,TK,KITH_HHV1,,,,,WOMBAT-PK,,,,,,,,,,,Human herpesvirus 1
2980,85,73,Thymidine kinase,Kinase,P04407,TK,KITH_HHV23,,,,,WOMBAT-PK,,,,,,,,,,,Human herpesvirus 2 (strain 333)
2981,85,2053,Thymidine kinase,Kinase,P09250,,KITH_VZVD,,,,,WOMBAT-PK,,,,,,,,,,,Varicella-zoster virus (strain Dumas)
3046,192,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3048,198,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3119,492,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3121,525,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3124,530,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3125,539,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3126,542,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3127,543,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3128,544,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3129,547,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3130,550,153,Beta-lactamase,Enzyme,P00808,penP,BLAC_BACLI,,,,,WOMBAT-PK,,,,,,,,,,,Bacillus licheniformis
3131,550,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3132,556,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3133,563,153,Beta-lactamase,Enzyme,P00808,penP,BLAC_BACLI,,,,,WOMBAT-PK,,,,,,,,,,,Bacillus licheniformis
3134,563,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3136,565,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3137,571,124,Penicillin-binding protein 3,Enzyme,P42971,pbpC,PBPC_BACSU,,,,,WOMBAT-PK,,,,,,,,,,,Bacillus subtilis (strain 168)
3138,574,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3139,575,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3140,576,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3189,678,122,50S ribosomal protein L10,Ribosomal protein,P15825,rpl10,RL10_HALMA,,,,,WOMBAT-PK,,,,,,,,,,,Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809)
3197,720,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
162330,3424,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.76,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL560,MODULATOR,,Tclin,,,Homo sapiens
162331,842,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.4584,,D2,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162332,437,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.3188,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162334,2572,168,Beta-lactamase TEM,Enzyme,P62593,bla; blaT-3; blaT-4;,BLAT_ECOLX,6.6021,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,INHIBITOR,,,,,Escherichia coli
162335,669,168,Beta-lactamase TEM,Enzyme,P62593,bla; blaT-3; blaT-4;,BLAT_ECOLX,10.1871,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,INHIBITOR,,,,,Escherichia coli
162336,640,227,Dipeptidase 1,Enzyme,P16444,DPEP1,DPEP1_HUMAN,6.9586,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL766,INHIBITOR,,Tclin,,,Homo sapiens
162337,3862,427,Retinoic acid receptor gamma,Nuclear hormone receptor,P13631,RARG,RARG_HUMAN,7.13,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,AGONIST,,Tclin,,,Homo sapiens
162339,2722,427,Retinoic acid receptor gamma,Nuclear hormone receptor,P13631,RARG,RARG_HUMAN,6.7,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,AGONIST,,Tclin,,,Homo sapiens
162341,2808,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,9.3979,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,AGONIST,,Tclin|Tclin,,,Homo sapiens
162342,2752,2801,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P30926|P32297,CHRNA3|CHRNB4,ACHA3_HUMAN|ACHB4_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1245,ANTAGONIST,,Tclin|Tclin,,,Homo sapiens
162343,1920,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,8.56,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,AGONIST,,Tclin|Tclin,,,Homo sapiens
162345,1646,2801,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P30926|P32297,CHRNA3|CHRNB4,ACHA3_HUMAN|ACHB4_HUMAN,6.2218,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267936,NEGATIVE ALLOSTERIC MODULATOR,,Tclin|Tclin,,,Homo sapiens
162349,489,2736,Neuronal acetylcholine receptor; alpha2/beta4,Ion channel,P30926|Q15822,CHRNA2|CHRNB4,ACHA2_HUMAN|ACHB4_HUMAN,4.3098,,IC50,,WOMBAT-PK,=,,,,,,,Tchem|Tclin,,,Homo sapiens
162352,1648,2501,Penicillin-binding protein 2,Enzyme,P0AD65,mrdA,PBP2_ECOLI,7.0353,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL530,INHIBITOR,,,,,Escherichia coli (strain K12)
162353,564,2501,Penicillin-binding protein 2,Enzyme,P0AD65,mrdA,PBP2_ECOLI,6.2125,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL161,INHIBITOR,,,,,Escherichia coli (strain K12)
162354,112,2497,Protein farnesyltransferase subunit beta,Enzyme,P49356,FNTB,FNTB_HUMAN,7.301,,IC50,,WOMBAT-PK,=,,,,,,,,,,Homo sapiens
162355,4802,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,9.036212,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103875,INHIBITOR,,Tclin,,,Homo sapiens
162357,4802,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,8.744727,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103875,INHIBITOR,,Tclin,,,Homo sapiens
162359,4758,51,Sodium/glucose cotransporter 2,Transporter,P31639,SLC5A2,SC5A2_HUMAN,8.6575775,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2048484,INHIBITOR,,Tclin,,,Homo sapiens
162360,4721,1704,Microsomal triglyceride transfer protein large subunit,Cytosolic other,P55157,MTTP,MTP_HUMAN,8.09691,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL354541,INHIBITOR,,Tclin,,,Homo sapiens
162361,4164,1700,Glucagon-like peptide 1 receptor,GPCR,P43220,GLP1R,GLP1R_HUMAN,10.2,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201866,AGONIST,,Tclin,,,Homo sapiens
162362,1851,1418,Penicillin-binding protein 1B,Enzyme,P02919,mrcB,PBPB_ECOLI,4.6372,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74632,INHIBITOR,,,,,Escherichia coli (strain K12)
162363,564,1418,Penicillin-binding protein 1B,Enzyme,P02919,mrcB,PBPB_ECOLI,5.744,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL161,INHIBITOR,,,,,Escherichia coli (strain K12)
162364,279,1418,Penicillin-binding protein 1B,Enzyme,P02919,mrcB,PBPB_ECOLI,4.3167,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158,INHIBITOR,,,,,Escherichia coli (strain K12)
162365,1851,1417,Penicillin-binding protein 1A,Enzyme,P02918,mrcA,PBPA_ECOLI,6.7164,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74632,INHIBITOR,,,,,Escherichia coli (strain K12)
162366,564,1417,Penicillin-binding protein 1A,Enzyme,P02918,mrcA,PBPA_ECOLI,6.5135,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL161,INHIBITOR,,,,,Escherichia coli (strain K12)
162367,546,1417,Penicillin-binding protein 1A,Enzyme,P02918,mrcA,PBPA_ECOLI,6.5123,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1010,INHIBITOR,,,,,Escherichia coli (strain K12)
162368,279,1417,Penicillin-binding protein 1A,Enzyme,P02918,mrcA,PBPA_ECOLI,5.3167,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158,INHIBITOR,,,,,Escherichia coli (strain K12)
162369,1944,1247,4-hydroxyphenylpyruvate dioxygenase,Enzyme,P32754,HPD,HPPD_HUMAN,7.398,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1337,INHIBITOR,,Tclin,,,Homo sapiens
162373,780,624,Ryanodine receptor 1,Ion channel,P21817,RYR1,RYR1_HUMAN,6.757,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL928,ANTAGONIST,,Tclin,,,Homo sapiens
162375,2448,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,7.774,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1422,INHIBITOR,,Tclin,,,Homo sapiens
162378,2544,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.8,,IC50,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5713,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021938s027lbl.pdf,INHIBITOR,,Tclin,,159,Homo sapiens
162379,4801,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,9.1549015,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2028663,INHIBITOR,,Tclin,,,Homo sapiens
162385,371,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,5.3,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200963,AGONIST,,Tclin,,,Homo sapiens
3290,866,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3352,961,122,50S ribosomal protein L10,Ribosomal protein,P15825,rpl10,RL10_HALMA,,,,,WOMBAT-PK,,,,,,,,,,,Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809)
3354,1013,195,DNA gyrase subunit A,Enzyme,P43700,gyrA,GYRA_HAEIN,,,,,WOMBAT-PK,,,,,,,,,,,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)
3358,1073,196,Probable arabinosyltransferase A,Enzyme,P9WNL8,embA,EMBA_MYCTO,,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
3359,1073,197,Probable arabinosyltransferase B,Enzyme,P9WNL6,embB,EMBB_MYCTO,,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
3360,1073,198,Probable arabinosyltransferase C,Enzyme,P9WNL5,embC,EMBC_MYCTU,,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
3410,1277,70,DNA polymerase catalytic subunit,Enzyme,P04293,,DPOL_HHV11,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182,INHIBITOR,,,,,Human herpesvirus 1 (strain 17)
3411,1277,72,Thymidine kinase,Kinase,Q9QNF7,TK,KITH_HHV1,,,,,WOMBAT-PK,,,,,,,,,,,Human herpesvirus 1
3467,1497,229,Catalase-peroxidase,Enzyme,P9WIE4,katG,KATG_MYCTO,,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
162407,4337,457,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,9.65,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022081s033lbl.pdf,ANTAGONIST,,Tclin,,611,Homo sapiens
3468,1497,230,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,P9WGR1,inhA,INHA_MYCTU,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64,INHIBITOR,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
3505,1582,122,50S ribosomal protein L10,Ribosomal protein,P15825,rpl10,RL10_HALMA,,,,,WOMBAT-PK,,,,,,,,,,,Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809)
3508,1603,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3528,1744,240,Beta-lactam-inducible penicillin-binding protein,Enzyme,P07944,pbp,PBP_STAAU,,,,,WOMBAT-PK,,,,,,,,,,,Staphylococcus aureus
3558,1795,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3573,1869,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3618,1981,256,DNA gyrase subunit B,Enzyme,P0AES7,gyrB,GYRB_ECO57,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli O157:H7
3624,2006,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3682,2187,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3692,2268,557,Solute carrier family 22 member 8,Transporter,Q8TCC7,SLC22A8,S22A8_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897,INHIBITOR,,Tclin,,,Homo sapiens
3717,2328,274,Cyclopropane mycolic acid synthase 1,Enzyme,P9WPB6,cmaA1,CMAS1_MYCTO,,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
3718,2328,275,Amidase; Nicotinamidase; Nicotinamidase/pyrazinamidase; Pyrazinamidase; Pyrazinamidase/nicotinamidase; Pyrazinamidase/nicotinamidase PncA,Enzyme,Q50575,pncA,Q50575_MYCTX,,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium tuberculosis
3737,2383,283,Matrix protein 2,Ion channel,P21430,M,M2_I60A0,,,,,WOMBAT-PK,,,,,,,,,,,Influenza A virus (strain A/Ann Arbor/6/1960 H2N2)
3756,2416,285,Salicylic acid-binding protein 2,Enzyme,Q6RYA0,SABP2,SABP2_TOBAC,,,,,WOMBAT-PK,,,,,,,,,,,Nicotiana tabacum
3771,2481,287,30S ribosomal protein S12,Ribosomal protein,P9WH62,rpsL,RS12_MYCTO,,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
3774,2500,288,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q08210,,PYRD_PLAF7,,,,,WOMBAT-PK,,,,,,,,,,,Plasmodium falciparum (isolate 3D7)
3775,2514,289,Bifunctional protein FolC,Enzyme,P08192,folC,FOLC_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
3778,2529,288,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q08210,,PYRD_PLAF7,,,,,WOMBAT-PK,,,,,,,,,,,Plasmodium falciparum (isolate 3D7)
3818,2611,193,30S ribosomal protein S4,Ribosomal protein,P0A7V8,rpsD,RS4_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
3819,2611,194,30S ribosomal protein S9,Ribosomal protein,P0A7X3,rpsI,RS9_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
3825,2656,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3962,536,225,Penicillin-binding protein 1,Enzyme,A1KS91,ponA,A1KS91_NEIMF,,,,,WOMBAT-PK,,,,,,,,,,,Neisseria meningitidis serogroup C / serotype 2a (strain ATCC 700532 / DSM 15464 / FAM18)
3963,536,124,Penicillin-binding protein 3,Enzyme,P42971,pbpC,PBPC_BACSU,,,,,WOMBAT-PK,,,,,,,,,,,Bacillus subtilis (strain 168)
3964,548,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
3965,562,308,Penicillin-binding protein,Enzyme,Q1J5W5,,Q1J5W5_STRPF,,,,,WOMBAT-PK,,,,,,,,,,,Streptococcus pyogenes serotype M4 (strain MGAS10750)
3966,562,309,Penicillin-binding protein 3,Enzyme,Q60FU1,pbp3,Q60FU1_HAEIF,,,,,WOMBAT-PK,,,,,,,,,,,Haemophilus influenzae
3968,2410,122,50S ribosomal protein L10,Ribosomal protein,P15825,rpl10,RL10_HALMA,,,,,WOMBAT-PK,,,,,,,,,,,Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809)
3970,521,310,Peptidoglycan synthase FtsI,Enzyme,P0AD68,ftsI,FTSI_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
162386,2632,526,Inosine-5'-monophosphate dehydrogenase 2,Enzyme,P12268,IMPDH2,IMDH2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL727,INHIBITOR,,Tclin,,,Homo sapiens
162387,1807,524,Ceramide glucosyltransferase,Enzyme,Q16739,UGCG,CEGT_HUMAN,5.13,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4841,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,INHIBITOR,,Tclin,,,Homo sapiens
162388,119,509,Renin,Enzyme,P00797,REN,RENI_HUMAN,9.22,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1639,INHIBITOR,,Tclin,,,Homo sapiens
162389,391,508,Proteasome subunit alpha type-1,Enzyme,P25786,PSMA1,PSA1_HUMAN,9.2076,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,INHIBITOR,,Tclin,,,Homo sapiens
162390,39,495,"Maltase-glucoamylase, intestinal",Enzyme,O43451,MGAM,MGA_HUMAN,5.6968,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1566,INHIBITOR,,Tclin,,,Homo sapiens
162392,138,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,8.8,,EC50,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162394,138,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,8,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495,AGONIST,,Tclin,,,Homo sapiens
162395,156,491,"Alkaline phosphatase, tissue-nonspecific isozyme",Enzyme,P05186,ALPL,PPBT_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
162397,1996,481,Pancreatic triacylglycerol lipase,Enzyme,P16233,PNLIP,LIPP_HUMAN,8.9,,IC50,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5277,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020766s035lbl.pdf,INHIBITOR,,Tclin,,502,Homo sapiens
162398,1283,480,UMP-CMP kinase,Kinase,P30085,CMPK1,KCY_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
162399,2620,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,4.11,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,INHIBITOR,,Tclin,,,Homo sapiens
162402,2403,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896,BLOCKER,,Tclin,,,Homo sapiens
162404,1999,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,5.2007,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900,BLOCKER,,Tclin,,,Homo sapiens
162405,4337,458,Endothelin B receptor,GPCR,P24530,EDNRB,EDNRB_HUMAN,6.98,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162411,2840,429,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,9.68,,EC50,Agonist activity at human VDR expressed in HEK293 cells by luciferase reporter gene assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1042,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1042,AGONIST,,Tclin,,,Homo sapiens
162412,2838,429,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1536,AGONIST,,Tclin,,,Homo sapiens
162413,2066,429,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,8.7,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200622,AGONIST,,Tclin,,,Homo sapiens
162414,466,429,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,8.4,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846,AGONIST,,Tclin,,,Homo sapiens
162415,3862,426,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,7.3,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,AGONIST,,Tclin,,,Homo sapiens
162416,2722,426,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,6.7,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,AGONIST,,Tclin,,,Homo sapiens
162417,3862,415,Retinoic acid receptor RXR-gamma,Nuclear hormone receptor,P48443,RXRG,RXRG_HUMAN,6.66,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,AGONIST,,Tclin,,,Homo sapiens
162419,3862,414,Retinoic acid receptor RXR-beta,Nuclear hormone receptor,P28702,RXRB,RXRB_HUMAN,6.7,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,AGONIST,,Tclin,,,Homo sapiens
162421,3862,413,Retinoic acid receptor RXR-alpha,Nuclear hormone receptor,P19793,RXRA,RXRA_HUMAN,6.5,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,AGONIST,,Tclin,,,Homo sapiens
162423,2809,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,9.1549,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1339,INHIBITOR,,Tclin,,,Homo sapiens
162424,2441,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,9,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4743,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,INHIBITOR,,Tclin,,,Homo sapiens
162431,2352,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,7.5229,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
162432,864,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,7.5768,,Ki,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
162433,864,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,7.6778,,Ki,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
162434,2767,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,6.27,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408,AGONIST,,Tclin,,,Homo sapiens
162436,2405,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,7.04,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,AGONIST,,Tclin,,,Homo sapiens
162437,2179,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,6.23,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595,AGONIST,,Tclin,,,Homo sapiens
162438,4110,392,Vasopressin V2 receptor,GPCR,P30518,AVPR2,V2R_HUMAN,9,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022275s014lbl.pdf,ANTAGONIST,,Tclin,,127,Homo sapiens
162439,2707,388,"DNA topoisomerase I, mitochondrial",Enzyme,Q969P6,TOP1MT,TOP1M_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84,INHIBITOR,,Tclin,,,Homo sapiens
162441,1045,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,9.22,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,INHIBITOR,,Tclin,,,Homo sapiens
162442,939,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,9.0862,,Kd,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
162443,475,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,ANTAGONIST,,Tclin,,,Homo sapiens
162445,60,384,Neprilysin,Enzyme,P08473,MME,NEP_HUMAN,9,,IC50,Inhibition of human NEP-mediated amyloid beta hydrolysis,CHEMBL,=,1,KEGG DRUG,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10247,http://www.kegg.jp/entry/D08464,INHIBITOR,,Tclin,,,Homo sapiens
162447,785,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,9.6,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5678,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,INHIBITOR,,Tclin,,,Homo sapiens
162449,2355,379,Melatonin receptor type 1B,GPCR,P49286,MTNR1B,MTR1B_HUMAN,10.39,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1218,AGONIST,,Tclin,,,Homo sapiens
162451,2355,378,Melatonin receptor type 1A,GPCR,P48039,MTNR1A,MTR1A_HUMAN,10.9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1218,AGONIST,,Tclin,,,Homo sapiens
162452,2852,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,6.4318,,Ki,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/10102460,INHIBITOR,,Tclin,,399,Homo sapiens
162453,239,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,7.39794,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1166,INHIBITOR,,Tclin,,,Homo sapiens
162455,2308,357,Thyroid peroxidase,Enzyme,P07202,TPO,PERT_HUMAN,5.06,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1518,INHIBITOR,,Tclin,,,Homo sapiens
162456,1745,357,Thyroid peroxidase,Enzyme,P07202,TPO,PERT_HUMAN,5.57,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1515,INHIBITOR,,Tclin,,,Homo sapiens
162457,2525,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL421,INHIBITOR,,Tclin,,,Homo sapiens
162458,1650,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,4.33,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,INHIBITOR,,Tclin,,,Homo sapiens
162459,2968,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,9.025,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200554,AGONIST,,Tclin,,,Homo sapiens
4896,1010,416,Envelope glycoprotein,Viral envelope protein,Q53I07,gp41,Q53I07_9HIV1,,,,,WOMBAT-PK,,,,,,,,,,,Human immunodeficiency virus 1
162460,1868,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,9.699,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200671,AGONIST,,Tclin,,,Homo sapiens
162461,1559,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,9.5229,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200775,AGONIST,,Tclin,,,Homo sapiens
162463,1422,341,Prostacyclin receptor,GPCR,P43119,PTGIR,PI2R_HUMAN,7.75,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL494,AGONIST,,Tclin,,,Homo sapiens
162464,1034,341,Prostacyclin receptor,GPCR,P43119,PTGIR,PI2R_HUMAN,7.8,,Ki,,IUPHAR,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL962,AGONIST,,Tclin,,,Homo sapiens
162465,138,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,9,,EC50,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162466,928,338,"Aldehyde dehydrogenase, mitochondrial",Enzyme,P05091,ALDH2,ALDH2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL964,INHIBITOR,,Tclin,,,Homo sapiens
162469,864,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,7.301,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,INHIBITOR,,Tclin,,,Homo sapiens
162471,2657,327,P2Y purinoceptor 12,GPCR,Q9H244,P2RY12,P2Y12_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL833,ANTAGONIST,,Tclin,,,Homo sapiens
162472,708,327,P2Y purinoceptor 12,GPCR,Q9H244,P2RY12,P2Y12_HUMAN,6.9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1771,ANTAGONIST,,Tclin,,,Homo sapiens
162473,2098,326,Adenosine deaminase,Enzyme,P00813,ADA,ADA_HUMAN,10.8,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4805,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1580,INHIBITOR,,Tclin,,,Homo sapiens
162475,2606,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,4.46,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7303,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1571,INHIBITOR,,Tclin,,,Homo sapiens
162476,1556,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,8.22,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1444,INHIBITOR,,Tclin,,,Homo sapiens
162478,1122,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,5.6925,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200374,INHIBITOR,,Tclin,,,Homo sapiens
162479,210,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,6.2218,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1399,INHIBITOR,,Tclin,,,Homo sapiens
162480,164,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,5.11,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL488,INHIBITOR,,Tclin,,,Homo sapiens
162483,1189,322,DNA polymerase alpha catalytic subunit,Enzyme,P09884,POLA1,DPOLA_HUMAN,,,,,WOMBAT-PK,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020038s033lbl.pdf,INHIBITOR,,Tclin,,565,Homo sapiens
162485,691,322,DNA polymerase alpha catalytic subunit,Enzyme,P09884,POLA1,DPOLA_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1750,INHIBITOR,,Tclin,,,Homo sapiens
162486,2609,320,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,7,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL117785,INHIBITOR,,Tclin,,,Homo sapiens
162487,2370,320,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,7.9,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4823,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL772,INHIBITOR,,Tclin,,,Homo sapiens
162488,864,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.301,,Ki,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
162490,1140,315,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,Q13224,GRIN2B,NMDE2_HUMAN,4.284,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094,ANTAGONIST,,Tclin,,,Homo sapiens
162491,2704,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,8.5086,,IC50,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/6422042,INHIBITOR,,Tclin,,347,Homo sapiens
162492,1021,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,7.6778,,IC50,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/3025043,INHIBITOR,,Tclin,,566,Homo sapiens
162493,1851,310,Peptidoglycan synthase FtsI,Enzyme,P0AD68,ftsI,FTSI_ECOLI,5.9383,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74632,INHIBITOR,,,,,Escherichia coli (strain K12)
162494,564,310,Peptidoglycan synthase FtsI,Enzyme,P0AD68,ftsI,FTSI_ECOLI,6.1419,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL161,INHIBITOR,,,,,Escherichia coli (strain K12)
162495,546,310,Peptidoglycan synthase FtsI,Enzyme,P0AD68,ftsI,FTSI_ECOLI,6.2435,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1010,INHIBITOR,,,,,Escherichia coli (strain K12)
162496,279,310,Peptidoglycan synthase FtsI,Enzyme,P0AD68,ftsI,FTSI_ECOLI,5.7358,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158,INHIBITOR,,,,,Escherichia coli (strain K12)
162498,1137,304,Xanthine dehydrogenase/oxidase,Enzyme,P47989,XDH,XDH_HUMAN,9.22,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1164729,INHIBITOR,,Tclin,,,Homo sapiens
162499,4112,302,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,O43526,KCNQ2,KCNQ2_HUMAN,8,,IC50,,WOMBAT-PK,=,,,,,BLOCKER,,Tclin,,,Homo sapiens
162502,989,299,Gag-Pol polyprotein,Polyprotein,P03369,gag-pol,POL_HV1A2,8.3,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2)
162503,799,299,Gag-Pol polyprotein,Polyprotein,P03369,gag-pol,POL_HV1A2,6.5,,IC50,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2)
162504,2847,298,Vitamin K epoxide reductase complex subunit 1,Enzyme,Q9BQB6,VKORC1,VKOR1_HUMAN,7,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1464,INHIBITOR,,Tclin,,,Homo sapiens
162506,2130,298,Vitamin K epoxide reductase complex subunit 1,Enzyme,Q9BQB6,VKORC1,VKOR1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL711,INHIBITOR,,Tclin,,,Homo sapiens
162508,2351,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,MODULATOR,,Tclin,,,Homo sapiens
4897,1893,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,,,,,WOMBAT-PK,,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
162509,1255,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.74,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358,ANTAGONIST,,Tclin,,,Homo sapiens
162510,128,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,7.2,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162511,2632,282,Inosine-5'-monophosphate dehydrogenase 1,Enzyme,P20839,IMPDH1,IMDH1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL727,INHIBITOR,,Tclin,,,Homo sapiens
162512,2373,282,Inosine-5'-monophosphate dehydrogenase 1,Enzyme,P20839,IMPDH1,IMDH1_HUMAN,6,,IC50,"<i>In vitro</i> inhibition of IMPDH (isoform not specified, human and mouse assayed)",IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6842,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1643,INHIBITOR,,Tclin,,,Homo sapiens
162513,790,271,DNA (cytosine-5)-methyltransferase 1,Enzyme,P26358,DNMT1,DNMT1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201129,INHIBITOR,,Tclin,,,Homo sapiens
162515,1797,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,6.6021,,IC50,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/18974361,BLOCKER,,Tclin,,239,Homo sapiens
162516,342,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,5.1487,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1008,BLOCKER,,Tclin,,,Homo sapiens
162523,1980,260,Somatostatin receptor type 5,GPCR,P35346,SSTR5,SSR5_HUMAN,8.5229,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680,AGONIST,,Tclin,,,Homo sapiens
162524,1980,259,Somatostatin receptor type 3,GPCR,P32745,SSTR3,SSR3_HUMAN,8.3,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680,AGONIST,,Tclin,,,Homo sapiens
162525,1980,258,Somatostatin receptor type 2,GPCR,P30874,SSTR2,SSR2_HUMAN,10.699,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680,AGONIST,,Tclin,,,Homo sapiens
162526,2551,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,7.14,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,INHIBITOR,,Tclin,,,Homo sapiens
162529,1897,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,7.59,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54126,INHIBITOR,,Tclin,,,Homo sapiens
162531,946,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,7.8,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,INHIBITOR,,Tclin,,,Homo sapiens
162532,1878,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,7.27,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162534,1874,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,6,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL895,AGONIST,,Tclin,,,Homo sapiens
162535,1765,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,7.99,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,ANTAGONIST,,Tclin,,,Homo sapiens
162540,434,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,8.07,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162542,1782,245,5-hydroxytryptamine receptor 4,GPCR,Q13639,HTR4,5HT4R_HUMAN,6,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,AGONIST,,Tclin,,,Homo sapiens
162543,2073,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,5.1805,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,INHIBITOR,,Tclin,,,Homo sapiens
162544,2445,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,7.77,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1064,INHIBITOR,,Tclin,,,Homo sapiens
162546,2214,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,8.1675,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201753,INHIBITOR,,Tclin,,,Homo sapiens
162547,1612,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,7.67,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503,INHIBITOR,,Tclin,,,Homo sapiens
162548,577,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,8,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1477,INHIBITOR,,Tclin,,,Homo sapiens
162549,257,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,8,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1487,INHIBITOR,,Tclin,,,Homo sapiens
162550,2279,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.8761,,ED50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,AGONIST,,Tclin,,,Homo sapiens
162551,1968,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200934,AGONIST,,Tclin,,,Homo sapiens
162552,1963,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,11.2596,,ED50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162,AGONIST,,Tclin,,,Homo sapiens
162553,1962,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,11.2596,,ED50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162,AGONIST,,Tclin,,,Homo sapiens
162554,1959,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200807,AGONIST,,Tclin,,,Homo sapiens
162555,1805,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,8.74,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276308,ANTAGONIST,,Tclin,,,Homo sapiens
162557,1659,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.59,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717,AGONIST,,Tclin,,,Homo sapiens
162559,1572,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,12.7959,,ED50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1389,AGONIST,,Tclin,,,Homo sapiens
162561,1225,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.77,,EC50,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162562,1110,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1531,AGONIST,,Tclin,,,Homo sapiens
162563,1095,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200624,AGONIST,,Tclin,,,Homo sapiens
162564,968,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,10.5,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1509,AGONIST,,Tclin,,,Homo sapiens
162565,818,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1533,AGONIST,,Tclin,,,Homo sapiens
162566,779,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1479,AGONIST,,Tclin,,,Homo sapiens
162567,1922,236,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,7.7,,IC50,Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2514,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,GATING INHIBITOR,,Tclin,,,Homo sapiens
162568,1511,236,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,9.3,,IC50,Recombinant Ca<sub>v</sub>1.3 calcium channel complexes expressed in tsA201-cells,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4488,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648,GATING INHIBITOR,,Tclin,,,Homo sapiens
162569,1142,236,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480,BLOCKER,,Tclin,,,Homo sapiens
162570,674,236,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132,BLOCKER,,Tclin,,,Homo sapiens
162571,183,236,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,7,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491,BLOCKER,,Tclin,,,Homo sapiens
162572,3862,231,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,6.52,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,AGONIST,,Tclin,,,Homo sapiens
162573,2722,231,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,6.7,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,AGONIST,,Tclin,,,Homo sapiens
162574,2255,215,Voltage-dependent calcium channel subunit alpha-2/delta-1,Ion channel,P54289,CACNA2D1,CA2D1_HUMAN,7.0969,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059,MODULATOR,,Tclin,,,Homo sapiens
162575,1264,215,Voltage-dependent calcium channel subunit alpha-2/delta-1,Ion channel,P54289,CACNA2D1,CA2D1_HUMAN,7.26,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940,MODULATOR,,Tclin,,,Homo sapiens
162577,864,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,8.301,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,INHIBITOR,,Tclin,,,Homo sapiens
162578,2073,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,6.4685,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,INHIBITOR,,Tclin,,,Homo sapiens
162579,1283,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
162580,480,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1773,INHIBITOR,,Tclin,,,Homo sapiens
162581,26,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185,INHIBITOR,,Tclin,,,Homo sapiens
162582,3483,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,9.3984,,MIC,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1397,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
162583,2846,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,8.7303,,MIC,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL638,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
162584,1527,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,7,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
162585,1513,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,9.2465,,MIC,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
162586,1187,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,6.699,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
162588,973,207,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,P18405,SRD5A1,S5A1_HUMAN,8.49,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200969,INHIBITOR,,Tclin,,,Homo sapiens
162590,1171,206,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,P31213,SRD5A2,S5A2_HUMAN,8.26,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020788s024lbl.pdf,INHIBITOR,,Tclin,,107,Homo sapiens
162592,973,206,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,P31213,SRD5A2,S5A2_HUMAN,9.2,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200969,INHIBITOR,,Tclin,,,Homo sapiens
162594,2751,204,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL695,BLOCKER,,Tclin,,,Homo sapiens
162595,1087,204,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL696,BLOCKER,,Tclin,,,Homo sapiens
162596,2607,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.2,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630,AGONIST,,Tclin,,,Homo sapiens
162597,2033,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200585,AGONIST,,Tclin,,,Homo sapiens
162598,1882,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.5,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200412,AGONIST,,Tclin,,,Homo sapiens
4674,639,70,DNA polymerase catalytic subunit,Enzyme,P04293,,DPOL_HHV11,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL152,INHIBITOR,,,,,Human herpesvirus 1 (strain 17)
162599,4749,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.0824943,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105395,MODULATOR,,Tclin,,,Homo sapiens
162600,2709,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1655,MODULATOR,,Tclin,,,Homo sapiens
162601,1255,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.62,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358,ANTAGONIST,,Tclin,,,Homo sapiens
162602,1082,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.83,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL691,AGONIST,,Tclin,,,Homo sapiens
162603,1057,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,10.3,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,AGONIST,,Tclin,,,Homo sapiens
162605,1679,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL807,NEGATIVE ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
162607,842,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,5.699,,IC50,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162609,2805,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096885,INHIBITOR,,Tclin,,,Homo sapiens
162610,2590,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,,,,Mechanism of Action; CHEMBL2094255; PROTEIN FAMILY,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL452231,INHIBITOR,,Tclin,,,Homo sapiens
162611,1821,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,5.9586,,IC90,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58,INHIBITOR,,Tclin,,,Homo sapiens
162612,1414,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1117,INHIBITOR,,Tclin,,,Homo sapiens
162616,786,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL178,INHIBITOR,,Tclin,,,Homo sapiens
162617,926,188,G protein-activated inward rectifier potassium channel 4,Ion channel,P48544,KCNJ5,KCNJ5_HUMAN,4.9208,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
4395,2447,85,30S ribosomal protein S12,Cytosolic other,P0A7S3,rpsL,RS12_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
4397,2082,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
4398,632,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
4399,1183,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
4400,524,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
4401,2083,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
4402,2512,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1191,INHIBITOR,,,,,Escherichia coli (strain K12)
4403,2524,351,Dihydropteroate synthase type-1,Enzyme,Q49184,sulI,DHP1_MYCFO,,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium fortuitum
4407,802,193,30S ribosomal protein S4,Ribosomal protein,P0A7V8,rpsD,RS4_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
4408,802,194,30S ribosomal protein S9,Ribosomal protein,P0A7X3,rpsI,RS9_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
4409,2041,193,30S ribosomal protein S4,Ribosomal protein,P0A7V8,rpsD,RS4_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
4410,2041,194,30S ribosomal protein S9,Ribosomal protein,P0A7X3,rpsI,RS9_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
4411,2468,85,30S ribosomal protein S12,Cytosolic other,P0A7S3,rpsL,RS12_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
4412,2624,122,50S ribosomal protein L10,Ribosomal protein,P15825,rpl10,RL10_HALMA,,,,,WOMBAT-PK,,,,,,,,,,,Haloarcula marismortui (strain ATCC 43049 / DSM 3752 / JCM 8966 / VKM B-1809)
4428,1331,356,Tubulin beta chain,Structural,P10875,TUB2,TBB_CANAX,,,,,WOMBAT-PK,,,,,,,,,,,Candida albicans
4454,2050,358,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,Kinase,P9WNC6,folK,HPPK_MYCTO,,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
4455,1083,229,Catalase-peroxidase,Enzyme,P9WIE4,katG,KATG_MYCTO,,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
4495,1561,368,Acetylcholine receptor subunit alpha-type unc-63,Ion channel,Q9N587,unc-63,ACH6_CAEEL,,,,,WOMBAT-PK,,,,,,,,,,,Caenorhabditis elegans
4505,2241,370,Glutathione S-transferase class-mu 26 kDa isozyme,Enzyme,P08515,,GST26_SCHJA,,,,,WOMBAT-PK,,,,,,,,,,,Schistosoma japonicum
4543,365,222,Penicillin-binding protein 2,Enzyme,Q9X6V3,pbpA,Q9X6V3_PSEAI,,,,,WOMBAT-PK,,,,,,,,,,,Pseudomonas aeruginosa
4544,365,223,Penicillin-binding protein 4,Enzyme,Q5D1E9,,Q5D1E9_STAAU,,,,,WOMBAT-PK,,,,,,,,,,,Staphylococcus aureus
4545,365,224,D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5,Enzyme,Q9X6V7,dacA,Q9X6V7_PSEAI,,,,,WOMBAT-PK,,,,,,,,,,,Pseudomonas aeruginosa
4546,365,225,Penicillin-binding protein 1,Enzyme,A1KS91,ponA,A1KS91_NEIMF,,,,,WOMBAT-PK,,,,,,,,,,,Neisseria meningitidis serogroup C / serotype 2a (strain ATCC 700532 / DSM 15464 / FAM18)
4547,365,226,D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6,Enzyme,Q7CHG0,dacC,Q7CHG0_YERPE,,,,,WOMBAT-PK,,,,,,,,,,,Yersinia pestis
4557,258,373,"Ubiquinol-cytochrome-c reductase complex core protein I, mitochondrial",Enzyme,P43264,,QCR1_EUGGR,,,,,WOMBAT-PK,,,,,,,,,,,Euglena gracilis
4559,759,375,Alanine racemase,Enzyme,P9WQA8,alr,ALR_MYCTO,,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
4619,783,389,Outer membrane porin protein OmpD,Transporter,Q57P83,ompD,OMPD_SALCH,,,,,WOMBAT-PK,,,,,,,,,,,Salmonella choleraesuis (strain SC-B67)
4623,1128,70,DNA polymerase catalytic subunit,Enzyme,P04293,,DPOL_HHV11,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL880,INHIBITOR,,,,,Human herpesvirus 1 (strain 17)
4624,1128,71,DNA polymerase catalytic subunit,Enzyme,P09252,,DPOL_VZVD,,,,,WOMBAT-PK,,,,,,,,,,,Varicella-zoster virus (strain Dumas)
4651,2188,394,Gamma-aminobutyric acid receptor subunit beta,Ion channel,O18276,gab-1,GBRB_CAEEL,,,,,WOMBAT-PK,,,,,,,,,,,Caenorhabditis elegans
4707,2798,70,DNA polymerase catalytic subunit,Enzyme,P04293,,DPOL_HHV11,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1349,INHIBITOR,,,,,Human herpesvirus 1 (strain 17)
4712,1857,402,Isoleucine--tRNA ligase,Enzyme,P00956,ileS,SYI_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
162618,2815,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,6,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,BLOCKER,,Tclin,,,Homo sapiens
162619,1511,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648,BLOCKER,,Tclin,,,Homo sapiens
162620,1142,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480,BLOCKER,,Tclin,,,Homo sapiens
162621,897,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,7.3188,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23,BLOCKER,,Tclin,,,Homo sapiens
162622,674,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132,BLOCKER,,Tclin,,,Homo sapiens
162623,183,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491,BLOCKER,,Tclin,,,Homo sapiens
162624,2733,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,7,,A2,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,INHIBITOR,,Tclin,,,Homo sapiens
162625,2228,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,9.09,,A2,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1587,INHIBITOR,,Tclin,,,Homo sapiens
162626,1433,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,7.54,,A2,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,INHIBITOR,,Tclin,,,Homo sapiens
162627,1392,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,7.37,,A2,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1763,INHIBITOR,,Tclin,,,Homo sapiens
162628,1385,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,7.01,,A2,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL435,INHIBITOR,,Tclin,,,Homo sapiens
162629,609,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,5.43,,A2,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL842,INHIBITOR,,Tclin,,,Homo sapiens
162630,332,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,8.17,,A2,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201039,INHIBITOR,,Tclin,,,Homo sapiens
162631,305,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,8.3,,A2,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1684,INHIBITOR,,Tclin,,,Homo sapiens
162632,824,184,Interleukin-4,Cytokine,P05112,IL4,IL4_HUMAN,8.33,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
162633,2475,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,9.8844,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1393,ANTAGONIST,,Tclin,,,Homo sapiens
162634,1032,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,7,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095097,ANTAGONIST,,Tclin,,,Homo sapiens
162635,968,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,10.5,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1509,ANTAGONIST,,Tclin,,,Homo sapiens
162636,822,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,11,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200592,AGONIST,,Tclin,,,Homo sapiens
162637,897,182,Voltage-dependent calcium channel gamma-1 subunit,Ion channel,Q06432,CACNG1,CCG1_HUMAN,6.1,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
162638,183,182,Voltage-dependent calcium channel gamma-1 subunit,Ion channel,Q06432,CACNG1,CCG1_HUMAN,7.2,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
162639,782,181,Dihydropteroate synthase 1,Enzyme,P0C0X1,folP1,DHPS1_MYCLE,5.9,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1043,INHIBITOR,,,,,Mycobacterium leprae (strain TN)
162640,760,180,Peptidyl-prolyl cis-trans isomerase A,Enzyme,P62937,PPIA,PPIA_HUMAN,8.0458,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,MODULATOR,,Tclin,,,Homo sapiens
162641,760,179,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q02127,DHODH,PYRD_HUMAN,6.699,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162642,2552,178,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,P62942,FKBP1A,FKB1A_HUMAN,9.398,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732,INHIBITOR,,Tclin,,,Homo sapiens
162643,2446,178,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,P62942,FKBP1A,FKB1A_HUMAN,8.96,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413,INHIBITOR,,Tclin,,,Homo sapiens
162644,2168,178,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,P62942,FKBP1A,FKB1A_HUMAN,9,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200686,INHIBITOR,,Tclin,,,Homo sapiens
162645,1118,178,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,P62942,FKBP1A,FKB1A_HUMAN,8.25964,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908360,INHIBITOR,,Tclin,,,Homo sapiens
162646,760,178,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,P62942,FKBP1A,FKB1A_HUMAN,7.7959,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162647,2034,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.8297,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,AGONIST,,Tclin,,,Homo sapiens
162648,1878,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,8.5,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162649,1874,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,8,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL895,AGONIST,,Tclin,,,Homo sapiens
162650,1765,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,8.93,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,ANTAGONIST,,Tclin,,,Homo sapiens
162652,847,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1685,ANTAGONIST,,Tclin,,,Homo sapiens
162655,434,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,9.01,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142,ANTAGONIST,,Tclin,,,Homo sapiens
162657,3584,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,9.08,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611,ANTAGONIST,,Tclin,,,Homo sapiens
162659,2146,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215,AGONIST,,Tclin,,,Homo sapiens
162662,954,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,9.1,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL707,ANTAGONIST,,Tclin,,,Homo sapiens
162663,429,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,,WOMBAT-PK,,1,KEGG DRUG,,http://www.kegg.jp/entry/D01887,ANTAGONIST,,Tclin,,,Homo sapiens
162664,1992,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,7.8,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,ANTAGONIST,,Tclin,,,Homo sapiens
162665,1782,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,6.699,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,ANTAGONIST,,Tclin,,,Homo sapiens
162666,1329,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,8.7,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289469,ANTAGONIST,,Tclin,,,Homo sapiens
162669,3584,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,9.2,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611,ANTAGONIST,,Tclin,,,Homo sapiens
162671,2146,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.9,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215,AGONIST,,Tclin,,,Homo sapiens
162672,1753,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,4.9,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL524,AGONIST,,Tclin,,,Homo sapiens
162673,954,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.85,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL707,ANTAGONIST,,Tclin,,,Homo sapiens
162675,228,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.1871,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162676,659,166,DNA gyrase subunit A,Enzyme,P0AES4,gyrA,GYRA_ECOLI,5.75,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8,INHIBITOR,,,,,Escherichia coli (strain K12)
162678,659,164,DNA topoisomerase 4 subunit A,Enzyme,P0C1U9,parC,PARC_STAAU,6,,IC50,,WOMBAT-PK,=,,,,,INHIBITOR,,,,,Staphylococcus aureus
162679,864,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.4202,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,INHIBITOR,,Tclin,,,Homo sapiens
162691,2865,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.3,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tchem,,,Homo sapiens
162692,2402,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.07,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tchem,,,Homo sapiens
162693,2389,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tchem,,,Homo sapiens
162694,2172,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.7447,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tchem,,,Homo sapiens
162695,2105,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.25,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tchem,,,Homo sapiens
162696,1982,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.7959,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tchem,,,Homo sapiens
162698,947,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,9,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tchem,,,Homo sapiens
162699,722,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.52,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tchem,,,Homo sapiens
162701,621,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.69,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tchem,,,Homo sapiens
162703,437,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
162704,242,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.65,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
162711,2099,149,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,Q07343,PDE4B,PDE4B_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628,INHIBITOR,,Tclin,,,Homo sapiens
162712,976,149,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,Q07343,PDE4B,PDE4B_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1752,INHIBITOR,,Tclin,,,Homo sapiens
162714,463,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,4.33,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tchem,,,Homo sapiens
162716,463,147,Adenosine receptor A2b,GPCR,P29275,ADORA2B,AA2BR_HUMAN,4.77,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,ANTAGONIST,,Tclin,,,Homo sapiens
162718,90,147,Adenosine receptor A2b,GPCR,P29275,ADORA2B,AA2BR_HUMAN,4.6198,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477,AGONIST,,Tclin,,,Homo sapiens
162719,90,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,6.5086,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477,AGONIST,,Tclin,,,Homo sapiens
162720,4501,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.4975,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201192,INHIBITOR,,Tclin,,,Homo sapiens
162721,2440,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.0255,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1419,INHIBITOR,,Tclin,,,Homo sapiens
162722,2133,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.8827,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200483,INHIBITOR,,Tclin,,,Homo sapiens
162723,841,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.68,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,RELEASING AGENT,,Tclin,,,Homo sapiens
162727,435,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.28,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL894,INHIBITOR,,Tclin,,,Homo sapiens
4900,200,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,,,,,WOMBAT-PK,,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
4914,1286,256,DNA gyrase subunit B,Enzyme,P0AES7,gyrB,GYRB_ECO57,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli O157:H7
4915,1286,257,DNA topoisomerase 4 subunit A,Enzyme,P72525,parC,PARC_STRPN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL430,INHIBITOR,,,,,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
4925,692,419,Uncharacterized oxidoreductase CzcO-like,Enzyme,Q5L2G3,,CZCO_GEOKA,,,,,WOMBAT-PK,,,,,,,,,,,Geobacillus kaustophilus (strain HTA426)
4971,2478,299,Gag-Pol polyprotein,Polyprotein,P03369,gag-pol,POL_HV1A2,,,,,WOMBAT-PK,,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2)
5017,2282,278,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,O02604,,DRTS_PLAVI,,,,,WOMBAT-PK,,,,,,,,,,,Plasmodium vivax
5018,2282,277,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q0IJY2,,Q0IJY2_PLAMA,,,,,WOMBAT-PK,,,,,,,,,,,Plasmodium malariae
5155,2599,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1306,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
5176,1364,471,D-lactate dehydrogenase,Enzyme,P06149,dld,DLD_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
5275,533,478,"Pencillin binding protein 2a; Penicillin binding protein 2'; Penicillin binding protein, PBP2; Penicillin-binding protein 2; Penicillin-binding protein 2'; Peptidase",Unclassified,O54286,mecA,O54286_STAAU,,,,,WOMBAT-PK,,,,,,,,,,,Staphylococcus aureus
5276,533,479,Penicillin-binding protein 3,Unclassified,Q14TG6,pbp3,Q14TG6_HAEIF,,,,,WOMBAT-PK,,,,,,,,,,,Haemophilus influenzae
5299,2434,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200725,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
5303,2593,299,Gag-Pol polyprotein,Polyprotein,P03369,gag-pol,POL_HV1A2,,,,,WOMBAT-PK,,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2)
5304,1243,484,UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1,Enzyme,Q836E5,murA1,MURA1_ENTFA,,,,,WOMBAT-PK,,,,,,,,,,,Enterococcus faecalis (strain ATCC 700802 / V583)
5305,1243,485,UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2,Enzyme,Q831A8,murA2,MURA2_ENTFA,,,,,WOMBAT-PK,,,,,,,,,,,Enterococcus faecalis (strain ATCC 700802 / V583)
5310,534,487,Penicillin-binding protein,Unclassified,Q54906,dacA,Q54906_STRPY,,,,,WOMBAT-PK,,,,,,,,,,,Streptococcus pyogenes
5311,534,479,Penicillin-binding protein 3,Unclassified,Q14TG6,pbp3,Q14TG6_HAEIF,,,,,WOMBAT-PK,,,,,,,,,,,Haemophilus influenzae
5314,1896,489,Phenylalanine--tRNA ligase alpha subunit,Enzyme,P08312,pheS,SYFA_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
5315,1896,490,Phenylalanine--tRNA ligase beta subunit,Enzyme,P07395,pheT,SYFB_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
5316,1896,85,30S ribosomal protein S12,Cytosolic other,P0A7S3,rpsL,RS12_ECOLI,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
5335,1358,492,Antithrombin-III,Secreted,P01008,SERPINC1,ANT3_HUMAN,7.85,,Kd,Catalyses the inactivation of coagulation proteases by activatted antithrombin-III,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4214,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526514,ACTIVATOR,,Tclin,,,Homo sapiens
5404,103,499,Tubulin alpha chain,Structural,P50719,,TBA_HAECO,,,,,WOMBAT-PK,,,,,,,,,,,Haemonchus contortus
5414,1601,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,,,,,WOMBAT-PK,,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
5417,2999,502,Acetylcholinesterase,Enzyme,O96529,ACHE,O96529_MELIC,,,,,WOMBAT-PK,,,,,,,,,,,Meloidogyne incognita
5426,2621,504,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",Enzyme,Q09508,sdha-1,SDHA_CAEEL,,,,,WOMBAT-PK,,,,,,,,,,,Caenorhabditis elegans
5445,1709,222,Penicillin-binding protein 2,Enzyme,Q9X6V3,pbpA,Q9X6V3_PSEAI,,,,,WOMBAT-PK,,,,,,,,,,,Pseudomonas aeruginosa
5446,1709,223,Penicillin-binding protein 4,Enzyme,Q5D1E9,,Q5D1E9_STAAU,,,,,WOMBAT-PK,,,,,,,,,,,Staphylococcus aureus
5447,1709,224,D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5,Enzyme,Q9X6V7,dacA,Q9X6V7_PSEAI,,,,,WOMBAT-PK,,,,,,,,,,,Pseudomonas aeruginosa
5448,1709,225,Penicillin-binding protein 1,Enzyme,A1KS91,ponA,A1KS91_NEIMF,,,,,WOMBAT-PK,,,,,,,,,,,Neisseria meningitidis serogroup C / serotype 2a (strain ATCC 700532 / DSM 15464 / FAM18)
5449,1709,226,D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6,Enzyme,Q7CHG0,dacC,Q7CHG0_YERPE,,,,,WOMBAT-PK,,,,,,,,,,,Yersinia pestis
5450,1046,222,Penicillin-binding protein 2,Enzyme,Q9X6V3,pbpA,Q9X6V3_PSEAI,,,,,WOMBAT-PK,,,,,,,,,,,Pseudomonas aeruginosa
5451,1046,223,Penicillin-binding protein 4,Enzyme,Q5D1E9,,Q5D1E9_STAAU,,,,,WOMBAT-PK,,,,,,,,,,,Staphylococcus aureus
5452,1046,224,D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5,Enzyme,Q9X6V7,dacA,Q9X6V7_PSEAI,,,,,WOMBAT-PK,,,,,,,,,,,Pseudomonas aeruginosa
5453,1046,225,Penicillin-binding protein 1,Enzyme,A1KS91,ponA,A1KS91_NEIMF,,,,,WOMBAT-PK,,,,,,,,,,,Neisseria meningitidis serogroup C / serotype 2a (strain ATCC 700532 / DSM 15464 / FAM18)
5454,1046,226,D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6,Enzyme,Q7CHG0,dacC,Q7CHG0_YERPE,,,,,WOMBAT-PK,,,,,,,,,,,Yersinia pestis
162728,138,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,6.8,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495,AGONIST,,Tclin,,,Homo sapiens
162729,2403,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896,BLOCKER,,Tclin,,,Homo sapiens
162730,1999,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,4.7645,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900,BLOCKER,,Tclin,,,Homo sapiens
162731,1700,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087,BLOCKER,,Tclin,,,Homo sapiens
162732,2403,141,Sodium channel protein type 8 subunit alpha,Ion channel,Q9UQD0,SCN8A,SCN8A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896,BLOCKER,,Tclin,,,Homo sapiens
162733,1700,141,Sodium channel protein type 8 subunit alpha,Ion channel,Q9UQD0,SCN8A,SCN8A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087,BLOCKER,,Tclin,,,Homo sapiens
162734,2403,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896,BLOCKER,,Tclin,,,Homo sapiens
162735,1999,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,5.6576,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900,BLOCKER,,Tclin,,,Homo sapiens
162736,1794,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,4.38,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,BLOCKER,,Tclin,,,Homo sapiens
162738,1700,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087,BLOCKER,,Tclin,,,Homo sapiens
162739,1097,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL492,BLOCKER,,Tclin,,,Homo sapiens
162740,432,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,6,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1098,BLOCKER,,Tclin,,,Homo sapiens
162741,4,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200749,BLOCKER,,Tclin,,,Homo sapiens
162742,2403,139,Sodium channel protein type 3 subunit alpha,Ion channel,Q9NY46,SCN3A,SCN3A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896,BLOCKER,,Tclin,,,Homo sapiens
162744,1700,139,Sodium channel protein type 3 subunit alpha,Ion channel,Q9NY46,SCN3A,SCN3A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087,BLOCKER,,Tclin,,,Homo sapiens
162745,2403,138,Sodium channel protein type 2 subunit alpha,Ion channel,Q99250,SCN2A,SCN2A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896,BLOCKER,,Tclin,,,Homo sapiens
162747,1700,138,Sodium channel protein type 2 subunit alpha,Ion channel,Q99250,SCN2A,SCN2A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087,BLOCKER,,Tclin,,,Homo sapiens
162748,2872,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,BLOCKER,,Tclin,,,Homo sapiens
162749,2403,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896,BLOCKER,,Tclin,,,Homo sapiens
162750,2114,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,,,,,WOMBAT-PK,,,,,,BLOCKER,,Tclin,,,Homo sapiens
162751,1999,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,4.8894,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900,BLOCKER,,Tclin,,,Homo sapiens
162752,1700,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087,BLOCKER,,Tclin,,,Homo sapiens
162755,427,136,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P05023,ATP1A1,AT1A1_HUMAN,7.52,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162756,2708,135,Solute carrier family 12 member 1,Transporter,Q13621,SLC12A1,S12A1_HUMAN,6.4,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1148,INHIBITOR,,Tclin,,,Homo sapiens
162757,1258,135,Solute carrier family 12 member 1,Transporter,Q13621,SLC12A1,S12A1_HUMAN,6.2,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,INHIBITOR,,Tclin,,,Homo sapiens
162758,1071,135,Solute carrier family 12 member 1,Transporter,Q13621,SLC12A1,S12A1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL456,INHIBITOR,,Tclin,,,Homo sapiens
162760,427,135,Solute carrier family 12 member 1,Transporter,Q13621,SLC12A1,S12A1_HUMAN,7.6,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1072,INHIBITOR,,Tclin,,,Homo sapiens
162761,419,134,Interferon gamma,Cytokine,P01579,IFNG,IFNG_HUMAN,9.5,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162762,824,133,Interleukin-5,Cytokine,P05113,IL5,IL5_HUMAN,8.456,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162763,419,133,Interleukin-5,Cytokine,P05113,IL5,IL5_HUMAN,9.92,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162764,2695,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.43,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770,ANTAGONIST,,Tclin,,,Homo sapiens
162765,2683,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1079,AGONIST,,Tclin,,,Homo sapiens
162766,1343,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.68,,EC50,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162767,922,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833,AGONIST,,Tclin,,,Homo sapiens
162768,704,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.7,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,AGONIST,,Tclin,,,Homo sapiens
162769,395,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.4685,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL844,AGONIST,,Tclin,,,Homo sapiens
162770,2869,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8.9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1185,AGONIST,,Tclin,,,Homo sapiens
162771,2393,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL905,AGONIST,,Tclin,,,Homo sapiens
162773,1884,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8.7959,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1278,AGONIST,,Tclin,,,Homo sapiens
162774,403,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162775,128,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.5,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1505,AGONIST,,Tclin,,,Homo sapiens
162776,2869,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.7,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1185,AGONIST,,Tclin,,,Homo sapiens
27126,2875,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,5.703993320465088,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
162777,2393,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL905,AGONIST,,Tclin,,,Homo sapiens
162779,128,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,8,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1505,AGONIST,,Tclin,,,Homo sapiens
162780,1499,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,8.5,,EC50,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162781,2726,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.3,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1504,AGONIST,,Tclin,,,Homo sapiens
162782,2253,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL635,AGONIST,,Tclin,,,Homo sapiens
162783,2245,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.8,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,AGONIST,,Tclin,,,Homo sapiens
162784,1805,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276308,ANTAGONIST,,Tclin,,,Homo sapiens
162785,1768,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.5,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL650,AGONIST,,Tclin,,,Homo sapiens
5582,104,499,Tubulin alpha chain,Structural,P50719,,TBA_HAECO,,,,,WOMBAT-PK,,,,,,,,,,,Haemonchus contortus
5626,1019,530,Protein P,Polyprotein,P17394,P,DPOL_HBVB1,,,,,WOMBAT-PK,,,,,,,,,,,Hepatitis B virus genotype B1 subtype adw (isolate Japan/pJDW233/1988)
5707,1798,551,"Beta-1,3-glucan synthase",Unclassified,Q5AIC4,GSC1,Q5AIC4_CANAL,,,,,WOMBAT-PK,,,,,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
5729,2449,256,DNA gyrase subunit B,Enzyme,P0AES7,gyrB,GYRB_ECO57,,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli O157:H7
5730,2449,257,DNA topoisomerase 4 subunit A,Enzyme,P72525,parC,PARC_STRPN,,,,,WOMBAT-PK,,,,,,,,,,,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
5838,1242,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,,WOMBAT-PK,,,,,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
5851,1240,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,,,,,WOMBAT-PK,,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
162786,1388,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.5,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL389621,AGONIST,,Tclin,,,Homo sapiens
162787,1225,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,10.74,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1473,AGONIST,,Tclin,,,Homo sapiens
162788,1201,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.1,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1512,AGONIST,,Tclin,,,Homo sapiens
162789,824,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.88,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,AGONIST,,Tclin,,,Homo sapiens
162791,734,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.02,,Kd,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D00973,AGONIST,,Tclin,,,Homo sapiens
162792,633,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.43,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2040682,AGONIST,,Tclin,,,Homo sapiens
162793,419,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,10.3,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370,AGONIST,,Tclin,,,Homo sapiens
162794,348,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.07,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL632,AGONIST,,Tclin,,,Homo sapiens
162796,342,126,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Ion channel,O00555,CACNA1A,CAC1A_HUMAN,6.6,,Ki,,WOMBAT-PK,=,,,,,BLOCKER,,Tchem,,,Homo sapiens
162797,2712,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.12,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1519,INHIBITOR,,Tclin,,,Homo sapiens
162800,2356,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.3418,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1168,INHIBITOR,,Tclin,,,Homo sapiens
162802,1587,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.92,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237,INHIBITOR,,Tclin,,,Homo sapiens
162806,641,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.7,,IC50,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/2419701,INHIBITOR,,Tclin,,211,Homo sapiens
162808,484,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.7,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,INHIBITOR,,Tclin,,,Homo sapiens
162809,299,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,6.51,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL838,INHIBITOR,,Tclin,,,Homo sapiens
162813,2620,121,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,3.85,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,INHIBITOR,,Tclin,,,Homo sapiens
162814,644,121,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,6.7,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7148,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL799,INHIBITOR,,Tclin,,,Homo sapiens
162815,201,121,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,4.78,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12856,INHIBITOR,,Tclin,,,Homo sapiens
162816,488,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.0969,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162817,333,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.5528,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162818,260,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,9.29,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162819,916,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.9508,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162820,333,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.9586,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162821,260,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,9.39,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162822,4191,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.2706,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201764,ANTAGONIST,,Tclin,,,Homo sapiens
162823,2776,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1888176,ANTAGONIST,,Tclin,,,Homo sapiens
162824,2677,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,11.1,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1182657,ANTAGONIST,,Tclin,,,Homo sapiens
162825,1475,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.2924,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1464005,ANTAGONIST,,Tclin,,,Homo sapiens
162826,1402,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.8,,Ki,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D00147,ANTAGONIST,,Tclin,,,Homo sapiens
162827,722,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.5911,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162828,584,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.3188,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL168815,AGONIST,,Tclin,,,Homo sapiens
162829,488,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.699,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,AGONIST,,Tclin,,,Homo sapiens
162830,333,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.9586,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162831,260,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.5,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,ANTAGONIST,,Tclin,,,Homo sapiens
162832,4191,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.401,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201764,ANTAGONIST,,Tclin,,,Homo sapiens
162833,1402,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,9.3,,Ki,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D00147,ANTAGONIST,,Tclin,,,Homo sapiens
162834,916,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.9208,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162835,488,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.9208,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162836,333,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.8539,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162837,260,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.97,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,ANTAGONIST,,Tclin,,,Homo sapiens
162838,2424,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL569713,ANTAGONIST,,Tclin,,,Homo sapiens
162839,2039,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200906,ANTAGONIST,,Tclin,,,Homo sapiens
162840,1402,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9,,Ki,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D00147,ANTAGONIST,,Tclin,,,Homo sapiens
162841,1086,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1206,ANTAGONIST,,Tclin,,,Homo sapiens
162842,916,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162843,763,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200828,ANTAGONIST,,Tclin,,,Homo sapiens
162844,584,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.6383,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL168815,AGONIST,,Tclin,,,Homo sapiens
162845,333,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.6364,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200383,ANTAGONIST,,Tclin,,,Homo sapiens
162846,260,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.31,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,ANTAGONIST,,Tclin,,,Homo sapiens
162847,621,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,6.87,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
162849,2358,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.86,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1790041,ANTAGONIST,,Tclin,,,Homo sapiens
162850,1955,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.92,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3183075,ANTAGONIST,,Tclin,,,Homo sapiens
162851,1129,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,7.93,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL902,ANTAGONIST,,Tclin,,,Homo sapiens
162852,645,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.14,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30,ANTAGONIST,,Tclin,,,Homo sapiens
162853,357,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200949,AGONIST,,Tclin,,,Homo sapiens
162855,2298,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL252103,ANTAGONIST,,Tclin,,,Homo sapiens
162856,2286,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.6198,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643,ANTAGONIST,,Tclin,,,Homo sapiens
162857,1999,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.9586,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900,ANTAGONIST,,Tclin,,,Homo sapiens
162858,1986,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.284,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1719,ANTAGONIST,,Tclin,,,Homo sapiens
162859,1605,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.97,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL998,ANTAGONIST,,Tclin,,,Homo sapiens
162861,1566,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.95,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201190,ANTAGONIST,,Tclin,,,Homo sapiens
162863,1564,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.279,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237102,ANTAGONIST,,Tclin,,,Homo sapiens
162864,1530,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.5086,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL534,ANTAGONIST,,Tclin,,,Homo sapiens
162865,1400,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.699,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL896,ANTAGONIST,,Tclin,,,Homo sapiens
162866,1170,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL914,ANTAGONIST,,Tclin,,,Homo sapiens
162867,1027,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1106,ANTAGONIST,,Tclin,,,Homo sapiens
162868,956,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.75,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022036lbl.pdf,ANTAGONIST,,Tclin,,136,Homo sapiens
162869,920,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.0757,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1492,ANTAGONIST,,Tclin,,,Homo sapiens
162870,916,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.81,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL657,ANTAGONIST,,Tclin,,,Homo sapiens
162872,814,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.4,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1172,ANTAGONIST,,Tclin,,,Homo sapiens
162873,812,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.12,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162874,765,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,10.2218,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,ANTAGONIST,,Tclin,,,Homo sapiens
162875,722,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.2,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162876,671,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.585,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1626,ANTAGONIST,,Tclin,,,Homo sapiens
162877,621,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.2,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162878,616,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.15,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL505,ANTAGONIST,,Tclin,,,Homo sapiens
162880,581,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.91,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1000,ANTAGONIST,,Tclin,,,Homo sapiens
162882,404,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.8861,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200967,ANTAGONIST,,Tclin,,,Homo sapiens
162883,271,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.1675,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL639,ANTAGONIST,,Tclin,,,Homo sapiens
162884,82,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.16,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1224,ANTAGONIST,,Tclin,,,Homo sapiens
162886,2105,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.76,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tchem,,,Homo sapiens
162887,947,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,9,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tchem,,,Homo sapiens
162888,722,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.5941,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
162889,2865,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.14,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162890,2637,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.3,,IC50,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162892,2402,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.43,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162893,2389,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.07,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
180708,759,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,5.64,,IC50,In vitro inhibition of [3H]glycine at NMDA receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771,,,,,,,Rattus norvegicus
180709,759,1344,D-alanine--D-alanine ligase,Enzyme,P9WP31,ddl,DDL_MYCTU,,,,Mechanism of Action; CHEMBL2030; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771,INHIBITOR,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
180710,759,1345,Alanine racemase,Enzyme,P9WQA9,alr,ALR_MYCTU,,,,Mechanism of Action; CHEMBL2031; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL771,INHIBITOR,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
180711,3097,1772,Acetylcholine receptor subunit delta,Ion channel,P02718,chrnd,ACHD_TORCA,4.38,,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920,,,,,,,Torpedo californica
180712,3097,2728,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P09483|P12392,Chrna4|Chrnb4,ACHA4_RAT|ACHB4_RAT,4.47,,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920,,,,,,,Rattus norvegicus
180713,3097,2727,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P09483|P12390,Chrna4|Chrnb2,ACHA4_RAT|ACHB2_RAT,4.43,,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920,,,,,,,Rattus norvegicus
180714,3097,3519,Creatine transporter,Unclassified,P28570,Slc6a8,SC6A8_RAT,4.38,,Ki,Inhibition of [3H]-choline brain uptake was determined by in situ brain perfusion studies in male rats,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920,,,,,,,Rattus norvegicus
27127,2875,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.154901504516602,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27128,2875,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.441171646118164,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
180715,3097,2725,Neuronal acetylcholine receptor; alpha3/beta2,Ion channel,P04757|P12390,Chrna3|Chrnb2,ACHA3_RAT|ACHB2_RAT,4.43,,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920,,,,,,,Rattus norvegicus
180716,3097,2726,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P04757|P12392,Chrna3|Chrnb4,ACHA3_RAT|ACHB4_RAT,4.32,,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920,,,,,,,Rattus norvegicus
180717,3097,2724,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,P12389|P12390,Chrna2|Chrnb2,ACHA2_RAT|ACHB2_RAT,4.74,,Ki,Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920,,,,,,,Rattus norvegicus
180718,3097,1961,High affinity choline transporter 1,Unclassified,Q8BGY9,Slc5a7,SC5A7_MOUSE,5.8,,IC50,In vitro ability to inhibit the transport of [3H]choline in to high affinity choline transport system HAChT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL920,,,,,,,Mus musculus
180719,3524,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,4.97,,Ki,Inhibition of human carbonic anhydrase 14 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147,,,,Tclin,,,Homo sapiens
180720,3524,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,5.06,,Ki,Inhibition of human carbonic anhydrase 5A by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147,,,,Tclin,,,Homo sapiens
180721,3524,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,4.2,,Ki,Inhibition of mouse carbonic anhydrase 13 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147,,,,,,,Mus musculus
180722,3524,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,4.16,,Ki,Inhibition of human carbonic anhydrase 9 catalytic domain by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147,,,,Tclin,,,Homo sapiens
180723,3524,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.12,,Ki,Inhibition of human carbonic anhydrase 12 catalytic domain by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147,,,,Tclin,,,Homo sapiens
180724,3524,2436,Carbonic anhydrase,Unclassified,Q2PCB5,ca,Q2PCB5_DICLA,5.19,,Ki,Inhibition of Dicentrarchus labrax CA using 4-nitrophenylacetate substrate by esterase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147,,,,,,,Dicentrarchus labrax
180725,3524,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.15,,Ki,Inhibition of human carbonic anhydrase 5B by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147,,,,Tclin,,,Homo sapiens
180726,3524,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,4.06,,Kd,Binding affinity to COX1 in sheep seminal vesicle,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147,,,,,,,Ovis aries
180727,3524,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.11,,Ki,Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24147,,,,Tclin,,,Homo sapiens
180728,3282,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,4.38,,Ki,Inhibition of human carbonic anhydrase 14 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,Tclin,,,Homo sapiens
180729,3282,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,4.97,,Ki,Inhibition of human carbonic anhydrase 4 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,Tclin,,,Homo sapiens
180730,3282,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,4.97,,Ki,Inhibition of human carbonic anhydrase 1 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,Tclin,,,Homo sapiens
180731,3282,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,4.85,,Ki,Inhibition of human carbonic anhydrase 5A by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,Tclin,,,Homo sapiens
180732,3282,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,4.13,,Ki,Inhibition of mouse carbonic anhydrase 13 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,,,,Mus musculus
180733,3282,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,4.49,,Ki,Inhibition of human carbonic anhydrase 9 catalytic domain by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,Tclin,,,Homo sapiens
180734,3282,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.11,,Ki,Inhibition of human carbonic anhydrase 12 catalytic domain by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,Tclin,,,Homo sapiens
180735,3282,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,4.97,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,,,,Mus musculus
180736,3282,2436,Carbonic anhydrase,Unclassified,Q2PCB5,ca,Q2PCB5_DICLA,5.23,,Ki,Inhibition of Dicentrarchus labrax CA using 4-nitrophenylacetate substrate by esterase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,,,,Dicentrarchus labrax
180737,3282,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,4.9,,Ki,Inhibition of human carbonic anhydrase 5B by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,Tclin,,,Homo sapiens
180738,3282,2031,Polyphenol oxidase 2,Enzyme,O42713,PPO2,PPO2_AGABI,5.01,,IC50,Inhibition of mushroom tyrosinase activity after 20 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,,,,Agaricus bisporus
180739,3282,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.09,,Ki,Inhibition of human carbonic anhydrase 3 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,Tclin,,,Homo sapiens
180740,3282,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.05,,Ki,Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL537,,,,Tclin,,,Homo sapiens
180741,1375,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,4.3,,Ki,Displacement of [125I]iodoaminopotentidine from human histamine H2 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,Tclin,,,Homo sapiens
180742,1375,1747,Histamine H2 receptor,GPCR,P47747,HRH2,HRH2_CAVPO,6,,EC50,Agonist activity at guinea pig atrium histamine H2 receptor assessed as potentiation of histamine-induced response after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,,,,Cavia porcellus
180743,1375,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,8.1,,Ki,"Displacement of [3H]-histamine from human histamine H4 receptor expressed in Sf9 cells coexpressing RGS19, Galphai2, Gbeta1gamma2",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,Tchem,,,Homo sapiens
180744,1375,788,Histamine H3 receptor,GPCR,Q9Y5N1,HRH3,HRH3_HUMAN,8.28,,Ki,Displacement of [3H[N-alpha-methylhistamine form human recombinant histamine H3 receptor expressed in CHO cells after 1 hr by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,Tclin,,,Homo sapiens
180745,1375,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,4.1,,Ki,Displacement of [3H]mepyramine from human wild-type histamine H1 receptor expressed in COS-7 cells by liquid scintillation counting,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,AGONIST,,Tclin,,,Homo sapiens
180746,1375,2402,Histamine H4 receptor,GPCR,Q91ZY2,Hrh4,HRH4_MOUSE,7.1,,Ki,Binding affinity to mouse histamine H4 receptor expressed in human SK-N-MC cells by radioligand displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,,,,Mus musculus
180747,1375,2154,Histamine H3 receptor,GPCR,P58406,Hrh3,HRH3_MOUSE,7.17,,Ki,"Displacement of 3-([1,1,1-3H]methyl)-2-(4-{[3-(1-pyrrolidinyl)propyl]oxy}phenyl)-4(3H)-quinazolinone from mouse histamine H3 receptor expressed in HEK293 cells",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,,,,Mus musculus
180748,1375,2403,Histamine H4 receptor,GPCR,Q91ZY1,Hrh4,HRH4_RAT,7.2,,Ki,Binding affinity to rat histamine H4 receptor expressed in human SK-N-MC cells by radioligand displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,,,,Rattus norvegicus
180749,1745,3520,Dopamine beta-hydroxylase,Unclassified,P15101,DBH,DOPO_BOVIN,4.35,,Ki,Compound was evaluated for the inhibition of Dopamine beta hydroxylase at pH 4.5,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1515,,,,,,,Bos taurus
180750,1745,2599,Lactoperoxidase,Enzyme,P80025,LPO,PERL_BOVIN,5.08,,IC50,Inhibition of Bos taurus (bovine) milk lactoperoxidase-catalyzed iodination of L-tyrosine substrate by reverse phase HPLC analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1515,,,,,,,Bos taurus
180751,1745,3415,Lactoperoxidase,Enzyme,P22079,LPO,PERL_HUMAN,4.93,,IC50,"Inhibition of lactoperoxidase-catalyzed iodination of L-tyrosine assessed as 3,5-diiodo-L-tyrosine formation by HPLC",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1515,,,,Tbio,,,Homo sapiens
180752,3229,930,Egl nine homolog 1,Enzyme,Q9GZT9,EGLN1,EGLN1_HUMAN,4.72,,IC50,Inhibition of 2-oxoglutarate-dependent human recombinant HIF PHD2 preincubated for 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503160,,,,Tclin,,,Homo sapiens
180753,2487,930,Egl nine homolog 1,Enzyme,Q9GZT9,EGLN1,EGLN1_HUMAN,5.52,,IC50,Inhibition of 2-oxoglutarate-dependent human recombinant HIF PHD2 preincubated for 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL576,,,,Tclin,,,Homo sapiens
180754,1906,3417,NAD-dependent deacetylase sirtuin 3,Enzyme,Q9NTG7,SIRT3,SIR3_HUMAN,4.85,,IC50,Inhibition of human recombinant SIRT3 after 60 mins by fluorimetric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140,,,,Tchem,,,Homo sapiens
180755,1906,1976,Fatty-acid amide hydrolase 1,Enzyme,P97612,Faah,FAAH1_RAT,5.48,,IC50,Inhibition of Wistar rat brain FAAH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140,,,,,,,Rattus norvegicus
180756,1906,842,NAD-dependent protein deacetylase sirtuin-2,Enzyme,Q8IXJ6,SIRT2,SIR2_HUMAN,5.92,,IC50,Inhibition of recombinant SIRT2 using ZMAL substrate after 4 hrs by homogeneous fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140,,,,Tchem,,,Homo sapiens
180757,1906,3418,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",Enzyme,Q9NXA8,SIRT5,SIR5_HUMAN,4.33,,IC50,Inhibition of SIRT5 using ZK(suc)A substrate after 1 hr by homogeneous fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140,,,,Tbio,,,Homo sapiens
180758,1906,3416,NAD-dependent deacetylase HST2,Enzyme,P53686,HST2,HST2_YEAST,4.04,,IC50,Inhibition of yeast Hst2 by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
180759,1906,3521,Putative silent information regulator 2,Unclassified,Q8I6E4,SIR2RP1,Q8I6E4_LEIIN,4.4,,IC50,Inhibition of Leishmania infantum SIR2RP1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140,,,,,,,Leishmania infantum
180760,1906,826,NAD-dependent protein deacetylase sirtuin-1,Enzyme,Q96EB6,SIRT1,SIR1_HUMAN,4.3,,IC50,Inhibition of recombinant SIRT1 using ZMAL substrate after 4 hrs by homogeneous fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1140,,,,Tchem,,,Homo sapiens
180761,2835,2052,Hydroxycarboxylic acid receptor 2,GPCR,Q9EP66,Hcar2,HCAR2_MOUSE,6.85,,IC50,Displacement of [3H]niacin from mouse GPR109A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL573,,,,,,,Mus musculus
180762,2835,1982,Hydroxycarboxylic acid receptor 2,GPCR,Q80Z39,Hcar2,HCAR2_RAT,7.48,,Ki,Inhibition of [3H]-nicotinic acid (20 nM) binding to nicotinic acid receptor in rat spleen membrane.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL573,,,,,,,Rattus norvegicus
180763,2835,361,Hydroxycarboxylic acid receptor 2,GPCR,Q8TDS4,HCAR2,HCAR2_HUMAN,7.3,,Ki,Displacement of [3H]nicotinic acid from human GPR109a receptor expressed in CHO cells,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL573,http://www.ncbi.nlm.nih.gov/pubmed/17705685,AGONIST,,Tclin,,501,Homo sapiens
180764,2328,2636,3-oxoacyl-ACP synthase; Fatty acid synthase Fas; Probable fatty acid synthase Fas (Fatty acid synthetase),Enzyme,P95029,fas,P95029_MYCTU,,,,Mechanism of Action; CHEMBL2011; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL614,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL614,INHIBITOR,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
180765,1334,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,4.22,,Ki,Inhibition of human erythrocyte CA1 esterase activity using 4-nitrophenyl acetate substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13766,,,,Tclin,,,Homo sapiens
180766,1334,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.53,,Ki,Inhibition of human erythrocyte CA2 esterase activity using 4-nitrophenyl acetate substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13766,,,,Tclin,,,Homo sapiens
27130,2875,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,7.537601947784424,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
180767,1241,70,DNA polymerase catalytic subunit,Enzyme,P04293,,DPOL_HHV11,4.13,,IC50,Inhibition of HSV-1 DNA polymerase in HSV-1 C42 plaque reduction assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL666,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL666,INHIBITOR,,,,,Human herpesvirus 1 (strain 17)
180768,1241,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,5.69,,IC50,Inhibitory activity against HIV-1 reverse transcriptase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL666,,,,,,,Human immunodeficiency virus 1
180769,1241,212,DNA polymerase catalytic subunit,Enzyme,P08546,UL54,DPOL_HCMVA,5.6,,IC50,"Inhibition of human cytomegalovirus DNA polymerase (95 uL) activity in a solution containing 6.4 mM HEPES (pH 7.5), incubation for 12 minutes at 26 degrees C",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL666,,,,,,,Human cytomegalovirus (strain AD169)
27018,4137,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,5.060580730438232,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27020,4137,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.617262840270996,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27021,4137,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.5561113357543945,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27022,4137,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27023,4137,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.208590030670166,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27024,4137,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.045757293701172,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27025,4137,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,9.154901504516602,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27026,4137,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.25103759765625,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27027,4137,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,8.568635940551758,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27028,4137,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.429807662963867,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27029,4137,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.991399765014648,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27030,4137,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.318758964538574,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27031,4137,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.95860767364502,,Ki,,PDSP,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021999s029lbl.pdf,ANTAGONIST,,Tclin,,306,Homo sapiens
27032,4137,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.638272285461426,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27033,4137,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.721246242523193,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27034,4137,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.916497230529785,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27035,4137,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,7.537601947784424,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27036,4137,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.265200138092041,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27037,4137,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.386845588684082,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27038,4137,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.195202827453613,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27039,4137,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.635498523712158,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27040,4137,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.4700288772583,,Ki,,PDSP,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021999s029lbl.pdf,ANTAGONIST,,Tclin,,306,Homo sapiens
27041,4137,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.925390243530273,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27042,4137,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.217679023742676,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27047,3912,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,8.664876937866211,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27048,3912,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.372364044189453,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27049,3912,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,9.397939682006836,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27051,3658,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.889999866485596,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27052,3658,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.980000019073486,,Ki,,PDSP,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/20030735,AGONIST,,Tclin,,269,Homo sapiens
27053,3658,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.820000171661377,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27056,3652,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.400000095367432,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27057,3652,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,5.800000190734863,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27066,3652,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27072,3620,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.559999942779541,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27073,3620,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.860000133514404,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27074,3620,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27079,3584,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.449771881103516,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27102,3369,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.389999866485596,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL761,AGONIST,,Tclin,,,Homo sapiens
27103,3369,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.389999866485596,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL761,AGONIST,,Tclin,,,Homo sapiens
27104,3369,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.679999828338623,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL761,AGONIST,,Tclin,,,Homo sapiens
27120,3294,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.309981346130371,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27123,3294,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.079980850219727,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27124,3294,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.480041027069092,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27125,2875,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.638272285461426,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27131,2875,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,6.3260579109191895,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27133,2875,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,8.301030158996582,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27136,2875,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.821022987365723,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27142,2875,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.301030158996582,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27143,2875,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.60554838180542,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
180774,2153,882,Beta-secretase 1,Enzyme,P56817,BACE1,BACE1_HUMAN,4.44,,IC50,Inhibition of human recombinant BACE1 after 60 mins by FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473159,,,,Tchem,,,Homo sapiens
180775,3508,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.54,,Ki,Inhibition of human recombinant carbonic anhydrase 14 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238,,,,Tclin,,,Homo sapiens
180776,3508,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.21,,Ki,Inhibition of human recombinant carbonic anhydrase 4 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238,,,,Tclin,,,Homo sapiens
180777,3508,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,5.11,,Ki,Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238,,,,Tclin,,,Homo sapiens
180778,3508,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,5.29,,Ki,Inhibition of human recombinant carbonic anhydrase 5A preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238,,,,Tclin,,,Homo sapiens
180779,3508,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.76,,Ki,Inhibition of human recombinant carbonic anhydrase 9 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238,,,,Tclin,,,Homo sapiens
180780,3508,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.27,,Ki,Inhibition of human recombinant carbonic anhydrase 12 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238,,,,Tclin,,,Homo sapiens
180781,3508,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,5.62,,Ki,Inhibition of human recombinant carbonic anhydrase 6 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238,,,,Tclin,,,Homo sapiens
180782,3508,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,5.38,,Ki,Inhibition of human recombinant carbonic anhydrase 13 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238,,,,Tclin,,,Homo sapiens
180783,3508,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.45,,Ki,Inhibition of human recombinant carbonic anhydrase 5B preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238,,,,Tclin,,,Homo sapiens
180784,3508,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.79,,Ki,Inhibition of human recombinant carbonic anhydrase 3 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238,,,,Tclin,,,Homo sapiens
180785,1188,602,Thymidylate synthase,Enzyme,P0CS13,TMP1,TYSY_CRYNB,,,,Mechanism of Action; CHEMBL4665; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1463,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1463,INHIBITOR,,,,,Cryptococcus neoformans var. neoformans serotype D (strain B-3501A)
180786,2819,3522,Gamma-amino-N-butyrate transaminase,Unclassified,P50554,Abat,GABT_RAT,4.38,,IC50,Inhibition of Rattus norvegicus (rat) brain gamma-amino butyrate aminotransferase using gamma-amino butyrate as substrate assessed as decrease in NADPH generation after 30 min by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL89598,,,,,,,Rattus norvegicus
180787,2819,318,"4-aminobutyrate aminotransferase, mitochondrial",Enzyme,P80404,ABAT,GABT_HUMAN,,,,Mechanism of Action; CHEMBL2044; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL89598,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL89598,INHIBITOR,,Tclin,,,Homo sapiens
180788,1725,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,4.54,,IC50,Inhibition of DPP4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1431,,,,Tclin,,,Homo sapiens
180789,1725,2815,Mitochondrial complex I (NADH dehydrogenase),Enzyme,O00217|O00483|O14561|O15239|O43181|O43674|O43676|O43677|O43678|O43920|O75251|O75306|O75380|O75438|O75489|O95139|O95167|O95168|O95169|O95178|O95182|O95298|O95299|O96000|P03886|P03891|P03897|P03901|P03905|P03915|P03923|P17568|P19404|P28331|P49821|P51970|P56181|P56556|Q16718|Q16795|Q86Y39|Q8N183|Q9BU61|Q9NRX3|Q9NX14|Q9P032|Q9P0J0|Q9UI09|Q9Y375|Q9Y6M9,MT-ND1|MT-ND2|MT-ND3|MT-ND4|MT-ND4L|MT-ND5|MT-ND6|NDUFA1|NDUFA10|NDUFA11|NDUFA12|NDUFA13|NDUFA2|NDUFA3|NDUFA4|NDUFA4L2|NDUFA5|NDUFA6|NDUFA7|NDUFA8|NDUFA9|NDUFAB1|NDUFAF1|NDUFAF2|NDUFAF3|NDUFAF4|NDUFB1|NDUFB10|NDUFB11|NDUFB2|NDUFB3|NDUFB4|NDUFB5|NDUFB6|NDUFB7|NDUFB8|NDUFB9|NDUFC1|NDUFC2|NDUFS1|NDUFS2|NDUFS3|NDUFS4|NDUFS5|NDUFS6|NDUFS7|NDUFS8|NDUFV1|NDUFV2|NDUFV3,ACPM_HUMAN|CIA30_HUMAN|MIMIT_HUMAN|NDUA1_HUMAN|NDUA2_HUMAN|NDUA3_HUMAN|NDUA4_HUMAN|NDUA5_HUMAN|NDUA6_HUMAN|NDUA7_HUMAN|NDUA8_HUMAN|NDUA9_HUMAN|NDUAA_HUMAN|NDUAB_HUMAN|NDUAC_HUMAN|NDUAD_HUMAN|NDUB1_HUMAN|NDUB2_HUMAN|NDUB3_HUMAN|NDUB4_HUMAN|NDUB5_HUMAN|NDUB6_HUMAN|NDUB7_HUMAN|NDUB8_HUMAN|NDUB9_HUMAN|NDUBA_HUMAN|NDUBB_HUMAN|NDUC1_HUMAN|NDUC2_HUMAN|NDUF3_HUMAN|NDUF4_HUMAN|NDUS1_HUMAN|NDUS2_HUMAN|NDUS3_HUMAN|NDUS4_HUMAN|NDUS5_HUMAN|NDUS6_HUMAN|NDUS7_HUMAN|NDUS8_HUMAN|NDUV1_HUMAN|NDUV2_HUMAN|NDUV3_HUMAN|NU1M_HUMAN|NU2M_HUMAN|NU3M_HUMAN|NU4LM_HUMAN|NU4M_HUMAN|NU5M_HUMAN|NU6M_HUMAN|NUA4L_HUMAN,,,,Mechanism of Action; CHEMBL2363065; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1431,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1431,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
27182,2865,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.590066909790039,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
180790,26,1790,Thymidylate synthase,Enzyme,P07607,Tyms,TYSY_MOUSE,7.7,,IC50,Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 24 hrs by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185,,,,,,,Mus musculus
180791,26,3523,Uracil phosphoribosyltransferase,Unclassified,P0A8F0,upp,UPP_ECOLI,4.89,,Ki,Inhibition of Escherichia coli K-12 MTCC 1302 UPRT activity by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185,,,,,,,Escherichia coli (strain K12)
180792,163,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,4.4,,IC50,Binding affinity to full length Glu-plasminogen in human plasma assessed as inhibition of interaction with fibrin in presence of tPA,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1046,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1046,INHIBITOR,,Tclin,,,Homo sapiens
180793,1550,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,5.79,,IC50,"Compound was evaluated for the inhibition of [3H]-CGS-19,755 binding at N-methyl-D-aspartate glutamate receptor",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274323,,,,,,,Rattus norvegicus
180794,2715,1626,Cationic trypsin,Enzyme,P00760,,TRY1_BOVIN,4.88,,Ki,Binding affinity against bovine trypsin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1179,,,,,,,Bos taurus
180795,2715,2614,Lysine-specific histone demethylase 1A,Enzyme,O60341,KDM1A,KDM1A_HUMAN,4.6,,Ki,Inhibition of human recombinant His-tagged full length LSD1 expressed in Escherichia coli BL21 (DE3) assessed as inactivation constant preincubated for 20 mins with substrate measured after 30 mins by AmplexRed based fluorescence quenching assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1179,,,,Tchem,,,Homo sapiens
180796,2715,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,7.48,,IC50,Compound was evaluated for inhibition of Microbial tyramine oxidase; irreversible,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1179,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1179,INHIBITOR,,Tclin,,,Homo sapiens
180797,89,3419,"Phosphatidylinositol 4-kinase, PI4K",Kinase,P42356|Q8TCG2|Q9BTU6|Q9UBF8,PI4K2A|PI4K2B|PI4KA|PI4KB,P4K2A_HUMAN|P4K2B_HUMAN|PI4KA_HUMAN|PI4KB_HUMAN,4.07,,Ki,Binding affinity (Ki) against human phosphatidylinositol 4-kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226345,,,,Tbio|Tbio|Tchem|Tchem,,,Homo sapiens
180798,89,304,Xanthine dehydrogenase/oxidase,Enzyme,P47989,XDH,XDH_HUMAN,4.96,,IC50,Inhibition of human xanthine oxidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226345,,,,Tclin,,,Homo sapiens
180799,1562,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,6.6,,EC50,Activation of human TAAR1 expressed in human HEK293T cells assessed as cAMP accumulation after 10 mins by BRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393,,,,Tclin,,,Homo sapiens
180800,1562,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,4.33,,Ki,Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393,,,,Tclin,,,Homo sapiens
180801,1562,2470,Trace amine-associated receptor 1,GPCR,Q923Y9,Taar1,TAAR1_RAT,7.47,,EC50,Activation of rat wild type TAAR1 expressed in HEK293 cells assessed as stimulation of cAMP production after 1 hr by chemiluminescent assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393,,,,,,,Rattus norvegicus
180802,1562,2471,Trace amine-associated receptor 1,GPCR,Q923Y8,Taar1,TAAR1_MOUSE,7.19,,EC50,Activation of mouse TAAR1 expressed in human HEK293 cells assessed as accumulation of cAMP after 15 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393,,,,,,,Mus musculus
180803,1562,2846,Serotonin (5-HT) receptor,GPCR,P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT,5.16,,Kd,Affinity against 5-hydroxytryptamine receptors in rat fundus model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393,,,,,,,Rattus norvegicus
180804,1562,2469,Trace amine-associated receptor 1,GPCR,Q8HZ64,TAAR1,TAAR1_MACMU,5.73,,EC50,Activation of rhesus monkey TAAR1 expressed in RD-HGA16 cells co-expressing Gq protein assessed as cAMP accumulation by fluorescence plate reader,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19393,,,,,,,Macaca mulatta
180805,841,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.31,,IC50,Inhibition of dopamine transporter-mediated [3H]dopamine uptake in Wistar rat striatal synaptosomes by liquid scintillation spectrometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,,,,,,,Rattus norvegicus
180806,841,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,4.84,,Ki,Inhibition of human recombinant MAOA by spectrophotometrically,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,,,,Tclin,,,Homo sapiens
180807,841,2470,Trace amine-associated receptor 1,GPCR,Q923Y9,Taar1,TAAR1_RAT,7.25,,EC50,Activation of rat wild type TAAR1 expressed in HEK293 cells assessed as stimulation of cAMP production after 1 hr by chemiluminescent assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,,,,,,,Rattus norvegicus
180808,841,2471,Trace amine-associated receptor 1,GPCR,Q923Y8,Taar1,TAAR1_MOUSE,8.7,,EC50,Activation of mouse TAAR1 expressed in human HEK293 cells assessed as accumulation of cAMP after 15 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,,,,,,,Mus musculus
180809,841,2846,Serotonin (5-HT) receptor,GPCR,P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT,5.35,,Kd,Affinity against 5-hydroxytryptamine receptors in rat fundus model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,,,,,,,Rattus norvegicus
180810,841,2469,Trace amine-associated receptor 1,GPCR,Q8HZ64,TAAR1,TAAR1_MACMU,6,,EC50,Activation of rhesus monkey TAAR1 expressed in RD-HGA16 cells co-expressing Gq protein assessed as cAMP accumulation by fluorescence plate reader,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,,,,,,,Macaca mulatta
180811,841,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,4.91,,Ki,Inhibition of MAOA in rat brain mitochondrial suspension,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,,,,,,,Rattus norvegicus
180812,841,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.24,,Ki,Inhibition of [3H]5-HT uptake at human SERT expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,,,,Tclin,,,Homo sapiens
180813,841,320,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,,,,Mechanism of Action; CHEMBL1893; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,INHIBITOR,,Tclin,,,Homo sapiens
180814,195,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,5.12,,Ki,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,,,,,,,Rattus norvegicus
180815,195,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,6.02,,IC50,Inhibition of [3H]dopamine uptake at dopamine transporter expressed in rat striatal homogenate after 5 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,,,,,,,Rattus norvegicus
180816,195,1842,Sodium-dependent serotonin transporter,Transporter,Q60857,Slc6a4,SC6A4_MOUSE,4.35,,IC50,Inhibition of 5-HT transporter in NMRI albino mouse brain assessed as [3H]5-HT accumulation in hypothalamus after 5 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,,,,,,,Mus musculus
180817,195,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,6.7,,IC50,Inhibition of [3H]norepinephrine uptake at NET expressed in rat hypothalamic homogenate containing synaptosomes after 5 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,,,,,,,Rattus norvegicus
180818,195,1835,5-hydroxytryptamine receptor 2B,GPCR,P30994,Htr2b,5HT2B_RAT,5.27,,Kd,Affinity against serotonergic receptor in the isolated rat stomach fundus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,,,,,,,Rattus norvegicus
180819,195,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,4.37,,Ki,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,,,,,,,Rattus norvegicus
180820,195,2846,Serotonin (5-HT) receptor,GPCR,P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT,5.27,,Kd,Affinity against 5-hydroxytryptamine receptors in rat fundus model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,,,,,,,Rattus norvegicus
180821,195,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,4.91,,Ki,Inhibition of MAOA in rat brain mitochondria,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,,,,,,,Rattus norvegicus
180822,195,1830,Sodium-dependent noradrenaline transporter,Transporter,O55192,Slc6a2,SC6A2_MOUSE,6,,IC50,Inhibition of noradrenaline transporter in NMRI albino mouse brain assessed as [3H]NA accumulation in hypothalamus after 5 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,,,,,,,Mus musculus
180823,195,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,Mechanism of Action; CHEMBL222; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,RELEASING AGENT,,Tclin,,,Homo sapiens
180824,124,1650,Xanthine dehydrogenase/oxidase,Enzyme,P80457,XDH,XDH_BOVIN,6,,Ki,Mixed-type inhibition of bovine milk xanthine oxidase using xanthine as substrate by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1467,,,,,,,Bos taurus
180825,124,2295,Xanthine dehydrogenase/oxidase,Enzyme,P22985,Xdh,XDH_RAT,6.12,,IC50,Inhibition of rat liver xanthine oxidase by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1467,,,,,,,Rattus norvegicus
180826,124,304,Xanthine dehydrogenase/oxidase,Enzyme,P47989,XDH,XDH_HUMAN,5.15,,Ki,Inhibitory activity against Xanthine Oxidase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1467,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1467,INHIBITOR,,Tclin,,,Homo sapiens
180827,2123,753,Membrane primary amine oxidase,Enzyme,Q16853,AOC3,AOC3_HUMAN,7.7,,IC50,Inhibition of human recombinant VAP-1 expressed in CHO cells after 30 mins by coupled colorimetric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089,,,,Tchem,,,Homo sapiens
180828,2123,2614,Lysine-specific histone demethylase 1A,Enzyme,O60341,KDM1A,KDM1A_HUMAN,4.75,,Ki,Inhibition of LSD1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089,,,,Tchem,,,Homo sapiens
180829,2123,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,7.52,,IC50,In vitro ability to inhibit Monoamine oxidase A activity in rat whole brain in vitro,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089,,,,,,,Rattus norvegicus
180830,2123,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,7.12,,IC50,In vitro ability to inhibit Monoamine oxidase B activity in rat whole brain in vitro,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089,,,,,,,Rattus norvegicus
180831,346,1966,Histamine H3 receptor,GPCR,Q9QYN8,Hrh3,HRH3_RAT,5.69,,Ki,Binding affinity to rat histamine H3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24441,,,,,,,Rattus norvegicus
180832,2049,1791,Acetylcholinesterase,Enzyme,P37136,Ache,ACES_RAT,7.45,,IC50,Inhibition of AChE activity in rat brain homogenate using acetylthiocholine as substrate by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542,,,,,,,Rattus norvegicus
180833,2049,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.08,,Ki,Inhibition of human cytosolic carbonic anhydrase 1 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542,,,,Tclin,,,Homo sapiens
180834,2049,2292,Dihydropteroate synthase,Enzyme,Q81VW8,folP,Q81VW8_BACAN,5.25,,Kd,Binding affinity to Bacillus anthracis DHPS expressed in Escherichia coli BL21 (DE3) after 30 mins by isothermal titration calorimetry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542,,,,,,,Bacillus anthracis
180835,2049,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.09,,Ki,Inhibition of human cytosolic carbonic anhydrase 2 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542,,,,Tclin,,,Homo sapiens
27184,2815,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.853871822357178,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
180836,1497,2593,Dihydrofolate reductase,Enzyme,P9WNX1,folA,DYR_MYCTU,9,,Ki,Inhibition of Mycobacterium tuberculosis dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
180837,2231,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.59,,Kd,Binding affinity to sarin-inhibited hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL748,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL748,ACTIVATOR,,Tclin,,,Homo sapiens
180838,2784,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,4.59,,EC50,Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11608,,,,Tclin,,,Homo sapiens
180839,2784,2615,TyR1,GPCR,H9TVJ1,,H9TVJ1_9NEOP,6.43,,EC50,Agonist activity at Chilo suppressalis (rice stem borer) tyramine receptor TyR1 expressed in HEK293 cells assessed as reduction in forskolin-induced cAMP accumulation incubated for 20 min,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11608,,,,,,,Chilo suppressalis
180840,2784,2846,Serotonin (5-HT) receptor,GPCR,P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT,5.07,,Kd,Affinity against 5-hydroxytryptamine receptors in rat fundus model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11608,,,,,,,Rattus norvegicus
180841,2784,882,Beta-secretase 1,Enzyme,P56817,BACE1,BACE1_HUMAN,2.7,,Kd,Binding affinity to BACE1 by surface plasmon resonance method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11608,,,,Tchem,,,Homo sapiens
180842,1243,486,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,Enzyme,P0A749,murA,MURA_ECOLI,7,,IC50,Inhibition of Escherichia coli MurA expressed in Escherichia coli BL21(lambdaDE3) using UNAG and PEP as substrate incubated for 10 mins prior to PEP addition measured after 60 mins by spectrophotometric analysis,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1757,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1757,INHIBITOR,,,,,Escherichia coli (strain K12)
180843,1243,3524,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,Unclassified,Q9HVW7,murA,MURA_PSEAE,4.98,,IC50,Inhibition of Pseudomonas aeruginosa PAO1293 MurA in presence of UNAG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1757,,,,,,,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
180844,2416,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,4.3,,Ki,Inhibition of human carbonic anhydrase 14 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,Tclin,,,Homo sapiens
180845,2416,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,4.95,,Ki,Inhibition of human carbonic anhydrase 4 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,Tclin,,,Homo sapiens
180846,2416,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5,,Ki,Inhibition of human carbonic anhydrase 1 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,Tclin,,,Homo sapiens
180847,2416,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,4.09,,Ki,Inhibition of human carbonic anhydrase 7 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,Tclin,,,Homo sapiens
180848,2416,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,4.17,,Ki,Inhibition of mouse carbonic anhydrase 13 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,,,,Mus musculus
180849,2416,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,4.1,,Ki,Inhibition of human carbonic anhydrase 9 catalytic domain by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,Tclin,,,Homo sapiens
180850,2416,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.06,,Ki,Inhibition of human carbonic anhydrase 12 catalytic domain by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,Tclin,,,Homo sapiens
180851,2416,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,5.14,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,,,,Mus musculus
180852,2416,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,4.92,,Ki,Inhibition of human carbonic anhydrase 6 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,Tclin,,,Homo sapiens
180853,2416,2031,Polyphenol oxidase 2,Enzyme,O42713,PPO2,PPO2_AGABI,4,,IC50,Inhibition of mushroom tyrosinase after 10 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,,,,Agaricus bisporus
180854,2416,2079,Solute carrier family 22 member 20,Transporter,Q80UJ1,Slc22a20,S22AK_MOUSE,4.36,,Ki,Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,,,,Mus musculus
180855,2416,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.15,,Ki,Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL424,,,,Tclin,,,Homo sapiens
180856,3977,2567,D-amino-acid oxidase,Enzyme,P14920,DAO,OXDA_HUMAN,5.7,,IC50,Inhibition of human recombinant DAAO expressed in HEK293 cell lysate assessed as D-Serine conversion to H2O2 after 20 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287556,,,,Tchem,,,Homo sapiens
180857,3977,3525,D-amino-acid oxidase,Unclassified,P00371,DAO,OXDA_PIG,4.68,,Ki,Competitive inhibition of pig kidney DAAO using D-Alanine as substrate by Michaelis-Menten plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287556,,,,,,,Sus scrofa
180858,3977,3526,Tyrosinase,Unclassified,P11344,Tyr,TYRO_MOUSE,4.21,,IC50,Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287556,,,,,,,Mus musculus
180859,3977,2031,Polyphenol oxidase 2,Enzyme,O42713,PPO2,PPO2_AGABI,4.65,,Ki,Inhibition of mashroom tyrosinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287556,,,,,,,Agaricus bisporus
180860,3977,432,Tyrosinase,Enzyme,P14679,TYR,TYRO_HUMAN,5.13,,IC50,Inhibition of Tyrosinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287556,,,,Tclin,,,Homo sapiens
27186,2813,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.554084777832031,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
180861,2803,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,4.25,,IC50,"Inhibition of Fischer-344 rat kidney ALR1 using D,L-glyceraldehyde as substrate by spectrophotometry",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109,,,,,,,Rattus norvegicus
180862,2803,633,Alcohol dehydrogenase [NADP(+)],Enzyme,P14550,AKR1A1,AK1A1_HUMAN,4.3,,IC50,Inhibition of AK1A1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109,,,,Tchem,,,Homo sapiens
180863,2803,973,Alcohol dehydrogenase [NADP(+)],Enzyme,P50578,AKR1A1,AK1A1_PIG,4.05,,IC50,Selectivity ratio measured as the IC50 ratio of aldehyde/aldose reductase values,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109,,,,,,,Sus scrofa
180864,2803,1788,Alcohol dehydrogenase [NADP(+)],Enzyme,P51635,Akr1a1,AK1A1_RAT,4.3,,IC50,Inhibition of rat kidney aldehyde reductase at 0.1 mM after 20 mins by spectrometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109,,,,,,,Rattus norvegicus
180865,2803,598,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,4.21,,IC50,Inhibition of human recombinant HDAC2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109,,,,Tclin,,,Homo sapiens
180866,2803,569,"Succinate-semialdehyde dehydrogenase, mitochondrial",Enzyme,P51649,ALDH5A1,SSDH_HUMAN,,,,Mechanism of Action; CHEMBL1911; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109,INHIBITOR,,Tclin,,,Homo sapiens
180867,3290,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,3.89,,IC50,Inhibition of human recombinant MMP2 after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL310555,,,,Tchem,,,Homo sapiens
180868,3290,987,Methionine aminopeptidase 2,Enzyme,P50579,METAP2,MAP2_HUMAN,5.69,,IC50,Inhibition of human methionine aminopeptidase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL310555,,,,Tchem,,,Homo sapiens
180869,3290,2309,Methionine aminopeptidase 1,Enzyme,P53582,METAP1,MAP11_HUMAN,4.67,,IC50,Inhibition of human MetAP1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL310555,,,,Tchem,,,Homo sapiens
180870,3290,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,4.67,,IC50,Inhibition of Sprague-Dawley rat liver COMT after 10 mins using 0.05 uCi [14CH3]-SAM as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL310555,,,,,,,Rattus norvegicus
180871,3474,2074,Solute carrier family 22 member 6,Transporter,Q8VC69,Slc22a6,S22A6_MOUSE,6.39,,Ki,Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1157,,,,,,,Mus musculus
180872,738,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.51,,Ki,Inhibition of human carbonic anhydrase 1 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,Tclin,,,Homo sapiens
180873,738,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.17,,Ki,Inhibition of human carbonic anhydrase 4 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,Tclin,,,Homo sapiens
180874,738,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,5.03,,Ki,Inhibition of human carbonic anhydrase 5A by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,Tclin,,,Homo sapiens
180875,738,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.28,,Ki,Inhibition of human carbonic anhydrase 5B by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,Tclin,,,Homo sapiens
180876,738,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,4.39,,IC50,"Inhibitory effect on monoamine oxidase A, SD on IC50 values < 10%",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,,,,Rattus norvegicus
180877,738,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,4.92,,IC50,"Inhibitory effect on Monoamine oxidase B, SD on IC50 values < 10%",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,,,,Rattus norvegicus
180878,738,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.04,,Ki,Inhibition of full length human CA2 cytosolic isoform by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,Tclin,,,Homo sapiens
180879,738,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.25,,Ki,Inhibition of human carbonic anhydrase 3 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,Tclin,,,Homo sapiens
180880,738,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,7.32,,Ki,Inhibition of human carbonic anhydrase 14 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,Tclin,,,Homo sapiens
180881,738,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,5.48,,Ki,Inhibition of human carbonic anhydrase 7 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,Tclin,,,Homo sapiens
180882,738,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,5.04,,Ki,Inhibition of mouse carbonic anhydrase 13 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,,,,Mus musculus
180883,738,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.05,,Ki,Inhibition of human carbonic anhydrase 12 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,Tclin,,,Homo sapiens
180884,738,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.04,,Ki,Inhibition of human carbonic anhydrase 9 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,Tclin,,,Homo sapiens
180885,738,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,4.4,,Ki,Inhibition of mouse carbonic anhydrase 15 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,,,,Mus musculus
180886,738,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,5.7,,Ki,Inhibition of human carbonic anhydrase 6 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6466,,,,Tclin,,,Homo sapiens
180887,1622,152,"Glutathione reductase, mitochondrial",Enzyme,P00390,GSR,GSHR_HUMAN,4.26,,Ki,Competitive inhibition of human erythrocyte Glutathione reductase using GSSG substrate by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8085,,,,Tclin,,,Homo sapiens
180888,65,2728,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P09483|P12392,Chrna4|Chrnb4,ACHA4_RAT|ACHB4_RAT,7.24,,Ki,Displacement of [3H]epibatidine from rat recombinant alpha4beta4 nAChR expressed in HEK293 cells after 4 hrs by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,,,,Rattus norvegicus
180889,65,1772,Acetylcholine receptor subunit delta,Ion channel,P02718,chrnd,ACHD_TORCA,7.37,,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,,,,Torpedo californica
180890,65,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,5.1,,Ki,Displacement of [3H]-MLA from human alpha7 nAChR expressed in human SH-SY5Y cells after 1.5 hrs by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,Tchem,,,Homo sapiens
180891,65,1783,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,Q05941,Chrna7,ACHA7_RAT,5.45,,Ki,Displacement of [3H]alpha-bungaro-toxine from nicotinic alpha-7 receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,,,,Rattus norvegicus
180892,65,2727,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P09483|P12390,Chrna4|Chrnb2,ACHA4_RAT|ACHB2_RAT,8.12,,Ki,Displacement of [3H]-cytisine from Alpha4-beta2 Nicotinic acetylcholine receptor of rat brain homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,,,,Rattus norvegicus
180893,65,3527,Nicotinic acetylcholine receptor alpha8 subunit,Unclassified,H6TY12,,H6TY12_PERAM,4.94,,EC50,Agonist activity at Periplaneta americana (American cockroach) nAChR in terminal abdominal ganglion assessed as assessed as inward current by tight-seal whole cell patch clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,,,,Periplaneta americana
180894,65,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,7.92,,IC50,Compound was tested in vitro for its binding affinity to muscarinic acetylcholine receptor from rat cortical homogenates using [3H]OXO-M as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,,,,Rattus norvegicus
180895,65,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.66,,EC50,Activation of M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,AGONIST,,Tclin,,,Homo sapiens
180896,65,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,5.8,,EC50,Partial agonist activity at human 2:3 alpha4beta2 nAChR expressed in Xenopus laevis oocytes after 1 min by two electrode voltage clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,Tclin|Tclin,,,Homo sapiens
180897,65,956,Acetylcholine-binding protein,Unclassified,P58154,,ACHP_LYMST,5.5,,Ki,Displacement of [125I]alpha-bungarotoxin from Lymnaea stagnalis His-tagged AchBP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,,,,Lymnaea stagnalis
180898,65,2725,Neuronal acetylcholine receptor; alpha3/beta2,Ion channel,P04757|P12390,Chrna3|Chrnb2,ACHA3_RAT|ACHB2_RAT,7.39,,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,,,,Rattus norvegicus
180899,65,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.1,,EC50,Activation of M5-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,Tclin,,,Homo sapiens
180900,65,2726,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P04757|P12392,Chrna3|Chrnb4,ACHA3_RAT|ACHB4_RAT,6.21,,Ki,Displacement of [3H]epibatidine from rat alpha3beta4 nAChR expressed in HEK292 cells after 3 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,,,,Rattus norvegicus
180901,65,2724,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,P12389|P12390,Chrna2|Chrnb2,ACHA2_RAT|ACHB2_RAT,7.96,,Ki,Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,,,,Rattus norvegicus
180902,65,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.11,,EC50,Activation of M1-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL667,,,,Tclin,,,Homo sapiens
180903,2738,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,4.46,,Ki,Inhibition of human carbonic anhydrase 4 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,Tclin,,,Homo sapiens
180904,2738,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,4,,Ki,Inhibition of human carbonic anhydrase 1 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,Tclin,,,Homo sapiens
180905,2738,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,4.42,,Ki,Inhibition of human carbonic anhydrase 5A by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,Tclin,,,Homo sapiens
180906,2738,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,4.31,,Ki,Inhibition of human carbonic anhydrase 5B by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,Tclin,,,Homo sapiens
180907,2738,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,4.32,,Ki,Inhibition of human carbonic anhydrase 3 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,Tclin,,,Homo sapiens
180908,2738,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,4.19,,Ki,Inhibition of human carbonic anhydrase 2 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,Tclin,,,Homo sapiens
180909,2738,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,4.92,,Ki,Inhibition of human carbonic anhydrase 14 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,Tclin,,,Homo sapiens
180910,2738,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,4.35,,Ki,Inhibition of human carbonic anhydrase 7 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,Tclin,,,Homo sapiens
180911,2738,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,4.28,,Ki,Inhibition of mouse carbonic anhydrase 13 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,,,,Mus musculus
180912,2738,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,4.24,,Ki,Inhibition of human carbonic anhydrase 12 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,Tclin,,,Homo sapiens
27188,2813,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.6981024742126465,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
180913,2738,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,4.41,,Ki,Inhibition of human carbonic anhydrase 9 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,Tclin,,,Homo sapiens
180914,2738,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,4.23,,Ki,Inhibition of mouse carbonic anhydrase 15 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,,,,Mus musculus
180915,2738,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,4.37,,Ki,Inhibition of human carbonic anhydrase 6 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL609,,,,Tclin,,,Homo sapiens
180916,3995,1026,Gamma-butyrobetaine dioxygenase,Enzyme,O75936,BBOX1,BODG_HUMAN,4.8,,Ki,Inhibition of BBOX (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104708,,,,Tchem,,,Homo sapiens
180917,488,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,8.1,,Ki,Compound was evaluated for the binding affinity by displacing [3H]oxotremorine from mouse cerebral cortex tissue.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Mus musculus
180918,488,1772,Acetylcholine receptor subunit delta,Ion channel,P02718,chrnd,ACHD_TORCA,6.35,,Ki,Binding affinity towards rat forebrain nicotinic acetylcholine receptor using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Torpedo californica
180919,488,2728,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P09483|P12392,Chrna4|Chrnb4,ACHA4_RAT|ACHB4_RAT,5.89,,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta4 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Rattus norvegicus
180920,488,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,4.18,,Ki,Binding affinity to alpha7 nAChR (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,Tchem,,,Homo sapiens
180921,488,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,8.4,,Ki,Binding affinity at [3H]CD radiolabeled muscarinic M2 receptor in rat cortex.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Rattus norvegicus
180922,488,2727,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P09483|P12390,Chrna4|Chrnb2,ACHA4_RAT|ACHB2_RAT,6.23,,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha4-beta2 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Rattus norvegicus
180923,488,2290,Muscarinic acetylcholine receptor,GPCR,Q8VH26,GPM3,Q8VH26_CAVPO,4.74,,Kd,Dissociation constant for complex with muscarinic acetylcholine receptor M3 of guinea pig ileum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Cavia porcellus
180924,488,1997,Muscarinic acetylcholine receptor M4,GPCR,P08485,Chrm4,ACM4_RAT,5.59,,Ki,Inhibition of binding of [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M4 in rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Rattus norvegicus
180925,488,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,8.89,,Ki,In vitro binding affinity for muscarinic receptor by displacing [3H]oxotremorine-M binding on rat brain homogenate.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Rattus norvegicus
180926,488,1809,Muscarinic acetylcholine receptor M2,GPCR,Q9ERZ4,Chrm2,ACM2_MOUSE,8.1,,Ki,Ability to displace [3H]oxotremorine ([3H]OXO-M) from mouse cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Mus musculus
180927,488,2583,Acetylcholine receptor subunit alpha,Ion channel,P02710,CHRNA1,ACHA_TORCA,5.12,,IC50,Displacement of [3H]alpha-BGT from nAChR in Torpedo nobiliana electric organs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Torpedo californica
180928,488,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,6.12,,Ki,Binding affinity to alpha4beta2 nAChR (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,Tclin|Tclin,,,Homo sapiens
180929,488,2725,Neuronal acetylcholine receptor; alpha3/beta2,Ion channel,P04757|P12390,Chrna3|Chrnb2,ACHA3_RAT|ACHB2_RAT,5.96,,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta2 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Rattus norvegicus
180930,488,1808,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,7.7,,Ki,Binding affinity (low) of [3H](R)-QNB binding to Muscarinic acetylcholine receptor M1 expressed in A9 L cell line in the absence of 300 uM GTP-gamma-S,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Mus musculus
180931,488,2726,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P04757|P12392,Chrna3|Chrnb4,ACHA3_RAT|ACHB4_RAT,5.32,,Ki,Binding affinity towards rat Nicotinic acetylcholine receptor alpha3-beta4 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Rattus norvegicus
180932,488,2724,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,P12389|P12390,Chrna2|Chrnb2,ACHA2_RAT|ACHB2_RAT,6.68,,Ki,Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Rattus norvegicus
180933,488,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,7.51,,Ki,"Affinity versus [3H]oxotremorine M (agonist) binding to Muscarinic acetylcholine receptor M1 in Rat Cerebral Cortical Membranes, (Kd=0.75 nM)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14,,,,,,,Rattus norvegicus
180934,3347,3528,S-ribosylhomocysteine lyase,Unclassified,O34667,luxS,LUXS_BACSU,4.21,,Ki,Inhibition of cobalt substituted Bacillus subtilis LuxS,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42336,,,,,,,Bacillus subtilis (strain 168)
180935,2081,1941,Succinyl-diaminopimelate desuccinylase,Enzyme,P44514,dapE,DAPE_HAEIN,4.3,,IC50,Inhibition of Haemophilus influenzae recombinant DapE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1430,,,,,,,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)
180936,1732,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,5.89,,EC50,Activation of human TAAR1 expressed in human HEK293T cells assessed as cAMP accumulation after 10 mins by BRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952,,AGONIST,,Tclin,,,Homo sapiens
27189,2813,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.651695251464844,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
180937,1732,2470,Trace amine-associated receptor 1,GPCR,Q923Y9,Taar1,TAAR1_RAT,6.88,,EC50,Activation of rat wild type TAAR1 expressed in HEK293 cells assessed as stimulation of cAMP production after 1 hr by chemiluminescent assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952,,,,,,,Rattus norvegicus
180938,1732,2471,Trace amine-associated receptor 1,GPCR,Q923Y8,Taar1,TAAR1_MOUSE,7.15,,EC50,Activation of mouse TAAR1 expressed in human HEK293 cells assessed as accumulation of cAMP after 15 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952,,,,,,,Mus musculus
180939,1732,2469,Trace amine-associated receptor 1,GPCR,Q8HZ64,TAAR1,TAAR1_MACMU,5.28,,EC50,Activation of rhesus monkey TAAR1 expressed in RD-HGA16 cells co-expressing Gq protein assessed as cAMP accumulation by fluorescence plate reader,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952,,,,,,,Macaca mulatta
180940,1732,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.08,,Ki,Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952,,,,Tclin,,,Homo sapiens
180941,1732,2286,Synaptic vesicular amine transporter,Transporter,Q01827,Slc18a2,VMAT2_RAT,5.61,,Ki,Inhibition of VMAT2-mediated [3H]-dopamine uptake in rat striata isolated synaptic vesicles by liquid scintillation spectroscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952,,,,,,,Rattus norvegicus
180942,931,40,Carbonic anhydrase 1; GH09688p,Enzyme,Q9V396,CAH1,Q9V396_DROME,5.63,,Ki,Inhibition of Drosophila melanogaster recombinant carbonic anhydrase-1 expressed in Escherichia coli BL21 (DE3) preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961,,,,,,,Drosophila melanogaster
180943,931,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.19,,Ki,Inhibition of human recombinant carbonic anhydrase 4-catalyzed CO2 hydration by stopped flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961,,,,Tclin,,,Homo sapiens
180944,931,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.1,,Ki,Inhibition of human recombinant carbonic anhydrase 1-catalyzed CO2 hydration by stopped flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961,,,,Tclin,,,Homo sapiens
180945,931,39,"Carbonic anhydrase 2, isoform A; LD26647p",Enzyme,Q9VTU8,CAH2,Q9VTU8_DROME,6.18,,Ki,Inhibition of Drosophila melanogaster recombinant carbonic anhydrase-2 expressed in Escherichia coli BL21 (DE3) preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961,,,,,,,Drosophila melanogaster
180946,931,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.51,,Ki,Inhibition of human recombinant carbonic anhydrase 2-catalyzed CO2 hydration by stopped flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961,,,,Tclin,,,Homo sapiens
180947,931,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,4.25,,Ki,Inhibition of mouse recombinant carbonic anhydrase 13-catalyzed CO2 hydration by stopped flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961,,,,,,,Mus musculus
180948,931,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.96,,Ki,Inhibition of human CA12 pre-incubated for 15 mins by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961,,,,Tclin,,,Homo sapiens
180949,931,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.85,,Ki,Inhibition of human CA9 pre-incubated for 15 mins by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL961,,,,Tclin,,,Homo sapiens
180950,52,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,4.94,,Ki,Inhibition of human carbonic anhydrase 4 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,Tclin,,,Homo sapiens
180951,52,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5,,Ki,Inhibition of human carbonic anhydrase 1 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,Tclin,,,Homo sapiens
180952,52,900,Arachidonate 5-lipoxygenase-activating protein,Cytosolic other,P20292,ALOX5AP,AL5AP_HUMAN,4.36,,IC50,Inhibition of FLAP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,Tchem,,,Homo sapiens
180953,52,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.15,,Ki,Inhibition of human carbonic anhydrase 3 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,Tclin,,,Homo sapiens
180954,52,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.21,,Ki,Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,Tclin,,,Homo sapiens
27146,2875,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.136677265167236,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27147,2875,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.015758514404297,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27148,2875,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,8.272577285766602,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27150,2875,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.744727611541748,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27151,2875,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.68590784072876,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27152,2875,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.585026741027832,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27154,2875,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.393618583679199,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27156,2875,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.853871822357178,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27159,2865,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.536107063293457,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27160,2865,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.564952373504639,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27162,2865,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,8.045757293701172,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27171,2865,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.455932140350342,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27172,2865,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.8181562423706055,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27175,2865,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27176,2865,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.113509178161621,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27177,2865,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.318758964538574,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27190,2799,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.735654354095459,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27191,2774,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.460000038146973,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27192,2758,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.422508239746094,,Ki,,PDSP,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7317,INHIBITOR,,Tclin,,,Homo sapiens
27193,2758,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.853872299194336,,Ki,,PDSP,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
27194,2758,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.826813697814941,,Ki,,PDSP,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7317,INHIBITOR,,Tclin,,,Homo sapiens
27195,2742,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.397939682006836,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27196,2742,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.552842140197754,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL570,ANTAGONIST,,Tclin,,,Homo sapiens
27197,2740,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.619788646697998,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27198,2740,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.84883451461792,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27199,2740,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.250844955444336,,Ki,,PDSP,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
27201,2740,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.536405563354492,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27204,2740,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.377243518829346,,Ki,,PDSP,=,,,,,ANTAGONIST,,Tchem,,,Homo sapiens
27205,2740,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.999566078186035,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27206,2740,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.407268047332764,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27207,2740,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.786216735839844,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27208,2740,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.840968132019043,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,ANTAGONIST,,Tclin,,,Homo sapiens
27209,2740,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.184621334075928,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27210,2740,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.022276401519775,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27211,2729,305,Platelet-activating factor receptor,GPCR,P25105,PTAFR,PTAFR_HUMAN,5.87948751449585,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27220,2717,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.97469425201416,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27221,2717,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.482804298400879,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27224,2717,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.809668064117432,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27231,2651,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.755865573883057,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27232,2651,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.853871822357178,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27233,2651,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.077264785766602,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27234,2639,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.939713001251221,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27235,2639,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.681102275848389,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27236,2639,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.442492961883545,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27237,2639,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,5.729787349700928,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27238,2639,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.411953926086426,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27239,2639,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.455932140350342,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27241,2639,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.816788673400879,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27242,2639,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.4113922119140625,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27243,2639,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.868134498596191,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27245,2639,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.821022987365723,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27246,2639,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.181114673614502,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27247,2639,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.386157989501953,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27248,2639,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.583359718322754,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27249,2639,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.692503929138184,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27250,2639,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.2924299240112305,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27251,2639,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.397940158843994,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27252,2639,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.284414768218994,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27253,2639,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.300163269042969,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27254,2639,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.346787452697754,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201,ANTAGONIST,,Tclin,,,Homo sapiens
27255,2639,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.585026741027832,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27256,2639,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.097181797027588,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27257,2639,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.317531585693359,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27258,2639,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.387004375457764,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27259,2639,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.812479496002197,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27260,2639,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.677780628204346,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27261,2637,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,5.619788646697998,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27263,2637,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.77365779876709,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27265,2637,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.43889856338501,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27267,2637,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,8.619789123535156,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27270,2637,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.899974346160889,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27271,2637,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.712198257446289,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27274,2637,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.962573528289795,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27275,2637,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.237321376800537,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27276,2637,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.866461277008057,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27278,2637,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.978810787200928,,Ki,,PDSP,=,,,,,ANTAGONIST,,Tchem,,,Homo sapiens
27280,2637,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.59522008895874,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27281,2637,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.125518798828125,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27282,2637,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.466418743133545,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27284,2637,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.568635940551758,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27285,2637,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.872409820556641,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27286,2637,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.886056423187256,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27288,2637,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.045757293701172,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27289,2637,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.853871822357178,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27290,2635,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.920818328857422,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27291,2635,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.346787452697754,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27295,2605,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.086962699890137,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27298,2558,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.481485843658447,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27299,2558,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,5.409999847412109,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27300,2558,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.900000095367432,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27301,2558,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,5.460000038146973,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27302,2558,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.480000019073486,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27303,2558,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.695000171661377,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27304,2558,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.690000057220459,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27305,2558,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.309467792510986,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27306,2558,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.914999961853027,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27307,2558,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.769999980926514,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27315,2541,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.42021656036377,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27316,2541,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.571333885192871,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27320,2532,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.154901504516602,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27321,2532,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.61092472076416,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27324,2491,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,7.301030158996582,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27329,2470,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.3222198486328125,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27331,2470,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,8.400116920471191,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27332,2470,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.2966227531433105,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27379,2436,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.886056423187256,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27380,2436,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.127814292907715,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27381,2436,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.721246242523193,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27382,2436,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.853871822357178,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27383,2436,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.677780628204346,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27384,2435,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.74472713470459,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27388,2435,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.552842140197754,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27396,2435,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.569924831390381,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27397,2435,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.346787452697754,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27398,2435,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.346787452697754,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27400,2435,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.193819999694824,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27405,2402,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.420000076293945,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27407,2402,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,5.820000171661377,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27408,2402,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.860000133514404,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27410,2402,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.920000076293945,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27413,2402,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.730000019073486,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27415,2397,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,7.465907096862793,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27430,2389,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.92081880569458,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27431,2389,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,7.022686004638672,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27434,2389,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27440,2389,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.537601947784424,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27441,2389,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.431798458099365,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27444,2337,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,5.505845546722412,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27446,2337,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.408935546875,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27448,2337,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.512013912200928,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27453,2337,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,5.821657180786133,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27455,2337,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,5.790055751800537,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27458,2337,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.79547643661499,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27460,2337,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.1269121170043945,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27463,2337,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.440093517303467,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
180955,52,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,4.97,,Ki,Inhibition of human carbonic anhydrase 14 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,Tclin,,,Homo sapiens
180956,52,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,5.04,,Ki,Inhibition of human carbonic anhydrase 7 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,Tclin,,,Homo sapiens
180957,52,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,4.52,,Ki,Inhibition of mouse carbonic anhydrase 13 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,,,,Mus musculus
180958,52,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,4.15,,Ki,Inhibition of human carbonic anhydrase 9 catalytic domain by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,Tclin,,,Homo sapiens
180959,52,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.39,,Ki,Inhibition of human carbonic anhydrase 12 catalytic domain by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,Tclin,,,Homo sapiens
180960,52,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,5.03,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,,,,Mus musculus
180961,52,2937,Myoglobin,Unclassified,P02144,MB,MYG_HUMAN,5.64,,IC50,Inhibition of myoglobin (unknown origin)-mediated arachidonic acid oxidation using [14C]AA as substrate after 3 hrs by GC/NICI/MS analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,,,,Tbio,,,Homo sapiens
180962,2149,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.01,,Ki,Binding affinity to alpha1A adrenoreceptor in Rattus norvegicus (rat) submaxillary gland by radioligand displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61006,,,,,,,Rattus norvegicus
180963,2149,2000,Alpha-1B adrenergic receptor,GPCR,P18841,ADRA1B,ADA1B_MESAU,5.02,,Ki,Binding affinity to Cricetinae (hamster) alpha1B adrenoreceptor by radioligand displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61006,,,,,,,Mesocricetus auratus
180964,2149,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,5.07,,Ki,Binding affinity to Rattus norvegicus (rat) alpha1D adrenoreceptor by radioligand displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61006,,,,,,,Rattus norvegicus
180965,2149,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,Mechanism of Action; CHEMBL229; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61006,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61006,AGONIST,,Tclin,,,Homo sapiens
180967,1394,2470,Trace amine-associated receptor 1,GPCR,Q923Y9,Taar1,TAAR1_RAT,7.3,,EC50,Activation of rat TAAR1 expressed in HEK293 cells assessed as accumulation of [3H]cAMP after 1 hr by competitive binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1546,,,,,,,Rattus norvegicus
180968,1394,882,Beta-secretase 1,Enzyme,P56817,BACE1,BACE1_HUMAN,3.1,,Kd,Binding affinity to BACE1 by surface plasmon resonance method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1546,,,,Tchem,,,Homo sapiens
180970,144,3529,Matrix protein 2,Unclassified,Q20MD5,M2,Q20MD5_9INFA,4.8,,IC50,Inhibition of Influenza A virus (A/Udorn/72) wild type matrix protein 2 expressed in xenopus oocytes after 2 mins by two-electrode voltage clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660,,,,,,,Influenza A virus (A/udorn/1972(H3N2))
180971,144,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.69,,Ki,Binding affinity towards sigma receptor in guinea pig brain membrane was determined by using [3H]DTG as the radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660,,,,Tclin,,,Homo sapiens
180972,144,2638,Matrix protein 2,Ion channel,P63231,M,M2_I72A2,4.8,,IC50,Inhibition of wild type Influenza A virus (A/udorn/72(H3N2)) M2 channel expressed in Xenopus oocyte plasma membrane incubated for 2 mins measured over 48 to 72 hrs by two-electrode voltage clamp method,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660,INHIBITOR,,,,,Influenza A virus (strain A/Udorn/307/1972 H3N2)
180973,144,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.42,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660,,,,Tchem,,,Homo sapiens
180975,1766,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.59,,Ki,Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372,,,,Tclin,,,Homo sapiens
27530,2181,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.455932140350342,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
180976,1766,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.47,,Ki,Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372,,,,Tclin,,,Homo sapiens
180977,1766,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.39,,Ki,Inhibition of human carbonic anhydrase 14 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372,,,,Tclin,,,Homo sapiens
180978,1766,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,6.11,,Ki,Inhibition of human carbonic anhydrase 7 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372,,,,Tclin,,,Homo sapiens
180979,1766,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.26,,Ki,Inhibition of human carbonic anhydrase 9 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372,,,,Tclin,,,Homo sapiens
180980,1766,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,6.09,,Ki,Inhibition of human carbonic anhydrase 12 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325372,,,,Tclin,,,Homo sapiens
180981,1708,3530,Purine nucleoside phosphorylase,Unclassified,P9WP01,punA,PUNA_MYCTU,4.1,,Kd,Binding affinity to Mycobacterium tuberculosis purine nucleoside phosphorylase by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1425,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
180982,470,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,4.3,,Ki,Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) using acetylthiocholine iodide substrate by Ellman method based colorimetry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL504760,,,,,,,Electrophorus electricus
180983,2050,424,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,2.92,,Kd,Dissociation constant for Protein-tyrosine phosphatase 1B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1169,,,,Tchem,,,Homo sapiens
180984,2050,2891,Cyclooxygenase,Enzyme,P23219|P35354,PTGS1|PTGS2,PGH1_HUMAN|PGH2_HUMAN,,,,Mechanism of Action; CHEMBL2094253; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1169,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1169,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
180985,1710,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,,,,Mechanism of Action; CHEMBL215; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL704,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL704,INHIBITOR,,Tclin,,,Homo sapiens
180986,3396,2615,TyR1,GPCR,H9TVJ1,,H9TVJ1_9NEOP,6.01,,EC50,Agonist activity at Chilo suppressalis (rice stem borer) tyramine receptor TyR1 expressed in HEK293 cells assessed as reduction in forskolin-induced cAMP accumulation incubated for 20 min,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53929,,,,,,,Chilo suppressalis
180987,3396,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,7.62,,EC50,Activity at SER3 receptor expressed in HEK293 cells assessed as increase in calcium by calcium imaging assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53929,,,,Tclin,,,Homo sapiens
180988,947,2851,Dopamine receptor,GPCR,P20288|Q95136,DRD1|DRD2,DRD1_BOVIN|DRD2_BOVIN,8.43,,IC50,Tested for binding to dopamine receptor using [3H]- ADTN as radioligand in calf caudate nucleus homogenates.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Bos taurus
180989,947,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,6.7,,IC50,Inhibition of dopamine transporter-mediated [3H]dopamine uptake in Wistar rat striatal synaptosomes by liquid scintillation spectrometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
180990,947,2862,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy2|Adcy3|Adcy4|Adcy5|Adcy6|Adcy8,ADCY2_RAT|ADCY3_RAT|ADCY4_RAT|ADCY5_RAT|ADCY6_RAT|ADCY8_RAT|D4A3N4_RAT|Q8CFM9_RAT,5.46,,EC50,Tested for ability to stimulate dopamine sensitive adenylate cyclase in rat caudate homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
180991,947,1801,D(1A) dopamine receptor,GPCR,Q95136,DRD1,DRD1_BOVIN,8.15,,Ki,Binding Affinity was tested on High Affinity Site of Bovine Dopamine receptor D1. Tested for ability to displace the radioligand [3H]-SCH- 23390,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Bos taurus
180992,947,1803,Beta-1 adrenergic receptor,GPCR,P18090,Adrb1,ADRB1_RAT,5,,Ki,Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
180993,947,1878,D(4) dopamine receptor,GPCR,P30729,Drd4,DRD4_RAT,8.62,,EC50,In vitro effective concentration tested on HEK293 cells co-transfected with rat Dopamine receptor D4 using FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
180994,947,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,4.19,,Kd,Binding affinity to human adrenergic beta2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,Tclin,,,Homo sapiens
180995,947,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,5.27,,IC50,Tested for Dopamine receptor activity by the inhibition against spiroperidol binding to rat caudate tissue.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
180996,947,378,Melatonin receptor type 1A,GPCR,P48039,MTNR1A,MTR1A_HUMAN,5.15,,Ki,Displacement of 2-[125I]iodomelatonin from human Melatonin receptor type 1A expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,Tclin,,,Homo sapiens
180997,947,379,Melatonin receptor type 1B,GPCR,P49286,MTNR1B,MTR1B_HUMAN,5.04,,Ki,Inhibition of 2-[125I]iodomelatonin binding to human Melatonin receptor type 1B expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,Tclin,,,Homo sapiens
180998,947,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.24,,Ki,Binding of [3H]clonidine to alpha-2-adrenergic receptor of rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
180999,947,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,4.85,,Ki,Binding of [3H]prazosin to alpha-1 adrenergic receptor of rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
27531,2181,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.939713001251221,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
181000,947,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,8.74,,Ki,Binding Affinity on high Affinity Site of Bovine dopamine receptor D2. Tested for ability to displace the radioligand [3H]pramipexole was tested,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Bos taurus
181001,947,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.19,,Ki,Displacement of [125I]RT155 binding in HEK cells expressing human DAT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,Tclin,,,Homo sapiens
181002,947,1824,Beta-2 adrenergic receptor,GPCR,P54833,ADRB2,ADRB2_CANFA,4.3,,Ki,Binding of [3H]dihydroalprenolol to beta-2 adrenergic receptor of rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Canis familiaris
181003,947,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,6.82,,Ki,Displacement of [3H]fenoldopam from Dopamine receptor D1 of rat striatum membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
181004,947,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.35,,Ki,Displacement of [3H]-spiperone from rat dopamine D2S receptor expressed in rat C6 cells after 45 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
181005,947,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,7.96,,Ki,Binding affinity which represents concentration giving half-maximal inhibition of [3H]7-OH-DPAT binding to Dopamine receptor D3 in rat tissue homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
181006,947,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,5.52,,IC50,Ability to inhibit the specific binding of [3H]- dihydromorphine to opiate receptors in rat brain membrane preparation by 50%,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
181007,3260,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.38,,Ki,Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461,,,,Tclin,,,Homo sapiens
181008,3260,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.39,,Ki,Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461,,,,Tclin,,,Homo sapiens
181009,3260,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,4.17,,Ki,Inhibition of human carbonic anhydrase 14 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461,,,,Tclin,,,Homo sapiens
181010,3260,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,4.17,,Ki,Inhibition of human carbonic anhydrase 7 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461,,,,Tclin,,,Homo sapiens
181011,3260,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,4.12,,IC50,Inhibition of human recombinant 5-lipoxygenase after 10 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461,,,,Tclin,,,Homo sapiens
181012,3260,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.18,,Ki,Inhibition of human carbonic anhydrase 9 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461,,,,Tclin,,,Homo sapiens
181013,3260,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.14,,Ki,Inhibition of human carbonic anhydrase 12 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1461,,,,Tclin,,,Homo sapiens
181027,2059,3421,Voltage-gated T-type calcium channel,Ion channel,O43497|O95180|Q9P0X4,CACNA1G|CACNA1H|CACNA1I,CAC1G_HUMAN|CAC1H_HUMAN|CAC1I_HUMAN,,,,Mechanism of Action; CHEMBL2362995; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1100,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1100,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
181028,2713,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,5.96,,Kd,Binding affinity to human plasma full length Glu-plasminogen K1 domain by surface plasmon resonance analysis,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL877,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL877,INHIBITOR,,Tclin,,,Homo sapiens
181029,2664,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,4.35,,IC50,Inhibition of Sprague-Dawley rat liver COMT after 10 mins using 0.05 uCi [14CH3]-SAM as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1410814,,,,,,,Rattus norvegicus
181030,2255,2030,Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit,Ion channel,O77773,CACNA2D1,O77773_PIG,7.14,,IC50,Displacement of [3H]gabapentin from alpha-2delta calcium channel in pig brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059,,,,,,,Sus scrofa
181031,2065,2111,"Aldehyde dehydrogenase, mitochondrial",Enzyme,P11884,Aldh2,ALDH2_RAT,5.25,,IC50,Inhibition of Sprague-Dawley rat mitochondrial aldehyde dehydrogenase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673,,,,,,,Rattus norvegicus
181032,2065,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,5.07,,Ki,Inhibition of MAO-A in rat liver homogenate after 60 mins by Lineweaver-Burke plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673,,,,,,,Rattus norvegicus
181033,2065,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,5.47,,Ki,Inhibition of MAO-B in rat liver homogenate after 60 mins by Lineweaver-Burke plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673,,,,,,,Rattus norvegicus
181034,2065,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,5.74,,Ki,Inhibition constant against human recombinant Monoamine oxidase-B ,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673,INHIBITOR,,Tclin,,,Homo sapiens
181035,2065,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.47,,IC50,Inhibition of MAOA (unknown origin) using kynuramine as substrate after 1 hr by fluorescence assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL673,INHIBITOR,,Tclin,,,Homo sapiens
181036,1384,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,5.72,,Ki,Inhibition of Equus caballus (horse) serum butyrylcholinesterase (BChE) assessed as inhibition of BTCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL276832,,,,,,,Equus caballus
181037,1384,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,5.15,,Ki,Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) assessed as inhibition of ATCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL276832,,,,,,,Electrophorus electricus
181038,2695,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,5.79,,Ki,"Displacement of (S)-4-(2,4-difluorophenyl-3-tritio) -4,5-dihydro-2-oxazolamine from human TAAR1 receptor expressed in HEK293 cells after 90 mins by beta counting analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770,,,,Tclin,,,Homo sapiens
181039,2695,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,6.74,,Ki,Displacement of [3H]clonidine from Alpha-2 adrenergic receptor of rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770,,,,,,,Rattus norvegicus
181040,2695,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.68,,IC50,Inhibition of specific [3H]-prazosin binding (0.2 nM) to rat brain membranes alpha1 adrenoceptor; 2.1*10e-6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770,,,,,,,Rattus norvegicus
181042,1726,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,7.23,,Ki,Inhibition of binding of [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M2 in rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978,,,,,,,Rattus norvegicus
181043,1726,1997,Muscarinic acetylcholine receptor M4,GPCR,P08485,Chrm4,ACM4_RAT,5.8,,Ki,Inhibition of binding of [3H]quinuclidinyl benzilate to Muscarinic acetylcholine receptor M4 in rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978,,,,,,,Rattus norvegicus
181044,1726,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.23,,Ki,Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978,,,,Tclin,,,Homo sapiens
181045,1726,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.8,,Ki,Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978,,,,Tclin,,,Homo sapiens
181046,1726,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,Mechanism of Action; CHEMBL245; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL978,AGONIST,,Tclin,,,Homo sapiens
181047,358,2290,Muscarinic acetylcholine receptor,GPCR,Q8VH26,GPM3,Q8VH26_CAVPO,4.9,,Kd,Binding affinity to muscarinic M3 receptor in guinea-pig ileum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1482,,,,,,,Cavia porcellus
181048,358,3531,Muscarinic receptor 2,Unclassified,Q8VH27,GPM2,Q8VH27_CAVPO,6,,EC50,Agonist activity at muscarinic M3 receptor in albino guinea pig ileum assessed as stimulation of electrically-induced response,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1482,,,,,,,Cavia porcellus
181049,1670,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,7.63,,Ki,Inhibitory constant against HMG-CoA reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50444,,,,Tclin,,,Homo sapiens
181050,513,2001,"Carnitine O-palmitoyltransferase 1, muscle isoform",Enzyme,Q63704,Cpt1b,CPT1B_RAT,4,,Ki,Tested against neonatal rat cardiac myocyte carnitine palmitoyltransferase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1149,,,,,,,Rattus norvegicus
181051,513,3532,Carnitine palmitoyltransferase 2,Unclassified,P18886,Cpt2,CPT2_RAT,4,,Ki,Tested against neonatal rat cardiac myocyte carnitine palmitoyltransferase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1149,,,,,,,Rattus norvegicus
181052,1920,1779,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,P09483,Chrna4,ACHA4_RAT,9.03,,Ki,Displacement of [3H]cytisine from alpha4beta2 nAChR in rat brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181053,1920,2605,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,O70174,Chrna4,ACHA4_MOUSE,8.15,,IC50,Inhibition of [3H]nicotine binding to alpha4 nicotinic acetylcholine receptor in Mus musculus (mouse) M10 cells co-expressing beta2 nicotinic acetylcholine receptor subunits,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Mus musculus
181054,1920,2762,Neuronal acetylcholine receptor,Ion channel,P04757|P09483|P12389|P12390|P12391|P12392|P20420|P25108|P25109|P43143|P43144|Q05941|Q9JLB5,Chrna1|Chrna10|Chrna2|Chrna3|Chrna4|Chrna5|Chrna6|Chrna7|Chrna9|Chrnb1|Chrnb2|Chrnb3|Chrnb4,ACH10_RAT|ACHA2_RAT|ACHA3_RAT|ACHA4_RAT|ACHA5_RAT|ACHA6_RAT|ACHA7_RAT|ACHA9_RAT|ACHA_RAT|ACHB2_RAT|ACHB3_RAT|ACHB4_RAT|ACHB_RAT,11,,Kd,Ability to enhance the binding of (+/-)-[3H]nicotine to the rat brain P2 fraction at binding site 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181055,1920,1909,Neuronal acetylcholine receptor subunit alpha-9,Ion channel,P43144,Chrna9,ACHA9_RAT,8.3,,Kd,The compound was tested for the inhibition of binding of [3H]epibatidine to central nicotinic acetylcholine receptor (nAChR) in rat brain.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181056,1920,1989,Neuronal acetylcholine receptor subunit beta-4,Ion channel,P12392,Chrnb4,ACHB4_RAT,7.14,,Ki,Binding affinity to Nicotinic acetylcholine receptor alpha3-beta4 using +/-[3H]epibatidine as radioligand in pig adrenal gland,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181057,1920,2156,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,P12389,Chrna2,ACHA2_RAT,7.92,,Ki,Displacement of [3H]epibatidine from rat alpha2beta2 nicotinic receptor expressed in human HEK293 cells by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181058,1920,2819,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNB1|CHRND|CHRNG,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN|ACHG_HUMAN,5.83,,Ki,Binding affinity to alpha-1-beta-gamma-delta nicotinic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181059,1920,2725,Neuronal acetylcholine receptor; alpha3/beta2,Ion channel,P04757|P12390,Chrna3|Chrnb2,ACHA3_RAT|ACHB2_RAT,9,,Ki,Affinity for Nicotinic acetylcholine receptor alpha4-beta2 tested by analogue-induced inhibition of [3H]NIC binding to rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181060,1920,2726,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P04757|P12392,Chrna3|Chrnb4,ACHA3_RAT|ACHB4_RAT,6.7,,Ki,Displacement of [3H]epibatidine from recombinant rat alpha-3-beta-4 nAChr in HEK293 cell line,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
27532,2181,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.065501689910889,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
181061,1920,2724,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,P12389|P12390,Chrna2|Chrnb2,ACHA2_RAT|ACHB2_RAT,8.26,,Ki,Displacement of [3H]epibatidine from rat nAChR alpha2beta2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181062,1920,2821,Neuronal acetylcholine receptor; alpha2/beta4,Ion channel,P12389|P12392,Chrna2|Chrnb4,ACHA2_RAT|ACHB4_RAT,7.15,,Ki,Displacement of [3H]epibatidine from rat nAChR alpha2beta4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181063,1920,2602,Nicotinic acetylcholine receptor alpha 5 subunit,Ion channel,A9XFY4,nAChRalpha5,A9XFY4_MUSDO,5.61,,Ki,Displacement of [3H]alpha-bungarotoxin from nAChR in Musca domestica (house fly) head membrane after 60 min by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Musca domestica
181064,1920,1772,Acetylcholine receptor subunit delta,Ion channel,P02718,chrnd,ACHD_TORCA,9,,Ki,Bindind affinity values obtained by measuring the displacement of radioligand [3H](-)-cytisine from a preparation of whole rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Torpedo californica
181065,1920,2728,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P09483|P12392,Chrna4|Chrnb4,ACHA4_RAT|ACHB4_RAT,8.26,,Ki,Displacement of [3H]epibatidine from rat alpha2beta2 nACHR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181066,1920,2727,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P09483|P12390,Chrna4|Chrnb2,ACHA4_RAT|ACHB2_RAT,9.4,,Kd,GRAC: rat AChR-alpha4-beta2 radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181067,1920,1783,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,Q05941,Chrna7,ACHA7_RAT,6.89,,Ki,Binding affinity to subtype Nicotinic acetylcholine receptor alpha-7 using [125I]-alpha-BTX as radioligand in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181068,1920,1895,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P49582,Chrna7,ACHA7_MOUSE,6.61,,Ki,Displacement of [125I]-alpha-Btx from alpha7 nAChR in mouse hippocampal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Mus musculus
181069,1920,2822,Acetylcholine receptor,Ion channel,P02710|P02712|P02714|P02718,CHRNA1|CHRNB1|CHRNG|chrnd,ACHA_TORCA|ACHB_TORCA|ACHD_TORCA|ACHG_TORCA,5.2,,Ki,Inhibition of [125I]alpha-bungarotoxin binding to nicotinic acetylcholine receptor alpha1 beta gamma delta of electroplax,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Torpedo californica
181070,1920,2107,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,P04757,Chrna3,ACHA3_RAT,7.33,,Ki,Displacement of [3H]epibatidine from rat alpha3beta2 nicotinic receptor expressed in human HEK293 cells by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181071,1920,2603,Acetylcholine receptor subunit beta-like 2,Ion channel,P25162,nAChRbeta2,ACH4_DROME,5.57,,Ki,Binding affinity to Drosophila brain nicotinic acetylcholine receptor assessed as [3H]IMI binding by radioligand binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Drosophila melanogaster
181072,1920,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,4.55,,IC50,Inhibitory concentration required for in vitro binding affinity to cholinergic central muscarinic receptor on rat brain cortex by using [3H]OXO-M,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Rattus norvegicus
181073,1920,2818,Serotonin 3 (5-HT3) receptor,Ion channel,A5X5Y0|O95264|P46098|Q70Z44|Q8WXA8,HTR3A|HTR3B|HTR3C|HTR3D|HTR3E,5HT3A_HUMAN|5HT3B_HUMAN|5HT3C_HUMAN|5HT3D_HUMAN|5HT3E_HUMAN,4.15,,Ki,In vitro Binding affinity towards 5-hydroxytryptamine 3 receptor was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,Tchem|Tchem|Tchem|Tchem|Tclin,,,Homo sapiens
181074,1920,3383,Acetylcholine receptor subunit alpha,Ion channel,P02708,CHRNA1,ACHA_HUMAN,4.68,,IC50,Inhibition of [3H]alpha-BGT binding to alpha1 nicotinic acetylcholine receptor in Homo sapiens (human) TE671 cells co-expressing gammaalpha1deltabeta1 nicotinic acetylcholine receptor subunits,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,Tclin,,,Homo sapiens
181075,1920,2601,Lycopene cyclase,Enzyme,P21687,crtY,CRTY_PANAN,5.32,,IC50,Inhibition of Pantoea ananatis lycopene cyclase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Pantoea ananas
181076,1920,2583,Acetylcholine receptor subunit alpha,Ion channel,P02710,CHRNA1,ACHA_TORCA,4.64,,IC50,Displacement of [3H]alpha-BGT from nAChR in Torpedo nobiliana electric organs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Torpedo californica
181077,1920,2473,Soluble acetylcholine receptor,Unclassified,Q8WSF8,,Q8WSF8_APLCA,7.52,,Ki,Binding affinity to salt water mollusc Aplysia californica AChBP Y55W mutant assessed as [3H]acetamiprid binding by radioligand binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Aplysia californica
181078,1920,2604,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,P09482,CHRNA4,ACHA4_CHICK,8.72,,Ki,Binding affinity to recombinant Gallus gallus (chicken) alpha4beta2 nicotinic acetylcholine receptor assessed as [3H]NIC binding by radioligand binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Gallus gallus
181079,1920,956,Acetylcholine-binding protein,Unclassified,P58154,,ACHP_LYMST,7.2,,Ki,Displacement of [125I]alpha-bungarotoxin from Lymnaea stagnalis His-tagged AchBP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,,,,Lymnaea stagnalis
181080,2676,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,5.72,,IC50,Inhibition of the activity of rabbit lung Angiotensin I converting enzyme,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1314,,,,,,,Oryctolagus cuniculus
181081,24,717,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,4.03,,IC50,Inhibition of human recombinant HDAC8,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1044,,,,Tclin,,,Homo sapiens
181082,24,606,Histone deacetylase 1,Enzyme,Q13547,HDAC1,HDAC1_HUMAN,4.19,,IC50,Inhibition of human recombinant HDAC1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1044,,,,Tclin,,,Homo sapiens
181083,24,598,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,4.19,,IC50,Inhibition of human recombinant HDAC2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1044,,,,Tclin,,,Homo sapiens
181105,1960,2867,Adrenergic receptor alpha,GPCR,P15823|P19328|P22086|P22909|P23944|P43140,Adra1a|Adra1b|Adra1d|Adra2a|Adra2b|Adra2c,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT|ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.8,,IC50,Binding affinity against Alpha adrenergic receptor using [3H]dihydroergocryptine radioligand in rat brain homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Rattus norvegicus
181084,1754,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,,,,Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1341,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1341,POSITIVE MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181085,2326,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,Mechanism of Action; CHEMBL222; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1590,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1590,RELEASING AGENT,,Tclin,,,Homo sapiens
181086,988,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,6.7,,Ki,Binding affinity against Acetylcholinesterase of purified calf forebrain (CFB),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1104,,,,,,,Bos taurus
181087,988,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,8.79,,Ki,Inhibition constant determined against Acetylcholinesterase (AChE) receptor.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1104,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1104,INHIBITOR,,Tclin,,,Homo sapiens
181088,2632,304,Xanthine dehydrogenase/oxidase,Enzyme,P47989,XDH,XDH_HUMAN,4.03,,IC50,Inhibition of human xanthine oxidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL727,,,,Tclin,,,Homo sapiens
181089,3577,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,4.2,,Ki,Displacement of [3H]8-OH-DPAT from 5HT1A receptor by vacuum filtration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33720,,,,Tclin,,,Homo sapiens
181090,2146,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,6.57,,Ki,Displacement of [3H]clonidine from Alpha-2 adrenergic receptor of rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215,,,,,,,Rattus norvegicus
181091,2146,2855,Adrenergic receptor alpha-2,GPCR,P08913|P18089|P18825,ADRA2A|ADRA2B|ADRA2C,ADA2A_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN,6.41,,Ki,Compound was tested for its ability to displace [3H]clonidine form alpha-2 adrenergic receptor site in guinea pig cerebral cortical membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215,,,,Tclin|Tclin|Tclin,,,Homo sapiens
181092,2146,1803,Beta-1 adrenergic receptor,GPCR,P18090,Adrb1,ADRB1_RAT,4.89,,Ki,Displacement of [3H]dihydroalprenolol from adrenergic beta 1 receptor of rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215,,,,,,,Rattus norvegicus
181093,2146,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.21,,Ki,Displacement of [3H]WB-4101 from adrenergic alpha 1 receptor of rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215,,,,,,,Rattus norvegicus
181094,811,2746,Glycine receptor (alpha-1/beta),Ion channel,P23415|P48167,GLRA1|GLRB,GLRA1_HUMAN|GLRB_HUMAN,,,,Mechanism of Action; CHEMBL2363052; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,POSITIVE MODULATOR,,Tclin|Tclin,,,Homo sapiens
181095,811,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,,,,Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181096,811,1680,Potassium channel subfamily K member 10,Ion channel,P57789,KCNK10,KCNKA_HUMAN,,,,Mechanism of Action; CHEMBL2331041; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,OPENER,,Tclin,,,Homo sapiens
181097,811,1692,Potassium channel subfamily K member 18,Ion channel,Q7Z418,KCNK18,KCNKI_HUMAN,,,,Mechanism of Action; CHEMBL2331042; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,OPENER,,Tclin,,,Homo sapiens
181098,811,641,Potassium channel subfamily K member 3,Ion channel,O14649,KCNK3,KCNK3_HUMAN,,,,Mechanism of Action; CHEMBL2321613; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,OPENER,,Tclin,,,Homo sapiens
181099,811,642,Potassium channel subfamily K member 9,Ion channel,Q9NPC2,KCNK9,KCNK9_HUMAN,,,,Mechanism of Action; CHEMBL2321614; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,OPENER,,Tclin,,,Homo sapiens
181100,811,397,Potassium channel subfamily K member 2,Ion channel,O95069,KCNK2,KCNK2_HUMAN,,,,Mechanism of Action; CHEMBL2321615; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733,OPENER,,Tclin,,,Homo sapiens
181101,3607,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.75,,IC50,Inhibition of human recombinant carbonic anhydrase 2 assessed as activity of carbonic anhydrase 2 esterase activity against 4-nitrophenyl acetate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442687,,,,Tclin,,,Homo sapiens
181102,1960,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,4.69,,Ki,Displacement of [3H]prazosin from human adrenergic Alpha-1B receptor expressed in CHO cell membrane,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,AGONIST,,Tclin,,,Homo sapiens
181103,1960,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.32,,Ki,Tested for binding affinity against alpha-2 adrenergic receptor in rat brain using [3H]- rauwolscine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Rattus norvegicus
181104,1960,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,5.22,,Ki,Tested for binding affinity against beta-2 adrenergic receptor in bovine lung using [3H]DHA as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Bos taurus
181106,1960,1824,Beta-2 adrenergic receptor,GPCR,P54833,ADRB2,ADRB2_CANFA,5.3,,Ki,Binding of [3H]dihydroalprenolol to beta-2 adrenergic receptor of rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Canis familiaris
181107,1960,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.2,,Ki,Binding affinity for human Alpha-2C adrenergic receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,AGONIST,,Tclin,,,Homo sapiens
181108,1960,2893,Adrenergic receptor beta,GPCR,P10608|P18090|P26255,Adrb1|Adrb2|Adrb3,ADRB1_RAT|ADRB2_RAT|ADRB3_RAT,6,,IC50,Inhibitory concentration required for displacement of Beta adrenergic receptor specific ligand [3H]dihydroalprenolol from rat brain cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Rattus norvegicus
181110,1960,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,4.85,,Ki,Compound was evaluated for binding affinity towards mu-specific opiate receptor from combinatorial peptoid library,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Rattus norvegicus
181111,1960,1803,Beta-1 adrenergic receptor,GPCR,P18090,Adrb1,ADRB1_RAT,6.9,,Ki,Tested for binding affinity against beta-1 adrenergic receptor in rat brain using [3H]-CGP- 26505 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Rattus norvegicus
181112,1960,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.4,,Kd,Binding affinity to human adrenergic beta2 receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,AGONIST,,Tclin,,,Homo sapiens
181113,1960,1733,Alpha-2B adrenergic receptor,GPCR,P19328,Adra2b,ADA2B_RAT,7.11,,Ki,Binding affinity for rat Alpha-2B adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Rattus norvegicus
181114,1960,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,6.41,,Ki,Binding affinity for alpha-1 adrenergic receptor in rat liver using [3H]prazosin.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Rattus norvegicus
181115,1960,1880,Beta-2 adrenergic receptor,GPCR,P10608,Adrb2,ADRB2_RAT,5.38,,Ki,Binding affinity against adrenergic beta 2 receptor versus 1 nM [3H]dihydroalprenolol in rat cerebral cerebellar membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Rattus norvegicus
181116,1960,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,6.4,,Ki,Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Cavia porcellus
27464,2337,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.524328708648682,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27466,2337,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.266000747680664,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27467,2337,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.03693962097168,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27469,2331,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.699904918670654,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27470,2320,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.677780628204346,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27473,2303,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.377896308898926,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27474,2303,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.19691276550293,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27475,2303,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.345717906951904,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27477,2303,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.912534236907959,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27485,2276,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.906578540802002,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27486,2276,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.337242126464844,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1761,ANTAGONIST,,Tclin,,,Homo sapiens
27487,2276,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.619788646697998,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27488,2276,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.154901504516602,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27489,2276,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.602059841156006,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27496,2274,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.229147911071777,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27497,2270,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.812479496002197,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27498,2263,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.193819999694824,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27499,2263,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.795880317687988,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27500,2263,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.798603057861328,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27501,2263,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.585026741027832,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27502,2263,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.149999618530273,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27507,2202,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,5.210000038146973,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27508,2202,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.659999847412109,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27511,2202,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.539999961853027,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27520,2193,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.552842140197754,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27521,2193,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.698969841003418,,Ki,,PDSP,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7557,ANTAGONIST,,Tclin,,,Homo sapiens
27522,2181,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.324221611022949,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27523,2181,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.602059841156006,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27525,2181,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.643974304199219,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27529,2181,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.537601947784424,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27538,2176,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.208854675292969,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27547,2172,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.058488368988037,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27549,2172,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.508638381958008,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27551,2172,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.708853244781494,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27555,2172,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.797784328460693,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27557,2142,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.397940158843994,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27558,2142,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.609269142150879,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27562,2142,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.667359352111816,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27563,2136,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,8.455931663513184,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL753,ANTAGONIST,,Tclin,,,Homo sapiens
27564,2132,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,5.378408432006836,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27565,2123,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.07572078704834,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27574,2113,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.733297824859619,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27580,2111,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.823908805847168,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27581,2111,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27582,2111,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.7044677734375,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27583,2111,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.522878646850586,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27584,2111,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.221848964691162,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27585,2080,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.682145595550537,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27586,2032,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.830002307891846,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27587,2032,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.378897666931152,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27589,2032,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.5900163650512695,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27595,1971,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.92081880569458,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27609,1922,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.494850158691406,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27616,1837,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27617,1837,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.133803367614746,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27618,1837,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27619,1830,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.583026885986328,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27620,1830,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.99653959274292,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27621,1830,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.4202165603637695,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27624,1830,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27626,1830,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.619788646697998,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27627,1830,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27628,1830,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.762959003448486,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27629,1830,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.25352144241333,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27631,1830,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.959793567657471,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27632,1830,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.420559406280518,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27638,1816,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.380176544189453,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27642,1796,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.026872158050537,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27648,1796,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.397940158843994,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27665,1767,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.067526340484619,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27666,1767,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.614930152893066,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27667,1767,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.251811981201172,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27668,1752,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.236572265625,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27669,1732,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.610834121704102,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200952,INHIBITOR,,Tclin,,,Homo sapiens
27670,1732,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27671,1732,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.133121967315674,,Ki,,PDSP,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
27672,1732,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.089535713195801,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27673,1732,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.1281938552856445,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27674,1732,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.3827900886535645,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27678,1726,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.638272285461426,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27679,1712,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.4202165603637695,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27680,1712,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.585026741027832,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27681,1712,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.743524551391602,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27682,1712,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.804100513458252,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27683,1712,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.12491512298584,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088,ANTAGONIST,,Tclin,,,Homo sapiens
27684,1712,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.040958404541016,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27685,1712,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.045757293701172,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27686,1712,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.72445821762085,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088,ANTAGONIST,,Tclin,,,Homo sapiens
27687,1712,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27688,1712,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.221848964691162,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27689,1712,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.721246242523193,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27690,1712,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.823908805847168,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27691,1707,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.236572265625,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27694,1677,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.677780628204346,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27696,1677,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.4685211181640625,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27699,1677,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.6575775146484375,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27700,1677,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.3565473556518555,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27701,1677,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.619788646697998,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27706,1640,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.221848964691162,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27709,1634,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.236571788787842,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27710,1613,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,5.296880722045898,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27711,1613,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.508638381958008,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27713,1613,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.110138416290283,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27714,1613,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,6.721246242523193,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27716,1613,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.275723934173584,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27719,1613,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.854182243347168,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27722,1613,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.411168098449707,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27723,1613,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.459920883178711,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27724,1613,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.681936740875244,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27725,1613,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,7.12493896484375,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27727,1613,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.267606258392334,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27728,1613,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.913640022277832,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27729,1613,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.097181797027588,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27730,1613,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.967381954193115,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27733,1613,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.821310997009277,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27734,1613,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.829470634460449,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27735,1613,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.609771728515625,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27736,1613,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.087092399597168,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27737,1613,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.376013278961182,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27742,1592,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.698969841003418,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27745,1592,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.337242126464844,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27750,1524,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.747146606445312,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27752,1524,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,8.90308952331543,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27759,1524,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.701147079467773,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27762,1478,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.185086727142334,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27763,1478,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.92081880569458,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27764,1478,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.79048490524292,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27765,1440,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,7.690557956695557,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27766,1427,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.070580959320068,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27774,1427,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.236571788787842,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27777,1423,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27780,1423,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27781,1423,890,Ephrin type-B receptor 1,Kinase,P54762,EPHB1,EPHB1_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27782,1423,922,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27784,1423,746,Cytoplasmic tyrosine-protein kinase BMX,Kinase,P51813,BMX,BMX_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27797,1423,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,5,,Ki,,PDSP,=,,,,,AGONIST,,Tclin,,,Homo sapiens
27799,1423,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27811,1353,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,5.648396968841553,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27814,1353,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,8.09691047668457,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27820,1353,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.568636417388916,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27822,1353,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.998699188232422,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27826,1353,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27827,1353,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.259637355804443,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27828,1353,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.318758964538574,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27830,1353,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.946921348571777,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27831,1353,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.182434558868408,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27848,1222,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.2924299240112305,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27849,1222,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.408935546875,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27853,1222,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,5.95078182220459,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27854,1222,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.055517196655273,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27855,1222,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.207608222961426,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27856,1222,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.318758964538574,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27857,1222,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.436447143554688,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27858,1222,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.2441253662109375,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27860,1222,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.229147911071777,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27861,1214,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.19045352935791,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27862,1214,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.4202165603637695,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27863,1214,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.838632106781006,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27864,1214,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.61092472076416,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27865,1214,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.886056423187256,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27866,1214,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.679545879364014,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27867,1214,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,8.09691047668457,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27868,1214,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.225482940673828,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27869,1214,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.267606258392334,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27870,1214,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.047779083251953,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27871,1214,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.978909015655518,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27872,1214,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.476253509521484,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27873,1214,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.476253509521484,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27874,1214,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.251811981201172,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27875,1214,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,7.887345314025879,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27876,1214,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.443697452545166,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27877,1214,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.677780628204346,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27878,1214,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.841336250305176,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27879,1214,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.53910493850708,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27880,1214,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.087247848510742,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27881,1214,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.267605781555176,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200951,ANTAGONIST,,Tclin,,,Homo sapiens
27882,1214,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.960586071014404,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27883,1214,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.5030012130737305,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27884,1214,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.44733190536499,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27885,1214,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.836540222167969,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27886,1214,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.2740068435668945,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27887,1214,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.144905090332031,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27896,1209,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.568636417388916,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27897,1209,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.537601947784424,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27898,1209,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.568636417388916,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27901,1153,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.960409164428711,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27903,1113,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,7.102373123168945,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27904,1111,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.508638381958008,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27905,1111,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.050610065460205,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27906,1111,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.638272285461426,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27907,1111,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.070580959320068,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27924,966,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,9.07572078704834,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27925,966,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.602060317993164,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108,ANTAGONIST,,Tclin,,,Homo sapiens
27931,947,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.083651542663574,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27943,832,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.041913986206055,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
27945,832,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.847711563110352,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27946,832,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,5.257053375244141,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27947,832,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.17587423324585,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27948,832,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.79048490524292,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27949,832,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.607303142547607,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27950,832,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,5.719649314880371,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27951,832,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.898252964019775,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27952,832,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.3258585929870605,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27953,832,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.705533981323242,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27954,832,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.619788646697998,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27955,832,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.733063220977783,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27956,832,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.274905681610107,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27957,832,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.080399036407471,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27958,832,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.001529216766357,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27959,832,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.155981063842773,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27960,832,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.576601028442383,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27966,812,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.631264686584473,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27969,812,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.193819999694824,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27972,789,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.602059841156006,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27981,765,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.886056423187256,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27988,746,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,5.531209945678711,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27989,746,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.602060317993164,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27993,746,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,8.42021656036377,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27994,746,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.494850158691406,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27995,746,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.236572265625,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27996,746,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.886056423187256,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27997,746,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.455932140350342,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
27999,746,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.92081880569458,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28000,746,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.376750946044922,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28002,704,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.5,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28009,701,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.411520481109619,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28010,701,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,9.703356742858887,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,INHIBITOR,,Tclin,,,Homo sapiens
28011,701,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.189767360687256,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28012,701,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.449771881103516,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28013,701,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.659555912017822,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28014,701,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.950311660766602,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28015,701,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.279840469360352,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28016,672,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,6.395557880401611,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
28020,663,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.875271320343018,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28024,621,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.9281182289123535,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
28025,621,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,6.010105609893799,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28027,621,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,9.091514587402344,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28031,621,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.463441371917725,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
28034,621,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,5.827105522155762,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28035,621,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.3448615074157715,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28036,621,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.759450912475586,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28040,621,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.250913619995117,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28044,621,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.602059841156006,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28046,621,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.376750946044922,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28048,621,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.397940158843994,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28049,621,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.745735168457031,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28050,619,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.986937522888184,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28051,619,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.638272285461426,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
28052,619,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.97930383682251,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28054,616,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.1674909591674805,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28061,517,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.823908805847168,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28062,517,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.060481071472168,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28068,455,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.40450382232666,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28069,455,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.866461277008057,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28077,408,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.217527389526367,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL811,ANTAGONIST,,Tclin,,,Homo sapiens
28080,407,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.146301746368408,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28082,407,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.1191864013671875,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28083,407,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.318758964538574,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28084,407,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.7695512771606445,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28085,407,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.744727611541748,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28096,374,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.20065975189209,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28107,242,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.492481708526611,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28109,242,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,5.906403064727783,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
28110,242,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,6.202040195465088,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28111,242,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,9.443697929382324,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28113,242,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.463470935821533,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28117,242,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.096909999847412,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
28122,242,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,5.681212902069092,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
28124,242,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.060016632080078,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28125,242,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.330032825469971,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28126,242,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.421360969543457,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28127,242,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.991399765014648,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28129,242,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.168898582458496,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28130,242,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.130768299102783,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28131,242,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.6329240798950195,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28133,242,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.850780963897705,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28134,242,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.818013668060303,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28135,242,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.454878330230713,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28142,229,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.938393592834473,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL647,AGONIST,,Tclin,,,Homo sapiens
28144,195,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.935542106628418,,Ki,,PDSP,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405,RELEASING AGENT,,Tclin,,,Homo sapiens
28145,195,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.753255367279053,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28147,193,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.79587984085083,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
28150,191,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.733623027801514,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28154,191,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.79587984085083,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28171,137,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.2924299240112305,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
28174,136,305,Platelet-activating factor receptor,GPCR,P25105,PTAFR,PTAFR_HUMAN,5.4573469161987305,,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
28176,105,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.612610340118408,,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
22832,4135,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01255,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201178,RELEASING AGENT,,Tclin,,,Homo sapiens
22896,4123,1060,Chloride channel protein 2,Ion channel,P51788,CLCN2,CLCN2_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01046,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201134,OPENER,,Tclin,,,Homo sapiens
26286,91,860,P2Y purinoceptor 2,GPCR,P41231,P2RY2,P2RY2_HUMAN,7.1,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,AGONIST,,Tclin,,,Homo sapiens
180605,4947,29,Aspergillus fumigatus,Fungi,,,,5.221848964691162,,ED50,iv administration in rat immunosuppressed model ED50(umol/kg) measures on Day 14,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/12482421,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207500Orig1s000lbl.pdf,MINIMUM INHIBITORY CONCENTRATION,,,195,196,
180606,4947,28,Candida albicans,Fungi,,,,5.823908805847168,,ED50,iv administration in rat model (C. albicans CY3003) ED50(umol/kg) measures on Day 14,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/12482421,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207500Orig1s000lbl.pdf,MINIMUM INHIBITORY CONCENTRATION,,,195,196,
23149,3016,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00892,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200,BLOCKER,,Tclin,,,Homo sapiens
23240,2801,70,DNA polymerase catalytic subunit,Enzyme,P04293,,DPOL_HHV11,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01610,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200454,INHIBITOR,,,,,Human herpesvirus 1 (strain 17)
23272,2746,934,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,Enzyme,P26439,HSD3B2,3BHS2_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01108,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200907,INHIBITOR,,Tclin,,,Homo sapiens
23331,2706,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00273,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,BLOCKER,,Tclin,,,Homo sapiens
23395,2612,1430,Phenylalanine-4-hydroxylase,Enzyme,P00439,PAH,PH4H_HUMAN,5.4,,Ki,Binding affinity for human PAH.,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5276,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201774,ACTIVATOR,,Tclin,,,Homo sapiens
23443,2529,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00263,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL453,INHIBITOR,,,,,Escherichia coli (strain K12)
23489,2474,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,9.1,,IC50,Compound tested in vitro for inhibition of Angiotensin I converting enzyme,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431,INHIBITOR,,Tclin,,,Homo sapiens
23538,2439,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01236,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,POSITIVE MODULATOR,,Tclin,,,Homo sapiens
23585,2377,1510,DNA-directed RNA polymerase subunit beta,Enzyme,P0A8V2,rpoB,RPOB_ECOLI,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01045,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL374478,INHIBITOR,,,,,Escherichia coli (strain K12)
23609,2342,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB04575,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201165,AGONIST,,Tclin,,,Homo sapiens
23634,2294,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00807,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1196,BLOCKER,,Tclin,,,Homo sapiens
23650,2282,1124,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,P13922,,DRTS_PLAFK,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01131,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1377,INHIBITOR,,,,,Plasmodium falciparum
23662,2271,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00721,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL569,BLOCKER,,Tclin,,,Homo sapiens
23669,2268,1529,Solute carrier family 22 member 11,Transporter,Q9NSA0,SLC22A11,S22AB_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01032,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897,INHIBITOR,,Tclin,,,Homo sapiens
23741,2123,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,7.82,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7266,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089,INHIBITOR,,Tclin,,,Homo sapiens
23760,2099,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00806,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628,INHIBITOR,,Tclin,,,Homo sapiens
23775,2079,70,DNA polymerase catalytic subunit,Enzyme,P04293,,DPOL_HHV11,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00299,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1540,INHIBITOR,,,,,Human herpesvirus 1 (strain 17)
23807,2011,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00621,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200436,AGONIST,,Tclin,,,Homo sapiens
23848,1960,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.4,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=505,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,AGONIST,,Tclin,,,Homo sapiens
23870,1943,1443,Pyruvate dehydrogenase [NADP(+)],Enzyme,Q968X7,PFOR,PNO_CRYPV,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00507,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1401,INHIBITOR,,,,,Cryptosporidium parvum
23875,1925,1059,Chloride channel protein ClC-Ka,Ion channel,P51800,CLCNKA,CLCKA_HUMAN,5,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2439,,ACTIVATOR,,Tbio,,,Homo sapiens
23922,1857,1581,Isoleucine--tRNA ligase,Enzyme,P41972,ileS,SYI1_STAAU,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00410,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL719,INHIBITOR,,,,,Staphylococcus aureus
23934,1832,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00764,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1161,AGONIST,,Tclin,,,Homo sapiens
23975,1792,1630,Tyrosine 3-monooxygenase,Enzyme,P07101,TH,TY3H_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00765,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200862,INHIBITOR,,Tclin,,,Homo sapiens
23999,1754,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01028,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1341,AGONIST,,Tclin,,,Homo sapiens
24011,1710,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00244,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL704,INHIBITOR,,Tclin,,,Homo sapiens
33786,191,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.958607315,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
24012,1709,1093,D-alanyl-D-alanine carboxypeptidase DacB,Enzyme,P24228,dacB,DACB_ECOLI,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00760,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127,INHIBITOR,,,,,Escherichia coli (strain K12)
24015,1708,1467,Amidophosphoribosyltransferase,Enzyme,Q06203,PPAT,PUR1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01033,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1425,INHIBITOR,,Tclin,,,Homo sapiens
24031,1694,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01365,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996,AGONIST,,Tclin,,,Homo sapiens
24054,1667,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00351,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201139,AGONIST,,Tclin,,,Homo sapiens
24093,1611,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00873,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200865,AGONIST,,Tclin,,,Homo sapiens
24203,1540,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,4.77,,IC50,Inhibition of human Nav1.7 expressed in SHSY5Y cells assessed as reduction in blue fluorescent signal by VSP-FRET assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,BLOCKER,,Tclin,,,Homo sapiens
24204,1540,141,Sodium channel protein type 8 subunit alpha,Ion channel,Q9UQD0,SCN8A,SCN8A_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00555,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,BLOCKER,,Tclin,,,Homo sapiens
24206,1540,139,Sodium channel protein type 3 subunit alpha,Ion channel,Q9NY46,SCN3A,SCN3A_HUMAN,4.77,,IC50,Inhibition of human Nav1.3 expressed in SHSY5Y cells assessed as reduction in blue fluorescent signal by VSP-FRET assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,BLOCKER,,Tclin,,,Homo sapiens
24208,1540,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00555,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,BLOCKER,,Tclin,,,Homo sapiens
24224,1490,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01247,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201168,INHIBITOR,,Tclin,,,Homo sapiens
24225,1490,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01247,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201168,INHIBITOR,,Tclin,,,Homo sapiens
24226,1482,596,DNA topoisomerase 1,Enzyme,P11387,TOP1,TOP1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00762,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL481,INHIBITOR,,Tclin,,,Homo sapiens
24235,1434,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00192,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200341,BLOCKER,,Tclin,,,Homo sapiens
24326,1339,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00226,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1037,SUBSTRATE,,Tclin,,,Homo sapiens
180607,4948,3501,glycolipid disialoganglioside (GD2),Glycolipid,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125516s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125516s000lbl.pdf,ANTIBODY BINDING,,,197,197,
24578,1247,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00252,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL919,BLOCKER,,Tclin,,,Homo sapiens
24647,1198,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,,DRUGBANK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200877,AGONIST,,Tclin,,,Homo sapiens
24651,1191,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,9.92,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2873,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201010,AGONIST,,Tclin,,,Homo sapiens
24658,1188,1633,Thymidylate synthase,Enzyme,P12461,TMP1,TYSY_CANAL,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01099,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1463,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
24662,1184,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00322,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL917,INHIBITOR,,Tclin,,,Homo sapiens
24678,1140,84,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,Q12879,GRIN2A,NMDE1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00949,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094,ANTAGONIST,,Tclin,,,Homo sapiens
24692,1116,415,Retinoic acid receptor RXR-gamma,Nuclear hormone receptor,P48443,RXRG,RXRG_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00459,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL464,AGONIST,,Tclin,,,Homo sapiens
24704,1083,230,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,P9WGR1,inhA,INHA_MYCTU,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00609,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1441,INHIBITOR,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
24731,1046,1418,Penicillin-binding protein 1B,Enzyme,P02919,mrcB,PBPB_ECOLI,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00303,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1232,INHIBITOR,,,,,Escherichia coli (strain K12)
24732,1046,1417,Penicillin-binding protein 1A,Enzyme,P02918,mrcA,PBPA_ECOLI,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00303,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1232,INHIBITOR,,,,,Escherichia coli (strain K12)
24735,1046,1093,D-alanyl-D-alanine carboxypeptidase DacB,Enzyme,P24228,dacB,DACB_ECOLI,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00303,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1232,INHIBITOR,,,,,Escherichia coli (strain K12)
24778,975,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.9,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2878,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200853,AGONIST,,Tclin,,,Homo sapiens
24779,974,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00645,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200478,BLOCKER,,Tclin,,,Homo sapiens
34555,719,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.15583359,,Ki,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
24790,965,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00858,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201048,AGONIST,,Tclin,,,Homo sapiens
24823,915,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB13720,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200880,ANTAGONIST,,Tclin,,,Homo sapiens
24871,870,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,4.88,,EC50,PUBCHEM_BIOASSAY: Estrogen Receptor-alpha Coactivator Binding Potentiators Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 639 (Primary screen preceding this dose response confirmation assay.)],CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1018,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1018,AGONIST,,Tclin,,,Homo sapiens
24883,859,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00527,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1086,BLOCKER,,Tclin,,,Homo sapiens
24885,859,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00527,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1086,BLOCKER,,Tclin,,,Homo sapiens
24918,830,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00405,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200638,ANTAGONIST,,Tclin,,,Homo sapiens
24940,801,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00944,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200514,INHIBITOR,,Tclin,,,Homo sapiens
25184,605,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01161,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL944,BLOCKER,,Tclin,,,Homo sapiens
25190,579,558,Cholecystokinin receptor type A,GPCR,P32238,CCKAR,CCKAR_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00403,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200755,AGONIST,,Tclin,,,Homo sapiens
25232,516,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01038,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201328,ANTAGONIST,,Tclin,,,Homo sapiens
25266,427,1519,Solute carrier family 12 member 2,Transporter,P55011,SLC12A2,S12A2_HUMAN,5.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4837,,INHIBITOR,,Tclin,,,Homo sapiens
25288,385,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,8.6,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6470,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103749,INHIBITOR,,Tclin,,,Homo sapiens
25316,359,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00217,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201260,SUBSTRATE,,Tclin,,,Homo sapiens
25323,341,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB04890,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201758,ANTAGONIST,,Tclin,,,Homo sapiens
25360,268,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00719,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL946,ANTAGONIST,,Tclin,,,Homo sapiens
25401,223,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00517,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1578,ANTAGONIST,,Tclin,,,Homo sapiens
25403,223,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00517,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1578,ANTAGONIST,,Tclin,,,Homo sapiens
25404,222,627,Vitamin K-dependent gamma-carboxylase,Enzyme,P38435,GGCX,VKGC_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01125,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL712,INHIBITOR,,Tclin,,,Homo sapiens
25413,209,121,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,7.27,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7114,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL760,INHIBITOR,,Tclin,,,Homo sapiens
25442,163,662,Tissue-type plasminogen activator,Enzyme,P00750,PLAT,TPA_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1046,INHIBITOR,,Tclin,,,Homo sapiens
25448,158,952,Acid-sensing ion channel 2,Ion channel,Q16515,ASIC2,ASIC2_HUMAN,4.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2421,,BLOCKER,,Tbio,,,Homo sapiens
25580,59,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB01063,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1085,ANTAGONIST,,Tclin,,,Homo sapiens
25606,25,271,DNA (cytosine-5)-methyltransferase 1,Enzyme,P26358,DNMT1,DNMT1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,http://www.drugbank.ca/drugs/DB00928,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1489,INHIBITOR,,Tclin,,,Homo sapiens
25609,13,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,,DRUGBANK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1367478,AGONIST,,Tclin,,,Homo sapiens
25618,522,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.9,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=551,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723,ANTAGONIST,,Tclin,,,Homo sapiens
25622,1895,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=983,,ANTAGONIST,,Tclin,,,Homo sapiens
25624,35,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,9.49,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1188,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1252,ANTAGONIST,,Tclin,,,Homo sapiens
25628,460,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.2,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201087,AGONIST,,Tclin,,,Homo sapiens
25652,1775,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,Tclin,,,Homo sapiens
25836,1422,527,Prostaglandin D2 receptor,GPCR,Q13258,PTGDR,PD2R_HUMAN,6.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,Tclin,,,Homo sapiens
25656,433,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.1,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=550,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=550,ANTAGONIST,,Tclin,,,Homo sapiens
25672,2032,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.2,,Ki,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=124,http://www.ncbi.nlm.nih.gov/pubmed/20030735,AGONIST,,Tclin,,269,Homo sapiens
25677,945,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.4,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=965,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=965,ANTAGONIST,,Tclin,,,Homo sapiens
25680,1588,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43,,AGONIST,,Tclin,,,Homo sapiens
25688,1613,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=205,,ANTAGONIST,,Tclin,,,Homo sapiens
25691,1211,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.96,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948,,ANTAGONIST,,Tclin,,,Homo sapiens
25699,1211,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.82,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948,ANTAGONIST,,Tclin,,,Homo sapiens
25722,433,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,9,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=550,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=550,ANTAGONIST,,Tclin,,,Homo sapiens
25735,2637,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100,,ANTAGONIST,,Tclin,,,Homo sapiens
25737,1775,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,Tclin,,,Homo sapiens
25747,1865,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,8.6,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=554,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL649,ANTAGONIST,,Tclin,,,Homo sapiens
25751,1942,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,7.1,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2524,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726,GATING INHIBITOR,,Tclin,,,Homo sapiens
25757,1211,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,8.4,,Ki,"Note that this assay uses the <i>cis</i> form of the compound, whereas the approved drug is a racemic mixture of <i>cis</i> and <i>trans</i> molecules.",IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948,ANTAGONIST,,Tclin,,,Homo sapiens
25770,433,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=550,,ANTAGONIST,,Tclin,,,Homo sapiens
25772,2202,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.9,,Ki,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49,http://www.ncbi.nlm.nih.gov/pubmed/20600305,AGONIST,,Tclin,,395,Homo sapiens
25782,1775,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,Tclin,,,Homo sapiens
25791,913,527,Prostaglandin D2 receptor,GPCR,Q13258,PTGDR,PD2R_HUMAN,7,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
25792,1775,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,Tchem,,,Homo sapiens
25793,1775,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,Tchem,,,Homo sapiens
25799,228,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,7.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33,,AGONIST,,Tchem,,,Homo sapiens
25801,1942,236,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726,BLOCKER,,Tclin,,,Homo sapiens
25803,913,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,6.9,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
25804,2393,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=51,,AGONIST,,Tclin,,,Homo sapiens
25813,1775,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,Tchem,,,Homo sapiens
25815,2032,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=124,,AGONIST,,Tclin,,,Homo sapiens
25818,4120,1210,Metabotropic glutamate receptor 8,GPCR,O00222,GRM8,GRM8_HUMAN,7.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1411,,AGONIST,,Tchem,,,Homo sapiens
25821,1848,245,5-hydroxytryptamine receptor 4,GPCR,Q13639,HTR4,5HT4R_HUMAN,6.9,,Ki,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=242,http://www.ncbi.nlm.nih.gov/pubmed/8950316,AGONIST,,Tclin,,268,Homo sapiens
25822,2543,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=54,,ANTAGONIST,,Tclin,,,Homo sapiens
25827,109,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.9,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=341,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
25828,3486,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.8,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=555,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=555,ANTAGONIST,,Tclin,,,Homo sapiens
93838,192,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.96,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
25850,1937,236,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428,BLOCKER,,Tclin,,,Homo sapiens
25862,2032,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.2,,Ki,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=124,http://www.ncbi.nlm.nih.gov/pubmed/20030735,AGONIST,,Tclin,,269,Homo sapiens
25863,2470,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99,,ANTAGONIST,,Tclin,,,Homo sapiens
25869,3396,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,5.8,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2149,,AGONIST,,Tclin,,,Homo sapiens
25878,875,812,Steroid hormone receptor ERR2,Nuclear hormone receptor,O95718,ESRRB,ERR2_HUMAN,5.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2801,,ANTAGONIST,,Tchem,,,Homo sapiens
25879,912,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,6,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
25888,1310,1210,Metabotropic glutamate receptor 8,GPCR,O00222,GRM8,GRM8_HUMAN,5.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1369,,AGONIST,,Tchem,,,Homo sapiens
25893,2966,904,P2Y purinoceptor 11,GPCR,Q96G91,P2RY11,P2Y11_HUMAN,6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728,,ANTAGONIST,,Tbio,,,Homo sapiens
25894,875,296,Estrogen-related receptor gamma,Nuclear hormone receptor,P62508,ESRRG,ERR3_HUMAN,5.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2801,,ANTAGONIST,,Tchem,,,Homo sapiens
25897,463,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,4.97,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=407,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,ANTAGONIST,,Tclin,,,Homo sapiens
25898,1422,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,6.68,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,Tclin,,,Homo sapiens
25899,65,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=294,,AGONIST,,Tclin,,,Homo sapiens
25902,3323,838,Free fatty acid receptor 1,GPCR,O14842,FFAR1,FFAR1_HUMAN,5.7,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1052,,AGONIST,,Tchem,,,Homo sapiens
25928,1368,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,10.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2823,,ANTAGONIST,,Tclin,,,Homo sapiens
25929,2293,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,10.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=329,,ANTAGONIST,,Tclin,,,Homo sapiens
25933,2293,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,10,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=329,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1240,ANTAGONIST,,Tclin,,,Homo sapiens
25942,2293,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.7,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=329,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1240,ANTAGONIST,,Tclin,,,Homo sapiens
25946,676,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.6,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=366,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL620,ANTAGONIST,,Tclin,,,Homo sapiens
25947,3165,393,Thromboxane A2 receptor,GPCR,P21731,TBXA2R,TA2R_HUMAN,9.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1979,,ANTAGONIST,,Tclin,,,Homo sapiens
25950,2293,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,9.5,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=329,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1240,ANTAGONIST,,Tclin,,,Homo sapiens
25954,522,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,9.5,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=551,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723,ANTAGONIST,,Tclin,,,Homo sapiens
25959,522,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,9.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=551,,ANTAGONIST,,Tclin,,,Homo sapiens
25960,1947,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,UNKNOWN,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/17276408,BLOCKER,,Tclin,,509,Homo sapiens
25969,2875,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,9.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103,,ANTAGONIST,,Tclin,,,Homo sapiens
25970,2878,843,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,Q00975,CACNA1B,CAC1B_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1795072,BLOCKER,,Tclin,,,Homo sapiens
25974,2470,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,9.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99,,ANTAGONIST,,Tclin,,,Homo sapiens
25980,460,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,AGONIST,,Tclin,,,Homo sapiens
26000,1371,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.9,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=323,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201325,ANTAGONIST,,Tclin,,,Homo sapiens
26001,2875,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103,,ANTAGONIST,,Tchem,,,Homo sapiens
26009,2875,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103,,ANTAGONIST,,Tclin,,,Homo sapiens
26014,746,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=84,,ANTAGONIST,,Tclin,,,Homo sapiens
93906,258,179,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q02127,DHODH,PYRD_HUMAN,5.03,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
26019,4151,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=493,,ANTAGONIST,,Tclin,,,Homo sapiens
26022,487,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,8.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=569,,AGONIST,,Tclin,,,Homo sapiens
26028,1371,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201325,ANTAGONIST,,Tclin,,,Homo sapiens
26030,2605,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,8.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=571,,ANTAGONIST,,Tclin,,,Homo sapiens
26033,2646,93,Thyroid hormone receptor beta,Nuclear hormone receptor,P10828,THRB,THB_HUMAN,8.52,,IC50,,IUPHAR,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL559,AGONIST,,Tclin,,,Homo sapiens
26040,2423,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=210,,ANTAGONIST,,Tclin,,,Homo sapiens
26041,1371,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=323,,ANTAGONIST,,Tclin,,,Homo sapiens
26053,2639,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=212,,ANTAGONIST,,Tclin,,,Homo sapiens
26057,1371,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=323,,ANTAGONIST,,Tclin,,,Homo sapiens
26058,2865,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=59,,AGONIST,,Tclin,,,Homo sapiens
26067,2181,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=92,,ANTAGONIST,,Tclin,,,Homo sapiens
26072,1524,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,Tclin,,,Homo sapiens
26073,1524,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,8.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,Tclin,,,Homo sapiens
26077,2637,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100,,ANTAGONIST,,Tchem,,,Homo sapiens
26083,1613,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=205,,ANTAGONIST,,Tclin,,,Homo sapiens
26085,3652,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57,,AGONIST,,Tclin,,,Homo sapiens
26086,1884,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,8.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=45,,AGONIST,,Tclin,,,Homo sapiens
26087,1775,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,8.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,Tclin,,,Homo sapiens
26088,460,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,AGONIST,,Tclin,,,Homo sapiens
26092,1211,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,8.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=948,,ANTAGONIST,,Tchem,,,Homo sapiens
26094,2470,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99,,ANTAGONIST,,Tclin,,,Homo sapiens
26097,3639,860,P2Y purinoceptor 2,GPCR,P41231,P2RY2,P2RY2_HUMAN,8.1,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1734,,AGONIST,,Tclin,,,Homo sapiens
26101,460,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,AGONIST,,Tclin,,,Homo sapiens
26120,1222,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=85,,ANTAGONIST,,Tclin,,,Homo sapiens
26122,460,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,ANTAGONIST,,Tclin,,,Homo sapiens
26129,1222,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=85,,ANTAGONIST,,Tclin,,,Homo sapiens
26132,2740,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=214,,ANTAGONIST,,Tclin,,,Homo sapiens
26133,746,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=84,,ANTAGONIST,,Tclin,,,Homo sapiens
26138,1524,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,Tclin,,,Homo sapiens
26145,2600,1668,Potassium voltage-gated channel subfamily H member 1,Ion channel,O95259,KCNH1,KCNH1_HUMAN,7.8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2608,,BLOCKER,,Tclin,,,Homo sapiens
26154,460,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,AGONIST,,Tchem,,,Homo sapiens
26155,4151,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=493,,ANTAGONIST,,Tclin,,,Homo sapiens
26156,460,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,AGONIST,,Tclin,,,Homo sapiens
26165,2637,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100,,ANTAGONIST,,Tclin,,,Homo sapiens
26166,460,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,ANTAGONIST,,Tclin,,,Homo sapiens
26170,1884,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=45,,AGONIST,,Tchem,,,Homo sapiens
26174,3652,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57,,ANTAGONIST,,Tclin,,,Homo sapiens
26176,1371,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=323,,ANTAGONIST,,Tclin,,,Homo sapiens
26194,1796,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,,ANTAGONIST,,Tclin,,,Homo sapiens
26200,2172,270,Voltage-dependent T-type calcium channel subunit alpha-1I,Ion channel,Q9P0X4,CACNA1I,CAC1I_HUMAN,7.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=90,,BLOCKER,,Tclin,,,Homo sapiens
26201,942,1668,Potassium voltage-gated channel subfamily H member 1,Ion channel,O95259,KCNH1,KCNH1_HUMAN,7.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2604,,BLOCKER,,Tclin,,,Homo sapiens
26211,1796,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,,ANTAGONIST,,Tclin,,,Homo sapiens
26212,2389,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=96,,ANTAGONIST,,Tclin,,,Homo sapiens
26213,2220,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=93,,ANTAGONIST,,Tclin,,,Homo sapiens
26223,228,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33,,ANTAGONIST,,Tclin,,,Homo sapiens
26224,1310,1209,Metabotropic glutamate receptor 3,GPCR,Q14832,GRM3,GRM3_HUMAN,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1369,,AGONIST,,Tchem,,,Homo sapiens
26228,2423,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=210,,ANTAGONIST,,Tclin,,,Homo sapiens
26229,3652,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57,,ANTAGONIST,,Tclin,,,Homo sapiens
26232,1440,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,7.38,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1909,,AGONIST,,Tclin,,,Homo sapiens
26234,3652,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57,,AGONIST,,Tclin,,,Homo sapiens
26235,460,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,AGONIST,,Tchem,,,Homo sapiens
26237,191,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=201,,ANTAGONIST,,Tchem,,,Homo sapiens
26245,2639,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=212,,ANTAGONIST,,Tclin,,,Homo sapiens
26249,2875,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103,,ANTAGONIST,,Tclin,,,Homo sapiens
26251,1028,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,AGONIST,,Tclin,,,Homo sapiens
26252,3652,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57,,AGONIST,,Tclin,,,Homo sapiens
26253,1222,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=85,,ANTAGONIST,,Tclin,,,Homo sapiens
26257,746,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=84,,ANTAGONIST,,Tclin,,,Homo sapiens
26262,228,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33,,ANTAGONIST,,Tclin,,,Homo sapiens
26263,2740,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=214,,ANTAGONIST,,Tclin,,,Homo sapiens
26265,2202,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49,,ANTAGONIST,,Tclin,,,Homo sapiens
26268,2435,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=98,,ANTAGONIST,,Tclin,,,Homo sapiens
26271,1649,60,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,Q14994,NR1I3,NR1I3_HUMAN,7.16,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2757,,ANTAGONIST,,Tchem,,,Homo sapiens
26274,3536,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=306,,AGONIST,,Tclin,,,Homo sapiens
26277,2202,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49,,ANTAGONIST,,Tclin,,,Homo sapiens
26278,2637,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100,,ANTAGONIST,,Tclin,,,Homo sapiens
26283,460,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,ANTAGONIST,,Tclin,,,Homo sapiens
163346,956,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.284,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
26304,228,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33,,ANTAGONIST,,Tclin,,,Homo sapiens
26310,228,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33,,AGONIST,,Tclin,,,Homo sapiens
26313,3652,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57,,AGONIST,,Tclin,,,Homo sapiens
26318,1865,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.9,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=554,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL649,ANTAGONIST,,Tclin,,,Homo sapiens
26324,228,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33,,ANTAGONIST,,Tclin,,,Homo sapiens
26325,3652,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57,,ANTAGONIST,,Tclin,,,Homo sapiens
26326,228,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33,,ANTAGONIST,,Tclin,,,Homo sapiens
26334,2181,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=92,,ANTAGONIST,,Tclin,,,Homo sapiens
26336,1937,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428,BLOCKER,,Tclin,,,Homo sapiens
26337,2393,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=51,,AGONIST,,Tchem,,,Homo sapiens
26340,460,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,AGONIST,,Tclin,,,Homo sapiens
26341,1524,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,Tclin,,,Homo sapiens
26348,249,1668,Potassium voltage-gated channel subfamily H member 1,Ion channel,O95259,KCNH1,KCNH1_HUMAN,6.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2603,,BLOCKER,,Tclin,,,Homo sapiens
26349,868,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=355,,ANTAGONIST,,Tclin,,,Homo sapiens
26350,2202,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49,,AGONIST,,Tclin,,,Homo sapiens
26355,1353,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=86,,ANTAGONIST,,Tclin,,,Homo sapiens
26358,99,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=198,,ANTAGONIST,,Tclin,,,Homo sapiens
26359,2423,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=210,,ANTAGONIST,,Tclin,,,Homo sapiens
26361,1153,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=939,,AGONIST,,Tchem,,,Homo sapiens
26362,2202,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49,,ANTAGONIST,,Tchem,,,Homo sapiens
26363,460,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,ANTAGONIST,,Tclin,,,Homo sapiens
26364,1028,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,AGONIST,,Tclin,,,Homo sapiens
26365,2032,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=124,,AGONIST,,Tclin,,,Homo sapiens
26367,1817,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,8.1,,Ki,,IUPHAR,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL606,AGONIST,,Tclin,,,Homo sapiens
26368,3652,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57,,AGONIST,,Tclin,,,Homo sapiens
26369,2172,438,Potassium voltage-gated channel subfamily A member 10,Ion channel,Q16322,KCNA10,KCA10_HUMAN,6.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=90,,BLOCKER,,Tclin,,,Homo sapiens
26370,4110,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,7.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2226,,ANTAGONIST,,Tclin,,,Homo sapiens
26371,2875,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103,,ANTAGONIST,,Tchem,,,Homo sapiens
26373,1830,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.5,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=207,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=207,ANTAGONIST,,Tclin,,,Homo sapiens
26375,65,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=294,,AGONIST,,Tclin,,,Homo sapiens
26376,2032,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=124,,AGONIST,,Tclin,,,Homo sapiens
26377,2202,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49,,AGONIST,,Tclin,,,Homo sapiens
26379,972,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=202,,ANTAGONIST,,Tchem,,,Homo sapiens
26384,912,228,Prostaglandin D2 receptor 2,GPCR,Q9Y5Y4,PTGDR2,PD2R2_HUMAN,6.4,,Ki,,IUPHAR,=,,,,,AGONIST,,Tchem,,,Homo sapiens
26388,4120,897,Metabotropic glutamate receptor 6,GPCR,O15303,GRM6,GRM6_HUMAN,6.4,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1411,,AGONIST,,Tbio,,,Homo sapiens
26390,2435,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=98,,ANTAGONIST,,Tclin,,,Homo sapiens
26392,2435,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=98,,ANTAGONIST,,Tchem,,,Homo sapiens
26393,2740,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=214,,ANTAGONIST,,Tclin,,,Homo sapiens
26394,460,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,AGONIST,,Tclin,,,Homo sapiens
26397,746,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=84,,ANTAGONIST,,Tclin,,,Homo sapiens
26399,3639,600,P2Y purinoceptor 4,GPCR,P51582,P2RY4,P2RY4_HUMAN,6.3,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1734,,AGONIST,,Tchem,,,Homo sapiens
26401,1865,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=554,,ANTAGONIST,,Tclin,,,Homo sapiens
26404,1551,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,6.3,,Ki,,IUPHAR,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1050,AGONIST,,Tclin,,,Homo sapiens
26406,972,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=202,,ANTAGONIST,,Tclin,,,Homo sapiens
26409,2181,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=92,,ANTAGONIST,,Tclin,,,Homo sapiens
26420,1353,1668,Potassium voltage-gated channel subfamily H member 1,Ion channel,O95259,KCNH1,KCNH1_HUMAN,6.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=86,,BLOCKER,,Tclin,,,Homo sapiens
26421,1422,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,6.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,Tclin,,,Homo sapiens
26423,460,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=37,,AGONIST,,Tclin,,,Homo sapiens
26424,99,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.2,,Ki,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=198,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000916/WC500038317.pdf,ANTAGONIST,,Tclin,,109,Homo sapiens
26425,719,60,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,Q14994,NR1I3,NR1I3_HUMAN,6.16,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2330,,ANTAGONIST,,Tchem,,,Homo sapiens
26429,2202,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49,,ANTAGONIST,,Tclin,,,Homo sapiens
26438,1947,150,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,O15554,KCNN4,KCNN4_HUMAN,7.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334,,BLOCKER,,Tchem,,,Homo sapiens
26442,1222,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=85,,ANTAGONIST,,Tclin,,,Homo sapiens
26445,1922,907,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,O60840,CACNA1F,CAC1F_HUMAN,6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2514,,GATING INHIBITOR,,Tclin,,,Homo sapiens
26446,1097,138,Sodium channel protein type 2 subunit alpha,Ion channel,Q99250,SCN2A,SCN2A_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL492,BLOCKER,,Tclin,,,Homo sapiens
26447,3312,1671,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Ion channel,O60741,HCN1,HCN1_HUMAN,5.7,,IC50,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2357,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206143Orig1s000lbl.pdf,BLOCKER,,Tclin,,253,Homo sapiens
26449,972,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=202,,ANTAGONIST,,Tclin,,,Homo sapiens
26451,3652,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57,,AGONIST,,Tchem,,,Homo sapiens
26455,1422,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,5.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,Tclin,,,Homo sapiens
26456,2389,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,5.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=96,,ANTAGONIST,,Tclin,,,Homo sapiens
26458,2337,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=50,,AGONIST,,Tchem,,,Homo sapiens
26459,2389,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=96,,ANTAGONIST,,Tchem,,,Homo sapiens
26460,2202,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=49,,ANTAGONIST,,Tclin,,,Homo sapiens
26461,109,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.8,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=341,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
26467,2346,1668,Potassium voltage-gated channel subfamily H member 1,Ion channel,O95259,KCNH1,KCNH1_HUMAN,5.8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2342,,BLOCKER,,Tclin,,,Homo sapiens
34934,887,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.308918508,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
26473,3643,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.7,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=349,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
26477,1830,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=207,,ANTAGONIST,,Tclin,,,Homo sapiens
26478,2337,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=50,,AGONIST,,Tclin,,,Homo sapiens
26480,1427,1668,Potassium voltage-gated channel subfamily H member 1,Ion channel,O95259,KCNH1,KCNH1_HUMAN,5.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=357,,BLOCKER,,Tclin,,,Homo sapiens
26483,2176,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=91,,AGONIST,,Tclin,,,Homo sapiens
26484,2382,150,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,O15554,KCNN4,KCNN4_HUMAN,5.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2326,,ACTIVATOR,,Tchem,,,Homo sapiens
26488,1524,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,Tchem,,,Homo sapiens
26489,2637,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100,,ANTAGONIST,,Tchem,,,Homo sapiens
26490,2405,838,Free fatty acid receptor 1,GPCR,O14842,FFAR1,FFAR1_HUMAN,5.6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1056,,AGONIST,,Tchem,,,Homo sapiens
26491,2181,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=92,,ANTAGONIST,,Tclin,,,Homo sapiens
26493,2543,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=54,,ANTAGONIST,,Tchem,,,Homo sapiens
26495,2966,1689,P2Y purinoceptor 13,GPCR,Q9BPV8,P2RY13,P2Y13_HUMAN,5.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728,,ANTAGONIST,,Tchem,,,Homo sapiens
26498,2181,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=92,,ANTAGONIST,,Tclin,,,Homo sapiens
26499,1024,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.6,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=556,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=556,AGONIST,,Tclin,,,Homo sapiens
26502,2337,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=50,,AGONIST,,Tclin,,,Homo sapiens
26505,1057,221,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,5.6,,EC50,,IUPHAR,=,,,,,ACTIVATOR,,Tclin,,,Homo sapiens
26506,3652,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=57,,AGONIST,,Tchem,,,Homo sapiens
26507,1222,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=85,,ANTAGONIST,,Tchem,,,Homo sapiens
26509,3312,1672,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Ion channel,Q9UL51,HCN2,HCN2_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206143Orig1s000lbl.pdf,BLOCKER,,Tclin,,253,Homo sapiens
26510,3312,1673,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,Ion channel,Q9P1Z3,HCN3,HCN3_HUMAN,5.7,,IC50,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2357,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206143Orig1s000lbl.pdf,BLOCKER,,Tclin,,253,Homo sapiens
26514,913,228,Prostaglandin D2 receptor 2,GPCR,Q9Y5Y4,PTGDR2,PD2R2_HUMAN,5.3,,Ki,,IUPHAR,=,,,,,AGONIST,,Tchem,,,Homo sapiens
26516,2470,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99,,ANTAGONIST,,Tclin,,,Homo sapiens
26518,91,1689,P2Y purinoceptor 13,GPCR,Q9BPV8,P2RY13,P2Y13_HUMAN,5.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,AGONIST,,Tchem,,,Homo sapiens
26519,432,445,Potassium voltage-gated channel subfamily A member 5,Ion channel,P22460,KCNA5,KCNA5_HUMAN,5.4,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2397,,BLOCKER,,Tclin,,,Homo sapiens
26521,99,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=198,,ANTAGONIST,,Tclin,,,Homo sapiens
26524,2470,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,5.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99,,ANTAGONIST,,Tchem,,,Homo sapiens
26528,2966,832,P2Y purinoceptor 1,GPCR,P47900,P2RY1,P2RY1_HUMAN,5.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728,,ANTAGONIST,,Tchem,,,Homo sapiens
26530,1817,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,7.6,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
26532,3505,361,Hydroxycarboxylic acid receptor 2,GPCR,Q8TDS4,HCAR2,HCAR2_HUMAN,5.3,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1590,,AGONIST,,Tclin,,,Homo sapiens
26535,2044,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,5.3,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2770,,AGONIST,,Tchem,,,Homo sapiens
26536,1209,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=203,,ANTAGONIST,,Tclin,,,Homo sapiens
26541,3639,830,P2Y purinoceptor 6,GPCR,Q15077,P2RY6,P2RY6_HUMAN,5.2,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1734,,AGONIST,,Tchem,,,Homo sapiens
26542,3639,904,P2Y purinoceptor 11,GPCR,Q96G91,P2RY11,P2Y11_HUMAN,5.2,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1734,,AGONIST,,Tbio,,,Homo sapiens
26546,1422,393,Thromboxane A2 receptor,GPCR,P21731,TBXA2R,TA2R_HUMAN,5.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,Tclin,,,Homo sapiens
26547,1672,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=224,,ANTAGONIST,,Tclin,,,Homo sapiens
26549,3643,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.1,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=349,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
26552,1034,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,5.1,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
26553,1176,1698,Potassium voltage-gated channel subfamily A member 7,Ion channel,Q96RP8,KCNA7,KCNA7_HUMAN,5.1,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2560,,BLOCKER,,Tclin,,,Homo sapiens
26554,3323,1699,Potassium voltage-gated channel subfamily B member 1,Ion channel,Q14721,KCNB1,KCNB1_HUMAN,5.6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1052,,ACTIVATOR,,Tclin,,,Homo sapiens
26555,912,393,Thromboxane A2 receptor,GPCR,P21731,TBXA2R,TA2R_HUMAN,5.1,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
26557,109,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=341,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
26558,831,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.9,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=354,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=354,ANTAGONIST,,Tclin,,,Homo sapiens
26562,1817,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,7.5,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
26563,1215,302,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,O43526,KCNQ2,KCNQ2_HUMAN,5,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2598,,ACTIVATOR,,Tclin,,,Homo sapiens
26564,342,1667,Potassium voltage-gated channel subfamily KQT member 4,Ion channel,P56696,KCNQ4,KCNQ4_HUMAN,5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2337,,BLOCKER,,Tclin,,,Homo sapiens
26565,1579,138,Sodium channel protein type 2 subunit alpha,Ion channel,Q99250,SCN2A,SCN2A_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79,BLOCKER,,Tclin,,,Homo sapiens
26567,2176,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=91,,AGONIST,,Tclin,,,Homo sapiens
26574,4109,1683,Transient receptor potential cation channel subfamily A member 1,Ion channel,O75762,TRPA1,TRPA1_HUMAN,4.9,,EC50,,IUPHAR,=,,,,,ACTIVATOR,,Tclin,,,Homo sapiens
26575,91,1686,Transient receptor potential cation channel subfamily M member 4,Ion channel,Q8TD43,TRPM4,TRPM4_HUMAN,5.8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,BLOCKER,,Tchem,,,Homo sapiens
26576,1797,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,4.9,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2522,,BLOCKER,,Tclin,,,Homo sapiens
26581,3643,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.8,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=349,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
26585,1034,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,4.8,,Ki,,IUPHAR,=,1,IUPHAR,,,AGONIST,,Tclin,,,Homo sapiens
26586,2346,1698,Potassium voltage-gated channel subfamily A member 7,Ion channel,Q96RP8,KCNA7,KCNA7_HUMAN,4.8,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2342,,BLOCKER,,Tclin,,,Homo sapiens
26588,1579,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,4.8,,Kd,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2623,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79,BLOCKER,,Tclin,,,Homo sapiens
26589,4004,391,Vasopressin V1b receptor,GPCR,P47901,AVPR1B,V1BR_HUMAN,4.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2197,,ANTAGONIST,,Tclin,,,Homo sapiens
26590,1524,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,4.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,Tchem,,,Homo sapiens
26591,4050,1209,Metabotropic glutamate receptor 3,GPCR,Q14832,GRM3,GRM3_HUMAN,4.7,,Ki,,IUPHAR,=,,,,,AGONIST,,Tchem,,,Homo sapiens
26592,92,1686,Transient receptor potential cation channel subfamily M member 4,Ion channel,Q8TD43,TRPM4,TRPM4_HUMAN,4.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2455,,GATING INHIBITOR,,Tchem,,,Homo sapiens
26594,2152,138,Sodium channel protein type 2 subunit alpha,Ion channel,Q99250,SCN2A,SCN2A_HUMAN,4.9,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2624,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,BLOCKER,,Tclin,,,Homo sapiens
26604,913,393,Thromboxane A2 receptor,GPCR,P21731,TBXA2R,TA2R_HUMAN,4.5,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
26606,4120,813,Metabotropic glutamate receptor 7,GPCR,Q14831,GRM7,GRM7_HUMAN,4.5,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1411,,AGONIST,,Tbio,,,Homo sapiens
26612,2966,860,P2Y purinoceptor 2,GPCR,P41231,P2RY2,P2RY2_HUMAN,4.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728,,ANTAGONIST,,Tclin,,,Homo sapiens
26616,362,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,4.3,,EC50,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2668,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2668,AGONIST,,Tclin,,,Homo sapiens
26618,358,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,4.2,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=297,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1482,AGONIST,,Tclin,,,Homo sapiens
26620,3643,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,4.2,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=349,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
94116,574,2468,Tyrosine-protein phosphatase non-receptor type 7,Enzyme,P35236,PTPN7,PTN7_HUMAN,6.04,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
26632,358,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,4,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=297,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1482,AGONIST,,Tclin,,,Homo sapiens
26633,358,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=297,,AGONIST,,Tclin,,,Homo sapiens
26634,1753,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,4,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=483,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL524,AGONIST,,Tclin,,,Homo sapiens
26641,1176,445,Potassium voltage-gated channel subfamily A member 5,Ion channel,P22460,KCNA5,KCNA5_HUMAN,4,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2560,,BLOCKER,,Tclin,,,Homo sapiens
26643,3401,1690,G-protein coupled receptor family C group 6 member A,GPCR,Q5T6X5,GPRC6A,GPC6A_HUMAN,4,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=725,,AGONIST,,Tbio,,,Homo sapiens
26645,1579,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79,BLOCKER,,Tclin,,,Homo sapiens
26646,626,150,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,O15554,KCNN4,KCNN4_HUMAN,4,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2322,,ACTIVATOR,,Tchem,,,Homo sapiens
26711,2382,795,Small conductance calcium-activated potassium channel protein 3,Ion channel,Q9UGI6,KCNN3,KCNN3_HUMAN,4.9,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2326,,ACTIVATOR,,Tchem,,,Homo sapiens
26714,865,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,6.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2714,,ANTAGONIST,,Tclin,,,Homo sapiens
26716,3862,1696,Nuclear receptor ROR-gamma,Nuclear hormone receptor,P51449,RORC,RORG_HUMAN,4.85,,EC50,Inverse agonist activity at human RoRc-LBD fusion protein with GST expressed in BL-21 (BL3) cells assessed as SRC1 coactivator peptide recruitment,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,,,,Tchem,,,Homo sapiens
26717,957,429,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200810,AGONIST,,Tclin,,,Homo sapiens
26720,1805,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,5,,EC50,,IUPHAR,~,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2805,,AGONIST,,Tchem,,,Homo sapiens
26729,888,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,9.9,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1732,AGONIST,,Tclin,,,Homo sapiens
26739,1723,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,9.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133,,ANTAGONIST,,Tclin,,,Homo sapiens
26743,1043,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,AGONIST,,Tclin,,,Homo sapiens
26752,888,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,9.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121,,AGONIST,,Tclin,,,Homo sapiens
26755,1043,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,8.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,AGONIST,,Tchem,,,Homo sapiens
26764,835,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,9.7,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=521,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL778,AGONIST,,Tclin,,,Homo sapiens
26770,3659,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,Tclin,,,Homo sapiens
26778,3659,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,Tclin,,,Homo sapiens
26782,835,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,9.3,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=521,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL778,AGONIST,,Tclin,,,Homo sapiens
26785,1764,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=150,,ANTAGONIST,,Tchem,,,Homo sapiens
26787,2994,1700,Glucagon-like peptide 1 receptor,GPCR,P43220,GLP1R,GLP1R_HUMAN,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1136,,AGONIST,,Tclin,,,Homo sapiens
26788,2538,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1919,,AGONIST,,Tclin,,,Homo sapiens
26790,3659,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,Tclin,,,Homo sapiens
26793,1723,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133,,ANTAGONIST,,Tchem,,,Homo sapiens
26794,888,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,7.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121,,AGONIST,,Tclin,,,Homo sapiens
26800,1043,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,AGONIST,,Tchem,,,Homo sapiens
26808,1723,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133,,ANTAGONIST,,Tchem,,,Homo sapiens
26813,76,361,Hydroxycarboxylic acid receptor 2,GPCR,Q8TDS4,HCAR2,HCAR2_HUMAN,5.6,,EC50,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1596,http://www.ncbi.nlm.nih.gov/pubmed/17705685,AGONIST,,Tclin,,501,Homo sapiens
94117,574,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.7,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
26816,3659,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,5.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,Tchem,,,Homo sapiens
26817,2484,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=347,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
26818,2484,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=347,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
26819,2484,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=347,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
26820,2484,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.7,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=347,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
26821,3400,838,Free fatty acid receptor 1,GPCR,O14842,FFAR1,FFAR1_HUMAN,5.7,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1054,,AGONIST,,Tchem,,,Homo sapiens
26828,2538,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,9.46,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1919,,AGONIST,,Tclin,,,Homo sapiens
26832,2601,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,9.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,,ANTAGONIST,,Tclin,,,Homo sapiens
26838,2601,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,9.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,,ANTAGONIST,,Tclin,,,Homo sapiens
26839,1764,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=150,,AGONIST,,Tclin,,,Homo sapiens
26845,2601,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,9.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,,ANTAGONIST,,Tclin,,,Homo sapiens
26847,2601,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,,AGONIST,,Tclin,,,Homo sapiens
26848,2994,1701,Glucagon receptor,GPCR,P47871,GCGR,GLR_HUMAN,9,,EC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1136,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266481,AGONIST,,Tclin,,,Homo sapiens
26852,2601,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,,AGONIST,,Tclin,,,Homo sapiens
26853,1043,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,AGONIST,,Tclin,,,Homo sapiens
26860,1723,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133,,ANTAGONIST,,Tclin,,,Homo sapiens
26862,1043,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,AGONIST,,Tclin,,,Homo sapiens
26865,2955,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,8.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2086,,AGONIST,,Tclin,,,Homo sapiens
26868,1723,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133,,ANTAGONIST,,Tclin,,,Homo sapiens
26870,2601,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,,ANTAGONIST,,Tclin,,,Homo sapiens
26871,2601,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,,AGONIST,,Tclin,,,Homo sapiens
26874,2579,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=226,,ANTAGONIST,,Tclin,,,Homo sapiens
26878,1764,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=150,,AGONIST,,Tclin,,,Homo sapiens
26879,2601,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.3,,Ki,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,http://www.ncbi.nlm.nih.gov/pubmed/21762037,AGONIST,,Tclin,,595,Homo sapiens
26884,2601,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.2,,Ki,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,http://www.ncbi.nlm.nih.gov/pubmed/21762037,ANTAGONIST,,Tclin,,595,Homo sapiens
26886,2601,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,,ANTAGONIST,,Tchem,,,Homo sapiens
26891,995,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=40,,AGONIST,,Tclin,,,Homo sapiens
26894,888,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121,,ANTAGONIST,,Tclin,,,Homo sapiens
26907,2601,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,,AGONIST,,Tclin,,,Homo sapiens
26909,722,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,,ANTAGONIST,,Tclin,,,Homo sapiens
26913,1764,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,7.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=150,,ANTAGONIST,,Tclin,,,Homo sapiens
26919,403,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35,,AGONIST,,Tchem,,,Homo sapiens
26922,1016,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1918,,AGONIST,,Tclin,,,Homo sapiens
26925,995,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=40,,AGONIST,,Tclin,,,Homo sapiens
26928,2601,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,,ANTAGONIST,,Tclin,,,Homo sapiens
26935,995,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=40,,AGONIST,,Tchem,,,Homo sapiens
26938,1723,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133,,ANTAGONIST,,Tclin,,,Homo sapiens
26940,1016,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,7.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1918,,AGONIST,,Tclin,,,Homo sapiens
26945,3659,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,Tclin,,,Homo sapiens
26948,722,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,6.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,,AGONIST,,Tclin,,,Homo sapiens
26950,1564,1702,Neurotensin receptor type 2,GPCR,O95665,NTSR2,NTR2_HUMAN,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1586,,AGONIST,,Tchem,,,Homo sapiens
26951,1043,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,AGONIST,,Tclin,,,Homo sapiens
26954,2538,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,6.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1919,,AGONIST,,Tclin,,,Homo sapiens
26957,2601,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=56,,AGONIST,,Tclin,,,Homo sapiens
26961,1723,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133,,ANTAGONIST,,Tclin,,,Homo sapiens
26962,2560,156,Thyrotropin-releasing hormone receptor,GPCR,P34981,TRHR,TRFR_HUMAN,6.5,,Ki,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2143,http://www.ncbi.nlm.nih.gov/pubmed/15931571,AGONIST,,Tclin,,492,Homo sapiens
26966,722,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,,AGONIST,,Tchem,,,Homo sapiens
26967,403,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35,,ANTAGONIST,,Tchem,,,Homo sapiens
26968,722,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,,AGONIST,,Tclin,,,Homo sapiens
26970,1527,438,Potassium voltage-gated channel subfamily A member 10,Ion channel,Q16322,KCNA10,KCA10_HUMAN,6.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2568,,BLOCKER,,Tclin,,,Homo sapiens
26973,403,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35,,AGONIST,,Tchem,,,Homo sapiens
26974,2410,622,Motilin receptor,GPCR,O43193,MLNR,MTLR_HUMAN,6.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1465,,AGONIST,,Tchem,,,Homo sapiens
26976,1723,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133,,ANTAGONIST,,Tchem,,,Homo sapiens
26978,722,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,,AGONIST,,Tclin,,,Homo sapiens
26980,403,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35,,AGONIST,,Tclin,,,Homo sapiens
26982,2407,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=941,,AGONIST,,Tchem,,,Homo sapiens
26983,3659,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,Tchem,,,Homo sapiens
26985,806,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.8,,Ki,,IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=534,http://www.ncbi.nlm.nih.gov/pubmed/12487507,AGONIST,,Tclin,,533,Homo sapiens
26989,1982,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=47,,AGONIST,,Tchem,,,Homo sapiens
26992,888,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121,,AGONIST,,Tchem,,,Homo sapiens
26993,3659,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,Tclin,,,Homo sapiens
26998,3170,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.2,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
26999,3170,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.1,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
27001,3096,924,G-protein coupled bile acid receptor 1,GPCR,Q8TDU6,GPBAR1,GPBAR_HUMAN,5,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=609,,AGONIST,,Tchem,,,Homo sapiens
27003,3170,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,4.6,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
27005,694,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,4.25,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2667,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL565,AGONIST,,Tclin,,,Homo sapiens
27007,3170,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,4.2,,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
33631,4,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.706858517,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33633,30,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,7.397940009,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33635,43,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,5.890084137,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33636,43,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,5.227165073,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33637,52,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,4.546987609,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
33639,80,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.152427341,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33641,100,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33643,129,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.193820026,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33647,129,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,6.218460031,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33648,130,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33650,141,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.397940009,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33651,147,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.744245213,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33653,147,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.253833036,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33654,156,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.1837587,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33656,158,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.40793433,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33658,176,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.111932887,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33660,176,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.339988779,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33662,176,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.177113052,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33666,176,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.912218582,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33668,176,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.647431614,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33670,176,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.988852639,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33672,176,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.231361899,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33674,176,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.673664139,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33676,176,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.044504671,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33678,176,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.230179742,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33680,176,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.387216143,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33682,176,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,4.983844488,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33684,176,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.201349355,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33686,176,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.743282254,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33688,176,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.168130226,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33690,176,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.295849483,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33692,176,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.967784297,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33694,176,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,4.498105832,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33696,176,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.701146924,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33698,176,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.003575896,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33700,176,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.206698646,,Ki,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33702,176,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.175743962,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33704,176,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.548981548,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33706,176,457,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,4.791102015,,Ki,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33708,176,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.087777943,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33709,176,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.038673844,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33710,176,798,C-C chemokine receptor type 2,GPCR,P41597,CCR2,CCR2_HUMAN,5.368049174,,Ki,DRUGMATRIX: Chemokine CCR2B  radioligand binding (ligand: [125I] MCP-1),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33712,176,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.191249028,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33714,176,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.550290244,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33716,176,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,4.407079692,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33718,176,1715,B2 bradykinin receptor,GPCR,P30411,BDKRB2,BKRB2_HUMAN,5.114978205,,Ki,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33720,176,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,4.878571482,,Ki,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33722,176,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,5.050171041,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33724,176,1718,Melanocortin receptor 3,GPCR,P41968,MC3R,MC3R_HUMAN,4.966696899,,Ki,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33726,176,1720,C-C chemokine receptor type 4,GPCR,P51679,CCR4,CCR4_HUMAN,4.94290471,,Ki,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33728,176,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.931814138,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33731,180,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.879426069,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33752,180,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.065501549,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33754,180,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.251811973,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33758,180,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.37675071,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33760,180,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.770830297,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33762,183,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.645891561,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33764,183,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.87095494,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33766,183,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.583359493,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33768,183,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.357832366,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33770,191,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.707743929,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33773,191,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.307153081,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33775,191,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.468521083,,IC50,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113,INHIBITOR,,Tclin,,,Homo sapiens
33777,191,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.886056648,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113,INHIBITOR,,Tclin,,,Homo sapiens
33779,191,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.18243463,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33783,191,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.59345982,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33788,191,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.542118103,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33790,191,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.030118356,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33792,191,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.4225082,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33794,191,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.616184634,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33796,191,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.211124884,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33798,191,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.336299075,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33800,191,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33801,191,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.841637508,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33805,191,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,6.57024772,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33807,191,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.22184875,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33809,200,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33810,200,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.172178572,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33811,249,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,4.998396076,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33813,249,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.217527376,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33815,249,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.697885623,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33817,249,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.821886748,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33819,249,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.740645073,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33821,249,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.025028006,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33823,249,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.15490196,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33825,249,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.86518563,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33827,249,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.358525889,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33829,249,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.253365801,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33831,249,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.125518182,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33833,249,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.026872146,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33835,249,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.819300799,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33837,249,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.756218084,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33839,249,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.829738285,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33842,249,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.781464495,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33844,249,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.590066877,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33846,249,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.300162274,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33848,249,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.749579998,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33850,249,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.586700236,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33852,249,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.296708622,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33854,249,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.218603695,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33856,249,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.54515514,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33858,249,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.100726813,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33860,249,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,4.783543785,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33862,249,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.670805585,,Ki,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33864,249,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.004364805,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33868,249,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,7.017728767,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33870,249,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.57741016,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33872,249,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.339608902,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33874,249,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.217742426,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33875,249,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,5.064744718,,Ki,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33877,249,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,4.700710666,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33878,249,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.545612533,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33879,249,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,4.883259465,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33880,249,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,6.002176919,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33882,249,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,5.311936303,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
33884,249,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.022276395,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33886,249,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,6.200659451,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33888,249,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,4.869634063,,Ki,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33890,249,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,5.673050006,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33892,249,1718,Melanocortin receptor 3,GPCR,P41968,MC3R,MC3R_HUMAN,4.868092757,,Ki,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33894,249,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.732828272,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33898,260,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.27572413,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33905,260,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.176525771,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33909,281,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.269459964,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33910,281,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.716020716,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33911,281,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.868381336,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33913,285,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33914,294,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.427128398,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370,AGONIST,,Tclin,,,Homo sapiens
33916,313,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.959793372,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33918,313,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.966576245,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33920,313,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.131355562,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33922,313,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.105130343,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33924,313,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.107905397,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL936,ANTAGONIST,,Tclin,,,Homo sapiens
33926,313,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.562249437,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33928,313,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.283996656,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33930,313,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.420216403,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33932,313,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.068033885,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33934,313,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.486382926,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33935,313,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.57921938,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33937,318,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.940058112,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33939,318,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.529883647,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33941,318,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,7.795880017,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33942,318,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,5.976336082,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33943,318,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,5.908333042,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33944,318,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,5.710857164,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33945,333,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.690369833,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33947,333,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.229147988,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33949,333,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.860435734,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33951,333,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.156767222,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33953,333,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.896196279,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33955,333,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.494850022,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33957,333,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.888065724,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33959,333,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.522878745,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33961,333,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.653647026,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33964,333,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.92628165,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33971,333,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.244125144,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33975,333,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.585026652,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33979,333,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.387216143,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33981,333,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.950781977,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
33984,375,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.755722879,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33986,375,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.010995384,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33988,375,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
33992,389,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.815308569,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33994,389,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.344861565,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94118,575,840,Interstitial collagenase,Enzyme,P03956,MMP1,MMP1_HUMAN,4.43,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
33996,389,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.013676223,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
33998,389,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6.463441557,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34000,389,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.261504838,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34002,395,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.836242476,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34005,395,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.072629637,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34009,402,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.602059991,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34011,402,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.954285941,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34013,402,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.708187313,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34014,402,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,7.443697499,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34016,403,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.85823677,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34021,403,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34030,403,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.549750892,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34034,403,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.817870786,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34036,403,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.707743929,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34038,403,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,7.327902142,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34042,419,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,5.701365217,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34043,419,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.962573502,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34045,419,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.568636236,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
34049,431,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8.399027104,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177,ANTAGONIST,,Tclin,,,Homo sapiens
34051,431,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.262807357,,Ki,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177,ANTAGONIST,,Tclin,,,Homo sapiens
34053,431,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.488116639,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34055,431,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.584692708,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34057,431,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.780415474,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34059,431,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6.59345982,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
34061,432,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.397940009,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34063,435,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.699339312,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34064,435,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.846185136,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34073,437,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.276544328,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34077,437,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.4710833,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34078,438,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,5.282745687,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34079,444,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.864358584,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34081,444,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.779499654,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34083,444,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.124938737,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34085,444,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.411448194,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34087,444,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.522878745,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34088,444,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.160704256,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34089,444,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.804931004,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34107,496,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.167810539,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34108,496,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.428174751,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34109,511,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.301029996,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34110,511,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.213177621,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34113,522,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.125518182,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34115,522,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.30980392,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34117,522,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.397940009,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34121,522,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.928117993,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34123,522,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.273272791,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34125,522,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.476253533,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34127,522,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.931814138,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34129,522,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.823908741,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34131,522,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.22184875,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34133,522,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.151810883,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34135,522,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.366531544,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34137,522,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.707743929,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34140,522,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.886056648,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34142,522,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.17327748,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34144,522,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,9.054039296,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
34148,522,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.742321425,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
34150,522,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.705533774,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34152,522,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,6.229884705,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34155,568,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,4.853965037,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34157,568,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.477034405,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34159,568,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.139841739,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34161,568,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.159893906,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34163,568,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,4.917465947,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94119,575,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.31,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
34166,568,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34167,568,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,4.856454373,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34169,568,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,5.033389013,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34170,568,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.626720107,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
34172,588,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,5.026271941,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34173,594,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.681936665,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34175,600,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.764471553,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34177,600,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34178,600,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,7.679853714,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34180,600,48,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,D2WKD8,ATP1A2,AT1A2_PIG,5.340121814,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",DRUG MATRIX,=,,,,,,,,,,Sus scrofa
34181,600,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,9.163043263,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
34183,621,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.233289793,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34188,621,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.723538196,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34193,621,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.721246399,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34210,621,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.677780705,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34213,621,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.707743929,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34218,621,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.353302269,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34220,621,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.132827249,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34222,621,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,4.539583303,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34223,621,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.061480275,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34224,621,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,4.712960072,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34225,621,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.042632192,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34227,621,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,4.797212085,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
34228,621,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.304518324,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34230,621,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.735890844,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34232,621,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,4.835082334,,Ki,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34234,621,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,5.145997767,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34236,621,1718,Melanocortin receptor 3,GPCR,P41968,MC3R,MC3R_HUMAN,4.672763707,,Ki,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34238,621,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.776504059,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34241,626,1714,"Nitric oxide synthase, brain",Enzyme,P29476,Nos1,NOS1_RAT,5.553773598,,IC50,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34242,644,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34244,654,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.035269079,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34246,654,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.586700236,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34248,654,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.777283529,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34250,654,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.769551079,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34252,654,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.237321436,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34254,654,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.551602897,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34256,654,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.208309351,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34258,654,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.987162775,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34260,654,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.332547047,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34262,654,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.990124366,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34264,654,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.065501549,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34266,654,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.064492734,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34268,654,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.218244625,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34270,654,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.790484985,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34272,654,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.292429824,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34274,654,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.263603498,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34276,654,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.022276395,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34278,654,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.884722409,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34280,654,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.241845378,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34284,654,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.299296283,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34286,654,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.793174124,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34289,660,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.176525771,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34291,660,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.378823718,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34295,660,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.522878745,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34296,660,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.690369833,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34304,660,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.395773947,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34306,660,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.280668713,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34308,660,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.30980392,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34310,660,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.946921557,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34312,660,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,7.15490196,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34313,660,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.30980392,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34317,660,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,5.472370099,,IC50,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34320,660,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.062983893,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34322,660,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.962573502,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34324,663,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.777283529,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35075,928,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.956637722,,Ki,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34330,663,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.931443105,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34334,663,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.148130399,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34338,663,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.739928612,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34340,667,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,5.440691989,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34341,671,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.115204636,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34343,671,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.346787486,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34345,671,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.161150909,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34347,671,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.853871964,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34350,671,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.514278574,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34352,671,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.036212173,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34354,671,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.638272164,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34356,671,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.283996656,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34358,671,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.443697499,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34360,671,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.847711656,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34362,671,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.603800653,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34365,671,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.438898616,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34367,671,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.083546051,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34369,671,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.557520231,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34371,671,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.220403509,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34373,671,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.853871964,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34375,671,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.269217724,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34378,671,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.823908741,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34382,671,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6.22184875,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34383,671,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.387216143,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34385,671,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,6.657577319,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34387,671,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.348721986,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34389,673,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,7.161150909,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34393,673,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.819587367,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34395,700,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.460923901,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34396,700,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.454692884,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34400,700,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.469800302,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34402,700,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.068033885,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34404,700,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.024568191,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34406,700,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.061980903,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34408,700,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.176525771,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34412,700,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.142064735,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34414,700,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.348721986,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34416,700,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.406713933,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34418,700,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.88941029,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34420,700,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.35753548,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34422,700,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.638272164,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34424,700,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.895512889,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34426,700,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.371202514,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34428,700,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.66756154,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34430,700,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.205511953,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34432,700,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34433,700,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.519418213,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34435,700,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,8.886056648,,Ki,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2355051,MODULATOR,,Tclin,,,Homo sapiens
34437,700,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.978810701,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34438,700,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.599807511,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34439,700,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.777543663,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34440,700,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.821598658,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34442,700,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.597051171,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34444,700,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,7.522878745,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34448,701,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.242603971,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34454,701,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.818156412,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34459,701,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.337242168,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34462,701,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.007446482,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34464,701,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.69572495,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34466,701,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.657577319,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34468,701,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.065501549,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34470,701,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.443697499,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34472,701,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.886056648,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34474,701,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.420216403,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34476,701,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.688246139,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34480,701,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.397940009,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34484,701,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.13667714,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34486,701,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.937418016,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34494,704,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.990124366,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34496,708,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.524328812,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34498,714,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.8247782,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34500,714,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.863279433,,Ki,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34502,719,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.186218922,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34504,719,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.378865279,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34505,719,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.136082623,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34507,719,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.346016093,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34509,719,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.391260081,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34511,719,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.146545159,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34513,719,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.350957366,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34515,719,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.514278574,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34517,719,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.104025268,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34519,719,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,4.995334767,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34521,719,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.497163361,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34523,719,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.1316495,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34525,719,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.120273503,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34527,719,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.234778634,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34529,719,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.428873723,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34531,719,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.046240308,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34533,719,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.466482138,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34535,719,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.294221787,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34537,719,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.781464495,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34539,719,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.286761538,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34541,719,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.676954265,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34543,719,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.785156152,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34545,719,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,5.829444941,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34547,719,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.267123959,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34549,719,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.353204311,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34551,719,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,5.106238238,,Ki,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34553,719,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.570893992,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34557,719,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,4.521390221,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34558,719,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.13200249,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34562,719,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.598427154,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34564,719,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.755722879,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34566,719,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.711974465,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34567,719,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,7.795880017,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34568,719,305,Platelet-activating factor receptor,GPCR,P25105,PTAFR,PTAFR_HUMAN,4.645219501,,Ki,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34570,719,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,4.158509135,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34571,719,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,5.058140873,,Ki,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34573,719,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,7.795880017,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34574,719,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,4.496876928,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34575,719,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,4.177799219,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34576,719,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,7.853871964,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34577,719,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.470698002,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34579,719,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.112157735,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34581,719,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,4.906123245,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34583,719,1726,Cysteinyl leukotriene receptor 1,GPCR,Q2NNR5,CYSLTR1,CLTR1_CAVPO,4.780258339,,Ki,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
34585,719,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.941573976,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
34613,722,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.444905551,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34621,749,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.235077015,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34623,749,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.193820026,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34625,749,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.623423043,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34627,749,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.271646218,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34629,749,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.993106292,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34631,749,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.35261703,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL648,ANTAGONIST,,Tclin,,,Homo sapiens
34633,749,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.787812396,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34635,749,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.385102784,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34637,749,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.798602876,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34639,749,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.924453039,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34641,749,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.341988603,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34643,749,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.217527376,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34645,749,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.206384206,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34646,749,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.224025669,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34648,749,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.860435734,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34650,760,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.860120914,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34654,765,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.974694135,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34656,765,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.854868883,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34665,765,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.769551079,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34669,765,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.709965389,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34674,765,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.659555885,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34676,765,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.559090918,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34678,765,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.732828272,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34682,765,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.356547324,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34684,765,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.898596649,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34686,766,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.052566278,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34691,766,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,8.315154638,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
34693,773,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,6.254925208,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34694,779,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.242983765,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34696,779,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,4.990336683,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34698,779,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.162853656,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34700,779,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.086557045,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34702,779,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.247874693,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34704,779,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.59722293,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34706,779,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,4.975760694,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34708,779,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.008773924,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34710,779,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.424581209,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34712,779,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,5.707522406,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34714,779,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,4.893979181,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34716,779,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.462055041,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34718,779,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.264720552,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34720,779,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.200039473,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34722,779,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.207118255,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34724,779,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,5.29387989,,Ki,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34726,779,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6.522878745,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34727,779,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.052566278,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34729,779,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,8.097453221,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34731,779,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.468521083,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
34733,781,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.929223537,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34735,781,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.761953897,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34737,781,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.172630727,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34739,781,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.485452247,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34741,781,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.279014256,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34743,781,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.388276692,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7155,ANTAGONIST,,Tclin,,,Homo sapiens
34747,781,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.522878745,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34750,814,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.913640169,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34752,814,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.955852379,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34754,814,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.024568191,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34756,814,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.552841969,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34758,814,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.795880017,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34760,814,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.996539468,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34762,814,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.008773924,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34764,814,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.189095719,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34767,814,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.966576245,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34774,814,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.511167366,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34776,814,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.697885623,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34778,819,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.931814138,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1766,AGONIST,,Tclin,,,Homo sapiens
34780,819,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.958607315,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
34784,824,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.785924791,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34786,824,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.51741223,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
34788,832,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.663540266,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34793,842,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.841637508,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34796,867,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,5.387958255,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34797,867,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,5.35398859,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34798,868,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.68613278,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34800,868,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.772892641,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34802,868,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.161150909,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34804,868,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.081969663,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34806,868,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.610833916,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94120,575,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.48,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
34808,868,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.8467951,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34810,868,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.386158178,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34812,868,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.796423225,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34814,868,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.078833949,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1123,ANTAGONIST,,Tclin,,,Homo sapiens
34817,868,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.032920266,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1123,ANTAGONIST,,Tclin,,,Homo sapiens
34819,868,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,9.386158178,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34821,868,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.76700389,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34823,868,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.326979093,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34824,868,1724,SMR1-alpha2,Unclassified,P70676,Vcsa2,P70676_RAT,6.537602002,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34825,875,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,4.894319537,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34827,875,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.251811973,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34828,875,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.629857153,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34830,875,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.410944469,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34832,875,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.35261703,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34834,875,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.295849483,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34836,875,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.275970027,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34838,875,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.178028182,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34840,875,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.438898616,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34842,875,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.863596552,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34844,875,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.699404516,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34846,875,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,4.574808264,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34848,875,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.222863287,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34850,875,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.272458743,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34852,875,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.524764777,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34854,875,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.437231457,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34856,875,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.408156589,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34858,875,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,5.317133204,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34860,875,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.657379957,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34862,875,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.07007044,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34864,875,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,5.778325003,,Ki,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34866,875,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.903785415,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34868,875,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.274006741,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34872,875,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.738737131,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34875,875,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,6.018634491,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34877,875,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.592609096,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34878,875,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,4.982924904,,Ki,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34880,875,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,4.846703551,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34881,875,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.360613131,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34882,875,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,4.482764503,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34883,875,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.497026941,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34885,875,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,5.315783205,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
34887,875,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.528268349,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
34888,875,1726,Cysteinyl leukotriene receptor 1,GPCR,Q2NNR5,CYSLTR1,CLTR1_CAVPO,5.051978467,,Ki,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
34890,875,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,6.21395879,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
34892,881,48,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,D2WKD8,ATP1A2,AT1A2_PIG,6.647817482,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",DRUG MATRIX,=,,,,,,,,,,Sus scrofa
34893,882,48,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,D2WKD8,ATP1A2,AT1A2_PIG,5.783306401,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",DRUG MATRIX,=,,,,,,,,,,Sus scrofa
34894,885,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.00656377,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34896,885,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.694648631,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34898,885,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.187086643,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34900,885,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8.525783736,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34902,885,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.22184875,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34903,885,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.823908741,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34905,885,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.853871964,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34907,885,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.085128182,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34909,885,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.113509275,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34911,885,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,8.121478204,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34913,885,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.920818754,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34915,885,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.698970004,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34917,885,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.727694156,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34919,885,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.261219442,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34921,885,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.368556231,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34925,885,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.22184875,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34926,885,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.100179498,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34928,885,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,8.299296283,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34930,887,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.462180905,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34932,887,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.229884705,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94121,575,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,4.84,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
34936,887,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,9.126679398,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34938,887,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34939,887,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,9.385102784,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34941,887,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.372634143,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34943,887,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.37675071,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34945,887,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.903089987,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34948,887,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,8.442492798,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34950,887,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.109578981,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34952,887,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.605373236,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34954,887,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.899629455,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34956,887,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,9.183096161,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34960,887,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34961,887,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
34962,887,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.086716098,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
34964,887,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.896196279,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34966,887,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,7.958607315,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34968,888,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.92190585,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34970,888,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.528708289,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34972,888,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,9.412289035,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34974,888,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.301029996,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34975,888,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,9.42365865,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34977,888,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.643974143,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34979,888,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.363512104,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34981,888,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.327902142,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34984,888,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,8.752026734,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34986,888,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.742321425,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34988,888,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.821023053,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34990,888,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.690369833,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34994,888,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.804100348,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
34996,888,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.348721986,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34998,888,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,9.415668776,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35000,897,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.73598542,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35001,901,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.79128998,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35003,901,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.312471039,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35005,901,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.694648631,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35007,901,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.70333481,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35009,901,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.959793372,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35011,901,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.478861916,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35013,901,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.603626272,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35015,901,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.431798276,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200406,ANTAGONIST,,Tclin,,,Homo sapiens
35017,901,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.962573502,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35019,901,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.785156152,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35021,901,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.022276395,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35023,901,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.096910013,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35025,901,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.643974143,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35027,901,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.74860515,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35029,901,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.82131076,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35030,901,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.8467951,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35036,916,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.431798276,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35038,916,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.148130399,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35040,916,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.289882635,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35049,924,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,5.80161787,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin,,,Homo sapiens
35050,924,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,7.537602002,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,INHIBITOR,,Tbio,,,Homo sapiens
35052,924,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.157640427,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35053,928,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.846185136,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35055,928,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.966978555,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35057,928,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.115034802,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35059,928,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.735418271,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35061,928,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,4.15606992,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35063,928,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,4.657893285,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35065,928,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.129069642,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35067,928,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.832978204,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35069,928,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.434152181,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35071,928,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.433680378,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35073,928,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.696803943,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35077,928,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.612432221,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35079,928,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.397940009,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35080,928,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,4.862202957,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35081,928,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,5.31884925,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35082,928,510,C-C chemokine receptor type 5,GPCR,P51681,CCR5,CCR5_HUMAN,4.737928787,,Ki,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35084,928,617,C-X-C chemokine receptor type 2,GPCR,P25025,CXCR2,CXCR2_HUMAN,5.375821074,,Ki,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35086,928,798,C-C chemokine receptor type 2,GPCR,P41597,CCR2,CCR2_HUMAN,6.020451625,,Ki,DRUGMATRIX: Chemokine CCR2B  radioligand binding (ligand: [125I] MCP-1),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35088,928,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.821023053,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35089,928,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,5.237471478,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
35091,928,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,4.794092237,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35092,928,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.668572703,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35094,928,1720,C-C chemokine receptor type 4,GPCR,P51679,CCR4,CCR4_HUMAN,5.356843534,,Ki,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35096,928,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,4.332537708,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35100,937,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.975514332,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35102,937,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.997402019,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35104,937,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.420216403,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35106,937,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.868381336,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35108,937,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.771343042,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35110,937,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.910094889,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35112,937,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.346787486,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35116,937,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.255628773,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35117,937,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.258139606,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35118,937,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.400662867,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35119,937,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,6.222573178,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35120,937,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.730487056,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35122,937,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.795880017,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35124,939,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35125,939,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,6.283162277,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35127,945,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.76649624,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35130,945,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.988429556,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35132,945,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.78968148,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35134,945,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.586197483,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94122,575,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,4.66,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
35136,945,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.958607315,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35138,945,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.781202002,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35140,945,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.156144577,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35142,945,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.013228266,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35145,945,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.806875402,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35147,945,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.832682665,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35149,945,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.935542011,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35153,945,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.55315229,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35155,945,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.060480747,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35157,953,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,7,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35158,954,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.723768042,,Ki,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35161,954,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.845271793,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35163,954,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.630784143,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35165,954,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.54515514,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35167,954,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.826813732,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35171,954,840,Interstitial collagenase,Enzyme,P03956,MMP1,MMP1_HUMAN,5.240407691,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloproteinase-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35172,954,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.896196279,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
35174,954,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,9.380906669,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35178,956,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.300162274,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35180,956,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.576754126,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35196,956,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.325138859,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35199,956,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.736127323,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35207,956,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.366531544,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35211,956,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.48148606,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35213,960,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.432620692,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35215,960,369,Caspase-1,Enzyme,P29466,CASP1,CASP1_HUMAN,4.913925046,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35216,960,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,4.496032368,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35217,960,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.288445832,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35218,960,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.604673607,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35219,960,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,5.682354457,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
35221,960,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,4.866780543,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35222,960,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,4.805041878,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35224,966,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.262807357,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35227,966,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.953895213,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35231,966,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.860120914,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35233,966,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.131943638,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108,ANTAGONIST,,Tclin,,,Homo sapiens
35235,966,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.068542129,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35237,966,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.623423043,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35239,966,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.995678626,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35241,966,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.027334408,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35243,966,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.279840697,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35245,966,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.270025714,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35247,966,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.782252927,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35249,966,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.591760035,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35251,966,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,9.174573882,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35255,966,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.199282922,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
35257,966,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.009661145,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35259,966,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.694648631,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35261,977,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.224389552,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35265,977,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.505984625,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35268,977,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.185219854,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35270,977,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.340654364,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35272,977,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.588380294,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35274,977,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.701365217,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35276,977,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.90517962,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35278,977,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.991314681,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35280,977,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.471983659,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35282,977,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.384049948,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35285,977,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.542557159,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35289,977,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.553618188,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35291,977,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.862645889,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35293,977,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.937418016,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35295,977,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.614930224,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35297,977,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.719171322,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35299,977,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.396855627,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94123,575,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,4.68,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
35301,977,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.105683937,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35303,977,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.743258207,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35305,977,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.341320971,,Ki,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35307,977,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.060181337,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35311,977,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.126104208,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35312,977,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,6.252510508,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35313,977,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.091461368,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35314,977,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.975719624,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35315,977,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,6.190911869,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35317,977,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.632830511,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35319,977,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.848599502,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35321,977,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.871245427,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35323,983,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.13053359,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35325,983,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,4.543224162,,Ki,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35327,983,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.636200055,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35329,983,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.336110701,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35331,983,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.369673845,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35333,983,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.085868487,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35335,983,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.78994915,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35337,983,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.051978467,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35339,983,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7.301029996,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35340,983,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.647817482,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35342,983,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.617082865,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35344,983,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.034140063,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35346,983,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.938547521,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35348,983,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.361710465,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35350,983,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.202317065,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35352,983,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.295849483,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35354,983,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.572351629,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35356,983,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.791827473,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35358,983,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.805485658,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35360,983,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.196542884,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35362,983,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.936291441,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35364,983,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.42136079,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35366,983,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.528708289,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35368,983,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.336110701,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35370,983,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.178486472,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35372,983,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.397940009,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35373,983,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,5.005594853,,Ki,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35375,983,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.736127323,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35377,983,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.485319456,,Ki,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35379,983,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.359220523,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35383,983,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.462684727,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35385,983,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,6.294136288,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35387,983,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.864009153,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35388,983,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6.698970004,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35389,983,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,6.522878745,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35390,983,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,4.489401377,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35391,983,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,5.18869316,,Ki,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35393,983,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,7.397940009,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35394,983,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,4.915924432,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35395,983,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,4.856860241,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35396,983,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,7.537602002,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35397,983,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,5.155088126,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35398,983,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.696587929,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35400,983,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.170696227,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35402,983,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,4.999305684,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35404,983,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,4.430754876,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35406,983,1718,Melanocortin receptor 3,GPCR,P41968,MC3R,MC3R_HUMAN,4.502710894,,Ki,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35408,983,1719,Neuropeptide Y receptor type 2,GPCR,P49146,NPY2R,NPY2R_HUMAN,4.959081349,,Ki,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35410,983,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.498393078,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35412,983,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.875495775,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35414,1001,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.853871964,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35416,1001,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.585026652,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35418,1001,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.578067187,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35420,1001,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.970210529,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35424,1022,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.769551079,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35426,1022,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.858550227,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35428,1022,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.080398976,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35430,1022,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.309502677,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35433,1028,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.559090918,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,AGONIST,,Tclin,,,Homo sapiens
35435,1028,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.401209493,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,AGONIST,,Tclin,,,Homo sapiens
35437,1028,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.448550002,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,AGONIST,,Tclin,,,Homo sapiens
35441,1028,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.484258583,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35442,1028,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.010105436,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35444,1030,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.285586408,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35445,1030,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,5.878440156,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
35447,1042,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.530177984,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35451,1042,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.200659451,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35453,1042,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.333482019,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35457,1042,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.580044252,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35459,1042,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.958607315,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35461,1042,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,8.823908741,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35463,1042,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.879426069,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35465,1042,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.714442691,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35467,1042,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,8.88941029,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35469,1043,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.621238825,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35471,1043,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.721703792,,Ki,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35473,1043,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.063486258,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35475,1043,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.844663963,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35477,1043,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,9.099086932,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35479,1043,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35480,1043,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,9.353596274,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35486,1043,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,8.754487332,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35488,1043,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.835647144,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35490,1043,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.742321425,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35492,1043,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.4867824,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35496,1043,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.187153463,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35497,1043,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.500312917,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35498,1043,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.513711239,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35499,1043,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.578396073,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
35501,1043,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.341988603,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35503,1043,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,10.04095861,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35507,1057,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.243059764,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35509,1057,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,4.72519581,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35511,1057,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,4.926391612,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35516,1057,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,4.947113765,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35517,1057,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.371917739,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35519,1058,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.709742731,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35521,1058,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,4.767334181,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35523,1058,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.133181197,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35525,1058,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,5.637140697,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35527,1058,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.445874418,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35529,1058,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,4.909671393,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35531,1058,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,7.744727495,,Ki,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35533,1058,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,4.638385473,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35534,1058,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,8.156144577,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35536,1058,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.902048929,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35538,1071,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,5.93930216,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35539,1082,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,4.963890333,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35541,1082,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,4.929925174,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35543,1082,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.537602002,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35545,1082,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.021819483,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35547,1082,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.109578981,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35549,1082,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.35261703,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35551,1082,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,4.730253627,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35553,1082,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,4.984724093,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35559,1082,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,5.877456476,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
35561,1082,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.245804612,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35562,1082,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,6.8569852,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35564,1084,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.022276395,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35566,1084,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,7.356547324,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35568,1084,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,8.110698297,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35570,1094,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.366531544,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35572,1094,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.681936665,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35574,1094,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.982966661,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35576,1094,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.494850022,,Ki,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35578,1094,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.186819467,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35579,1094,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.88917469,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35580,1094,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,7.744727495,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35582,1094,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.585026652,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35584,1095,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.367542708,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35585,1095,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.684659523,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35587,1095,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.677780705,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35590,1103,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.576918042,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35591,1112,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.496617937,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35594,1141,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.048662481,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D01675,INHIBITOR,,Tclin,,,Homo sapiens
35595,1142,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.224025669,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35597,1142,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.339181937,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35598,1152,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,4.67302955,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35600,1152,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.218244625,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35602,1152,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.905878404,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35604,1152,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,4.33059943,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35606,1152,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,4.031708557,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35608,1152,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.163739197,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35610,1152,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.491874464,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35612,1152,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.808241679,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35613,1171,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35614,1171,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35615,1175,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.704426303,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35619,1200,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,5.621420424,,Ki,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35623,1200,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.712870379,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35625,1200,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.931814138,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35627,1200,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.661543506,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35629,1200,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35631,1200,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.304255725,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94124,575,1066,Cytochrome P450 3A5,Enzyme,P20815,CYP3A5,CP3A5_HUMAN,5.11,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
35633,1200,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.576754126,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35635,1200,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.876801925,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35637,1200,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.611543547,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35639,1200,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.935542011,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35641,1200,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.159893906,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35643,1200,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.454692884,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35645,1200,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.063486258,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35647,1200,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.48148606,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35649,1200,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.744727495,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35651,1200,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.150580586,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35653,1200,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.504455662,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35655,1200,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.102922997,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35657,1200,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.099632871,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35659,1200,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.494850022,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35661,1200,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.333482019,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35663,1200,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.531948209,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35665,1200,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.356547324,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35669,1200,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.217527376,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35671,1200,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,7.420216403,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35675,1201,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.327902142,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35677,1204,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.847711656,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL989,AGONIST,,Tclin,,,Homo sapiens
35679,1204,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,8.474955193,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35681,1205,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.621602099,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL989,AGONIST,,Tclin,,,Homo sapiens
35683,1205,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,8.537602002,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35685,1207,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6.042201225,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35686,1208,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.801342913,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200600,AGONIST,,Tclin,,,Homo sapiens
35688,1208,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,6.067019178,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35690,1208,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,6.974694135,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35701,1209,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.156144577,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35706,1209,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.15490196,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35707,1212,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.074636333,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35712,1212,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.066512712,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94125,575,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,4.85,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
35714,1212,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.330255545,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35716,1212,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.100726813,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35718,1212,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.710857164,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35722,1212,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.602059991,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35724,1212,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.455931956,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35732,1212,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.575118363,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35734,1212,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.999132278,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35736,1212,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.315154638,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35738,1212,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,4.655293419,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35741,1212,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.787546039,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35743,1212,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.170953663,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35746,1212,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.018634491,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35750,1212,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.004759798,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35752,1212,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.071962794,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35754,1212,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,4.396779822,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35755,1212,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.097453221,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35756,1212,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,4.708409174,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35757,1212,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.125228363,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35759,1212,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.721246399,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35761,1212,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,6.060980224,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35763,1212,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,5.049197177,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35765,1212,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,7.013228266,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35766,1217,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.694648631,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201012,AGONIST,,Tclin,,,Homo sapiens
35768,1217,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.657577319,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
35770,1223,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.082441979,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35772,1223,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.049294465,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35774,1223,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,5.646276062,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
35777,1229,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6.397940009,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35779,1273,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.148130399,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/18305010,NEGATIVE ALLOSTERIC MODULATOR,,Tclin,,495,Homo sapiens
35781,1314,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.795337488,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,INHIBITOR,,Tchem,,,Homo sapiens
35784,1343,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.064996849,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35786,1343,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.874518734,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35788,1343,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.118615343,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35792,1343,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.262807357,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35794,1353,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.003488328,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35802,1353,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.739928612,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35814,1353,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.552841969,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35818,1353,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.305394801,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35820,1353,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,7.443697499,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35822,1355,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.549750892,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35824,1355,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.339134522,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35826,1355,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.36552273,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35828,1355,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.561141341,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35830,1355,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.159893906,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35832,1355,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.865504144,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35834,1355,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.730020323,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35836,1355,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.600326279,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35838,1355,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.779891912,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35840,1355,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.230622674,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35842,1355,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.805485658,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35844,1355,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.899629455,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35846,1355,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.338187314,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35848,1355,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,6.308918508,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35850,1364,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.190911869,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35851,1364,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,6.042871802,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35853,1364,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.685879866,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35855,1364,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.636275231,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35857,1364,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.440823795,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35859,1364,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.617676717,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35861,1364,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.994176247,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35863,1364,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.442372512,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35865,1364,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.520727088,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35866,1364,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.881636056,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35867,1364,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,6.125750177,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35868,1364,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.911332447,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35869,1364,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.613947151,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35870,1364,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.458670422,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35871,1364,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.479018919,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35872,1364,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.510463371,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35873,1364,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.604778479,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35874,1364,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,7.057495894,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35875,1364,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.860215336,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35877,1364,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.479267622,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35879,1364,48,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,D2WKD8,ATP1A2,AT1A2_PIG,5.212404936,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",DRUG MATRIX,=,,,,,,,,,,Sus scrofa
35880,1364,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.707743929,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35881,1379,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.494850022,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35883,1379,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.124938737,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35885,1379,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.795880017,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35887,1379,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.853871964,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35889,1379,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.408935393,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35891,1384,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.437826137,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35894,1395,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.979224512,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35896,1395,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.629671992,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35898,1416,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.15490196,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35899,1416,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35900,1416,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.301029996,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35901,1416,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6.096910013,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35902,1423,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.127843727,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35904,1423,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.26760624,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35906,1423,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.714442691,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35908,1423,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.70333481,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35909,1429,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.524764777,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35911,1429,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.829444941,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35913,1429,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.890084137,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35915,1433,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.534914712,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35916,1437,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.397940009,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35917,1437,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.732593581,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35918,1437,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.769551079,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35920,1440,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,5.439973751,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35921,1457,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.278189385,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35923,1457,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.723768042,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35924,1457,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.608888386,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35925,1457,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.803823815,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35926,1457,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.06666459,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35927,1457,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.278684119,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35928,1457,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,6.438898616,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35929,1457,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,6.042871802,,IC50,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35930,1457,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.53165267,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35931,1477,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.531017941,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35932,1477,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.603504248,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35934,1482,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.663540266,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35936,1482,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.336299075,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35939,1482,840,Interstitial collagenase,Enzyme,P03956,MMP1,MMP1_HUMAN,5.217527376,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloproteinase-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35942,1499,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.752026734,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35943,1508,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.26760624,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35945,1508,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.520136887,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35947,1508,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.627640417,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35949,1508,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,5.597051171,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35950,1508,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.335358024,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35951,1513,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.045757491,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35952,1513,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.410050399,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35953,1527,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.129654629,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35956,1527,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.549750892,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35958,1527,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,4.619734475,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35960,1527,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.084125497,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35962,1527,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,4.667420165,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35964,1527,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.028353118,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35966,1527,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,4.728506898,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35968,1527,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,4.839771643,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35970,1527,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.345727173,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94126,575,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,4.07,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
35972,1527,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.664542099,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35973,1527,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.240483241,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35975,1527,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,5.821023053,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
35977,1527,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.265600257,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
35978,1527,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,4.896778008,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35980,1527,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.210842508,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35982,1527,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.009084245,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35984,1529,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,5.214029875,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
35985,1530,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.360513511,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35987,1530,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.086186148,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35989,1530,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.838631998,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35991,1530,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.046723663,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35993,1530,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.537602002,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35995,1530,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.075720714,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35997,1530,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.27572413,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
35999,1530,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.48945499,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36001,1530,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.175874166,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36004,1530,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.391473966,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36011,1530,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.737074531,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36013,1531,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8.233587153,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429,ANTAGONIST,,Tclin,,,Homo sapiens
36015,1531,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.958607315,,Ki,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429,ANTAGONIST,,Tclin,,,Homo sapiens
36017,1531,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.117475462,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36019,1531,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.478077755,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36021,1531,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.647817482,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36023,1531,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.713768146,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36025,1531,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.893809103,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36027,1531,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.096910013,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36028,1531,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.638272164,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
36032,1531,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.490797478,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36034,1532,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.045757491,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36035,1532,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.245116772,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36037,1532,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.678608722,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36039,1532,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.641874715,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36041,1532,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36042,1532,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36043,1532,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.771086594,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36044,1532,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.583026827,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36046,1547,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.274513074,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36047,1547,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6.472756884,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36048,1552,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.338092707,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36050,1552,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.639974911,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36052,1552,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,6.301029996,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36053,1552,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,4.684113584,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36054,1552,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,5.287434472,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
36056,1561,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.568153954,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36057,1567,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.540607512,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36058,1567,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.428407617,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36059,1567,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.668370282,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36060,1567,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.646276062,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
36061,1572,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.225483034,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36063,1572,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.167491087,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36065,1572,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,8.369572125,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36067,1572,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,9.339134522,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
36071,1585,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,6.620331966,,Ki,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36074,1588,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.490797478,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36076,1588,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.537602002,,Ki,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36082,1588,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,9.935542011,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36086,1588,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.061480275,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36088,1588,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.48945499,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,1,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2011/05/WC500106736.pdf,ANTAGONIST,,Tclin,,574,Homo sapiens
36091,1588,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,8.258848401,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36093,1588,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,9.625251654,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36097,1588,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.721246399,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36099,1588,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.990549104,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36101,1588,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,9.203425667,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36103,1588,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,7.795880017,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36104,1588,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.036684489,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36108,1588,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.173925197,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36110,1588,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,8.338187314,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36112,1599,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.684869683,,Ki,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36115,1599,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.578396073,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36117,1599,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.931814138,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36119,1599,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.58286059,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36121,1599,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.342944147,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36123,1599,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.518557371,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36125,1599,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36126,1599,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.599116784,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36130,1599,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.272458743,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36132,1599,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.071604148,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36134,1605,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.806875402,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36137,1605,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,7.795880017,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36138,1610,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.540306024,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36139,1612,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.061480275,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36141,1612,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.095392636,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36143,1612,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,4.807265328,,Ki,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36146,1612,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.026502691,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36148,1612,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.696587929,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36152,1634,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.164943898,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36154,1634,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.364315237,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36158,1634,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.669586227,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36160,1634,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.387216143,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36162,1634,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.382999659,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36164,1634,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.876148359,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36168,1634,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.40560745,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36170,1634,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.844663963,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36172,1634,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.164309429,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36174,1634,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36176,1634,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.236572006,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36178,1634,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.93930216,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36180,1634,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.354577731,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36183,1634,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.709965389,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36187,1634,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.045757491,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36189,1650,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,5.502517463,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36192,1659,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36195,1659,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.031517051,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
36197,1659,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,4.56141019,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36204,1667,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.057000407,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36206,1667,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36207,1667,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,7.698970004,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36209,1667,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,8.841637508,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
36213,1688,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.262807357,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36215,1688,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.119186408,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36217,1688,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.730253627,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36219,1688,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.958607315,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36221,1688,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.485452247,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36223,1688,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.586700236,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36225,1688,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.069050969,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36227,1688,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.742321425,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36229,1688,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.166852888,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36231,1688,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.504455662,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36233,1688,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.721246399,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36235,1688,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.696803943,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36237,1688,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.397940009,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36239,1688,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.721246399,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36241,1688,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.552841969,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36243,1688,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.236572006,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36247,1688,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.468521083,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36249,1688,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.411168274,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36251,1708,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.789360494,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36252,1714,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,4.647200257,,Ki,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36254,1714,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.657577319,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36256,1714,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.862962545,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36258,1714,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,8.282329497,,Ki,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201151,AGONIST,,Tclin,,,Homo sapiens
36260,1714,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.147459014,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36262,1714,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,4.958212681,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
36265,1723,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.431798276,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36267,1723,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.677780705,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36269,1723,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.657577319,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36271,1723,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.504455662,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36273,1723,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.440093375,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36281,1723,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,8.123782159,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36283,1723,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.583359493,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36285,1723,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.318758763,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36287,1723,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.018181393,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36289,1723,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.568636236,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36291,1723,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.301029996,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36293,1723,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.698970004,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36294,1723,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.420216403,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36298,1723,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.871600731,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36299,1723,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.867420152,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36301,1723,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.562249437,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
36303,1723,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.838631998,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36307,1738,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.359518563,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36309,1738,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.974694135,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36311,1738,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.860120914,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36313,1738,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.744727495,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36315,1738,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.270025714,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36317,1738,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.408935393,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36319,1738,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.843148099,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36321,1738,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.819587367,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36323,1738,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.744727495,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36325,1738,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.93930216,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36327,1738,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.227678293,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36329,1738,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.629671992,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36331,1738,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.659555885,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36333,1738,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.559657759,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36344,1762,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.281664421,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36345,1762,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.286005732,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36346,1762,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.67243674,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
36347,1764,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.268411235,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200843,ANTAGONIST,,Tclin,,,Homo sapiens
36349,1764,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.559090918,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36351,1764,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.22475374,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36353,1764,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.632644079,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36358,1764,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,8.928117993,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36360,1764,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.677780705,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36362,1764,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.244125144,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36364,1764,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.698970004,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36365,1764,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,8.033389013,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36368,1765,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36373,1768,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.749921712,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36375,1775,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.326058001,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36377,1775,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.57024772,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36379,1775,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.21395879,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36381,1775,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.508638306,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,PARTIAL AGONIST,,Tclin,,,Homo sapiens
36387,1775,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.662540739,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36389,1775,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.229147988,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36391,1775,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,6.966576245,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36394,1782,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.991399828,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36396,1782,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.978810701,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36398,1782,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.396855627,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36400,1782,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.903785415,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36403,1782,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.096910013,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36407,1791,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.096910013,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36408,1794,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.140261434,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36422,1796,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.003488328,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36424,1796,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.46470588,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36426,1796,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.416801226,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36428,1796,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.525783736,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36430,1796,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.540607512,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36432,1796,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.638272164,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36437,1796,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,6.209714836,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36439,1796,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.180456064,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36441,1800,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.136915175,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36443,1800,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.587640268,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36444,1800,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,4.779525794,,Ki,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36446,1800,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.609064893,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36448,1800,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.505288975,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36450,1800,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.38007229,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36452,1800,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.096801453,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36454,1800,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.827689031,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36456,1800,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36457,1800,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.382999659,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36459,1800,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.535361441,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36461,1800,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.183427304,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36463,1800,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.952335805,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36465,1800,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.452348342,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36467,1800,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.555330769,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36469,1800,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.29627884,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36471,1800,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.784626847,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36473,1800,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.964170175,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36475,1800,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.178028182,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36477,1800,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.019542108,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36479,1800,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.811915626,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36481,1800,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.175223538,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36483,1800,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.350665141,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36485,1800,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.386052523,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36487,1800,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.869023308,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36489,1800,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36490,1800,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,5.136498699,,Ki,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36492,1800,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.798876103,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36494,1800,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.271321633,,Ki,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
94127,575,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.01,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
36496,1800,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.8247782,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36498,1800,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.57888987,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36500,1800,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.922995673,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36502,1800,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.729111635,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36503,1800,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6.698970004,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36504,1800,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,4.533785053,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36505,1800,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,5.429924295,,Ki,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36507,1800,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,7.795880017,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36508,1800,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.380906669,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36509,1800,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,4.561774192,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36510,1800,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.580044252,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36511,1800,862,Type-2 angiotensin II receptor,GPCR,P50052,AGTR2,AGTR2_HUMAN,5.109076229,,Ki,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36513,1800,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.792365633,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36515,1800,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.325506283,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36517,1800,48,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,D2WKD8,ATP1A2,AT1A2_PIG,4.714915497,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",DRUG MATRIX,=,,,,,,,,,,Sus scrofa
36518,1800,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.028538595,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36520,1800,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,4.92190585,,Ki,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36522,1800,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,4.673541243,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36524,1800,1718,Melanocortin receptor 3,GPCR,P41968,MC3R,MC3R_HUMAN,4.792311787,,Ki,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36526,1800,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.691649051,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36528,1800,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.711080394,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
36530,1805,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.001304842,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36532,1805,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,4.956755646,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36534,1805,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,4.917861169,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36537,1805,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.094851998,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36541,1805,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,4.670459752,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36542,1805,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,4.080602845,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36543,1805,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,8.254925208,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36545,1805,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,6.255707017,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
36546,1805,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,9.373659633,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
36548,1820,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.559878397,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36550,1820,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.795608668,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36552,1820,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.090443971,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94128,575,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.24,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
36554,1820,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.51215488,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36556,1820,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.186419011,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36558,1820,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.099632871,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36560,1820,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.375924269,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36562,1821,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.532096053,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36564,1821,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.305526425,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36566,1821,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.729158188,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36568,1821,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.744004273,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36570,1821,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.108462542,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36572,1821,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.046723663,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36574,1821,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.268741714,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36575,1821,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.900353883,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36576,1821,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.691392906,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36577,1821,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.748288795,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
36578,1826,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.836838625,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1373,INHIBITOR,,Tclin,,,Homo sapiens
36580,1834,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.428757149,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36581,1834,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.991825816,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36582,1834,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.41408829,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36584,1834,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.310513552,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
36585,1836,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.620150821,,Ki,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36587,1836,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.832682665,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36589,1836,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.573976984,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36591,1836,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.400007822,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36593,1836,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.579879152,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36595,1836,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.712646227,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36597,1836,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.852632892,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36599,1836,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.494850022,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36601,1836,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.115204636,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36603,1836,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.684659523,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36605,1836,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.610833916,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36607,1836,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.772113295,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36609,1836,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.495257364,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94129,575,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,4.89,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
36610,1836,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.327717375,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36611,1836,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.816730156,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36612,1836,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,6.067526235,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36613,1836,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.894830572,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36617,1848,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.860183859,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36619,1848,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.891434976,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36621,1848,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.15490196,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36622,1848,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.69359642,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36624,1848,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.72514968,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36626,1848,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.682563503,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36628,1848,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.059981845,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36630,1848,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36631,1848,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,6.397940009,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36632,1848,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36635,1856,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.396639076,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36637,1863,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.732124581,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36639,1863,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.301029996,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36640,1863,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,6.000869459,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36644,1878,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36645,1879,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,8.677780705,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36647,1879,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.649751982,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
36649,1893,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.232176502,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36651,1893,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.189297139,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36653,1893,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36654,1893,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.056554951,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36656,1893,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,4.208730519,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36658,1893,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,4.592337215,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36660,1893,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,4.908860846,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36662,1893,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.077637903,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36664,1893,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,4.841697831,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36666,1893,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,4.632290078,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36668,1893,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,4.254698747,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36669,1893,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,4.101461298,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36670,1893,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.098487191,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36671,1893,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,4.675511767,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36672,1893,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,4.64775958,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36673,1893,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,4.739356293,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36674,1893,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.009084245,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36676,1893,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.615127106,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36678,1893,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,4.860215336,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
36679,1893,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.236272596,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
36681,1922,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.01899731,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36683,1922,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,5.347560252,,Ki,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36687,1922,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,6.522878745,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36688,1922,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,4.354990605,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36689,1922,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,4.730627173,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36690,1922,798,C-C chemokine receptor type 2,GPCR,P41597,CCR2,CCR2_HUMAN,6.07211659,,Ki,DRUGMATRIX: Chemokine CCR2B  radioligand binding (ligand: [125I] MCP-1),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36692,1922,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,5.088682558,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
36694,1922,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,4.820994292,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
36695,1925,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.037157319,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36696,1925,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.973058372,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36699,1935,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,4.927162125,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36701,1935,840,Interstitial collagenase,Enzyme,P03956,MMP1,MMP1_HUMAN,4.631806122,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloproteinase-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36702,1937,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,5.862962545,,Ki,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36704,1937,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36705,1937,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.397940009,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36706,1937,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,6.363512104,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
36708,1942,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.64244628,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36710,1942,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.395342028,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36712,1942,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36713,1947,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6.522878745,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36714,1947,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36715,1955,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.250681179,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36716,1962,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.61780279,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36718,1962,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.705533774,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36720,1962,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.63638802,,Ki,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94130,575,1886,Somatostatin receptor type 4,GPCR,P31391,SSTR4,SSR4_HUMAN,5.17,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
36724,1962,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,8.913640169,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
36726,1963,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.53313238,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36728,1963,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6.096910013,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36729,1963,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,7.148741651,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36731,1963,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,8.441291429,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
36733,1971,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.57024772,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36735,1971,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.560667306,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36742,1971,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.065501549,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36748,1971,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.214670165,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36751,1971,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.63921731,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36758,1971,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.522878745,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36762,1971,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.910094889,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36766,1971,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36767,1971,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.943095149,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36769,1971,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.837435593,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36771,1973,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.087390069,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36772,1973,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6.39761441,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36776,1982,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.260427656,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36789,1982,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.585026652,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36794,1982,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.557833914,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
36795,1982,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.677780705,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36797,1982,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,6.363512104,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36799,1992,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.341035157,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36802,1999,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.092051478,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36804,1999,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.614393726,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36806,1999,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.577902837,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
36808,1999,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.903089987,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36810,1999,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.66594856,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36812,1999,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.552841969,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36814,1999,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.283162277,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36816,1999,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.062983893,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36819,1999,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.164626548,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36822,1999,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.872895202,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36824,1999,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.431798276,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36826,1999,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.769551079,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36828,1999,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.698970004,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36830,1999,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.397940009,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36831,2004,48,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,D2WKD8,ATP1A2,AT1A2_PIG,6.168770306,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",DRUG MATRIX,=,,,,,,,,,,Sus scrofa
36832,2013,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.067526235,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1071,INHIBITOR,,Tclin,,,Homo sapiens
36833,2028,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.991399828,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36835,2028,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.589442077,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36837,2028,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.297569464,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36839,2028,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.836838625,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36850,2028,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.168130226,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36852,2028,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6.22184875,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36853,2028,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.086027288,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36856,2032,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.493494968,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36861,2032,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.110698297,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36864,2032,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.341988603,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36866,2032,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.019088062,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36869,2032,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.698970004,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36872,2032,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.161780778,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36874,2032,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,9.041436117,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36876,2033,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,6.863279433,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36878,2044,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.829444941,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36880,2044,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,4.621493085,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36881,2044,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,4.954364129,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36882,2044,558,Cholecystokinin receptor type A,GPCR,P32238,CCKAR,CCKAR_HUMAN,5.642827742,,Ki,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36884,2044,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.689944262,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36886,2044,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,4.793930076,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36888,2056,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6.118045029,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36889,2056,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,6.087777943,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36890,2068,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.646853454,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36892,2068,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.068313346,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36898,2068,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.455931956,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94131,575,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.34,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
36900,2068,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.723538196,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36902,2068,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.420216403,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36904,2068,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.468521083,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36906,2068,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.050609993,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36910,2068,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36911,2075,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.382789905,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36913,2090,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.287350298,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36915,2090,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.890077393,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36917,2090,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.658367664,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36919,2090,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.329754147,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36921,2090,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.765229705,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36923,2090,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.86710023,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36925,2090,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.294992041,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36927,2090,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.657577319,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36929,2090,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.683400698,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36931,2090,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.600326279,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36933,2090,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.308918508,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36935,2090,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,6.100726813,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36936,2090,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.271646218,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36949,2105,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.698970004,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36950,2105,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.128427064,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36954,2105,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.838033384,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36956,2105,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,7.397940009,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36958,2106,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.961618309,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36960,2106,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.485850866,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36962,2106,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.185219854,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36964,2106,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.179798541,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36966,2106,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.300248968,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36968,2106,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.104909103,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36970,2106,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.026502691,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36971,2106,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.828215059,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36972,2106,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.391046301,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36973,2113,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.461665093,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36975,2123,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36976,2123,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36977,2123,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.397940009,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36978,2123,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,6.835647144,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089,INHIBITOR,,Tclin,,,Homo sapiens
36979,2123,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6.096910013,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
36981,2142,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.783886903,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36984,2142,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.615825861,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36986,2142,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.684029655,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36990,2142,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36993,2142,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.346787486,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
36995,2159,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.698970004,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37001,2179,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.943095149,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37002,2179,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,4.455076618,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37003,2179,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,4.879426069,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37004,2180,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.795880017,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37006,2180,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.869666232,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37008,2180,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.602059991,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37010,2180,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.318758763,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37012,2180,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.460923901,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37014,2180,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.350665141,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37016,2180,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.992252222,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37018,2180,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.256490235,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37020,2180,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.508638306,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37022,2180,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.958607315,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37024,2180,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.283996656,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37026,2180,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,9.104577454,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37028,2180,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.798602876,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37030,2180,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.93930216,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37032,2180,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.646083769,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37034,2180,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.189095719,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37036,2180,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,7,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37037,2180,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,9.019996628,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94132,575,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,4.59,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
37041,2180,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.847711656,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37043,2180,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.864231485,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37045,2180,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.42945706,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37052,2253,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,5.771599641,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
37054,2266,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.075204004,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37056,2266,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,6.738975166,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37057,2274,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.107905397,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37060,2274,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.200659451,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37062,2274,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.638272164,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37064,2274,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.819845441,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37066,2274,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.2069084,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37068,2274,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.402304814,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37072,2274,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.187086643,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37075,2274,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.906578315,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37077,2274,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,8.324221658,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37081,2274,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.612610174,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37083,2274,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.955852379,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37085,2274,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.493494968,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37087,2274,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.721246399,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37089,2274,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.801342913,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37091,2274,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.920818754,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37093,2274,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.860435734,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37095,2274,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.522878745,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37097,2274,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.886056648,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37101,2274,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37102,2274,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.245345931,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37103,2274,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.71219827,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
37105,2274,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.30980392,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37107,2274,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.919012953,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37109,2274,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.380906669,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37117,2279,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,5.173730781,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
37119,2279,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,8.441291429,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
94133,575,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.06,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
37121,2284,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.909389292,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37124,2284,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.899629455,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37126,2284,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.943095149,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37128,2284,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.337242168,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37131,2284,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.886056648,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37132,2284,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.529442515,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37135,2284,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.655607726,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37137,2284,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.283996656,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37139,2284,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.896196279,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37144,2284,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.55129368,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37147,2284,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.412289035,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37149,2284,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.055517328,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37151,2284,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.37675071,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37153,2284,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.337242168,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37155,2284,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.431798276,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37157,2284,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.522878745,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37158,2284,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.427128398,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37162,2284,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.343901798,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37164,2284,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.80631897,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37165,2286,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.862645889,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37168,2286,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.591760035,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37170,2286,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.920818754,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37174,2286,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.37644061,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37176,2286,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.828566099,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37179,2286,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.366531544,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37181,2286,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.188424994,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37183,2286,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.9476909,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37185,2286,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.619788758,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37187,2286,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.721246399,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37190,2286,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.940815382,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37192,2286,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.478861916,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37194,2286,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.920818754,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37337,2350,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.102372909,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37196,2286,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.381951903,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37198,2286,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.974694135,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37200,2286,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.480172006,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37202,2286,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.452225295,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37204,2286,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.494850022,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37208,2286,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.677780705,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37210,2291,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.688246139,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL631,ANTAGONIST,,Tclin,,,Homo sapiens
37212,2291,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.443697499,,Ki,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),DRUG MATRIX,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
37214,2291,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.959793372,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37216,2291,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.524183587,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37218,2291,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.029188389,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37220,2291,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.728158393,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37222,2291,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.236572006,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37224,2291,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.696803943,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37226,2291,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.062983893,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37228,2291,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6.49757288,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37230,2291,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.828566099,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37232,2291,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.336921287,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37233,2291,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.604149624,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37235,2291,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.482540173,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37236,2291,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.848936747,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37238,2294,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37240,2294,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.750312572,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37241,2302,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.4165745,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37242,2302,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.03077052,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37244,2302,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.456056058,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37246,2302,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.218172847,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37248,2302,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.119415044,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
37251,2303,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.918652692,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37253,2303,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.694648631,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37257,2303,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.661543506,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37259,2303,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.920095532,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37261,2303,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.8467951,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37264,2303,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37265,2303,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.397940009,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37266,2303,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.670805585,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37268,2313,48,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,D2WKD8,ATP1A2,AT1A2_PIG,7.055517328,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",DRUG MATRIX,=,,,,,,,,,,Sus scrofa
37269,2331,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.952335805,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37271,2331,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.1837587,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37275,2331,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.602059991,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37278,2331,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.751046385,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37280,2331,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.227678293,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37283,2331,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.155522824,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37285,2331,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.522878745,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37288,2337,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.01596802,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37297,2337,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.457174573,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37301,2337,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.866461092,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37303,2337,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.935504573,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37305,2338,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.068033885,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37307,2338,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.541815564,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37309,2338,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.118615343,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37311,2338,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.079354999,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37313,2338,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.348721986,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37315,2338,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.458920232,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37317,2338,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.444905551,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37319,2338,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.46470588,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37321,2338,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.575118363,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37323,2338,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.557520231,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37325,2338,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.571217489,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37327,2338,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.251811973,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37329,2338,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.993533958,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37331,2338,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.573976984,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37332,2338,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.723538196,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37334,2340,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,5.397072287,,IC50,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
37335,2350,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.100726813,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37339,2350,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.739928612,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37341,2351,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.321481621,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37343,2351,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.713992878,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37345,2351,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.407823243,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37347,2351,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.92628165,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37349,2351,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.20481541,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37353,2351,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.721246399,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37355,2351,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.552841969,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37357,2351,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.382999659,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37361,2351,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.209714836,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37363,2351,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.772627558,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37365,2351,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.274905479,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37367,2351,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.970616222,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37369,2351,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.828273546,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37371,2351,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.320572103,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37375,2351,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.19314197,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37377,2351,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.630413109,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37379,2351,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,6.397940009,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37380,2351,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37381,2351,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.435807539,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37382,2351,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.876148359,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37384,2351,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.826522357,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37386,2351,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,6.072629637,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37388,2351,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.625251654,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37390,2370,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.77314243,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37392,2377,369,Caspase-1,Enzyme,P29466,CASP1,CASP1_HUMAN,5.079928876,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37393,2377,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.530325227,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
37394,2382,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.764976841,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37409,2389,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.277909285,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37412,2389,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.966576245,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37414,2391,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,4.575020413,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37416,2391,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,4.301029996,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37417,2391,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.262648304,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37419,2391,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,7.795880017,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37420,2391,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,5.302683458,,Ki,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37422,2391,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,7.119186408,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37423,2391,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,6.058488567,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37426,2405,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.39051231,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37427,2405,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.448550002,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37428,2410,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.261219442,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37430,2422,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.408156589,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37432,2422,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.61225434,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37434,2422,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.282412703,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37436,2422,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,4.554629351,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37438,2422,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.555955204,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37440,2422,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.003050752,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37442,2422,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,5.153044675,,Ki,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37444,2422,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.661145254,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37445,2422,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.683819901,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37447,2428,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,5.577902837,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37448,2429,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.171340103,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37450,2429,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.764471553,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37453,2436,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.965371543,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37457,2436,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.166591497,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37462,2436,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.106182776,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37464,2436,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.665646792,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37466,2436,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.246187216,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37468,2436,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.081969663,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37474,2436,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.186752699,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37477,2436,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37478,2436,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.475084852,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37480,2436,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,5.365200403,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37482,2436,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.884722409,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37486,2440,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.962175249,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37491,2441,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,6.059981845,,Ki,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37494,2441,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.093664958,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37496,2446,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94134,575,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.29,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
37497,2446,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37498,2446,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.397940009,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37499,2446,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,6.430509046,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
37503,2466,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.413194478,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37506,2475,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37509,2475,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,6.663140179,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
37511,2477,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.032732908,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37512,2477,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.327440372,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37514,2477,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,7.494850022,,Ki,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37516,2477,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.947844933,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37517,2477,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,7.318758763,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37518,2477,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,7.823908741,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37520,2477,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,6.316052869,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
37522,2495,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.819300799,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37524,2495,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7.15490196,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37525,2495,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.124938737,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37527,2495,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.696803943,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37529,2495,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.950007143,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37531,2495,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.716246617,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37533,2495,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.835944708,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37535,2495,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.786216701,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37537,2495,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.977159389,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37539,2495,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.053056729,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37541,2495,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.142064735,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37543,2495,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.258060922,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37545,2495,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.727462223,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37547,2495,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.144480844,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37549,2495,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.862962545,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37551,2495,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.096910013,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37552,2495,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.828273546,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37554,2495,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6.698970004,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37555,2495,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,6.22184875,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37556,2495,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,7.795880017,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
94135,575,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,4.82,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
37557,2495,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.431329022,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37558,2495,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.73754891,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37559,2495,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.781727146,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37561,2501,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.206209615,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37563,2523,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6.698970004,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37564,2525,369,Caspase-1,Enzyme,P29466,CASP1,CASP1_HUMAN,4.540426594,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37565,2525,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,4.70688063,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37566,2525,840,Interstitial collagenase,Enzyme,P03956,MMP1,MMP1_HUMAN,4.62802753,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloproteinase-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37567,2525,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.533117558,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37569,2525,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,4.768479439,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37570,2525,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,5.198459094,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37573,2534,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,6.361510743,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37574,2536,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.119929916,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37576,2536,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.307153081,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37578,2536,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.176656209,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37580,2536,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.857360292,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37582,2536,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.507798549,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37584,2536,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.22366209,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37586,2536,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.145997767,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37588,2536,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.6062669,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37590,2536,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,7.053056729,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37592,2536,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.964570262,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37594,2536,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.008773924,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37596,2536,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.196474604,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37598,2536,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.491672325,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37600,2536,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.426293127,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37602,2536,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.300422409,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37604,2536,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.689965531,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37606,2536,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.678898901,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37608,2536,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,6.099960765,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37609,2536,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.141402655,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37610,2536,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.645066033,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37613,2537,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.12090412,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
163347,926,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
37619,2551,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.289882635,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37621,2551,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.522878745,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37622,2551,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.953504836,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37625,2552,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37626,2561,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.000695428,,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37628,2561,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.357436563,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37629,2561,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.146180154,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37631,2561,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.371508895,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37633,2561,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.33460665,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37635,2561,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.399571674,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37637,2561,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.139063379,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37642,2561,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.906578315,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37644,2561,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.835944708,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37646,2561,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.158077688,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37648,2561,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.862645889,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37650,2561,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.877456476,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37652,2561,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.617982957,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37656,2561,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.794254459,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37658,2561,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.438898616,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37660,2561,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.034328029,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37662,2561,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.166852888,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37664,2561,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.557363474,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37666,2561,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.200659451,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37668,2561,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.172630727,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37670,2561,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.731188096,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37672,2561,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.238222462,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37674,2561,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.835052627,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37676,2561,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,4.85811145,,Ki,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37678,2561,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.67943832,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37680,2561,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.407490152,,Ki,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37682,2561,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.611011215,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37686,2561,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.203981031,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37688,2561,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.327717375,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94136,575,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.21,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
37690,2561,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.449404793,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37691,2561,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,5.068542129,,Ki,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37693,2561,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.095122233,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37694,2561,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.922632095,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37695,2561,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.530325227,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37696,2561,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.038104526,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37697,2561,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.912573543,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37699,2561,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.820793024,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37701,2561,48,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,D2WKD8,ATP1A2,AT1A2_PIG,4.806569276,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",DRUG MATRIX,=,,,,,,,,,,Sus scrofa
37702,2561,1715,B2 bradykinin receptor,GPCR,P30411,BDKRB2,BKRB2_HUMAN,4.919085041,,Ki,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37704,2561,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,4.533013817,,Ki,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37706,2561,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,4.604044903,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37708,2561,1718,Melanocortin receptor 3,GPCR,P41968,MC3R,MC3R_HUMAN,4.761226498,,Ki,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37710,2561,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.419075024,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37712,2561,1725,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,Enzyme,Q08209,PPP3CA,PP2BA_HUMAN,4.514661944,,IC50,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37713,2561,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.58686795,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
37715,2572,1708,Beta-lactamase 1,Enzyme,P10424,penPC,BLA1_BACCE,6.524328812,,IC50,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),DRUG MATRIX,=,,,,,,,,,,Bacillus cereus
37716,2595,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.943095149,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37717,2597,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.669870438,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37719,2597,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.628193541,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37721,2597,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.387703674,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37723,2597,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.698970004,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37724,2597,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,7.661543506,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37726,2599,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,4.894830572,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37728,2599,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.432973634,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37730,2599,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.669586227,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37732,2599,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.215668052,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37734,2599,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,4.59890978,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37736,2599,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.631527162,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37738,2599,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.438183336,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37740,2599,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.904481958,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37742,2599,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.795880017,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37744,2599,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.861697302,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37746,2599,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.338187314,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37748,2599,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.511308302,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37750,2599,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.71828503,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37752,2599,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.503901008,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37754,2599,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.214670165,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37756,2599,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.36181036,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37758,2599,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.269702338,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37762,2599,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.666089457,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37763,2599,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,4.962732905,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37764,2599,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,5.373044049,,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
37766,2599,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,5.608535588,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
37768,2599,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.611543547,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
37769,2599,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.101549081,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37771,2599,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,4.388680381,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37773,2599,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.709965389,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37775,2600,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.873868593,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37777,2600,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.68697689,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37779,2600,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.718512112,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37781,2600,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.13667714,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37783,2600,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.522878745,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37785,2600,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.190440285,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37787,2600,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.217527376,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37789,2600,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.2915791,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37792,2600,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.263603498,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37794,2600,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.692503962,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37796,2600,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.447818661,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37797,2600,510,C-C chemokine receptor type 5,GPCR,P51681,CCR5,CCR5_HUMAN,6.069560405,,Ki,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37799,2600,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.213035741,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37800,2600,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,6.049635146,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37802,2600,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.733768303,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37804,2607,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,5.836540448,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37808,2607,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,6.598599459,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
37810,2610,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.153044675,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37812,2610,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.010550182,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37814,2610,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.76649624,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37816,2610,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,6.498940738,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37819,2621,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,6.096910013,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37820,2632,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.221125528,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37821,2632,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,4.911580383,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37823,2632,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.258375742,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37824,2632,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,4.791585519,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
37826,2637,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.815308569,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37830,2637,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.813043665,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37834,2637,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.086186148,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37848,2637,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.751389255,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37850,2637,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.68613278,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37854,2637,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.001740662,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37856,2637,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.030011309,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37857,2637,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.530619864,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37858,2637,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.195329104,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37859,2637,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.296708622,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37860,2637,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.585026652,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37862,2637,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.283996656,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37865,2651,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.108462542,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37868,2655,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.316952962,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37870,2655,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.907279355,,Ki,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37872,2655,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37873,2655,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,7.122628654,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37875,2655,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.542118103,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
37877,2657,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.844663963,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37879,2657,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.747146969,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37881,2657,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.8569852,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37883,2657,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.76700389,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37885,2657,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.201156071,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37886,2657,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6.175353585,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37887,2657,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.697452628,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37889,2658,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,5.494036482,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37890,2694,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.29191919,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
37891,2699,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,5.66695597,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37892,2703,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.252588192,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37894,2703,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.341035157,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37896,2703,1722,SMR1-alpha3,Unclassified,P70634,VCS-alpha3,P70634_RAT,5.684869683,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37897,2703,1723,BetaB2-crystallin,Unclassified,P70635,Crybb2,P70635_RAT,5.474048659,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37898,2707,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.817842234,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37902,2717,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.033389013,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37909,2717,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.749579998,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37911,2717,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.895854449,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37915,2717,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.327902142,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37919,2717,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.214670165,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37921,2717,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,6.080921908,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37923,2717,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.083019953,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37925,2722,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.642065153,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37927,2722,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.525492361,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37929,2722,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.239577517,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37930,2725,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.585026652,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1451,AGONIST,,Tclin,,,Homo sapiens
37934,2726,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.638272164,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
37936,2728,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37937,2728,369,Caspase-1,Enzyme,P29466,CASP1,CASP1_HUMAN,5.436163081,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37938,2728,732,Cathepsin G,Enzyme,P08311,CTSG,CATG_HUMAN,5.130006,,IC50,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37939,2740,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.292361705,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37941,2745,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.346787486,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37953,2745,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.61086937,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37954,2759,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,6.132532512,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37956,2759,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.90868484,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37958,2759,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,6.080398976,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37959,2767,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.078313525,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37961,2767,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.531209738,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37963,2767,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.013228266,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37964,2767,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.397940009,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37965,2767,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.527828853,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37966,2767,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,5.69079582,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
37967,2767,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,5.907279355,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37968,2774,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.167491087,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37970,2774,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.431798276,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37972,2774,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.522878745,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200604,ANTAGONIST,,Tclin,,,Homo sapiens
37975,2774,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.193820026,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37977,2774,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37978,2774,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37979,2775,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.586700236,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37981,2775,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.605723473,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37986,2777,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,4.306167567,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37988,2777,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.395449967,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
37989,2799,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.537152964,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37994,2815,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.663540266,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37996,2815,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.896196279,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37998,2815,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.762959209,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38001,2815,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.978810701,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38003,2815,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.809668302,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38005,2815,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.200659451,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38007,2815,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.593971055,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38009,2815,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.07211659,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38011,2815,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.026872146,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38013,2815,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,5.759950228,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38015,2823,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.728158393,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38016,2823,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.297828049,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
38017,2827,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38018,2827,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,6.271199976,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38020,2855,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.113509275,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38022,2855,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.646372241,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38023,2855,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.240256632,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38024,2855,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.419075024,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38141,3408,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.684449466,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38025,2855,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.358922687,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38026,2855,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,6.452225295,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38027,2855,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.269217724,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38030,3018,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.934420285,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38032,3018,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.051098239,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38034,3018,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.887730232,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38036,3018,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.045757491,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38038,3018,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.431798276,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38040,3018,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.269217724,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38042,3018,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.53165267,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38044,3018,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.004364805,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38046,3018,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.690369833,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38048,3018,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.091514981,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38050,3018,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.443697499,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38052,3018,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.017728767,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38054,3018,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.54515514,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38056,3018,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.964570262,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38058,3018,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.648590248,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38059,3018,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.11463878,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38060,3018,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.681102285,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38061,3018,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,6.192464972,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38063,3018,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,7.15490196,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38065,3032,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.650528201,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38067,3032,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,6.1837587,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38069,3032,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.843450849,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38071,3032,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.911863911,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38073,3032,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.501413791,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38075,3032,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.364516253,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38077,3032,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.33733659,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38079,3032,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.251811973,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38081,3032,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.84375381,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38083,3032,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.195179321,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94137,575,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,4.85,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
38085,3032,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.761201437,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38087,3032,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.329754147,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38089,3032,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,6.211831629,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38090,3032,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.646853454,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38091,3032,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.668167956,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38092,3032,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.735182177,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38093,3032,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,6.49757288,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38094,3032,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.808828544,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38096,3032,48,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,D2WKD8,ATP1A2,AT1A2_PIG,5.299123292,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",DRUG MATRIX,=,,,,,,,,,,Sus scrofa
38097,3032,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.41453927,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38099,3064,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38100,3067,1706,Cytochrome P450 2E1,Enzyme,P05181,CYP2E1,CP2E1_HUMAN,4.958607315,,IC50,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
38101,3094,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.927750102,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38103,3094,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.737786295,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38104,3187,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.260348556,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38106,3187,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,4.747535339,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38109,3187,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.063737658,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
38110,3188,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.55036735,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38112,3188,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.061680457,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38115,3188,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.110978578,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38117,3188,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.181180492,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
38118,3188,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.677780705,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
38120,3219,457,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,5.217240807,,Ki,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38122,3219,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,6.57024772,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38123,3219,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,4.85933486,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38124,4189,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.638272164,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38126,4189,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.260744197,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38128,4189,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.572838597,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38130,4189,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.500725418,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38131,4189,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,6.307153081,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38133,4189,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,8.809668302,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
38135,3356,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.076755981,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38139,3356,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.48148606,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
38143,3408,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.815024809,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38145,3408,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7.045757491,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38146,3408,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.371508895,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38148,3408,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.72250539,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38150,3408,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.49660431,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38152,3408,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.924672066,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38154,3408,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.532924916,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38156,3408,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.778246806,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38158,3408,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.169347186,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38160,3408,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.942828558,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38162,3408,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.017547849,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38164,3408,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.448708622,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38166,3408,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.218172847,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38168,3408,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.675758712,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38170,3408,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38171,3408,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.445389715,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38173,3408,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.727879791,,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38175,3408,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.332874059,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38176,3408,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38177,3408,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,7.397940009,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38178,3408,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.209433375,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38179,3408,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.969036158,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38181,3481,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.22184875,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38182,3481,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.397940009,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38183,3481,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.301029996,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38184,3487,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.292429824,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38186,3487,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.19859629,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38198,3617,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.893809103,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38200,3617,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38201,3659,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.163043263,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38206,3659,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.105683937,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38210,3659,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.692140419,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38215,3659,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.181774106,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38217,3787,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.31554065,,Ki,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38220,3871,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.698970004,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38223,3927,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,6.787812396,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
38225,3952,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.823908741,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL420,AGONIST,,Tclin,,,Homo sapiens
38227,3952,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.927750102,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38229,3952,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.950781977,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38231,3952,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.207608311,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38233,3952,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.970616222,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38235,3952,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.167491087,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL420,AGONIST,,Tclin,,,Homo sapiens
38237,3952,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.793174124,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL420,AGONIST,,Tclin,,,Homo sapiens
38239,3952,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.801342913,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38243,3952,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.747875447,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38244,3952,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.122053048,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38246,3972,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.646391479,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38248,3972,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.659575716,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38250,3972,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.407279327,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38252,3972,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.124765054,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38254,3972,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.924197646,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38256,3972,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.891096872,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38258,3972,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.586331494,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38260,3972,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.244353781,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38262,3972,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.451033544,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38264,3972,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.538501473,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38268,4061,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.809668302,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38270,4061,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6.469800302,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38272,4063,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,4.8074883,,Ki,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38274,4063,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.242603971,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38276,4063,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,4.928965325,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38278,4063,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.424812155,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38280,4063,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,4.857485395,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38282,4063,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.940058112,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38284,4063,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,4.690433704,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38285,4063,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,4.801727902,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38286,4063,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.952335805,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38287,4063,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,4.788826043,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38288,4063,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,5.130416292,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38289,4122,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.480172006,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38291,4122,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.440093375,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38293,4122,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.649751982,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38295,4122,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.222573178,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38297,4122,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.020451625,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38299,4122,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.404503778,,Ki,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38301,4122,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.92190585,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38302,4138,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.059981845,,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38304,4138,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.809388202,,Ki,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38306,4138,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.97510404,,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38308,4138,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.723768042,,Ki,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38310,4138,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.696803943,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38312,4138,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.439650931,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38313,4138,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.124360063,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38315,4138,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.241088108,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38317,4138,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.549750892,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38319,4138,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.944621669,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38321,4138,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.578396073,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38323,4138,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.294136288,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38325,4138,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.037157319,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38327,4138,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.853871964,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38329,4138,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.415668776,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38331,4138,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.562249437,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38333,4138,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.490394295,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38335,4138,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.083862017,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38336,4138,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.628009089,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38338,4138,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.01188716,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38340,4138,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.210419288,,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38342,4138,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.233066906,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38343,4138,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,6.325138859,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38344,4138,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.667965723,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38345,4138,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,6.251811973,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38347,4138,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.430275051,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38349,4138,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.701146924,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38355,4209,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.581532979,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38365,4209,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,5.157203605,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38366,4209,840,Interstitial collagenase,Enzyme,P03956,MMP1,MMP1_HUMAN,5.394048842,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloproteinase-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38369,4344,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.157990201,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38371,4344,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.935916564,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38372,4344,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.659873294,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38373,4344,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.726327538,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38374,4344,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.362600341,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38376,4344,1725,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,Enzyme,Q08209,PPP3CA,PP2BA_HUMAN,5.958488887,,IC50,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38377,4392,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.620150821,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38379,4392,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.581532979,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38380,4392,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,4.639236234,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38381,4392,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.321208566,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38382,4392,617,C-X-C chemokine receptor type 2,GPCR,P25025,CXCR2,CXCR2_HUMAN,5.024062958,,Ki,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38384,4392,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.029327757,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38385,4392,798,C-C chemokine receptor type 2,GPCR,P41597,CCR2,CCR2_HUMAN,5.154158093,,Ki,DRUGMATRIX: Chemokine CCR2B  radioligand binding (ligand: [125I] MCP-1),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38387,4392,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.334982175,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38388,4392,48,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,D2WKD8,ATP1A2,AT1A2_PIG,5.025626493,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",DRUG MATRIX,=,,,,,,,,,,Sus scrofa
38389,4392,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,5.219322726,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38391,4411,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.117760152,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38393,4411,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.156767222,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38395,4411,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.886056648,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38397,4411,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.307593765,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38399,4411,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.97674754,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38401,4411,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.914709422,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38403,4411,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.677160727,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38407,4411,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.084705717,,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38409,4411,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.477555766,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38411,4411,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.604324215,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38413,4411,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.262012674,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38415,4411,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.559090918,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38417,4411,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.125518182,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38419,4411,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.131355562,,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38421,4411,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,4.780546463,,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38423,4411,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.064845553,,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38425,4411,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,4.930887149,,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38427,4425,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.823908741,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38428,4425,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.018181393,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38429,4425,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.652279783,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38430,4425,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,6.092051478,,Ki,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38432,4425,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,6.603800653,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38434,4425,1718,Melanocortin receptor 3,GPCR,P41968,MC3R,MC3R_HUMAN,6.774690718,,Ki,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38436,4452,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.179142011,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1159650,AGONIST,,Tclin,,,Homo sapiens
38438,4452,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.599116784,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38440,4452,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,8.818156412,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
38442,4485,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.536107011,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200545,AGONIST,,Tclin,,,Homo sapiens
38444,4485,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.823908741,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
38446,4507,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.135488919,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200845,AGONIST,,Tclin,,,Homo sapiens
38448,4507,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,6.229147988,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
38450,4507,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,9.91721463,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
38452,4536,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,5.496481687,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38453,4536,1708,Beta-lactamase 1,Enzyme,P10424,penPC,BLA1_BACCE,5.222283261,,IC50,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),DRUG MATRIX,=,,,,,,,,,,Bacillus cereus
38454,4667,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.932185489,,Ki,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38456,4667,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.775725986,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38458,4667,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.865504144,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38460,4667,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.779107751,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38462,4667,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.248105312,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38464,4667,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.428291168,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200762,AGONIST,,Tclin,,,Homo sapiens
38466,4704,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.744004273,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38468,4706,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.074172425,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
94138,576,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,5.4,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
38470,4706,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.623605558,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38471,4706,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.090979146,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38472,4728,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.573488739,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38473,4728,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,7.259637311,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38474,4728,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6.15490196,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38475,4728,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38476,4733,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.698970004,,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38478,4733,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.970616222,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38480,4733,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.034798299,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38482,4733,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.559720787,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38484,4733,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.070581074,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38486,4733,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.537602002,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38488,4733,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.135488919,,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38490,4733,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.522878745,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38491,4733,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.718058067,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38493,4733,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,6.111259039,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38494,4794,457,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,5.736363931,,Ki,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38496,4794,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.960982678,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38497,4794,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.477425367,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38498,4794,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.111259039,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38499,4794,931,Substance-K receptor,GPCR,P21452,TACR2,NK2R_HUMAN,5.817870786,,Ki,DRUGMATRIX: Tachykinin NK2  radioligand binding (ligand: [3H] SR-48968),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
38501,4794,48,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,D2WKD8,ATP1A2,AT1A2_PIG,5.288783476,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",DRUG MATRIX,=,,,,,,,,,,Sus scrofa
38502,4794,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,5.496754229,,Ki,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38504,4794,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,5.72399801,,Ki,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
181117,1960,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.18,,Ki,Binding affinity for human Alpha-2A adrenergic receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,AGONIST,,Tclin,,,Homo sapiens
181118,1960,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.82,,Ki,Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,AGONIST,,Tclin,,,Homo sapiens
181119,626,328,"Nitric oxide synthase, inducible",Enzyme,P35228,NOS2,NOS2_HUMAN,4.85,,IC50,Inhibitory activity against Inducible nitric oxide synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1371,,,,Tchem,,,Homo sapiens
181120,626,809,"Nitric oxide synthase, brain",Enzyme,P29475,NOS1,NOS1_HUMAN,4.3,,IC50,Inhibitory activity against Neuronal nitric oxide synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1371,,,,Tchem,,,Homo sapiens
181121,626,885,"Nitric oxide synthase, endothelial",Enzyme,P29474,NOS3,NOS3_HUMAN,5.06,,IC50,Inhibitory activity against Endothelial nitric oxide synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1371,,,,Tchem,,,Homo sapiens
181122,1563,1364,Synaptic vesicle glycoprotein 2A,Transporter,Q7L0J3,SV2A,SV2A_HUMAN,6.099999904632568,,Ki,Mechanism of Action; CHEMBL1998; SINGLE PROTEIN,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1286,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1286,MODULATOR,,Tclin,480,480,Homo sapiens
181124,2308,2635,Type I iodothyronine deiodinase,Enzyme,P49895,DIO1,IOD1_HUMAN,,,,Mechanism of Action; CHEMBL2019; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1518,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1518,INHIBITOR,,Tclin,,,Homo sapiens
181125,1264,2030,Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit,Ion channel,O77773,CACNA2D1,O77773_PIG,7.15,,IC50,Displacement of [3H]gabapentin from alpha-2delta calcium channel in pig brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940,,,,,,,Sus scrofa
181126,1264,2029,Voltage-dependent calcium channel subunit alpha-2/delta-1,Ion channel,O08532,Cacna2d1,CA2D1_MOUSE,6.92,,Ki,Displacement of [3H]L-leucine from alpha-2delta containing calcium channel in murine brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940,,,,,,,Mus musculus
181127,3521,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,6.39,,IC50,In vitro inhibitory concentration against Monoamine oxidase A of rat brain homogenates; value ranges from 0.28-0.54,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL887,,,,,,,Rattus norvegicus
181128,3521,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.01,,Ki,Binding affinity towards monoamine oxidase A activity was measured using a kynuramine assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL887,,,,Tclin,,,Homo sapiens
181129,3521,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,8.36,,IC50,In vitro inhibitory concentration against Monoamine oxidase B of rat brain homogenates; value ranges from 0.0035-0.053,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL887,,,,,,,Rattus norvegicus
181130,3521,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,6.15,,Ki,Binding affinity towards monoamine oxidase B activity was measured using a benzylamine assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL887,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL887,INHIBITOR,,Tclin,,,Homo sapiens
181131,1683,1634,Trypanothione reductase,Enzyme,P28593,TPR,TYTR_TRYCR,4.26,,IC50,Concentration required for inhibition of Trypanothione reductase (TcTR) from Trypanosoma cruzi in the presence of 50 uM TS2 as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590,,,,,,,Trypanosoma cruzi
181132,1683,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,4.59,,Ki,Competitive inhibition of human recombinant MAO-A expressed in baculovirus infected insect cells using p-tyramine as substrate by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590,,,,Tclin,,,Homo sapiens
181133,1683,152,"Glutathione reductase, mitochondrial",Enzyme,P00390,GSR,GSHR_HUMAN,4.92,,Ki,Inhibitory concentration against human glutathione reductase (In presence of glutathione disulfide),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590,,,,Tclin,,,Homo sapiens
181134,1683,3422,Dual specificity phosphatase Cdc25C,Enzyme,P30307,CDC25C,MPIP3_HUMAN,4.73,,IC50,Inhibitory concentration for human cell division cycle 25 degree C phosphatase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590,,,,Tchem,,,Homo sapiens
181135,1683,886,M-phase inducer phosphatase 2,Enzyme,P30305,CDC25B,MPIP2_HUMAN,5.66,,IC50,"Inhibition of MBP-fused recombinant wild type CDC25B3 using fluorescein 3,6 diphosphate as substrate measured for 30 mins in presence of 1 mM dithiothreitol",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590,,,,Tchem,,,Homo sapiens
181136,1683,3534,Dual specificity protein phosphatase 6,Unclassified,Q64346,Dusp6,DUS6_RAT,4.69,,IC50,Inhibition of histidine-tagged rat recombinant MKP3 catalytic domain expressed in Escherichia coli BL21(DE3),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590,,,,,,,Rattus norvegicus
181137,1683,3423,Ubiquitin carboxyl-terminal hydrolase isozyme L3,Enzyme,P15374,UCHL3,UCHL3_HUMAN,4.15,,IC50,Inhibition of UCHL3 in human H1299 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590,,,,Tchem,,,Homo sapiens
181138,1683,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,6.4,,Ki,Competitive inhibition of human recombinant MAO-B expressed in baculovirus infected insect cells using benzylamine as substrate by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590,,,,Tclin,,,Homo sapiens
181139,1683,3535,Dual specificity protein phosphatase 1,Unclassified,P28563,Dusp1,DUS1_MOUSE,4.62,,IC50,Inhibition of histidine-tagged mouse MKP1 catalytic domain expressed in human Hela cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590,,,,,,,Mus musculus
181140,1683,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,6,,IC50,Inhibition of purified human recombinant IDO,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590,,,,Tchem,,,Homo sapiens
181141,2521,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,6.52,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Stylophora pistillata
181142,2521,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,6.74,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Thalassiosira weissflogii
181143,2521,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,4.49,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181144,2521,2428,Carbonic anhydrase 2,Unclassified,Q3I4V7,CAN2,Q3I4V7_CRYNV,6.11,,Ki,Inhibition of Cryptococcus neoformans recombinant Can2 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Cryptococcus neoformans var. grubii
181145,2521,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,4.73,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
181146,2521,2611,Carbonic anhydrase 2,Enzyme,P00921,CA2,CAH2_BOVIN,6.07,,Ki,Binding affinity to bovine carbonic anhydrase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Bos taurus
181147,2521,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.62,,Ki,Ki value against human carbonic anhydrase II,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181148,2521,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.27,,Ki,Inhibitory constant against human carbonic anhydrase XIV in CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181149,2521,2010,Carbonic anhydrase,Enzyme,Q50565,,Q50565_METTH,4.24,,Ki,Inhibitory activity against beta carbonic anhydrase (Cab) from Methanobacterium thermoautotrophicum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H)
181150,2521,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,7.15,,Ki,Ki value against human carbonic anhydrase VII,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181151,2521,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,7.49,,Ki,Inhibitory activity against murine carbonic anhydrase XIII (mCA XIII) by using CO2 hydrase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Mus musculus
181152,2521,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,7.43,,Ki,Inhibitory constant against catalytic domain of human carbonic anhydrase XII,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181153,2521,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,6.62,,Ki,Inhibition of catalytic domain of human recombinant CA IX,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181154,2521,401,Carbonic anhydrase,Enzyme,O24855,cynT,CYNT_HELPY,6.37,,Ki,Inhibition of Helicobacter pylori recombinant CA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
181155,2521,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,5.02,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Mus musculus
181156,2521,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,6.44,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Stylophora pistillata
181157,2521,2143,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878,,P96878_MYCTU,5.2,,Ki,Inhibition of Mycobacterium tuberculosis recombinant beta-carbonic anhydrase Rv3273 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181158,2521,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.52,,Ki,"Inhibition of cloned isozyme, human carbonic anhydrase IV",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181159,2521,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.52,,Ki,Inhibition of human carbonic anhydrase 1-catalyzed CO2 hydration preincubated for 10 mins by stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181160,2521,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,5.11,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Astrosclera willeyana
181161,2521,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.44,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181162,2521,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,6.01,,Ki,Inhibition of human recombinant CA3 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181163,2521,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,6.62,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
181164,2521,2009,Carbonic anhydrase,Enzyme,P40881,,CAH_METTE,6.6,,Ki,Inhibitory activity against alpha carbonic anhydrase (Zn-Cam) from Methanosarcina thermophila,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Methanosarcina thermophila
181165,2521,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,5.03,,Ki,Inhibition of Mycobacterium tuberculosis recombinant beta-carbonic anhydrase Rv1284 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181166,2521,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,4.53,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181167,2521,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,7.49,,Ki,Inhibition of human recombinant CA13 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181168,2521,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,6.03,,Ki,Inhibition of full length human recombinant CA VI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,Tclin,,,Homo sapiens
181169,2521,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,5.52,,Ki,"Inhibition constant against bovine Carbonic anhydrase IV, isolated from lung microsomes",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Bos taurus
181170,2521,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,INHIBITOR,,,,,Escherichia coli (strain K12)
181171,1549,328,"Nitric oxide synthase, inducible",Enzyme,P35228,NOS2,NOS2_HUMAN,5.15,,Kd,Binding affinity to truncated iNOS construct (1-490) by spectral assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1485,,,,Tchem,,,Homo sapiens
181173,1401,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,4.21,,IC50,Compound was tested for inhibitory concentration against rat lens aldose reductase (noncompetitive inhibition type),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12208,,,,,,,Rattus norvegicus
181174,1401,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.09,,Ki,Inhibition of human recombinant CA12 after 6 hrs by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12208,,,,Tclin,,,Homo sapiens
181175,1401,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,6.25,,Ki,Inhibition of human recombinant CA9 after 6 hrs by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12208,,,,Tclin,,,Homo sapiens
181176,1401,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,4.09,,IC50,Inhibition of human recombinant MAOB by fluorimetric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12208,,,,Tclin,,,Homo sapiens
181370,2551,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,7.74,,Kd,Dissociation constant towards Acetylcholinesterase in mouse,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Mus musculus
181177,1401,895,Testosterone 17-beta-dehydrogenase 3,Enzyme,P37058,HSD17B3,DHB3_HUMAN,6,,IC50,Inhibition of human 17beta-HSD3 expressed in HeLa cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12208,,,,Tchem,,,Homo sapiens
181178,1401,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,4.61,,IC50,Inhibition human recombinant aldose reductase 1 by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12208,,,,Tclin,,,Homo sapiens
181179,2302,1976,Fatty-acid amide hydrolase 1,Enzyme,P97612,Faah,FAAH1_RAT,4.85,,IC50,Inhibition of rat FAAH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526,,,,,,,Rattus norvegicus
181180,2302,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,5.7,,EC50,Potentiation of GABA responses at human Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-2,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
181181,2302,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,5.39,,EC50,GABA-modulatory action compound was evaluated on Oocytes expressing recombinant human alpha-1-beta-3-gamma-2L GABA A receptor at concentrations of >=100 micro<M,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
181182,2302,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,5.4,,IC50,Inhibition of [35S]TBPS binding to GABA-A receptor in rat cerebral cortex.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526,,,,,,,Rattus norvegicus
181183,2302,2760,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,P18507|P47869|P47870,GABRA2|GABRB2|GABRG2,GBRA2_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,4.95,,EC50,Effective concentration against GABA-evoked chloride currents mediated by human Gamma-aminobutyric acid GABA-A receptor alpha2-beta2-gamma2L expressed in Xenopus oocytes,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
181184,1480,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,5.3,,IC50,Inhibition of MAOA in Sprague-Dawley rat brain mitochondria using kynuramine substrate by fluorimetry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL92401,,,,,,,Rattus norvegicus
181185,1480,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.18,,IC50,Inhibition of human recombinant MAOA,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL92401,http://www.ncbi.nlm.nih.gov/pubmed/1101049,INHIBITOR,,Tclin,,385,Homo sapiens
181186,1480,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,5.12,,IC50,Inhibition of MAOB in Sprague-Dawley rat brain mitochondria using kynuramine substrate by fluorimetry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL92401,,,,,,,Rattus norvegicus
181187,1480,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,5.12,,IC50,Inhibition of human recombinant MAOB,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL92401,http://www.ncbi.nlm.nih.gov/pubmed/1101049,INHIBITOR,,Tclin,,385,Homo sapiens
181188,1794,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,4.25,,IC50,Inhibition of human recombinant Nav1.8 channel expressed in HEK293 cells by whole cell voltage clamp technique,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,BLOCKER,,Tclin,,,Homo sapiens
181189,1794,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,4.89,,Ki,Binding affinity to inactivated human sodium channel Nav1.7 expressed in human HEK293 cells by patch-clamp electrophysiological assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,BLOCKER,,Tclin,,,Homo sapiens
181190,1794,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,,,,Tclin,,,Homo sapiens
181191,1794,3536,Sodium channel protein type X alpha subunit,Unclassified,Q62968,Scn10a,SCNAA_RAT,4.51,,IC50,Blockade of Nav1.8 channel in rat dorsal root ganglion neurons assessed as inhibition of TTX-R current by whole cell patch clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,,,,,,,Rattus norvegicus
181192,1794,138,Sodium channel protein type 2 subunit alpha,Ion channel,Q99250,SCN2A,SCN2A_HUMAN,5.54,,IC50,Inhibition of human recombinant Nav1.2 channel expressed in HEK293 cells by whole cell voltage clamp technique,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,BLOCKER,,Tclin,,,Homo sapiens
181193,2383,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.14,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL959,,,,Tchem,,,Homo sapiens
181194,2383,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.36,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL959,,,,Tchem,,,Homo sapiens
181195,2383,2638,Matrix protein 2,Ion channel,P63231,M,M2_I72A2,,,,Mechanism of Action; CHEMBL2052; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL959,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL959,INHIBITOR,,,,,Influenza A virus (strain A/Udorn/307/1972 H3N2)
181196,1679,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.57,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL807,,,,Tchem,,,Homo sapiens
181197,1679,1839,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,Q00961,Grin2c,NMDE3_RAT,6.15,,Ki,Compound with the N-methyl-D-aspartate glutamate receptor blocking activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL807,,,,,,,Rattus norvegicus
94139,576,1886,Somatostatin receptor type 4,GPCR,P31391,SSTR4,SSR4_HUMAN,4.3,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
181198,1679,2816,Glutamate NMDA receptor; GRIN1/GRIN2B,Ion channel,Q05586|Q13224,GRIN1|GRIN2B,NMDE2_HUMAN|NMDZ1_HUMAN,5.26,,IC50,Inhibition of dexamethasone-induced human NR1-1a/NR2B receptor-mediated excitotoxicity in (S)-glutamate/glycine-stimulated mouse L13-E6 cells assessed as LDH release after 30 mins,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL807,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL807,NEGATIVE ALLOSTERIC MODULATOR,,Tclin|Tclin,,,Homo sapiens
181199,1679,2817,Glutamate NMDA receptor; GRIN1/GRIN2A,Ion channel,Q05586|Q12879,GRIN1|GRIN2A,NMDE1_HUMAN|NMDZ1_HUMAN,9.02,,IC50,Antagonist activity at recombinant GluN1/GluN2A receptor (unknown origin) expressed in Xenopus laevis oocytes assessed as inhibition of glycine/glutamate-induced inward current at -70mV by two-electrode voltage clamp assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL807,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL807,NEGATIVE ALLOSTERIC MODULATOR,,Tclin|Tclin,,,Homo sapiens
181200,1679,629,"Glutamate receptor ionotropic, NMDA 1",Ion channel,Q05586,GRIN1,NMDZ1_HUMAN,5.02,,IC50,Inhibition of NMDA NR1/NR2B receptor expressed in xenopus oocytes assessed as inhibition of NMDA and glycine-induced current response by two-electrode voltage clamp assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL807,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL807,NEGATIVE ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
181201,3114,987,Methionine aminopeptidase 2,Enzyme,P50579,METAP2,MAP2_HUMAN,5.9,,IC50,Inhibition of human methionine aminopeptidase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225164,,,,Tchem,,,Homo sapiens
181202,3114,2309,Methionine aminopeptidase 1,Enzyme,P53582,METAP1,MAP11_HUMAN,4.89,,IC50,Inhibition of human methionine aminopeptidase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225164,,,,Tchem,,,Homo sapiens
181203,3114,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,4.63,,IC50,Inhibition of Sprague-Dawley rat liver COMT after 10 mins using 0.05 uCi [14CH3]-SAM as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225164,,,,,,,Rattus norvegicus
181204,74,562,Gamma-glutamyltranspeptidase 1,Enzyme,P19440,GGT1,GGT1_HUMAN,4.44,,IC50,Inhibition of gamma-glutamyltranspeptidase by colorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25,,,,Tbio,,,Homo sapiens
181205,74,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,6.46,,IC50,Inhibition of bovine COX-1 by enzyme immuno assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25,,,,,,,Bos taurus
181206,74,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,5.62,,IC50,In vitro inhibition of ovine prostaglandin G/H synthase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25,,,,,,,Ovis aries
181207,74,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,6.52,,IC50,In vitro inhibitory concentration against COX-1 enzyme,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25,,,,,,,Ovis aries
181208,2620,147,Adenosine receptor A2b,GPCR,P29275,ADORA2B,AA2BR_HUMAN,5.57,,Ki,Displacement of [3H]DPCPX from human recombinant adenosine A2B receptor expressed in HEK293 cell membrane,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,ANTAGONIST,,Tclin,,,Homo sapiens
181209,2620,704,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,4.12,,IC50,Inhibition of PI3Kdelta (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,Tclin,,,Homo sapiens
181210,2620,1958,Adenosine receptor A1,GPCR,P28190,ADORA1,AA1R_BOVIN,5.42,,Ki,Binding affinity towards adenosine A1 receptor of bovine brain membrane using [3H]-CHA at 20 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,,,,Bos taurus
181211,2620,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,7.85,,Ki,Binding affinity for adenosine A3 receptor by displacement of specific binding of [125I]AB-MECA in membranes from CHO-A3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,ANTAGONIST,,Tchem,,,Homo sapiens
181212,2620,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,6.15,,Ki,Inhibition of [3H]-CHA binding to rat brain membrane Adenosine A1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,,,,Rattus norvegicus
181213,2620,3537,Adenosine A2a receptor,Unclassified,P46616,ADORA2A,AA2AR_CAVPO,4.89,,Ki,Antagonist binding of N6-cyclohexyl-[3H]-adenosine to guinea pig brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,,,,Cavia porcellus
181214,2620,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,5.17,,Ki,Binding affinity at rat Adenosine A2A receptor by [3H]-CGS- 21680 displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,,,,Rattus norvegicus
181215,2620,2839,Adenosine A2 receptor,GPCR,P29276|P30543,Adora2a|Adora2b,AA2AR_RAT|AA2BR_RAT,5.88,,Ki,Binding of Adenosine A2 receptor in whole rat brain membrane using [3H]CHA as a Radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,,,,Rattus norvegicus
181217,2620,3427,Heart phosphodiesterase,Enzyme,E1BN64|P14100|Q01061,PDE1A|PDE1B|PDE3B,E1BN64_BOVIN|PDE1A_BOVIN|PDE1B_BOVIN,4.04,,IC50,Inhibition of bovine heart phosphodiesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,,,,Bos taurus
181218,2620,1938,Adenosine receptor A3,GPCR,P28647,Adora3,AA3R_RAT,4.07,,Ki,Binding affinity to rat adenosine A3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,,,,Rattus norvegicus
181219,2620,1914,Uncharacterized protein,Enzyme,E1BN64,PDE3B,E1BN64_BOVIN,4.11,,Ki,Inhibition of bovine heart phosphodiesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,,,,Bos taurus
181220,2620,3424,Adenosine A2b receptor,GPCR,P29276,Adora2b,AA2BR_RAT,4.82,,Ki,Inhibition of [125I]-APOBX binding to rat Adenosine A2B receptor expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,,,,Rattus norvegicus
181221,2620,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,9.22,,Ki,Binding affinity for adenosine A2a receptor by using as [3H]ZM-241385 radioligand in membranes from HEK-A2A cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,ANTAGONIST,,Tclin,,,Homo sapiens
181222,2620,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,9.22,,Ki,Binding affinity for adenosine A1 receptor by using as [3H]CPX iradioligand n membranes from Chinese hamster ovary cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,ANTAGONIST,,Tclin,,,Homo sapiens
181223,2620,491,"Alkaline phosphatase, tissue-nonspecific isozyme",Enzyme,P05186,ALPL,PPBT_HUMAN,4.09,,Ki,Inhibition of TNSALP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,Tchem,,,Homo sapiens
181224,2620,1959,Adenosine receptor A1,GPCR,P47745,ADORA1,AA1R_CAVPO,5.01,,Ki,Affinity against adenosine A1 receptor in the brain membranes by the displacement of [3H]CPX.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,,,,Cavia porcellus
181225,2620,3425,Adenosine receptor,GPCR,P25099|P28647|P29276|P30543,Adora1|Adora2a|Adora2b|Adora3,AA1R_RAT|AA2AR_RAT|AA2BR_RAT|AA3R_RAT,4.7,,Ki,Antagonist binding of N6-cyclohexyl-[3H]-adenosine to rat testes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190,,,,,,,Rattus norvegicus
181226,2381,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.37,,Ki,Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289480,,,,Tclin,,,Homo sapiens
181227,2381,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.9,,Ki,Displacement of [3H]RX821001 from human alpha2C adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289480,,,,Tclin,,,Homo sapiens
181228,2381,2116,Nischarin,Unclassified,Q4G017,Nisch,NISCH_RAT,7.95,,Ki,Displacement of [3H]paraiodoclonidine from imidazoline I1 receptor in rat PC12 cells after 30 mins by gamma counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289480,,,,,,,Rattus norvegicus
181229,2381,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,7.23,,Ki,Displacement of [125I]PIC from human imidazoline receptor 1 in human platelets analyzed under norepinephrine mask of alpha 2AR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289480,,,,Tclin,,,Homo sapiens
181230,2381,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.44,,Ki,Displacement of [3H]RX821001 from human alpha2A adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289480,,,,Tclin,,,Homo sapiens
181231,38,2778,Glutamate [NMDA] receptor,Ion channel,O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,NMD3A_HUMAN|NMD3B_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMDE4_HUMAN|NMDZ1_HUMAN,,,,Mechanism of Action; CHEMBL2094124; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201293,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201293,ANTAGONIST,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181232,2330,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,4.71,,Ki,Inhibitory activity against Acetylcholinesterase (AChE),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL812,,,,,,,Bos taurus
181233,2330,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,6.44,,IC50,Inhibition of human whole RBC AChE pretreated for 30 mins by Ellman technique,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL812,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL812,INHIBITOR,,Tclin,,,Homo sapiens
181234,2330,955,Acetylcholinesterase,Enzyme,P04058,ache,ACES_TORCA,7.09,,IC50,Inhibition of Torpedo californica eel AChE using acetylthiocholine/DTNB as substrate preincubated for 10 mins followed by substrate addition measured every 30 secs for 30 mins by Ellmans method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL812,,,,,,,Torpedo californica
181235,2330,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,5.46,,Ki,Inhibition of anticholinesterase activity by their ability to inactivate human serum butyrylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL812,,,,Tclin,,,Homo sapiens
181236,990,3538,Ornithine decarboxylase,Unclassified,P09057,Odc1,DCOR_RAT,4.41,,Ki,The apparent dissociation constant for irreversible inhibition of rat liver ornithine decarboxylase (ODC),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL830,,,,,,,Rattus norvegicus
181237,1028,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.89,,Ki,Binding of [3H]clonidine to alpha-2-adrenergic receptor of rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,,,,,,,Rattus norvegicus
181238,1028,1824,Beta-2 adrenergic receptor,GPCR,P54833,ADRB2,ADRB2_CANFA,6.18,,Ki,Binding of [3H]dihydroalprenolol to beta-2 adrenergic receptor of rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,,,,,,,Canis familiaris
181239,1028,2893,Adrenergic receptor beta,GPCR,P10608|P18090|P26255,Adrb1|Adrb2|Adrb3,ADRB1_RAT|ADRB2_RAT|ADRB3_RAT,4.54,,IC50,Binding affinity against Beta adrenergic receptor using [3H]dihydroalprenolol radioligand in rat brain homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,,,,,,,Rattus norvegicus
181240,1028,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,4.26,,Kd,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,,,,Tclin,,,Homo sapiens
181241,1028,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,5.4,,Ki,Compound was evaluated for binding affinity towards mu-specific opiate receptor from combinatorial peptoid library,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,,,,,,,Rattus norvegicus
181242,1028,1803,Beta-1 adrenergic receptor,GPCR,P18090,Adrb1,ADRB1_RAT,5.96,,Ki,Binding of [3H]dihydroalprenolol to beta-1 adrenergic receptor of rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,,,,,,,Rattus norvegicus
181243,1028,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.2,,Kd,Binding affinity to human adrenergic beta2 receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,AGONIST,,Tclin,,,Homo sapiens
181244,1028,1880,Beta-2 adrenergic receptor,GPCR,P10608,Adrb2,ADRB2_RAT,6.14,,Ki,Binding affinity against adrenergic beta 2 receptor versus 1 nM [3H]dihydroalprenolol in rat cerebral cerebellar membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,,,,,,,Rattus norvegicus
181245,1028,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,5.52,,Ki,Binding affinity against beta-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of Dihydro-[3H]-alprenolol,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,,,,,,,Cavia porcellus
181246,1028,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.7,,Ki,Binding affinity against alpha-1 adrenergic receptor in guinea pig cerebral cortical membranes by displacement of [3H]- WB-4101,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,AGONIST,,Tclin,,,Homo sapiens
181247,1494,2041,Lysosomal protective protein,Enzyme,P10619,CTSA,PPGB_HUMAN,5,,IC50,Inhibition of recombinant CatA using [14C]GS-7340 substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1025,,,,Tchem,,,Homo sapiens
181248,1494,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.22,,Ki,Inhibition of human AChE assessed as equilibrium binding by modified Ellman's spectrophotometric method,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1025,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1025,INHIBITOR,,Tclin,,,Homo sapiens
181249,1494,955,Acetylcholinesterase,Enzyme,P04058,ache,ACES_TORCA,4.15,,Kd,Inhibition of Torpedo californica AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1025,,,,,,,Torpedo californica
181250,1494,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,6.32,,IC50,In vitro inhibitory activity against acetylcholinesterase from electric eel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1025,,,,,,,Electrophorus electricus
181251,1494,2042,Liver carboxylesterase,Enzyme,Q29550,,EST1_PIG,7.3,,IC50,Inhibition of porcine liver carboxylesterase using [14C]GS-7340 substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1025,,,,,,,Sus scrofa
181252,3362,1820,S-adenosylmethionine decarboxylase proenzyme,Enzyme,P17708,Amd1,DCAM_RAT,6,,IC50,Inhibitory concentration of compound against S-Adenosyl-methionine decarboxylase (SAMDC) from rat liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL216913,,,,,,,Rattus norvegicus
181253,3362,1821,Amiloride-sensitive amine oxidase [copper-containing],Enzyme,P36633,Aoc1,AOC1_RAT,5.82,,IC50,In vitro inhibition of Diamine oxidase (DAO) from rat small intestine.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL216913,,,,,,,Rattus norvegicus
181254,1493,2746,Glycine receptor (alpha-1/beta),Ion channel,P23415|P48167,GLRA1|GLRB,GLRA1_HUMAN|GLRB_HUMAN,,,,Mechanism of Action; CHEMBL2363052; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,POSITIVE MODULATOR,,Tclin|Tclin,,,Homo sapiens
181255,1493,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,,,,Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181256,1493,1680,Potassium channel subfamily K member 10,Ion channel,P57789,KCNK10,KCNKA_HUMAN,,,,Mechanism of Action; CHEMBL2331041; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,OPENER,,Tclin,,,Homo sapiens
181257,1493,1692,Potassium channel subfamily K member 18,Ion channel,Q7Z418,KCNK18,KCNKI_HUMAN,,,,Mechanism of Action; CHEMBL2331042; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,OPENER,,Tclin,,,Homo sapiens
181258,1493,641,Potassium channel subfamily K member 3,Ion channel,O14649,KCNK3,KCNK3_HUMAN,,,,Mechanism of Action; CHEMBL2321613; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,OPENER,,Tclin,,,Homo sapiens
181259,1493,642,Potassium channel subfamily K member 9,Ion channel,Q9NPC2,KCNK9,KCNK9_HUMAN,,,,Mechanism of Action; CHEMBL2321614; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,OPENER,,Tclin,,,Homo sapiens
181260,1493,397,Potassium channel subfamily K member 2,Ion channel,O95069,KCNK2,KCNK2_HUMAN,,,,Mechanism of Action; CHEMBL2321615; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256,OPENER,,Tclin,,,Homo sapiens
181261,1009,1680,Potassium channel subfamily K member 10,Ion channel,P57789,KCNK10,KCNKA_HUMAN,,,,Mechanism of Action; CHEMBL2331041; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,OPENER,,Tclin,,,Homo sapiens
181262,1009,1692,Potassium channel subfamily K member 18,Ion channel,Q7Z418,KCNK18,KCNKI_HUMAN,,,,Mechanism of Action; CHEMBL2331042; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,OPENER,,Tclin,,,Homo sapiens
181263,1009,641,Potassium channel subfamily K member 3,Ion channel,O14649,KCNK3,KCNK3_HUMAN,,,,Mechanism of Action; CHEMBL2321613; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,OPENER,,Tclin,,,Homo sapiens
181264,1009,642,Potassium channel subfamily K member 9,Ion channel,Q9NPC2,KCNK9,KCNK9_HUMAN,,,,Mechanism of Action; CHEMBL2321614; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,OPENER,,Tclin,,,Homo sapiens
181265,1009,397,Potassium channel subfamily K member 2,Ion channel,O95069,KCNK2,KCNK2_HUMAN,,,,Mechanism of Action; CHEMBL2321615; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,OPENER,,Tclin,,,Homo sapiens
181266,2427,2594,3-oxoacyl-[acyl-carrier-protein] synthase 3,Enzyme,C3TDZ2,fabH,C3TDZ2_ECOLX,4.55,,IC50,Inhibition of N-terminal His-tagged Escherichia coli FabH expressed in Escherichia coli BL21 (DE3) using [3H]acetyl-coA after 25 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL498847,,,,,,,Escherichia coli
181267,1624,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,6.29,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Stylophora pistillata
181268,1624,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,6.37,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Thalassiosira weissflogii
181269,1624,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,4.56,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,Tclin,,,Homo sapiens
181270,1624,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,6.36,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
181271,1624,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.77,,Ki,Inhibitory activity against human carbonic anhydrase II (hCA II) by using esterase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,Tclin,,,Homo sapiens
181272,1624,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.49,,Ki,Inhibitory constant against human carbonic anhydrase XIV in CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,Tclin,,,Homo sapiens
181273,1624,2010,Carbonic anhydrase,Enzyme,Q50565,,Q50565_METTH,4.55,,Ki,Inhibitory activity against beta carbonic anhydrase (Cab) from Methanobacterium thermoautotrophicum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H)
181274,1624,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,7.12,,Ki,Ki value against human carbonic anhydrase VII,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,Tclin,,,Homo sapiens
181275,1624,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,7.39,,Ki,Inhibitory activity against murine carbonic anhydrase XIII (mCA XIII) by using CO2 hydrase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Mus musculus
181276,1624,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,9.52,,Ki,Inhibitory constant against catalytic domain of human carbonic anhydrase XII,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,Tclin,,,Homo sapiens
181277,1624,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,6.99,,Ki,Inhibitory activity against human carbonic anhydrase IX (hCA IX) by using CO2 hydrase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,Tclin,,,Homo sapiens
181278,1624,401,Carbonic anhydrase,Enzyme,O24855,cynT,CYNT_HELPY,6.08,,Ki,Inhibition of Helicobacter pylori recombinant CA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
181279,1624,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,6.01,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Mus musculus
181280,1624,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,7.08,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Stylophora pistillata
181281,1624,2143,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878,,P96878_MYCTU,5.13,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase Rv3273 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181282,1624,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.55,,Ki,"Inhibition of cloned isozyme, human carbonic anhydrase IV",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,Tclin,,,Homo sapiens
181283,1624,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.77,,Ki,Inhibition of human carbonic anhydrase 1-catalyzed CO2 hydration preincubated for 10 mins by stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,Tclin,,,Homo sapiens
181284,1624,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,6.01,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Astrosclera willeyana
181285,1624,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,4.91,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,Tclin,,,Homo sapiens
181286,1624,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,6.77,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
181287,1624,2009,Carbonic anhydrase,Enzyme,P40881,,CAH_METTE,6.46,,Ki,Inhibitory activity against alpha carbonic anhydrase (Zn-Cam) from Methanosarcina thermophila,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Methanosarcina thermophila
181288,1624,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,5.06,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181289,1624,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,4.51,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181290,1624,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,5.32,,Ki,Inhibition of full length human recombinant CA VI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,Tclin,,,Homo sapiens
181291,1624,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,5.55,,Ki,Inhibition of bovine membrane bound isozyme carbonic anhydrase IV isolated from microsomes at 20 degree C,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Bos taurus
181292,1624,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,INHIBITOR,,,,,Escherichia coli (strain K12)
181293,497,3415,Lactoperoxidase,Enzyme,P22079,LPO,PERL_HUMAN,4.98,,IC50,"Inhibition of lactoperoxidase-catalyzed iodination of L-tyrosine assessed as 3,5-diiodo-L-tyrosine formation by HPLC",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508102,,,,Tbio,,,Homo sapiens
181294,201,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,4.39,,IC50,Inhibition of canine heart Phosphodiesterase 4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12856,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181295,2429,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,4.98,,Ki,Competitive inhibition of rat liver MAO-A after 60 mins using p-tyramine as substrate by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL972,,,,,,,Rattus norvegicus
182971,1812,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.07,,IC50,Inhibition of AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL278819,,,,Tclin,,,Homo sapiens
181296,2429,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.04,,Ki,Inhibition of human MAO-A expressed in BTI insect cells using p-tyramine as substrate after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL972,,,,Tclin,,,Homo sapiens
181297,2429,1901,Amine oxidase [flavin-containing] A,Enzyme,P21398,MAOA,AOFA_BOVIN,5.42,,Ki,Inhibition of bovine brain mitochondria MAOA by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL972,,,,,,,Bos taurus
181298,2429,1902,Amine oxidase [flavin-containing] B,Enzyme,P56560,MAOB,AOFB_BOVIN,6.01,,Ki,Inhibitory activity against monoamine oxidase B in isolated bovine brain mitochondria,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL972,,,,,,,Bos taurus
181299,2429,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,7.26,,Ki,Irreversible inhibition of recombinant human MAO-B expressed in baculovirus infected BT1 cells using benzylamine as substrate at 200 uM preincubated for 30 mins by Lineweaver-Burk plot analysis,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL972,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL972,INHIBITOR,,Tclin,,,Homo sapiens
181300,2429,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,5.87,,Ki,Inhibition of MAO-B in rat liver homogenate after 60 mins by Lineweaver-Burke plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL972,,,,,,,Rattus norvegicus
181301,2429,2905,Monoamine oxidase,Enzyme,P19643|P21396,Maoa|Maob,AOFA_RAT|AOFB_RAT,7.89,,IC50,In vitro inhibition of Monoamine oxidase at rat hyphalamic mitochondrial PEA by displacing 2.5 uM of [14C]PEA.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL972,,,,,,,Rattus norvegicus
181302,2139,3421,Voltage-gated T-type calcium channel,Ion channel,O43497|O95180|Q9P0X4,CACNA1G|CACNA1H|CACNA1I,CAC1G_HUMAN|CAC1H_HUMAN|CAC1I_HUMAN,,,,Mechanism of Action; CHEMBL2362995; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL797,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL797,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
181303,3068,2642,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",Enzyme,P31327,CPS1,CPSM_HUMAN,,,,Mechanism of Action; CHEMBL2362990; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201780,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201780,POSITIVE ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
181304,1954,987,Methionine aminopeptidase 2,Enzyme,P50579,METAP2,MAP2_HUMAN,7.26,,IC50,Inhibition of human methionine aminopeptidase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1454910,,,,Tchem,,,Homo sapiens
181305,1954,733,Cathepsin B,Enzyme,P07858,CTSB,CATB_HUMAN,4.4,,Ki,Mixed inhibition of cathepsin B (unknown origin) endopeptidase activity assessed as inhibition constant for enzyme-substrate-inhibitor complex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1454910,,,,Tchem,,,Homo sapiens
181306,1954,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,4.7,,IC50,Inhibition of Sprague-Dawley rat liver COMT after 10 mins using 0.05 uCi [14CH3]-SAM as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1454910,,,,,,,Rattus norvegicus
181307,1954,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6,,Ki,Inhibition of COX-2 (unknown origin) using arachidonic acid as substrate assessed as formation of prostanoid products preincubated for 10 mins prior to substrate addition measured after 2 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1454910,,,,Tclin,,,Homo sapiens
181308,1506,2827,Soluble guanylate cyclase,Enzyme,O75343|P33402|Q02108|Q02153,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,GCYA2_HUMAN|GCYA3_HUMAN|GCYB1_HUMAN|GCYB2_HUMAN,,,,Mechanism of Action; CHEMBL2111348; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1311,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1311,ACTIVATOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181309,2122,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,4.9,,Kd,Binding affinity to 5HT1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1744,,,,Tclin,,,Homo sapiens
181310,2122,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,,,,Mechanism of Action; CHEMBL238; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1744,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1744,INHIBITOR,,Tclin,,,Homo sapiens
181311,2122,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,Mechanism of Action; CHEMBL222; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1744,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1744,INHIBITOR,,Tclin,,,Homo sapiens
181312,666,2027,3-dehydroquinate dehydratase,Enzyme,Q48255,aroQ,AROQ_HELPY,5.6,,Kd,Binding affinity for Helicobacter pylori DHQase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1261,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
181313,666,2028,3-dehydroquinate dehydratase,Enzyme,P15474,aroQ,AROQ_STRCO,5.14,,Kd,Binding affinity for Streptomyces coelicolor DHQase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1261,,,,,,,Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145)
181314,3293,1738,Prostaglandin G/H synthase 2,Enzyme,Q05769,Ptgs2,PGH2_MOUSE,5.26,,IC50,Inhibition of mouse COX2-mediated 2-arachidonoylglycerol oxygenation preincubated for 3 mins before 2-arachidonoylglycerol addition measured after 30 seconds,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL341812,,,,,,,Mus musculus
181315,3536,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.22,,IC50,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134641,,,,Tclin,,,Homo sapiens
181316,3536,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.24,,EC50,Partial agonist activity at human M4 receptor co-expressed with Galpha16 in CHO cells assessed as calcium mobilization after 60 mins by FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134641,,,,Tclin,,,Homo sapiens
181317,3536,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.74,,IC50,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M2",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134641,,,,Tclin,,,Homo sapiens
181318,3536,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,7.85,,IC50,In vitro affinity evaluated using [3H]- oxotremorine as radioligand in rat cerebral cortex for muscarinic acetylcholine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134641,,,,,,,Rattus norvegicus
94157,588,730,Cathepsin D,Enzyme,P07339,CTSD,CATD_HUMAN,8.93,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
181319,3536,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.77,,IC50,In vitro affinity against human Muscarinic acetylcholine receptor M1 using quinuclidynyl benzylate (QNB),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134641,,,,Tclin,,,Homo sapiens
181320,165,2074,Solute carrier family 22 member 6,Transporter,Q8VC69,Slc22a6,S22A6_MOUSE,5.03,,Ki,Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL463,,,,,,,Mus musculus
181321,165,556,Solute carrier family 22 member 6,Transporter,Q4U2R8,SLC22A6,S22A6_HUMAN,5.22,,Ki,Inhibition of human Oat1 expressed in Drosophila S2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL463,,,,Tclin,,,Homo sapiens
181322,1015,147,Adenosine receptor A2b,GPCR,P29275,ADORA2B,AA2BR_HUMAN,5.33,,Ki,"Binding affinity at human Adenosine A2B receptor expressed in HEK293 cells, using [125I]ABOPX as radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279898,,,,Tclin,,,Homo sapiens
181323,1015,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,4.03,,Ki,Displacement of [125I]AB-MECA from human adenosine A3 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279898,,,,Tchem,,,Homo sapiens
181324,1015,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,4.49,,Ki,Binding affinity at Adenosine A1 receptor in rat brain cortical membrane using [3H]N6-R-phenylisopropyladenosine (R-PIA) as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279898,,,,,,,Rattus norvegicus
181325,1015,3537,Adenosine A2a receptor,Unclassified,P46616,ADORA2A,AA2AR_CAVPO,4.04,,Ki,Affinity against adenosine A2 receptor in the brain membranes measured by the displacement of [3H]-CPX,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279898,,,,,,,Cavia porcellus
181326,1015,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,4.49,,Ki,Binding affinity to rat adenosine A2A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279898,,,,,,,Rattus norvegicus
181328,1015,1938,Adenosine receptor A3,GPCR,P28647,Adora3,AA3R_RAT,4.19,,Ki,Binding affinity to rat adenosine A3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279898,,,,,,,Rattus norvegicus
181329,1015,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,4.49,,Ki,Binding affinity to human adenosine A2A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279898,,,,Tclin,,,Homo sapiens
181330,1015,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,4.38,,Ki,Displacement of [3H]CPX from human adenosine A3 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279898,,,,Tclin,,,Homo sapiens
181331,1015,1959,Adenosine receptor A1,GPCR,P47745,ADORA1,AA1R_CAVPO,4.22,,Ki,Affinity against adenosine A1 receptor in the brain membranes by the displacement of [3H]CPX.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279898,,,,,,,Cavia porcellus
181332,463,704,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,4.12,,IC50,Inhibition of PI3Kdelta (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,Tclin,,,Homo sapiens
181333,463,3428,Guanine deaminase,Enzyme,Q9Y2T3,GDA,GUAD_HUMAN,4.99,,Ki,Inhibition of GDA by colorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,Tbio,,,Homo sapiens
181334,463,1958,Adenosine receptor A1,GPCR,P28190,ADORA1,AA1R_BOVIN,4.54,,Ki,Affinity to A1 adenosine receptor was measured by the displacement of [3H]PIA in bovine brain cortical membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,,,,Bos taurus
181335,463,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,4.77,,Ki,Displacement of [3H]CHA from adenosine A1 receptor in rat brain cortical membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,,,,Rattus norvegicus
181336,463,3537,Adenosine A2a receptor,Unclassified,P46616,ADORA2A,AA2AR_CAVPO,4.1,,Ki,Antagonist binding of N6-cyclohexyl-[3H]-adenosine to guinea pig brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,,,,Cavia porcellus
181337,463,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.14,,IC50,Inhibition of human AChE using acetylthiocholine iodide as substrate treated 5 mins before substrate addition measured up to 4 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,Tclin,,,Homo sapiens
181338,463,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,5.03,,Ki,Displacement of [3H]CGS21680 from adenosine A2A receptor in rat brain striatal membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,,,,Rattus norvegicus
181339,463,2839,Adenosine A2 receptor,GPCR,P29276|P30543,Adora2a|Adora2b,AA2AR_RAT|AA2BR_RAT,4.57,,Ki,Binding affinity against adenosine A2 receptor in rat striatal membranes using N-[3H]-ethyladenosin-5''-uronamide as radioligand in the presence of 50 nM cyclopentyladenosine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,,,,Rattus norvegicus
181340,463,1476,"Glycogen phosphorylase, muscle form",Enzyme,P00489,PYGM,PYGM_RABIT,4.13,,IC50,Inhibition of rabbit muscle glycogen phosphorylase A assessed as release of phosphate from glucose-1-phosphate after 25 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,,,,Oryctolagus cuniculus
181341,463,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.31,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,Tclin,,,Homo sapiens
181342,463,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.61,,Ki,Competitive binding affinity to human adenosine A2A receptor expressed in HEK293 cells after 60 mins by fluorescence polarization assay in presence of MRS5346,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,ANTAGONIST,,Tclin,,,Homo sapiens
181343,463,1959,Adenosine receptor A1,GPCR,P47745,ADORA1,AA1R_CAVPO,4,,Ki,Binding affinity against adenosine A1 receptor in guinea pig forebrain membranes using N6-[3H]cyclohexyladenosine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,,,,Cavia porcellus
181344,463,3425,Adenosine receptor,GPCR,P25099|P28647|P29276|P30543,Adora1|Adora2a|Adora2b|Adora3,AA1R_RAT|AA2AR_RAT|AA2BR_RAT|AA3R_RAT,4.22,,Ki,Antagonist binding of N6-cyclohexyl-[3H]-adenosine to rat testes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113,,,,,,,Rattus norvegicus
181345,160,1634,Trypanothione reductase,Enzyme,P28593,TPR,TYTR_TRYCR,4.42,,Ki,The competitive inhibitory activity against trypanothione reductase was evaluated from Lineweaver Burk plots,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL43184,,,,,,,Trypanosoma cruzi
94158,588,2502,Cathepsin E,Enzyme,P14091,CTSE,CATE_HUMAN,8.78,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
181346,1374,2031,Polyphenol oxidase 2,Enzyme,O42713,PPO2,PPO2_AGABI,6.01,,IC50,"Inhibition of mushroom tyrosine kinase assessed as oxidation of 0.25 mM L-3,4-dihydroxyphenylalanine",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL443605,,,,,,,Agaricus bisporus
181347,1374,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,5.55,,IC50,Inhibition of 5-LO in human PMNL using arachidonic acid as substrate preincubated for 15 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL443605,,,,Tclin,,,Homo sapiens
181349,1356,2746,Glycine receptor (alpha-1/beta),Ion channel,P23415|P48167,GLRA1|GLRB,GLRA1_HUMAN|GLRB_HUMAN,,,,Mechanism of Action; CHEMBL2363052; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,POSITIVE MODULATOR,,Tclin|Tclin,,,Homo sapiens
181350,1356,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,,,,Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181351,1356,1680,Potassium channel subfamily K member 10,Ion channel,P57789,KCNK10,KCNKA_HUMAN,,,,Mechanism of Action; CHEMBL2331041; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,OPENER,,Tclin,,,Homo sapiens
181352,1356,1692,Potassium channel subfamily K member 18,Ion channel,Q7Z418,KCNK18,KCNKI_HUMAN,,,,Mechanism of Action; CHEMBL2331042; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,OPENER,,Tclin,,,Homo sapiens
181353,1356,641,Potassium channel subfamily K member 3,Ion channel,O14649,KCNK3,KCNK3_HUMAN,,,,Mechanism of Action; CHEMBL2321613; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,OPENER,,Tclin,,,Homo sapiens
181354,1356,642,Potassium channel subfamily K member 9,Ion channel,Q9NPC2,KCNK9,KCNK9_HUMAN,,,,Mechanism of Action; CHEMBL2321614; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,OPENER,,Tclin,,,Homo sapiens
181355,1356,397,Potassium channel subfamily K member 2,Ion channel,O95069,KCNK2,KCNK2_HUMAN,,,,Mechanism of Action; CHEMBL2321615; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931,OPENER,,Tclin,,,Homo sapiens
181356,244,367,"Thioredoxin reductase 1, cytoplasmic",Enzyme,Q16881,TXNRD1,TRXR1_HUMAN,,,,Mechanism of Action; CHEMBL1927; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200978,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200978,INHIBITOR,,Tclin,,,Homo sapiens
181357,1950,3539,Snake venom metalloproteinase Bap1,Unclassified,P83512,,VM1B1_BOTAS,4.06,,IC50,Inhibition of snake venom BaP1 using Abz-Ala-Gly-Leu-Ala-Nba as substrate incubated for 30 mins prior to substrate addition by fluorescence spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL869,,,,,,,Bothrops asper
181358,1740,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,,,,Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL450,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL450,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181359,2551,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,7.4,,Ki,Inhibition of fetal Bovine serum AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Bos taurus
181360,2551,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,5.68,,IC50,Binding affinity against mouse M2 muscarinic receptor using heart tissue and [3H]N-methylscopolamine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Rattus norvegicus
181361,2551,625,Acetylcholine receptor subunit epsilon,Ion channel,Q04844,CHRNE,ACHE_HUMAN,7.36,,IC50,Inhibition of acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,Tclin,,,Homo sapiens
181362,2551,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,7.4,,IC50,Inhibition of mitochondrial MAO-A in rat liver homogenates using [14C]-(5-hydroxy-triptamine) as substrate preincubated for 30 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Rattus norvegicus
181363,2551,1809,Muscarinic acetylcholine receptor M2,GPCR,Q9ERZ4,Chrm2,ACM2_MOUSE,6.66,,Ki,Ability to displace [3H]oxotremorine ([3H]-OXO-M) from mouse cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Mus musculus
181364,2551,2051,Muscarinic acetylcholine receptor M2,GPCR,P06199,CHRM2,ACM2_PIG,5.2,,EC50,Inhibition of [3H]NMS dissociation from porcine muscarinic M2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Sus scrofa
181365,2551,955,Acetylcholinesterase,Enzyme,P04058,ache,ACES_TORCA,7.4,,Ki,Inhibition of Torpedo californica AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Torpedo californica
181366,2551,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,8,,Ki,Tested for in vitro inhibition of acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Electrophorus electricus
181367,2551,1998,Histamine N-methyltransferase,Enzyme,Q01984,Hnmt,HNMT_RAT,6.96,,IC50,Inhibition of rat kidney Histamine N-Methyltransferase (HMT) activity determined by the formation of N-methyl-histamine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Rattus norvegicus
181368,2551,1802,Choline O-acetyltransferase,Enzyme,P32738,Chat,CLAT_RAT,9.82,,Ki,Inhibition constant determined against Acetylcholinesterase (AChE) receptor.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Rattus norvegicus
181369,2551,1791,Acetylcholinesterase,Enzyme,P37136,Ache,ACES_RAT,7.34,,IC50,Inhibition of Acetylcholinesterase in rat red blood cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Rattus norvegicus
181371,2551,1774,Butyrylcholinesterase; Protein Bche,Enzyme,Q9JKC1,Bche,Q9JKC1_RAT,8.05,,IC50,Inhibition of rat plasma butyrylcholine esterase in presence of butyrylcholine substrate by chemiluminescent assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Rattus norvegicus
181372,2551,2816,Glutamate NMDA receptor; GRIN1/GRIN2B,Ion channel,Q05586|Q13224,GRIN1|GRIN2B,NMDE2_HUMAN|NMDZ1_HUMAN,4.36,,IC50,Inhibition of dexamethasone-induced human NR1-1a/NR2B receptor-mediated excitotoxicity in (S)-glutamate/glycine-stimulated mouse L13-E6 cells assessed as LDH release after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,Tclin|Tclin,,,Homo sapiens
181373,2551,2817,Glutamate NMDA receptor; GRIN1/GRIN2A,Ion channel,Q05586|Q12879,GRIN1|GRIN2A,NMDE1_HUMAN|NMDZ1_HUMAN,5.31,,IC50,Inhibition of dexamethasone-induced human NR1-1a/NR2A receptor-mediated excitotoxicity in (S)-glutamate/glycine-stimulated mouse L12-G10 cells assessed as LDH release after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,Tclin|Tclin,,,Homo sapiens
181374,2551,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,8.61,,IC50,Inhibition of equine BuChE using butyrylthiocholine iodide as substrate preincubated for 5 mins before substrate addition measured for 10 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Equus caballus
181375,2551,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,5.23,,IC50,Inhibition of [3H]quinuclidinyl benzilate (QNB) binding from rat forebrain membranes in the presence of Zn,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Rattus norvegicus
181376,2551,1808,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,5.7,,IC50,Binding affinity against mouse Muscarinic acetylcholine receptor M1 using cerebral cortex and [3H]pirenzepine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Mus musculus
181377,2551,2007,Butyrylcholinesterase,Enzyme,Q9N1N9,BCHE,Q9N1N9_HORSE,8.15,,Ki,Inhibition of Equine Butyrylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Equus caballus
181378,669,2380,Beta-lactamase GES-13,Enzyme,D1MIX9,blaGES-13,D1MIX9_PSEAI,7,,IC50,Inhibition of Pseudomonas aeruginosa GES-13 beta lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Pseudomonas aeruginosa
181379,669,2044,Beta-lactamase,Enzyme,A4KCT8,BlaGIL-1,A4KCT8_9ENTR,8.05,,IC50,Inhibition of Citrobacter gillenii CIP 106783 Beta-lactamase GIL1 expressed in Escherichia coli DH10B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Citrobacter gillenii
181380,669,1851,Beta-lactamase,Enzyme,P05364,ampC,AMPC_ENTCL,6.4,,Kd,Kd for TEM-1 beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Enterobacter cloacae
181381,669,2117,Beta-lactamase,Enzyme,Q9EXV5,blaUOE-1,Q9EXV5_ECOLX,8.05,,IC50,Inhibition of Escherichia coli CTX-M-15,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Escherichia coli
181382,669,2098,Carbapenem-hydrolizing beta-lactamase SFC-1,Enzyme,Q6JP75,,Q6JP75_SERFO,4.14,,IC50,Inhibition of Serratia fonticola UTAD54 SFC1 beta lactamase expressed in Escherichia coli BL21(DE3) by SDS-PAGE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Serratia fonticola
181383,669,2099,Carbepenem-hydrolyzing beta-lactamase KPC,Enzyme,Q9F663,bla,BLKPC_KLEPN,4.96,,Ki,Inhibition of Klebsiella pneumoniae 1534 beta-lactamase KPC-2 by competitive assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Klebsiella pneumoniae
181384,669,2148,Beta-lactamase,Enzyme,Q6GWS8,blaTEM-125,Q6GWS8_ECOLX,5.07,,IC50,Inhibition of Escherichia coli DH5alpha beta-lactamase TEM-158,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Escherichia coli
181385,669,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,7.82,,IC50,Inhibitory activity against Escherichia coli TEM-3 Beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Escherichia coli (strain K12)
181386,669,2415,Beta-lactamase,Enzyme,Q2XPY6,blaCTX-M-53,Q2XPY6_SALET,8,,IC50,Inhibition of Salmonella enterica serotype Westhampton beta-lactamase CTX-M-53,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Salmonella enterica subsp. enterica serovar Westhampton
181387,669,1963,Beta-lactamase,Enzyme,P24735,ampC,AMPC_PSEAE,6.1,,IC50,Inhibitory concentration was evaluated as concentration required for 50% inhibition of Pseudomonas aeruginosa 18SH Beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
181388,669,2385,Beta-lactamase,Enzyme,A0ZX81,blaSHV-72,A0ZX81_KLEPN,5.76,,IC50,Inhibition of Klebsiella pneumoniae Beta-Lactamase SHV-72,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Klebsiella pneumoniae
181389,669,3540,Beta-lactamase SHV-5,Unclassified,P0A3M1,bla,BLA5_KLEPN,4.6,,Ki,Inhibition of Klebsiella pneumoniae beta-lactamase SHV-105,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Klebsiella pneumoniae
181390,669,2100,Beta-lactamase,Enzyme,A2RP81,blaPER-2,A2RP81_CITFR,7.17,,IC50,Inhibition of Citrobacter freundii PER2 beta lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Citrobacter freundii
181391,669,2118,Beta-lactamase SHV-1,Enzyme,P0AD64,bla,BLA1_KLEPN,6.77,,IC50,Inhibition of Klebsiella pneumoniae Beta-Lactamase SHV-1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Klebsiella pneumoniae
181392,669,2097,Beta-lactamase,Enzyme,A8RR46,bcl1,A8RR46_BACCS,7.07,,IC50,Inhibition of Bacillus clausii NR beta-lactamase BCL1 expressed in Escherichia coli BL21 (DE3),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Bacillus clausii
181393,669,2061,Beta-lactamase,Enzyme,A1E3K9,blaSCO-1,A1E3K9_ECOLX,7.15,,IC50,Inhibition of Escherichia coli beta-lactamase SCO1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Escherichia coli
181394,669,786,Beta-lactamase,Enzyme,Q59401,,Q59401_ENTCL,4,,IC50,The compound was tested for its inhibitory activity towards Class C beta-lactamase from Enterobacter cloacae 908R at 0.8 umol concentration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Enterobacter cloacae
181395,669,1022,Beta-lactamase SHV-1,Enzyme,P0AD63,bla,BLA1_ECOLX,7.55,,IC50,Inhibition of Escherichia coli SHV1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Escherichia coli
181396,669,1917,Beta-lactamase OXA-1,Enzyme,P13661,bla,BLO1_ECOLX,5.49,,IC50,Inhibitory activity against Beta-lactamase type OXA1 (penicillinase) from Escherichia coli OXA1 using ampicillin (40 uM) as a substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Escherichia coli
181397,669,2386,Beta-lactamase,Enzyme,Q4TVR4,blaSHV-55,Q4TVR4_KLEPN,7.7,,IC50,Inhibition of Klebsiella pneumoniae Beta-Lactamase SHV-55,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Klebsiella pneumoniae
181398,669,2387,Class D beta-lactamase,Unclassified,Q50H31,oxa-63,Q50H31_BRAPL,5.7,,IC50,Inhibition of Brachyspira pilosicoli beta-lactamase OXA-63 expressed in Escherichia coli BL21 (DE3) assessed as reduction in nitrocefin hydrolysis by spectrophotometry relative to oxacillin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL777,,,,,,,Brachyspira pilosicoli
181399,873,2754,Nematode GABA-A receptor,Ion channel,E1FVX6|E1G1C3,,E1FVX6_LOALO|E1G1C3_LOALO,,,,Mechanism of Action; CHEMBL2364676; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL684,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL684,POSITIVE MODULATOR,,,,,Loa loa
181400,2439,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,,,,Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181401,2439,1680,Potassium channel subfamily K member 10,Ion channel,P57789,KCNK10,KCNKA_HUMAN,,,,Mechanism of Action; CHEMBL2331041; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,OPENER,,Tclin,,,Homo sapiens
181402,2439,1692,Potassium channel subfamily K member 18,Ion channel,Q7Z418,KCNK18,KCNKI_HUMAN,,,,Mechanism of Action; CHEMBL2331042; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,OPENER,,Tclin,,,Homo sapiens
181403,2439,641,Potassium channel subfamily K member 3,Ion channel,O14649,KCNK3,KCNK3_HUMAN,,,,Mechanism of Action; CHEMBL2321613; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,OPENER,,Tclin,,,Homo sapiens
181404,2439,642,Potassium channel subfamily K member 9,Ion channel,Q9NPC2,KCNK9,KCNK9_HUMAN,,,,Mechanism of Action; CHEMBL2321614; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,OPENER,,Tclin,,,Homo sapiens
181405,2439,397,Potassium channel subfamily K member 2,Ion channel,O95069,KCNK2,KCNK2_HUMAN,,,,Mechanism of Action; CHEMBL2321615; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,OPENER,,Tclin,,,Homo sapiens
181406,1834,432,Tyrosinase,Enzyme,P14679,TYR,TYRO_HUMAN,,,,Mechanism of Action; CHEMBL1973; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1388,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1388,INHIBITOR,,Tclin,,,Homo sapiens
181407,3591,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.52,,IC50,Binding affinity against Alpha-2 adrenergic receptor is the ability to inhibit the specific [3H]clonidine binding (0.4 nM) to rat isolated brain membranes by 50% was reported; 3.0*10e-8,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1266,,,,,,,Rattus norvegicus
181408,3591,2867,Adrenergic receptor alpha,GPCR,P15823|P19328|P22086|P22909|P23944|P43140,Adra1a|Adra1b|Adra1d|Adra2a|Adra2b|Adra2c,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT|ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.96,,Ki,Displacement of [3H]clonidine from alpha-adrenergic receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1266,,,,,,,Rattus norvegicus
181409,3591,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.8,,IC50,Binding affinity against alpha-1 adrenergic receptor is the ability to inhibit the specific [3H]prazosin binding (0.2 nM) to rat isolated brain membranes by 50% was reported; 1.6*10e-6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1266,,,,,,,Rattus norvegicus
181410,3591,2900,Adrenergic receptor alpha,GPCR,P08913|P18089|P18825|P25100|P35348|P35368,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C,ADA1A_HUMAN|ADA1B_HUMAN|ADA1D_HUMAN|ADA2A_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN,,,,Mechanism of Action; CHEMBL2095203; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1266,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1266,AGONIST,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181411,1655,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.72,,Ki,Tested for its binding affinity against alpha-2 receptor in rat brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL77921,,,,,,,Rattus norvegicus
181412,1655,2855,Adrenergic receptor alpha-2,GPCR,P08913|P18089|P18825,ADRA2A|ADRA2B|ADRA2C,ADA2A_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN,8.52,,EC50,Tested for its inhibitory activity against alpha-2 adrenoceptor in guinea pig ileum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL77921,,,,Tclin|Tclin|Tclin,,,Homo sapiens
181413,1655,2856,Adrenergic receptor alpha-1,GPCR,P25100|P35348|P35368,ADRA1A|ADRA1B|ADRA1D,ADA1A_HUMAN|ADA1B_HUMAN|ADA1D_HUMAN,5.93,,EC50,Tested for its inhibitory activity against alpha-1 adrenoceptor in guinea pig ileum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL77921,,,,Tclin|Tclin|Tclin,,,Homo sapiens
181414,1655,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.96,,Ki,Alpha-1 adrenergic receptor binding affinity in rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL77921,,,,,,,Rattus norvegicus
181415,835,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,10.82,,Ki,In vitro binding affinity against alpha-2 adrenergic receptor in rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL778,,,,,,,Rattus norvegicus
181416,835,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,10.82,,Ki,In vitro binding affinity against alpha-2D adrenergic receptor of male Wistar rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL778,,,,Tclin,,,Homo sapiens
181417,835,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,8.3,,Ki,Tested for Binding affinity towards alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL778,,,,,,,Rattus norvegicus
94159,588,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.55,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
181418,835,1833,Alpha-2A adrenergic receptor,GPCR,P22909,Adra2a,ADA2A_RAT,10.82,,Ki,Binding affinity towards alpha-2D adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL778,,,,,,,Rattus norvegicus
181419,835,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8.82,,EC50,Agonist activity at human recombinant alpha2A adrenergic receptor expressed in CHO cells assessed as induction of [35S]GTPgammaS binding after 60 mins by scintillation counting,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL778,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL778,AGONIST,,Tclin,,,Homo sapiens
181420,3066,2620,Acetylcholinesterase,Enzyme,K4JQ36,ace2,K4JQ36_9HEMI,7.32,,IC50,Inhibition of acetylcholinesterase in Laodelphax striatella Ibaraki (small brown planthopper) homogenate preincubated for 10 min before substrate addition measured after 10 min by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46917,,,,,,,Laodelphax striatella
181421,3066,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,5.21,,IC50,Inhibition of Bos taurus (bovine) erythrocytes acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46917,,,,,,,Bos taurus
181422,3066,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,5.51,,IC50,Inhibitory activity towards eel acetylcholinesterase (AChE),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46917,,,,,,,Electrophorus electricus
181423,3066,2619,Acetylcholinesterase,Enzyme,Q7YWJ9,Ache,Q7YWJ9_MUSDO,6.7,,IC50,Inhibition of Musca domestica (house fly) NAIDM head acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46917,,,,,,,Musca domestica
181424,3066,2618,Ace-orthologous acetylcholinesterase; Acetylcholinesterase,Unclassified,Q9NJH6,AO-AChE,Q9NJH6_NEPCI,7.54,,IC50,Inhibition of drug-susceptible Nephotettix cincticeps Ageo (green rice leafhopper) acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46917,,,,,,,Nephotettix cincticeps
181425,2621,987,Methionine aminopeptidase 2,Enzyme,P50579,METAP2,MAP2_HUMAN,4.35,,IC50,Inhibition of human MetAP2 expressed in baculovirus infected Sf9 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL625,,,,Tchem,,,Homo sapiens
181426,2621,2309,Methionine aminopeptidase 1,Enzyme,P53582,METAP1,MAP11_HUMAN,5.47,,EC50,Inhibition of human methionine aminopeptidase 1 in presence of Co2+,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL625,,,,Tchem,,,Homo sapiens
181427,2621,178,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,P62942,FKBP1A,FKB1A_HUMAN,4.22,,Kd,Binding affinity to human FKBP12 expressed in Escherichia coli BL21(DE3) by isothermal titration calorimetry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL625,,,,Tclin,,,Homo sapiens
181428,2621,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,4.84,,IC50,HIV-1 reverse transcriptase (RT) activity using Poly (rC)/oligo (dG) as template/primer and [3H]dGTP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL625,,,,,,,Human immunodeficiency virus 1
181429,2621,1897,Methionine aminopeptidase,Enzyme,P0AE18,map,MAP1_ECOLI,6.33,,IC50,Inhibition of Co2+ loaded MetAP expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL625,,,,,,,Escherichia coli (strain K12)
181430,2621,2750,Tubulin,Structural,C4PKY4|C4PKZ2|C4PKZ6,,C4PKY4_ECHGR|C4PKZ2_ECHGR|C4PKZ6_ECHGR,,,,Mechanism of Action; CHEMBL2364704; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL625,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL625,INHIBITOR,,,,,Echinococcus granulosus
181431,2621,2751,Tubulin,Structural,F1L005|F1L4P8|F1L5G6|F1L7U3|F1L7Y0|F1L8A5|F1LCS0,,F1L005_ASCSU|F1L4P8_ASCSU|F1L5G6_ASCSU|F1L7U3_ASCSU|F1L7Y0_ASCSU|F1L8A5_ASCSU|F1LCS0_ASCSU,,,,Mechanism of Action; CHEMBL2364705; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL625,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL625,INHIBITOR,,,,,Ascaris suum
181432,1366,2727,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P09483|P12390,Chrna4|Chrnb2,ACHA4_RAT|ACHB2_RAT,4.66,,Ki,Binding affinity for nicotinic acetylcholine receptor alpha4-beta2 was evaluated by its ability to inhibit [3H]NIC binding to rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL100622,,,,,,,Rattus norvegicus
181433,1366,2822,Acetylcholine receptor,Ion channel,P02710|P02712|P02714|P02718,CHRNA1|CHRNB1|CHRNG|chrnd,ACHA_TORCA|ACHB_TORCA|ACHD_TORCA|ACHG_TORCA,5.74,,Kd,Compound was evaluated for the binding constant for association with nicotinic acetylcholine receptor (nAChR),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL100622,,,,,,,Torpedo californica
181434,1758,3421,Voltage-gated T-type calcium channel,Ion channel,O43497|O95180|Q9P0X4,CACNA1G|CACNA1H|CACNA1I,CAC1G_HUMAN|CAC1H_HUMAN|CAC1I_HUMAN,,,,Mechanism of Action; CHEMBL2362995; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL697,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL697,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
181445,1088,3429,Sodium channel alpha subunit,Ion channel,P35498|P35499|Q01118|Q14524|Q15858|Q99250|Q9NY46|Q9UI33|Q9UQD0|Q9Y5Y9,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN|SCN4A_HUMAN|SCN5A_HUMAN|SCN7A_HUMAN|SCN8A_HUMAN|SCN9A_HUMAN|SCNAA_HUMAN|SCNBA_HUMAN,,,,Mechanism of Action; CHEMBL2331043; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181446,1561,491,"Alkaline phosphatase, tissue-nonspecific isozyme",Enzyme,P05186,ALPL,PPBT_HUMAN,4.8,,Ki,Inhibition of TNSALP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1454,,,,Tchem,,,Homo sapiens
181447,1561,1363,Nicotinic acetylcholine receptor alpha subunit,Ion channel,O96760,,O96760_ASCSU,,,,Mechanism of Action; CHEMBL1884; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1454,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1454,AGONIST,,,,,Ascaris suum
181448,1073,1361,Probable arabinosyltransferase A,Enzyme,P9WNL9,embA,EMBA_MYCTU,,,,Mechanism of Action; CHEMBL1877; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL44884,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL44884,INHIBITOR,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181449,874,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,,,,Mechanism of Action; CHEMBL238; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1693,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1693,INHIBITOR,,Tclin,,,Homo sapiens
181450,874,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,Mechanism of Action; CHEMBL222; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1693,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1693,INHIBITOR,,Tclin,,,Homo sapiens
163348,916,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.6402,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
181451,3851,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,4.49,,IC50,"Inhibition of human recombinant N-terminal His6-tagged AKR1C3 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,Tchem,,,Homo sapiens
181452,3851,346,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,4.37,,IC50,"Inhibition of human recombinant N-terminal His6-tagged AKR1C2 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,Tchem,,,Homo sapiens
181453,3851,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,5.82,,IC50,Inhibition of sheep COX2 by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Ovis aries
181454,3851,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,7.01,,IC50,Inhibition of COX1 in human HEL 92.1.7 cells assessed as thromboxane B2 production incubated for 30 mins before arachidonic acid addition measured after 15 mins by ELISA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,Tclin,,,Homo sapiens
181455,3851,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.14,,IC50,Inhibition of COX2 in LPS-stimulated and PMA-treated human U937 cells assessed as PGE2 production after 15 mins by ELISA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,Tclin,,,Homo sapiens
181456,3851,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,5.83,,IC50,Inhibition of ovine COX1 by EIA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Ovis aries
181457,1407,1877,Prostaglandin-H2 D-isomerase,Enzyme,O09114,Ptgds,PTGDS_MOUSE,4.89,,IC50,Concentration required to inhibit 50% activity of prostaglandin synthetase was determined in vitro in mouse brain microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Mus musculus
181458,1407,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,4.48,,IC50,Inhibition of recombinant human AKR1C3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,Tchem,,,Homo sapiens
181459,1407,1859,Prostaglandin G/H synthase 2,Enzyme,O62698,PTGS2,PGH2_BOVIN,5.96,,IC50,Inhibition of bovine COX2 by enzyme immunoassay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Bos taurus
181460,1407,1738,Prostaglandin G/H synthase 2,Enzyme,Q05769,Ptgs2,PGH2_MOUSE,6.07,,IC50,Inhibition of COX-2 in mouse RAW264.7 cells assessed as decrease in LPS-induced PGE2 production treated prior to LPS challenge by enzyme immunoassay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Mus musculus
181461,1407,2064,Serum albumin,Secreted,P02769,ALB,ALBU_BOVIN,5.52,,IC50,Binding affinity to bovine serum albumin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Bos taurus
181462,1407,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,4.32,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Rattus norvegicus
181463,1407,3541,Dehydrogenase/reductase SDR family member 9,Unclassified,Q8VD48,Dhrs9,DHRS9_RAT,4,,IC50,Inhibition of rat liver 3-alpha-HSD assessed as 5-beta-dihydrocortisone reduction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Rattus norvegicus
181464,1407,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,5.54,,IC50,Inhibition of bovine COX1 by enzyme immunoassay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Bos taurus
181465,1407,2845,Cyclooxygenase,Enzyme,P35355|Q63921,Ptgs1|Ptgs2,PGH1_RAT|PGH2_RAT,5.7,,IC50,Inhibition of Prostaglandin G/H synthase in intact RBL-1 cell line,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Rattus norvegicus
181466,1407,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,5.05,,Ki,Inhibition of sheep placental cotyledons COX2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Ovis aries
181467,1407,2079,Solute carrier family 22 member 20,Transporter,Q80UJ1,Slc22a20,S22AK_MOUSE,5.96,,Ki,Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Mus musculus
181468,1407,2074,Solute carrier family 22 member 6,Transporter,Q8VC69,Slc22a6,S22A6_MOUSE,5.33,,Ki,Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Mus musculus
181469,1407,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,5.05,,Ki,Inhibition of sheep placental cotyledons COX1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,,,,Ovis aries
181470,1806,495,"Maltase-glucoamylase, intestinal",Enzyme,O43451,MGAM,MGA_HUMAN,6,,Ki,Inhibition of human recombinant N-terminal subunit of maltase-glucoamylase after 60 mins by glucose oxidase assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561,INHIBITOR,,Tclin,,,Homo sapiens
181471,1806,2123,Glycogen debranching enzyme,Enzyme,P35574,AGL,GDE_RABIT,6.41,,IC50,"Inhibition of rabbit muscle amylo-1,6-glucosidase",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561,,,,,,,Oryctolagus cuniculus
181472,1806,3430,Lactase-phlorizin hydrolase,Enzyme,P09848,LCT,LPH_HUMAN,4.3,,IC50,Inhibition of lactase by HPLC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561,,,,Tbio,,,Homo sapiens
181473,1806,2122,Lysosomal alpha-glucosidase,Enzyme,Q6P7A9,Gaa,LYAG_RAT,6.34,,Ki,Competitive inhibition of rat intestinal maltase by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561,,,,,,,Rattus norvegicus
181474,1806,1898,"Sucrase-isomaltase, intestinal",Enzyme,P23739,Si,SUIS_RAT,6.96,,IC50,Inhibition of rat intestinal brush border membrane sucrase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561,,,,,,,Rattus norvegicus
181475,1806,731,Lysosomal alpha-glucosidase,Enzyme,P10253,GAA,LYAG_HUMAN,6.46,,IC50,Inhibition of human lysosomal alpha-glucosidase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561,INHIBITOR,,Tclin,,,Homo sapiens
181476,1806,615,Glucosylceramidase,Enzyme,P04062,GBA,GLCM_HUMAN,4.08,,IC50,Inhibition of human lysosomal beta-glucosidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561,,,,Tclin,,,Homo sapiens
94160,588,2503,Disintegrin and metalloproteinase domain-containing protein 9,Enzyme,Q13443,ADAM9,ADAM9_HUMAN,7.25,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
181477,1806,2302,"Sucrase-isomaltase, intestinal",Enzyme,P14410,SI,SUIS_HUMAN,6.3,,IC50,Inhibition of sucrase by HPLC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561,,,,Tchem,,,Homo sapiens
181478,2702,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,6.42,,Ki,Inhibitory concentration for rat Monoamine oxidase A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18116,,,,,,,Rattus norvegicus
181479,2702,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.82,,Ki,Inhibition of MAO-A (unknown origin) by luciferase reporter gene assay,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18116,http://www.ncbi.nlm.nih.gov/pubmed/1546145,INHIBITOR,,Tclin,,415,Homo sapiens
181480,2702,1901,Amine oxidase [flavin-containing] A,Enzyme,P21398,MAOA,AOFA_BOVIN,6.42,,Ki,Inhibition of bovine brain mitochondrial Monoamine oxidase A (MAO-A) compared to toloxatone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18116,,,,,,,Bos taurus
181481,2702,1902,Amine oxidase [flavin-containing] B,Enzyme,P56560,MAOB,AOFB_BOVIN,4.82,,Ki,Inhibition of bovine brain mitochondrial Monoamine oxidase B (MAO-B) compared to toloxatone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18116,,,,,,,Bos taurus
181482,2702,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,4.82,,Ki,Inhibitory concentration for human Monoamine oxidase B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18116,,,,Tclin,,,Homo sapiens
181483,2166,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,5.01,,Ki,"Compound was evaluated for its affinity towards Muscarinic acetylcholine receptor M2, using [3H]- N-methyl-scopolamine, a radioligand displacement assay in rat heart membranes",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL550,,,,,,,Rattus norvegicus
181484,2166,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,5.51,,Ki,"Compound was evaluated for its affinity towards Muscarinic acetylcholine receptor M1, using [3H]- pirenzepine, a radioligand displacement assay in rat hippocampal membranes",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL550,,,,,,,Rattus norvegicus
181485,2166,2608,Muscarinic acetylcholine receptor DM1,GPCR,P16395,mAChR-A,ACM1_DROME,5.55,,Ki,Displacement of [3H]AF-DX 384 from Drosophila melanogaster mAChR by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL550,,,,,,,Drosophila melanogaster
181486,2166,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,7.08,,Ki,Inhibition of [3H]OXO-M binding against muscarinic acetylcholine receptor in rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL550,,,,,,,Rattus norvegicus
181487,2166,1808,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,5.16,,EC50,Tested against Muscarinic acetylcholine receptor M1 expressed in A9 L cell line,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL550,,,,,,,Mus musculus
181488,1814,2813,"Sulfonylurea receptor 2, Kir6.2",Ion channel,O60706|Q14654,ABCC9|KCNJ11,ABCC9_HUMAN|KCJ11_HUMAN,,,,Mechanism of Action; CHEMBL2095198; PROTEIN COMPLEX,CHEMBL,,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL802,http://www.ncbi.nlm.nih.gov/pubmed/18258787,OPENER,,Tclin|Tclin,,496,Homo sapiens
181489,2558,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.6,,IC50,Binding affinity against Alpha-2 adrenergic receptor is the ability to inhibit the specific [3H]clonidine binding (0.4 nM) to rat isolated brain membranes by 50% was reported; 2.5*10e-8,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279085,,,,,,,Rattus norvegicus
181490,2558,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.24,,Ki,In vitro binding affinity to rat striatal Dopamine receptor D2 was determined using the agonist [3H]quinpirole to label the high affinity state (D2 high),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279085,,,,,,,Rattus norvegicus
181491,3369,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.24,,Ki,Displacement of [3H]clonidine from Alpha-2 adrenergic receptor of rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL761,,,,,,,Rattus norvegicus
181492,3369,2867,Adrenergic receptor alpha,GPCR,P15823|P19328|P22086|P22909|P23944|P43140,Adra1a|Adra1b|Adra1d|Adra2a|Adra2b|Adra2c,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT|ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.24,,Ki,Displacement of [3H]clonidine from alpha-adrenergic receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL761,,,,,,,Rattus norvegicus
181493,3369,2116,Nischarin,Unclassified,Q4G017,Nisch,NISCH_RAT,6.61,,Ki,Binding affinity to I1 imidazoline binding site in Rattus norvegicus (rat) PC12 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL761,,,,,,,Rattus norvegicus
181494,3369,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,6.92,,Ki,Displacement of [125I]PIC from human imidazoline receptor 1 in human platelets analyzed under norepinephrine mask of alpha 2AR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL761,,,,Tclin,,,Homo sapiens
181495,3369,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,7.92,,EC50,Compound was evaluated for Adrenergic activity against Alpha-1 adrenergic receptor from rat aorta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL761,,,,,,,Rattus norvegicus
181496,2856,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,7.29,,Ki,Inhibitory constant against HIV-1 reverse transcriptase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL853,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL853,INHIBITOR,,,,,Human immunodeficiency virus 1
181497,1809,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,5.22,,IC50,Inhibition of canine cardiac cAMP phosphodiesterase (cAMP-PDE),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181498,1809,1890,Cyclic nucleotide phosphodiesterase PDE3A,Enzyme,Q9XSW7,,Q9XSW7_PIG,6.07,,IC50,"Inhibition of phosphodiesterase 3 (PDE3) from porcine platelets, range 0.581-1.23",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189,,,,,,,Sus scrofa
181499,1809,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,6.13,,IC50,Inhibitory activity against cGMP-phosphodiesterase from porcine aorta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189,,,,Tclin,,,Homo sapiens
181500,1809,877,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",Enzyme,Q13370,PDE3B,PDE3B_HUMAN,6.55,,IC50,Inhibitory concentration required to inhibit human phosphodiesterase 3B expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189,,,,Tclin,,,Homo sapiens
181501,1809,121,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,6.36,,IC50,Inhibitory concentration required to inhibit human phosphodiesterase 3A expressed in Escherichia coli,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189,INHIBITOR,,Tclin,,,Homo sapiens
181502,1809,1891,Cyclic AMP-specific phosphodiesterase SSPDE4A1A,Enzyme,O77823,PDE4A,O77823_PIG,4.89,,IC50,"Inhibition of phosphodiesterase 4 (PDE4) from porcine liver, range 10.4-16.3",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189,,,,,,,Sus scrofa
181503,1809,1926,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,Q28156,PDE5A,PDE5A_BOVIN,5.3,,IC50,Inhibition of bovine arterial Phosphodiesterase 5,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189,,,,,,,Bos taurus
181504,1809,1914,Uncharacterized protein,Enzyme,E1BN64,PDE3B,E1BN64_BOVIN,6,,IC50,Inhibition of bovine arterial Phosphodiesterase 3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189,,,,,,,Bos taurus
181505,1809,2600,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,O89085,PDE4A,PDE4A_CAVPO,5.33,,Ki,Inhibition of Cavia porcellus (guinea pig) PDE3 isolated from heart using [3H]cAMP as substrate by two-step method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189,,,,,,,Cavia porcellus
181506,1809,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,6.82,,Ki,Inhibition of human phosphodiesterase 3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189,,,,Tclin|Tclin,,,Homo sapiens
181507,1753,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.44,,IC50,50% inhibition of specific [3H]clonidine binding (0.4 nM) to Alpha-2 adrenergic receptors in rat isolated brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL524,,,,,,,Rattus norvegicus
181508,1720,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,5.04,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL776,,,,,,,Bos taurus
181509,1720,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.3,,Kd,Binding affinity to beta-2 adrenergic receptor (unknown origin) at 1 to 10000 nM,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL776,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL776,AGONIST,,Tclin,,,Homo sapiens
181510,1499,3542,Beta-2 adrenergic receptor,GPCR,P04274,ADRB2,ADRB2_MESAU,6.87,,Ki,Displacement of [125I](-)-iodopindolol from adrenergic beta2 receptor in Syrian hamster DDT1 MF2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL434,,,,,,,Mesocricetus auratus
181511,2808,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,6.9,,Ki,Displacement of [3H]epibatidine from alpha7 nicotinic receptor expressed in human HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,,,,Tchem,,,Homo sapiens
181512,2808,2819,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNB1|CHRND|CHRNG,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN|ACHG_HUMAN,5.09,,Ki,Binding affinity to alpha-1-beta-gamma-delta nicotinic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181513,2808,2725,Neuronal acetylcholine receptor; alpha3/beta2,Ion channel,P04757|P12390,Chrna3|Chrnb2,ACHA3_RAT|ACHB2_RAT,8.72,,Ki,Displacement of [3H]epibatidine from rat alpha3beta2 nAChR expressed in HEK293 cells after 4 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,,,,,,,Rattus norvegicus
181514,2808,2726,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P04757|P12392,Chrna3|Chrnb4,ACHA3_RAT|ACHB4_RAT,7.07,,Ki,Displacement of [3H]epibatidine from rat alpha3beta4 nACHR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,,,,,,,Rattus norvegicus
181515,2808,2724,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,P12389|P12390,Chrna2|Chrnb2,ACHA2_RAT|ACHB2_RAT,9.66,,Ki,Displacement of [3H]epibatidine from rat alpha2beta2 nAChR expressed in HEK293 cells after 4 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,,,,,,,Rattus norvegicus
181516,2808,2821,Neuronal acetylcholine receptor; alpha2/beta4,Ion channel,P12389|P12392,Chrna2|Chrnb4,ACHA2_RAT|ACHB4_RAT,7.15,,Ki,Displacement of [3H]epibatidine from rat alpha2beta4 nAChR expressed in HEK293 cells after 4 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,,,,,,,Rattus norvegicus
181517,2808,2728,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P09483|P12392,Chrna4|Chrnb4,ACHA4_RAT|ACHB4_RAT,7.82,,Ki,Displacement of [3H]epibatidine from rat alpha4beta4 nAChR expressed in HEK293 cells after 4 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,,,,,,,Rattus norvegicus
181518,2808,1783,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,Q05941,Chrna7,ACHA7_RAT,7.49,,Ki,Displacement of [125I]iodoMLA from alpha-7 nAChR in rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,,,,,,,Rattus norvegicus
181519,2808,2727,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P09483|P12390,Chrna4|Chrnb2,ACHA4_RAT|ACHB2_RAT,10.3,,Ki,Displacement of [3H]epibatidine from rat alpha4beta2 nACHR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,,,,,,,Rattus norvegicus
181520,2808,2822,Acetylcholine receptor,Ion channel,P02710|P02712|P02714|P02718,CHRNA1|CHRNB1|CHRNG|chrnd,ACHA_TORCA|ACHB_TORCA|ACHD_TORCA|ACHG_TORCA,5.45,,Ki,Inhibition of [125I]alpha-bungarotoxin binding to nicotinic acetylcholine receptor alpha1 beta gamma delta of electroplax,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,,,,,,,Torpedo californica
181521,2233,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.51,,Ki,Displacement of [3H]Spiperone from D2 receptor in Sprague-Dawley rat caudate-putamen,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL301265,,,,,,,Rattus norvegicus
181522,2233,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,9.31,,Ki,in vitro high binding affinity was determined on human Dopamine receptor D4 expressed in chinese hamster ovary(CHO) K-1 cells using [3H]spiperone as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL301265,,AGONIST,,Tchem,,,Homo sapiens
181523,2233,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,8.8,,Kd,Binding affinity of compound against Dopamine receptor D2 was measured using [3H]pramipexole in Bovine striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL301265,,,,,,,Bos taurus
181524,2233,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,9.35,,Ki,Displacement of [3H]R(+)-7-OH-DPAT from Sprague-Dawley rat dopamine D3 receptor after 90 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL301265,,,,,,,Rattus norvegicus
162911,2683,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1079,AGONIST,,Tclin,,,Homo sapiens
181525,3707,699,Poly [ADP-ribose] polymerase 1,Enzyme,P09874,PARP1,PARP1_HUMAN,5.07,,IC50,The compound was tested for poly(ADP-ribose)-polymerase (PARP) inhibition,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL124815,,,,Tclin,,,Homo sapiens
181526,2872,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,6.19,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Stylophora pistillata
181527,2872,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,6.39,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Thalassiosira weissflogii
181528,2872,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,7.7,,Ki,Inhibition of human recombinant CA5A by CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,Tclin,,,Homo sapiens
181529,2872,2428,Carbonic anhydrase 2,Unclassified,Q3I4V7,CAN2,Q3I4V7_CRYNV,6.01,,Ki,Inhibition of Cryptococcus neoformans recombinant Can2 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Cryptococcus neoformans var. grubii
181530,2872,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,6.97,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
181531,2872,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.28,,Ki,Inhibitory constant against human carbonic anhydrase XIV in CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,Tclin,,,Homo sapiens
181532,2872,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,6.93,,Ki,Inhibition of human recombinant CA7 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,Tclin,,,Homo sapiens
181533,2872,401,Carbonic anhydrase,Enzyme,O24855,cynT,CYNT_HELPY,6.66,,Ki,Inhibition of Helicobacter pylori recombinant CA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
181534,2872,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,6.2,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Mus musculus
181535,2872,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,6.59,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Stylophora pistillata
181536,2872,2837,Carbonic anhydrase V,Enzyme,P35218|Q9Y2D0,CA5A|CA5B,CAH5A_HUMAN|CAH5B_HUMAN,7.69,,Ki,Mean inhibitory constant towards human carbonic anhydrase V determined by spectrophotometric dansylamide binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,Tclin|Tclin,,,Homo sapiens
181537,2872,2143,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878,,P96878_MYCTU,6.68,,Ki,Inhibition of Mycobacterium tuberculosis recombinant Rv3273 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181538,2872,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.07,,Ki,Inhibition of truncated human cloned membrane-associated carbonic anhydrase 4 preincubated for 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,Tclin,,,Homo sapiens
181539,2872,3431,Carbonic anhydrase 3,Enzyme,Q3SZX4,CA3,CAH3_BOVIN,5.07,,Ki,Inhibition of bovine carbonic anhydrase 3 using 4-nitrophenylacetate as substrate after 3 mins using spectrophotometry by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Bos taurus
181540,2872,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,6.78,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Astrosclera willeyana
181541,2872,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.22,,Ki,Inhibition of human recombinant CA5B by CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,Tclin,,,Homo sapiens
181542,2872,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,5.54,,Ki,Competitive inhibition of rat MAO B by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Rattus norvegicus
181543,2872,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,5.51,,Ki,Competitive inhibition of human MAO B by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,Tclin,,,Homo sapiens
181544,2872,3543,Amine oxidase [flavin-containing],Unclassified,Q6NSN2,mao,AOF_DANRE,4.51,,Ki,Competitive inhibition of zebrafish MAO by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Danio rerio
181545,2872,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,7.46,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
181546,2872,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,4.54,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181547,2872,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,6.06,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181548,2872,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,6.37,,Ki,Inhibition of human recombinant CA13 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,Tclin,,,Homo sapiens
181549,2872,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,7.05,,Ki,Inhibition of human full length recombinant carbonic anhydrase 6 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,Tclin,,,Homo sapiens
162912,1343,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.9257,,EC50,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
181550,335,2103,Hormone-sensitive lipase,Enzyme,P15304,Lipe,LIPS_RAT,5.96,,IC50,Inhibition of HSL in Wistar rat isolated fat cells by spectrophotometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1239,,,,,,,Rattus norvegicus
181551,335,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,4.05,,IC50,Compound was tested for the inhibition of beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1239,,,,,,,Escherichia coli (strain K12)
181552,971,3420,Adrenergic receptor,GPCR,P07550|P08588|P08913|P13945|P18089|P18825|P25100|P35348|P35368,ADRA1A|ADRA1B|ADRA1D|ADRA2A|ADRA2B|ADRA2C|ADRB1|ADRB2|ADRB3,ADA1A_HUMAN|ADA1B_HUMAN|ADA1D_HUMAN|ADA2A_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN|ADRB1_HUMAN|ADRB2_HUMAN|ADRB3_HUMAN,,,,Mechanism of Action; CHEMBL2331074; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827,AGONIST,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181553,3201,408,Glutamate receptor 1,Ion channel,P42261,GRIA1,GRIA1_HUMAN,5.13,,Ki,Compound was tested for binding affinity against human Ionotropic glutamate receptor AMPA 1 in HEK293 cells using [3H]-AMPA as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,Tclin,,,Homo sapiens
181554,3201,2785,"Glutamate receptor ionotropic, AMPA",Ion channel,P19490|P19491|P19492|P19493,Gria1|Gria2|Gria3|Gria4,GRIA1_RAT|GRIA2_RAT|GRIA3_RAT|GRIA4_RAT,7.53,,Ki,Displacement of [3H]SYM2081 from kainate receptor in rat brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,,,,Rattus norvegicus
181555,3201,1987,"Glutamate receptor ionotropic, kainate 1",Ion channel,P22756,Grik1,GRIK1_RAT,7.15,,Ki,Displacement of [3H]SYM2081 from rat recombinant iGluR5,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,,,,Rattus norvegicus
181556,3201,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,7.11,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,Tchem,,,Homo sapiens
181557,3201,2106,Glutamate receptor 4,Ion channel,P19493,Gria4,GRIA4_RAT,5.45,,Ki,"Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR4 expressed in Sf9 cells",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,,,,Rattus norvegicus
181558,3201,2824,"Glutamate receptor ionotropic, kainate",Ion channel,P22756|P42260|P42264|Q01812|Q63273,Grik1|Grik2|Grik3|Grik4|Grik5,GRIK1_RAT|GRIK2_RAT|GRIK3_RAT|GRIK4_RAT|GRIK5_RAT,8.37,,IC50,Compound was evaluated for the inhibition of [3H]-KA binding to Ionotropic glutamate receptor kainate from rat brain synaptic membrane.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,,,,Rattus norvegicus
181559,3201,2105,Glutamate receptor 3,Ion channel,P19492,Gria3,GRIA3_RAT,5.7,,Ki,"Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR3 expressed in Sf9 cells",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,,,,Rattus norvegicus
181560,3201,2104,Glutamate receptor 1,Ion channel,P19490,Gria1,GRIA1_RAT,6.32,,Ki,"Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR1 expressed in Sf9 cells",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,,,,Rattus norvegicus
181561,3201,2114,"Glutamate receptor ionotropic, kainate 3",Ion channel,P42264,Grik3,GRIK3_RAT,8.42,,Ki,Displacement of [3H]SYM2081 from rat recombinant iGluR7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,,,,Rattus norvegicus
181562,3201,691,"Glutamate receptor ionotropic, kainate 5",Ion channel,Q16478,GRIK5,GRIK5_HUMAN,8.1,,Ki,Ability to bind to Ionotropic glutamate receptor kainate (kainate 2) was evaluated.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,Tclin,,,Homo sapiens
181563,3201,2112,"Glutamate receptor ionotropic, kainate 4",Ion channel,Q01812,Grik4,GRIK4_RAT,8.33,,Ki,Binding affinity to rat cloned KA1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,,,,Rattus norvegicus
181564,3201,2113,"Glutamate receptor ionotropic, kainate 5",Ion channel,Q63273,Grik5,GRIK5_RAT,7.82,,Ki,Binding affinity to rat cloned KA2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,,,,Rattus norvegicus
181565,3201,716,Glutamate receptor 4,Ion channel,P48058,GRIA4,GRIA4_HUMAN,5.77,,Ki,Compound was tested for binding affinity against human Ionotropic glutamate receptor AMPA 4 in HEK293 cells using [3H]AMPA as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,Tclin,,,Homo sapiens
181566,3201,1204,Glutamate receptor 2,Ion channel,P19491,Gria2,GRIA2_RAT,5.43,,Ki,"Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR2(R) expressed in Sf9 cells",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,,,,Rattus norvegicus
181567,3201,1789,"Glutamate receptor ionotropic, kainate 2",Ion channel,P42260,Grik2,GRIK2_RAT,8.43,,Ki,Inhibition of [3H]kainate binding at rat forebrain ionotropic glutamate receptor kainate 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,,,,Rattus norvegicus
181568,3201,738,"Glutamate receptor ionotropic, kainate 2",Ion channel,Q13002,GRIK2,GRIK2_HUMAN,7.49,,Ki,Binding affinity against human ionotropic glutamate receptor ionotropic kainate 2 in HEK293 cells using [3H]kainate as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,Tclin,,,Homo sapiens
181569,3201,520,Glutamate receptor 2,Ion channel,P42262,GRIA2,GRIA2_HUMAN,4.91,,Ki,Compound was tested for binding affinity against human Ionotropic glutamate receptor AMPA 2 in HK293 cells using [3H]AMPA as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,Tclin,,,Homo sapiens
181570,3201,482,"Glutamate receptor ionotropic, kainate 1",Ion channel,P39086,GRIK1,GRIK1_HUMAN,6.75,,Ki,Binding affinity against human ionotropic glutamate receptor kainate 1 in HK293 cells using [3H]kainate as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,Tclin,,,Homo sapiens
181571,3201,739,"Glutamate receptor ionotropic, kainate 3",Ion channel,Q13003,GRIK3,GRIK3_HUMAN,8,,Ki,Ability to bind to Ionotropic glutamate receptor ionotropic kainate 3 was evaluated,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275040,,,,Tclin,,,Homo sapiens
181572,2120,3539,Snake venom metalloproteinase Bap1,Unclassified,P83512,,VM1B1_BOTAS,4.27,,IC50,Inhibition of snake venom BaP1 using Abz-Ala-Gly-Leu-Ala-Nba as substrate incubated for 30 mins prior to substrate addition by fluorescence spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1242,,,,,,,Bothrops asper
181595,695,1899,Peroxisome proliferator-activated receptor alpha,Transcription factor,P23204,Ppara,PPARA_MOUSE,7.38,,EC50,Effective concentration against murine PPARalpha in transactivation assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL683,,,,,,,Mus musculus
181573,2120,3429,Sodium channel alpha subunit,Ion channel,P35498|P35499|Q01118|Q14524|Q15858|Q99250|Q9NY46|Q9UI33|Q9UQD0|Q9Y5Y9,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN|SCN4A_HUMAN|SCN5A_HUMAN|SCN7A_HUMAN|SCN8A_HUMAN|SCN9A_HUMAN|SCNAA_HUMAN|SCNBA_HUMAN,,,,Mechanism of Action; CHEMBL2331043; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1242,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1242,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181574,282,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,7.3,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL701,,,,Tchem,,,Homo sapiens
181575,282,2776,GABA-B receptor,GPCR,O75899|Q9UBS5,GABBR1|GABBR2,GABR1_HUMAN|GABR2_HUMAN,7.46,,IC50,Inhibition of [3H]-baclofen binding to Gamma-aminobutyric acid type B receptor of cat cerebellum,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL701,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL701,AGONIST,,Tclin|Tclin,,,Homo sapiens
181576,282,2763,GABA B receptor,GPCR,O88871|Q9Z0U4,Gabbr1|Gabbr2,GABR1_RAT|GABR2_RAT,7.52,,IC50,In vitro displacement of [3H]GABA from Gamma-aminobutyric acid type B receptor sites in rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL701,,,,,,,Rattus norvegicus
181577,282,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,7.52,,IC50,Displacement of [3H]GABA from Gamma-aminobutyric acid A (GABA-A) receptor in rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL701,,,,,,,Rattus norvegicus
181578,611,1957,Botulinum neurotoxin type A,Enzyme,P10845,botA,BXA1_CLOBO,4.94,,IC50,Inhibition of Clostridium botulinum BoNT/A LC expressed in Escherichia coli assessed as cleavage of SNAPtide preincubated for 5 mins followed by SNAPtide addition measured for 105 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200596,,,,,,,Clostridium botulinum
181579,611,743,"Arachidonate 12-lipoxygenase, 12S-type",Enzyme,P18054,ALOX12,LOX12_HUMAN,5.72,,IC50,Inhibition of human platelet-type N-terminally His6-tagged 12-lipoxygenase assessed as conjugated diene product formation using arachidonic acid by UV-vis spectrophotometer analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200596,,,,Tchem,,,Homo sapiens
181580,611,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,5.44,,IC50,Inhibition of human 5-lipoxygenase assessed as conjugated diene product formation using arachidonic acid by UV-vis spectrophotometer analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200596,,,,Tclin,,,Homo sapiens
181581,611,3432,"Arachidonate 15-lipoxygenase, type II",Enzyme,O15296,ALOX15B,LX15B_HUMAN,4.55,,IC50,Inhibition of human reticulocyte N-terminally His6-tagged 15-lipoxygenase-2 assessed as conjugated diene product formation using arachidonic acid by UV-vis spectrophotometer analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200596,,,,Tchem,,,Homo sapiens
181582,611,680,Arachidonate 15-lipoxygenase,Enzyme,P16050,ALOX15,LOX15_HUMAN,5.62,,IC50,Inhibition of human reticulocyte N-terminally His6-tagged 15-lipoxygenase-1 assessed as conjugated diene product formation using arachidonic acid by UV-vis spectrophotometer analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200596,,,,Tchem,,,Homo sapiens
181583,512,152,"Glutathione reductase, mitochondrial",Enzyme,P00390,GSR,GSHR_HUMAN,5.09,,IC50,Inhibition of human recombinant glutathione reductase using glutathione as substrate preincubated for 30 mins by colorimetric assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL513,INHIBITOR,,Tclin,,,Homo sapiens
181584,2497,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,4.74,,IC50,Inhibition of human DHFR after 2 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL455,,,,Tclin,,,Homo sapiens
181585,2497,3544,Dihydrofolate reductase,Unclassified,P00376,DHFR,DYR_BOVIN,4.66,,IC50,Inhibition of bovine DHFR after 2 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL455,,,,,,,Bos taurus
181586,2497,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL455,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL455,INHIBITOR,,,,,Escherichia coli (strain K12)
181587,2505,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,7.02,,Ki,Inhibitory activity against human thrombin (using Chromozym TH as the substrate),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL338802,,,,Tclin,,,Homo sapiens
181588,2505,2870,Trypsin,Enzyme,P07477|P07478|P35030,PRSS1|PRSS2|PRSS3,TRY1_HUMAN|TRY2_HUMAN|TRY3_HUMAN,5.87,,Ki,Inhibitory activity against human trypsin (using Chromozym TH as the substrate),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL338802,,,,Tchem|Tchem|Tclin,,,Homo sapiens
181589,3848,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,6.79,,IC50,Inhibition of acetylcholinesterase (AChE) of human red blood cell (type XIII) by modified radiometric AChE assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23455,,,,Tclin,,,Homo sapiens
181590,3848,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,7.22,,IC50,Inhibition of acetylcholinesterase (AChE) in electric eel (type V-S) by modified radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23455,,,,,,,Electrophorus electricus
181591,3848,1791,Acetylcholinesterase,Enzyme,P37136,Ache,ACES_RAT,6.44,,IC50,Inhibition of Acetylcholinesterase in rat red blood cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23455,,,,,,,Rattus norvegicus
181592,3848,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,6,,IC50,Inhibition of Acetylcholinesterase in mouse red blood cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23455,,,,,,,Mus musculus
181593,3848,2007,Butyrylcholinesterase,Enzyme,Q9N1N9,BCHE,Q9N1N9_HORSE,7.27,,IC50,Inhibition of (BChE) Butyrylcholinesterase of horse serum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23455,,,,,,,Equus caballus
181594,695,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,4.4,,EC50,Effective concentration against human PPARalpha expressed in HepG2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL683,,,,Tclin,,,Homo sapiens
94161,589,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.25,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
181596,3976,2397,Endochitinase,Enzyme,P29029,CTS1,CHIT_YEAST,5.49,,Ki,Inhibition of Saccharomyces cerevisiae CTS1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL228792,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
181597,3620,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.38,,Ki,Displacement of [3H]clonidine from Alpha-2 adrenergic receptor of rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32573,,,,,,,Rattus norvegicus
181598,3620,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.96,,IC50,50% inhibition of specific [3H]prazosin binding (0.4 nM) to Alpha-2 adrenergic receptors in rat isolated brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32573,,,,,,,Rattus norvegicus
181599,2649,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.04,,IC50,Binding affinity against Alpha-2 adrenergic receptor is the ability to inhibit the specific [3H]clonidine binding (0.4 nM) to rat isolated brain membranes by 50% was reported; 9.1*10e-9,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL295409,,,,,,,Rattus norvegicus
181600,2649,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.31,,IC50,Binding affinity against alpha-1 adrenergic receptor is the ability to inhibit the specific [3H]-prazosin binding (0.2 nM) to rat isolated brain membranes by 50% was reported; 4.85*10e-6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL295409,,,,,,,Rattus norvegicus
181601,3021,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,4.86,,IC50,Inhibition of MAO-A (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24171,,,,Tclin,,,Homo sapiens
181602,30,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,4.07,,IC50,Inhibition of MAO-A activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL416,,,,Tclin,,,Homo sapiens
181603,30,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,6.12,,IC50,Inhibition of acetylcholinesterase (unknown origin) using acetylcholine iodide as substrate preincubated for 15 mins prior to substrate addition by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL416,,,,Tclin,,,Homo sapiens
181604,484,1942,Beta-lactamase,Enzyme,Q79MP6,blaIMP-1,Q79MP6_PSEAI,5.62,,Ki,Inhibition of recombinant Pseudomonas aeruginosa MBL IMP-1 using nitrocefin as substrate preincubated for 20 mins by UV-spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,,,,,,,Pseudomonas aeruginosa
181605,484,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,7.32,,Ki,Inhibitory activity against thrombin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,,,,Tclin,,,Homo sapiens
181606,484,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,8.77,,Ki,Inhibitory activity against rabbit lung angiotensin-1 converting enzyme,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,,,,,,,Oryctolagus cuniculus
181607,484,864,Leukotriene A-4 hydrolase,Enzyme,P09960,LTA4H,LKHA4_HUMAN,7.15,,IC50,Inhibitory activity against Leukotriene A4 hydrolase from human leukocytes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,,,,Tchem,,,Homo sapiens
181608,484,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.77,,Ki,Inhibition of COX-1 (unknown origin) using arachidonic acid as substrate assessed as formation of prostanoid products preincubated for 10 mins prior to substrate addition measured after 2 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,,,,Tclin,,,Homo sapiens
181609,484,1792,Angiotensin-converting enzyme,Enzyme,P47820,Ace,ACE_RAT,8.7,,Ki,Inhibition of Angiotensin I converting enzyme (ACE),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,,,,,,,Rattus norvegicus
181610,484,509,Renin,Enzyme,P00797,REN,RENI_HUMAN,8.77,,Ki,Antihypertensive activity against human renin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,,,,Tclin,,,Homo sapiens
181611,484,1941,Succinyl-diaminopimelate desuccinylase,Enzyme,P44514,dapE,DAPE_HAEIN,5.74,,Ki,Inhibition of Haemophilus influenzae recombinant DapE by competitive binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,,,,,,,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)
181612,484,3545,Beta-lactamase II,Unclassified,Q93T40,bla2,Q93T40_BACAN,4.75,,Ki,Inhibition of Bacillus anthracis MBL Bla2 using nitrocefin as substrate preincubated for 20 mins by UV-spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,,,,,,,Bacillus anthracis
181613,484,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.92,,Ki,Inhibition of COX-2 (unknown origin) using arachidonic acid as substrate assessed as formation of prostanoid products preincubated for 10 mins prior to substrate addition measured after 2 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,,,,Tclin,,,Homo sapiens
181615,1695,3429,Sodium channel alpha subunit,Ion channel,P35498|P35499|Q01118|Q14524|Q15858|Q99250|Q9NY46|Q9UI33|Q9UQD0|Q9Y5Y9,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN|SCN4A_HUMAN|SCN5A_HUMAN|SCN7A_HUMAN|SCN8A_HUMAN|SCN9A_HUMAN|SCNAA_HUMAN|SCNBA_HUMAN,,,,Mechanism of Action; CHEMBL2331043; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL861,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL861,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181616,1807,495,"Maltase-glucoamylase, intestinal",Enzyme,O43451,MGAM,MGA_HUMAN,5.68,,IC50,Inhibition of Glycosidases (maltase) in rat intestinal brush border membranes by D-glucose oxidase-peroxidase method maltase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,Tclin,,,Homo sapiens
181617,1807,2303,Glycogen debranching enzyme,Enzyme,P35573,AGL,GDE_HUMAN,5,,IC50,Inhibition of glycogen glycogen de-branching enzyme by HPLC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,Tbio,,,Homo sapiens
181618,1807,2122,Lysosomal alpha-glucosidase,Enzyme,Q6P7A9,Gaa,LYAG_RAT,5.68,,IC50,Inhibition of rat intestinal maltase using moltose as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,,,,Rattus norvegicus
181619,1807,3546,Trehalase,Unclassified,O70282,Treh,O70282_RAT,4.89,,IC50,Inhibition of Glycosidases (trehalase)in rat intestinal brush border membranes by D-glucose oxidase-peroxidase method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,,,,Rattus norvegicus
181620,1807,3547,Uncharacterized protein,Unclassified,I3LIR5,TREH,I3LIR5_PIG,4.44,,IC50,Inhibition of porcine kidney trehalase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,,,,Sus scrofa
94162,589,2500,Streptokinase A,Enzyme,P10520,ska,STRP_STRP1,6.01,,EC50,,WOMBAT-PK,=,,,,,,,,,,Streptococcus pyogenes serotype M1
181621,1807,1898,"Sucrase-isomaltase, intestinal",Enzyme,P23739,Si,SUIS_RAT,6.24,,IC50,Inhibition of Sucrase in rat intestinal brush border membranes by D-glucose oxidase-peroxidase method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,,,,Rattus norvegicus
181622,1807,2075,Non-lysosomal glucosylceramidase,Enzyme,Q69ZF3,Gba2,GBA2_MOUSE,6.85,,IC50,Inhibition of conduritol beta-epoxide-sensitive mouse glucosylceramidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,,,,Mus musculus
181623,1807,2545,Putative alpha-glucosidase,Enzyme,Q9LGC6,P0504H10.9,Q9LGC6_ORYSJ,6.38,,IC50,Inhibitory activity against alpha-Glucosidase from rice,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,,,,Oryza sativa subsp. japonica
181624,1807,731,Lysosomal alpha-glucosidase,Enzyme,P10253,GAA,LYAG_HUMAN,7,,IC50,Inhibition of human lysosomal alpha glucosidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,Tclin,,,Homo sapiens
181625,1807,2414,Sucrase-isomaltase,Enzyme,B5THE3,Sis,B5THE3_MOUSE,6.22,,IC50,Inhibition of sucrase in mouse intestinal input by glucose release assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,,,,Mus musculus
181626,1807,2288,Non-lysosomal glucosylceramidase,Enzyme,Q9HCG7,GBA2,GBA2_HUMAN,6.64,,IC50,Inhibition of human GBA2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,Tchem,,,Homo sapiens
181627,1807,2413,Lysosomal alpha-glucosidase,Enzyme,P70699,Gaa,LYAG_MOUSE,5.05,,IC50,Inhibition of maltase in mouse intestinal input by glucose release assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,,,,Mus musculus
181628,1807,3548,Ceramide glucosyltransferase,Unclassified,O88693,Ugcg,CEGT_MOUSE,4.64,,IC50,Inhibition mouse glucosylceramide synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,,,,Mus musculus
181629,1807,2302,"Sucrase-isomaltase, intestinal",Enzyme,P14410,SI,SUIS_HUMAN,6.3,,IC50,Inhibition of sucrase by HPLC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1029,,,,Tchem,,,Homo sapiens
181630,1411,2845,Cyclooxygenase,Enzyme,P35355|Q63921,Ptgs1|Ptgs2,PGH1_RAT|PGH2_RAT,5,,IC50,Inhibition of Prostaglandin G/H synthase in intact RBL-1 cell line,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL292707,,,,,,,Rattus norvegicus
181631,1411,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,5.32,,IC50,In vitro inhibitory activity against 5-lipoxygenase in rat RBL-1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL292707,,,,,,,Rattus norvegicus
181632,2130,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,4.82,,IC50,In vitro inhibition of 5-lipoxygenase activity in RBL-1 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL711,,,,,,,Rattus norvegicus
181633,56,40,Carbonic anhydrase 1; GH09688p,Enzyme,Q9V396,CAH1,Q9V396_DROME,6.97,,Ki,Inhibition of Drosophila melanogaster recombinant carbonic anhydrase-1 expressed in Escherichia coli BL21 (DE3) preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Drosophila melanogaster
181634,56,39,"Carbonic anhydrase 2, isoform A; LD26647p",Enzyme,Q9VTU8,CAH2,Q9VTU8_DROME,7.11,,Ki,Inhibition of Drosophila melanogaster recombinant carbonic anhydrase-2 expressed in Escherichia coli BL21 (DE3) preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Drosophila melanogaster
181635,56,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,7.13,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Stylophora pistillata
181636,56,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,7.08,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Thalassiosira weissflogii
181637,56,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,7.22,,Ki,Inhibition of recombinant human mitochondrial isozyme CA VA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,Tclin,,,Homo sapiens
181638,56,2835,Carbonic anhydrase,Enzyme,O43570|P00915|P00918|P07451|P22748|P23280|P35218|P43166|Q16790|Q8N1Q1|Q9ULX7|Q9Y2D0,CA1|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9,CAH12_HUMAN|CAH13_HUMAN|CAH14_HUMAN|CAH1_HUMAN|CAH2_HUMAN|CAH3_HUMAN|CAH4_HUMAN|CAH5A_HUMAN|CAH5B_HUMAN|CAH6_HUMAN|CAH7_HUMAN|CAH9_HUMAN,9.1,,Ki,Compound was evaluated for the inhibition of Carbonic anhydrase (Non competitive),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181639,56,2428,Carbonic anhydrase 2,Unclassified,Q3I4V7,CAN2,Q3I4V7_CRYNV,8,,Ki,Inhibition of Cryptococcus neoformans recombinant Can2 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Cryptococcus neoformans var. grubii
181640,56,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,7.09,,Ki,Inhibition of Saccharomyces cerevisiae beta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
181641,56,2436,Carbonic anhydrase,Unclassified,Q2PCB5,ca,Q2PCB5_DICLA,5.24,,Ki,Inhibition of Dicentrarchus labrax CA using 4-nitrophenylacetate substrate by esterase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Dicentrarchus labrax
181642,56,2611,Carbonic anhydrase 2,Enzyme,P00921,CA2,CAH2_BOVIN,6.02,,IC50,Inhibition of bovine erythrocyte carbonic anhydrase 2 using p-nitrophenyl acetate as substrate preincubated for 10 mins before substrate addition measured after 30 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Bos taurus
181643,56,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,8.48,,Ki,Inhibitory constant value for Carbonic anhydrase II in human determined in pH-shift assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,INHIBITOR,,Tclin,,,Homo sapiens
181644,56,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,7.39,,Ki,Inhibitory constant against human carbonic anhydrase XIV in CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,Tclin,,,Homo sapiens
181645,56,2010,Carbonic anhydrase,Enzyme,Q50565,,Q50565_METTH,4.92,,Ki,Inhibitory activity against beta carbonic anhydrase (Cab) from Methanobacterium thermoautotrophicum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H)
181646,56,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,8.6,,Ki,Ki value against human carbonic anhydrase VII,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,Tclin,,,Homo sapiens
181647,56,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,7.77,,Ki,Inhibitory activity against murine carbonic anhydrase XIII (mCA XIII) by using CO2 hydrase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Mus musculus
181648,56,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,8.6,,Ki,Inhibition of human recombinant carbonic anhydrase 12 catalytic domain preincubated for 15 mins by CO2 hydration method,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,INHIBITOR,,Tclin,,,Homo sapiens
181649,56,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,8.05,,Ki,Inhibition of human recombinant carbonic anhydrase 9 catalytic domain expressed in Escherichia coli by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,Tclin,,,Homo sapiens
181650,56,401,Carbonic anhydrase,Enzyme,O24855,cynT,CYNT_HELPY,7.7,,Ki,Inhibition of Helicobacter pylori recombinant CA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
181651,56,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.14,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Mus musculus
181652,56,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,7.8,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Stylophora pistillata
181653,56,2837,Carbonic anhydrase V,Enzyme,P35218|Q9Y2D0,CA5A|CA5B,CAH5A_HUMAN|CAH5B_HUMAN,8.74,,Ki,Mean inhibitory constant towards human carbonic anhydrase V determined by spectrophotometric dansylamide binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,Tclin|Tclin,,,Homo sapiens
181654,56,2008,Carbonic anhydrase 7,Enzyme,Q9ERQ8,Ca7,CAH7_MOUSE,7.8,,Ki,Ki value against mouse carbonic anhydrase VII,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Mus musculus
181655,56,2143,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878,,P96878_MYCTU,7.92,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase Rv3273 by by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181656,56,2836,Carbonic anhydrase,Enzyme,P00921|P18915|Q3SZX4|Q95323,CA2|CA3|CA4|CA6,CAH2_BOVIN|CAH3_BOVIN|CAH4_BOVIN|CAH6_BOVIN,7.8,,IC50,In vitro concentration that causes 50% inhibition of carbonic anhydrase carbonate hydro-lyase (EC.4.2.1.1) isolated from bovine erythrocyte,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Bos taurus
181657,56,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,7.96,,Ki,Inhibition of human secreted carbonic anhydrase 4 measured by CO2 hydration reaction assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,INHIBITOR,,Tclin,,,Homo sapiens
181658,56,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,7.92,,Ki,Inhibition of human carbonic anhydrase 1-catalyzed CO2 hydration preincubated for 10 mins by stopped-flow assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,INHIBITOR,,Tclin,,,Homo sapiens
181659,56,2397,Endochitinase,Enzyme,P29029,CTS1,CHIT_YEAST,4.68,,Ki,Inhibition of Saccharomyces cerevisiae CTS1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
181660,56,3431,Carbonic anhydrase 3,Enzyme,Q3SZX4,CA3,CAH3_BOVIN,4.08,,Ki,Inhibition of bovine carbonic anhydrase 3 using 4-nitrophenylacetate as substrate after 3 mins using spectrophotometry by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Bos taurus
181661,56,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,7.29,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Astrosclera willeyana
181662,56,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,7.27,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,Tclin,,,Homo sapiens
181663,56,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,8.51,,Ki,Inhibition of human carbonic anhydrase 3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,Tclin,,,Homo sapiens
181664,56,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,7.4,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
181665,56,2009,Carbonic anhydrase,Enzyme,P40881,,CAH_METTE,7.22,,Ki,Inhibitory activity against alpha carbonic anhydrase (Zn-Cam) from Methanosarcina thermophila,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Methanosarcina thermophila
181666,56,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,6.6,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase Rv1284 by by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181667,56,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,8.05,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181668,56,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,8.24,,Ki,Inhibition of human recombinant carbonic anhydrase 13 preincubated for 15 mins by CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,Tclin,,,Homo sapiens
181669,56,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,7.96,,Ki,Inhibition of full length human recombinant CA VI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,Tclin,,,Homo sapiens
181670,56,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,7.96,,Ki,Inhibition of Candida glabrata carbonic anhydrase by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
181671,56,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,7.15,,Ki,Compound was evaluated for inhibition against bovine carbonic anhydrase IV,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Bos taurus
181672,56,2938,Carbonic anhydrase,Enzyme,P46510,,CAHX_FLABI,7.57,,Ki,Inhibition of Flaveria bidentis recombinant CA by CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Flaveria bidentis
181673,3047,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,6.89,,IC50,Logarithmic value of inhibitory concentration against 5-lipoxygenase in rat basophilic leukemia cells (RBL-1),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94394,,,,,,,Rattus norvegicus
181674,578,806,Fatty acid synthase,Enzyme,P49327,FASN,FAS_HUMAN,5.24,,IC50,Inhibition of human FAS assessed as synthesis of long chain fatty acids from malonyl CoA after 60 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45627,,,,Tchem,,,Homo sapiens
181675,578,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,5.6,,IC50,The compound was tested for its affinity against HIV-1 protease in vitro,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45627,,,,,,,Human immunodeficiency virus 1
181676,1126,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,10.3,,Ki,Competitive inhibition of human aromatase using dibenzylfluorescein substrate after 10 mins preincubation measured every 10 sec for 5 mins by Michaelis-Menten and Dixon plot analysis,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9298,http://www.ncbi.nlm.nih.gov/pubmed/2521224,INHIBITOR,,Tclin,,412,Homo sapiens
181677,1126,443,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,8.2,,IC50,Inhibition of human CYP11B1 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9298,,INHIBITOR,,Tclin,,,Homo sapiens
181678,1126,673,"Cytochrome P450 11B2, mitochondrial",Enzyme,P19099,CYP11B2,C11B2_HUMAN,9.1,,IC50,Inhibition of human CYP11B2 expressed in V79MZh cells using [14C]-11-deoxycorticosterone as substrate by HPTLC/phosphoimaging method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9298,,INHIBITOR,,Tchem,,,Homo sapiens
181679,1897,955,Acetylcholinesterase,Enzyme,P04058,ache,ACES_TORCA,8.34,,IC50,Inhibition of Torpedo californica eel AChE using acetylthiocholine/DTNB as substrate preincubated for 10 mins followed by substrate addition measured every 30 secs for 30 mins by Ellmans method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54126,,,,,,,Torpedo californica
181680,1897,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,6,,Ki,Tested for in vitro inhibition of acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54126,,,,,,,Electrophorus electricus
181681,1897,1791,Acetylcholinesterase,Enzyme,P37136,Ache,ACES_RAT,7.46,,IC50,Inhibition of Wistar rat brain AChE by Ellman colorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54126,,,,,,,Rattus norvegicus
181682,1897,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,7.22,,IC50,Inhibition of human plasma BChE pretreated for 30 mins by Ellman technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54126,,,,Tclin,,,Homo sapiens
181683,1897,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,7.15,,IC50,Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate after 10 mins by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54126,,,,,,,Equus caballus
181684,3616,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,7.36,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL67096,,,,,,,Bos taurus
181685,3616,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,8.75,,Kd,Beta-1 adrenergic receptor activation measured by isoprenaline-induced positive inotropic effect in guinea pig left atrium,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL67096,,,,,,,Cavia porcellus
181686,2478,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,7.3,,EC50,Effective concentration that reduces HIV-induced cytopathic effect by 50% was determined by reverse transcriptase (RT) assay.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL991,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL991,INHIBITOR,,,,,Human immunodeficiency virus 1
181687,1107,147,Adenosine receptor A2b,GPCR,P29275,ADORA2B,AA2BR_HUMAN,4.76,,Ki,"Binding affinity at human Adenosine A2B receptor expressed in HEK293 cells, using [125I]ABOPX as radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL699,,,,Tclin,,,Homo sapiens
181688,3380,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,5.88,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127349,,,,,,,Bos taurus
181689,2556,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,,,,Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200802,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200802,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181690,85,3530,Purine nucleoside phosphorylase,Unclassified,P9WP01,punA,PUNA_MYCTU,4.9,,Kd,Binding affinity to Mycobacterium tuberculosis purine nucleoside phosphorylase by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL184,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181691,2598,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,5.4,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1760,,,,,,,Bos taurus
181692,2258,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,5.97,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1160714,,,,,,,Bos taurus
181693,226,2597,5-lipoxygenase,Enzyme,Q9BEG3,,Q9BEG3_BOVIN,4.43,,IC50,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46469,,,,,,,Bos taurus
94163,589,1037,Chloramphenicol acetyltransferase,Enzyme,P62580,cat,CAT_SALTI,4.89,,Kd,,WOMBAT-PK,=,,,,,,,,,,Salmonella typhi
181694,496,2435,Lysine-specific demethylase 4E,Enzyme,B2RXH2,KDM4E,KDM4E_HUMAN,5.7,,Ki,Uncompetitive inhibition of JMJD2E relative to alpha-ketoglutarate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200748,,,,Tchem,,,Homo sapiens
181695,496,244,Aromatic-L-amino-acid decarboxylase,Enzyme,P20711,DDC,DDC_HUMAN,,,,Mechanism of Action; CHEMBL1843; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200748,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200748,INHIBITOR,,Tclin,,,Homo sapiens
181696,2095,78,Gamma-aminobutyric acid receptor subunit beta-3,Ion channel,P28472,GABRB3,GBRB3_HUMAN,4.06,,IC50,Displacement of [3H]R-(-)-14 from human FLAG-tagged beta3 GABA A receptor expressed in HEK293S cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448,POSITIVE ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
181697,2095,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,5.77,,IC50,Ability to allosterically modulate the binding of [35S]TBPS to gamma-aminobutyric-acid A receptor in rat brain cortical P2 membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448,,,,,,,Rattus norvegicus
181698,1791,443,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,7.84,,IC50,Inhibition of human steroid-11beta-hydroxylase expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL934,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012911Orig1s033lbl.pdf,INHIBITOR,,Tclin,,368,Homo sapiens
181699,1791,3549,Cytochrome P450 11B1,Unclassified,P15150,CYP11B1,C11B1_BOVIN,6.24,,Ki,Inhibition of bovine adrenal gland 11beta-hydroxylase assessed as inhibition of [14C]-deoxycorticosterone hydroxylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL934,,,,,,,Bos taurus
181700,1791,673,"Cytochrome P450 11B2, mitochondrial",Enzyme,P19099,CYP11B2,C11B2_HUMAN,7.38,,IC50,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL934,,,,Tchem,,,Homo sapiens
181701,1952,2827,Soluble guanylate cyclase,Enzyme,O75343|P33402|Q02108|Q02153,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,GCYA2_HUMAN|GCYA3_HUMAN|GCYB1_HUMAN|GCYB2_HUMAN,,,,Mechanism of Action; CHEMBL2111348; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL730,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL730,ACTIVATOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181702,790,272,DNA (cytosine-5)-methyltransferase 3A,Enzyme,Q9Y6K1,DNMT3A,DNM3A_HUMAN,,,,Mechanism of Action; CHEMBL1992; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201129,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201129,INHIBITOR,,Tclin,,,Homo sapiens
181703,2782,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,6.89,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1159717,,,,,,,Bos taurus
181704,3095,1957,Botulinum neurotoxin type A,Enzyme,P10845,botA,BXA1_CLOBO,5,,IC50,Inhibition of Clostridium botulinum BoNT/A LC expressed in Escherichia coli assessed as cleavage of SNAPtide preincubated for 5 mins followed by SNAPtide addition measured for 105 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL224325,,,,,,,Clostridium botulinum
181705,3412,2103,Hormone-sensitive lipase,Enzyme,P15304,Lipe,LIPS_RAT,5.49,,IC50,Inhibition of HSL in Wistar rat isolated fat cells by spectrophotometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1625,,,,,,,Rattus norvegicus
181706,2043,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,7.96,,IC50,Inhibitory activity against human thromboxane synthetase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11662,,,,Tchem,,,Homo sapiens
181707,2043,1832,Thromboxane-A synthase,Enzyme,P49430,Tbxas1,THAS_RAT,6.7,,IC50,Tested in vitro against TXA2 synthetase inhibitory activity in rat platelet,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11662,,,,,,,Rattus norvegicus
181708,1863,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,Mechanism of Action; CHEMBL230; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1070,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1070,INHIBITOR,,Tclin,,,Homo sapiens
181709,1432,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,8.7,,Ki,Effect of compound on Serotonin transporter uptake from rat cortex using [3H]citalopram as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL276520,,,,,,,Rattus norvegicus
181710,1539,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,7.38,,EC50,In vitro antiviral activity against HIV-1 Reverse transcriptase wild type,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL141,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL141,INHIBITOR,,,,,Human immunodeficiency virus 1
181711,1539,652,Protein P,Polyprotein,Q9IF40,P,Q9IF40_HBV,,,,Mechanism of Action; CHEMBL2362994; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL141,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL141,INHIBITOR,,,,,Hepatitis B virus
181712,2289,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,6.8,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16476,,,,,,,Bos taurus
181713,2735,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,,,,Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200789,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200789,POSITIVE MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181714,158,2761,"Amiloride-sensitive sodium channel, ENaC",Ion channel,P37088|P51168|P51170,SCNN1A|SCNN1B|SCNN1G,SCNNA_HUMAN|SCNNB_HUMAN|SCNNG_HUMAN,6.7,,IC50,GRAC: human ENaC blocker,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL945,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL945,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
181715,158,86,Amiloride-sensitive sodium channel subunit alpha,Ion channel,P37088,SCNN1A,SCNNA_HUMAN,6.11,,IC50,Inhibition of dog bronchi prototypical epithelial sodium channel by electrophysiological assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL945,,,,Tclin,,,Homo sapiens
181716,158,953,Acid-sensing ion channel 1,Ion channel,P78348,ASIC1,ASIC1_HUMAN,5,,IC50,GRAC: human ASIC1 blocker,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL945,,,,Tchem,,,Homo sapiens
181717,158,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.24,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL945,,,,Tchem,,,Homo sapiens
181718,158,3550,Sodium/hydrogen exchanger,Unclassified,Q9W6Q1,NHE1,Q9W6Q1_9SALA,4.01,,IC50,Inhibition of Amphiuma tridactylum wild type NHE1 expressed in chinese hamster AP1 cells assessed as intracellular pHi recovery by ammonium chloride prepulse protocol,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL945,,,,,,,Amphiuma tridactylum
181719,158,1985,Membrane primary amine oxidase,Enzyme,O08590,Aoc3,AOC3_RAT,5,,Ki,Inhibitory activity against porcine kidney amine oxidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL945,,,,,,,Rattus norvegicus
181720,158,2121,Acid-sensing ion channel 3,Ion channel,Q9UHC3,ASIC3,ASIC3_HUMAN,5.36,,IC50,Inhibition of ASIC3 assessed as inhibition of peak current by patch clamp electrophysiology,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL945,,,,Tchem,,,Homo sapiens
181721,158,561,Sodium/hydrogen exchanger 1,Transporter,P19634,SLC9A1,SL9A1_HUMAN,4.22,,IC50,Inhibition of human wild type NHE1 expressed in chinese hamster AP1 cells assessed as intracellular pHi recovery by ammonium chloride prepulse protocol,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL945,,,,Tchem,,,Homo sapiens
181722,704,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.59,,Kd,The compound was tested for alpha-adrenergic activity against Alpha-1 adrenergic receptor from rat aorta.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,,,,Rattus norvegicus
181723,704,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.82,,Ki,In vitro binding affinity was measured as the inhibition of [3H]clonidine binding to alpha-2 adrenergic receptor of rat cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,,,,Rattus norvegicus
181724,704,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.5,,Ki,Displacement of [3H]RX821001 from human alpha2B adrenoceptor expressed in CHO cells after 60 mins by gamma counter,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,AGONIST,,Tclin,,,Homo sapiens
181725,704,1868,Alpha-2A adrenergic receptor,GPCR,Q28838,ADRA2A,ADA2A_BOVIN,8.7,,IC50,Concentration necessary to achieve half maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor at 1 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,,,,Bos taurus
181726,704,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.65,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,Tchem,,,Homo sapiens
181727,704,2116,Nischarin,Unclassified,Q4G017,Nisch,NISCH_RAT,6.95,,Ki,Binding affinity to I1 imidazoline binding site in Rattus norvegicus (rat) PC12 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,,,,Rattus norvegicus
181728,704,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.48,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,Tchem,,,Homo sapiens
181729,704,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,8.05,,Ki,Displacement of [3H]-clonidine from bovine imidazoline receptor I-1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,Tclin,,,Homo sapiens
181730,704,1733,Alpha-2B adrenergic receptor,GPCR,P19328,Adra2b,ADA2B_RAT,8.08,,Ki,Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,,,,Rattus norvegicus
181731,704,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.49,,Ki,Displacement of [3H]8-OH-DPAT from human 5HT1A receptor expressed in HeLa cells after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,Tclin,,,Homo sapiens
181732,704,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,4.4,,Kd,The compound was tested for beta-adrenergic activity against Beta-1 adrenergic receptor from guinea pig right atria,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,,,,Cavia porcellus
181733,704,1833,Alpha-2A adrenergic receptor,GPCR,P22909,Adra2a,ADA2A_RAT,9.41,,Ki,Binding affinity towards alpha-2D adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,,,,Rattus norvegicus
181734,704,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8.42,,Ki,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,AGONIST,,Tclin,,,Homo sapiens
181735,1883,1877,Prostaglandin-H2 D-isomerase,Enzyme,O09114,Ptgds,PTGDS_MOUSE,4.89,,IC50,Concentration required to inhibit 50% activity of prostaglandin synthetase was determined in vitro in mouse brain microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154,,,,,,,Mus musculus
181736,1883,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,6.32,,IC50,Inhibition of recombinant human AKR1C3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154,,,,Tchem,,,Homo sapiens
181737,1883,2103,Hormone-sensitive lipase,Enzyme,P15304,Lipe,LIPS_RAT,5.92,,IC50,Inhibition of HSL in Wistar rat isolated fat cells by spectrophotometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154,,,,,,,Rattus norvegicus
181738,1883,346,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,4.5,,IC50,"Inhibition of human recombinant N-terminal His6-tagged AKR1C2 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154,,,,Tchem,,,Homo sapiens
181739,1883,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,4.96,,IC50,Inhibition of bovine seminal microsomal COX1 assessed as PGE2 production preincubated for 10 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154,,,,,,,Bos taurus
181740,1883,2845,Cyclooxygenase,Enzyme,P35355|Q63921,Ptgs1|Ptgs2,PGH1_RAT|PGH2_RAT,7.22,,IC50,In vitro inhibitory activity against Prostaglandin G/H synthase in rat neutrophils,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154,,,,,,,Rattus norvegicus
181741,1883,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.6,,IC50,Inhibition activity against recombinant human Prostaglandin G/H synthase 2,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154,INHIBITOR,,Tclin,,,Homo sapiens
181742,1883,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,6.74,,IC50,Inhibition of ovine COX-1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154,,,,,,,Ovis aries
181743,1406,559,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,Q08499,PDE4D,PDE4D_HUMAN,6.78,,IC50,Inhibition of human PDE4D,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19449,,,,Tclin,,,Homo sapiens
181744,1406,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,7.27,,IC50,Inhibition of human PDE4A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19449,,,,Tclin,,,Homo sapiens
181745,1406,825,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",Enzyme,Q08493,PDE4C,PDE4C_HUMAN,6.62,,IC50,Inhibition of human PDE4C,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19449,,,,Tclin,,,Homo sapiens
181746,1406,149,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,Q07343,PDE4B,PDE4B_HUMAN,7.19,,IC50,Inhibition of human PDE4B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19449,,,,Tclin,,,Homo sapiens
181747,854,365,Nicotinamide phosphoribosyltransferase,Enzyme,P43490,NAMPT,NAMPT_HUMAN,3.64,,Kd,Binding affinity to NAMPT (2 to 491) (unknown origin) by surface plasmon resonance analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL181,,,,Tchem,,,Homo sapiens
181749,3952,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.77,,IC50,50% inhibition of specific [3H]clonidine binding (0.4 nM) to Alpha-2 adrenergic receptors in rat isolated brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL420,,,,,,,Rattus norvegicus
181750,3952,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,7.46,,Ki,Displacement of [125I]PIC from human imidazoline receptor 1 in human platelets analyzed under norepinephrine mask of alpha 2AR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL420,,,,Tclin,,,Homo sapiens
181751,2134,2875,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P04774|P04775|P08104,Scn1a|Scn2a|Scn3a,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,5.6,,IC50,Inhibition of [3H]BTX-B binding to neurotoxin site 2 of sodium channel of rat cerebral cortex synaptoneurosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL40,,,,,,,Rattus norvegicus
181752,1875,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,,,,Mechanism of Action; CHEMBL2311224; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL5,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL5,INHIBITOR,,,,,Escherichia coli (strain K12)
181753,1672,297,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,P16083,NQO2,NQO2_HUMAN,7.56,,Ki,Ability to inhibit 2-[125I]iodomelatonin specific binding to melatonin receptor 3 (MT3) of Syrian hamster brain.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45,,,,Tchem,,,Homo sapiens
181754,1672,2841,Melatonin receptor,GPCR,P49285|P49288|P51050,,MTR1A_CHICK|MTR1B_CHICK|MTR1C_CHICK,9.75,,Ki,Effect of compound on Melatonin receptor in chicken brain in the presence of MnCl2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45,,,,,,,Gallus gallus
181755,1672,1849,Melatonin receptor type 1B,GPCR,P51050,,MTR1B_CHICK,9.15,,Ki,Binding affinity measured against Chicken brain melatonin receptor by using 2-[125I]iodomelatonin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45,,,,,,,Gallus gallus
181756,164,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,4.73,,IC50,Inhibition of Thromboxane-A synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL488,,,,Tchem,,,Homo sapiens
181757,164,1911,Aromatase,Enzyme,P22443,Cyp19a1,CP19A_RAT,6.59,,EC50,In vitro inhibition of cytochrome P450 19A1 by rat ovarian microsomes incubated with [3H]androstenedione and NADPH-generating system.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL488,,,,,,,Rattus norvegicus
181758,164,3551,Cytochrome P450 11A1,Unclassified,P00189,CYP11A1,CP11A_BOVIN,4.54,,IC50,Inhibition of bovine adrenal desmolase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL488,,,,,,,Bos taurus
181759,164,654,"Cholesterol side-chain cleavage enzyme, mitochondrial",Enzyme,P05108,CYP11A1,CP11A_HUMAN,,,,Mechanism of Action; CHEMBL2033; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL488,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL488,INHIBITOR,,Tclin,,,Homo sapiens
181760,2492,2380,Beta-lactamase GES-13,Enzyme,D1MIX9,blaGES-13,D1MIX9_PSEAI,6.43,,IC50,Inhibition of Pseudomonas aeruginosa GES-13 beta lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Pseudomonas aeruginosa
181761,2492,2392,Beta-lactamase,Enzyme,Q7X575,SHV-11,Q7X575_ECOLX,5.62,,IC50,Inhibition of Escherichia coli JM109 beta-lactamase SHV-11,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Escherichia coli
181762,2492,1851,Beta-lactamase,Enzyme,P05364,ampC,AMPC_ENTCL,6,,IC50,Compound was evaluated for beta-lactamase inhibition activity of Escherichia cloacae after 15 min of pre-incubation with the enzyme at 37 degree C,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Enterobacter cloacae
181763,2492,168,Beta-lactamase TEM,Enzyme,P62593,bla; blaT-3; blaT-4;,BLAT_ECOLX,6.1,,Ki,Inhibition constant (Ki) for TEM-1 beta-lactamase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,INHIBITOR,,,,,Escherichia coli
181764,2492,167,Beta-lactamase,Enzyme,P00807,blaZ,BLAC_STAAU,5.19,,IC50,Inhibitory activity against Penicillinase from Staphylococcus aureus TH-14 using piperacillin (40 uM) as a substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Staphylococcus aureus
181765,2492,2406,Beta-lactamase,Enzyme,Q0VTR6,adc-14,Q0VTR6_ACIPI,5.95,,IC50,Inhibition of Acinetobacter genomosp. 3 isolate 65 ADC-14,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Acinetobacter pittii
162913,922,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833,AGONIST,,Tclin,,,Homo sapiens
181766,2492,2407,Beta-lactamase,Enzyme,Q0VTR8,adc-16,Q0VTR8_ACIPI,5.11,,IC50,Inhibition of Acinetobacter genomosp. 3 isolate 103 ADC-16,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Acinetobacter pittii
181767,2492,2098,Carbapenem-hydrolizing beta-lactamase SFC-1,Enzyme,Q6JP75,,Q6JP75_SERFO,4.64,,IC50,Inhibition of Serratia fonticola UTAD54 SFC1 beta lactamase expressed in Escherichia coli BL21(DE3) by SDS-PAGE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Serratia fonticola
181768,2492,3552,ADC-18 protein,Unclassified,Q0VTS0,adc-18,Q0VTS0_ACIPI,4.93,,IC50,Inhibition of Acinetobacter genomosp. 3 isolate 195 ADC-18,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Acinetobacter pittii
181769,2492,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,4.18,,IC50,Inhibitory activity against AmpC (class C) beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Escherichia coli (strain K12)
181770,2492,1963,Beta-lactamase,Enzyme,P24735,ampC,AMPC_PSEAE,4.57,,IC50,Inhibition of Pseudomonas aeruginosa beta-lactamase AmpC assessed as nitrocefin hydrolysis after 5 mins enzyme-compound preincubation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
181771,2492,3553,Beta-lactamase 1,Unclassified,P00809,blaY,BLAC_BACCE,4.6,,IC50,Inhibition of Beta-lactamase of Bacillus cereus (class A enzyme) without pre-incubation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Bacillus cereus
181772,2492,2427,Beta-lactamase,Enzyme,D5HSX5,blaPER-6,D5HSX5_9GAMM,5.4,,IC50,Inhibition of Aeromonas allosaccharophila AL-1 beta-lactamase PER6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Aeromonas allosaccharophila
181773,2492,2097,Beta-lactamase,Enzyme,A8RR46,bcl1,A8RR46_BACCS,7.12,,IC50,Inhibition of Bacillus clausii NR beta-lactamase BCL1 expressed in Escherichia coli BL21 (DE3),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Bacillus clausii
181774,2492,2061,Beta-lactamase,Enzyme,A1E3K9,blaSCO-1,A1E3K9_ECOLX,5.21,,IC50,Inhibition of Escherichia coli beta-lactamase SCO1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Escherichia coli
181775,2492,1917,Beta-lactamase OXA-1,Enzyme,P13661,bla,BLO1_ECOLX,4.66,,IC50,Inhibitory activity against Beta-lactamase type OXA1 (penicillinase) from Escherichia coli OXA1 using ampicillin (40 uM) as a substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Escherichia coli
181776,2492,2387,Class D beta-lactamase,Unclassified,Q50H31,oxa-63,Q50H31_BRAPL,4.92,,IC50,Inhibition of Brachyspira pilosicoli beta-lactamase OXA-63 expressed in Escherichia coli BL21 (DE3) assessed as reduction in nitrocefin hydrolysis by spectrophotometry relative to oxacillin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL403,,,,,,,Brachyspira pilosicoli
181777,1767,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,7.08,,IC50,Tested for the ability to bind stereoselectively and enantioselectively to the dopamine transporter (DAT); Value ranges from 34 - 83 nM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796,,,,,,,Rattus norvegicus
181778,1767,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.96,,Ki,Displacement of [125I]RTI-55 from human DAT expressing HEK293 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796,INHIBITOR,,Tclin,,,Homo sapiens
181779,1767,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.18,,Ki,Displacement of [125I]RTI-55 from human NET expressing HEK293 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796,INHIBITOR,,Tclin,,,Homo sapiens
181780,1767,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,4.19,,Ki,Displacement of [125I]RTI-55 from human SERT expressing HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL796,,,,Tclin,,,Homo sapiens
181781,836,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,7.13,,Ki,Displacement of [3H]WIN-35428 from DAT in Sprague-Dawley rat striatum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL827,,,,,,,Rattus norvegicus
181782,836,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,7.08,,IC50,Potency of inhibiting [3H]WIN-35428 binding to dopamine receptor in rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL827,,,,,,,Rattus norvegicus
181783,836,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.8,,Ki,"Displacement of [3H]WIN-35,428 from human DAT expressed in mouse N2A cells after 15 mins by liquid scintillation counting",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL827,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL827,INHIBITOR,,Tclin,,,Homo sapiens
181784,836,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,6.57,,Ki,Displacement of [3H]nisoxetine from NET in Sprague-Dawley rat cortical tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL827,,,,,,,Rattus norvegicus
181785,1706,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,4.39,,IC50,Inhibition of mouse brain AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL314437,,,,,,,Mus musculus
181786,1706,1881,Cholinesterase,Enzyme,Q03311,Bche,CHLE_MOUSE,4.82,,IC50,Inhibition of mouse serum BChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL314437,,,,,,,Mus musculus
181787,2382,2289,Pteridine reductase 1,Enzyme,Q01782,PTR1,PTR1_LEIMA,5.4,,Ki,Inhibition of Leishmania major PTR1 by Lineweaver-Burk analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL744,,,,,,,Leishmania major
181788,1579,2875,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P04774|P04775|P08104,Scn1a|Scn2a|Scn3a,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,4.25,,IC50,Concentration required to inhibit [3H]BTX binding to Sodium channel of rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79,,,,,,,Rattus norvegicus
181789,1579,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,5.7,,IC50,Modulation of human Nav1.4 in open-inactivated state assessed as inhibition of inward current after 4 mins by whole-cell electrophysiology,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79,BLOCKER,,Tclin,,,Homo sapiens
181790,1579,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,4.54,,IC50,Modulation of human Nav1.7 in open-inactivated state assessed as inhibition of inward current after 4 mins by whole-cell electrophysiology,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79,BLOCKER,,Tclin,,,Homo sapiens
181791,1579,139,Sodium channel protein type 3 subunit alpha,Ion channel,Q9NY46,SCN3A,SCN3A_HUMAN,4.98,,IC50,Modulation of human Nav1.3 in open-inactivated state assessed as inhibition of inward current after 4 mins by whole-cell electrophysiology,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79,BLOCKER,,Tclin,,,Homo sapiens
181792,2048,344,Farnesyl pyrophosphate synthase,Enzyme,P14324,FDPS,FPPS_HUMAN,7.25,,Ki,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL676,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL676,INHIBITOR,,Tclin,,,Homo sapiens
181793,2048,3554,Hypoxanthine-guanine phosphoribosyltransferase,Unclassified,Q07010,HGPRT,HPRT_TRYBB,4.3,,Ki,Inhibition of hypoxanthine-guanine phosphoribosyltransferase (TcHPRT),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL676,,,,,,,Trypanosoma brucei brucei
181794,2048,1964,Farnesyl pyrophosphate synthase,Enzyme,Q0GKD7,,Q0GKD7_LEIDO,6.72,,Ki,Binding affinity towards Farnesyl diphosphate synthase from leishmania major,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL676,,,,,,,Leishmania donovani
181795,3770,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.12,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127810,,,,Tclin|Tclin|Tclin,,,Homo sapiens
181796,265,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.89,,IC50,Inhibition of specific [3H]clonidine binding (0.4 nM) to rat brain membranes alpha-2 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103986,,,,,,,Rattus norvegicus
181797,265,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,6.69,,IC50,Inhibition of specific [3H]-prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103986,,,,,,,Rattus norvegicus
181798,2270,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,6,,Ki,Binding affinity against Acetylcholinesterase of purified calf forebrain (CFB),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605,,,,,,,Bos taurus
181799,1505,2827,Soluble guanylate cyclase,Enzyme,O75343|P33402|Q02108|Q02153,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,GCYA2_HUMAN|GCYA3_HUMAN|GCYB1_HUMAN|GCYB2_HUMAN,,,,Mechanism of Action; CHEMBL2111348; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6622,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6622,ACTIVATOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181809,489,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,4.28,,Ki,Affinity for inactive human SkM1 sodium channel expressed in HEK293 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108,BLOCKER,,Tclin,,,Homo sapiens
181810,489,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,4.66,,IC50,Blockade of human Nav1.7 channel expressed in HEK293 cells by FRET assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108,BLOCKER,,Tclin,,,Homo sapiens
181811,1741,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,6.88,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Stylophora pistillata
181812,1741,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,6.77,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Thalassiosira weissflogii
181813,1741,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,7.19,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,Tclin,,,Homo sapiens
181814,1741,2835,Carbonic anhydrase,Enzyme,O43570|P00915|P00918|P07451|P22748|P23280|P35218|P43166|Q16790|Q8N1Q1|Q9ULX7|Q9Y2D0,CA1|CA12|CA13|CA14|CA2|CA3|CA4|CA5A|CA5B|CA6|CA7|CA9,CAH12_HUMAN|CAH13_HUMAN|CAH14_HUMAN|CAH1_HUMAN|CAH2_HUMAN|CAH3_HUMAN|CAH4_HUMAN|CAH5A_HUMAN|CAH5B_HUMAN|CAH6_HUMAN|CAH7_HUMAN|CAH9_HUMAN,7.7,,IC50,Evaluated for its activity against carbonic anhydrase (CA) in anesthetized rabbits,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181815,1741,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,6.92,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
181816,1741,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,8.05,,Ki,Inhibitory activity against human carbonic anhydrase II,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,INHIBITOR,,Tclin,,,Homo sapiens
181817,1741,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,7.37,,Ki,Inhibitory constant against human carbonic anhydrase XIV in CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,Tclin,,,Homo sapiens
181818,1741,2010,Carbonic anhydrase,Enzyme,Q50565,,Q50565_METTH,4.49,,Ki,Inhibitory activity against beta carbonic anhydrase (Cab) from Methanobacterium thermoautotrophicum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H)
181819,1741,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,8.68,,Ki,Ki value against human carbonic anhydrase VII,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,INHIBITOR,,Tclin,,,Homo sapiens
181820,1741,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,7.72,,Ki,Inhibitory activity against murine carbonic anhydrase XIII (mCA XIII) by using CO2 hydrase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Mus musculus
181821,1741,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,8.47,,Ki,Ki value against human carbonic anhydrase XII (hCA XII),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,Tclin,,,Homo sapiens
181822,1741,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.57,,Ki,Inhibitory activity against human carbonic anhydrase IX (hCA IX) by using CO2 hydrase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,Tclin,,,Homo sapiens
181823,1741,401,Carbonic anhydrase,Enzyme,O24855,cynT,CYNT_HELPY,6.77,,Ki,Inhibition of Helicobacter pylori recombinant CA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
181824,1741,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.19,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Mus musculus
181825,1741,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,7.67,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Stylophora pistillata
181826,1741,2837,Carbonic anhydrase V,Enzyme,P35218|Q9Y2D0,CA5A|CA5B,CAH5A_HUMAN|CAH5B_HUMAN,8.6,,Ki,Mean inhibitory constant towards human carbonic anhydrase V determined by spectrophotometric dansylamide binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,Tclin|Tclin,,,Homo sapiens
181827,1741,2143,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878,,P96878_MYCTU,6.25,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase Rv3273 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181828,1741,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.62,,Ki,"Inhibition of cloned isozyme, human carbonic anhydrase IV",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,INHIBITOR,,Tclin,,,Homo sapiens
181829,1741,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,7.85,,Ki,Inhibition of human carbonic anhydrase 1-catalyzed CO2 hydration preincubated for 10 mins by stopped-flow assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,INHIBITOR,,Tclin,,,Homo sapiens
181830,1741,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,6.49,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Astrosclera willeyana
181831,1741,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,7.21,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,Tclin,,,Homo sapiens
181832,1741,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,8.96,,Ki,Inhibition of human carbonic anhydrase 3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,Tclin,,,Homo sapiens
181833,1741,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,7.85,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
181834,1741,2009,Carbonic anhydrase,Enzyme,P40881,,CAH_METTE,6.85,,Ki,Inhibitory activity against alpha carbonic anhydrase (Zn-Cam) from Methanosarcina thermophila,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Methanosarcina thermophila
181835,1741,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,6.11,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181836,1741,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,6.18,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181837,1741,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,7.72,,Ki,Inhibition of human recombinant cytosolic carbonic anhydrase 13 preincubated for 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,Tclin,,,Homo sapiens
181838,1741,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,8,,Ki,Inhibition of full length human recombinant CA VI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,Tclin,,,Homo sapiens
181839,1741,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,7.44,,Ki,Compound was evaluated for inhibition against bovine carbonic anhydrase IV,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Bos taurus
181840,2862,1250,Bifunctional epoxide hydrolase 2,Enzyme,P34913,EPHX2,HYES_HUMAN,6.23,,IC50,Inhibition of human recombinant soluble epoxide hydrolase expressed in Escherichia coli using 3-phenyl-cyano(6-methoxy-2-naphthalenyl)methylester-2-oxiraneacetic acid as substrate after 30 mins by fluorescence-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93,,,,Tchem,,,Homo sapiens
181841,2862,900,Arachidonate 5-lipoxygenase-activating protein,Cytosolic other,P20292,ALOX5AP,AL5AP_HUMAN,5.66,,IC50,Inhibition of FLAP in human whole blood assessed as inhibition of calcium ionophore A23187-induced LTB4 production preincubated for 15 mins by ELISA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93,,,,Tchem,,,Homo sapiens
181842,2862,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,6.85,,IC50,Inhibition of 5-Lipoxygenase of rat basophilic leukemia cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93,,,,,,,Rattus norvegicus
181843,2862,878,Leukotriene B4 receptor 1,GPCR,Q15722,LTB4R,LT4R1_HUMAN,6.38,,IC50,In vitro activities of Leukotriene B4 receptor (LTB4) in human neutrophils,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93,,,,Tchem,,,Homo sapiens
181844,2862,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,6.52,,IC50,Inhibition of 5-LOX (unknown origin) using arachidonic acid as substrate after 5 mins by EIA,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93,INHIBITOR,,Tclin,,,Homo sapiens
181845,3053,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.26,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL124211,,,,Tclin|Tclin|Tclin,,,Homo sapiens
181846,2820,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,4.32,,Ki,Inhibition of [3H]- DA reuptake into rat striatal synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL251072,,,,,,,Rattus norvegicus
181847,2820,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,4.78,,Ki,Inhibition of [3H]5-HT reuptake into rat frontal cortex synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL251072,,,,,,,Rattus norvegicus
181848,2820,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.81,,Kd,Equilibrium dissociation constant (KD) for Competitive binding between [3H]WIN-35428 and the compound at human transporter-hDAT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL251072,,,,Tclin,,,Homo sapiens
181849,2820,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,6.77,,Ki,Inhibition of [3H]- NE reuptake into rat hippocampal synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL251072,,,,,,,Rattus norvegicus
181851,2820,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,4.76,,Kd,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- imipramine and the compound at human transporter-hSERT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL251072,,,,Tclin,,,Homo sapiens
181852,1523,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,6.21,,IC50,Inhibition of [3H]-MK-801 binding to NMDA receptor from rat cerebral cortical synaptic membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL742,,,,,,,Rattus norvegicus
181853,1523,2583,Acetylcholine receptor subunit alpha,Ion channel,P02710,CHRNA1,ACHA_TORCA,5.31,,IC50,Displacement of [3H]PCP from nAChR in Torpedo nobiliana electric organs membranes in presence of 100 uM carbachol by scintillation counting method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL742,,,,,,,Torpedo californica
181854,3534,3429,Sodium channel alpha subunit,Ion channel,P35498|P35499|Q01118|Q14524|Q15858|Q99250|Q9NY46|Q9UI33|Q9UQD0|Q9Y5Y9,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN|SCN4A_HUMAN|SCN5A_HUMAN|SCN7A_HUMAN|SCN8A_HUMAN|SCN9A_HUMAN|SCNAA_HUMAN|SCNBA_HUMAN,,,,Mechanism of Action; CHEMBL2331043; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201754,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201754,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181855,49,147,Adenosine receptor A2b,GPCR,P29275,ADORA2B,AA2BR_HUMAN,4.56,,Ki,"Binding affinity at human Adenosine A2B receptor expressed in HEK293 cells, using [125I]ABOPX as radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70246,,,,Tclin,,,Homo sapiens
181856,1958,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,7.59,,Ki,Inhibition of DAT in rat synaptosomal membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273575,,,,,,,Rattus norvegicus
181857,1958,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,6.06,,Ki,Inhibition of serotonin (5-HT) uptake into rat brain synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273575,,,,,,,Rattus norvegicus
181858,1958,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,8.4,,Ki,Inhibition of NET in rat synaptosomal membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273575,,,,,,,Rattus norvegicus
181859,1958,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,8.42,,Ki,Inhibition of uptake of tritiated norepinephrine (NE) in rat synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273575,,,,,,,Rattus norvegicus
181860,1958,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.85,,Ki,Inhibition of human recombinant SERT expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273575,,,,Tclin,,,Homo sapiens
181861,1575,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.42,,Ki,Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells in presence of 100 uM boric acid,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1002,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1002,AGONIST,,Tclin,,,Homo sapiens
181862,1491,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6,,Kd,Binding affinity to beta-2 adrenergic receptor (unknown origin) at 1 to 10000 nM,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200920,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200920,AGONIST,,Tclin,,,Homo sapiens
181863,105,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,6.28,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL714,,,,,,,Bos taurus
181864,105,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,5.94,,Kd,Binding affinity to adrenergic beta2 receptor in Hartley guinea pig tracheal ring,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL714,,,,,,,Cavia porcellus
181865,329,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,Mechanism of Action; CHEMBL222; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544906,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544906,RELEASING AGENT,,Tclin,,,Homo sapiens
181866,329,320,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,,,,Mechanism of Action; CHEMBL1893; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544906,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544906,INHIBITOR,,Tclin,,,Homo sapiens
181867,435,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.91,,IC50,Compound was tested for its ability to inhibit the neurotransmitter dopamine-DA reuptake system using [3H]dopamine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL894,,,,,,,Rattus norvegicus
181868,435,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,4.3,,IC50,Inhibitory concentration against Nicotinic acetylcholine receptor alpha 7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL894,,,,Tchem,,,Homo sapiens
181869,435,2802,Neuronal acetylcholine receptor; alpha3/beta2,Ion channel,P17787|P32297,CHRNA3|CHRNB2,ACHA3_HUMAN|ACHB2_HUMAN,6,,IC50,Inhibitory concentration against Nicotinic acetylcholine receptor alpha3-beta2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL894,,,,Tclin|Tclin,,,Homo sapiens
181870,435,2801,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P30926|P32297,CHRNA3|CHRNB4,ACHA3_HUMAN|ACHB4_HUMAN,5.74,,IC50,Inhibitory concentration against Nicotinic acetylcholine receptor alpha3-beta4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL894,,,,Tclin|Tclin,,,Homo sapiens
181917,2373,2637,NS5B protein,Enzyme,Q8JXU8,NS5B,Q8JXU8_9HEPC,,,,Mechanism of Action; CHEMBL5375; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1643,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1643,INHIBITOR,,,,,Hepatitis C virus
181871,435,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.16,,Ki,Displacement of [125I]RTI55 from cloned human NET expressed in HEK293 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL894,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL894,INHIBITOR,,Tclin,,,Homo sapiens
181872,1194,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,5.02,,IC50,In vitro inhibition of 5-lipoxygenase activity in RBL-1 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24924,,,,,,,Rattus norvegicus
181873,1429,553,Toll-like receptor 7,Membrane receptor,Q9NYK1,TLR7,TLR7_HUMAN,4.97,,EC50,Agonist activity at human TLR-7 expressed in HEK293 cells after 24 hrs by SEAP reporter gene assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1282,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1282,AGONIST,,Tclin,,,Homo sapiens
181874,2132,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.48,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1193,,,,Tclin|Tclin|Tclin,,,Homo sapiens
181875,2132,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action; CHEMBL231; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1193,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1193,ANTAGONIST,,Tclin,,,Homo sapiens
181876,2096,2801,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P30926|P32297,CHRNA3|CHRNB4,ACHA3_HUMAN|ACHB4_HUMAN,,,,Mechanism of Action; CHEMBL1907594; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1271,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1271,ANTAGONIST,,Tclin|Tclin,,,Homo sapiens
181877,3601,2287,Monoglyceride lipase,Enzyme,Q99685,MGLL,MGLL_HUMAN,6.01,,IC50,Inhibition of human MGL activity using [3H]2-oleoylglycerol substrate by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120563,,,,Tchem,,,Homo sapiens
181878,3601,59,Fatty-acid amide hydrolase 1,Enzyme,O00519,FAAH,FAAH1_HUMAN,4.35,,IC50,Inhibition of human recombinant FAAH-maltose binding protein,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120563,,,,Tchem,,,Homo sapiens
181879,2612,809,"Nitric oxide synthase, brain",Enzyme,P29475,NOS1,NOS1_HUMAN,5.95,,Kd,Activity of tetrahydrobiopterin free nNOS,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201774,,,,Tchem,,,Homo sapiens
181883,1663,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,6.52,,Ki,Inhibition of human recombinant AKR1C3 assessed as 1-acenaphthenol oxidation by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686,,,,Tchem,,,Homo sapiens
181884,1663,346,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,6.66,,Ki,Inhibition of human recombinant AKR1C2 assessed as 1-acenaphthenol oxidation by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686,,,,Tchem,,,Homo sapiens
181885,1663,955,Acetylcholinesterase,Enzyme,P04058,ache,ACES_TORCA,5.21,,IC50,Inhibition of Torpedo californica eel AChE using acetylthiocholine/DTNB as substrate assessed as ROS-induced enzyme inactivation preincubated for 10 mins followed by substrate addition measured every 30 secs for 20 mins in presence of horseradish peroxidase and H2O2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686,,,,,,,Torpedo californica
181886,1663,345,Aldo-keto reductase family 1 member C1,Enzyme,Q04828,AKR1C1,AK1C1_HUMAN,6.09,,Ki,Inhibition of human recombinant AKR1C1 assessed as 1-acenaphthenol oxidation by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686,,,,Tchem,,,Homo sapiens
181887,1856,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.7,,Ki,Binding affinity for human Alpha-2C adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19236,,,,Tclin,,,Homo sapiens
181888,1856,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,8.38,,Ki,Displacement of [125I]PIC from human imidazoline receptor 1 in human platelets analyzed under norepinephrine mask of alpha 2AR,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19236,http://www.ncbi.nlm.nih.gov/pubmed/8872297,AGONIST,,Tclin,,513,Homo sapiens
181889,1856,1733,Alpha-2B adrenergic receptor,GPCR,P19328,Adra2b,ADA2B_RAT,6,,Ki,Binding affinity for rat Alpha-2B adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19236,,,,,,,Rattus norvegicus
181890,1856,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.82,,Ki,Binding affinity for human Alpha-2A adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19236,,,,Tclin,,,Homo sapiens
181891,1154,2844,Cyclooxygenase,Enzyme,O62664|O62698,PTGS1|PTGS2,PGH1_BOVIN|PGH2_BOVIN,4.01,,IC50,Evaluated for the inhibition of Prostaglandin synthetase obtained from bovine seminal vesicles at the dose of 20 mg/kg (p.o.),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1297,,,,,,,Bos taurus
181892,2633,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,4.53,,IC50,The concentration required to inhibit 50% of binding of [35S]TBPS to Gamma-aminobutyric acid A receptor to rat whole brain membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL441,,,,,,,Rattus norvegicus
181893,694,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,5.22,,Kd,Binding affinity to rat recombinant L-FABP high affinity site expressed in Escherichia coli BL21(DE3) at 5 deg C by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL565,,,,,,,Rattus norvegicus
181894,394,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,Mechanism of Action; CHEMBL222; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095292,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095292,SUBSTRATE,,Tclin,,,Homo sapiens
181895,770,2566,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,Q5NGQ3,fabI,Q5NGQ3_FRATT,4.23,,IC50,Inhibition of C-terminal His6-tagged Francisella tularensis SCHU S4 FabI expressed in Escherichia coli BL21 (DE3) using CrCoA as substrate assessed as oxidation of NADH to NAD+ by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL803,,,,,,,Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4)
162914,722,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.42,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
181896,770,3433,DNA polymerase (alpha/delta/epsilon),Enzyme,P09884|P28340|Q07864,POLA1|POLD1|POLE,DPOD1_HUMAN|DPOE1_HUMAN|DPOLA_HUMAN,,,,Mechanism of Action; CHEMBL2363042; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL803,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL803,INHIBITOR,,Tclin|Tclin|Tclin,,,Homo sapiens
181897,99,2841,Melatonin receptor,GPCR,P49285|P49288|P51050,,MTR1A_CHICK|MTR1B_CHICK|MTR1C_CHICK,9.28,,Ki,Binding affinity is evaluated for chicken brain melatonin receptor using 2-[125I]iodomelatonin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10878,,,,,,,Gallus gallus
181898,99,2840,Melatonin receptor,GPCR,P48039|P49286,MTNR1A|MTNR1B,MTR1A_HUMAN|MTR1B_HUMAN,10,,Ki,Binding affinity against ovine pars tuberalis melatonin receptor using 2-[125I]- melatonin radioligand binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10878,,,,Tclin|Tclin,,,Homo sapiens
181899,99,378,Melatonin receptor type 1A,GPCR,P48039,MTNR1A,MTR1A_HUMAN,10.22,,Ki,Binding affinity for human Melatonin receptor type 1A stably transfected in human embryonic kidney cells (HEK 293) using 2-[125I]iodomelatonin as radioligand,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10878,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000916/WC500038317.pdf,AGONIST,,Tclin,,109,Homo sapiens
181900,99,379,Melatonin receptor type 1B,GPCR,P49286,MTNR1B,MTR1B_HUMAN,10,,Ki,Displacement of [125I]2-iodomelatonin from human recombinant MT2 receptor expressed in HEK293 cells after 2 hrs by gamma counting,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10878,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000916/WC500038317.pdf,AGONIST,,Tclin,,109,Homo sapiens
181901,1251,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.99,,Ki,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1279,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1279,AGONIST,,Tclin,,,Homo sapiens
181902,1251,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8.36,,Ki,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1279,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1279,AGONIST,,Tclin,,,Homo sapiens
181903,1251,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.21,,Ki,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1279,,,,Tclin,,,Homo sapiens
181904,2121,1372,"Glutamate receptor ionotropic, NMDA 1",Ion channel,P35439,Grin1,NMDZ1_RAT,7.28,,Ki,Binding affinity by displacement of [3H]TCP from PCP N-methyl-D-aspartate glutamate receptor of tissue homogenate preparation of rat brain without cerebellum (in vitro),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,,,,Rattus norvegicus
181905,2121,572,Lysosomal Pro-X carboxypeptidase,Enzyme,P42785,PRCP,PCP_HUMAN,7.04,,IC50,Inhibition of [3H]-TCP binding to PCP receptor obtained from tissue homogenate preparation of fresh whole rat brain minus cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,Tchem,,,Homo sapiens
181906,2121,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.96,,Ki,Compound was evaluated for its ability to displace [3H](+)-pentazocine from sigma receptor in Guinea pig brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,Tclin,,,Homo sapiens
181907,2121,2873,Muscarinic acetylcholine receptor,GPCR,P12657|P32211|Q920H4|Q9ERZ3|Q9ERZ4,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_MOUSE|ACM2_MOUSE|ACM3_MOUSE|ACM4_MOUSE|ACM5_MOUSE,5.04,,Kd,Dissociation constant towards Muscarinic acetylcholine receptor was determined by using [3H]4NMPB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,,,,Mus musculus
181908,2121,1839,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,Q00961,Grin2c,NMDE3_RAT,7.22,,Ki,Binding affinity against phencyclidine receptor was determined by the displacement of [3H]TCP of whole rat brain minus cerebellum.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,,,,Rattus norvegicus
181909,2121,1881,Cholinesterase,Enzyme,Q03311,Bche,CHLE_MOUSE,6.28,,Ki,Compound was evaluated for the protection of butyrylcholinesterase against DFT in mice,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,,,,Mus musculus
181910,2121,2816,Glutamate NMDA receptor; GRIN1/GRIN2B,Ion channel,Q05586|Q13224,GRIN1|GRIN2B,NMDE2_HUMAN|NMDZ1_HUMAN,5.9,,IC50,Inhibition of human recombinant NR1/NR2B receptor expressed in U2OS assessed as change in intracellular calcium level by FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,Tclin|Tclin,,,Homo sapiens
181911,2121,2817,Glutamate NMDA receptor; GRIN1/GRIN2A,Ion channel,Q05586|Q12879,GRIN1|GRIN2A,NMDE1_HUMAN|NMDZ1_HUMAN,6.4,,IC50,Inhibition of human recombinant NR1/NR2A receptor expressed in U2OS assessed as change in intracellular calcium level by FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,Tclin|Tclin,,,Homo sapiens
181912,2121,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,7.42,,Ki,Binding affinity was determined towards NMDA receptor using [3H]thienylcyclidine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,,,,Rattus norvegicus
181913,2121,2583,Acetylcholine receptor subunit alpha,Ion channel,P02710,CHRNA1,ACHA_TORCA,6.66,,IC50,Displacement of [3H]PCP from nAChR in Torpedo nobiliana electric organs membranes in presence of 100 uM carbachol by scintillation counting method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,,,,Torpedo californica
181914,2121,2778,Glutamate [NMDA] receptor,Ion channel,O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,NMD3A_HUMAN|NMD3B_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMDE4_HUMAN|NMDZ1_HUMAN,7.82,,Ki,"Affinity to NMDA receptor, using [3H]MK-801 as radioligand in pig brain cortex membranes",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181915,2121,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,6.28,,IC50,Inhibition of [3H]NANM binding to sigma receptor obtained from tissue homogenate preparation of fresh whole rat brain minus cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL275528,,,,,,,Rattus norvegicus
181916,2373,596,DNA topoisomerase 1,Enzyme,P11387,TOP1,TOP1_HUMAN,4.18,,IC50,Inhibition of human topoisomerase 1 activity assessed as DNA triplex formation and presence of supercoiled DNA by microplate assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1643,,,,Tclin,,,Homo sapiens
181918,25,272,DNA (cytosine-5)-methyltransferase 3A,Enzyme,Q9Y6K1,DNMT3A,DNM3A_HUMAN,,,,Mechanism of Action; CHEMBL1992; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1489,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1489,INHIBITOR,,Tclin,,,Homo sapiens
181919,1219,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,5.81,,IC50,"Inhibition of human recombinant N-terminal His6-tagged AKR1C3 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL563,,,,Tchem,,,Homo sapiens
181920,1219,1738,Prostaglandin G/H synthase 2,Enzyme,Q05769,Ptgs2,PGH2_MOUSE,6.3,,IC50,Inhibition of mouse COX2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL563,,,,,,,Mus musculus
181921,1219,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,5.93,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL563,,,,,,,Rattus norvegicus
181922,1219,869,"Fatty acid-binding protein, intestinal",Cytosolic other,P12104,FABP2,FABPI_HUMAN,4.59,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from I-FABP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL563,,,,Tchem,,,Homo sapiens
181923,1219,346,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,4.49,,IC50,"Inhibition of human recombinant N-terminal His6-tagged AKR1C2 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL563,,,,Tchem,,,Homo sapiens
181924,1219,1893,Prostaglandin G/H synthase 1,Enzyme,Q63921,Ptgs1,PGH1_RAT,6.77,,IC50,Concentration required to inhibit cyclooxygenase-1 in rat blood,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL563,,,,,,,Rattus norvegicus
181925,1219,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,6,,Ki,Binding affinity of compound towards prostaglandin G/H synthase 1 was evaluated,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL563,,,,,,,Ovis aries
181926,1109,443,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,9.3,,IC50,Inhibition of human CYP11B1 expressed in chinese hamster V79 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681,,,,Tclin,,,Homo sapiens
181927,1109,673,"Cytochrome P450 11B2, mitochondrial",Enzyme,P19099,CYP11B2,C11B2_HUMAN,10,,IC50,Inhibition of human CYP11B2 expressed in hamster V79MZ cells using 11-deoxycorticosterone substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681,,,,Tchem,,,Homo sapiens
181928,1109,1772,Acetylcholine receptor subunit delta,Ion channel,P02718,chrnd,ACHD_TORCA,4.3,,IC50,Inhibition of recombinant embryonic mouse muscle Nicotinic Acetylcholine Receptor (3 oocytes),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681,,,,,,,Torpedo californica
181929,155,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,4.72,,IC50,50% inhibition of specific [3H]clonidine binding (0.4 nM) to Alpha-2 adrenergic receptors in rat isolated brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL146408,,,,,,,Rattus norvegicus
181930,155,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,4.4,,IC50,Binding affinity against alpha-1 adrenergic receptor is the ability to inhibit the specific [3H]prazosin binding (0.4 nM) to rat isolated brain membranes by 50% was reported.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL146408,,,,,,,Rattus norvegicus
181931,3658,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.64,,IC50,Binding affinity against Alpha-2 adrenergic receptor is the ability to inhibit the specific [3H]clonidine binding (0.4 nM) to rat isolated brain membranes by 50% was reported; 2.3*10e-8,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL312448,,,,,,,Rattus norvegicus
181932,3658,2867,Adrenergic receptor alpha,GPCR,P15823|P19328|P22086|P22909|P23944|P43140,Adra1a|Adra1b|Adra1d|Adra2a|Adra2b|Adra2c,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT|ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.32,,Ki,Displacement of [3H]clonidine from alpha-adrenergic receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL312448,,,,,,,Rattus norvegicus
181933,3658,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.89,,Ki,Binding affinity towards human 5-hydroxytryptamine 1B receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL312448,,,,Tclin,,,Homo sapiens
181934,3658,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,9.15,,Ki,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL312448,,,,Tclin,,,Homo sapiens
181935,3658,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,6.24,,IC50,Binding affinity against alpha-1 adrenergic receptor is the ability to inhibit the specific [3H]prazosin binding (0.2 nM) to rat isolated brain membranes by 50% was reported; 5.8*10e-7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL312448,,,,,,,Rattus norvegicus
181936,3658,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.04,,Ki,Binding affinity towards human Alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL312448,,,,Tclin,,,Homo sapiens
181937,229,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.52,,Ki,Compound was tested in vitro for binding affinity against Alpha-2C adrenergic receptor from cloned human C-2 receptor transfected into Chinese hamster ovary (CHO) cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL647,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL647,AGONIST,,Tclin,,,Homo sapiens
181938,229,2856,Adrenergic receptor alpha-1,GPCR,P25100|P35348|P35368,ADRA1A|ADRA1B|ADRA1D,ADA1A_HUMAN|ADA1B_HUMAN|ADA1D_HUMAN,6.74,,Ki,Compound was tested for binding affinity based on dissociation constant of Alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL647,,,,Tclin|Tclin|Tclin,,,Homo sapiens
181939,229,1733,Alpha-2B adrenergic receptor,GPCR,P19328,Adra2b,ADA2B_RAT,8.32,,Ki,Compound was tested in vitro for binding affinity against Alpha-2B adrenergic receptor from cloned rat RNG receptor transfected into Chinese hamster ovary (CHO) cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL647,,,,,,,Rattus norvegicus
181988,1027,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,8.8,,IC50,Potency against histamine H1 receptor on guinea pig ileum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1106,,,,,,,Cavia porcellus
181940,229,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8.54,,Ki,Compound was tested in vitro for binding affinity against Alpha-2A adrenergic receptor from cloned human C-10 receptor transfected into Chinese hamster ovary (CHO) cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL647,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL647,AGONIST,,Tclin,,,Homo sapiens
181941,2173,217,ATP-binding cassette sub-family C member 9,Ion channel,O60706,ABCC9,ABCC9_HUMAN,5.45,,EC50,Channel opening activity at SUR2B/Kir6.2 potassium ATP channel in human TE671 cells assessed as isometric force by FLIPR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1159,,,,Tclin,,,Homo sapiens
181942,2173,2813,"Sulfonylurea receptor 2, Kir6.2",Ion channel,O60706|Q14654,ABCC9|KCNJ11,ABCC9_HUMAN|KCJ11_HUMAN,6.49,,Ki,Binding affinity was determined by displacement of [3H]P1075 from its binding sites in canine cardiac membranes,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1159,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1159,OPENER,,Tclin|Tclin,,,Homo sapiens
181943,3511,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,8.1,,Ki,Displacement of [3H]WIN-35428 from human dopamine transporter expressed in mouse N2A cells by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL201960,,,,Tclin,,,Homo sapiens
181944,3511,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.71,,Ki,Displacement of [125I]RTI-55 from human NET expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL201960,,,,Tclin,,,Homo sapiens
181945,3511,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.42,,Ki,Displacement of [125I]RTI-55 from human SERT expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL201960,,,,Tclin,,,Homo sapiens
181946,847,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,7.42,,EC50,Agonist activity at human cloned mu opioid receptor by [35S]GTPgammaS binding assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1685,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1685,PARTIAL AGONIST,,Tclin,,,Homo sapiens
181947,1343,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,7.72,,Ki,Displacement of [125I]PIC from human imidazoline receptor 1 in human platelets analyzed under norepinephrine mask of alpha 2AR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL862,,,,Tclin,,,Homo sapiens
181948,1184,1790,Thymidylate synthase,Enzyme,P07607,Tyms,TYSY_MOUSE,9.4,,IC50,Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 4 hrs by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL917,,,,,,,Mus musculus
181949,1615,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.19,,IC50,Inhibitory potency against Prostaglandin G/H synthase 1 in human whole blood assay,CHEMBL,=,1,KEGG DRUG,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19299,http://www.kegg.jp/entry/D08149,INHIBITOR,,Tclin,,,Homo sapiens
181950,1615,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5,,IC50,Inhibition of COX2 in human whole blood assessed as PGE2 biosynthesis after 24 hrs by EIA,CHEMBL,=,1,KEGG DRUG,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19299,http://www.kegg.jp/entry/D08149,INHIBITOR,,Tclin,,,Homo sapiens
181951,1808,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,4.43,,IC50,"Displacement of 3,4-[ring-2,5,6-3H]dihydroxyphenylethylamine from rat synaptosomal DAT expressed in HEK293 cells by microplate scintillation counter",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL259209,,,,,,,Rattus norvegicus
181952,1808,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,7.33,,IC50,"Displacement of [alpha,beta-3H(N)]-5-hydroxytryptamine from rat synaptosomal SERT expressed in HEK293 cells by microplate scintillation counter",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL259209,,,,,,,Rattus norvegicus
181953,1808,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,7.52,,IC50,"Displacement of Levo[ring-2,5,6-3H]norepinephrine from rat synaptosomal NET expressed in HEK293 cells by microplate scintillation counter",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL259209,,,,,,,Rattus norvegicus
181954,1808,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.21,,IC50,Inhibition of human DAT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL259209,,,,Tclin,,,Homo sapiens
181955,3506,580,P2X purinoceptor 1,Ion channel,P51575,P2RX1,P2RX1_HUMAN,5,,IC50,Antagonist activity at P2X1 receptor (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL82202,,,,Tchem,,,Homo sapiens
181956,1003,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,,,,Mechanism of Action; CHEMBL247; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL885,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL885,INHIBITOR,,,,,Human immunodeficiency virus 1
181957,1690,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,6.39,,Ki,Displacement of [3H]paroxetine from serotonin transporter (SERT),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL607,,,,,,,Rattus norvegicus
181958,1690,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,4.75,,Ki,Displacement of [3H]WIN-35428 from dopamine transporter (DAT),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL607,,,,,,,Rattus norvegicus
181959,1690,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.04,,Ki,Inhibition of [3H]DAMGO binding to mu-opioid receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL607,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL607,AGONIST,,Tclin,,,Homo sapiens
181960,1690,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.49,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL607,,,,Tclin,,,Homo sapiens
181961,1690,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,6.35,,Ki,Binding affinity against mu opioid receptor was determined in brain membrane preparations from male Hartley guinea-pigs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL607,,,,,,,Cavia porcellus
181962,1690,2894,Opioid receptor,GPCR,O55242|P32300|P33534|P42866,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_MOUSE|OPRK_MOUSE|OPRM_MOUSE|SGMR1_MOUSE,6.3,,IC50,Tested for displacement of radioligand [3H]-Naloxone from opiate receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL607,,,,,,,Mus musculus
181963,1690,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,6.15,,EC50,Displacement of radiolabeled dihydromorphine from opioid receptor in rat brain homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL607,,,,,,,Rattus norvegicus
181964,1526,2894,Opioid receptor,GPCR,O55242|P32300|P33534|P42866,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_MOUSE|OPRK_MOUSE|OPRM_MOUSE|SGMR1_MOUSE,5.15,,IC50,Tested for displacement of radioligand [3H]-Naloxone from opiate receptor; value ranges from 7-10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL47072,,,,,,,Mus musculus
181965,1526,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,8.7,,EC50,Displacement of radiolabeled dihydromorphine from opioid receptor in rat brain homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL47072,,,,,,,Rattus norvegicus
181966,1014,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,5.54,,IC50,Inhibition of canine heart Phosphodiesterase 4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL249856,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181967,782,436,Dihydrofolate reductase,Enzyme,P16184,,DYR_PNECA,5.82,,IC50,Inhibitory activity was determined against dihydrofolate reductase in Pneumocystis carinii. ,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1043,,,,,,,Pneumocystis carinii
181968,782,3555,"Dihydropteroate synthetase, putative",Unclassified,Q4Z710,,Q4Z710_PLABA,4.91,,IC50,Inhibitory activity against dihydropteroic acid synthase (SYN) from Plasmodium berghei,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1043,,,,,,,Plasmodium berghei (strain Anka)
181969,782,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.74,,Ki,Antagonist activity at recombinant human 5-HT6 receptor expressed in HEK293 cells assessed as 5-HT-induced intracellular cAMP production after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1043,,,,Tchem,,,Homo sapiens
181970,2176,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,4.53,,Ki,Binding affinity to 5-hydroxytryptamine 2 receptor in rat frontal cortical membranes by [3H]- KET displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500,,,,,,,Rattus norvegicus
181971,2176,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,7,,Ki,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500,,,,,,,Rattus norvegicus
181972,2176,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,7.1,,Ki,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500,,,,,,,Rattus norvegicus
181973,2176,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,7.7,,Ki,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500,,,,,,,Rattus norvegicus
181974,2176,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,4.27,,Ki,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500,,,,Tclin,,,Homo sapiens
181975,2176,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6.78,,Kd,Displacement of [3H]-CGP 12177 from human beta-3 adrenergic receptor expressed in CHOK1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500,,,,Tclin,,,Homo sapiens
181976,2332,1124,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,P13922,,DRTS_PLAFK,9.72,,Ki,Inhibitor constant of compound for Plasmodium falciparum dihydrofolate reductase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36,INHIBITOR,,,,,Plasmodium falciparum
181977,2332,436,Dihydrofolate reductase,Enzyme,P16184,,DYR_PNECA,8.01,,Ki,Binding affinity was reported with purified recombinant Pneumocystis carinii Dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36,,,,,,,Pneumocystis carinii
181978,2332,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,8.1,,Ki,Cytotoxicity by selective inhibition against human dihydrofolate reductase (DHFR).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36,,,,Tclin,,,Homo sapiens
181979,2332,2610,Multidrug and toxin extrusion protein 1,Unclassified,Q8K0H1,Slc47a1,S47A1_MOUSE,6.84,,Ki,Inhibition of mouse Mate1 transfected in HEK293 cells assessed as uptake of [14C]-TEA preincubated for 15 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36,,,,,,,Mus musculus
181980,2332,1906,Dihydrofolate reductase,Enzyme,P22906,DFR1,DYR_CANAX,5.3,,IC50,Inhibition of dihydrofolate reductase in Candida albicans (in vitro).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36,,,,,,,Candida albicans
181981,2332,1752,Dihydrofolate reductase,Enzyme,Q920D2,Dhfr,DYR_RAT,5.85,,IC50,In vitro inhibitory concentration against rat liver dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36,,,,,,,Rattus norvegicus
181982,2332,2102,Dihydrofolate reductase,Unclassified,B0BL08,dfrA17,B0BL08_ECOLX,8.92,,Ki,Inhibitor constant of compound for mutant T46A Escherichia coli dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36,,,,,,,Escherichia coli
181983,2332,2609,Solute carrier family 22 member 1,Unclassified,O08966,Slc22a1,S22A1_MOUSE,5.44,,Ki,Inhibition of mouse Oct1 transfected in HEK293 cells assessed as uptake of [14C]-TEA preincubated for 15 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36,,,,,,,Mus musculus
181984,112,344,Farnesyl pyrophosphate synthase,Enzyme,P14324,FDPS,FPPS_HUMAN,7.35,,Ki,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL675,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL675,INHIBITOR,,Tclin,,,Homo sapiens
181985,112,1964,Farnesyl pyrophosphate synthase,Enzyme,Q0GKD7,,Q0GKD7_LEIDO,7.02,,Ki,Binding affinity towards Farnesyl diphosphate synthase from leishmania major,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL675,,,,,,,Leishmania donovani
181986,3101,446,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,Q9Y233,PDE10A,PDE10_HUMAN,3.9,,Kd,Binding affinity to human PDE10A catalytic domain expressed in Escherichia coli BL21-Gold(DE3) after 15 mins by SPR inhibition in solution assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL348000,,,,Tclin,,,Homo sapiens
181987,2524,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL700,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL700,INHIBITOR,,,,,Escherichia coli (strain K12)
181989,1027,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.53,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1106,,,,Tchem,,,Homo sapiens
181990,1027,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.96,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1106,,,,Tchem,,,Homo sapiens
181991,1027,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.37,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1106,,,,Tchem,,,Homo sapiens
181992,137,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,8.53,,IC50,Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-2 adrenergic receptor in calf lung membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266195,,,,,,,Bos taurus
181993,137,1755,Squalene synthase,Enzyme,Q02769,Fdft1,FDFT_RAT,5.38,,IC50,Inhibition of rat microsomal squalene synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266195,,,,,,,Rattus norvegicus
181994,137,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6.86,,Kd,Displacement of [3H]-CGP 12177 from human beta-3 adrenergic receptor expressed in CHOK1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266195,,,,Tclin,,,Homo sapiens
181995,880,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.03,,Ki,Inhibition of human carbonic anhydrase 2 esterase activity by non-competitive Lineweaver-Burke plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL898,,,,Tclin,,,Homo sapiens
181996,880,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.07,,Ki,Inhibition of human carbonic anhydrase 1 esterase activity by noncompetitive Lineweaver-Burke plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL898,,,,Tclin,,,Homo sapiens
181997,2500,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,4.68,,IC50,Inhibition of aurora kinase A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439,,,,Tchem,,,Homo sapiens
181998,2500,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439,INHIBITOR,,,,,Escherichia coli (strain K12)
181999,1285,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,5.73,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL457,,,,,,,Rattus norvegicus
182000,2392,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,6.21,,IC50,Inhibition of bovine AChE after 120 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL636,,,,,,,Bos taurus
182001,2392,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,7.43,,IC50,Inhibition of human erythrocytes BChE,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL636,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6602,INHIBITOR,,Tclin,,,Homo sapiens
182002,2392,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,5.38,,IC50,Inhibition of electric eel AChE preincubated for 5 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL636,,,,,,,Electrophorus electricus
182003,2392,1791,Acetylcholinesterase,Enzyme,P37136,Ache,ACES_RAT,5.74,,IC50,In vitro inhibitory concentration against rat cortex acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL636,,,,,,,Rattus norvegicus
182004,2392,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,5.95,,IC50,Inhibition of Swiss albino mouse RBC AChE after 30 mins by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL636,,,,,,,Mus musculus
182005,2392,1774,Butyrylcholinesterase; Protein Bche,Enzyme,Q9JKC1,Bche,Q9JKC1_RAT,6.46,,IC50,In vitro inhibitory concentration against butyrylcholinesterase was determined using rat serum homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL636,,,,,,,Rattus norvegicus
182006,2392,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,7.52,,IC50,Inhibition of human recombinant butyrylcholinesterase,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL636,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6602,INHIBITOR,,Tclin,,,Homo sapiens
182007,2392,1881,Cholinesterase,Enzyme,Q03311,Bche,CHLE_MOUSE,5.8,,IC50,Inhibition of mouse serum BChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL636,,,,,,,Mus musculus
182008,2392,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,6.08,,IC50,Inhibition of horse serum BChE preincubated for 5 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL636,,,,,,,Equus caballus
182009,2392,2007,Butyrylcholinesterase,Enzyme,Q9N1N9,BCHE,Q9N1N9_HORSE,6.8,,IC50,Inhibition of equine BuChE after 120 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL636,,,,,,,Equus caballus
182010,754,1124,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,P13922,,DRTS_PLAFK,8.96,,Ki,Inhibition constant against Plasmodium falciparum dihydrofolate reductase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL747,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL747,INHIBITOR,,,,,Plasmodium falciparum
182011,754,436,Dihydrofolate reductase,Enzyme,P16184,,DYR_PNECA,7.63,,Ki,Binding affinity was reported with purified recombinant Pneumocystis carinii Dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL747,,,,,,,Pneumocystis carinii
182012,754,1786,Dihydrofolate reductase,Enzyme,P00381,folA,DYR_LACCA,4.76,,Ki,Inhibitory activity against Lactobacillus casei dihydrofolate reductase (DHFR),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL747,,,,,,,Lactobacillus casei
182013,754,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,7.25,,Ki,Binding affinity to human recombinant DHFR expressed in Escherichia coli BL21(DE3) by competitive binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL747,,,,Tclin,,,Homo sapiens
182014,754,1956,Dihydrofolate reductase,Enzyme,P00378,DHFR,DYR_CHICK,6.95,,Ki,Inhibitory activity against isolated chicken liver dihydrofolate reductase (DHFR),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL747,,,,,,,Gallus gallus
182015,754,1752,Dihydrofolate reductase,Enzyme,Q920D2,Dhfr,DYR_RAT,6.96,,IC50,Inhibitory activity against dihydrofolate reductase in rat liver.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL747,,,,,,,Rattus norvegicus
182016,222,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,5.04,,IC50,In vitro inhibition of 5-lipoxygenase activity in RBL-1 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL712,,,,,,,Rattus norvegicus
182017,2152,2875,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P04774|P04775|P08104,Scn1a|Scn2a|Scn3a,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,4.4,,IC50,In vitro inhibition of Voltage-gated sodium channel by the displacement of [3H]batrachotoxin A 20-alpha-benzoate in rat brain cerebral cortex synaptoneurosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,,,,,,,Rattus norvegicus
182018,2152,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,4.62,,Ki,Affinity for inactive human SkM1 sodium channel expressed in HEK293 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,BLOCKER,,Tclin,,,Homo sapiens
182019,2152,1798,Sodium channel protein type 2 subunit alpha,Ion channel,P04775,Scn2a,SCN2A_RAT,4.66,,IC50,Inhibition of rat Nav1.2 channel expressed in chinese hamster CHL1610 cells at preconditioning pulse of -67 mV after 2 to 3 mins by whole-cell patch-clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,,,,,,,Rattus norvegicus
182020,645,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.92,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30,,,,Tchem,,,Homo sapiens
182021,645,1747,Histamine H2 receptor,GPCR,P47747,HRH2,HRH2_CAVPO,6.58,,Kd,In vitro inhibitory activity against histamine H2-receptor in isolated Guinea pig right atria.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30,,,,,,,Cavia porcellus
182022,2079,2062,Thymidine kinase,Kinase,A3RLP8,UL23,A3RLP8_CHV1,4.07,,IC50,Inhibition of Herpes B virus recombinant thymidine kinase-mediated [3H]TdR phosphorylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1540,,,,,,,Cercopithecine herpesvirus 1
182023,2079,72,Thymidine kinase,Kinase,Q9QNF7,TK,KITH_HHV1,4.96,,IC50,Inhibition of recombinant HSV-1 TK assessed as [CH3-H3]dThd phosphorylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1540,,,,,,,Human herpesvirus 1
182024,2728,2289,Pteridine reductase 1,Enzyme,Q01782,PTR1,PTR1_LEIMA,5.47,,Ki,Inhibition of Leishmania major recombinant PTR1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL585,,,,,,,Leishmania major
182025,2514,436,Dihydrofolate reductase,Enzyme,P16184,,DYR_PNECA,7,,IC50,Inhibitory activity against dihydrofolate reductase in Pneumocystis carinii in the prence of 100 micro M PABA.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL443,,,,,,,Pneumocystis carinii
182026,2514,1807,Endothelin-1 receptor,GPCR,P26684,Ednra,EDNRA_RAT,5.4,,IC50,Antagonism of [125 I]ET-1 binding to the rat endothelin receptor in vascular smooth muscle VSM-A10 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL443,,,,,,,Rattus norvegicus
182027,2514,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,8,,Ki,Inhibition constant for human immunodeficiency virus type 1 protease,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL443,,,,,,,Human immunodeficiency virus 1
182028,2514,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,5.33,,IC50,In vitro inhibition of dihydropteroate synthase from Escherichia coli.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL443,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL443,INHIBITOR,,,,,Escherichia coli (strain K12)
182029,3194,728,Telomerase reverse transcriptase,Enzyme,O14746,TERT,TERT_HUMAN,5.09,,IC50,Inhibitory activity against telomerase (Compound released from RNA/DNA heteroduplex derivatized resin [sequence (TTAGGG)3),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94007,,,,Tchem,,,Homo sapiens
182030,2683,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,7.55,,Ki,Displacement of [125I]PIC from human imidazoline receptor 1 in human platelets analyzed under norepinephrine mask of alpha 2AR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1079,,,,Tclin,,,Homo sapiens
182031,976,121,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,,,,Mechanism of Action; CHEMBL241; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1752,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1752,INHIBITOR,,Tclin,,,Homo sapiens
182032,1684,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,4.09,,IC50,Inhibitory activity measured against rat lens aldose reductase using 3-pyridinecarboxaldehyde as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107211,,,,,,,Rattus norvegicus
182033,1528,2844,Cyclooxygenase,Enzyme,O62664|O62698,PTGS1|PTGS2,PGH1_BOVIN|PGH2_BOVIN,5.47,,IC50,Evaluated for the inhibition of Prostaglandin synthetase obtained from bovine seminal vesicles at the dose of 4 mg/kg p.o.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL571,,,,,,,Bos taurus
182034,1145,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,5.09,,IC50,Inhibition of ovine COX2 by enzyme-immuno assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL277522,,,,,,,Ovis aries
182035,1145,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,5.41,,IC50,Inhibition of ovine COX1 by enzyme-immuno assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL277522,,,,,,,Ovis aries
182036,833,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,8.72,,IC50,Concentration required for 50% inhibition against Prostaglandin G/H synthase 1 from human,CHEMBL,=,1,KEGG DRUG,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75435,http://www.kegg.jp/entry/D07269,INHIBITOR,,Tclin,,,Homo sapiens
182037,833,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,7.57,,IC50,Concentration required for 50% inhibition against Prostaglandin G/H synthase 2 from human,CHEMBL,=,1,KEGG DRUG,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75435,http://www.kegg.jp/entry/D07269,INHIBITOR,,Tclin,,,Homo sapiens
182038,2626,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,,,,Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
182206,1796,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.2,,Ki,Binding affinity towards 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182039,1277,3530,Purine nucleoside phosphorylase,Unclassified,P9WP01,punA,PUNA_MYCTU,4.8,,Kd,Binding affinity to Mycobacterium tuberculosis purine nucleoside phosphorylase by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
182040,2238,1893,Prostaglandin G/H synthase 1,Enzyme,Q63921,Ptgs1,PGH1_RAT,6.41,,IC50,"Inhibitory activity against COX-1 from rat peritoneal leukocytes, measured by PGE-2 produced (enzyme immunoassay)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL367463,,,,,,,Rattus norvegicus
182041,2238,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,5.51,,IC50,Inhibitory activity against COX-1 from ram seminal vesicles,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL367463,,,,,,,Ovis aries
182042,1529,1877,Prostaglandin-H2 D-isomerase,Enzyme,O09114,Ptgds,PTGDS_MOUSE,6.64,,IC50,Concentration required to inhibit 50% activity of prostaglandin synthetase was determined in vitro in mouse brain microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL469,,,,,,,Mus musculus
182043,1529,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,4.94,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL469,,,,,,,Rattus norvegicus
182044,1899,2844,Cyclooxygenase,Enzyme,O62664|O62698,PTGS1|PTGS2,PGH1_BOVIN|PGH2_BOVIN,6.7,,IC50,Inhibition of PG synthetase activity obtained from bovine seminal vesicles,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1021,,,,,,,Bos taurus
182045,1899,2845,Cyclooxygenase,Enzyme,P35355|Q63921,Ptgs1|Ptgs2,PGH1_RAT|PGH2_RAT,7,,IC50,Inhibitory activity against Prostaglandin G/H synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1021,,,,,,,Rattus norvegicus
182046,2527,1807,Endothelin-1 receptor,GPCR,P26684,Ednra,EDNRA_RAT,4.16,,IC50,Antagonism of [125 I]ET-1 binding to the rat endothelin receptor in vascular smooth muscle VSM-A10 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL437,,,,,,,Rattus norvegicus
182047,2527,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,5.6,,IC50,In vitro inhibition of dihydropteroate synthase from Escherichia coli.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL437,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL437,INHIBITOR,,,,,Escherichia coli (strain K12)
182048,2150,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.56,,Ki,Binding affinity for human recombinant dopamine receptor D2L,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL186720,,,,Tclin,,,Homo sapiens
182049,2150,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.38,,Ki,Binding affinity for human recombinant dopamine receptor D5,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL186720,,,,Tchem,,,Homo sapiens
182050,2150,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.46,,Ki,Binding affinity for human recombinant dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL186720,,,,Tclin,,,Homo sapiens
182051,2150,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.56,,Ki,Binding affinity for human recombinant dopamine receptor D4.4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL186720,,,,Tchem,,,Homo sapiens
182052,916,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,4.37,,Ki,"Displacement of [3H]histamine from human H4R expressed in Sf9 cells co-expressing RGS19, Galphai2 and Gbeta1gamma2 after 60 mins by liquid scintillation counting",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL657,,,,Tchem,,,Homo sapiens
182053,916,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,9,,IC50,Antihistaminic activity against Histamine H1 receptor was measured on isolated terminal part of guinea pig ileum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL657,,,,,,,Cavia porcellus
182054,916,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.59,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL657,,,,Tclin,,,Homo sapiens
182055,916,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.22,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL657,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182056,256,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.85,,Ki,Inhibition of [3H]- DA reuptake into rat striatal synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL641,,,,,,,Rattus norvegicus
182057,256,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,7.37,,Ki,Inhibition of [3H]5-HT reuptake into rat frontal cortex synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL641,,,,,,,Rattus norvegicus
182058,256,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,8.4,,Ki,Displacement of [3H]nisoxetine from Sprague-dawley rat NET by liquid scintillation spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL641,,,,,,,Rattus norvegicus
182059,256,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.97,,Kd,Equilibrium dissociation constant (KD) for Competitive binding between [3H]WIN-35428 and the compound at human transporter-hDAT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL641,,,,Tclin,,,Homo sapiens
182060,256,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,9.15,,Ki,Inhibition of [3H]- NE reuptake into rat hippocampal synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL641,,,,,,,Rattus norvegicus
182061,256,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,8.69,,Kd,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL641,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL641,INHIBITOR,,Tclin,,,Homo sapiens
182062,256,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.68,,IC50,Inhibition of human ERG expressed in HEK293 cells by patch-clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL641,,,,Tclin,,,Homo sapiens
182063,256,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.05,,Kd,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- imipramine and the compound at human transporter-hSERT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL641,,,,Tclin,,,Homo sapiens
182064,2762,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.4,,IC50,Inhibitory activity against human Histamine H1 receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1241,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1241,ANTAGONIST,,Tclin,,,Homo sapiens
182065,209,693,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Enzyme,O00408,PDE2A,PDE2A_HUMAN,4.47,,IC50,Inhibition of human platelet PDE by inhibiting cyclic Guanosine monophosphate (cGMP) hydrolysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL760,,,,Tclin,,,Homo sapiens
182066,1540,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,4.02,,IC50,Inhibition of human recombinant Nav1.8 channel expressed in HEK293 cells by whole cell voltage clamp technique,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,BLOCKER,,Tclin,,,Homo sapiens
182067,1540,2875,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P04774|P04775|P08104,Scn1a|Scn2a|Scn3a,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,4.51,,IC50,Concentration required to inhibit [3H]BTX binding to Sodium channel of rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,,,,,,,Rattus norvegicus
182068,1540,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,4.21,,IC50,Inhibition of human recombinant Nav1.5 channel expressed in HEK293 cells by whole cell voltage clamp technique,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,BLOCKER,,Tclin,,,Homo sapiens
182069,1540,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,4.77,,Ki,Affinity for inactive human SkM1 sodium channel expressed in HEK293 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,BLOCKER,,Tclin,,,Homo sapiens
182070,1540,3536,Sodium channel protein type X alpha subunit,Unclassified,Q62968,Scn10a,SCNAA_RAT,4.6,,IC50,Blockade of Nav1.8 channel in rat dorsal root ganglion neurons assessed as inhibition of TTX-R current by whole cell patch clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,,,,,,,Rattus norvegicus
182071,1540,138,Sodium channel protein type 2 subunit alpha,Ion channel,Q99250,SCN2A,SCN2A_HUMAN,5,,IC50,Inhibition of human recombinant Nav1.2 channel expressed in HEK293 cells by whole cell voltage clamp technique,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,BLOCKER,,Tclin,,,Homo sapiens
182072,1540,1798,Sodium channel protein type 2 subunit alpha,Ion channel,P04775,Scn2a,SCN2A_RAT,4.46,,IC50,Inhibition of rat Nav1.2 channel expressed in chinese hamster CHL1610 cells at preconditioning pulse of -67 mV after 2 to 3 mins by whole-cell patch-clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741,,,,,,,Rattus norvegicus
182073,3173,2062,Thymidine kinase,Kinase,A3RLP8,UL23,A3RLP8_CHV1,6.82,,IC50,Inhibition of Herpes B virus recombinant thymidine kinase-mediated [3H]TdR phosphorylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL318153,,,,,,,Cercopithecine herpesvirus 1
182074,982,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,,,,Mechanism of Action; CHEMBL220; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200367,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200367,INHIBITOR,,Tclin,,,Homo sapiens
182075,3111,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,5.3,,IC50,In vitro inhibition of 5-lipoxygenase activity in RBL-1 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL278519,,,,,,,Rattus norvegicus
182076,511,2087,Acid ceramidase,Enzyme,Q6P7S1,Asah1,ASAH1_RAT,7.54,,IC50,Inhibition of rat recombinant acid ceramidase expressed in human HEK293 cells using N-lauroylceramide as substrate incubated for 30 mins prior to substrate addition measured after 30 mins by LC/MS analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460499,,,,,,,Rattus norvegicus
182077,2699,1255,Interleukin-8,Cytokine,P10145,CXCL8,IL8_HUMAN,7.05,,IC50,Inhibition of CXCL8-induced chemotaxis in human polymorphonuclear leukocyte pretreated for 15 mins measured after 4 hrs by cell migration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1020,,,,Tchem,,,Homo sapiens
182078,2699,613,Lactoylglutathione lyase,Enzyme,Q04760,GLO1,LGUL_HUMAN,4.06,,Ki,Inhibition of glyoxalase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1020,,,,Tchem,,,Homo sapiens
182079,2699,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,5.62,,IC50,Inhibition of Homo sapiens (human) aldose reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1020,,,,Tclin,,,Homo sapiens
182080,1574,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,8.64,,Ki,Inhibition of [3H]U-69593 binding to Opioid receptor kappa 1 of Chinese hamster ovary membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,Tclin,,,Homo sapiens
182081,1574,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,8.38,,Ki,Inhibition of [3H]naltrindole binding to opioid receptor delta 1 of Chinese hamster ovary membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,Tclin,,,Homo sapiens
182082,1574,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.68,,Ki,Inhibition of [3H]-DAMGO binding to Opioid receptor mu 1 of Chinese hamster ovary membrane,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,AGONIST,,Tclin,,,Homo sapiens
182083,1574,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,8.64,,Ki,"Binding affinity against opioid receptor kappa 1 using [3H]-U-69,593 as radioligand in guinea pig brain membranes.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,,,,Cavia porcellus
182084,1574,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,4.6,,Ki,Inhibition of electric eel AChE by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,,,,Electrophorus electricus
182085,1574,1758,Mu-type opioid receptor,GPCR,P42866,Oprm1,OPRM_MOUSE,9.52,,Ki,Binding affinity for mouse opioid receptor mu,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,,,,Mus musculus
182086,1574,1857,Kappa-type opioid receptor,GPCR,P33534,Oprk1,OPRK_MOUSE,8,,Ki,Binding affinity for mouse opioid receptor kappa,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,,,,Mus musculus
182087,1574,1999,Sigma non-opioid intracellular receptor 1,Membrane receptor,O55242,Sigmar1,SGMR1_MOUSE,8.72,,Ki,Binding affinity for mouse sigma opioid receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,,,,Mus musculus
162916,395,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.2596,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL844,AGONIST,,Tclin,,,Homo sapiens
182088,1574,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,5.92,,IC50,Binding affinity against PCP binding site associated with N-methyl-D-aspartate glutamate receptor from rat synaptic plasma membrane(SPM) determined using [3H]TCP as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,,,,Rattus norvegicus
182089,1574,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,9.68,,Ki,Binding affinity against opioid receptor mu 1 using [3H]DAMGO as radioligand in guinea pig brain membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,,,,Cavia porcellus
182090,1574,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.6,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182091,1574,2778,Glutamate [NMDA] receptor,Ion channel,O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,NMD3A_HUMAN|NMD3B_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMDE4_HUMAN|NMDZ1_HUMAN,5.6,,IC50,Binding affinity against dextromethorpin binding site associated with N-methyl-D-aspartate glutamate receptor from guinea pig mitochondriall pellet P2 determined using [3H]1 as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
182092,1574,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,9.15,,EC50,Binding affinity to opioid receptor in rat brain homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592,,,,,,,Rattus norvegicus
182093,2616,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,6.3,,IC50,Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL468,,,,,,,Ovis aries
182094,2616,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,6.43,,IC50,Inhibitory activity (RA1) against Prostaglandin G/H synthase 1 was calculated relative to aspirin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL468,,,,,,,Ovis aries
182095,1089,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,6.98,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Stylophora pistillata
182096,1089,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,7.07,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Thalassiosira weissflogii
182097,1089,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,7.6,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VA,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182098,1089,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,7.01,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
182099,1089,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,9.31,,Ki,In vitro binding to human erythrocyte carbonic anhydrase was determined by fluorescence competition assay employing the fluorescent CA inhibitor dansylamide,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182100,1089,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,8.6,,Ki,Inhibition of human recombinant full length CA14 by stopped-flow CO2 hydration method,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182101,1089,2010,Carbonic anhydrase,Enzyme,Q50565,,Q50565_METTH,5.27,,Ki,Inhibitory activity against beta carbonic anhydrase (Cab) from Methanobacterium thermoautotrophicum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H)
182102,1089,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,9.15,,Kd,Binding affinity to human recombinant CA7 at 37 degC and pH 7.0 by thermal shift assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182103,1089,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,7.3,,Ki,Inhibition of mouse full length carbonic anhydrase 13 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Mus musculus
182104,1089,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,7.66,,Ki,Ki value against human carbonic anhydrase XII (hCA XII),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182105,1089,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.47,,Ki,Inhibitory activity against human tumor-associated transmembrane carbonic anhydrase IX.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182106,1089,401,Carbonic anhydrase,Enzyme,O24855,cynT,CYNT_HELPY,6.81,,Ki,Inhibition of Helicobacter pylori recombinant CA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
182107,1089,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.24,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Mus musculus
182108,1089,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,7.4,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Stylophora pistillata
182109,1089,2837,Carbonic anhydrase V,Enzyme,P35218|Q9Y2D0,CA5A|CA5B,CAH5A_HUMAN|CAH5B_HUMAN,8.7,,Ki,Mean inhibitory constant towards human carbonic anhydrase V determined by spectrophotometric dansylamide binding assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
182110,1089,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,7.03,,Ki,Inhibitory activity against human carbonic anhydrase IV (hCAIV),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182111,1089,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,7.85,,Kd,Binding affinity to human recombinant CA1 at 37 degC and pH 7.0 by thermal shift assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182112,1089,3431,Carbonic anhydrase 3,Enzyme,Q3SZX4,CA3,CAH3_BOVIN,5.02,,Ki,Inhibition of bovine carbonic anhydrase 3 using 4-nitrophenylacetate as substrate after 3 mins using spectrophotometry by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Bos taurus
182113,1089,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,6.41,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Astrosclera willeyana
182114,1089,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,7.72,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VB,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182115,1089,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.3,,Ki,Inhibition of human carbonic anhydrase 3,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182116,1089,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,8.1,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
182117,1089,2009,Carbonic anhydrase,Enzyme,P40881,,CAH_METTE,6.7,,Ki,Inhibitory activity against alpha carbonic anhydrase (Zn-Cam) from Methanosarcina thermophila,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Methanosarcina thermophila
182118,1089,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,5.99,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
182119,1089,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,7.57,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
182120,1089,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,7.89,,Kd,Binding affinity to human recombinant CA13 at 37 degC and pH 7.0 by thermal shift assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182121,1089,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,7.48,,Kd,Binding affinity to human recombinant carbonic anhydrase 6 expressed in Escherichia coli Rosetta2 (DE3) by thermal shift assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,INHIBITOR,,Tclin,,,Homo sapiens
182122,1089,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,7.89,,Ki,Inhibitory activity against bovine carbonic anhydrase IV from lung microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Bos taurus
182123,789,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.23,,IC50,Inhibition of AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1134,,,,Tclin,,,Homo sapiens
182124,789,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,5.46,,Ki,Inhibition of mouse AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1134,,,,,,,Mus musculus
182125,789,2727,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P09483|P12390,Chrna4|Chrnb2,ACHA4_RAT|ACHB2_RAT,5.24,,Ki,Binding affinity for nicotinic acetylcholine receptor alpha4-beta2 was evaluated by its ability to inhibit [3H]NIC binding to rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1134,,,,,,,Rattus norvegicus
182126,789,788,Histamine H3 receptor,GPCR,Q9Y5N1,HRH3,HRH3_HUMAN,6.09,,IC50,Inhibition of histamine H3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1134,,,,Tclin,,,Homo sapiens
182127,789,2744,Muscle-type nicotinic acetylcholine receptor,Ion channel,P02708|P07510|P11230|Q04844|Q07001,CHRNA1|CHRNB1|CHRND|CHRNE|CHRNG,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN|ACHE_HUMAN|ACHG_HUMAN,,,,Mechanism of Action; CHEMBL2362997; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1134,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1134,PARTIAL AGONIST,,Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
182128,2047,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,4.99,,Ki,Binding affinity for adenosine A1 receptor from rat brain membranes using [3H]PIA as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL316160,,,,,,,Rattus norvegicus
182129,1593,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.6,,IC50,Binding affinity against Alpha-2 adrenergic receptor is the ability to inhibit the specific [3H]clonidine binding (0.4 nM) to rat isolated brain membranes by 50% was reported; 2.5*10e-9,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17860,,,,,,,Rattus norvegicus
182130,1593,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.17,,Ki,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2B expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17860,,,,Tclin,,,Homo sapiens
182131,1593,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.16,,Ki,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2C expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17860,,,,Tclin,,,Homo sapiens
182132,1593,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.9,,Ki,Displacement of [3H]8-OH-DPAT from human 5HT1A receptor expressed in HeLa cells after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17860,,,,Tclin,,,Homo sapiens
182133,1593,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,6.18,,IC50,Binding affinity against alpha-1 adrenergic receptor is the ability to inhibit the specific [3H]prazosin binding (0.2 nM) to rat isolated brain membranes by 50% was reported; 6.6*10e-7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17860,,,,,,,Rattus norvegicus
182134,1593,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8.36,,Ki,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2A expressed in CHO cells,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17860,http://www.ncbi.nlm.nih.gov/pubmed/20040696,AGONIST,,Tclin,,530,Homo sapiens
182135,2303,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,9.05,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27,,,,,,,Bos taurus
182136,2303,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,7.3,,Ki,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27,,,,,,,Rattus norvegicus
182137,2303,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.32,,Ki,High affinity constant at binding site of human P-Glycoprotein (P-gp) in two-affinity model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27,,,,Tchem,,,Homo sapiens
182138,2303,1824,Beta-2 adrenergic receptor,GPCR,P54833,ADRB2,ADRB2_CANFA,7.77,,IC50,Tested for Beta-2 adrenergic receptor selectivity in canine lung tissue in anesthetized dogs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27,,,,,,,Canis familiaris
182139,2303,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,7.05,,Ki,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27,,,,,,,Rattus norvegicus
182140,2303,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,4.89,,Ki,Inhibitory constant against binding of [125I]- IBZM to D2 receptor in rat striatal membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27,,,,,,,Rattus norvegicus
182141,2303,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.2,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27,,,,Tchem,,,Homo sapiens
182142,2303,2893,Adrenergic receptor beta,GPCR,P10608|P18090|P26255,Adrb1|Adrb2|Adrb3,ADRB1_RAT|ADRB2_RAT|ADRB3_RAT,8.62,,Ki,Inhibitory activity against beta adrenergic receptor of rat frontal cortex homogenate using (1.0 nM) [3H]- dihydroalprenolol,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27,,,,,,,Rattus norvegicus
182143,2303,1803,Beta-1 adrenergic receptor,GPCR,P18090,Adrb1,ADRB1_RAT,8.52,,Ki,Displacement of [3H]CGP12177 from beta1 adrenoreceptor in Rattus norvegicus (rat) cerebral cortex by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27,,,,,,,Rattus norvegicus
182144,2303,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,9.01,,Kd,In vitro inhibitory activity against beta-2 adrenergic receptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27,,,,,,,Cavia porcellus
182145,2303,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,8.76,,Kd,In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27,,,,,,,Cavia porcellus
182146,2266,3556,Chloroquine resistance transporter,Unclassified,Q9N623,CRT,CRT_PLAFA,4.17,,IC50,Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes plasma membrane assessed as reduction of [3H]-chloroquine transportation after 1 to 2 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506,,,,,,,Plasmodium falciparum
182147,2266,297,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,P16083,NQO2,NQO2_HUMAN,5.12,,IC50,Inhibition of human recombinant NQO2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506,,,,Tchem,,,Homo sapiens
182148,2266,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,4.12,,IC50,Inhibition of human recombinant MAOA assessed as conversion of kynuramine to 4-hydroxyquinoline preincubated for 15 mins by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506,,,,Tclin,,,Homo sapiens
182149,2266,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,4.02,,IC50,Inhibition of human recombinant MAOB assessed as conversion of kynuramine to 4-hydroxyquinoline preincubated for 15 mins by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506,,,,Tclin,,,Homo sapiens
182150,2402,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,5.57,,Ki,Displacement of [3H]spiperone from rat D2 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL589,,,,,,,Rattus norvegicus
182151,2402,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,5.17,,IC50,Displacement of [3H]spiroperidol from homogenized bovine pituitary Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL589,,,,,,,Bos taurus
182152,2402,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,7.53,,Ki,Displacement of [3H]spiperone from rat D3 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL589,,,,,,,Rattus norvegicus
182153,2032,2902,Alpha-2 adrenergic receptor,GPCR,P30545|Q01337|Q01338,Adra2a|Adra2b|Adra2c,ADA2A_MOUSE|ADA2B_MOUSE|ADA2C_MOUSE,7.48,,Ki,Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in mouse Malpha2-10H clone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,,,,Mus musculus
182154,2032,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.72,,Ki,The ability to displace [3H]clonidine from the Alpha-2 adrenergic receptor was determined in rat brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,,,,Rattus norvegicus
182155,2032,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,9,,Ki,Displacement of [125I]Clonidine from adrenergic alpha2C receptor (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,AGONIST,,Tclin,,,Homo sapiens
182156,2032,1868,Alpha-2A adrenergic receptor,GPCR,Q28838,ADRA2A,ADA2A_BOVIN,8.82,,Ki,Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,,,,Bos taurus
182157,2032,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,8.21,,Ki,Displacement of [125I]PIC from human imidazoline receptor 1 in human platelets analyzed under norepinephrine mask of alpha 2AR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,Tclin,,,Homo sapiens
182158,2032,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,9.52,,Ki,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT trifluoroacetate as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,Tclin,,,Homo sapiens
182159,2032,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,9.4,,Ki,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,Tclin,,,Homo sapiens
182160,2032,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,9.54,,Ki,Displacement of [125I]Clonidine from adrenergic alpha2A receptor (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,AGONIST,,Tclin,,,Homo sapiens
182161,2032,1864,Alpha-2A adrenergic receptor,GPCR,P18871,ADRA2A,ADA2A_PIG,7.68,,Ki,Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in porcine alpha2-clone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,,,,Sus scrofa
182162,3215,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,6.97,,Ki,Displacement of [3H]TCP from tissue homogenate preparation of whole rat brain minus cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305904,,,,,,,Rattus norvegicus
182163,1373,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.15,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1197,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1197,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
182164,2129,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,8.8,,Kd,Potency against histamine H1 receptor on guinea pig ileum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL278398,,,,,,,Cavia porcellus
182165,2698,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,8.1,,Ki,"Inhibition of human AKR1C3 using S-(+)-1,2,3,4-tetrahydro-1-naphthol as substrate",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121626,,,,Tchem,,,Homo sapiens
182166,657,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,,,,Mechanism of Action; CHEMBL2311224; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1208,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1208,INHIBITOR,,,,,Escherichia coli (strain K12)
182167,3686,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.67,,Ki,Inhibition of human carbonic anhydrase 2-catalyzed CO2 hydration preincubated for 10 mins by stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104196,,,,Tclin,,,Homo sapiens
182168,3686,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.93,,Ki,Inhibition of human carbonic anhydrase 1-catalyzed CO2 hydration preincubated for 10 mins by stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104196,,,,Tclin,,,Homo sapiens
182169,630,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.06,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87045,,,,Tclin,,,Homo sapiens
182170,1283,3433,DNA polymerase (alpha/delta/epsilon),Enzyme,P09884|P28340|Q07864,POLA1|POLD1|POLE,DPOD1_HUMAN|DPOE1_HUMAN|DPOLA_HUMAN,,,,Mechanism of Action; CHEMBL2363042; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL888,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL888,INHIBITOR,,Tclin|Tclin|Tclin,,,Homo sapiens
182171,2711,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,7.85,,Ki,Displacement of [3H]U69593 form human kappa opioid receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237044,,,,Tclin,,,Homo sapiens
182172,2711,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,8.03,,Ki,Displacement of [3H]Naltrindole form human delta opioid receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237044,,,,Tclin,,,Homo sapiens
182173,2711,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.8,,Ki,Displacement of [3H]DAMGO form human mu opioid receptor expressed in CHO cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237044,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237044,AGONIST,,Tclin,,,Homo sapiens
182174,2711,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.1,,IC50,Inhibition of reuptake of Norepinephrine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237044,,,,Tclin,,,Homo sapiens
182175,2711,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,5.62,,Ki,Displacement of [3H]-dihydromorphine from mu opioid receptor in rat cerebral cortex by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237044,,,,,,,Rattus norvegicus
182176,2711,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.83,,IC50,Inhibition of SERT mediated 5-hydroxytryptamine uptake,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237044,,,,Tclin,,,Homo sapiens
182177,2320,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,8.96,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL668,,,,Tchem,,,Homo sapiens
182178,1971,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.67,,Ki,Displacement of [3H]LSD from human 5HT6 receptor expressed in HEK293 cells after 1.5 hrs by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445,,,,Tchem,,,Homo sapiens
182179,1971,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,10.4,,IC50,Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445,,,,,,,Rattus norvegicus
182180,1971,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,10.3,,IC50,Compound tested for its inhibitory activity against Histamine H1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445,,,,,,,Rattus norvegicus
182181,2510,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL438,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL438,INHIBITOR,,,,,Escherichia coli (strain K12)
182232,1816,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.7,,Ki,Inhibition of [3H]rauwolscine binding to Alpha-2A adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,ANTAGONIST,,Tclin,,,Homo sapiens
182182,2610,2875,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P04774|P04775|P08104,Scn1a|Scn2a|Scn3a,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,5.22,,IC50,Inhibition of [3H]batrachotoxin binding to rat brain neuronal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698,,,,,,,Rattus norvegicus
182183,2610,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,6.28,,IC50,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698,BLOCKER,,Tclin,,,Homo sapiens
182184,2610,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,6.3,,Ki,Displacement of [3H]BTX from human Nav1.7 expressed in human HEK293 cells after 1 hr by MicroBeta analyzer,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698,BLOCKER,,Tclin,,,Homo sapiens
182185,2610,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.47,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
182186,2610,138,Sodium channel protein type 2 subunit alpha,Ion channel,Q99250,SCN2A,SCN2A_HUMAN,5.96,,IC50,Inhibition of human NaV1.2 alpha subunit expressed in CHOK1 cells at -65 mV holding potential by patch clamp electrophysiological assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698,BLOCKER,,Tclin,,,Homo sapiens
182187,2610,2020,cGMP-gated cation channel alpha-1,Ion channel,Q00194,CNGA1,CNGA1_BOVIN,5.17,,Kd,Apparent dissociation constant against Cyclic nucleotide gated channel alpha 1 at +40 mV,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698,,,,,,,Bos taurus
182188,1796,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,5.54,,IC50,The binding affinity at the 5-HT reuptake sites determined using competition binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182189,1796,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,8.96,,Ki,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182190,1796,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.55,,Ki,Inhibition of [125I]iodosulpiride binding to human Dopamine receptor D3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,Tclin,,,Homo sapiens
182191,1796,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.66,,Ki,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,Tclin,,,Homo sapiens
182192,1796,1879,Muscarinic acetylcholine receptor M5,GPCR,P08911,Chrm5,ACM5_RAT,5.72,,IC50,Binding affinity towards muscarinic acetylcholine receptor by inhibiting specific binding of [3H]quinuclidinyl benzilate (0.8 nM) in vitro to membranes of rat brain without cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182193,1796,2898,Serotonin 3 receptor (5HT3),Ion channel,P23979|Q9JHJ5,Htr3a|Htr3b,5HT3A_MOUSE|5HT3B_MOUSE,6.6,,Ki,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Mus musculus
182194,1796,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,10.15,,IC50,Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182195,1796,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.21,,Ki,Binding affinity towards alpha-2 adrenergic receptor at 1.0 uM concentration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182196,1796,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,6.24,,Ki,Binding affinity towards serotonin S1 receptor at 1.0 uM concentration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182197,1796,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,7.37,,Ki,Displacement of [3H]prazosin from calf cerebral cortex alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Bos taurus
182198,1796,2859,Cerebral cortex alpha adrenergic receptor,GPCR,P18130|Q28838,ADRA1A|ADRA2A,ADA1A_BOVIN|ADA2A_BOVIN,8.22,,IC50,In vitro binding affinity towards alpha-adrenoceptor of calf cortex membrane Site B using [3H]-clonidine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Bos taurus
182199,1796,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.33,,Ki,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182200,1796,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,5.85,,Ki,Inhibition of [3H]SCH-23390 binding to rat Dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182201,1796,1868,Alpha-2A adrenergic receptor,GPCR,Q28838,ADRA2A,ADA2A_BOVIN,7.77,,Ki,"Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Bos taurus
182202,1796,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.08,,Ki,Binding affinity towards Dopamine receptor D2 at 1.0 uM concentration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182203,1796,2783,Serotonin 3 (5-HT3) receptor,Ion channel,P35563|Q9JJ16,Htr3a|Htr3b,5HT3A_RAT|5HT3B_RAT,7.15,,Ki,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182204,1796,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,7.59,,Ki,Inhibition of uptake of tritiated norepinephrine (NE) in rat synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182205,1796,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.48,,IC50,Binding affinity for human cloned Dopamine receptor D4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,Tchem,,,Homo sapiens
182207,1796,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,8.85,,Ki,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182208,1796,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.26,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182209,1796,3557,G-protein coupled receptor,Unclassified,Q9NG02,tyr1,Q9NG02_APIME,4.14,,IC50,Antagonist activity at Apis mellifera tyramine receptor TyR1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Apis mellifera
182210,1796,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,5.82,,Ki,Tested for binding affinity against dopamine receptor D3 expressed in Sf9 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182211,1796,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.82,,Ki,The binding affinity at 5-hydroxytryptamine 2A receptor was determined using [3H]ketanserin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Rattus norvegicus
182212,1796,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.39,,IC50,Binding affinity for human cloned Alpha-1A adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,Tclin,,,Homo sapiens
182213,3413,446,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,Q9Y233,PDE10A,PDE10_HUMAN,4.82,,Kd,Binding affinity to human PDE10A catalytic domain expressed in Escherichia coli BL21-Gold(DE3) after 15 mins by SPR inhibition in solution assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL219376,,,,Tclin,,,Homo sapiens
182214,3413,179,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q02127,DHODH,PYRD_HUMAN,4.92,,IC50,Inhibition of human recombinant DHOD expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL219376,,,,Tclin,,,Homo sapiens
182215,103,2750,Tubulin,Structural,C4PKY4|C4PKZ2|C4PKZ6,,C4PKY4_ECHGR|C4PKZ2_ECHGR|C4PKZ6_ECHGR,,,,Mechanism of Action; CHEMBL2364704; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1483,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1483,INHIBITOR,,,,,Echinococcus granulosus
182216,103,2751,Tubulin,Structural,F1L005|F1L4P8|F1L5G6|F1L7U3|F1L7Y0|F1L8A5|F1LCS0,,F1L005_ASCSU|F1L4P8_ASCSU|F1L5G6_ASCSU|F1L7U3_ASCSU|F1L7Y0_ASCSU|F1L8A5_ASCSU|F1LCS0_ASCSU,,,,Mechanism of Action; CHEMBL2364705; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1483,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1483,INHIBITOR,,,,,Ascaris suum
182217,3805,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.62,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL421669,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182218,2027,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.54,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL546,,,,Tchem,,,Homo sapiens
182219,1816,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.24,,Ki,Inhibition of [125I]iodosulpiride binding to human Dopamine receptor D3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,,,Tclin,,,Homo sapiens
182220,1816,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.58,,Ki,Inhibition of [3H]5-HT binding to human 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,,,Tclin,,,Homo sapiens
182221,1816,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.65,,IC50,Binding affinity at human Alpha-2B adrenergic receptor in CHO cells by [3H]rauwolscine (1 nM) displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,ANTAGONIST,,Tclin,,,Homo sapiens
182222,1816,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,5.38,,Ki,Inhibition of [3H]SCH-23390 binding to rat Dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,,,,,,Rattus norvegicus
182223,1816,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,5.84,,Ki,The binding affinity at the Dopamine receptor D2 determined using [3H]spiperone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,,,,,,Rattus norvegicus
182224,1816,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.74,,Ki,Inhibition of [3H]rauwolscine binding to Alpha-2C adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,ANTAGONIST,,Tclin,,,Homo sapiens
182225,1816,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,5.54,,Ki,Displacement of [3H]GR65630 from human 5-HT3A receptor expressed in HEK293 cells by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,,,Tclin,,,Homo sapiens
182226,1816,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,5.79,,Ki,Inhibition of [3H]nisoxetine binding to rat Norepinephrine transporter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,,,,,,Rattus norvegicus
182227,1816,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,8.26,,Ki,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,,,,,,Rattus norvegicus
182228,1816,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.41,,Ki,Inhibition of [3H]mesulergine binding to human 5-hydroxytryptamine 2C receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,ANTAGONIST,,Tclin,,,Homo sapiens
182229,1816,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.16,,Ki,Inhibition of [125I]R91150 binding to human 5-hydroxytryptamine 2A receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,ANTAGONIST,,Tclin,,,Homo sapiens
182230,1816,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.3,,Kd,Binding affinity to 5HT1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,,,Tclin,,,Homo sapiens
182231,1816,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,6.22,,Ki,Inhibition of [3H]prazosin binding to rat Alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,,,,,,Rattus norvegicus
182233,1816,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.7,,Ki,The binding affinity at 5-hydroxytryptamine 2A receptor was determined using [3H]ketanserin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,,,,,,Rattus norvegicus
182234,1816,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.5,,IC50,Binding affinity at human Alpha-1A adrenergic receptor in CHO cells uby [3H]prazosin (0.25 nM) displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654,,,,Tclin,,,Homo sapiens
182235,224,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action; CHEMBL231; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1305,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1305,ANTAGONIST,,Tclin,,,Homo sapiens
182236,2832,2511,Heat shock protein HSP 90-alpha,Cytosolic other,P07900,HSP90AA1,HS90A_HUMAN,4.9,,IC50,Inhibition of recombinant Homo sapiens (human) Hsp90 alpha ATPase activity assessed as inorganic phosphate release by malachite green colorimetric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1547,,,,Tchem,,,Homo sapiens
182237,3689,304,Xanthine dehydrogenase/oxidase,Enzyme,P47989,XDH,XDH_HUMAN,6,,IC50,Inhibition of C-terminally FLAG-tagged human xanthine oxidase (amino acid 1 to 1333) expressed in baculovirus system after 15 mins by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL37387,,,,Tclin,,,Homo sapiens
182238,317,2066,Solute carrier family 22 member 12,Transporter,Q96S37,SLC22A12,S22AC_HUMAN,5.55,,IC50,Inhibition of human URAT1 expressed in xenopus oocyte assessed as inhibition of [14C]-labelled urate uptake after 60 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1474963,,,,Tclin,,,Homo sapiens
182239,1904,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,6.4,,Ki,Inhibition of HIV-1 wild-type RT,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL57,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL57,INHIBITOR,,,,,Human immunodeficiency virus 1
182240,1904,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,6.3,,IC50,Inhibition of RNA-dependent DNA polymerase activity of Human immunodeficiency virus 1 recombinant reverse transcriptase expressed in Escherichia coli using poly(rA)oligo(dT) template primer after 30 min,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL57,,,,,,,Human immunodeficiency virus 1
182241,1904,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,7,,IC50,Inhibition of HIV-1 RT using rC-dG as template,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL57,,,,,,,Human immunodeficiency virus 1
182242,3486,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,4.69,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6995,,,,,,,Bos taurus
182243,3486,1803,Beta-1 adrenergic receptor,GPCR,P18090,Adrb1,ADRB1_RAT,6.47,,Kd,Antagonist activity at beta1 adrenergic receptor in isolated rat atria,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6995,,,,,,,Rattus norvegicus
182244,3486,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,5.8,,Kd,Ability to block Beta-2 adrenergic receptor in guinea pig trachea preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6995,,,,,,,Cavia porcellus
182245,3486,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,6.98,,Kd,In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6995,,,,,,,Cavia porcellus
182246,3486,3558,Beta-2 adrenergic receptor,Unclassified,P18762,Adrb2,ADRB2_MOUSE,4.87,,Ki,Ki value was determined by accumulation of c-AMP in S-49 mouse lymphoma cells (Beta2).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6995,,,,,,,Mus musculus
182247,2750,2001,"Carnitine O-palmitoyltransferase 1, muscle isoform",Enzyme,Q63704,Cpt1b,CPT1B_RAT,5.89,,IC50,Inhibition of CPT1A in rat myocardium,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL203266,,,,,,,Rattus norvegicus
182248,255,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,8.75,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24,,,,Tchem,,,Homo sapiens
182249,255,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,5.93,,Kd,In vitro beta-2 adrenergic receptor activity was determined by measuring inhibition of the isoproterenol induced relaxation in isolated guinea pig tracheal chains contracted with PGF2-alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24,,,,,,,Cavia porcellus
182250,255,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,7.62,,Kd,In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24,,,,,,,Cavia porcellus
182251,812,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.19,,Ki,Inhibition of the uptake of tritiated dopamine (DA) in rat synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,,,,Rattus norvegicus
182252,812,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,6.79,,Ki,Ability to inhibit reuptake of serotonin ([3H]5-HT) at serotonin transporter of rat midbrian,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,,,,Rattus norvegicus
182253,812,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,9.11,,Ki,Displacement of [3H]nisoxetine from rat NET in rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,,,,Rattus norvegicus
182254,812,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,9.6,,IC50,Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,,,,Rattus norvegicus
182255,812,1830,Sodium-dependent noradrenaline transporter,Transporter,O55192,Slc6a2,SC6A2_MOUSE,5.8,,IC50,Inhibition of noradrenaline transporter in NMRI albino mouse brain assessed as [3H]NA accumulation in hypothalamus after 5 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,,,,Mus musculus
182256,812,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,9.31,,Ki,In vitro competitive binding versus [N-methyl-3H]WIN-35428 in murine kidney cells transfected with cDNA for human dopamine transporter (DAT),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,Tclin,,,Homo sapiens
182644,1845,1857,Kappa-type opioid receptor,GPCR,P33534,Oprk1,OPRK_MOUSE,6.52,,Ki,Evaluated for the binding affinity at kappa receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Mus musculus
182257,812,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.25,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,Tchem,,,Homo sapiens
182258,812,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,9.19,,Ki,Inhibition of uptake of tritiated norepinephrine (NE) in rat synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,,,,Rattus norvegicus
182259,812,1842,Sodium-dependent serotonin transporter,Transporter,Q60857,Slc6a4,SC6A4_MOUSE,5.03,,IC50,Inhibition of 5-HT transporter in NMRI albino mouse brain assessed as [3H]5-HT accumulation in hypothalamus after 5 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,,,,Mus musculus
182260,812,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.62,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182261,812,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,9.1,,IC50,Compound tested for its inhibitory activity against Histamine H1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,,,,Rattus norvegicus
182262,812,2846,Serotonin (5-HT) receptor,GPCR,P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT,6.46,,IC50,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,,,,,,,Rattus norvegicus
182263,2861,3559,Thymidine kinase,Unclassified,Q9PPP5,tdk,KITH_UREPA,4.9,,IC50,Inhibition of Ureaplasma parvum thymidine kinase by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL129,,,,,,,Ureaplasma parvum serovar 3 (strain ATCC 700970)
182264,2861,2617,Thymidylate kinase,Kinase,P9WKE1,tmk,KTHY_MYCTU,4.55,,Ki,Inhibitory activity against thymidine monophosphate kinase (TMPK) in Mycobacterium tuberculosis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL129,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
182265,2861,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,8.52,,IC50,Inhibitory concentration against human immunodeficiency virus type 1 (HIV-1 strain IIIB RT) reverse transcriptase was determined by triplicate assay at low (~0.1 pfu/cell) multiplicity of injection (moi),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL129,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL129,INHIBITOR,,,,,Human immunodeficiency virus 1
182266,2861,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,8.22,,IC50,"Inhibitory effect on HIV-1 RT activity using template primer,poly (rA)-oligo (dT)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL129,,,,,,,Human immunodeficiency virus 1
182267,2861,681,"Thymidine kinase, cytosolic",Kinase,P04183,TK1,KITH_HUMAN,5.54,,Ki,Inhibitory affect against rabbit thymus thymidine kinase and represented as molt/4F kinase.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL129,,,,Tchem,,,Homo sapiens
182268,2818,3560,Adenosylhomocysteinase ,Unclassified,P50247,Ahcy,SAHH_MOUSE,4.52,,Ki,Activity determined in mouse liver S-adenosyl-L-homocysteine hydrolase and expressed as KI values.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1090,,,,,,,Mus musculus
182269,2818,3434,Adenylate cyclase type V,Enzyme,Q04400,Adcy5,ADCY5_RAT,4.09,,IC50,Compound was evaluated for inhibition of adenylate cyclase from rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1090,,,,,,,Rattus norvegicus
182270,2818,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,7.21,,IC50,Inhibition of human DPP4 from human Caco-2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1090,,,,Tclin,,,Homo sapiens
182271,2818,70,DNA polymerase catalytic subunit,Enzyme,P04293,,DPOL_HHV11,,,,Mechanism of Action; CHEMBL1872; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1090,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1090,INHIBITOR,,,,,Human herpesvirus 1 (strain 17)
182272,90,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,8.29,,Ki,Inhibition of [3H]-CHA binding to rat brain membrane Adenosine A1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477,,,,,,,Rattus norvegicus
182273,90,3561,cAMP-dependent protein kinase A,Unclassified,P00515|P00517|P05131|P31322,PRKACA|PRKACB|PRKAR2A|PRKAR2B,KAP2_BOVIN|KAP3_BOVIN|KAPCA_BOVIN|KAPCB_BOVIN,4.82,,Ki,Inhibitory constant for Protein Kinase A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477,,,,,,,Bos taurus
182274,90,1939,Adenosine kinase,Kinase,Q9TVW2,AK,ADK_TOXGO,5.05,,Ki,Binding affinity to purified Toxoplasma gondii adenosine kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477,,,,,,,Toxoplasma gondii
182275,90,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,7.52,,Ki,Displacement of specific [3H]-CGS- 21680 binding to adenosine A2A receptor in rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477,,,,,,,Rattus norvegicus
182276,90,2839,Adenosine A2 receptor,GPCR,P29276|P30543,Adora2a|Adora2b,AA2AR_RAT|AA2BR_RAT,8.3,,Ki,Binding affinity for Adenosine A2 receptor in corpora striata of rats using [3H]NECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477,,,,,,,Rattus norvegicus
182277,90,3435,Glyceraldehyde-3-phosphate dehydrogenase liver,Enzyme,P04406,GAPDH,G3P_HUMAN,4.46,,IC50,Tested for the inhibitory activity against Glycosomal glyceraldehyde 3-phosphate dehydrogenase (gGAPDH) of human erythrocyte,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477,,,,Tchem,,,Homo sapiens
182278,90,1938,Adenosine receptor A3,GPCR,P28647,Adora3,AA3R_RAT,7,,Ki,Displacement of [125I]- AB-MECA from rat adenosine A3 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477,,,,,,,Rattus norvegicus
182279,2845,2123,Glycogen debranching enzyme,Enzyme,P35574,AGL,GDE_RABIT,4.15,,IC50,"Inhibition of rabbit muscle amylo-1,6-glucosidase",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL476960,,,,,,,Oryctolagus cuniculus
182280,2845,2122,Lysosomal alpha-glucosidase,Enzyme,Q6P7A9,Gaa,LYAG_RAT,6.96,,IC50,Inhibition of rat intestinal brush border membrane maltase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL476960,,,,,,,Rattus norvegicus
162917,3584,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.95,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611,ANTAGONIST,,Tclin,,,Homo sapiens
182281,2845,1898,"Sucrase-isomaltase, intestinal",Enzyme,P23739,Si,SUIS_RAT,7.15,,IC50,Inhibition of rat intestinal brush border membrane sucrase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL476960,,,,,,,Rattus norvegicus
182282,2845,731,Lysosomal alpha-glucosidase,Enzyme,P10253,GAA,LYAG_HUMAN,7.15,,IC50,Inhibition of maltase in human Caco-2 cell model system after 2 hrs,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL476960,http://www.ncbi.nlm.nih.gov/pubmed/8536820,INHIBITOR,,Tclin,,349,Homo sapiens
182283,2529,1807,Endothelin-1 receptor,GPCR,P26684,Ednra,EDNRA_RAT,6.11,,IC50,Antagonism of [125 I]ET-1 binding to the rat endothelin receptor in vascular smooth muscle VSM-A10 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL453,,,,,,,Rattus norvegicus
182284,2529,457,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,6.11,,IC50,Inhibitory concentration against Endothelin A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL453,,,,Tclin,,,Homo sapiens
182285,2529,458,Endothelin B receptor,GPCR,P24530,EDNRB,EDNRB_HUMAN,4.62,,IC50,Binding affinity against human Endothelin B receptor in transfected COS 7 cell membrane preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL453,,,,Tclin,,,Homo sapiens
182286,228,1953,D(1A) dopamine receptor,GPCR,Q61616,Drd1,DRD1_MOUSE,7,,Ki,Displacement of [3H]SCH23390 from dopamine D1 receptor in mouse Ltk- fibroblast cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Mus musculus
182287,228,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.59,,Ki,Displacement of [3H]domperidone from human cloned dopamine D3 receptor expressed in mouse CCL1-3 cells by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,AGONIST,,Tclin,,,Homo sapiens
182288,228,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,9,,IC50,Inhibition of [3H]apomorphine binding to calf caudate membrane preparation (p4),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Rattus norvegicus
182289,228,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.21,,Ki,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,AGONIST,,Tclin,,,Homo sapiens
182290,228,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.2,,IC50,Alpha-2 adrenergic receptor activity assessed in vitro for displacement of [3H]clonidine from specific binding sites on rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Rattus norvegicus
182291,228,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.53,,Ki,Ability to displace [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Rattus norvegicus
182292,228,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,7.28,,Ki,Displacement of [3H]fenoldopam from Dopamine receptor D1 of rat striatum membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Rattus norvegicus
182293,228,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.74,,Ki,Displacement of [3H]domperidone from dopamine D2 receptor high binding site in Sprague-Dawley rat striatum by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Rattus norvegicus
182294,228,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.68,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,Tchem,,,Homo sapiens
182295,228,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,8.34,,Ki,Binding affinity to dopamine D1 receptor high binding site by radioligand displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,Tclin,,,Homo sapiens
182296,228,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.05,,Ki,Displacement of [3H]A369508 from human D4 receptor expressed in HEK293 cell membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,AGONIST,,Tchem,,,Homo sapiens
182297,228,2851,Dopamine receptor,GPCR,P20288|Q95136,DRD1|DRD2,DRD1_BOVIN|DRD2_BOVIN,9,,IC50,Tested for binding to dopamine receptor using [3H]apomorphine as radioligand in calf caudate nucleus homogenates.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Bos taurus
182298,228,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,6.73,,Ki,Binding affinity against Rat 5-hydroxytryptamine 7 receptor using [3H]5-HT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Rattus norvegicus
182299,228,1878,D(4) dopamine receptor,GPCR,P30729,Drd4,DRD4_RAT,8.82,,EC50,In vitro effective concentration tested on HEK293 cells co-transfected with ferret Dopamine receptor D4 using FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Rattus norvegicus
182300,228,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.53,,Ki,Binding affinity was measured on cloned Human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,Tclin,,,Homo sapiens
182301,228,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.11,,IC50,In vitro inhibitory activity against alpha-1 adrenergic receptor from whole rat brain using [3H]WB-4101 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Rattus norvegicus
182302,228,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,6.7,,Ki,Compound was tested for inhibition of [3H]spiroperidol binding against Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Bos taurus
182303,228,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,7.44,,Ki,Displacement of [3H]spiperone from rat recombinant dopamine D3 receptor expressed in SF9 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Rattus norvegicus
182304,228,2846,Serotonin (5-HT) receptor,GPCR,P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT,5.35,,IC50,In vitro inhibitory activity against serotonin receptor from rat frontal cortex using [3H]spiperone as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Rattus norvegicus
162919,2695,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.5,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770,ANTAGONIST,,Tclin,,,Homo sapiens
182305,228,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,6.52,,IC50,Ability to inhibit the specific binding of [3H]- dihydromorphine to opiate receptors in rat brain membrane preparation by 50%,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Rattus norvegicus
182306,1786,2893,Adrenergic receptor beta,GPCR,P10608|P18090|P26255,Adrb1|Adrb2|Adrb3,ADRB1_RAT|ADRB2_RAT|ADRB3_RAT,6.3,,IC50,The compound was tested for its ability to inhibit (-)-[3H]dihydroalprenolol binding to beta-adrenergic receptor sites in rat cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13,,,,,,,Rattus norvegicus
182307,1786,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,6.79,,Kd,In vitro beta-2 adrenergic receptor activity was determined by measuring inhibition of the isoproterenol induced relaxation in isolated guinea pig tracheal chains contracted with PGF2-alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13,,,,,,,Cavia porcellus
182308,1786,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,7.83,,Kd,In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13,,,,,,,Cavia porcellus
182309,3680,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.85,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127508,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182310,3680,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.18,,Ki,Displacement of [3H]pyrilamine from human recombinant histamine H1 receptor expressed in CHO cell by Betaplate scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127508,,,,Tclin,,,Homo sapiens
182311,2098,1737,Adenosine deaminase,Enzyme,P56658,ADA,ADA_BOVIN,11,,Ki,Binding affinity against Adenosine deaminase from calf intestinal mucosa was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1580,,,,,,,Bos taurus
182312,2386,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,6.17,,IC50,Displacement of [3H]flunitrazepam from GABA-A benzodiazepine receptor in synaptic membranes of rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL159298,,,,,,,Rattus norvegicus
182314,875,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.66,,Ki,Displacement of [3H]Estradiol from human recombinant estrogen receptor alpha expressed in Sf9 cells after 2 hrs,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL411,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL411,AGONIST,,Tclin,,,Homo sapiens
182315,875,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.85,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL411,,,,,,,Rattus norvegicus
182316,875,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,9.2,,Ki,In vitro displacement of 0.5 nM [3H]17-beta-estradiol from human Estrogen receptor beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL411,,,,Tclin,,,Homo sapiens
182317,875,2037,UDP-glucose 4-epimerase,Enzyme,Q14376,GALE,GALE_HUMAN,4.12,,IC50,Inhibition of human GalE by HPAEC assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL411,,,,Tchem,,,Homo sapiens
182318,1825,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,8.3,,Ki,Inhibition of MAO-A in rat liver homogenate by spectrophotometry-based Holt method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86304,,,,,,,Rattus norvegicus
182319,1825,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,8.3,,Ki,Inhibition of human MAO-A expressed in BTI insect cells using p-tyramine as substrate after 60 mins,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86304,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7428,INHIBITOR,,Tclin,,,Homo sapiens
182320,1825,1901,Amine oxidase [flavin-containing] A,Enzyme,P21398,MAOA,AOFA_BOVIN,4.94,,Ki,Inhibitory activity against monoamine oxidase A in isolated bovine brain mitochondria,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86304,,,,,,,Bos taurus
182321,1825,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.1,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86304,,,,Tclin,,,Homo sapiens
182322,1825,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,5.97,,Ki,Competitive inhibition of MAOB in rat liver homogenate by spectrophotometrically,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86304,,,,,,,Rattus norvegicus
182323,1825,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,5.97,,Ki,Inhibition of human MAO-B expressed in BTI insect cells using p-tyramine as substrate after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86304,,,,Tclin,,,Homo sapiens
182324,1825,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.3,,Kd,Binding affinity to 5HT1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86304,,,,Tclin,,,Homo sapiens
182325,863,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,4.15,,IC50,Inhibition of human recombinant IDO expressed in Escherichia coli BL21 AI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33845,,,,Tchem,,,Homo sapiens
182326,2393,2783,Serotonin 3 (5-HT3) receptor,Ion channel,P35563|Q9JJ16,Htr3a|Htr3b,5HT3A_RAT|5HT3B_RAT,5.4,,IC50,Binding activity radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL905,,,,,,,Rattus norvegicus
182327,2393,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.1,,IC50,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL905,,,,Tclin,,,Homo sapiens
182328,2393,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.1,,IC50,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL905,,,,Tclin,,,Homo sapiens
182329,2393,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.85,,Ki,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL905,,,,Tclin,,,Homo sapiens
182330,2393,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,5.2,,IC50,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL905,,,,,,,Rattus norvegicus
182331,2393,1780,5-hydroxytryptamine receptor 1D,GPCR,P79400,HTR1D,5HT1D_PIG,7.3,,IC50,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL905,,,,,,,Sus scrofa
182332,1999,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.9,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900,,,,Tchem,,,Homo sapiens
182333,1999,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,6.79,,IC50,Displacement of [3H]mepyramine from histamine H1 receptor in Sprague-Dawley rat brain membrane after 2 hr by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900,,,,,,,Rattus norvegicus
182334,369,3436,Lethal(3)malignant brain tumor-like protein 1,Unclassified,Q9Y468,L3MBTL1,LMBL1_HUMAN,4.04,,IC50,Inhibition of L3MBTL1 by alpha-screening,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1192517,,,,Tchem,,,Homo sapiens
182335,1552,1480,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q63707,Dhodh,PYRD_RAT,8.05,,IC50,Inhibitory concentration tested against enzyme dihydroorotate dehydrogenase in rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL960,,,,,,,Rattus norvegicus
182336,1552,179,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q02127,DHODH,PYRD_HUMAN,5,,IC50,Immunosuppressive activity expressed as ability to inhibit human recombinant dihydroorotate dehydrogenase (DHODH),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL960,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL960,INHIBITOR,,Tclin,,,Homo sapiens
182337,1552,1761,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,O35435,Dhodh,PYRD_MOUSE,7.52,,IC50,Inhibitory concentration tested on enzyme dihydroorotate dehydrogenase in mouse,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL960,,,,,,,Mus musculus
182338,2696,1952,Solute carrier family 22 member 6,Transporter,O35956,Slc22a6,S22A6_RAT,4.26,,Ki,Inhibition of rat Oat1 expressed in Xenopus oocytes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL782,,,,,,,Rattus norvegicus
182339,3188,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.15,,EC50,Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1405,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1405,AGONIST,,Tclin,,,Homo sapiens
182340,3188,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,8.18,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1405,,,,Tchem,,,Homo sapiens
182341,3188,500,Steryl-sulfatase,Enzyme,P08842,STS,STS_HUMAN,4.29,,IC50,Inhibition of human steroid sulfatase using 4-methylumbelliferyl sulfate substrate after 10 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1405,,,,Tchem,,,Homo sapiens
182342,3188,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.68,,EC50,Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1405,,,,Tclin,,,Homo sapiens
182343,3188,703,Estradiol 17-beta-dehydrogenase 1,Enzyme,P14061,HSD17B1,DHB1_HUMAN,8.52,,Ki,Inhibition of 17beta-HSD1 assessed as conversion of [14C]estradiol to [14C]estrone using NADP+,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1405,,,,Tchem,,,Homo sapiens
182344,962,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action; CHEMBL231; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1004,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1004,ANTAGONIST,,Tclin,,,Homo sapiens
182345,2701,2491,Microtubule-associated protein tau,Structural,P10636,MAPT,TAU_HUMAN,7.16,,Ki,Inhibition of recombinant tau (unknown origin) aggregation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1197206,,,,Tchem,,,Homo sapiens
182346,816,2789,GABA-A receptor; anion channel,Ion channel,A2AMW3|P16305|P22723|P22933|P26048|P26049|P27681|P50571|P62812|P63080|Q8BHJ7|Q8QZW7|Q9D6F4|Q9JLF1|Q9R0Y8,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,A2AMW3_MOUSE|GBRA1_MOUSE|GBRA2_MOUSE|GBRA3_MOUSE|GBRA4_MOUSE|GBRA5_MOUSE|GBRA6_MOUSE|GBRB1_MOUSE|GBRB3_MOUSE|GBRD_MOUSE|GBRG1_MOUSE|GBRG2_MOUSE|GBRG3_MOUSE|GBRP_MOUSE|GBRT_MOUSE,4.14,,Ki,Binding affinity for umolar GABA-A central benzodiazepine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL523,,,,,,,Mus musculus
182347,1654,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,6.28,,Ki,In vitro binding affinity against benzodiazepine receptor using [3H]diazepam as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL28333,,,,,,,Rattus norvegicus
182348,3134,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,9.22,,EC50,Binding affinity to opioid receptor in rat brain homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106274,,,,,,,Rattus norvegicus
182353,842,2875,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P04774|P04775|P08104,Scn1a|Scn2a|Scn3a,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,5.89,,IC50,Inhibition of [3H]batrachotoxin binding to rat brain sodium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52440,,,,,,,Rattus norvegicus
182354,842,2048,Sigma non-opioid intracellular receptor 1,Membrane other,Q60492,SIGMAR1,SGMR1_CAVPO,7.82,,IC50,Displacement of [3H]pentazocine from sigma1 receptor in guinea pig membrane in presence of phenytoin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52440,,,,,,,Cavia porcellus
182444,2813,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.05,,IC50,Inhibition of binding of [3H]imipramine to imipramine receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL637,,,,,,,Rattus norvegicus
182355,842,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,5.65,,Ki,Binding affinity was measured against phencyclidine (PCP) receptor in rat using [3H]TCP as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52440,,,,,,,Rattus norvegicus
182356,842,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,5.29,,Ki,Binding affinity was measured as selectivity for sigma-1 site over muscarinic (M1) receptor in rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52440,,,,,,,Rattus norvegicus
182364,2868,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,4.28,,IC50,Inhibition of MMP9 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,Tchem,,,Homo sapiens
182365,2868,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,5.15,,IC50,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,Tchem,,,Homo sapiens
182366,2868,344,Farnesyl pyrophosphate synthase,Enzyme,P14324,FDPS,FPPS_HUMAN,10.15,,Ki,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,INHIBITOR,,Tclin,,,Homo sapiens
182367,2868,866,Neutrophil collagenase,Enzyme,P22894,MMP8,MMP8_HUMAN,4.75,,IC50,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,Tclin,,,Homo sapiens
182368,2868,873,Geranylgeranyl pyrophosphate synthase,Enzyme,O95749,GGPS1,GGPPS_HUMAN,5.57,,Ki,Binding affinity to human GGPPS,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,Tchem,,,Homo sapiens
182369,2868,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.21,,IC50,Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,Tclin,,,Homo sapiens
182370,2868,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,7.04,,IC50,Inhibition of human recombinant carbonic anhydrase 14 preincubated for 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,Tclin,,,Homo sapiens
182371,2868,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,6.5,,IC50,Inhibition of human recombinant carbonic anhydrase 12 preincubated for 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,Tclin,,,Homo sapiens
182372,2868,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.27,,IC50,Inhibition of human recombinant carbonic anhydrase 9 preincubated for 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,Tclin,,,Homo sapiens
182373,2868,2063,Geranylgeranyl pyrophosphate synthase,Enzyme,Q12051,BTS1,GGPPS_YEAST,6.59,,Ki,Binding affinity to Saccharomyces cerevisiae GGPPS,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
182374,2868,1964,Farnesyl pyrophosphate synthase,Enzyme,Q0GKD7,,Q0GKD7_LEIDO,7.96,,Ki,Binding affinity towards Farnesyl diphosphate synthase from leishmania major,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,,,,Leishmania donovani
182375,2868,763,Matrix metalloproteinase-14,Enzyme,P50281,MMP14,MMP14_HUMAN,4.9,,IC50,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,Tchem,,,Homo sapiens
182376,2868,1261,Farnesyl diphosphate synthase,Enzyme,P22939,ispA,ISPA_ECOLI,5.96,,IC50,Inhibition of Escherichia coli FPPS,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL924,,,,,,,Escherichia coli (strain K12)
182377,2464,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,6.24,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL471,,,,,,,Bos taurus
182378,2464,1824,Beta-2 adrenergic receptor,GPCR,P54833,ADRB2,ADRB2_CANFA,5.3,,IC50,In vitro Beta-2 adrenergic receptor affinity in partially purified membrane fractions from canine lung tissue using [SH]dihydroalprenolol (4.5 nM),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL471,,,,,,,Canis familiaris
182379,1057,1990,Estrogen receptor,Transcription factor,P06211,Esr1,ESR1_RAT,8.72,,IC50,Inhibition of [3H]17-beta-estradiol binding to rat ER alpha expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,,,,Rattus norvegicus
182380,1057,2013,Estrogen receptor,Transcription factor,P19785,Esr1,ESR1_MOUSE,8.66,,IC50,Inhibition of [3H]17-beta-estradiol binding to mouse ER alpha expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,,,,Mus musculus
182381,1057,1991,Estrogen receptor beta,Transcription factor,Q62986,Esr2,ESR2_RAT,8.77,,IC50,Inhibition of [3H]17-beta-estradiol binding to rat ER beta expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,,,,Rattus norvegicus
182382,1057,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,8.83,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,Tchem,,,Homo sapiens
182383,1057,500,Steryl-sulfatase,Enzyme,P08842,STS,STS_HUMAN,4.08,,IC50,Inhibition of steroid sulfatase activity of JEG-3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,Tchem,,,Homo sapiens
182384,1057,812,Steroid hormone receptor ERR2,Nuclear hormone receptor,O95718,ESRRB,ERR2_HUMAN,8.49,,IC50,Inhibition of human ERbeta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,Tchem,,,Homo sapiens
182385,1057,2883,Estrogen receptor,Transcription factor,P06211|Q62986,Esr1|Esr2,ESR1_RAT|ESR2_RAT,9.45,,IC50,Inhibition of estradiol binding to estrogen receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,,,,Rattus norvegicus
182386,1057,752,Steroid hormone receptor ERR1,Nuclear hormone receptor,P11474,ESRRA,ERR1_HUMAN,8.44,,IC50,Inhibition of human ERalpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,Tchem,,,Homo sapiens
182387,1057,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,6.39,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,,,,Rattus norvegicus
182388,1057,2012,Estrogen receptor beta,Transcription factor,O08537,Esr2,ESR2_MOUSE,8.64,,IC50,Inhibition of [3H]17-beta-estradiol binding to mouse ER beta expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,,,,Mus musculus
182389,1057,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.72,,IC50,Inhibitory activity against AR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,Tclin,,,Homo sapiens
182390,3153,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.47,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127643,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182391,2167,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.69,,IC50,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL163238,,,,Tclin,,,Homo sapiens
182392,2697,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,8.66,,IC50,Inhibition of Catechol O-methyltransferase activity in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1324,,,,,,,Rattus norvegicus
182393,1826,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.6,,Ki,Displacement of [3H]WIN35428 from DAT in Sprague-Dawley rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1373,,,,,,,Rattus norvegicus
182394,1826,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,4.19,,IC50,Inhibition of rat NET-mediated norepinephrine reuptake,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1373,,,,,,,Rattus norvegicus
182395,518,1976,Fatty-acid amide hydrolase 1,Enzyme,P97612,Faah,FAAH1_RAT,4.1,,IC50,Inhibition of FAAH in rat brain homogenates pre-incubated for 10 mins before addition of [3H]anandamide and [3H]AEA substrates for 30 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1316,,,,,,,Rattus norvegicus
182396,518,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.88,,IC50,Inhibitory activity against cell-free canine COX-1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1316,,,,Tclin,,,Homo sapiens
182397,518,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,7,,IC50,Inhibition of human recombinant COX2 after 5 mins,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1316,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1316,INHIBITOR,,Tclin,,,Homo sapiens
182398,518,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,4.89,,IC50,Inhibition of ovine COX1 after 5 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1316,,,,,,,Ovis aries
182404,1879,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,6.3,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757,,,,Tchem,,,Homo sapiens
182405,1879,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.45,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757,,,,Tchem,,,Homo sapiens
182406,616,3556,Chloroquine resistance transporter,Unclassified,Q9N623,CRT,CRT_PLAFA,4.27,,IC50,Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes plasma membrane assessed as reduction of [3H]-chloroquine transportation after 1 to 2 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL505,,,,,,,Plasmodium falciparum
182407,616,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,8.06,,IC50,Inhibition of [3H]mepyramine binding to the Histamine H1 receptor in guinea pig cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL505,,,,,,,Cavia porcellus
182408,616,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.96,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL505,,,,Tclin,,,Homo sapiens
182409,616,3437,Lethal(3)malignant brain tumor-like protein 3,Unclassified,Q96JM7,L3MBTL3,LMBL3_HUMAN,4.38,,IC50,Inhibition of L3MBTL3 by alpha-screening,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL505,,,,Tchem,,,Homo sapiens
182410,616,3436,Lethal(3)malignant brain tumor-like protein 1,Unclassified,Q9Y468,L3MBTL1,LMBL1_HUMAN,4.39,,IC50,Inhibition of L3MBTL1 by alpha-screening,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL505,,,,Tchem,,,Homo sapiens
182411,616,3438,MBT domain-containing protein 1,Unclassified,Q05BQ5,MBTD1,MBTD1_HUMAN,4.47,,IC50,Inhibition of MBTD1 by alpha-screening,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL505,,,,Tdark,,,Homo sapiens
182412,616,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL505,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182413,616,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,8.7,,Ki,Ability to displace [3H]pyrilamine from histamine H1 receptor in male Sprague-Dawley rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL505,,,,,,,Rattus norvegicus
182414,1928,2426,Signal transducer and activator of transcription 3,Transcription factor,P40763,STAT3,STAT3_HUMAN,5.52,,EC50,Inhibition of STAT3 expressed in human U3A cells after 1 hr by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL244888,,,,Tchem,,,Homo sapiens
182415,2159,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,7.52,,IC50,Concentration required to inhibit hydrolytic activity of Acetylcholinesterase by 50%,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,,,,Bos taurus
182416,2159,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,9.37,,IC50,In vitro inhibitory activity against acetylcholinesterase,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6598,INHIBITOR,,Tclin,,,Homo sapiens
163339,916,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.585,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
182417,2159,955,Acetylcholinesterase,Enzyme,P04058,ache,ACES_TORCA,7.96,,IC50,Inhibition of Pacific electric ray AChE using acetylthiocholine iodide as substrate after 60 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,,,,Torpedo californica
182418,2159,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,7.47,,Ki,Time dependent inhibition of Electric eel AChE assessed as stability constants of inhibitor-enzyme complex using acetylthiocholine as substrate after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,,,,Electrophorus electricus
182419,2159,3562,Acetylcholinesterase,Unclassified,P36196,ACHE,ACES_CHICK,7.7,,IC50,Inhibition of acetylcholine esterase in chicken biventer cervicis muscle assessed as rate of acetylcholine hydrolysis by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,,,,Gallus gallus
182420,2159,1791,Acetylcholinesterase,Enzyme,P37136,Ache,ACES_RAT,9.17,,IC50,Inhibitory concentration in vitro and ex vivo for anti-AChE activity in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,,,,Rattus norvegicus
182421,2159,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,9.17,,IC50,Inhibitory activity against acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,,,,Mus musculus
182422,2159,1774,Butyrylcholinesterase; Protein Bche,Enzyme,Q9JKC1,Bche,Q9JKC1_RAT,8.12,,IC50,Inhibition of rat plasma BChE by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,,,,Rattus norvegicus
182423,2159,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,5.3,,Ki,Inhibition of anticholinesterase activity by their ability to inactivate human serum butyrylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,Tclin,,,Homo sapiens
182424,2159,1881,Cholinesterase,Enzyme,Q03311,Bche,CHLE_MOUSE,6.55,,IC50,Inhibition of mouse serum BChE after 1 hr by modified Ellman's colorimetric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,,,,Mus musculus
182425,2159,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,7.39,,Ki,Time dependent inhibition of equine serum BChE assessed as stability constants of inhibitor-enzyme complex using acetylthiocholine as substrate after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,,,,Equus caballus
182426,2159,1808,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,4.43,,IC50,Binding affinity against mouse muscarinic acetylcholine receptor M1 using cerebral cortex and [3H]pirenzepine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,,,,Mus musculus
182427,2159,2007,Butyrylcholinesterase,Enzyme,Q9N1N9,BCHE,Q9N1N9_HORSE,7.8,,IC50,Compound was evaluated for its inhibitory concentration against Horse serum Butyrylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94,,,,,,,Equus caballus
182428,1223,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,5.89,,Ki,Binding affinity against GST-hARLBD was measured in SC-3 cell by using [3H]testosterone as radioligand,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL806,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL806,ANTAGONIST,,Tclin,,,Homo sapiens
182429,2156,2903,Phosphodiesterase 1,Enzyme,P54750|Q01064|Q14123,PDE1A|PDE1B|PDE1C,PDE1A_HUMAN|PDE1B_HUMAN|PDE1C_HUMAN,5,,Ki,Binding affinity for [Ca(2+)]/calmodulin dependent phosphodiesterase PDE 1 of human brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL153427,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182430,2156,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,5.85,,Ki,Binding affinity for low Km cAMP phosphodiesterase PDE III of human platelets,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL153427,,,,Tclin|Tclin,,,Homo sapiens
182431,1830,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.58,,Ki,Binding affinity towards human 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460,,,,Tclin,,,Homo sapiens
182432,622,1952,Solute carrier family 22 member 6,Transporter,O35956,Slc22a6,S22A6_RAT,4.4,,Ki,Inhibition of rat Oat1 expressed in Xenopus oocytes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL498,,,,,,,Rattus norvegicus
182433,3377,344,Farnesyl pyrophosphate synthase,Enzyme,P14324,FDPS,FPPS_HUMAN,7.2,,Ki,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55214,,,,Tclin,,,Homo sapiens
182434,673,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,7.44,,Kd,Affinity for cow beta-2 adrenergic receptor by measuring displacement (-)-[3H]dihydroalprenolol (DHA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49080,,,,,,,Bos taurus
182435,673,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.8,,Kd,Binding affinity to beta-2 adrenergic receptor (unknown origin) at 1 to 10000 nM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49080,,,,Tclin,,,Homo sapiens
182436,1019,652,Protein P,Polyprotein,Q9IF40,P,Q9IF40_HBV,,,,Mechanism of Action; CHEMBL2362994; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL713,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL713,INHIBITOR,,,,,Hepatitis B virus
182437,996,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.3,,IC50,Inhibitory activity against Fibroblast growth factor receptor 3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16699,,,,Tclin,,,Homo sapiens
182438,996,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,6.4,,IC50,Inhibitory concentration against c-Kit wild type expressed in recombinant baculovirus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16699,,,,Tclin,,,Homo sapiens
182439,996,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,6.15,,IC50,Inhibitory activity against Platelet-derived growth factor receptor alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16699,,,,Tclin,,,Homo sapiens
182441,2813,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,6.44,,Ki,Inhibition of [3H]- DA reuptake into rat striatal synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL637,,,,,,,Rattus norvegicus
182442,2813,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,7.6,,Ki,Displacement of [3H]-citalopram from Sprague-Dawley rat brain SERT after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL637,,,,,,,Rattus norvegicus
182443,2813,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,6.19,,IC50,Inhibition of norepinephrine uptake at rat brain norepinephrine transporter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL637,,,,,,,Rattus norvegicus
163340,812,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.84,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
182445,2813,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.44,,Ki,Inhibition of [3H]dopamine uptake at human DAT expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL637,,,,Tclin,,,Homo sapiens
182446,2813,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,6.86,,Ki,Inhibition of [3H]- NE reuptake into rat hippocampal synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL637,,,,,,,Rattus norvegicus
182447,180,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,5.07,,IC50,In vitro inhibition of [14C]5-HT transporter uptake by rat brain slices,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,,,,Rattus norvegicus
182448,180,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,5.8,,IC50,Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,Tclin,,,Homo sapiens
182449,180,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,10.7,,IC50,Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,,,,Rattus norvegicus
182450,180,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.21,,Ki,Inhibition of [3H]dopamine uptake at human DAT expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,Tclin,,,Homo sapiens
182451,180,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.77,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,Tchem,,,Homo sapiens
182452,180,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,5.6,,IC50,Inhibition of the NE [3H]norepinephrine uptake by rat brain slices In vitro,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,,,,Rattus norvegicus
182453,180,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,6,,IC50,Inhibition of recombinant human NaV1.7 alpha subunit expressed in HEK293 cells at -65 mV holding potential by patch clamp electrophysiological assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,Tclin,,,Homo sapiens
182454,180,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,6.52,,IC50,Inhibition of radioligand [3H]QNB binding to muscarinic acetylcholine receptor in the rat forebrain in the presence of zinc,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,,,,Rattus norvegicus
182455,180,138,Sodium channel protein type 2 subunit alpha,Ion channel,Q99250,SCN2A,SCN2A_HUMAN,5.51,,IC50,Inhibition of human NaV1.2 alpha subunit expressed in CHOK1 cells at -65 mV holding potential by patch clamp electrophysiological assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,Tclin,,,Homo sapiens
182456,180,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,10.7,,IC50,Compound tested for its inhibitory activity against Histamine H1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,,,,Rattus norvegicus
182457,2106,3532,Carnitine palmitoyltransferase 2,Unclassified,P18886,Cpt2,CPT2_RAT,4.1,,IC50,Inhibition of CPT2 in rat mitochondria using [3H]carnitine by radiometric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75880,,,,,,,Rattus norvegicus
182458,2106,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.11,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75880,,,,Tclin,,,Homo sapiens
182459,2106,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,6.7,,Kd,Alpha adrenergic receptor activity in rat aorta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75880,,,,,,,Rattus norvegicus
182460,2106,3563,Carnitine palmitoyltransferase 1A,Unclassified,P32198,Cpt1a,CPT1A_RAT,4.11,,IC50,Inhibition of CPT1 in rat cardiac mitochondria using [3H]carnitine by radiometric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75880,,,,,,,Rattus norvegicus
182461,2106,349,"Carnitine O-palmitoyltransferase 2, mitochondrial",Enzyme,P23786,CPT2,CPT2_HUMAN,4.14,,IC50,Inhibition of human CPT2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75880,,,,Tchem,,,Homo sapiens
182462,2099,147,Adenosine receptor A2b,GPCR,P29275,ADORA2B,AA2BR_HUMAN,5.29,,Ki,"Binding affinity at human Adenosine A2B receptor expressed in HEK293 cells, using [125I]ABOPX as radioligand",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628,ANTAGONIST,,Tclin,,,Homo sapiens
182463,2099,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.18,,IC50,Inhibition of human AChE using acetylthiocholine iodide as substrate treated 5 mins before substrate addition measured up to 4 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628,,,,Tclin,,,Homo sapiens
182464,2502,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL446,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL446,INHIBITOR,,,,,Escherichia coli (strain K12)
182465,2311,2844,Cyclooxygenase,Enzyme,O62664|O62698,PTGS1|PTGS2,PGH1_BOVIN|PGH2_BOVIN,7.15,,IC50,Inhibition of PG synthetase activity obtained from bovine seminal vesicles,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL268501,,,,,,,Bos taurus
182466,2763,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,9.9,,Kd,Potency against histamine H1 receptor on guinea pig ileum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL855,,,,,,,Cavia porcellus
182467,2763,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.9,,Ki,GRAC: human H1 selective antagonist,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL855,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL855,ANTAGONIST,,Tclin,,,Homo sapiens
182468,915,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200880,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200880,ANTAGONIST,,Tclin,,,Homo sapiens
182643,1845,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,9.11,,Ki,"mu-1 receptor binding affinity in rat brain by 3H [d-Ala2, d-Leu5] enkephalin displacement.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Rattus norvegicus
182469,1276,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,5.66,,IC50,Displacement of [3H]BRL49653 from Homo sapiens (human) PPARgamma receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL464982,,,,Tclin,,,Homo sapiens
182470,1276,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,6.12,,IC50,Displacement of [3H]GW2433 from Homo sapiens (human) PPARdelta receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL464982,,,,Tchem,,,Homo sapiens
182471,1276,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,6.57,,IC50,Inhibition of PPAR-alpha (unknown origin) by SPA assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL464982,,,,Tclin,,,Homo sapiens
182472,1276,1940,Tissue factor,Membrane receptor,P13726,F3,TF_HUMAN,4.52,,IC50,Inhibition of amidolytic activity of human tissue factor/human factor 7a,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL464982,,,,Tchem,,,Homo sapiens
182473,2357,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,10.22,,Ki,Binding affinity to human 5HT3A receptor,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1643895,http://www.ncbi.nlm.nih.gov/pubmed/17652911,ANTAGONIST,,Tclin,,470,Homo sapiens
182476,956,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.98,,Ki,Displacement of [3H]LSD from human 5HT6 receptor expressed in HEK293 cells after 1.5 hrs by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628227,,,,Tchem,,,Homo sapiens
182477,956,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,11,,IC50,Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628227,,,,,,,Rattus norvegicus
182478,956,2846,Serotonin (5-HT) receptor,GPCR,P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT,6.7,,IC50,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628227,,,,,,,Rattus norvegicus
182479,2517,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1525826,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1525826,INHIBITOR,,,,,Escherichia coli (strain K12)
182480,2511,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200359,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200359,INHIBITOR,,,,,Escherichia coli (strain K12)
182481,2138,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,6.1,,Ki,Binding affinity towards HIV protease was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1465,,,,,,,Human immunodeficiency virus 1
182482,1427,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,7.38,,Ki,Inhibition the uptake of tritiated serotonin (5-HT) by the serotonin transporter SERT in rat synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182483,1427,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,7.64,,Ki,Binding affinity towards 5-hydroxytryptamine 2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182484,1427,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,8.36,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,Tchem,,,Homo sapiens
182485,1427,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,6.19,,IC50,Concentration of compound for 50% displacement of [3H]spiperone from Dopamine receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182486,1427,1879,Muscarinic acetylcholine receptor M5,GPCR,P08911,Chrm5,ACM5_RAT,6.52,,IC50,Binding affinity towards muscarinic acetylcholine receptor by inhibiting specific binding of [3H]quinuclidinyl benzilate (0.8 nM) in vitro to membranes of rat brain without cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182487,1427,1829,Sodium-dependent dopamine transporter,Transporter,Q61327,Slc6a3,SC6A3_MOUSE,7.38,,Ki,Tested in vitro for serotonin(5-HT) neuronal uptake inhibition,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Mus musculus
182488,1427,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.77,,IC50,Inhibition of binding of [3H]imipramine to imipramine receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182489,1427,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,6.59,,Ki,In vitro binding affinity at Alpha-2 adrenergic receptor in rat cortex by radioligand binding assay using [3H]rauwolscine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182490,1427,1830,Sodium-dependent noradrenaline transporter,Transporter,O55192,Slc6a2,SC6A2_MOUSE,7.92,,Ki,Tested in vitro for norepinephrine (NE) neuronal uptake inhibition,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Mus musculus
182491,1427,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,4.66,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
182492,1427,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.77,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,Tchem,,,Homo sapiens
182493,1427,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,7.92,,Ki,Inhibition of uptake of tritiated norepinephrine (NE) in rat synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182494,1427,1840,5-hydroxytryptamine receptor 2C,GPCR,P34968,Htr2c,5HT2C_MOUSE,6.8,,Ki,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Mus musculus
182495,1427,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,4.85,,IC50,Inhibition of [3H]MK-801 binding to NMDA receptor of rat cerebral cortical synaptic membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182496,1427,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,7.19,,Ki,Binding affinity against Muscarinic acetylcholine receptor was determined in homogenized rat cortex tissue using [3H]N-methylscopolamine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182497,1427,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,7.34,,Ki,In vitro binding affinity at Alpha-1 adrenergic receptor by radioligand binding assay using [3H]prazosin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182498,1427,1841,D(2) dopamine receptor,GPCR,P61168,Drd2,DRD2_MOUSE,6.14,,Ki,Binding affinity to Dopamine receptor D2 using [3H]spiperone as radioligand in stably transfected NIH3T3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Mus musculus
182499,1427,1842,Sodium-dependent serotonin transporter,Transporter,Q60857,Slc6a4,SC6A4_MOUSE,8.3,,Ki,Binding affinity to Serotonin transporter using [3H]-paroxetine as radioligand in stably transfected NIH3T3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Mus musculus
182500,1427,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.44,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182501,1427,906,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,Tchem,,,Homo sapiens
182502,1427,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,10.22,,IC50,Compound tested for its inhibitory activity against Histamine H1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182503,1427,2846,Serotonin (5-HT) receptor,GPCR,P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT,7.36,,IC50,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,,,,,,,Rattus norvegicus
182504,3323,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,4.32,,IC50,Inhibition of aromatase in human placental microsomes by radiometric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476,,,,Tclin,,,Homo sapiens
182505,3323,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,5.21,,IC50,Displacement of [3H]BRL49653 from Homo sapiens (human) PPARgamma receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476,,,,Tclin,,,Homo sapiens
182506,3323,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,4.19,,IC50,Displacement of [3H]DPCPX from rat adenosine A1 receptor by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476,,,,,,,Rattus norvegicus
182507,3323,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,4.03,,IC50,Inhibition of sheep COX2-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476,,,,,,,Ovis aries
182508,3323,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,5,,IC50,Displacement of [3H]GW2433 from Homo sapiens (human) PPARdelta receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476,,,,Tchem,,,Homo sapiens
182509,3323,722,"Fatty acid-binding protein, heart",Cytosolic other,P05413,FABP3,FABPH_HUMAN,9.7,,Kd,Binding affinity to human FABP3 expressed in Escherichia coli BL21 (DE3) in DMPC liposomes by surface plasmon resonance analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476,,,,Tchem,,,Homo sapiens
182510,3323,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.89,,IC50,Inhibition of COX1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476,,,,Tclin,,,Homo sapiens
182511,3323,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,8.32,,Kd,Binding affinity to PPAR-alpha (unknown origin) by fluorescence-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476,,,,Tclin,,,Homo sapiens
182512,3323,1936,Seed linoleate 13S-lipoxygenase-1,Enzyme,P08170,LOX1.1,LOX1_SOYBN,6,,IC50,Allosteric inhibition of soybean LO1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476,,,,,,,Glycine max
182513,3323,1940,Tissue factor,Membrane receptor,P13726,F3,TF_HUMAN,4.39,,IC50,Inhibition of amidolytic activity of human tissue factor/human factor 7a,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476,,,,Tchem,,,Homo sapiens
182514,3323,577,"Fatty acid-binding protein, adipocyte",Cytosolic other,P15090,FABP4,FABP4_HUMAN,6,,IC50,Displacement of 8-anilino-1-naphthalene-sulfonic acid from human His-FABP4 expressed in Escherichia coli BL21 (DE3) cells after 3 mins relative to linoleic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267476,,,,Tchem,,,Homo sapiens
182515,1193,566,Myeloperoxidase,Enzyme,P05164,MPO,PERM_HUMAN,5.74,,IC50,Inhibition of chlorinating activity of recombinant myeloperoxidase by taurine assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23588,,,,Tchem,,,Homo sapiens
182516,1193,1686,Transient receptor potential cation channel subfamily M member 4,Ion channel,Q8TD43,TRPM4,TRPM4_HUMAN,5.55,,IC50,GRAC: human TRPM4 blocker,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23588,,,,Tchem,,,Homo sapiens
182517,1193,1685,Transient receptor potential cation channel subfamily M member 2,Ion channel,O94759,TRPM2,TRPM2_HUMAN,4.15,,IC50,Inhibition of human recombinant TRPM2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23588,,,,Tchem,,,Homo sapiens
182518,1193,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,4,,IC50,In vitro inhibition of rabbit lens aldose reductase.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23588,,,,Tclin,,,Homo sapiens
182519,1945,2777,GABA-A receptor; anion channel,Ion channel,P08219|P08220|P10063|P10064|P20237|P22300,GABRA1|GABRA2|GABRA3|GABRA4|GABRB1|GABRG2,GBRA1_BOVIN|GBRA2_BOVIN|GBRA3_BOVIN|GBRA4_BOVIN|GBRB1_BOVIN|GBRG2_BOVIN,7.42,,IC50,Inhibition of [3H]flunitrazepam binding to GABA-A central Benzodiazepine receptor of bovine brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13209,,,,,,,Bos taurus
182520,1442,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,5.9,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15870,,,,,,,Rattus norvegicus
182523,2142,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.32,,Ki,Binding affinity towards human alpha-1B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,ANTAGONIST,,Tclin,,,Homo sapiens
182524,2142,2000,Alpha-1B adrenergic receptor,GPCR,P18841,ADRA1B,ADA1B_MESAU,6.66,,Ki,Displacement of [3H]prazosin (0.5 nM) from hamster Alpha-1B adrenergic receptor expressed in rat-1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,,,,,,,Mesocricetus auratus
182525,2142,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.85,,Ki,"Binding affinity towards Alpha-2 adrenergic receptor, using [3H]- atipamezole as radioligand from rat frontal cortex membranes",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,,,,,,,Rattus norvegicus
182526,2142,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.26,,IC50,The compound was tested for affinity towards sigma-3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,,,,Tclin,,,Homo sapiens
182527,2142,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,8.17,,Ki,Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,,,,,,,Bos taurus
182528,2142,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,8.12,,Ki,Binding affinity against Alpha-2B adrenergic receptor from human clones.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,ANTAGONIST,,Tclin,,,Homo sapiens
182529,2142,1868,Alpha-2A adrenergic receptor,GPCR,Q28838,ADRA2A,ADA2A_BOVIN,9.03,,Ki,"Binding affinity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,,,,,,,Bos taurus
182530,2142,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.08,,Ki,Binding affinity against Alpha-2C adrenergic receptor from human clones.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,ANTAGONIST,,Tclin,,,Homo sapiens
182532,2142,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.71,,Ki,Binding affinity towards human alpha-1D adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,ANTAGONIST,,Tclin,,,Homo sapiens
182533,2142,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,7.94,,Ki,Displacement of [125I]PIC from human imidazoline receptor 1 in human platelets analyzed under norepinephrine mask of alpha 2AR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,,,,Tclin,,,Homo sapiens
182535,2142,1833,Alpha-2A adrenergic receptor,GPCR,P22909,Adra2a,ADA2A_RAT,8.33,,Ki,"The compound was tested for binding affinity against alpha-2D adrenergic receptor, from rat clones.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,,,,,,,Rattus norvegicus
182536,2142,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.08,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182537,2142,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8.77,,Ki,Displacement of [3H]RX781094 from alpha2 adrenergic receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,ANTAGONIST,,Tclin,,,Homo sapiens
182538,2142,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,4.9,,IC50,Displacement of [3H]mepyramine from histamine H1 receptor in Sprague-Dawley rat brain membrane after 2 hr by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,,,,,,,Rattus norvegicus
182539,2142,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,7.35,,Ki,Displacement of [3H]prazosin (0.3 nM) from rat Alpha-1D adrenergic receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,,,,,,,Rattus norvegicus
182540,2142,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.39,,Ki,Binding affinity towards alpha-1A adrenergic receptor expressed in human embryonic kidney (HEK293) cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,ANTAGONIST,,Tclin,,,Homo sapiens
182541,920,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,6.38,,IC50,Displacement of [125I]RTI-55 dopamine transporter binding in rat striatal membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1492,,,,,,,Rattus norvegicus
182542,3652,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,7.8,,IC50,In vitro Muscarinic acetylcholine receptor M2 binding was evaluated in rat brain membranes by using [3H]- Oxo-M,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21536,,,,,,,Rattus norvegicus
182543,3652,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.89,,Ki,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21536,,,,Tclin,,,Homo sapiens
182544,3652,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.14,,Ki,Displacement of [3H]-4-DAMP from human muscarinic M4 receptor expressed in BHK-21 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21536,,,,Tclin,,,Homo sapiens
182545,3652,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.1,,Ki,Displacement of [3H]-4-DAMP from human muscarinic M5 receptor expressed in BHK-21 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21536,,,,Tclin,,,Homo sapiens
182546,3652,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.7,,IC50,Binding affinity for muscarinic acetylcholine receptor M1 using [3H]oxotremorine-M (Oxo-M) radioligand in rat hippocampus membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21536,,,,,,,Rattus norvegicus
182547,3652,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.92,,Ki,Displacement of [3H]-AFDX-384 from human muscarinic M2 receptor expressed in CHO-K1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21536,,,,Tclin,,,Homo sapiens
182548,3652,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,8.01,,IC50,Binding affinity against muscarinic receptor in rat brain membranes using oxotremorine-M as ligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21536,,,,,,,Rattus norvegicus
182549,3652,1808,Muscarinic acetylcholine receptor M1,GPCR,P12657,Chrm1,ACM1_MOUSE,5.24,,EC50,Tested against Muscarinic acetylcholine receptor M1 expressed in A9 L cell line,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21536,,,,,,,Mus musculus
182550,3652,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.38,,Ki,Affinity towards human M1 receptor expressed in CHO cells using [3H]QNB as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21536,,,,Tclin,,,Homo sapiens
182551,2603,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.3,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL363295,,,,Tclin,,,Homo sapiens
182552,1925,2478,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,5.44,,Ki,Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL63323,,,,Tchem,,,Homo sapiens
182553,3400,59,Fatty-acid amide hydrolase 1,Enzyme,O00519,FAAH,FAAH1_HUMAN,5.22,,Ki,Inhibition of FAAH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,Tchem,,,Homo sapiens
182554,3400,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,4.49,,IC50,Inhibition of aromatase in human placental microsomes by radiometric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,Tclin,,,Homo sapiens
182555,3400,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,5.39,,IC50,Displacement of [3H]BRL49653 from Homo sapiens (human) PPARgamma receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,Tclin,,,Homo sapiens
182556,3400,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,6.74,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,,,,Rattus norvegicus
182557,3400,760,"Fatty acid-binding protein, epidermal",Cytosolic other,Q01469,FABP5,FABP5_HUMAN,6.61,,Ki,"Displacement of 1,8-ANS from eFABP by fluorescence based-assay",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,Tchem,,,Homo sapiens
182558,3400,909,"Fatty acid-binding protein, liver",Unclassified,P07148,FABP1,FABPL_HUMAN,6.7,,Kd,Binding affinity to L-FABP high binding affinity site by titration calorimetry method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,Tchem,,,Homo sapiens
182559,3400,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,5.28,,IC50,Displacement of [3H]GW2433 from Homo sapiens (human) PPARdelta receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,Tchem,,,Homo sapiens
182560,3400,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,6.22,,IC50,Inhibition of PPAR-alpha (unknown origin) by SPA assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,Tclin,,,Homo sapiens
182561,3400,1936,Seed linoleate 13S-lipoxygenase-1,Enzyme,P08170,LOX1.1,LOX1_SOYBN,4.66,,Ki,Binding affinity to soybean LO1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,,,,Glycine max
182562,3400,1940,Tissue factor,Membrane receptor,P13726,F3,TF_HUMAN,4.1,,IC50,Inhibition of amidolytic activity of human tissue factor/human factor 7a,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,Tchem,,,Homo sapiens
182563,3400,577,"Fatty acid-binding protein, adipocyte",Cytosolic other,P15090,FABP4,FABP4_HUMAN,6.73,,Ki,"Displacement of 1,8-ANS from aFABP by fluorescence based-assay",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,Tchem,,,Homo sapiens
182564,3400,596,DNA topoisomerase 1,Enzyme,P11387,TOP1,TOP1_HUMAN,4.51,,IC50,Inhibition of DNA topoisomerase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,Tclin,,,Homo sapiens
182565,2387,344,Farnesyl pyrophosphate synthase,Enzyme,P14324,FDPS,FPPS_HUMAN,9.44,,Ki,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL923,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL923,INHIBITOR,,Tclin,,,Homo sapiens
182566,2387,2433,Farnesyl diphosphate synthase,Enzyme,Q197X6,FPPS,Q197X6_TOXGO,7.13,,IC50,Inhibition of Toxoplasma gondii FPPS after 30 mins using [14C]IPP by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL923,,,,,,,Toxoplasma gondii
182567,2387,3440,Farnesyl diphosphate synthase,Unclassified,Q8WS26,,Q8WS26_TRYCR,7.57,,IC50,Inhibition of Trypanosoma cruzi FPPS after 30 mins using [14C]IPP by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL923,,,,,,,Trypanosoma cruzi
182568,2387,1964,Farnesyl pyrophosphate synthase,Enzyme,Q0GKD7,,Q0GKD7_LEIDO,7.77,,Ki,Binding affinity towards Farnesyl diphosphate synthase from leishmania major,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL923,,,,,,,Leishmania donovani
182569,1560,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.32,,Ki,Displacement of [125I]-IBOxyA from MOR-1 expressed in CHO cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1254682,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1254682,ANTAGONIST,,Tclin,,,Homo sapiens
182570,1560,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,4.92,,Ki,Inhibition of electric eel AChE by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1254682,,,,,,,Electrophorus electricus
182571,1560,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,9.2,,IC50,Displacement of [3H]-dihydromorphine from mu opioid receptor in rat cerebral cortex by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1254682,,,,,,,Rattus norvegicus
182572,1560,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,9.27,,IC50,Inhibition of [3H]naloxone binding to opioid receptor in presence of NaCl,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1254682,,,,,,,Rattus norvegicus
182576,2775,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,8.16,,Ki,Inhibition constant against nicotinic acetylcholine receptor alpha7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,Tchem,,,Homo sapiens
182577,2775,2389,5-hydroxytryptamine receptor 3A,Ion channel,O70212,HTR3A,5HT3A_CAVPO,7.52,,Kd,Antagonist activity at 5HT3 receptor in spontaneously beating guinea pig right atrium assessed as inhibition of serotonin-induced maximum response by competitive binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,,,,Cavia porcellus
182578,2775,2898,Serotonin 3 receptor (5HT3),Ion channel,P23979|Q9JHJ5,Htr3a|Htr3b,5HT3A_MOUSE|5HT3B_MOUSE,8.42,,Ki,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,,,,Mus musculus
182579,2775,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,4.26,,Ki,In vitro Binding affinity towards Nicotinic acetylcholine receptor alpha4-beta2 was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,Tclin|Tclin,,,Homo sapiens
182580,2775,2819,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNB1|CHRND|CHRNG,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN|ACHG_HUMAN,4.57,,Ki,In vitro Binding affinity towards alpha-1-beta-1-gamma-delta nAChR was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
182581,2775,2783,Serotonin 3 (5-HT3) receptor,Ion channel,P35563|Q9JJ16,Htr3a|Htr3b,5HT3A_RAT|5HT3B_RAT,8.89,,Ki,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]- 1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,,,,Rattus norvegicus
182582,2775,3384,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,P32297,CHRNA3,ACHA3_HUMAN,4.8,,Ki,In vitro Binding affinity towards alpha-3 (PC12) nAChR was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,Tclin,,,Homo sapiens
182583,2775,1783,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,Q05941,Chrna7,ACHA7_RAT,8,,EC50,Activation responses to that evoked by ACh at human Nicotinic acetylcholine receptor alpha-7 expressed in xenopus oocytes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,,,,Rattus norvegicus
182584,2775,1895,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P49582,Chrna7,ACHA7_MOUSE,8.16,,Ki,In vitro Binding affinity towards alpha-7 nAChR was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,,,,Mus musculus
182585,2775,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.28,,Ki,Inhibition constant against 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,Tclin,,,Homo sapiens
182586,2775,3374,5-hydroxytryptamine receptor 3B,Ion channel,O95264,HTR3B,5HT3B_HUMAN,8.8,,Ki,GRAC: human 5-HT3B selective antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,Tchem,,,Homo sapiens
182587,2775,1855,5-hydroxytryptamine receptor 4,GPCR,Q62758,Htr4,5HT4R_RAT,7.2,,Ki,Displacement of [3H]GR-113808 from rat striatum 5-hydroxytryptamine 4 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,,,,Rattus norvegicus
182588,2775,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.9,,Ki,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56564,,,,,,,Cavia porcellus
182589,3070,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.29,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1093,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1093,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
182590,1763,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,4.26,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191083,,,,,,,Trypanosoma cruzi
182591,1763,784,Glutathione reductase,Enzyme,O15770,GR3,GSHR_PLAF7,5.19,,IC50,Inhibitory concentration against Plasmodium falciparum glutathione reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191083,,,,,,,Plasmodium falciparum (isolate 3D7)
182592,1763,152,"Glutathione reductase, mitochondrial",Enzyme,P00390,GSR,GSHR_HUMAN,4.8,,IC50,Inhibitory concentration against human glutathione reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191083,,,,Tclin,,,Homo sapiens
182593,1763,2491,Microtubule-associated protein tau,Structural,P10636,MAPT,TAU_HUMAN,5.72,,IC50,Inhibition of human recombinant brain tau protein (412 amino acid residues) filament assembly expressed in Escherichia coli BL21(DE3) by electron microscopic analysis in presence of heparin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191083,,,,Tchem,,,Homo sapiens
182594,1763,367,"Thioredoxin reductase 1, cytoplasmic",Enzyme,Q16881,TXNRD1,TRXR1_HUMAN,4.52,,IC50,Inhibition of human recombinant TrxR1 at pH 7.4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191083,,,,Tclin,,,Homo sapiens
182595,2286,3556,Chloroquine resistance transporter,Unclassified,Q9N623,CRT,CRT_PLAFA,4.07,,IC50,Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocytes plasma membrane assessed as reduction of [3H]-chloroquine transportation after 1 to 2 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643,,,,,,,Plasmodium falciparum
182596,2286,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,4.75,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
182597,2286,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.45,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643,,,,Tchem,,,Homo sapiens
182598,2286,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.16,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182599,2286,906,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.1,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643,,,,Tchem,,,Homo sapiens
182600,2286,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.12,,IC50,Binding affinity to SERT (unknown origin) by radioligand binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643,,,,Tclin,,,Homo sapiens
182601,2284,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,5.98,,IC50,Compound was tested for inhibition of [3H]spiperone binding in membrane preparations obtained from rat corpus striatum.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,,,,,,,Rattus norvegicus
182602,2284,1634,Trypanothione reductase,Enzyme,P28593,TPR,TYTR_TRYCR,4.23,,Ki,Inhibitory activity against recombinant Trypanosoma cruzi (Trypanosoma cruzi) Trypanothione reductase (linear competitive type),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,,,,,,,Trypanosoma cruzi
182603,2284,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,4.95,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
182604,2284,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.76,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,,,,Tchem,,,Homo sapiens
182605,2284,2851,Dopamine receptor,GPCR,P20288|Q95136,DRD1|DRD2,DRD1_BOVIN|DRD2_BOVIN,6.89,,IC50,Compound was tested for inhibition of [3H]spiperone binding in membrane preparations obtained from calf caudate.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,,,,,,,Bos taurus
182606,2284,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.27,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182607,2284,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,5.9,,IC50,Displacement of [3H]mepyramine from histamine H1 receptor in Sprague-Dawley rat brain membrane after 2 hr by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,,,,,,,Rattus norvegicus
182608,2284,906,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.3,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,,,,Tchem,,,Homo sapiens
182609,3082,1931,Dynamin-1,Structural,Q05193,DNM1,DYN1_HUMAN,5.36,,IC50,Concentration required against dynamin-1 GTPase activity of sheep brain.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL307346,,,,Tbio,,,Homo sapiens
182610,1640,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,6.61,,Ki,Binding affinity to the serotonin transporter (SERT) measured by displacement of [3H]paroxetine in male wistar rats,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781,,,,,,,Rattus norvegicus
182611,1640,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,8.06,,Kd,"Binding affinity to a single, sodium-dependent site on the Dopamine transporter in rat striatal membranes",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781,,,,,,,Rattus norvegicus
182612,1640,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.63,,IC50,The compound was tested for affinity towards sigma-3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781,,,,Tclin,,,Homo sapiens
182613,1640,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,8,,Ki,GRAC: human DAT selective inhibitor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781,INHIBITOR,,Tclin,,,Homo sapiens
182614,1640,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,9.1,,Ki,Binding affinity against norepinephrine transporter (NET) by displacement of [3H]nisoxetine in male wistar rats,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781,,,,,,,Rattus norvegicus
182615,1640,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,9.3,,Kd,GRAC: human NET probe,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781,INHIBITOR,,Tclin,,,Homo sapiens
182616,1640,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.3,,Ki,Displacement of [125I]- RTI-55 from Serotonin transporter expressed in HEK cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781,INHIBITOR,,Tclin,,,Homo sapiens
182617,852,2146,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P23576,Gabra2,GBRA2_RAT,7.82,,Ki,Displacement of [3H]flumazenil from rat GABA-A alpha-2-beta-2-gamma-2 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Rattus norvegicus
182618,852,2788,GABA-A receptor; alpha-1/beta-2/gamma-2,Ion channel,P18508|P62813|P63138,Gabra1|Gabrb2|Gabrg2,GBRA1_RAT|GBRB2_RAT|GBRG2_RAT,7.92,,Ki,Displacement of [3H]Ro15-1788 from rat recombinant GABA alpha-1-beta-2-gamma-2 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Rattus norvegicus
182619,852,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,7.92,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,Tchem,,,Homo sapiens
182620,852,2145,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P62813,Gabra1,GBRA1_RAT,7.96,,Ki,Displacement of [3H]flumazenil from rat GABA-A alpha-1-beta-2-gamma-2 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Rattus norvegicus
94331,657,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,4.08,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
182621,852,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,6.27,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Rattus norvegicus
182622,852,2147,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,P19969,Gabra5,GBRA5_RAT,8.01,,Ki,Displacement of [3H]flumazenil from rat GABA-A alpha-5-beta-3-gamma-2 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Rattus norvegicus
182623,852,2777,GABA-A receptor; anion channel,Ion channel,P08219|P08220|P10063|P10064|P20237|P22300,GABRA1|GABRA2|GABRA3|GABRA4|GABRB1|GABRG2,GBRA1_BOVIN|GBRA2_BOVIN|GBRA3_BOVIN|GBRA4_BOVIN|GBRB1_BOVIN|GBRG2_BOVIN,8,,Ki,Displacement of [3H]Ro-151788 from GABA-A benzodiazepine receptor of bovine brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Bos taurus
182624,852,2786,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,P18508|P20236|P63138,Gabra3|Gabrb2|Gabrg2,GBRA3_RAT|GBRB2_RAT|GBRG2_RAT,7.86,,Ki,Displacement of [3H]Ro-151788 from rat GABA-A receptor alpha-3-beta-2-gamma-2 subunits expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Rattus norvegicus
182625,852,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,4.89,,Ki,Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) assessed as inhibition of ATCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Electrophorus electricus
182626,852,2791,GABA A receptor alpha-5/beta-3/gamma-2,Ion channel,P18508|P19969|P63079,Gabra5|Gabrb3|Gabrg2,GBRA5_RAT|GBRB3_RAT|GBRG2_RAT,7.96,,Ki,Binding affinity for recombinant rat GABA-A receptor alpha-5-beta-3-gamma-2 subunits expressed in HEK 293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Rattus norvegicus
182627,852,2787,GABA A receptor alpha-6/beta-2/gamma-2,Ion channel,P18508|P30191|P63138,Gabra6|Gabrb2|Gabrg2,GBRA6_RAT|GBRB2_RAT|GBRG2_RAT,8.68,,Ki,"Binding affinity for mutant rat GABA-A receptor alpha-6-(his,thr,gly,val)beta2gamma2 subunits expressed in HEK293 cells",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Rattus norvegicus
182628,852,1852,Translocator protein,Membrane receptor,P16257,Tspo,TSPO_RAT,6.67,,Kd,Binding affinity constant for peripheral (mitochondrial) Benzodiazepine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Rattus norvegicus
182629,852,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,7.37,,Ki,Inhibition of Equus caballus (horse) serum butyrylcholinesterase (BChE) assessed as inhibition of BTCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Equus caballus
182630,852,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,8.54,,Ki,In vitro binding affinity against benzodiazepine receptor using [3H]diazepam as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Rattus norvegicus
182631,852,2789,GABA-A receptor; anion channel,Ion channel,A2AMW3|P16305|P22723|P22933|P26048|P26049|P27681|P50571|P62812|P63080|Q8BHJ7|Q8QZW7|Q9D6F4|Q9JLF1|Q9R0Y8,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,A2AMW3_MOUSE|GBRA1_MOUSE|GBRA2_MOUSE|GBRA3_MOUSE|GBRA4_MOUSE|GBRA5_MOUSE|GBRA6_MOUSE|GBRB1_MOUSE|GBRB3_MOUSE|GBRD_MOUSE|GBRG1_MOUSE|GBRG2_MOUSE|GBRG3_MOUSE|GBRP_MOUSE|GBRT_MOUSE,4.07,,Ki,Binding affinity for umolar GABA-A central benzodiazepine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Mus musculus
182632,852,2790,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,P18508|P23576|P63138,Gabra2|Gabrb2|Gabrg2,GBRA2_RAT|GBRB2_RAT|GBRG2_RAT,7.7,,Ki,Binding affinity for recombinant rat GABA-A receptor alpha-2-beta-2-gamma-2 subunits expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,,,,Rattus norvegicus
182633,1556,443,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,5.58,,IC50,"Inhibition of human CYP11B1 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1444,,,,Tclin,,,Homo sapiens
182634,1556,673,"Cytochrome P450 11B2, mitochondrial",Enzyme,P19099,CYP11B2,C11B2_HUMAN,5.85,,IC50,"Inhibition of human CYP11B2 expressed in hamster V79MZh cells using [1,2-3H]-11-deoxy-corticosterone as substrate",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1444,,,,Tchem,,,Homo sapiens
182635,1845,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,8.27,,IC50,Concentration inhibiting the specific binding of [3H]naloxone by 50% in the absence of NaCl,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Rattus norvegicus
182636,1845,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,7.62,,Ki,Binding affinity towards guinea pig Opioid receptor kappa 1 using radioligand [3H]U-69593,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Cavia porcellus
182637,1845,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.55,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,Tchem,,,Homo sapiens
182638,1845,1760,Delta-type opioid receptor,GPCR,P32300,Oprd1,OPRD_MOUSE,7,,Ki,Displacement of [3H]DPDPE from delta opioid receptor in CD1 mouse brain membranes after 1 hr by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Mus musculus
182639,1845,1758,Mu-type opioid receptor,GPCR,P42866,Oprm1,OPRM_MOUSE,8.92,,Ki,Displacement of [3H]DAMGO from mu opioid receptor in CD1 mouse brain membranes after 1 hr by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Mus musculus
182640,1845,1836,Kappa-type opioid receptor,GPCR,P34975,Oprk1,OPRK_RAT,7.57,,Ki,Inhibition of 9 (2 nM) binding to Opioid receptor kappa 1 of rat brain homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Rattus norvegicus
182641,1845,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,8.74,,Ki,Displacement of [3H]DPDPE from delta opioid receptor in rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Rattus norvegicus
182642,1845,1979,Mu-type opioid receptor,GPCR,P79350,OPRM1,OPRM_BOVIN,9.3,,Ki,Binding affinity towards opioid receptor mu 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Bos taurus
182645,1845,2546,Nociceptin receptor,GPCR,P47748,OPRL1,OPRX_CAVPO,7.86,,Ki,Displacement of radiolabeled NalBzOH from kappa3 opioid receptor in Hartley guinea pig brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Cavia porcellus
182646,1845,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,9.06,,Ki,Binding affinity towards Opioid receptor mu 1 of guinea pig brain membranes using radioligand 0.25 nM [3H]DAMGO,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Cavia porcellus
182647,1845,2894,Opioid receptor,GPCR,O55242|P32300|P33534|P42866,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_MOUSE|OPRK_MOUSE|OPRM_MOUSE|SGMR1_MOUSE,7.57,,IC50,Concentration required to inhibit [3H]naltrexone binding to Opioid receptors,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Mus musculus
182648,1845,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,8.22,,Ki,Inhibition of [3H]- naloxone binding to Opioid receptors in rat brain membrane in the absence of Na,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Rattus norvegicus
182649,1393,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,8.55,,Ki,"Displacement of [3H]U69,593 from human kappa opioid receptor expressed in CHO cells after 60 mins by scintillation counting",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL398707,,,,Tclin,,,Homo sapiens
182650,1393,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,7.42,,Ki,Displacement of [3H]naltrindole from human delta opioid receptor expressed in CHO cells after 3 hrs by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL398707,,,,Tclin,,,Homo sapiens
182651,1393,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.55,,Ki,Displacement of [3H]DAMGO from human mu opioid receptor expressed in CHO cells after 60 mins by scintillation counting,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL398707,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL398707,AGONIST,,Tclin,,,Homo sapiens
182652,1393,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,9,,EC50,Binding affinity to opioid receptor in rat brain homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL398707,,,,,,,Rattus norvegicus
182653,2268,2066,Solute carrier family 22 member 12,Transporter,Q96S37,SLC22A12,S22AC_HUMAN,4.3,,IC50,Inhibition of human URAT1-mediated urate uptake in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897,,,,Tclin,,,Homo sapiens
182654,2268,3441,UDP-glucuronosyltransferase 1-7,Enzyme,Q9HAW7,UGT1A7,UD17_HUMAN,4.02,,Ki,Inhibition of 4-methylumbelliferone glucuronidation by human recombinant UGT1A7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897,,,,Tbio,,,Homo sapiens
182655,2268,2079,Solute carrier family 22 member 20,Transporter,Q80UJ1,Slc22a20,S22AK_MOUSE,5.08,,Ki,Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897,,,,,,,Mus musculus
182656,2268,2074,Solute carrier family 22 member 6,Transporter,Q8VC69,Slc22a6,S22A6_MOUSE,5.2,,Ki,Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897,,,,,,,Mus musculus
182657,2331,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,8.89,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511,,,,Tchem,,,Homo sapiens
182658,2331,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,9.5,,Kd,Antagonist activity at histamine H1 receptor in Cavia porcellus (guinea pig) ileum assessed as inhibition of electrically-induced contraction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511,,,,,,,Cavia porcellus
182659,2331,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.96,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511,,,,Tclin,,,Homo sapiens
182660,2331,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,8.24,,IC50,Displacement of [3H]mepyramine from histamine H1 receptor in Sprague-Dawley rat brain membrane after 2 hr by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511,,,,,,,Rattus norvegicus
182661,2331,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.1,,Ki,GRAC: human H1 selective antagonist,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511,ANTAGONIST,,Tclin,,,Homo sapiens
182662,3424,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,7.12,,Ki,Binding affinity to Opioid receptor kappa 1 in guinea pig cortex using [3H]EKC as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL560,,,,,,,Cavia porcellus
182663,3424,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,8.16,,Ki,Binding affinity to Opioid receptor mu 1 in rat brain using [3H]-NAL as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL560,,,,,,,Rattus norvegicus
182664,3424,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,7.9,,IC50,Inhibition of [3H]-Naloxone binding to rat brain membrane without NaCl,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL560,,,,,,,Rattus norvegicus
182665,3424,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,7.92,,Ki,Displacement of (+)-[3H]pentazocine from sigma1 receptor in Sprague-Dawley rat cerebral membrane after 90 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL560,,,,,,,Rattus norvegicus
182666,667,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,5.14,,Ki,Binding affinity to adenosine A1 receptor in rat brain membranes by measuring displacement of specific [3H]PIA as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1619,,,,,,,Rattus norvegicus
182667,667,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,4.69,,Ki,Binding affinity to adenosine A2A receptor in rat striatal membranes by measuring displacement of specific [3H]-CGS- 21680 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1619,,,,,,,Rattus norvegicus
182668,34,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,5.28,,EC50,In vitro antiviral activity against HIV-1 Reverse transcriptase wild type,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1380,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1380,INHIBITOR,,,,,Human immunodeficiency virus 1
182669,215,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,7.7,,Ki,Binding affinity for aromatase cytochrome P45019A1 by analysis of Dixon plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274826,,,,Tclin,,,Homo sapiens
182670,215,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,7.46,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274826,,,,Tchem,,,Homo sapiens
182671,215,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.89,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274826,,,,,,,Rattus norvegicus
182672,215,895,Testosterone 17-beta-dehydrogenase 3,Enzyme,P37058,HSD17B3,DHB3_HUMAN,6.31,,IC50,Ability to inhibit the Type-3 17-beta- hydroxysteroid dehydrogenase activity transfected in human embryonic kidney (HEK)-293 cells experiment 3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274826,,,,Tchem,,,Homo sapiens
182673,2831,2291,Beta-lactoglobulin,Unclassified,P02754,LGB,LACB_BOVIN,7.44,,Kd,Binding affinity to bovine beta-lactoglobulins by fluorescence spectroscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL986,,,,,,,Bos taurus
182674,2831,465,Retinol-binding protein 4,Secreted,P02753,RBP4,RET4_HUMAN,6.74,,Kd,Binding affinity to His-tagged recombinant human sRBP expressed in Escherichia coli BL21(DE3) assessed as apparent dissociation constant after 5 mins by fluorescence spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL986,,,,Tchem,,,Homo sapiens
182675,3227,3564,Uracil-DNA glycosylase,Unclassified,P04303,UNG,UNG_VACCW,4.41,,IC50,Inhibition of Vaccinia virus WR strain processivity factor D4 interaction with A20 protein assessed as inhibition of E9 DNA polymerase-mediated DIG-dUTP incorporation into DNA strand by rapid plate assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473535,,,,,,,Vaccinia virus (strain Western Reserve)
182677,1431,3565,Vacuolar-type proton translocating pyrophosphatase 1,Unclassified,Q8MTZ4,PPase1,Q8MTZ4_9TRYP,4.35,,IC50,Inhibition of recombinant Trypanosoma brucei soluble vacuolar pyrophosphatase expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53950,,,,,,,Trypanosoma brucei
182678,3574,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,4.68,,IC50,In vitro inhibition of PDE-V isolated from porcine pulmonary artery.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL286020,,,,Tclin,,,Homo sapiens
182679,3574,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,4.3,,IC50,"Concentration of compound required for 50% inhibition of type III cAMP phosphodiesterase from dog ventricles, activity expressed as pIC50",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL286020,,,,Tclin|Tclin,,,Homo sapiens
182680,1272,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,5.06,,IC50,Inhibition of bovine AChE by Elman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL659,,,,,,,Bos taurus
182681,1272,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,7.21,,Ki,Inhibition of human recombinant AChE using acetylthiocholine as substrate,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL659,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL659,INHIBITOR,,Tclin,,,Homo sapiens
182682,1272,955,Acetylcholinesterase,Enzyme,P04058,ache,ACES_TORCA,6.44,,IC50,Inhibitory activity against acetylcholinesterase (AChE) from Torpedo californica (Reversible type of inhibition),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL659,,,,,,,Torpedo californica
182683,1272,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,6.37,,Ki,Competitive inhibition of Electrophorus electricus AChE by Lineweaver-Burke plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL659,,,,,,,Electrophorus electricus
182684,1272,1791,Acetylcholinesterase,Enzyme,P37136,Ache,ACES_RAT,6.27,,IC50,In vitro inhibitory effect on rat Acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL659,,,,,,,Rattus norvegicus
182685,1272,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,5.6,,IC50,Inhibition of ICR mouse brain AChE using acetylthiocholine iodide as substrate incubated 10 mins prior to substrate addition measured after 10 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL659,,,,,,,Mus musculus
182686,1272,1774,Butyrylcholinesterase; Protein Bche,Enzyme,Q9JKC1,Bche,Q9JKC1_RAT,5.23,,IC50,Inhibition of BChE from rat serum by Ellmans method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL659,,,,,,,Rattus norvegicus
182687,1272,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,6.72,,Ki,Inhibition of human recombinant BChE using acetylthiocholine as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL659,,,,Tclin,,,Homo sapiens
182688,1272,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,5.03,,Ki,Inhibition of equine serum BChE using butyrylthiocholine iodide as substrate after 20 mins measured for 1 min interval for 30 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL659,,,,,,,Equus caballus
182689,1272,2007,Butyrylcholinesterase,Enzyme,Q9N1N9,BCHE,Q9N1N9_HORSE,5.1,,Ki,Inhibitory activity against BuChE from horse serum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL659,,,,,,,Equus caballus
182690,1103,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.7,,IC50,Inhibition of COX2 in human whole blood assessed as inhibition of TXB2 production by radioimmunoassay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL622,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL622,INHIBITOR,,Tclin,,,Homo sapiens
182691,2869,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.15,,Kd,Binding affinity against Alpha-2 adrenergic receptor in rat cortex using [3H]-idazoxan as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1185,,,,,,,Rattus norvegicus
182692,2869,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,10.4,,Kd,Binding affinity against Dopamine receptor D2 in rat striatum using [3H]-spiperone as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1185,,,,,,,Rattus norvegicus
182693,2869,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,9.52,,Kd,Binding affinity against dopamine receptor D1 in rat striatum using [3H]SCH-23390 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1185,,,,,,,Rattus norvegicus
182694,1872,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.06,,Ki,Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL626,,,,Tclin,,,Homo sapiens
182768,2755,436,Dihydrofolate reductase,Enzyme,P16184,,DYR_PNECA,6.82,,Ki,Inhibition of dihydrofolate reductase (DHFR) from Pneumocystis carinii.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Pneumocystis carinii
182695,1872,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,6.51,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL626,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
182696,1872,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,5.82,,Ki,Affinity for human EMP expressed in ERG2 deficient strain of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL626,,,,Tchem,,,Homo sapiens
182697,1872,1339,Squalene epoxidase,Enzyme,Q4JEY0,,Q4JEY0_TRIRU,,,,Mechanism of Action; CHEMBL2364679; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL626,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL626,INHIBITOR,,,,,Trichophyton rubrum
182698,765,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,8.51,,IC50,Binding affinity at serotonin 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Rattus norvegicus
182699,765,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,7.2,,Ki,Displacement of [3H]- spiperone radioligand binding at the dopamine binding site of rat caudate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Rattus norvegicus
182700,765,1830,Sodium-dependent noradrenaline transporter,Transporter,O55192,Slc6a2,SC6A2_MOUSE,6.54,,Ki,Binding affinity to Norepinephrine transporter using [3H]-nisoxatine as radioligand in stably transfected NIH3T3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Mus musculus
182701,765,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.85,,IC50,Binding affinity at dopamine D2 receptor by [3H]spiperone displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Rattus norvegicus
182702,765,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,9,,Kd,Potency against histamine H1 receptor on guinea pig ileum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Cavia porcellus
182703,765,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.54,,Ki,Binding affinity towards Norepinephrine transporter using [3H]nisoxitine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,Tclin,,,Homo sapiens
182704,765,1840,5-hydroxytryptamine receptor 2C,GPCR,P34968,Htr2c,5HT2C_MOUSE,7.96,,Ki,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Mus musculus
182705,765,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.3,,Ki,Binding affinity towards 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Rattus norvegicus
182706,765,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,8.4,,Ki,Displacement of [3H]- QNB binding at the muscarinic-cholinergic binding site of rat brain S1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Rattus norvegicus
182707,765,1841,D(2) dopamine receptor,GPCR,P61168,Drd2,DRD2_MOUSE,6.95,,Ki,Binding affinity to Dopamine receptor D2 using [3H]spiperone as radioligand in stably transfected NIH3T3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Mus musculus
182708,765,1842,Sodium-dependent serotonin transporter,Transporter,Q60857,Slc6a4,SC6A4_MOUSE,5.39,,Ki,Binding affinity to Serotonin transporter using [3H]-paroxetine as radioligand in stably transfected NIH3T3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Mus musculus
182709,765,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,6,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182710,765,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.8,,Ki,Binding affinity against 5-hydroxytryptamine 2A receptor from rat forebrain using [3H]ketanserin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Rattus norvegicus
182711,765,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.39,,Ki,Binding affinity towards Serotonin transporter using [3H]paroxetine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,Tclin,,,Homo sapiens
182712,2276,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,5.17,,IC50,Displacement of [3H]mepyramine from histamine H1 receptor in Sprague-Dawley rat brain membrane after 2 hr by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1761,,,,,,,Rattus norvegicus
182713,2276,2778,Glutamate [NMDA] receptor,Ion channel,O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,NMD3A_HUMAN|NMD3B_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMDE4_HUMAN|NMDZ1_HUMAN,5.77,,Ki,The compound was tested for its ability to block PCP N-methyl-D-aspartate glutamate receptor at the PCP (phencyclidine) binding site in postmortem human frontal cortex.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1761,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
182715,3187,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,6.63,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482,,,,Tchem,,,Homo sapiens
182717,3187,2119,Lanosterol 14-alpha demethylase,Enzyme,P9WPP9,cyp51,CP51_MYCTU,4,,Kd,Binding affinity to Mycobacterium tuberculosis His4-tagged recombinant CYP51 substrate binding site expressed in Escherichia coli HMS174(DE3) by UV-visible spectral titration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
182718,2607,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,6.22,,Ki,Inhibition of human placental aromatase Cytochrome P450 19A1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630,,,,Tclin,,,Homo sapiens
182719,2607,2880,Steroid 5-alpha-reductase,Enzyme,P24008|P31214,Srd5a1|Srd5a2,S5A1_RAT|S5A2_RAT,5.72,,IC50,In vitro inhibitory activity against rat prostatic steroid 5-alpha-reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630,,,,,,,Rattus norvegicus
183130,3514,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,7.92,,IC50,Inhibition of human placental microsome CYP19,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
182720,2607,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.92,,Ki,Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630,,,,Tclin,,,Homo sapiens
182721,2607,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,9.2,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630,,,,Tchem,,,Homo sapiens
182722,2607,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,4.3,,IC50,Inhibition of human CYP51 expressed in Topp 3 cells by lanosterol demethylase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630,,,,Tchem,,,Homo sapiens
182723,2607,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,8.85,,Ki,Inhibitory constant against rat prostate cytosol androgen receptor using [3H]mibolerone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630,,,,,,,Rattus norvegicus
182724,2607,3566,Constitutive androstane receptor,Unclassified,O35627,Nr1i3,NR1I3_MOUSE,4.52,,IC50,Inhibitory concentration against mammalian m-constitutive androstane receptor (mCAR) activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630,,,,,,,Mus musculus
182725,2607,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,5.11,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
182726,795,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,7.84,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90593,,,,Tchem,,,Homo sapiens
182727,795,921,Glucose-6-phosphate 1-dehydrogenase,Enzyme,P11413,G6PD,G6PD_HUMAN,5.21,,Ki,Inhibition of human G6PDH using NADP as substrate by Lineweaver-Burke plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90593,,,,Tchem,,,Homo sapiens
182728,795,2138,Glucose-6-phosphate 1-dehydrogenase,Enzyme,Q9GRG7,g6pd,Q9GRG7_9TRYP,5.96,,Ki,Inhibition of Trypanosoma brucei G6PDH using NADP as substrate by Lineweaver-Burke plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90593,,,,,,,Trypanosoma brucei
182729,432,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.66,,IC50,Inhibition of wild-type human ERG channel expressed in CHO cells by whole-cell patch clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1098,,,,Tclin,,,Homo sapiens
182730,4,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.89,,IC50,Inhibition of wild-type human ERG channel expressed in HEK293 cells assessed as blockade of potassium tail current by whole-cell patch clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200749,,,,Tclin,,,Homo sapiens
182731,1094,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,Mechanism of Action; CHEMBL1871; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200623,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200623,AGONIST,,Tclin,,,Homo sapiens
182732,658,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,6.05,,EC50,Transactivation of GAL4-fused PPARalpha LBD expressed in HepG2 cells after 20 hrs by luminescence assay,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL557555,http://www.ncbi.nlm.nih.gov/pubmed/15123680,AGONIST,,Tclin,,475,Homo sapiens
182733,260,1867,Muscarinic receptor M1,GPCR,Q8WMX0,,Q8WMX0_BOVIN,9.7,,Ki,Binding affinity against Muscarinic acetylcholine receptor M1 by displacement of [3H]pirenzepine in bovine striatum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,,,,,,,Bos taurus
182734,260,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,9.15,,Ki,Binding affinity against Muscarinic acetylcholine receptor M2 by displacement of [3H]QNB in rat myocardium,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,,,,,,,Rattus norvegicus
182735,260,1879,Muscarinic acetylcholine receptor M5,GPCR,P08911,Chrm5,ACM5_RAT,9.07,,Ki,Displacement of [3H]NMS from rat recombinant muscarinic M5 receptor expressed in CHO cells after 2 hrs by microplate scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,,,,,,,Rattus norvegicus
182736,260,1809,Muscarinic acetylcholine receptor M2,GPCR,Q9ERZ4,Chrm2,ACM2_MOUSE,9.46,,Ki,Ability to displace [3H]oxotremorine ([3H]-OXO-M) from mouse cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,,,,,,,Mus musculus
182737,260,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.91,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,,,,Tchem,,,Homo sapiens
182738,260,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.59,,Ki,Ability to displace [3H]pirenzepine (PZ) from M1 receptor in rat cortex homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,,,,,,,Rattus norvegicus
182739,260,2602,Nicotinic acetylcholine receptor alpha 5 subunit,Ion channel,A9XFY4,nAChRalpha5,A9XFY4_MUSDO,4.49,,Ki,Displacement of [3H]alpha-bungarotoxin from nAChR in Musca domestica (house fly) head membrane after 60 min by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,,,,,,,Musca domestica
182740,260,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,9.46,,Ki,Compound was evaluated for the binding affinity by displacing [3H]oxotremorine from mouse cerebral cortex tissue.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,,,,,,,Mus musculus
182741,260,1845,Muscarinic acetylcholine receptor M3,GPCR,P08483,Chrm3,ACM3_RAT,9.92,,Ki,Ability to displace [3H]N-methylscopolamine (NMS) from M3 receptor in rat submaxillary gland homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,,,,,,,Rattus norvegicus
182742,260,1997,Muscarinic acetylcholine receptor M4,GPCR,P08485,Chrm4,ACM4_RAT,9.28,,Ki,Displacement of [3H]NMS from rat recombinant muscarinic M4 receptor expressed in CHO cells after 2 hrs by microplate scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,,,,,,,Rattus norvegicus
182743,260,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,9.52,,Ki,The compound was tested for inhibition of [3H]NMS binding against muscarinic acetylcholine receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712,,,,,,,Rattus norvegicus
182744,486,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.29,,Ki,Binding affinity against dopamine transporter was determined by the displacement of [3H]WIN-35428 radioligand in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61946,,,,,,,Rattus norvegicus
182745,486,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,7.5,,Ki,Displacement of [3H](-)-quinuclidinyl benzilate(QNB) from muscarinic (M2) receptor in rat heart homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61946,,,,,,,Rattus norvegicus
182746,486,572,Lysosomal Pro-X carboxypeptidase,Enzyme,P42785,PRCP,PCP_HUMAN,7.59,,Ki,Inhibition of [3H]- (+) - pentazocine binding to PCP receptor obtained from tissue homogenate preparation of fresh whole rat brain minus cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61946,,,,Tchem,,,Homo sapiens
182747,486,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.81,,Ki,Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61946,,,,Tclin,,,Homo sapiens
182748,486,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.92,,Ki,Displacement of [3H]pirenzepine from muscarinic acetylcholine receptor M1 in rat cortex homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61946,,,,,,,Rattus norvegicus
182749,3631,913,Carbonyl reductase [NADPH] 1,Enzyme,P16152,CBR1,CBR1_HUMAN,7.22,,Ki,Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as NADPH oxidation using isatin as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849,,,,Tchem,,,Homo sapiens
182750,3631,2487,Enoyl-[acyl-carrier-protein] reductase [NADPH],Enzyme,Q9RMI3,fabI,Q9RMI3_STAAU,7.23,,IC50,Inhibition of Staphylococcus aureus recombinant FabI using trans-2-octenoyl N-acetylcysteamine thioester as substrate preincubated for 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849,,,,,,,Staphylococcus aureus
182751,3631,230,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,P9WGR1,inhA,INHA_MYCTU,6.7,,Ki,Inhibition of Mycobacterium tuberculosis H37RV InhA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
182752,3631,2439,Enoyl-ACP reductase,Unclassified,Q9BJJ9,FabI,Q9BJJ9_PLAFA,6.7,,IC50,Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849,,,,,,,Plasmodium falciparum
182753,3631,2566,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,Q5NGQ3,fabI,Q5NGQ3_FRATT,5.89,,IC50,Inhibition of C-terminal His6-tagged wild type Francisella tularensis SCHU S4 FabI expressed in Escherichia coli BL21 (DE3) using CrCoA as substrate by UV-vis spectrophotometric analysis in presence of non pre-equilibrated NAD+,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849,,,,,,,Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4)
182754,3631,1765,Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI,Enzyme,Q6GI75,fabI,FABI_STAAR,7.15,,IC50,Inhibitory activity against Enoyl-ACP reductase FabI in Staphylococcus aureus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849,,,,,,,Staphylococcus aureus (strain MRSA252)
182755,3631,2025,Enoyl-acyl-carrier protein reductase,Enzyme,Q965D5,fabI,Q965D5_PLAFA,10.28,,Ki,Inhibition of Plasmodium falciparum ENR in presence of ECG by dilution assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849,,,,,,,Plasmodium falciparum
182756,3631,2072,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,Enzyme,P54616,fabI,FABI_BACSU,6.3,,IC50,Inhibition of Bacillus anthracis Enoyl ACP reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849,,,,,,,Bacillus subtilis (strain 168)
182757,3631,1981,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,Enzyme,P0AEK4,fabI,FABI_ECOLI,6.37,,IC50,Antibacterial activity against Escherichia coli FabI,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849,INHIBITOR,,,,,Escherichia coli (strain K12)
182758,3631,2312,Enoyl-acyl carrier reductase; Enoyl-acyl carrier reductase ENR,Enzyme,Q6UCJ9,ENR,Q6UCJ9_TOXGO,7.82,,IC50,Inhibition of Toxoplasma gondii enoyl reductase assessed as conversion of trans-2-acyl-ACP to acyl-ACP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL849,,,,,,,Toxoplasma gondii
182759,2343,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,,,,Mechanism of Action; CHEMBL1876; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1532,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1532,INHIBITOR,,Tclin,,,Homo sapiens
182760,606,672,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.24,,Kd,Binding affinity to biotinylated human FAK FAT domain by biolayer interoferometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194287,,,,Tclin,,,Homo sapiens
182761,629,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,4.31,,Kd,Inhibition of human thrombin assessed as equilibrium dissociation constant at 50 to 1000 uM by BIAcore analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
182762,629,2624,Arginase,Enzyme,O96394,,O96394_LEIAM,6.22,,Ki,Noncompetitive inhibition of Leishmania amazonensis recombinant arginase expressed in Escherichia coli Rosetta (DE3) pLysS using L-arginine as substrate by Dixon reciprocal plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,,,,Leishmania amazonensis
182763,629,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,4.1,,IC50,Inhibition of bovine seminal vesicle microsomal COX1-mediated prostaglandin production,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,,,,Bos taurus
182764,629,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.44,,IC50,Inhibition of COX1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
182765,629,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.03,,IC50,Inhibition of COX2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
182766,629,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,4.39,,Kd,Binding affinity to COX1 in sheep seminal vesicle,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,,,,Ovis aries
182767,2755,1124,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,P13922,,DRTS_PLAFK,7.99,,Ki,Inhibitory activity against wild-type dihydrofolate reductase (S108N DHFR),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Plasmodium falciparum
163341,722,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.7916,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
182769,2755,2420,Dihydrofolate reductase,Enzyme,P0A017,folA,DYR_STAAU,8.92,,Ki,Inhibition of Staphylococcus aureus DHFR using dihydrofolate as substrate preincubated for 10 mins followed by substrate addition by spectrophotometric analysis in presence of NADPH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Staphylococcus aureus
182770,2755,1786,Dihydrofolate reductase,Enzyme,P00381,folA,DYR_LACCA,6.88,,Ki,Inhibitory activity against Lactobacillus casei dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Lactobacillus casei
182771,2755,2554,Dihydrofolate reductase,Enzyme,P04174,folA,DYR_NEIGO,6.35,,IC50,Inhibitory activity against dihydrofolate reductase (DHFR) of Neisseria gonorrhoea,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Neisseria gonorrhoeae
182772,2755,1123,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q27713,,DRTS_PLABA,6.92,,IC50,In vitro inhibition of dihydrofolate reductase of Plasmodium berghei,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Plasmodium berghei (strain Anka)
182773,2755,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,8,,Ki,Inhibition of recombinant Dihydrofolate reductase from humans.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,Tclin,,,Homo sapiens
182774,2755,1781,Dihydrofolate reductase,Enzyme,P0ABQ4,folA,DYR_ECOLI,5.57,,IC50,Inhibition of dihydrofolate reductase from Toxoplasma gondii.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,INHIBITOR,,,,,Escherichia coli (strain K12)
182775,2755,276,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q07422,,DRTS_TOXGO,8.14,,IC50,Inhibitory activity against recombinant Dihydrofolate reductase from Toxoplasma gondii (tgDHFR),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Toxoplasma gondii
182776,2755,1828,Dihydrofolate reductase,Enzyme,P07807,DFR1,DYR_YEAST,4.92,,IC50,Inhibitory activity against Pneumocystis carinii dihydrofolate reductase.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
182778,2755,1906,Dihydrofolate reductase,Enzyme,P22906,DFR1,DYR_CANAX,8.66,,IC50,Inhibitory activity against cell free dihydrofolate reductase (DHFR) from Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Candida albicans
182779,2755,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.25,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,Tchem,,,Homo sapiens
182780,2755,3567,Bifunctional dihydrofolate reductase-thymidylate synthase,Unclassified,Q27552,DHFR-TS,Q27552_CRYPV,5.4,,IC50,Inhibition of Cryptosporidium parvum recombinant DHFR using dihydrofolate as substrate incubated for 5 min prior to substrate addition by spectrophotometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Cryptosporidium parvum
182781,2755,1736,Dihydrofolate reductase,Enzyme,P00375,Dhfr,DYR_MOUSE,6.3,,Ki,Competitive inhibition of mouse DHFR by enzyme kinetics assay in presence of variable DHFA level,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Mus musculus
182782,2755,1752,Dihydrofolate reductase,Enzyme,Q920D2,Dhfr,DYR_RAT,4.84,,Ki,Inhibition of rat liver DHFR by enzyme kinetics assay in presence of variable DHFA level,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Rattus norvegicus
182783,2755,3442,Dihydrofolate reductase,Enzyme,Q81R22,dfrA,Q81R22_BACAN,4.62,,Ki,Inhibition of wild type Bacillus anthracis recombinant DHFR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Bacillus anthracis
182784,2755,2555,Dihydrofolate reductase,Enzyme,Q59487,folA,DYR_LACLA,6.35,,IC50,In vitro inhibition of dihydrofolate reductase enzymes in Neisseria gonorrhoeae,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Lactococcus lactis subsp. lactis (strain IL1403)
182785,2755,2102,Dihydrofolate reductase,Unclassified,B0BL08,dfrA17,B0BL08_ECOLX,8.89,,Ki,Binding affinity for Escherichia coli Dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Escherichia coli
182786,2755,3568,Dihydrofolate reductase type 1,Unclassified,P00382,dhfrI,DYR1_ECOLX,6.3,,IC50,Inhibitory activity to dihydrofolate reductase in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Escherichia coli
182787,2755,2004,Dihydrofolate reductase,Enzyme,O30463,folA,O30463_MYCAV,6.72,,IC50,Inhibitory activity against DHFR (Dihydrofolate reductase) from Mycobacterium avium,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Mycobacterium avium
182788,2540,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,6.91,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,,,,Stylophora pistillata
182789,2540,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,6.77,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,,,,Thalassiosira weissflogii
182790,2540,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,5.99,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
182791,2540,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,8.05,,Ki,Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,Tclin,,,Homo sapiens
182792,2540,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.37,,Ki,Inhibition of human recombinant carbonic anhydrase 9 catalytic domain by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,Tclin,,,Homo sapiens
182793,2540,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.19,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,,,,Mus musculus
182794,2540,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,7.34,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,,,,Stylophora pistillata
183185,3514,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.15,,Ki,Inhibition of human CA9 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
182795,2540,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.43,,Ki,Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,Tclin,,,Homo sapiens
182796,2540,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,6.56,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,,,,Astrosclera willeyana
182797,2540,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,8.05,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
182798,2540,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,5.29,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
182799,2540,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,6.18,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
182800,2540,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,6.87,,Ki,Inhibition of human full length recombinant carbonic anhydrase 6 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,Tclin,,,Homo sapiens
182801,2489,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,4.68,,Ki,Inhibition of mouse AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL703,,,,,,,Mus musculus
182802,2489,2744,Muscle-type nicotinic acetylcholine receptor,Ion channel,P02708|P07510|P11230|Q04844|Q07001,CHRNA1|CHRNB1|CHRND|CHRNE|CHRNG,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN|ACHE_HUMAN|ACHG_HUMAN,,,,Mechanism of Action; CHEMBL2362997; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL703,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL703,AGONIST,,Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
182803,268,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,8.41,,Ki,Binding affinity to histamine H1 receptor in rat brain membranes was evaluated using [3H]-pyrilamine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL946,,,,,,,Rattus norvegicus
182804,3927,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,6.66,,Ki,Competitive inhibition of binding to human placental Cytochrome P450 19A1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27769,,,,Tclin,,,Homo sapiens
182805,3927,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,9.74,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27769,,,,Tchem,,,Homo sapiens
182806,3927,1850,Androgen receptor,Transcription factor,P19091,Ar,ANDR_MOUSE,9,,IC50,Displacement of [3H] ]5alpha-DHT from mouse androgen receptor expressed in monkey COS7 cells after 2 hrs by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27769,,,,,,,Mus musculus
182807,3927,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,4.7,,IC50,Displacement of [3H]dexamethasone from Sprague-Dawley rat GR by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27769,,,,,,,Rattus norvegicus
182808,3927,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,9.57,,Ki,Binding affinity to rat androgen receptor by competitive inhibition assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27769,,,,,,,Rattus norvegicus
182809,3927,2424,Mineralocorticoid receptor,Transcription factor,P22199,Nr3c2,MCR_RAT,5.68,,IC50,Displacement of [3H]aldosterone from Sprague-Dawley rat MR by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27769,,,,,,,Rattus norvegicus
182810,3927,2003,Progesterone receptor,Transcription factor,P06186,PGR,PRGR_RABIT,6.36,,IC50,Displacement of [3H]progesterone from rabbit PR by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27769,,,,,,,Oryctolagus cuniculus
182811,3927,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.7,,Ki,Displacement of [3H]DHT from human androgen receptor expressed in MDA-MB-453 cells by whole cell receptor binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27769,,,,Tclin,,,Homo sapiens
182812,214,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.74,,IC50,Binding affinity at human recombinant ERalpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440283,,,,Tclin,,,Homo sapiens
182813,214,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,9.17,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440283,,,,Tchem,,,Homo sapiens
182814,214,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8,,IC50,Binding affinity at human recombinant ERbeta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440283,,,,Tclin,,,Homo sapiens
182815,214,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.86,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440283,,,,,,,Rattus norvegicus
182816,214,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,6.64,,IC50,Binding affinity at AR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440283,,,,Tclin,,,Homo sapiens
182817,499,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action; CHEMBL231; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL864,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL864,ANTAGONIST,,Tclin,,,Homo sapiens
182818,1583,78,Gamma-aminobutyric acid receptor subunit beta-3,Ion channel,P28472,GABRB3,GBRB3_HUMAN,9.05,,IC50,Displacement of [3H]EBOB from recombinant Homo sapiens (human) GABA beta3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891,,,,Tclin,,,Homo sapiens
182819,1583,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,7.68,,IC50,Displacement of [3H]EBOB from recombinant Homo sapiens (human) GABA alpha1beta3gamma2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163342,956,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.0862,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
182820,1583,2596,Gamma-aminobutyric acid receptor subunit rho-1,Ion channel,P24046,GABRR1,GBRR1_HUMAN,7.04,,IC50,Displacement of [3H]EBOB from recombinant Homo sapiens (human) GABA rho1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891,,,,Tchem,,,Homo sapiens
182821,1583,2595,Gamma-aminobutyric acid receptor subunit beta,Ion channel,Q75NA5,Rdl,GBRB_MUSDO,7.96,,IC50,Inhibition of Musca domestica (house fly) GABA receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891,,,,,,,Musca domestica
182822,1583,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.39,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891,,,,,,,Rattus norvegicus
182823,1583,2804,GABA A receptor alpha-1/beta-1/gamma-2,Ion channel,P14867|P18505|P18507,GABRA1|GABRB1|GABRG2,GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN,7.17,,IC50,Displacement of [3H]EBOB from recombinant Homo sapiens (human) GABA alpha1beta1gamma2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182824,1583,2797,GABA-A receptor alpha-6/beta-3/gamma-2,Ion channel,P18507|P28472|Q16445,GABRA6|GABRB3|GABRG2,GBRA6_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,8.31,,IC50,Displacement of [3H]EBOB from recombinant Homo sapiens (human) GABA alpha6beta3gamma2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182825,1583,2757,GABA-A receptor,Ion channel,H9U2V9|H9U2W0|H9U2W1,Rdl1|Rdl2|Rdl3,H9U2V9_TETUR|H9U2W0_TETUR|H9U2W1_TETUR,,,,Mechanism of Action; CHEMBL2364024; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891,NEGATIVE ALLOSTERIC MODULATOR,,,,,Tetranychus urticae
182826,1583,2758,GABA-A receptor,Ion channel,E0V9W2|E0VY07|E0W492,,E0V9W2_PEDHC|E0VY07_PEDHC|E0W492_PEDHC,,,,Mechanism of Action; CHEMBL2364025; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15891,NEGATIVE ALLOSTERIC MODULATOR,,,,,Pediculus humanus subsp. corporis
182827,3186,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,6.82,,IC50,Ex vivo inhibition of human erythrocyte Acetylcholinesterase.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL123248,,,,Tclin,,,Homo sapiens
182828,3186,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,7.92,,IC50,Ex vivo inhibition of human plasma Butyrylcholinesterase.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL123248,,,,Tclin,,,Homo sapiens
182829,1132,1041,C-C motif chemokine 2,Cytokine,P13500,CCL2,CCL2_HUMAN,5.16,,IC50,Inhibition of MCP1-mediated human THP cell migration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38380,,,,Tchem,,,Homo sapiens
182830,1132,670,Rho-associated protein kinase 1,Kinase,Q13464,ROCK1,ROCK1_HUMAN,7,,Ki,Inhibition of ROCK-1,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38380,http://www.ncbi.nlm.nih.gov/pubmed/10644512,INHIBITOR,,Tclin,,467,Homo sapiens
182831,1132,787,Protein kinase C epsilon type,Kinase,Q02156,PRKCE,KPCE_HUMAN,5.52,,IC50,Inhibition of PKCepsilon,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38380,,,,Tchem,,,Homo sapiens
182832,1132,899,Ribosomal protein S6 kinase alpha-5,Kinase,O75582,RPS6KA5,KS6A5_HUMAN,5.3,,IC50,Inhibition of His-tagged human MSK1 expressed in Sf9 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38380,,,,Tchem,,,Homo sapiens
182833,1132,614,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,4.44,,Ki,Inhibition of MLCK by HTRF assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38380,,,,Tchem,,,Homo sapiens
182835,1132,2321,Rho-associated protein kinase 2,Kinase,Q62868,Rock2,ROCK2_RAT,5.72,,IC50,Inhibition of rat ROCK2 expressed in Sf9 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38380,,,,,,,Rattus norvegicus
182836,1132,713,Rho-associated protein kinase 2,Kinase,O75116,ROCK2,ROCK2_HUMAN,7.11,,Kd,Displacement of fluorescent-ARC-1063 from His6-tagged recombinant human ROCK2 by luminescence intensity assay,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38380,http://www.ncbi.nlm.nih.gov/pubmed/10644512,INHIBITOR,,Tclin,,467,Homo sapiens
182837,1132,2089,Serine/threonine-protein kinase N2,Kinase,Q16513,PKN2,PKN2_HUMAN,6.11,,IC50,Inhibition of PKN2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38380,,,,Tchem,,,Homo sapiens
182839,1132,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.6,,Ki,Displacement of [3H]dofetilide from human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38380,,,,Tclin,,,Homo sapiens
182840,1132,815,Serine/threonine-protein kinase N1,Kinase,Q16512,PKN1,PKN1_HUMAN,5.77,,IC50,Inhibition of Protein kinase C related kinase 1 (PRK1),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38380,,,,Tchem,,,Homo sapiens
182841,757,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,Mechanism of Action; CHEMBL245; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200473,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200473,ANTAGONIST,,Tclin,,,Homo sapiens
182842,2111,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,5.57,,IC50,Inhibition of spiropiperidone binding at dopamine receptor D2 of rat.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL340801,,,,,,,Rattus norvegicus
182843,2597,3569,Squalene monooxygenase,Unclassified,P52020,Sqle,ERG1_RAT,4.03,,IC50,Inhibitory activity against rat liver Squalene Epoxidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL822,,,,,,,Rattus norvegicus
182844,2597,477,Squalene monooxygenase,Enzyme,Q14534,SQLE,ERG1_HUMAN,7.52,,Ki,Inhibitory activity against Candida albicans Squalene Epoxidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL822,,,,Tchem,,,Homo sapiens
182845,2597,1339,Squalene epoxidase,Enzyme,Q4JEY0,,Q4JEY0_TRIRU,,,,Mechanism of Action; CHEMBL2364679; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL822,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL822,INHIBITOR,,,,,Trichophyton rubrum
182846,2871,2844,Cyclooxygenase,Enzyme,O62664|O62698,PTGS1|PTGS2,PGH1_BOVIN|PGH2_BOVIN,4.82,,IC50,Inhibition of prostaglandin G/H synthase obtained from bovine seminal vesicles.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19490,,,,,,,Bos taurus
182847,395,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.52,,Ki,Binding affinity towards alpha-2 adrenergic receptor in rat using [3H]rauwolscine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL844,,,,,,,Rattus norvegicus
163343,812,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
182848,395,1733,Alpha-2B adrenergic receptor,GPCR,P19328,Adra2b,ADA2B_RAT,7.28,,Ki,Displacement of rauwolscine from rat Alpha-2B adrenergic receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL844,,,,,,,Rattus norvegicus
182849,395,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,6.13,,Ki,Binding affinity against alpha-1 adrenergic receptor in rat using [3H]prazosin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL844,,,,,,,Rattus norvegicus
182850,987,1942,Beta-lactamase,Enzyme,Q79MP6,blaIMP-1,Q79MP6_PSEAI,4.55,,IC50,Inhibition of recombinant Pseudomonas aeruginosa MBL IMP-1 using nitrocefin as substrate after 12 hrs by UV-spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL858,,,,,,,Pseudomonas aeruginosa
182851,987,3570,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Unclassified,J3SE37,,J3SE37_CROAD,4.13,,IC50,Inhibition of Serpentes (snake) venom phosphodiesterase using bis(p-nitrophenyl)phosphate as substrate incubated for 30 min prior to substrate addition by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL858,,,,,,,Crotalus adamanteus
182852,987,2391,Beta-lactamase VIM-1; Class B carbapenemase VIM-1; Metallo-beta-lactamase; Metallo-beta-lactamase VIM-1; Metallobeta-lactamase; VIM-1; VIM-1 metallo-beta lactamase; VIM-1 metallo-beta-lactamase; VIM-1,Unclassified,Q9XAY4,blaVIM,Q9XAY4_PSEAI,5.03,,IC50,Inhibition of Pseudomonas aeruginosa VIM-1 beta-lactamase after 10 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL858,,,,,,,Pseudomonas aeruginosa
182853,2162,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,5.88,,IC50,Tested for inhibition of specific binding of [3H]-EBOB to GABA-Gated Chloride channels of Gamma-aminobutyric acid A receptor in rat brain cortex (Potency expressed as IC50),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908342,,,,,,,Rattus norvegicus
182854,1992,1856,5-hydroxytryptamine receptor 3A,Ion channel,P35563,Htr3a,5HT3A_RAT,9.11,,Ki,Displacement of [3H]LY 278584 from 5-HT3 receptor in Sprague-Dawley rat cerebral cortex after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182855,1992,2514,Solute carrier family 22 member 3,Transporter,O75751,SLC22A3,S22A3_HUMAN,4.76,,IC50,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,Tchem,,,Homo sapiens
182856,1992,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,5,,Ki,The binding affinity was measured on 5-hydroxytryptamine 2 receptor using [3H]- spiperone as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182857,1992,2898,Serotonin 3 receptor (5HT3),Ion channel,P23979|Q9JHJ5,Htr3a|Htr3b,5HT3A_MOUSE|5HT3B_MOUSE,7.92,,Ki,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Mus musculus
182858,1992,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.43,,Ki,The binding affinity was measured on 5-hydroxytryptamine 1B receptor using [3H]- serotonin as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182859,1992,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.69,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,Tchem,,,Homo sapiens
182860,1992,1872,5-hydroxytryptamine receptor 1D,GPCR,P28565,Htr1d,5HT1D_RAT,4.7,,Ki,The binding affinity was measured on 5-hydroxytryptamine 1D receptor using [3H]- serotonin as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182861,1992,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,4.34,,Ki,In vitro Binding affinity towards Nicotinic acetylcholine receptor alpha4-beta2 was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,Tclin|Tclin,,,Homo sapiens
182862,1992,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,6.8,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,Tchem,,,Homo sapiens
182863,1992,2783,Serotonin 3 (5-HT3) receptor,Ion channel,P35563|Q9JJ16,Htr3a|Htr3b,5HT3A_RAT|5HT3B_RAT,9.11,,Ki,"Compound was evaluated for its in vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182864,1992,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,7.52,,IC50,Inhibition of human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells after 1.5 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,Tchem,,,Homo sapiens
182865,1992,1767,Gastrin/cholecystokinin type B receptor,GPCR,P30553,Cckbr,GASR_RAT,6.17,,Ki,The binding affinity was measured on cholecystokinin type B receptor using [3H]- CCK-8 as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182866,1992,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,5,,Ki,The binding affinity was measured on muscarine M1 receptor using [3H]- pirenzepine as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182867,1992,1783,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,Q05941,Chrna7,ACHA7_RAT,4.6,,IC50,Inhibition of the response to ACh when coapplied with Nicotinic acetylcholine receptor alpha7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182868,1992,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,5.54,,Ki,The binding affinity was measured on mu-opiate receptor using [3H]- naloxone as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182869,1992,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,5.3,,Ki,The binding affinity was measured on 5-hydroxytryptamine 1C receptor using [3H]- serotonin as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182870,1992,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.77,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,Tchem,,,Homo sapiens
182871,1992,3374,5-hydroxytryptamine receptor 3B,Ion channel,O95264,HTR3B,5HT3B_HUMAN,8.3,,Ki,GRAC: human 5-HT3B selective antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,Tchem,,,Homo sapiens
182872,1992,1855,5-hydroxytryptamine receptor 4,GPCR,Q62758,Htr4,5HT4R_RAT,5.92,,Ki,The binding affinity was measured on 5-hydroxytryptamine 4 receptor using [3H]- GR-113808 as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182873,1992,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,6.17,,Ki,The binding affinity was measured on sigma receptor using [3H]- (+)-3-PPP as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46,,,,,,,Rattus norvegicus
182874,3487,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.67,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1198,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182875,2169,3571,Transcriptional activator protein luxR,Unclassified,P12746,luxR,LUXR_ALIFS,4.25,,IC50,Inhibition of LuxR-dependent quorum sensing in Vibrio fischeri assessed as reduction of 3-oxo-C6-HSL-induced bioluminescence intensity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL152408,,,,,,,Aliivibrio fischeri
182876,2169,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.6,,Ki,Binding affinity against 5-hydroxytryptamine 2A receptor from rat forebrain using [3H]ketanserin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL152408,,,,,,,Rattus norvegicus
182877,420,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.07,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL334491,,,,Tclin,,,Homo sapiens
182878,420,2778,Glutamate [NMDA] receptor,Ion channel,O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,NMD3A_HUMAN|NMD3B_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMDE4_HUMAN|NMDZ1_HUMAN,4.93,,Ki,The compound was tested for its ability to block PCP N-methyl-D-aspartate glutamate receptor at the PCP (phencyclidine) binding site in postmortem human frontal cortex.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL334491,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
182879,1618,1738,Prostaglandin G/H synthase 2,Enzyme,Q05769,Ptgs2,PGH2_MOUSE,7.4,,IC50,Inhibition of purified mouse COX-2 assessed as inhibition of PGE2-G/PGD2-G formation preincubated for 3 mins before 2-AG substrate addition measured after 30 seconds by LC-MS-MS method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404108,,,,,,,Mus musculus
182880,1618,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,8.15,,IC50,Inhibition of COX1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404108,,,,Tclin,,,Homo sapiens
182881,1618,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.49,,Ki,Inhibition of human COX2 preincubated before addition of [1-14C]arachidonic acid,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404108,http://www.ncbi.nlm.nih.gov/pubmed/15017615,INHIBITOR,,Tclin,,270,Homo sapiens
182882,2499,2639,"7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; Dihydropteroate synthetase",Kinase,Q25704,PPPK-DHPS,Q25704_PLAFA,,,,Mechanism of Action; CHEMBL2013; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201056,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201056,INHIBITOR,,,,,Plasmodium falciparum
182883,129,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,9.3,,Ki,Binding affinity to human HT3A receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1110,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1110,ANTAGONIST,,Tclin,,,Homo sapiens
182884,129,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.64,,IC50,Inhibition of human ERG expressed in HEK cells by patch clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1110,,,,Tclin,,,Homo sapiens
182885,3496,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.62,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1195,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1195,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
182886,2294,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.72,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1196,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1196,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
182887,2758,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.56,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL644,,,,Tchem,,,Homo sapiens
182892,1641,2481,Calmodulin-domain protein kinase 1,Kinase,Q9BJF5,CDPK1,Q9BJF5_TOXGO,6.17,,IC50,Inhibition of Toxoplasma gondii CDPK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL685,,,,,,,Toxoplasma gondii
182893,1641,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,5.34,,Ki,Inhibition of human ABL by radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL685,,,,Tclin,,,Homo sapiens
182894,1641,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,5.44,,IC50,Inhibition of VEGFR2 after 60 mins by electrophoretic mobility shift assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL685,,,,Tclin,,,Homo sapiens
182895,1641,2750,Tubulin,Structural,C4PKY4|C4PKZ2|C4PKZ6,,C4PKY4_ECHGR|C4PKZ2_ECHGR|C4PKZ6_ECHGR,,,,Mechanism of Action; CHEMBL2364704; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL685,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL685,INHIBITOR,,,,,Echinococcus granulosus
163344,722,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.2218,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
182896,1641,2751,Tubulin,Structural,F1L005|F1L4P8|F1L5G6|F1L7U3|F1L7Y0|F1L8A5|F1LCS0,,F1L005_ASCSU|F1L4P8_ASCSU|F1L5G6_ASCSU|F1L7U3_ASCSU|F1L7Y0_ASCSU|F1L8A5_ASCSU|F1LCS0_ASCSU,,,,Mechanism of Action; CHEMBL2364705; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL685,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL685,INHIBITOR,,,,,Ascaris suum
182897,1054,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,5.2,,Kd,Ability to block Beta-2 adrenergic receptor in guinea pig trachea preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL768,,,,,,,Cavia porcellus
182898,1054,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,7,,Kd,Ability to block Beta-1 adrenergic receptor in guinea pig right atria preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL768,,,,,,,Cavia porcellus
182900,2543,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,7.59,,Ki,Binding affinity towards human 5-hydroxytryptamine 1F receptor was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,Tclin,,,Homo sapiens
182901,2543,2551,5-hydroxytryptamine receptor 1B,GPCR,Q9N2B7,HTR1B,5HT1B_GORGO,8.19,,Ki,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1B receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,,,,Gorilla gorilla gorilla
182902,2543,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.3,,IC50,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor from pig cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,Tchem,,,Homo sapiens
182903,2543,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,7.64,,Ki,Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,,,,Rattus norvegicus
182904,2543,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.19,,IC50,Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,,,,Rattus norvegicus
182905,2543,1872,5-hydroxytryptamine receptor 1D,GPCR,P28565,Htr1d,5HT1D_RAT,7.21,,IC50,Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,,,,Rattus norvegicus
182906,2543,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,8.03,,IC50,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,Tclin,,,Homo sapiens
182907,2543,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.17,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,Tchem,,,Homo sapiens
182908,2543,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.14,,IC50,Compound was evaluated for the affinity at 5-hydroxytryptamine 2C receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,Tclin,,,Homo sapiens
182909,2543,1854,5-hydroxytryptamine receptor 1A,GPCR,Q64264,Htr1a,5HT1A_MOUSE,6.35,,IC50,Compound was evaluated for the affinity at 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,,,,Mus musculus
182910,2543,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,8.26,,Ki,Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,AGONIST,,Tclin,,,Homo sapiens
182911,2543,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.42,,Ki,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,Tclin,,,Homo sapiens
182912,2543,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8.92,,Ki,Displacement of [3H]5-hydroxytryptamine from human cloned 5HT1D receptor expressed in CHOK1 cells by liquid scintillation counting,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,AGONIST,,Tclin,,,Homo sapiens
182913,2543,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.64,,Ki,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,Tclin,,,Homo sapiens
182914,2543,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.26,,IC50,Compound was evaluated for the affinity at 5-hydroxytryptamine 1E receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,Tchem,,,Homo sapiens
182915,2543,1780,5-hydroxytryptamine receptor 1D,GPCR,P79400,HTR1D,5HT1D_PIG,7.7,,IC50,Binding activity radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,,,,Sus scrofa
182916,2605,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.11,,Ki,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 1 mM of MnCl2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL434200,,,,,,,Rattus norvegicus
182917,2220,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.62,,Ki,Binding affinity to dopamine D2 receptor (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294951,,,,Tclin,,,Homo sapiens
182918,2220,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.6,,Ki,Displacement of [3H]5-HT from human 5-HT7 receptor expressed in CHO cells by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294951,,,,Tclin,,,Homo sapiens
182919,2220,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.85,,Ki,Binding affinity to 5-HT2C receptor (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294951,,,,Tclin,,,Homo sapiens
182920,2220,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.7,,Ki,Displacement of [3H]Mesulergine from human 5-HT2B receptor expressed in HEK293 cells by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294951,,,,Tclin,,,Homo sapiens
182921,2220,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.12,,Ki,Binding affinity to 5-HT2A receptor (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294951,,,,Tclin,,,Homo sapiens
183362,2787,2490,Aminopeptidase N,Enzyme,P97449,Anpep,AMPN_MOUSE,5.52,,Ki,Inhibition of mouse APN,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,,,,Mus musculus
182922,2220,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.7,,Ki,Binding affinity to muscarinic M1 receptor (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294951,,,,Tclin,,,Homo sapiens
182923,1650,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,6.27,,IC50,"Inhibition of human recombinant N-terminal His6-tagged AKR1C3 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,,,,Tchem,,,Homo sapiens
182924,1650,1738,Prostaglandin G/H synthase 2,Enzyme,Q05769,Ptgs2,PGH2_MOUSE,6.7,,IC50,Inhibition of the murine wild type Prostaglandin G/H synthase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,,,,,,,Mus musculus
182925,1650,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,6.59,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP low binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,,,,,,,Rattus norvegicus
182926,1650,869,"Fatty acid-binding protein, intestinal",Cytosolic other,P12104,FABP2,FABPI_HUMAN,5.05,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from I-FABP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,,,,Tchem,,,Homo sapiens
182927,1650,346,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,5.06,,IC50,"Inhibition of human recombinant N-terminal His6-tagged AKR1C2 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,,,,Tchem,,,Homo sapiens
182928,1650,2845,Cyclooxygenase,Enzyme,P35355|Q63921,Ptgs1|Ptgs2,PGH1_RAT|PGH2_RAT,7,,IC50,Compound was evaluated for its inhibitory activity against CO(cyclooxygenase),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,,,,,,,Rattus norvegicus
182929,1650,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,4.62,,IC50,Compound was evaluated for its inhibitory activity against 5-LO (5-lipoxygenase),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,,,,,,,Rattus norvegicus
182930,1650,345,Aldo-keto reductase family 1 member C1,Enzyme,Q04828,AKR1C1,AK1C1_HUMAN,5.5,,IC50,"Inhibition of human recombinant N-terminal His6-tagged AKR1C1 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,,,,Tchem,,,Homo sapiens
182931,1650,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,7.3,,IC50,Inhibition of the ovine Prostaglandin G/H synthase 1 was determined by thin-layer chromatography assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,,,,,,,Ovis aries
182932,865,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,5.59,,IC50,Inhibition of recombinant human AKR1C3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,Tchem,,,Homo sapiens
182933,865,3446,UDP-glucuronosyltransferase 1-10,Enzyme,Q9HAW8,UGT1A10,UD110_HUMAN,4.55,,Ki,Inhibition of 4-methylumbelliferone glucuronidation by human recombinant UGT1A10,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,Tbio,,,Homo sapiens
182934,865,1255,Interleukin-8,Cytokine,P10145,CXCL8,IL8_HUMAN,8.1,,IC50,Inhibition of CXCL8-induced chemotaxis in human polymorphonuclear leukocyte pretreated for 15 mins measured after 4 hrs by cell migration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,Tchem,,,Homo sapiens
182935,865,3444,UDP-glucuronosyltransferase 1-6,Enzyme,P19224,UGT1A6,UD16_HUMAN,4.64,,Ki,Inhibition of 4-methylumbelliferone glucuronidation by human recombinant UGT1A6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,Tbio,,,Homo sapiens
182936,865,3441,UDP-glucuronosyltransferase 1-7,Enzyme,Q9HAW7,UGT1A7,UD17_HUMAN,4.72,,Ki,Inhibition of 4-methylumbelliferone glucuronidation by human recombinant UGT1A7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,Tbio,,,Homo sapiens
182937,865,1738,Prostaglandin G/H synthase 2,Enzyme,Q05769,Ptgs2,PGH2_MOUSE,7.66,,IC50,Inhibition of mouse COX2 for 17 mins pre-incubated before addition of [1-14C]arachidonic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,,,,Mus musculus
182938,865,3445,UDP-glucuronosyltransferase 1-9,Enzyme,O60656,UGT1A9,UD19_HUMAN,4.96,,Ki,Inhibition of 4-methylumbelliferone glucuronidation by human recombinant UGT1A9,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,Tbio,,,Homo sapiens
182939,865,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,5.49,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,,,,Rattus norvegicus
182940,865,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,8.52,,IC50,Inhibition of COX1 in bovine platelets assessed as formation of 12-hydroxyheptadecatrienoic acid by HPLC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,,,,Bos taurus
182941,865,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,7.22,,IC50,Inhibition of sheep placental cotyledons COX2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,,,,Ovis aries
182942,865,2155,C-X-C chemokine receptor type 1,GPCR,P25024,CXCR1,CXCR1_HUMAN,7.92,,IC50,Inhibition of wild type CXCR1 transfected in mouse L1.2 cells assessed as inhibition of CXCL8-induced cell migration pretreated for 15 mins measured after 4 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,Tchem,,,Homo sapiens
182943,865,2446,UDP-glucuronosyltransferase 1-1,Enzyme,P22309,UGT1A1,UD11_HUMAN,4.28,,Ki,Inhibition of 4-methylumbelliferone glucuronidation by human recombinant UGT1A1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,Tbio,,,Homo sapiens
182944,865,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,7.17,,IC50,Inhibition of ovine COX1 for 17 mins pre-incubated before addition of [1-14C]arachidonic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,,,,Ovis aries
182945,2743,2062,Thymidine kinase,Kinase,A3RLP8,UL23,A3RLP8_CHV1,5.7,,IC50,Inhibition of Herpes B virus recombinant thymidine kinase-mediated [3H]TdR phosphorylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1129,,,,,,,Cercopithecine herpesvirus 1
182970,487,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.94,,Ki,Displacement of [3H]DHA from human beta2 adrenoceptor by liquid scintillation counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL324665,,,,Tclin,,,Homo sapiens
182946,2743,2617,Thymidylate kinase,Kinase,P9WKE1,tmk,KTHY_MYCTU,4.01,,Ki,Inhibitory activity against thymidine monophosphate kinase (TMPK) in Mycobacterium tuberculosis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1129,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
182947,1082,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,6.81,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL691,,,,Tchem,,,Homo sapiens
182948,1082,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.69,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL691,,,,Tchem,,,Homo sapiens
182949,1082,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.68,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL691,,,,Tchem,,,Homo sapiens
182950,1082,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.09,,IC50,Binding affinity to ERbeta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL691,,,,Tclin,,,Homo sapiens
182951,1082,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.09,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL691,,,,,,,Rattus norvegicus
182952,1082,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.66,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL691,,,,Tchem,,,Homo sapiens
182953,2046,2834,Serotonin 3 receptor (5HT3),Ion channel,O95264|P46098,HTR3A|HTR3B,5HT3A_HUMAN|5HT3B_HUMAN,9.74,,Kd,Binding affinity to human wild type 5-HT3A/5-HT3B receptor expressed in HEK293 cells after 24 hrs by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1720,,,,Tchem|Tclin,,,Homo sapiens
182954,2046,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,10.5,,Ki,Binding affinity to 5HT3A receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1720,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1720,ANTAGONIST,,Tclin,,,Homo sapiens
182955,1742,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action; CHEMBL231; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200532,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200532,ANTAGONIST,,Tclin,,,Homo sapiens
182956,928,2287,Monoglyceride lipase,Enzyme,Q99685,MGLL,MGLL_HUMAN,5.9,,IC50,Inhibition of human MGL activity using [3H]2-oleoylglycerol substrate by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL964,,,,Tchem,,,Homo sapiens
182957,928,2111,"Aldehyde dehydrogenase, mitochondrial",Enzyme,P11884,Aldh2,ALDH2_RAT,4.4,,IC50,Inhibition of recombinant rat ALDH activity in liver mitochondria,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL964,,,,,,,Rattus norvegicus
182958,972,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,6.43,,IC50,Displacement of [125I]RTI55 from DAT in Sprague-dawley rat striatum by liquid scintillation spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1175,,,,,,,Rattus norvegicus
182959,972,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,10.09,,Ki,Displacement of [3H]-citalopram from Sprague-Dawley rat brain SERT after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1175,,,,,,,Rattus norvegicus
182960,972,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,8.52,,Ki,Displacement of [3H]nisoxetine from rat NET in rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1175,,,,,,,Rattus norvegicus
182961,972,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.62,,Ki,Ability to inhibit the reuptake of dopamine at human dopamine transporter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1175,,,,Tclin,,,Homo sapiens
182962,972,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,8.22,,Ki,Inhibition of human NET,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1175,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1175,INHIBITOR,,Tclin,,,Homo sapiens
182963,972,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,9.62,,Ki,Displacement of [3H]citalopram from human SERT transfected in HEK293 cells after 3 hrs by Wallac counting analysis,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1175,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1175,INHIBITOR,,Tclin,,,Homo sapiens
182964,1385,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,5.37,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL435,,,,,,,Thalassiosira weissflogii
182965,1385,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.48,,Ki,Inhibition of human carbonic anhydrase 1 after 15 mins by CO2 hydrase assay at pH 7.5,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL435,,,,Tclin,,,Homo sapiens
182966,1385,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,6.4,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL435,,,,,,,Astrosclera willeyana
182967,182,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,,,,Mechanism of Action; CHEMBL2093863; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096,INHIBITOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
182968,1781,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,5.72,,IC50,Inhibition of human BCRP expressed in MDCK2 cells assessed as Hoechst 33342 accumulation preincubated for 30 mins by fluorimetry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36584,,,,Tchem,,,Homo sapiens
182969,3434,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.77,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127123,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182972,1812,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,4.77,,IC50,Displacement of [3H]pirenzepine from cerebral Muscarinic acetylcholine receptor M1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL278819,,,,,,,Rattus norvegicus
182973,1812,1791,Acetylcholinesterase,Enzyme,P37136,Ache,ACES_RAT,4.07,,IC50,In vitro inhibition of acetylcholinesterase in homogenized rat striatum.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL278819,,,,,,,Rattus norvegicus
182974,1812,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.77,,Ki,Binding affinity towards muscarinic M1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL278819,,,,Tclin,,,Homo sapiens
182975,1965,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.81,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1387,,,,,,,Rattus norvegicus
182976,1965,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,Mechanism of Action; CHEMBL208; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1387,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1387,AGONIST,,Tclin,,,Homo sapiens
182977,1962,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,7.97,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162,,,,Tchem,,,Homo sapiens
182978,1962,2883,Estrogen receptor,Transcription factor,P06211|Q62986,Esr1|Esr2,ESR1_RAT|ESR2_RAT,9.2,,Kd,Equilibrium dissociation constant for rat uterine estrogen receptor binding [3H]estradiol,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162,,,,,,,Rattus norvegicus
182979,1962,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,6.92,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162,,,,,,,Rattus norvegicus
182980,2749,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action; CHEMBL231; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL829,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL829,ANTAGONIST,,Tclin,,,Homo sapiens
182981,872,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,4.99,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1620412,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
182982,1426,2380,Beta-lactamase GES-13,Enzyme,D1MIX9,blaGES-13,D1MIX9_PSEAI,6.82,,IC50,Inhibition of Pseudomonas aeruginosa GES-13 beta lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL148,,,,,,,Pseudomonas aeruginosa
182983,1426,2100,Beta-lactamase,Enzyme,A2RP81,blaPER-2,A2RP81_CITFR,7.22,,Ki,Inhibition of Citrobacter freundii PER2 beta lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL148,,,,,,,Citrobacter freundii
182984,1426,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL148,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL148,INHIBITOR,,,,,Escherichia coli (strain K12)
182985,1386,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.59,,Ki,"Displacement of [3H]-U69,593 from human kappa opioid receptor expressed in CHO cells after 60 mins by scintillation counting",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1457,,AGONIST,,Tclin,,,Homo sapiens
182986,1386,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,8.02,,Ki,Displacement of [3H]-DAMGO from human mu opioid receptor expressed in CHO cells after 60 mins by scintillation counting,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1457,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1457,AGONIST,,Tclin,,,Homo sapiens
182987,725,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,4.59,,Ki,Displacement of [3H]diprenorphine from recombinant kappa opioid receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL485,,AGONIST,,Tclin,,,Homo sapiens
182988,725,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,4.28,,Ki,Displacement of [3H]diprenorphine from recombinant delta opioid receptor expressed in C6 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL485,,AGONIST,,Tclin,,,Homo sapiens
182989,725,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.14,,Ki,Displacement of [3H]diprenorphine from recombinant mu opioid receptor expressed in C6 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL485,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL485,AGONIST,,Tclin,,,Homo sapiens
182990,725,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,8,,IC50,50% Inhibition of stereospecific [3H]-naltrexone (10e-9 M) binding towards opiate receptor in rat brain homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL485,,,,,,,Rattus norvegicus
182991,1976,2856,Adrenergic receptor alpha-1,GPCR,P25100|P35348|P35368,ADRA1A|ADRA1B|ADRA1D,ADA1A_HUMAN|ADA1B_HUMAN|ADA1D_HUMAN,6.21,,Kd,"In vitro blocking activity against alpha adrenergic receptor, isolated from rabbit aortic strip",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL114655,,,,Tclin|Tclin|Tclin,,,Homo sapiens
182992,2045,1976,Fatty-acid amide hydrolase 1,Enzyme,P97612,Faah,FAAH1_RAT,5.3,,IC50,Inhibition of rat recombinant FAAH assessed as [3H]AEA hydrolysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL417675,,,,,,,Rattus norvegicus
182993,594,3449,Cholecystokinin receptor,GPCR,P30551|P30553,Cckar|Cckbr,CCKAR_RAT|GASR_RAT,4,,IC50,Binding affinity towards cholecystokinin receptor by the displacement of [125I]CCK-33 in rat pancreatic tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,,,,,,,Rattus norvegicus
182994,594,2777,GABA-A receptor; anion channel,Ion channel,P08219|P08220|P10063|P10064|P20237|P22300,GABRA1|GABRA2|GABRA3|GABRA4|GABRB1|GABRG2,GBRA1_BOVIN|GBRA2_BOVIN|GBRA3_BOVIN|GBRA4_BOVIN|GBRB1_BOVIN|GBRG2_BOVIN,6.1,,IC50,Inhibition of [3H]flunitrazepam binding to benzodiazepine receptor in bovine brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,,,,,,,Bos taurus
182995,594,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,4.3,,Ki,Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) assessed as inhibition of ATCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,,,,,,,Electrophorus electricus
182996,594,1852,Translocator protein,Membrane receptor,P16257,Tspo,TSPO_RAT,6.36,,Ki,Binding affinity against rat benzodiazepine (BZD) receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,,,,,,,Rattus norvegicus
182997,594,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,6.52,,Ki,Inhibition of Equus caballus (horse) serum butyrylcholinesterase (BChE) assessed as inhibition of BTCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,,,,,,,Equus caballus
182998,594,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,6.7,,IC50,Inhibitory concentration against specific binding of [3H]diazepam to Benzodiazepine receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,,,,,,,Rattus norvegicus
182999,594,3448,Cholecystokinin receptor,GPCR,P32238|P32239,CCKAR|CCKBR,CCKAR_HUMAN|GASR_HUMAN,4,,IC50,Binding affinity towards cholecystokinin receptor by displacement of [125I]CCK-33 from guinea pig brain tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,,,,Tclin|Tclin,,,Homo sapiens
183000,1782,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,4.88,,IC50,Inhibitory activity against 5-hydroxytryptamine 2 receptor by 3H ligand binding experiments.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,,,,Rattus norvegicus
183001,1782,2898,Serotonin 3 receptor (5HT3),Ion channel,P23979|Q9JHJ5,Htr3a|Htr3b,5HT3A_MOUSE|5HT3B_MOUSE,6.7,,Ki,Compound was evaluated for the binding affinity at 5- HT3 receptor subtype,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,,,,Mus musculus
183002,1782,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.11,,IC50,Inhibitory activity against alpha-2 adrenergic receptor by 3H ligand binding experiments.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,,,,Rattus norvegicus
183003,1782,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,5.11,,IC50,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,,,,Rattus norvegicus
183004,1782,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.98,,Ki,Compound was evaluated for binding affinity towards DA D-2 receptor using radioligand [3H]SPI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,,,,Rattus norvegicus
183005,1782,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.02,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,Tchem,,,Homo sapiens
183006,1782,2783,Serotonin 3 (5-HT3) receptor,Ion channel,P35563|Q9JJ16,Htr3a|Htr3b,5HT3A_RAT|5HT3B_RAT,6.68,,Ki,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,,,,Rattus norvegicus
183007,1782,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,4.48,,IC50,Inhibitory activity against Alpha-1 adrenergic receptor by 3H ligand binding experiments.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,,,,Rattus norvegicus
183008,1782,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,7.1,,Ki,Compound was evaluated for the binding affinity at Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,,,,Bos taurus
183009,1782,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,7.21,,IC50,Concentration of compound required to inhibit the binding of radioligand [3H](R)-7-OH-DPAT to Dopamine receptor D3 in rat striatum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,,,,Rattus norvegicus
183010,1782,1855,5-hydroxytryptamine receptor 4,GPCR,Q62758,Htr4,5HT4R_RAT,6.05,,Ki,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,,,,Rattus norvegicus
183011,1782,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.26,,Ki,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,,,,Cavia porcellus
183012,2572,2380,Beta-lactamase GES-13,Enzyme,D1MIX9,blaGES-13,D1MIX9_PSEAI,7.22,,IC50,Inhibition of Pseudomonas aeruginosa GES-13 beta lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Pseudomonas aeruginosa
183013,2572,1974,Beta-lactamase,Enzyme,P05193,ampC,AMPC_CITFR,6.03,,IC50,Compound was tested for inhibition of Beta-lactamase from Citrobacter freundii 1982,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Citrobacter freundii
183014,2572,2044,Beta-lactamase,Enzyme,A4KCT8,BlaGIL-1,A4KCT8_9ENTR,7.4,,IC50,Inhibition of Citrobacter gillenii CIP 106783 Beta-lactamase GIL1 expressed in Escherichia coli DH10B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Citrobacter gillenii
183015,2572,1851,Beta-lactamase,Enzyme,P05364,ampC,AMPC_ENTCL,7,,IC50,In vitro inhibitory activity against Beta-lactamase TEM-1 of class A enzyme,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Enterobacter cloacae
183016,2572,1927,Beta-lactamase,Enzyme,Q6W9J1,blaTEM-1,Q6W9J1_ENTCL,7.22,,IC50,Inhibitory activity against class A Beta-lactamase TEM isolated from Enterobacter coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Enterobacter cloacae
183017,2572,2117,Beta-lactamase,Enzyme,Q9EXV5,blaUOE-1,Q9EXV5_ECOLX,8.7,,IC50,Inhibition of Escherichia coli CTX-M-15,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Escherichia coli
183018,2572,2098,Carbapenem-hydrolizing beta-lactamase SFC-1,Enzyme,Q6JP75,,Q6JP75_SERFO,5.16,,IC50,Inhibition of Serratia fonticola UTAD54 SFC1 beta lactamase expressed in Escherichia coli BL21(DE3) by SDS-PAGE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Serratia fonticola
183019,2572,2148,Beta-lactamase,Enzyme,Q6GWS8,blaTEM-125,Q6GWS8_ECOLX,6.62,,IC50,Inhibition of Escherichia coli DH5alpha beta-lactamase TEM-158,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Escherichia coli
183020,2572,2099,Carbepenem-hydrolyzing beta-lactamase KPC,Enzyme,Q9F663,bla,BLKPC_KLEPN,4.13,,Ki,Inhibition of Klebsiella pneumoniae 1534 beta-lactamase KPC-2 by competitive assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Klebsiella pneumoniae
183021,2572,2415,Beta-lactamase,Enzyme,Q2XPY6,blaCTX-M-53,Q2XPY6_SALET,8.66,,IC50,Inhibition of Salmonella enterica serotype Westhampton beta-lactamase CTX-M-53,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Salmonella enterica subsp. enterica serovar Westhampton
183022,2572,1963,Beta-lactamase,Enzyme,P24735,ampC,AMPC_PSEAE,6.09,,IC50,Compound was tested for inhibition of Beta-lactamase from Pseudomonas aeruginosa 18SH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
183023,2572,2385,Beta-lactamase,Enzyme,A0ZX81,blaSHV-72,A0ZX81_KLEPN,7.1,,IC50,Inhibition of Klebsiella pneumoniae Beta-Lactamase SHV-72,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Klebsiella pneumoniae
183024,2572,1762,IMI-1; IMI-1 carbapenemase,Enzyme,Q46991,imiA,Q46991_ENTCL,7.52,,IC50,In vitro inhibitory activity against Class A (Imi-1) beta-Lactamases,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Enterobacter cloacae
183025,2572,2100,Beta-lactamase,Enzyme,A2RP81,blaPER-2,A2RP81_CITFR,7.02,,IC50,Inhibition of Citrobacter freundii PER2 beta lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Citrobacter freundii
183026,2572,2401,Beta-lactamase,Enzyme,B8R6A5,penB1,B8R6A5_9BURK,6.3,,IC50,Inhibition of Burkholderia cenocepacia 07-34 beta-lactamase PenB1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Burkholderia cenocepacia
183027,2572,2118,Beta-lactamase SHV-1,Enzyme,P0AD64,bla,BLA1_KLEPN,6.96,,IC50,Inhibition of Klebsiella pneumoniae Beta-Lactamase SHV-1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Klebsiella pneumoniae
183028,2572,1973,Beta-lactamase,Enzyme,P94958,ampC,AMPC_MORMO,6.72,,IC50,Compound was tested for inhibition of beta-Lactamases from Morganell morgani U1627,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Morganella morganii
183029,2572,2097,Beta-lactamase,Enzyme,A8RR46,bcl1,A8RR46_BACCS,8.4,,IC50,Inhibition of Bacillus clausii NR beta-lactamase BCL1 expressed in Escherichia coli BL21 (DE3),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Bacillus clausii
183030,2572,786,Beta-lactamase,Enzyme,Q59401,,Q59401_ENTCL,5.47,,IC50,The compound was evaluated for inhibition against the GC1 extended spectrum Class C beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Enterobacter cloacae
183031,2572,2061,Beta-lactamase,Enzyme,A1E3K9,blaSCO-1,A1E3K9_ECOLX,8,,IC50,Inhibition of Escherichia coli beta-lactamase SCO1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Escherichia coli
183032,2572,1022,Beta-lactamase SHV-1,Enzyme,P0AD63,bla,BLA1_ECOLX,6.65,,IC50,Inhibition of Escherichia coli SHV1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Escherichia coli
183033,2572,153,Beta-lactamase,Enzyme,P00808,penP,BLAC_BACLI,6.29,,IC50,Compound was tested for inhibition of Beta-lactamase from Bacillus licheniformis 749/C,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Bacillus licheniformis
183034,2572,2387,Class D beta-lactamase,Unclassified,Q50H31,oxa-63,Q50H31_BRAPL,6.8,,IC50,Inhibition of Brachyspira pilosicoli beta-lactamase OXA-63 expressed in Escherichia coli BL21 (DE3) assessed as reduction in nitrocefin hydrolysis by spectrophotometry relative to oxacillin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404,,,,,,,Brachyspira pilosicoli
183035,3862,1875,Retinoic acid receptor alpha,Transcription factor,P11416,Rara,RARA_MOUSE,8.15,,Kd,Dissociation constant for binding to Retinoic acid receptor alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,,,,,,,Mus musculus
183036,3862,1870,Retinoic acid receptor RXR-gamma,Transcription factor,P28705,Rxrg,RXRG_MOUSE,8.4,,Kd,Dissociation constant for binding to Retinoid X receptor gamma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,,,,,,,Mus musculus
183037,3862,1869,Retinoic acid receptor RXR-beta,Transcription factor,P28704,Rxrb,RXRB_MOUSE,7.92,,Kd,Dissociation constant for binding to Retinoid X receptor beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,,,,,,,Mus musculus
183038,3862,1916,Retinoic acid receptor gamma,Transcription factor,P18911,Rarg,RARG_MOUSE,7.77,,Kd,Dissociation constant for binding to Retinoic acid receptor gamma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,,,,,,,Mus musculus
183039,3862,1876,Retinoic acid receptor RXR-alpha,Transcription factor,P28700,Rxra,RXRA_MOUSE,7.49,,Kd,Dissociation constant for binding to Retinoid X receptor alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,,,,,,,Mus musculus
183040,3862,2582,Retinoic acid receptor RXR-alpha,Unclassified,Q05343,Rxra,RXRA_RAT,6.96,,EC50,Agonist activity at RXR-alpha in rat R3KE cells infected with oncogene KLF4-ER assessed as inhibition of KLF4-mediated oncogenic transformation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,,,,,,,Rattus norvegicus
183041,3862,1915,Retinoic acid receptor beta,Transcription factor,P22605,Rarb,RARB_MOUSE,8.15,,Kd,Dissociation constant for binding to Retinoic acid receptor beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,,,,,,,Mus musculus
183042,2722,413,Retinoic acid receptor RXR-alpha,Nuclear hormone receptor,P19793,RXRA,RXRA_HUMAN,9.4,,Ki,Binding affinity for retinoic acid receptor RAR alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,Tclin,,,Homo sapiens
183043,2722,1875,Retinoic acid receptor alpha,Transcription factor,P11416,Rara,RARA_MOUSE,7.82,,Kd,Dissociation constant for binding to Retinoic acid receptor alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,,,,Mus musculus
183044,2722,1870,Retinoic acid receptor RXR-gamma,Transcription factor,P28705,Rxrg,RXRG_MOUSE,6.46,,Kd,Dissociation constant for binding to Retinoid X receptor gamma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,,,,Mus musculus
183045,2722,414,Retinoic acid receptor RXR-beta,Nuclear hormone receptor,P28702,RXRB,RXRB_HUMAN,9.3,,Ki,Binding affinity for retinoic acid receptor RAR beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,Tclin,,,Homo sapiens
183046,2722,1869,Retinoic acid receptor RXR-beta,Transcription factor,P28704,Rxrb,RXRB_MOUSE,6.51,,Kd,Inhibition of [3H]9-cis-RA binding to mouse Retinoid X receptor RXR beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,,,,Mus musculus
183047,2722,1916,Retinoic acid receptor gamma,Transcription factor,P18911,Rarg,RARG_MOUSE,7.74,,Kd,Dissociation constant for binding to Retinoic acid receptor gamma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,,,,Mus musculus
183048,2722,415,Retinoic acid receptor RXR-gamma,Nuclear hormone receptor,P48443,RXRG,RXRG_HUMAN,8.85,,Ki,Binding affinity for retinoic acid receptor RAR gamma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,Tclin,,,Homo sapiens
183049,2722,1838,Cellular retinoic acid-binding protein 1,Cytosolic other,P40220,CRABP1,RABP1_CHICK,6.43,,IC50,Tested for its ability to inhibit the binding of (all-E-)-RA to cytoplasmic retinoic acid-binding protein (CRABP) from chick skin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,,,,Gallus gallus
183050,2722,1876,Retinoic acid receptor RXR-alpha,Transcription factor,P28700,Rxra,RXRA_MOUSE,6,,Kd,Dissociation constant for binding to Retinoid X receptor alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,,,,Mus musculus
183051,2722,1873,Cellular retinoic acid-binding protein 1,Cytosolic other,P62965,Crabp1,RABP1_MOUSE,9.4,,Kd,Inhibition of [3H]ATRA binding to murine Cytoplasmic retinoic acid binding protein (CRABP) type 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,,,,Mus musculus
183052,2722,1915,Retinoic acid receptor beta,Transcription factor,P22605,Rarb,RARB_MOUSE,7.89,,Kd,Dissociation constant for binding to Retinoic acid receptor beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,,,,Mus musculus
183053,2722,2492,"Indoleamine 2,3-dioxygenase 2",Enzyme,Q8R0V5,Ido2,I23O2_MOUSE,4.54,,IC50,Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,,,,Mus musculus
183054,2722,1874,Cellular retinoic acid-binding protein 2,Cytosolic other,P22935,Crabp2,RABP2_MOUSE,8.7,,Kd,Inhibition of [3H]ATRA binding to murine Cytoplasmic retinoic acid binding protein (CRABP) type 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,,,,Mus musculus
183055,1508,1838,Cellular retinoic acid-binding protein 1,Cytosolic other,P40220,CRABP1,RABP1_CHICK,6.05,,IC50,Tested for its ability to inhibit the binding of (all-E-)-RA to cytoplasmic retinoic acid-binding protein (CRABP) from chick skin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL547,,,,,,,Gallus gallus
183056,1508,426,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,,,,Mechanism of Action; CHEMBL2008; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL547,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL547,INHIBITOR,,Tclin,,,Homo sapiens
183057,593,525,Apoptosis regulator Bcl-2,Cytosolic other,P10415,BCL2,BCL2_HUMAN,4.22,,Kd,Binding affinity to Bcl-2 by NMR titration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22150,,,,Tclin,,,Homo sapiens
183058,2034,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,7.3,,Ki,Inhibitory binding constant in guinea pig brain homogenate was reported at Opioid receptor delta 1 at a a temperature 25 degree Celsius labeled with [3H](D-Ala2-D-Leu5)-enkephalin (0.7 nM),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,AGONIST,,Tclin,,,Homo sapiens
183059,2034,2897,Opioid receptors; mu and delta,GPCR,P32300|P42866,Oprd1|Oprm1,OPRD_MOUSE|OPRM_MOUSE,8.33,,Ki,Displacement of [3H]-DAMGO from mouse MOR/DOR expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,,,,,,,Mus musculus
183060,2034,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,7.24,,Ki,Displacement of [3H]U69593 from kappa opioid receptor in guinea pig cerebellum homogenate by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,,,,,,,Cavia porcellus
183061,2034,1760,Delta-type opioid receptor,GPCR,P32300,Oprd1,OPRD_MOUSE,6.21,,Ki,Displacement of [3H]- diprenorphine from delta-W284E-receptor expressed in HEK 293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,,,,,,,Mus musculus
183062,2034,1758,Mu-type opioid receptor,GPCR,P42866,Oprm1,OPRM_MOUSE,8.3,,Ki,Displacement of [3H]-DAMGO from mouse MOR expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,,,,,,,Mus musculus
183063,2034,1836,Kappa-type opioid receptor,GPCR,P34975,Oprk1,OPRK_RAT,7.02,,Ki,Displacement of [3H]diprenorphine from k-E297A-receptor expressed in HEK 293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,,,,,,,Rattus norvegicus
183064,2034,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,7.09,,Ki,"Inhibition of [3H][Ile5,6]deltorphin II binding to opioid receptor delta from rat brain membranes",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,,,,,,,Rattus norvegicus
183065,2034,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,9.01,,Ki,Inhibition of [3H]DAMGO binding to opioid receptor mu from rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,,,,,,,Rattus norvegicus
183066,2034,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,9.27,,Ki,Displacement of [3H]DAMGO from mu opioid receptor in guinea pig forebrain homogenate by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,,,,,,,Cavia porcellus
183067,2034,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,10.89,,IC50,Concentration for 50% inhibition of [3H]naloxone (1 M) binding to opioid receptor in rat brain membrane was determined in the absence of NaCl,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,,,,,,,Rattus norvegicus
183068,937,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,6.14,,Ki,Inhibition of human carbonic anhydrase 5a after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
183069,937,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.32,,Ki,Inhibition of human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
183070,937,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,4.92,,Ki,Inhibition of human carbonic anhydrase 14 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
183071,937,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,5.37,,Ki,Inhibition of human carbonic anhydrase 7 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
183072,937,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.36,,Ki,Inhibition of human carbonic anhydrase 12 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
183073,937,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.01,,Ki,Inhibition of human carbonic anhydrase 9 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
163345,488,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.5768,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
183074,937,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,6.41,,Ki,Inhibition of mouse carbonic anhydrase 15 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,,,,Mus musculus
183075,937,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.05,,Ki,Inhibition of human carbonic anhydrase 4 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
183076,937,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.72,,Ki,Inhibition of human carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
183077,937,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,6.05,,Ki,Inhibition of human carbonic anhydrase 5b after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
183078,937,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.13,,Ki,Inhibition of human carbonic anhydrase 3 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
183079,937,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,5.02,,Ki,Inhibition of human carbonic anhydrase 13 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
183080,937,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,5.02,,Ki,Inhibition of human carbonic anhydrase 6 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,Tclin,,,Homo sapiens
183081,886,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,,,,Mechanism of Action; CHEMBL233; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1595,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1595,AGONIST,,Tclin,,,Homo sapiens
183082,2579,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,5.6,,Ki,Binding affinity to human recombinant 5HT3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76370,,,,Tclin,,,Homo sapiens
183083,2579,245,5-hydroxytryptamine receptor 4,GPCR,Q13639,HTR4,5HT4R_HUMAN,8.4,,Ki,Binding affinity at 5HT4 receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76370,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76370,PARTIAL AGONIST,,Tclin,,,Homo sapiens
183084,2579,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,7.9,,EC50,Induction of 5-HT4 receptor-mediated contraction in guinea pig longitudinal muscle myenteric plexus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76370,,,,,,,Cavia porcellus
183085,2745,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.58,,IC50,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1092,,,,Tclin,,,Homo sapiens
183086,2745,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.17,,IC50,Evaluated for its binding affinity at human muscarinic receptor m4 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1092,,,,Tclin,,,Homo sapiens
183087,2745,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.99,,IC50,Evaluated for its binding affinity at human muscarinic receptor m5 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1092,,,,Tclin,,,Homo sapiens
183088,2745,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.73,,IC50,Evaluated for its binding affinity at human muscarinic receptor m2 by displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1092,,,,Tclin,,,Homo sapiens
183089,2745,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.89,,IC50,Evaluated for its binding affinity at human muscarinic receptor m1 by displacement of [3H]NMS binding using membranes in transfected chinese hamster ovarian cell,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1092,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1092,ANTAGONIST,,Tclin,,,Homo sapiens
183090,3514,672,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,5.92,,IC50,Inhibition of FAK (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183091,3514,2180,Casein kinase II subunit alpha,Kinase,P68400,CSNK2A1,CSK21_HUMAN,5.93,,Ki,Inhibitory constant against Zea mays CK2alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183092,3514,1583,Lysine--tRNA ligase,Enzyme,Q15046,KARS,SYK_HUMAN,4.7,,IC50,Inhibition of SYK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183093,3514,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,6.23,,IC50,Inhibition of recombinant FLT3 (unknown origin) by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183094,3514,1756,Aldose reductase,Enzyme,P16116,AKR1B1,ALDR_BOVIN,5.55,,IC50,Inhibition of aldose reductase from calf lense by AR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Bos taurus
183095,3514,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,6.05,,IC50,Inhibition of EGFR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183096,3514,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,7.41,,Kd,Inhibition of human thrombin assessed as equilibrium dissociation constant at 50 to 1000 uM by BIAcore analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183097,3514,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,4.52,,Ki,Displacement of [125I]AB-MECA binding to human Adenosine A3 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183098,3514,850,RAC-alpha serine/threonine-protein kinase,Kinase,P31749,AKT1,AKT1_HUMAN,5.27,,IC50,Inhibition of AKT1 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183099,3514,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.6,,Ki,Inhibition of human CA2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
162920,2146,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.3,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215,AGONIST,,Tclin,,,Homo sapiens
183100,3514,3572,Cell division protein kinase 5,Unclassified,Q03114,Cdk5,CDK5_RAT,4.2,,EC50,Inhibition of rat fetal brain CDK5 assessed as phosphorylated histone H1 levels by immuno-precipitation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Rattus norvegicus
183101,3514,88,Urokinase-type plasminogen activator,Enzyme,P00749,PLAU,UROK_HUMAN,4.92,,IC50,Inhibition of urokinase amidolytic activity (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183102,3514,1626,Cationic trypsin,Enzyme,P00760,,TRY1_BOVIN,5.15,,IC50,Inhibitory concentration of the compounds against Bovine trypsin enzyme.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Bos taurus
183103,3514,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,5.04,,Ki,Inhibition of mouse CA13 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Mus musculus
183104,3514,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,6.37,,IC50,Inhibition of 15LOX in rabbit reticulocytes by EIA assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Oryctolagus cuniculus
183105,3514,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,5.4,,IC50,Inhibitory activity against Amp C beta-Lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Escherichia coli (strain K12)
183106,3514,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.15,,Kd,Binding affinity to ABCB1 nucleotide binding domain 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183107,3514,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.03,,Ki,Inhibition of human CA12 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183108,3514,976,Aldose reductase,Enzyme,P80276,AKR1B1,ALDR_PIG,4.3,,IC50,Inhibition of pig lens aldose reductase by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Sus scrofa
183109,3514,1901,Amine oxidase [flavin-containing] A,Enzyme,P21398,MAOA,AOFA_BOVIN,8,,IC50,Inhibition of bovine MAO-A by fluorimetric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Bos taurus
183110,3514,841,Phospholipase A2,Enzyme,P04054,PLA2G1B,PA21B_HUMAN,5.7,,IC50,Inhibition of phospholipase A2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183111,3514,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,6.55,,IC50,Inhibition of VEGFR2 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183112,3514,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.92,,IC50,Inhibition of SRC (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183113,3514,626,Alpha-amylase 1,Enzyme,P04745,AMY1A,AMY1_HUMAN,4.67,,IC50,Inhibition of human salivary alpha-amylase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183114,3514,597,Cyclin-dependent kinase 2,Kinase,P24941,CDK2,CDK2_HUMAN,4.4,,IC50,Inhibition of CDK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183115,3514,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.1,,Ki,Inhibition of human CA4 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183116,3514,2563,NADPH oxidase 4,Enzyme,Q9NPH5,NOX4,NOX4_HUMAN,6.17,,IC50,Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183117,3514,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,6.7,,IC50,In vitro inhibition against 5-lipoxygenase in RBL-1 cells was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Rattus norvegicus
183118,3514,1650,Xanthine dehydrogenase/oxidase,Enzyme,P80457,XDH,XDH_BOVIN,5.92,,Ki,Inhibition of bovine xanthine oxidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Bos taurus
183119,3514,2768,Cyclin-dependent kinase 5/CDK5 activator 1,Kinase,Q00535|Q15078,CDK5|CDK5R1,CD5R1_HUMAN|CDK5_HUMAN,4.64,,IC50,Inhibition of Cyclin-dependent kinase 5-p25nck5a,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem|Tchem,,,Homo sapiens
183120,3514,3498,Chymotrypsin C,Enzyme,Q99895,CTRC,CTRC_HUMAN,4,,IC50,Inhibitory activity against chymotrypsinogen,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183121,3514,2812,Cyclin-dependent kinase 4/cyclin D1,Kinase,P11802|P24385,CCND1|CDK4,CCND1_HUMAN|CDK4_HUMAN,4.21,,IC50,Inhibitory activity against cyclin-dependent kinase 4-cyclin D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem|Tclin,,,Homo sapiens
183122,3514,3452,Sorbitol dehydrogenase,Enzyme,Q00796,SORD,DHSO_HUMAN,4.45,,IC50,In vitro inhibitory activity against sorbitol dehydrogenase (SD) from sheep liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183123,3514,2766,Cyclin-dependent kinase 1/cyclin B1,Kinase,P06493|P14635,CCNB1|CDK1,CCNB1_HUMAN|CDK1_HUMAN,4.7,,IC50,Inhibition of Cyclin-dependent kinase 1-cyclin B1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem|Tchem,,,Homo sapiens
183124,3514,3573,Hypoxia-inducible factor 1-alpha inhibitor,Unclassified,Q9NWT6,HIF1AN,HIF1N_HUMAN,4.99,,IC50,Inhibition of human recombinant FIH1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tbio,,,Homo sapiens
183125,3514,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,6.24,,IC50,Inhibition of wild type MET (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183126,3514,1950,Cyclin-dependent kinase 6,Kinase,Q00534,CDK6,CDK6_HUMAN,4.6,,IC50,Inhibition of human cyclin-dependent kinase 6 complex with a virus-encoded cyclin from herpesvirus saimiri (Vcyclin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183127,3514,3574,D-alanylalanine synthetase,Unclassified,P07862,ddlB,DDLB_ECOLI,4.7,,IC50,Competitive inhibition of Escherichia coli DdlB using ATP as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Escherichia coli (strain K12)
183128,3514,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,6.1,,IC50,Inhibition of 5LOX in human PBMC by EIA assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183129,3514,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,5.79,,IC50,Inhibition of human recombinant MMP9 catalytic domain incubated for 20 mins by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183131,3514,757,Calcium/calmodulin-dependent protein kinase type II subunit beta,Kinase,Q13554,CAMK2B,KCC2B_HUMAN,5.52,,IC50,Inhibition of CAMK2 using autocamtide-2 as substrate after 30 mins by PKLight assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183132,3514,1250,Bifunctional epoxide hydrolase 2,Enzyme,P34913,EPHX2,HYES_HUMAN,4.47,,IC50,Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis after 1 hr by fluorescence method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183133,3514,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,5.62,,Ki,Inhibition of MRP1 transfected in human HeLa cells assessed as inhibition of [3H]LTC4 transport by rapid filtration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183134,3514,2298,Sialidase,Enzyme,P10481,nanH,NANH_CLOPF,5.77,,IC50,Inhibition of Clostridium perfringens neuraminidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Clostridium perfringens
183135,3514,424,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,4.63,,IC50,The inhibitory activity tested against human Protein-tyrosine phosphatase 1B enzyme,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183136,3514,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.55,,IC50,Inhibition of human MAOA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183137,3514,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.42,,Ki,Inhibition of human recombinant AChE by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183138,3514,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,5.16,,Ki,Affinity at Adenosine A2A receptor in rat striatal membranes by [3H]- CGS 21680 displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Rattus norvegicus
183139,3514,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.11,,Ki,Binding affinity to dopamine D4 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183140,3514,2562,Phosphatidylinositol 3-kinase regulatory subunit alpha,Kinase,P27986,PIK3R1,P85A_HUMAN,5.42,,IC50,Inhibition of PI3K,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183141,3514,881,Chymotrypsinogen B,Enzyme,P17538,CTRB1,CTRB1_HUMAN,4,,IC50,Inhibitory activity against Chymotrypsinogen from Thermus flavus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183142,3514,689,Serine/threonine-protein kinase PLK1,Kinase,P53350,PLK1,PLK1_HUMAN,5.24,,IC50,Inhibition of PLK1 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183143,3514,2216,NUAK family SNF1-like kinase 1,Kinase,O60285,NUAK1,NUAK1_HUMAN,5.29,,IC50,Inhibition of ARK5 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183144,3514,1981,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,Enzyme,P0AEK4,fabI,FABI_ECOLI,4.7,,IC50,Inhibition of Escherichia coli ENR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Escherichia coli (strain K12)
183145,3514,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,4.49,,IC50,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183146,3514,1902,Amine oxidase [flavin-containing] B,Enzyme,P56560,MAOB,AOFB_BOVIN,4.7,,IC50,Inhibition of bovine MAO-B by fluorimetric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Bos taurus
183147,3514,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,4.05,,IC50,Inhibition of human MAOB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183148,3514,2564,Replicase polyprotein 1ab,Enzyme,P0C6X7,rep,R1AB_CVHSA,5.09,,IC50,Inhibition of SARS coronavirus helicase assessed as duplex-DNA unwinding by FRET based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Human SARS coronavirus
183149,3514,720,Prolyl endopeptidase,Enzyme,P48147,PREP,PPCE_HUMAN,4.89,,IC50,Inhibition of human brain prolyl oligopeptidase expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183150,3514,392,Vasopressin V2 receptor,GPCR,P30518,AVPR2,V2R_HUMAN,5.2,,IC50,Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183151,3514,2478,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,4.81,,IC50,Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183152,3514,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.54,,IC50,Inhibition of human recombinant COX2 expressed in insect Sf21 cells by EIA assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183153,3514,882,Beta-secretase 1,Enzyme,P56817,BACE1,BACE1_HUMAN,4.85,,Ki,Noncompetitive inhibition of human recombinant BACE1 after 60 mins by Dixon plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183154,3514,2065,Aldo-keto reductase family 1 member C21,Enzyme,Q91WR5,Akr1c21,AK1CL_MOUSE,4.96,,Ki,Inhibition of mouse recombinant AKR1C21,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Mus musculus
183155,3514,219,Calmodulin,Cytosolic other,P0DP23|P0DP24|P0DP25,CALM1|CALM2|CALM3,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,4.89,,IC50,Inhibition of human recombinant calmodulin assessed as inhibition of calmodulin-sensitive cAMP phosphodiesterase activation after 15 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183156,3514,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,5.18,,IC50,Inhibition of human recombinant MMP2 catalytic domain incubated for 20 mins by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183157,3514,566,Myeloperoxidase,Enzyme,P05164,MPO,PERM_HUMAN,5.9,,IC50,Inhibition of myeloperoxidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183363,2787,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,5.47,,IC50,Inhibition of MMP2 after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,Tchem,,,Homo sapiens
183158,3514,687,Stromelysin-1,Enzyme,P08254,MMP3,MMP3_HUMAN,5.25,,IC50,Inhibition of human recombinant MMP3 catalytic domain incubated for 20 mins by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183159,3514,595,Cyclin-dependent kinase 1,Kinase,P06493,CDK1,CDK1_HUMAN,6.35,,IC50,Inhibition of CDK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183160,3514,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,5.61,,Ki,Displacement of specific [3H]PIA binding from adenosine A1 receptor in rat brain membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Rattus norvegicus
183161,3514,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,6,,IC50,In vitro inhibitory activity against L-Hexonate Dehydrogenase from rat kidney,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Rattus norvegicus
183162,3514,2534,Cytochrome P450 1B1,Enzyme,Q16678,CYP1B1,CP1B1_HUMAN,7.11,,IC50,Inhibition of human CYP1B1 by EROD assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183163,3514,3575,Lymphocyte differentiation antigen CD38,Tumour-associated antigen,P28907,CD38,CD38_HUMAN,4.42,,IC50,"Inhibition of human CD38 using 20 uM 1, N6-etheno NAD+ as substrate by continuous fluorimetric method",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183164,3514,1720,C-C chemokine receptor type 4,GPCR,P51679,CCR4,CCR4_HUMAN,5,,IC50,Inhibition of CCL22-stimulated CCR4 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183165,3514,304,Xanthine dehydrogenase/oxidase,Enzyme,P47989,XDH,XDH_HUMAN,5.58,,IC50,Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183166,3514,743,"Arachidonate 12-lipoxygenase, 12S-type",Enzyme,P18054,ALOX12,LOX12_HUMAN,6.36,,IC50,Inhibition of 12-hLO,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183167,3514,605,Serine/threonine-protein kinase pim-1,Kinase,P11309,PIM1,PIM1_HUMAN,7.6,,Kd,Binding affinity to non phosphorylated PIM1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183168,3514,3576,Phosphodiesterase 2A,Unclassified,Q01062,Pde2a,PDE2A_RAT,4.09,,IC50,Inhibition of rat brain particulate cGMP phosphodiesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Rattus norvegicus
183169,3514,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,4.89,,IC50,Ability to inhibit protein-tyrosine kinase activity of p56lck (isolated from bovine thymus) in vitro.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183170,3514,3577,Cytosol aminopeptidase,Unclassified,P28839,LAP3,AMPL_PIG,4.46,,IC50,Inhibition of pig kidney cytosolic Leucyl aminopeptidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Sus scrofa
183171,3514,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.09,,Ki,Inhibition of human CA3 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183172,3514,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,6.02,,IC50,Inhibition of AXL (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183173,3514,707,Estradiol 17-beta-dehydrogenase 2,Enzyme,P37059,HSD17B2,DHB2_HUMAN,5.81,,IC50,Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183174,3514,680,Arachidonate 15-lipoxygenase,Enzyme,P16050,ALOX15,LOX15_HUMAN,5.66,,IC50,Inhibition of 15-hLO1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183175,3514,2155,C-X-C chemokine receptor type 1,GPCR,P25024,CXCR1,CXCR1_HUMAN,5.35,,IC50,Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183176,3514,1788,Alcohol dehydrogenase [NADP(+)],Enzyme,P51635,Akr1a1,AK1A1_RAT,5.63,,IC50,In vitro inhibitory activity against aldehyde reductase 1 (ALR1) from rat kidney.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Rattus norvegicus
183177,3514,2769,Cyclin-dependent kinase 1/cyclin B,Kinase,O95067|P06493|P14635|Q8WWL7,CCNB1|CCNB2|CCNB3|CDK1,CCNB1_HUMAN|CCNB2_HUMAN|CCNB3_HUMAN|CDK1_HUMAN,4.12,,IC50,Inhibition of cyclin-dependent kinase 1/cyclinB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tbio|Tbio|Tchem|Tchem,,,Homo sapiens
183178,3514,1741,Integrase,Enzyme,Q7ZJM1,pol,Q7ZJM1_9HIV1,6.22,,IC50,Inhibition of His6-tagged HIV-1 integrase assessed as decrease in integrase-Flag-LEDGF/p75 interaction preincubated with enzyme for 30 mins followed by addition of Flag-LEDGF/p75 for 1 hr by AlphaScreen assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Human immunodeficiency virus 1
183179,3514,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,5.17,,Ki,Inhibition of human CA5A by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183180,3514,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,5.16,,IC50,Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183181,3514,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,5.48,,IC50,Inhibition of ALK (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183182,3514,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.27,,Ki,Inhibition of human CA14 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183183,3514,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,5.32,,Ki,Inhibition of human CA7 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183184,3514,2624,Arginase,Enzyme,O96394,,O96394_LEIAM,5.4,,IC50,Inhibition of Leishmania amazonensis recombinant arginase expressed in Escherichia coli Rosetta (DE3) pLysS using L-arginine as substrate incubated for 10 mins prior to substrate addition measured after 10 mins by colorimetry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Leishmania amazonensis
183186,3514,2622,D-alanine--D-alanine ligase,Enzyme,Q1CTD3,ddl,DDL_HELPH,5.37,,Ki,Competitive inhibition of Helicobacter pylori Ddl using ATP as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Helicobacter pylori (strain HPAG1)
183187,3514,2559,5'-nucleotidase,Enzyme,P21588,Nt5e,5NTD_RAT,7.34,,Ki,Inhibition of rat ecto-5'-nucleotidase expressed in Sf9 cells by capillary electrophoresis method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Rattus norvegicus
183188,3514,2031,Polyphenol oxidase 2,Enzyme,O42713,PPO2,PPO2_AGABI,4.51,,IC50,Inhibition of mushroom tyrosinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Agaricus bisporus
183189,3514,973,Alcohol dehydrogenase [NADP(+)],Enzyme,P50578,AKR1A1,AK1A1_PIG,4.42,,IC50,Inhibition of pig ALR1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Sus scrofa
183190,3514,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.57,,Ki,Inhibition of human CA1 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183191,3514,858,Macrophage metalloelastase,Enzyme,P39900,MMP12,MMP12_HUMAN,4.99,,IC50,Inhibition of human recombinant MMP12 catalytic domain incubated for 20 mins by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183192,3514,609,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,6.52,,IC50,Inhibition of IGF1R (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183193,3514,884,Glycogen synthase kinase-3 beta,Kinase,P49841,GSK3B,GSK3B_HUMAN,5.7,,IC50,Inhibition of Homo sapiens (human) recombinant GSK3beta after 30 min by Kinase-Glo assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183194,3514,3578,Glutathione reductase,Unclassified,P41921,GLR1,GSHR_YEAST,4.31,,IC50,In vitro inhibitory activity against glutathione reductase (GR) from bakers yeast,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
183195,3514,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,4.17,,Ki,Inhibition of human plasma BChE by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183196,3514,2025,Enoyl-acyl-carrier protein reductase,Enzyme,Q965D5,fabI,Q965D5_PLAFA,7.66,,Ki,Inhibition of Plasmodium falciparum ENR in presence of triclosan,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Plasmodium falciparum
183197,3514,2560,3-oxoacyl-acyl-carrier protein reductase,Enzyme,Q965D6,fabG,Q965D6_PLAFA,5.27,,IC50,Inhibition of FabG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Plasmodium falciparum
183198,3514,2561,Beta-hydroxyacyl-ACP dehydratase; Fatty acid synthesis protein,Enzyme,Q965D7,fabZ,Q965D7_PLAFA,5.82,,IC50,Inhibition of FabZ,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Plasmodium falciparum
183199,3514,2221,Aurora kinase B,Kinase,Q96GD4,AURKB,AURKB_HUMAN,6.04,,IC50,Inhibition of aurora-B (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183200,3514,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,4.92,,Ki,Inhibition of human CA5B by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183201,3514,2623,Serine/threonine-protein kinase Nek6,Kinase,Q9HC98,NEK6,NEK6_HUMAN,5.37,,IC50,Inhibition of NEK6 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tbio,,,Homo sapiens
183202,3514,867,Collagenase 3,Enzyme,P45452,MMP13,MMP13_HUMAN,5.07,,IC50,Inhibition of human recombinant MMP13 catalytic domain incubated for 20 mins by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183203,3514,613,Lactoylglutathione lyase,Enzyme,Q04760,GLO1,LGUL_HUMAN,5.49,,IC50,Inhibition of human recombinant His-tagged Glyoxalase 1 expressed in Sf21-Baculovirus system,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183204,3514,2558,Malate dehydrogenase,Enzyme,P10584,mdh,MDH_THETH,5.22,,IC50,Inhibitory activity against malate dehydrogenase (MDH) from Thermus flavus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Thermus thermophilus
183205,3514,747,Serine/threonine-protein kinase Nek2,Kinase,P51955,NEK2,NEK2_HUMAN,5.24,,IC50,Inhibition of NEK2 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183206,3514,815,Serine/threonine-protein kinase N1,Kinase,Q16512,PKN1,PKN1_HUMAN,5.24,,IC50,Inhibition of PRK1 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
183207,3514,3414,"Nitric oxide synthase, inducible",Enzyme,P29477,Nos2,NOS2_MOUSE,4.79,,IC50,Inhibition of iNOS-mediated nitric oxide production in LPS-stimulated mouse RAW264.7 cells after 24 hrs by Griess reaction analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Mus musculus
183208,3514,2886,Glycogen synthase kinase-3,Kinase,P49840|P49841,GSK3A|GSK3B,GSK3A_HUMAN|GSK3B_HUMAN,5.68,,IC50,Inhibition of glycogen synthase kinase 3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin|Tclin,,,Homo sapiens
183209,3514,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,5.21,,Ki,Inhibition of human CA6 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183210,3514,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,7.83,,IC50,Inhibition of cataracted human eye lens aldose reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
183211,1988,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,,,,Mechanism of Action; CHEMBL215; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL425,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL425,INHIBITOR,,Tclin,,,Homo sapiens
183212,1988,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,,,,Mechanism of Action; CHEMBL235; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL425,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL425,AGONIST,,Tclin,,,Homo sapiens
183213,1988,2891,Cyclooxygenase,Enzyme,P23219|P35354,PTGS1|PTGS2,PGH1_HUMAN|PGH2_HUMAN,,,,Mechanism of Action; CHEMBL2094253; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL425,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL425,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
183214,1362,2534,Cytochrome P450 1B1,Enzyme,Q16678,CYP1B1,CP1B1_HUMAN,6.29,,IC50,Inhibition of human CYP1B1 by EROD assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL399121,,,,Tchem,,,Homo sapiens
183215,1362,884,Glycogen synthase kinase-3 beta,Kinase,P49841,GSK3B,GSK3B_HUMAN,4.57,,IC50,Inhibition of Homo sapiens (human) recombinant GSK3beta after 30 min by Kinase-Glo assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL399121,,,,Tclin,,,Homo sapiens
183216,1637,2598,Arachidonate 5-lipoxygenase,Enzyme,P48999,Alox5,LOX5_MOUSE,6.4,,IC50,Inhibition of 5-LOX in calcium ionophore A23187-stimulated NMRI mouse macrophage assessed as inhibition of LTC4 production preincubated for 60 mins before stimulation measured after 2 hrs by ELISA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,,,,Mus musculus
183217,1637,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,6.96,,IC50,Inhibitory concentration against isolated rabbit reticulocyte 15-lipoxygenase measured in the presence of linoleic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,,,,Oryctolagus cuniculus
183218,1637,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,8,,IC50,Inhibition of 5-lipoxygenase from rat basophilic leukemia(RBL-1) cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,,,,Rattus norvegicus
183219,1637,1936,Seed linoleate 13S-lipoxygenase-1,Enzyme,P08170,LOX1.1,LOX1_SOYBN,6.74,,IC50,Inhibitory activity against soybean 1-lipoxygenase (SLO),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,,,,Glycine max
183220,1637,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,7.6,,IC50,Inhibition of recombinant human 5-LOX in human PBML assessed as inhibition of A23187-induced LTB4 production preincubated for 15 mins measured after 15 mins by enzyme immunoassay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,Tclin,,,Homo sapiens
183221,1637,3432,"Arachidonate 15-lipoxygenase, type II",Enzyme,O15296,ALOX15B,LX15B_HUMAN,4.96,,IC50,Inhibition of 15-hLO2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,Tchem,,,Homo sapiens
183222,1637,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,4.41,,IC50,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,Tclin,,,Homo sapiens
183223,1637,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,7.96,,IC50,Inhibition of human placental microsome CYP19,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,Tclin,,,Homo sapiens
183224,1637,2597,5-lipoxygenase,Enzyme,Q9BEG3,,Q9BEG3_BOVIN,6.4,,IC50,Inhibitory activity against 5-lipoxygenase (inhibition of 5-HETE and LTB4 biosynthesis) in bovine polymorphonuclear leukocytes (PMNL).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,,,,Bos taurus
183225,1637,743,"Arachidonate 12-lipoxygenase, 12S-type",Enzyme,P18054,ALOX12,LOX12_HUMAN,6.96,,IC50,Inhibition of human platelet-type 12-lipoxygenase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,Tchem,,,Homo sapiens
183226,1637,680,Arachidonate 15-lipoxygenase,Enzyme,P16050,ALOX15,LOX15_HUMAN,6.96,,IC50,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,Tchem,,,Homo sapiens
183227,1637,2844,Cyclooxygenase,Enzyme,O62664|O62698,PTGS1|PTGS2,PGH1_BOVIN|PGH2_BOVIN,4.85,,IC50,In vitro inhibition of Prostaglandin G/H synthase in BSV cell line.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,,,,Bos taurus
183228,1637,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,4.3,,IC50,Inhibition of COX1 in bovine platelets assessed as formation of 12-hydroxyheptadecatrienoic acid by HPLC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,,,,Bos taurus
183229,1637,609,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,6.05,,IC50,Inhibition of IGF1R,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,Tclin,,,Homo sapiens
183230,1637,878,Leukotriene B4 receptor 1,GPCR,Q15722,LTB4R,LT4R1_HUMAN,7.07,,IC50,The compound was tested for its inhibitory activity against LTB4 in human PMN,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,Tchem,,,Homo sapiens
183231,3356,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,8.43,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1395,,,,Tchem,,,Homo sapiens
183232,3356,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,7.8,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1395,,,,,,,Rattus norvegicus
183233,3174,2621,Oxoeicosanoid receptor 1,GPCR,Q8TDS5,OXER1,OXER1_HUMAN,5.7,,IC50,Antagonist activity at human OXE receptor fused with G-alphai assessed as inhibition of 5-oxo-ETE-induced GTPgammaS binding after 60 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460026,,,,Tchem,,,Homo sapiens
183234,3174,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,4.27,,IC50,Inhibition of aromatase in human placental microsomes by radiometric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460026,,,,Tclin,,,Homo sapiens
183235,3174,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,5.15,,IC50,Inhibition of sheep COX2-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460026,,,,,,,Ovis aries
183236,3174,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,5.4,,IC50,Displacement of [3H]GW2433 from Homo sapiens (human) PPARdelta receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460026,,,,Tchem,,,Homo sapiens
183237,3174,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,5.7,,Kd,Binding affinity to PPARgamma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460026,,,,Tclin,,,Homo sapiens
183238,3174,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,5.96,,IC50,Inhibition of PPAR-alpha (unknown origin) by SPA assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460026,,,,Tclin,,,Homo sapiens
183239,3174,1940,Tissue factor,Membrane receptor,P13726,F3,TF_HUMAN,4.11,,IC50,Inhibition of amidolytic activity of human tissue factor/human factor 7a,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460026,,,,Tchem,,,Homo sapiens
183240,3174,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,4.89,,IC50,Inhibition of bovine COX1-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460026,,,,,,,Bos taurus
162972,1212,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.0443,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
183241,412,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,5.39,,IC50,Inhibition of Sprague-Dawley rat liver COMT after 10 mins using 0.05 uCi [14CH3]-SAM as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL223448,,,,,,,Rattus norvegicus
183242,1071,765,Glutathione S-transferase P,Enzyme,P09211,GSTP1,GSTP1_HUMAN,5.47,,IC50,Inhibition of GST P1-1 in human HL60 cell lysate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL456,,,,Tchem,,,Homo sapiens
183243,1071,2037,UDP-glucose 4-epimerase,Enzyme,Q14376,GALE,GALE_HUMAN,4.85,,IC50,Inhibition of human GalE by HPAEC assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL456,,,,Tchem,,,Homo sapiens
183244,1071,814,Glutathione S-transferase A1,Enzyme,P08263,GSTA1,GSTA1_HUMAN,5.3,,IC50,Inhibition of GST A1-1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL456,,,,Tchem,,,Homo sapiens
183245,1195,2787,GABA A receptor alpha-6/beta-2/gamma-2,Ion channel,P18508|P30191|P63138,Gabra6|Gabrb2|Gabrg2,GBRA6_RAT|GBRB2_RAT|GBRG2_RAT,7.82,,Ki,"Binding affinity for mutant rat GABA-A receptor alpha-6-(his,thr,gly)beta2gamma2 subunits expressed in HEK293 cells",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,,,,,,,Rattus norvegicus
183246,1195,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,9.1,,Ki,Binding affinity against Diazepam sensitive (DS) Gamma-aminobutyric acid A receptor in rat cerebellum.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,,,,,,,Rattus norvegicus
183247,1195,2777,GABA-A receptor; anion channel,Ion channel,P08219|P08220|P10063|P10064|P20237|P22300,GABRA1|GABRA2|GABRA3|GABRA4|GABRB1|GABRG2,GBRA1_BOVIN|GBRA2_BOVIN|GBRA3_BOVIN|GBRA4_BOVIN|GBRB1_BOVIN|GBRG2_BOVIN,10.05,,Ki,Displacement of [3H]- Ro.15-1788 from GABA-A central Benzodiazepine receptor (BzR) of Bovine cerebral cortex membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,,,,,,,Bos taurus
183248,1195,306,Gamma-aminobutyric acid receptor subunit alpha-4,Ion channel,P48169,GABRA4,GBRA4_HUMAN,8.7,,Ki,Displacement of [3H]Ro-154513 from benzodiazepine binding site of GABAA alpha-4-beta-2-gamma-2 receptor expressed in HEK293T cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,ALLOSTERIC ANTAGONIST,,Tclin,,,Homo sapiens
183249,1195,2788,GABA-A receptor; alpha-1/beta-2/gamma-2,Ion channel,P18508|P62813|P63138,Gabra1|Gabrb2|Gabrg2,GBRA1_RAT|GBRB2_RAT|GBRG2_RAT,9.3,,Ki,Binding affinity for rat GABA-A receptor alpha-1-beta-2-gamma-2 subunits expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,,,,,,,Rattus norvegicus
183250,1195,2786,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,P18508|P20236|P63138,Gabra3|Gabrb2|Gabrg2,GBRA3_RAT|GBRB2_RAT|GBRG2_RAT,9.22,,Ki,Binding affinity for rat GABA-A receptor alpha-3-beta-2-gamma-2 subunits expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,,,,,,,Rattus norvegicus
183251,2424,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,10.1,,Ki,Inhibition of [3H]pirenzepine binding to muscarinic receptor in rat cortical homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL569713,,,,,,,Rattus norvegicus
183252,2424,1867,Muscarinic receptor M1,GPCR,Q8WMX0,,Q8WMX0_BOVIN,9.39,,Ki,Binding affinity towards Muscarinic acetylcholine receptor M1 was determined in calf brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL569713,,,,,,,Bos taurus
183253,2424,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.28,,Ki,Binding affinity towards rat Muscarinic acetylcholine receptor M1 was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL569713,,,,,,,Rattus norvegicus
183254,2424,1845,Muscarinic acetylcholine receptor M3,GPCR,P08483,Chrm3,ACM3_RAT,9.19,,Kd,In vitro receptor binding against Muscarinic acetylcholine receptor M3 in rat submandibular gland was determined using [3H]pirenzepine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL569713,,,,,,,Rattus norvegicus
183255,2424,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,8.52,,Kd,In vitro receptor binding against Muscarinic acetylcholine receptor M2 in rat heart was determined using [3H]pirenzepine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL569713,,,,,,,Rattus norvegicus
183256,2424,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.75,,Ki,Displacement of [3H]NMS from human M5 muscarinic receptor expressed in CHO-K1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL569713,,,,Tclin,,,Homo sapiens
183257,1155,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,7.22,,IC50,In vitro inhibitory concentration Beta-2 adrenergic receptor in Guinea pig trachea,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32800,,,,,,,Cavia porcellus
183258,723,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,7.35,,Ki,Binding affinity towards serotonin transporter 5-HTT was determined using [3H]paroxetine radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120901,,,,,,,Rattus norvegicus
183259,723,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,5.5,,Ki,Displacement of [3H]nisoxetine from NET in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120901,,,,,,,Rattus norvegicus
183260,723,3579,Dopamine transporter,Unclassified,P27922,SLC6A3,SC6A3_BOVIN,7.19,,IC50,In vitro inhibitory activity towards [3H]cocaine binding to rat striatal tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120901,,,,,,,Bos taurus
183261,723,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,6.97,,Ki,Inhibition of high affinity uptake of [3H]NE by norepinephrine transporter in nerve endings obtained from rat brain.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120901,,,,,,,Rattus norvegicus
183262,723,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.31,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120901,,,,Tclin|Tclin|Tclin,,,Homo sapiens
183263,723,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,7.49,,Ki,Displacement of [3H]WIN-35428 from dopamine transporter (DAT) in Rat Caudate Putamen,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120901,,,,,,,Rattus norvegicus
183264,723,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,4.21,,Ki,Displacement of [3H]pirenzepine from muscarinic acetylcholine receptor M1 of rat brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120901,,,,,,,Rattus norvegicus
183265,723,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.05,,Ki,Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120901,,,,Tclin,,,Homo sapiens
183266,723,3580,Dopamine transporter,Unclassified,Q9GJT6,SLC6A3,SC6A3_MACFA,7.02,,IC50,Inhibition of [3H]WIN-35428 binding to dopamine transporter (DAT) of cynomolgus monkey caudate-putamen,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120901,,,,,,,Macaca fascicularis
183267,3642,829,Prolyl endopeptidase FAP,Enzyme,Q12884,FAP,SEPR_HUMAN,5.43,,IC50,Inhibition of 6xHis-tagged recombinant FAP (unknown origin) expressed in baculovirus expression system assessed as hydrolysis of Nle-Pro-aminomethylcoumarin after 20 mins by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL142703,,,,Tchem,,,Homo sapiens
183268,3642,2476,Prolyl endopeptidase FAP,Enzyme,P97321,Fap,SEPR_MOUSE,4.28,,IC50,Inhibition of mouse recombinant FAP expressed in HEK293 cells assessed as pNA release from Ala-Pro-p-nitroanilide pre-incubated with enzyme for 15 mins prior to substrate addition by fluorescence technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL142703,,,,,,,Mus musculus
183269,3642,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,8.52,,Ki,Inhibition of DPP4 in human plasma using Gly-Pro-AMC as substrate by fluorimetric analysis,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL142703,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000771/WC500020327.pdf,INHIBITOR,,Tclin,,265,Homo sapiens
183270,3642,844,Dipeptidyl peptidase 8,Enzyme,Q6V1X1,DPP8,DPP8_HUMAN,6.09,,Ki,Inhibition of DPP8,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL142703,,,,Tchem,,,Homo sapiens
183271,3642,880,Dipeptidyl peptidase 9,Enzyme,Q86TI2,DPP9,DPP9_HUMAN,7.17,,Ki,Inhibition of DPP9,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL142703,,,,Tchem,,,Homo sapiens
183274,2136,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.82,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL753,,,,Tchem,,,Homo sapiens
183275,2136,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,8.74,,Ki,In vitro binding affinity was measured as the inhibition of [3H]WB-4101 binding to alpha-1 adrenergic receptor of rat cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL753,,,,,,,Rattus norvegicus
183276,2136,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.35,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL753,,,,Tclin|Tclin|Tclin,,,Homo sapiens
183277,2136,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,6.92,,Ki,In vitro binding affinity to Dopamine receptors of rat striatal membranes by [3H]spiroperidol displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL753,,,,,,,Rattus norvegicus
183278,3342,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,9.6,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL258918,,,,Tchem,,,Homo sapiens
183279,3341,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,8.81,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL261514,,,,Tchem,,,Homo sapiens
183280,3083,1961,High affinity choline transporter 1,Unclassified,Q8BGY9,Slc5a7,SC5A7_MOUSE,4.49,,Ki,Inhibition of [3H]choline uptake at choline transporter 1 in mouse brain synaptosome,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL34833,,,,,,,Mus musculus
183281,3083,3450,Caspase-2,Enzyme,P42575,CASP2,CASP2_HUMAN,4.68,,EC50,Activation of procaspase 2 after 24 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL34833,,,,Tchem,,,Homo sapiens
183282,864,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,7.64,,Ki,Inhibitory activity against murine carbonic anhydrase XIII (mCA XIII) by using CO2 hydrase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Mus musculus
183283,864,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,7.02,,Ki,Inhibition of human full length carbonic anhydrase 4 by stopped flow CO2 hydrase assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,INHIBITOR,,Tclin,,,Homo sapiens
183284,864,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,7.64,,Ki,Inhibition of human recombinant cytosolic carbonic anhydrase 13 preincubated for 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,Tclin,,,Homo sapiens
183285,864,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,6.37,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Stylophora pistillata
183286,864,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,7.21,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Astrosclera willeyana
183287,864,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,6.06,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183288,864,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,7.1,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Stylophora pistillata
183414,2163,1179,Glycine receptor subunit alpha-3,Ion channel,O75311,GLRA3,GLRA3_HUMAN,5.22,,IC50,GRAC: human Glycine receptor subunit alpha-3 channel blocker,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL478523,,,,Tchem,,,Homo sapiens
183289,864,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,6.34,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Thalassiosira weissflogii
183290,864,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,6.99,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
183291,864,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,6.46,,Ki,Inhibitory constant against human carbonic anhydrase XIV in CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,Tclin,,,Homo sapiens
183292,864,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.02,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Mus musculus
183293,864,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,7.42,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
183294,864,2009,Carbonic anhydrase,Enzyme,P40881,,CAH_METTE,6.82,,Ki,Inhibitory activity against alpha carbonic anhydrase (Co-Cam) from Methanosarcina thermophila,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Methanosarcina thermophila
183295,864,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,5.7,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183296,864,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,7.1,,Ki,Inhibition of full length human recombinant CA VI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,Tclin,,,Homo sapiens
183297,864,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,6.42,,Ki,Inhibitory activity against bovine carbonic anhydrase IV from lung microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Bos taurus
183298,1678,3581,L-type amino acid transporter 1,Unclassified,Q63016,Slc7a5,LAT1_RAT,4.26,,Ki,Inhibition of LAT1-mediated L-[14C]leucine uptake in Sprague-Dawley rat brain by duel-labeled liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL852,,,,,,,Rattus norvegicus
183299,1018,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,7.89,,IC50,Inhibition of Catechol O-methyltransferase activity in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL953,,,,,,,Rattus norvegicus
183300,3064,701,"Tyrosine--tRNA ligase, cytoplasmic",Enzyme,P54577,YARS,SYYC_HUMAN,4.38,,Ki,Compound was tested for the inhibition of aminoacyl tRNA Synthetase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294199,,,,Tchem,,,Homo sapiens
183301,3064,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.42,,IC50,Inhibition of COX1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294199,,,,Tclin,,,Homo sapiens
183302,3064,1968,Transient receptor potential cation channel subfamily V member 1,Ion channel,O35433,Trpv1,TRPV1_RAT,5.77,,Ki,In vitro binding to Rat Vanilloid receptor 1 (VR1) expressing CHO cells compared to capsaicin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294199,,,,,,,Rattus norvegicus
183303,3064,57,Transient receptor potential cation channel subfamily V member 1,Ion channel,Q8NER1,TRPV1,TRPV1_HUMAN,8.22,,Ki,Binding affinity to human recombinant TRPV1,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294199,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294199,OPENER,,Tclin,,,Homo sapiens
183304,3064,3582,NADH-ubiquinone oxidoreductase chain 1 ,Unclassified,P03887,MT-ND1,NU1M_BOVIN,4.28,,IC50,Inhibition of Bos taurus (bovine) heart submitochondrial particle NDH1 assessed as NADH-DB reductase activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294199,,,,,,,Bos taurus
183305,3064,3583,Transient receptor potential cation channel subfamily M member 8,Unclassified,Q8R4D5,Trpm8,TRPM8_MOUSE,4.55,,IC50,Antagonist at TRPM8 isolated from mouse dorsal root ganglion cells expressed in HEK T-REx cells assessed as inhibition of menthol-induced intracellular Ca2+ influx by fluorescence-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL294199,,,,,,,Mus musculus
183306,681,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,5.32,,IC50,Inhibition of Sprague-Dawley rat liver COMT after 10 mins using 0.05 uCi [14CH3]-SAM as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL497,,,,,,,Rattus norvegicus
183307,681,1957,Botulinum neurotoxin type A,Enzyme,P10845,botA,BXA1_CLOBO,4.69,,IC50,Inhibition of Clostridium botulinum BoNT/A LC expressed in Escherichia coli assessed as cleavage of SNAPtide preincubated for 5 mins followed by SNAPtide addition measured for 105 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL497,,,,,,,Clostridium botulinum
183308,681,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,5.63,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL497,,,,,,,Mus musculus
183309,1153,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,6.1,,Ki,Compound was tested for inhibition of [3H]spiroperidol binding against Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL588,,,,,,,Bos taurus
183310,1153,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.09,,Ki,Affinity towards Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL588,,,,Tclin,,,Homo sapiens
183311,1153,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.55,,Kd,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL588,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL588,AGONIST,,Tclin,,,Homo sapiens
183312,1153,2435,Lysine-specific demethylase 4E,Enzyme,B2RXH2,KDM4E,KDM4E_HUMAN,5.72,,Ki,Non-competitive inhibition of JMJD2E relative to alpha-ketoglutarate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL588,,,,Tchem,,,Homo sapiens
183313,1153,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,8.52,,Ki,Displacement of [3H]fenoldopam from Dopamine receptor D1 of rat striatum membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL588,,,,,,,Rattus norvegicus
162973,956,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.45,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
183314,1153,2856,Adrenergic receptor alpha-1,GPCR,P25100|P35348|P35368,ADRA1A|ADRA1B|ADRA1D,ADA1A_HUMAN|ADA1B_HUMAN|ADA1D_HUMAN,5.3,,Kd,Activity at alpha-1 adrenergic receptor in rabbit aorta rings,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL588,,,,Tclin|Tclin|Tclin,,,Homo sapiens
183315,1153,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,5.89,,Kd,In vitro affinity at wild type Dopamine receptor D2 on C6 (glioma) cell membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL588,,,,,,,Rattus norvegicus
183316,2436,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,9.07,,Ki,Inhibition the uptake of tritiated serotonin (5-HT) by the serotonin transporter SERT in rat synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL809,,,,,,,Rattus norvegicus
183317,2436,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,6.8,,Ki,Inhibition of uptake of tritiated norepinephrine (NE) in rat synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL809,,,,,,,Rattus norvegicus
183318,2436,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,7.11,,Ki,Inhibition of the uptake of tritiated dopamine (DA) in rat synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL809,,,,,,,Rattus norvegicus
183319,2436,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,9.54,,Kd,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- imipramine and the compound at human transporter-hSERT,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL809,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL809,INHIBITOR,,Tclin,,,Homo sapiens
183320,2436,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.24,,Ki,Binding affinity to sigma 1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL809,,,,Tclin,,,Homo sapiens
183321,2436,3571,Transcriptional activator protein luxR,Unclassified,P12746,luxR,LUXR_ALIFS,4.57,,IC50,Inhibition of LuxR-dependent quorum sensing in Vibrio fischeri assessed as reduction of 3-oxo-C6-HSL-induced bioluminescence intensity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL809,,,,,,,Aliivibrio fischeri
183322,1187,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,4.4,,Kd,Binding affinity to human His-tagged CYP51 expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106,,,,Tchem,,,Homo sapiens
183323,1187,2119,Lanosterol 14-alpha demethylase,Enzyme,P9WPP9,cyp51,CP51_MYCTU,6.7,,Kd,Binding affinity to Mycobacterium tuberculosis CYP51,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183324,1187,2422,14-alpha sterol demethylase,Enzyme,Q96W81,cyp51B,Q96W81_ASPFM,5.39,,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme B expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106,,,,,,,Neosartorya fumigata
183325,1187,2421,14-alpha sterol demethylase Cyp51A,Enzyme,Q4WNT5,,Q4WNT5_ASPFU,4.92,,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme A expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106,,,,,,,Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100)
183326,1187,2587,Mycocyclosin synthase,Enzyme,P9WPP7,cyp121,CP121_MYCTU,5.22,,Kd,Binding affinity to Mycobacterium tuberculosis CYP121,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183327,44,3555,"Dihydropteroate synthetase, putative",Unclassified,Q4Z710,,Q4Z710_PLABA,4.75,,IC50,Inhibitory activity against dihydropteroic acid synthase (SYN) from Plasmodium berghei,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48396,,,,,,,Plasmodium berghei (strain Anka)
183328,44,1756,Aldose reductase,Enzyme,P16116,AKR1B1,ALDR_BOVIN,4.7,,IC50,Inhibition of Aldose reductase (AR),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48396,,,,,,,Bos taurus
183329,2296,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.19,,IC50,Inhibition of human AChE using acetylthiocholine iodide as substrate treated 5 mins before substrate addition measured up to 4 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1079905,,,,Tclin,,,Homo sapiens
183330,3050,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.57,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL129529,,,,Tclin|Tclin|Tclin,,,Homo sapiens
183331,3042,681,"Thymidine kinase, cytosolic",Kinase,P04183,TK1,KITH_HUMAN,5.3,,Ki,Binding affinity against HSV-1(KOS) thymidine kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222280,,,,Tchem,,,Homo sapiens
183332,3042,2617,Thymidylate kinase,Kinase,P9WKE1,tmk,KTHY_MYCTU,5.3,,Ki,Inhibition of Mycobacterium tuberculosis recombinant TMPK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222280,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183333,1943,2631,Pyruvate:ferredoxin oxidoreductase,Enzyme,Q24982,,Q24982_GIAIN,,,,Mechanism of Action; CHEMBL2364027; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1401,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1401,INHIBITOR,,,,,Giardia intestinalis
183334,1312,1223,Glutathione S-transferase kappa 1,Enzyme,Q9Y2Q3,GSTK1,GSTK1_HUMAN,7.7,,IC50,Affinity towards recombinant Glutathione S-transferase (GST) Enzyme.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1543,,,,Tchem,,,Homo sapiens
183335,422,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,7.22,,Ki,Affinity for human EMP expressed in ERG2 deficient strain of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL188921,,,,Tchem,,,Homo sapiens
183336,422,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.89,,Ki,Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL188921,,,,Tclin,,,Homo sapiens
183337,422,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,5.15,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL188921,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
183338,2870,2146,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P23576,Gabra2,GBRA2_RAT,6.12,,Ki,Displacement of [3H]flumazenil from rat GABA-A alpha-2-beta-2-gamma-2 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,,,,Rattus norvegicus
183339,2870,2147,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,P19969,Gabra5,GBRA5_RAT,7.46,,Ki,Displacement of [3H]flumazenil from rat GABA-A alpha-5-beta-3-gamma-2 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,,,,Rattus norvegicus
183340,2870,2787,GABA A receptor alpha-6/beta-2/gamma-2,Ion channel,P18508|P30191|P63138,Gabra6|Gabrb2|Gabrg2,GBRA6_RAT|GBRB2_RAT|GBRG2_RAT,6.01,,Ki,"Binding affinity for mutant rat GABA-A receptor alpha-6-(his,thr,gly)beta2gamma2 subunits expressed in HEK293 cells",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,,,,Rattus norvegicus
183341,2870,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,7.6,,Ki,Displacement of [3H]- flunitrazepam from rat GABA-A benzodiazepine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,,,,Rattus norvegicus
183342,2870,2788,GABA-A receptor; alpha-1/beta-2/gamma-2,Ion channel,P18508|P62813|P63138,Gabra1|Gabrb2|Gabrg2,GBRA1_RAT|GBRB2_RAT|GBRG2_RAT,7.72,,Ki,Binding affinity for rat GABA-A receptor alpha-1-beta-2-gamma-2 subunits expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,,,,Rattus norvegicus
183343,2870,1852,Translocator protein,Membrane receptor,P16257,Tspo,TSPO_RAT,5.33,,IC50,Displacement of Ro 5-4864 from peripheral (renal cell) Benzodiazepine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,,,,Rattus norvegicus
183344,2870,2790,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,P18508|P23576|P63138,Gabra2|Gabrb2|Gabrg2,GBRA2_RAT|GBRB2_RAT|GBRG2_RAT,6.81,,Ki,Binding affinity for recombinant rat GABA-A receptor alpha-2-beta-2-gamma-2 subunits expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,,,,Rattus norvegicus
183345,2870,2145,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P62813,Gabra1,GBRA1_RAT,7.3,,Ki,Displacement of [3H]flumazenil from rat GABA-A alpha-1-beta-2-gamma-2 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,,,,Rattus norvegicus
183346,2870,2786,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,P18508|P20236|P63138,Gabra3|Gabrb2|Gabrg2,GBRA3_RAT|GBRB2_RAT|GBRG2_RAT,6.42,,Ki,Displacement of [3H]Ro-151788 from rat GABA-A receptor alpha-3-beta-2-gamma-2 subunits expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,,,,Rattus norvegicus
183347,3617,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,4.3,,IC50,Inhibition of human CYP51 expressed in Topp 3 cells by lanosterol demethylase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83668,,,,Tchem,,,Homo sapiens
183348,356,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,6.18,,IC50,Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-2 adrenergic receptor in calf lung membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL423,,,,,,,Bos taurus
183349,356,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,6.98,,Kd,In vitro beta-2 adrenergic receptor activity was determined by measuring inhibition of the isoproterenol induced relaxation in isolated guinea pig tracheal chains contracted with PGF2-alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL423,,,,,,,Cavia porcellus
183350,356,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,8.76,,Kd,In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL423,,,,,,,Cavia porcellus
183351,333,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,5.29,,Ki,Binding affinity against serotonin transporter using [125]RTI-55,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200383,,,,,,,Rattus norvegicus
183352,333,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,6.93,,Ki,Displacement of [3H]WIN-35428 binding to the dopamine transporter in rat caudate putamen tissue.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200383,,,,,,,Rattus norvegicus
183353,333,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.23,,Ki,Displacement of [3H]pirenzepine binding at Muscarinic acetylcholine receptor M1 in rat brain P2 membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200383,,,,,,,Rattus norvegicus
183354,333,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,4.62,,IC50,Binding affinity of [3H]citalopram for serotonin transporter in monkey,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200383,,,,Tclin,,,Homo sapiens
183355,333,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,8.59,,Ki,Affinity for rat M1 acetylcholine receptor using [3H]-AF DX 384 displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200383,,,,,,,Rattus norvegicus
183356,1935,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,5.21,,IC50,Inhibition of ovine COX1 assessed as PGF2alpha level by EIA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56367,,,,,,,Ovis aries
183357,1935,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,6.4,,IC50,Inhibition of ovine COX2 assessed as PGF2alpha level by EIA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56367,,,,,,,Ovis aries
183358,1935,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.42,,IC50,Inhibition of COX1 in human whole blood assessed as inhibition of calcium ionophore A-23187-stimulated platelet aggregation by measuring TXB2 production,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56367,,,,Tclin,,,Homo sapiens
183359,1935,566,Myeloperoxidase,Enzyme,P05164,MPO,PERM_HUMAN,5.68,,IC50,Inhibition of recombinant human myeloperoxidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56367,,,,Tchem,,,Homo sapiens
183360,2847,2438,Proprotein convertase subtilisin/kexin type 7,Enzyme,Q16549,PCSK7,PCSK7_HUMAN,4.61,,IC50,Inhibition of recombinant type 8 subtilisin using Arg-Glu-(EDANS)- Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys-(DALBCYL)-Arg fluorogenic substrate preincubated for 1 hr measured after 1 hr at 1 min interval by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1464,,,,Tchem,,,Homo sapiens
183361,2787,801,Cytosol aminopeptidase,Enzyme,P28838,LAP3,AMPL_HUMAN,9.22,,Ki,Binding affinity for cytosolic leucine aminopeptidase (LAP) from porcine kidney,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,Tchem,,,Homo sapiens
162974,812,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.7959,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
183364,2787,3584,Aminopeptidase N,Unclassified,P15684,Anpep,AMPN_RAT,4.71,,IC50,Compound was evaluated for its inhibitory potency against purified membrane bound rat brain Aminopeptidase M using [3H]Leu-enkephalin as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,,,,Rattus norvegicus
183365,2787,2556,Bacterial leucyl aminopeptidase,Enzyme,Q01693,,AMPX_VIBPR,8.8,,Ki,Inhibition of Aeromonas proteolytica leucyl aminopeptidase using L-leucine para-notroanilide as substrate assessed as release of para-nitroaniline by Dixon plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,,,,Vibrio proteolyticus
183366,2787,2418,Cytosol aminopeptidase,Enzyme,P00727,LAP3,AMPL_BOVIN,6.3,,Ki,Competitive inhibition of bovine LAPc using L-leucine-p-nitroanilide as substrate by Dixon-plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,,,,Bos taurus
183367,2787,1919,Aminopeptidase B,Enzyme,O09175,Rnpep,AMPB_RAT,7.85,,Ki,Inhibition of aminopeptidase B or arginyl aminopeptidase purified from rat liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,,,,Rattus norvegicus
183368,2787,1918,Leucyl-cystinyl aminopeptidase,Enzyme,P97629,Lnpep,LCAP_RAT,7.7,,Ki,Inhibition of leucine aminopeptidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,,,,Rattus norvegicus
183369,2787,864,Leukotriene A-4 hydrolase,Enzyme,P09960,LTA4H,LKHA4_HUMAN,6.3,,IC50,Inhibition of aminopeptidase activity of human leukotriene A4 hydrolase by Dixon plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,Tchem,,,Homo sapiens
183370,2787,1800,Aminopeptidase B,Enzyme,Q8VCT3,Rnpep,AMPB_MOUSE,5.22,,IC50,Inhibition of Aminopeptidase B in murine L-cells by Aoyagi method.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,,,,Mus musculus
183371,2787,570,Aminopeptidase N,Enzyme,P15144,ANPEP,AMPN_HUMAN,5.62,,IC50,Inhibition of aminopeptidase N,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,Tchem,,,Homo sapiens
183372,2787,1785,Aminopeptidase N,Enzyme,P15145,ANPEP,AMPN_PIG,9.3,,Ki,Competitive inhibition of pig APN using L-leucine-p-nitroanilide as substrate by Dixon-plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,,,,Sus scrofa
183373,2787,1797,M1 family aminopeptidase,Enzyme,O96935,,AMP1_PLAFQ,6.72,,Ki,Inhibition of Plasmodium falciparum recombinant M1-aminopeptidase expressed in Escherichia coli after 40 mins uisng fluorogenic substrate L-Leucyl-7-amido-40-methylcoumarin by fluorescence spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29292,,,,,,,Plasmodium falciparum (isolate FcB1 / Columbia)
183374,2145,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.52,,IC50,Compound was evaluated for inhibition of Prostaglandin G/H synthase 1,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL101,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL101,INHIBITOR,,Tclin,,,Homo sapiens
183375,2145,2845,Cyclooxygenase,Enzyme,P35355|Q63921,Ptgs1|Ptgs2,PGH1_RAT|PGH2_RAT,4.82,,IC50,Compound was tested for inhibition of prostaglandin synthetase when administered perorally,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL101,,,,,,,Rattus norvegicus
183376,2145,1742,Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein,Enzyme,Q8SPQ9,PTGS2,Q8SPQ9_CANFA,5.42,,IC50,Inhibitory activity of the compound against canine COX-2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL101,,,,,,,Canis familiaris
183377,1292,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,8.11,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1868702,,,,Tchem,,,Homo sapiens
183378,3016,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.54,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
183381,136,1766,Cholecystokinin receptor type A,GPCR,P30551,Cckar,CCKAR_RAT,4.19,,IC50,Displacement of [125I]CCK from Cholecystokinin receptor of rat pancreas,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL661,,,,,,,Rattus norvegicus
183382,136,2475,Bromodomain-containing protein 4,Unclassified,O60885,BRD4,BRD4_HUMAN,5.61,,Kd,Binding affinity to BRD4-BD1 by isothermal titration calorimetry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL661,,,,Tchem,,,Homo sapiens
183383,1209,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,8.7,,Ki,Displacement of [3H]citalopram from serotonin transporter in Sprague-Dawley rat brain after 1 hr by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,,,,Rattus norvegicus
183384,1209,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,6.8,,Ki,Displacement of [3H]-dopamine from rat cerebral cortex NET after 7 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,,,,Rattus norvegicus
183385,1209,1829,Sodium-dependent dopamine transporter,Transporter,Q61327,Slc6a3,SC6A3_MOUSE,7.97,,Ki,Tested in vitro for serotonin(5-HT) neuronal uptake inhibition,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,,,,Mus musculus
183386,1209,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,6.84,,Ki,Inhibition of [3H]- NE reuptake into rat hippocampal synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,,,,Rattus norvegicus
183387,1209,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,6.22,,Ki,Binding affinity against rat cortical alpha-1 adrenergic receptor labeled with [3H]prazosin radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,,,,Rattus norvegicus
183388,1209,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,6.11,,Ki,Displacement of [3H]WIN 35428 from dopamine transporter in Sprague-Dawley rat brain after 1 hr by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,,,,Rattus norvegicus
183389,1209,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.72,,Ki,Evaluated for affinity at Alpha-2 adrenergic receptor of rat brain using [3H]rauwolscine as radioligand in radioligand binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,,,,Rattus norvegicus
183390,1209,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,6.89,,IC50,Inhibition of AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,Tclin,,,Homo sapiens
162975,765,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.4192,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
183391,1209,3585,Potassium voltage-gated channel subfamily C member 1,Unclassified,P25122,Kcnc1,KCNC1_RAT,4.88,,IC50,Inhibition of rat voltage-gated K channel 3.1 expressed in CHO cells by patch clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,,,,Rattus norvegicus
183392,1209,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,7.82,,IC50,Compound was evaluated for inhibition of 5-HT uptake by measuring its ability to inhibit [3H]paroxetine binding to rat cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,,,,Rattus norvegicus
183393,1209,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.07,,IC50,The compound was tested for affinity towards sigma-3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,Tclin,,,Homo sapiens
183394,1209,1830,Sodium-dependent noradrenaline transporter,Transporter,O55192,Slc6a2,SC6A2_MOUSE,7.07,,Ki,Tested in vitro for norepinephrine (NE) neuronal uptake inhibition,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,,,,Mus musculus
183395,1209,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,6.96,,Ki,Displacement of [3H]mesulergine from 5-HT2C receptor in Sprague-Dawley rat choroid plexus membranes after 30 mins by liquid scintillation spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,,,,Rattus norvegicus
183396,1209,788,Histamine H3 receptor,GPCR,Q9Y5N1,HRH3,HRH3_HUMAN,5.14,,Ki,Binding affinity to human histamine H3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,Tclin,,,Homo sapiens
183397,1779,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,Mechanism of Action; CHEMBL213; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1291,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1291,ANTAGONIST,,Tclin,,,Homo sapiens
183398,1779,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,Mechanism of Action; CHEMBL210; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1291,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1291,ANTAGONIST,,Tclin,,,Homo sapiens
183399,3158,2048,Sigma non-opioid intracellular receptor 1,Membrane other,Q60492,SIGMAR1,SGMR1_CAVPO,7.46,,Ki,Displacement of [3H](+)-pentazocine from sigma1 opioid receptor from guinea pig brain cortex after 150 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26479,,,,,,,Cavia porcellus
183400,3881,2827,Soluble guanylate cyclase,Enzyme,O75343|P33402|Q02108|Q02153,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,GCYA2_HUMAN|GCYA3_HUMAN|GCYB1_HUMAN|GCYB2_HUMAN,5.99,,EC50,The cGMP produced by compound was expressed as a ratio between the percentage of the DEA/NO response for the compound,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12610,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
183401,1530,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,9.51,,Ki,"The compound was tested in vitro for binding affinity against histamine H1 receptor from guinea pig cerebellum, using [3H]pyrilamine as radioligand at 0.1 uM",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL534,,,,,,,Cavia porcellus
183402,1728,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.29,,IC50,"Binding affinity against opioid receptor kappa 1 using [3H]- U-69,593 radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL651,,,,Tclin,,,Homo sapiens
183403,1728,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.96,,IC50,Binding affinity against delta-opiate receptor (human) using [3H]-DPDPE radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL651,,,,Tclin,,,Homo sapiens
183404,1728,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.01,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL651,,,,Tclin,,,Homo sapiens
183405,1728,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,7.29,,IC50,Displacement of [3H]naloxone from Sprague-Dawley rat cerebellum opioid receptor assessed as relative receptor affinity by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL651,,,,,,,Rattus norvegicus
183406,313,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.47,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL936,,,,Tclin|Tclin|Tclin,,,Homo sapiens
183407,1780,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,5.8,,IC50,Inhibition of Equine serum BChE using butyrylthiocholine iodide as a substrate after 20 mins by Ellman's assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200426,,,,,,,Equus caballus
183408,1780,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200426,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200426,ANTAGONIST,,Tclin,,,Homo sapiens
183409,1780,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,,,,Mechanism of Action; CHEMBL225; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200426,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200426,ANTAGONIST,,Tclin,,,Homo sapiens
183410,868,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.55,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1123,,,,Tclin|Tclin|Tclin,,,Homo sapiens
183411,868,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.61,,Ki,Displacement of [3H]pirenzepine from muscarinic acetylcholine receptor M1 in rat cortex homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1123,,,,,,,Rattus norvegicus
183412,868,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,7.33,,Ki,Displacement of [3H](-)-quinuclidinyl benzilate(QNB) from muscarinic (M2) receptor in rat heart homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1123,,,,,,,Rattus norvegicus
183413,2163,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.28,,IC50,GRAC: human Glycine receptor subunit alpha-1 channel blocker,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL478523,,,,Tclin,,,Homo sapiens
183469,1084,2031,Polyphenol oxidase 2,Enzyme,O42713,PPO2,PPO2_AGABI,5.58,,IC50,Inhibition of mushroom tyrosinase after 10 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL241694,,,,,,,Agaricus bisporus
183415,2503,2639,"7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; Dihydropteroate synthetase",Kinase,Q25704,PPPK-DHPS,Q25704_PLAFA,,,,Mechanism of Action; CHEMBL2013; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1539,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1539,INHIBITOR,,,,,Plasmodium falciparum
183416,370,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,6.47,,IC50,Inhibition of human CYP51 expressed in Topp 3 cells by lanosterol demethylase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL277535,,,,Tchem,,,Homo sapiens
183417,370,425,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,7.25,,Ki,In vitro inhibition of human Cytochrome P450 17A1 activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL277535,,,,Tclin,,,Homo sapiens
183418,818,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,6.6,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1533,,,,Tchem,,,Homo sapiens
183419,1877,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,7.82,,Ki,Binding affinity to Opioid receptor kappa 1 in guinea pig cortex using [3H]EKC as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415284,,,,,,,Cavia porcellus
183420,1877,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,9.42,,Ki,Displacement of [3H]U69593 form human kappa opioid receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415284,,,,Tclin,,,Homo sapiens
183421,1877,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,6.92,,Ki,Displacement of [3H]Naltrindole form human delta opioid receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415284,,,,Tclin,,,Homo sapiens
183422,1877,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.72,,Ki,Displacement of [3H]DAMGO form human mu opioid receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415284,,,,Tclin,,,Homo sapiens
183423,1877,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.32,,IC50,Inhibition of specific binding of [3H]NANM of sigma receptor in Guinea pig brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415284,,,,Tclin,,,Homo sapiens
183424,1877,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,8.82,,EC50,Binding affinity to rat brain opioid receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415284,,,,,,,Rattus norvegicus
183425,1877,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,8.7,,Ki,Compound administered subcutaneously was evaluated for inhibition constant measured as the displacement of [3H]DAGO from rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415284,,,,,,,Rattus norvegicus
183426,1877,2894,Opioid receptor,GPCR,O55242|P32300|P33534|P42866,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_MOUSE|OPRK_MOUSE|OPRM_MOUSE|SGMR1_MOUSE,7.23,,IC50,Concentration required to inhibit the stereospecific [3H]diprenorphine binding Opioid receptors in the absence of sodium(Na+) was determined in mouse isolated vas deferens,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415284,,,,,,,Mus musculus
183427,2694,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,,,,Mechanism of Action; CHEMBL2096972; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL817,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL817,BLOCKER,,Tclin|Tclin,,,Homo sapiens
183428,3220,1829,Sodium-dependent dopamine transporter,Transporter,Q61327,Slc6a3,SC6A3_MOUSE,8.04,,Ki,Tested in vitro for serotonin(5-HT) neuronal uptake inhibition,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94739,,,,,,,Mus musculus
183429,3220,1830,Sodium-dependent noradrenaline transporter,Transporter,O55192,Slc6a2,SC6A2_MOUSE,6.92,,Ki,Tested in vitro for norepinephrine (NE) neuronal uptake inhibition,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94739,,,,,,,Mus musculus
183430,94,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,7.45,,Kd,Affinity for the Muscarinic acetylcholine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL353846,,,,,,,Rattus norvegicus
183431,94,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,4.77,,IC50,Displacement of [3H]mepyramine from histamine H1 receptor in Sprague-Dawley rat brain membrane after 2 hr by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL353846,,,,,,,Rattus norvegicus
183432,3493,549,Trypsin-1,Enzyme,P07477,PRSS1,TRY1_HUMAN,5.48,,Ki,Inhibition of trypsin by amidase assay.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23013,,,,Tclin,,,Homo sapiens
183433,3493,3586,Acrosin,Unclassified,P08001,ACR,ACRO_PIG,5.46,,Ki,Reversible competitive inhibition of boar spermatozoa acrosin using BzArgOEt as substrate by Dixon plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23013,,,,,,,Sus scrofa
183434,2001,1794,Neuraminidase,Enzyme,P03468,NA,NRAM_I34A1,8.15,,IC50,Inhibition of human Influenza A virus A/PR/8/34(H1N1) neuraminidase by fluorometric method using 4MU-NeuAc substrate,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,INHIBITOR,,,,,Influenza A virus (strain A/Puerto Rico/8/1934 H1N1)
183435,2001,1795,Neuraminidase,Enzyme,P03474,NA,NRAM_INBLE,8.96,,Ki,Inhibition of influenza B/Memphis/3/89 neuraminidase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,INHIBITOR,,,,,Influenza B virus (strain B/Lee/1940)
183436,2001,2412,Neuraminidase,Enzyme,C4LRQ6,NA,C4LRQ6_9INFA,8.96,,Ki,Inhibition of Influenza A virus (A/duck/Laos/25/2006(H5N1)) neuraminidase by Michaelis-Menten equation analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,,,,,,,Influenza A virus (A/duck/Laos/25/2006(H5N1))
183437,2001,2411,Neuraminidase,Enzyme,Q2LFS1,NA,Q2LFS1_9INFA,8.31,,Ki,Inhibition of Influenza A virus (A/chicken/Yogjakarta/BBVet-IX/2004(H5N1)) neuraminidase by Michaelis-Menten equation analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,,,,,,,Influenza A virus (A/chicken/Yogjakarta/BBVet-IX/2004(H5N1))
183438,2001,2410,Neuraminidase,Enzyme,A5Z252,NA,A5Z252_9INFA,8.1,,Ki,Inhibition of Influenza A virus (A/Turkey/651242/2006(H5N1)) neuraminidase by Michaelis-Menten equation analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,,,,,,,Influenza A virus (A/Turkey/651242/2006(H5N1))
183470,1086,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.61,,Ki,Inhibition of human recombinant AChE assessed as dissociation constant for enzyme-inhibitor complex by Lineweaver-Burk plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1206,,,,Tclin,,,Homo sapiens
183439,2001,2409,Neuraminidase,Enzyme,Q6Q793,,Q6Q793_9INFA,10,,Ki,Inhibition of Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) neuraminidase by by Michaelis-Menten equation analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,,,,,,,Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1))
183440,2001,2393,Neuraminidase,Enzyme,Q75VQ4,NA,NRAM_I68A0,8.81,,IC50,Inhibition of human influenza A virus A/Aichi/2/1968(H3N2) neuraminidase by fluorometric method using 4MU-NeuAc substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,,,,,,,Influenza A virus (strain A/Aichi/2/1968 H3N2)
183441,2001,3458,Neuraminidase,Enzyme,Q194T1,,Q194T1_9INFA,6.1,,IC50,Inhibition of Influenza A virus (A/RI/5+/1957(H2N2)) recombinant neuraminidase using MUNANA as substrate after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,,,,,,,Influenza A virus (A/RI/5+/1957(H2N2))
183442,2241,2633,High voltage-activated calcium channel beta subunit CavB1,Ion channel,Q95US7,,Q95US7_SCHMA,,,,Mechanism of Action; CHEMBL2363079; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL976,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL976,BLOCKER,,,,,Schistosoma mansoni
183443,2241,2634,High voltage-activated calcium channel beta subunit CavB2,Ion channel,Q962H3,,Q962H3_SCHMA,,,,Mechanism of Action; CHEMBL2363080; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL976,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL976,BLOCKER,,,,,Schistosoma mansoni
183444,1329,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,4.42,,Ki,In vitro Binding affinity towards Nicotinic acetylcholine receptor alpha4-beta2 was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289469,,,,Tclin|Tclin,,,Homo sapiens
183445,1329,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.37,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289469,,,,Tchem,,,Homo sapiens
183446,1329,2783,Serotonin 3 (5-HT3) receptor,Ion channel,P35563|Q9JJ16,Htr3a|Htr3b,5HT3A_RAT|5HT3B_RAT,9.46,,Ki,Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289469,,,,,,,Rattus norvegicus
183447,1329,3384,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,P32297,CHRNA3,ACHA3_HUMAN,4.17,,Ki,In vitro Binding affinity towards alpha-3 (PC12) nAChR was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289469,,,,Tclin,,,Homo sapiens
183448,1329,3374,5-hydroxytryptamine receptor 3B,Ion channel,O95264,HTR3B,5HT3B_HUMAN,8.8,,Ki,GRAC: human 5-HT3B selective antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289469,,,,Tchem,,,Homo sapiens
183449,1329,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.3,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289469,,,,Tchem,,,Homo sapiens
183450,1982,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,5.7,,Ki,Binding affinity to rat NET,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
183451,1982,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,6.02,,Ki,Inhibition of [3H]nisoxetine binding to rat Norepinephrine transporter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
183452,1982,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.9,,Kd,Binding affinity to 5HT1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,Tclin,,,Homo sapiens
183453,1982,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,7.41,,Ki,Half-maximal inhibition of [3H]-spiperone binding to Dopamine receptor D3 in rat tissue homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
183454,1982,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,7.92,,Ki,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor rat tissue homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
183455,1982,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.54,,Ki,Half-maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor in rat frontal cortex homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
183456,1982,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,7.66,,Ki,Half-maximal inhibition of [3H]QNB binding to Muscarinic acetylcholine receptor M1 in rat frontal cortex homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
183457,1982,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.21,,Ki,Displacement of [3H]8OH-DPAT from 5HT1A receptor in CRL:CD(SD)BR-COBS rat hippocampus by scintillation spectrometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
183458,1982,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,7.7,,Ki,Displacement of [3H]SCH23390 from dopamine D1 receptor in CRL:CD(SD)BR-COBS rat striatum by scintillation spectrometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
183459,1982,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,9.52,,Ki,Half-maximal inhibition of [3H]7-OH-DPAT binding to Histamine H1 receptor in rat tissue homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
183460,1982,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,7.9,,Ki,Displacement of [3H]nemonapride from Rattus norvegicus (rat) wild type dopamine D2 receptor transfected in african green monkey COS7 cells after 1 hr by beta scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
183461,1982,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.4,,Ki,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
183467,1572,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,8.91,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1389,,,,Tchem,,,Homo sapiens
183468,1084,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,8.78,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL241694,,,,Tchem,,,Homo sapiens
183471,1086,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,6.14,,IC50,Inhibition of Equine serum BChE using butyrylthiocholine iodide as a substrate after 20 mins by Ellman's assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1206,,,,,,,Equus caballus
183472,1086,2007,Butyrylcholinesterase,Enzyme,Q9N1N9,BCHE,Q9N1N9_HORSE,7.7,,Ki,Dissociation constant for inhibition of equine Butyrylcholinesterase (BuChE),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1206,,,,,,,Equus caballus
183473,1086,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,7.7,,Ki,Inhibitory activity against Equine Butyrylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1206,,,,Tclin,,,Homo sapiens
183474,1597,3451,Prostaglandin E synthase,Enzyme,O14684,PTGES,PTGES_HUMAN,4.35,,IC50,Inhibition of mPGES-1 in human IL-1beta-stimulated A549 cell microsomes assessed as inhibition of PGE2 formation from PGH2 after 15 mins by RP-HPLC analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1334692,,,,Tchem,,,Homo sapiens
183475,1202,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,8.82,,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13280,,,,,,,Rattus norvegicus
183476,2361,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,6.3,,Ki,Inhibition of SERT in rat cerebral cortex assessed as [3H]serotonin accumulation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14370,,,,,,,Rattus norvegicus
183477,2361,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,9.16,,Ki,Displacement of [3H]-dopamine from rat cerebral cortex NET after 7 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14370,,,,,,,Rattus norvegicus
183478,2361,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,7.86,,Ki,Binding affinity against norepinephrine transporter (NET) by displacement of [3H]nisoxetine in male wistar rats,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14370,,,,,,,Rattus norvegicus
183479,2361,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,8.96,,Ki,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14370,,,,Tclin,,,Homo sapiens
183480,2361,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.05,,Ki,In vitro competitive binding versus [3H]-citalopram in murine kidney cells transfected with cDNA for human serotonin transporter (SERT),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14370,,,,Tclin,,,Homo sapiens
183481,2361,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.22,,Ki,In vitro competitive binding versus [N-methyl-3H]WIN-35428 in murine kidney cells transfected with cDNA for human dopamine transporter (DAT),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14370,,,,Tclin,,,Homo sapiens
183482,191,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.66,,Ki,Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor expressed in CHO cells after 60 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113,,,,Tclin,,,Homo sapiens
183483,191,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.47,,Ki,Displacement of [3H]-YM09151-2 from human cloned dopamine D4 receptor expressed in insect Sf9 cells after 60 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113,,ANTAGONIST,,Tchem,,,Homo sapiens
183484,191,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.75,,Ki,Displacement of [3H]ketanserin from human recombinant 5HT2A receptor expressed in CHO cells after 60 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113,,,,Tclin,,,Homo sapiens
183485,191,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.3,,Ki,Binding affinity towards human 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113,,,,Tclin,,,Homo sapiens
183486,780,1346,Ryanodine receptor 3,Ion channel,Q15413,RYR3,RYR3_HUMAN,,,,Mechanism of Action; CHEMBL2062; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL928,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL928,ANTAGONIST,,Tclin,,,Homo sapiens
183487,2397,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,4.63,,IC50,Inhibition of sheep COX1 by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL122,,,,,,,Ovis aries
183488,2397,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,6.52,,IC50,Inhibition of ovine COX2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL122,,,,,,,Ovis aries
183489,2397,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.77,,IC50,In vitro potency against human Prostaglandin G/H synthase 1 in U937 microsomes. ,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL122,,,,Tclin,,,Homo sapiens
183490,2397,1859,Prostaglandin G/H synthase 2,Enzyme,O62698,PTGS2,PGH2_BOVIN,6.37,,IC50,In vitro inhibitory activity against prostaglandin G/H synthase 2 (COX-2),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL122,,,,,,,Bos taurus
183491,2397,1738,Prostaglandin G/H synthase 2,Enzyme,Q05769,Ptgs2,PGH2_MOUSE,7.92,,IC50,In vitro inhibitory activity against Prostaglandin G/H synthase 2 in murine J774 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL122,,,,,,,Mus musculus
183492,2397,1892,Prostaglandin G/H synthase 2,Enzyme,P35355,Ptgs2,PGH2_RAT,6.12,,IC50,In vitro inhibitory concentration against rat Prostaglandin G/H synthase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL122,,,,,,,Rattus norvegicus
183493,2397,1893,Prostaglandin G/H synthase 1,Enzyme,Q63921,Ptgs1,PGH1_RAT,4.94,,IC50,In vitro inhibitory concentration against rat prostaglandin G/H synthase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL122,,,,,,,Rattus norvegicus
183494,2799,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,6.37,,Ki,Inhibitory activity against murine carbonic anhydrase XIII (mCA XIII) by using CO2 hydrase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Mus musculus
183495,2799,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,7.89,,Ki,Inhibitory activity against cloned human CA12,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tclin,,,Homo sapiens
183496,2799,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.87,,Ki,Inhibitory activity against human carbonic anhydrase IV (hCAIV),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tclin,,,Homo sapiens
183497,2799,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,6.37,,Ki,Inhibition of human recombinant CA13 catalytic domain pre-incubated for 15 mins by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tclin,,,Homo sapiens
183498,2799,2010,Carbonic anhydrase,Enzyme,Q50565,,Q50565_METTH,4.21,,Ki,Inhibitory activity against beta carbonic anhydrase (Cab) from Methanobacterium thermoautotrophicum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H)
183499,2799,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,7.54,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Stylophora pistillata
183500,2799,2143,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878,,P96878_MYCTU,5.11,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase Rv3273 pre-incubated for 15 mins by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183501,2799,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.57,,IC50,In vitro inhibitory concentration against Prostaglandin G/H synthase 1 in human whole blood assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tclin,,,Homo sapiens
183502,2799,927,Cytochrome c oxidase subunit 2,Enzyme,P00403,MT-CO2,COX2_HUMAN,5.96,,IC50,Inhibition of human recombinant cyclooxygenase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tchem,,,Homo sapiens
183503,2799,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,6.29,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Astrosclera willeyana
183504,2799,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,4.11,,Ki,Inhibition of human recombinant full length CA3 pre-incubated for 15 mins by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tclin,,,Homo sapiens
183505,2799,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,4.89,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183506,2799,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,5.24,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Stylophora pistillata
183507,2799,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,6.42,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Thalassiosira weissflogii
183508,2799,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,6.04,,Ki,Inhibition of human recombinant full length CA5A pre-incubated for 15 mins by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tclin,,,Homo sapiens
183509,2799,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,6.18,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
183510,2799,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,6.97,,Ki,Inhibition of human recombinant CA14 catalytic domain pre-incubated for 15 mins by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tclin,,,Homo sapiens
183511,2799,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,5.41,,Ki,Inhibition of human recombinant full length CA7 pre-incubated for 15 mins by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tclin,,,Homo sapiens
183512,2799,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.18,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Mus musculus
183513,2799,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,4.27,,Ki,Inhibitory activity against human carbonic anhydrase I (hCA I) by using esterase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tclin,,,Homo sapiens
183514,2799,3587,Cytochrome c oxidase subunit 1,Unclassified,O78749,MT-CO1,COX1_SHEEP,4.02,,IC50,Inhibition of ovine cyclooxygenase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Ovis aries
183515,2799,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,7.06,,Ki,Inhibition of human recombinant full length CA5B pre-incubated for 15 mins by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tclin,,,Homo sapiens
183516,2799,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,7.37,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
183517,2799,2009,Carbonic anhydrase,Enzyme,P40881,,CAH_METTE,6.89,,Ki,Inhibitory activity against alpha carbonic anhydrase (Zn-Cam) from Methanosarcina thermophila,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Methanosarcina thermophila
183518,2799,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,6.17,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183519,2799,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,6.24,,Ki,Inhibition of human full length recombinant carbonic anhydrase 6 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,Tclin,,,Homo sapiens
183520,2799,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,6.47,,Ki,Inhibitory activity against bovine carbonic anhydrase IV (bCAIV),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Bos taurus
183521,2523,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1109,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1109,INHIBITOR,,,,,Escherichia coli (strain K12)
183522,2358,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,6.19,,IC50,Inhibition of guinea pig acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1790041,,,,Tclin,,,Homo sapiens
183523,2358,1747,Histamine H2 receptor,GPCR,P47747,HRH2,HRH2_CAVPO,7.19,,Kd,Compound was evaluated in vitro inhibitory activity against histamine H2 receptor in isolated Guinea pig right atria.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1790041,,,,,,,Cavia porcellus
183524,2358,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.08,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1790041,,,,Tchem,,,Homo sapiens
183525,4109,2568,G-protein coupled receptor 55,GPCR,Q9Y2T6,GPR55,GPR55_HUMAN,4.85,,IC50,Antagonist activity at human GPR55 transfected in CHO cells assessed as inhibition of LPI-induced beta-arrestin recruitment incubated 60 mins prior to LPI addition by beta-arrestin translocation assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465,,,,Tclin,,,Homo sapiens
183526,4109,608,Cannabinoid receptor 2,GPCR,P34972,CNR2,CNR2_HUMAN,8.48,,Ki,Binding affinity to human CB2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465,,,,Tchem,,,Homo sapiens
183527,4109,2914,Cannabinoid receptor,GPCR,P21554|P34972,CNR1|CNR2,CNR1_HUMAN|CNR2_HUMAN,7.39,,Ki,Binding affinity was determined in vitro against cannabinoid receptor by ability to displace [3H]CP-55940,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465,,,,Tchem|Tclin,,,Homo sapiens
183528,4109,1195,N-arachidonyl glycine receptor,GPCR,Q14330,GPR18,GPR18_HUMAN,6.02,,EC50,Agonist activity at human GPR18 expressed in HEK203 cells by MAP kinase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465,,,,Tbio,,,Homo sapiens
183529,4109,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,8.54,,Ki,Displacement of [3H]CP-55940 from human CB1 receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465,AGONIST,,Tclin,,,Homo sapiens
183530,4109,1955,Cannabinoid receptor 1,GPCR,P47746,Cnr1,CNR1_MOUSE,7.4,,Ki,Binding affinity to mouse CB1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465,,,,,,,Mus musculus
183531,4109,1811,Cannabinoid receptor 1,GPCR,P20272,Cnr1,CNR1_RAT,7.43,,Ki,Binding affinity for cannabinoid receptor 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465,,,,,,,Rattus norvegicus
183532,4109,1910,Cannabinoid receptor 2,GPCR,P47936,Cnr2,CNR2_MOUSE,8.04,,Ki,Binding affinity to mouse CB2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465,,,,,,,Mus musculus
183533,4109,2915,Cannabinoid receptor,GPCR,P20272|Q9QZN9,Cnr1|Cnr2,CNR1_RAT|CNR2_RAT,7.34,,Ki,"Compound was evaluated for the competitive inhibition of [3H]3-(1,1-Dimethyl-heptyl)-9-hydroxymethyl-6,6-dimethyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol to cannabinoid receptor from synaptosomal membranes of rat whole brain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465,,,,,,,Rattus norvegicus
183534,2279,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,6.94,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,Tchem,,,Homo sapiens
183535,2279,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.32,,IC50,Inhibition of P-glycoprotein expressed in A2780/ADR cells by calcein AM assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,Tchem,,,Homo sapiens
183536,2279,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.52,,Ki,Displacement of Dexamethasone from human glucocorticoid receptor expressed in baculovirus SF-12 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,Tclin,,,Homo sapiens
183537,2279,2003,Progesterone receptor,Transcription factor,P06186,PGR,PRGR_RABIT,7.98,,Ki,Inhibition of [3H]R5020 binding to rabbit uterine progesterone receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,,,,Oryctolagus cuniculus
183538,2279,724,Sterol O-acyltransferase 1,Enzyme,P35610,SOAT1,SOAT1_HUMAN,4.77,,IC50,In vitro inhibitory activity against acyl coenzyme A:cholesterol acyltransferase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,Tchem,,,Homo sapiens
183539,2279,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.07,,Ki,Displacement of DHT from human androgen receptor expressed in baculovirus SF-12 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,Tclin,,,Homo sapiens
183540,2279,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,7.57,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,,,,Rattus norvegicus
183541,2279,1850,Androgen receptor,Transcription factor,P19091,Ar,ANDR_MOUSE,7.43,,IC50,Inhibitory activity against Androgen receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,,,,Mus musculus
183542,2279,2883,Estrogen receptor,Transcription factor,P06211|Q62986,Esr1|Esr2,ESR1_RAT|ESR2_RAT,8.41,,Kd,Equilibrium dissociation constant for rat uterine estrogen receptor binding [3H]estradiol,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,,,,Rattus norvegicus
183543,2279,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.81,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,,,,Rattus norvegicus
183544,2279,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.59,,Ki,Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,Tclin,,,Homo sapiens
183545,2279,869,"Fatty acid-binding protein, intestinal",Cytosolic other,P12104,FABP2,FABPI_HUMAN,4.7,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from I-FABP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,Tchem,,,Homo sapiens
183546,2279,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,6.62,,Kd,Displacement of [3H]pentazocine from sigma-1 opioid receptor in rat liver membranes after 1 hr by liquid scintillation spectrometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,,,,Rattus norvegicus
183547,2279,2880,Steroid 5-alpha-reductase,Enzyme,P24008|P31214,Srd5a1|Srd5a2,S5A1_RAT|S5A2_RAT,5.8,,IC50,Inhibition of rat testosterone-5 alpha-reductase activity at pH 6.6 from rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,,,,Rattus norvegicus
183548,2279,2048,Sigma non-opioid intracellular receptor 1,Membrane other,Q60492,SIGMAR1,SGMR1_CAVPO,6.18,,Ki,Displacement of (+)-[3H]pentazocine from guinea pig brain sigma 1 receptor after 180 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,,,,Cavia porcellus
183549,2279,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,5.35,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
183550,3557,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,4.54,,IC50,In vitro inhibition of [3H]- [p-Cl-Phe4]DPDPE binding to Opioid receptor delta 1 using rat brain membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL151803,,,,,,,Rattus norvegicus
183551,3557,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,4.55,,IC50,In vitro inhibition of [3H]DAMGO (Tyr-D-Ala-Gly-(Me)-Phe-Gly-ol) binding to Opioid receptor mu 1 using rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL151803,,,,,,,Rattus norvegicus
183552,2105,2851,Dopamine receptor,GPCR,P20288|Q95136,DRD1|DRD2,DRD1_BOVIN|DRD2_BOVIN,7.74,,IC50,In vitro inhibitory activity against dopamine receptor from calf caudate using [3H]dopamine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL531,,,,,,,Bos taurus
183553,2105,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,7.32,,IC50,Inhibitory activity against Dopamine receptor D2 in calf corpus striatum using [3H]spiperone as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL531,,,,,,,Bos taurus
183554,2105,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,8.62,,IC50,Displacement of [3H]nemonapride from Rattus norvegicus (rat) chimeric dopamine D3 trunk/D3 tail receptor transfected in african green monkey COS7 cells after 1 hr by beta scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL531,,,,,,,Rattus norvegicus
183555,2105,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,8.51,,IC50,In vitro affinity for dopamine receptor by displacement of [3H]- apomorphine in rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL531,,,,,,,Rattus norvegicus
183556,2105,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.39,,IC50,Alpha-2 adrenergic receptor activity assessed in vitro for displacement of [3H]clonidine from specific binding sites on rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL531,,,,,,,Rattus norvegicus
183557,2105,2859,Cerebral cortex alpha adrenergic receptor,GPCR,P18130|Q28838,ADRA1A|ADRA2A,ADA1A_BOVIN|ADA2A_BOVIN,7.39,,IC50,In vitro affinity for alpha adrenergic receptor by displacement of 3[H]clonidine in calf cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL531,,,,,,,Bos taurus
183559,2105,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.92,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL531,,,,Tclin,,,Homo sapiens
183560,2105,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.4,,Kd,In vitro affinity at mutant D2 receptor (S194A) in C6 (glioma) cell membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL531,,,,,,,Rattus norvegicus
183561,701,1634,Trypanothione reductase,Enzyme,P28593,TPR,TYTR_TRYCR,5.19,,Ki,Compound was evaluated for the competitive inhibition of trypanothione reduction by recombinant Trypanothione reductase from Trypanosoma cruzi,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,,,,Trypanosoma cruzi
183562,701,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.71,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,Tchem,,,Homo sapiens
183563,701,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,8.08,,Ki,Binding affinity towards 5-hydroxytryptamine 2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,,,,Rattus norvegicus
183564,701,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.95,,Ki,Displacement of [3H]LSD from human 5HT6 receptor expressed in HEK293 cells after 1.5 hrs by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,Tchem,,,Homo sapiens
183565,701,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.29,,Ki,Binding affinity towards alpha-2 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,,,,Rattus norvegicus
183566,701,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,10.4,,IC50,Compound was tested for its inhibitory activity against Alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,,,,Rattus norvegicus
183567,701,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,5.3,,Ki,Binding affinity towards serotonin S1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,,,,Rattus norvegicus
183568,701,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.56,,IC50,Displacement of [3H]Win35428 from human recombinant DAT over-expressed in CHOK1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,Tclin,,,Homo sapiens
183569,701,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,9.7,,IC50,Compound tested for its inhibitory activity against Histamine H1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,,,,Rattus norvegicus
183570,701,2846,Serotonin (5-HT) receptor,GPCR,P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT,8.3,,IC50,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,,,,Rattus norvegicus
183571,701,1830,Sodium-dependent noradrenaline transporter,Transporter,O55192,Slc6a2,SC6A2_MOUSE,6.05,,IC50,Inhibition of noradrenaline transporter in NMRI albino mouse brain assessed as [3H]NA accumulation in hypothalamus after 5 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,,,,Mus musculus
183572,701,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,7.25,,Ki,Binding affinity towards Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,,,,Rattus norvegicus
183573,701,1842,Sodium-dependent serotonin transporter,Transporter,Q60857,Slc6a4,SC6A4_MOUSE,7.15,,IC50,Inhibition of 5-HT transporter in NMRI albino mouse brain assessed as [3H]5-HT accumulation in hypothalamus after 5 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,,,,Mus musculus
183574,2029,1857,Kappa-type opioid receptor,GPCR,P33534,Oprk1,OPRK_MOUSE,4.8,,EC50,Agonist activity at mouse KOR assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by cell based TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656,,,,,,,Mus musculus
183575,2029,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,4.8,,EC50,Agonist activity at human KOR assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by cell based TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656,,,,Tclin,,,Homo sapiens
183576,2029,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.4,,EC50,Agonist activity at human DOR assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by cell based TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656,,,,Tclin,,,Homo sapiens
183577,2029,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,4.12,,IC50,Inhibition of electric eel AChE by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656,,,,,,,Electrophorus electricus
183578,2029,1758,Mu-type opioid receptor,GPCR,P42866,Oprm1,OPRM_MOUSE,6.8,,EC50,Agonist activity at mouse MOR assessed as inhibition of forskolin-stimulated cAMP accumulation after 30 mins by cell based TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656,,,,,,,Mus musculus
183579,2029,1836,Kappa-type opioid receptor,GPCR,P34975,Oprk1,OPRK_RAT,5.58,,Ki,Displacement of [3H]U-69593 from kappa opioid receptor of rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656,,,,,,,Rattus norvegicus
183580,2029,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,5.96,,Ki,"Displacement of [3H[Ile5,6]-deltorphin II from delta opioid receptor of rat brain membranes",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656,,,,,,,Rattus norvegicus
183581,2029,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,7.36,,Ki,Displacement of [3H]DAMGO from mu opioid receptor of rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656,,,,,,,Rattus norvegicus
183582,120,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.7,,IC50,In vitro antagonistic activity against Dopamine receptor D2 was evaluated for the inhibition of [3H]spiperone binding,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290194,,,,,,,Rattus norvegicus
183583,4114,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,9.22,,Ki,Inhibition of human DPP4 expressed in Caco-2 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL385517,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL385517,INHIBITOR,,Tclin,,,Homo sapiens
183584,4114,844,Dipeptidyl peptidase 8,Enzyme,Q6V1X1,DPP8,DPP8_HUMAN,6.89,,Ki,Inhibition of DPP8,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL385517,,,,Tchem,,,Homo sapiens
183585,4114,880,Dipeptidyl peptidase 9,Enzyme,Q86TI2,DPP9,DPP9_HUMAN,7.15,,Ki,Inhibition of DPP9,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL385517,,,,Tchem,,,Homo sapiens
183586,1148,505,Extracellular calcium-sensing receptor,GPCR,P41180,CASR,CASR_HUMAN,6,,EC50,Positive allosteric modulation of human CaSR transfected in CHO cells after 5 hrs by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254832,,,,Tclin,,,Homo sapiens
183587,1148,3571,Transcriptional activator protein luxR,Unclassified,P12746,luxR,LUXR_ALIFS,4.04,,IC50,Inhibition of LuxR-dependent quorum sensing in Vibrio fischeri assessed as reduction of 3-oxo-C6-HSL-induced bioluminescence intensity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254832,,,,,,,Aliivibrio fischeri
183588,1148,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.49,,Ki,Displacement of [3H]LSD from human cloned 5HT2B receptor expressed in CHO cells by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254832,,,,Tclin,,,Homo sapiens
183589,2407,1801,D(1A) dopamine receptor,GPCR,Q95136,DRD1,DRD1_BOVIN,6.3,,Ki,Binding affinity of compound for Dopamine receptor D1 using [3H]-SCH- 23390,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1303,,,,,,,Bos taurus
183590,2407,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,7.82,,Ki,Binding affinity of compound for Dopamine receptor D2 using [3H]N-0437,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1303,,,,,,,Bos taurus
183591,2407,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.26,,Ki,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D4.2 of CHO K-1 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1303,,AGONIST,,Tchem,,,Homo sapiens
183592,3630,1250,Bifunctional epoxide hydrolase 2,Enzyme,P34913,EPHX2,HYES_HUMAN,7.89,,IC50,Inhibition of human recombinant soluble epoxide hydrolase using CMNPC as substrate after 10 mins by fluorescent assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1076347,,,,Tchem,,,Homo sapiens
183593,3630,2442,Epoxide hydrolase; Epoxide hydrolase EphB,Enzyme,P95276,,P95276_MYCTO,6.66,,IC50,Inhibition of Mycobacterium tuberculosis recombinant EphB expressed in Escherichia coli BL21 using CMNPC as substrate after 30 mins by fluorescent assay relative to control,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1076347,,,,,,,Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
183594,989,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,8.52,,Ki,Binding affinity towards wild type HIV-1 reverse transcriptase (as per ref 10 in the article),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL223228,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL223228,INHIBITOR,,,,,Human immunodeficiency virus 1
183595,989,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,8.89,,IC50,Inhibition of wild type Human immunodeficiency virus 1 reverse transcriptase after 30 min by fluorescence microplate reader analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL223228,,,,,,,Human immunodeficiency virus 1
183620,2609,2057,Synaptic vesicular amine transporter,Transporter,Q27963,SLC18A2,VMAT2_BOVIN,8.4,,Ki,Inhibition of dopamine uptake at VMAT in bovine chromaffin granule ghosts,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL117785,,,,,,,Bos taurus
163168,176,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,7.1,,IC50,,WOMBAT-PK,=,,,,,BLOCKER,,Tclin,,,Homo sapiens
183596,703,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,8.77,,IC50,Displacement of [3H]diazepam from rat brain GABA-A benzodiazepine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL452,,,,,,,Rattus norvegicus
183597,703,2777,GABA-A receptor; anion channel,Ion channel,P08219|P08220|P10063|P10064|P20237|P22300,GABRA1|GABRA2|GABRA3|GABRA4|GABRB1|GABRG2,GBRA1_BOVIN|GBRA2_BOVIN|GBRA3_BOVIN|GBRA4_BOVIN|GBRB1_BOVIN|GBRG2_BOVIN,9.07,,Ki,In vitro inhibition of [3H]-Ro- 15-1788 binding to GABA-A Benzodiazepine receptor of bovine brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL452,,,,,,,Bos taurus
183598,1165,228,Prostaglandin D2 receptor 2,GPCR,Q9Y5Y4,PTGDR2,PD2R2_HUMAN,6.26,,IC50,Displacement of[3H]PGD2 from human CRTH2 receptor expressed in HEK385-7 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL589092,,,,Tchem,,,Homo sapiens
183599,623,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.11,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908,,,,Tchem,,,Homo sapiens
183600,623,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,8.25,,Ki,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908,,,,,,,Rattus norvegicus
183601,623,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,8.52,,Ki,Binding affinity towards human 5-hydroxytryptamine 6 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908,,,,Tchem,,,Homo sapiens
183602,623,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.53,,Ki,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908,ANTAGONIST,,Tclin,,,Homo sapiens
183603,623,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,5.29,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
183604,623,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.74,,Ki,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908,,,,Tclin,,,Homo sapiens
183605,623,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.43,,Ki,Displacement of [3H]pyrilamine from human histamine H1 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908,,,,Tclin,,,Homo sapiens
183606,623,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.34,,Ki,Displacement of [3H]spiperone from human dopamine D3 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908,,ANTAGONIST,,Tclin,,,Homo sapiens
183607,623,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,8.97,,IC50,Displacement of [3H]mepyramine from histamine H1 receptor in Sprague-Dawley rat brain membrane after 2 hr by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908,,,,,,,Rattus norvegicus
183608,623,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,8.05,,Ki,Displacement of [3H]SCH23390 from human dopamine D5 receptor expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908,,,,Tchem,,,Homo sapiens
183610,1137,1650,Xanthine dehydrogenase/oxidase,Enzyme,P80457,XDH,XDH_BOVIN,8.52,,IC50,Inhibition of bovine xanthine oxidase by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1164729,,,,,,,Bos taurus
183611,1137,2295,Xanthine dehydrogenase/oxidase,Enzyme,P22985,Xdh,XDH_RAT,8.4,,IC50,Inhibition of rat xanthine oxidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1164729,,,,,,,Rattus norvegicus
183612,4061,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,9.78,,Kd,In vitro inhibitory activity against beta-2 adrenoceptor was measured by the inhibition of isoproterenol-induced relaxation of PGF2-alpha contracted guinea pig trachea,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499,,,,,,,Cavia porcellus
183613,4061,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,9.44,,Kd,In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499,,,,,,,Cavia porcellus
183614,2256,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,7.15,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL253363,,,,Tchem,,,Homo sapiens
183615,2256,921,Glucose-6-phosphate 1-dehydrogenase,Enzyme,P11413,G6PD,G6PD_HUMAN,4.09,,IC50,Inhibition of human recombinant N-terminal His tagged G6PD expressed in Escherichia coli JM109 (DE3) cells assessed as production of NADPH after 30 mins by Amplite fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL253363,,,,Tchem,,,Homo sapiens
183616,1933,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.05,,IC50,Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1274,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1274,ANTAGONIST,,Tclin,,,Homo sapiens
183617,806,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.33,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL493682,,,,Tchem,,,Homo sapiens
183618,2609,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.07,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL117785,,,,Tclin|Tclin|Tclin,,,Homo sapiens
183619,2609,2286,Synaptic vesicular amine transporter,Transporter,Q01827,Slc18a2,VMAT2_RAT,8.12,,Ki,Displacement of [3H]DHTBZ from Sprague-Dawley rat striatum VMAT2 after 1 hr by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL117785,,,,,,,Rattus norvegicus
183621,1886,1952,Solute carrier family 22 member 6,Transporter,O35956,Slc22a6,S22A6_RAT,5.04,,Ki,Inhibition of rat Oat1 expressed in Xenopus oocytes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL783,,,,,,,Rattus norvegicus
183622,444,2566,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,Q5NGQ3,fabI,Q5NGQ3_FRATT,4.12,,IC50,Inhibition of C-terminal His6-tagged Francisella tularensis SCHU S4 FabI expressed in Escherichia coli BL21 (DE3) using CrCoA as substrate assessed as oxidation of NADH to NAD+ by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL990,,,,,,,Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4)
183623,444,1339,Squalene epoxidase,Enzyme,Q4JEY0,,Q4JEY0_TRIRU,,,,Mechanism of Action; CHEMBL2364679; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL990,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL990,INHIBITOR,,,,,Trichophyton rubrum
183624,2135,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,5.92,,Ki,"Inhibition of human thymidylate synthase using N5,N10-methylene tetrahydrofolate by chromogenic assay",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL63857,,,,Tclin,,,Homo sapiens
183625,2135,2018,Thymidylate synthase,Enzyme,P00469,thyA,TYSY_LACCA,5.33,,Ki,"Inhibition of Lactobacillus casei thymidylate synthase using N5,N10-methylene tetrahydrofolate by chromogenic assay",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL63857,,,,,,,Lactobacillus casei
183626,2135,2437,Thymidylate synthase,Enzyme,Q834R3,thyA,TYSY_ENTFA,5.85,,Ki,"Inhibition of Enterococcus faecalis thymidylate synthase using N5,N10-methylene tetrahydrofolate by chromogenic assay",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL63857,,,,,,,Enterococcus faecalis (strain ATCC 700802 / V583)
183627,2135,1782,Thymidylate synthase,Enzyme,P0A884,thyA,TYSY_ECOLI,5.33,,Ki,In vitro inhibition of Lactobacillus casei Thymidylate synthase.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL63857,,,,,,,Escherichia coli (strain K12)
183628,1230,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.44,,Ki,Binding affinity to sigma 1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL814,,,,Tclin,,,Homo sapiens
183629,1230,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,8.84,,Ki,In vitro competitive binding versus [N-methyl-3H]WIN-35428 in murine kidney cells transfected with cDNA for human dopamine transporter (DAT),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL814,,,,Tclin,,,Homo sapiens
183630,1230,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,7.44,,Ki,Displacement of [3H]-(+)pentazocine from rat brain sigma 1-type opioid receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL814,,,,,,,Rattus norvegicus
183631,1757,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.9,,Ki,,IUPHAR,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL376897,ANTAGONIST,,Tclin,,,Homo sapiens
183632,3025,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.99,,Ki,Displacement of [3H] N-methylscopolamine from human muscarinic M2 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106541,,,,Tclin,,,Homo sapiens
183633,3025,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.57,,Ki,Displacement of [3H] N-methylscopolamine from human muscarinic M1 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106541,,,,Tclin,,,Homo sapiens
183634,3025,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.73,,Ki,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106541,,,,Tclin,,,Homo sapiens
183635,997,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,7.36,,IC50,Allosteric modulation of [35S]TBPS binding to Gamma-aminobutyric acid A receptor in rat brain cortical P2 membranes (inhibits binding with two components),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL210952,,,,,,,Rattus norvegicus
183636,2737,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,Mechanism of Action; CHEMBL245; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200771,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200771,ANTAGONIST,,Tclin,,,Homo sapiens
183637,2737,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200771,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200771,ANTAGONIST,,Tclin,,,Homo sapiens
183638,2666,763,Matrix metalloproteinase-14,Enzyme,P50281,MMP14,MMP14_HUMAN,4.52,,IC50,Inhibition of MMP14 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1350,,,,Tchem,,,Homo sapiens
183639,2666,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,5.14,,IC50,Inhibition of APMA-activated recombinant human MMP2 using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1350,,,,Tchem,,,Homo sapiens
183640,2666,866,Neutrophil collagenase,Enzyme,P22894,MMP8,MMP8_HUMAN,4.49,,IC50,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1350,,,,Tclin,,,Homo sapiens
183641,621,1634,Trypanothione reductase,Enzyme,P28593,TPR,TYTR_TRYCR,5.49,,Ki,Inhibition of Trypanosoma cruzi recombinant trypanothione reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Trypanosoma cruzi
183642,621,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,6.22,,Ki,High affinity constant at binding site of human P-Glycoprotein (P-gp) in two-affinity model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,Tchem,,,Homo sapiens
183725,1621,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.81,,Ki,Binding affinity towards Histamine H1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,Tclin,,,Homo sapiens
183643,621,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.57,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,Tchem,,,Homo sapiens
183644,621,2851,Dopamine receptor,GPCR,P20288|Q95136,DRD1|DRD2,DRD1_BOVIN|DRD2_BOVIN,7.6,,IC50,compound was tested for its ability to displace [3H]- spiroperidol from dopamine receptor.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Bos taurus
183645,621,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.68,,Ki,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Rattus norvegicus
183646,621,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,5.89,,IC50,Binding affinity against dextromethorpin binding site of N-methyl-D-aspartate glutamate receptor from rat brain using [3H]1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Rattus norvegicus
183647,621,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,7.22,,Ki,In vitro binding affinity against Muscarinic acetylcholine receptors in rat brain.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Rattus norvegicus
183648,621,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.17,,Ki,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,Tclin,,,Homo sapiens
183649,621,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,7.1,,IC50,"Competition in vitro with the dopamine receptor D2 antagonist [3H]spiperone, for binding sites on calf caudate membranes.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Bos taurus
183650,621,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.37,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,Tclin|Tclin|Tclin,,,Homo sapiens
183651,621,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,9.15,,Ki,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Rattus norvegicus
183652,621,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,7.85,,Ki,In vitro ability to displace [3H]spiroperidol from rat dopamine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Rattus norvegicus
183653,621,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,5.35,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
183654,621,906,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.7,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,Tchem,,,Homo sapiens
183655,621,1968,Transient receptor potential cation channel subfamily V member 1,Ion channel,O35433,Trpv1,TRPV1_RAT,5.89,,Ki,Displacement of [3H]RTX from rat TRPV1 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Rattus norvegicus
183656,621,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.92,,IC50,Binding affinity to SERT (unknown origin) by radioligand binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,Tclin,,,Homo sapiens
183657,621,219,Calmodulin,Cytosolic other,P0DP23|P0DP24|P0DP25,CALM1|CALM2|CALM3,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,5.91,,Kd,Binding affinity to human calmodulin expressed in Escherichia coli using M124C-mBBr fluorescent biosensor by spectrofluorometer analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,Tclin,,,Homo sapiens
183658,621,2862,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy2|Adcy3|Adcy4|Adcy5|Adcy6|Adcy8,ADCY2_RAT|ADCY3_RAT|ADCY4_RAT|ADCY5_RAT|ADCY6_RAT|ADCY8_RAT|D4A3N4_RAT|Q8CFM9_RAT,6.93,,Ki,Inhibitory activity against Dopamine sensitive adenylate cyclase in rats,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Rattus norvegicus
183659,621,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.75,,Ki,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 radioligand in rat hippocampus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Rattus norvegicus
183660,621,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,7.46,,Ki,In vitro binding affinity against Dopamine receptor D1 in rat striatal tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Rattus norvegicus
183661,621,2583,Acetylcholine receptor subunit alpha,Ion channel,P02710,CHRNA1,ACHA_TORCA,5.89,,IC50,Displacement of [3H]PCP from nAChR in Torpedo nobiliana electric organs membranes in presence of 100 uM carbachol by scintillation counting method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Torpedo californica
183662,621,2778,Glutamate [NMDA] receptor,Ion channel,O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,NMD3A_HUMAN|NMD3B_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMDE4_HUMAN|NMDZ1_HUMAN,6.22,,IC50,Inhibition of [3H]1 binding to dextromethorpin binding site of guinea pig microsomal pellet P3 N-methyl-D-aspartate glutamate receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
183663,621,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.92,,Ki,Compound was tested for inhibitory activity against the binding of [3H]spiperone to Dopamine receptor D2 in rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Rattus norvegicus
183664,621,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.28,,Ki,Displacement of [3H]LSD from human cloned 5HT2B receptor expressed in CHO cells by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,Tclin,,,Homo sapiens
183665,1404,344,Farnesyl pyrophosphate synthase,Enzyme,P14324,FDPS,FPPS_HUMAN,8.44,,Ki,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL997,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL997,INHIBITOR,,Tclin,,,Homo sapiens
183666,1404,873,Geranylgeranyl pyrophosphate synthase,Enzyme,O95749,GGPS1,GGPPS_HUMAN,4.1,,IC50,Inhibition of human recombinant geranylgeranyl diphosphate synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL997,,,,Tchem,,,Homo sapiens
183667,1404,1755,Squalene synthase,Enzyme,Q02769,Fdft1,FDFT_RAT,6.19,,IC50,Inhibition of squalene synthase in rat liver microsomes assessed as conversion of [1-3H]FPP to [3H]squalene level after 60 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL997,,,,,,,Rattus norvegicus
183668,408,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.96,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL811,,,,Tclin|Tclin|Tclin,,,Homo sapiens
183669,408,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.05,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL811,,,,Tclin,,,Homo sapiens
183670,1967,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,7.7,,IC50,Inhibition of [3H]muscimol binding to GABA A receptor 4-biphenylacetic acid at 10 e-4 M,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9,,,,,,,Rattus norvegicus
183671,1967,3588,Multidrug resistance protein mdtK,Unclassified,P37340,mdtK,MDTK_ECOLI,4.01,,Kd,Binding affinity to Escherichia coli K-12 multidrug efflux protein YdhE expressed in Escherichia coli AG100AX in presence of 0.02% DDM surfactant by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9,,,,,,,Escherichia coli (strain K12)
183672,1967,164,DNA topoisomerase 4 subunit A,Enzyme,P0C1U9,parC,PARC_STAAU,5.46,,IC50,Inhibition of topoisomerase 4 decatenation in Staphylococcus aureus ATCC 29213,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9,,,,,,,Staphylococcus aureus
183673,1021,1756,Aldose reductase,Enzyme,P16116,AKR1B1,ALDR_BOVIN,6.77,,IC50,Inhibition of bovine lens aldose reductase assessed as inhibition of NDAPH oxidation by non-linear regression analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56337,,,,,,,Bos taurus
183674,1021,3452,Sorbitol dehydrogenase,Enzyme,Q00796,SORD,DHSO_HUMAN,4.17,,IC50,Inhibition sorbitol dehydrogenase by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56337,,,,Tchem,,,Homo sapiens
183675,1021,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,8,,IC50,Inhibition of crude aldose reductase of rat lens,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56337,,,,,,,Rattus norvegicus
183676,1021,633,Alcohol dehydrogenase [NADP(+)],Enzyme,P14550,AKR1A1,AK1A1_HUMAN,5.59,,IC50,Inhibition of N-terminal 6His-tagged human aldehyde reductase expressed in Escherichia coli BL21(DE3) mediated D-glucuronate reduction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56337,,,,Tchem,,,Homo sapiens
183677,1021,1788,Alcohol dehydrogenase [NADP(+)],Enzyme,P51635,Akr1a1,AK1A1_RAT,5.82,,IC50,In vitro inhibitory activity against rat kidney aldehyde reductase(ALR).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56337,,,,,,,Rattus norvegicus
183678,1021,2070,Aldo-keto reductase family 1 member B10,Enzyme,O60218,AKR1B10,AK1BA_HUMAN,6.48,,IC50,Inhibition of reductase activity of N-terminal 6His-tagged AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as inhibition of NADPH linked pyridine-3-aldehyde reduction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56337,,,,Tchem,,,Homo sapiens
183679,1021,973,Alcohol dehydrogenase [NADP(+)],Enzyme,P50578,AKR1A1,AK1A1_PIG,5.82,,IC50,Selectivity ratio measured as the IC50 ratio of aldehyde/aldose reductase values,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL56337,,,,,,,Sus scrofa
183689,607,1904,Histidine-rich protein PFHRP-II,Cytosolic other,P05227,,HRP1_PLAFA,6.4,,IC50,Inhibition of beta-hematin polymerization,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76,,,,,,,Plasmodium falciparum
183690,607,906,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.4,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76,,,,Tchem,,,Homo sapiens
183691,607,297,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,P16083,NQO2,NQO2_HUMAN,5.82,,IC50,Inhibition of human recombinant NQO2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76,,,,Tchem,,,Homo sapiens
183692,607,2474,Riboflavin-binding protein,Unclassified,P02752,,RBP_CHICK,5.68,,Kd,Binding affinity to chicken riboflavin binding protein assessed as dissociation constant at pH 7.4 in phosphate buffer by isothermal titration calorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76,,,,,,,Gallus gallus
183693,1820,654,"Cholesterol side-chain cleavage enzyme, mitochondrial",Enzyme,P05108,CYP11A1,CP11A_HUMAN,,,,Mechanism of Action; CHEMBL2033; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1670,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1670,INHIBITOR,,Tclin,,,Homo sapiens
183694,1013,2157,"V-type proton ATPase subunit B, brain isoform",Enzyme,P21281,ATP6V1B2,VATB2_HUMAN,5,,IC50,Inhibition of maltose binding protein-fused human V-ATPase subunit B2 binding to F-actin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL826,,,,Tbio,,,Homo sapiens
183695,1013,2755,Topoisomerase IV,Enzyme,P48374|Q5EP76,parC|topB,PARC_NEIGO|Q5EP76_NEIGO,,,,Mechanism of Action; CHEMBL2363077; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL826,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL826,INHIBITOR,,,,,Neisseria gonorrhoeae
183696,1013,2756,DNA gyrase,Enzyme,P22118|P48371,gyrA|gyrB,GYRA_NEIGO|GYRB_NEIGO,,,,Mechanism of Action; CHEMBL2311244; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL826,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL826,INHIBITOR,,,,,Neisseria gonorrhoeae
183726,1621,1953,D(1A) dopamine receptor,GPCR,Q61616,Drd1,DRD1_MOUSE,6.74,,Ki,Binding affinities towards Dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,,,,Mus musculus
183697,1860,526,Inosine-5'-monophosphate dehydrogenase 2,Enzyme,P12268,IMPDH2,IMDH2_HUMAN,8.22,,Ki,Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 2 (IMPDH type II isoform); Range is 6-10 nM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL866,,,,Tclin,,,Homo sapiens
183698,1860,282,Inosine-5'-monophosphate dehydrogenase 1,Enzyme,P20839,IMPDH1,IMDH1_HUMAN,7.48,,Ki,Inhibitory activity against human Inosine-5'-monophosphate dehydrogenase 1 (IMPDH type I isoform); Range is 33-37 nM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL866,,,,Tclin,,,Homo sapiens
183699,1860,3453,Inosine-5'-monophosphate dehydrogenase (IMPDH),Enzyme,P12268|P20839,IMPDH1|IMPDH2,IMDH1_HUMAN|IMDH2_HUMAN,4.7,,IC50,Inhibitory activity against (IMPDH) inosine 5'-monophosphate dehydrogenase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL866,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL866,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
183702,1606,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,4.89,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL580,,,,,,,Rattus norvegicus
183703,3257,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,6.05,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87563,,,,Tchem,,,Homo sapiens
183704,3257,1985,Membrane primary amine oxidase,Enzyme,O08590,Aoc3,AOC3_RAT,4.57,,Ki,Inhibitory activity against porcine kidney amine oxidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87563,,,,,,,Rattus norvegicus
183705,3257,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.97,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87563,,,,Tchem,,,Homo sapiens
183706,3257,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,6.3,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87563,,,,Tchem,,,Homo sapiens
183707,2119,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,8.7,,Ki,Displacement of [3H]U69593 form human kappa opioid receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46399,,,,Tclin,,,Homo sapiens
183708,2119,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,8.3,,Ki,Displacement of [3H]Naltrindole form human delta opioid receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46399,,,,Tclin,,,Homo sapiens
183709,2119,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.7,,Ki,Displacement of [3H]DAMGO form human mu opioid receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46399,,,,Tclin,,,Homo sapiens
183710,2119,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,8.01,,IC50,Ability to induce 50% of maximal effect in guinea pig ileum expressing Opioid receptor mu 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46399,,,,,,,Cavia porcellus
183711,2119,1758,Mu-type opioid receptor,GPCR,P42866,Oprm1,OPRM_MOUSE,8.1,,IC50,Ability to induce 50% of maximal effect in mouse vas deferens expressing Opioid receptor delta 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46399,,,,,,,Mus musculus
183712,4074,2063,Geranylgeranyl pyrophosphate synthase,Enzyme,Q12051,BTS1,GGPPS_YEAST,6.89,,Ki,Binding affinity to Saccharomyces cerevisiae GGPPS,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL319144,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
183713,4074,344,Farnesyl pyrophosphate synthase,Enzyme,P14324,FDPS,FPPS_HUMAN,8.52,,IC50,Inhibition of human FPPS after 10 mins using [14C]IPP as substrate by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL319144,,,,Tclin,,,Homo sapiens
183714,4074,873,Geranylgeranyl pyrophosphate synthase,Enzyme,O95749,GGPS1,GGPPS_HUMAN,5.74,,Ki,Binding affinity to human GGPPS,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL319144,,,,Tchem,,,Homo sapiens
183715,4074,1261,Farnesyl diphosphate synthase,Enzyme,P22939,ispA,ISPA_ECOLI,5.96,,IC50,Inhibition of Escherichia coli FPPS,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL319144,,,,,,,Escherichia coli (strain K12)
183716,1707,1634,Trypanothione reductase,Enzyme,P28593,TPR,TYTR_TRYCR,4.66,,IC50,Inhibition of Trypanosoma cruzi Trypanothione reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73451,,,,,,,Trypanosoma cruzi
183717,1707,3589,Trypanothione reductase,Unclassified,Q389T8,,Q389T8_TRYB2,4.27,,IC50,Inhibition of Trypanosoma brucei Trypanothione reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73451,,,,,,,Trypanosoma brucei brucei (strain 927/4 GUTat10.1)
183718,1621,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,8.7,,Ki,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,,,,Rattus norvegicus
183719,1621,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.13,,Ki,Binding affinity towards Beta-2 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,Tclin,,,Homo sapiens
183720,1621,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.85,,Ki,Binding affinity towards Beta-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,Tclin,,,Homo sapiens
183721,1621,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,8.05,,Ki,Binding affinities towards 5-hydroxytryptamine 5A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,Tchem,,,Homo sapiens
183722,1621,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,8.6,,Ki,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,,,,Rattus norvegicus
183723,1621,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.25,,Ki,Binding affinity towards Dopamine receptor D4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,Tchem,,,Homo sapiens
183724,1621,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8.41,,Ki,Binding affinity towards 5-hydroxytryptamine 1D receptor alpha using [3H]8-OH-DPAT as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,Tclin,,,Homo sapiens
183727,1621,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.3,,Ki,Affinity in displacing [3H]8-OH-DPAT from rat hippocampal 5-HT1A receptor.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,,,,Rattus norvegicus
183728,1621,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,7.03,,Ki,Binding affinity towards 5-hydroxytryptamine 1E receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,Tchem,,,Homo sapiens
183729,1621,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.47,,Ki,Binding affinity towards Dopamine receptor D5,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,Tchem,,,Homo sapiens
183730,1621,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,8.52,,Kd,GRAC: human 5-HT7 radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,Tclin,,,Homo sapiens
183731,1621,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,8.42,,Ki,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,,,,Rattus norvegicus
183732,1621,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.52,,Ki,Binding affinity towards 5-hydroxytryptamine 2B receptor using [125I]DOI as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,Tclin,,,Homo sapiens
183733,1621,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.46,,Ki,In vitro binding to 5-hydroxytryptamine 2A receptor using [125 I]-DOI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL263881,,,,,,,Rattus norvegicus
183734,1256,905,Mitogen-activated protein kinase 9,Kinase,P45984,MAPK9,MK09_HUMAN,4.87,,IC50,Inhibition of human JNK2alpha2 using GST-c-jun (1 to 221) as substrate preincubated for 30 mins before [gamma-32P]-ATP addition measured after 10 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1189513,,,,Tchem,,,Homo sapiens
183735,2036,2891,Cyclooxygenase,Enzyme,P23219|P35354,PTGS1|PTGS2,PGH1_HUMAN|PGH2_HUMAN,,,,Mechanism of Action; CHEMBL2094253; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1228,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1228,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
183736,1053,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,9.05,,Ki,Displacement of [3H]citalopram from SERT in rat brain stem by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1508,,,,,,,Rattus norvegicus
183737,1053,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,4.98,,Ki,Displacement of [3H]nisoxetine from NET in rat frontal cortex by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1508,,,,,,,Rattus norvegicus
183738,1053,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.09,,Ki,Displacement of [3H]WIN-35428 from DAT in rat caudate-putamen by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1508,,,,,,,Rattus norvegicus
183739,663,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,8.82,,Ki,Inhibition of [3H]citalopram binding to Serotonin transporter of rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL549,,,,,,,Rattus norvegicus
183740,663,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,5.23,,Ki,Displacement of [3H]nisoxetine from NET in rat frontal cortex by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL549,,,,,,,Rattus norvegicus
183741,663,1829,Sodium-dependent dopamine transporter,Transporter,Q61327,Slc6a3,SC6A3_MOUSE,8.54,,Ki,Tested in vitro for serotonin(5-HT) neuronal uptake inhibition,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL549,,,,,,,Mus musculus
183742,663,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.73,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL549,,,,Tchem,,,Homo sapiens
183743,663,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,5.21,,Ki,Displacement of [3H]nisoxetine from norepinephrine transporter of rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL549,,,,,,,Rattus norvegicus
183744,663,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.03,,Ki,Displacement of [3H]WIN-35428 from DAT in rat caudate-putamen by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL549,,,,,,,Rattus norvegicus
183745,663,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.21,,Ki,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL549,,,,Tclin,,,Homo sapiens
162895,2284,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.7986,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162896,2233,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.6685,,EC50,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162897,2172,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.0455,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162898,2105,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9,,EC50,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162899,1982,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.0969,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162900,1353,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.52,,Ki,,WOMBAT-PK,=,,,,,INVERSE AGONIST,,Tclin,,,Homo sapiens
162901,1212,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.3704,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162902,947,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162903,722,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.59,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162905,621,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.54,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162907,403,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.5,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
162908,242,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.53,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162910,2695,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.5,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770,ANTAGONIST,,Tclin,,,Homo sapiens
93836,192,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.22,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162921,2136,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.27,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL753,ANTAGONIST,,Tclin,,,Homo sapiens
162922,1803,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255027,AGONIST,,Tclin,,,Homo sapiens
162923,1753,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.1,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL524,AGONIST,,Tclin,,,Homo sapiens
162924,1721,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201319,AGONIST,,Tclin,,,Homo sapiens
162926,1212,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.1905,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162927,1043,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,AGONIST,,Tclin,,,Homo sapiens
162928,954,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.8,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL707,ANTAGONIST,,Tclin,,,Homo sapiens
162931,812,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162932,781,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201044,ANTAGONIST,,Tclin,,,Homo sapiens
162933,522,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.66,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162934,429,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,1,KEGG DRUG,,http://www.kegg.jp/entry/D01887,ANTAGONIST,,Tclin,,,Homo sapiens
162935,403,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.38,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162936,242,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.244,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162937,1212,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,8.0969,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162938,722,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.78,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162940,2865,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.89,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162941,2717,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.65,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL621,ANTAGONIST,,Tclin,,,Homo sapiens
162942,2389,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.7,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162944,2337,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7,,IC50,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162945,1982,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.9586,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162946,956,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162947,765,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.6517,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162948,751,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.2441,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162949,621,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.4,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162951,242,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.36,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162953,180,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162954,956,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.2,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162955,765,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.8125,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162956,722,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.26,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162958,403,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.3,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162959,4115,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.61,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201756,ANTAGONIST,,Tclin,,,Homo sapiens
162961,3294,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.8594,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376,ANTAGONIST,,Tclin,,,Homo sapiens
162962,2865,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.4,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL708,ANTAGONIST,,Tclin,,,Homo sapiens
162963,2717,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.35,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL621,ANTAGONIST,,Tclin,,,Homo sapiens
162964,2637,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8,,EC50,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162965,2389,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.3643,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,ANTAGONIST,,Tclin,,,Homo sapiens
162966,2337,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.1311,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,ANTAGONIST,,Tclin,,,Homo sapiens
162967,2284,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.7959,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,ANTAGONIST,,Tclin,,,Homo sapiens
162968,2172,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.5585,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162969,1982,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.3188,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,ANTAGONIST,,Tclin,,,Homo sapiens
162970,1890,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL623,ANTAGONIST,,Tclin,,,Homo sapiens
162971,1353,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162976,751,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.5409,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL669,ANTAGONIST,,Tclin,,,Homo sapiens
162977,722,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.3,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,ANTAGONIST,,Tclin,,,Homo sapiens
162978,621,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.1,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
162979,242,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,ANTAGONIST,,Tclin,,,Homo sapiens
162981,180,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.96,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162982,437,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.25,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,PARTIAL AGONIST,,Tclin,,,Homo sapiens
162984,403,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162985,242,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.15,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,PARTIAL AGONIST,,Tclin,,454,Homo sapiens
162987,4380,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.2747,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1118,INHIBITOR,,Tclin,,,Homo sapiens
162988,2813,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.9747,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL637,INHIBITOR,,Tclin,,,Homo sapiens
162989,2758,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.61,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7317,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL644,INHIBITOR,,Tclin,,,Homo sapiens
162990,2440,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.2635,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1419,INHIBITOR,,Tclin,,,Homo sapiens
162991,2320,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,8.39,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL668,INHIBITOR,,Tclin,,,Homo sapiens
162993,2140,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1574,INHIBITOR,,Tclin,,,Homo sapiens
162994,2133,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.2976,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200483,INHIBITOR,,Tclin,,,Homo sapiens
162995,1971,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,8.3595,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445,INHIBITOR,,Tclin,,,Homo sapiens
162996,1890,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.4437,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL623,INHIBITOR,,Tclin,,,Homo sapiens
162997,1808,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.6,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL259209,INHIBITOR,,Tclin,,,Homo sapiens
162998,1634,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,8.27,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21731,INHIBITOR,,Tclin,,,Homo sapiens
162999,1427,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.4318,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,INHIBITOR,,Tclin,,,Homo sapiens
163000,1342,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL765,SUBSTRATE,,Tclin,,,Homo sapiens
163001,956,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.53,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628227,INHIBITOR,,Tclin,,,Homo sapiens
163002,836,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL827,INHIBITOR,,Tclin,,,Homo sapiens
163003,812,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,9.0809,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL72,INHIBITOR,,Tclin,,,Homo sapiens
163004,723,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.57,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163006,180,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.4559,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,INHIBITOR,,Tclin,,,Homo sapiens
163007,4380,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.3251,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1118,INHIBITOR,,Tclin,,,Homo sapiens
163008,2813,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.0506,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL637,INHIBITOR,,Tclin,,,Homo sapiens
163009,2717,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.8,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL621,INHIBITOR,,Tclin,,,Homo sapiens
163010,2440,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.5257,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1419,INHIBITOR,,Tclin,,,Homo sapiens
163011,2320,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.34,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL668,INHIBITOR,,Tclin,,,Homo sapiens
163013,1971,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.34,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445,INHIBITOR,,Tclin,,,Homo sapiens
163015,1890,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.699,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL623,INHIBITOR,,Tclin,,,Homo sapiens
93837,192,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.8,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163016,1808,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.29,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL259209,INHIBITOR,,Tclin,,,Homo sapiens
163017,1427,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.8539,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11,INHIBITOR,,Tclin,,,Homo sapiens
163018,1230,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.51,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL814,INHIBITOR,,Tclin,,,Homo sapiens
163020,1209,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,9.0915,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,INHIBITOR,,Tclin,,,Homo sapiens
163021,1053,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.9586,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1508,INHIBITOR,,Tclin,,,Homo sapiens
163022,812,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.7545,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163023,723,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.92,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163024,663,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.9355,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL549,INHIBITOR,,Tclin,,,Homo sapiens
163025,618,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.4711,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200595,SUBSTRATE,,Tclin,,,Homo sapiens
163026,489,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,4.4949,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163027,180,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.3665,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,INHIBITOR,,Tclin,,,Homo sapiens
163029,1170,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.699,,Km,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163030,1027,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163031,814,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.37,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163033,271,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163034,82,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163035,2464,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL471,BLOCKER,,Tclin,,,Homo sapiens
163036,176,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL633,BLOCKER,,Tclin,,,Homo sapiens
163037,2695,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.64,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770,ANTAGONIST,,Tclin,,,Homo sapiens
163038,2683,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1079,AGONIST,,Tclin,,,Homo sapiens
163039,2136,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.28,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL753,ANTAGONIST,,Tclin,,,Homo sapiens
163040,1762,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL459,AGONIST,,Tclin,,,Homo sapiens
163041,1343,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.1642,,EC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022037s011lbl.pdf,AGONIST,,Tclin,,400,Homo sapiens
163042,922,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833,AGONIST,,Tclin,,,Homo sapiens
163043,403,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163044,395,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8.3872,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL844,AGONIST,,Tclin,,,Homo sapiens
163045,176,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.3,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163046,2362,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.8861,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL317052,AGONIST,,Tclin,,,Homo sapiens
163047,90,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,6.1549,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477,AGONIST,,Tclin,,,Homo sapiens
163049,4115,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.75,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201756,ANTAGONIST,,Tclin,,,Homo sapiens
163051,3294,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.9687,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376,ANTAGONIST,,Tclin,,,Homo sapiens
163052,2865,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.32,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL708,ANTAGONIST,,Tclin,,,Homo sapiens
163053,2637,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.4,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,ANTAGONIST,,Tclin,,,Homo sapiens
163054,2630,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.699,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1378,ANTAGONIST,,Tclin,,,Homo sapiens
163057,2389,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.49,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,ANTAGONIST,,Tclin,,,Homo sapiens
163059,2337,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.4828,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,ANTAGONIST,,Tclin,,,Homo sapiens
163060,2284,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.7037,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,ANTAGONIST,,Tclin,,,Homo sapiens
163061,2274,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.7642,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL728,ANTAGONIST,,Tclin,,,Homo sapiens
163062,2233,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.6,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL301265,AGONIST,,Tclin,,,Homo sapiens
163063,2172,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.8623,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,ANTAGONIST,,Tclin,,,Homo sapiens
163064,2113,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.32,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL567,ANTAGONIST,,Tclin,,,Homo sapiens
163065,2105,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.3,,EC50,,WOMBAT-PK,=,1,DRUG LABEL,,"http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19385slr030,031,035_permax_lbl.pdf",AGONIST,,Tclin,,413,Homo sapiens
163066,1982,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.5229,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,ANTAGONIST,,Tclin,,,Homo sapiens
163067,1830,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.1568,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460,ANTAGONIST,,Tclin,,,Homo sapiens
163068,1782,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.1938,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,ANTAGONIST,,Tclin,,,Homo sapiens
163069,1353,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.15,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,INVERSE AGONIST,,Tclin,,,Homo sapiens
163070,1212,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.269,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL726,ANTAGONIST,,Tclin,,,Homo sapiens
163071,947,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
163072,722,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.86,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,ANTAGONIST,,Tclin,,,Homo sapiens
163074,621,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.15,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,ANTAGONIST,,Tclin,,,Homo sapiens
163076,437,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.68,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163078,403,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.7,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL493,AGONIST,,Tclin,,,Homo sapiens
163079,242,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.71,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,PARTIAL AGONIST,,Tclin,,,Homo sapiens
163082,947,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,9,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
163083,722,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.89,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163086,4616,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,7.55,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1186579,ANTAGONIST,,Tclin,,,Homo sapiens
163087,2491,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,8.13,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL658,AGONIST,,Tclin,,,Homo sapiens
163088,2363,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1005,AGONIST,,Tclin,,,Homo sapiens
163089,2034,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.4437,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL963,AGONIST,,Tclin,,,Homo sapiens
163091,2029,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,7.7959,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656,AGONIST,,Tclin,,,Homo sapiens
163093,1878,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,8.81,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80,ANTAGONIST,,Tclin,,,Homo sapiens
163095,1874,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,8.8,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL895,AGONIST,,Tclin,,,Homo sapiens
163096,1845,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,7.86,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,AGONIST,,Tclin,,,Homo sapiens
163100,1765,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.38,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,ANTAGONIST,,Tclin,,,Homo sapiens
163102,1728,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,8.78,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL651,AGONIST,,Tclin,,,Homo sapiens
163104,1599,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,8.8239,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL841,AGONIST,,Tclin,,,Homo sapiens
163105,1571,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1514,AGONIST,,Tclin,,,Homo sapiens
163106,1164,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.0014,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,AGONIST,,Tclin,,,Homo sapiens
163107,918,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,7.1674,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200665,AGONIST,,Tclin,,,Homo sapiens
163108,844,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1213351,AGONIST,,Tclin,,,Homo sapiens
163110,434,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,8.29,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142,PARTIAL AGONIST,,Tclin,,,Homo sapiens
93690,4810,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,9.142667770385742,,Ki,measured in anti-IgM stimulated Ramos human B cell line,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17154430,http://www.ncbi.nlm.nih.gov/pubmed/17154430,INHIBITOR,,Tclin,37,37,Homo sapiens
93692,4810,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,7.853871822357178,,Ki,measured in anti-IgM stimulated Ramos human B cell line,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/17154430,,,,Tclin,37,,Homo sapiens
163112,220,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200543,AGONIST,,Tclin,,,Homo sapiens
163113,143,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.3979,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL270190,ANTAGONIST,,Tclin,,,Homo sapiens
163114,114,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,8.5,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL634,AGONIST,,Tclin,,,Homo sapiens
163115,2699,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.27,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1020,INHIBITOR,,Tclin,,,Homo sapiens
163117,2546,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.96,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL956,INHIBITOR,,Tclin,,,Homo sapiens
163118,2210,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.18,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL527,INHIBITOR,,Tclin,,,Homo sapiens
163121,1883,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.16,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154,INHIBITOR,,Tclin,,,Homo sapiens
163123,1710,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL704,INHIBITOR,,Tclin,,,Homo sapiens
163124,1663,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.78,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686,INHIBITOR,,Tclin,,,Homo sapiens
163126,1650,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.66,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,INHIBITOR,,Tclin,,,Homo sapiens
163127,1529,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,9.72,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL469,INHIBITOR,,Tclin,,,Homo sapiens
163128,1528,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,7.33,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL571,INHIBITOR,,Tclin,,,Homo sapiens
163129,1440,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,7.21,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,INHIBITOR,,Tclin,,,Homo sapiens
163131,1407,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.12,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,INHIBITOR,,Tclin,,,Homo sapiens
163132,1219,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,8.74,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL563,INHIBITOR,,Tclin,,,Homo sapiens
163133,1154,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.36,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1297,INHIBITOR,,Tclin,,,Homo sapiens
163135,880,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.4,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL898,INHIBITOR,,Tclin,,,Homo sapiens
163137,865,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,7.52,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,INHIBITOR,,Tclin,,,Homo sapiens
163139,401,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,8.29,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL751,INHIBITOR,,Tclin,,,Homo sapiens
163140,284,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200760,INHIBITOR,,Tclin,,,Homo sapiens
163141,1899,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.6,,IC50,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D05143,INHIBITOR,,Tclin,,,Homo sapiens
163142,74,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.77,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25,INHIBITOR,,Tclin,,,Homo sapiens
163151,2706,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,BLOCKER,,Tclin,,,Homo sapiens
163153,2403,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,4.56,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7602,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1077896,BLOCKER,,Tclin,,,Homo sapiens
163154,2382,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL744,BLOCKER,,Tclin,,,Homo sapiens
163157,2152,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,BLOCKER,,Tclin,,,Homo sapiens
163158,2017,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1068,BLOCKER,,Tclin,,,Homo sapiens
163159,1999,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,4.8861,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900,BLOCKER,,Tclin,,,Homo sapiens
163160,1842,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1075,BLOCKER,,Tclin,,,Homo sapiens
163161,1794,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,4.53,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,BLOCKER,,Tclin,,,Homo sapiens
163163,1700,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1087,BLOCKER,,Tclin,,,Homo sapiens
163164,1097,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL492,BLOCKER,,Tclin,,,Homo sapiens
163165,926,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517,BLOCKER,,Tclin,,,Homo sapiens
163166,723,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163167,489,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108,BLOCKER,,Tclin,,,Homo sapiens
163170,52,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,,,,,WOMBAT-PK,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/23940628,AGONIST,,Tclin,,300,Homo sapiens
163171,52,57,Transient receptor potential cation channel subfamily V member 1,Ion channel,Q8NER1,TRPV1,TRPV1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,OPENER,,Tclin,,,Homo sapiens
163172,2799,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,8.3,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,INHIBITOR,,Tclin,,,Homo sapiens
163173,2699,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.84,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1020,INHIBITOR,,Tclin,,,Homo sapiens
163175,2546,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.06,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL956,INHIBITOR,,Tclin,,,Homo sapiens
163176,2534,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.25,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15770,INHIBITOR,,Tclin,,,Homo sapiens
163177,2397,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.51,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL122,INHIBITOR,,Tclin,,,Homo sapiens
163178,2210,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.7,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL527,INHIBITOR,,Tclin,,,Homo sapiens
163180,2013,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.44,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7252,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1071,INHIBITOR,,Tclin,,,Homo sapiens
163181,1663,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.83,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686,INHIBITOR,,Tclin,,,Homo sapiens
163183,1650,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.7,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,INHIBITOR,,Tclin,,,Homo sapiens
163184,1529,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.9,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL469,INHIBITOR,,Tclin,,,Homo sapiens
163186,1528,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.62,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL571,INHIBITOR,,Tclin,,,Homo sapiens
163187,1440,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.33,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,INHIBITOR,,Tclin,,,Homo sapiens
163189,1407,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.14,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,INHIBITOR,,Tclin,,,Homo sapiens
163190,1219,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,8.39,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL563,INHIBITOR,,Tclin,,,Homo sapiens
163191,1154,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.23,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1297,INHIBITOR,,Tclin,,,Homo sapiens
163192,1113,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.1,,IC50,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2896,INHIBITOR,,Tclin,,,Homo sapiens
163193,880,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.09,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL898,INHIBITOR,,Tclin,,,Homo sapiens
163194,865,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,7.7,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,INHIBITOR,,Tclin,,,Homo sapiens
163195,568,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,7.24,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,INHIBITOR,,Tclin,,,Homo sapiens
163196,401,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,8.4,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL751,INHIBITOR,,Tclin,,,Homo sapiens
163197,284,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200760,INHIBITOR,,Tclin,,,Homo sapiens
163198,1899,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.82,,IC50,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D05143,INHIBITOR,,Tclin,,,Homo sapiens
163199,74,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.12,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25,INHIBITOR,,Tclin,,,Homo sapiens
163200,52,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.31,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112,INHIBITOR,,Tclin,,,Homo sapiens
163201,4799,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.4,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1084172,AGONIST,,Tclin,,,Homo sapiens
163202,4061,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.7,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499,ANTAGONIST,,Tclin,,,Homo sapiens
163203,2598,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.6,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1760,AGONIST,,Tclin,,,Homo sapiens
163204,2464,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL471,ANTAGONIST,,Tclin,,,Homo sapiens
163205,2390,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.62,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL785,AGONIST,,Tclin,,,Homo sapiens
163206,2303,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,8.25,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/016419s029lbl.pdf,ANTAGONIST,,Tclin,,410,Homo sapiens
163207,2199,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094966,AGONIST,,Tclin,,,Homo sapiens
163208,2176,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500,PARTIAL AGONIST,,Tclin,,,Homo sapiens
163209,2078,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1290,ANTAGONIST,,Tclin,,,Homo sapiens
163210,2027,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,8,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL546,ANTAGONIST,,Tclin,,,Homo sapiens
163211,1887,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.5,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL434394,ANTAGONIST,,Tclin,,,Homo sapiens
163212,1499,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.8,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL434,AGONIST,,Tclin,,,Homo sapiens
163213,937,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.2,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,AGONIST,,Tclin,,,Homo sapiens
163214,520,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.2,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL839,ANTAGONIST,,Tclin,,,Homo sapiens
163215,105,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.95,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL714,AGONIST,,Tclin,,,Homo sapiens
163216,4061,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,9,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499,ANTAGONIST,,Tclin,,,Homo sapiens
163217,2464,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.1,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL471,ANTAGONIST,,Tclin,,,Homo sapiens
163218,2303,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8.71,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/016419s029lbl.pdf,ANTAGONIST,,Tclin,,410,Homo sapiens
163219,2176,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,9.4,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500,PARTIAL AGONIST,,Tclin,,,Homo sapiens
163220,2078,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8.8,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1290,ANTAGONIST,,Tclin,,,Homo sapiens
163221,2027,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8.11,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL546,ANTAGONIST,,Tclin,,,Homo sapiens
163222,1887,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8.5,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL434394,ANTAGONIST,,Tclin,,,Homo sapiens
163223,1786,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,7.6,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13,ANTAGONIST,,Tclin,,,Homo sapiens
163224,1499,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,9,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL434,AGONIST,,Tclin,,,Homo sapiens
163227,947,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,AGONIST,,Tclin,,,Homo sapiens
163228,937,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.5,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,AGONIST,,Tclin,,,Homo sapiens
163229,520,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,9.3,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL839,ANTAGONIST,,Tclin,,,Homo sapiens
163230,380,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,7.65,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL645,ANTAGONIST,,Tclin,,,Homo sapiens
163231,356,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8.8,,Kd,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL423,ANTAGONIST,,Tclin,,,Homo sapiens
163232,255,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,7.3,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24,ANTAGONIST,,Tclin,,,Homo sapiens
163233,40,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,7.3,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL642,ANTAGONIST,,Tclin,,,Homo sapiens
163234,176,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163235,74,69,Acidic phospholipase A2 3,Enzyme,P60045,,PA2A3_NAJSG,5.2,,Kd,,WOMBAT-PK,=,,,,,,,,,,Naja sagittifera
163236,176,93,Thyroid hormone receptor beta,Nuclear hormone receptor,P10828,THRB,THB_HUMAN,6.22,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163237,701,765,Glutathione S-transferase P,Enzyme,P09211,GSTP1,GSTP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163238,719,425,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,7.0888,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163239,2707,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163240,1112,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163241,719,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163242,489,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163243,852,2794,GABA A receptor alpha-3/beta-2/gamma-3,Ion channel,P34903|P47870|Q99928,GABRA3|GABRB2|GABRG3,GBRA3_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,6.6655,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163244,852,2737,GABA-A receptor alpha-1/beta-2/gamma-3,Ion channel,P14867|P47870|Q99928,GABRA1|GABRB2|GABRG3,GBRA1_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,6.7055,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163245,770,2510,Prostatic acid phosphatase,Enzyme,P15309,ACPP,PPAP_HUMAN,7,,GI50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163246,546,2501,Penicillin-binding protein 2,Enzyme,P0AD65,mrdA,PBP2_ECOLI,4.6171,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1010,INHIBITOR,,,,,Escherichia coli (strain K12)
163247,704,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.7959,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163248,180,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.8539,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163249,546,1418,Penicillin-binding protein 1B,Enzyme,P02919,mrcB,PBPB_ECOLI,5.6585,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1010,INHIBITOR,,,,,Escherichia coli (strain K12)
163250,138,527,Prostaglandin D2 receptor,GPCR,Q13258,PTGDR,PD2R_HUMAN,7.3,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163252,779,500,Steryl-sulfatase,Enzyme,P08842,STS,STS_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163253,691,498,Uridine-cytidine kinase 2,Kinase,Q9BZX2,UCK2,UCK2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163254,691,497,Uridine-cytidine kinase 1,Kinase,Q9HA47,UCK1,UCK1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163255,2815,440,Potassium voltage-gated channel subfamily C member 2,Ion channel,Q96PR1,KCNC2,KCNC2_HUMAN,4.9,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163256,466,430,Vitamin D 25-hydroxylase,Enzyme,Q6VVX0,CYP2R1,CP2R1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163257,466,428,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",Enzyme,O15528,CYP27B1,CP27B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163258,864,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,6.2007,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163259,841,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,6.87,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163261,691,360,Ribose-phosphate pyrophosphokinase 1,Kinase,P60891,PRPS1,PRPS1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163262,138,341,Prostacyclin receptor,GPCR,P43119,PTGIR,PI2R_HUMAN,7.5,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163263,56,331,Aquaporin-1,Transporter,P29972,AQP1,AQP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163266,2286,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,7.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163267,2869,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,7.45,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163268,864,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.6021,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163269,939,266,Multidrug resistance-associated protein 7,Transporter,Q5T3U5,ABCC10,MRP7_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163270,432,253,Potassium voltage-gated channel subfamily D member 3,Ion channel,Q9UK17,KCND3,KCND3_HUMAN,4.5,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163271,2270,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163272,259,246,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,Q15822,CHRNA2,ACHA2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163273,2707,243,Multidrug resistance-associated protein 4,Transporter,O15439,ABCC4,MRP4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163274,1482,243,Multidrug resistance-associated protein 4,Transporter,O15439,ABCC4,MRP4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163275,765,219,Calmodulin,Cytosolic other,P0DP23|P0DP24|P0DP25,CALM1|CALM2|CALM3,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163276,2590,205,Canalicular multispecific organic anion transporter 2,Transporter,O15438,ABCC3,MRP3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163277,1112,205,Canalicular multispecific organic anion transporter 2,Transporter,O15438,ABCC3,MRP3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163278,2590,192,Multidrug resistance-associated protein 6,Transporter,O95255,ABCC6,MRP6_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163279,1112,192,Multidrug resistance-associated protein 6,Transporter,O95255,ABCC6,MRP6_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163280,960,192,Multidrug resistance-associated protein 6,Transporter,O95255,ABCC6,MRP6_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163281,786,192,Multidrug resistance-associated protein 6,Transporter,O95255,ABCC6,MRP6_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
94063,492,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.37,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94064,492,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94068,525,2500,Streptokinase A,Enzyme,P10520,ska,STRP_STRP1,6.33,,EC50,,WOMBAT-PK,=,,,,,,,,,,Streptococcus pyogenes serotype M1
94076,537,2500,Streptokinase A,Enzyme,P10520,ska,STRP_STRP1,7.22,,EC50,,WOMBAT-PK,=,,,,,,,,,,Streptococcus pyogenes serotype M1
94077,537,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,4.24,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94078,542,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,5.04,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
94079,542,1886,Somatostatin receptor type 4,GPCR,P31391,SSTR4,SSR4_HUMAN,4.24,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94080,542,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.48,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94086,547,840,Interstitial collagenase,Enzyme,P03956,MMP1,MMP1_HUMAN,4.89,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94087,547,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,4.49,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
94088,547,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,4.72,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
94089,547,632,Catechol O-methyltransferase,Enzyme,P21964,COMT,COMT_HUMAN,4.85,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94090,547,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.05,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94091,548,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,4.46,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
94092,548,2499,Vasoactive intestinal polypeptide receptor 1,GPCR,P32241,VIPR1,VIPR1_HUMAN,4.47,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
94093,550,2500,Streptokinase A,Enzyme,P10520,ska,STRP_STRP1,5.48,,EC50,,WOMBAT-PK,=,,,,,,,,,,Streptococcus pyogenes serotype M1
94110,565,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.92,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94111,565,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,4.37,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
94112,565,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,4.96,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
94113,571,2496,Solute carrier family 15 member 2,Transporter,Q16348,SLC15A2,S15A2_HUMAN,4.38,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
94114,574,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,4.66,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
94115,574,1886,Somatostatin receptor type 4,GPCR,P31391,SSTR4,SSR4_HUMAN,4.4,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94164,589,2504,Probable HTH-type transcriptional regulator TtgR,Unclassified,Q88N29,ttgR,TTGR_PSEPK,4.88,,Kd,,WOMBAT-PK,=,,,,,,,,,,Pseudomonas putida (strain KT2440)
163282,2707,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163283,2590,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163284,1821,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,5.1549,,Kact,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163285,1482,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163286,1112,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163288,960,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163289,786,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163290,1821,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,6.2869,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163291,1482,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163292,1414,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163293,1112,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163295,960,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163296,786,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163297,726,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163298,880,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,7.125,,Kd1,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163300,824,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,9,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163301,812,182,Voltage-dependent calcium channel gamma-1 subunit,Ion channel,Q06432,CACNG1,CCG1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163302,841,177,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,Q16568,CARTPT,CART_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163303,723,177,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,Q16568,CARTPT,CART_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163304,723,174,Sodium- and chloride-dependent GABA transporter 1,Transporter,P30531,SLC6A1,SC6A1_HUMAN,5.5,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163305,1212,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.8861,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163306,765,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163307,722,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.98,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163309,723,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,5.71,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163310,722,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,7.28,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163313,659,163,DNA topoisomerase 4 subunit A,Enzyme,Q45066,parC,PARC_BACSU,5.6576,,IC50,,WOMBAT-PK,=,,,,,,,,,,Bacillus subtilis (strain 168)
163314,659,162,DNA topoisomerase 4 subunit A,Enzyme,P0AFI2,parC,PARC_ECOLI,5.6021,,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
163315,625,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.56,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163316,609,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163317,1212,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.5355,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163318,594,156,Thyrotropin-releasing hormone receptor,GPCR,P34981,TRHR,TRFR_HUMAN,6.538,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163319,916,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,4.9318,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163321,701,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.6576,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163322,1212,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.5391,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163323,956,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163324,722,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.54,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163325,403,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163326,242,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.2,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163327,403,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.5,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163328,348,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163329,2707,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163330,1821,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163331,1482,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163333,960,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163334,2815,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.4559,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163335,751,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.5086,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163336,722,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.3565,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163337,701,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,6.3187,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163338,956,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.1249,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163349,812,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.68,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163350,765,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163351,926,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163352,812,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.27,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163353,765,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163355,722,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.3,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163357,671,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.703,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163358,956,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.4202,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163359,926,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163360,812,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.76,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163361,765,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163362,751,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.95,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163363,722,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.1813,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163364,671,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.7959,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163365,488,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.5229,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163366,956,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,6.79,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163367,765,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,8.1851,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163368,722,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,8.23,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163369,616,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,6.67,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163371,180,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,8.14,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163372,722,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.8153,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163373,1212,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.7934,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163374,926,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.5686,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163375,751,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.8288,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163376,489,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,4.125,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163377,333,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.9586,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163378,242,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.2147,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163379,1212,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,7.8873,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163380,765,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.0969,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163381,1212,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.0872,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163382,956,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.21,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163384,812,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163385,403,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.5,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163386,180,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,8,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163387,2286,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163388,1027,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163389,956,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.6289,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163390,765,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.4,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163391,722,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163392,701,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.4949,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163393,437,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.4353,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163394,180,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.9,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163395,956,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163396,751,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.821,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163397,242,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.69,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163399,1212,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.4644,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163400,751,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.8386,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163401,722,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.95,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163402,621,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.44,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163404,242,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.51,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163406,180,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.05,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163407,812,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.5,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163408,722,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.05,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163409,663,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.2097,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163410,437,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.04,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163412,403,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163413,812,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.5,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163414,751,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.8125,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163415,437,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.41,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163417,180,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.4,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163418,2286,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.7696,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163419,1027,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163420,437,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163422,403,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163423,765,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.2291,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163424,947,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,8.18,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163425,751,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.4437,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163426,701,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.4202,,Kd,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2398,INHIBITOR,,Tclin,,,Homo sapiens
163427,956,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.17,,Kd,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
163428,751,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.9666,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163429,435,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.04,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163430,242,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.83,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163432,2707,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163433,2590,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163434,1821,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.841,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163435,1482,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163436,1414,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163438,960,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163439,939,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163440,786,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163441,765,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163442,760,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,6.301,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163444,1802,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6,,Km,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163446,760,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.3098,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163447,719,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7.699,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163448,954,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.23,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163449,812,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.86,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163450,722,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.6,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94466,720,2507,Beta-lactamase TEM,Enzyme,P62594,bla,BLAT_SALTI,4.89,,Ki,,WOMBAT-PK,=,,,,,,,,,,Salmonella typhi
94538,758,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.68,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94539,759,317,"Glutamate receptor ionotropic, NMDA 2D",Ion channel,O15399,GRIN2D,NMDE4_HUMAN,5.64,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94540,759,725,"Glutamate receptor ionotropic, NMDA 3B",Ion channel,O60391,GRIN3B,NMD3B_HUMAN,5.64,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94541,759,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.31,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94543,759,629,"Glutamate receptor ionotropic, NMDA 1",Ion channel,Q05586,GRIN1,NMDZ1_HUMAN,5.26,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94545,759,84,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,Q12879,GRIN2A,NMDE1_HUMAN,5.64,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94546,759,315,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,Q13224,GRIN2B,NMDE2_HUMAN,5.64,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94547,759,316,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,Q14957,GRIN2C,NMDE3_HUMAN,5.34,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94548,759,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,5.64,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163452,176,92,Thyroid hormone receptor alpha,Nuclear hormone receptor,P10827,THRA,THA_HUMAN,5.64,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163453,1027,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163454,722,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.1541,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163455,956,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.5,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163456,1212,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.6488,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163457,956,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.5,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163458,621,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.19,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163460,180,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.0506,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163461,2585,60,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,Q14994,NR1I3,NR1I3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163462,356,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.2,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163463,722,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.2,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163464,180,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.25,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163465,928,81,Translocator protein,Transporter,P30536,TSPO,TSPO_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163466,989,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163467,489,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163468,392,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163469,1129,2511,Heat shock protein HSP 90-alpha,Cytosolic other,P07900,HSP90AA1,HS90A_HUMAN,5.3036,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163470,2815,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.0706,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163471,1218,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.2218,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163472,2815,1698,Potassium voltage-gated channel subfamily A member 7,Ion channel,Q96RP8,KCNA7,KCNA7_HUMAN,4.8,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163473,2815,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,4.3478,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163474,391,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,4.7447,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163475,2815,438,Potassium voltage-gated channel subfamily A member 10,Ion channel,Q16322,KCNA10,KCA10_HUMAN,4.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2406,,BLOCKER,,Tclin,,,Homo sapiens
163477,4122,367,"Thioredoxin reductase 1, cytoplasmic",Enzyme,Q16881,TXNRD1,TRXR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163478,947,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,6.3747,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163480,4122,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163481,2869,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,7.7,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163482,1212,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.2676,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163483,1212,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.8386,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163484,2270,273,DNA (cytosine-5)-methyltransferase 3B,Enzyme,Q9UBC3,DNMT3B,DNM3B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163485,2270,272,DNA (cytosine-5)-methyltransferase 3A,Enzyme,Q9Y6K1,DNMT3A,DNM3A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163486,2270,271,DNA (cytosine-5)-methyltransferase 1,Enzyme,P26358,DNMT1,DNMT1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163487,2815,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,4.4854,,Ki,,WOMBAT-PK,=,,,,,BLOCKER,,Tclin,,,Homo sapiens
163488,2815,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163489,183,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163490,26,211,ATP-binding cassette sub-family C member 11,Transporter,Q96J66,ABCC11,ABCCB_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163491,26,210,Multidrug resistance-associated protein 5,Transporter,O15440,ABCC5,MRP5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163492,270,206,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,P31213,SRD5A2,S5A2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163493,844,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,5.301,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163494,723,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.1,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163495,722,173,UDP-glucuronosyltransferase 1-4,Enzyme,P22310,UGT1A4,UD14_HUMAN,4.2076,,app Km,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163496,568,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.68,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163497,616,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,4.9666,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163499,568,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.18,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163500,333,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.2533,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163501,432,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,5.5143,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163502,621,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163504,1212,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.4763,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163505,1212,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.4763,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163506,380,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.04,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163507,824,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163508,2286,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,6.2924,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163509,180,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,6.585,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163510,1212,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.4473,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163511,814,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.3,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163512,180,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163513,814,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163514,180,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.14,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163515,814,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.49,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163516,180,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.89,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163517,956,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.7959,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163518,814,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163519,180,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163520,1212,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163521,814,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.74,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163522,180,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.83,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
163523,2286,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,6.8233,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163524,1212,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.2518,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163525,1027,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163526,180,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.8,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163527,723,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.67,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163528,663,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.4559,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163529,180,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.3,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
163530,621,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.93,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163532,180,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.7696,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163533,2370,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.2233,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163534,180,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.6861,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163535,621,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163536,723,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.68,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163537,621,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.41,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163539,180,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.4,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163540,2869,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163541,1212,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.8376,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163542,956,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.5376,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163543,180,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.7212,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163544,916,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.0177,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163545,722,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.83,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163547,946,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.0458,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163548,616,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.8181,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163551,751,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.7282,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163552,176,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,7.6,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163553,852,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.42,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163554,782,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.57,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163556,176,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.22,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163557,1027,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163558,882,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.1361,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163559,700,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.7447,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163560,671,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.9208,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163561,663,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.4,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163562,607,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.6,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163917,3317,503,Tumor necrosis factor,Cytokine,P01375,TNF,TNFA_HUMAN,7.886,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163563,244,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.824,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163564,1212,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.503,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163565,158,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.48,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163566,158,88,Urokinase-type plasminogen activator,Enzyme,P00749,PLAU,UROK_HUMAN,5.16,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163567,2370,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.2321,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163568,2286,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.6094,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163569,180,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.7077,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163570,2815,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163571,326,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163572,52,60,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,Q14994,NR1I3,NR1I3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163573,380,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.94,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163574,40,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.4,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163575,176,1698,Potassium voltage-gated channel subfamily A member 7,Ion channel,Q96RP8,KCNA7,KCNA7_HUMAN,6,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163576,1579,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,4.9547,,IC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163581,956,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.8861,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163582,916,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.6778,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163583,621,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.8539,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163584,937,632,Catechol O-methyltransferase,Enzyme,P21964,COMT,COMT_HUMAN,4.301,,Km,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163588,785,531,Breakpoint cluster region protein,Kinase,P11274,BCR,BCR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163589,864,401,Carbonic anhydrase,Enzyme,O24855,cynT,CYNT_HELPY,6.4225,,Ki,,WOMBAT-PK,=,,,,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
163592,90,326,Adenosine deaminase,Enzyme,P00813,ADA,ADA_HUMAN,4.6021,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163593,897,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,4.0168,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163594,726,201,Glycine receptor subunit alpha-2,Ion channel,P23416,GLRA2,GLRA2_HUMAN,4.1938,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163595,723,175,Sodium channel protein type 11 subunit alpha,Ion channel,Q9UI33,SCN11A,SCNBA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163596,765,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163597,2286,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.4202,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163599,671,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.699,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163601,621,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.1549,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163602,435,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163603,191,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.3655,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163604,723,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,5.47,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163605,242,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163606,276,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,4.16,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163607,621,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,6.2441,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163608,183,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.2596,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163609,799,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,5.2757,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163610,700,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.1871,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163611,841,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163612,765,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163613,765,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.8,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163614,1802,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.3526,,Km,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163616,954,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163617,719,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.1739,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
94778,866,693,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Enzyme,O00408,PDE2A,PDE2A_HUMAN,4.42,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94779,866,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.66,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94780,866,2500,Streptokinase A,Enzyme,P10520,ska,STRP_STRP1,7.22,,EC50,,WOMBAT-PK,=,,,,,,,,,,Streptococcus pyogenes serotype M1
94781,866,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.96,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94782,866,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.6,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94783,866,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,4.8,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94784,866,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,4.11,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
94785,869,2513,Reverse transcriptase/RNaseH,Enzyme,Q72549,pol,Q72549_9HIV1,5.21,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1460,INHIBITOR,,,,,Human immunodeficiency virus 1
163618,176,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.3,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163619,119,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.6778,,Km,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163620,2729,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.27,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163621,437,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.13,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163622,119,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.61,,Km,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163623,723,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.14,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163624,668,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.23,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163625,621,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.83,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163626,180,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163627,841,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163628,621,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.2,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163629,765,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.9508,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163630,765,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.9318,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163631,257,60,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,Q14994,NR1I3,NR1I3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163632,255,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.8,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163633,176,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,4.7,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163634,1440,228,Prostaglandin D2 receptor 2,GPCR,Q9Y5Y4,PTGDR2,PD2R2_HUMAN,6.53,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163636,2630,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.1549,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163637,2561,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.5,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163638,2172,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.8416,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163639,1830,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.9066,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163640,1427,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.284,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163641,1353,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.92,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163642,407,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,9.02,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163643,388,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.54,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163644,312,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.94,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163645,1906,361,Hydroxycarboxylic acid receptor 2,GPCR,Q8TDS4,HCAR2,HCAR2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163646,1612,361,Hydroxycarboxylic acid receptor 2,GPCR,Q8TDS4,HCAR2,HCAR2_HUMAN,7.3,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163647,1808,84,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,Q12879,GRIN2A,NMDE1_HUMAN,5.2,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163648,2832,456,Transketolase-like protein 1,Enzyme,P51854,TKTL1,TKTL1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163649,1906,362,Hydroxycarboxylic acid receptor 3,GPCR,P49019,HCAR3,HCAR3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163650,1612,362,Hydroxycarboxylic acid receptor 3,GPCR,P49019,HCAR3,HCAR3_HUMAN,6.53,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163651,2552,293,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,Enzyme,P48454,PPP3CC,PP2BC_HUMAN,7.456,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163652,2168,293,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,Enzyme,P48454,PPP3CC,PP2BC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163653,1118,441,Serine/threonine-protein kinase mTOR,Kinase,P42345,MTOR,MTOR_HUMAN,8.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5889,,INHIBITOR,,Tclin,,,Homo sapiens
163654,1388,328,"Nitric oxide synthase, inducible",Enzyme,P35228,NOS2,NOS2_HUMAN,8,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163655,93,81,Translocator protein,Transporter,P30536,TSPO,TSPO_HUMAN,7.1,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163656,1922,579,Potassium voltage-gated channel subfamily A member 2,Ion channel,P16389,KCNA2,KCNA2_HUMAN,4.7,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163657,1550,518,"Aspartate--tRNA ligase, cytoplasmic",Enzyme,P14868,DARS,SYDC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163659,2831,469,Retinaldehyde-binding protein 1,Unclassified,P12271,RLBP1,RLBP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163660,2831,462,Retinol-binding protein 3,Surface antigen,P10745,RBP3,RET3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163661,2391,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7.55,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163662,2001,409,Neuraminidase,Enzyme,P06818,NA,NRAM_I79A0,9.83,,IC50,,WOMBAT-PK,=,,,,,,,,,,Influenza A virus (strain A/Bangkok/1/1979 H3N2)
163663,2706,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163664,2561,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,7.4559,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163665,2475,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163666,2391,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163667,1612,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2739,,AGONIST,,Tchem,,,Homo sapiens
163668,1511,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163669,2811,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin,,,Homo sapiens
163670,2811,2736,Neuronal acetylcholine receptor; alpha2/beta4,Ion channel,P30926|Q15822,CHRNA2|CHRNB4,ACHA2_HUMAN|ACHB4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem|Tclin,,,Homo sapiens
163671,2811,2803,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P30926|P43681,CHRNA4|CHRNB4,ACHA4_HUMAN|ACHB4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin,,,Homo sapiens
163672,2808,2801,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P30926|P32297,CHRNA3|CHRNB4,ACHA3_HUMAN|ACHB4_HUMAN,7.0655,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin,,,Homo sapiens
163673,2781,2799,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,P17787|Q15822,CHRNA2|CHRNB2,ACHA2_HUMAN|ACHB2_HUMAN,7.38,,IC50,,WOMBAT-PK,=,,,,,,,Tchem|Tclin,,,Homo sapiens
163674,2781,2803,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P30926|P43681,CHRNA4|CHRNB4,ACHA4_HUMAN|ACHB4_HUMAN,6.0655,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin,,,Homo sapiens
163675,2781,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,5.5786,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin,,,Homo sapiens
163679,2183,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin,,,Homo sapiens
163680,2183,2736,Neuronal acetylcholine receptor; alpha2/beta4,Ion channel,P30926|Q15822,CHRNA2|CHRNB4,ACHA2_HUMAN|ACHB4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem|Tclin,,,Homo sapiens
163681,2183,2803,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P30926|P43681,CHRNA4|CHRNB4,ACHA4_HUMAN|ACHB4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin,,,Homo sapiens
163682,2052,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,8.26,,IC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin,,,Homo sapiens
163685,1920,2801,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P30926|P32297,CHRNA3|CHRNB4,ACHA3_HUMAN|ACHB4_HUMAN,5.95,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin,,,Homo sapiens
163687,1920,2802,Neuronal acetylcholine receptor; alpha3/beta2,Ion channel,P17787|P32297,CHRNA3|CHRNB2,ACHA3_HUMAN|ACHB2_HUMAN,7.8539,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin,,,Homo sapiens
163688,1748,2799,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,P17787|Q15822,CHRNA2|CHRNB2,ACHA2_HUMAN|ACHB2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem|Tclin,,,Homo sapiens
163689,1646,2803,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P30926|P43681,CHRNA4|CHRNB4,ACHA4_HUMAN|ACHB4_HUMAN,6.48,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3990,,BLOCKER,,Tclin|Tclin,,,Homo sapiens
163690,1646,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,5.6021,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin,,,Homo sapiens
163691,908,2799,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,P17787|Q15822,CHRNA2|CHRNB2,ACHA2_HUMAN|ACHB2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem|Tclin,,,Homo sapiens
163692,109,2803,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P30926|P43681,CHRNA4|CHRNB4,ACHA4_HUMAN|ACHB4_HUMAN,4.3468,,IC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin,,,Homo sapiens
163693,2361,2807,Kir3.1/Kir3.2,Ion channel,P48051|P48549,KCNJ3|KCNJ6,KCNJ3_HUMAN|KCNJ6_HUMAN,4.317,,IC50,,WOMBAT-PK,=,,,,,,,Tbio|Tchem,,,Homo sapiens
163694,2361,2808,Kir3.1/Kir3.4,Ion channel,P48544|P48549,KCNJ3|KCNJ5,KCNJ3_HUMAN|KCNJ5_HUMAN,4.3872,,IC50,,WOMBAT-PK,=,,,,,,,Tbio|Tbio,,,Homo sapiens
163695,256,2807,Kir3.1/Kir3.2,Ion channel,P48051|P48549,KCNJ3|KCNJ6,KCNJ3_HUMAN|KCNJ6_HUMAN,4.4776,,IC50,,WOMBAT-PK,=,,,,,,,Tbio|Tchem,,,Homo sapiens
163696,256,2808,Kir3.1/Kir3.4,Ion channel,P48544|P48549,KCNJ3|KCNJ5,KCNJ3_HUMAN|KCNJ5_HUMAN,4.8447,,IC50,,WOMBAT-PK,=,,,,,,,Tbio|Tbio,,,Homo sapiens
163697,1958,2809,Hemoglobin HbA,Enzyme,P68871|P69905,HBA1|HBB,HBA_HUMAN|HBB_HUMAN,4.6778,,Km,,WOMBAT-PK,=,,,,,,,Tbio|Tbio,,,Homo sapiens
163698,2873,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,7.1759,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021476s030lbl.pdf,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,292,Homo sapiens
163699,2873,2793,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,P18507|P34903|P47870,GABRA3|GABRB2|GABRG2,GBRA3_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,6.5817,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021476s030lbl.pdf,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,292,Homo sapiens
163700,2870,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,6.7033,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163702,2870,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,7.5735,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163703,2870,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,6.8069,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163704,2870,2793,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,P18507|P34903|P47870,GABRA3|GABRB2|GABRG2,GBRA3_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,6.1643,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163705,2870,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,6.4168,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163706,2857,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,6.5302,,EC50,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/11755161,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,157,Homo sapiens
163707,2857,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,5.7889,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1521,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163708,2729,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,9.02,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163709,2729,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,9.1549,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163710,2729,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,9.0969,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163711,2729,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,9.2291,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163712,2729,2793,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,P18507|P34903|P47870,GABRA3|GABRB2|GABRG2,GBRA3_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8.8761,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163713,2729,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,8.8447,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163715,2706,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163716,2633,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL441,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163717,2585,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL967,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163718,2428,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL447,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163719,2336,2805,GABA A receptor alpha-3/beta-1/gamma-2,Ion channel,P18505|P18507|P34903,GABRA3|GABRB1|GABRG2,GBRA3_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN,6.6271,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200472,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163720,2336,2806,GABA A receptor alpha-2/beta-1/gamma-2,Ion channel,P18505|P18507|P47869,GABRA2|GABRB1|GABRG2,GBRA2_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN,6.6882,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200472,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163721,2278,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,4.3979,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163722,2267,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163723,2240,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL969,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163724,2134,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163725,2095,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,4.301,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163726,2015,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,7.745,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL568,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163727,1945,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8,,EC50,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D00531,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163728,1802,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8.7447,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL655,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163729,1802,2793,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,P18507|P34903|P47870,GABRA3|GABRB2|GABRG2,GBRA3_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8.4437,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL655,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163730,1774,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200790,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163731,1748,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL7413,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163736,1704,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL979,AGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163769,1102,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163737,1704,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL979,AGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163738,1704,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL979,AGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163739,1704,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL979,AGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163740,1696,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163741,1606,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,8.456,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL580,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163742,1602,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163743,1602,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163744,1602,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163745,1602,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
94942,961,2124,"Tetracycline resistance protein, class B",Transporter,P02980,tetA,TCR2_ECOLX,5.04,,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli
94943,961,2516,Zinc finger protein mex-5,Cytosolic other,Q9XUB2,mex-5,MEX5_CAEEL,4.42,,EC50,,WOMBAT-PK,=,,,,,,,,,,Caenorhabditis elegans
163746,1369,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163747,1369,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163748,1369,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163749,1369,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163750,1313,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1102,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163751,1218,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8.1,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL968,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163752,1202,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,8.47,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163753,1202,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,8.84,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163756,1202,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8.699,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163757,1202,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,8.699,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163758,1202,2793,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,P18507|P34903|P47870,GABRA3|GABRB2|GABRG2,GBRA3_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8.8239,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163759,1202,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,8.3468,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163761,1195,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,9.0969,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,ALLOSTERIC ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163762,1195,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,9.0458,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,ALLOSTERIC ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163763,1195,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,8.9788,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,ALLOSTERIC ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163764,1195,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,9.2218,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,ALLOSTERIC ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163765,1195,2797,GABA-A receptor alpha-6/beta-3/gamma-2,Ion channel,P18507|P28472|Q16445,GABRA6|GABRB3|GABRG2,GBRA6_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,6.8297,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,ALLOSTERIC ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163766,1109,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,5.4559,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163767,1102,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8.1,,EC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163768,1102,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163916,231,508,Proteasome subunit alpha type-1,Enzyme,P25786,PSMA1,PSA1_HUMAN,5.3979,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163770,1102,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163771,1078,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL591,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163772,1076,2796,GABA A receptor alpha-4/beta-2/delta,Ion channel,O14764|P47870|P48169,GABRA4|GABRB2|GABRD,GBRA4_HUMAN|GBRB2_HUMAN|GBRD_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163773,1068,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163774,1068,2793,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,P18507|P34903|P47870,GABRA3|GABRB2|GABRG2,GBRA3_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163775,1056,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285674,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163776,1056,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285674,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163777,1056,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285674,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163778,1056,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285674,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163779,997,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,7.301,,IC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163780,852,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,7.65,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163781,852,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,7.1427,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163783,852,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,7.8539,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163784,852,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,7.699,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163785,852,2793,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,P18507|P34903|P47870,GABRA3|GABRB2|GABRG2,GBRA3_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,7.9393,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163787,852,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,7.9586,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163788,816,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,6.284,,IC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163789,809,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8.699,,IC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163790,800,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8.745,,IC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163791,711,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,7.47,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1213252,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163792,711,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1213252,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163793,711,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1213252,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163794,711,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1213252,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163795,703,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8.0706,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL452,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163796,682,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70418,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163797,602,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163798,594,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,6.2518,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163799,594,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,6.3372,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163800,594,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,6.5607,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163801,594,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,6.4949,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163802,441,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL454,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163803,439,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL449,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163804,399,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163805,191,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163806,136,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,7.4318,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL661,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163807,136,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRA2|GABRB3|GABRG2,GBRA2_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,7.9208,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL661,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163808,136,2733,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,P18507|P28472|P34903,GABRA3|GABRB3|GABRG2,GBRA3_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,7.1612,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL661,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163809,136,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,8,,EC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL661,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163810,133,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,5.699,,EC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
95032,1073,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.25,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95033,1073,1066,Cytochrome P450 3A5,Enzyme,P20815,CYP3A5,CP3A5_HUMAN,4.72,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95034,1073,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.48,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95035,1073,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.16,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95036,1073,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.15,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95107,1183,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,6.25,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95108,1183,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,4.19,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
95111,1188,2519,ATP-dependent molecular chaperone HSP82,Cytosolic other,P02829,HSP82,HSP82_YEAST,6.15,,EC50,,WOMBAT-PK,=,,,,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
95112,1188,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.1,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163811,38,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201293,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163812,2336,2804,GABA A receptor alpha-1/beta-1/gamma-2,Ion channel,P14867|P18505|P18507,GABRA1|GABRB1|GABRG2,GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN,7.7077,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200472,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163813,2974,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237099,ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163814,2811,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.8239,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200629,ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163815,2781,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.6198,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163816,2396,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.7696,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200648,ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163817,2271,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,4.342,,IC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163818,2183,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200722,ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163819,2052,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,8.2007,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185073,ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163820,1822,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL984,ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163821,908,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.7447,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1259,ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163822,661,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,8,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200641,ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163823,259,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.7696,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1360,ANTAGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
163824,109,2798,Acetylcholine receptor,Ion channel,P02708|P11230|Q07001,CHRNA1|CHRNB1|CHRND,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163825,2873,2794,GABA A receptor alpha-3/beta-2/gamma-3,Ion channel,P34903|P47870|Q99928,GABRA3|GABRB2|GABRG3,GBRA3_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,6.4881,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021476s030lbl.pdf,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,292,Homo sapiens
163826,2729,2794,GABA A receptor alpha-3/beta-2/gamma-3,Ion channel,P34903|P47870|Q99928,GABRA3|GABRB2|GABRG3,GBRA3_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,8.1079,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163827,1802,2794,GABA A receptor alpha-3/beta-2/gamma-3,Ion channel,P34903|P47870|Q99928,GABRA3|GABRB2|GABRG3,GBRA3_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,7.6126,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL655,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163828,1202,2794,GABA A receptor alpha-3/beta-2/gamma-3,Ion channel,P34903|P47870|Q99928,GABRA3|GABRB2|GABRG3,GBRA3_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,7.5003,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163829,1068,2794,GABA A receptor alpha-3/beta-2/gamma-3,Ion channel,P34903|P47870|Q99928,GABRA3|GABRB2|GABRG3,GBRA3_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163830,2873,2737,GABA-A receptor alpha-1/beta-2/gamma-3,Ion channel,P14867|P47870|Q99928,GABRA1|GABRB2|GABRG3,GBRA1_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,7.1549,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021476s030lbl.pdf,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,292,Homo sapiens
163831,2729,2737,GABA-A receptor alpha-1/beta-2/gamma-3,Ion channel,P14867|P47870|Q99928,GABRA1|GABRB2|GABRG3,GBRA1_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,8.6383,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163832,1802,2737,GABA-A receptor alpha-1/beta-2/gamma-3,Ion channel,P14867|P47870|Q99928,GABRA1|GABRB2|GABRG3,GBRA1_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,7.7496,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL655,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163833,1202,2737,GABA-A receptor alpha-1/beta-2/gamma-3,Ion channel,P14867|P47870|Q99928,GABRA1|GABRB2|GABRG3,GBRA1_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,7.4572,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
163834,1068,2737,GABA-A receptor alpha-1/beta-2/gamma-3,Ion channel,P14867|P47870|Q99928,GABRA1|GABRB2|GABRG3,GBRA1_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
163840,2755,2526,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q27783,,DRTS_TRYBB,8,,Ki,,WOMBAT-PK,=,,,,,,,,,,Trypanosoma brucei brucei
163841,2332,2526,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q27783,,DRTS_TRYBB,7.9586,,Ki,,WOMBAT-PK,=,,,,,,,,,,Trypanosoma brucei brucei
163842,1813,2531,30S ribosomal protein S9,Unclassified,Q9Z8T8,rpsI,RS9_CHLPN,5.7559,,Ka,,WOMBAT-PK,=,,,,,,,,,,Chlamydia pneumoniae
163843,1813,2530,30S ribosomal protein S4,Unclassified,Q9Z7H2,rpsD,RS4_CHLPN,6,,Ka,,WOMBAT-PK,=,,,,,,,,,,Chlamydia pneumoniae
163845,1193,2520,Transient receptor potential cation channel subfamily M member 5,Ion channel,Q9NZQ8,TRPM5,TRPM5_HUMAN,4.6198,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163846,2600,2511,Heat shock protein HSP 90-alpha,Cytosolic other,P07900,HSP90AA1,HS90A_HUMAN,5.46,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163847,2266,2511,Heat shock protein HSP 90-alpha,Cytosolic other,P07900,HSP90AA1,HS90A_HUMAN,8.2218,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163848,1803,2511,Heat shock protein HSP 90-alpha,Cytosolic other,P07900,HSP90AA1,HS90A_HUMAN,7.699,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163849,1239,2511,Heat shock protein HSP 90-alpha,Cytosolic other,P07900,HSP90AA1,HS90A_HUMAN,8.5229,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163850,2684,2498,"Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)",Enzyme,O32553,mphB,O32553_ECOLX,5.8239,,Km,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli
163851,1519,2498,"Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)",Enzyme,O32553,mphB,O32553_ECOLX,5.6778,,Km,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli
163852,1486,2498,"Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)",Enzyme,O32553,mphB,O32553_ECOLX,4.8697,,Km,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli
163853,855,2498,"Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)",Enzyme,O32553,mphB,O32553_ECOLX,5.9208,,Km,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli
163854,157,2498,"Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)",Enzyme,O32553,mphB,O32553_ECOLX,4.2013,,Km,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli
163855,2561,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.0605,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163856,2440,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.5376,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163857,2346,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.0605,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163858,2291,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.6021,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163859,1794,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.2596,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163860,1475,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.8239,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163861,2376,2467,DNA-directed RNA polymerase subunit beta,Enzyme,P9WGY9,rpoB,RPOB_MYCTU,8,,Ki,,WOMBAT-PK,=,,,,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
163862,254,2446,UDP-glucuronosyltransferase 1-1,Enzyme,P22309,UGT1A1,UD11_HUMAN,5.7212,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163863,2755,2308,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q27793,,DRTS_TRYCR,6,,Ki,,WOMBAT-PK,=,,,,,,,,,,Trypanosoma cruzi
163864,2332,2308,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q27793,,DRTS_TRYCR,7.0088,,Ki,,WOMBAT-PK,=,,,,,,,,,,Trypanosoma cruzi
163865,1813,2124,"Tetracycline resistance protein, class B",Transporter,P02980,tetA,TCR2_ECOLX,5.6383,,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli
163866,2846,2119,Lanosterol 14-alpha demethylase,Enzyme,P9WPP9,cyp51,CP51_MYCTU,5.8444,,MIC,,WOMBAT-PK,=,,,,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
163867,2755,1831,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,P07382,,DRTS_LEIMA,6.9208,,Ki,,WOMBAT-PK,=,,,,,,,,,,Leishmania major
163868,2332,1831,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,P07382,,DRTS_LEIMA,6.6021,,Ki,,WOMBAT-PK,=,,,,,,,,,,Leishmania major
163869,2615,1781,Dihydrofolate reductase,Enzyme,P0ABQ4,folA,DYR_ECOLI,8.35,,Ki,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
163870,398,1781,Dihydrofolate reductase,Enzyme,P0ABQ4,folA,DYR_ECOLI,8.18,,Ki,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
163871,2346,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,4.1062,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163872,2303,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,4.2967,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163873,2291,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,4.8447,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163874,630,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,4.3298,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163875,342,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,5.3098,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163876,231,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,4.3595,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163877,176,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,5.3468,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163878,191,1535,Sodium- and chloride-dependent glycine transporter 2,Transporter,Q9Y345,SLC6A5,SC6A5_HUMAN,4.0362,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163879,559,1418,Penicillin-binding protein 1B,Enzyme,P02919,mrcB,PBPB_ECOLI,4.9595,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL44354,INHIBITOR,,,,,Escherichia coli (strain K12)
163880,558,1418,Penicillin-binding protein 1B,Enzyme,P02919,mrcB,PBPB_ECOLI,5.3284,,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
163881,559,1417,Penicillin-binding protein 1A,Enzyme,P02918,mrcA,PBPA_ECOLI,6.5335,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL44354,INHIBITOR,,,,,Escherichia coli (strain K12)
163882,558,1417,Penicillin-binding protein 1A,Enzyme,P02918,mrcA,PBPA_ECOLI,6.5222,,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
163883,231,1330,Sodium/calcium exchanger 1,Transporter,P32418,SLC8A1,NAC1_HUMAN,4.301,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163884,2071,1237,DNA gyrase subunit B,Enzyme,P0AES6,gyrB,GYRB_ECOLI,6.7852,,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
163885,2862,849,Cysteinyl leukotriene receptor 2,GPCR,Q9NS75,CYSLTR2,CLTR2_HUMAN,5.824,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163888,2534,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163889,461,566,Myeloperoxidase,Enzyme,P05164,MPO,PERM_HUMAN,5.301,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163890,1576,564,ATP-sensitive inward rectifier potassium channel 8,Ion channel,Q15842,KCNJ8,KCNJ8_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163894,834,558,Cholecystokinin receptor type A,GPCR,P32238,CCKAR,CCKAR_HUMAN,6.8861,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163895,355,557,Solute carrier family 22 member 8,Transporter,Q8TCC7,SLC22A8,S22A8_HUMAN,4.32,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163896,355,556,Solute carrier family 22 member 6,Transporter,Q4U2R8,SLC22A6,S22A6_HUMAN,4.62,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163898,217,554,Plasminogen activator inhibitor 1,Secreted,P05121,SERPINE1,PAI1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163899,2632,552,Hypoxanthine-guanine phosphoribosyltransferase,Enzyme,P00492,HPRT1,HPRT_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163901,2366,547,Solute carrier organic anion transporter family member 1B1,Transporter,Q9Y6L6,SLCO1B1,SO1B1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163902,1548,547,Solute carrier organic anion transporter family member 1B1,Transporter,Q9Y6L6,SLCO1B1,SO1B1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163904,226,528,"Arachidonate 12-lipoxygenase, 12R-type",Enzyme,O75342,ALOX12B,LX12B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163905,987,524,Ceramide glucosyltransferase,Enzyme,Q16739,UGCG,CEGT_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163906,1310,523,"Glutamate dehydrogenase 2, mitochondrial",Enzyme,P49448,GLUD2,DHE4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163907,1310,522,"Glutamate dehydrogenase 1, mitochondrial",Enzyme,P00367,GLUD1,DHE3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163908,1550,519,Aspartyl/asparaginyl beta-hydroxylase,Enzyme,Q12797,ASPH,ASPH_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163909,1550,517,"Aspartate aminotransferase, mitochondrial",Enzyme,P00505,GOT2,AATM_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163910,1550,516,Aminoacylase-1,Enzyme,Q03154,ACY1,ACY1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163911,1550,515,Argininosuccinate synthase,Enzyme,P00966,ASS1,ASSY_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163912,1550,514,Asparagine synthetase [glutamine-hydrolyzing],Enzyme,P08243,ASNS,ASNS_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163913,1550,513,Aspartoacylase,Enzyme,P45381,ASPA,ACY2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163914,1550,512,"Aspartate aminotransferase, cytoplasmic",Enzyme,P17174,GOT1,AATC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163915,1550,511,Calcium-binding mitochondrial carrier protein Aralar1,Unclassified,O75746,SLC25A12,CMC1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163918,2616,503,Tumor necrosis factor,Cytokine,P01375,TNF,TNFA_HUMAN,8,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163919,2655,500,Steryl-sulfatase,Enzyme,P08842,STS,STS_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163920,1806,496,Pancreatic alpha-amylase,Enzyme,P04746,AMY2A,AMYP_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163921,631,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,7.4,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163922,2666,488,V-type proton ATPase 116 kDa subunit a isoform 3,Enzyme,Q13488,TCIRG1,VPP3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163923,2767,483,"Glycogen [starch] synthase, liver",Enzyme,P54840,GYS2,GYS2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163924,1872,477,Squalene monooxygenase,Enzyme,Q14534,SQLE,ERG1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163925,2834,476,Riboflavin kinase,Kinase,Q969G6,RFK,RIFK_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163926,2834,475,Flavin reductase (NADPH),Enzyme,P30043,BLVRB,BLVRB_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163927,1935,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,5.7,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163928,1990,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.301,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163929,1826,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163930,2831,468,Retinal dehydrogenase 1,Enzyme,P00352,ALDH1A1,AL1A1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163931,2831,467,Retinal dehydrogenase 2,Enzyme,O94788,ALDH1A2,AL1A2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163932,2831,466,Retinol-binding protein 2,Cytosolic other,P50120,RBP2,RET2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163933,2831,464,Retinoid-binding protein 7,Cytosolic other,Q96R05,RBP7,RET7_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163934,2831,463,Retinol-binding protein 5,Cytosolic other,P82980,RBP5,RET5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163935,2831,461,Retinol dehydrogenase 13,Enzyme,Q8NBN7,RDH13,RDH13_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tdark,,,Homo sapiens
163936,2831,460,Retinol dehydrogenase 12,Enzyme,Q96NR8,RDH12,RDH12_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163937,2840,459,"Sterol 26-hydroxylase, mitochondrial",Enzyme,Q02318,CYP27A1,CP27A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163938,2832,455,Thiamine-triphosphatase,Enzyme,Q9BU02,THTPA,THTPA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163939,2832,454,Thiamin pyrophosphokinase 1,Kinase,Q9H3S4,TPK1,TPK1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
95234,1277,2522,Capsid scaffolding protein,Enzyme,P10210,UL26,SCAF_HHV11,6.07,,EC50,,WOMBAT-PK,=,,,,,,,,,,Human herpesvirus 1 (strain 17)
95235,1277,694,Metabotropic glutamate receptor 5,GPCR,P41594,GRM5,GRM5_HUMAN,5.41,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
95236,1277,521,Metabotropic glutamate receptor 1,GPCR,Q13255,GRM1,GRM1_HUMAN,6.05,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163940,2832,453,Transketolase,Enzyme,P29401,TKT,TKT_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163941,2832,452,Thiamine transporter 1,Transporter,O60779,SLC19A2,S19A2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163942,2836,451,Phosphoserine aminotransferase,Enzyme,Q9Y617,PSAT1,SERC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163943,2836,450,Cystathionine beta-synthase,Enzyme,P35520,CBS,CBS_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163944,2836,449,Pyridoxal kinase,Kinase,O00764,PDXK,PDXK_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163945,2836,448,Pyridoxal phosphate phosphatase,Enzyme,Q96GD0,PDXP,PLPP_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163946,2836,447,Pyridoxine-5'-phosphate oxidase,Enzyme,Q9NVS9,PNPO,PNPO_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163948,1820,444,"Adrenodoxin, mitochondrial",Unclassified,P10109,FDX1,ADX_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163949,2446,442,Peptidyl-prolyl cis-trans isomerase FKBP3,Enzyme,Q00688,FKBP3,FKBP3_HUMAN,9.7,,Kd,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
163950,2042,435,Oxytocin-neurophysin 1,Secreted,P01178,OXT,NEU1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163951,1811,433,Ribonucleoside-diphosphate reductase large subunit,Enzyme,P08543,,RIR1_HHV11,4.39,,IC50,,WOMBAT-PK,=,,,,,,,,,,Human herpesvirus 1 (strain 17)
163952,1811,432,Tyrosinase,Enzyme,P14679,TYR,TYRO_HUMAN,5.43,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163953,2836,431,"Serine hydroxymethyltransferase, cytosolic",Enzyme,P34896,SHMT1,GLYC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163954,1811,431,"Serine hydroxymethyltransferase, cytosolic",Enzyme,P34896,SHMT1,GLYC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163955,2840,430,Vitamin D 25-hydroxylase,Enzyme,Q6VVX0,CYP2R1,CP2R1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163956,2838,430,Vitamin D 25-hydroxylase,Enzyme,Q6VVX0,CYP2R1,CP2R1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163957,2840,428,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",Enzyme,O15528,CYP27B1,CP27B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163958,2838,428,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",Enzyme,O15528,CYP27B1,CP27B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163959,2666,424,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163960,690,424,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163961,690,423,ADP/ATP translocase 3,Enzyme,P12236,SLC25A6,ADT3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163962,690,422,ADP/ATP translocase 1,Transporter,P12235,SLC25A4,ADT1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163963,690,421,ADP/ATP translocase 2,Enzyme,P05141,SLC25A5,ADT2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163964,2809,420,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",Enzyme,P54750,PDE1A,PDE1A_HUMAN,7.041,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163965,2809,412,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",Enzyme,P16499,PDE6A,PDE6A_HUMAN,7.4647,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163966,2441,412,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",Enzyme,P16499,PDE6A,PDE6A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163968,2859,410,Neuraminidase,Enzyme,P16207,NA,NRAM_INBVI,8.4,,IC50,,WOMBAT-PK,=,,,,,,,,,,Influenza B virus (strain B/Victoria/3/1985)
163969,2001,410,Neuraminidase,Enzyme,P16207,NA,NRAM_INBVI,8.1,,IC50,,WOMBAT-PK,=,,,,,,,,,,Influenza B virus (strain B/Victoria/3/1985)
164021,2865,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,6.44,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163970,4300,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,8,,IC50,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
163971,4143,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,9.6576,,Ki,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
163972,2422,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,10.1871,,Ki,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
163973,2391,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,9.23,,Ki,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
163974,1437,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,9.2218,,IC50,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
163975,254,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,8.5751,,Ki,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
163976,942,397,Potassium channel subfamily K member 2,Ion channel,O95069,KCNK2,KCNK2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163978,2042,392,Vasopressin V2 receptor,GPCR,P30518,AVPR2,V2R_HUMAN,6.1,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163979,2042,391,Vasopressin V1b receptor,GPCR,P47901,AVPR1B,V1BR_HUMAN,6.35,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163980,2042,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,6.9101,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163981,1446,388,"DNA topoisomerase I, mitochondrial",Enzyme,Q969P6,TOP1MT,TOP1M_HUMAN,6.52,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163983,1672,380,Nuclear receptor ROR-alpha,Nuclear hormone receptor,P35398,RORA,RORA_HUMAN,9,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
163984,1672,379,Melatonin receptor type 1B,GPCR,P49286,MTNR1B,MTR1B_HUMAN,9.7,,EC50,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=224,AGONIST,,Tclin,,,Homo sapiens
163985,1672,378,Melatonin receptor type 1A,GPCR,P48039,MTNR1A,MTR1A_HUMAN,9.4,,EC50,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=224,AGONIST,,Tclin,,,Homo sapiens
163986,1225,377,Cytosolic phospholipase A2,Enzyme,P47712,PLA2G4A,PA24A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163987,2130,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
163988,2351,372,Interleukin-6,Cytokine,P05231,IL6,IL6_HUMAN,8.05,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163989,4349,367,"Thioredoxin reductase 1, cytoplasmic",Enzyme,Q16881,TXNRD1,TRXR1_HUMAN,8.398,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
163991,2784,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,7.16,,EC50,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/21073468,AGONIST,,Tclin,,377,Homo sapiens
163993,2835,365,Nicotinamide phosphoribosyltransferase,Enzyme,P43490,NAMPT,NAMPT_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163994,2835,364,Nicotinate-nucleotide pyrophosphorylase [carboxylating],Enzyme,Q15274,QPRT,NADC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163995,1906,364,Nicotinate-nucleotide pyrophosphorylase [carboxylating],Enzyme,Q15274,QPRT,NADC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
163996,2835,363,Nicotinamide N-methyltransferase,Enzyme,P40261,NNMT,NNMT_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163997,1906,363,Nicotinamide N-methyltransferase,Enzyme,P40261,NNMT,NNMT_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
163998,2835,362,Hydroxycarboxylic acid receptor 3,GPCR,P49019,HCAR3,HCAR3_HUMAN,6.52,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1588,,AGONIST,,Tbio,,,Homo sapiens
163999,2818,360,Ribose-phosphate pyrophosphokinase 1,Kinase,P60891,PRPS1,PRPS1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164000,2818,359,"Deoxyguanosine kinase, mitochondrial",Kinase,Q16854,DGUOK,DGUOK_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164001,497,357,Thyroid peroxidase,Enzyme,P07202,TPO,PERT_HUMAN,,,,,WOMBAT-PK,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/1278093,INHIBITOR,,Tclin,,567,Homo sapiens
164002,2126,355,5'-AMP-activated protein kinase subunit beta-1,Kinase,Q9Y478,PRKAB1,AAKB1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164003,1725,355,5'-AMP-activated protein kinase subunit beta-1,Kinase,Q9Y478,PRKAB1,AAKB1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164005,1836,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,4.3279,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164006,1824,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164007,873,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
95396,1497,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.31,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95397,1497,1066,Cytochrome P450 3A5,Enzyme,P20815,CYP3A5,CP3A5_HUMAN,4.96,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164008,2525,352,"Acetyl-CoA acetyltransferase, mitochondrial",Enzyme,P24752,ACAT1,THIL_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164010,2106,348,"Carnitine O-palmitoyltransferase 1, liver isoform",Enzyme,P50416,CPT1A,CPT1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164011,1193,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,6.1,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164012,2797,346,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164013,1193,346,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,6,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164014,1193,345,Aldo-keto reductase family 1 member C1,Enzyme,Q04828,AKR1C1,AK1C1_HUMAN,5.22,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164015,1889,343,Cysteinyl leukotriene receptor 1,GPCR,Q9Y271,CYSLTR1,CLTR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164016,631,341,Prostacyclin receptor,GPCR,P43119,PTGIR,PI2R_HUMAN,7.8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164017,343,341,Prostacyclin receptor,GPCR,P43119,PTGIR,PI2R_HUMAN,8.37,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2009/10/WC500005871.pdf,AGONIST,,Tclin,,122,Homo sapiens
164018,1422,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,7.3,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164019,1016,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,7.9,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164020,631,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,6.6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164022,1042,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,7.7,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164023,1327,337,Lutropin-choriogonadotropic hormone receptor,GPCR,P22888,LHCGR,LSHR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164024,436,337,Lutropin-choriogonadotropic hormone receptor,GPCR,P22888,LHCGR,LSHR_HUMAN,8.5686,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164025,1433,332,Potassium voltage-gated channel subfamily KQT member 1,Ion channel,P51787,KCNQ1,KCNQ1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164026,1388,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,7.881,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164027,1034,327,P2Y purinoceptor 12,GPCR,Q9H244,P2RY12,P2Y12_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164028,1238,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,7.5686,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164029,2818,324,Ribonucleoside-diphosphate reductase subunit M2,Enzyme,P31350,RRM2,RIR2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164030,1399,324,Ribonucleoside-diphosphate reductase subunit M2,Enzyme,P31350,RRM2,RIR2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL467,INHIBITOR,,Tclin,,,Homo sapiens
164031,1283,324,Ribonucleoside-diphosphate reductase subunit M2,Enzyme,P31350,RRM2,RIR2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL888,INHIBITOR,,Tclin,,,Homo sapiens
164032,1189,324,Ribonucleoside-diphosphate reductase subunit M2,Enzyme,P31350,RRM2,RIR2_HUMAN,6,,IC50,Inhibition of ADP reduction by ribonucleotide reductase from HeLa cells,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4802,,INHIBITOR,,Tclin,,,Homo sapiens
164034,691,324,Ribonucleoside-diphosphate reductase subunit M2,Enzyme,P31350,RRM2,RIR2_HUMAN,8.3,,IC50,Inhibition of growth of K562 cells,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6802,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1750,INHIBITOR,,Tclin,,,Homo sapiens
164035,2818,323,Ribonucleoside-diphosphate reductase large subunit,Enzyme,P23921,RRM1,RIR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164036,1399,323,Ribonucleoside-diphosphate reductase large subunit,Enzyme,P23921,RRM1,RIR1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL467,INHIBITOR,,Tclin,,,Homo sapiens
164037,1283,323,Ribonucleoside-diphosphate reductase large subunit,Enzyme,P23921,RRM1,RIR1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL888,INHIBITOR,,Tclin,,,Homo sapiens
164038,1189,323,Ribonucleoside-diphosphate reductase large subunit,Enzyme,P23921,RRM1,RIR1_HUMAN,6,,IC50,Inhibition of ADP reduction by ribonucleotide reductase from HeLa cells,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4802,,INHIBITOR,,Tclin,,,Homo sapiens
164040,691,323,Ribonucleoside-diphosphate reductase large subunit,Enzyme,P23921,RRM1,RIR1_HUMAN,8.3,,IC50,Inhibition of K562 cell growth,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6802,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1750,INHIBITOR,,Tclin,,,Homo sapiens
164041,2818,322,DNA polymerase alpha catalytic subunit,Enzyme,P09884,POLA1,DPOLA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164042,1524,320,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,6.1549,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164043,2872,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,8.301,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164044,2799,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.57,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164045,1599,317,"Glutamate receptor ionotropic, NMDA 2D",Ion channel,O15399,GRIN2D,NMDE4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164046,1599,316,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,Q14957,GRIN2C,NMDE3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164047,1599,315,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,Q13224,GRIN2B,NMDE2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164048,2767,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164049,2133,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164050,788,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164051,2071,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,4.0969,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164052,2068,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,4.96,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164053,1990,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,4.74,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164054,1826,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,4.3958,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164055,1230,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.07,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164056,1223,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.3565,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164057,254,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,4.9208,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164058,867,311,NAD(P)H dehydrogenase [quinone] 1,Enzyme,P15559,NQO1,NQO1_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164059,559,310,Peptidoglycan synthase FtsI,Enzyme,P0AD68,ftsI,FTSI_ECOLI,6.2605,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL44354,INHIBITOR,,,,,Escherichia coli (strain K12)
164060,266,304,Xanthine dehydrogenase/oxidase,Enzyme,P47989,XDH,XDH_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164061,1215,303,Potassium voltage-gated channel subfamily KQT member 3,Ion channel,O43525,KCNQ3,KCNQ3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164062,2078,301,Alpha-1-acid glycoprotein 1,Secreted,P02763,ORM1,A1AG1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164063,2856,300,Deoxycytidine kinase,Kinase,P27707,DCK,DCK_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164064,2818,300,Deoxycytidine kinase,Kinase,P27707,DCK,DCK_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164065,1904,299,Gag-Pol polyprotein,Polyprotein,P03369,gag-pol,POL_HV1A2,7.0969,,IC50,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2)
164066,1115,299,Gag-Pol polyprotein,Polyprotein,P03369,gag-pol,POL_HV1A2,9,,IC50,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2)
164067,34,299,Gag-Pol polyprotein,Polyprotein,P03369,gag-pol,POL_HV1A2,5.2757,,EC50,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate ARV2/SF2)
164068,1091,298,Vitamin K epoxide reductase complex subunit 1,Enzyme,Q9BQB6,VKORC1,VKOR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164069,3584,297,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,P16083,NQO2,NQO2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164070,429,297,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,P16083,NQO2,NQO2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164071,2709,296,Estrogen-related receptor gamma,Nuclear hormone receptor,P62508,ESRRG,ERR3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164072,2561,296,Estrogen-related receptor gamma,Nuclear hormone receptor,P62508,ESRRG,ERR3_HUMAN,7.1,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164073,2561,295,G-protein coupled estrogen receptor 1,GPCR,Q99527,GPER1,GPER1_HUMAN,7.5,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164074,2351,295,G-protein coupled estrogen receptor 1,GPCR,Q99527,GPER1,GPER1_HUMAN,6.5,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164075,1255,295,G-protein coupled estrogen receptor 1,GPCR,Q99527,GPER1,GPER1_HUMAN,7,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164076,1057,295,G-protein coupled estrogen receptor 1,GPCR,Q99527,GPER1,GPER1_HUMAN,9.52,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164077,2561,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,5.91,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164079,1057,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,9.7,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164080,2552,292,Interleukin-2,Cytokine,P60568,IL2,IL2_HUMAN,9.72,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164081,2168,292,Interleukin-2,Cytokine,P60568,IL2,IL2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164082,1982,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,6.5086,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164083,1796,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,8.06,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164085,1584,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,4.5,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164086,788,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164087,749,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164088,4115,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,8.6,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164090,2389,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.6866,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164091,1643,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.9208,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164092,888,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164093,2373,281,Cytosolic purine 5'-nucleotidase,Enzyme,P49902,NT5C2,5NTC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164094,2373,280,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,Enzyme,P22413,ENPP1,ENPP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164095,2373,279,Adenosine kinase,Kinase,P55263,ADK,ADK_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164096,90,279,Adenosine kinase,Kinase,P55263,ADK,ADK_HUMAN,6,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164097,2332,276,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q07422,,DRTS_TOXGO,6.4089,,IC50,,WOMBAT-PK,=,,,,,,,,,,Toxoplasma gondii
164099,2106,270,Voltage-dependent T-type calcium channel subunit alpha-1I,Ion channel,Q9P0X4,CACNA1I,CAC1I_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164101,2106,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,5.3565,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164102,1947,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,5.0555,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164103,1942,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,5.3372,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164104,1937,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,5.2518,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164105,1922,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,4.6716,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164106,1909,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,5.5528,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164107,1511,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,5.50863,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164108,1142,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,5.1675,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164109,837,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,5.8239,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164110,183,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,4.50724,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164111,176,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,5.284,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164112,2847,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.8665,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164113,2546,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.3468,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164114,2302,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.9101,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164115,2145,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.72,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164116,1990,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.3468,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164118,1912,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,7.0458,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164119,1663,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.301,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164120,1585,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6.301,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164121,1407,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.3,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164956,2298,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164122,254,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.9208,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164123,176,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,7.3979,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164124,2145,267,Prostacyclin synthase,Enzyme,Q16647,PTGIS,PTGIS_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164125,2036,267,Prostacyclin synthase,Enzyme,Q16647,PTGIS,PTGIS_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164126,2825,266,Multidrug resistance-associated protein 7,Transporter,Q5T3U5,ABCC10,MRP7_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164127,2823,266,Multidrug resistance-associated protein 7,Transporter,Q5T3U5,ABCC10,MRP7_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164128,2044,266,Multidrug resistance-associated protein 7,Transporter,Q5T3U5,ABCC10,MRP7_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164129,2044,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164131,2528,263,fMet-Leu-Phe receptor,GPCR,P21462,FPR1,FPR1_HUMAN,4.7,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164132,2145,263,fMet-Leu-Phe receptor,GPCR,P21462,FPR1,FPR1_HUMAN,4.69,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164133,2036,263,fMet-Leu-Phe receptor,GPCR,P21462,FPR1,FPR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164134,2013,263,fMet-Leu-Phe receptor,GPCR,P21462,FPR1,FPR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164139,1599,260,Somatostatin receptor type 5,GPCR,P35346,SSTR5,SSR5_HUMAN,5.3449,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164140,1952,255,Atrial natriuretic peptide receptor 1,Enzyme,P16066,NPR1,ANPRA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164141,1919,255,Atrial natriuretic peptide receptor 1,Enzyme,P16066,NPR1,ANPRA_HUMAN,7.2,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164142,2715,254,Cytochrome P450 2A6,Enzyme,P11509,CYP2A6,CP2A6_HUMAN,7.187,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164143,2657,254,Cytochrome P450 2A6,Enzyme,P11509,CYP2A6,CP2A6_HUMAN,6.7,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164144,1920,254,Cytochrome P450 2A6,Enzyme,P11509,CYP2A6,CP2A6_HUMAN,5.3565,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164145,2440,253,Potassium voltage-gated channel subfamily D member 3,Ion channel,Q9UK17,KCND3,KCND3_HUMAN,4.7,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164146,1920,253,Potassium voltage-gated channel subfamily D member 3,Ion channel,Q9UK17,KCND3,KCND3_HUMAN,7.4,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164147,4,253,Potassium voltage-gated channel subfamily D member 3,Ion channel,Q9UK17,KCND3,KCND3_HUMAN,4.5,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164148,2752,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164149,1920,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,5.39,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164151,1646,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,5.1612,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164152,406,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.17,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164153,2572,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,7.8239,,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
164154,3424,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,7.3071,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164155,1845,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,6.62,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164157,1599,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,6.9101,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164158,1526,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,6.844664,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164159,1919,248,ATP-sensitive inward rectifier potassium channel 1,Ion channel,P48048,KCNJ1,KCNJ1_HUMAN,5.95,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164160,1814,248,ATP-sensitive inward rectifier potassium channel 1,Ion channel,P48048,KCNJ1,KCNJ1_HUMAN,6.97,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164161,1822,246,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,Q15822,CHRNA2,ACHA2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164162,737,246,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,Q15822,CHRNA2,ACHA2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164163,374,246,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,Q15822,CHRNA2,ACHA2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164164,109,246,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,Q15822,CHRNA2,ACHA2_HUMAN,4.7212,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164165,2775,245,5-hydroxytryptamine receptor 4,GPCR,Q13639,HTR4,5HT4R_HUMAN,6.85,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164166,1762,244,Aromatic-L-amino-acid decarboxylase,Enzyme,P20711,DDC,DDC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164167,314,244,Aromatic-L-amino-acid decarboxylase,Enzyme,P20711,DDC,DDC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164168,2632,243,Multidrug resistance-associated protein 4,Transporter,O15439,ABCC4,MRP4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164169,1751,243,Multidrug resistance-associated protein 4,Transporter,O15439,ABCC4,MRP4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164170,2757,242,"Folylpolyglutamate synthase, mitochondrial",Enzyme,Q05932,FPGS,FOLC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164171,2073,242,"Folylpolyglutamate synthase, mitochondrial",Enzyme,Q05932,FPGS,FOLC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164172,986,242,"Folylpolyglutamate synthase, mitochondrial",Enzyme,Q05932,FPGS,FOLC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164173,986,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,8.36,,IC50,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D03942,INHIBITOR,,Tclin,,,Homo sapiens
164174,2752,239,Neuronal acetylcholine receptor subunit alpha-10,Ion channel,Q9GZZ6,CHRNA10,ACH10_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164175,2096,239,Neuronal acetylcholine receptor subunit alpha-10,Ion channel,Q9GZZ6,CHRNA10,ACH10_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164176,1728,239,Neuronal acetylcholine receptor subunit alpha-10,Ion channel,Q9GZZ6,CHRNA10,ACH10_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164177,2725,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164178,2655,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165141,4196,2713,Transcobalamin-1,Secreted,P20061,TCN1,TCO1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164179,2475,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.0286,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164180,1832,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.9,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164181,766,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.678,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164182,1508,235,17-beta-hydroxysteroid dehydrogenase type 6,Enzyme,O14756,HSD17B6,H17B6_HUMAN,5.398,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164183,2831,234,11-cis retinol dehydrogenase,Enzyme,Q92781,RDH5,RDH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164184,2722,234,11-cis retinol dehydrogenase,Enzyme,Q92781,RDH5,RDH1_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164185,1508,234,11-cis retinol dehydrogenase,Enzyme,Q92781,RDH5,RDH1_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164186,1508,233,Dehydrogenase/reductase SDR family member 9,Enzyme,Q9BPW9,DHRS9,DHRS9_HUMAN,4.523,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164187,1508,232,Alcohol dehydrogenase 4,Enzyme,P08319,ADH4,ADH4_HUMAN,5.523,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164188,1508,231,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,8.2291,,ED50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164189,1116,231,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL464,AGONIST,,Tclin,,,Homo sapiens
164190,78,231,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,,,,Mechanism of Action,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1131,AGONIST,,Tclin,,,Homo sapiens
164191,1426,225,Penicillin-binding protein 1,Enzyme,A1KS91,ponA,A1KS91_NEIMF,7,,IC50,,WOMBAT-PK,=,,,,,,,,,,Neisseria meningitidis serogroup C / serotype 2a (strain ATCC 700532 / DSM 15464 / FAM18)
164192,1426,223,Penicillin-binding protein 4,Enzyme,Q5D1E9,,Q5D1E9_STAAU,7.3,,IC50,,WOMBAT-PK,=,,,,,,,,,,Staphylococcus aureus
164193,2173,221,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164194,1385,221,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164196,332,221,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164197,305,221,Calcium-activated potassium channel subunit alpha-1,Ion channel,Q12791,KCNMA1,KCMA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164198,1385,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164199,332,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164200,305,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164201,2172,219,Calmodulin,Cytosolic other,P0DP23|P0DP24|P0DP25,CALM1|CALM2|CALM3,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,5.2218,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164202,1599,219,Calmodulin,Cytosolic other,P0DP23|P0DP24|P0DP25,CALM1|CALM2|CALM3,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164203,1353,219,Calmodulin,Cytosolic other,P0DP23|P0DP24|P0DP25,CALM1|CALM2|CALM3,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,6.3,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164204,945,219,Calmodulin,Cytosolic other,P0DP23|P0DP24|P0DP25,CALM1|CALM2|CALM3,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164205,249,219,Calmodulin,Cytosolic other,P0DP23|P0DP24|P0DP25,CALM1|CALM2|CALM3,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,6,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164206,231,219,Calmodulin,Cytosolic other,P0DP23|P0DP24|P0DP25,CALM1|CALM2|CALM3,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,4.7447,,ID50,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/6186851,INHIBITOR,,Tclin,,320,Homo sapiens
164207,2361,218,G protein-activated inward rectifier potassium channel 2,Ion channel,P48051,KCNJ6,KCNJ6_HUMAN,4.1938,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164208,256,218,G protein-activated inward rectifier potassium channel 2,Ion channel,P48051,KCNJ6,KCNJ6_HUMAN,4.2823,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164216,1836,216,Cytochrome P450 2C8,Enzyme,P10632,CYP2C8,CP2C8_HUMAN,5.958,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164217,1285,216,Cytochrome P450 2C8,Enzyme,P10632,CYP2C8,CP2C8_HUMAN,5.74,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164218,2255,214,Large neutral amino acids transporter small subunit 1,Transporter,Q01650,SLC7A5,LAT1_HUMAN,3.8013,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164219,1264,214,Large neutral amino acids transporter small subunit 1,Transporter,Q01650,SLC7A5,LAT1_HUMAN,4.5229,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164220,2872,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,7.2518,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164221,2302,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,4.71,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164222,1563,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164224,332,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164225,305,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164226,2632,210,Multidrug resistance-associated protein 5,Transporter,O15440,ABCC5,MRP5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164227,1751,210,Multidrug resistance-associated protein 5,Transporter,O15440,ABCC5,MRP5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164228,1232,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,4.0706,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164230,958,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164231,1171,207,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,P18405,SRD5A1,S5A1_HUMAN,7.58,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020788s024lbl.pdf,INHIBITOR,,Tclin,,107,Homo sapiens
164233,2872,204,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164235,2106,204,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164236,1563,204,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164237,2698,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,4.33,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164238,2655,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164239,1963,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.12,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164240,1962,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.12,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164241,1805,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.33,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164243,1659,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.2,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164244,1650,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,4.19,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164245,1193,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,4.12,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164246,1122,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164247,1082,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.3,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164248,968,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.5,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164249,766,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.432,,IC50,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2865,ANTAGONIST,,Tclin,,,Homo sapiens
164250,213,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164251,2351,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.4,,IC50,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2820,ANTAGONIST,,Tclin,,,Homo sapiens
164252,2033,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164253,1882,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.7,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164254,1572,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164256,1110,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164257,1095,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164259,610,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164260,1076,201,Glycine receptor subunit alpha-2,Ion channel,P23416,GLRA2,GLRA2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164261,1076,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164262,1009,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,POSITIVE MODULATOR,,Tclin,,,Homo sapiens
164263,2382,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164264,1728,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164265,1690,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164266,1526,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,4.585,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164267,1264,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164268,1086,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164269,1076,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164270,1594,195,DNA gyrase subunit A,Enzyme,P43700,gyrA,GYRA_HAEIN,5.15,,IC50,,WOMBAT-PK,=,,,,,,,,,,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)
164271,1751,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164272,1634,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
95660,1709,2500,Streptokinase A,Enzyme,P10520,ska,STRP_STRP1,6.9,,EC50,,WOMBAT-PK,=,,,,,,,,,,Streptococcus pyogenes serotype M1
95667,1744,2515,NH(3)-dependent NAD(+) synthetase,Unclassified,P18843,nadE,NADE_ECOLI,5.5,,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
95734,1795,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95735,1795,676,Serum albumin,Secreted,P02768,ALB,ALBU_HUMAN,4.18,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
95737,1795,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.17,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95738,1795,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,4.01,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95739,1795,1255,Interleukin-8,Cytokine,P10145,CXCL8,IL8_HUMAN,7.3,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
95740,1795,216,Cytochrome P450 2C8,Enzyme,P10632,CYP2C8,CP2C8_HUMAN,6.74,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
95741,1795,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.72,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
95743,1795,2525,Interleukin-1 receptor type 1,Membrane receptor,P14778,IL1R1,IL1R1_HUMAN,6.52,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95744,1795,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,5.34,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95745,1795,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,4,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95746,1795,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.41,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95748,1795,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.25,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
95749,1795,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,4.92,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
95750,1795,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,4.89,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
95751,1795,608,Cannabinoid receptor 2,GPCR,P34972,CNR2,CNR2_HUMAN,4.2,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
95752,1795,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,4.33,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95753,1795,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.22,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95755,1795,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,4.33,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95756,1795,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,4.3,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95757,1795,2527,Prostaglandin-H2 D-isomerase,Enzyme,P41222,PTGDS,PTGDS_HUMAN,6.3,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
95758,1795,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,6.12,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
95759,1795,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,4.33,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95760,1795,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,6.68,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95763,1795,527,Prostaglandin D2 receptor,GPCR,Q13258,PTGDR,PD2R_HUMAN,4.92,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
95765,1795,418,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,Q9HCR9,PDE11A,PDE11_HUMAN,5.13,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
95767,1795,228,Prostaglandin D2 receptor 2,GPCR,Q9Y5Y4,PTGDR2,PD2R2_HUMAN,6.26,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164273,1548,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164274,249,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164275,2825,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164276,2823,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164277,2528,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164278,2422,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164279,2172,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,6,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164280,1751,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164281,1423,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164282,1446,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,5.82,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164284,510,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164285,252,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164286,2303,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,4.3188,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164287,1008,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164288,969,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164289,461,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164290,1947,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,5.9208,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164291,1922,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,5.6576,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164292,1193,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,7.25,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164293,2279,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,11,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164294,1805,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,5.68,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164296,4112,182,Voltage-dependent calcium channel gamma-1 subunit,Ion channel,Q06432,CACNG1,CCG1_HUMAN,6.69897,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164297,422,182,Voltage-dependent calcium channel gamma-1 subunit,Ion channel,Q06432,CACNG1,CCG1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164298,195,177,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,Q16568,CARTPT,CART_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164299,4616,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.65,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164300,3424,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,8.6576,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164301,2491,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.7,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164302,1845,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.97,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164304,1690,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.6253,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164305,1599,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.8097,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164306,1526,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.222573,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164307,2480,174,Sodium- and chloride-dependent GABA transporter 1,Transporter,P30531,SLC6A1,SC6A1_HUMAN,4.3,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164308,133,174,Sodium- and chloride-dependent GABA transporter 1,Transporter,P30531,SLC6A1,SC6A1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164309,2796,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.1,,Ki,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D01333,ANTAGONIST,,Tclin,,,Homo sapiens
164311,2389,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,8.48,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164313,2298,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164314,1982,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.5817,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164315,1826,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164316,1342,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164317,1042,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.3665,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164318,945,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.2757,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164319,888,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164320,887,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164321,781,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164322,422,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164323,2865,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,6.4,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164324,2781,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,7.0604,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164326,2271,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,5.5686,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164327,1982,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,6.6946,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164328,1848,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,5.7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164329,1679,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164330,1540,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,4.744,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164332,432,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,4.2328,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164334,2796,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.9,,Ki,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D01333,ANTAGONIST,,Tclin,,,Homo sapiens
164336,1342,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164337,422,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164338,1285,169,Lipoprotein lipase,Enzyme,P06858,LPL,LIPL_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
95901,1875,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.1,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164339,695,169,Lipoprotein lipase,Enzyme,P06858,LPL,LIPL_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164340,362,169,Lipoprotein lipase,Enzyme,P06858,LPL,LIPL_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164341,2572,167,Beta-lactamase,Enzyme,P00807,blaZ,BLAC_STAAU,6.5272,,IC50,,WOMBAT-PK,=,,,,,,,,,,Staphylococcus aureus
164342,669,167,Beta-lactamase,Enzyme,P00807,blaZ,BLAC_STAAU,8.719,,MPC,,WOMBAT-PK,=,,,,,,,,,,Staphylococcus aureus
164343,2071,166,DNA gyrase subunit A,Enzyme,P0AES4,gyrA,GYRA_ECOLI,6.7852,,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
164344,1177,166,DNA gyrase subunit A,Enzyme,P0AES4,gyrA,GYRA_ECOLI,4.79,,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
164346,659,165,DNA gyrase subunit A,Enzyme,P9WG47,gyrA,GYRA_MYCTU,6.2,,IC50,,WOMBAT-PK,=,,,,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
164347,2872,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.99,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164349,2799,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.37,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164350,2537,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.3979,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164351,1385,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164353,332,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164354,305,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164360,1919,159,ATP-sensitive inward rectifier potassium channel 11,Ion channel,Q14654,KCNJ11,KCJ11_HUMAN,5.8861,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164362,1576,159,ATP-sensitive inward rectifier potassium channel 11,Ion channel,Q14654,KCNJ11,KCJ11_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164367,630,159,ATP-sensitive inward rectifier potassium channel 11,Ion channel,Q14654,KCNJ11,KCJ11_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164370,4115,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.71,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164372,3294,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.6,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164373,2298,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164374,2274,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.17,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164376,2113,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.5882,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164377,1677,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.3872,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164378,1443,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.7447,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164379,407,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.8,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164380,312,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.7,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164381,2266,157,Hemoglobin subunit alpha,Secreted,P69905,HBA1,HBA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164382,1395,157,Hemoglobin subunit alpha,Secreted,P69905,HBA1,HBA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164383,816,155,Gamma-aminobutyric acid receptor subunit rho-2,Ion channel,P28476,GABRR2,GBRR2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164384,1264,154,Gamma-aminobutyric acid type B receptor subunit 2,GPCR,O75899,GABBR2,GABR2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164385,816,154,Gamma-aminobutyric acid type B receptor subunit 2,GPCR,O75899,GABBR2,GABR2_HUMAN,8.027,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164386,2056,149,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,Q07343,PDE4B,PDE4B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164387,1015,149,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,Q07343,PDE4B,PDE4B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164388,969,149,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,Q07343,PDE4B,PDE4B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164389,1937,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.0721,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164391,2362,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,4.3979,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164392,1264,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164393,4616,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164394,2393,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,4.8539,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164395,1971,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.2248,,Km,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164397,1677,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164398,1400,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.4089,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164400,945,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.0969,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164401,424,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,4.59,,Ks,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164402,231,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,7.757,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164403,3294,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.53,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164404,2717,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.13,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164405,2436,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.6,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164406,2140,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.8013,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164407,2068,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.3098,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164408,1958,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.31,,Ki,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4792,INHIBITOR,,Tclin,,,Homo sapiens
164409,1890,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.4437,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164410,1690,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164411,1634,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164412,1209,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.4437,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164413,920,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.3767,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164414,618,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.4045,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164415,1422,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,7.7,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164416,1016,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,7.5,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164417,631,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,5.9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164418,4,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164419,1176,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,4.7447,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164420,1563,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164421,1200,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,6.2,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164422,432,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,5.2932,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164423,4,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,5.79,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164424,2350,136,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P05023,ATP1A1,AT1A1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164425,2313,136,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P05023,ATP1A1,AT1A1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164426,2004,136,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P05023,ATP1A1,AT1A1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164427,1761,136,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P05023,ATP1A1,AT1A1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164428,1705,136,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P05023,ATP1A1,AT1A1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164429,2728,135,Solute carrier family 12 member 1,Transporter,Q13621,SLC12A1,S12A1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164430,2201,135,Solute carrier family 12 member 1,Transporter,Q13621,SLC12A1,S12A1_HUMAN,8.3,,Kd,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D01634,INHIBITOR,,Tclin,,,Homo sapiens
164431,1783,135,Solute carrier family 12 member 1,Transporter,Q13621,SLC12A1,S12A1_HUMAN,8.45,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164432,2552,134,Interferon gamma,Cytokine,P01579,IFNG,IFNG_HUMAN,10.22,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164433,2168,134,Interferon gamma,Cytokine,P01579,IFNG,IFNG_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164434,2552,133,Interleukin-5,Cytokine,P05113,IL5,IL5_HUMAN,10.22,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164435,2168,133,Interleukin-5,Cytokine,P05113,IL5,IL5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164436,3584,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.88,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164438,3294,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.7902,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164439,2609,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.8861,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164440,2440,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164441,2389,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.4949,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164442,2337,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.241,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164443,2172,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.4242,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164444,2113,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.0696,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164445,2105,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.2,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164446,1982,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.5376,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164447,1796,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.4202,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164448,1342,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164449,422,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164450,120,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164451,3294,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.8239,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164452,2865,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8.7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164453,2579,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164454,2389,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.6,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
164455,2351,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.5229,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164456,2350,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.1192,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164457,2105,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164458,1982,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.1207,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164459,1796,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.99,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164461,1042,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,9,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164462,887,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164463,4115,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,8.4,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164464,3294,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.05,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164465,2389,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.49,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
164467,2176,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96083,1967,166,DNA gyrase subunit A,Enzyme,P0AES4,gyrA,GYRA_ECOLI,6.05,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9,INHIBITOR,,,,,Escherichia coli (strain K12)
96084,1967,162,DNA topoisomerase 4 subunit A,Enzyme,P0AFI2,parC,PARC_ECOLI,5.29,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9,INHIBITOR,,,,,Escherichia coli (strain K12)
96085,1967,75,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P14867,GABRA1,GBRA1_HUMAN,6.29,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96086,1967,80,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,P31644,GABRA5,GBRA5_HUMAN,6.29,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96087,1967,79,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,P34903,GABRA3,GBRA3_HUMAN,6.29,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96088,1967,77,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,6.29,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96089,1967,306,Gamma-aminobutyric acid receptor subunit alpha-4,Ion channel,P48169,GABRA4,GBRA4_HUMAN,6.29,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96090,1967,820,DNA topoisomerase 2-beta,Enzyme,Q02880,TOP2B,TOP2B_HUMAN,6.22,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
96091,1967,729,Gamma-aminobutyric acid receptor subunit alpha-6,Ion channel,Q16445,GABRA6,GBRA6_HUMAN,6.29,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96117,1981,2506,Gag-Pro-Pol polyprotein,Polyprotein,P03362,gag-pro-pol,POL_HTL1A,4.82,,IC50,,WOMBAT-PK,=,,,,,,,,,,Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A)
96118,1981,166,DNA gyrase subunit A,Enzyme,P0AES4,gyrA,GYRA_ECOLI,5.28,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL4,INHIBITOR,,,,,Escherichia coli (strain K12)
96120,1981,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.41,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96124,1981,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,4.54,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96126,1981,77,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,4.23,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96130,1981,788,Histamine H3 receptor,GPCR,Q9Y5N1,HRH3,HRH3_HUMAN,4.55,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96206,2006,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,7.02,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96207,2006,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.85,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96208,2006,418,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,Q9HCR9,PDE11A,PDE11_HUMAN,5.04,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164468,2105,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.6,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164469,1982,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.2332,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164470,1796,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.53,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164472,4799,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6.1,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164473,2390,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6.72,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164474,2303,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6.22,,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
164475,4452,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164476,2726,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164477,2725,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164478,2253,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164479,2245,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164480,1768,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164481,1388,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164482,1191,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164483,734,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164484,2475,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.2272,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164485,1191,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.2,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164486,766,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.796,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164487,1599,126,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Ion channel,O00555,CACNA1A,CAC1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164488,2825,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164489,2823,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164490,2422,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,4.699,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164491,1751,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
164492,1576,121,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164493,1014,121,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,5.3449,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164494,2637,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,6.7959,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164495,2561,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.6576,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164496,2551,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.301,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164497,2419,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.0044,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164498,2351,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,8.5376,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164499,2338,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.4815,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164500,2337,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.8539,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164501,2291,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.6021,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164502,2284,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.7959,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164503,2113,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,7.4815,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164504,1992,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.6778,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164505,1982,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.2218,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164506,1971,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,6.0706,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164507,1782,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,4.5086,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164508,1634,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.8539,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164509,1599,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164510,1527,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.4559,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164511,1142,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,6.5229,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164512,1082,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,6.2441,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164513,1057,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,6.5376,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164514,1048,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,4.8239,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164515,945,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,5.5229,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
164516,4191,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.9788,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164517,2776,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164518,2677,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,11,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164519,2630,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164520,2320,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.86,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164522,2298,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164523,2200,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.55,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164524,1982,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.0458,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164525,1971,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.0132,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164526,1592,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.3372,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164527,1530,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.7304,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164528,1475,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.7696,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164529,1427,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.0809,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164530,1402,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,9.2,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164531,951,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.0362,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164532,584,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.2007,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164533,4191,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.1871,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164534,2677,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,11,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164535,2630,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164536,2424,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,9.37,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164538,2320,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.94,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164540,2298,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164541,2200,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.12,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164543,1982,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.6819,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164544,1971,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.0757,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164545,1592,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.4685,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164546,1530,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.0749,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164547,1475,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,9.1805,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164548,1427,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.9508,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164549,1402,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,9.9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164550,951,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.2147,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164551,584,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.8827,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164552,458,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164553,109,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164554,2630,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164555,2424,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.4,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164556,2320,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164558,2298,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164559,2200,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.61,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164561,1982,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.136,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164562,1971,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.301,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164563,1592,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.8861,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164564,1530,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.5771,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164565,1427,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.2218,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164566,1209,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164567,951,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.4202,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164568,458,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164569,2781,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.0132,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164570,2677,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,11,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164571,2630,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164572,2424,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.86,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164574,2320,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164575,2298,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164576,1982,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.1024,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164577,1971,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.9586,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164578,1816,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164579,1592,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.4815,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164580,1530,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.359,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164581,1475,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.8239,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164582,1427,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.08,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164584,951,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.9625,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164585,584,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.983,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164586,458,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164587,4191,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.3925,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164588,2865,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.55,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164589,2776,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164590,2677,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,11,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164591,2630,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164592,2320,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164593,2298,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164594,2284,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.825,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164595,2200,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.68,,Ki,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=328,ANTAGONIST,,Tclin,,,Homo sapiens
164597,2014,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.1304,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164598,1999,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.39,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164599,1982,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.506,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164600,1971,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.3979,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164601,1816,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164602,1782,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164603,1643,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.7447,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164604,1592,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.1739,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164605,1530,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.0163,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164606,1475,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.3098,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164607,1427,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.3768,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164608,1209,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.0472,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164609,951,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.744,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164610,920,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.699,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164611,458,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164612,1796,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,6.1249,,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164613,4115,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,8.21,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164614,2408,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,7.6,,Kd,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/1717223,ANTAGONIST,,Tclin,,116,Homo sapiens
164615,1982,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,7.3565,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164616,4115,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164617,3294,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.91,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164618,2865,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.33,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164619,2717,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.21,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164621,2630,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.6021,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164622,2600,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.699,,Ki,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2608,ANTAGONIST,,Tclin,,,Homo sapiens
164623,2389,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.4815,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164624,2337,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.35,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164625,2320,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.22,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164626,2303,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,4.699,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164627,2284,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.699,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164628,2274,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.7228,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164629,2172,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.71,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164631,2113,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.0881,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164632,2014,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.699,,Ki,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/6200290,ANTAGONIST,,Tclin,,520,Homo sapiens
164633,1982,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.1549,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164634,1971,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.0325,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164635,1958,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.57,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164636,1890,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.4318,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164637,1824,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.84,,Ki,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/1354949,ANTAGONIST,,Tclin,,486,Homo sapiens
164639,1816,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.7959,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164640,1796,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.2454,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164641,1677,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.2366,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164642,1643,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.1192,,Ki,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D01786,ANTAGONIST,,Tclin,,,Homo sapiens
164643,1634,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.7773,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164644,1599,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.699,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164645,1592,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.4437,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164646,1427,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.6138,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164647,1209,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.9586,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164648,977,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8,,Ki,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/2905151,ANTAGONIST,,Tclin,,484,Homo sapiens
164649,951,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.699,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164650,407,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.155,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164651,249,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.58,,A2,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/6114717,ANTAGONIST,,Tclin,,293,Homo sapiens
164652,3294,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.4962,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164653,1982,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,7.0458,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164654,1634,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.3675,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164655,1353,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,7.52,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164656,4115,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.06,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164658,3294,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.15,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164659,2630,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.699,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164660,2274,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.611,,Ki,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7279,ANTAGONIST,,Tclin,,,Homo sapiens
164661,2113,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.5211,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164662,2068,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.4202,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164663,2014,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.2027,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164664,1782,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.66,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164666,1677,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.063,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164667,1634,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.2976,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164668,1621,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164670,1427,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.4122,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164671,1209,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.699,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164672,407,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.5,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164673,312,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,10.18,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164674,179,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.4946,,Ki,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/11740949,ANTAGONIST,,Tclin,,319,Homo sapiens
164675,4115,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,8.73,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164677,3584,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.93,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164679,3294,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.79,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164680,2402,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.12,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164681,2389,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.77,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164683,2284,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.5,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164684,2233,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.2,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164685,2172,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.0856,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164686,2113,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.9792,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164687,2105,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.5,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164688,1982,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.0862,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164689,1971,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164690,1890,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.6348,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164691,1796,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.5686,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164692,1427,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.1,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164693,1342,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164694,951,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.9208,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164695,429,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164696,4137,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.5528,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164697,4115,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.92,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164698,3294,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.44,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164699,2877,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164700,2865,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164701,2796,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.85,,Ki,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D01333,ANTAGONIST,,Tclin,,,Homo sapiens
164703,2717,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,9.5513,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164704,2637,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.9,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164705,2630,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.699,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164706,2436,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.8632,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164707,2389,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.5528,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164708,2337,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.0269,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164709,2326,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164710,2284,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.2262,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164711,2274,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.6216,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96488,2187,2500,Streptokinase A,Enzyme,P10520,ska,STRP_STRP1,6.55,,EC50,,WOMBAT-PK,=,,,,,,,,,,Streptococcus pyogenes serotype M1
164712,2172,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.704,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164713,2113,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164714,1982,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.7212,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164715,1971,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.2596,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164716,1890,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.7892,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164717,1677,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.74,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164718,1658,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.08,,pA2,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164719,1634,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,9.854,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164720,1592,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164721,1427,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.4949,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164722,1353,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164723,1342,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164724,1339,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164725,1211,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164726,951,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.3778,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164727,945,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.65,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164730,888,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164731,887,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164732,832,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.5702,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164733,422,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164734,407,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164735,388,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.25,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164736,329,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164737,195,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164739,4115,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,9.47,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164741,3294,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.66,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164742,2865,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,8.3,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164743,2389,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,8.47,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164745,2172,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,9.301,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164746,2113,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.6383,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164747,1982,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.9788,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164748,1796,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.06,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164750,1353,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.45,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164751,4115,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,9.22,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164753,3294,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.37,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164754,2865,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.22,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164755,2361,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.3401,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164756,2351,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.3,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164757,2172,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.1487,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164758,2113,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.55,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164760,1982,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,8.0969,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164761,1796,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.1748,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164762,1621,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,8.4,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164763,4115,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,9.93,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164765,3294,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.2269,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164766,2630,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164767,2320,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.5,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164768,2298,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164769,2274,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.9136,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164770,2113,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.8794,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164771,2105,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.5,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164772,1971,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96652,2328,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.77,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96653,2328,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.89,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96654,2328,1066,Cytochrome P450 3A5,Enzyme,P20815,CYP3A5,CP3A5_HUMAN,4.89,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164773,1796,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.5204,,Ki,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,ANTAGONIST,,Tclin,,,Homo sapiens
164774,1621,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.3,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164775,1592,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164776,1427,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.7959,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164777,1209,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.4,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164778,4115,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,9.8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164779,2717,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.08,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164780,2630,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164781,2389,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.42,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164783,2337,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.523,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164784,2320,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164785,2105,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.2,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164786,2014,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.1475,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164787,1982,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.9208,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164788,1796,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.12,,Ki,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,ANTAGONIST,,Tclin,,,Homo sapiens
164789,1353,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164790,832,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.3836,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164791,4209,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.73,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164793,2877,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164794,2630,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164795,2320,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.2,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164797,2298,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164798,2274,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.824,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164799,2113,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.2518,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164800,2105,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.1,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164801,2014,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.0555,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164802,1971,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.3565,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164803,1796,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.17,,Ki,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,ANTAGONIST,,Tclin,,,Homo sapiens
164805,1677,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.7167,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164806,1634,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.9208,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164807,1621,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.12,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164808,1427,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.8249,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164809,1209,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.61,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164810,1042,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.5,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164811,951,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.5884,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164813,312,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164814,4115,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.97,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164816,3294,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.1809,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164817,2865,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.47,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164818,2796,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,9.4559,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164819,2717,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.0177,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164820,2630,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.1549,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164821,2579,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164822,2402,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.54,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164823,2389,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.4433,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164824,2337,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.8297,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164825,2233,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.16,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164826,2176,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.1,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164827,2172,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.63,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164829,2113,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.07,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164831,2105,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.5,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164833,2078,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.92,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164834,1971,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.5086,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164835,1958,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.93,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164836,1890,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.0969,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164837,1887,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164838,1796,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.13,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164840,1621,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.8558,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164841,3294,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.83,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164842,2717,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.07,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164843,2436,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.38,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164844,2068,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.3979,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164845,1958,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.67,,Ki,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4792,INHIBITOR,,Tclin,,,Homo sapiens
164846,1796,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.1487,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164847,1592,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,8.2676,,Ki,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7551,INHIBITOR,,Tclin,,,Homo sapiens
164848,1209,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.6198,,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164849,951,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.3372,,Kd,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7549,INHIBITOR,,Tclin,,,Homo sapiens
164850,2865,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164851,1592,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.1549,,Ki,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7551,INHIBITOR,,Tclin,,,Homo sapiens
164852,951,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.0655,,Kd,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7549,INHIBITOR,,Tclin,,,Homo sapiens
164853,3972,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,7,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164854,2825,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164855,2600,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.8539,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164856,2561,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164857,2557,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164858,2446,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,6.2,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164859,2422,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.9208,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164861,2391,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.83,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164862,2359,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164863,2291,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,7.0555,,ED50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164864,2172,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.5376,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164865,1832,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,6.13,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164866,1797,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.8,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164867,1751,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164868,1704,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,6.8207,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164869,1605,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.94,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164870,1548,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164871,1530,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164872,1353,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,6.7,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164873,1118,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
164874,837,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,7.4318,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164875,249,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,6.05,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164877,2561,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,8.301,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164878,2351,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,9,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164879,1353,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,6.72,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164880,2855,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.8729,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164881,2826,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.6073,,Km,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164882,1990,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.3098,,Km,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164883,1937,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.12,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164885,1805,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.64,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164886,1797,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.22,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164887,254,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.6289,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164888,249,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.4815,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164889,3931,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.2255,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164890,2865,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.92,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164891,2717,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.54,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164892,2637,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164893,2600,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.2518,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164895,2552,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164896,2389,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.7878,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164897,2359,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.9208,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164898,2320,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.9281,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164899,2291,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.0969,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164900,2269,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.6861,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164901,2266,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.6676,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164902,2172,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.7447,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164903,2004,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.0088,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164904,1999,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.1739,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164905,1992,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.0915,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164906,1982,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.74,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164908,1824,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.4559,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164909,1800,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164910,1677,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164911,1605,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.77,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164912,1524,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.97,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164913,1511,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164914,1427,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.9,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164915,1395,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164916,1353,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.5,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164917,1329,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.4283,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164918,1209,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.1549,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164920,1137,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.44,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164921,977,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.55,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164922,945,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.7905,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164923,923,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164924,889,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164925,881,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.857,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164926,342,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.26,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164927,312,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8.47,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164928,249,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,9.0458,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164929,231,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164930,3584,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.2596,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164931,3294,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.79,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164932,2865,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.3,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164933,2717,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.58,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164935,2609,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.0177,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164936,2389,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164937,2326,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164938,2149,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.56,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164939,2113,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.19,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164941,2105,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.3,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164942,1982,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.4915,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164943,1796,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8.3188,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164944,1677,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.82,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164945,1524,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,Ki,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164946,1342,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164947,1264,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164948,422,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164949,329,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164950,195,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164951,1599,84,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,Q12879,GRIN2A,NMDE1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164952,4501,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.9208,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164954,2877,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,,,,,WOMBAT-PK,,1,DRUG LABEL,,http://www.medicines.org.uk/emc/medicine/1073,ANTAGONIST,,Tclin,,647,Homo sapiens
96880,2492,2507,Beta-lactamase TEM,Enzyme,P62594,bla,BLAT_SALTI,6.1,,Ki,,WOMBAT-PK,=,,,,,,,,,,Salmonella typhi
96881,2492,2505,"Serine beta-lactamase-like protein LACTB, mitochondrial",Enzyme,P83111,LACTB,LACTB_HUMAN,5.01,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
96882,2500,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.03,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96883,2500,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,4.96,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
96884,2500,1534,High affinity choline transporter 1,Transporter,Q9GZV3,SLC5A7,SC5A7_HUMAN,4.24,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
96896,2529,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,5.55,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
97011,2624,2500,Streptokinase A,Enzyme,P10520,ska,STRP_STRP1,5.77,,EC50,,WOMBAT-PK,=,,,,,,,,,,Streptococcus pyogenes serotype M1
97012,2624,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.12,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164955,2609,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.6778,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164957,1890,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.7447,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164958,1826,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.6198,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164960,1677,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.9788,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164961,1634,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.1772,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164962,1621,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.9788,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164963,1567,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,,,,,WOMBAT-PK,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/7878037,AGONIST,,Tclin,,420,Homo sapiens
164964,1427,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.1733,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164965,1042,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164966,407,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.43,,Ki,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D01101,ANTAGONIST,,Tclin,,,Homo sapiens
164967,406,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.85,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164969,312,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,10.57,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164970,179,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.5528,,Ki,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/11740949,ANTAGONIST,,Tclin,,319,Homo sapiens
164971,120,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.15,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164972,4115,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,8.7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164974,3294,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.67,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164975,2877,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,,,,,WOMBAT-PK,,1,DRUG LABEL,,http://www.medicines.org.uk/emc/medicine/1073,ANTAGONIST,,Tclin,,647,Homo sapiens
164976,2637,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.1,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164977,2630,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.301,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164979,2298,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164980,1982,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.3979,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164981,1796,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164982,1634,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.308,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164983,1567,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,,,,,WOMBAT-PK,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/7878037,AGONIST,,Tclin,,420,Homo sapiens
164984,1353,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.82,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164985,948,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164986,407,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164987,3424,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,8.409,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164988,2663,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.1,,EC50,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/15627429,AGONIST,,Tclin,,596,Homo sapiens
164989,2299,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,,,,Mechanism of Action,WOMBAT-PK,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/7693433,AGONIST,,Tclin,,602,Homo sapiens
164991,1706,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,8.06,,EC50,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/6141283,PARTIAL AGONIST,,Tclin,,603,Homo sapiens
164992,1526,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164994,2698,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.24,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164996,2657,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.28,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164997,2652,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.9,,IC50,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/6782492,INHIBITOR,,Tclin,,214,Homo sapiens
164998,2616,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.4318,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164999,2311,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165000,2213,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165001,2115,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165002,1509,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.1,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165003,1439,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165004,1193,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.52,,IC50,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D01581,INHIBITOR,,Tclin,,,Homo sapiens
165005,1145,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,WOMBAT-PK,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/6356910,INHIBITOR,,Tclin,,568,Homo sapiens
165006,873,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165007,266,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165008,171,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165009,107,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165011,2346,65,Sodium channel subunit beta-4,Ion channel,Q8IWT1,SCN4B,SCN4B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165012,2291,65,Sodium channel subunit beta-4,Ion channel,Q8IWT1,SCN4B,SCN4B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165013,1794,65,Sodium channel subunit beta-4,Ion channel,Q8IWT1,SCN4B,SCN4B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165014,1607,65,Sodium channel subunit beta-4,Ion channel,Q8IWT1,SCN4B,SCN4B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165015,1007,65,Sodium channel subunit beta-4,Ion channel,Q8IWT1,SCN4B,SCN4B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165016,889,65,Sodium channel subunit beta-4,Ion channel,Q8IWT1,SCN4B,SCN4B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165019,2346,64,Sodium channel subunit beta-3,Ion channel,Q9NY72,SCN3B,SCN3B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165020,2291,64,Sodium channel subunit beta-3,Ion channel,Q9NY72,SCN3B,SCN3B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165021,1794,64,Sodium channel subunit beta-3,Ion channel,Q9NY72,SCN3B,SCN3B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165022,1607,64,Sodium channel subunit beta-3,Ion channel,Q9NY72,SCN3B,SCN3B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165023,1007,64,Sodium channel subunit beta-3,Ion channel,Q9NY72,SCN3B,SCN3B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165024,889,64,Sodium channel subunit beta-3,Ion channel,Q9NY72,SCN3B,SCN3B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165027,2346,63,Sodium channel subunit beta-2,Ion channel,O60939,SCN2B,SCN2B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165028,1794,63,Sodium channel subunit beta-2,Ion channel,O60939,SCN2B,SCN2B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165029,1607,63,Sodium channel subunit beta-2,Ion channel,O60939,SCN2B,SCN2B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165030,1007,63,Sodium channel subunit beta-2,Ion channel,O60939,SCN2B,SCN2B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165031,889,63,Sodium channel subunit beta-2,Ion channel,O60939,SCN2B,SCN2B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165034,2346,62,Sodium channel subunit beta-1,Ion channel,Q07699,SCN1B,SCN1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165035,2291,62,Sodium channel subunit beta-1,Ion channel,Q07699,SCN1B,SCN1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165036,1794,62,Sodium channel subunit beta-1,Ion channel,Q07699,SCN1B,SCN1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165037,1607,62,Sodium channel subunit beta-1,Ion channel,Q07699,SCN1B,SCN1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165038,1007,62,Sodium channel subunit beta-1,Ion channel,Q07699,SCN1B,SCN1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165039,889,62,Sodium channel subunit beta-1,Ion channel,Q07699,SCN1B,SCN1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165041,2207,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165042,1891,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165043,1607,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165044,1264,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165045,1007,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165046,923,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165047,889,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165048,342,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165049,231,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165051,2637,60,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,Q14994,NR1I3,NR1I3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165052,2445,60,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,Q14994,NR1I3,NR1I3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165053,2152,60,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,Q14994,NR1I3,NR1I3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165054,577,60,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,Q14994,NR1I3,NR1I3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165056,2698,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,8.3,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165057,2657,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.33,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165058,2652,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,7.1,,IC50,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/6782492,INHIBITOR,,Tclin,,214,Homo sapiens
165059,2616,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.301,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165060,2595,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165061,2561,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,4.46,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165063,2311,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165064,2213,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165065,1935,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.91,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165067,1509,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.2,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165068,1439,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165069,1193,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.93,,IC50,,WOMBAT-PK,=,1,KEGG DRUG,,http://www.kegg.jp/entry/D01581,INHIBITOR,,Tclin,,,Homo sapiens
165071,1145,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,,WOMBAT-PK,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/6356910,INHIBITOR,,Tclin,,568,Homo sapiens
165072,171,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165073,107,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165074,2326,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165075,1786,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.3,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165076,1155,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.9,,EC50,,WOMBAT-PK,=,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=557,AGONIST,,Tclin,,,Homo sapiens
165077,948,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165078,637,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.2,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165079,569,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.8,,Ki,,WOMBAT-PK,=,,,,,AGONIST,,Tclin,,,Homo sapiens
165080,424,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,8.8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165081,394,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165082,389,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.65,,Ki,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/11314603,ANTAGONIST,,Tclin,,645,Homo sapiens
165083,285,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165084,4799,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.4,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165085,2557,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165086,2258,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.6,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165087,2068,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165088,1658,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,7.82,,pA2,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165089,1209,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.3565,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165090,923,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165091,637,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165092,569,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8.1,,Ki,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/9205952,ANTAGONIST,,Tclin,,404,Homo sapiens
165093,424,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8.2,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165094,394,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165095,389,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,9.51,,Ki,,WOMBAT-PK,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/11314603,ANTAGONIST,,Tclin,,645,Homo sapiens
165096,360,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,,WOMBAT-PK,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/2858236,ANTAGONIST,,Tclin,,283,Homo sapiens
165098,1550,2688,Calcium-binding mitochondrial carrier protein Aralar2,Unclassified,Q9UJS0,SLC25A13,CMC2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165100,4072,2689,Solute carrier family 23 member 1,Unclassified,Q9UHI7,SLC23A1,S23A1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165102,4112,2690,THAP domain-containing protein 1,Unclassified,Q9NVV9,THAP1,THAP1_HUMAN,4.2291,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
165103,2646,2690,THAP domain-containing protein 1,Unclassified,Q9NVV9,THAP1,THAP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165104,1585,2690,THAP domain-containing protein 1,Unclassified,Q9NVV9,THAP1,THAP1_HUMAN,9,,EC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
165105,176,2690,THAP domain-containing protein 1,Unclassified,Q9NVV9,THAP1,THAP1_HUMAN,6.19,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
165106,4196,2691,Protein amnionless,Unclassified,Q9BXJ7,AMN,AMNLS_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165108,1540,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,3.839,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165112,4196,2692,"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial",Enzyme,Q96EY8,MMAB,MMAB_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165113,2552,2693,Peptidyl-prolyl cis-trans isomerase FKBP10,Enzyme,Q96AY3,FKBP10,FKB10_HUMAN,9.02,,IC50,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
165114,444,2694,Squalene monooxygenase,Enzyme,Q92206,ERG1,ERG1_CANAL,7.3468,,IC50,,WOMBAT-PK,=,,,,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
165115,4196,2695,"Methylmalonic aciduria type A protein, mitochondrial",Enzyme,Q8IVH4,MMAA,MMAA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165116,1527,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,7.1972,,app Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165117,4310,2696,Dihydropyrimidinase-related protein 2,Unclassified,Q16555,DPYSL2,DPYL2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165118,773,2697,DNA polymerase alpha subunit B,Unclassified,Q14181,POLA2,DPOA2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165119,1527,2698,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",Enzyme,Q07973,CYP24A1,CP24A_HUMAN,6.5058,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165124,726,2699,Tubulin beta-4B chain,Structural,P68371,TUBB4B,TBB4B_HUMAN,5.2403,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165125,219,2699,Tubulin beta-4B chain,Structural,P68371,TUBB4B,TBB4B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165126,2370,2700,Chromaffin granule amine transporter,Transporter,P54219,SLC18A1,VMAT1_HUMAN,7.45,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4823,,INHIBITOR,,Tchem,,,Homo sapiens
165127,88,2701,DNA polymerase subunit gamma-1,Enzyme,P54098,POLG,DPOG1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165128,1708,2702,Thiopurine S-methyltransferase,Enzyme,P51580,TPMT,TPMT_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165129,269,2702,Thiopurine S-methyltransferase,Enzyme,P51580,TPMT,TPMT_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165130,1170,2703,Solute carrier organic anion transporter family member 1A2,Unclassified,P46721,SLCO1A2,SO1A2_HUMAN,5.699,,Km,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
165131,527,2704,Solute carrier family 15 member 1,Transporter,P46059,SLC15A1,S15A1_HUMAN,2.09,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165132,526,2704,Solute carrier family 15 member 1,Transporter,P46059,SLC15A1,S15A1_HUMAN,2.14,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165135,2266,2705,Aryl hydrocarbon receptor,Transcription factor,P35869,AHR,AHR_HUMAN,5.3279,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165136,2803,2706,UDP-glucuronosyltransferase 1-5,Enzyme,P35504,UGT1A5,UD15_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tdark,,,Homo sapiens
165137,90,2711,Adenosylhomocysteinase,Enzyme,P23526,AHCY,SAHH_HUMAN,5.7959,,Km,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165140,4196,2712,Transcobalamin-2,Secreted,P20062,TCN2,TCO2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165147,2831,2714,Retinol-binding protein 1,Cytosolic other,P09455,RBP1,RET1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165148,947,2715,Dopamine beta-hydroxylase,Enzyme,P09172,DBH,DOPO_HUMAN,3,,Km,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165149,770,2716,DNA polymerase beta,Enzyme,P06746,POLB,DPOLB_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165150,1527,425,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,7.28,,IC50,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003906/WC500181492.pdf,INHIBITOR,,Tclin,,163,Homo sapiens
165151,66,2717,"Superoxide dismutase [Mn], mitochondrial",Enzyme,P04179,SOD2,SODM_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165154,2134,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165157,1909,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165158,1527,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
97275,2861,2506,Gag-Pro-Pol polyprotein,Polyprotein,P03362,gag-pro-pol,POL_HTL1A,8.31,,EC50,,WOMBAT-PK,=,,,,,,,,,,Human T-cell leukemia virus 1 (strain Japan ATK-1 subtype A)
97276,2861,889,Thymidylate kinase,Kinase,P23919,DTYMK,KTHY_HUMAN,4.55,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
97277,2861,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.51,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
97278,2861,2513,Reverse transcriptase/RNaseH,Enzyme,Q72549,pol,Q72549_9HIV1,6.11,,IC50,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus 1
97280,2861,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,4,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
97292,2977,2532,"Beta-1,3-glucan synthase catalytic subunit 1",Enzyme,O13428,GSC1,O13428_CANAX,8.89,,IC50,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499808,INHIBITOR,,,,,Candida albicans
165160,1044,2718,Toll-like receptor 4,Membrane receptor,O00206,TLR4,TLR4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165161,391,2719,PH and SEC7 domain-containing protein 1,Unclassified,A5PKW4,PSD,PSD1_HUMAN,7.7447,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
165163,2873,2931,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,P18507|P31644|P47870,GABRA5|GABRB2|GABRG2,GBRA5_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,7.2782,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021476s030lbl.pdf,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,292,Homo sapiens
165164,2873,2932,GABA A receptor alpha-5/beta-2/gamma-3,Ion channel,P31644|P47870|Q99928,GABRA5|GABRB2|GABRG3,GBRA5_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,6.7496,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021476s030lbl.pdf,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,292,Homo sapiens
165165,2729,2931,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,P18507|P31644|P47870,GABRA5|GABRB2|GABRG2,GBRA5_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,9.2218,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
165166,2729,2932,GABA A receptor alpha-5/beta-2/gamma-3,Ion channel,P31644|P47870|Q99928,GABRA5|GABRB2|GABRG3,GBRA5_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,8.699,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
165168,1802,2931,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,P18507|P31644|P47870,GABRA5|GABRB2|GABRG2,GBRA5_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,9.1249,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL655,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
165169,1802,2932,GABA A receptor alpha-5/beta-2/gamma-3,Ion channel,P31644|P47870|Q99928,GABRA5|GABRB2|GABRG3,GBRA5_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,8.2596,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL655,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
165170,1202,2931,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,P18507|P31644|P47870,GABRA5|GABRB2|GABRG2,GBRA5_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,9,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
165171,1202,2932,GABA A receptor alpha-5/beta-2/gamma-3,Ion channel,P31644|P47870|Q99928,GABRA5|GABRB2|GABRG3,GBRA5_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,8.4202,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
165172,1068,2931,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,P18507|P31644|P47870,GABRA5|GABRB2|GABRG2,GBRA5_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
165173,1068,2932,GABA A receptor alpha-5/beta-2/gamma-3,Ion channel,P31644|P47870|Q99928,GABRA5|GABRB2|GABRG3,GBRA5_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
165174,852,2931,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,P18507|P31644|P47870,GABRA5|GABRB2|GABRG2,GBRA5_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,8.0044,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
165175,852,2932,GABA A receptor alpha-5/beta-2/gamma-3,Ion channel,P31644|P47870|Q99928,GABRA5|GABRB2|GABRG3,GBRA5_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,7.2034,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
165180,1725,2514,Solute carrier family 22 member 3,Transporter,O75751,SLC22A3,S22A3_HUMAN,2.4988,,Km,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165181,4072,2512,Solute carrier family 23 member 2,Transporter,Q9UGH3,SLC23A2,S23A2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165183,1725,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,3.4012,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165184,1427,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.2218,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165187,1483,2325,Serine/threonine-protein kinase Chk2,Kinase,O96017,CHEK2,CHK2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165192,2353,1782,Thymidylate synthase,Enzyme,P0A884,thyA,TYSY_ECOLI,5.2441,,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
165200,1794,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,3.51,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165201,1579,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,3.5591,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165202,1176,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,2.7696,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165203,926,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,3.6038,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165207,66,1643,Vascular endothelial growth factor A,Secreted,P15692,VEGFA,VEGFA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165208,4410,1542,Stromal cell-derived factor 1,Cytokine,P48061,CXCL12,SDF1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165209,269,1487,Ras-related C3 botulinum toxin substrate 1,Unclassified,P63000,RAC1,RAC1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165210,4072,1441,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",Enzyme,Q02809,PLOD1,PLOD1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165211,4072,1399,Prolyl 4-hydroxylase subunit alpha-1,Enzyme,P13674,P4HA1,P4HA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165213,4196,1324,Methionine synthase reductase,Enzyme,Q9UBK8,MTRR,MTRR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165214,4196,1306,Methionine synthase,Enzyme,Q99707,MTR,METH_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165219,66,1090,Cytochrome c,Unclassified,P99999,CYCS,CYC_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165220,1291,1066,Cytochrome P450 3A5,Enzyme,P20815,CYP3A5,CP3A5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165222,2533,921,Glucose-6-phosphate 1-dehydrogenase,Enzyme,P11413,G6PD,G6PD_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165297,4879,492,Antithrombin-III,Secreted,P01008,SERPINC1,ANT3_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201476,ACTIVATOR,,Tclin,,,Homo sapiens
165300,147,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165301,4501,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165303,2480,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165307,2527,457,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,4.1612,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165311,4,445,Potassium voltage-gated channel subfamily A member 5,Ion channel,P22460,KCNA5,KCNA5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165312,4161,442,Peptidyl-prolyl cis-trans isomerase FKBP3,Enzyme,Q00688,FKBP3,FKBP3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165315,2841,429,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165317,130,429,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,,,,,WOMBAT-PK,,1,KEGG DRUG,,http://www.kegg.jp/entry/D01518,AGONIST,,Tclin,,,Homo sapiens
165331,362,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,4.1778,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165339,203,388,"DNA topoisomerase I, mitochondrial",Enzyme,Q969P6,TOP1MT,TOP1M_HUMAN,7.43,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165343,1708,386,Purine nucleoside phosphorylase,Enzyme,P00491,PNP,PNPH_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
97459,4811,2544,Genome polyprotein,Polyprotein,P27958,,POLG_HCVH,6.958607196807861,,EC90,ET-lunet cells; S96T mutant,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20845908,http://www.ncbi.nlm.nih.gov/pubmed/20845908,INHIBITOR,,,38,38,Hepatitis C virus genotype 1a (isolate H)
97460,4812,2544,Genome polyprotein,Polyprotein,P27958,,POLG_HCVH,9.443697929382324,,Ki,inhibition of the full-length HCV NS3/4A protease,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/18678486,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205123s008lbl.pdf,INHIBITOR,,,39,297,Hepatitis C virus genotype 1a (isolate H)
97462,4813,28,Candida albicans,Fungi,,,,7.057981491088867,,MIC,in vitro antifungal activities against stock cultures of Candida albicans,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/10461840,,,,,40,,
97463,4813,29,Aspergillus fumigatus,Fungi,,,,9.057981491088867,,MIC,in vitro antifungal activities against stock cultures of Aspergillus fumigatus,SCIENTIFIC LITERATURE,<=,,,http://www.ncbi.nlm.nih.gov/pubmed/10461840,,,,,40,,
97464,4813,26,Trichophyton mentagrophytes,Fungi,,,,8.151402473449707,,MIC,in vitro antifungal activities against stock cultures of T. mentagrophytes,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9559824,,,,,41,,
97465,4813,27,Trichophyton rubrum,Fungi,,,,8.75000286102295,,MIC,in vitro antifungal activities against stock cultures of T. rubrum,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9559824,,,,,41,,
183746,663,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,4.78,,Ki,In vitro binding affinity against human dopamine transporter in dog kidney cell line by using [125I]RTI-55 radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL549,,,,Tclin,,,Homo sapiens
183747,2346,3590,Potassium voltage-gated channel subfamily D member 2,Unclassified,Q63881,Kcnd2,KCND2_RAT,5.66,,IC50,Inhibition of rat potassium channel Kv4.2 by patch-clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1294,,,,,,,Rattus norvegicus
183748,2346,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.59,,Ki,High affinity constant at binding site of human P-Glycoprotein (P-gp) in two-affinity model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1294,,,,Tchem,,,Homo sapiens
183749,2346,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.49,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1294,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1294,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
183750,2346,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,5.16,,IC50,Inhibition of human heart sodium channel Nav1.5 by patch-clamp method,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1294,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1294,BLOCKER,,Tclin,,,Homo sapiens
183751,2346,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,5.13,,IC50,Inhibition of horse BChE by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1294,,,,,,,Equus caballus
183752,2346,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.49,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1294,,,,Tclin,,,Homo sapiens
184671,670,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,6.05,,IC50,Inhibition of AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,,Tclin,,,Homo sapiens
183753,2346,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.95,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1294,,,,Tchem,,,Homo sapiens
183754,2346,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,5.91,,IC50,Inhibition of human BChE by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1294,,,,Tclin,,,Homo sapiens
183755,949,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,9.7,,Ki,Inhibition of human recombinant carbonic anhydrase 2 by dansylamide (DNSA) competition assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,INHIBITOR,,Tclin,,,Homo sapiens
183756,949,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,7.74,,Ki,Inhibitory activity against murine carbonic anhydrase XIII (mCA XIII) by using CO2 hydrase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Mus musculus
183757,949,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,8.46,,Ki,Inhibitory activity against catalytic domain of human carbonic anhydrase XII,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,Tclin,,,Homo sapiens
183758,949,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,7.37,,Ki,"Inhibition of cloned isozyme, human carbonic anhydrase IV",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,Tclin,,,Homo sapiens
183759,949,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,7.74,,Ki,Inhibition of human carbonic anhydrase13 preincubated for 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,Tclin,,,Homo sapiens
183760,949,2010,Carbonic anhydrase,Enzyme,Q50565,,Q50565_METTH,4.51,,Ki,Inhibitory activity against beta carbonic anhydrase (Cab) from Methanobacterium thermoautotrophicum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H)
183761,949,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,7.74,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Stylophora pistillata
183762,949,2143,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878,,P96878_MYCTU,6.86,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase Rv3273 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183763,949,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,6.55,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Astrosclera willeyana
183764,949,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.1,,Ki,Inhibition of human carbonic anhydrase 3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,Tclin,,,Homo sapiens
183765,949,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,6.13,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183766,949,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,6.95,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Stylophora pistillata
183767,949,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,7.3,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Thalassiosira weissflogii
183768,949,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,7.38,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,Tclin,,,Homo sapiens
183769,949,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,6.96,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
183770,949,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,7.57,,Ki,Inhibitory constant against human carbonic anhydrase XIV in CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,Tclin,,,Homo sapiens
183771,949,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,8.46,,Ki,Ki value against human carbonic anhydrase VII,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,Tclin,,,Homo sapiens
183772,949,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.28,,Ki,Inhibitory activity against human carbonic anhydrase IX (hCA IX) by using CO2 hydrase assay method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,Tclin,,,Homo sapiens
183773,949,401,Carbonic anhydrase,Enzyme,O24855,cynT,CYNT_HELPY,5.37,,Ki,Inhibition of Helicobacter pylori recombinant CA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
183774,949,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.21,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Mus musculus
183775,949,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.3,,Ki,Inhibition of human cloned CA1 by CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,Tclin,,,Homo sapiens
183776,949,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,7.48,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,Tclin,,,Homo sapiens
183777,949,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,8.05,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
183778,949,2009,Carbonic anhydrase,Enzyme,P40881,,CAH_METTE,6.39,,Ki,Inhibitory activity against alpha carbonic anhydrase (Zn-Cam) from Methanosarcina thermophila,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Methanosarcina thermophila
183779,949,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,7,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183780,949,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,8,,Ki,Inhibition of full length human recombinant CA VI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,Tclin,,,Homo sapiens
183781,949,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,7.37,,Ki,Inhibitory activity against bovine carbonic anhydrase IV from lung microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Bos taurus
183782,1110,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,8.23,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1531,,,,Tchem,,,Homo sapiens
183783,3651,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,8.86,,IC50,Inhibition of human placental microsome CYP19,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL224060,http://www.ncbi.nlm.nih.gov/pubmed/7726994,INHIBITOR,,Tclin,,534,Homo sapiens
183784,1419,1372,"Glutamate receptor ionotropic, NMDA 1",Ion channel,P35439,Grin1,NMDZ1_RAT,7.14,,IC50,Inhibition of rat recombinant NR1/NR2B receptor expressed in Xenopus oocytes assessed as inhibition of glutamate and glycine-induced evoked current by two electrode voltage clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,,,,Rattus norvegicus
183785,1419,2816,Glutamate NMDA receptor; GRIN1/GRIN2B,Ion channel,Q05586|Q13224,GRIN1|GRIN2B,NMDE2_HUMAN|NMDZ1_HUMAN,8,,Ki,Displacement of [3H]ifenprodil from human recombinant NR1-1a/NR2B receptor expressed in mouse L(tk-) cells after 120 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,Tclin|Tclin,,,Homo sapiens
183786,1419,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,7,,IC50,Compound was tested for the binding affinity against Alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,,,,Rattus norvegicus
183787,1419,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6,,IC50,Compound was tested for the binding affinity against histamine H1 receptor by using [3H]mepyramine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,Tclin,,,Homo sapiens
183788,1419,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.41,,IC50,Compound was tested for the binding affinity against sigma receptor by using [3H]-+3PPP as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,Tclin,,,Homo sapiens
183789,1419,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,Tclin,,,Homo sapiens
183790,1419,1833,Alpha-2A adrenergic receptor,GPCR,P22909,Adra2a,ADA2A_RAT,6.96,,IC50,Compound was tested for the binding affinity against Alpha-1 adrenergic receptor by using [3H]prazosin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,,,,Rattus norvegicus
183791,1419,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,8.7,,Ki,Displacement of [3H](+)-pentazocine from sigma1 receptor in rat liver membrane by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,,,,Rattus norvegicus
183792,1419,1954,5-hydroxytryptamine receptor 2A,GPCR,Q75Z89,HTR2A,5HT2A_BOVIN,6.21,,IC50,Compound was tested for the binding affinity against 5-hydroxytryptamine 2 receptor by using [3H]ketanserin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,,,,Bos taurus
183793,1419,315,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,Q13224,GRIN2B,NMDE2_HUMAN,7.7,,IC50,Inhibition of NMDA receptor GluN2B subunit (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,Tclin,,,Homo sapiens
183794,1419,3591,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",Unclassified,Q60490,EBP,EBP_CAVPO,8.57,,Ki,Inhibition of [3H]-emopamil binding to Sterol delta 8-delta 7 isomerase in guinea pig liver membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,,,,Cavia porcellus
183795,1419,2048,Sigma non-opioid intracellular receptor 1,Membrane other,Q60492,SIGMAR1,SGMR1_CAVPO,8.99,,Ki,Displacement of [3H]-(+)-pentazocine from guinea pig brain sigma1 receptor after 150 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,,,,Cavia porcellus
183796,1419,1854,5-hydroxytryptamine receptor 1A,GPCR,Q64264,Htr1a,5HT1A_MOUSE,6.62,,IC50,Compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor by using [3H]DPAT as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,,,,Mus musculus
183797,1419,3455,Glutamate [NMDA] receptor subunit epsilon 2,Ion channel,Q00960,Grin2b,NMDE2_RAT,7.96,,Ki,Displacement of [3H]ifenprodil from rat brain membrane NR2B receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305187,,,,,,,Rattus norvegicus
183798,2705,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.57,,Ki,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M2 receptor expressed in CHO cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1382,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1382,ANTAGONIST,,Tclin,,,Homo sapiens
183799,2705,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.85,,Ki,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M1 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1382,,,,Tclin,,,Homo sapiens
183800,2705,1845,Muscarinic acetylcholine receptor M3,GPCR,P08483,Chrm3,ACM3_RAT,8.15,,Ki,Affinity for rat Muscarinic acetylcholine receptor M3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1382,,,,,,,Rattus norvegicus
183801,2705,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,8.16,,Ki,Affinity for rat Muscarinic acetylcholine receptor M2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1382,,,,,,,Rattus norvegicus
183802,2705,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.77,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1382,,,,Tclin,,,Homo sapiens
183851,722,2034,D(1A) dopamine receptor,GPCR,P50130,DRD1,DRD1_PIG,6.38,,Ki,Displacement of [3H]SCH 23990 from dopamine receptor D1 in porcine striatal membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Sus scrofa
183803,2705,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.49,,Ki,Binding affinity to human muscarinic M3 receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1382,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1382,ANTAGONIST,,Tclin,,,Homo sapiens
183804,2705,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.51,,Ki,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M4 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1382,,,,Tclin,,,Homo sapiens
183805,2705,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.66,,Ki,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M5 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1382,,,,Tclin,,,Homo sapiens
183806,1802,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,8.7,,Ki,Binding affinity to rat benzodiazepine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL655,,,,,,,Rattus norvegicus
183807,1802,1852,Translocator protein,Membrane receptor,P16257,Tspo,TSPO_RAT,8.7,,Ki,Binding affinity against rat benzodiazepine (BZD) receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL655,,,,,,,Rattus norvegicus
183808,672,781,Heme oxygenase 2,Enzyme,P23711,Hmox2,HMOX2_RAT,5.47,,IC50,Inhibition of HO-2 in Sprague-Dawley rat brain microsomal fractions assessed as carbon monoxide formation from methemalbumin after 10 mins by gas chromatography analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1407943,,,,,,,Rattus norvegicus
183809,3366,2876,Estrogen receptor,Nuclear hormone receptor,P03372|Q92731,ESR1|ESR2,ESR1_HUMAN|ESR2_HUMAN,8.6,,IC50,Binding affinity for estrogen receptor of rabbit uterine skeletal muscle tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628161,,,,Tclin|Tclin,,,Homo sapiens
183810,73,906,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,5.3,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL39560,,,,Tchem,,,Homo sapiens
183811,2285,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.4,,Kd,Binding affinity to progesterone receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL196003,,,,Tclin,,,Homo sapiens
183812,2285,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.88,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL196003,,,,,,,Rattus norvegicus
183813,940,3456,Envelope glycoprotein,Membrane other,O09800|P04288|P04488|P06477|P06480|P06484|P06487|P10185|P10211|P10228|P68331|Q69091,gB|gC|gD|gE|gG|gH|gI|gJ|gK|gL|gM|gN,GB_HHV11|GC_HHV11|GD_HHV11|GE_HHV11|GG_HHV11|GH_HHV11|GI_HHV11|GJ_HHV11|GK_HHV11|GL_HHV11|GM_HHV11|GN_HHV11,,,,Mechanism of Action; CHEMBL2364696; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200453,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200453,INHIBITOR,,,,,Human herpesvirus 1 (strain 17)
183814,722,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,6.41,,Ki,Binding affinity to rat NET,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183815,722,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.81,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,Tchem,,,Homo sapiens
183816,722,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,8.42,,Ki,Displacement of [3H]mepyramine from histamine H1 receptor in guinea pig cerebellum after 60 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Cavia porcellus
183817,722,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,6.16,,Ki,Inhibition of [3H]nisoxetine binding to rat Norepinephrine transporter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183818,722,2851,Dopamine receptor,GPCR,P20288|Q95136,DRD1|DRD2,DRD1_BOVIN|DRD2_BOVIN,6.74,,IC50,Inhibition of [3H]haloperidol binding to Dopamine receptor in calf caudate nuclei.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Bos taurus
183819,722,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,8.2,,Ki,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183820,722,1801,D(1A) dopamine receptor,GPCR,Q95136,DRD1,DRD1_BOVIN,6.38,,Ki,Binding affinity against bovine dopamine receptor D1 using radioligand [3H]-SCH- 23390,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Bos taurus
183821,722,1803,Beta-1 adrenergic receptor,GPCR,P18090,Adrb1,ADRB1_RAT,4.59,,Ki,Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183822,722,1878,D(4) dopamine receptor,GPCR,P30729,Drd4,DRD4_RAT,8.05,,Ki,Binding affinity of [3H]-spiperone towards cloned mammalian Dopamine receptor D4 expressed in cultured cells or from rat whole brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183823,722,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,7.6,,Ki,In vitro binding affinity against Muscarinic acetylcholine receptors in rat brain.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183824,722,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.2,,Ki,Binding affinity to 5-HT1A receptor (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,Tclin,,,Homo sapiens
183825,722,1841,D(2) dopamine receptor,GPCR,P61168,Drd2,DRD2_MOUSE,6.54,,IC50,Inhibition of mouse Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Mus musculus
183826,722,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,6.16,,Ki,Binding affinity was evaluated for the displacement of [3H]spiperone against bovine Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Bos taurus
184124,2090,549,Trypsin-1,Enzyme,P07477,PRSS1,TRY1_HUMAN,5.64,,Ki,Inhibition of trypsin by amidase assay.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tclin,,,Homo sapiens
183827,722,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,6.79,,Ki,Displacement of [3H]nemonapride from Rattus norvegicus (rat) wild type dopamine D3 receptor transfected in african green monkey COS7 cells after 1 hr by beta scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183828,722,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6,,Ki,Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,Tchem,,,Homo sapiens
183829,722,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,8.74,,Ki,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183830,722,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,6.49,,Ki,In vitro ability to displace [3H]spiroperidol from rat dopamine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183831,722,1970,5-hydroxytryptamine receptor 3A,Ion channel,P23979,Htr3a,5HT3A_MOUSE,7.49,,Ki,Compound was tested for the Binding affinity against N1e-115 neuroblastoma 5-hydroxytryptamine 3 receptor by Radio ligand [3H]GR-65630 binding assay.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Mus musculus
183832,722,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,7.24,,Ki,Binding affinity towards alpha-2 adrenergic receptors in rat brain synaptosomal preparations,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183833,722,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,6.8,,IC50,Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Bos taurus
183834,722,2783,Serotonin 3 (5-HT3) receptor,Ion channel,P35563|Q9JJ16,Htr3a|Htr3b,5HT3A_RAT|5HT3B_RAT,7.28,,Ki,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183835,722,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.68,,Ki,Compound was tested for the binding affinity against rat cortical Muscarinic acetylcholine receptor M1 by radioligand [3H]pirenzepine binding assay.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183836,722,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.41,,Ki,Binding affinity to human SERT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,Tclin,,,Homo sapiens
183837,722,2862,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy2|Adcy3|Adcy4|Adcy5|Adcy6|Adcy8,ADCY2_RAT|ADCY3_RAT|ADCY4_RAT|ADCY5_RAT|ADCY6_RAT|ADCY8_RAT|D4A3N4_RAT|Q8CFM9_RAT,6.85,,IC50,Inhibition of dopamine-sensitive rat brain adenylyl cyclase activity assessed as cAMP level,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183838,722,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,7.34,,Ki,Compound was tested for the binding affinity against rat heart Muscarinic acetylcholine receptor M2 by Radio ligand [3H]quinuclidinyl binding assay.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183839,722,2265,D(3) dopamine receptor,GPCR,P52703,DRD3,DRD3_CHLAE,6.33,,Ki,Displacement of [3H]-YM 09151 from african monkey Dopamine receptor D3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Chlorocebus aethiops
183840,722,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.66,,Ki,Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183841,722,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,6.68,,Ki,The binding affinity was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183842,722,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.6,,IC50,Affinity towards 5-hydroxytryptamine 1B receptor in membranes from rat frontal cortex using [3H]5-HT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183843,722,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,7.41,,Ki,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 radioligand in rat hippocampus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183844,722,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,7.37,,Ki,Affinity was evaluated as inhibition constant for dopamine receptor D1 using [3H]-SCH- 23390 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183845,722,1833,Alpha-2A adrenergic receptor,GPCR,P22909,Adra2a,ADA2A_RAT,7.72,,Ki,Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183846,722,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,8.54,,Ki,In vitro binding affinity towards Histamine H1 receptor of rat frontal cortex homogenate by using radioligand [3H]pyrilamine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183847,722,1905,D(2) dopamine receptor,GPCR,P52702,DRD2,DRD2_CHLAE,6.6,,Ki,Displacement of [3H]-YM 09151 from african green monkey Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Chlorocebus aethiops
183848,722,2866,Serotonin 2 (5-HT2) receptor,GPCR,P34968|P35363|Q02152,Htr2a|Htr2b|Htr2c,5HT2A_MOUSE|5HT2B_MOUSE|5HT2C_MOUSE,7.55,,IC50,Inhibitory activity against serotonin 5-hydroxytryptamine 2 receptor from mice.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Mus musculus
183849,722,1954,5-hydroxytryptamine receptor 2A,GPCR,Q75Z89,HTR2A,5HT2A_BOVIN,8.52,,IC50,Affinity towards 5-hydroxytryptamine 2A receptor in membranes from bovine frontal cortex using [3H]ketanserin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Bos taurus
183850,722,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,7.47,,Ki,In vitro binding affinity for dopamine receptor D2 of rat nucleus accumbens labeled with [3H]spiperone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183852,722,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,8.1,,Ki,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2C receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183853,722,1854,5-hydroxytryptamine receptor 1A,GPCR,Q64264,Htr1a,5HT1A_MOUSE,5.7,,IC50,Inhibitory activity against serotonin 5-hydroxytryptamine 1A receptor from mice.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Mus musculus
183854,722,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.22,,Ki,Displacement of [3H]ketanserin from 5HT2A receptor in rat cortical membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42,,,,,,,Rattus norvegicus
183855,1912,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,4.98,,IC50,Inhibition of EGFR after 60 mins by radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tclin,,,Homo sapiens
183856,1912,850,RAC-alpha serine/threonine-protein kinase,Kinase,P31749,AKT1,AKT1_HUMAN,4.23,,IC50,Inhibition of Akt1 after 60 mins by radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tchem,,,Homo sapiens
183857,1912,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,4.64,,IC50,Inhibition of VEGFR2 after 60 mins by radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tclin,,,Homo sapiens
183858,1912,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5,,IC50,Inhibition of Src kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tclin,,,Homo sapiens
183859,1912,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,4.17,,IC50,Inhibition of TIE2 after 60 mins by radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tclin,,,Homo sapiens
183860,1912,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,5,,IC50,Inhibition of JAK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tclin,,,Homo sapiens
183861,1912,2426,Signal transducer and activator of transcription 3,Transcription factor,P40763,STAT3,STAT3_HUMAN,6.6,,IC50,Inhibition of STAT3 in human HeLa cells after 24 hrs by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tchem,,,Homo sapiens
183862,1912,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,4.27,,IC50,Inhibition of Aurora-A after 60 mins by radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tchem,,,Homo sapiens
183863,1912,1426,3-phosphoinositide-dependent protein kinase 1,Kinase,O15530,PDPK1,PDPK1_HUMAN,4.08,,IC50,Inhibition of PDK1 after 60 mins by radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tchem,,,Homo sapiens
183864,1912,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,4.88,,IC50,Inhibition of FGFR-1 after 60 mins by radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tclin,,,Homo sapiens
183865,1912,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,4.56,,IC50,Inhibition of KIT after 60 mins by radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tclin,,,Homo sapiens
183866,1912,884,Glycogen synthase kinase-3 beta,Kinase,P49841,GSK3B,GSK3B_HUMAN,4.11,,IC50,Inhibition of GSK3-beta after 60 mins by radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tclin,,,Homo sapiens
183867,1912,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,4.62,,IC50,Inhibition of LYN after 60 mins by radiometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1448,,,,Tclin,,,Homo sapiens
183868,2714,1246,Hematopoietic prostaglandin D synthase,Enzyme,O60760,HPGDS,HPGDS_HUMAN,4.94,,IC50,Inhibition of glutathione-S-transferase activity of prostaglandin D2 synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415324,,,,Tchem,,,Homo sapiens
183869,1878,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,8.8,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80,,,,Tchem,,,Homo sapiens
183870,1878,2078,C-C chemokine receptor type 5,GPCR,P51682,Ccr5,CCR5_MOUSE,7.98,,Kd,Binding affinity to CCR5 in NY1DD transgenic mouse brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80,,,,,,,Mus musculus
183871,1878,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,8.5,,Ki,Displacement of [3H]U-69593 from kappa opioid receptor in guinea pig brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80,,,,,,,Cavia porcellus
183872,1878,1760,Delta-type opioid receptor,GPCR,P32300,Oprd1,OPRD_MOUSE,7.3,,Kd,Tested for inhibitory activity against (DPDE)delta receptor in mouse vas deferens,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80,,,,,,,Mus musculus
183873,1878,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,9.17,,Ki,"Affinity to mu-receptor, using [3H]DAMGO as radioligand in homogenates of guinea pig brain membranes",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80,,,,,,,Cavia porcellus
183874,1878,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,9,,Kd,Displacement of [3H]-(-)-naloxone from opiate receptor in rat brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80,,,,,,,Rattus norvegicus
183875,1878,1836,Kappa-type opioid receptor,GPCR,P34975,Oprk1,OPRK_RAT,9,,Kd,Compound was evaluated for Opioid receptor kappa 1 affinity against the receptor site model site 4(kappa),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80,,,,,,,Rattus norvegicus
183876,1878,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,7.74,,Kd,Affinity against the Opioid receptor delta 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80,,,,,,,Rattus norvegicus
183877,1878,1979,Mu-type opioid receptor,GPCR,P79350,OPRM1,OPRM_BOVIN,8.3,,IC50,Inhibition of 0.5 nM [3H]- Bremazocine binding to Opioid receptor mu 1 of bovine striatum membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80,,,,,,,Bos taurus
183878,1878,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,9.4,,Kd,Opioid receptor mu 1 affinity against the receptor site model site 1 (mu1),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL80,,,,,,,Rattus norvegicus
183879,454,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,9.92,,Ki,Displacement of [3H]U69593 from human kappa opioid receptor expressed in CHO cell membrane,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33986,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33986,PARTIAL AGONIST,,Tclin,,,Homo sapiens
183880,454,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,7.92,,Ki,Displacement of [3H]Naltindole from human delta opioid receptor expressed in CHO cell membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33986,,,,Tclin,,,Homo sapiens
183881,454,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.92,,Ki,Displacement of [3H]DAMGO form human mu opioid receptor expressed in CHO cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33986,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33986,PARTIAL AGONIST,,Tclin,,,Homo sapiens
183882,1613,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.37,,Ki,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,,,,,,,Rattus norvegicus
183883,1613,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,7.74,,IC50,In vitro binding affinity towards Alpha-1 adrenergic receptor by the displacement of [3H]prazosin radioligand in rat cortical homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,,,,,,,Rattus norvegicus
183884,1613,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.26,,IC50,Inhibition of binding of 1.0 nM [3H]pirenzepine to cloned human Muscarinic acetylcholine receptor M1 expressed in membranes from CHO-K1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,,,,Tclin,,,Homo sapiens
183885,1613,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,7.82,,Ki,Binding affinity towards human 5-hydroxytryptamine 6 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,,,,Tchem,,,Homo sapiens
183886,1613,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.68,,Ki,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,ANTAGONIST,,Tclin,,,Homo sapiens
183887,1613,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.31,,Ki,Affinity was evaluated by inhibition of [3H]-spiperone binding to COS cells transfected with human dopamine D-4 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,,ANTAGONIST,,Tchem,,,Homo sapiens
183888,1613,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.62,,Ki,Displacement of [3H]ketanserin from human recombinant 5HT2A receptor expressed in CHO cells after 60 mins by liquid scintillation counting,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,ANTAGONIST,,Tclin,,,Homo sapiens
183889,1613,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.66,,IC50,Binding affinity towards human Dopamine receptor D3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,,ANTAGONIST,,Tclin,,,Homo sapiens
183890,1613,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,6,,IC50,Binding affinity towards histamine H1 receptor from rat brain membranes using [3H]mepyramine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,,,,,,,Rattus norvegicus
183891,1613,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,7.68,,Ki,In vitro binding affinity towards Dopamine receptor D2 in rat tissue homogenate using [3H]-spiperone as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,,,,,,,Rattus norvegicus
183892,1613,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,6,,IC50,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,,,,,,,Rattus norvegicus
183893,1613,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.22,,IC50,Binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]ketanserin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831,,,,,,,Rattus norvegicus
183894,1752,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,5.02,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1764,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
183896,2477,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,Mechanism of Action; CHEMBL1871; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2079587,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2079587,AGONIST,,Tclin,,,Homo sapiens
183897,1944,1837,4-hydroxyphenylpyruvate dioxygenase,Enzyme,Q02110,HPD,HPPD_PIG,7.4,,IC50,Inhibition of 4-hydroxyphenylpyruvate dioxygenase of purified pig liver by enol-borate method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1337,,,,,,,Sus scrofa
183898,2068,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,10.3,,Ki,Displacement of [3H]citalopram from serotonin transporter in Sprague-Dawley rat brain after 1 hr by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,,,,Rattus norvegicus
183899,2068,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,7.23,,Ki,Displacement of [3H]nisoxetine from norepinephrine transporter in Sprague-Dawley rat frontal cortex after 1 hr by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,,,,Rattus norvegicus
183900,2068,1829,Sodium-dependent dopamine transporter,Transporter,Q61327,Slc6a3,SC6A3_MOUSE,9.36,,Ki,Tested in vitro for serotonin(5-HT) neuronal uptake inhibition,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,,,,Mus musculus
183901,2068,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,7.48,,Ki,Inhibition of [3H]- NE reuptake into rat hippocampal synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,,,,Rattus norvegicus
183902,2068,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,4.52,,Kd,Binding affinity to 5HT1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,Tclin,,,Homo sapiens
183903,2068,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.27,,Ki,Evaluated for affinity at Alpha-1 adrenergic receptor of rat brain using [3H]prazosin as radioligand in radioligand binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,,,,Rattus norvegicus
183904,2068,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,7.01,,Ki,Displacement of [3H]WIN 35428 from dopamine transporter in Sprague-Dawley rat brain after 1 hr by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,,,,Rattus norvegicus
215587,91,3320,P2X purinoceptor 3,Ion channel,P56373,P2RX3,P2RX3_HUMAN,7.835647144,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
183905,2068,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.2,,Ki,Evaluated for affinity at Alpha-2 adrenergic receptor of rat brain using [3H]rauwolscine as radioligand in radioligand binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,,,,Rattus norvegicus
183906,2068,2440,Quinolone resistance protein NorA,Transporter,P0A0J7,norA,NORA_STAAU,5.15,,IC50,Inhibition of NorA in Staphylococcus aureus 1199B assessed as inhibition of ethidium bromide efflux dose response curve based fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,,,,Staphylococcus aureus
183907,2068,2607,P2X purinoceptor 4,Ion channel,Q99571,P2RX4,P2RX4_HUMAN,5.33,,IC50,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,Tchem,,,Homo sapiens
183908,2068,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,10.4,,Ki,Binding inhibition towards human serotonin transporter,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,INHIBITOR,,Tclin,,,Homo sapiens
183909,2068,1830,Sodium-dependent noradrenaline transporter,Transporter,O55192,Slc6a2,SC6A2_MOUSE,7.7,,Ki,Tested in vitro for norepinephrine (NE) neuronal uptake inhibition,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,,,,Mus musculus
183910,2068,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,6.05,,IC50,Displacement of [125I]substance P from human recombinant NK1 receptor expressed in human U373 cells after 1 hr by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490,,,,Tclin,,,Homo sapiens
183911,2261,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,6.52,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24072,,,,Tclin|Tclin|Tclin,,,Homo sapiens
183912,2261,2874,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,6.68,,Kd,Inhibition of [3H]nitrendipine binding to calcium channel of rat brain membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24072,,,,,,,Rattus norvegicus
183913,1626,1365,Acetylcholinesterase,Enzyme,A2PZ98,Ace1,A2PZ98_9NEOP,,,,Mechanism of Action; CHEMBL2362988; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200468,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200468,INHIBITOR,,,,,Pediculus humanus capitis
183914,820,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,7.38,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1498,,,,Tchem,,,Homo sapiens
183915,1258,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.19,,Ki,Inhibition of human recombinant full length CA2 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tclin,,,Homo sapiens
183916,1258,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,6.26,,Ki,Inhibition of mouse recombinant full length CA13 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,,,,Mus musculus
183917,1258,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,6.58,,Ki,Inhibition of human recombinant CA12 catalytic domain by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tclin,,,Homo sapiens
183918,1258,3592,Holo-[acyl-carrieir-protein] synthase,Unclassified,P96618,acpS,ACPS_BACSU,4.9,,IC50,Inhibitory activity against Bacillus subtilis AcpS by HTRF assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,,,,Bacillus subtilis (strain 168)
183919,1258,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.25,,Ki,Inhibition of human recombinant full length CA4 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tclin,,,Homo sapiens
183920,1258,896,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,P28845,HSD11B1,DHI1_HUMAN,5.42,,IC50,Inhibition of human 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay in presence of NADPH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tclin,,,Homo sapiens
183921,1258,2478,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,5.49,,Ki,Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tchem,,,Homo sapiens
183922,1258,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,6.3,,Ki,Inhibition of human recombinant full length CA5A by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tclin,,,Homo sapiens
183923,1258,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,7.28,,Ki,Inhibition of human recombinant full length CA14 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tclin,,,Homo sapiens
183924,1258,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,6.29,,Ki,Inhibition of human recombinant full length CA7 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tclin,,,Homo sapiens
183925,1258,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,6.38,,Ki,Inhibition of human recombinant CA9 catalytic domain by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tclin,,,Homo sapiens
183926,1258,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,7.21,,Ki,Inhibition of human recombinant full length CA1 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tclin,,,Homo sapiens
183927,1258,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,6.49,,Ki,Inhibition of human recombinant full length CA5B by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tclin,,,Homo sapiens
183928,1258,2058,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,P50172,Hsd11b1,DHI1_MOUSE,5.42,,IC50,Inhibition of mouse 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay in presence of NADPH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,,,,Mus musculus
183929,1258,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,6.61,,Ki,Inhibition of human recombinant full length CA6 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL35,,,,Tclin,,,Homo sapiens
183930,659,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,6.39,,IC50,Inhibition of [3H]muscimol binding to GABA A receptor 4-biphenylacetic acid at 10 e-4 M,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8,,,,,,,Rattus norvegicus
183931,659,3588,Multidrug resistance protein mdtK,Unclassified,P37340,mdtK,MDTK_ECOLI,4.04,,Kd,Binding affinity to Escherichia coli K-12 multidrug efflux protein YdhE expressed in Escherichia coli AG100AX in presence of 0.02% DDM surfactant by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8,,,,,,,Escherichia coli (strain K12)
183932,659,2848,DNA topoisomerase II,Enzyme,P11388|Q02880,TOP2A|TOP2B,TOP2A_HUMAN|TOP2B_HUMAN,7.52,,EC50,Inhibitory activity against HeLa cell Topoisomerase II,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8,,,,Tchem|Tclin,,,Homo sapiens
183934,2210,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,4.68,,IC50,Tested for inhibitory activity against Prostaglandin G/H synthase 1 from ovine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL527,,,,,,,Ovis aries
183935,2210,2845,Cyclooxygenase,Enzyme,P35355|Q63921,Ptgs1|Ptgs2,PGH1_RAT|PGH2_RAT,7,,IC50,In vitro inhibitory activity against Prostaglandin G/H synthase in rat neutrophils,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL527,,,,,,,Rattus norvegicus
183936,2210,2844,Cyclooxygenase,Enzyme,O62664|O62698,PTGS1|PTGS2,PGH1_BOVIN|PGH2_BOVIN,4.19,,IC50,Inhibition of bovine Prostaglandin G/H synthase after oral administration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL527,,,,,,,Bos taurus
183937,2318,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,Mechanism of Action; CHEMBL210; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200893,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200893,AGONIST,,Tclin,,,Homo sapiens
183947,2875,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.48,,Ki,Binding affinity towards human 5-hydroxytryptamine 1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285802,,,,Tclin,,,Homo sapiens
183948,2875,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.96,,Ki,Binding affinity towards human D2 dopamine receptor.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285802,,,,Tclin,,,Homo sapiens
183949,2875,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.54,,Ki,Binding affinity against dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285802,,,,Tclin,,,Homo sapiens
183950,2875,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.41,,Ki,Binding affinity towards human dopamine-4.2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285802,,,,Tchem,,,Homo sapiens
183951,2875,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.54,,Ki,Binding affinity towards human serotonin 5-hydroxytryptamine 2C receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285802,,,,Tclin,,,Homo sapiens
183952,2875,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.04,,Ki,Binding affinity towards human serotonin 5-hydroxytryptamine 2A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285802,,,,Tclin,,,Homo sapiens
183953,2875,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.21,,Ki,Binding affinity towards human H1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285802,,,,Tclin,,,Homo sapiens
183954,2875,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.19,,Ki,Binding affinity towards human dopamine receptor D3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285802,,,,Tclin,,,Homo sapiens
183955,2875,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.26,,Ki,Binding affinity towards human muscarinic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285802,,,,Tclin,,,Homo sapiens
183956,1207,2074,Solute carrier family 22 member 6,Transporter,Q8VC69,Slc22a6,S22A6_MOUSE,5.53,,Ki,Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL177756,,,,,,,Mus musculus
183957,1207,912,Protein arginine N-methyltransferase 1,Enzyme,Q99873,PRMT1,ANM1_HUMAN,4.12,,IC50,Inhibition of human recombinant GST-PRMT1 expressed in BL21 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL177756,,,,Tchem,,,Homo sapiens
183958,1207,2079,Solute carrier family 22 member 20,Transporter,Q80UJ1,Slc22a20,S22AK_MOUSE,4,,Ki,Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL177756,,,,,,,Mus musculus
183959,2859,3459,Sialidase 3,Enzyme,Q9UQ49,NEU3,NEUR3_HUMAN,5.17,,IC50,Inhibition of human NEU3 expressed in HEK293 cells by fluorometric high-performance liquid chromatography using ganglioside GM3 substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,,,,Tbio,,,Homo sapiens
183960,2859,1794,Neuraminidase,Enzyme,P03468,NA,NRAM_I34A1,9.3,,IC50,Inhibitory activity was determined against Neuraminidase A from influenza virus A/Tokyo/3/67,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,INHIBITOR,,,,,Influenza A virus (strain A/Puerto Rico/8/1934 H1N1)
183961,2859,2150,Neuraminidase,Enzyme,B4URF0,NA,B4URF0_9INFA,8.62,,IC50,Inhibition of influenza A virus A/WSN/1933 H1N1 neuraminidase using NA-STAR substrate after 15 mins incubation at room temperature by fluorescent assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,,,,,,,Influenza A virus (A/WSN/1933(H1N1))
183962,2859,1795,Neuraminidase,Enzyme,P03474,NA,NRAM_INBLE,10,,Ki,Inhibition of influenza B/Memphis/3/89 neuraminidase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,INHIBITOR,,,,,Influenza B virus (strain B/Lee/1940)
183963,2859,3460,Sialidase 2,Enzyme,Q9Y3R4,NEU2,NEUR2_HUMAN,4.77,,Ki,Inhibition of human neuraminidase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,,,,Tbio,,,Homo sapiens
183964,2859,2412,Neuraminidase,Enzyme,C4LRQ6,NA,C4LRQ6_9INFA,9.3,,Ki,Inhibition of Influenza A virus (A/duck/Laos/25/2006(H5N1)) neuraminidase by Michaelis-Menten equation analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,,,,,,,Influenza A virus (A/duck/Laos/25/2006(H5N1))
183965,2859,2411,Neuraminidase,Enzyme,Q2LFS1,NA,Q2LFS1_9INFA,9.4,,Ki,Inhibition of Influenza A virus (A/chicken/Yogjakarta/BBVet-IX/2004(H5N1)) neuraminidase by Michaelis-Menten equation analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,,,,,,,Influenza A virus (A/chicken/Yogjakarta/BBVet-IX/2004(H5N1))
183966,2859,2410,Neuraminidase,Enzyme,A5Z252,NA,A5Z252_9INFA,9,,Ki,Inhibition of Influenza A virus (A/Turkey/651242/2006(H5N1)) neuraminidase by Michaelis-Menten equation analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,,,,,,,Influenza A virus (A/Turkey/651242/2006(H5N1))
183967,2859,2409,Neuraminidase,Enzyme,Q6Q793,,Q6Q793_9INFA,9.3,,Ki,Inhibition of Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) neuraminidase by by Michaelis-Menten equation analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,,,,,,,Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1))
183968,2859,2393,Neuraminidase,Enzyme,Q75VQ4,NA,NRAM_I68A0,8.58,,IC50,Inhibition of human influenza A virus A/Aichi/2/1968(H3N2) neuraminidase by fluorometric method using 4MU-NeuAc substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,,,,,,,Influenza A virus (strain A/Aichi/2/1968 H3N2)
183969,2859,2489,Neuraminidase,Enzyme,P03470,NA,NRAM_I33A0,8.54,,IC50,Inhibition of wild type Influenza A virus A/WSN/1933(H1N1) neuraminidase in virus-infected allantoic fluid using 2'-(4-methylumbelliferyl)-alpha-D-N-acetylneuraminic acid as substrate incubated for 10 mins prior to substrate addition by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,,,,,,,Influenza A virus (strain A/Wilson-Smith/1933 H1N1)
183970,2859,3458,Neuraminidase,Enzyme,Q194T1,,Q194T1_9INFA,5.85,,IC50,Inhibition of Influenza A virus (A/RI/5+/1957(H2N2)) recombinant neuraminidase using MUNANA as substrate after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,,,,,,,Influenza A virus (A/RI/5+/1957(H2N2))
183971,2859,2488,Neuraminidase,Enzyme,Q20MD3,NA,Q20MD3_9INFA,7.64,,IC50,Inhibition of Influenza A virus A/Udorn/1972(H3N2) neuraminidase in virus-infected allantoic fluid using 2'-(4-methylumbelliferyl)-alpha-D-N-acetylneuraminic acid as substrate incubated for 10 mins prior to substrate addition by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222813,,,,,,,Influenza A virus (A/udorn/1972(H3N2))
183972,1475,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.54,,Ki,Displacement of [3H]-NMS from Sprague-Dawley rat muscarinic M1 receptor in cortex membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1464005,,,,,,,Rattus norvegicus
183973,1475,1845,Muscarinic acetylcholine receptor M3,GPCR,P08483,Chrm3,ACM3_RAT,9.74,,Ki,Displacement of [3H]-NMS from Sprague-Dawley rat muscarinic M3 receptor in submandibular gland,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1464005,,,,,,,Rattus norvegicus
183974,1475,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,9.11,,Ki,Displacement of [3H]-NMS from Sprague-Dawley rat muscarinic M2 receptor in heart,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1464005,,,,,,,Rattus norvegicus
183975,133,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,6.52,,IC50,Inhibition of [35S]TBPS binding to GABA-A receptor in rat cerebral cortex.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190279,,,,,,,Rattus norvegicus
183976,397,72,Thymidine kinase,Kinase,Q9QNF7,TK,KITH_HHV1,6.62,,Ki,Inhibition of Herpes simplex virus 1 recombinant thymidine kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31634,,,,,,,Human herpesvirus 1
183977,397,2062,Thymidine kinase,Kinase,A3RLP8,UL23,A3RLP8_CHV1,4.49,,IC50,Inhibition of Herpes B virus recombinant thymidine kinase-mediated [3H]TdR phosphorylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31634,,,,,,,Cercopithecine herpesvirus 1
183978,397,681,"Thymidine kinase, cytosolic",Kinase,P04183,TK1,KITH_HUMAN,7,,Ki,Binding affinity constant against HSV-1 thymidine kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31634,,,,Tchem,,,Homo sapiens
183979,397,1776,Thymidine kinase,Kinase,P06479,TK,KITH_HHV1S,6.52,,IC50,Binding affinity towards HSV-1 thymidine kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31634,,,,,,,Human herpesvirus 1 (strain SC16)
183980,494,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.78,,Ki,Binding affinity towards muscarinic m2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73234,,,,Tclin,,,Homo sapiens
183981,494,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.12,,Ki,Binding affinity towards muscarinic m1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73234,,,,Tclin,,,Homo sapiens
183982,494,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.51,,Ki,Binding affinity against dopamine transporter was determined by the displacement of [3H]WIN-35428 radioligand in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73234,,,,,,,Rattus norvegicus
183983,494,572,Lysosomal Pro-X carboxypeptidase,Enzyme,P42785,PRCP,PCP_HUMAN,7.49,,IC50,Inhibition of [3H]- (+) - pentazocine binding to PCP receptor obtained from tissue homogenate preparation of fresh whole rat brain minus cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73234,,,,Tchem,,,Homo sapiens
183984,494,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.71,,Ki,Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73234,,,,Tclin,,,Homo sapiens
183985,494,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,7.96,,Ki,Tested for its binding affinity towards sigma-1 site in presence of [3H]- -(+)3 PPP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73234,,,,,,,Rattus norvegicus
183986,808,2473,Soluble acetylcholine receptor,Unclassified,Q8WSF8,,Q8WSF8_APLCA,5.2,,Ki,Displacement of [3H]epibatidine from Aplysia californica acetylcholine binding protein expressed using baculoviral system after 1.5 hrs by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1946186,,,,,,,Aplysia californica
183987,808,956,Acetylcholine-binding protein,Unclassified,P58154,,ACHP_LYMST,5.7,,Ki,Displacement of [3H]epibatidine from Lymnaea stagnalis acetylcholine binding protein expressed using baculoviral system after 1.5 hrs by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1946186,,,,,,,Lymnaea stagnalis
183988,401,2844,Cyclooxygenase,Enzyme,O62664|O62698,PTGS1|PTGS2,PGH1_BOVIN|PGH2_BOVIN,7.1,,IC50,Inhibition of prostaglandin G/H synthase obtained from bovine seminal vesicles.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL751,,,,,,,Bos taurus
183989,1819,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,4.6,,Ki,Uncompetitive inhibition of hexahistidyl-tagged human IDO1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL105,,,,Tchem,,,Homo sapiens
183990,2615,1786,Dihydrofolate reductase,Enzyme,P00381,folA,DYR_LACCA,6.26,,Ki,Inhibitory activity against Lactobacillus casei dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32039,,,,,,,Lactobacillus casei
183991,2615,2102,Dihydrofolate reductase,Unclassified,B0BL08,dfrA17,B0BL08_ECOLX,7.74,,IC50,Inhibitory activity against Dihydrofolate reductase of Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32039,,,,,,,Escherichia coli
183992,2171,1815,Type-1 angiotensin II receptor,GPCR,P25104,AGTR1,AGTR1_BOVIN,4.77,,IC50,"Concentration required for 50% inhibition of binding against Angiotensin II receptor, type 1 in bovine adrenal cortex",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24646,,,,,,,Bos taurus
183993,2082,168,Beta-lactamase TEM,Enzyme,P62593,bla; blaT-3; blaT-4;,BLAT_ECOLX,4.7,,Ki,Inhibition constant (Ki) for TEM-1 beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29,,,,,,,Escherichia coli
183994,2082,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29,INHIBITOR,,,,,Escherichia coli (strain K12)
183995,2281,3593,Histamine H2 receptor,Unclassified,P25102,Hrh2,HRH2_RAT,2.6,,IC50,Inhibitory activity against binding of [125I](Nle11)-HG-13 to Histamine H2 receptor in vitro,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL316561,,,,,,,Rattus norvegicus
183996,2484,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,4.7,,IC50,GRAC: human Glycine receptor subunit alpha-1 selective antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL227934,,,,Tclin,,,Homo sapiens
183997,2484,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.68,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL227934,,,,Tclin|Tclin|Tclin,,,Homo sapiens
183998,2278,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,4.85,,Ki,Displacement of [3H]gamma-amino butyric acid from Gamma-aminobutyric acid (GABA-A) receptor of rat ganglion neurons,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287631,,,,,,,Rattus norvegicus
183999,1884,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.35,,Ki,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1278,,,,Tclin,,,Homo sapiens
184000,1884,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,8.48,,Ki,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1278,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1278,AGONIST,,Tclin,,,Homo sapiens
184001,867,3413,Urease,Enzyme,P07374,,UREA_CANEN,4.82,,IC50,Inhibition of jack bean urease,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1466,,,,,,,Canavalia ensiformis
184002,867,2566,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,Q5NGQ3,fabI,Q5NGQ3_FRATT,4.33,,IC50,Inhibition of C-terminal His6-tagged Francisella tularensis SCHU S4 FabI expressed in Escherichia coli BL21 (DE3) using CrCoA as substrate assessed as oxidation of NADH to NAD+ by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1466,,,,,,,Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4)
184003,867,2478,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,7.41,,Ki,Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1466,,,,Tchem,,,Homo sapiens
184004,867,2438,Proprotein convertase subtilisin/kexin type 7,Enzyme,Q16549,PCSK7,PCSK7_HUMAN,5.89,,IC50,Inhibition of recombinant type 8 subtilisin using Arg-Glu-(EDANS)- Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys-(DALBCYL)-Arg fluorogenic substrate preincubated for 1 hr measured after 1 hr at 1 min interval by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1466,,,,Tchem,,,Homo sapiens
184005,867,3594,ATP phosphoribosyltransferase,Unclassified,P9WMN1,hisG,HIS1_MYCTU,4.22,,Ki,Inhibition of Mycobacterium tuberculosis HisG assessed as phosphoribosyl ATP production by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1466,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184006,1210,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.24,,Ki,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1445,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1445,AGONIST,,Tclin,,,Homo sapiens
184007,1164,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,6.71,,Ki,Binding affinity towards Opioid receptor kappa 1 using [3H]U-69593 as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,,,,Cavia porcellus
184008,1164,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.71,,Ki,Binding affinity against Opioid receptor kappa 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,Tclin,,,Homo sapiens
184009,1164,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,6.17,,Ki,Binding affinity against Opioid receptor delta 1 in guinea pig brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,Tclin,,,Homo sapiens
184010,1164,1760,Delta-type opioid receptor,GPCR,P32300,Oprd1,OPRD_MOUSE,8.03,,IC50,Inhibition of delta opioid receptor in mouse vas deferens assessed as inhibition of electrically-stimulated muscle contraction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,,,,Mus musculus
184011,1164,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.74,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,Tclin,,,Homo sapiens
184012,1164,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,8.07,,Ki,Binding affinity against mu opioid receptor in guinea pig brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,,,,Cavia porcellus
184013,1164,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,4.7,,IC50,Displacement of [3H]mepyramine from histamine H1 receptor in Sprague-Dawley rat brain membrane after 2 hr by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,,,,Rattus norvegicus
184014,1164,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,8.67,,Ki,In vitro affinity to displace [3H]naloxone from opiate receptor in freshly prepared rat brain homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,,,,Rattus norvegicus
184015,1164,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,6.4,,Ki,Binding affinity of compound evaluated for Opioid receptor delta 1 isolated from rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,,,,Rattus norvegicus
184016,1164,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,8.82,,Ki,Inhibition of [3H]DAMGO binding to mu opioid receptor of rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,,,,Rattus norvegicus
184017,1164,2885,Monoamine oxidase,Enzyme,P21397|P27338,MAOA|MAOB,AOFA_HUMAN|AOFB_HUMAN,5.26,,Ki,Displacement of [3H]2-BFI (1 nM) from imidazoline receptor I-2 in human brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,Tclin|Tclin,,,Homo sapiens
184018,1584,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.1,,Ki,Inhibition of MAO-A (unknown origin) by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL126,,,,Tclin,,,Homo sapiens
184019,1584,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,4.77,,IC50,Compound was evaluated for inhibition of Mono aminoxidase B in rat primary hepatocytes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL126,,,,,,,Rattus norvegicus
184020,1986,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,7.8,,Ki,"Binding affinity for histamine H1 receptor from guinea pig cerebellum, using [3H]pyrilamine as radioligand at 0.1 uM",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1719,,,,,,,Cavia porcellus
184021,1129,2514,Solute carrier family 22 member 3,Transporter,O75751,SLC22A3,S22A3_HUMAN,4.97,,IC50,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL902,,,,Tchem,,,Homo sapiens
184022,1129,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.44,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL902,,,,Tchem,,,Homo sapiens
184023,1129,1747,Histamine H2 receptor,GPCR,P47747,HRH2,HRH2_CAVPO,7,,Kd,In vitro inhibitory activity against histamine H2-receptor in isolated Guinea pig right atria.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL902,,,,,,,Cavia porcellus
184024,1129,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.44,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL902,,,,Tchem,,,Homo sapiens
184025,1129,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,6.12,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL902,,,,Tchem,,,Homo sapiens
184035,779,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,8.2,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1479,,,,Tchem,,,Homo sapiens
184037,161,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,6,,IC50,Inhibition of dopamine transporter-mediated [3H]dopamine uptake in Wistar rat striatal synaptosomes by liquid scintillation spectrometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL418995,,,,,,,Rattus norvegicus
184038,1588,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,9.4,,Ki,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H]-(+)-8-OH-DPAT.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157138,,,,Tclin,,,Homo sapiens
184039,1588,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.3,,Ki,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157138,,,,Tclin,,,Homo sapiens
184040,1588,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.11,,Ki,Affinity towards Dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157138,,,,Tclin,,,Homo sapiens
184041,1588,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.77,,Ki,Binding affinity towards Dopamine receptor D3 by displacement of [3H](+)-7-OH-DPAT.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157138,,,,Tclin,,,Homo sapiens
184042,1588,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,9.52,,Kd,In vitro affinity at mutant D2 receptor (S194A) in C6 (glioma) cell membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157138,,,,,,,Rattus norvegicus
184043,625,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,7.82,,Ki,Inhibition of mouse recombinant full length CA13 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,,,,,,,Mus musculus
184044,625,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,8.35,,Ki,Inhibition of human recombinant CA12 catalytic domain by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,,,,Tclin,,,Homo sapiens
184045,625,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.71,,Ki,Inhibition of human recombinant full length CA4 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,,,,Tclin,,,Homo sapiens
184046,625,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,4.96,,Ki,Inhibition of human recombinant full length CA3 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,,,,Tclin,,,Homo sapiens
184779,568,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,7.4,,IC50,Inhibition of ovine COX2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Ovis aries
184047,625,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,6.04,,Ki,Inhibition of human recombinant full length CA5A by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,,,,Tclin,,,Homo sapiens
184048,625,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.38,,Ki,Inhibition of human recombinant full length CA14 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,,,,Tclin,,,Homo sapiens
184049,625,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,8.55,,Ki,Inhibition of human recombinant full length CA7 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,,,,Tclin,,,Homo sapiens
184050,625,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.64,,Ki,Inhibition of human recombinant CA9 catalytic domain by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,,,,Tclin,,,Homo sapiens
184051,625,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.46,,Ki,Inhibition of human recombinant full length CA1 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,,,,Tclin,,,Homo sapiens
184052,625,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,8.05,,Ki,Inhibition of human recombinant full length CA5B by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,,,,Tclin,,,Homo sapiens
184053,625,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,5.87,,Ki,Inhibition of human recombinant full length CA6 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,,,,Tclin,,,Homo sapiens
184054,625,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,,,,Mechanism of Action; CHEMBL1876; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1055,INHIBITOR,,Tclin,,,Homo sapiens
184055,398,436,Dihydrofolate reductase,Enzyme,P16184,,DYR_PNECA,7.51,,IC50,Inhibition of Pneumocystis carinii Dihydrofolate Reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31891,,,,,,,Pneumocystis carinii
184056,398,1786,Dihydrofolate reductase,Enzyme,P00381,folA,DYR_LACCA,7.95,,Ki,Inhibition constant of compound against Lactobacillus casei dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31891,,,,,,,Lactobacillus casei
184057,398,276,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q07422,,DRTS_TOXGO,7.77,,IC50,Inhibition of Toxoplasma gondii Dihydrofolate Reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31891,,,,,,,Toxoplasma gondii
184058,398,1956,Dihydrofolate reductase,Enzyme,P00378,DHFR,DYR_CHICK,4.54,,Ki,Inhibitory activity against chicken liver dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31891,,,,,,,Gallus gallus
184059,398,1752,Dihydrofolate reductase,Enzyme,Q920D2,Dhfr,DYR_RAT,7.82,,IC50,Inhibition of rat liver Dihydrofolate Reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31891,,,,,,,Rattus norvegicus
184060,1829,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,8.85,,IC50,Inhibition of COX1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL259972,,,,Tclin,,,Homo sapiens
184061,1829,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.36,,IC50,Inhibition of COX2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL259972,,,,Tclin,,,Homo sapiens
184062,2706,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,8.3,,Ki,Compound was evaluated for inhibition against human carbonic anhydrase II,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,INHIBITOR,,Tclin,,,Homo sapiens
184063,2706,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,7.33,,Ki,Inhibition of murine CA13 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Mus musculus
184064,2706,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,8.42,,Ki,Ki value against human carbonic anhydrase XII (hCA XII),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,Tclin,,,Homo sapiens
184065,2706,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.31,,Ki,Inhibitory activity against human carbonic anhydrase IV (hCAIV),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,INHIBITOR,,Tclin,,,Homo sapiens
184066,2706,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,7.33,,Ki,Inhibition of human recombinant CA13 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,Tclin,,,Homo sapiens
184067,2706,2428,Carbonic anhydrase 2,Unclassified,Q3I4V7,CAN2,Q3I4V7_CRYNV,6.43,,Ki,Inhibition of Cryptococcus neoformans recombinant Can2 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Cryptococcus neoformans var. grubii
184068,2706,2010,Carbonic anhydrase,Enzyme,Q50565,,Q50565_METTH,4.63,,Ki,Inhibitory activity against beta carbonic anhydrase (Cab) from Methanobacterium thermoautotrophicum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H)
184069,2706,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,7.54,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Stylophora pistillata
184070,2706,2143,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878,,P96878_MYCTU,5.52,,Ki,Inhibition of Mycobacterium tuberculosis recombinant Rv3273 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184071,2706,2837,Carbonic anhydrase V,Enzyme,P35218|Q9Y2D0,CA5A|CA5B,CAH5A_HUMAN|CAH5B_HUMAN,7.6,,Ki,Mean inhibitory constant towards human carbonic anhydrase V determined by spectrophotometric dansylamide binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,Tclin|Tclin,,,Homo sapiens
184072,2706,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,7.42,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Astrosclera willeyana
215588,2149,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.823908741,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
184073,2706,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,6.21,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184074,2706,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,6.44,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Stylophora pistillata
184075,2706,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,6.41,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Thalassiosira weissflogii
184076,2706,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,7.6,,Kd,Inhibition of human carbonic anhydrase 5A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,Tclin,,,Homo sapiens
184077,2706,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,6.96,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
184078,2706,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.84,,Ki,Inhibitory constant against human carbonic anhydrase XIV in CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,Tclin,,,Homo sapiens
184079,2706,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,9.06,,Ki,Ki value against human carbonic anhydrase VII,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,Tclin,,,Homo sapiens
184080,2706,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.24,,Ki,Compound was evaluated for inhibition against human carbonic anhydrase IX,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,Tclin,,,Homo sapiens
184081,2706,401,Carbonic anhydrase,Enzyme,O24855,cynT,CYNT_HELPY,6.76,,Ki,Inhibition of Helicobacter pylori recombinant carbonic anhydrase by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
184082,2706,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.11,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Mus musculus
184083,2706,2006,Carbonic anhydrase 2,Enzyme,P27139,Ca2,CAH2_RAT,5.85,,IC50,Inhibition concentration against carbonic anhydrase II in rat determined in esterase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Rattus norvegicus
184084,2706,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.6,,Ki,Compound was evaluated for inhibition against human carbonic anhydrase I,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,Tclin,,,Homo sapiens
184085,2706,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,7.52,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,Tclin,,,Homo sapiens
184086,2706,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,8,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
184087,2706,2009,Carbonic anhydrase,Enzyme,P40881,,CAH_METTE,6.92,,Ki,Inhibitory activity against alpha carbonic anhydrase (Co-Cam) from Methanosarcina thermophila,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Methanosarcina thermophila
184088,2706,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,6.32,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184089,2706,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,7.35,,Ki,Inhibition of full length human recombinant CA VI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,Tclin,,,Homo sapiens
184090,2706,1798,Sodium channel protein type 2 subunit alpha,Ion channel,P04775,Scn2a,SCN2A_RAT,4.01,,IC50,Inhibition of rat Nav1.2 channel expressed in chinese hamster CHL1610 cells at preconditioning pulse of -67 mV after 2 to 3 mins by whole-cell patch-clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Rattus norvegicus
184091,2706,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,7.27,,Ki,Compound was evaluated for inhibition against bovine carbonic anhydrase IV,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Bos taurus
184092,2706,2925,Glutamate receptor ionotropic AMPA,Ion channel,P42261|P42262|P42263|P48058,GRIA1|GRIA2|GRIA3|GRIA4,GRIA1_HUMAN|GRIA2_HUMAN|GRIA3_HUMAN|GRIA4_HUMAN,,,,Mechanism of Action; CHEMBL2096670; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,ANTAGONIST,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
184093,2706,2924,Glutamate receptor ionotropic kainate,Ion channel,P39086|Q13002|Q13003|Q16099|Q16478,GRIK1|GRIK2|GRIK3|GRIK4|GRIK5,GRIK1_HUMAN|GRIK2_HUMAN|GRIK3_HUMAN|GRIK4_HUMAN|GRIK5_HUMAN,,,,Mechanism of Action; CHEMBL2109241; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,ANTAGONIST,,Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
184094,2056,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,5.06,,IC50,Inhibitory activity against cyclic GMP-phosphodiesterase (PDE V) isolated from porcine aorta.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,Tclin,,,Homo sapiens
184095,2056,877,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",Enzyme,Q13370,PDE3B,PDE3B_HUMAN,6.38,,Ki,Inhibition of human recombinant PDE3B transfected in Sf9 cells by SPA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,Tclin,,,Homo sapiens
184096,2056,2443,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,Q9QYJ6,Pde10a,PDE10_RAT,7.44,,IC50,Inhibition of rat PDE10A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,,,,Rattus norvegicus
184097,2056,2904,Phosphodiesterase 1,Enzyme,P14100|Q01061,PDE1A|PDE1B,PDE1A_BOVIN|PDE1B_BOVIN,5.06,,IC50,Inhibitory activity against cyclic nucleotide phosphodiesterase in bovine heart carried out at 37 C with cAMP (1 M) as substrate.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,,,,Bos taurus
184098,2056,1891,Cyclic AMP-specific phosphodiesterase SSPDE4A1A,Enzyme,O77823,PDE4A,O77823_PIG,5.77,,IC50,Inhibition of cAMP specific phosphodiesterase from porcine coronary arteries,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,,,,Sus scrofa
184099,2056,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.61,,IC50,Inhibition of AChE activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,Tclin,,,Homo sapiens
184100,2056,121,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,6.55,,Ki,Inhibition of human recombinant PDE3A transfected in Sf9 cells by SPA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,Tclin,,,Homo sapiens
184101,2056,693,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Enzyme,O00408,PDE2A,PDE2A_HUMAN,5.64,,IC50,Inhibition of cGMP-stimulated phosphodiesterase 2 of porcine coronary arteries,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,Tclin,,,Homo sapiens
184102,2056,2903,Phosphodiesterase 1,Enzyme,P54750|Q01064|Q14123,PDE1A|PDE1B|PDE1C,PDE1A_HUMAN|PDE1B_HUMAN|PDE1C_HUMAN,5.05,,IC50,Inhibition of [Ca(2+)]/calmodulin dependent phosphodiesterase PDE 1 of human lung,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184103,2056,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.14,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,Tclin,,,Homo sapiens
184104,2056,2907,Phosphodiesterase 1,Enzyme,Q01066|Q63421|Q9EPR9,Pde1a|Pde1b|Pde1c,PDE1B_RAT|PDE1C_RAT|Q9EPR9_RAT,4.92,,IC50,Inhibition of Ca-dependent phosphodiesterase from Rat cerebral cortex using 1 uM cAMP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,,,,Rattus norvegicus
184105,2056,1890,Cyclic nucleotide phosphodiesterase PDE3A,Enzyme,Q9XSW7,,Q9XSW7_PIG,6.21,,IC50,Inhibition of cGMP-inhibited phosphodiesterase from porcine coronary arteries,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,,,,Sus scrofa
184106,2056,446,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,Q9Y233,PDE10A,PDE10_HUMAN,7.77,,IC50,Inhibition of human PDE10A expressed in Sf9 cells using [3H]cAMP by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,Tclin,,,Homo sapiens
184107,2056,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,4.61,,IC50,Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) using acetylcholine iodide as substrate by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,,,,Electrophorus electricus
184110,2848,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.18,,Kd,Antagonist activity at human beta2 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75753,,,,Tclin,,,Homo sapiens
184111,2848,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,7.75,,Kd,Antagonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75753,,,,Tclin,,,Homo sapiens
184112,2848,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,4.7,,Kd,Antagonist activity at human beta3 adrenoceptor expressed in CHOK1 cells assessed as inhibition of cimaterol-induced [3H]cAMP accumulation incubated for 15 mins prior to cimaterol induction measured after 5 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL75753,,,,Tclin,,,Homo sapiens
184113,1876,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,8.7,,Ki,Binding affinity towards kappa opioid receptor by displacement of [3H]EKC in guinea pig cortical tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL982,,,,,,,Cavia porcellus
184114,1876,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,9.92,,Ki,Displacement of [3H]U69593 form human kappa opioid receptor expressed in CHO cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL982,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL982,ANTAGONIST,,Tclin,,,Homo sapiens
184115,1876,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,9.04,,Kd,Activity at human delta opioid receptor by [35S]GTPgammaS binding assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL982,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL982,ANTAGONIST,,Tclin,,,Homo sapiens
184116,1876,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.53,,Kd,Activity at human mu opioid receptor by [35S]GTPgammaS binding assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL982,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL982,ANTAGONIST,,Tclin,,,Homo sapiens
184117,1876,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,8.47,,Ki,Binding affinity towards delta-opioid receptor by displacement of [3H]DADL in rat brain homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL982,,,,,,,Rattus norvegicus
184118,1876,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,9.54,,Ki,Binding affinity towards mu-opioid receptor by the displacement of [3H]Nal in rat brain homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL982,,,,,,,Rattus norvegicus
184119,1764,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,9.1,,Ki,Displacement of [3H]LSD from human cloned 5HT2B receptor expressed in CHO cells by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200843,,PARTIAL AGONIST,,Tclin,,,Homo sapiens
184120,926,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.09,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517,,,,Tchem,,,Homo sapiens
184121,2090,2514,Solute carrier family 22 member 3,Transporter,O75751,SLC22A3,S22A3_HUMAN,5.02,,IC50,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tchem,,,Homo sapiens
184122,2090,3461,Protein-tyrosine phosphatase 4A3,Enzyme,O75365,PTP4A3,TP4A3_HUMAN,4.27,,IC50,Inhibition of human recombinant PRL-3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tchem,,,Homo sapiens
184123,2090,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.66,,IC50,Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tchem,,,Homo sapiens
215589,1588,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.78,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
184125,2090,2817,Glutamate NMDA receptor; GRIN1/GRIN2A,Ion channel,Q05586|Q12879,GRIN1|GRIN2A,NMDE1_HUMAN|NMDZ1_HUMAN,6.14,,IC50,Antagonist activity at NR1/NR2A receptor (unknown origin) expressed in Xenopus laevis oocytes assessed as inhibition of glutamate/glycine-induced current at pH 7.6 at -40mV holding potential by two-electrode voltage-clamp electrophysiology,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tclin|Tclin,,,Homo sapiens
184126,2090,3586,Acrosin,Unclassified,P08001,ACR,ACRO_PIG,5.64,,Ki,Reversible competitive inhibition of boar spermatozoa acrosin using BzArgOEt as substrate by Dixon plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,,,,Sus scrofa
184127,2090,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.92,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tchem,,,Homo sapiens
184128,2090,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,5.88,,IC50,"Inhibition of [3H]MK-801 binding to the NMDA receptor of rat hippocampal membranes, measured in buffer containing 20 mM TRIS acetate, pH 7",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,,,,Rattus norvegicus
184129,2090,948,Amiloride-sensitive amine oxidase [copper-containing],Enzyme,P19801,AOC1,AOC1_HUMAN,6.54,,Ki,Mixed type inhibition of recombinant human DAO expressed in drosophila S2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tchem,,,Homo sapiens
184130,2090,683,Suppressor of tumorigenicity 14 protein,Enzyme,Q9Y5Y6,ST14,ST14_HUMAN,5.94,,Ki,compound was tested for inhibitory activity against Matriptase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tchem,,,Homo sapiens
184131,2090,835,Protein S100-B,Cytosolic other,P04271,S100B,S100B_HUMAN,6,,Kd,Binding to holo-S100B protein,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tchem,,,Homo sapiens
184132,2090,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,5.57,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tchem,,,Homo sapiens
184133,2090,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,6.39,,IC50,Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tchem,,,Homo sapiens
184134,2090,3439,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,P21673,SAT1,SAT1_HUMAN,5.7,,Ki,Inhibition of human SSAT using spermidine as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,Tbio,,,Homo sapiens
184136,1689,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.19,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1724,,,,Tchem,,,Homo sapiens
184137,1689,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,9.17,,Ki,Displacement of [3H]NMS from human M2R expressed in CHOK1 cells after 2 hrs by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1724,,,,Tclin,,,Homo sapiens
184138,1689,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.59,,Ki,Displacement of [3H]NMS from human M3R expressed in CHOK1 cells after 2 hrs by scintillation counting analysis,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1724,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1724,ANTAGONIST,,Tclin,,,Homo sapiens
184139,1689,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1724,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1724,ANTAGONIST,,Tclin,,,Homo sapiens
184140,2601,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,7.6,,IC50,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73151,,,,,,,Rattus norvegicus
184141,2601,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,7.16,,IC50,"In vitro binding activity against Dopamine receptor D1 from homogenized rat brain, using [3H]SCH-23390 as the radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73151,,,,,,,Rattus norvegicus
184142,2601,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.4,,IC50,"In vitro binding activity against dopamine receptor D2 from homogenized rat brain, using [3H]spiperone as the radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73151,,,,,,,Rattus norvegicus
184143,3855,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,4.52,,IC50,Displacement of [3H]GW2433 from Homo sapiens (human) PPARdelta receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173474,,,,Tchem,,,Homo sapiens
184144,3855,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,4.52,,IC50,Displacement of [3H]BRL49653 from Homo sapiens (human) PPARgamma receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173474,,,,Tclin,,,Homo sapiens
184145,3855,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,4.52,,IC50,Displacement of [3H]GW2331 from Homo sapiens (human) PPARalpha receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173474,,,,Tclin,,,Homo sapiens
184146,1765,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,9.51,,Ki,Binding affinity towards guinea pig Opioid receptor kappa 1 using radioligand [3H]U-69593,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,,,,Cavia porcellus
184147,1765,1857,Kappa-type opioid receptor,GPCR,P33534,Oprk1,OPRK_MOUSE,8.84,,Ki,Displacement of [3H]-diprenorphine from mouse kappa opioid receptor expressed in CHO cells after 1.5 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,,,,Mus musculus
184148,1765,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,4.6,,IC50,Blockage of Nicotinic acetylcholine receptor alpha-7 noncompetitively in hippocampal primary cultures,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,Tchem,,,Homo sapiens
184981,1045,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.15,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
184149,1765,1779,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,P09483,Chrna4,ACHA4_RAT,4.51,,IC50,Blockage of Nicotinic acetylcholine receptor alpha4-beta2 noncompetitively in acute hippocampal slices,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,,,,Rattus norvegicus
184150,1765,1760,Delta-type opioid receptor,GPCR,P32300,Oprd1,OPRD_MOUSE,7.91,,Ki,Displacement of [3H]DPDPE from mouse delta opioid receptor in whole brain without cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,,,,Mus musculus
184151,1765,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,9.77,,Ki,Binding affinity towards Opioid receptor mu 1 of guinea pig brain membranes using radioligand 0.25 nM [3H]DAMGO,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,,,,Cavia porcellus
184152,1765,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,9.26,,Ki,Inhibition of [3H]diprenorphine binding to rat brain membrane opioid receptors;(T= total opioid receptor family),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,,,,Rattus norvegicus
184153,1765,2897,Opioid receptors; mu and delta,GPCR,P32300|P42866,Oprd1|Oprm1,OPRD_MOUSE|OPRM_MOUSE,9.06,,Ki,Displacement of [3H]-DAMGO from mouse MOR/DOR expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,,,,Mus musculus
184154,1765,1758,Mu-type opioid receptor,GPCR,P42866,Oprm1,OPRM_MOUSE,9.58,,Ki,Displacement of [3H]DAMGO from mouse mu opioid receptor in whole brain without cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,,,,Mus musculus
184155,1765,1836,Kappa-type opioid receptor,GPCR,P34975,Oprk1,OPRK_RAT,8.97,,Ki,Displacement of [3H]U69593 from kappa opioid receptor in rat brain homogenate after 1 hr by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,,,,Rattus norvegicus
184156,1765,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,8.32,,Ki,In vito concentration required to displace [3H]DADLE (Kd = 12.2 nM and concentration is 2.1 nM) from low affinity delta-site in rat brain membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,,,,Rattus norvegicus
184157,1765,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,9.34,,Ki,Displacement of [3H]DAMGO from mu opioid receptor in rat brain homogenate after 1 hr by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019,,,,,,,Rattus norvegicus
184158,2537,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,8.41,,Ki,Ki value against human carbonic anhydrase XII (hCA XII),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,Tclin,,,Homo sapiens
184159,2537,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,5.8,,Ki,In vitro ability to displace [3H]spiroperidol from rat dopamine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Rattus norvegicus
184160,2537,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.12,,Ki,Antagonist activity at dopamine D2 receptor (unknown origin),CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5501,ANTAGONIST,,Tclin,,,Homo sapiens
184161,2537,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,6.37,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Stylophora pistillata
184162,2537,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.68,,Ki,Binding affinity for Dopamine receptor D4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,Tchem,,,Homo sapiens
184163,2537,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.1,,Ki,Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,Tclin,,,Homo sapiens
184164,2537,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,6.42,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Astrosclera willeyana
184165,2537,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,4.97,,Ki,Inhibition of human recombinant CA 3 assessed as CO2 hydration by stopped flow kinetic assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,Tclin,,,Homo sapiens
184166,2537,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,5.64,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184167,2537,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,6.38,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Stylophora pistillata
184168,2537,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,6.59,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Thalassiosira weissflogii
184169,2537,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,6.76,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,Tclin,,,Homo sapiens
184170,2537,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,6.91,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
184171,2537,1921,D(2) dopamine receptor,GPCR,Q9GJU1,DRD2,DRD2_CANFA,6.7,,IC50,"The IC50 value was reported as apparent, since [3H]NCA was purported to be irreversible (dopamine receptor from Canine striatal membranes). Result indicates the mean of two separate experiments, each performed in triplicate.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Canis familiaris
184172,2537,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,8.44,,Ki,Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,Tclin,,,Homo sapiens
184173,2537,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.82,,Kd,Affinity constant of compound was evaluated in rat striatum tissue preparation.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Rattus norvegicus
184174,2537,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.51,,Ki,Inhibition of human recombinant carbonic anhydrase 9 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,Tclin,,,Homo sapiens
184175,2537,401,Carbonic anhydrase,Enzyme,O24855,cynT,CYNT_HELPY,6.75,,Ki,Inhibition of Helicobacter pylori recombinant CA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
184176,2537,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.14,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Mus musculus
184177,2537,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.92,,Ki,Ki value against human carbonic anhydrase I (hCA I),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,Tclin,,,Homo sapiens
184178,2537,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,7.74,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,Tclin,,,Homo sapiens
184179,2537,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,7.4,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
184180,2537,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,6.58,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184181,2537,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,9.1,,Ki,Inhibition of full length human recombinant CA VI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,Tclin,,,Homo sapiens
184182,1577,1801,D(1A) dopamine receptor,GPCR,Q95136,DRD1,DRD1_BOVIN,4.3,,Ki,In vitro displacement of [3H]- SCH 23390 from the dopamine receptor D1 of bovine striatal membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267044,,,,,,,Bos taurus
184183,1577,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,4.82,,Ki,Ability to inhibit [3H]WB-4101 binding to alpha-1 adrenergic receptor was determined in rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267044,,,,,,,Rattus norvegicus
184184,1577,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,4.57,,Ki,Ability to inhibit [3H]spiperone binding to 5-hydroxytryptamine 2 receptor determined in rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267044,,,,,,,Rattus norvegicus
120146,4876,766,Histone deacetylase 4,Enzyme,P56524,HDAC4,HDAC4_HUMAN,7.568636417388916,,IC50,histone deacetylase activity in vitro in HeLa cell extracts,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/12939461,http://www.ncbi.nlm.nih.gov/pubmed/12939461,INHIBITOR,,Tclin,42,42,Homo sapiens
184185,1577,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,6.68,,IC50,Antidopamine activity in vitro by ability to displace [3H]spiperone from rat brain striatal preparations.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267044,,,,,,,Rattus norvegicus
184186,1577,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.29,,Ki,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267044,,,,Tclin,,,Homo sapiens
184187,1577,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.68,,Ki,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D4 expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267044,,,,Tchem,,,Homo sapiens
184188,1577,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.06,,Ki,In vitro displacement of [3H]spiperone from the cloned human dopamine receptor D3 stably expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267044,,,,Tclin,,,Homo sapiens
184189,1577,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.16,,Ki,Inhibition of [3H]spiperone binding to rat striatal membrane Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267044,,,,,,,Rattus norvegicus
184190,632,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200356,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200356,INHIBITOR,,,,,Escherichia coli (strain K12)
184191,2291,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.95,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL631,,,,Tchem,,,Homo sapiens
184192,2291,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,5.48,,IC50,Inhibition of human cloned Nav1.5 channel expressed in chinese hamster CHO cells assessed as tonic inhibition after 5 mins by patch clamp assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL631,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL631,BLOCKER,,Tclin,,,Homo sapiens
184193,2291,2813,"Sulfonylurea receptor 2, Kir6.2",Ion channel,O60706|Q14654,ABCC9|KCNJ11,ABCC9_HUMAN|KCJ11_HUMAN,5.66,,IC50,Inhibition of human kir6.2/SUR2A ion channel coexpressed in human HEK293 cells after 5 mins by patch clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL631,,,,Tclin|Tclin,,,Homo sapiens
184194,3715,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,7.52,,Ki,Compound was evaluated for its ability to displace [3H]WIN-35428 binding in rat caudate-putamen,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146132,,,,,,,Rattus norvegicus
184195,2729,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,9.1,,Ki,Binding affinity for Diazepam sensitive (DS) isoform of the benzodiazepine (Bz) binding site on GABAA receptors,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,,,,,,,Rattus norvegicus
215590,623,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.744727495,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
184196,2729,1766,Cholecystokinin receptor type A,GPCR,P30551,Cckar,CCKAR_RAT,4.41,,IC50,Displacement of [125I]CCK from Cholecystokinin receptor of rat pancreas,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,,,,,,,Rattus norvegicus
184202,859,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.85,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1086,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184203,717,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,6.87,,Ki,In vitro binding affinity against Muscarinic acetylcholine receptors in rat brain.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL304902,,,,,,,Rattus norvegicus
184204,717,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,9.23,,Ki,Binding affinity against serotonin 5-hydroxytryptamine 2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL304902,,,,,,,Rattus norvegicus
184205,717,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,7.85,,Ki,In vitro binding affinity against Dopamine receptor D1 in rat striatal tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL304902,,,,,,,Rattus norvegicus
184206,717,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.36,,Ki,In vitro binding affinity against Dopamine D2 receptor in rat striatal tissue.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL304902,,,,,,,Rattus norvegicus
184207,671,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,5.31,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1626,,,,Tchem,,,Homo sapiens
184208,1239,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,8.6,,Kd,Binding affinity to beta-2 adrenergic receptor (unknown origin) at 1 to 10000 nM,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256786,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256786,AGONIST,,Tclin,,,Homo sapiens
184209,1239,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.5,,Ki,Displacement of [3H]CGP12177 from human beta-1 adrenoceptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256786,,,,Tclin,,,Homo sapiens
184210,1239,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,8.8,,EC50,Agonist activity at beta2 receptor in guinea pig trachea assessed as fast onset of inhibition of electrically stimulated contraction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256786,,,,,,,Cavia porcellus
184211,1239,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,7.6,,EC50,Agonist activity at human recombinant beta3 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256786,,,,Tclin,,,Homo sapiens
184212,2026,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,Mechanism of Action; CHEMBL245; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1495,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1495,ANTAGONIST,,Tclin,,,Homo sapiens
184213,2026,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1495,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1495,ANTAGONIST,,Tclin,,,Homo sapiens
184214,1662,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201173,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201173,AGONIST,,Tclin,,,Homo sapiens
184215,1659,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,6.52,,IC50,Inhibition of recombinant AKR1C3 (unknown origin) assessed as decrease in oxidation of 1-acenaphthenol substrate by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717,,,,Tchem,,,Homo sapiens
184216,1659,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,6.2,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717,,,,Tchem,,,Homo sapiens
184217,1659,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.88,,Ki,Inhibition of Dexamethasone binding to human glucocorticoid receptor expressed in baculovirus SF-12 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717,,,,Tclin,,,Homo sapiens
184218,1659,345,Aldo-keto reductase family 1 member C1,Enzyme,Q04828,AKR1C1,AK1C1_HUMAN,5.74,,IC50,Inhibition of human recombinant AKR1C1 expressed in Escherichia coli assessed as decrease in oxidation of 1-acenaphthenol substrate by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717,,,,Tchem,,,Homo sapiens
184219,1659,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,5.92,,IC50,Inhibitory activity against human Mineralocorticoid receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717,,,,Tclin,,,Homo sapiens
184220,1659,2876,Estrogen receptor,Nuclear hormone receptor,P03372|Q92731,ESR1|ESR2,ESR1_HUMAN|ESR2_HUMAN,6.03,,IC50,Inhibition of binding to human estrogen receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717,,,,Tclin|Tclin,,,Homo sapiens
184221,1659,346,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,5.39,,IC50,Inhibition of recombinant AKR1C2 (unknown origin) assessed as decrease in oxidation of 1-acenaphthenol substrate by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717,,,,Tchem,,,Homo sapiens
184222,1659,1850,Androgen receptor,Transcription factor,P19091,Ar,ANDR_MOUSE,8.21,,EC50,Effective concentration against Androgen receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717,,,,,,,Mus musculus
184223,1659,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,7.45,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL717,,,,,,,Rattus norvegicus
184224,719,150,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,O15554,KCNN4,KCNN4_HUMAN,7.15,,IC50,Inhibition of human cloned IK1 expressed in african green monkey COS7 cells by whole cell patch clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,Tchem,,,Homo sapiens
184225,719,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,4.7,,IC50,Compound was tested for the inhibition of beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,,,,Escherichia coli (strain K12)
184226,719,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,5.49,,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,Tclin,,,Homo sapiens
184227,719,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,8.74,,IC50,Inhibition of human placental microsome CYP19,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,Tclin,,,Homo sapiens
184228,719,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,6.89,,IC50,Inhibition of human CYP51 expressed in Topp 3 cells by lanosterol demethylase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,Tchem,,,Homo sapiens
184229,719,3595,Alpha-chymotrypsin,Unclassified,P00766,,CTRA_BOVIN,4.07,,IC50,Compound was tested for the inhibition of Chymotrypsinogen,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,,,,Bos taurus
184230,719,2119,Lanosterol 14-alpha demethylase,Enzyme,P9WPP9,cyp51,CP51_MYCTU,6.7,,Kd,Binding affinity to Mycobacterium tuberculosis CYP51,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184231,719,392,Vasopressin V2 receptor,GPCR,P30518,AVPR2,V2R_HUMAN,5.6,,IC50,Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,Tclin,,,Homo sapiens
184232,719,2422,14-alpha sterol demethylase,Enzyme,Q96W81,cyp51B,Q96W81_ASPFM,6.99,,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme B expressed in Escherichia coli assessed as tight binding affinity constant,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,,,,Neosartorya fumigata
184233,719,2421,14-alpha sterol demethylase Cyp51A,Enzyme,Q4WNT5,,Q4WNT5_ASPFU,5.32,,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme A expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,,,,Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100)
184234,719,3464,Malate dehydrogenase cytoplasmic ,Enzyme,P40925,MDH1,MDHC_HUMAN,4.46,,IC50,Inhibition of malate dehydrogenase (MDH),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,Tbio,,,Homo sapiens
184235,719,3465,Putative cytochrome P450 130,Unclassified,P9WPN5,cyp130,CP130_MYCTU,4.88,,Kd,Binding affinity to Mycobacterium tuberculosis CYP130,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184236,719,1720,C-C chemokine receptor type 4,GPCR,P51679,CCR4,CCR4_HUMAN,5.8,,IC50,Inverse agonist activity at CCR4 in human HTLA cells assessed as depression of basal activity incubated for 20 mins by beta arrestin-recruitment mediated luciferase reporter gene assay in absence of CCL22,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,Tclin,,,Homo sapiens
184237,719,3596,"Indoleamine 2,3-dioxygenase 1",Enzyme,P28776,Ido1,I23O1_MOUSE,4.29,,IC50,Inhibition of mouse Ido1 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,,,,Mus musculus
184238,719,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.52,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,Tclin,,,Homo sapiens
184239,719,2155,C-X-C chemokine receptor type 1,GPCR,P25024,CXCR1,CXCR1_HUMAN,5.7,,IC50,Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,Tchem,,,Homo sapiens
184240,719,2492,"Indoleamine 2,3-dioxygenase 2",Enzyme,Q8R0V5,Ido2,I23O2_MOUSE,5.23,,IC50,Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,,,,Mus musculus
184241,719,439,Potassium voltage-gated channel subfamily A member 3,Ion channel,P22001,KCNA3,KCNA3_HUMAN,5.22,,IC50,Inhibition of cloned Kv1.3 channel expressed in mammalian cells by whole cell patch clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,Tclin,,,Homo sapiens
184242,719,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,Mechanism of Action; CHEMBL1780; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
184243,3912,2000,Alpha-1B adrenergic receptor,GPCR,P18841,ADRA1B,ADA1B_MESAU,9.25,,Ki,Displacement of [3H]prozosin from hamster cloned alpha-1b receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,,,,Mesocricetus auratus
184244,3912,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,9.74,,IC50,Ability to inhibit binding of [3H]PRAZ to alpha-1 adrenergic receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,,,,Rattus norvegicus
184245,3912,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,8.62,,Ki,Half-maximal inhibition of [3H]-7-OH-DPAT binding to Dopamine receptor D3 in rat tissue homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,,,,Rattus norvegicus
184246,3912,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,9.24,,IC50,Ability to inhibit binding of [3H]KET to 5-hydroxytryptamine 2 receptor in rat cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,,,,Rattus norvegicus
184247,3912,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,8.52,,IC50,"Ability to displace [3H]haloperidol from rat striatal membranes, in order to measure its intrinsic affinity for the dopamine (DA) receptor",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,,,,Rattus norvegicus
184248,3912,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.17,,Ki,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,Tclin,,,Homo sapiens
185013,1045,853,Ephrin type-A receptor 3,Kinase,P29320,EPHA3,EPHA3_HUMAN,5.62,,Kd,Binding constant for EPHA3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184249,3912,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,9.18,,Ki,Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,,,,Bos taurus
184250,3912,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,9.24,,Ki,Displacement of [3H]prozosin from human cloned 5HT2C receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,Tclin,,,Homo sapiens
184251,3912,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.72,,Ki,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,Tclin,,,Homo sapiens
184252,3912,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,8.64,,Ki,Half-maximal inhibition of [3H]-SCH- 23390 binding to Dopamine receptor D1 in rat striatal homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,,,,Rattus norvegicus
184253,3912,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,9.11,,Ki,Displacement of [3H]prozosin from rat cloned alpha1d receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,,,,Rattus norvegicus
184254,3912,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,9.3,,Ki,Half-maximal inhibition of [3H]spiperone binding to Dopamine receptor D2 in rat striatal homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,,,,Rattus norvegicus
184255,3912,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,9.64,,Ki,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL64249,,,,,,,Rattus norvegicus
184256,2723,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,5.3,,Ki,Inhibition of [3H]spiroperidol binding to dopamine receptor from rat striatum membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL299175,,,,,,,Rattus norvegicus
184257,2723,2867,Adrenergic receptor alpha,GPCR,P15823|P19328|P22086|P22909|P23944|P43140,Adra1a|Adra1b|Adra1d|Adra2a|Adra2b|Adra2c,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT|ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5,,Ki,Inhibition of [3H]WB-4101 binding to alpha adrenergic receptor from rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL299175,,,,,,,Rattus norvegicus
184258,2723,2843,Adrenergic receptor beta,GPCR,P07550|P08588|P13945,ADRB1|ADRB2|ADRB3,ADRB1_HUMAN|ADRB2_HUMAN|ADRB3_HUMAN,7.51,,EC50,Compound was tested for its intrinsic activity against beta adrenergic receptor of isolated guinea pig atrial pairs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL299175,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184259,2723,2893,Adrenergic receptor beta,GPCR,P10608|P18090|P26255,Adrb1|Adrb2|Adrb3,ADRB1_RAT|ADRB2_RAT|ADRB3_RAT,7,,Ki,Inhibition of [3H]dihydroalprenolol binding to Beta adrenergic receptor from rat cerebral cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL299175,,,,,,,Rattus norvegicus
184260,2723,393,Thromboxane A2 receptor,GPCR,P21731,TBXA2R,TA2R_HUMAN,6.35,,IC50,"Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL299175,,,,Tclin,,,Homo sapiens
184261,1990,2752,Potassium-transporting ATPase,Transporter,P20648|P51164,ATP4A|ATP4B,ATP4A_HUMAN|ATP4B_HUMAN,5.7,,IC50,In vitro inhibitory activity against H+/K+ ATPase prepared from canine fundic mucosa,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1503,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1503,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
184262,1990,2772,Potassium-transporting ATPase,Enzyme,P18434|P19156,ATP4A|ATP4B,ATP4A_PIG|ATP4B_PIG,5.42,,IC50,In vitro inhibition against H+/K+ ATPase from porcine gastric mucosal membrane vesicles,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1503,,,,,,,Sus scrofa
184263,1055,2752,Potassium-transporting ATPase,Transporter,P20648|P51164,ATP4A|ATP4B,ATP4A_HUMAN|ATP4B_HUMAN,,,,Mechanism of Action; CHEMBL2095173; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200470,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200470,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
184264,1922,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.48,,IC50,GRAC: human Glycine receptor subunit alpha-1 selective antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,Tclin,,,Homo sapiens
184265,1922,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.08,,Ki,Inhibition of [125I]- AB-MECA binding to human Adenosine A3 receptors expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,Tchem,,,Homo sapiens
184266,1922,1827,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P15381,CACNA1C,CAC1C_RABIT,9,,IC50,Inhibition of [3H]nitrendipine binding to calcium channels in Rabbit cardiac muscle.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Oryctolagus cuniculus
184267,1922,152,"Glutathione reductase, mitochondrial",Enzyme,P00390,GSR,GSHR_HUMAN,4.76,,Ki,Competitive inhibition of human erythrocyte Glutathione reductase using GSSG substrate by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,Tclin,,,Homo sapiens
184268,1922,2606,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,O35505,CACNA1C,CAC1C_CAVPO,8.59,,IC50,Antagonist activity at Cavia porcellus albino (guinea pig) calcium channel assessed as inhibition of KCl-induced ileal longitudinal smooth muscle contraction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Cavia porcellus
184269,1922,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.43,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184270,1922,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,4.74,,Ki,Displacement of [3H]-CGS- 21680 binding to Adenosine A2A receptor in rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Rattus norvegicus
184271,1922,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,5.92,,Ki,Inhibition of Equus caballus (horse) serum butyrylcholinesterase (BChE) assessed as inhibition of BTCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Equus caballus
184342,2828,2904,Phosphodiesterase 1,Enzyme,P14100|Q01061,PDE1A|PDE1B,PDE1A_BOVIN|PDE1B_BOVIN,4.72,,IC50,Evaluated for inhibitory activity against Phosphodiesterase 1 (PDE1) purified from bovine aorta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71752,,,,,,,Bos taurus
184272,1922,2874,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,8.33,,Ki,Inhibition of [3H]nitrendipine binding to L-type calcium channel from rat brain cortex homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Rattus norvegicus
184273,1922,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,5.54,,Ki,Binding affinity against adenosine A1 receptor in rat cerebral cortex membrane by radioligand binding assay using [3H](R)-PIA.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Rattus norvegicus
184274,1922,3596,"Indoleamine 2,3-dioxygenase 1",Enzyme,P28776,Ido1,I23O1_MOUSE,4.34,,IC50,Inhibition of mouse Ido1 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Mus musculus
184275,1922,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,9.4,,Kd,Displacement of [3H]nitrendipine from dihydropyridine receptor of guinea pig myocardial membranes,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,http://www.ncbi.nlm.nih.gov/pubmed/17276408,BLOCKER,,Tclin,,509,Homo sapiens
184276,1922,1882,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,P27732,Cacna1d,CAC1D_RAT,8.92,,Ki,Binding affinity for L-type [Ca2+] channels was measured through displacement of [3H]nitrendipine on rat cortex homogenates.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Rattus norvegicus
184277,1922,1853,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,8.46,,Ki,"Inhibition of [3H](+)-PN200-110 binding to L-type calcium channel 1,4-DHP binding site of rat ventricular myocytes",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Rattus norvegicus
184278,1922,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,5.4,,Ki,Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) assessed as inhibition of ATCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Electrophorus electricus
184279,1922,445,Potassium voltage-gated channel subfamily A member 5,Ion channel,P22460,KCNA5,KCNA5_HUMAN,5.21,,IC50,Inhibition of human Kv1.5 channel expressed in mouse L929 cells by EP voltage clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,Tclin,,,Homo sapiens
184280,1922,2492,"Indoleamine 2,3-dioxygenase 2",Enzyme,Q8R0V5,Ido2,I23O2_MOUSE,5.82,,IC50,Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Mus musculus
184281,1922,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,4.65,,Ki,"Binding affinity for HA-tagged mutant human Adenosine A2A receptor (V84L), using [3H]CGS-21680 as radioligand expressed in COS-7 cells",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,Tclin,,,Homo sapiens
184282,1227,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,5.21,,EC50,Agonist activity at PXR (unknown origin) expressed in human HepG2 cells assessed as induction of CYP3A4 transactivation after 16 hrs by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107430,,,,Tchem,,,Homo sapiens
184283,1227,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,4.86,,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107430,,,,Tclin,,,Homo sapiens
184284,92,41,"Fructose-1,6-bisphosphatase 1",Enzyme,P09467,FBP1,F16P1_HUMAN,6.85,,IC50,"Inhibition of FBPase in human liver using fructose-2,6phosphate as a substrate",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752,,,,Tchem,,,Homo sapiens
184285,92,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7,,IC50,Inhibition of p60c-src expressed in chick embryo fibroblast,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752,,,,Tclin,,,Homo sapiens
184286,92,1685,Transient receptor potential cation channel subfamily M member 2,Ion channel,O94759,TRPM2,TRPM2_HUMAN,4.15,,IC50,Inhibition of TRPM2 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752,,,,Tchem,,,Homo sapiens
184287,92,3597,Ketopantoate reductase,Unclassified,P0A9J4,panE,PANE_ECOLI,2.2,,Ki,Inhibition of Escherichia coli KPR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752,,,,,,,Escherichia coli (strain K12)
184288,92,3466,L-lactate dehydrogenase A chain,Enzyme,P00338,LDHA,LDHA_HUMAN,3.19,,Kd,Binding affinity to 6-His-tagged human LDHA (2 to 322 amino acid residue) expressed in Escherichia coli BL21 (DE3) cells by NMR analysis in presence of NADH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752,,,,Tchem,,,Homo sapiens
184289,92,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,9.64,,Ki,Inhibition constant against HIV-1 Protease,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752,,,,,,,Human immunodeficiency virus 1
184290,92,3598,Adenylate kinase 2,Unclassified,P29410,Ak2,KAD2_RAT,4.1,,Ki,Inhibitory activity against rat adenylate kinase II was determined in the presence of AMP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752,,,,,,,Rattus norvegicus
184291,92,42,"Fructose-1,6-bisphosphatase 1",Enzyme,P00636,FBP1,F16P1_PIG,5.89,,IC50,Inhibition of pig FBPase expressed in Escherichia coli EK1601 by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752,,,,,,,Sus scrofa
184292,92,2889,Alcohol dehydrogenase,Enzyme,P00327|P00328,,ADH1E_HORSE|ADH1S_HORSE,4.42,,Ki,Inhibition constant was evaluated against horse liver alcohol dehydrogenase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752,,,,,,,Equus caballus
184293,1867,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,6.54,,IC50,Compound was evaluated for inhibitory activity against Thrombin.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264,,,,Tclin,,,Homo sapiens
184294,1867,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,6.62,,IC50,Compound was evaluated for inhibitory activity against plasmin.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264,,,,Tclin,,,Homo sapiens
184295,1867,1626,Cationic trypsin,Enzyme,P00760,,TRY1_BOVIN,7.77,,IC50,The compound was evaluated to inhibit trypsin and is expressed in IC50 (The concentration required to inhibit 50% of the enzyme).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264,,,,,,,Bos taurus
184296,1867,549,Trypsin-1,Enzyme,P07477,PRSS1,TRY1_HUMAN,7.77,,IC50,In vitro for inhibition of purified bovine trypsin.,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4262,INHIBITOR,,Tclin,,,Homo sapiens
184297,1867,863,Complement C1r subcomponent,Enzyme,P00736,C1R,C1R_HUMAN,6,,IC50,Inhibition of C1r serine protease,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4262,INHIBITOR,,Tclin,,,Homo sapiens
184298,1867,879,Complement C1s subcomponent,Enzyme,P09871,C1S,C1S_HUMAN,6.85,,IC50,Compound was evaluated for inhibitory activity against C1s serine protease. ,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264,,,,Tchem,,,Homo sapiens
184299,1867,568,Kallikrein-1,Enzyme,P06870,KLK1,KLK1_HUMAN,6.19,,IC50,Compound was evaluated for inhibitory activity against Kallikrein.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264,,,,Tchem,,,Homo sapiens
184300,1867,631,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,4.68,,IC50,Inhibitory concentration against Coagulation factor X,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264,,,,Tclin,,,Homo sapiens
184301,571,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1727,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1727,INHIBITOR,,,,,Escherichia coli (strain K12)
184302,1443,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,7.61,,Ki,Affinity for alpha-1 adrenoceptor of rat cerebral cortex was determined by ligand binding using [3H]prazosin.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279516,,,,,,,Rattus norvegicus
184303,1443,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.65,,Ki,The compound was tested for binding affinity against Alpha-2A adrenergic receptor from human clones.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279516,,,,Tclin,,,Homo sapiens
184304,1443,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,4.92,,Ki,Affinity for alpha-2 adrenergic receptor of rat cerebral cortex was determined by ligand binding using [3H]yohimbine.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279516,,,,,,,Rattus norvegicus
184305,1443,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,7.92,,Ki,The compound was tested for binding affinity against Alpha-1A adrenergic receptor from bovine clones.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279516,,,,,,,Bos taurus
184306,1443,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.96,,Ki,"Binding affinity against Alpha-1D adrenergic receptor, from human clones.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279516,,,,Tclin,,,Homo sapiens
184307,1443,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.43,,Ki,The compound was tested for binding affinity against Alpha-1A adrenergic receptor from human clones.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279516,,,,Tclin,,,Homo sapiens
184308,1443,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.6,,Ki,"The compound was tested for binding affinity against Alpha-1B adrenergic receptor, from hamster clones.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279516,,,,Tclin,,,Homo sapiens
184310,1443,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,6.21,,Ki,"Binding affinity against Alpha-1D adrenergic receptor, from rat clones.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279516,,,,,,,Rattus norvegicus
184311,1443,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.28,,Ki,Binding affinity against Alpha-2B adrenergic receptor from human clones.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279516,,,,Tclin,,,Homo sapiens
184312,1443,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.32,,Ki,Binding affinity against Alpha-2C adrenergic receptor from human clones.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279516,,,,Tclin,,,Homo sapiens
184313,1006,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,8.85,,Ki,Inhibitory activity against rabbit lung angiotensin-1 converting enzyme,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL577,,,,,,,Oryctolagus cuniculus
184314,1006,2005,Angiotensin-converting enzyme 2,Enzyme,Q5EGZ1,Ace2,ACE2_RAT,9.3,,Ki,Binding affinity towards Angiotensin I converting enzyme of rat brain IgG immobilized enzyme.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL577,,,,,,,Rattus norvegicus
184315,1006,1792,Angiotensin-converting enzyme,Enzyme,P47820,Ace,ACE_RAT,9.02,,IC50,Compound was tested for inhibitory activity against angiotensin I converting enzyme,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL577,,,,,,,Rattus norvegicus
184316,82,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,5.21,,IC50,Inhibition of H1 receptor in Cavia porcellus Hartley (guinea pig) ileum assessed as inhibition of histamine-induced spasms incubated 2 min prior histamine-challenge,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1224,,,,,,,Cavia porcellus
184317,361,413,Retinoic acid receptor RXR-alpha,Nuclear hormone receptor,P19793,RXRA,RXRA_HUMAN,7.85,,Kd,Inhibition of [3H]9-cis-RA binding to baculovirus expressed retinoid receptor RXR alpha,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,AGONIST,,Tclin,,,Homo sapiens
184318,361,414,Retinoic acid receptor RXR-beta,Nuclear hormone receptor,P28702,RXRB,RXRB_HUMAN,8.23,,Ki,Selective activity towards retinoid X receptor-beta,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,AGONIST,,Tclin,,,Homo sapiens
184319,361,415,Retinoic acid receptor RXR-gamma,Nuclear hormone receptor,P48443,RXRG,RXRG_HUMAN,8.08,,Ki,Selective activity towards retinoid X receptor-gamma,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,AGONIST,,Tclin,,,Homo sapiens
184320,361,426,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,7.3,,Ki,Selective activity towards retinoic acid receptor-beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,,,,Tclin,,,Homo sapiens
184321,361,231,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,6.74,,Ki,Selective activity towards retinoic acid receptor-alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,,,,Tclin,,,Homo sapiens
184322,361,1870,Retinoic acid receptor RXR-gamma,Transcription factor,P28705,Rxrg,RXRG_MOUSE,7.54,,Kd,Binding affinity to Retinoic acid receptor RXR-gamma was evaluated in a competitive binding assay.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,,,,,,,Mus musculus
215591,1310,1208,"Glutamate receptor ionotropic, kainate 4",Ion channel,Q16099,GRIK4,GRIK4_HUMAN,7.73754891,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
184323,361,1876,Retinoic acid receptor RXR-alpha,Transcription factor,P28700,Rxra,RXRA_MOUSE,7.4,,EC50,Transactivation of Gal4-LBD fused mouse RXRalpha (218 to 467) transfected in african green monkey CV1 cells assessed as luciferase activity at after 6 hrs by Dual-light chemiluminescent assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,,,,,,,Mus musculus
184324,361,2582,Retinoic acid receptor RXR-alpha,Unclassified,Q05343,Rxra,RXRA_RAT,7.4,,EC50,Agonist activity at RXRalpha in rat RK3E cells assessed as transcriptional activation by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,,,,,,,Rattus norvegicus
184325,361,1869,Retinoic acid receptor RXR-beta,Transcription factor,P28704,Rxrb,RXRB_MOUSE,7.68,,Kd,Binding affinity to Retinoic acid receptor RXR-beta was determined in a competitive binding assay.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,,,,,,,Mus musculus
184326,361,427,Retinoic acid receptor gamma,Nuclear hormone receptor,P13631,RARG,RARG_HUMAN,6.89,,Ki,Selective activity towards retinoic acid receptor-gamma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1023,,,,Tclin,,,Homo sapiens
184327,2039,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,Mechanism of Action; CHEMBL245; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200906,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200906,ANTAGONIST,,Tclin,,,Homo sapiens
184328,2463,72,Thymidine kinase,Kinase,Q9QNF7,TK,KITH_HHV1,5.44,,IC50,Inhibition of HSV1 TK assessed as [methyl-3H]dThd phosphorylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70046,,,,,,,Human herpesvirus 1
126953,4877,26,Trichophyton mentagrophytes,Fungi,,,,4.880616188049316,,MIC,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17588934,http://www.ncbi.nlm.nih.gov/pubmed/17588934,MINIMUM INHIBITORY CONCENTRATION,,,43,43,
126954,4877,27,Trichophyton rubrum,Fungi,,,,4.880616188049316,,MIC,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17588934,http://www.ncbi.nlm.nih.gov/pubmed/17588934,MINIMUM INHIBITORY CONCENTRATION,,,43,43,
126955,4878,704,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,8.602060317993164,,IC50,in vitro Invitrogen SelectScreen kinase inhibitor assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20959606,http://www.ncbi.nlm.nih.gov/pubmed/20959606,INHIBITOR,,Tclin,44,44,Homo sapiens
126956,4878,2314,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Kinase,P48736,PIK3CG,PK3CG_HUMAN,7.050610065460205,,IC50,in vitro Invitrogen SelectScreen kinase inhibitor assay,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20959606,,,,Tclin,44,,Homo sapiens
126957,4878,2313,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Kinase,P42338,PIK3CB,PK3CB_HUMAN,6.247951507568359,,IC50,in vitro Invitrogen SelectScreen kinase inhibitor assay,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20959606,,,,Tchem,44,,Homo sapiens
126958,4878,2142,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,P42336,PIK3CA,PK3CA_HUMAN,6.086185932159424,,IC50,in vitro Invitrogen SelectScreen kinase inhibitor assay,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20959606,,,,Tclin,44,,Homo sapiens
184329,2463,3468,"Thymidine kinase, mitochondrial",Kinase,O00142,TK2,KITM_HUMAN,4.98,,Ki,Inhibition of thymidine kinase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70046,,,,Tchem,,,Homo sapiens
184330,2463,3467,Deoxynucleoside kinase,Kinase,Q9XZT6,dnk,DNK_DROME,4.55,,IC50,Inhibition of Drosophila melanogaster dNK assessed as [methyl-3H]dThd phosphorylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70046,,,,,,,Drosophila melanogaster
184331,2463,2053,Thymidine kinase,Kinase,P09250,,KITH_VZVD,5.49,,IC50,Inhibition of VZV TK assessed as [methyl-3H]dThd phosphorylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70046,,,,,,,Varicella-zoster virus (strain Dumas)
184332,2846,2422,14-alpha sterol demethylase,Enzyme,Q96W81,cyp51B,Q96W81_ASPFM,6.37,,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme B expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL638,,,,,,,Neosartorya fumigata
184333,2846,2421,14-alpha sterol demethylase Cyp51A,Enzyme,Q4WNT5,,Q4WNT5_ASPFU,5.44,,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme A expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL638,,,,,,,Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100)
184334,576,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1604,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1604,INHIBITOR,,,,,Escherichia coli (strain K12)
184335,198,1686,Transient receptor potential cation channel subfamily M member 4,Ion channel,Q8TD43,TRPM4,TRPM4_HUMAN,4.72,,IC50,GRAC: human TRPM4 blocker,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL174,,,,Tchem,,,Homo sapiens
184336,198,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,4.09,,Kd,Binding affinity to human recombinant Tie2 by SPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL174,,,,Tclin,,,Homo sapiens
184337,198,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL174,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL174,INHIBITOR,,,,,Escherichia coli (strain K12)
184338,1603,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1013,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1013,INHIBITOR,,,,,Escherichia coli (strain K12)
184339,2083,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL615,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL615,INHIBITOR,,,,,Escherichia coli (strain K12)
185014,1045,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,7.72,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184343,2828,420,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",Enzyme,P54750,PDE1A,PDE1A_HUMAN,5.1,,IC50,GRAC: human PDE1A selective inhibitor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71752,,,,Tclin,,,Homo sapiens
184344,1594,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,,,,Mechanism of Action; CHEMBL2311224; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL561,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL561,INHIBITOR,,,,,Escherichia coli (strain K12)
184345,1676,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.85,,IC50,In vitro for its inhibitory activity against human whole blood Prostaglandin G/H synthase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL599,,,,Tclin,,,Homo sapiens
184346,1676,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.8,,IC50,Concentration that caused a 50% decrease in the maximal inhibition of Prostaglandin G/H synthase 2 activity as measured by PGE-2 production.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL599,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL599,INHIBITOR,,Tclin,,,Homo sapiens
184347,2200,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,7.66,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967,,,,Tchem,,,Homo sapiens
184348,2200,2873,Muscarinic acetylcholine receptor,GPCR,P12657|P32211|Q920H4|Q9ERZ3|Q9ERZ4,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_MOUSE|ACM2_MOUSE|ACM3_MOUSE|ACM4_MOUSE|ACM5_MOUSE,6.12,,IC50,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to muscarinic receptor in mice,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967,,,,,,,Mus musculus
184349,2200,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.76,,Ki,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M2 receptor expressed in CHOK1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967,,,,Tclin,,,Homo sapiens
184350,2200,2608,Muscarinic acetylcholine receptor DM1,GPCR,P16395,mAChR-A,ACM1_DROME,6.41,,Ki,Displacement of [3H]AF-DX 384 from Drosophila melanogaster mAChR by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967,,,,,,,Drosophila melanogaster
184351,2200,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,7.22,,Ki,Binding affinity against Muscarinic acetylcholine receptor was determined in homogenized rat cortex tissue using [3H]N-methylscopolamine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967,,,,,,,Rattus norvegicus
184352,2200,1867,Muscarinic receptor M1,GPCR,Q8WMX0,,Q8WMX0_BOVIN,8.44,,Ki,Binding affinity against Muscarinic acetylcholine receptor M1 by displacement of [3H]pirenzepine in bovine striatum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967,,,,,,,Bos taurus
184353,2200,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.28,,Ki,Displacement of [3H]pirenzepine from muscarinic acetylcholine receptor M1 in rat cortex homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967,,,,,,,Rattus norvegicus
184354,2200,1845,Muscarinic acetylcholine receptor M3,GPCR,P08483,Chrm3,ACM3_RAT,7.55,,Ki,Ability to displace [3H]N-methylscopolamine (NMS) from M3 receptor in rat submaxillary gland homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967,,,,,,,Rattus norvegicus
184355,2200,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,6.92,,Ki,Inhibition of carbachol-induced release of alpha-amylase from pancreatic acinar cells from that of rat ileum contained the muscarinic acetylcholine receptor M2 subtypes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967,,,,,,,Rattus norvegicus
184356,2200,2290,Muscarinic acetylcholine receptor,GPCR,Q8VH26,GPM3,Q8VH26_CAVPO,6.96,,Ki,Binding affinity for muscarinic acetylcholine receptor M3 by measuring displacement of [3H]QNB from guinea pig parotid gland,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967,,,,,,,Cavia porcellus
184357,2200,1997,Muscarinic acetylcholine receptor M4,GPCR,P08485,Chrm4,ACM4_RAT,6.48,,Ki,Inhibition of binding of [3H]N-Methyl-scopolamine to muscarinic acetylcholine receptor M4 of rat heart NG108-15 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9967,,,,,,,Rattus norvegicus
184358,3580,231,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,7.11,,IC50,Binding affinity for Retinoic Acid Receptor alpha (RAR alpha),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25202,,,,Tclin,,,Homo sapiens
184359,2571,426,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,9.1,,EC50,Activity at human RARbeta ligand binding domain expressed in COS7 cells co-transfected with Gal4-DBD assessed as transcriptional activation after 16 hrs by Gal4 response element-driven luciferase reporter gene assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1657,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1657,AGONIST,,Tclin,,,Homo sapiens
184360,2571,231,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,7.2,,EC50,Activity at human RARalpha ligand binding domain expressed in COS7 cells co-transfected with Gal4-DBD assessed as transcriptional activation after 16 hrs by Gal4 response element-driven luciferase reporter gene assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1657,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1657,AGONIST,,Tclin,,,Homo sapiens
184361,2571,427,Retinoic acid receptor gamma,Nuclear hormone receptor,P13631,RARG,RARG_HUMAN,7.4,,EC50,Activity at human RARgamma ligand binding domain expressed in COS7 cells co-transfected with Gal4-DBD assessed as transcriptional activation after 16 hrs by Gal4 response element-driven luciferase reporter gene assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1657,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1657,AGONIST,,Tclin,,,Homo sapiens
184362,2742,1634,Trypanothione reductase,Enzyme,P28593,TPR,TYTR_TRYCR,4.52,,Ki,Inhibitory activity against recombinant Trypanosoma cruzi (Trypanosoma cruzi) Trypanothione reductase (linear competitive type),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL570,,,,,,,Trypanosoma cruzi
184363,2742,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.8,,Ki,Concentration giving half of the maximal ATPase activity calculated for the high-affinity binding site of the CHO P-Glycoprotein (P-gp) in two-affinity model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL570,,,,Tchem,,,Homo sapiens
184388,1729,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.66,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL170179,,,,Tclin,,,Homo sapiens
184364,2742,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,5.31,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL570,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
184365,2742,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,5.13,,IC50,Inhibition of Equine serum BChE using butyrylthiocholine iodide as a substrate after 20 mins by Ellman's assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL570,,,,,,,Equus caballus
184366,676,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL620,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL620,ANTAGONIST,,Tclin,,,Homo sapiens
184367,913,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,9.77,,Ki,Binding affinity to human prostanoid EP4 receptor by radioligand displacement assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,AGONIST,,Tclin,,,Homo sapiens
184368,913,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,8.04,,Ki,Displacement of [3H]PGE2 from human EP1 receptor expressed in HEK293 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,AGONIST,,Tclin,,,Homo sapiens
184369,913,2074,Solute carrier family 22 member 6,Transporter,Q8VC69,Slc22a6,S22A6_MOUSE,5.47,,Ki,Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,,,,,,,Mus musculus
184370,913,341,Prostacyclin receptor,GPCR,P43119,PTGIR,PI2R_HUMAN,6.59,,IC50,Agonist activity at prostanoid IP receptor (unknown origin) by functional assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,,,,Tclin,,,Homo sapiens
184371,913,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,8.77,,Ki,Binding affinity to human prostanoid EP2 receptor by radioligand displacement assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,AGONIST,,Tclin,,,Homo sapiens
184372,913,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,9.48,,Ki,Displacement of [3H]PGE2 from human EP3 receptor expressed in HEK293 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,AGONIST,,Tclin,,,Homo sapiens
184373,913,2079,Solute carrier family 22 member 20,Transporter,Q80UJ1,Slc22a20,S22AK_MOUSE,4.74,,Ki,Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,,,,,,,Mus musculus
184374,913,1923,Prostaglandin E2 receptor EP2 subtype,GPCR,Q62053,Ptger2,PE2R2_MOUSE,7.66,,Ki,Displacement of [3H]-PGE2 from mouse EP2 receptor expressed in CHO cells after 60 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,,,,,,,Mus musculus
184375,913,1922,Prostaglandin E2 receptor EP1 subtype,GPCR,P35375,Ptger1,PE2R1_MOUSE,8.22,,Ki,Displacement of [3H]-PGE2 from mouse EP1 receptor expressed in CHO cells after 20 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,,,,,,,Mus musculus
184376,913,1924,Prostaglandin E2 receptor EP3 subtype,GPCR,P30557,Ptger3,PE2R3_MOUSE,8.3,,Ki,Displacement of [3H]-PGE2 from mouse EP3 receptor expressed in CHO cells after 60 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,,,,,,,Mus musculus
184377,913,1925,Prostaglandin E2 receptor EP4 subtype,GPCR,P32240,Ptger4,PE2R4_MOUSE,8.51,,Ki,Displacement of [3H]-PGE2 from mouse EP4 receptor expressed in CHO cells after 60 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,,,,,,,Mus musculus
184378,913,2151,Prostaglandin E2 receptor EP2 subtype,GPCR,Q62928,Ptger2,PE2R2_RAT,8.28,,IC50,Inhibition of rat EP2 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,,,,,,,Rattus norvegicus
184379,913,2152,Prostaglandin E2 receptor EP4 subtype,GPCR,P43114,Ptger4,PE2R4_RAT,8.68,,IC50,Inhibition of rat EP4 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,,,,,,,Rattus norvegicus
184381,1348,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,,,,Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL970,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL970,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
184382,1331,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,4.3,,IC50,Inhibition of human CYP51 expressed in Topp 3 cells by lanosterol demethylase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL562,,,,Tchem,,,Homo sapiens
184383,1331,2741,Tubulin,Structural,F2SG63|F2SZ02|F2SZD3,,F2SG63_TRIRC|F2SZ02_TRIRC|F2SZD3_TRIRC,,,,Mechanism of Action; CHEMBL2364703; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL562,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL562,INHIBITOR,,,,,Trichophyton rubrum (strain ATCC MYA-4607 / CBS 118892)
184384,1775,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.9,,Ki,Binding affinity towards 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1065,,,,,,,Rattus norvegicus
184385,1775,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,8.28,,Ki,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor from rat tissue homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1065,,,,,,,Rattus norvegicus
184386,1775,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.04,,IC50,The compound was tested for affinity towards sigma-3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1065,,,,Tclin,,,Homo sapiens
184387,1775,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.8,,Ki,Binding affinity to 5-hydroxytryptamine 2A receptor from rat cortex assayed using [3H]ketanserin as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1065,,,,,,,Rattus norvegicus
184389,1500,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,,,,Mechanism of Action; CHEMBL245; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200347,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200347,ANTAGONIST,,Tclin,,,Homo sapiens
184390,1500,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200347,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200347,ANTAGONIST,,Tclin,,,Homo sapiens
184391,1417,2062,Thymidine kinase,Kinase,A3RLP8,UL23,A3RLP8_CHV1,5.82,,IC50,Inhibition of Herpes B virus recombinant thymidine kinase-mediated [3H]TdR phosphorylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL788,,,,,,,Cercopithecine herpesvirus 1
184392,1417,681,"Thymidine kinase, cytosolic",Kinase,P04183,TK1,KITH_HUMAN,7.05,,Ki,Binding affinity constant against HSV-1 thymidine kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL788,,,,Tchem,,,Homo sapiens
184393,2432,393,Thromboxane A2 receptor,GPCR,P21731,TBXA2R,TA2R_HUMAN,8.13,,IC50,"In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70972,,,,Tclin,,,Homo sapiens
184394,3659,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,7.02,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,Tchem,,,Homo sapiens
184395,3659,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.48,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184396,3659,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,5.61,,Ki,Tested for binding affinity against dopamine receptor D3 expressed in Sf9 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Rattus norvegicus
184397,3659,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,9.38,,Ki,Binding affinity against human Alpha-2A adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,ANTAGONIST,,Tclin,,,Homo sapiens
184398,3659,596,DNA topoisomerase 1,Enzyme,P11387,TOP1,TOP1_HUMAN,4.52,,IC50,Inhibition of human recombinant DNA topoisomerase1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,Tclin,,,Homo sapiens
184399,3659,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,5.7,,Ki,In vitro binding affinity to Dopamine receptors of rat striatal membranes by [3H]spiroperidol displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Rattus norvegicus
184400,3659,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,9.22,,Ki,Compound was evaluated for inhibition of binding of [3H]-yohimbine to Alpha-2 adrenergic receptor in alpha-2 C4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Rattus norvegicus
184401,3659,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,8.44,,Ki,Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in bovine pineal,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Bos taurus
184402,3659,1868,Alpha-2A adrenergic receptor,GPCR,Q28838,ADRA2A,ADA2A_BOVIN,7.31,,Ki,"Binding activity against alpha-2 adrenergic receptor from calf cerebral cortex, using [3H]clonidine as the radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Bos taurus
184403,3659,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.8,,Ki,"Binding affinity against Alpha-1D adrenergic receptor, from human clones.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,Tclin,,,Homo sapiens
184404,3659,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.4,,Kd,Inhibition of specific [3H]prazosin binding (0.2 nM) to rat brain membranes alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,Tclin,,,Homo sapiens
184405,3659,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,8.96,,Ki,Binding affinity against Alpha-1B adrenergic receptor from hamster clones.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,Tclin,,,Homo sapiens
184406,3659,3469,Dual specificity phosphatase Cdc25A,Enzyme,P30304,CDC25A,MPIP1_HUMAN,4.65,,IC50,Inhibition of His-tagged Cdc25A expressed in the Escherichia coli BL21(DE3) using p-nitrophenyl phosphate as substrate for 80 mins by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,Tchem,,,Homo sapiens
184408,3659,1733,Alpha-2B adrenergic receptor,GPCR,P19328,Adra2b,ADA2B_RAT,8.7,,Ki,Inhibition of [3H]- Yohimbine binding against rat kidney cortex Alpha-2B adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Rattus norvegicus
184409,3659,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,7.28,,Ki,"Binding affinity against Alpha-1D adrenergic receptor, from rat clones.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Rattus norvegicus
184410,3659,1864,Alpha-2A adrenergic receptor,GPCR,P18871,ADRA2A,ADA2A_PIG,8.36,,Ki,Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in porcine alpha2-clone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Sus scrofa
184411,3659,2902,Alpha-2 adrenergic receptor,GPCR,P30545|Q01337|Q01338,Adra2a|Adra2b|Adra2c,ADA2A_MOUSE|ADA2B_MOUSE|ADA2C_MOUSE,9.22,,Ki,Compound was evaluated for inhibition of binding of [3H]yohimbine to Alpha-2 adrenergic receptor in NG-108 cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Mus musculus
184412,3659,1853,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,7.35,,Ki,Inhibition of [3H]nitrendipine binding to membrane homogenates of rat cardiac muscle.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Rattus norvegicus
184413,3659,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,8.7,,Ki,Binding affinity against human alpha 2b-adrenergic receptor expressed stably in CHO cells using [3H]rauwolscine as radioligand,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,ANTAGONIST,,Tclin,,,Homo sapiens
215592,2601,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.7,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
184414,3659,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,9.3,,Ki,Displacement of [3H]RX821002 from human recombinant alpha2C adrenoceptor expressed in CHO cells,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,ANTAGONIST,,Tclin,,,Homo sapiens
184415,3659,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,5.95,,IC50,In vitro inhibition of specific binding of [3H]-YM 09151-2 to Dopamine receptor D2 site in rat striatal tissue.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Rattus norvegicus
184416,3659,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,5.79,,Ki,Binding affinity for 5-HT 2A in rat stomach fundus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Rattus norvegicus
184417,3275,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,6.65,,Ki,compound was tested for inhibitory activity against Thrombin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25105,,,,Tclin,,,Homo sapiens
184418,3275,88,Urokinase-type plasminogen activator,Enzyme,P00749,PLAU,UROK_HUMAN,4.84,,Ki,compound was tested for inhibitory activity against Urokinase-type plasminogen activator (microPa),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25105,,,,Tchem,,,Homo sapiens
184419,3275,549,Trypsin-1,Enzyme,P07477,PRSS1,TRY1_HUMAN,5.57,,Ki,Inhibition of trypsin by amidase assay.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25105,,,,Tclin,,,Homo sapiens
184420,3275,683,Suppressor of tumorigenicity 14 protein,Enzyme,Q9Y5Y6,ST14,ST14_HUMAN,6.03,,Ki,compound was tested for inhibitory activity against Matriptase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25105,,,,Tchem,,,Homo sapiens
184421,912,527,Prostaglandin D2 receptor,GPCR,Q13258,PTGDR,PD2R_HUMAN,5.35,,IC50,Affinity for human Prostaglandin D2 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL815,,,,Tclin,,,Homo sapiens
184422,912,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,5.38,,IC50,Affinity for Prostanoid EP4 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL815,,,,Tclin,,,Homo sapiens
184423,912,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,6.66,,IC50,In vitro binding at EP1 human prostaglandin receptor using [3H]PGE-2 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL815,,,,Tclin,,,Homo sapiens
184424,912,2108,Prostaglandin F2-alpha receptor,GPCR,P43117,Ptgfr,PF2R_MOUSE,7.9,,EC50,Agonist activity at FP receptor in mouse 3T3 fibroblast cells assessed as intracellular calcium mobilization by FLIPR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL815,,,,,,,Mus musculus
184425,912,1819,Prostaglandin F2-alpha receptor,GPCR,P37289,PTGFR,PF2R_BOVIN,6.89,,Ki,Binding affinity for Prostanoid FP receptor of bovine corpus luteum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL815,,,,,,,Bos taurus
184426,912,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,8.4,,Kd,GRAC: human FP probe,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL815,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL815,AGONIST,,Tclin,,,Homo sapiens
184427,912,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,6.96,,IC50,In vitro binding at EP3 human prostaglandin receptor using [3H]PGE-2 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL815,,,,Tclin,,,Homo sapiens
184428,138,1923,Prostaglandin E2 receptor EP2 subtype,GPCR,Q62053,Ptger2,PE2R2_MOUSE,7.66,,Ki,Affinity for mouse Prostanoid EP2 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495,,,,,,,Mus musculus
184429,138,1922,Prostaglandin E2 receptor EP1 subtype,GPCR,P35375,Ptger1,PE2R1_MOUSE,8.22,,Ki,Affinity for mouse Prostanoid EP1 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495,,,,,,,Mus musculus
184430,138,1924,Prostaglandin E2 receptor EP3 subtype,GPCR,P30557,Ptger3,PE2R3_MOUSE,8.3,,Ki,Binding affinity towards mouse Prostanoid EP3 receptor in CHO cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495,,,,,,,Mus musculus
184431,138,1925,Prostaglandin E2 receptor EP4 subtype,GPCR,P32240,Ptger4,PE2R4_MOUSE,8.51,,Ki,Affinity for mouse Prostanoid EP4 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495,,,,,,,Mus musculus
184432,186,3470,Heparanase,Enzyme,Q9Y251,HPSE,HPSE_HUMAN,4.28,,Kd,Binding affinity to recombinant heparanase catalytic stie (unknown origin) expressed in Escherichia coli BL21 (DE3) by surface plasmon resonance assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL682,,,,Tchem,,,Homo sapiens
184433,186,616,Histamine N-methyltransferase,Enzyme,P50135,HNMT,HNMT_HUMAN,7.72,,Ki,Inhibition of histamine N-methyltransferase by radiochemical assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL682,,,,Tchem,,,Homo sapiens
184434,186,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.62,,IC50,Inhibition of human cloned ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL682,,,,Tclin,,,Homo sapiens
184435,3032,2514,Solute carrier family 22 member 3,Transporter,O75751,SLC22A3,S22A3_HUMAN,5.26,,IC50,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290106,,,,Tchem,,,Homo sapiens
184436,3032,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,5.41,,IC50,Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290106,,,,Tchem,,,Homo sapiens
184437,3032,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.72,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290106,,,,Tchem,,,Homo sapiens
184438,3032,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,5.18,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290106,,,,Tchem,,,Homo sapiens
184439,3032,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.28,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290106,,,,Tchem,,,Homo sapiens
184470,2405,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,5.38,,Ki,Competitive inhibition of human MAOB expressed in Pichia pastoris,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,,,,Tclin,,,Homo sapiens
184440,2534,413,Retinoic acid receptor RXR-alpha,Nuclear hormone receptor,P19793,RXRA,RXRA_HUMAN,4.08,,IC50,Displacement of [3H]-9-cis-RA from RXRalpha (unknown origin) by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15770,,,,Tclin,,,Homo sapiens
184441,2534,3451,Prostaglandin E synthase,Enzyme,O14684,PTGES,PTGES_HUMAN,4.1,,IC50,Inhibition of microsomal PGES,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15770,,,,Tchem,,,Homo sapiens
184442,2534,613,Lactoylglutathione lyase,Enzyme,Q04760,GLO1,LGUL_HUMAN,4.11,,Ki,Inhibition of glyoxalase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15770,,,,Tchem,,,Homo sapiens
184443,2534,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,6.43,,IC50,Inhibition of Homo sapiens (human) aldose reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15770,,,,Tclin,,,Homo sapiens
184448,2179,1900,Peroxisome proliferator-activated receptor gamma,Transcription factor,P37238,Pparg,PPARG_MOUSE,6.15,,IC50,Displacement of [3H]rosiglitazone from mouse PPARgamma receptor by scintillation proximation assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595,,,,,,,Mus musculus
184449,2179,2566,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,Q5NGQ3,fabI,Q5NGQ3_FRATT,4.1,,IC50,Inhibition of C-terminal His6-tagged Francisella tularensis SCHU S4 FabI expressed in Escherichia coli BL21 (DE3) using CrCoA as substrate assessed as oxidation of NADH to NAD+ by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595,,,,,,,Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4)
184450,2179,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,5.68,,Ki,Competitive inhibition of rat MAOB expressed in Pichia pastoris,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595,,,,,,,Rattus norvegicus
184451,2179,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,6.3,,Ki,Competitive inhibition of human MAOB expressed in Pichia pastoris,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595,,,,Tclin,,,Homo sapiens
184452,2179,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,5.18,,EC50,In vitro transactivation of human Peroxisome proliferator activated receptor alpha (hPPARalpha),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595,,,,Tclin,,,Homo sapiens
184453,2179,2101,Peroxisome proliferator-activated receptor gamma,Transcription factor,O88275,Pparg,PPARG_RAT,6.15,,IC50,Displacement of [3H]rosigliatzone from PPARgamma in rat adipocytes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595,,,,,,,Rattus norvegicus
184454,1064,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,Mechanism of Action; CHEMBL206; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1511,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1511,AGONIST,,Tclin,,,Homo sapiens
184455,284,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,,,,Mechanism of Action; CHEMBL215; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200760,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200760,INHIBITOR,,Tclin,,,Homo sapiens
184456,284,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,,,,Mechanism of Action; CHEMBL235; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200760,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200760,AGONIST,,Tclin,,,Homo sapiens
184457,2704,1756,Aldose reductase,Enzyme,P16116,AKR1B1,ALDR_BOVIN,7.48,,IC50,In vitro inhibition of aldose reductase activity in a partially purified bovine lens preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL436,,,,,,,Bos taurus
184458,2704,976,Aldose reductase,Enzyme,P80276,AKR1B1,ALDR_PIG,7.82,,IC50,In vitro inhibitory activity against aldose reductase in porcine lens.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL436,,,,,,,Sus scrofa
184459,2704,2065,Aldo-keto reductase family 1 member C21,Enzyme,Q91WR5,Akr1c21,AK1CL_MOUSE,4.66,,Ki,Inhibition of mouse recombinant AKR1C21,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL436,,,,,,,Mus musculus
184460,2704,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,8.7,,IC50,In vitro inhibition of Aldose reductase (AR) from rat lens (RL),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL436,,,,,,,Rattus norvegicus
184461,2704,633,Alcohol dehydrogenase [NADP(+)],Enzyme,P14550,AKR1A1,AK1A1_HUMAN,6.14,,IC50,Inhibition of N-terminal 6His-tagged human aldehyde reductase expressed in Escherichia coli BL21(DE3) mediated D-glucuronate reduction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL436,,,,Tchem,,,Homo sapiens
184462,2704,1788,Alcohol dehydrogenase [NADP(+)],Enzyme,P51635,Akr1a1,AK1A1_RAT,5.92,,IC50,Evaluated for inhibition of Aldehyde reductase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL436,,,,,,,Rattus norvegicus
184463,2704,2070,Aldo-keto reductase family 1 member B10,Enzyme,O60218,AKR1B10,AK1BA_HUMAN,7.3,,Ki,Inhibition of reductase activity of N-terminal 6His-tagged human AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as pyridine-3-aldehyde reduction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL436,,,,Tchem,,,Homo sapiens
184464,2704,973,Alcohol dehydrogenase [NADP(+)],Enzyme,P50578,AKR1A1,AK1A1_PIG,6.27,,IC50,Selectivity ratio measured as the IC50 ratio of aldehyde/aldose reductase values,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL436,,,,,,,Sus scrofa
184465,647,505,Extracellular calcium-sensing receptor,GPCR,P41180,CASR,CASR_HUMAN,7.7,,EC50,Positive allosteric modulation of calcium sensing receptor by cell based assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200776,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200776,POSITIVE ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
184466,2405,2071,Type-1A angiotensin II receptor,GPCR,P25095,Agtr1,AGTRA_RAT,9.64,,Ki,Displacement of [125I]-SI-Ang-2 from AT1 receptor in Rattus norvegicus Sprague-Dawley (rat) liver membranes after 2 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,,,,,,,Rattus norvegicus
184467,2405,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,4.56,,Ki,Competitive inhibition of human MAOA expressed in Pichia pastoris,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,,,,Tclin,,,Homo sapiens
184468,2405,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,5.44,,EC50,In vitro transcription activation on human peroxisome proliferator activated receptor-delta (PPAR delta),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,,,,Tchem,,,Homo sapiens
184469,2405,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,5.24,,Ki,Competitive inhibition of rat MAOB expressed in Pichia pastoris,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,,,,,,,Rattus norvegicus
184471,2405,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,7.41,,EC50,Agonist activity at human PPARalpha ligand binding domain expressed in human HepG2 cells co-transfected with Gal4 by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,,,,Tclin,,,Homo sapiens
184472,2405,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,4.49,,Ki,Competitive inhibition of rat MAOA expressed in Pichia pastoris,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,,,,,,,Rattus norvegicus
184473,2405,427,Retinoic acid receptor gamma,Nuclear hormone receptor,P13631,RARG,RARG_HUMAN,5,,Ki,Binding affinity against Retinoic acid receptor gamma was determined in vitro by using [3H]ATRA as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,,,,Tclin,,,Homo sapiens
184474,2028,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.09,,Ki,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M2 receptor expressed in Sf9 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133,,ANTAGONIST,,Tclin,,,Homo sapiens
184475,2028,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9,,Ki,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M1 receptor expressed in Sf9 cells,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000532/WC500040171.pdf,ANTAGONIST,,Tclin,,179,Homo sapiens
184476,2028,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.23,,Ki,Binding affinity for rat cortex muscarinic acetylcholine receptor M1 using [3H]pirenzepine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133,,,,,,,Rattus norvegicus
184477,2028,1845,Muscarinic acetylcholine receptor M3,GPCR,P08483,Chrm3,ACM3_RAT,9.02,,Ki,Affinity for rat Muscarinic acetylcholine receptor M3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133,,,,,,,Rattus norvegicus
184478,2028,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,8.16,,Ki,Affinity for rat Muscarinic acetylcholine receptor M2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133,,,,,,,Rattus norvegicus
184479,2028,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.11,,Ki,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000532/WC500040171.pdf,ANTAGONIST,,Tclin,,179,Homo sapiens
184480,2028,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.44,,Ki,Displacement of [3H]N-methylscopolamine from human muscarinic M4 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133,,,,Tclin,,,Homo sapiens
184481,2028,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.85,,Ki,Displacement of [3H]N-methylscopolamine from human muscarinic M5 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133,,,,Tclin,,,Homo sapiens
184482,1440,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,7,,IC50,"Inhibition of human recombinant AKR1C3-mediated NADP+-dependent oxidation of S-(+)-1,2,3,4-tetrahydro-1-naphthol",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,Tchem,,,Homo sapiens
184483,1440,1255,Interleukin-8,Cytokine,P10145,CXCL8,IL8_HUMAN,7.3,,IC50,Inhibition of CXCL8-induced chemotaxis in human polymorphonuclear leukocyte pretreated for 15 mins measured after 4 hrs by cell migration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,Tchem,,,Homo sapiens
184484,1440,1756,Aldose reductase,Enzyme,P16116,AKR1B1,ALDR_BOVIN,5.3,,IC50,Inhibition of Aldose reductase (AR),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Bos taurus
184485,1440,2892,Prostaglandin G/H synthase (cyclooxygenase),Enzyme,P05979|P79208,PTGS1|PTGS2,PGH1_SHEEP|PGH2_SHEEP,6.82,,IC50,Inhibition of ram seminal vesicle Cyclooxygenase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Ovis aries
184486,1440,3451,Prostaglandin E synthase,Enzyme,O14684,PTGES,PTGES_HUMAN,4.39,,IC50,Inhibition of mPGES-1 in human IL-1beta-stimulated A549 cell microsomes assessed as inhibition of PGE2 formation from PGH2 after 15 mins by RP-HPLC analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,Tchem,,,Homo sapiens
184487,1440,3471,Aldo-keto reductase family 1 member C4,Enzyme,P17516,AKR1C4,AK1C4_HUMAN,4.27,,IC50,Inhibition of human recombinant GST-tagged AKR1C4 expressed in Escherichia coli using S-tetralol as substrate by fluorometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,Tbio,,,Homo sapiens
184488,1440,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.85,,EC50,Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,Tclin,,,Homo sapiens
184489,1440,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,5.1,,Ki,Inhibition of ovine COX1 pre-incubated before addition of [1-14C]arachidonic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Ovis aries
184490,1440,1877,Prostaglandin-H2 D-isomerase,Enzyme,O09114,Ptgds,PTGDS_MOUSE,6.3,,IC50,Concentration required to inhibit 50% activity of prostaglandin synthetase was determined in vitro in mouse brain microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Mus musculus
184491,1440,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,4.92,,IC50,Inhibition of human MRP1 in human 2008 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,Tchem,,,Homo sapiens
184492,1440,346,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,4.44,,IC50,"Inhibition of human recombinant AKR1C2-mediated NADP+-dependent oxidation of S-(+)-1,2,3,4-tetrahydro-1-naphthol",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,Tchem,,,Homo sapiens
184493,1440,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,6.47,,IC50,Inhibition of ovine COX2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Ovis aries
184494,1440,1738,Prostaglandin G/H synthase 2,Enzyme,Q05769,Ptgs2,PGH2_MOUSE,8.19,,IC50,IC50 value was determined against Prostaglandin G/H synthase 2 of J7744A.1 cell lines.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Mus musculus
185015,1045,774,Serine/threonine-protein kinase 17B,Kinase,O94768,STK17B,ST17B_HUMAN,5.03,,Kd,Binding constant for DRAK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184495,1440,1739,Prostaglandin G/H synthase 1,Enzyme,P22437,Ptgs1,PGH1_MOUSE,8.7,,IC50,In vitro inhibitory activity against Prostaglandin G/H synthase 1 in murine J774 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Mus musculus
184496,1440,2845,Cyclooxygenase,Enzyme,P35355|Q63921,Ptgs1|Ptgs2,PGH1_RAT|PGH2_RAT,7,,IC50,In vitro inhibitory activity against polymorphonuclear leukocyte Prostaglandin G/H synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Rattus norvegicus
184497,1440,1892,Prostaglandin G/H synthase 2,Enzyme,P35355,Ptgs2,PGH2_RAT,8,,IC50,Inhibition of Prostaglandin G/H synthase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Rattus norvegicus
184498,1440,2844,Cyclooxygenase,Enzyme,O62664|O62698,PTGS1|PTGS2,PGH1_BOVIN|PGH2_BOVIN,6.37,,IC50,Inhibitory activity against Prostaglandin G/H synthase (bovine seminal vesicles),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Bos taurus
184499,1440,1893,Prostaglandin G/H synthase 1,Enzyme,Q63921,Ptgs1,PGH1_RAT,8.22,,IC50,Inhibition of Prostaglandin G/H synthase 1 using whole cell assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Rattus norvegicus
184500,1440,233,Dehydrogenase/reductase SDR family member 9,Enzyme,Q9BPW9,DHRS9,DHRS9_HUMAN,4.85,,IC50,Inhibition of 3alphaHSD,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,Tbio,,,Homo sapiens
184501,1440,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,8.39,,IC50,Inhibition of bovine COX1 assessed as inhibition of calcium ionophore A23187-induced 12-hydroxyheptadecatrienoic acid formation by reverse-phase HPLC analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Bos taurus
184502,1440,613,Lactoylglutathione lyase,Enzyme,Q04760,GLO1,LGUL_HUMAN,4.74,,Ki,Inhibition of glyoxalase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,Tchem,,,Homo sapiens
184503,1440,3414,"Nitric oxide synthase, inducible",Enzyme,P29477,Nos2,NOS2_MOUSE,4.7,,IC50,Inhibition of iNOS in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production for 2 hrs by DAF-FMDA dye based fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,,,,Mus musculus
184504,1440,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,5.22,,IC50,In vitro inhibition of rabbit lens aldose reductase.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,Tclin,,,Homo sapiens
184505,698,1877,Prostaglandin-H2 D-isomerase,Enzyme,O09114,Ptgds,PTGDS_MOUSE,6.7,,IC50,Concentration required to inhibit 50% activity of prostaglandin synthetase was determined in vitro in mouse brain microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13376,,,,,,,Mus musculus
184506,640,1983,Dipeptidase 1,Enzyme,P22412,DPEP1,DPEP1_PIG,6.96,,Ki,Inhibitory activity against beta-lactamase renal dipeptidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL766,,,,,,,Sus scrofa
184507,1113,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.92,,IC50,Inhibition of Prostaglandin G/H synthase 1 was measured by the inhibition of PGE-2 produced by microsomes from U937 cells at subsaturating arachidonic acid conc.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL416146,,,,Tclin,,,Homo sapiens
184508,1113,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,6.28,,IC50,Inhibitory concentration against p38 alpha MAP kinase calculated by CoMFA model; FlexX score = -18.6kcal/mol ,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL416146,,,,Tchem,,,Homo sapiens
184509,1330,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.3,,IC50,Inhibitory activity against Potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL583,,,,Tclin,,,Homo sapiens
184510,1330,2745,DNA gyrase,Enzyme,P0A4L9|P72524,gyrA|gyrB,GYRA_STRPN|GYRB_STRPN,,,,Mechanism of Action; CHEMBL2311225; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL583,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL583,INHIBITOR,,,,,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
184511,1330,2740,DNA topoisomerase 4,Enzyme,P72525|Q59961,parC|parE,PARC_STRPN|PARE_STRPN,,,,Mechanism of Action; CHEMBL2363033; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL583,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL583,INHIBITOR,,,,,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
184512,2350,2752,Potassium-transporting ATPase,Transporter,P20648|P51164,ATP4A|ATP4B,ATP4A_HUMAN|ATP4B_HUMAN,,,,Mechanism of Action; CHEMBL2095173; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1219,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1219,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
184513,3123,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.7,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127487,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184514,2734,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,4.82,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1086440,,,,,,,Trypanosoma cruzi
184515,1759,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,,,,Mechanism of Action; CHEMBL1876; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1577,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1577,INHIBITOR,,Tclin,,,Homo sapiens
184516,1947,2557,Platelet-activating factor receptor,GPCR,P21556,PTAFR,PTAFR_CAVPO,4.13,,Ki,Tested for inhibition of [3H]PAF binding to rabbit Platelet activating factor receptor ,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL475534,,,,,,,Cavia porcellus
184517,1947,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.44,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL475534,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184518,1947,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,4.64,,Ki,Displacement of [3H]-CGS- 21680 binding to Adenosine A2A receptor in rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL475534,,,,,,,Rattus norvegicus
184519,1947,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,5.05,,Ki,Displacement of [3H](R)-PIA binding to Adenosine A1 receptor in rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL475534,,,,,,,Rattus norvegicus
184520,1947,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL475534,,,,Tclin,,,Homo sapiens
184521,2245,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,9.54,,Ki,Displacement of [3H]-aldosterone from human mineralocorticoid receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,Tclin,,,Homo sapiens
184522,2245,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,5.6,,Ki,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,Tclin,,,Homo sapiens
184523,2245,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,5.58,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,,,,Rattus norvegicus
184524,2245,2019,Glucocorticoid receptor,Transcription factor,P06537,Nr3c1,GCR_MOUSE,8.47,,EC50,Inhibition of mouse glutamine synthetase by GR-mediated transactivation in C2C12 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,,,,Mus musculus
184525,2245,1176,Glutamine synthetase,Enzyme,P15104,GLUL,GLNA_HUMAN,7.49,,EC50,Ability to induce human glutamine synthetase in skeletal muscle cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,Tchem,,,Homo sapiens
184526,734,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,6.43,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1650,,,,Tchem,,,Homo sapiens
184527,734,407,Potassium voltage-gated channel subfamily A member 1,Ion channel,Q09470,KCNA1,KCNA1_HUMAN,4.48,,EC50,Activation of KV1.1 expressed in Xenopus laevis oocytes coexpressing Kvbeta1 W155A mutant assessed as increase in steady state current normalized to initial inactivating current by electrophysiology method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1650,,,,Tclin,,,Homo sapiens
184528,734,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.67,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1650,,,,Tchem,,,Homo sapiens
184529,111,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,5.32,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273453,,,,Tchem,,,Homo sapiens
184530,111,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,8.42,,EC50,Agonist activity at mineralocorticoid receptor ligand binding domain expressed in african green monkey COS7 cells co-transfected with Gal4-LBD by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273453,,,,Tclin,,,Homo sapiens
184531,111,2424,Mineralocorticoid receptor,Transcription factor,P22199,Nr3c2,MCR_RAT,7.37,,IC50,Displacement of [3H]aldosterone from Sprague-Dawley rat MR by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273453,,,,,,,Rattus norvegicus
184532,1152,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,4.21,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL672,,,,,,,Trypanosoma cruzi
184533,1152,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,7.74,,Kd,Binding affinity to rat recombinant L-FABP high affinity site expressed in Escherichia coli BL21(DE3) at 5 deg C by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL672,,,,,,,Rattus norvegicus
184534,1152,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,6.24,,EC50,In vitro activation of human peroxisome proliferator activated receptor gamma (PPAR gamma),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL672,,,,Tclin,,,Homo sapiens
184535,1152,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,6,,IC50,Inhibition of human PPARalpha receptor by scintillation proximity assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL672,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL672,AGONIST,,Tclin,,,Homo sapiens
184536,1981,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,4.96,,IC50,Inhibition of [3H]muscimol binding to GABA A receptor 4-biphenylacetic acid at 10 e-4 M,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL4,,,,,,,Rattus norvegicus
184537,1569,165,DNA gyrase subunit A,Enzyme,P9WG47,gyrA,GYRA_MYCTU,4.28,,IC50,Inhibition of DNA supercoiling activity of wild type Mycobacterium tuberculosis DNA gyrase A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184538,1569,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.75,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33,,,,Tchem,,,Homo sapiens
184539,1569,2745,DNA gyrase,Enzyme,P0A4L9|P72524,gyrA|gyrB,GYRA_STRPN|GYRB_STRPN,,,,Mechanism of Action; CHEMBL2311225; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33,INHIBITOR,,,,,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
184540,1569,2740,DNA topoisomerase 4,Enzyme,P72525|Q59961,parC|parE,PARC_STRPN|PARE_STRPN,,,,Mechanism of Action; CHEMBL2363033; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33,INHIBITOR,,,,,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
184541,1355,2037,UDP-glucose 4-epimerase,Enzyme,Q14376,GALE,GALE_HUMAN,6.3,,IC50,Inhibition of human GalE by HPAEC assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289,,,,Tchem,,,Homo sapiens
184564,1189,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,8.23,,Ki,Binding affinity to adenosine A1 receptor in rat brain membranes by measuring displacement of specific [3H]PIA as radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1568,,,,,,,Rattus norvegicus
184542,362,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,4.35,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP low binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL264374,,,,,,,Rattus norvegicus
184543,362,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,4.45,,EC50,Agonist activity at human PPARdelta expressed in HEK293 cells cotransfected with PPREx4-TK-luc assessed as activation of luciferase activity measured after 48 hrs by transactivation assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL264374,,,,Tchem,,,Homo sapiens
184544,362,869,"Fatty acid-binding protein, intestinal",Cytosolic other,P12104,FABP2,FABPI_HUMAN,4.48,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from I-FABP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL264374,,,,Tchem,,,Homo sapiens
184545,2316,2547,Thyrotropin-releasing hormone receptor,GPCR,P21761,Trhr,TRFR_MOUSE,8,,Ki,Binding affinity against TRH-R receptor in AtT-20 mouse pituitary tumor cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1472,,,,,,,Mus musculus
184546,2316,156,Thyrotropin-releasing hormone receptor,GPCR,P34981,TRHR,TRFR_HUMAN,7.7,,Ki,Displacement of [3H]N(1)-Me-His-TRH from TRHR1,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1472,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1472,AGONIST,,Tclin,,,Homo sapiens
184547,2316,2021,Protein Trhr2; Thyrotropin releasing hormone receptor 2; Thyrotropin-releasing hormone receptor 2,GPCR,Q9R297,Trhr2,Q9R297_RAT,8,,Ki,Inhibitory constant against thyrotropin releasing hormone receptor 2 expressed in HEK 293EM cells upon incubation at 37 degree C for 1 hr at pH 7.4 using [3H]Ntau(1)-Me-His-TRH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1472,,,,,,,Rattus norvegicus
184548,2316,1967,Thyrotropin-releasing hormone receptor,GPCR,Q01717,Trhr,TRFR_RAT,7.7,,Ki,Inhibitory constant against thyrotropin releasing hormone receptor 1 expressed in HEK 293EM cells upon incubation at 37 degree C for 1 hr at pH 7.4 using [3H]Ntau(1)-Me-His-TRH; Range = 0.001-0.003 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1472,,,,,,,Rattus norvegicus
184549,1388,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,6.2,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL389621,,,,Tchem,,,Homo sapiens
184550,1388,2019,Glucocorticoid receptor,Transcription factor,P06537,Nr3c1,GCR_MOUSE,7.37,,Kd,"Displacement of 1 x 10'-8 M of [1,2,3-3H]-triamcinolone acetonide from glucocorticoid receptor in soluble fraction of mouse L929 cells after 20 hrs",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL389621,,,,,,,Mus musculus
184551,2457,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.24,,IC50,Displacement of [3H]NMS from human muscarinic M2 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1734,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1734,ANTAGONIST,,Tclin,,,Homo sapiens
184552,2457,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.2,,IC50,Displacement of [3H]NMS from human muscarinic M1 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1734,,,,Tclin,,,Homo sapiens
184553,2457,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8,,Ki,Binding affinity for rat cortex muscarinic acetylcholine receptor M1 using [3H]pirenzepine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1734,,,,,,,Rattus norvegicus
184554,2457,1845,Muscarinic acetylcholine receptor M3,GPCR,P08483,Chrm3,ACM3_RAT,8,,Ki,Binding affinity for rat salivary gland muscarinic acetylcholine receptor M3 using [3H]N-methylscopolamine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1734,,,,,,,Rattus norvegicus
184555,2457,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,6.92,,Ki,Binding affinity for rat heart muscarinic acetylcholine receptor M2 using [3H]quinuclidinyl benzilate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1734,,,,,,,Rattus norvegicus
184556,2457,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.88,,IC50,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1734,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1734,ANTAGONIST,,Tclin,,,Homo sapiens
184557,831,2873,Muscarinic acetylcholine receptor,GPCR,P12657|P32211|Q920H4|Q9ERZ3|Q9ERZ4,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_MOUSE|ACM2_MOUSE|ACM3_MOUSE|ACM4_MOUSE|ACM5_MOUSE,8.48,,IC50,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to muscarinic receptor in mice,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908364,,,,,,,Mus musculus
184558,526,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1644,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1644,INHIBITOR,,,,,Escherichia coli (strain K12)
184559,1993,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,7.89,,Ki,Affinity for human EMP expressed in ERG2 deficient strain of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL370753,,,,Tchem,,,Homo sapiens
184560,1993,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,9.7,,Ki,Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL370753,,,,Tclin,,,Homo sapiens
184561,1993,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,7.77,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL370753,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
184562,1189,1938,Adenosine receptor A3,GPCR,P28647,Adora3,AA3R_RAT,4.98,,Ki,Binding affinity determined by displacement of specific binding of [125I]N-(4-amino-3-iodophenethyl)-adenosine in membranes of CHO cells stably transfected with the rat adenosine A3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1568,,,,,,,Rattus norvegicus
184563,1189,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,7.55,,Ki,Binding affinity to adenosine A2A receptor in rat striatal membranes by measuring displacement of specific [3H]-CGS- 21680 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1568,,,,,,,Rattus norvegicus
184565,192,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1082,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1082,INHIBITOR,,,,,Escherichia coli (strain K12)
184566,2107,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,5.15,,IC50,Inhibition of bovine erythrocyte AChE using acetylthiocholine iodide as a substrate after 20 mins by Ellman's assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL251940,,,,,,,Bos taurus
184567,2107,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.52,,Ki,Displacement of [3H]mibolerone from rat androgen receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL251940,,,,,,,Rattus norvegicus
184568,2107,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,6.64,,IC50,Inhibition of Equine serum BChE using butyrylthiocholine iodide as a substrate after 20 mins by Ellman's assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL251940,,,,,,,Equus caballus
184569,2752,2602,Nicotinic acetylcholine receptor alpha 5 subunit,Ion channel,A9XFY4,nAChRalpha5,A9XFY4_MUSDO,5.56,,Ki,Displacement of [3H]alpha-bungarotoxin from nAChR in Musca domestica (house fly) head membrane after 60 min by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1245,,,,,,,Musca domestica
184570,2752,2583,Acetylcholine receptor subunit alpha,Ion channel,P02710,CHRNA1,ACHA_TORCA,5.15,,IC50,Displacement of [3H]PCP from nAChR in Torpedo nobiliana electric organs membranes in presence of 100 uM carbachol by scintillation counting method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1245,,,,,,,Torpedo californica
184571,1783,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,8.68,,Ki,Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL878,,,,Tclin,,,Homo sapiens
184572,1783,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,,,,Mechanism of Action; CHEMBL1876; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL878,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL878,INHIBITOR,,Tclin,,,Homo sapiens
184573,1433,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.7,,Kd,Binding affinity to human recombinant carbonic anhydrase 2 by isothermal titration calorimetry assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,Tclin,,,Homo sapiens
184574,1433,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,7.89,,Ki,Inhibition of mouse recombinant full length CA13 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,,,,Mus musculus
184575,1433,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,8,,Ki,Inhibition of human recombinant CA12 catalytic domain by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,Tclin,,,Homo sapiens
184576,1433,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.67,,Ki,Inhibition of human recombinant full length CA4 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,Tclin,,,Homo sapiens
184577,1433,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,7,,Kd,Binding affinity to human recombinant carbonic anhydrase 13 by thermal shift assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,Tclin,,,Homo sapiens
184578,1433,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,6.05,,Ki,Inhibition of human recombinant full length CA5A by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,Tclin,,,Homo sapiens
184579,1433,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.31,,Ki,Inhibition of human recombinant full length CA14 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,Tclin,,,Homo sapiens
184580,1433,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,9.64,,Ki,Inhibition of human recombinant full length CA7 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,Tclin,,,Homo sapiens
184581,1433,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.44,,Ki,Inhibition of human recombinant CA9 catalytic domain by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,Tclin,,,Homo sapiens
184582,1433,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5,,Kd,Binding affinity to human recombinant carbonic anhydrase 1 by thermal shift assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,Tclin,,,Homo sapiens
184583,1433,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,6.56,,Ki,Inhibition of human recombinant full length CA5B by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,Tclin,,,Homo sapiens
184584,1433,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,6.6,,Kd,Binding affinity to human recombinant carbonic anhydrase 6 expressed in Escherichia coli Rosetta2 (DE3) by thermal shift assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406,,,,Tclin,,,Homo sapiens
184586,762,1741,Integrase,Enzyme,Q7ZJM1,pol,Q7ZJM1_9HIV1,4,,IC50,Inhibitory activity against HIV-1 Integrase (HIV-1-IN),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17205,,,,,,,Human immunodeficiency virus 1
184587,342,1827,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P15381,CACNA1C,CAC1C_RABIT,4.66,,IC50,Inhibition of [3H]nitrendipine binding to calcium channels in Rabbit cardiac muscle.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1008,,,,,,,Oryctolagus cuniculus
184588,342,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,6.08,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1008,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184589,342,1283,Lethal factor,Enzyme,P15917,lef,LEF_BACAN,5.32,,IC50,Protection against Bacillus anthracis lethal toxin-mediated cytotoxicity in mouse RAW264.7 cells assessed as change in viability after 24 hrs by WST1 dye reduction assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1008,,,,,,,Bacillus anthracis
184590,258,1480,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q63707,Dhodh,PYRD_RAT,6.15,,IC50,Inhibition of rat purified recombinant DHODH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1450,,,,,,,Rattus norvegicus
184591,258,655,Cytochrome b,Enzyme,Q02768,MT-CYB,CYB_PLAFA,,,,Mechanism of Action; CHEMBL1777; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1450,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1450,INHIBITOR,,,,,Plasmodium falciparum
184592,525,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL680,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL680,INHIBITOR,,,,,Escherichia coli (strain K12)
184593,3502,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,5.4,,Ki,Binding affinity at 5HT3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL117287,,,,Tclin,,,Homo sapiens
184594,3502,245,5-hydroxytryptamine receptor 4,GPCR,Q13639,HTR4,5HT4R_HUMAN,8.6,,Ki,Binding affinity at 5HT4 receptor,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL117287,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001012/WC500053998.pdf,AGONIST,,Tclin,,267,Homo sapiens
184595,2108,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.82,,IC50,Inhibition of ACE (unknown origin),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1581,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1581,INHIBITOR,,Tclin,,,Homo sapiens
184596,502,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,,,,Mechanism of Action; CHEMBL1987; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237105,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237105,AGONIST,,Tclin,,,Homo sapiens
184597,654,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,6.36,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL43064,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184598,1547,2491,Microtubule-associated protein tau,Structural,P10636,MAPT,TAU_HUMAN,8.6,,Ki,Binding affinity to heparin induced human Tau 441 at 50 pM to 500 nM after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL480,,,,Tchem,,,Homo sapiens
184599,1547,3596,"Indoleamine 2,3-dioxygenase 1",Enzyme,P28776,Ido1,I23O1_MOUSE,4.03,,IC50,Inhibition of mouse Ido1 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL480,,,,,,,Mus musculus
184600,1547,2492,"Indoleamine 2,3-dioxygenase 2",Enzyme,Q8R0V5,Ido2,I23O2_MOUSE,5.09,,IC50,Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL480,,,,,,,Mus musculus
184601,1547,2752,Potassium-transporting ATPase,Transporter,P20648|P51164,ATP4A|ATP4B,ATP4A_HUMAN|ATP4B_HUMAN,,,,Mechanism of Action; CHEMBL2095173; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL480,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL480,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
184602,2757,436,Dihydrofolate reductase,Enzyme,P16184,,DYR_PNECA,9.15,,Ki,Binding affinity was reported with purified recombinant Pneumocystis carinii Dihydrofolate reductase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,INHIBITOR,,,,,Pneumocystis carinii
184603,2757,1786,Dihydrofolate reductase,Enzyme,P00381,folA,DYR_LACCA,7.57,,IC50,Inhibitory activity against Dihydrofolate reductase from Lactobacillus casei,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,,,,,,,Lactobacillus casei
184604,2757,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,8.85,,Ki,Inhibition of human recombinant Dihydrofolate reductase enzyme,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,,,,Tclin,,,Homo sapiens
184605,2757,1781,Dihydrofolate reductase,Enzyme,P0ABQ4,folA,DYR_ECOLI,8,,IC50,Inhibition of dihydrofolate reductase in Toxoplasma gondii.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,,,,,,,Escherichia coli (strain K12)
184606,2757,276,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q07422,,DRTS_TOXGO,8.29,,IC50,Inhibitory activity against Toxoplasma gondii (tg) Dihydrofolate reductase (DHFR),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,,,,,,,Toxoplasma gondii
184607,2757,1736,Dihydrofolate reductase,Enzyme,P00375,Dhfr,DYR_MOUSE,10.22,,Ki,Inhibitory constant for murine Wild-type dihydrofolate reductase (DHFR),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,,,,,,,Mus musculus
184608,2757,1828,Dihydrofolate reductase,Enzyme,P07807,DFR1,DYR_YEAST,7.38,,IC50,Inhibitory activity against Pneumocystis carinii dihydrofolate reductase.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
184609,2757,2308,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q27793,,DRTS_TRYCR,8.18,,Ki,Inhibition of Trypanosoma cruzi DHFR by spectrophotometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,,,,,,,Trypanosoma cruzi
184610,2757,1906,Dihydrofolate reductase,Enzyme,P22906,DFR1,DYR_CANAX,8.72,,Ki,Inhibition of Dihydrofolate reductase enzyme from Candida albicans,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,,,,,,,Candida albicans
184611,2757,1752,Dihydrofolate reductase,Enzyme,Q920D2,Dhfr,DYR_RAT,8.52,,IC50,Inhibitory activity against Dihydrofolate reductase from rat liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,,,,,,,Rattus norvegicus
184612,2757,2004,Dihydrofolate reductase,Enzyme,O30463,folA,O30463_MYCAV,8.82,,IC50,Inhibitory concentration against Mycobacterium avium dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,,,,,,,Mycobacterium avium
184613,2757,2102,Dihydrofolate reductase,Unclassified,B0BL08,dfrA17,B0BL08_ECOLX,8.15,,IC50,Inhibitory activity against Escherichia coli (ec) Dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119,,,,,,,Escherichia coli
184614,2384,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200617,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200617,AGONIST,,Tclin,,,Homo sapiens
184639,2561,2552,Emopamil-binding protein-like,Unclassified,Q9BY08,EBPL,EBPL_HUMAN,8.55,,Ki,Binding affinity to emopamil binding protein (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,,,,Tchem,,,Homo sapiens
184615,2637,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,8.7,,IC50,Displacement of [3H]quinuclidinyl benzilate (QNB) from Muscarinic acetylcholine receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,,,,Rattus norvegicus
184616,2637,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.19,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184617,2637,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,7.74,,IC50,Binding affinity towards 5-hydroxytryptamine 2 receptor was measured using radioligand ([3H]spiperone) binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,,,,Rattus norvegicus
184618,2637,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,7.07,,IC50,Inhibition of [3H]spiperone binding to dopamine receptor from rat corpus striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,,,,Rattus norvegicus
184619,2637,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.89,,IC50,Displacement of [3H]clonidine from alpha-2 adrenergic receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,,,,Rattus norvegicus
184620,2637,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,5.89,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
184621,2637,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,5.06,,IC50,Displacement of [3H]-5-HT from serotonin-1 neurotransmitter receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,,,,Rattus norvegicus
184622,2637,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,7.76,,IC50,Affinity for displacement of [3H]WB-4101 labeled Dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,,,,Rattus norvegicus
184623,2637,605,Serine/threonine-protein kinase pim-1,Kinase,P11309,PIM1,PIM1_HUMAN,5.16,,IC50,Inhibition of PIM-1 (unknown origin) after 1 hr by HTRF assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,Tchem,,,Homo sapiens
184624,2637,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,7,,IC50,Binding affinity against Histamine H1 receptor was measured using radioligand ([3H]pyrilamine) binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,,,,Rattus norvegicus
184625,2637,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.15,,Ki,Binding affinity towards human 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,Tclin,,,Homo sapiens
184626,2637,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.55,,IC50,In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]haloperidol from rat striatal membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,,,,Rattus norvegicus
184627,2365,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.4,,Kd,Binding affinity to 5HT1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22242,,,,Tclin,,,Homo sapiens
184628,2365,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,5.8,,IC50,Antidopamine activity in vitro by ability to displace [3H]spiperone from rat brain striatal preparations.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22242,,,,,,,Rattus norvegicus
184629,2365,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.06,,IC50,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",CHEMBL,=,1,KEGG DRUG,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22242,http://www.kegg.jp/entry/D02682,ANTAGONIST,,Tclin,,,Homo sapiens
184630,2365,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.41,,Ki,Displacement of [3H]-YM 09151 from human Dopamine receptor D4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22242,,,,Tchem,,,Homo sapiens
184631,2365,2265,D(3) dopamine receptor,GPCR,P52703,DRD3,DRD3_CHLAE,5.34,,Ki,Displacement of [3H]-YM 09151 from african monkey Dopamine receptor D3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22242,,,,,,,Chlorocebus aethiops
184632,2365,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.26,,Ki,Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22242,,,,Tclin,,,Homo sapiens
184633,2365,1905,D(2) dopamine receptor,GPCR,P52702,DRD2,DRD2_CHLAE,6.06,,Ki,Displacement of [3H]-YM 09151 from african green monkey Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22242,,,,,,,Chlorocebus aethiops
184634,2365,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,5.85,,IC50,Binding affinity against the Dopamine receptor D2 in rat striatnrn by using [3H]spiperone radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22242,,,,,,,Rattus norvegicus
184635,1511,1827,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P15381,CACNA1C,CAC1C_RABIT,6.97,,IC50,Antagonist activity at rabbit voltage-dependent L-type calcium channel Cav1.2alpha-1C expressed in HEK293 cells by FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648,,,,,,,Oryctolagus cuniculus
184636,1511,1882,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,P27732,Cacna1d,CAC1D_RAT,6.66,,IC50,Antagonist activity at rat voltage-dependent L-type calcium channel Cav1.3alpha-1D expressed in HEK293 cells by FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648,,,,,,,Rattus norvegicus
184637,2561,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,7.51,,Ki,"Displacement of [2,4,6,7-3H]estradiol from human ERalpha expressed in HeLa cells after 18 hrs by liquid scintillation counting",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,MODULATOR,,Tclin,,,Homo sapiens
184638,2561,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.98,,Ki,Displacement of [3H]LSD from human 5HT6 receptor expressed in HEK293 cells after 1.5 hrs by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,,,,Tchem,,,Homo sapiens
184640,2561,3571,Transcriptional activator protein luxR,Unclassified,P12746,luxR,LUXR_ALIFS,4.4,,IC50,Inhibition of LuxR-dependent quorum sensing in Vibrio fischeri assessed as reduction of 3-oxo-C6-HSL-induced bioluminescence intensity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,,,,,,,Aliivibrio fischeri
184641,2561,752,Steroid hormone receptor ERR1,Nuclear hormone receptor,P11474,ESRRA,ERR1_HUMAN,6.7,,IC50,Antagonist activity at ERalpha receptor in human MCF7 cells assessed as inhibition of cell growth after 6 days by crystal violet staining method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,,,,Tchem,,,Homo sapiens
184642,2561,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.8,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,,,,Tclin,,,Homo sapiens
184643,2561,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,5.82,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
184644,2717,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,7.77,,IC50,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL621,,,,,,,Rattus norvegicus
184645,174,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,4,,IC50,Inhibition of human MMP-9 after 60 mins by FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87223,,,,Tchem,,,Homo sapiens
184646,174,1957,Botulinum neurotoxin type A,Enzyme,P10845,botA,BXA1_CLOBO,5.14,,IC50,Inhibition of Clostridium bolulinum BoNT/A assessed as cleavage of MOCAc-Lys-Lys-Val-Tyr-Pro-Tyr-Pro-Met-Glu-Lys(Dnp)-NH2 after 40 mins by FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87223,,,,,,,Clostridium botulinum
184647,174,840,Interstitial collagenase,Enzyme,P03956,MMP1,MMP1_HUMAN,4.51,,IC50,Inhibition of human MMP-1 after 60 mins by FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87223,,,,Tclin,,,Homo sapiens
184648,174,1283,Lethal factor,Enzyme,P15917,lef,LEF_BACAN,6.3,,Ki,Competitive inhibition of Bacillus anthracis lethal factor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87223,,,,,,,Bacillus anthracis
184649,1702,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201148,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201148,AGONIST,,Tclin,,,Homo sapiens
184650,821,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,,,,Mechanism of Action; CHEMBL1994; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200542,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200542,AGONIST,,Tclin,,,Homo sapiens
184651,1862,608,Cannabinoid receptor 2,GPCR,P34972,CNR2,CNR2_HUMAN,8.2,,Ki,Displacement of [3H]-CP55940 from human CB2 receptor expressed in CHO cells by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL947,,,,Tchem,,,Homo sapiens
184652,1862,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,8.4,,Ki,Displacement of [3H]-CP55940 from human CB1 receptor expressed in CHO cells by liquid scintillation counting,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL947,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL947,AGONIST,,Tclin,,,Homo sapiens
184653,1171,1883,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,P24008,Srd5a1,S5A1_RAT,8.17,,Ki,Inhibition of recombinant Steroid 5-alpha-reductase type I was evaluated as binding affinity (in vitro),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL710,,,,,,,Rattus norvegicus
184654,1171,1907,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,P31214,Srd5a2,S5A2_RAT,9.55,,IC50,Inhibitory activity was measured on rat Steroid 5-alpha-reductase type 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL710,,,,,,,Rattus norvegicus
184655,1171,2880,Steroid 5-alpha-reductase,Enzyme,P24008|P31214,Srd5a1|Srd5a2,S5A1_RAT|S5A2_RAT,7.26,,Ki,Ability to inhibit Steroid 5-alpha-reductase in rat using Enzyme kinetics method.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL710,,,,,,,Rattus norvegicus
184656,1171,610,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,Enzyme,P14060,HSD3B1,3BHS1_HUMAN,4.96,,Ki,Binding affinity for 3-beta-hydroxysteroid dehydrogenase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL710,,,,Tchem,,,Homo sapiens
184657,2008,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,5.12,,IC50,Tested for inhibition of 5-Lipoxygenase (ARBL) in calcium-stimulated rat basophilic leukemia cells(RBL-1),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL295829,,,,,,,Rattus norvegicus
184658,2008,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.55,,IC50,Inhibition of COX1 in human whole blood assessed as effect on A23187-induced thromboxane B2 production,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL295829,,,,Tclin,,,Homo sapiens
184659,2008,2845,Cyclooxygenase,Enzyme,P35355|Q63921,Ptgs1|Ptgs2,PGH1_RAT|PGH2_RAT,5.96,,IC50,Tested for inhibition of cyclooxygenase (ARBC) in calcium-stimulated rat basophilic leukemia cells(RBL-1),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL295829,,,,,,,Rattus norvegicus
184666,670,1801,D(1A) dopamine receptor,GPCR,Q95136,DRD1,DRD1_BOVIN,5.22,,Ki,Displacement of [3H]SCH-23390 [0.3 nM (Kd=0.35 nM)] from dopamine receptor D1 in bovine striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,,,,,Bos taurus
184667,670,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.98,,Ki,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,,,,,Cavia porcellus
184668,670,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,7.05,,Ki,In vitro binding affinity on 5-hydroxytryptamine 2 receptor is inhibition of binding of [125I]- I-LSD to P11 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,,,,,Rattus norvegicus
184669,670,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.92,,Ki,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,,Tclin,,,Homo sapiens
184670,670,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,6.22,,Ki,In vitro binding affinity on alpha-2 receptor is inhibition of binding of [3H]- rauwolscine to rat cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,,,,,Rattus norvegicus
184672,670,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.49,,Ki,Ability to displace [3H]spiperone [0.5 nM (Kd=0.1-0.45 nM)] from human recombinant dopamine receptor D4 expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,,Tchem,,,Homo sapiens
184673,670,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.98,,Ki,In vitro binding affinity on D3 receptor is inhibition of binding of [125I]- NCQ 298 to Sf9 cells infected with recombinant baculovirus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,,Tclin,,,Homo sapiens
184674,670,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.22,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,,Tclin,,,Homo sapiens
184675,670,1855,5-hydroxytryptamine receptor 4,GPCR,Q62758,Htr4,5HT4R_RAT,6.98,,Ki,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,,,,,Rattus norvegicus
184676,670,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.95,,Ki,Inhibition of [125I]- NCQ 298 binding to D2 receptor of rat striatal tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325109,,,,,,,Rattus norvegicus
184677,2274,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.3,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL728,,,,Tchem,,,Homo sapiens
184678,2274,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,5.77,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL728,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
184679,1280,165,DNA gyrase subunit A,Enzyme,P9WG47,gyrA,GYRA_MYCTU,5.03,,IC50,Inhibition of DNA supercoiling activity of wild type Mycobacterium tuberculosis DNA gyrase A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184680,1280,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,6.3,,IC50,Inhibitory activity against wild type Escherichia coli gyrase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31,,,,,,,Escherichia coli (strain K12)
184681,1280,164,DNA topoisomerase 4 subunit A,Enzyme,P0C1U9,parC,PARC_STAAU,5.92,,IC50,Inhibitory activity against wild type Staphylococcus aureus topoisomerase 4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31,,,,,,,Staphylococcus aureus
184682,1280,2745,DNA gyrase,Enzyme,P0A4L9|P72524,gyrA|gyrB,GYRA_STRPN|GYRB_STRPN,,,,Mechanism of Action; CHEMBL2311225; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31,INHIBITOR,,,,,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
184683,1280,2740,DNA topoisomerase 4,Enzyme,P72525|Q59961,parC|parE,PARC_STRPN|PARE_STRPN,,,,Mechanism of Action; CHEMBL2363033; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31,INHIBITOR,,,,,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
184684,2648,1937,Sodium- and chloride-dependent GABA transporter 1,Transporter,P23978,Slc6a1,SC6A1_RAT,7.17,,Ki,In vitro inhibition of [3H]GABA uptake at the Sodium- and chloride-dependent GABA transporter 1 (GAT-1) uptake site in rat brain synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1027,,,,,,,Rattus norvegicus
184685,2648,174,Sodium- and chloride-dependent GABA transporter 1,Transporter,P30531,SLC6A1,SC6A1_HUMAN,7.77,,Ki,Displacement of [3H]Tiagabine from human recombinant GAT1 expressed in HEK293 cells by equilibrium binding assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1027,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1027,INHIBITOR,,Tclin,,,Homo sapiens
184686,2648,2054,Sodium- and chloride-dependent GABA transporter 1,Transporter,P31648,Slc6a1,SC6A1_MOUSE,7.41,,Ki,Binding affinity to mouse GAT1 stably transfected in HEK293 cells by NO-711 binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1027,,,,,,,Mus musculus
184687,2648,2553,Sodium- and chloride-dependent betaine transporter,Unclassified,P31651,Slc6a12,S6A12_MOUSE,6.74,,IC50,Inhibition of [3H]GABA uptake at GAT2 in mouse astrocytes after 3 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1027,,,,,,,Mus musculus
184688,1353,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,5.26,,Ki,Binding affinity to rat NET,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184689,1353,2851,Dopamine receptor,GPCR,P20288|Q95136,DRD1|DRD2,DRD1_BOVIN|DRD2_BOVIN,8.74,,IC50,Inhibition of [3H]haloperidol binding to Dopamine receptor in calf caudate nuclei.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Bos taurus
184690,1353,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,6.58,,Ki,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184691,1353,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,5.13,,Ki,In vitro binding affinity against Muscarinic acetylcholine receptors in rat brain.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184692,1353,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.55,,Ki,Binding affinity for 5-hydroxytryptamine 1A receptor determined using [3H]8-OH-DPAT as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,Tclin,,,Homo sapiens
184693,1353,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,9.52,,Ki,"Evaluated for binding towards Dopamine receptor D2 using [3H]-spiperone as radioligand, in cloned mammalian receptors expressed in CHO-K1 cells",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Bos taurus
184694,1353,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.92,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184695,1353,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,8.52,,Ki,Binding affinity towards baculovirus expressed rat dopamine D3 receptors,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184696,1353,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.8,,Ki,Binding affinity to human cloned muscarinic M1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,Tclin,,,Homo sapiens
184697,1353,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,8.38,,Ki,Binding affinity towards 5-hydroxytryptamine 2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184698,1353,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.22,,Ki,Binding affinity to human cloned 5HT6 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,Tchem,,,Homo sapiens
184699,1353,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,8.7,,Ki,In vitro ability to displace [3H]spiroperidol from rat dopamine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184700,1353,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.57,,Ki,Half-maximal inhibition of [3H]clonidine binding to Alpha-2 adrenergic receptor in rat frontal cortex homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184701,1353,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,7.7,,IC50,Affinity towards Alpha-1A adrenergic receptor in membranes from bovine frontal cortex using [3H]prazosin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Bos taurus
184702,1353,2430,AP-2 complex subunit sigma,Unclassified,P62744,Ap2s1,AP2S1_RAT,7.62,,Ki,Displacement of [3H]-DTG from rat sigma2 receptor by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184703,1353,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,5.74,,Ki,Compound was tested for the binding affinity against rat cortical Muscarinic acetylcholine receptor M1 by Radio ligand [3H]pirenzepine binding assay.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184704,1353,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.33,,Ki,Binding affinity to human cloned 5HT2C receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,Tclin,,,Homo sapiens
184705,1353,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.36,,Ki,Binding affinity to human cloned histamine H1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,Tclin,,,Homo sapiens
184706,1353,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.74,,Ki,Binding affinity to human SERT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,Tclin,,,Homo sapiens
184707,1353,2862,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy2|Adcy3|Adcy4|Adcy5|Adcy6|Adcy8,ADCY2_RAT|ADCY3_RAT|ADCY4_RAT|ADCY5_RAT|ADCY6_RAT|ADCY8_RAT|D4A3N4_RAT|Q8CFM9_RAT,5.64,,IC50,Inhibition of dopamine-sensitive rat brain adenylyl cyclase activity assessed as cAMP level,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184708,1353,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,6.62,,Ki,Inhibition of [3H]N-methylscopolamine binding to Muscarinic acetylcholine receptor M2 of rat heart membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184709,1353,2265,D(3) dopamine receptor,GPCR,P52703,DRD3,DRD3_CHLAE,8.52,,Ki,Displacement of [3H]-YM 09151 from african monkey Dopamine receptor D3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Chlorocebus aethiops
184710,1353,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.76,,Kd,Binding affinity towards Alpha-1A adrenergic receptor in rat denuded thoracic aorta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184711,1353,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,4.7,,IC50,Binding affinity against serotonin-1 receptor in rat brain using [3H]5-HT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184712,1353,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.4,,Ki,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 radioligand in rat hippocampus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184713,1353,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,7.7,,Ki,Affinity for Dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184714,1353,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,7,,Ki,Binding affinity for HIV-1 protease,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Human immunodeficiency virus 1
184715,1353,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,6.42,,Ki,Half-maximal inhibition of [3H]pyrilamine binding to Histamine H1 receptor in rat frontal cortex homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184716,1353,2115,5-hydroxytryptamine receptor 2A,GPCR,P50129,HTR2A,5HT2A_PIG,7.52,,Ki,Displacement of [3H]Ketanserin from 5-HT2 receptor in pig cortex membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Sus scrofa
184717,1353,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,5.92,,Ki,Binding affinity was measured against opioid receptor in rat using [3H]naloxone as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184718,1353,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,9.05,,Ki,Displacement of [3H](+)-pentazocine from sigma 1 receptor in rat brain homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184719,1353,1905,D(2) dopamine receptor,GPCR,P52702,DRD2,DRD2_CHLAE,8.32,,Ki,Displacement of [3H]YM-09151 from recombinant African green monkey Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Chlorocebus aethiops
184720,1353,2866,Serotonin 2 (5-HT2) receptor,GPCR,P34968|P35363|Q02152,Htr2a|Htr2b|Htr2c,5HT2A_MOUSE|5HT2B_MOUSE|5HT2C_MOUSE,7.58,,Ki,Binding affinity against 5-hydroxytryptamine 2 receptor from rat cortical synaptosomal membrane using radioligand [3H]ketanserin.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Mus musculus
184721,1353,1954,5-hydroxytryptamine receptor 2A,GPCR,Q75Z89,HTR2A,5HT2A_BOVIN,7.52,,IC50,Affinity towards 5-hydroxytryptamine 2A receptor in membranes from bovine frontal cortex using [3H]ketanserin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Bos taurus
184722,1353,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,9.7,,Ki,Binding towards Dopamine receptor D2 using [3H]spiperone from rat striatal membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184723,1353,1888,Protease,Enzyme,Q4U254,protease,Q4U254_9ENTO,7,,Ki,The compound was tested for its affinity against HIV-2 protease,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Human rhinovirus sp
184724,1353,2034,D(1A) dopamine receptor,GPCR,P50130,DRD1,DRD1_PIG,7.03,,Ki,Displacement of [3H]SCH23390 from D1 receptor from porcine cerebral cortex homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Sus scrofa
184725,1353,2048,Sigma non-opioid intracellular receptor 1,Membrane other,Q60492,SIGMAR1,SGMR1_CAVPO,9.08,,Ki,Displacement of [3H](+)-PTZ from sigma1 receptor in Hartley guinea pig brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Cavia porcellus
184726,1353,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,9.3,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
184727,1353,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,7.35,,Ki,In vitro ability to displace [3H]ketanserin from 5-hydroxytryptamine 2A receptor in rat brain.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Rattus norvegicus
184728,2834,2474,Riboflavin-binding protein,Unclassified,P02752,,RBP_CHICK,8.3,,Kd,Binding affinity to chicken riboflavin binding protein assessed as dissociation constant at pH 7.4 in phosphate buffer by isothermal titration calorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1534,,,,,,,Gallus gallus
184733,1058,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,5.94,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL282575,,,,Tchem,,,Homo sapiens
184734,147,615,Glucosylceramidase,Enzyme,P04062,GBA,GLCM_HUMAN,5.39,,IC50,Inhibition of beta-glucocerebrosidase in human fibroblast lysate using 4-methylumbelliferyl beta-D-glycopyranoside as substrate by fluorimetric analysis,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL153479,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10692,,,Tclin,,,Homo sapiens
184735,1665,3599,Protein kinase Pfmrk,Unclassified,P90584,Pfmrk,P90584_PLAFA,4.92,,IC50,Inhibition of Plasmodium falciparum cyclin-dependent kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL416956,,,,,,,Plasmodium falciparum
184736,492,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1214,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1214,INHIBITOR,,,,,Escherichia coli (strain K12)
184737,1216,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200774,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200774,AGONIST,,Tclin,,,Homo sapiens
184738,953,641,Potassium channel subfamily K member 3,Ion channel,O14649,KCNK3,KCNK3_HUMAN,,,,Mechanism of Action; CHEMBL2321613; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1754,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1754,BLOCKER,,Tclin,,,Homo sapiens
184739,953,642,Potassium channel subfamily K member 9,Ion channel,Q9NPC2,KCNK9,KCNK9_HUMAN,,,,Mechanism of Action; CHEMBL2321614; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1754,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1754,BLOCKER,,Tclin,,,Homo sapiens
184740,966,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,6.13,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184741,966,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.49,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108,,,,Tclin,,,Homo sapiens
184742,946,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,8.54,,Ki,Inhibition of fetal Bovine serum AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,,,,Bos taurus
184743,946,955,Acetylcholinesterase,Enzyme,P04058,ache,ACES_TORCA,8.24,,IC50,Inhibition of Torpedo californica AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,,,,Torpedo californica
184744,946,1802,Choline O-acetyltransferase,Enzyme,P32738,Chat,CLAT_RAT,8.28,,IC50,In vitro inhibitory activity against acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,,,,Rattus norvegicus
184745,946,1774,Butyrylcholinesterase; Protein Bche,Enzyme,Q9JKC1,Bche,Q9JKC1_RAT,5.56,,IC50,Inhibition of BChE in rat serum after 15 mins by modified Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,,,,Rattus norvegicus
184746,946,1791,Acetylcholinesterase,Enzyme,P37136,Ache,ACES_RAT,8.77,,IC50,In vitro inhibitory effect on rat Acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,,,,Rattus norvegicus
184747,946,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,8.24,,IC50,Inhibitory activity against acetylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,,,,Mus musculus
184748,946,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,6.08,,IC50,Inhibition of equine serum BuChE by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,,,,Equus caballus
184749,946,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,4.82,,IC50,Inhibition of human recombinant MAO-B using tyramine as substrate preincubated for 30 mins followed by substrate addition measured for 1 hr by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,Tclin,,,Homo sapiens
184750,946,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,4.82,,IC50,Inhibition of rat liver mitochondrial MAO-B using [14C]-phenylethylamine after 30 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,,,,Rattus norvegicus
184751,946,882,Beta-secretase 1,Enzyme,P56817,BACE1,BACE1_HUMAN,5.49,,IC50,Inhibition of BACE1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,Tchem,,,Homo sapiens
184752,946,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.84,,Ki,Displacement of [3H]DTG from sigma 1 receptor (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,Tclin,,,Homo sapiens
184753,946,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.7,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,Tclin,,,Homo sapiens
184754,946,2007,Butyrylcholinesterase,Enzyme,Q9N1N9,BCHE,Q9N1N9_HORSE,6.19,,Ki,Inhibition of Equine Butyrylcholinesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,,,,Equus caballus
184755,946,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,7.25,,Ki,Non competitive inhibition of electric eel AChE using acetylthiocholine iodide as substrate by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,,,,Electrophorus electricus
184756,946,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,4.9,,Ki,Non competitive inhibition of human serum BChE using butyrylthiocholine iodide as substrate by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,Tclin,,,Homo sapiens
184757,946,788,Histamine H3 receptor,GPCR,Q9Y5N1,HRH3,HRH3_HUMAN,6.46,,IC50,Inhibition of histamine H3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,Tclin,,,Homo sapiens
184758,1744,3472,Penicillin-binding protein,Enzyme,P72355|Q53707|Q53725|Q53729|Q9XDB3,PBP2|mecA|pbp4|pbpA|pbpF,P72355_STAAU|Q53707_STAAU|Q53725_STAAU|Q53729_STAAU|Q9XDB3_STAAU,,,,Mechanism of Action; CHEMBL2363021; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL575,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL575,INHIBITOR,,,,,Staphylococcus aureus
184759,2733,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.04,,Ki,Inhibition of human recombinant full length CA2 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,,,,Tclin,,,Homo sapiens
184760,2733,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,6.19,,Ki,Inhibition of mouse recombinant full length CA13 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,,,,,,,Mus musculus
184761,2733,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,6.51,,Ki,Inhibition of human recombinant CA12 catalytic domain by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,,,,Tclin,,,Homo sapiens
184762,2733,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.35,,Ki,Inhibition of human recombinant full length CA4 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,,,,Tclin,,,Homo sapiens
184763,2733,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,6.12,,Ki,Inhibition of human recombinant full length CA5A by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,,,,Tclin,,,Homo sapiens
184764,2733,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.46,,Ki,Inhibition of human recombinant full length CA14 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,,,,Tclin,,,Homo sapiens
184765,2733,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,8.1,,Ki,Inhibition of human recombinant full length CA7 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,,,,Tclin,,,Homo sapiens
184766,2733,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.06,,Ki,Inhibition of human recombinant CA9 catalytic domain by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,,,,Tclin,,,Homo sapiens
184767,2733,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.46,,Ki,Inhibition of human recombinant full length CA1 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,,,,Tclin,,,Homo sapiens
184768,2733,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,6.87,,Ki,Inhibition of human recombinant full length CA5B by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,,,,Tclin,,,Homo sapiens
184769,2733,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,5.61,,Ki,Inhibition of human recombinant full length CA6 by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1054,,,,Tclin,,,Homo sapiens
184770,610,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,,,,Mechanism of Action; CHEMBL242; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200761,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200761,MODULATOR,,Tclin,,,Homo sapiens
184771,568,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,7.74,,Ki,Inhibitory activity against cloned human CA12,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184772,568,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.06,,Ki,Inhibitory activity against human carbonic anhydrase IV (hCAIV),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184773,568,2384,Cytochrome c oxidase subunit 2,Enzyme,O78750,MT-CO2,COX2_SHEEP,7.22,,IC50,Inhibition of sheep COX2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Ovis aries
184774,568,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,7.01,,Ki,Inhibition of human recombinant carbonic anhydrase 13 after 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184775,568,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,8.43,,IC50,Inhibition of COX1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Ovis aries
184776,568,2010,Carbonic anhydrase,Enzyme,Q50565,,Q50565_METTH,4.41,,Ki,Inhibitory activity against beta carbonic anhydrase (Cab) from Methanobacterium thermoautotrophicum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H)
184777,568,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,7.47,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Stylophora pistillata
184778,568,2143,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878,,P96878_MYCTU,5.11,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase Rv3273 pre-incubated for 15 mins by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184780,568,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,7.3,,IC50,Inhibition of COX-1 in U-937 (human lymphoma) cell microsomes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184781,568,1859,Prostaglandin G/H synthase 2,Enzyme,O62698,PTGS2,PGH2_BOVIN,7.24,,IC50,In vitro inhibitory activity against prostaglandin G/H synthase 2 (COX-2),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Bos taurus
184782,568,1738,Prostaglandin G/H synthase 2,Enzyme,Q05769,Ptgs2,PGH2_MOUSE,9.29,,IC50,Inhibition of LPS-induced COX2 activity in C57BL/6J mouse peritoneal macrophages by RIA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Mus musculus
184783,568,1739,Prostaglandin G/H synthase 1,Enzyme,P22437,Ptgs1,PGH1_MOUSE,9.15,,IC50,Tested for inhibition against Prostaglandin G/H synthase 2 from mouse resident macrophages,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Mus musculus
184784,568,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,6.14,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Astrosclera willeyana
184785,568,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.13,,Ki,Inhibition of human recombinant full length CA3 pre-incubated for 15 mins by stopped-flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184786,568,1892,Prostaglandin G/H synthase 2,Enzyme,P35355,Ptgs2,PGH2_RAT,5.96,,IC50,In vitro inhibitory concentration against rat Prostaglandin G/H synthase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Rattus norvegicus
184787,568,1426,3-phosphoinositide-dependent protein kinase 1,Kinase,O15530,PDPK1,PDPK1_HUMAN,4.32,,IC50,Inhibition of recombinant PDK1 using RPRAATF as substrate by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tchem,,,Homo sapiens
184788,568,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,4.99,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184789,568,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,6.16,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Stylophora pistillata
184790,568,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,6.58,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Thalassiosira weissflogii
184791,568,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,6.1,,Ki,Inhibition of human recombinant carbonic anhydrase 5a after 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184792,568,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,6.97,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
184793,568,1742,Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein,Enzyme,Q8SPQ9,PTGS2,Q8SPQ9_CANFA,6.05,,IC50,In vitro inhibitory activity against canine prostaglandin G/H synthase 2.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Canis familiaris
184794,568,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,6.16,,Ki,Inhibition of human recombinant carbonic anhydrase 14 after 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184795,568,1920,Prostaglandin G/H synthase 1,Enzyme,Q8HZR1,PTGS1,PGH1_CANFA,5.25,,IC50,In vitro inhibitory activity against canine prostaglandin G/H synthase 1.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Canis familiaris
184796,568,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,5.66,,Ki,Inhibition of human recombinant carbonic anhydrase 7 after 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184797,568,1893,Prostaglandin G/H synthase 1,Enzyme,Q63921,Ptgs1,PGH1_RAT,4.85,,IC50,In vitro inhibitory concentration against rat prostaglandin G/H synthase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Rattus norvegicus
184798,568,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,4.8,,Ki,Inhibitory activity against human carbonic anhydrase IX at 0.09 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184799,568,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.35,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Mus musculus
184800,568,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,5.11,,IC50,Inhibition of bovine COX1 by enzyme immunoassay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Bos taurus
184801,568,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,4.3,,Ki,Inhibitory activity against human carbonic anhydrase I (hCAI),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184802,568,3587,Cytochrome c oxidase subunit 1,Unclassified,O78749,MT-CO1,COX1_SHEEP,4.61,,IC50,Inhibition of sheep COX1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Ovis aries
184803,568,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,7.03,,Ki,Inhibition of human recombinant carbonic anhydrase 5b after 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184804,568,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,7.68,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
184805,568,2009,Carbonic anhydrase,Enzyme,P40881,,CAH_METTE,6.85,,Ki,Inhibitory activity against alpha carbonic anhydrase (Zn-Cam) from Methanosarcina thermophila,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Methanosarcina thermophila
184953,1649,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action; CHEMBL231; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1623,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1623,ANTAGONIST,,Tclin,,,Homo sapiens
184806,568,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,6.15,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184807,568,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,7.03,,Ki,Inhibition of human full length recombinant carbonic anhydrase 6 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tclin,,,Homo sapiens
184808,568,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,6.09,,IC50,Inhibitory concentration against p38 alpha MAP kinase calculated by CoMFA model; FlexX score=-12.4 kcal/mol,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,Tchem,,,Homo sapiens
184809,568,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,6.54,,Ki,Inhibitory activity against bovine carbonic anhydrase IV (bCAIV),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Bos taurus
184810,983,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,4.6,,IC50,Compound was tested for the inhibition of beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,,,,,,,Escherichia coli (strain K12)
184811,983,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,7.3,,IC50,Inhibition of human CYP51 expressed in Topp 3 cells by lanosterol demethylase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,,,,Tchem,,,Homo sapiens
184812,983,2119,Lanosterol 14-alpha demethylase,Enzyme,P9WPP9,cyp51,CP51_MYCTU,6.7,,Kd,Binding affinity to Mycobacterium tuberculosis CYP51,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184813,983,3464,Malate dehydrogenase cytoplasmic ,Enzyme,P40925,MDH1,MDHC_HUMAN,4.6,,IC50,Inhibition of malate dehydrogenase (MDH),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,,,,Tbio,,,Homo sapiens
184814,983,3596,"Indoleamine 2,3-dioxygenase 1",Enzyme,P28776,Ido1,I23O1_MOUSE,4.95,,IC50,Inhibition of mouse Ido1 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,,,,,,,Mus musculus
184815,983,425,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,6.49,,Ki,In vitro inhibition of human Cytochrome P450 17A1 activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,,,,Tclin,,,Homo sapiens
184816,983,2492,"Indoleamine 2,3-dioxygenase 2",Enzyme,Q8R0V5,Ido2,I23O2_MOUSE,5.12,,IC50,Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,,,,,,,Mus musculus
184817,983,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,Mechanism of Action; CHEMBL1780; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
184818,271,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.3,,Ki,Binding affinity to human adrenergic alpha1A receptor expressed in rat intact fibroblasts,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL639,,,,Tclin,,,Homo sapiens
184819,271,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.3,,Ki,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL639,,,,Tclin,,,Homo sapiens
184820,271,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7,,IC50,Displacement of labeled dofetilide human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL639,,,,Tclin,,,Homo sapiens
184821,271,788,Histamine H3 receptor,GPCR,Q9Y5N1,HRH3,HRH3_HUMAN,6.83,,Ki,Antagonist activity at human H3 receptor expressed in CHO cells assessed as inhibition of histamine-induced GTPgamma[S] binding by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL639,,,,Tclin,,,Homo sapiens
184822,995,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,8.52,,Kd,GRAC: human 5-HT1B probe,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1510,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1510,AGONIST,,Tclin,,,Homo sapiens
184823,995,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,9.05,,Kd,GRAC: human 5-HT1D probe,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1510,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1510,AGONIST,,Tclin,,,Homo sapiens
184824,1605,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,5.52,,EC50,Agonist activity at PXR (unknown origin) expressed in human HepG2 cells assessed as induction of CYP3A4 transactivation after 16 hrs by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL998,,,,Tchem,,,Homo sapiens
184825,1605,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,5.51,,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL998,,,,Tclin,,,Homo sapiens
184826,1605,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,6.46,,Ki,Binding affinity to histamine H1 receptor in rat brain membranes was evaluated using [3H]-pyrilamine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL998,,,,,,,Rattus norvegicus
184827,2054,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.82,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1502,,,,Tchem,,,Homo sapiens
184828,2054,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.36,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1502,,,,Tchem,,,Homo sapiens
184829,2054,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.55,,IC50,Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1502,,,,Tchem,,,Homo sapiens
184830,2054,2492,"Indoleamine 2,3-dioxygenase 2",Enzyme,Q8R0V5,Ido2,I23O2_MOUSE,4.9,,IC50,Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1502,,,,,,,Mus musculus
184831,2054,2752,Potassium-transporting ATPase,Transporter,P20648|P51164,ATP4A|ATP4B,ATP4A_HUMAN|ATP4B_HUMAN,,,,Mechanism of Action; CHEMBL2095173; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1502,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1502,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
184832,563,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL528,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL528,INHIBITOR,,,,,Escherichia coli (strain K12)
184833,2563,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.49,,Ki,Binding affinity to 5-hydroxytryptamine 1A receptor was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274047,,,,Tclin,,,Homo sapiens
184834,2563,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.55,,Ki,Binding affinity for DA2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274047,,,,Tclin,,,Homo sapiens
184835,2563,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.14,,Ki,Binding affinity to Dopamine receptor D4 was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274047,,,,Tchem,,,Homo sapiens
184836,2337,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,6.17,,Ki,Binding affinity to rat NET,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,,,,,Rattus norvegicus
184837,2337,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.25,,Ki,Binding affinity towards human M1 receptor.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,,Tclin,,,Homo sapiens
184838,2337,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.85,,Ki,Binding affinity to human cloned 5HT6 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,,Tchem,,,Homo sapiens
184839,2337,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.41,,Ki,Binding affinity against dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,,Tclin,,,Homo sapiens
184840,2337,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.8,,Ki,Binding affinity towards human dopamine-4.2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,ANTAGONIST,,Tchem,,,Homo sapiens
184841,2337,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.49,,Ki,Binding affinity to human cloned dopamine D3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,ANTAGONIST,,Tclin,,,Homo sapiens
184842,2337,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.64,,Ki,Displacement of [3H]8OH-DPAT from 5HT1A in rat brain cerebral cortex after 15 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,,,,,Rattus norvegicus
184843,2337,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.24,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,,Tclin,,,Homo sapiens
184844,2337,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,7.4,,IC50,Displacement of [3H]mepyramine from H1R in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,,,,,Rattus norvegicus
184845,2337,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.74,,Ki,Displacement of [3H]spiperone from dopamine D2 receptor in rat striatum tissue after 20 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,,,,,Rattus norvegicus
184846,2337,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,6.66,,Ki,Displacement of [3H]ketanserin from 5HT2A in rat brain cerebral cortex after 20 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,,,,,Rattus norvegicus
184847,396,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,9.9,,Ki,Inhibition of human recombinant carbonic anhydrase 2 by dansylamide (DNSA) competition assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,INHIBITOR,,Tclin,,,Homo sapiens
184848,396,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,8,,Ki,Inhibition of mouse full length carbonic anhydrase 13 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Mus musculus
184849,396,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,8.52,,Ki,Inhibitory activity against catalytic domain of human carbonic anhydrase XII,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,Tclin,,,Homo sapiens
184850,396,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.4,,Ki,Inhibition of human full length carbonic anhydrase 4 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,Tclin,,,Homo sapiens
184851,396,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,7.96,,Ki,Inhibition of human carbonic anhydrase13 preincubated for 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,Tclin,,,Homo sapiens
184852,396,2285,Alpha carbonic anhydrase,Unclassified,B5SU02,CA,B5SU02_9CNID,7.32,,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Stylophora pistillata
184853,396,2143,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878,,P96878_MYCTU,6.7,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase Rv3273 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184854,396,2472,Astrosclerin-3,Unclassified,A6YCJ1,,A6YCJ1_9METZ,6.56,,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Astrosclera willeyana
184855,396,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,6.08,,Ki,Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184856,396,2405,Carbonic anhydrase,Unclassified,C0IX24,CA2,C0IX24_9CNID,6.77,,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Stylophora pistillata
215593,2723,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.670195478,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
184857,396,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,6.93,,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Thalassiosira weissflogii
184858,396,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,7.3,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,Tclin,,,Homo sapiens
184859,396,2093,Carbonic anhydrase,Enzyme,P53615,NCE103,CAN_YEAST,6.94,,Ki,Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
184860,396,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,7.62,,Ki,Inhibitory constant against human carbonic anhydrase XIV in CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,Tclin,,,Homo sapiens
184861,396,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,8.55,,Ki,Ki value against human carbonic anhydrase VII,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,Tclin,,,Homo sapiens
184862,396,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.44,,Ki,Inhibition of human carbonic anhydrase9 preincubated for 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,Tclin,,,Homo sapiens
184863,396,401,Carbonic anhydrase,Enzyme,O24855,cynT,CYNT_HELPY,6.68,,Ki,Inhibition of Helicobacter pylori recombinant carbonic anhydrase by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
184864,396,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.21,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Mus musculus
184865,396,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,8.52,,Ki,Compound was evaluated for binding affinity against human carbonic anhydrase II (hCA -II),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,Tclin,,,Homo sapiens
184866,396,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,7.52,,Ki,Inhibitory activity against human recombinant mitochondrial isozyme CA VB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,Tclin,,,Homo sapiens
184867,396,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,8.52,,Ki,Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
184868,396,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,6.9,,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
184869,396,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,9.05,,Ki,Inhibition of full length human recombinant CA VI,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,Tclin,,,Homo sapiens
184870,396,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,7.35,,Ki,Inhibitory activity against Carbonic anhydrase IV isolated from bovine lung,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Bos taurus
184871,1870,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.82,,Ki,Displacement of [3H]ketanserin from 5HT2A receptor expressed in HEK293 cells by liquid scintillation spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1439099,,,,Tclin,,,Homo sapiens
184872,391,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,4.89,,Ki,Inhibitory activity against thrombin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,,,,Tclin,,,Homo sapiens
184873,391,732,Cathepsin G,Enzyme,P08311,CTSG,CATG_HUMAN,6.2,,Ki,Inhibitory activity against human cathepsin G,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,,,,Tchem,,,Homo sapiens
184874,391,2041,Lysosomal protective protein,Enzyme,P10619,CTSA,PPGB_HUMAN,5.04,,IC50,Inhibition of recombinant cathepsin A (unknown origin) using Mca-Arg-Pro-Pro-Gly-Phe-Ser-Ala-Phe-Lys(Dnp)-OH as substrate incubated with enzyme for 5 mins prior to substrate challenge for 2 hrs by spectrofluorometer analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,,,,Tchem,,,Homo sapiens
184875,391,3595,Alpha-chymotrypsin,Unclassified,P00766,,CTRA_BOVIN,5.62,,Ki,Inhibition of bovine pancreatic alpha-chymotrypsin using Suc-Leu-Leu-Val-Tyr-AMC as substrate by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,,,,,,,Bos taurus
184876,391,756,Chymase,Enzyme,P23946,CMA1,CMA1_HUMAN,5.92,,IC50,Inhibition of human chymase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,,,,Tchem,,,Homo sapiens
184877,391,881,Chymotrypsinogen B,Enzyme,P17538,CTRB1,CTRB1_HUMAN,6.49,,Ki,Inhibitory activity against human Chymotrypsinogen,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,,,,Tchem,,,Homo sapiens
184878,391,2482,Proteasome subunit beta type-1,Enzyme,P20618,PSMB1,PSB1_HUMAN,7.28,,IC50,Reversible inhibition of human erythrocyte derived 20S proteasome subunit beta1 after 30 mins by fluorogenic assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,INHIBITOR,,Tclin,,,Homo sapiens
184879,391,2484,Proteasome subunit beta type-5,Enzyme,P28074,PSMB5,PSB5_HUMAN,9.26,,Ki,Inhibition of 20S proteasome beta5 subunit (unknown origin) assessed as formation of reversible adduct with N-terminal threonine,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,INHIBITOR,,Tclin,,,Homo sapiens
184880,391,2483,Proteasome subunit beta type-2,Enzyme,P49721,PSMB2,PSB2_HUMAN,6.23,,IC50,Reversible inhibition of human erythrocyte derived 20S proteasome subunit beta2 after 30 mins by fluorogenic assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,INHIBITOR,,Tclin,,,Homo sapiens
184881,391,3473,Nuclear factor NF-kappa-B complex,Unclassified,P19838|Q00653|Q04206,NFKB1|NFKB2|RELA,NFKB1_HUMAN|NFKB2_HUMAN|TF65_HUMAN,8.01,,IC50,Inhibition of NFkappaB in HEK293 cells incubated for 1 hr prior to TNF-alpha challenge measured after 3 hrs by luciferase reporter gene assay relative to control,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,,,,Tchem|Tchem|Tchem,,,Homo sapiens
215594,623,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.657577319,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
184882,391,928,Proteasome subunit beta type-8,Enzyme,P28062,PSMB8,PSB8_HUMAN,8.09,,IC50,Inhibition of chymotrypsin-like activity of LMP7 immunoproteasome by proteasome active site ELISA,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,INHIBITOR,,Tclin,,,Homo sapiens
184883,391,663,Neutrophil elastase,Enzyme,P08246,ELANE,ELNE_HUMAN,5.64,,Ki,Inhibitory activity against human leukocyte elastase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL325041,,,,Tclin,,,Homo sapiens
184884,1142,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.43,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184885,1142,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,5.3,,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480,,,,Tclin,,,Homo sapiens
184887,2656,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1449,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1449,INHIBITOR,,,,,Escherichia coli (strain K12)
184888,1412,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL533,,BLOCKER,,Tclin,,,Homo sapiens
184889,437,1801,D(1A) dopamine receptor,GPCR,Q95136,DRD1,DRD1_BOVIN,5.21,,Ki,Inhibition of [3H]SCH-23390 binding to Dopamine receptor D1 of bovine striatum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Bos taurus
184890,437,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.92,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,Tchem,,,Homo sapiens
184891,437,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,6.86,,Ki,The compound was tested for its binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]WB-4101 radioligand in rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Rattus norvegicus
184892,437,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,7.36,,Ki,Inhibition of [3H]raclopride binding to Dopamine receptor D2 of bovine striatum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Bos taurus
184893,437,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,6.76,,Ki,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [3H]ketanserin radioligand in rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Rattus norvegicus
184894,437,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,6.92,,IC50,Inhibition of [3H]spiperone binding to dopamine receptor from rat corpus striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Rattus norvegicus
184895,437,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5,,IC50,Binding affinity against Alpha-2 adrenergic receptor in rat brain membrane using [3H]yohimbine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Rattus norvegicus
184896,437,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,4.8,,IC50,Binding affinity against alpha-1 adrenergic receptor in calf frontal cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Bos taurus
184897,437,1868,Alpha-2A adrenergic receptor,GPCR,Q28838,ADRA2A,ADA2A_BOVIN,5,,IC50,Binding affinity against alpha-2 adrenergic receptor in calf frontal cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Bos taurus
184898,437,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.18,,Ki,Inhibition of [3H]spiperone binding to Dopamine receptor D3 in bovine cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,Tclin,,,Homo sapiens
184899,437,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,7.02,,IC50,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]5-HT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Rattus norvegicus
184900,437,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,7.77,,Ki,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Rattus norvegicus
184901,437,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.42,,Ki,Displacement of [3H]8-OH-DPAT from 5HT1A receptor in rat hippocampal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Rattus norvegicus
184902,437,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.4,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,Tclin,,,Homo sapiens
184903,437,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,7.32,,Ki,Inhibition of [3H]DTG binding to sigma receptor in rat hippocampus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Rattus norvegicus
184904,437,1954,5-hydroxytryptamine receptor 2A,GPCR,Q75Z89,HTR2A,5HT2A_BOVIN,6.75,,Ki,Binding affinity against 5-hydroxytryptamine 2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Bos taurus
184905,437,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.92,,Ki,In vitro ability to inhibit [3H]spiperone binding to dopamine receptor D2 of rat limbic structures,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Rattus norvegicus
184906,437,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.34,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,Tchem,,,Homo sapiens
184979,1045,2332,G protein-coupled receptor kinase 4,Kinase,P32298,GRK4,GRK4_HUMAN,5.14,,Kd,Binding constant for GRK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184907,437,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.77,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,Tchem,,,Homo sapiens
184908,437,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,6,,IC50,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Rattus norvegicus
184909,437,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,6.32,,Ki,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49,,,,,,,Rattus norvegicus
184910,2491,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,10.7,,Ki,In vitro affinity to displace [3H]naloxone from opiate receptor in freshly prepared rat brain homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL658,,,,,,,Rattus norvegicus
184911,2491,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,9.66,,Ki,Ability to displace [3H]naloxone from the Opioid receptor mu 1 isolated from the rat brain membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL658,,,,,,,Rattus norvegicus
184912,1712,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.5,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088,,,,Tclin,,,Homo sapiens
184913,3584,2000,Alpha-1B adrenergic receptor,GPCR,P18841,ADRA1B,ADA1B_MESAU,9.16,,Ki,In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1b expressed in LTK cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611,,,,,,,Mesocricetus auratus
184914,3584,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.63,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611,,,,Tchem,,,Homo sapiens
184915,3584,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,7.59,,Ki,Binding affinity against Alpha-1A adrenergic receptor from bovine clone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611,,,,,,,Bos taurus
184916,3584,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,9.09,,Ki,In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611,,,,,,,Rattus norvegicus
184917,3584,1733,Alpha-2B adrenergic receptor,GPCR,P19328,Adra2b,ADA2B_RAT,8.11,,Ki,Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611,,,,,,,Rattus norvegicus
184918,3584,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.75,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611,,,,Tclin,,,Homo sapiens
184919,3584,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,9,,Ki,In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1d expressed in LTK cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611,,,,,,,Rattus norvegicus
184920,3584,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.72,,Ki,Compound was evaluated for its ability to displace [125I]HEAT binding from rat Alpha-1B adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL611,,,,,,,Rattus norvegicus
184921,2675,425,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,6.3,,Ki,In vitro inhibition of human Cytochrome P450 17A1 activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200438,,,,Tclin,,,Homo sapiens
184922,2675,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,Mechanism of Action; CHEMBL1780; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200438,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200438,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
184923,1895,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,9.8,,Ki,Binding affinity to rat Dopamine receptor D3 expressed in CHO cells was determined using [125 I] iodosulpride as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20734,,,,,,,Rattus norvegicus
184924,1895,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,9.68,,Kd,Binding Affinity to Human Dopamine receptor D4 expressed in CHO cells was determined using [3H]- nemonapride as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20734,,,,Tchem,,,Homo sapiens
184925,1895,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.27,,IC50,Binding affinity to the alpha-1 adrenergic receptor using a radioligand [3H]prazosin binding assay in rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20734,,,,,,,Rattus norvegicus
184926,1895,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,9.8,,Ki,Binding affinity to rat Dopamine receptor D2 expressed in CHO cells was determined using [125 I ] iodosulpride as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20734,,,,,,,Rattus norvegicus
184927,1895,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,7.31,,IC50,Binding affinity to serotonin 5-hydroxytryptamine 2A receptors using a radioligand [3H]ketanserin binding assay in rat cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20734,,,,,,,Rattus norvegicus
184928,1942,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.59,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726,,,,Tclin|Tclin|Tclin,,,Homo sapiens
184929,2873,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,7.54,,IC50,Binding affinity against central benzodiazepine receptor(CBR).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135400,,,,,,,Rattus norvegicus
184980,1045,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,5.24,,Kd,Binding constant for VEGFR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
184930,1068,306,Gamma-aminobutyric acid receptor subunit alpha-4,Ion channel,P48169,GABRA4,GBRA4_HUMAN,6.99,,Ki,Displacement of [3H]Ro-154513 from benzodiazepine binding site of GABAA alpha-4-beta-2-gamma-2 receptor expressed in HEK293T cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,POSITIVE ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
184931,1068,77,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,6.94,,Ki,Displacement of [3H]Ro-151788 from benzodiazepine binding site of GABAA alpha-2-beta-2-gamma-2 receptor expressed in HEK293T cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,POSITIVE ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
184932,581,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,4.05,,Kd,Binding affinity to human recombinant Tie2 by SPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1000,,,,Tclin,,,Homo sapiens
184933,581,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.52,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1000,,,,Tclin,,,Homo sapiens
184934,2553,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,8,,Ki,Inhibition of human phosphodiesterase 5,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL779,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL779,INHIBITOR,,Tclin,,,Homo sapiens
184935,2553,1913,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O54735,Pde5a,PDE5A_RAT,8.3,,Ki,Inhibition of phosphodiesterase 5 in rat fetal lung fibroblast (RFL-6) cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL779,,,,,,,Rattus norvegicus
184936,2553,2299,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",Enzyme,P11541,PDE6A,PDE6A_BOVIN,5.52,,IC50,Inhibition of bovine retina PDE6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL779,,,,,,,Bos taurus
184937,2553,2878,Phosphodiesterase 6,Enzyme,O43924|P16499|P18545|P35913|P51160|Q13956,PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H,CNCG_HUMAN|CNRG_HUMAN|PDE6A_HUMAN|PDE6B_HUMAN|PDE6C_HUMAN|PDE6D_HUMAN,6.01,,IC50,Inhibition of human phosphodiesterase 6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL779,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
184938,2553,2906,Phosphodiesterase 6,Enzyme,P04972|P11541|P16586|P22571|P23439|Q95142,PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H,CNCG_BOVIN|CNRG_BOVIN|PDE6A_BOVIN|PDE6B_BOVIN|PDE6C_BOVIN|PDE6D_BOVIN,5.29,,IC50,Inhibition of bovine retina PDE6 (Phosphodiesterase 6),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL779,,,,,,,Bos taurus
184939,2553,1926,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,Q28156,PDE5A,PDE5A_BOVIN,8.48,,IC50,Inhibition of bovine PDE5 after 24 hrs by HTRF,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL779,,,,,,,Bos taurus
184940,2553,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4,,IC50,Inhibition of human ERG channel in HEK293 cells by voltage-clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL779,,,,Tclin,,,Homo sapiens
184941,2553,418,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,Q9HCR9,PDE11A,PDE11_HUMAN,7.48,,IC50,Inhibition of human phosphodiesterase 11,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL779,,,,Tchem,,,Homo sapiens
184942,115,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,7.64,,Ki,Binding affinity against Alpha-1A adrenergic receptor from bovine clone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL709,,,,,,,Bos taurus
184943,115,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.44,,Ki,"Binding affinity against Alpha-1D adrenergic receptor, from human clones.",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL709,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL709,ANTAGONIST,,Tclin,,,Homo sapiens
184944,115,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.09,,Ki,Binding affinity against Alpha-1A adrenergic receptor from human clone,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL709,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL709,ANTAGONIST,,Tclin,,,Homo sapiens
184945,115,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,8.55,,Ki,Binding affinity against Alpha-1B adrenergic receptor from human clone,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL709,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL709,ANTAGONIST,,Tclin,,,Homo sapiens
184946,115,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,8.46,,Ki,"Binding affinity against Alpha-1D adrenergic receptor, from rat clones.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL709,,,,,,,Rattus norvegicus
184947,1363,3474,Penicillin-binding protein,Enzyme,Q54618|Q75Y37|Q75Y54|Q75YD8|Q75YK0|Q9RET4,PBP2X|pbp1a|pbp1b|pbp2a|pbp2b|pbp3,Q54618_STREE|Q75Y37_STREE|Q75Y54_STREE|Q75YD8_STREE|Q75YK0_STREE|Q9RET4_STREE,,,,Mechanism of Action; CHEMBL2362973; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201116,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201116,INHIBITOR,,,,,Streptococcus pneumoniae
184948,761,520,Glutamate receptor 2,Ion channel,P42262,GRIA2,GRIA2_HUMAN,5.65,,EC50,Activity at human recombinant GluA2 receptor flip isoform expressed in HEK293 cells assessed as effect on glutamate-induced calcium flux by Fluo-4/AM staining-based fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61593,,,,Tclin,,,Homo sapiens
184949,761,2785,"Glutamate receptor ionotropic, AMPA",Ion channel,P19490|P19491|P19492|P19493,Gria1|Gria2|Gria3|Gria4,GRIA1_RAT|GRIA2_RAT|GRIA3_RAT|GRIA4_RAT,5.21,,IC50,Inhibition of binding to AMPA receptor from rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61593,,,,,,,Rattus norvegicus
184950,761,408,Glutamate receptor 1,Ion channel,P42261,GRIA1,GRIA1_HUMAN,5.7,,EC50,Activity at recombinant GluA1 receptor flip isoform expressed in Xenopus oocytes co-expressing gamma2-TARP assessed as effect on 10 uM glutamate-induced current by voltage-clamp electrophysiological assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61593,,,,Tclin,,,Homo sapiens
184951,761,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,,,,Mechanism of Action; CHEMBL1876; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61593,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61593,INHIBITOR,,Tclin,,,Homo sapiens
184952,2362,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,6.54,,Ki,Receptor binding affinity for the adenosine A2A receptor was determined using [3H]ZM-241385 as a radioligand in rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL317052,,,,,,,Rattus norvegicus
215595,4115,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,7.643974143,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
184954,1175,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,,,,Mechanism of Action; CHEMBL2093863; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1493,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1493,INHIBITOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
184955,1175,2877,Phosphodiesterase 7,Enzyme,Q13946|Q9NP56,PDE7A|PDE7B,PDE7A_HUMAN|PDE7B_HUMAN,,,,Mechanism of Action; CHEMBL2111411; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1493,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1493,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
184956,1175,3475,Phosphodiesterase 8,Enzyme,O60658|O95263,PDE8A|PDE8B,PDE8A_HUMAN|PDE8B_HUMAN,,,,Mechanism of Action; CHEMBL2363067; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1493,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1493,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
184957,3883,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.96,,Ki,Ability to compete with [3H]YM-09151-2 binding to the human dopamine receptor D3 transfected in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL136711,,,,Tclin,,,Homo sapiens
184958,2466,2749,Topoisomerase IV,Enzyme,P0AFI2|P20083,parC|parE,PARC_ECOLI|PARE_ECOLI,,,,Mechanism of Action; CHEMBL2363076; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL850,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL850,INHIBITOR,,,,,Escherichia coli (strain K12)
184959,2466,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,,,,Mechanism of Action; CHEMBL2311224; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL850,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL850,INHIBITOR,,,,,Escherichia coli (strain K12)
184960,824,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.25,,Ki,Displacement of [3H]-methyltrienolone from human progesterone receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
184961,824,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,5.85,,Ki,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
184962,824,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,4.66,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Rattus norvegicus
184963,824,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,7.66,,IC50,Displacement of [3H]dexamethasone from Sprague-Dawley rat GR by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Rattus norvegicus
184964,1873,1824,Beta-2 adrenergic receptor,GPCR,P54833,ADRB2,ADRB2_CANFA,6,,Ki,Beta-2 adrenergic receptor binding affinity by measuring the displacement of [3H]DHA binding in rat lung,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL142635,,,,,,,Canis familiaris
184965,1873,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,7.41,,Ki,Alpha-1 adrenergic receptor binding affinity by measuring the displacement of [3H]prazosin binding in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL142635,,,,,,,Rattus norvegicus
184966,1873,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.8,,Ki,Alpha-2 adrenergic receptor binding affinity by measuring the displacement of [3H]clonidine binding in rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL142635,,,,,,,Rattus norvegicus
184967,2776,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,,,,Mechanism of Action; CHEMBL211; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1888176,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1888176,ANTAGONIST,,Tclin,,,Homo sapiens
184968,2677,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,9.8,,Ki,Displacement of [3H]-NMS from Sprague-Dawley rat muscarinic M1 receptor in cortex membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1182657,,,,,,,Rattus norvegicus
184969,2677,1845,Muscarinic acetylcholine receptor M3,GPCR,P08483,Chrm3,ACM3_RAT,9.52,,Ki,Displacement of [3H]-NMS from Sprague-Dawley rat muscarinic M3 receptor in submandibular gland,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1182657,,,,,,,Rattus norvegicus
184970,2677,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,9.82,,Ki,Displacement of [3H]-NMS from Sprague-Dawley rat muscarinic M2 receptor in heart,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1182657,,,,,,,Rattus norvegicus
184971,2797,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,,,,Mechanism of Action; CHEMBL2047; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1551,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1551,AGONIST,,Tclin,,,Homo sapiens
184972,1045,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,5.37,,Kd,Binding constant for JNK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184973,1045,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,6.89,,Kd,Binding constant for FLT3(D835Y) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
184974,1045,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,7.24,,Kd,Binding constant for ABL1(H396P)-phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
184975,1045,2268,Tubulin alpha-1A chain,Structural,P68370,Tuba1a,TBA1A_RAT,6.64,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,,,,Rattus norvegicus
184976,1045,2209,Serine/threonine-protein kinase MRCK gamma,Kinase,Q6DT37,CDC42BPG,MRCKG_HUMAN,5.47,,Kd,Binding constant for DMPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tbio,,,Homo sapiens
184977,1045,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,5.36,,Kd,Binding constant for FLT1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
184978,1045,905,Mitogen-activated protein kinase 9,Kinase,P45984,MAPK9,MK09_HUMAN,5.7,,Kd,Binding constant for JNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185180,2544,2251,Myosin-IIIb,Kinase,Q8WXR4,MYO3B,MYO3B_HUMAN,5.35,,Kd,Binding constant for MYO3B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tdark,,,Homo sapiens
184982,1045,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,5.6,,Kd,Binding constant for MAP3K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184983,1045,2357,Serine/threonine-protein kinase ULK3,Kinase,Q6PHR2,ULK3,ULK3_HUMAN,6.04,,Kd,Binding constant for ULK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184984,1045,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,6.7,,Kd,Binding constant for ABL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184985,1045,2328,Dual specificity tyrosine-phosphorylation-regulated kinase 2,Kinase,Q92630,DYRK2,DYRK2_HUMAN,5.89,,Kd,Binding constant for DYRK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184986,1045,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,5.74,,Kd,Binding constant for PDGFRA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
184987,1045,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,6.72,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184988,1045,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,5.96,,Kd,Binding constant for MET(Y1235D) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
184989,1045,837,Casein kinase I isoform epsilon,Kinase,P49674,CSNK1E,KC1E_HUMAN,6.3,,Kd,Binding constant for CSNK1E kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184990,1045,2368,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,5.96,,Kd,Binding constant for ERBB3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184991,1045,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,5.77,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184992,1045,887,Receptor-interacting serine/threonine-protein kinase 2,Kinase,O43353,RIPK2,RIPK2_HUMAN,6.39,,Kd,Average Binding Constant for RIPK2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184993,1045,922,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,5.66,,Kd,Binding constant for EPHB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184994,1045,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,5.43,,Kd,Binding constant for JAK2(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
184995,1045,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,5.59,,Kd,Binding constant for SIK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184996,1045,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,8.51,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184997,1045,2447,Serine/threonine-protein kinase SBK1,Kinase,Q52WX2,SBK1,SBK1_HUMAN,5.92,,Kd,Binding constant for SBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tdark,,,Homo sapiens
184998,1045,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,5.66,,Kd,Binding constant for AURKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
184999,1045,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,7.02,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185000,1045,2172,Casein kinase I isoform delta,Kinase,P48730,CSNK1D,KC1D_HUMAN,5.46,,Kd,Binding constant for full-length CSNK1D,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185001,1045,2276,"Interferon-induced, double-stranded RNA-activated protein kinase",Kinase,P19525,EIF2AK2,E2AK2_HUMAN,5.89,,Kd,Binding constant for PRKR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tbio,,,Homo sapiens
185002,1045,2270,Mitogen-activated protein kinase 4,Kinase,P31152,MAPK4,MK04_HUMAN,5.6,,Kd,Binding constant for ERK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tbio,,,Homo sapiens
185003,1045,2318,Serine/threonine-protein kinase TBK1,Kinase,Q9UHD2,TBK1,TBK1_HUMAN,5.51,,Kd,Binding constant for TBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185004,1045,543,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,5.68,,Kd,Binding constant for FLT4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185005,1045,2257,AarF domain-containing protein kinase 4,Kinase,Q96D53,COQ8B,COQ8B_HUMAN,5.6,,Kd,Binding constant for full-length ADCK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tbio,,,Homo sapiens
185006,1045,2188,MAP kinase-interacting serine/threonine-protein kinase 1,Kinase,Q9BUB5,MKNK1,MKNK1_HUMAN,6.16,,Kd,Binding constant for full-length MKNK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185007,1045,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,5.96,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185008,1045,623,Death-associated protein kinase 3,Kinase,O43293,DAPK3,DAPK3_HUMAN,5.22,,Kd,Binding constant for DAPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185009,1045,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,5.7,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185010,1045,736,Ephrin type-A receptor 8,Kinase,P29322,EPHA8,EPHA8_HUMAN,6.03,,Kd,Binding constant for EPHA8 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185011,1045,796,Dual specificity protein kinase TTK,Kinase,P33981,TTK,TTK_HUMAN,5.43,,Kd,Binding constant for TTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185012,1045,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,6.07,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185016,1045,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,5.72,,Kd,Binding constant for PLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185017,1045,741,AP2-associated protein kinase 1,Kinase,Q2M2I8,AAK1,AAK1_HUMAN,5.92,,Kd,Binding constant for AAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185018,1045,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,6.15,,Kd,Binding constant for JAK3(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185019,1045,2192,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,Q9P2K8,EIF2AK4,E2AK4_HUMAN,5.36,,Kd,"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185020,1045,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.48,,Kd,Binding constant for RET(M918T) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185021,1045,2206,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,5.54,,Kd,Binding constant for DMPK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185022,1045,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,6.1,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185023,1045,2082,Tyrosine-protein kinase receptor TYRO3,Kinase,Q06418,TYRO3,TYRO3_HUMAN,5.41,,Kd,Binding constant for TYRO3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185024,1045,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,5.66,,Kd,Binding constant for YES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185025,1045,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,6.6,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185026,1045,723,"Myosin light chain kinase 2, skeletal/cardiac muscle",Kinase,Q9H1R3,MYLK2,MYLK2_HUMAN,6.01,,Kd,Binding constant for MYLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tbio,,,Homo sapiens
185027,1045,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,6.05,,Kd,Binding constant for LTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185028,1045,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,7.6,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185029,1045,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,5.02,,Kd,Binding constant for CSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185030,1045,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,5.4,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185031,1045,2202,Serine/threonine-protein kinase TNNI3K,Kinase,Q59H18,TNNI3K,TNI3K_HUMAN,6.24,,Kd,Binding constant for full-length TNNI3K,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185032,1045,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.54,,Kd,Binding constant for ERBB2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185033,1045,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,5.74,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185034,1045,792,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.22,,Kd,Binding constant for full-length AURKC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185035,1045,2350,SRSF protein kinase 3,Kinase,Q9UPE1,SRPK3,SRPK3_HUMAN,5.08,,Kd,Binding constant for SRPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185036,1045,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,5.42,,Kd,Binding constant for TXK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185037,1045,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,5.85,,Kd,Binding constant for PDGFRB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185038,1045,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,5.72,,Kd,Average Binding Constant for FGFR2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185039,1045,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,5.92,,Kd,Binding constant for ALK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185040,1045,2245,Citron Rho-interacting kinase,Kinase,O14578,CIT,CTRO_HUMAN,6.17,,Kd,Binding constant for CIT kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tbio,,,Homo sapiens
185041,1045,2336,Homeodomain-interacting protein kinase 4,Kinase,Q8NE63,HIPK4,HIPK4_HUMAN,6.02,,Kd,Binding constant for HIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185042,1045,2207,"Chaperone activity of bc1 complex-like, mitochondrial",Kinase,Q8NI60,COQ8A,COQ8A_HUMAN,5.72,,Kd,Binding constant for ADCK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tbio,,,Homo sapiens
185043,1045,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,5.64,,Kd,Binding constant for MAP3K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185044,1045,2023,Serine/threonine-protein kinase ULK3,Kinase,Q3U3Q1,Ulk3,ULK3_MOUSE,6.2,,Kd,Average Binding Constant for ULK3 m; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,,,,Mus musculus
185045,1045,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,5.89,,Kd,Binding constant for MINK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185046,1045,2464,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,5.54,,Kd,Binding constant for LRRK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185047,1045,2460,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,Kinase,Q8TBX8,PIP4K2C,PI42C_HUMAN,6,,Kd,Binding constant for PIP5K2C kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tbio,,,Homo sapiens
185048,1045,852,Serine/threonine-protein kinase 36,Kinase,Q9NRP7,STK36,STK36_HUMAN,5.36,,Kd,Binding constant for STK36 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tbio,,,Homo sapiens
185049,1045,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,5.89,,Kd,"Binding constant for KIT(V559D,T670I) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185050,1045,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,6.64,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185051,1045,855,BMP-2-inducible protein kinase,Kinase,Q9NSY1,BMP2K,BMP2K_HUMAN,5.92,,Kd,Binding constant for BIKE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185052,1045,822,Serine/threonine-protein kinase 17A,Kinase,Q9UEE5,STK17A,ST17A_HUMAN,5.2,,Kd,Binding constant for DRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185053,1045,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,6.36,,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185054,1045,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,5.35,,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185055,1045,721,Calcium/calmodulin-dependent protein kinase type II subunit delta,Kinase,Q13557,CAMK2D,KCC2D_HUMAN,5.19,,Kd,Binding constant for CAMK2D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185056,1045,2284,Ribosomal protein S6 kinase alpha-4,Kinase,O75676,RPS6KA4,KS6A4_HUMAN,5.15,,Kd,Binding constant for RPS6KA4(Kin.Dom.2 - N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185057,1045,2221,Aurora kinase B,Kinase,Q96GD4,AURKB,AURKB_HUMAN,5.85,,Kd,Binding constant for AURKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185058,1045,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,7.59,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185059,1045,903,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,Q9HBH9,MKNK2,MKNK2_HUMAN,6,,Kd,Binding constant for MKNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185060,1045,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,5.62,,Kd,Binding constant for TYK2(JH2domain-pseudokinase) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185061,1045,898,Ephrin type-A receptor 7,Kinase,Q15375,EPHA7,EPHA7_HUMAN,5.85,,Kd,Binding constant for EPHA7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185062,1045,2362,Receptor-interacting serine/threonine-protein kinase 4,Kinase,P57078,RIPK4,RIPK4_HUMAN,5.31,,Kd,Binding constant for RIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185063,1045,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.28,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tclin,,,Homo sapiens
185064,1045,802,Ephrin type-A receptor 5,Kinase,P54756,EPHA5,EPHA5_HUMAN,6.15,,Kd,Binding constant for EPHA5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185065,1045,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,6.01,,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185066,1045,890,Ephrin type-B receptor 1,Kinase,P54762,EPHB1,EPHB1_HUMAN,5.96,,Kd,Binding constant for EPHB1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185067,1045,2136,Non-receptor tyrosine-protein kinase TNK1,Kinase,Q13470,TNK1,TNK1_HUMAN,6.2,,Kd,Binding constant for full-length TNK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL553,,,,Tchem,,,Homo sapiens
185068,203,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,5.3,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL43,,,,Tchem,,,Homo sapiens
185069,203,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,5,,IC50,Inhibition of human DNA topoisomerase 2-mediated Crithidia fasciculata kDNA decatenation using ethidium bromide staining by agarose gel electrophoresis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL43,,,,Tclin,,,Homo sapiens
185070,203,820,DNA topoisomerase 2-beta,Enzyme,Q02880,TOP2B,TOP2B_HUMAN,4.96,,EC50,Inhibition of calf thymus DNA/ethidium bromide complex formation.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL43,,,,Tchem,,,Homo sapiens
185071,203,2848,DNA topoisomerase II,Enzyme,P11388|Q02880,TOP2A|TOP2B,TOP2A_HUMAN|TOP2B_HUMAN,6.14,,EC50,Tested for inhibition of topoisomerase II isolated from HeLa cells by DNA-cleavage assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL43,,,,Tchem|Tclin,,,Homo sapiens
185072,203,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.68,,IC50,Inhibition of human ERG potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL43,,,,Tclin,,,Homo sapiens
185073,409,305,Platelet-activating factor receptor,GPCR,P25105,PTAFR,PTAFR_HUMAN,6.52,,IC50,In vitro for platelet activating factor receptor antagonist activity in a binding assay using washed whole dog platelets.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32479,,,,Tchem,,,Homo sapiens
185074,4111,2749,Topoisomerase IV,Enzyme,P0AFI2|P20083,parC|parE,PARC_ECOLI|PARE_ECOLI,,,,Mechanism of Action; CHEMBL2363076; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201760,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201760,INHIBITOR,,,,,Escherichia coli (strain K12)
185075,4111,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,,,,Mechanism of Action; CHEMBL2311224; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201760,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201760,INHIBITOR,,,,,Escherichia coli (strain K12)
185076,533,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL927,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL927,INHIBITOR,,,,,Escherichia coli (strain K12)
185077,1524,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,8.57,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,Tchem,,,Homo sapiens
185078,1524,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,7.82,,IC50,Inhibition of [3H]prazosin binding to alpha-1 adrenergic receptor from rat cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,,,,Rattus norvegicus
185079,1524,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,9.4,,Ki,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,,,,Rattus norvegicus
185080,1524,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.55,,Ki,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,Tchem,,,Homo sapiens
185081,1524,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.62,,Ki,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,Tclin,,,Homo sapiens
185082,1524,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.46,,Ki,Binding affinity towards human dopamine receptor D4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,Tchem,,,Homo sapiens
185083,1524,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,5.19,,IC50,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells by [3H]5-HT binding displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,Tclin,,,Homo sapiens
185084,1524,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.7,,Ki,GRAC: human 5-HT2A selective antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,Tclin,,,Homo sapiens
185085,1524,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.59,,IC50,Binding affinity by displacement to human cloned 5-hydroxytryptamine 1D receptor in CHO cells by [3H]5-HT displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,Tclin,,,Homo sapiens
185086,1524,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,9,,IC50,The compound was tested for affinity towards sigma-3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,Tclin,,,Homo sapiens
185087,1524,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.72,,Ki,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,,,,Rattus norvegicus
185088,1524,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.74,,Ki,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,,,,Rattus norvegicus
185089,1524,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.44,,Ki,Inhibitory constant against binding of [125I]- IBZM to rat striatal membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,,,,Rattus norvegicus
185090,1524,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,7.3,,Ki,Binding affinity against 5-hydroxytryptamine 1C receptor in rat using [3H]mesulergine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,,,,Rattus norvegicus
185091,1524,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,9.33,,Ki,Displacement of [3H]ketanserin from 5-HT2A receptor in Sprague-Dawley rat frontal cortex after 15 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51,,,,,,,Rattus norvegicus
185092,2817,877,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",Enzyme,Q13370,PDE3B,PDE3B_HUMAN,4.88,,IC50,Inhibition of human PDE3B by fluorescence microplate reader,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17423,,,,Tclin,,,Homo sapiens
185093,2817,121,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,4.97,,IC50,Inhibition of human PDE3A by fluorescence microplate reader,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17423,,,,Tclin,,,Homo sapiens
185094,2817,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.96,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17423,,,,Tclin,,,Homo sapiens
185095,2817,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,5.21,,IC50,In vivo inhibition of cyclic AMP phosphodiesterase from human platelets,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17423,,,,Tclin|Tclin,,,Homo sapiens
185100,2470,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,7.2,,Ki,Binding affinity towards mouse 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Mus musculus
185101,2470,3600,Dopamine receptor,Unclassified,P30728|P51436|P61168|Q61616|Q8BLD9,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_MOUSE|DRD2_MOUSE|DRD3_MOUSE|DRD4_MOUSE|DRD5_MOUSE,4.46,,IC50,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to Dopamine receptor of mice,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Mus musculus
185102,2470,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,8,,Ki,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185103,2470,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,4.3,,Ki,Displacement of [3H]- QNB binding at the muscarinic-cholinergic binding site of rat brain S1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185104,2470,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.4,,Kd,Binding affinity to 5HT1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,Tclin,,,Homo sapiens
215596,2601,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,7.63,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
185105,2470,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,6.22,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,Tclin|Tclin|Tclin,,,Homo sapiens
185106,2470,2381,Vesicular acetylcholine transporter,Transporter,Q62666,Slc18a3,VACHT_RAT,5.99,,Ki,Displacement of [125I]O-iodo-trans-decalinvesamicol from VAChT in Sprague-Dawley rat cerebral membrane after 1 hr by gamma counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185107,2470,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,4.2,,Ki,Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,Tchem,,,Homo sapiens
185108,2470,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,9.35,,Ki,The compound was tested in vitro for binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [125]I-LSD radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185109,2470,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.8,,Ki,Binding affinity towards human 5-hydroxytryptamine 6 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,Tchem,,,Homo sapiens
185110,2470,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,8.7,,Ki,Displacement of [3H]- spiperone radioligand binding at the dopamine binding site of rat caudate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185111,2470,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,10.22,,Ki,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,CHEMBL,=,1,KEGG DRUG,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,http://www.kegg.jp/entry/D01051,ANTAGONIST,,Tclin,,,Homo sapiens
185112,2470,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.49,,Ki,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,Tclin,,,Homo sapiens
185113,2470,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,9.7,,Ki,Displacement of [3H]Spiperone from human recombinant dopamine D4 receptor expressed in CHOK1 cells after 2 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,Tchem,,,Homo sapiens
185114,2470,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.94,,Ki,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,Tclin,,,Homo sapiens
185115,2470,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.65,,Ki,Displacement of [3H]Ketanserin from human 5HT2A receptor expressed in HEK293 cells,CHEMBL,=,1,KEGG DRUG,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,http://www.kegg.jp/entry/D01051,ANTAGONIST,,Tclin,,,Homo sapiens
185116,2470,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.1,,Ki,Binding constant measured against Alpha-1A adrenergic receptor in human prostate; ++:moderately active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,Tclin,,,Homo sapiens
185117,2470,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.92,,Ki,Displacement of [3H]Spiperone from human recombinant dopamine D3 receptor expressed in CHO cells after 2 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,Tclin,,,Homo sapiens
185118,2470,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.14,,Ki,Overall binding displacement in tissues containing only the Alpha-1A adrenergic receptor from rat submaxillary gland,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185119,2470,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,6.8,,Ki,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185120,2470,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.02,,IC50,The compound was tested for affinity towards sigma-3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,Tclin,,,Homo sapiens
185121,2470,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.32,,Ki,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185122,2470,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,7.52,,Ki,Binding affinity of compound against 5-hydroxytryptamine 1A receptor binding site using radioligand [3H]8-OH-DPAT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185123,2470,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.96,,Ki,Binding affinity towards human 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,Tclin,,,Homo sapiens
185124,2470,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.89,,Ki,"Overall binding displacement in tissues containing only the Alpha-1B adrenergic receptor (rat spleen, rat liver)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185125,2470,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,10.82,,Ki,Competitive binding assay against Dopamine receptor D2 in rat striatal membranes and [125I]-IBF radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185126,2470,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,6,,Ki,Tested for binding affinity against 5-hydroxytryptamine 1C receptor from rat frontal cortical regions using [3H]mesulergine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185127,2470,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,9,,Ki,Displacement of [3H]ketanserin from rat 5HT2A receptor expressed in mouse NIH3T3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
185128,2339,2851,Dopamine receptor,GPCR,P20288|Q95136,DRD1|DRD2,DRD1_BOVIN|DRD2_BOVIN,7.72,,IC50,"In vitro inhibitory activity was evaluated against,[3H]spiperone calf caudate (SPC) dopamine receptor",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290962,,,,,,,Bos taurus
185129,2339,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.22,,IC50,"In vitro inhibitory activity was evaluated against,[3H]WB 4101 whole rat brain alpha 1-adrenoceptor",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290962,,,,,,,Rattus norvegicus
185130,2339,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.25,,IC50,In vitro inhibitory activity against alpha-2 adrenergic receptor from rat brain minus cerebellum using [3H]clonidine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290962,,,,,,,Rattus norvegicus
185131,2339,2846,Serotonin (5-HT) receptor,GPCR,P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Htr1a|Htr1b|Htr1d|Htr1f|Htr2a|Htr2b|Htr2c|Htr3a|Htr3b|Htr4|Htr5a|Htr5b|Htr6|Htr7,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2A_RAT|5HT2B_RAT|5HT2C_RAT|5HT3A_RAT|5HT3B_RAT|5HT4R_RAT|5HT5A_RAT|5HT5B_RAT|5HT6R_RAT|5HT7R_RAT,5.64,,IC50,"In vitro inhibitory activity was evaluated against,[3H]spiperone rat frontal cortex (SPFC) serotonin receptor",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290962,,,,,,,Rattus norvegicus
185132,574,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL617,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL617,INHIBITOR,,,,,Escherichia coli (strain K12)
185133,1059,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,Mechanism of Action; CHEMBL206; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200973,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200973,AGONIST,,Tclin,,,Homo sapiens
185134,1457,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,5.25,,IC50,Inhibition of Sprague-Dawley rat liver COMT after 10 mins using 0.05 uCi [14CH3]-SAM as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86754,,,,,,,Rattus norvegicus
185135,3734,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.89,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL338667,,,,Tclin|Tclin|Tclin,,,Homo sapiens
185136,2495,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,4.85,,IC50,Compound was tested for the inhibition of beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1221,,,,,,,Escherichia coli (strain K12)
185137,2495,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,5.16,,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1221,,,,Tclin,,,Homo sapiens
185138,2495,3464,Malate dehydrogenase cytoplasmic ,Enzyme,P40925,MDH1,MDHC_HUMAN,4.7,,IC50,Inhibition of malate dehydrogenase (MDH),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1221,,,,Tbio,,,Homo sapiens
185139,2495,3596,"Indoleamine 2,3-dioxygenase 1",Enzyme,P28776,Ido1,I23O1_MOUSE,4.53,,IC50,Inhibition of mouse Ido1 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1221,,,,,,,Mus musculus
185140,2495,2492,"Indoleamine 2,3-dioxygenase 2",Enzyme,Q8R0V5,Ido2,I23O2_MOUSE,5,,IC50,Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1221,,,,,,,Mus musculus
185141,2495,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,Mechanism of Action; CHEMBL1780; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1221,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1221,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
185142,2525,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.06,,Ki,Inhibition of human carbonic anhydrase 2 esterase activity by non-competitive Lineweaver-Burke plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL421,,,,Tclin,,,Homo sapiens
185143,2525,354,Cystine/glutamate transporter,Transporter,Q9UPY5,SLC7A11,XCT_HUMAN,4.52,,IC50,Inhibition of xc-cystine-glutamate antiporter-mediated cystine uptake in human U87 cells using L-[14C]cystine as substrate after 15 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL421,,,,Tbio,,,Homo sapiens
185144,2525,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.16,,Ki,Inhibition of human carbonic anhydrase 1 esterase activity by noncompetitive Lineweaver-Burke plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL421,,,,Tclin,,,Homo sapiens
185145,2525,2891,Cyclooxygenase,Enzyme,P23219|P35354,PTGS1|PTGS2,PGH1_HUMAN|PGH2_HUMAN,,,,Mechanism of Action; CHEMBL2094253; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL421,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL421,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
185146,471,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,4.5,,IC50,Concentration required to inhibit enzymatic cleavage of the chromogenic substrate (H-D-Phe-Pip-Arg-pNA) thrombin in vitro.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590799,,,,Tclin,,,Homo sapiens
185147,471,549,Trypsin-1,Enzyme,P07477,PRSS1,TRY1_HUMAN,7.3,,IC50,Concentration required to inhibit enzymatic cleavage of the chromogenic substrate (Boc-Phe-Ser-Arg-AMC) for trypsin in vitro.,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590799,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6432,INHIBITOR,,Tclin,,,Homo sapiens
185148,471,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.78,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590799,,,,Tchem,,,Homo sapiens
185149,471,780,Plasminogen,Enzyme,Q01177,Plg,PLMN_RAT,5.58,,IC50,Concentration required to inhibit enzymatic cleavage of the chromogenic substrate (H-D-Val-Leu-Lys-pNA) for plasmin in vitro.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590799,,,,,,,Rattus norvegicus
185150,471,568,Kallikrein-1,Enzyme,P06870,KLK1,KLK1_HUMAN,5.83,,IC50,Concentration required to inhibit enzymatic cleavage of the chromogenic substrate (H-D-Pro-Phe-Arg-pNA) for plasma kallikrein in vitro.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590799,,,,Tchem,,,Homo sapiens
215583,1732,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.910094889,,Ki,,PDSP,,,,,,INHIBITOR,,Tclin,,,Homo sapiens
185151,471,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.9,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590799,,,,Tchem,,,Homo sapiens
185152,471,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.54,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590799,,,,Tchem,,,Homo sapiens
185153,376,311,NAD(P)H dehydrogenase [quinone] 1,Enzyme,P15559,NQO1,NQO1_HUMAN,4.6,,IC50,Inhibition of human recombinant NQO1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25336,,,,Tchem,,,Homo sapiens
185154,2544,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,5.37,,Kd,Binding constant for JNK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185155,2544,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,6.89,,Kd,Binding constant for full-length MEK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185156,2544,2323,Cyclin-dependent kinase-like 2,Kinase,Q92772,CDKL2,CDKL2_HUMAN,5.96,,Kd,Binding affinity to CDKL2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185157,2544,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,9.66,,Kd,Binding constant for FLT3(K663Q) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,INHIBITOR,,Tclin,,,Homo sapiens
185158,2544,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,7.26,,Kd,Binding constant for ABL1(T315I)-phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185159,2544,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,6.07,,Kd,"Binding constant for EGFR(L858R,T790M) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185160,2544,817,Protein kinase C theta type,Kinase,Q04759,PRKCQ,KPCT_HUMAN,5.37,,Kd,Binding constant for PRKCQ kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185161,2544,2248,Serine/threonine-protein kinase DCLK1,Kinase,O15075,DCLK1,DCLK1_HUMAN,6.43,,Kd,Binding constant for DCAMKL1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185162,2544,2244,"Muscle, skeletal receptor tyrosine-protein kinase",Kinase,O15146,MUSK,MUSK_HUMAN,6.31,,Kd,Binding constant for MUSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185163,2544,2314,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Kinase,P48736,PIK3CG,PK3CG_HUMAN,4.89,,IC50,Inhibition of recombinant PI3Kgamma by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185164,2544,905,Mitogen-activated protein kinase 9,Kinase,P45984,MAPK9,MK09_HUMAN,5.62,,Kd,Binding constant for JNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185165,2544,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,9.7,,Kd,Inhibition of KDR by cellular assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,INHIBITOR,,Tclin,,,Homo sapiens
185166,2544,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.68,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185167,2544,2144,Proto-oncogene tyrosine-protein kinase Src,Kinase,P00523,SRC,SRC_CHICK,6.26,,IC50,Inhibition of chicken wild-type cSRC (251 to 533)-mediated phosphorylation of biotinylated poly-Glu-Tyr expressed in Escherichia coli BL21(DE3) preincubated for 30 to 60 mins prior to substrate addition by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,,,,Gallus gallus
185168,2544,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.54,,Kd,Binding constant for FGFR3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185169,2544,660,Calcium/calmodulin-dependent protein kinase type 1,Kinase,Q14012,CAMK1,KCC1A_HUMAN,6.01,,Kd,Binding constant for full-length CAMK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185170,2544,2364,Serine/threonine-protein kinase 35,Kinase,Q8TDR2,STK35,STK35_HUMAN,5.89,,Kd,Binding affinity to STK35,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185171,2544,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,6.74,,Kd,Average Binding Constant for INSR; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,AGONIST,,Tclin,,,Homo sapiens
185172,2544,2232,Calcium/calmodulin-dependent protein kinase type IV,Kinase,Q16566,CAMK4,KCC4_HUMAN,6.05,,Kd,Binding constant for CAMK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185173,2544,2225,Serine/threonine-protein kinase BRSK1,Kinase,Q8TDC3,BRSK1,BRSK1_HUMAN,5.46,,Kd,Binding constant for BRSK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185174,2544,2281,Fibroblast growth factor receptor 4,Kinase,P22455,FGFR4,FGFR4_HUMAN,5.68,,Kd,Binding constant for FGFR4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185175,2544,2197,SRSF protein kinase 1,Kinase,Q96SB4,SRPK1,SRPK1_HUMAN,6.6,,Kd,Binding constant for full-length SRPK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185176,2544,2328,Dual specificity tyrosine-phosphorylation-regulated kinase 2,Kinase,Q92630,DYRK2,DYRK2_HUMAN,6.17,,Kd,Binding affinity to DYRK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185177,2544,2195,Serine/threonine-protein kinase RIO3,Kinase,O14730,RIOK3,RIOK3_HUMAN,5.42,,Kd,Binding constant for full-length RIOK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185178,2544,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,5.92,,Kd,Binding constant for MET(M1250T) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185179,2544,837,Casein kinase I isoform epsilon,Kinase,P49674,CSNK1E,KC1E_HUMAN,7.89,,Kd,Binding constant for full-length CSNK1E,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185181,2544,2186,Dual specificity mitogen-activated protein kinase kinase 3,Kinase,P46734,MAP2K3,MP2K3_HUMAN,5.77,,Kd,Binding constant for MEK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185182,2544,2159,Serine/threonine-protein kinase PAK 3,Kinase,O75914,PAK3,PAK3_HUMAN,7.8,,Kd,Binding constant for full-length PAK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185183,2544,757,Calcium/calmodulin-dependent protein kinase type II subunit beta,Kinase,Q13554,CAMK2B,KCC2B_HUMAN,5.85,,Kd,Binding constant for CAMK2B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185184,2544,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,6.39,,Kd,Binding constant for JAK2(Kin.Dom.2/JH1 - catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185185,2544,2134,Ribosomal protein S6 kinase alpha-6,Kinase,Q9UK32,RPS6KA6,KS6A6_HUMAN,5.62,,Kd,Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185186,2544,911,MAP/microtubule affinity-regulating kinase 3,Kinase,P27448,MARK3,MARK3_HUMAN,6.39,,Kd,Binding constant for full-length MARK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185187,2544,2283,Ribosomal protein S6 kinase alpha-1,Kinase,Q15418,RPS6KA1,KS6A1_HUMAN,7.02,,Kd,Binding affinity to RPS6KA4(Kin.Dom.1-N-terminal),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185188,2544,2346,Serine/threonine-protein kinase NIM1,Kinase,Q8IY84,NIM1K,NIM1_HUMAN,6.07,,Kd,Binding affinity to NIM1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185189,2544,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,7.7,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185190,2544,2447,Serine/threonine-protein kinase SBK1,Kinase,Q52WX2,SBK1,SBK1_HUMAN,6.7,,Kd,Binding constant for SBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tdark,,,Homo sapiens
185191,2544,2360,Mitogen-activated protein kinase kinase kinase 15,Kinase,Q6ZN16,MAP3K15,M3K15_HUMAN,5.89,,Kd,Binding affinity to MAP3K15,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185192,2544,2344,Microtubule-associated serine/threonine-protein kinase 1,Kinase,Q9Y2H9,MAST1,MAST1_HUMAN,6.7,,Kd,Binding affinity to MAST1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185193,2544,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,5.77,,Kd,Binding constant for AURKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185194,2544,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,7.34,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185195,2544,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,8.05,,Kd,Inhibition of Jak1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185196,2544,2172,Casein kinase I isoform delta,Kinase,P48730,CSNK1D,KC1D_HUMAN,7.82,,Kd,Binding constant for full-length CSNK1D,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185197,2544,1822,Tyrosine-protein kinase ITK/TSK,Kinase,Q08881,ITK,ITK_HUMAN,7.89,,Kd,Binding constant for ITK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185198,2544,2335,Homeodomain-interacting protein kinase 3,Kinase,Q9H422,HIPK3,HIPK3_HUMAN,7.39,,Kd,Binding affinity to HIPK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185199,2544,2334,Homeodomain-interacting protein kinase 2,Kinase,Q9H2X6,HIPK2,HIPK2_HUMAN,7.51,,Kd,Binding affinity to HIPK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185200,2544,2217,Serine/threonine-protein kinase pim-3,Kinase,Q86V86,PIM3,PIM3_HUMAN,5.62,,Kd,Binding constant for PIM3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185201,2544,2187,Maternal embryonic leucine zipper kinase,Kinase,Q14680,MELK,MELK_HUMAN,6.46,,Kd,Binding constant for full-length MELK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185202,2544,2166,Wee1-like protein kinase,Kinase,P30291,WEE1,WEE1_HUMAN,5.96,,Kd,Binding constant for WEE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185203,2544,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,5.68,,Kd,Binding constant for BTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185204,2544,2276,"Interferon-induced, double-stranded RNA-activated protein kinase",Kinase,P19525,EIF2AK2,E2AK2_HUMAN,6.17,,Kd,Binding constant for PRKR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185205,2544,2216,NUAK family SNF1-like kinase 1,Kinase,O60285,NUAK1,NUAK1_HUMAN,7.32,,Kd,Binding constant for ARK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185206,2544,2258,Serine/threonine-protein kinase BRSK2,Kinase,Q8IWQ3,BRSK2,BRSK2_HUMAN,5.96,,Kd,Binding constant for full-length BRSK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185207,2544,2348,U4/U6 small nuclear ribonucleoprotein Prp4,Unclassified,O43172,PRPF4,PRP4_HUMAN,6.41,,Kd,Binding affinity to PRP4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185208,2544,2085,Serine/threonine-protein kinase D1,Kinase,Q15139,PRKD1,KPCD1_HUMAN,6.51,,Kd,Binding constant for PRKD1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185209,2544,2341,Mitogen-activated protein kinase kinase kinase 13,Kinase,O43283,MAP3K13,M3K13_HUMAN,7.02,,Kd,Binding affinity to LZK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185210,2544,2318,Serine/threonine-protein kinase TBK1,Kinase,Q9UHD2,TBK1,TBK1_HUMAN,6.92,,Kd,Binding affinity to TBK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185211,2544,2338,Serine/threonine-protein kinase ICK,Kinase,Q9UPZ9,ICK,ICK_HUMAN,6.33,,Kd,Binding affinity to ICK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
215584,4115,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.886056648,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
185212,2544,2190,Serine/threonine-protein kinase Nek7,Kinase,Q8TDX7,NEK7,NEK7_HUMAN,5.39,,Kd,Binding constant for full-length NEK7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185213,2544,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,7.8,,Kd,Binding constant for MAP4K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185214,2544,2330,Serine/threonine-protein kinase/endoribonuclease IRE1,Kinase,O75460,ERN1,ERN1_HUMAN,6.22,,Kd,Binding affinity to ERN1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185215,2544,2188,MAP kinase-interacting serine/threonine-protein kinase 1,Kinase,Q9BUB5,MKNK1,MKNK1_HUMAN,5.41,,Kd,Binding constant for MKNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185216,2544,2228,MAP/microtubule affinity-regulating kinase 4,Kinase,Q96L34,MARK4,MARK4_HUMAN,5.44,,Kd,Binding constant for MARK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185217,2544,2347,Serine/threonine-protein kinase OSR1,Kinase,O95747,OXSR1,OXSR1_HUMAN,6.28,,Kd,Binding affinity to OSR1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185218,2544,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,6.57,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185219,2544,2274,Serine/threonine-protein kinase D3,Kinase,O94806,PRKD3,KPCD3_HUMAN,6.55,,Kd,Binding constant for PRKD3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185220,2544,2456,Serine/threonine-protein kinase Sgk3,Kinase,Q96BR1,SGK3,SGK3_HUMAN,6.66,,Kd,Binding constant for SGK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185221,2544,2351,STE20/SPS1-related proline-alanine-rich protein kinase,Kinase,Q9UEW8,STK39,STK39_HUMAN,6.85,,Kd,Binding affinity to STK39,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185222,2544,2352,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,7.03,,Kd,Binding affinity to TAK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185223,2544,871,Dual specificity protein kinase CLK2,Kinase,P49760,CLK2,CLK2_HUMAN,7.7,,Kd,Binding constant for CLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185224,2544,2333,G protein-coupled receptor kinase 7,Kinase,Q8WTQ7,GRK7,GRK7_HUMAN,6.74,,Kd,Binding affinity to GRK7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185225,2544,2165,Myosin light chain kinase family member 4,Kinase,Q86YV6,MYLK4,MYLK4_HUMAN,7.82,,Kd,Binding constant for SgK085 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185226,2544,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,6.28,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185227,2544,2359,Homeodomain-interacting protein kinase 1,Kinase,Q86Z02,HIPK1,HIPK1_HUMAN,7.26,,Kd,Binding constant for HIPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185228,2544,870,Dual specificity protein kinase CLK1,Kinase,P49759,CLK1,CLK1_HUMAN,7.66,,Kd,Binding constant for full-length CLK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185229,2544,796,Dual specificity protein kinase TTK,Kinase,P33981,TTK,TTK_HUMAN,7.2,,Kd,Binding constant for TTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185230,2544,2177,Serine/threonine-protein kinase tousled-like 2,Kinase,Q86UE8,TLK2,TLK2_HUMAN,6.48,,Kd,Binding constant for TLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185231,2544,853,Ephrin type-A receptor 3,Kinase,P29320,EPHA3,EPHA3_HUMAN,5.68,,Kd,Binding constant for EPHA3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185232,2544,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,7.72,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185233,2544,776,Tyrosine-protein kinase Fer,Kinase,P16591,FER,FER_HUMAN,5.96,,Kd,Binding constant for FER kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185234,2544,793,Serine/threonine-protein kinase 16,Kinase,O75716,STK16,STK16_HUMAN,6.6,,Kd,Binding constant for STK16 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185235,2544,774,Serine/threonine-protein kinase 17B,Kinase,O94768,STK17B,ST17B_HUMAN,6.96,,Kd,Binding constant for full-length DRAK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185236,2544,740,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Kinase,Q13555,CAMK2G,KCC2G_HUMAN,6.36,,Kd,Binding affinity to CAMK1G,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185237,2544,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,6.72,,Kd,Binding constant for PLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185238,2544,741,AP2-associated protein kinase 1,Kinase,Q2M2I8,AAK1,AAK1_HUMAN,7.96,,Kd,Binding constant for AAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185239,2544,742,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,6.51,,Kd,Binding constant for MARK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185240,2544,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,5.92,,Kd,Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185241,2544,899,Ribosomal protein S6 kinase alpha-5,Kinase,O75582,RPS6KA5,KS6A5_HUMAN,7.77,,Kd,Binding affinity to RPS6KA2(Kin.Dom.1-N-terminal),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185242,2544,2181,Casein kinase II subunit alpha',Kinase,P19784,CSNK2A2,CSK22_HUMAN,6.8,,Kd,Binding constant for CSNK2A2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
215585,179,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.886056648,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
185243,2544,2237,"Myosin light chain kinase, smooth muscle",Kinase,P11799,Mylk,MYLK_CHICK,7.64,,Kd,Binding constant for MLCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,,,,Gallus gallus
185244,2544,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,6.92,,Kd,Binding constant for YES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185245,2544,2345,Serine/threonine-protein kinase 38,Kinase,Q15208,STK38,STK38_HUMAN,6.39,,Kd,Binding affinity to NDR1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185246,2544,2089,Serine/threonine-protein kinase N2,Kinase,Q16513,PKN2,PKN2_HUMAN,5.89,,Kd,Binding constant for PKN2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185247,2544,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.3,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185248,2544,2353,Serine/threonine-protein kinase TAO1,Kinase,Q7L7X3,TAOK1,TAOK1_HUMAN,6.05,,Kd,Binding affinity to TAOK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185249,2544,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,6.06,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185250,2544,792,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.66,,Kd,Binding constant for full-length AURKC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185251,2544,574,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,8.23,,Kd,Binding constant for PHKG2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185252,2544,2246,Casein kinase I isoform gamma-1,Kinase,Q9HCP0,CSNK1G1,KC1G1_HUMAN,6.03,,Kd,Binding constant for CSNK1G1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185253,2544,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,7,,Kd,Binding constant for TRKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185254,2544,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,10.12,,Kd,Binding constant for PDGFRB kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,INHIBITOR,,Tclin,,,Homo sapiens
185255,2544,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,6.28,,Kd,Binding constant for FGFR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185256,2544,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.28,,Kd,Average Binding Constant for FGFR2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185257,2544,670,Rho-associated protein kinase 1,Kinase,Q13464,ROCK1,ROCK1_HUMAN,6.34,,Kd,Binding affinity to ROCK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185258,2544,573,Ribosomal protein S6 kinase alpha-3,Kinase,P51812,RPS6KA3,KS6A3_HUMAN,7.26,,Kd,Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185259,2544,2245,Citron Rho-interacting kinase,Kinase,O14578,CIT,CTRO_HUMAN,5.41,,Kd,Binding constant for CIT kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185260,2544,2250,Myosin-IIIa,Kinase,Q8NEV4,MYO3A,MYO3A_HUMAN,5.51,,Kd,Binding constant for MYO3A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185261,2544,2336,Homeodomain-interacting protein kinase 4,Kinase,Q8NE63,HIPK4,HIPK4_HUMAN,6.8,,Kd,Binding affinity to HIPK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185262,2544,2204,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,Q8NFD2,ANKK1,ANKK1_HUMAN,6.51,,Kd,Binding constant for ANKK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185263,2544,2167,Serine/threonine-protein kinase 25,Kinase,O00506,STK25,STK25_HUMAN,6.54,,Kd,Binding constant for YSK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185264,2544,2023,Serine/threonine-protein kinase ULK3,Kinase,Q3U3Q1,Ulk3,ULK3_MOUSE,6.96,,Kd,Average Binding Constant for ULK3 m; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,,,,Mus musculus
185265,2544,614,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,7.64,,Kd,Binding affinity to MLCK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185266,2544,876,Mitogen-activated protein kinase kinase kinase 4,Kinase,Q9Y6R4,MAP3K4,M3K4_HUMAN,5.48,,Kd,Average Binding Constant for MAP3K4; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185267,2544,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,7.39,,Kd,Binding constant for MAP4K5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185268,2544,874,Serine/threonine-protein kinase 38-like,Kinase,Q9Y2H1,STK38L,ST38L_HUMAN,6.01,,Kd,Binding constant for NDR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185269,2544,2249,Serine/threonine-protein kinase DCLK2,Kinase,Q8N568,DCLK2,DCLK2_HUMAN,5.57,,Kd,Binding constant for DCAMKL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185270,2544,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,7.54,,Kd,Binding affinity to MINK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185271,2544,2171,Casein kinase I isoform alpha-like,Kinase,Q8N752,CSNK1A1L,KC1AL_HUMAN,6.26,,Kd,Binding constant for full-length CSNK1A1L,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tdark,,,Homo sapiens
185272,2544,2464,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,7.12,,Kd,Binding constant for LRRK2(G2019S) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185273,2544,2214,Serine/threonine-protein kinase PAK 6,Kinase,Q9NQU5,PAK6,PAK6_HUMAN,5.62,,Kd,Binding constant for PAK6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185274,2544,2320,Interleukin-1 receptor-associated kinase 4,Kinase,Q9NWZ3,IRAK4,IRAK4_HUMAN,7.18,,Kd,Binding constant for IRAK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185275,2544,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,9.68,,Kd,"Binding constant for KIT(V559D,V654A) kinase domain",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,INHIBITOR,,Tclin,,,Homo sapiens
185276,2544,2193,Insulin receptor-related protein,Kinase,P14616,INSRR,INSRR_HUMAN,6.37,,Kd,Binding constant for INSRR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185277,2544,855,BMP-2-inducible protein kinase,Kinase,Q9NSY1,BMP2K,BMP2K_HUMAN,8.26,,Kd,Binding constant for BIKE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185278,2544,856,Serine/threonine-protein kinase pim-2,Kinase,Q9P1W9,PIM2,PIM2_HUMAN,5.3,,Kd,Average Binding Constant for PIM2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185279,2544,2215,Serine/threonine-protein kinase PAK 7,Kinase,Q9P286,PAK5,PAK5_HUMAN,6.19,,Kd,Binding constant for PAK7/PAK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185280,2544,822,Serine/threonine-protein kinase 17A,Kinase,Q9UEE5,STK17A,ST17A_HUMAN,9,,Kd,Binding constant for DRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185281,2544,609,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,5.59,,Kd,Binding constant for IGF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185282,2544,2240,Mitogen-activated protein kinase kinase kinase 11,Kinase,Q16584,MAP3K11,M3K11_HUMAN,5.89,,Kd,Binding constant for MLK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185283,2544,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,6.02,,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185284,2544,2367,Megakaryocyte-associated tyrosine-protein kinase,Kinase,P42679,MATK,MATK_HUMAN,5.11,,Kd,Binding constant for CTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185285,2544,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,7.6,,Kd,Average Binding Constant for TNIK; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185286,2544,908,Calcium/calmodulin-dependent protein kinase kinase 2,Kinase,Q96RR4,CAMKK2,KKCC2_HUMAN,5.82,,Kd,Binding constant for CAMKK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185287,2544,2284,Ribosomal protein S6 kinase alpha-4,Kinase,O75676,RPS6KA4,KS6A4_HUMAN,7.02,,Kd,Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185288,2544,2221,Aurora kinase B,Kinase,Q96GD4,AURKB,AURKB_HUMAN,6.42,,Kd,Binding constant for AURKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185289,2544,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,7.25,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185290,2544,902,Dual specificity protein kinase CLK4,Kinase,Q9HAZ1,CLK4,CLK4_HUMAN,7.54,,Kd,Binding constant for CLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185291,2544,903,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,Q9HBH9,MKNK2,MKNK2_HUMAN,5.24,,Kd,Binding constant for MKNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185292,2544,702,Death-associated protein kinase 2,Kinase,Q9UIK4,DAPK2,DAPK2_HUMAN,6.82,,Kd,Binding constant for full-length DAPK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185293,2544,2375,Bone morphogenetic protein receptor type-1B,Kinase,O00238,BMPR1B,BMR1B_HUMAN,5.62,,Kd,Binding constant for BMPR1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185294,2544,2022,Serine/threonine-protein kinase 3,Kinase,Q9JI10,Stk3,STK3_MOUSE,6.8,,Kd,Average Binding Constant for STK3_m; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,,,,Mus musculus
185295,2544,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,6.44,,Kd,Binding affinity to TYK2(JH2domain-pseudokinase),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185296,2544,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,7.85,,Kd,Binding affinity to IRAK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185297,2544,893,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,7.72,,Kd,Binding constant for full-length MST1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185298,2544,2024,Protein-tyrosine kinase 6,Kinase,Q13882,PTK6,PTK6_HUMAN,5.34,,Kd,Binding constant for BRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185299,2544,914,Calcium/calmodulin-dependent protein kinase kinase 1,Kinase,Q8N5S9,CAMKK1,KKCC1_HUMAN,6.38,,Kd,Binding constant for CAMKK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185300,2544,891,Calcium/calmodulin-dependent protein kinase type 1D,Kinase,Q8IU85,CAMK1D,KCC1D_HUMAN,6.29,,Kd,Binding constant for CAMK1D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185301,2544,2133,Serine/threonine-protein kinase 3,Kinase,Q13188,STK3,STK3_HUMAN,7.25,,Kd,Binding constant for MST2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185302,2544,915,Calcium/calmodulin-dependent protein kinase type 1G,Kinase,Q96NX5,CAMK1G,KCC1G_HUMAN,6.36,,Kd,Binding constant for CAMK1G kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185303,2544,755,5'-AMP-activated protein kinase catalytic subunit alpha-1,Kinase,Q13131,PRKAA1,AAPK1_HUMAN,7.72,,Kd,Binding constant for AMPK-alpha1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185304,2544,747,Serine/threonine-protein kinase Nek2,Kinase,P51955,NEK2,NEK2_HUMAN,6.3,,Kd,Average Binding Constant for NEK2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185305,2544,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.57,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185306,2544,750,Ribosomal protein S6 kinase alpha-2,Kinase,Q15349,RPS6KA2,KS6A2_HUMAN,7.77,,Kd,Binding constant for RPS6KA2(Kin.Dom.1 - N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185307,2544,802,Ephrin type-A receptor 5,Kinase,P54756,EPHA5,EPHA5_HUMAN,5.92,,Kd,Binding constant for EPHA5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185308,2544,2356,Serine/threonine-protein kinase ULK2,Kinase,Q8IYT8,ULK2,ULK2_HUMAN,7.89,,Kd,Binding affinity to ULK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185309,2544,890,Ephrin type-B receptor 1,Kinase,P54762,EPHB1,EPHB1_HUMAN,6.32,,Kd,Binding constant for EPHB1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185310,2544,769,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",Kinase,Q16816,PHKG1,PHKG1_HUMAN,8.26,,Kd,Binding constant for full-length PHKG1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185311,2544,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,5.66,,Kd,Average Binding Constant for ACK1; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185312,2544,2142,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,P42336,PIK3CA,PK3CA_HUMAN,4.96,,IC50,Inhibition of recombinant PI3Kalpha by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185313,2544,892,Cyclin-dependent kinase 16,Kinase,Q00536,CDK16,CDK16_HUMAN,6.89,,Kd,Average Binding Constant for PCTK1; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185314,2544,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,6.74,,Kd,Binding constant for MAP4K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185315,2544,672,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.36,,Kd,Binding constant for PTK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185316,2544,2180,Casein kinase II subunit alpha,Kinase,P68400,CSNK2A1,CSK21_HUMAN,7.09,,Kd,Binding constant for full-length CSNK2A1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185317,2544,2090,RAC-beta serine/threonine-protein kinase,Kinase,P31751,AKT2,AKT2_HUMAN,5.57,,Kd,Binding constant for AKT2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185318,2544,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,5.29,,Kd,Binding constant for TRKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185319,2544,2185,Serine/threonine-protein kinase STK11,Kinase,Q15831,STK11,STK11_HUMAN,7.42,,Kd,Binding constant for full-length LKB1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185320,2544,2331,Rhodopsin kinase,Kinase,Q15835,GRK1,RK_HUMAN,6.54,,Kd,Binding affinity to GRK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185321,2544,2194,Interleukin-1 receptor-associated kinase 3,Kinase,Q9Y616,IRAK3,IRAK3_HUMAN,6.03,,Kd,Binding constant for IRAK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185322,2544,773,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,Q9UQM7,CAMK2A,KCC2A_HUMAN,7.1,,Kd,Binding constant for CAMK2A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185323,2544,2332,G protein-coupled receptor kinase 4,Kinase,P32298,GRK4,GRK4_HUMAN,6.85,,Kd,Binding affinity to GRK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185324,2544,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,7.24,,Kd,Binding affinity to MAP3K2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185325,2544,2357,Serine/threonine-protein kinase ULK3,Kinase,Q6PHR2,ULK3,ULK3_HUMAN,7.38,,Kd,Binding affinity to ULK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185326,2544,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,6,,Kd,Binding constant for ABL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185327,2544,2227,Serine/threonine-protein kinase MARK1,Kinase,Q9P0L2,MARK1,MARK1_HUMAN,5.92,,Kd,Binding constant for MARK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185328,2544,2189,Serine/threonine-protein kinase 26,Kinase,Q9P289,STK26,STK26_HUMAN,6.47,,Kd,Binding constant for full-length MST4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185329,2544,2361,Serine/threonine-protein kinase PLK2,Kinase,Q9NYY3,PLK2,PLK2_HUMAN,5.33,,Kd,Binding affinity to PLK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185330,2544,2224,Bone morphogenetic protein receptor type-2,Kinase,Q13873,BMPR2,BMPR2_HUMAN,6.24,,Kd,Binding constant for BMPR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185331,2544,2169,Protein-tyrosine kinase 2-beta,Kinase,Q14289,PTK2B,FAK2_HUMAN,7.09,,Kd,Binding constant for full-length PTK2B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185332,2544,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,7.19,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185333,2544,2211,Serine/threonine-protein kinase LATS2,Kinase,Q9NRM7,LATS2,LATS2_HUMAN,6.34,,Kd,Binding constant for LATS2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185334,2544,2339,Inhibitor of nuclear factor kappa-B kinase subunit alpha,Kinase,O15111,CHUK,IKKA_HUMAN,6.28,,Kd,Binding affinity to IKK-alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185335,2544,2182,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Kinase,Q9Y463,DYRK1B,DYR1B_HUMAN,5.64,,Kd,Binding constant for full-length DYRK1B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185336,2544,2183,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,Q14164,IKBKE,IKKE_HUMAN,6.21,,Kd,Binding constant for full-length IKK-epsilon,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185337,2544,2452,Serine/threonine-protein kinase PRP4 homolog,Kinase,Q13523,PRPF4B,PRP4B_HUMAN,6.41,,Kd,Binding constant for PRP4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185338,2544,2459,SNF-related serine/threonine-protein kinase,Kinase,Q9NRH2,SNRK,SNRK_HUMAN,6.19,,Kd,Binding constant for SNRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185339,2544,2465,Dual serine/threonine and tyrosine protein kinase,Kinase,Q6XUX3,DSTYK,DUSTY_HUMAN,5.89,,Kd,Binding constant for RIPK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185340,2544,2612,Serine/threonine-protein kinase PknB,Kinase,P9WI81,pknB,PKNB_MYCTU,7.06,,Kd,Binding constant for PKNB(M.tuberculosis) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
185341,2544,2466,Calcium-dependent protein kinase 1,Kinase,P62344,CPK1,CDPK1_PLAF7,5.89,,Kd,Binding constant for PFCDPK1(P.falciparum) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,,,,Plasmodium falciparum
185342,2544,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,6.07,,Kd,Binding affinity to EPHB6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185343,2544,704,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,4.92,,IC50,Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185344,2544,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,6.24,,Kd,Binding constant for full-length SNF1LK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185345,2544,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,6.68,,Kd,Binding affinity to TAOK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185346,2544,2315,Casein kinase I isoform alpha,Kinase,P48729,CSNK1A1,KC1A_HUMAN,7,,Kd,Binding constant for CSNK1A1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185347,2544,2365,Tankyrase-2,Enzyme,Q9H2K2,TNKS2,TNKS2_HUMAN,5.05,,Kd,Binding affinity to TNK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185348,2544,2084,Cyclin-dependent kinase 7,Kinase,P50613,CDK7,CDK7_HUMAN,6.48,,Kd,Binding constant for full-length CDK7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185349,2544,713,Rho-associated protein kinase 2,Kinase,O75116,ROCK2,ROCK2_HUMAN,6.85,,Kd,Binding affinity to ROCK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185350,2544,2243,Serine/threonine-protein kinase 24,Kinase,Q9Y6E0,STK24,STK24_HUMAN,7.2,,Kd,Binding constant for MST3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185351,2544,2174,Casein kinase I isoform gamma-3,Kinase,Q9Y6M4,CSNK1G3,KC1G3_HUMAN,6.62,,Kd,Binding constant for full-length CSNK1G3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185352,2544,2247,Death-associated protein kinase 1,Kinase,P53355,DAPK1,DAPK1_HUMAN,6.92,,Kd,Binding constant for DAPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185353,2544,2203,5'-AMP-activated protein kinase catalytic subunit alpha-2,Kinase,P54646,PRKAA2,AAPK2_HUMAN,7.05,,Kd,Binding constant for AMPK-alpha2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185354,2544,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.28,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185355,2544,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,8.7,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,INHIBITOR,,Tclin,,,Homo sapiens
185356,2544,543,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,7.77,,Ki,Binding affinity to VEGFR3 (unknown origin),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,INHIBITOR,,Tclin,,,Homo sapiens
185357,2544,2363,Uncharacterized serine/threonine-protein kinase SBK3,Kinase,P0C264,SBK3,SBK3_HUMAN,5.72,,Kd,Binding affinity to SgK110,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tdark,,,Homo sapiens
185358,2544,2337,Hormonally up-regulated neu tumor-associated kinase,Kinase,P57058,HUNK,HUNK_HUMAN,6.3,,Kd,Binding affinity to HUNK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185359,2544,2205,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,5.54,,Kd,Binding constant for DDR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185360,2544,2160,Cyclin-dependent kinase 17,Kinase,Q00537,CDK17,CDK17_HUMAN,5.92,,Kd,Binding constant for full-length PCTK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185361,2544,623,Death-associated protein kinase 3,Kinase,O43293,DAPK3,DAPK3_HUMAN,7.66,,Kd,Binding constant for DAPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185362,2544,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,5.41,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185363,2544,2256,Serine/threonine-protein kinase PAK 4,Kinase,O96013,PAK4,PAK4_HUMAN,5.64,,Kd,Binding constant for PAK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185364,2544,2132,Serine/threonine-protein kinase DCLK3,Kinase,Q9C098,DCLK3,DCLK3_HUMAN,6.96,,Kd,Binding constant for DCAMKL3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185365,2544,2162,Cyclin-dependent kinase 14,Kinase,O94921,CDK14,CDK14_HUMAN,6.57,,Kd,Binding constant for full-length PFTK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185366,2544,2192,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,Q9P2K8,EIF2AK4,E2AK4_HUMAN,6.74,,Kd,"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185367,2544,2327,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,Q13627,DYRK1A,DYR1A_HUMAN,6.7,,Kd,Binding affinity to DYRK1A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185368,2544,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,5.7,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185369,2544,2161,Cyclin-dependent kinase 18,Kinase,Q07002,CDK18,CDK18_HUMAN,5.77,,Kd,Binding constant for full-length PCTK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185370,2544,2226,Mitogen-activated protein kinase kinase kinase kinase 4,Kinase,O95819,MAP4K4,M4K4_HUMAN,6.85,,Kd,Binding constant for MAP4K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185371,2544,2210,Serine/threonine-protein kinase LATS1,Kinase,O95835,LATS1,LATS1_HUMAN,6.2,,Kd,Binding constant for LATS1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185372,2544,2082,Tyrosine-protein kinase receptor TYRO3,Kinase,Q06418,TYRO3,TYRO3_HUMAN,7.31,,Kd,Binding constant for TYRO3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185373,2544,2280,Tyrosine-protein kinase Fes/Fps,Kinase,P07332,FES,FES_HUMAN,6.02,,Kd,Binding constant for FES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185374,2544,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,6.64,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185375,2544,723,"Myosin light chain kinase 2, skeletal/cardiac muscle",Kinase,Q9H1R3,MYLK2,MYLK2_HUMAN,7.31,,Kd,Binding constant for MYLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185376,2544,2238,Mitogen-activated protein kinase kinase kinase 9,Kinase,P80192,MAP3K9,M3K9_HUMAN,5.47,,Kd,Binding constant for MLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185377,2544,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,5.74,,Kd,Binding constant for LTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185378,2544,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,7.77,,Kd,Binding affinity to YSK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185379,2544,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,8.05,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185380,2544,2164,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,Kinase,P78356,PIP4K2B,PI42B_HUMAN,7.41,,Kd,Binding constant for full-length PIP5K2B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185381,2544,1426,3-phosphoinositide-dependent protein kinase 1,Kinase,O15530,PDPK1,PDPK1_HUMAN,5.46,,Kd,Binding constant for full-length PDPK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185382,2544,2273,Serine/threonine-protein kinase D2,Kinase,Q9BZL6,PRKD2,KPCD2_HUMAN,6.42,,Kd,Binding constant for PRKD2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185383,2544,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,6.23,,Kd,Binding constant for TRKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185384,2544,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.82,,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185385,2544,2326,Protein delta homolog 1,Unclassified,P80370,DLK1,DLK1_HUMAN,7,,Kd,Binding affinity to DLK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185386,2544,2198,SRSF protein kinase 2,Kinase,P78362,SRPK2,SRPK2_HUMAN,6.72,,Kd,Binding constant for full-length SRPK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185387,2544,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,6.96,,Kd,Binding constant for full-length MEK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185388,2544,2229,Dual specificity mitogen-activated protein kinase kinase 4,Kinase,P45985,MAP2K4,MP2K4_HUMAN,6.15,,Kd,Binding constant for MEK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185389,2544,2176,Serine/threonine-protein kinase tousled-like 1,Kinase,Q9UKI8,TLK1,TLK1_HUMAN,6.13,,Kd,Binding constant for TLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185390,2544,2350,SRSF protein kinase 3,Kinase,Q9UPE1,SRPK3,SRPK3_HUMAN,7.23,,Kd,Binding affinity to SRPK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185391,2544,2230,Dual specificity mitogen-activated protein kinase kinase 6,Kinase,P52564,MAP2K6,MP2K6_HUMAN,5.28,,Kd,Binding constant for MEK6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185392,2544,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,6.77,,Kd,Binding constant for ALK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185393,2544,2454,Mitogen-activated protein kinase kinase kinase 12,Kinase,Q12852,MAP3K12,M3K12_HUMAN,7,,Kd,Binding constant for DLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185394,2544,2463,Myosin light chain kinase 3,Kinase,Q32MK0,MYLK3,MYLK3_HUMAN,7.64,,Kd,Binding constant for MLCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185395,2544,2277,Receptor-interacting serine/threonine-protein kinase 1,Kinase,Q13546,RIPK1,RIPK1_HUMAN,6.43,,Kd,Binding constant for RIPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185396,2544,2163,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,Kinase,Q99755,PIP5K1A,PI51A_HUMAN,5.27,,Kd,Binding constant for full-length PIP5K1A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185397,2544,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,6.66,,Kd,Binding affinity to MAP3K3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185398,2544,772,Cyclin-dependent-like kinase 5,Kinase,Q00535,CDK5,CDK5_HUMAN,5.16,,Kd,Binding constant for CDK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185399,2544,2170,Serine/threonine-protein kinase RIO1,Kinase,Q9BRS2,RIOK1,RIOK1_HUMAN,7.46,,Kd,Binding constant for full-length RIOK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185400,2544,2322,Cyclin-dependent kinase 4,Kinase,P11802,CDK4,CDK4_HUMAN,5.7,,Kd,Binding constant for CDK4-cyclinD3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tclin,,,Homo sapiens
185401,2544,2349,Serine/threonine-protein kinase RIO2,Kinase,Q9BVS4,RIOK2,RIOK2_HUMAN,7.31,,Kd,Binding affinity to RIOK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185402,2544,2088,Ribosomal protein S6 kinase beta-1,Kinase,P23443,RPS6KB1,KS6B1_HUMAN,7.32,,Kd,Binding constant for S6K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185403,2544,2355,Serine/threonine-protein kinase ULK1,Kinase,O75385,ULK1,ULK1_HUMAN,7.64,,Kd,Binding affinity to ULK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185404,2544,2201,Serine/threonine-protein kinase 33,Kinase,Q9BYT3,STK33,STK33_HUMAN,7.77,,Kd,Binding constant for full-length STK33,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185405,2544,2325,Serine/threonine-protein kinase Chk2,Kinase,O96017,CHEK2,CHK2_HUMAN,8.15,,Kd,Binding affinity to CHEK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185406,2544,2173,Casein kinase I isoform gamma-2,Kinase,P78368,CSNK1G2,KC1G2_HUMAN,6.96,,Kd,Binding constant for full-length CSNK1G2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185407,2544,925,Testis-specific serine/threonine-protein kinase 1,Kinase,Q9BXA7,TSSK1B,TSSK1_HUMAN,5.2,,Kd,Binding constant for full-length TSSK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185408,2544,721,Calcium/calmodulin-dependent protein kinase type II subunit delta,Kinase,Q13557,CAMK2D,KCC2D_HUMAN,6.38,,Kd,Binding constant for CAMK2D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185409,2544,2141,Serine/threonine-protein kinase Chk1,Kinase,O14757,CHEK1,CHK1_HUMAN,6.52,,Kd,Binding constant for CHEK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185410,2544,2362,Receptor-interacting serine/threonine-protein kinase 4,Kinase,P57078,RIPK4,RIPK4_HUMAN,5.68,,Kd,Binding affinity to RIPK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185411,2544,815,Serine/threonine-protein kinase N1,Kinase,Q16512,PKN1,PKN1_HUMAN,6.15,,Kd,Binding constant for PKN1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185412,2544,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,7.48,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185413,2544,2260,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,5.49,,Kd,Binding constant for SNF1LK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185414,2544,714,Protein kinase C alpha type,Kinase,P17252,PRKCA,KPCA_HUMAN,5.22,,Kd,Average Binding Constant for PRKACA; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185415,2544,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,7.59,,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185416,2544,2271,Mitogen-activated protein kinase 7,Kinase,Q13164,MAPK7,MK07_HUMAN,5,,Kd,Binding constant for ERK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tbio,,,Homo sapiens
185417,2544,2136,Non-receptor tyrosine-protein kinase TNK1,Kinase,Q13470,TNK1,TNK1_HUMAN,6.17,,Kd,Binding constant for full-length TNK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL535,,,,Tchem,,,Homo sapiens
185418,726,2869,Tubulin,Structural,P02550|P02554,TUBA1A,TBA1A_PIG|TBB_PIG,5.24,,Ki,Binding affinity against tubulin usingf [3H]-colchicine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL107,,,,,,,Sus scrofa
185419,726,1806,Tubulin alpha-1A chain,Structural,P02550,TUBA1A,TBA1A_PIG,5.6,,Ki,Compound was evaluated for its ability to inhibit the binding of [3H]-colchicine to tubulin in competitive binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL107,,,,,,,Sus scrofa
185420,726,1871,Tubulin beta-2B chain,Structural,Q6B856,TUBB2B,TBB2B_BOVIN,6.11,,Ki,Binding constant at colchicine site of bovine brain tubulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL107,,,,,,,Bos taurus
185421,726,2868,Tubulin,Structural,Q6B856|Q862F3|Q862L2,TUBB2B,Q862F3_BOVIN|Q862L2_BOVIN|TBB2B_BOVIN,6.1,,IC50,Inhibition of bovine brain tubulin polymerization (ITP).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL107,,,,,,,Bos taurus
185422,726,2584,Tubulin polymerization-promoting protein,Unclassified,Q27957,TPPP,TPPP_BOVIN,6.12,,EC50,Inhibition of Bos taurus (bovine) brain tubulin polymerization,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL107,,,,,,,Bos taurus
185423,2414,2575,Phenylethanolamine N-methyltransferase,Enzyme,P11086,PNMT,PNMT_HUMAN,5.32,,Kd,Activity of human wild type PNMT assessed as phenylethanolamine methylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088977,,,,Tchem,,,Homo sapiens
185424,2414,3476,Protein-beta-aspartate methyltransferase,Enzyme,P22061,PCMT1,PIMT_HUMAN,4.32,,Ki,Kinetic constant was measured for PMII of Leishmania donovani promastigotes using supernatant (S12) fraction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088977,,,,Tbio,,,Homo sapiens
185425,2414,1820,S-adenosylmethionine decarboxylase proenzyme,Enzyme,P17708,Amd1,DCAM_RAT,4.22,,Ki,In vitro inhibitory activity against S-adenosyl-L-methionine decarboxylase using liver from rat in presence of 1 mM putrescine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088977,,,,,,,Rattus norvegicus
185426,2414,912,Protein arginine N-methyltransferase 1,Enzyme,Q99873,PRMT1,ANM1_HUMAN,4.92,,IC50,Inhibition of GST-fused human recombinant PRMT1 after 90 mins by SDS-PAGE based scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088977,,,,Tchem,,,Homo sapiens
185427,2414,2548,Met repressor,Unclassified,C3SIU2,metJ,C3SIU2_ECOLX,8.4,,Kd,Binding affinity to Escherichia coli metJ in presence of operator DNA complex by filter binding study,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1088977,,,,,,,Escherichia coli
185428,2630,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,5.64,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1378,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
185429,2338,1634,Trypanothione reductase,Enzyme,P28593,TPR,TYTR_TRYCR,4.72,,Ki,The competitive inhibitory activity against trypanothione reductase was evaluated from Lineweaver Burk plots,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL7568,,,,,,,Trypanosoma cruzi
185430,2338,2923,Bacterial DNA-directed RNA polymerase,Enzyme,P0A7Z4|P0A800|P0A8T7|P0A8V2,rpoA|rpoB|rpoC|rpoZ,RPOA_ECOLI|RPOB_ECOLI|RPOC_ECOLI|RPOZ_ECOLI,4.7,,IC50,Inhibition of Escherichia coli DNA-primed RNA polymerase activity using [8-14C]ATP by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL7568,,,,,,,Escherichia coli (strain K12)
185431,2338,906,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,6.52,,EC50,Half maximal inhibition of Prion protein PrPsc formation was assayed in ScN2a cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL7568,,,,Tchem,,,Homo sapiens
185432,2338,3601,Phospholipase A2 group 1B,Unclassified,P04055,Pla2g1b,PA21B_RAT,4,,IC50,Inhibitory activity against polymorphonuclear cell phospholipase-A2 in rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL7568,,,,,,,Rattus norvegicus
185433,2338,3477,Phospholipase A2 group 1B,Enzyme,P00592,PLA2G1B,PA21B_PIG,4,,IC50,Tested for its inhibitory activity against Phospholipase A2 (PLA2),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL7568,,,,,,,Sus scrofa
185434,2338,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.48,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL7568,,,,Tclin|Tclin|Tclin,,,Homo sapiens
185435,2338,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,5.35,,IC50,Inhibition of Equine serum BChE using butyrylthiocholine iodide as a substrate after 20 mins by Ellman's assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL7568,,,,,,,Equus caballus
185436,2338,2474,Riboflavin-binding protein,Unclassified,P02752,,RBP_CHICK,6.58,,Kd,Binding affinity to chicken riboflavin binding protein assessed as dissociation constant at pH 7.4 in phosphate buffer by isothermal titration calorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL7568,,,,,,,Gallus gallus
185437,2338,2844,Cyclooxygenase,Enzyme,O62664|O62698,PTGS1|PTGS2,PGH1_BOVIN|PGH2_BOVIN,4.49,,IC50,Tested for its inhibitory activity against PGS (prostaglandin synthetase).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL7568,,,,,,,Bos taurus
185438,2673,2441,"Epoxide hydrolase EphE; Hydrolase, alpha/beta hydrolase fold family",Enzyme,O69638,,O69638_MYCTO,7.66,,IC50,Inhibition of Mycobacterium tuberculosis recombinant EphE expressed in Escherichia coli BL21 using CMNPC as substrate after 30 mins by fluorescent assay relative to control,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL214920,,,,,,,Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
185439,464,429,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,,,,Mechanism of Action; CHEMBL1977; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1040,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1040,AGONIST,,Tclin,,,Homo sapiens
185440,2877,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.77,,Ki,Displacement of [3H]LSD from human 5HT6 receptor expressed in HEK293 cells after 1.5 hrs by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53904,,,,Tchem,,,Homo sapiens
185441,1854,164,DNA topoisomerase 4 subunit A,Enzyme,P0C1U9,parC,PARC_STAAU,6.1,,IC50,Inhibitory activity against Staphylococcus aureus ATCC 29213 wild type Topo 4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32,,,,,,,Staphylococcus aureus
185442,1854,165,DNA gyrase subunit A,Enzyme,P9WG47,gyrA,GYRA_MYCTU,5.04,,IC50,Inhibition of DNA supercoiling activity of wild type Mycobacterium tuberculosis DNA gyrase A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
185443,1854,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,6.52,,IC50,Inhibitory activity against wild type Escherichia coli gyrase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32,INHIBITOR,,,,,Escherichia coli (strain K12)
185444,1854,2749,Topoisomerase IV,Enzyme,P0AFI2|P20083,parC|parE,PARC_ECOLI|PARE_ECOLI,,,,Mechanism of Action; CHEMBL2363076; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32,INHIBITOR,,,,,Escherichia coli (strain K12)
185445,2006,3472,Penicillin-binding protein,Enzyme,P72355|Q53707|Q53725|Q53729|Q9XDB3,PBP2|mecA|pbp4|pbpA|pbpF,P72355_STAAU|Q53707_STAAU|Q53725_STAAU|Q53729_STAAU|Q9XDB3_STAAU,,,,Mechanism of Action; CHEMBL2362972; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL693,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL693,INHIBITOR,,,,,Staphylococcus aureus
185446,193,59,Fatty-acid amide hydrolase 1,Enzyme,O00519,FAAH,FAAH1_HUMAN,6.34,,IC50,Inhibition of human FAAH-mediated hydrolysis of [3H]AEA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1079935,,,,Tchem,,,Homo sapiens
215578,623,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.958607315,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215579,3220,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.958607315,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215580,1707,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.954677021,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215581,179,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.93930216,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215582,1980,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,7.920818754,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215586,1707,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.853871964,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215597,623,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.602059991,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215598,623,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.552841969,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215599,2601,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.55,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215600,1891,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.537602002,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215601,820,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.49757288,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215602,1891,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.48148606,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215603,2601,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.46,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215604,3535,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.45432185,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215605,2865,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.356547324,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215606,2233,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.282329497,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215607,1891,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.251811973,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215608,751,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.22184875,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215609,460,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.22,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215610,1546,1886,Somatostatin receptor type 4,GPCR,P31391,SSTR4,SSR4_HUMAN,7.180456064,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215611,2149,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.165579296,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215612,2365,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.15490196,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215613,1890,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.142667504,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215614,2233,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.12090412,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215615,1211,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.057991947,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215616,1775,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.054039296,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215617,3220,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,7.036212173,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215618,2871,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,7.017728767,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215619,812,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.974694135,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215620,824,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.886056648,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215621,654,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,6.848936747,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215622,1150,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.847711656,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215623,4673,628,Nociceptin receptor,GPCR,P41146,OPRL1,OPRX_HUMAN,6.832682665,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215624,3220,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.823908741,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215625,2863,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.818156412,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215626,242,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.787812396,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215627,460,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.78,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215628,1043,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,6.769551079,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215629,1494,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.769551079,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215630,2966,2607,P2X purinoceptor 4,Ion channel,Q99571,P2RX4,P2RX4_HUMAN,6.749336081,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215631,1150,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.735182177,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215632,1150,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.716698771,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215633,835,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.699999416,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215634,3220,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.657577319,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215635,1310,1205,Glutamate receptor 3,Ion channel,P42263,GRIA3,GRIA3_HUMAN,6.595166283,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215636,2149,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.576754126,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215637,1150,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.57024772,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215638,4115,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.565431096,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215639,835,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.499999953,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215640,704,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,6.499999953,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215641,1891,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.48148606,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215642,1960,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.480000028,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215643,1150,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.428291168,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215644,2650,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.416801226,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215645,3220,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.397940009,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215646,2149,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.397940009,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215647,1150,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.397940009,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215648,2871,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.366531544,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215649,4115,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,6.349109922,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215650,2361,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.3400838,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215651,3220,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.327902142,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215652,3912,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,6.307153081,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215653,1546,1980,Somatostatin receptor type 1,GPCR,P30872,SSTR1,SSR1_HUMAN,6.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215654,1891,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.274905479,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215655,331,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.241088108,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215656,3220,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.229147988,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215657,1150,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.195179321,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215658,2601,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.18,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215659,1150,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.175874166,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215660,1150,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.171984936,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215661,228,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.17,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215662,2105,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.16,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215663,2717,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.153044675,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215664,403,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.13,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215665,3220,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.119186408,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215666,4115,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.106793247,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215667,1043,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.064492734,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215668,1043,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.040481623,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215669,4115,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.038578906,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215670,1150,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.016373713,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215671,1150,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.003926346,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215672,2105,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.98,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215673,2966,3320,P2X purinoceptor 3,Ion channel,P56373,P2RX3,P2RX3_HUMAN,5.962573502,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215674,179,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.953114809,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215675,1230,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.951169913,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215676,2233,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,5.925183559,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215677,1982,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,5.91649738,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215678,228,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.91,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215679,260,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.906578315,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215680,1053,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.905878404,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215681,1478,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.898940645,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215682,631,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,5.872895202,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215683,631,527,Prostaglandin D2 receptor,GPCR,Q13258,PTGDR,PD2R_HUMAN,5.872895202,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215684,179,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.872571222,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215685,812,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.860435734,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215686,1150,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.844663963,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215687,179,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.812479279,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215688,2865,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.795880017,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215689,2865,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.795880017,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215690,1150,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.790484985,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215691,722,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.782516056,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215692,2233,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.78,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215693,1891,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.773400095,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215694,179,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,5.758453519,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215695,1551,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,5.756961951,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215696,2717,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,5.7490923,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215697,2370,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.737074531,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215698,1150,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,5.735890844,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215699,2863,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.727230413,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215700,1150,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.72607322,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215701,1053,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.705533774,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215702,228,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.7,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215703,1209,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.698970004,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215704,3220,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.688246139,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215705,242,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.679853714,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215706,972,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.677780705,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215707,972,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,5.645699438,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215708,3220,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.641113796,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215709,972,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.638272164,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215710,3502,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.628932138,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215711,179,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.625434939,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215712,897,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.619788758,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215713,3659,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.603975103,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215714,1053,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.596707855,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215715,1971,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.590066877,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215716,3639,3320,P2X purinoceptor 3,Ion channel,P56373,P2RX3,P2RX3_HUMAN,5.583359493,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215717,3201,1205,Glutamate receptor 3,Ion channel,P42263,GRIA3,GRIA3_HUMAN,5.580044252,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215718,2233,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.571379327,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215719,228,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,5.53,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215720,972,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.522878745,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215721,2865,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.522878745,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215722,1775,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.522878745,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215723,2365,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.508638306,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215724,1375,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,5.507658747,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215725,4115,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.503623946,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215726,4115,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.490528648,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215727,1150,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.489053051,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215728,2717,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.455931956,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215729,2233,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,5.454940415,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215730,331,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.444663672,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215731,1028,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.434152181,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215732,2717,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.428291168,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215733,972,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.42794201,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215734,2370,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.414652089,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215735,1053,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.412289035,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215736,972,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,5.402414498,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215737,1028,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.401209493,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215738,1932,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,5.387110231,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215739,179,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.381533508,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215740,1150,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,5.377785977,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215741,3220,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.37675071,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215742,1960,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.366531544,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215743,972,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,5.351932871,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215744,1816,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.337242168,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215745,1775,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.334231449,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215746,1932,746,Cytoplasmic tyrosine-protein kinase BMX,Kinase,P51813,BMX,BMX_HUMAN,5.318035541,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215747,1836,849,Cysteinyl leukotriene receptor 2,GPCR,Q9NS75,CYSLTR2,CLTR2_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215748,2045,608,Cannabinoid receptor 2,GPCR,P34972,CNR2,CNR2_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215749,2181,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215750,1353,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215751,2181,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215752,1353,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215753,972,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215754,2045,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215755,4137,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215756,4115,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215757,2865,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215758,2435,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215759,2389,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215760,2337,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215761,2181,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215762,1982,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215763,1353,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215764,4137,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215765,4115,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215766,2435,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215767,2389,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215768,2337,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215769,2181,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215770,1982,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215771,722,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.301029996,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215772,2715,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.292429824,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215773,455,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.292429824,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215774,951,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.274905479,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215775,1816,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.263284866,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215776,1775,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.262886906,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215777,812,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.262807357,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215778,1613,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.244277555,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215779,2715,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.229147988,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215780,2715,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.224535191,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215781,1775,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.212823008,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215782,663,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.19064233,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215783,1551,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,5.186886246,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215784,1053,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.186152246,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215785,841,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.180061431,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215786,2149,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.171275673,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215787,1150,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,5.167299529,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215788,2149,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,5.15490196,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215789,645,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.154858533,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215790,260,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.154858533,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215791,2855,878,Leukotriene B4 receptor 1,GPCR,Q15722,LTB4R,LT4R1_HUMAN,5.147276089,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
215792,1932,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,5.141462802,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215793,2538,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,5.111259039,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215794,1150,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5.111202933,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215795,1493,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.109020403,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215796,1932,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,5.09560908,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215797,1211,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.095392636,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215798,179,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.080712659,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215799,1960,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.070581074,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215800,1932,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,5.068592986,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215801,1150,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.041914151,,Ki,,PDSP,,,,,,,,Tchem,,,Homo sapiens
185595,2247,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1152,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1152,AGONIST,,Tclin,,,Homo sapiens
185596,3531,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,9.1,,IC50,Inhibition of human phosphodiesterase 4,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193240,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193240,INHIBITOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
185597,3531,559,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,Q08499,PDE4D,PDE4D_HUMAN,9.57,,IC50,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193240,,,,Tclin,,,Homo sapiens
185598,3531,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,9.46,,IC50,Inhibition of human full length PDE4A4 expressed in baculovirus infected sf21 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193240,,,,Tclin,,,Homo sapiens
185599,3531,149,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,Q07343,PDE4B,PDE4B_HUMAN,9.4,,IC50,Inhibition of human recombinant PDE4B by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193240,,,,Tclin,,,Homo sapiens
185600,1723,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,8.2,,Ki,Binding affinity towards 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19215,,,,,,,Rattus norvegicus
185601,1723,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.64,,Ki,Displacement of [3H]8-OH-DPAT from human recombinant 5HT1A receptor expressed in CHOK1 cells after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19215,,,,Tclin,,,Homo sapiens
185602,1723,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,9.52,,Ki,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19215,,,,,,,Rattus norvegicus
185603,1723,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,9.3,,Ki,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19215,,,,Tclin,,,Homo sapiens
185604,1723,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,7.7,,Ki,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19215,,,,,,,Rattus norvegicus
185605,1723,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,7.6,,Ki,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19215,,,,,,,Rattus norvegicus
185606,1723,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.22,,Ki,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19215,,,,,,,Rattus norvegicus
185607,1723,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,8.2,,Ki,Displacement of [3H]5CT from 5HT7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19215,,,,Tclin,,,Homo sapiens
185608,2113,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,5.85,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL567,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
185609,134,1852,Translocator protein,Membrane receptor,P16257,Tspo,TSPO_RAT,9.3,,Ki,Displacement of [3H]PK 11195 from peripheral-type benzodiazepine receptor in rat kidney mitochondrial membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54349,,,,,,,Rattus norvegicus
185610,134,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,7.59,,IC50,Displacement of [3H]flunitrazepam from rat brain GABA-A Benzodiazepine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54349,,,,,,,Rattus norvegicus
185611,2533,181,Dihydropteroate synthase 1,Enzyme,P0C0X1,folP1,DHPS1_MYCLE,,,,Mechanism of Action; CHEMBL2362993; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1570,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1570,INHIBITOR,,,,,Mycobacterium leprae (strain TN)
185612,2528,2066,Solute carrier family 22 member 12,Transporter,Q96S37,SLC22A12,S22AC_HUMAN,4,,IC50,Inhibition of human URAT1-mediated urate uptake in HEK293 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL832,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL832,INHIBITOR,,Tclin,,,Homo sapiens
185613,1200,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,5.44,,Kd,Inhibition of T-type Cav3.2 channel,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,http://www.ncbi.nlm.nih.gov/pubmed/19582593,BLOCKER,,Tclin,,491,Homo sapiens
185614,1200,270,Voltage-dependent T-type calcium channel subunit alpha-1I,Ion channel,Q9P0X4,CACNA1I,CAC1I_HUMAN,6.08,,Kd,Inhibition of T-type Cav3.3 channel,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,http://www.ncbi.nlm.nih.gov/pubmed/19582593,BLOCKER,,Tclin,,491,Homo sapiens
185615,1200,204,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,6.28,,Kd,Inhibition of T-type Cav3.1 channel,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,http://www.ncbi.nlm.nih.gov/pubmed/19582593,BLOCKER,,Tclin,,491,Homo sapiens
185616,1200,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.02,,IC50,Binding affinity against opioid receptor kappa 1 by using [3H]U-69593 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,,,,Tclin,,,Homo sapiens
185617,1200,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.44,,IC50,Binding affinity against delta opiate receptor using [3H]DPDPE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,,,,Tclin,,,Homo sapiens
185618,1200,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,5.62,,IC50,Binding affinity against mu opioid receptor using [3H]DAMGO,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,,,,Tclin,,,Homo sapiens
185619,1200,2875,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P04774|P04775|P08104,Scn1a|Scn2a|Scn3a,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,7.28,,Ki,Inhibition of [3H]- batrachotoxin binding to sodium channel in rat neocortical membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,,,,,,,Rattus norvegicus
185620,1200,843,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,Q00975,CACNA1B,CAC1B_HUMAN,5.78,,IC50,Inhibition of calcium channel Cav2.2 in IMR32 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,,,,Tclin,,,Homo sapiens
165450,2332,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.2882,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
185621,1200,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.64,,IC50,Inhibition of [3H]raclopride binding to Dopamine receptor D2 of rat striatum membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,,,,,,,Rattus norvegicus
185622,1200,1798,Sodium channel protein type 2 subunit alpha,Ion channel,P04775,Scn2a,SCN2A_RAT,6.31,,IC50,Inhibitory activity against type IIA sodium channel in CNaIIA-1 cell line expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,,,,,,,Rattus norvegicus
185623,1612,630,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,4.79,,IC50,Inhibition of recombinant HDAC6 (unknown origin) after 10 mins by fluorimetric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503,,,,Tclin,,,Homo sapiens
185624,1612,3478,Leukocyte adhesion glycoprotein LFA-1 alpha,Adhesion,P20701,ITGAL,ITAL_HUMAN,4.89,,Kd,Binding affinity to I-domain of human integrin alphaL (amino acid residues 128 to 307) plus initial methionine expressed in Escherichia coli by NMR spectroscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503,,,,Tclin,,,Homo sapiens
185625,1612,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,5.57,,Ki,Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) assessed as inhibition of ATCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503,,,,,,,Electrophorus electricus
185626,1612,606,Histone deacetylase 1,Enzyme,Q13547,HDAC1,HDAC1_HUMAN,4.92,,IC50,Inhibition of recombinant HDAC1 (unknown origin) after 10 mins by fluorimetric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503,,,,Tclin,,,Homo sapiens
185627,1612,598,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,4.59,,IC50,Inhibition of recombinant HDAC2 (unknown origin) after 10 mins by fluorimetric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503,,,,Tclin,,,Homo sapiens
185628,1612,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,5.96,,Ki,Inhibition of Equus caballus (horse) serum butyrylcholinesterase (BChE) assessed as inhibition of BTCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503,,,,,,,Equus caballus
185629,1612,1796,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P51639,Hmgcr,HMDH_RAT,8.52,,IC50,Inhibition of rat liver microsomal HMG-CoA reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503,,,,,,,Rattus norvegicus
185630,1612,1889,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,Q01237,Hmgcr,HMDH_MOUSE,7.57,,IC50,In vitro inhibitory activity against isolated enzyme HMG-CoA reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503,,,,,,,Mus musculus
185631,572,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200971,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200971,INHIBITOR,,,,,Escherichia coli (strain K12)
185632,1424,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,5,,IC50,Inhibitory activity on Angiotensin I converting enzyme (ACE) obtained from pig renal cortex and hippuryl-histidyl-leucine as substrate,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL99701,http://www.ncbi.nlm.nih.gov/pubmed/1666418,INHIBITOR,,Tclin,,511,Homo sapiens
185633,1923,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.99,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL360861,,,,Tchem,,,Homo sapiens
185634,1923,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL360861,,,,Tclin,,,Homo sapiens
185635,1923,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,5.57,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL360861,,,,Tchem,,,Homo sapiens
185636,1923,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,6.19,,IC50,Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL360861,,,,Tchem,,,Homo sapiens
134489,1413,2707,Diacylglycerol O-acyltransferase 1,Enzyme,O75907,DGAT1,DGAT1_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202057s009lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202057s009lbl.pdf,INHIBITOR,,Tclin,191,191,Homo sapiens
134490,1901,255,Atrial natriuretic peptide receptor 1,Enzyme,P16066,NPR1,ANPRA_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/20920s033lbl.pdf,AGONIST,,Tclin,,186,Homo sapiens
134492,2995,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,13,,Ki,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6469,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020807s011lbl.pdf,INHIBITOR,,Tclin,,145,Homo sapiens
134493,2990,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,12.7,,Ki,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6458,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021271s006lbl.pdf,INHIBITOR,,Tclin,,318,Homo sapiens
134495,3249,2782,GABA-A receptor,Ion channel,O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|Q16445|Q8N1C3|Q99928,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRG1|GABRG2|GABRG3,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019627s062lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019627s062lbl.pdf,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,303,303,Homo sapiens
134496,4855,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21396_prempro_lbl.pdf,AGONIST,,Tclin,,535,Homo sapiens
134497,4855,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21396_prempro_lbl.pdf,AGONIST,,Tclin,,535,Homo sapiens
134500,4451,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021959s004lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021959s004lbl.pdf,AGONIST,,Tclin,325,325,Homo sapiens
134502,4498,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022264s013s014lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022264s013s014lbl.pdf,ANTAGONIST,,Tclin,249,249,Homo sapiens
134503,4498,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022264s013s014lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022264s013s014lbl.pdf,ANTAGONIST,,Tclin,249,249,Homo sapiens
134504,4804,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125103s146lbl.pdf,AGONIST,,Tclin,,298,Homo sapiens
134505,4826,2709,Leptin receptor,Membrane receptor,P48357,LEPR,LEPR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125390s004lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125390s004lbl.pdf,AGONIST,,Tclin,192,192,Homo sapiens
134506,4846,1935,Plasma kallikrein,Enzyme,P03952,KLKB1,KLKB1_HUMAN,10.602060317993164,,Ki,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125277s071lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125277s071lbl.pdf,INHIBITOR,,Tclin,146,146,Homo sapiens
134507,4848,2710,Growth hormone receptor,GPCR,P10912,GHR,GHR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020280s077lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020280s077lbl.pdf,AGONIST,,Tclin,193,193,Homo sapiens
134508,4857,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/083220s041lbl.pdf,AGONIST,,Tclin,,308,Homo sapiens
134509,4857,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/083220s041lbl.pdf,AGONIST,,Tclin,,308,Homo sapiens
134514,4832,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204760s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204760s000lbl.pdf,ANTAGONIST,,Tclin,408,408,Homo sapiens
134517,1180,632,Catechol O-methyltransferase,Enzyme,P21964,COMT,COMT_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://eisai.jp/medical/products/di/EPI/CSP_C_EPI.pdf,http://eisai.jp/medical/products/di/EPI/CSP_C_EPI.pdf,INHIBITOR,,Tclin,309,309,Homo sapiens
134573,4897,631,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,9.251811981201172,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20503967,http://www.ncbi.nlm.nih.gov/pubmed/20503967,INHIBITOR,,Tclin,46,46,Homo sapiens
185637,1587,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,7.29,,Ki,Inhibition of rabbit testis recombinant ACE C domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237,,,,,,,Oryctolagus cuniculus
185638,2709,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.38,,Ki,Displacement of [3H]LSD from human 5HT6 receptor expressed in HEK293 cells after 1.5 hrs by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1655,,,,Tchem,,,Homo sapiens
185639,700,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.1,,Ki,Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2355051,,,,Tclin,,,Homo sapiens
185640,700,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,6.8,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2355051,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
185641,700,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.71,,Ki,Displacement of [3H]LSD from human 5HT6 receptor expressed in HEK293 cells after 1.5 hrs by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2355051,,,,Tchem,,,Homo sapiens
185642,700,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.87,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2355051,,,,,,,Rattus norvegicus
185643,700,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,9,,Ki,Affinity for human EMP expressed in ERG2 deficient strain of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2355051,,,,Tchem,,,Homo sapiens
185644,522,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.12,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723,,,,Tchem,,,Homo sapiens
185645,522,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.46,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723,,,,Tclin,,,Homo sapiens
185646,522,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.03,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723,,,,Tchem,,,Homo sapiens
185647,522,1803,Beta-1 adrenergic receptor,GPCR,P18090,Adrb1,ADRB1_RAT,9.09,,Ki,Displacement of [3H]CGP12177 from beta-1 adrenergic receptor in rat cerebral cortex by liquid scintillation method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723,,,,,,,Rattus norvegicus
185648,1364,1981,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,Enzyme,P0AEK4,fabI,FABI_ECOLI,,,,Mechanism of Action; CHEMBL2364678; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496,INHIBITOR,,,,,Escherichia coli (strain K12)
185649,2448,785,Dipeptidyl peptidase 4,Enzyme,P28843,Dpp4,DPP4_MOUSE,7.16,,IC50,Inhibition of mouse DPP4 at 3 mg/kg,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1422,,,,,,,Mus musculus
185650,2448,844,Dipeptidyl peptidase 8,Enzyme,Q6V1X1,DPP8,DPP8_HUMAN,4.96,,IC50,Inhibition of human DPP8 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1422,,,,Tchem,,,Homo sapiens
185651,2448,880,Dipeptidyl peptidase 9,Enzyme,Q86TI2,DPP9,DPP9_HUMAN,4.7,,IC50,Inhibition of human DPP9 expressed in HEK293 cells using Ala-Pro-p-nitroanilide hydrochloride salt as substrate preincubated for 10 mins prior to addition of substrate measured after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1422,,,,Tchem,,,Homo sapiens
185652,2740,1634,Trypanothione reductase,Enzyme,P28593,TPR,TYTR_TRYCR,4.64,,Ki,Inhibitory activity against recombinant Trypanosoma cruzi (Trypanosoma cruzi) Trypanothione reductase (linear competitive type),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,,,,Trypanosoma cruzi
185653,2740,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.19,,Ki,Concentration giving half of the maximal ATPase activity calculated for the high-affinity binding site of the CHO P-Glycoprotein (P-gp) in two-affinity model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,Tchem,,,Homo sapiens
185654,2740,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,8.98,,Kd,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,,,,Rattus norvegicus
185655,2740,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,5.85,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
166218,331,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.4,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7124,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200707,AGONIST,,Tclin,,,Homo sapiens
166223,374,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.32,,Kd,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7128,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1101,ANTAGONIST,,Tclin,,,Homo sapiens
185656,2740,2552,Emopamil-binding protein-like,Unclassified,Q9BY08,EBPL,EBPL_HUMAN,8.41,,Ki,Binding affinity to emopamil binding protein (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,Tchem,,,Homo sapiens
185657,2740,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.82,,Ki,Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,Tclin,,,Homo sapiens
185658,2740,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,6.3,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
185659,2740,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,7.53,,Ki,The compound was tested for its binding affinity towards Alpha-1 adrenergic receptor by displacing [3H]WB-4101 radioligand in rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,,,,Rattus norvegicus
185660,2740,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.3,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,Tclin|Tclin|Tclin,,,Homo sapiens
185661,2740,1988,NS3,Enzyme,A3EZI9,NS3,A3EZI9_9HEPC,6.15,,IC50,Inhibitory concentration against hepatitis C virus helicase; range 0.6-0.7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,,,,Hepatitis C virus
185662,2740,1984,DNA-dependent protein kinase catalytic subunit,Kinase,P78527,PRKDC,PRKDC_HUMAN,4,,IC50,Inhibition of DNA-PK in human U1810 cells after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,Tchem,,,Homo sapiens
185663,2740,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,8.1,,Ki,Affinity for human EMP expressed in ERG2 deficient strain of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,Tchem,,,Homo sapiens
185664,2740,1992,Beta-glucuronidase,Enzyme,P06760,Gusb,BGLR_RAT,5.11,,IC50,Inhibitory effect of compound on the release of Beta-glucuronidase in rat neutrophils stimulated with fMLP/CB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,,,,Rattus norvegicus
185665,2740,219,Calmodulin,Cytosolic other,P0DP23|P0DP24|P0DP25,CALM1|CALM2|CALM3,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,6,,Kd,Binding affinity to calmodulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,Tclin,,,Homo sapiens
185666,2740,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.39,,Ki,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 from rat hippocampus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,,,,Rattus norvegicus
185667,2740,1993,Lysozyme C-1,Enzyme,P00697,Lyz1,LYSC1_RAT,5.05,,IC50,Inhibitory effect of compound on the release of lysozyme in rat neutrophils stimulated with fMLP/CB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,,,,Rattus norvegicus
185668,2740,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,9.27,,Kd,Compound was tested for its effect on dopamine saturation analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL422,,,,,,,Rattus norvegicus
185672,2562,2000,Alpha-1B adrenergic receptor,GPCR,P18841,ADRA1B,ADA1B_MESAU,9.7,,Ki,In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1b expressed in LTK cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,,,,Mesocricetus auratus
185673,2562,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,9.1,,Ki,Binding affinity towards recombinant human Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,Tclin,,,Homo sapiens
165451,1909,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6.5528,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
185674,2562,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.87,,Ki,Binding affinity against human adrenergic receptor subtype Alpha-2A adrenergic receptor using [3H]rauwolscine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,Tclin,,,Homo sapiens
185675,2562,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.89,,Ki,Binding affinity towards recombinant human Dopamine receptor D2L was determined using [3H]spiperone as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,Tclin,,,Homo sapiens
185676,2562,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,10.24,,Ki,Binding affinity against human adrenergic receptor subtype Alpha-1D adrenergic receptor using [3H]prazosin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,Tclin,,,Homo sapiens
185677,2562,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,10.54,,Ki,Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]prazosin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,Tclin,,,Homo sapiens
185678,2562,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,9.21,,Ki,Binding affinity against human adrenergic receptor subtype Alpha-1B adrenergic receptor using [3H]prazosin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,Tclin,,,Homo sapiens
185679,2562,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.55,,Ki,Binding affinity towards recombinant human Dopamine receptor D3 was determined using [3H]spiperone as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,Tclin,,,Homo sapiens
185680,2562,1733,Alpha-2B adrenergic receptor,GPCR,P19328,Adra2b,ADA2B_RAT,8.17,,Ki,Binding affinity against rat Alpha-2B adrenergic receptor using [3H]rauwolscine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,,,,Rattus norvegicus
185681,2562,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,10.15,,Ki,In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1d expressed in LTK cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,,,,Rattus norvegicus
185682,2562,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,8.1,,Ki,Binding affinity against human Alpha-2C adrenergic receptor using [3H]rauwolscine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,Tclin,,,Homo sapiens
185683,2562,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,10.52,,Ki,In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,,,,Rattus norvegicus
185684,2562,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,6.03,,Ki,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,,,,Rattus norvegicus
185686,2562,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,7.08,,Ki,Binding affinity towards recombinant human 5-hydroxytryptamine 7 receptor was determined using [3H]LSD as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,Tclin,,,Homo sapiens
185687,1989,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,8.3,,IC50,In vitro inhibitory activity against Angiotensin I converting enzyme (ACE) isolated from rabbit lung extract using hippuryl-L-histidyl-L-leucine (HHL) as the substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289556,,,,,,,Oryctolagus cuniculus
185688,1989,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.22,,Ki,Inhibition of human somatic ACE C-terminal domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289556,,,,Tclin,,,Homo sapiens
185689,1989,384,Neprilysin,Enzyme,P08473,MME,NEP_HUMAN,8.05,,Ki,Inhibition of human somatic NEP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289556,,,,Tclin,,,Homo sapiens
185690,1989,1894,Neprilysin,Enzyme,P07861,Mme,NEP_RAT,8.1,,IC50,In vitro inhibitory activity against purified rat kidney neutral endopeptidase (NEP) using a fluorometric assay with dansyl-Gly-Phe-Arg as the substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289556,,,,,,,Rattus norvegicus
185691,1810,850,RAC-alpha serine/threonine-protein kinase,Kinase,P31749,AKT1,AKT1_HUMAN,5.02,,IC50,Inhibition of Akt phosphorylation in human insulin-stimulated A549 cells incubated for 2 hrs prior to insulin-induction measured after 30 mins by ELISA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL125,,,,Tchem,,,Homo sapiens
185692,1810,3469,Dual specificity phosphatase Cdc25A,Enzyme,P30304,CDC25A,MPIP1_HUMAN,4.6,,IC50,Inhibition of Cell division cycle 25 (Cdc25) phosphatase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL125,,,,Tchem,,,Homo sapiens
185693,183,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.27,,Ki,Binding affinity against human Alpha-1d adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491,,,,Tclin,,,Homo sapiens
185694,183,397,Potassium channel subfamily K member 2,Ion channel,O95069,KCNK2,KCNK2_HUMAN,6.4,,IC50,Inhibition of TREK-1 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491,,,,Tclin,,,Homo sapiens
185695,183,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.63,,Ki,Binding affinity against human Alpha-1a adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491,,,,Tclin,,,Homo sapiens
185696,183,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,5.1,,Ki,Binding affinity against human Alpha-1b adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491,,,,Tclin,,,Homo sapiens
185697,183,1853,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,8.7,,Ki,Binding affinity against rat L-type calcium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1491,,,,,,,Rattus norvegicus
185698,2741,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,9.08,,Ki,Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15023,,,,Tclin,,,Homo sapiens
185699,2741,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,9.82,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15023,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
142104,4903,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,8.301030158996582,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19522465,http://www.ncbi.nlm.nih.gov/pubmed/19522465,INHIBITOR,,Tclin,52,52,Homo sapiens
185700,2741,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,6.78,,Ki,Affinity for human EMP expressed in ERG2 deficient strain of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15023,,,,Tchem,,,Homo sapiens
185701,2741,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,9.1,,Ki,Displacement of [3H](+)-pentazocine from sigma1 receptor in rat liver membrane by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15023,,,,,,,Rattus norvegicus
185702,1125,2056,Niemann-Pick C1-like protein 1,Unclassified,Q6T3U3,Npc1l1,NPCL1_RAT,6.7,,Ki,Displacement of [3H]ezetimibe-glucuronide from NPC1L1 in Sprague-Dawley rat brush border membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1138,,,,,,,Rattus norvegicus
185703,562,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1605,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1605,INHIBITOR,,,,,Escherichia coli (strain K12)
185704,2389,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,4.55,,Ki,Binding affinity to rat NET,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185705,2389,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,7.66,,Ki,Displacement of [3H]mepyramine from histamine H1 receptor in guinea pig cerebellum after 60 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Cavia porcellus
185706,2389,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,8.85,,Ki,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185707,2389,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.96,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,Tchem,,,Homo sapiens
185708,2389,1841,D(2) dopamine receptor,GPCR,P61168,Drd2,DRD2_MOUSE,7.64,,IC50,Inhibition of mouse Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Mus musculus
185709,2389,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,8.01,,Ki,Displacement of [3H]7-OH-DPAT from dopamine D3 receptor in rat olfactory tubercle after 60 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185710,2389,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.55,,Ki,Binding affinity to human cloned muscarinic M1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,Tclin,,,Homo sapiens
185711,2389,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,9.85,,Ki,Ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185712,2389,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.68,,Ki,Binding affinity against dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,Tclin,,,Homo sapiens
185713,2389,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.85,,Ki,Binding affinity to human SERT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,Tclin,,,Homo sapiens
185714,2389,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.37,,Ki,Binding affinity measured at the sigma receptor by the inhibition of [3H]-3-PPP binding to guinea pig cerebellum using unlabeled 3-PPP for nonspecific binding.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,Tclin,,,Homo sapiens
185715,2389,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,7.66,,Ki,Affinity for Dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185716,2389,1833,Alpha-2A adrenergic receptor,GPCR,P22909,Adra2a,ADA2A_RAT,7.6,,Ki,Binding affinity measured at the Alpha-2 adrenergic receptor by the inhibition of [3H]clonidine binding to rat cortex using unlabeled NAbitartrate for nonspecific binding.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185717,2389,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,7.1,,IC50,Displacement of [3H]mepyramine from H1R in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
142097,4898,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,9.022275924682617,,Ki,displacement of [3H]-labelled substance P from cloned human receptor expressed in CHO cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/16332435,http://www.ncbi.nlm.nih.gov/pubmed/16332435,ANTAGONIST,,Tclin,47,47,Homo sapiens
142098,4899,2544,Genome polyprotein,Polyprotein,P27958,,POLG_HCVH,10.508638381958008,,EC50,replicon antiviral assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/24320933,http://www.ncbi.nlm.nih.gov/pubmed/24320933,INHIBITOR,,,48,48,Hepatitis C virus genotype 1a (isolate H)
142099,4899,2536,Genome polyprotein,Polyprotein,P26663,,POLG_HCVBK,11.397939682006836,,EC50,replicon antiviral assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/24320933,http://www.ncbi.nlm.nih.gov/pubmed/24320933,INHIBITOR,,,48,48,Hepatitis C virus genotype 1b (isolate BK)
142100,4900,860,P2Y purinoceptor 2,GPCR,P41231,P2RY2,P2RY2_HUMAN,7.4685211181640625,,EC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/18232657,http://www.ncbi.nlm.nih.gov/pubmed/18232657,AGONIST,,Tclin,49,49,Homo sapiens
142101,4365,445,Potassium voltage-gated channel subfamily A member 5,Ion channel,P22460,KCNA5,KCNA5_HUMAN,4.874518871307373,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17872968,http://www.ncbi.nlm.nih.gov/pubmed/17872968,BLOCKER,,Tclin,50,50,Homo sapiens
142102,4902,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.498940467834473,,Kb,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/10428387,http://www.ncbi.nlm.nih.gov/pubmed/10428387,ANTAGONIST,,Tclin,51,51,Homo sapiens
142103,4902,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.384050369262695,,Kb,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/10428387,,,,Tclin,51,,Homo sapiens
142153,4519,17,pH (H+ ion activity),Unclassified,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019071s012lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019071s012lbl.pdf,OTHER,,,557,557,
142105,4903,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,7.4202165603637695,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19522465,http://www.ncbi.nlm.nih.gov/pubmed/19522465,INHIBITOR,,Tclin,52,52,Homo sapiens
142106,4903,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,7.744727611541748,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19522465,http://www.ncbi.nlm.nih.gov/pubmed/19522465,INHIBITOR,,Tclin,52,52,Homo sapiens
142107,4903,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,6.982966423034668,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19522465,http://www.ncbi.nlm.nih.gov/pubmed/19522465,INHIBITOR,,Tclin,52,52,Homo sapiens
142108,4903,543,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,8.301030158996582,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19522465,http://www.ncbi.nlm.nih.gov/pubmed/19522465,INHIBITOR,,Tclin,52,52,Homo sapiens
142109,2589,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021029s028lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021029s028lbl.pdf,OTHER,,,311,311,
142110,4904,503,Tumor necrosis factor,Cytokine,P01375,TNF,TNFA_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125057s367lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125057s367lbl.pdf,ANTIBODY BINDING,,Tclin,187,187,Homo sapiens
142112,1576,565,"Troponin C, slow skeletal and cardiac muscles",Cytosolic other,P63316,TNNC1,TNNC1_HUMAN,3.1549019813537598,,Kd,affinity for the binding of levosimendan to cNTnC-Ca2+-cTnI-(144-163) complex,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/18570382,http://www.ncbi.nlm.nih.gov/pubmed/18570382,OPENER,,Tclin,53,53,Homo sapiens
142113,4906,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.376750946044922,,IC50,antagonism of angiotensin II induced contraction,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22264484,http://www.ncbi.nlm.nih.gov/pubmed/22264484,ANTAGONIST,,Tclin,54,54,Homo sapiens
142114,2167,140,Sodium channel protein type 4 subunit alpha,Ion channel,P35499,SCN4A,SCN4A_HUMAN,4.376750946044922,,IC50,pH 8.2; use-dependent block at -70mV,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20590641,http://www.ncbi.nlm.nih.gov/pubmed/20590641,BLOCKER,,Tclin,55,55,Homo sapiens
142115,4907,699,Poly [ADP-ribose] polymerase 1,Enzyme,P09874,PARP1,PARP1_HUMAN,8.301030158996582,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/18800822,http://www.ncbi.nlm.nih.gov/pubmed/18800822,INHIBITOR,,Tclin,56,56,Homo sapiens
142116,4907,34,Poly [ADP-ribose] polymerase 2,Enzyme,Q9UGN5,PARP2,PARP2_HUMAN,9,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/18800822,http://www.ncbi.nlm.nih.gov/pubmed/18800822,INHIBITOR,,Tclin,56,56,Homo sapiens
142117,4907,2537,Tankyrase-1,Enzyme,O95271,TNKS,TNKS1_HUMAN,5.823908805847168,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/18800822,,,,Tchem,56,,Homo sapiens
142119,4836,2523,Melanocyte-stimulating hormone receptor,GPCR,Q01726,MC1R,MSHR_HUMAN,10,,IC50,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1324,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002548/WC500182307.pdf,AGONIST,,Tclin,,189,Homo sapiens
142120,4905,1643,Vascular endothelial growth factor A,Secreted,P15692,VEGFA,VEGFA_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021756s018lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021756s018lbl.pdf,ANTAGONIST,,Tclin,251,251,Homo sapiens
142123,4330,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002055/WC500127968.pdf,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002055/WC500127968.pdf,OTHER,,,310,310,
142124,4192,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,6.812,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002294/WC500117862.pdf,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002294/WC500117862.pdf,BINDING AGENT,,Tclin,184,184,Homo sapiens
142125,4188,2,iron,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021825s003lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021825s003lbl.pdf,CHELATING AGENT,,,538,538,
142126,992,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/17276408,BLOCKER,,Tclin|Tclin,,509,Homo sapiens
142130,234,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,KEGG DRUG,,http://www.kegg.jp/entry/D01562,BLOCKER,,Tclin|Tclin,,,Homo sapiens
142133,5,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022276s003lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022276s003lbl.pdf,BLOCKER,,Tclin|Tclin,277,277,Homo sapiens
142134,290,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,KEGG DRUG,,http://www.kegg.jp/entry/D07494,BLOCKER,,Tclin|Tclin,,,Homo sapiens
142137,272,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,KEGG DRUG,,http://www.kegg.jp/entry/D01145,BLOCKER,,Tclin|Tclin,,,Homo sapiens
142142,4745,8,glutamine,Amino acid,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203284s001lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203284s001lbl.pdf,OTHER,,,317,317,
142143,666,17,pH (H+ ion activity),Unclassified,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019481s013lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019481s013lbl.pdf,OTHER,,,540,540,
142146,4205,17,pH (H+ ion activity),Unclassified,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/077394lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/077394lbl.pdf,OTHER,,,554,554,
165452,1285,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.5229,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
142156,4287,14,phosphate,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21160lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21160lbl.pdf,SEQUESTERING AGENT,,,555,555,
142157,4324,14,phosphate,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021179Orig1s030lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021179Orig1s030lbl.pdf,SEQUESTERING AGENT,,,313,313,
142158,4331,14,phosphate,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022127s011lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022127s011lbl.pdf,SEQUESTERING AGENT,,,556,556,
142162,4585,14,phosphate,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021468s019lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021468s019lbl.pdf,SEQUESTERING AGENT,,,312,312,
142168,4624,8,glutamine,Amino acid,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020645s008lbl.pdf,OTHER,,,,522,
142169,728,16,bile acids,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,"http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/017563s023,020222s005lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/017563s023,020222s005lbl.pdf",CHELATING AGENT,,,315,315,
142171,4405,16,bile acids,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21176lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21176lbl.pdf,CHELATING AGENT,,,316,316,
142172,2486,15,lead,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019998s013lbl.pdf,CHELATING AGENT,,,,523,
142173,987,15,lead,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/008922s016lbl.pdf,CHELATING AGENT,,,,524,
142174,2092,15,lead,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021749s008lbl.pdf,CHELATING AGENT,,,,525,
142175,987,4,calcium,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/008922s016lbl.pdf,CHELATING AGENT,,,,524,
142176,3128,2,iron,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021882s021lbl.pdf,CHELATING AGENT,,,,460,
142177,792,2,iron,Inorganic material,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016267s050lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016267s050lbl.pdf,CHELATING AGENT,,,542,542,
142179,4747,7,RNA,RNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203568s004lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203568s004lbl.pdf,ANTISENSE INHIBITOR,,,278,278,
142181,4889,2544,Genome polyprotein,Polyprotein,P27958,,POLG_HCVH,9.397939682006836,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22869577,http://www.ncbi.nlm.nih.gov/pubmed/22869577,INHIBITOR,,,57,57,Hepatitis C virus genotype 1a (isolate H)
142183,4696,509,Renin,Enzyme,P00797,REN,RENI_HUMAN,9.154901504516602,,IC50,purified human renin,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/1830563,http://www.ncbi.nlm.nih.gov/pubmed/1830563,INHIBITOR,,Tclin,58,58,Homo sapiens
142187,2255,1030,Voltage-dependent calcium channel subunit alpha-2/delta-2,Ion channel,Q9NY47,CACNA2D2,CA2D2_HUMAN,7.259637355804443,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21651903,http://www.ncbi.nlm.nih.gov/pubmed/21651903,MODULATOR,,Tclin,60,60,Homo sapiens
142189,1264,1030,Voltage-dependent calcium channel subunit alpha-2/delta-2,Ion channel,Q9NY47,CACNA2D2,CA2D2_HUMAN,6.9281182289123535,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21651903,http://www.ncbi.nlm.nih.gov/pubmed/21651903,MODULATOR,,Tclin,60,60,Homo sapiens
142190,4170,2585,Growth hormone-releasing hormone receptor,GPCR,Q02643,GHRHR,GHRHR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022505s004lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022505s004lbl.pdf,AGONIST,,Tclin,190,190,Homo sapiens
142191,4119,2916,Histone deacetylase,Enzyme,O15379|P56524|Q13547|Q8WUI4|Q92769|Q969S8|Q96DB2|Q9BY41|Q9UBN7|Q9UKV0|Q9UQL6,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,HDA10_HUMAN|HDA11_HUMAN|HDAC1_HUMAN|HDAC2_HUMAN|HDAC3_HUMAN|HDAC4_HUMAN|HDAC5_HUMAN|HDAC6_HUMAN|HDAC7_HUMAN|HDAC8_HUMAN|HDAC9_HUMAN,5.96,,Ki,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7006,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022393s013lbl.pdf,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,304,304,Homo sapiens
142192,2678,335,Muscarinic acetylcholine receptor,GPCR,F1PT23,CHRM1,F1PT23_CANFA,8.699999809265137,,Ki,radioligand ([3H]QNB) displacement assay,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/8839659,,,,,61,,Canis familiaris
142193,2678,2538,Muscarinic acetylcholine receptor,GPCR,F1PWR7,CHRM2,F1PWR7_CANFA,8.9399995803833,,Ki,radioligand ([3H]QNB) displacement assay,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/8839659,,,,,61,,Canis familiaris
142194,2678,2539,Muscarinic acetylcholine receptor,GPCR,F1PGZ2,CHRM3,F1PGZ2_CANFA,9.109999656677246,,Ki,radioligand ([3H]QNB) displacement assay,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/8839659,,,,,61,,Canis familiaris
142196,2551,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,7.301030158996582,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/24508831,http://www.ncbi.nlm.nih.gov/pubmed/24508831,INHIBITOR,,Tclin,62,62,Homo sapiens
142197,4908,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.522878646850586,,IC50,recombinant human AChE,DRUG LABEL,=,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/21651906,INHIBITOR,,Tclin,,285,Homo sapiens
142198,2586,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,8.443697929382324,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/2851680,,INHIBITOR,,,63,,Oryctolagus cuniculus
142199,2586,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/8427943,INHIBITOR,,Tclin,,213,Homo sapiens
142200,798,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,6.92081880569458,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/3021350,,,,,64,,Oryctolagus cuniculus
165453,219,266,Multidrug resistance-associated protein 7,Transporter,Q5T3U5,ABCC10,MRP7_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
142203,798,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,9.970000267028809,,Ki,ACE inhibition in human coronary artery tissue,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/8891872,http://www.ncbi.nlm.nih.gov/pubmed/8891872,INHIBITOR,,Tclin,65,65,Homo sapiens
142206,101,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/3000389,INHIBITOR,,Tclin,,210,Homo sapiens
142208,4901,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021081s062lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021081s062lbl.pdf,AGONIST,,Tclin,188,188,Homo sapiens
185718,2389,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.8,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,Tchem,,,Homo sapiens
185719,2389,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,7.84,,Ki,Displacement of [3H]mesulergine from 5HT2C receptor in rat cerebral cortex after 15 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185720,2389,1854,5-hydroxytryptamine receptor 1A,GPCR,Q64264,Htr1a,5HT1A_MOUSE,6.37,,IC50,Inhibitory activity against serotonin 5-hydroxytryptamine 1A receptor from mice.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Mus musculus
185721,2389,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,9.82,,Ki,Displacement of [3H]ketanserin from 5HT2A receptor in CRL:CD(SD)BR-COBS rat cortex by scintillation spectrometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185722,2389,1803,Beta-1 adrenergic receptor,GPCR,P18090,Adrb1,ADRB1_RAT,4.66,,Ki,Binding affinity measured at the Beta-1 adrenergic receptor by the inhibition of [3H]DHA binding to rat cortex using unlabeled isoprenalin for nonspecific binding.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185723,2389,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.65,,Ki,Displacement of [3H]5-LSD from human 5HT6 receptor expressed in human HeLa cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,Tchem,,,Homo sapiens
185724,2389,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.89,,Ki,Binding affinity measured at the Alpha-1A adrenergic receptor by the inhibition of [3H]prazosin binding to rat cortex using unlabeled WB-4101 for nonspecific binding.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185725,2389,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,6.47,,Ki,The binding affinity was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185726,2389,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.89,,Ki,Ability to displace [3H]-8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185727,2389,2866,Serotonin 2 (5-HT2) receptor,GPCR,P34968|P35363|Q02152,Htr2a|Htr2b|Htr2c,5HT2A_MOUSE|5HT2B_MOUSE|5HT2C_MOUSE,8.82,,IC50,Inhibitory activity against serotonin 5-hydroxytryptamine 2 receptor from mice.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Mus musculus
185728,2389,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.74,,Ki,Ability to displace [3H]spiperone from D2 dopamine receptor isolated from the striata of male Wistar rats,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,,,,Rattus norvegicus
185734,3839,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,7.49,,IC50,"Compound was tested for inhibition against Angiotensin II receptor, type 1",CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL432162,http://www.ncbi.nlm.nih.gov/pubmed/10487332,ANTAGONIST,,Tclin,,510,Homo sapiens
185735,3839,2881,Angiotensin II receptor (AT-1) type-1,GPCR,P25095|P29089,Agtr1|Agtr1b,AGTRA_RAT|AGTRB_RAT,8.92,,IC50,"Compound was evaluated for the in vitro inhibition of specific binding of [125I]-A II to Angiotensin II receptor, type 1 from rat adrenal membranes.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL432162,,,,,,,Rattus norvegicus
185736,1229,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,7.55,,IC50,Inhibitory concentration against 3-hydroxy-3-methylglutaryl-CoA reductase,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218894,"http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020261s048,021192s021lbl.pdf",INHIBITOR,,Tclin,,259,Homo sapiens
185737,1229,1796,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P51639,Hmgcr,HMDH_RAT,8.6,,IC50,Inhibitory activity against partially purified rat liver HMG-CoA reductase in vitro; 0.0015-0.0040,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218894,,,,,,,Rattus norvegicus
185738,59,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,6.1,,Ki,Displacement of [3H]mibolerone from rat androgen receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1085,,,,,,,Rattus norvegicus
185739,450,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,Mechanism of Action; CHEMBL1780; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1295,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1295,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
185740,87,231,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,5.96,,Ki,Binding affinity towards Retinoic acid receptor alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1265,,,,Tclin,,,Homo sapiens
185741,87,427,Retinoic acid receptor gamma,Nuclear hormone receptor,P13631,RARG,RARG_HUMAN,6.89,,Ki,Binding affinity towards Retinoic acid receptor gamma,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1265,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1265,AGONIST,,Tclin,,,Homo sapiens
185742,87,426,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,7.47,,Ki,Binding affinity towards Retinoic acid receptor beta,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1265,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1265,AGONIST,,Tclin,,,Homo sapiens
185743,648,1726,Cysteinyl leukotriene receptor 1,GPCR,Q2NNR5,CYSLTR1,CLTR1_CAVPO,8.19,,Ki,Binding affinity towards Cysteinyl leukotriene D4 receptor (cysLT1) was measured by the displacement of [3H]LTD4 radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL283754,,,,,,,Cavia porcellus
185744,465,429,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,9.51,,Kd,Binding affinity to VDR receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200666,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200666,AGONIST,,Tclin,,,Homo sapiens
185745,3018,1930,KiSS-1 receptor,GPCR,Q969F8,KISS1R,KISSR_HUMAN,5.44,,Ki,Displacement of [125]metastin from metastin receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221753,,,,Tchem,,,Homo sapiens
185746,2865,2092,Transporter,Transporter,Q63380,NET,Q63380_RAT,7.32,,Ki,Binding affinity to rat NET,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL708,,,,,,,Rattus norvegicus
185747,2865,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,8.02,,Ki,Binding affinity against dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL708,,,,Tclin,,,Homo sapiens
185748,2865,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,6.82,,IC50,Displacement of [3H]mepyramine from H1R in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL708,,,,,,,Rattus norvegicus
185749,2865,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,7.96,,Ki,Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL708,,,,,,,Rattus norvegicus
185750,2865,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,9.3,,Ki,Displacement of [3H]prazosin from rat adrenergic alpha1A receptor expressed in fibroblast cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL708,,,,,,,Rattus norvegicus
185751,2865,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.32,,Ki,Displacement of [3H]NPA from rat brain Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL708,,,,,,,Rattus norvegicus
185752,1973,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.59,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL364713,,,,Tchem,,,Homo sapiens
185753,1973,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.46,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL364713,,,,Tchem,,,Homo sapiens
185754,1176,3590,Potassium voltage-gated channel subfamily D member 2,Unclassified,Q63881,Kcnd2,KCND2_RAT,5,,IC50,Inhibition of rat potassium channel Kv4.2 by patch-clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL652,,,,,,,Rattus norvegicus
185755,1176,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,5.19,,IC50,Inhibition of human heart sodium channel Nav1.5 by patch-clamp method,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL652,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL652,BLOCKER,,Tclin,,,Homo sapiens
185756,1176,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.41,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL652,,,,Tclin,,,Homo sapiens
185757,3481,2869,Tubulin,Structural,P02550|P02554,TUBA1A,TBA1A_PIG|TBB_PIG,5.66,,Ki,Binding affinity against tubulin using [3H]colchicine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61,,,,,,,Sus scrofa
185758,3481,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.85,,IC50,Inhibition of human glucocorticoid receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61,,,,Tclin,,,Homo sapiens
185759,3481,1806,Tubulin alpha-1A chain,Structural,P02550,TUBA1A,TBA1A_PIG,6.34,,IC50,Inhibition of tubulin polymerization. (ITP),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61,,,,,,,Sus scrofa
185760,3481,3602,Human papillomavirus regulatory protein E2,Unclassified,P03120,E2,VE2_HPV16,4.15,,Kd,Binding affinity to HPV16 recombinant E2 protein by surface plasmon resonance method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61,,,,,,,Human papillomavirus type 16
185761,3481,1642,Regulatory protein E2,Unclassified,P04015,E2,VE2_HPV11,4.7,,Kd,Binding affinity to HPV11 recombinant E2 protein by surface plasmon resonance method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61,,,,,,,Human papillomavirus type 11
185762,3481,2091,Regulatory protein E2,Unclassified,P03118,E2,VE2_HPV1A,5.98,,Kd,Binding affinity to HPV1a recombinant E2 protein hinge domain by surface plasmon resonance assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61,,,,,,,Human papillomavirus type 1a
185763,3481,2784,Tubulin,Structural,P04350|P07437|P68363|P68366|P68371|Q13509|Q13748|Q13885|Q3ZCM7|Q6PEY2|Q71U36|Q9BQE3|Q9BUF5|Q9BVA1|Q9H4B7,TUBA1A|TUBA1B|TUBA1C|TUBA3C|TUBA3E|TUBA4A|TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBA1A_HUMAN|TBA1B_HUMAN|TBA1C_HUMAN|TBA3C_HUMAN|TBA3E_HUMAN|TBA4A_HUMAN|TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,6,,IC50,In vitro inhibition of mammalian tubulin polymerization by 50%,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61,,,,Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
166514,841,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2147,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL612,INHIBITOR,,Tclin,,,Homo sapiens
166545,924,601,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B",Enzyme,O95263,PDE8B,PDE8B_HUMAN,4.3,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4807,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin,,,Homo sapiens
166560,934,1683,Transient receptor potential cation channel subfamily A member 1,Ion channel,O75762,TRPA1,TRPA1_HUMAN,4.5,,EC50,"Calcium imaging, patch clamp",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2430,,ACTIVATOR,,Tclin,,,Homo sapiens
166576,961,866,Neutrophil collagenase,Enzyme,P22894,MMP8,MMP8_HUMAN,4.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6464,,INHIBITOR,,Tclin,,,Homo sapiens
166605,990,1101,Ornithine decarboxylase,Enzyme,P11926,ODC1,DCOR_HUMAN,4.89,,Kd,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5176,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL830,INHIBITOR,,Tclin,,,Homo sapiens
166824,1546,260,Somatostatin receptor type 5,GPCR,P35346,SSTR5,SSR5_HUMAN,9.3,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2031,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201184,AGONIST,,Tclin,,,Homo sapiens
166656,1125,1362,Niemann-Pick C1-like protein 1,Membrane other,Q9UHC9,NPC1L1,NPCL1_HUMAN,6.66,,Kd,Measure of ezetimibe glucuronide binding to NPC1L1,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6816,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1138,ANTAGONIST,,Tclin,,,Homo sapiens
166695,1285,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,4.23,,EC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3439,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL457,AGONIST,,Tclin,,,Homo sapiens
185764,3481,2868,Tubulin,Structural,Q6B856|Q862F3|Q862L2,TUBB2B,Q862F3_BOVIN|Q862L2_BOVIN|TBB2B_BOVIN,6.34,,IC50,Inhibition of bovine brain tubulin polymerization (ITP).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61,,,,,,,Bos taurus
185765,1869,3472,Penicillin-binding protein,Enzyme,P72355|Q53707|Q53725|Q53729|Q9XDB3,PBP2|mecA|pbp4|pbpA|pbpF,P72355_STAAU|Q53707_STAAU|Q53725_STAAU|Q53729_STAAU|Q9XDB3_STAAU,,,,Mechanism of Action; CHEMBL2362972; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1443,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1443,INHIBITOR,,,,,Staphylococcus aureus
185766,1032,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,4.74,,IC50,Antagonist activity at glucocorticoid receptor (unknown origin) by NH Pro assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095097,,,,Tclin,,,Homo sapiens
185767,897,1827,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P15381,CACNA1C,CAC1C_RABIT,4.52,,IC50,Inhibition of [3H]nitrendipine binding to calcium channels in rabbit cardiac muscle,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23,,,,,,,Oryctolagus cuniculus
185768,897,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.37,,IC50,Inhibition of P-glycoprotein expressed in A2780/ADR cells by calcein AM assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23,,,,Tchem,,,Homo sapiens
185769,897,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.91,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23,,,,Tchem,,,Homo sapiens
185770,897,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.76,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23,,,,Tclin,,,Homo sapiens
185771,897,437,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q13698,CACNA1S,CAC1S_HUMAN,6.42,,Ki,Displacement of [3H]diltiazem from L-type calcium channel of guinea pig striated muscle,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23,,,,Tclin,,,Homo sapiens
185772,897,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.35,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23,,,,Tclin|Tclin|Tclin,,,Homo sapiens
185773,897,2874,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,7.8,,Ki,Inhibitory constant against calcium channel receptors (CCRs),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23,,,,,,,Rattus norvegicus
185774,897,1882,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,P27732,Cacna1d,CAC1D_RAT,7.34,,IC50,"Inhibition of [3H]nitrendipine binding to L-type [Ca2+] channel in rat cortex homogenate, activity expressed as pIC50",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23,,,,,,,Rattus norvegicus
185775,897,1853,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,7.27,,IC50,Ability to inhibit [3H]nitrendipine binding to the L-type calcium channel receptor(CCR) in rat heart homogenate.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23,,,,,,,Rattus norvegicus
185776,2451,1366,Nuclear factor NF-kappa-B p105 subunit,Cytosolic other,P19838,NFKB1,NFKB1_HUMAN,5.6,,IC50,Inhibition of NF-KB p50 subunit/DNA interaction after 20 mins by EMSA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53569,,,,Tclin,,,Homo sapiens
185779,2419,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.41,,Ki,Displacement of [125I]cyanopindolol from human recombinant beta2 adrenergic receptor expressed in CHO cells by filtration assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1263,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1263,AGONIST,,Tclin,,,Homo sapiens
185780,2419,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.1,,Ki,Displacement of [3H]CGP12177 from human beta-1 adrenoceptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1263,,,,Tclin,,,Homo sapiens
185781,2419,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,7.5,,EC50,Agonist activity at beta2 receptor in guinea pig trachea assessed as slow onset of inhibition of electrically stimulated contraction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1263,,,,,,,Cavia porcellus
185782,2419,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6,,EC50,Agonist activity at human recombinant beta3 receptor assessed as cAMP accumulation by radioimmunoassay and cell based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1263,,,,Tclin,,,Homo sapiens
185783,47,613,Lactoylglutathione lyase,Enzyme,Q04760,GLO1,LGUL_HUMAN,4.89,,Ki,Inhibition of glyoxalase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189171,,,,Tchem,,,Homo sapiens
185784,2413,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.41,,IC50,Inhibitory concentration against histamine H1 receptor,CHEMBL,=,1,KEGG DRUG,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91397,http://www.kegg.jp/entry/D07407,ANTAGONIST,,Tclin,,,Homo sapiens
166780,1395,553,Toll-like receptor 7,Membrane receptor,Q9NYK1,TLR7,TLR7_HUMAN,5.56,,IC50,Inhibition of hTLR7 R848-induced luciferase reporter gene activation.,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7198,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1535,ANTAGONIST,,Tclin,,,Homo sapiens
166781,1395,649,Toll-like receptor 9,Membrane receptor,Q9NR96,TLR9,TLR9_HUMAN,7.1,,IC50,Inhibition of hTLR9 CpG2006-induced luciferase reporter gene activation.,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7198,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1535,ANTAGONIST,,Tclin,,,Homo sapiens
165420,1283,300,Deoxycytidine kinase,Kinase,P27707,DCK,DCK_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165421,667,300,Deoxycytidine kinase,Kinase,P27707,DCK,DCK_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
166825,1546,258,Somatostatin receptor type 2,GPCR,P30874,SSTR2,SSR2_HUMAN,9.6,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2031,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201184,AGONIST,,Tclin,,,Homo sapiens
185785,2413,305,Platelet-activating factor receptor,GPCR,P25105,PTAFR,PTAFR_HUMAN,5.43,,IC50,Inhibitory concentration against platelet activating factor receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91397,,,,Tchem,,,Homo sapiens
185786,3309,425,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,6.21,,Ki,In vitro inhibition of human Cytochrome P450 17A1 activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1571863,,,,Tclin,,,Homo sapiens
185787,1800,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,6.22,,IC50,Inhibition of human placental microsome CYP19,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,Tclin,,,Homo sapiens
185788,1800,3464,Malate dehydrogenase cytoplasmic ,Enzyme,P40925,MDH1,MDHC_HUMAN,4.6,,IC50,Inhibition of malate dehydrogenase (MDH),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,Tbio,,,Homo sapiens
185789,1800,2492,"Indoleamine 2,3-dioxygenase 2",Enzyme,Q8R0V5,Ido2,I23O2_MOUSE,5.17,,IC50,Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,,,,Mus musculus
185790,1800,1911,Aromatase,Enzyme,P22443,Cyp19a1,CP19A_RAT,6.4,,EC50,In vitro inhibition of cytochrome P450 19A1 by rat ovarian microsomes incubated with [3H]androstenedione and NADPH-generating system.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,,,,Rattus norvegicus
185791,1800,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,4.4,,IC50,Compound was tested for the inhibition of beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,,,,Escherichia coli (strain K12)
185792,1800,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,6.7,,IC50,Inhibition of human CYP51 expressed in Topp 3 cells by lanosterol demethylase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,Tchem,,,Homo sapiens
185793,1800,2119,Lanosterol 14-alpha demethylase,Enzyme,P9WPP9,cyp51,CP51_MYCTU,6.7,,Kd,Binding affinity to Mycobacterium tuberculosis CYP51,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
185794,1800,3596,"Indoleamine 2,3-dioxygenase 1",Enzyme,P28776,Ido1,I23O1_MOUSE,4.75,,IC50,Inhibition of mouse Ido1 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,,,,Mus musculus
185795,1800,425,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,6.61,,Ki,In vitro inhibition of human Cytochrome P450 17A1 activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,Tclin,,,Homo sapiens
185796,1800,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,Mechanism of Action; CHEMBL1780; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
185797,2777,2749,Topoisomerase IV,Enzyme,P0AFI2|P20083,parC|parE,PARC_ECOLI|PARE_ECOLI,,,,Mechanism of Action; CHEMBL2363076; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL428,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL428,INHIBITOR,,,,,Escherichia coli (strain K12)
185798,2777,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,,,,Mechanism of Action; CHEMBL2311224; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL428,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL428,INHIBITOR,,,,,Escherichia coli (strain K12)
185799,2354,527,Prostaglandin D2 receptor,GPCR,Q13258,PTGDR,PD2R_HUMAN,4.96,,Ki,Binding affinity to prostanoid DP1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL361812,,,,Tclin,,,Homo sapiens
185800,2354,228,Prostaglandin D2 receptor 2,GPCR,Q9Y5Y4,PTGDR2,PD2R2_HUMAN,8.37,,Ki,Inhibition of [3H]PGD-2 binding to human chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL361812,,,,Tchem,,,Homo sapiens
185801,2354,393,Thromboxane A2 receptor,GPCR,P21731,TBXA2R,TA2R_HUMAN,9.24,,Ki,Binding affinity to thromboxane receptor,CHEMBL,=,1,KEGG DRUG,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL361812,http://www.kegg.jp/entry/D01128,INVERSE AGONIST,,Tclin,,,Homo sapiens
185802,3135,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201109,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201109,AGONIST,,Tclin,,,Homo sapiens
185803,2356,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,6.6,,IC50,Inhibition of rabbit lung ACE assessed as hydrolysis of hippuryl-histidyl-leucine to hippuric acid and histidyl-leucine after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1168,,,,,,,Oryctolagus cuniculus
185804,114,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,7.82,,IC50,In vitro binding activity against opioid receptor mu using [3H]DAGO) as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL634,,,,,,,Cavia porcellus
185805,114,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,8.09,,Ki,In vitro affinity to displace [3H]naloxone from opiate receptor in freshly prepared rat brain homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL634,,,,,,,Rattus norvegicus
185806,114,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,8.09,,Ki,Ability to displace [3H]naloxone from the Opioid receptor mu 1 isolated from the rat brain membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL634,,,,,,,Rattus norvegicus
185807,2475,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.4,,Ki,Binding affinity to human androgen receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1393,,,,Tclin,,,Homo sapiens
166904,1747,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,7.6,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6829,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201117,INHIBITOR,,Tclin,,,Homo sapiens
166975,1937,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,6.8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2523,,ANTAGONIST,,Tclin,,,Homo sapiens
165444,1384,273,DNA (cytosine-5)-methyltransferase 3B,Enzyme,Q9UBC3,DNMT3B,DNM3B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
166986,1960,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=505,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,AGONIST,,Tclin,,,Homo sapiens
166989,1985,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,8.1,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=591,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1516,ANTAGONIST,,Tclin,,,Homo sapiens
185808,2475,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,5.48,,EC50,Agonist activity at estrogen receptor beta (unknown origin) by NH Pro assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1393,,,,Tclin,,,Homo sapiens
185809,2475,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.73,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1393,,,,Tchem,,,Homo sapiens
185810,2475,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,6.17,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1393,,,,,,,Rattus norvegicus
185811,466,2039,Vitamin D3 receptor,Transcription factor,Q28037,VDR,VDR_BOVIN,10.3,,EC50,"Displacement of [3H]1,25-(OH)2D3 from bovine thymus vitamin D receptor",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846,,,,,,,Bos taurus
185812,466,2304,Vitamin D3 receptor,Unclassified,A3RGC1,VDR,VDR_PIG,10.15,,Kd,"Displacement of [3H]1-alpha,25-(OH)2D3 from VDR in pig intestinal mucosa",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846,,,,,,,Sus scrofa
185813,466,1804,Vitamin D3 receptor,Transcription factor,P13053,Vdr,VDR_RAT,10.3,,Ki,"Displacement of [3H]1-alpha,25-(OH)2D3 from rat recombinant full length VDR",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846,,,,,,,Rattus norvegicus
185814,466,1843,Vitamin D3 receptor,Transcription factor,O42392,VDR,VDR_CHICK,10.6,,Ki,Displacement from vitamin D receptor in chick intestine: 50% displacement,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846,,,,,,,Gallus gallus
185815,466,664,Vitamin D-binding protein,Secreted,P02774,GC,VTDB_HUMAN,7.62,,Kd,Binding affinity to human vitamin D binding protein,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846,,,,Tchem,,,Homo sapiens
185816,466,3479,Vitamin D3 receptor A,Nuclear hormone receptor,Q9PTN2,vdra,VDRA_DANRE,8.26,,EC50,Agonist activity at zebrafish gal4-VDR LBD expressed in human MCF7 cells by luciferase reporter gene based transactivation assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846,,,,,,,Danio rerio
185817,1937,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,6.41,,EC50,Agonist activity at PXR (unknown origin) expressed in human HepG2 cells assessed as induction of CYP3A4 transactivation after 16 hrs by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428,,,,Tchem,,,Homo sapiens
185818,1937,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,5.05,,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428,,,,Tclin,,,Homo sapiens
185819,1937,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,4.35,,Ki,Displacement of [3H]-CGS- 21680 binding to Adenosine A2A receptor in rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428,,,,,,,Rattus norvegicus
185820,1937,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,4.7,,Ki,Displacement of [3H](R)-PIA binding to Adenosine A1 receptor in rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428,,,,,,,Rattus norvegicus
185821,2445,3603,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Unclassified,Q10283,hmg1,HMDH_SCHPO,4.02,,IC50,Inhibition of Schizosaccharomyces pombe HMG-CoA reductase by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1064,,,,,,,Schizosaccharomyces pombe (strain 972 / ATCC 24843)
185822,2445,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,5.74,,Ki,Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) assessed as inhibition of ATCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1064,,,,,,,Electrophorus electricus
185823,2445,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,6.12,,Ki,Inhibition of Equus caballus (horse) serum butyrylcholinesterase (BChE) assessed as inhibition of BTCh hydrolysis by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1064,,,,,,,Equus caballus
185824,2445,1796,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P51639,Hmgcr,HMDH_RAT,8.37,,IC50,Inhibition of HMGR in rat hepatic microsomes assessed as conversion of [14C]HMG-CoA to [14C]mevalonic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1064,,,,,,,Rattus norvegicus
185825,1564,3604,Neurotensin receptor 2,Unclassified,Q63384,Ntsr2,NTR2_RAT,7.48,,Ki,Displacement of [125I]NT at rat NTS2 overexpressed in CHOK1 cells after 30 mins by gamma counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237102,,,,,,,Rattus norvegicus
185826,2707,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.21,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84,,,,Tchem,,,Homo sapiens
185827,2707,596,DNA topoisomerase 1,Enzyme,P11387,TOP1,TOP1_HUMAN,7.58,,Kd,Binding affinity to topoisomerase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84,,,,Tclin,,,Homo sapiens
185828,2707,2390,Hypoxia-inducible factor 1-alpha,Transcription factor,Q16665,HIF1A,HIF1A_HUMAN,7.22,,IC50,Inhibition of HIF1alpha in human U251 cells under hypoxic condition by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84,,,,Tchem,,,Homo sapiens
185829,2707,3605,DNA topoisomerase I,Unclassified,Q04750,Top1,TOP1_MOUSE,4.7,,IC50,Average concentration to cause 50% inhibition of topo 1 using the cleavable complex assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84,,,,,,,Mus musculus
185830,2707,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,5.07,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84,,,,Tchem,,,Homo sapiens
185831,2707,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.89,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84,,,,Tchem,,,Homo sapiens
185832,2214,1796,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P51639,Hmgcr,HMDH_RAT,4.98,,IC50,Inhibition of Holtzman-Sprague-Dawley rat liver HMG CoA reductase after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201753,,,,,,,Rattus norvegicus
185833,1848,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,7.16,,Ki,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL60889,,,,,,,Cavia porcellus
185834,1848,2783,Serotonin 3 (5-HT3) receptor,Ion channel,P35563|Q9JJ16,Htr3a|Htr3b,5HT3A_RAT|5HT3B_RAT,5.92,,Ki,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL60889,,,,,,,Rattus norvegicus
185835,1848,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.32,,IC50,Inhibition of human ERG expressed in HEK293 cells by whole cell patch clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL60889,,,,Tclin,,,Homo sapiens
185836,732,392,Vasopressin V2 receptor,GPCR,P30518,AVPR2,V2R_HUMAN,9.44,,Ki,Displacement [3H]Arg human recombinant Vasopressin V2 receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1755,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1755,ANTAGONIST,,Tclin,,,Homo sapiens
185837,732,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,9.37,,Ki,Displacement [3H]Arg human recombinant Vasopressin V1a receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1755,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1755,ANTAGONIST,,Tclin,,,Homo sapiens
185838,1610,2419,Type-1 angiotensin II receptor,GPCR,P34976,AGTR1,AGTR1_RABIT,8.8,,Kd,In vitro binding affinity against Angiotensin II receptor in rabbit aorta rings,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,,,,Oryctolagus cuniculus
185839,1610,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,4.59,,IC50,Inhibitory effect in cAMP-specific Phosphodiesterase 4 (PDE 4) isolated from guinea pig ventricular tissue.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
185840,1610,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,7.72,,IC50,Inhibitory activity against angiotensin I converting enzyme (ACE),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,Tclin,,,Homo sapiens
185841,1610,2882,Angiotensin II receptor,GPCR,P25095|P29089|P35351,Agtr1|Agtr1b|Agtr2,AGTR2_RAT|AGTRA_RAT|AGTRB_RAT,8.34,,IC50,Displacement of [3H]-AII from the Angiotensin II receptor isolated from the liver of rats,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,,,,Rattus norvegicus
185842,1610,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.48,,IC50,Inhibition of angiotensin AT1 receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,ANTAGONIST,,Tclin,,,Homo sapiens
185843,1610,1731,Type-1B angiotensin II receptor,GPCR,P29089,Agtr1b,AGTRB_RAT,8.44,,Ki,Displacement of [125I]-Sar1-Ile8-A II from rat adrenal Angiotensin-1 (AT-1) receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,,,,Rattus norvegicus
185844,1610,862,Type-2 angiotensin II receptor,GPCR,P50052,AGTR2,AGTR2_HUMAN,5,,IC50,In vitro binding affinity of compound against angiotensin II AT-2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,Tchem,,,Homo sapiens
185845,1610,1805,Type-2 angiotensin II receptor,GPCR,P35351,Agtr2,AGTR2_RAT,5.13,,IC50,"In vitro inhibitory activity against Angiotensin II receptor, type 2 in rat midbrain membrane preparations.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,,,,Rattus norvegicus
185846,1610,2071,Type-1A angiotensin II receptor,GPCR,P25095,Agtr1,AGTRA_RAT,7.84,,Ki,Binding affinity against angiotensin II receptor from rat liver; n=8,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,,,,Rattus norvegicus
185847,1610,1815,Type-1 angiotensin II receptor,GPCR,P25104,AGTR1,AGTR1_BOVIN,7.02,,IC50,Displacement of [125I]AngII from type 1 angiotensin 2 receptor in bovine adrenal cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,,,,Bos taurus
185848,1610,2895,Angiotensin II receptor,GPCR,P30556|P50052,AGTR1|AGTR2,AGTR1_HUMAN|AGTR2_HUMAN,8.43,,Kd,Potency to antagonize the ability of angiotensin II to contract rabbit aorta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,Tchem|Tclin,,,Homo sapiens
185849,1610,2881,Angiotensin II receptor (AT-1) type-1,GPCR,P25095|P29089,Agtr1|Agtr1b,AGTRA_RAT|AGTRB_RAT,8.72,,Ki,Displacement of [125I]-Ang II from rat liver membrane angiotensin II type 1 (AT1) receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,,,,Rattus norvegicus
185850,1610,2535,Type-1 angiotensin II receptor,GPCR,Q9WV26,AGTR1,AGTR1_CAVPO,7.74,,IC50,In vitro inhibition of the specific binding of [125I]angiotensin II to a guinea pig adrenal membrane preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,,,,Cavia porcellus
185851,1610,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,4.89,,IC50,Inhibition of Phosphodiesterase 3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191,,,,Tclin|Tclin,,,Homo sapiens
185852,575,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1599,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1599,INHIBITOR,,,,,Escherichia coli (strain K12)
185853,1273,2051,Muscarinic acetylcholine receptor M2,GPCR,P06199,CHRM2,ACM2_PIG,6.89,,EC50,Inhibition of [3H]NMS dissociation from porcine muscarinic M2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL360055,,,,,,,Sus scrofa
185854,1273,955,Acetylcholinesterase,Enzyme,P04058,ache,ACES_TORCA,4.82,,Ki,Inhibition of Torpedo californica AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL360055,,,,,,,Torpedo californica
185855,1273,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.07,,Ki,Competitive inhibition of EGFP-fused human M1 receptor N-terminal truncated at 17 residues expressed in HEK293 cells after 4 hrs by FRET assay in presence of para-LRB-AC42,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL360055,,,,Tclin,,,Homo sapiens
185856,1273,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.43,,Ki,Inhibition of human AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL360055,,,,Tclin,,,Homo sapiens
165445,1384,272,DNA (cytosine-5)-methyltransferase 3A,Enzyme,Q9Y6K1,DNMT3A,DNM3A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
185857,318,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,6.72,,Ki,Inhibition of human MRP1 expressed in Spodoptera frugiperda Sf9 cells assessed as inhibition of NEM-GS-induced vanadate-sensitive ATPase activity measured by generation of inorganic phosphate by spectrophotometry in presence of glutathione,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL388590,,,,Tchem,,,Homo sapiens
185858,318,345,Aldo-keto reductase family 1 member C1,Enzyme,Q04828,AKR1C1,AK1C1_HUMAN,7.32,,IC50,Inhibition of 20-alpha HSD,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL388590,,,,Tchem,,,Homo sapiens
185859,318,2066,Solute carrier family 22 member 12,Transporter,Q96S37,SLC22A12,S22AC_HUMAN,7.59,,IC50,Inhibition of human URAT1 expressed in xenopus oocyte assessed as inhibition of [14C]-labelled urate uptake after 60 mins by liquid scintillation counting,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL388590,http://www.ncbi.nlm.nih.gov/pubmed/16135657,INHIBITOR,,Tclin,,2208,Homo sapiens
185860,565,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1436,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1436,INHIBITOR,,,,,Escherichia coli (strain K12)
185861,299,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,8.7,,IC50,Tested for 50% inhibition of Angiotensin converting enzyme(ACE) obtained from rabbit lung (in vitro),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL838,,,,,,,Oryctolagus cuniculus
185862,299,1792,Angiotensin-converting enzyme,Enzyme,P47820,Ace,ACE_RAT,8.77,,IC50,In vitro inhibitory activity against Angiotensin I converting enzyme,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL838,,,,,,,Rattus norvegicus
185863,1037,2882,Angiotensin II receptor,GPCR,P25095|P29089|P35351,Agtr1|Agtr1b|Agtr2,AGTR2_RAT|AGTRA_RAT|AGTRB_RAT,9,,IC50,"Inhibition of [125I]AII binding to Angiotensin II receptor, type 1 of rat mesenteric arteries",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL813,,,,,,,Rattus norvegicus
185864,1037,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,8.7,,IC50,"Tested for Angiotensin II receptor, type 1 affinity in the absence of bovine serum albumin (BSA)",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL813,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL813,ANTAGONIST,,Tclin,,,Homo sapiens
185865,1037,1731,Type-1B angiotensin II receptor,GPCR,P29089,Agtr1b,AGTRB_RAT,9,,IC50,"Tested for inhibition of [125I]- AII specific binding to rat mesenteric arteries, expressed as IC50",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL813,,,,,,,Rattus norvegicus
185866,1037,1805,Type-2 angiotensin II receptor,GPCR,P35351,Agtr2,AGTR2_RAT,9,,IC50,In vitro inhibition of [125I]AII specific binding towards Angiotensin II receptor in rat mesenteric membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL813,,,,,,,Rattus norvegicus
185867,1037,2881,Angiotensin II receptor (AT-1) type-1,GPCR,P25095|P29089,Agtr1|Agtr1b,AGTRA_RAT|AGTRB_RAT,9,,IC50,Compound was tested for inhibition of 125 I-Angiotensin II specific binding to rat mesenteric arteries,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL813,,,,,,,Rattus norvegicus
185868,2239,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,7.52,,IC50,Tested in vitro for the inhibition of HMG-CoA reductase from partially purified microsomal preparations.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL690,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL690,INHIBITOR,,Tclin,,,Homo sapiens
185869,2239,1952,Solute carrier family 22 member 6,Transporter,O35956,Slc22a6,S22A6_RAT,4.28,,Ki,Inhibition of rat Oat1 expressed in pig LLC-PK11 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL690,,,,,,,Rattus norvegicus
185870,2239,1796,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P51639,Hmgcr,HMDH_RAT,8.38,,IC50,In vitro HMG-CoA reductase inhibitory activity to inhibit sterol synthesis in cell free system in rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL690,,,,,,,Rattus norvegicus
185871,143,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,7,,Ki,Displacement of [3H]diprenorphine from human cloned kappa opioid receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL270190,,,,Tclin,,,Homo sapiens
167134,2268,556,Solute carrier family 22 member 6,Transporter,Q4U2R8,SLC22A6,S22A6_HUMAN,4.9,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4357,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897,INHIBITOR,,Tclin,,,Homo sapiens
185872,143,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,7.92,,Ki,Displacement of [3H]diprenorphine from human cloned delta opioid receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL270190,,,,Tclin,,,Homo sapiens
185873,878,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,,,,Mechanism of Action; CHEMBL233; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200599,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200599,AGONIST,,Tclin,,,Homo sapiens
185874,516,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,,,,Mechanism of Action; CHEMBL224; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201328,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201328,ANTAGONIST,,Tclin,,,Homo sapiens
185876,945,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.1,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL219916,,,,Tchem,,,Homo sapiens
185877,945,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,7.93,,Ki,Displacement of [3H]nemonapride from Rattus norvegicus (rat) wild type dopamine D3 receptor transfected in african green monkey COS7 cells after 1 hr by beta scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL219916,,,,,,,Rattus norvegicus
185878,945,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.46,,Ki,Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL219916,,,,Tclin,,,Homo sapiens
185879,945,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.83,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL219916,,,,Tchem,,,Homo sapiens
165446,1384,271,DNA (cytosine-5)-methyltransferase 1,Enzyme,P26358,DNMT1,DNMT1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
185880,945,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.64,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL219916,,,,Tchem,,,Homo sapiens
185881,945,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,9.28,,Ki,Displacement of [3H]nemonapride from Rattus norvegicus (rat) wild type dopamine D2 receptor transfected in african green monkey COS7 cells after 1 hr by beta scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL219916,,,,,,,Rattus norvegicus
185882,3294,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,8.05,,IC50,Affinity for 5-hydroxytryptamine 2 receptor binding sites by its ability to displace [3H]spiperone from rat frontal cortex.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376,,,,,,,Rattus norvegicus
185883,3294,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.19,,IC50,"Binding affinity against sigma receptor using [3H]-( +)-SKF10,047 radioligand",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376,,,,Tclin,,,Homo sapiens
185884,3294,1833,Alpha-2A adrenergic receptor,GPCR,P22909,Adra2a,ADA2A_RAT,9.4,,IC50,Binding affinity against Alpha-1 adrenergic receptor was determined using [3H]WB-4101 radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376,,,,,,,Rattus norvegicus
185885,3294,1954,5-hydroxytryptamine receptor 2A,GPCR,Q75Z89,HTR2A,5HT2A_BOVIN,8.05,,IC50,Binding affinity against 5-hydroxytryptamine 2 receptor was determined using [ [3H]spiperone radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376,,,,,,,Bos taurus
185886,3294,1854,5-hydroxytryptamine receptor 1A,GPCR,Q64264,Htr1a,5HT1A_MOUSE,6.68,,IC50,Binding affinity against 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376,,,,,,,Mus musculus
185887,3294,1953,D(1A) dopamine receptor,GPCR,Q61616,Drd1,DRD1_MOUSE,6.12,,IC50,Binding affinity against Dopamine receptor D1 was determined using [3H]SCH-23390 radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376,,,,,,,Mus musculus
185888,3294,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.96,,IC50,Affinity for dopamine receptor D2 binding sites by its ability to displace [3H]spiperone from rat striatum.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376,,,,,,,Rattus norvegicus
185889,784,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.6,,Ki,GRAC: human M2 antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1346,,ANTAGONIST,,Tclin,,,Homo sapiens
185890,784,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.3,,Ki,GRAC: human M1 antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1346,,,,Tclin,,,Homo sapiens
185891,784,1845,Muscarinic acetylcholine receptor M3,GPCR,P08483,Chrm3,ACM3_RAT,8.6,,Ki,Displacement of [3H]N-methylscopolamine from muscarinic M3 receptor in rat submandibular gland,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1346,,,,,,,Rattus norvegicus
185892,784,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.52,,Kd,GRAC: human M3 probe,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1346,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1346,ANTAGONIST,,Tclin,,,Homo sapiens
185893,784,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.1,,Ki,GRAC: human M4 antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1346,,,,Tclin,,,Homo sapiens
167233,2548,2640,Secretin receptor,GPCR,P47872,SCTR,SCTR_HUMAN,9.7,,EC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3643,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201488,AGONIST,,Tclin,,,Homo sapiens
167288,2720,341,Prostacyclin receptor,GPCR,P43119,PTGIR,PI2R_HUMAN,8.72,,EC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5820,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237119,AGONIST,,Tclin,,,Homo sapiens
167290,2728,2761,"Amiloride-sensitive sodium channel, ENaC",Ion channel,P37088|P51168|P51170,SCNN1A|SCNN1B|SCNN1G,SCNNA_HUMAN|SCNNB_HUMAN|SCNNG_HUMAN,5.300000191,,IC50,Mechanism of Action; CHEMBL2107836; PROTEIN COMPLEX,IUPHAR,~,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4329,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL585,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
167291,2729,2782,GABA-A receptor,Ion channel,O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|Q16445|Q8N1C3|Q99928,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRG1|GABRG2|GABRG3,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN,9.100000381469727,,Ki,Mechanism of Action; CHEMBL2093872; PROTEIN COMPLEX GROUP,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7313,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
167361,3356,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.66,,EC50,22Rv1 human prostate cells transfected with hAR and luciferase reporter plasmid driven by the androgen response element.,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6945,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1395,AGONIST,,Tclin,,,Homo sapiens
167788,852,2795,GABA A receptor alpha-5/beta-3/gamma-3,Ion channel,P28472|P31644|Q99928,GABRA5|GABRB3|GABRG3,GBRA5_HUMAN|GBRB3_HUMAN|GBRG3_HUMAN,7.2034,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
167789,1202,2795,GABA A receptor alpha-5/beta-3/gamma-3,Ion channel,P28472|P31644|Q99928,GABRA5|GABRB3|GABRG3,GBRA5_HUMAN|GBRB3_HUMAN|GBRG3_HUMAN,8.4202,,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
167454,4117,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,7.35,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6840,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201746,INHIBITOR,,Tclin,,,Homo sapiens
167510,4166,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.7,,IC50,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7460,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7460,ANTAGONIST,,Tclin,,,Homo sapiens
167528,4181,302,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,O43526,KCNQ2,KCNQ2_HUMAN,5.6,,EC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2601,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41355,ACTIVATOR,,Tclin,,,Homo sapiens
167529,4181,1667,Potassium voltage-gated channel subfamily KQT member 4,Ion channel,P56696,KCNQ4,KCNQ4_HUMAN,5.2,,EC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2601,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41355,ACTIVATOR,,Tclin,,,Homo sapiens
167531,4181,635,Potassium voltage-gated channel subfamily KQT member 5,Ion channel,Q9NR82,KCNQ5,KCNQ5_HUMAN,5,,EC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2601,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41355,ACTIVATOR,,Tclin,,,Homo sapiens
167532,4181,303,Potassium voltage-gated channel subfamily KQT member 3,Ion channel,O43525,KCNQ3,KCNQ3_HUMAN,6.2,,EC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2601,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41355,ACTIVATOR,,Tclin,,,Homo sapiens
167540,4223,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,9.3,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7427,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,INHIBITOR,,Tclin,,,Homo sapiens
167541,4223,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,9.7,,Ki,Binding of vilazodone to human 5-HT<sub>1A</sub> receptors against [<sup></sup>3H]8-OH-DPAT (DPAT),IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7427,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,AGONIST,,Tclin,,,Homo sapiens
167603,4322,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL57242,ANTAGONIST,,Tclin,,,Homo sapiens
167604,4329,259,Somatostatin receptor type 3,GPCR,P32745,SSTR3,SSR3_HUMAN,8.8,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2018,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039583,AGONIST,,Tclin,,,Homo sapiens
167605,4329,1980,Somatostatin receptor type 1,GPCR,P30872,SSTR1,SSR1_HUMAN,8,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2018,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039583,AGONIST,,Tclin,,,Homo sapiens
167606,4329,260,Somatostatin receptor type 5,GPCR,P35346,SSTR5,SSR5_HUMAN,9.8,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2018,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039583,AGONIST,,Tclin,,,Homo sapiens
167607,4329,258,Somatostatin receptor type 2,GPCR,P30874,SSTR2,SSR2_HUMAN,9,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2018,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039583,AGONIST,,Tclin,,,Homo sapiens
165223,2266,921,Glucose-6-phosphate 1-dehydrogenase,Enzyme,P11413,G6PD,G6PD_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165224,1950,921,Glucose-6-phosphate 1-dehydrogenase,Enzyme,P11413,G6PD,G6PD_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165225,1949,921,Glucose-6-phosphate 1-dehydrogenase,Enzyme,P11413,G6PD,G6PD_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165226,782,921,Glucose-6-phosphate 1-dehydrogenase,Enzyme,P11413,G6PD,G6PD_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165228,2711,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.2798,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165229,1725,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,2.6968,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165233,624,906,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165236,2862,864,Leukotriene A-4 hydrolase,Enzyme,P09960,LTA4H,LKHA4_HUMAN,6.0706,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165238,708,848,Cytochrome P450 2B6,Enzyme,P20813,CYP2B6,CP2B6_HUMAN,6.3,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
165242,1310,813,Metabotropic glutamate receptor 7,GPCR,Q14831,GRM7,GRM7_HUMAN,5.93,,EC50,Agonist activity at human mGlu7 receptor expressed in HEK293 assessed as inhibition of forskolin stimulated cAMP production,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tbio,,,Homo sapiens
165243,4119,766,Histone deacetylase 4,Enzyme,P56524,HDAC4,HDAC4_HUMAN,6.2924,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165248,4119,668,Histone deacetylase 7,Enzyme,Q8WUI4,HDAC7,HDAC7_HUMAN,5.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7006,,INHIBITOR,,Tclin,,,Homo sapiens
165249,4119,630,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,6.5227,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165250,2271,624,Ryanodine receptor 1,Ion channel,P21817,RYR1,RYR1_HUMAN,2.2218,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165251,621,624,Ryanodine receptor 1,Ion channel,P21817,RYR1,RYR1_HUMAN,3.5686,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165253,4119,619,Histone deacetylase 3,Enzyme,O15379,HDAC3,HDAC3_HUMAN,7.6038,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165254,2502,613,Lactoylglutathione lyase,Enzyme,Q04760,GLO1,LGUL_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165257,4119,606,Histone deacetylase 1,Enzyme,Q13547,HDAC1,HDAC1_HUMAN,7,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165259,4119,598,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,7.3279,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165260,1958,566,Myeloperoxidase,Enzyme,P05164,MPO,PERM_HUMAN,3.9626,,Km,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165265,124,552,Hypoxanthine-guanine phosphoribosyltransferase,Enzyme,P00492,HPRT1,HPRT_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165371,4706,367,"Thioredoxin reductase 1, cytoplasmic",Enzyme,Q16881,TXNRD1,TRXR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165375,1407,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165376,513,348,"Carnitine O-palmitoyltransferase 1, liver isoform",Enzyme,P50416,CPT1A,CPT1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165387,1016,341,Prostacyclin receptor,GPCR,P43119,PTGIR,PI2R_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165394,583,337,Lutropin-choriogonadotropic hormone receptor,GPCR,P22888,LHCGR,LSHR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165401,1935,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,4.57,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165410,1958,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,2.9469,,Km,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165413,4501,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165414,2480,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165419,1539,300,Deoxycytidine kinase,Kinase,P27707,DCK,DCK_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165456,4631,255,Atrial natriuretic peptide receptor 1,Enzyme,P16066,NPR1,ANPRA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165457,1506,255,Atrial natriuretic peptide receptor 1,Enzyme,P16066,NPR1,ANPRA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165459,1505,255,Atrial natriuretic peptide receptor 1,Enzyme,P16066,NPR1,ANPRA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165462,109,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,5.9586,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165464,285,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,3.25,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165474,2974,246,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,Q15822,CHRNA2,ACHA2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165480,1708,243,Multidrug resistance-associated protein 4,Transporter,O15439,ABCC4,MRP4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165481,269,243,Multidrug resistance-associated protein 4,Transporter,O15439,ABCC4,MRP4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165485,2353,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,4.6778,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165493,1291,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165495,1947,236,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,8.4,,IC50,Recombinant Cav1.3 calcium channel complexes expressed in tsA-cells,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334,GATING INHIBITOR,,Tclin,,,Homo sapiens
165498,1934,236,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165508,2815,218,G protein-activated inward rectifier potassium channel 2,Ion channel,P48051,KCNJ6,KCNJ6_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165519,4392,210,Multidrug resistance-associated protein 5,Transporter,O15440,ABCC5,MRP5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165520,1708,210,Multidrug resistance-associated protein 5,Transporter,O15440,ABCC5,MRP5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165521,269,210,Multidrug resistance-associated protein 5,Transporter,O15440,ABCC5,MRP5_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165533,2279,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165537,1748,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165538,726,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,3.4895,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165539,2271,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,3.5287,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165540,4719,192,Multidrug resistance-associated protein 6,Transporter,O95255,ABCC6,MRP6_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165541,4392,192,Multidrug resistance-associated protein 6,Transporter,O95255,ABCC6,MRP6_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165542,4719,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165545,269,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165546,4719,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165547,219,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165548,4719,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165555,1934,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165560,1384,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165562,1947,182,Voltage-dependent calcium channel gamma-1 subunit,Ion channel,Q06432,CACNG1,CCG1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165563,1937,182,Voltage-dependent calcium channel gamma-1 subunit,Ion channel,Q06432,CACNG1,CCG1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165564,1934,182,Voltage-dependent calcium channel gamma-1 subunit,Ion channel,Q06432,CACNG1,CCG1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165580,4501,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165590,894,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165597,1579,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,3.2958,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165599,4,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165616,2302,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,4.005,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165633,4523,157,Hemoglobin subunit alpha,Secreted,P69905,HBA1,HBA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165634,1665,157,Hemoglobin subunit alpha,Secreted,P69905,HBA1,HBA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165636,1947,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.0809,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165649,920,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165650,842,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,4.48,,Ks,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165652,256,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,4.7696,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165653,203,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.12,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165654,2865,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165673,2054,136,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P05023,ATP1A1,AT1A1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165674,1258,136,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P05023,ATP1A1,AT1A1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165675,881,136,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P05023,ATP1A1,AT1A1_HUMAN,,,,,WOMBAT-PK,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254219,INHIBITOR,,Tclin,,,Homo sapiens
165724,819,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165733,1942,126,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Ion channel,O00555,CACNA1A,CAC1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165744,4392,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165745,1112,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,3.2104,,Km,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
165746,219,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165750,1384,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
165784,2974,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165818,358,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=297,,AGONIST,,Tclin,,,Homo sapiens
165820,1643,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165865,894,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165876,660,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,5.7,,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165961,4719,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165962,4161,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165963,4151,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165964,4141,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165965,4114,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165967,3609,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165968,2870,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,3.7033,,Km,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165972,1990,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.0506,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165974,1667,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165975,1665,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165976,1610,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,3.4981,,Km,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165977,1564,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165978,1527,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,6,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165980,1112,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,3.2823,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165982,945,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165984,726,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,3.8013,,Kd,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165985,424,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165986,419,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165987,276,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,3.7,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165988,219,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165989,191,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
165990,114,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,3.9508,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
165994,4114,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165995,3483,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165996,2847,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,3.98,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165997,2767,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,3.2082,,Km,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
165998,2480,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
165999,2422,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.8239,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166001,1922,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.26,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166002,1909,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.3768,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166003,1527,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166005,726,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.19,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166006,230,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
166007,136,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,3.85,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166009,4523,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
166017,2270,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,3.86,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166018,2149,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
166020,2095,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,2.5528,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166023,1942,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.6383,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166024,1922,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.3,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166028,1665,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.25,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166029,1569,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,3.04,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166030,1527,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.72,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166037,926,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.0362,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166041,276,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,3.39,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166114,1863,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,3.34,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
166118,2291,63,Sodium channel subunit beta-2,Ion channel,O60939,SCN2B,SCN2B_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
166126,844,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
166127,2134,60,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,Q14994,NR1I3,NR1I3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
166128,1229,60,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,Q14994,NR1I3,NR1I3_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
166130,2302,59,Fatty-acid amide hydrolase 1,Enzyme,O00519,FAAH,FAAH1_HUMAN,4.284,,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
166149,894,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
166157,894,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
167609,4379,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,8.77,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5585,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415606,ANTAGONIST,,Tclin,,,Homo sapiens
167611,4411,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200927,ANTAGONIST,,Tclin,,,Homo sapiens
167625,90,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.54,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2844,,AGONIST,,Tchem,,,Homo sapiens
167630,4470,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,8.92,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7623,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1199324,ANTAGONIST,,Tclin,,,Homo sapiens
167641,4514,2684,Parathyroid hormone/parathyroid hormone-related peptide receptor,GPCR,Q03431,PTH1R,PTH1R_HUMAN,7.4,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4448,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL525610,AGONIST,,Tclin,,,Homo sapiens
167651,4654,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,7.9,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5891,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1946170,INHIBITOR,,Tclin,,,Homo sapiens
167676,4141,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,8.083545684814453,,IC50,PDE5 activity in human platelets,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/12510841,http://www.ncbi.nlm.nih.gov/pubmed/12510841,INHIBITOR,,Tclin,66,66,Homo sapiens
167677,4909,2720,CAMPATH-1 antigen,Surface antigen,P31358,CD52,CD52_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103948s5139lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103948s5139lbl.pdf,ANTIBODY BINDING,,Tclin,194,194,Homo sapiens
167679,2817,2721,Transitional endoplasmic reticulum ATPase,Enzyme,P55072,VCP,TERA_HUMAN,,,,Vesnarinone binds to the D1 domain of VCP,SCIENTIFIC LITERATURE,,,,http://www.ncbi.nlm.nih.gov/pubmed/23393163,,,,Tchem,97,,Homo sapiens
167680,1873,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.920818328857422,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/10976457,http://www.ncbi.nlm.nih.gov/pubmed/10976457,ANTAGONIST,,Tclin,67,67,Homo sapiens
167681,1873,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.431797981262207,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/10976457,http://www.ncbi.nlm.nih.gov/pubmed/10976457,ANTAGONIST,,Tclin,67,67,Homo sapiens
167682,1873,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.698969841003418,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/10976457,http://www.ncbi.nlm.nih.gov/pubmed/10976457,ANTAGONIST,,Tclin,67,67,Homo sapiens
167683,3713,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2572952,http://www.ncbi.nlm.nih.gov/pubmed/2572952,MODULATOR,,Tclin,68,68,Homo sapiens
167684,1729,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,KEGG DRUG,http://www.ncbi.nlm.nih.gov/pubmed/19153939,http://www.kegg.jp/entry/D04973,AGONIST,,Tclin,69,,Homo sapiens
167685,4910,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/5224878,http://www.ncbi.nlm.nih.gov/pubmed/18655903,AGONIST,,Tclin,70,559,Homo sapiens
167686,741,2722,Protein S100-P,Unclassified,P25815,S100P,S100P_HUMAN,,,,cromolyn blocked the coimmunoprecipitation of S100P and RAGE,SCIENTIFIC LITERATURE,,,,http://www.ncbi.nlm.nih.gov/pubmed/17179482,,,,Tbio,71,,Homo sapiens
167687,39,2302,"Sucrase-isomaltase, intestinal",Enzyme,P14410,SI,SUIS_HUMAN,6.609065055847168,,Ki,C-terminal catalytic subunit,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21669536,,,,Tchem,72,,Homo sapiens
167688,48,298,Vitamin K epoxide reductase complex subunit 1,Enzyme,Q9BQB6,VKORC1,VKOR1_HUMAN,6.113509178161621,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17275317,http://www.ncbi.nlm.nih.gov/pubmed/3207986,INHIBITOR,,Tclin,73,453,Homo sapiens
167689,2138,298,Vitamin K epoxide reductase complex subunit 1,Enzyme,Q9BQB6,VKORC1,VKOR1_HUMAN,5.744727611541748,,IC50,,SCIENTIFIC LITERATURE,=,1,CHEMBL,http://www.ncbi.nlm.nih.gov/pubmed/17275317,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1465,INHIBITOR,,Tclin,73,,Homo sapiens
167690,867,298,Vitamin K epoxide reductase complex subunit 1,Enzyme,Q9BQB6,VKORC1,VKOR1_HUMAN,5.508638381958008,,IC50,,SCIENTIFIC LITERATURE,=,1,CHEMBL,http://www.ncbi.nlm.nih.gov/pubmed/17275317,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1466,INHIBITOR,,Tclin,73,,Homo sapiens
168151,867,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.9715,,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
167691,50,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-09/mepronizine_ct_8952.pdf,ANTAGONIST,,Tclin,,527,Homo sapiens
167692,93,2782,GABA-A receptor,Ion channel,O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|Q16445|Q8N1C3|Q99928,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRG1|GABRG2|GABRG3,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,KEGG DRUG,http://www.ncbi.nlm.nih.gov/pubmed/6148400,http://www.kegg.jp/entry/D02770,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,74,,Homo sapiens
167695,871,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022252s004lbl.pdf,AGONIST,,Tclin,,526,Homo sapiens
167697,388,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.853872299194336,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/15686911,http://www.ncbi.nlm.nih.gov/pubmed/15686911,ANTAGONIST,,Tclin,77,77,Homo sapiens
167699,388,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.091514587402344,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/15686911,http://www.ncbi.nlm.nih.gov/pubmed/15686911,ANTAGONIST,,Tclin,77,77,Homo sapiens
167704,4226,710,Protein kinase C delta type,Kinase,Q05655,PRKCD,KPCD_HUMAN,8.327901840209961,,EC50,Colo-205 cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/15126366,http://www.ncbi.nlm.nih.gov/pubmed/15126366,ACTIVATOR,,Tclin,79,79,Homo sapiens
167705,4226,714,Protein kinase C alpha type,Kinase,P17252,PRKCA,KPCA_HUMAN,6.197226047515869,,EC50,Colo-205 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/15126366,,,,Tchem,79,,Homo sapiens
167706,4226,685,Protein kinase C beta type,Kinase,P05771,PRKCB,KPCB_HUMAN,6.835647106170654,,EC50,Colo-205 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/15126366,,,,,79,,Homo sapiens
167707,4226,787,Protein kinase C epsilon type,Kinase,Q02156,PRKCE,KPCE_HUMAN,8.95860767364502,,EC50,Colo-205 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/15126366,,,,Tchem,79,,Homo sapiens
167708,4226,2085,Serine/threonine-protein kinase D1,Kinase,Q15139,PRKD1,KPCD1_HUMAN,7.522878646850586,,EC50,Colo-205 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/15126366,,,,Tchem,79,,Homo sapiens
167709,768,18,cystine,Unnatural amino acid,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002465/WC500151313.pdf,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002465/WC500151313.pdf,OTHER,,,314,314,
167712,4112,1671,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Ion channel,O60741,HCN1,HCN1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23647933,http://www.ncbi.nlm.nih.gov/pubmed/23647933,BLOCKER,,Tclin,81,81,Homo sapiens
167714,4112,1672,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Ion channel,Q9UL51,HCN2,HCN2_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23647933,http://www.ncbi.nlm.nih.gov/pubmed/23647933,BLOCKER,,Tclin,81,81,Homo sapiens
167715,4112,1673,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,Ion channel,Q9P1Z3,HCN3,HCN3_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23647933,http://www.ncbi.nlm.nih.gov/pubmed/23647933,BLOCKER,,Tclin,81,81,Homo sapiens
167716,4112,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23647933,http://www.ncbi.nlm.nih.gov/pubmed/23647933,BLOCKER,,Tclin,81,81,Homo sapiens
167717,4912,2544,Genome polyprotein,Polyprotein,P27958,,POLG_HCVH,10.853872299194336,,EC50,in vitro replicon assay,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24400777,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206619s003lbl.pdf,INHIBITOR,,,82,250,Hepatitis C virus genotype 1a (isolate H)
167718,4912,2536,Genome polyprotein,Polyprotein,P26663,,POLG_HCVBK,11.301030158996582,,EC50,in vitro replicon assay,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24400777,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206619s003lbl.pdf,INHIBITOR,,,82,250,Hepatitis C virus genotype 1b (isolate BK)
167734,1440,1698,Potassium voltage-gated channel subfamily A member 7,Ion channel,Q96RP8,KCNA7,KCNA7_HUMAN,7.5,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
167790,1802,2795,GABA A receptor alpha-5/beta-3/gamma-3,Ion channel,P28472|P31644|Q99928,GABRA5|GABRB3|GABRG3,GBRA5_HUMAN|GBRB3_HUMAN|GBRG3_HUMAN,8.2596,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL655,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
167791,2729,2795,GABA A receptor alpha-5/beta-3/gamma-3,Ion channel,P28472|P31644|Q99928,GABRA5|GABRB3|GABRG3,GBRA5_HUMAN|GBRB3_HUMAN|GBRG3_HUMAN,8.699,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
167792,2873,2795,GABA A receptor alpha-5/beta-3/gamma-3,Ion channel,P28472|P31644|Q99928,GABRA5|GABRB3|GABRG3,GBRA5_HUMAN|GBRB3_HUMAN|GBRG3_HUMAN,6.7496,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021476s030lbl.pdf,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,292,Homo sapiens
167826,1802,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,9.1249,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL655,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,,,Homo sapiens
167829,2873,2734,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,P18507|P28472|P31644,GABRA5|GABRB3|GABRG2,GBRA5_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,7.2782,,Ki,,WOMBAT-PK,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021476s030lbl.pdf,POSITIVE MODULATOR,,Tclin|Tclin|Tclin,,292,Homo sapiens
167928,203,596,DNA topoisomerase 1,Enzyme,P11387,TOP1,TOP1_HUMAN,7.43,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
167929,1446,596,DNA topoisomerase 1,Enzyme,P11387,TOP1,TOP1_HUMAN,6.52,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
167946,391,507,26S proteasome non-ATPase regulatory subunit 1,Cytosolic other,Q99460,PSMD1,PSMD1_HUMAN,7.7447,,Ki,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
168056,726,333,Tubulin beta chain,Structural,P07437,TUBB,TBB5_HUMAN,5.2403,,Ki,,WOMBAT-PK,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
168255,183,215,Voltage-dependent calcium channel subunit alpha-2/delta-1,Ion channel,P54289,CACNA2D1,CA2D1_HUMAN,7.2,,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
169485,4112,92,Thyroid hormone receptor alpha,Nuclear hormone receptor,P10827,THRA,THA_HUMAN,4.2291,,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
169776,2346,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,7.92081880569458,,Ki,CYP2D6 catalyzed AMMC-O-demethylation in HepG2 transfected cells,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24786236,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021879s005lbl.pdf,INHIBITOR,,Tclin,86,183,Homo sapiens
169778,1353,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,9.42021656036377,,Kd,radioligand [3H]spiperone 0.5nM competition binding; human recombinant dopaminereceptors in CHO cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/12388666,,INVERSE AGONIST,,Tchem,87,,Homo sapiens
169779,137,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,9.677781105041504,,Kd,radioligand  [3H]CGP12177  0.15nM competition binding; human recombinant beta-adrenoreceptors in Sf9 cells,SCIENTIFIC LITERATURE,=,1,KEGG DRUG,http://www.ncbi.nlm.nih.gov/pubmed/12388666,http://www.kegg.jp/entry/D01182,ANTAGONIST,,Tclin,87,,Homo sapiens
169781,137,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,9.657577514648438,,Kd,radioligand  [3H]CGP12177  0.15nM competition binding; human recombinant beta-adrenoceptors in Sf9 cells,SCIENTIFIC LITERATURE,=,1,IUPHAR,http://www.ncbi.nlm.nih.gov/pubmed/12388666,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=563,ANTAGONIST,,Tclin,87,,Homo sapiens
170133,1282,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.420216403,,Kd,,SCIENTIFIC LITERATURE,,,,http://www.ncbi.nlm.nih.gov/pubmed/22037378,,,,Tclin,104,,Homo sapiens
170333,2544,922,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,5.508638306,,Kd,,SCIENTIFIC LITERATURE,,,,http://www.ncbi.nlm.nih.gov/pubmed/22037378,,,,Tchem,104,,Homo sapiens
170336,2544,898,Ephrin type-A receptor 7,Kinase,Q15375,EPHA7,EPHA7_HUMAN,5.619788758,,Kd,,SCIENTIFIC LITERATURE,,,,http://www.ncbi.nlm.nih.gov/pubmed/22037378,,,,Tchem,104,,Homo sapiens
170500,4863,2776,GABA-B receptor,GPCR,O75899|Q9UBS5,GABBR1|GABBR2,GABR1_HUMAN|GABR2_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/11830761,AGONIST,,Tclin|Tclin,,106,Homo sapiens
170509,1148,2979,Extracellular calcium-sensing receptor,GPCR,P35384,CASR,CASR_BOVIN,4.92081880569458,,EC50,increase in intracellular Ca2+ in bovine parathyroid cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9520489,,POSITIVE ALLOSTERIC MODULATOR,,,111,,Bos taurus
170510,2672,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,4.9871625900268555,,EC50,CHO-K1 cells stably expressing the human A1AR,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/19751980,,ANTAGONIST,,Tclin,113,,Homo sapiens
170511,4917,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,10.3,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7390,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125477s007lbl.pdf,ANTIBODY BINDING,,Tclin,,114,Homo sapiens
170512,2236,2980,Amylin receptor AMY1,GPCR,O60894|P30988,CALCR|RAMP1,CALCR_HUMAN|RAMP1_HUMAN,9.449999809265137,,EC50,HEK293S cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/24169554,http://www.ncbi.nlm.nih.gov/pubmed/24169554,AGONIST,,Tclin|Tclin,115,115,Homo sapiens
170513,2236,2982,Amylin receptor AMY3,GPCR,O60896|P30988,CALCR|RAMP3,CALCR_HUMAN|RAMP3_HUMAN,9.050000190734863,,EC50,HEK293S cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/24169554,http://www.ncbi.nlm.nih.gov/pubmed/24169554,AGONIST,,Tclin|Tclin,115,115,Homo sapiens
170514,2236,2981,Amylin receptor AMY2,GPCR,O60895|P30988,CALCR|RAMP2,CALCR_HUMAN|RAMP2_HUMAN,8.640000343322754,,EC50,HEK293S cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/24169554,http://www.ncbi.nlm.nih.gov/pubmed/15494035,AGONIST,,Tchem|Tclin,115,78,Homo sapiens
170503,4916,2978,Vascular endothelial growth factor B,Secreted,P49765,VEGFB,VEGFB_HUMAN,11.71669864654541,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125418s020lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125418s020lbl.pdf,INHIBITOR,,Tclin,108,108,Homo sapiens
170505,4916,2977,Placenta growth factor,Secreted,P49763,PGF,PLGF_HUMAN,10.408935546875,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125418s020lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125418s020lbl.pdf,INHIBITOR,,Tclin,108,108,Homo sapiens
170507,4916,1643,Vascular endothelial growth factor A,Secreted,P15692,VEGFA,VEGFA_HUMAN,12.301030158996582,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125418s020lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125418s020lbl.pdf,INHIBITOR,,Tclin,108,108,Homo sapiens
170544,4924,3394,Programmed cell death protein 1,Membrane receptor,Q15116,PDCD1,PDCD1_HUMAN,10,,Kd,,IUPHAR,~,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7499,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125514lbl.pdf,ANTIBODY BINDING,,Tclin,,133,Homo sapiens
170545,4361,263,fMet-Leu-Phe receptor,GPCR,P21462,FPR1,FPR1_HUMAN,4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=608,,ANTAGONIST,,Tchem,,,Homo sapiens
170549,1925,3335,Chloride channel protein ClC-Kb,Ion channel,P51801,CLCNKB,CLCKB_HUMAN,5,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2439,,ACTIVATOR,,Tbio,,,Homo sapiens
170552,865,2121,Acid-sensing ion channel 3,Ion channel,Q9UHC3,ASIC3,ASIC3_HUMAN,4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2714,,BLOCKER,,Tchem,,,Homo sapiens
170558,1366,3385,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,P43681,CHRNA4,ACHA4_HUMAN,5.17,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3963,,BLOCKER,,Tclin,,,Homo sapiens
170559,1366,3386,Neuronal acetylcholine receptor subunit alpha-6,Ion channel,Q15825,CHRNA6,ACHA6_HUMAN,4.04,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3963,,BLOCKER,,Tchem,,,Homo sapiens
170561,852,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,4.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3364,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
170562,2775,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,4.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=260,,ANTAGONIST,,Tclin,,,Homo sapiens
186972,239,631,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,4.28,,Ki,Inhibition of human factor 10a,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1166,,,,Tclin,,,Homo sapiens
170563,2781,795,Small conductance calcium-activated potassium channel protein 3,Ion channel,Q9UGI6,KCNN3,KCNN3_HUMAN,4.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2294,,BLOCKER,,Tchem,,,Homo sapiens
170567,1407,3400,Sodium-coupled monocarboxylate transporter 1,Transporter,Q8N695,SLC5A8,SC5A8_HUMAN,4.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2713,,INHIBITOR,,Tbio,,,Homo sapiens
170570,2525,1422,Proton-coupled folate transporter,Transporter,Q96NT5,SLC46A1,PCFT_HUMAN,4.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4840,,INHIBITOR,,Tchem,,,Homo sapiens
170571,1867,952,Acid-sensing ion channel 2,Ion channel,Q16515,ASIC2,ASIC2_HUMAN,4.2,,IC50,,IUPHAR,~,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4262,,BLOCKER,,Tbio,,,Homo sapiens
170579,2828,2529,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",Enzyme,Q14123,PDE1C,PDE1C_HUMAN,4.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5285,,INHIBITOR,,Tclin,,,Homo sapiens
170587,2781,3268,Small conductance calcium-activated potassium channel protein 1,Ion channel,Q92952,KCNN1,KCNN1_HUMAN,4.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2294,,BLOCKER,,Tchem,,,Homo sapiens
170594,1797,3270,Cation channel sperm-associated protein 1,Ion channel,Q8NEC5,CATSPER1,CTSR1_HUMAN,4.5,,IC50,"Patch clamp electrophysiology, kinetic rapid mixing fluometry",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2522,,BLOCKER,,Tchem,,,Homo sapiens
170595,1797,3271,Cation channel sperm-associated protein 2,Ion channel,Q96P56,CATSPER2,CTSR2_HUMAN,4.5,,IC50,Patch clamp electrophysiology and kinetic rapid mixing fluometry.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2522,,BLOCKER,,Tchem,,,Homo sapiens
170596,1797,3272,Cation channel sperm-associated protein 3,Ion channel,Q86XQ3,CATSPER3,CTSR3_HUMAN,4.5,,IC50,"Patch clamp electrophysiology, kinetic rapid mixing fluometry.",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2522,,BLOCKER,,Tchem,,,Homo sapiens
170597,1797,3273,Cation channel sperm-associated protein 4,Ion channel,Q7RTX7,CATSPER4,CTSR4_HUMAN,4.5,,IC50,"Patch clamp electrophysiology, kinetic rapid mixing fluometry.",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2522,,BLOCKER,,Tchem,,,Homo sapiens
170600,2781,2834,Serotonin 3 receptor (5HT3),Ion channel,O95264|P46098,HTR3A|HTR3B,5HT3A_HUMAN|5HT3B_HUMAN,4.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2294,,ANTAGONIST,,Tchem|Tclin,,,Homo sapiens
170601,2162,563,Glycine receptor subunit beta,Ion channel,P48167,GLRB,GLRB_HUMAN,4.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4051,,BLOCKER,,Tclin,,,Homo sapiens
170602,1922,1179,Glycine receptor subunit alpha-3,Ion channel,O75311,GLRA3,GLRA3_HUMAN,4.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2514,,ANTAGONIST,,Tchem,,,Homo sapiens
170606,2405,3291,Short transient receptor potential channel 5,Ion channel,Q9UL62,TRPC5,TRPC5_HUMAN,4.51,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1056,,ACTIVATOR,,Tchem,,,Homo sapiens
170607,201,877,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",Enzyme,Q13370,PDE3B,PDE3B_HUMAN,4.51,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7202,,INHIBITOR,,Tclin,,,Homo sapiens
170609,4523,3395,Equilibrative nucleoside transporter 4,Transporter,Q7RTT9,SLC29A4,S29A4_HUMAN,4.57,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2510,,INHIBITOR,,Tbio,,,Homo sapiens
170610,1154,3400,Sodium-coupled monocarboxylate transporter 1,Transporter,Q8N695,SLC5A8,SC5A8_HUMAN,4.57,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4820,,INHIBITOR,,Tbio,,,Homo sapiens
170612,2346,3395,Equilibrative nucleoside transporter 4,Transporter,Q7RTT9,SLC29A4,S29A4_HUMAN,4.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2342,,INHIBITOR,,Tbio,,,Homo sapiens
170613,2163,563,Glycine receptor subunit beta,Ion channel,P48167,GLRB,GLRB_HUMAN,4.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4286,,BLOCKER,,Tclin,,,Homo sapiens
170623,1314,1047,Cystic fibrosis transmembrane conductance regulator,Ion channel,P13569,CFTR,CFTR_HUMAN,4.66,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2414,,BLOCKER,,Tclin,,,Homo sapiens
170625,897,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,4.68,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2298,,BLOCKER,,Tclin,,,Homo sapiens
170629,3400,3189,Free fatty acid receptor 4,GPCR,Q5NUL3,FFAR4,FFAR4_HUMAN,4.7,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1054,,AGONIST,,Tchem,,,Homo sapiens
170630,2609,2700,Chromaffin granule amine transporter,Transporter,P54219,SLC18A1,VMAT1_HUMAN,4.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4834,,INHIBITOR,,Tchem,,,Homo sapiens
170635,2815,3395,Equilibrative nucleoside transporter 4,Transporter,Q7RTT9,SLC29A4,S29A4_HUMAN,4.73,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2406,,INHIBITOR,,Tbio,,,Homo sapiens
170636,90,3402,Phosphatidylinositol 4-kinase type 2-alpha,Kinase,Q9BTU6,PI4K2A,P4K2A_HUMAN,5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2844,,INHIBITOR,,Tbio,,,Homo sapiens
170637,90,3403,Phosphatidylinositol 4-kinase type 2-beta,Kinase,Q8TCG2,PI4K2B,P4K2B_HUMAN,5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2844,,INHIBITOR,,Tbio,,,Homo sapiens
170644,723,2834,Serotonin 3 receptor (5HT3),Ion channel,O95264|P46098,HTR3A|HTR3B,5HT3A_HUMAN|5HT3B_HUMAN,4.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2286,,ANTAGONIST,,Tchem|Tclin,,,Homo sapiens
170646,4588,635,Potassium voltage-gated channel subfamily KQT member 5,Ion channel,Q9NR82,KCNQ5,KCNQ5_HUMAN,4.8,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2599,,BLOCKER,,Tclin,,,Homo sapiens
170647,1920,1683,Transient receptor potential cation channel subfamily A member 1,Ion channel,O75762,TRPA1,TRPA1_HUMAN,4.8,,EC50,Patch clamp,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2585,,ACTIVATOR,,Tclin,,,Homo sapiens
170654,761,1205,Glutamate receptor 3,Ion channel,P42263,GRIA3,GRIA3_HUMAN,4.86,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4167,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
170658,4523,592,Potassium voltage-gated channel subfamily B member 2,Ion channel,Q92953,KCNB2,KCNB2_HUMAN,4.9,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2510,,BLOCKER,,Tclin,,,Homo sapiens
170663,1867,953,Acid-sensing ion channel 1,Ion channel,P78348,ASIC1,ASIC1_HUMAN,4.9,,IC50,,IUPHAR,~,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4262,,BLOCKER,,Tchem,,,Homo sapiens
170670,4588,1667,Potassium voltage-gated channel subfamily KQT member 4,Ion channel,P56696,KCNQ4,KCNQ4_HUMAN,4.9,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2599,,BLOCKER,,Tclin,,,Homo sapiens
170671,2775,201,Glycine receptor subunit alpha-2,Ion channel,P23416,GLRA2,GLRA2_HUMAN,4.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=260,,ANTAGONIST,,Tchem,,,Homo sapiens
170673,2163,201,Glycine receptor subunit alpha-2,Ion channel,P23416,GLRA2,GLRA2_HUMAN,4.9,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4286,,BLOCKER,,Tchem,,,Homo sapiens
170675,1922,563,Glycine receptor subunit beta,Ion channel,P48167,GLRB,GLRB_HUMAN,5.9,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2514,,ANTAGONIST,,Tclin,,,Homo sapiens
170676,3047,917,Histone deacetylase 10,Enzyme,Q969S8,HDAC10,HDA10_HUMAN,4.91,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7498,,INHIBITOR,,Tclin,,,Homo sapiens
170678,1481,3401,Sodium/bile acid cotransporter,Transporter,Q14973,SLC10A1,NTCP_HUMAN,4.92,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=589,,INHIBITOR,,Tchem,,,Homo sapiens
170684,2872,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,4.96,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7047,,INHIBITOR,,Tclin,,,Homo sapiens
170685,1646,3386,Neuronal acetylcholine receptor subunit alpha-6,Ion channel,Q15825,CHRNA6,ACHA6_HUMAN,4.96,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3990,,BLOCKER,,Tchem,,,Homo sapiens
170686,3047,630,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,4.97,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7498,,INHIBITOR,,Tclin,,,Homo sapiens
170706,1524,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,Tclin,,,Homo sapiens
170720,3972,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,5.1,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2373,,ALLOSTERIC MODULATOR,,Tchem,,,Homo sapiens
170729,645,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,5.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1231,,INHIBITOR,,Tchem,,,Homo sapiens
170730,228,1683,Transient receptor potential cation channel subfamily A member 1,Ion channel,O75762,TRPA1,TRPA1_HUMAN,5.1,,EC50,"Calcium imaging, patch clamp",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=33,,ACTIVATOR,,Tclin,,,Homo sapiens
170731,1646,3384,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,P32297,CHRNA3,ACHA3_HUMAN,6.41,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3990,,BLOCKER,,Tclin,,,Homo sapiens
170732,760,3401,Sodium/bile acid cotransporter,Transporter,Q14973,SLC10A1,NTCP_HUMAN,6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1024,,INHIBITOR,,Tchem,,,Homo sapiens
170733,2855,849,Cysteinyl leukotriene receptor 2,GPCR,Q9NS75,CYSLTR2,CLTR2_HUMAN,5.15,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3322,,ANTAGONIST,,Tchem,,,Homo sapiens
170735,1258,1519,Solute carrier family 12 member 2,Transporter,P55011,SLC12A2,S12A2_HUMAN,5.13,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4839,,INHIBITOR,,Tclin,,,Homo sapiens
170746,2162,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4051,,BLOCKER,,Tclin,,,Homo sapiens
170749,2346,445,Potassium voltage-gated channel subfamily A member 5,Ion channel,P22460,KCNA5,KCNA5_HUMAN,5.2,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2342,,BLOCKER,,Tclin,,,Homo sapiens
170761,427,2478,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,5.54,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4837,,AGONIST,,Tchem,,,Homo sapiens
170773,2279,3291,Short transient receptor potential channel 5,Ion channel,Q9UL62,TRPC5,TRPC5_HUMAN,5.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2377,,BLOCKER,,Tchem,,,Homo sapiens
170778,4588,302,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,O43526,KCNQ2,KCNQ2_HUMAN,5.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2599,,BLOCKER,,Tclin,,,Homo sapiens
170780,2775,563,Glycine receptor subunit beta,Ion channel,P48167,GLRB,GLRB_HUMAN,5.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=260,,ANTAGONIST,,Tclin,,,Homo sapiens
170789,4361,924,G-protein coupled bile acid receptor 1,GPCR,Q8TDU6,GPBAR1,GPBAR_HUMAN,5.4,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=608,,AGONIST,,Tchem,,,Homo sapiens
170802,761,716,Glutamate receptor 4,Ion channel,P48058,GRIA4,GRIA4_HUMAN,5.41,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4167,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
170803,1646,3385,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,P43681,CHRNA4,ACHA4_HUMAN,6.48,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3990,,BLOCKER,,Tclin,,,Homo sapiens
170808,2237,849,Cysteinyl leukotriene receptor 2,GPCR,Q9NS75,CYSLTR2,CLTR2_HUMAN,5.44,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3634,,ANTAGONIST,,Tchem,,,Homo sapiens
170818,276,622,Motilin receptor,GPCR,O43193,MLNR,MTLR_HUMAN,5.5,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6510,,AGONIST,,Tchem,,,Homo sapiens
170827,2162,201,Glycine receptor subunit alpha-2,Ion channel,P23416,GLRA2,GLRA2_HUMAN,5.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4051,,BLOCKER,,Tchem,,,Homo sapiens
170835,2720,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5820,,AGONIST,,Tclin,,,Homo sapiens
170844,1867,2121,Acid-sensing ion channel 3,Ion channel,Q9UHC3,ASIC3,ASIC3_HUMAN,5.6,,IC50,,IUPHAR,~,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4262,,BLOCKER,,Tchem,,,Homo sapiens
170850,2201,1519,Solute carrier family 12 member 2,Transporter,P55011,SLC12A2,S12A2_HUMAN,5.62,,IC50,,IUPHAR,=,1,KEGG DRUG,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4742,http://www.kegg.jp/entry/D01634,INHIBITOR,,Tclin,,,Homo sapiens
170868,4289,838,Free fatty acid receptor 1,GPCR,O14842,FFAR1,FFAR1_HUMAN,6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1051,,AGONIST,,Tchem,,,Homo sapiens
170869,2781,854,Small conductance calcium-activated potassium channel protein 2,Ion channel,Q9H2S1,KCNN2,KCNN2_HUMAN,5.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2294,,BLOCKER,,Tchem,,,Homo sapiens
170886,2373,526,Inosine-5'-monophosphate dehydrogenase 2,Enzyme,P12268,IMPDH2,IMDH2_HUMAN,6,,IC50,"<i>In vitro</i> inhibition of IMPDH (isoform not specified, human and mouse assayed)",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6842,,INHIBITOR,,Tclin,,,Homo sapiens
170892,1524,2700,Chromaffin granule amine transporter,Transporter,P54219,SLC18A1,VMAT1_HUMAN,5.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,INHIBITOR,,Tchem,,,Homo sapiens
170899,2377,3399,Solute carrier organic anion transporter family member 1B3,Transporter,Q9NPD5,SLCO1B3,SO1B3_HUMAN,5.8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2765,,INHIBITOR,,Tchem,,,Homo sapiens
170901,1646,3383,Acetylcholine receptor subunit alpha,Ion channel,P02708,CHRNA1,ACHA_HUMAN,5.82,,IC50,,IUPHAR,~,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3990,,BLOCKER,,Tclin,,,Homo sapiens
170911,3323,3189,Free fatty acid receptor 4,GPCR,Q5NUL3,FFAR4,FFAR4_HUMAN,5.89,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1052,,AGONIST,,Tchem,,,Homo sapiens
170930,4119,810,Histone deacetylase 9,Enzyme,Q9UKV0,HDAC9,HDAC9_HUMAN,5.96,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7006,,INHIBITOR,,Tclin,,,Homo sapiens
170938,4172,2041,Lysosomal protective protein,Enzyme,P10619,CTSA,PPGB_HUMAN,6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7876,,INHIBITOR,,Tchem,,,Homo sapiens
170939,4122,1683,Transient receptor potential cation channel subfamily A member 1,Ion channel,O75762,TRPA1,TRPA1_HUMAN,6,,EC50,Calcium imaging,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6306,,ACTIVATOR,,Tclin,,,Homo sapiens
170956,2337,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.03,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=50,,INHIBITOR,,Tclin,,,Homo sapiens
170963,2441,3399,Solute carrier organic anion transporter family member 1B3,Transporter,Q9NPD5,SLCO1B3,SO1B3_HUMAN,6.1,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4743,,INHIBITOR,,Tchem,,,Homo sapiens
170965,760,3399,Solute carrier organic anion transporter family member 1B3,Transporter,Q9NPD5,SLCO1B3,SO1B3_HUMAN,6.1,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1024,,INHIBITOR,,Tchem,,,Homo sapiens
170966,2720,494,Prostaglandin E2 receptor EP4 subtype,GPCR,P35408,PTGER4,PE2R4_HUMAN,6.7,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5820,,AGONIST,,Tclin,,,Homo sapiens
170974,4728,3283,Inward rectifier potassium channel 4,Ion channel,P48050,KCNJ4,KCNJ4_HUMAN,6.4,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2395,,ACTIVATOR,,Tchem,,,Homo sapiens
170980,4223,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.18,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7427,,AGONIST,,Tclin,,,Homo sapiens
170981,4410,1720,C-C chemokine receptor type 4,GPCR,P51679,CCR4,CCR4_HUMAN,6.19,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=844,,ANTAGONIST,,Tclin,,,Homo sapiens
170996,1524,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,Tclin,,,Homo sapiens
171015,760,263,fMet-Leu-Phe receptor,GPCR,P21462,FPR1,FPR1_HUMAN,6.3,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1024,,ANTAGONIST,,Tchem,,,Homo sapiens
171018,4119,575,Histone deacetylase 5,Enzyme,Q9UQL6,HDAC5,HDAC5_HUMAN,6.26,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7006,,INHIBITOR,,Tclin,,,Homo sapiens
171051,4900,600,P2Y purinoceptor 4,GPCR,P51582,P2RY4,P2RY4_HUMAN,6.4,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1736,,AGONIST,,Tchem,,,Homo sapiens
171060,1524,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,Tclin,,,Homo sapiens
171065,4376,3268,Small conductance calcium-activated potassium channel protein 1,Ion channel,Q92952,KCNN1,KCNN1_HUMAN,6.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2313,,BLOCKER,,Tchem,,,Homo sapiens
171067,2803,606,Histone deacetylase 1,Enzyme,Q13547,HDAC1,HDAC1_HUMAN,6.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7009,,INHIBITOR,,Tclin,,,Homo sapiens
171074,644,877,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",Enzyme,Q13370,PDE3B,PDE3B_HUMAN,6.42,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7148,,INHIBITOR,,Tclin,,,Homo sapiens
171091,4223,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7427,,AGONIST,,Tclin,,,Homo sapiens
171121,2722,1687,Nuclear receptor ROR-beta,Nuclear hormone receptor,Q92753,RORB,RORB_HUMAN,9.82,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2644,,ANTAGONIST,,Tchem,,,Homo sapiens
171131,4223,245,5-hydroxytryptamine receptor 4,GPCR,Q13639,HTR4,5HT4R_HUMAN,6.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7427,,AGONIST,,Tclin,,,Homo sapiens
171174,4186,3064,B1 bradykinin receptor,GPCR,P46663,BDKRB1,BKRB1_HUMAN,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=667,,ANTAGONIST,,Tchem,,,Homo sapiens
171209,4839,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,6.8,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6570,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201619,INHIBITOR,,Tclin,,,Homo sapiens
171222,4410,3079,Atypical chemokine receptor 3,GPCR,P25106,ACKR3,ACKR3_HUMAN,6.85,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=844,,AGONIST,,Tchem,,,Homo sapiens
171282,4173,2041,Lysosomal protective protein,Enzyme,P10619,CTSA,PPGB_HUMAN,7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7871,,INHIBITOR,,Tchem,,,Homo sapiens
171314,2332,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,7.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4800,,INHIBITOR,,Tchem,,,Homo sapiens
171342,1524,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,Tclin,,,Homo sapiens
171343,817,434,Oxytocin receptor,GPCR,P30559,OXTR,OXYR_HUMAN,7.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2182,,AGONIST,,Tclin,,,Homo sapiens
171345,4223,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.15,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7427,,AGONIST,,Tclin,,,Homo sapiens
171346,2875,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,7.15,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103,,INHIBITOR,,Tclin,,,Homo sapiens
171390,820,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2871,,AGONIST,,Tclin,,,Homo sapiens
171412,3659,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,Tclin,,,Homo sapiens
171500,91,3088,Uracil nucleotide/cysteinyl leukotriene receptor,GPCR,Q13304,GPR17,GPR17_HUMAN,7.43,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,AGONIST,,Tchem,,,Homo sapiens
171544,2870,75,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P14867,GABRA1,GBRA1_HUMAN,7.68,,Ki,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;1&beta;3&gamma;2.,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4348,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4348,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
171570,1546,259,Somatostatin receptor type 3,GPCR,P32745,SSTR3,SSR3_HUMAN,8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2031,,AGONIST,,Tclin,,,Homo sapiens
171612,1588,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43,,AGONIST,,Tclin,,,Homo sapiens
171628,4514,3226,Parathyroid hormone 2 receptor,GPCR,P49190,PTH2R,PTH2R_HUMAN,7.8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4448,,AGONIST,,Tchem,,,Homo sapiens
171656,2722,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,7.8,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2644,,AGONIST,,Tchem,,,Homo sapiens
171663,1202,79,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,P34903,GABRA3,GBRA3_HUMAN,7.8,,Ki,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;3&beta;1&gamma;2.,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4193,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4193,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
171737,4115,339,5-hydroxytryptamine receptor 1E,GPCR,P28566,HTR1E,5HT1E_HUMAN,8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=22,,AGONIST,,Tchem,,,Homo sapiens
171772,2044,333,Tubulin beta chain,Structural,P07437,TUBB,TBB5_HUMAN,8.05,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2770,,INHIBITOR,,Tclin,,,Homo sapiens
171776,2279,3270,Cation channel sperm-associated protein 1,Ion channel,Q8NEC5,CATSPER1,CTSR1_HUMAN,8.11,,EC50,"Patch clamp electrophysiology, kinetic rapid mixing fluorometry,  2-3  &micro;M shows the saturating efficacy.",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2377,,ACTIVATOR,,Tchem,,,Homo sapiens
171809,2279,3273,Cation channel sperm-associated protein 4,Ion channel,Q7RTX7,CATSPER4,CTSR4_HUMAN,8.11,,EC50,"Patch clamp electrophysiology, kinetic rapid mixing fluorometry, 2-3&micro;M shows the saturating efficacy.",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2377,,ACTIVATOR,,Tchem,,,Homo sapiens
171812,2279,3271,Cation channel sperm-associated protein 2,Ion channel,Q96P56,CATSPER2,CTSR2_HUMAN,8.11,,EC50,"Patch clamp electrophysiology, kinetic rapid mixing fluorometry; 2-3  &micro;M shows the saturating efficacy.",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2377,,ACTIVATOR,,Tchem,,,Homo sapiens
171813,2279,3272,Cation channel sperm-associated protein 3,Ion channel,Q86XQ3,CATSPER3,CTSR3_HUMAN,8.11,,EC50,"Patch clamp electrophysiology, kinetic rapid mixing fluorometry, 2-3&micro;M shows the saturating efficacy.",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2377,,ACTIVATOR,,Tchem,,,Homo sapiens
171834,374,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,8.2,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7128,,ANTAGONIST,,Tclin,,,Homo sapiens
171864,1202,80,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,P31644,GABRA5,GBRA5_HUMAN,8.26,,Ki,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;5&beta;1&gamma;2.,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4193,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4193,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
171868,1202,75,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P14867,GABRA1,GBRA1_HUMAN,8.28,,Ki,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;1&beta;3&gamma;2.,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4193,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4193,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
171869,1202,77,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,8.28,,Ki,Assay using recombinant GABA<sub>A</sub> channels with subunit composition; &alpha;2&beta;1&gamma;2.,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4193,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4193,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
171881,1588,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43,,ANTAGONIST,,Tclin,,,Homo sapiens
171882,1588,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43,,AGONIST,,Tchem,,,Homo sapiens
171899,331,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,8.32,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7124,,INHIBITOR,,Tclin,,,Homo sapiens
171932,4115,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=22,,AGONIST,,Tclin,,,Homo sapiens
171946,1142,1047,Cystic fibrosis transmembrane conductance regulator,Ion channel,P13569,CFTR,CFTR_HUMAN,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4190,,ACTIVATOR,,Tclin,,,Homo sapiens
171952,374,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.41,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7128,,ANTAGONIST,,Tclin,,,Homo sapiens
171956,2273,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,8.43,,EC50,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3464,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3464,AGONIST,,Tclin,,,Homo sapiens
171967,3257,3398,Tryptase alpha/beta-1,Enzyme,Q15661,TPSAB1,TRYB1_HUMAN,8.47,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7863,,INHIBITOR,,Tclin,,,Homo sapiens
171973,4727,429,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,8.5,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2780,,AGONIST,,Tclin,,,Homo sapiens
171984,1588,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,8.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43,,AGONIST,,Tchem,,,Homo sapiens
171988,285,291,Cholinesterase,Enzyme,P06276,BCHE,CHLE_HUMAN,8.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6601,,INHIBITOR,,Tclin,,,Homo sapiens
172035,374,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.62,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7128,,ANTAGONIST,,Tclin,,,Homo sapiens
172039,4836,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,8.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1324,,AGONIST,,Tclin,,,Homo sapiens
172134,4836,1718,Melanocortin receptor 3,GPCR,P41968,MC3R,MC3R_HUMAN,8.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1324,,AGONIST,,Tchem,,,Homo sapiens
172158,4836,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,9,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1324,,AGONIST,,Tchem,,,Homo sapiens
172175,1588,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=43,,AGONIST,,Tclin,,,Homo sapiens
172230,2112,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.22,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7556,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7556,ANTAGONIST,,Tclin,,,Homo sapiens
172312,2112,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.55,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7556,,ANTAGONIST,,Tclin,,,Homo sapiens
172358,4226,726,Protein kinase C gamma type,Kinase,P05129,PRKCG,KPCG_HUMAN,9.79,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7443,,ACTIVATOR,,Tchem,,,Homo sapiens
172366,4119,717,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,9.82,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7006,,INHIBITOR,,Tclin,,,Homo sapiens
172392,1867,3398,Tryptase alpha/beta-1,Enzyme,Q15661,TPSAB1,TRYB1_HUMAN,10,,IC50,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4262,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4262,INHIBITOR,,Tclin,,,Homo sapiens
172394,2112,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,10.05,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7556,,ANTAGONIST,,Tchem,,,Homo sapiens
172419,4234,3397,Erythropoietin receptor,Membrane receptor,P19235,EPOR,EPOR_HUMAN,10.43,,IC50,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7447,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202799s001lbl.pdf,AGONIST,,Tclin,,359,Homo sapiens
172427,820,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,11,,IC50,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2871,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1498,AGONIST,,Tclin,,,Homo sapiens
172433,1971,1694,ATP-sensitive inward rectifier potassium channel 10,Ion channel,P78508,KCNJ10,KCJ10_HUMAN,4.79587984085083,,IC50,inhibition at +30 mV,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/17071817,,BLOCKER,,Tbio,135,,Homo sapiens
172434,1299,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,6.221848964691162,,Kd,[86]Rb+ efflux in RINm5F insulinoma cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2445740,http://www.ncbi.nlm.nih.gov/pubmed/2445740,BLOCKER,,Tclin|Tclin,137,137,Homo sapiens
172436,1314,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,9.522878646850586,,Kd,[86]Rb+ efflux in RINm5F insulinoma cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2445740,http://www.ncbi.nlm.nih.gov/pubmed/2445740,BLOCKER,,Tclin|Tclin,137,137,Homo sapiens
172439,1314,2813,"Sulfonylurea receptor 2, Kir6.2",Ion channel,O60706|Q14654,ABCC9|KCNJ11,ABCC9_HUMAN|KCJ11_HUMAN,8.210000038146973,,Ki,,WOMBAT-PK,=,,,,,BLOCKER,,Tclin|Tclin,,,Homo sapiens
172440,1301,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,9.09691047668457,,Kd,[86]Rb+ efflux in RINm5F insulinoma cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2445740,http://www.ncbi.nlm.nih.gov/pubmed/2445740,BLOCKER,,Tclin|Tclin,137,137,Homo sapiens
172441,1302,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,9,,Kd,[86]Rb+ efflux in RINm5F insulinoma cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2445740,http://www.ncbi.nlm.nih.gov/pubmed/2445740,BLOCKER,,Tclin|Tclin,137,137,Homo sapiens
172442,1305,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,7.958607196807861,,Kd,[86]Rb+ efflux in RINm5F insulinoma cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2445740,http://www.ncbi.nlm.nih.gov/pubmed/2445740,BLOCKER,,Tclin|Tclin,137,137,Homo sapiens
172443,1298,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,7.045757293701172,,Kd,[86]Rb+ efflux in RINm5F insulinoma cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2445740,http://www.ncbi.nlm.nih.gov/pubmed/2445740,BLOCKER,,Tclin|Tclin,137,137,Homo sapiens
172444,1298,2813,"Sulfonylurea receptor 2, Kir6.2",Ion channel,O60706|Q14654,ABCC9|KCNJ11,ABCC9_HUMAN|KCJ11_HUMAN,5.170000076293945,,Ki,,WOMBAT-PK,=,,,,,BLOCKER,,Tclin|Tclin,,,Homo sapiens
172445,1299,2813,"Sulfonylurea receptor 2, Kir6.2",Ion channel,O60706|Q14654,ABCC9|KCNJ11,ABCC9_HUMAN|KCJ11_HUMAN,5.130000114440918,,Ki,,WOMBAT-PK,=,,,,,BLOCKER,,Tclin|Tclin,,,Homo sapiens
172446,622,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,5.045757293701172,,Kd,[86]Rb+ efflux in RINm5F insulinoma cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2445740,http://www.ncbi.nlm.nih.gov/pubmed/2445740,BLOCKER,,Tclin|Tclin,137,137,Homo sapiens
172447,2696,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,5.045757293701172,,Kd,[86]Rb+ efflux in RINm5F insulinoma cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2445740,http://www.ncbi.nlm.nih.gov/pubmed/2445740,BLOCKER,,Tclin|Tclin,137,137,Homo sapiens
172448,505,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,4.602059841156006,,Kd,[86]Rb+ efflux in RINm5F insulinoma cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2445740,http://www.ncbi.nlm.nih.gov/pubmed/2445740,BLOCKER,,Tclin|Tclin,137,137,Homo sapiens
172449,1300,2813,"Sulfonylurea receptor 2, Kir6.2",Ion channel,O60706|Q14654,ABCC9|KCNJ11,ABCC9_HUMAN|KCJ11_HUMAN,7.980000019073486,,Ki,,WOMBAT-PK,=,,,,,BLOCKER,,Tclin|Tclin,,,Homo sapiens
172450,1300,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,9.239999771118164,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1481,BLOCKER,,Tclin|Tclin,,,Homo sapiens
172451,1886,2813,"Sulfonylurea receptor 2, Kir6.2",Ion channel,O60706|Q14654,ABCC9|KCNJ11,ABCC9_HUMAN|KCJ11_HUMAN,4.989999771118164,,Ki,,WOMBAT-PK,=,,,,,BLOCKER,,Tclin|Tclin,,,Homo sapiens
172452,1886,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,6.460000038146973,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL783,BLOCKER,,Tclin|Tclin,,,Homo sapiens
172453,2366,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,9.140000343322754,,Ki,,WOMBAT-PK,=,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1272,BLOCKER,,Tclin|Tclin,,,Homo sapiens
172454,2366,2813,"Sulfonylurea receptor 2, Kir6.2",Ion channel,O60706|Q14654,ABCC9|KCNJ11,ABCC9_HUMAN|KCJ11_HUMAN,8.8100004196167,,Ki,,WOMBAT-PK,=,,,,,BLOCKER,,Tclin|Tclin,,,Homo sapiens
172455,4806,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.267606258392334,,Ki,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204447s004lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204447s004lbl.pdf,ANTAGONIST,,Tclin,139,139,Homo sapiens
172457,1775,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.449999809265137,,Ki,Displacement of [3H]ketanserin from human 5HT2AR expressed in HEK-293 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/15322733,,AGONIST,,Tclin,140,,Homo sapiens
172458,1775,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,9.34000015258789,,Ki,Displacement of [3H]mesulergine from human HTR2B expressed in CHO-K1 cells,SCIENTIFIC LITERATURE,=,1,IUPHAR,http://www.ncbi.nlm.nih.gov/pubmed/15322733,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,AGONIST,,Tclin,140,,Homo sapiens
172459,1775,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.34000015258789,,Ki,Displacement of [3H]mesulergine from human HTR2B expressed in HEK-293 cells,SCIENTIFIC LITERATURE,=,1,IUPHAR,http://www.ncbi.nlm.nih.gov/pubmed/15322733,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,AGONIST,,Tclin,140,,Homo sapiens
172461,1757,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,10.4,,Ki,,IUPHAR,=,1,IUPHAR,,,ANTAGONIST,,Tclin,,,Homo sapiens
172462,1818,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,7,,IC50,inside-out patches in COS-1 cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/11716850,http://www.ncbi.nlm.nih.gov/pubmed/11716850,BLOCKER,,Tclin|Tclin,142,142,Homo sapiens
172463,57,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,4.639406681060791,,Ki,displacement of [3H]glyburide binding in HEK-293 cells expressing hSUR1-hKir6.2,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/10742287,http://www.ncbi.nlm.nih.gov/pubmed/10742287,BLOCKER,,Tclin|Tclin,143,143,Homo sapiens
172464,4925,2814,Platelet-derived growth factor receptor,Kinase,P09619|P16234,PDGFRA|PDGFRB,PGFRA_HUMAN|PGFRB_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103691s5095lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103691s5095lbl.pdf,AGONIST,,Tclin|Tclin,144,144,Homo sapiens
172465,2232,3193,Growth hormone secretagogue receptor type 1,GPCR,Q92847,GHSR,GHSR_HUMAN,,,,,UNKNOWN,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/15646370,AGONIST,,Tclin,,396,Homo sapiens
172466,2433,2585,Growth hormone-releasing hormone receptor,GPCR,Q02643,GHRHR,GHRHR_HUMAN,,,,,UNKNOWN,,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6998,AGONIST,,Tclin,,,Homo sapiens
172467,4927,1700,Glucagon-like peptide 1 receptor,GPCR,P43220,GLP1R,GLP1R_HUMAN,9.698969841003418,,EC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/15331566,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125431s000lbl.pdf,AGONIST,,Tclin,148,147,Homo sapiens
172468,4928,3195,Follicle-stimulating hormone receptor,GPCR,P23945,FSHR,FSHR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021289s019lbl.pdf,AGONIST,,Tclin,,149,Homo sapiens
172469,4929,337,Lutropin-choriogonadotropic hormone receptor,GPCR,P22888,LHCGR,LSHR_HUMAN,10.9,,IC50,,IUPHAR,=,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21322lbl.pdf,AGONIST,,Tclin,150,150,Homo sapiens
215153,92,3705,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,Enzyme,O43598,DNPH1,DNPH1_HUMAN,4.71999979019165,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752,,,,Tchem,,,Homo sapiens
172471,4930,3196,Thyrotropin receptor,GPCR,P16473,TSHR,TSHR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21322lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21322lbl.pdf,AGONIST,,Tclin,150,150,Homo sapiens
172472,436,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,10.52,,EC50,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3860,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3860,AGONIST,,Tclin,,,Homo sapiens
172473,4931,2523,Melanocyte-stimulating hormone receptor,GPCR,Q01726,MC1R,MSHR_HUMAN,8.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1331,,AGONIST,,Tclin,,,Homo sapiens
172474,4931,1718,Melanocortin receptor 3,GPCR,P41968,MC3R,MC3R_HUMAN,7.06,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1331,,AGONIST,,Tchem,,,Homo sapiens
172475,4931,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,6.16,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1331,,AGONIST,,Tclin,,,Homo sapiens
172476,4931,2685,Adrenocorticotropic hormone receptor,GPCR,Q01718,MC2R,ACTHR_HUMAN,,,,,UNKNOWN,,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1331,AGONIST,,Tclin,,,Homo sapiens
172477,2775,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,8.8,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=260,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=260,ANTAGONIST,,Tclin,,,Homo sapiens
172478,4932,3404,glucocerebroside,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20367s066lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20367s066lbl.pdf,HYDROLYTIC ENZYME,,,151,151,
172479,4933,3004,Interleukin-6 receptor,Membrane receptor,P08887|P40189,IL6R|IL6ST,IL6RA_HUMAN|IL6RB_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125276s092lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125276s092lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin,152,152,Homo sapiens
172481,4935,3406,Fusion glycoprotein F0,Surface antigen,P03420,F,FUS_HRSVA,5.357348442077637,,EC50,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103770s5185lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103770s5185lbl.pdf,ANTIBODY BINDING,,,155,155,Human respiratory syncytial virus A (strain A2)
172483,2544,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,7.229147911071777,,IC50,inhibition at physiological ATP concentration,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/23279183,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021938s027lbl.pdf,INHIBITOR,,Tclin,158,159,Homo sapiens
172484,2544,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,6.958607196807861,,IC50,inhibition at physiological ATP concentration,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/23279183,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021938s027lbl.pdf,INHIBITOR,,Tclin,158,159,Homo sapiens
172486,4937,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,8.721246719360352,,IC50,TR-FRET in vitro assay ATP concentration 30uM,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/21575866,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208434s000lbl.pdf,INHIBITOR,,Tclin,160,503,Homo sapiens
172487,4939,2536,Genome polyprotein,Polyprotein,P26663,,POLG_HCVBK,10.301030158996582,,Ki,in vitro NS3 mediated hydrolysis of the peptide substrate using time-resolved fluorescence assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20163176,http://www.ncbi.nlm.nih.gov/pubmed/20163176,INHIBITOR,,,161,161,Hepatitis C virus genotype 1b (isolate BK)
172488,4939,3407,Genome polyprotein,Polyprotein,Q99IB8,,POLG_HCVJF,9.045757293701172,,Ki,in vitro NS3 mediated hydrolysis of the peptide substrate using time-resolved fluorescence assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20163176,http://www.ncbi.nlm.nih.gov/pubmed/20163176,INHIBITOR,,,161,161,Hepatitis C virus genotype 2a (isolate JFH-1)
172490,3972,3408,Glycine Receptor,Ion channel,O75311|P23415|P23416|P48167,GLRA1|GLRA2|GLRA3|GLRB,GLRA1_HUMAN|GLRA2_HUMAN|GLRA3_HUMAN|GLRB_HUMAN,6.400000095367432,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2373,,AGONIST,,Tchem|Tchem|Tclin|Tclin,,,Homo sapiens
172491,4109,201,Glycine receptor subunit alpha-2,Ion channel,P23416,GLRA2,GLRA2_HUMAN,6,,EC50,,IUPHAR,~,,,,,ALLOSTERIC MODULATOR,,Tchem,,,Homo sapiens
172492,4109,1179,Glycine receptor subunit alpha-3,Ion channel,O75311,GLRA3,GLRA3_HUMAN,5.3,,EC50,,IUPHAR,~,,,,,ALLOSTERIC MODULATOR,,Tchem,,,Homo sapiens
172493,1527,443,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,6.896196365356445,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/18672868,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003906/WC500181492.pdf,INHIBITOR,,Tclin,164,163,Homo sapiens
172494,1527,673,"Cytochrome P450 11B2, mitochondrial",Enzyme,P19099,CYP11B2,C11B2_HUMAN,7.173925399780273,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/18672868,,INHIBITOR,,Tchem,164,,Homo sapiens
172495,4940,3409,Interleukin-2 receptor subunit alpha,Membrane receptor,P01589,IL2RA,IL2RA_HUMAN,10,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/basnova032301LB.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/basnova032301LB.pdf,ANTIBODY BINDING,,Tclin,165,165,Homo sapiens
172496,4938,713,Rho-associated protein kinase 2,Kinase,O75116,ROCK2,ROCK2_HUMAN,7.721246242523193,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/25414122,http://www.ncbi.nlm.nih.gov/pubmed/25414122,INHIBITOR,,Tclin,167,167,Homo sapiens
172497,4938,670,Rho-associated protein kinase 1,Kinase,Q13464,ROCK1,ROCK1_HUMAN,7.2924299240112305,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/25414122,http://www.ncbi.nlm.nih.gov/pubmed/25414122,INHIBITOR,,Tclin,167,167,Homo sapiens
172498,4936,2684,Parathyroid hormone/parathyroid hormone-related peptide receptor,GPCR,Q03431,PTH1R,PTH1R_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125511s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125511s000lbl.pdf,AGONIST,,Tclin,168,168,Homo sapiens
172480,4934,3405,Interleukin-17A,Cytokine,Q16552,IL17A,IL17_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23253932,http://www.ncbi.nlm.nih.gov/pubmed/23253932,ANTIBODY BINDING,,Tclin,153,153,Homo sapiens
172516,4943,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.946921348571777,,Kd,displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/12090787,,AGONIST,,Tclin,176,,Homo sapiens
172517,4943,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,8.537602424621582,,Kd,displacement of [125I]-iodopindololreceptor in Sf9 cells expressing human recombinant beta2,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/12090787,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021912s013lbl.pdf,AGONIST,,Tclin,176,174,Homo sapiens
172519,4946,1851,Beta-lactamase,Enzyme,P05364,ampC,AMPC_ENTCL,8.154901504516602,,Kd,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23913691,http://www.ncbi.nlm.nih.gov/pubmed/23913691,INHIBITOR,,,178,178,Enterobacter cloacae
172520,4946,2117,Beta-lactamase,Enzyme,Q9EXV5,blaUOE-1,Q9EXV5_ECOLX,8.698969841003418,,Kd,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23913691,http://www.ncbi.nlm.nih.gov/pubmed/23913691,INHIBITOR,,,178,178,Escherichia coli
172521,4946,1963,Beta-lactamase,Enzyme,P24735,ampC,AMPC_PSEAE,6.180456161499023,,Kd,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23913691,http://www.ncbi.nlm.nih.gov/pubmed/23913691,INHIBITOR,,,178,178,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
185894,784,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.64,,Ki,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M5,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1346,,,,Tclin,,,Homo sapiens
185895,784,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,7.2,,Ki,Displacement of [3H]N-methylscopolamine from muscarinic M2 receptor in rat heart,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1346,,,,,,,Rattus norvegicus
185896,2014,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,8.05,,IC50,Inhibitory activity against Tritiated [3H]- mepyramine binding to Histamine H1 receptor in guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13828,,,,,,,Cavia porcellus
185897,2073,1786,Dihydrofolate reductase,Enzyme,P00381,folA,DYR_LACCA,5.64,,IC50,Inhibitory concentration against isolated Lactobacillus casei Dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,,,,Lactobacillus casei
185898,2073,276,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q07422,,DRTS_TOXGO,6.37,,IC50,Inhibition of Toxoplasma gondii DHFR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,,,,Toxoplasma gondii
185899,2073,2153,Thymidylate synthase,Enzyme,C3SWJ7,thyA,C3SWJ7_ECOLX,5.96,,IC50,Inhibitory activity against Escherichia coli thymidylate synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,,,,Escherichia coli
185900,2073,2018,Thymidylate synthase,Enzyme,P00469,thyA,TYSY_LACCA,6.26,,Ki,Binding affinity against TS,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,,,,Lactobacillus casei
185901,2073,431,"Serine hydroxymethyltransferase, cytosolic",Enzyme,P34896,SHMT1,GLYC_HUMAN,4.77,,Kd,"Binding affinity to human recombinant Serine hydroxymethyltransferase, cytosolic by isothermal titration calorimetry",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,Tbio,,,Homo sapiens
185902,2073,2002,Thymidylate synthase,Enzyme,P45352,Tyms,TYSY_RAT,4.7,,IC50,Inhibitory concentration against isolated rat thymidylate synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,,,,Rattus norvegicus
185903,2073,2102,Dihydrofolate reductase,Unclassified,B0BL08,dfrA17,B0BL08_ECOLX,5.64,,IC50,Inhibitory activity against recombinant Escherichia coli dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,,,,Escherichia coli
185904,2073,1790,Thymidylate synthase,Enzyme,P07607,Tyms,TYSY_MOUSE,6.47,,Ki,Compound was evaluated for competitive inhibition of recombinant mouse thymidylate synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,,,,Mus musculus
185905,2073,1422,Proton-coupled folate transporter,Transporter,Q96NT5,SLC46A1,PCFT_HUMAN,7.03,,Ki,Inhibition of [3H]MTX transport at human PCFT expressed in Chinese hamster R2 cells at pH 5.5 by Dixon plot,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,Tchem,,,Homo sapiens
185906,2073,1736,Dihydrofolate reductase,Enzyme,P00375,Dhfr,DYR_MOUSE,6.25,,Ki,Binding affinity against dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,,,,Mus musculus
185907,2073,1994,Trifunctional purine biosynthetic protein adenosine-3,Enzyme,P22102,GART,PUR2_HUMAN,6.42,,Ki,Inhibition of GARFT,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021462lbl.pdf,INHIBITOR,,Tclin,,2308,Homo sapiens
185908,2073,3606,Thymidylate synthase (EC 2.1.1.45) (TS) (TSase),Enzyme,E2QDN0,,E2QDN0_ECOLX,4.12,,IC50,Inhibition of Escherichia coli TS assessed as oxidation of tetrahydrofolate to dihydrofolate after 2 to 12 mins by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,,,,Escherichia coli
185909,550,2100,Beta-lactamase,Enzyme,A2RP81,blaPER-2,A2RP81_CITFR,6.85,,Ki,Inhibition of Citrobacter freundii PER2 beta lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL996,,,,,,,Citrobacter freundii
185910,550,2416,Beta-lactamase,Enzyme,B2ZTR6,,B2ZTR6_ACIBA,7,,Ki,Activity of Acinetobacter baumannii ADC-33 beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL996,,,,,,,Acinetobacter baumannii
185911,550,2417,Beta-lactamase,Enzyme,D6NSM8,ampC,D6NSM8_ACIBA,6.3,,Ki,Activity of Acinetobacter baumannii ADC-11 beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL996,,,,,,,Acinetobacter baumannii
185912,550,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL996,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL996,INHIBITOR,,,,,Escherichia coli (strain K12)
185913,2359,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,,,,Mechanism of Action; CHEMBL1980; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1404,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1404,BLOCKER,,Tclin,,,Homo sapiens
185915,4004,1863,Vasopressin V2 receptor,GPCR,Q00788,Avpr2,V2R_RAT,7.92,,IC50,Displacement of [3H]-AVP from its AVP-V2 receptor binding site in rat kidney,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106229,,,,,,,Rattus norvegicus
185916,4004,434,Oxytocin receptor,GPCR,P30559,OXTR,OXYR_HUMAN,6.18,,Ki,Binding affinity to oxytocin receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106229,,,,Tclin,,,Homo sapiens
185917,4004,392,Vasopressin V2 receptor,GPCR,P30518,AVPR2,V2R_HUMAN,8.03,,Ki,Concentration which inhibit [3H]AVP binding to human Vasopressin V2 receptor coded HeLa cells by 50%,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106229,http://www.ncbi.nlm.nih.gov/pubmed/1387020,ANTAGONIST,,Tclin,,463,Homo sapiens
185918,4004,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,6.71,,Ki,Binding affinity to vasopressin V1a receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106229,,,,Tclin,,,Homo sapiens
185919,4004,1971,Vasopressin V1a receptor,GPCR,P30560,Avpr1a,V1AR_RAT,5.85,,IC50,Displacement of [3H]AVP from AVP-V1a receptor binding site in rat liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106229,,,,,,,Rattus norvegicus
185920,4004,2908,Vasopressin V1 receptor,GPCR,P30560|P48974,Avpr1a|Avpr1b,V1AR_RAT|V1BR_RAT,5.3,,IC50,Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106229,,,,,,,Rattus norvegicus
185921,3248,2876,Estrogen receptor,Nuclear hormone receptor,P03372|Q92731,ESR1|ESR2,ESR1_HUMAN|ESR2_HUMAN,,,,Mechanism of Action; CHEMBL2093866; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200598,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200598,AGONIST,,Tclin|Tclin,,,Homo sapiens
185922,1481,2882,Angiotensin II receptor,GPCR,P25095|P29089|P35351,Agtr1|Agtr1b|Agtr2,AGTR2_RAT|AGTRA_RAT|AGTRB_RAT,8.89,,IC50,Inhibition of [125I]-AII binding to Angiotensin II receptor of rat uterine membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1513,,,,,,,Rattus norvegicus
185923,1481,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.1,,Ki,"Inhibitory concentration against angiotensin II receptor, type 1",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1513,ANTAGONIST,,Tclin,,,Homo sapiens
185924,1481,1731,Type-1B angiotensin II receptor,GPCR,P29089,Agtr1b,AGTRB_RAT,9.1,,Ki,"Compound was evaluated for its binding affinity towards rat Angiotensin II receptor, type 1",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1513,,,,,,,Rattus norvegicus
185925,1481,457,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,5,,Ki,Binding affinity to ETA receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1513,,,,Tclin,,,Homo sapiens
185926,1481,2881,Angiotensin II receptor (AT-1) type-1,GPCR,P25095|P29089,Agtr1|Agtr1b,AGTRA_RAT|AGTRB_RAT,8.89,,IC50,"Binding affinity towards Angiotensin II receptor, type 1 in rat liver membrane using [125I]-angiotensin II (0.1 nM)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1513,,,,,,,Rattus norvegicus
185927,1881,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,Mechanism of Action; CHEMBL1871; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757,AGONIST,,Tclin,,,Homo sapiens
185928,3408,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,Mechanism of Action; CHEMBL1780; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1262,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1262,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
185929,2423,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,7.75,,Ki,Inhibition of 5-hydroxytryptamine 2 induced vasoconstriction of rat caudal artery.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52939,,,,,,,Rattus norvegicus
185930,2866,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,9.4,,IC50,Inhibitory activity against angiotensin I converting enzyme (ACE),CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16332,http://www.ncbi.nlm.nih.gov/pubmed/2484083,INHIBITOR,,Tclin,,212,Homo sapiens
185931,1805,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,5.3,,IC50,Antagonist activity at estrogen receptor by Gal4-DNA binding domain-hormone receptor LBD one-hybrid assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276308,,,,Tclin,,,Homo sapiens
185932,1805,2026,Progesterone receptor,Transcription factor,Q63449,Pgr,PRGR_RAT,8.46,,IC50,Inhibition of [3H]R5020 binding to cytosolic progesterone receptor (PRc) of rat uterus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276308,,,,,,,Rattus norvegicus
185933,1805,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,5.54,,Ki,Displacement of [3H]E2 from human ERbeta after 16 hrs by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276308,,,,Tclin,,,Homo sapiens
185934,1805,3607,P-glycoprotein 3,Unclassified,P21447,Abcb1a,MDR1A_MOUSE,4.7,,Kd,Compound was tested for the binding affinity towards recombinant NBD2 C-terminal cytotoxic nucleotide-binding domain of mouse P-Glycoprotein,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276308,,,,,,,Mus musculus
185935,1805,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,8.85,,IC50,Inhibition of [3H]dexamethasone binding to rat glucocorticoid receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276308,,,,,,,Rattus norvegicus
185936,367,2003,Progesterone receptor,Transcription factor,P06186,PGR,PRGR_RABIT,5.25,,IC50,Displacement of [3H]progesterone from rabbit PR by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409,,,,,,,Oryctolagus cuniculus
185937,367,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.72,,Ki,Inhibition of human AR,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409,ANTAGONIST,,Tclin,,,Homo sapiens
185938,367,2026,Progesterone receptor,Transcription factor,Q63449,Pgr,PRGR_RAT,5.14,,Ki,Inhibition of rat PR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409,,,,,,,Rattus norvegicus
185939,367,1850,Androgen receptor,Transcription factor,P19091,Ar,ANDR_MOUSE,6.17,,IC50,Antiandrogen activity against androgen receptor in androgen-dependent mouse SC3 cells assessed as inhibition of testosterone-induced cell proliferation by WST1 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409,,,,,,,Mus musculus
185940,367,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,7.85,,Ki,Inhibition of rat AR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409,,,,,,,Rattus norvegicus
185943,419,3609,Interleukin-5,Unclassified,P04401,Il5,IL5_MOUSE,4.58,,IC50,Inhibition of IL5-mediated proliferation of mouse Y16 cells by WST1 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370,,,,,,,Mus musculus
185944,419,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,8.54,,IC50,Steroid binding against the rat thymus glucocorticoid receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370,,,,,,,Rattus norvegicus
185946,3959,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1683,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1683,AGONIST,,Tclin,,,Homo sapiens
185947,416,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action; CHEMBL231; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200403,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200403,ANTAGONIST,,Tclin,,,Homo sapiens
185948,3328,1798,Sodium channel protein type 2 subunit alpha,Ion channel,P04775,Scn2a,SCN2A_RAT,6.59,,IC50,In vitro inhibition of [14C]- guanidinium influx in Chinese hamster ovary (CHO) cells expressing rat brain sodium channel type IIA (CNaIIA-1),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL281724,,,,,,,Rattus norvegicus
185949,2452,663,Neutrophil elastase,Enzyme,P08246,ELANE,ELNE_HUMAN,6.7,,Ki,Binding affinity against Elastase.,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76688,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6441,,,Tclin,,,Homo sapiens
185950,826,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1651,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1651,AGONIST,,Tclin,,,Homo sapiens
185951,349,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200538,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200538,AGONIST,,Tclin,,,Homo sapiens
185952,1211,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.05,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42055,,,,Tchem,,,Homo sapiens
185953,1211,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,8.52,,IC50,"Ability to displace [3H]haloperidol from rat striatal membranes, in order to measure its intrinsic affinity for the dopamine (DA) receptor",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42055,,,,,,,Rattus norvegicus
185954,1211,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.65,,IC50,The compound was tested for affinity towards sigma-3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42055,,,,Tclin,,,Homo sapiens
185955,1211,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,9.52,,IC50,In vivo binding affinity against dopamine (D1) receptor in rat caudate-putamen tissue using [3H]SCH-23390 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42055,,,,,,,Rattus norvegicus
185956,1115,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,5.11,,IC50,Inhibition of MRP2 expressed in MDCK2 cells assessed as cell growth inhibition by calcein and pheophorbide A efflux assays,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL308954,,,,Tbio,,,Homo sapiens
185957,1115,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,5.4,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL308954,,,,,,,Trypanosoma cruzi
185958,1115,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.12,,IC50,Inhibition of MDR1 expressed in MDCK2 cells assessed as inhibition of cell proliferation by calcein and pheophorbide A efflux assays,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL308954,,,,Tchem,,,Homo sapiens
185959,1115,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,5.07,,IC50,Inhibition of MRP1 expressed in MDCK2 cells assessed as cell growth inhibition by calcein and pheophorbide A efflux assays,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL308954,,,,Tchem,,,Homo sapiens
185960,1115,205,Canalicular multispecific organic anion transporter 2,Transporter,O15438,ABCC3,MRP3_HUMAN,5.29,,IC50,Inhibition of MRP3 expressed in MDCK2 cells assessed as cell growth inhibition by calcein and pheophorbide A efflux assays,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL308954,,,,Tbio,,,Homo sapiens
185961,1115,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,5.22,,IC50,Inhibition of BCRP expressed in MDCK2 cells assessed as cell growth inhibition by calcein and pheophorbide A efflux assays,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL308954,,,,Tchem,,,Homo sapiens
185962,1115,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,,,,Mechanism of Action; CHEMBL247; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL308954,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL308954,INHIBITOR,,,,,Human immunodeficiency virus 1
185963,279,659,Penicillin-binding protein 1A,Enzyme,Q07806,mrcA,PBPA_PSEAE,5.48,,IC50,Displacement of fluorescent Bocillin FL from N-terminal His tagged Pseudomonas aeruginosa PAO1 PBP1a (residues 36 to 822) expressed in Escherichia coli BL21 (Gold cells),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158,,,,,,,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
185964,279,2139,Beta-lactamase,Enzyme,A4ZYU9,blaACC-4,A4ZYU9_ECOLX,7.49,,IC50,Inhibition of Escherichia coli beta-lactamase ACC4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158,,,,,,,Escherichia coli
185965,279,2100,Beta-lactamase,Enzyme,A2RP81,blaPER-2,A2RP81_CITFR,5.7,,Ki,Inhibition of Citrobacter freundii PER2 beta lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158,,,,,,,Citrobacter freundii
185966,279,2388,AmpC,Unclassified,Q83TT7,ampC,Q83TT7_ECOLX,7.22,,IC50,Inhibition of Escherichia coli ATCC 25922 AmpC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158,,,,,,,Escherichia coli
185967,279,2416,Beta-lactamase,Enzyme,B2ZTR6,,B2ZTR6_ACIBA,8.15,,Ki,Activity of Acinetobacter baumannii ADC-33 beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158,,,,,,,Acinetobacter baumannii
185968,279,2417,Beta-lactamase,Enzyme,D6NSM8,ampC,D6NSM8_ACIBA,5.52,,Ki,Activity of Acinetobacter baumannii ADC-11 beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158,,,,,,,Acinetobacter baumannii
185995,4118,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,6.7,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
185969,279,2398,Efflux transporter; SugE,Unclassified,Q3S5C3,sugE,Q3S5C3_SALNE,8.22,,IC50,Inhibition of Salmonella enterica serotype Newport AM17274 cephalosporinase CMY-31 by UV spectrophotometer in presence of 100 uM of cephalothin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158,,,,,,,Salmonella newport
185970,279,2399,Beta-lactamase,Enzyme,Q48435,bla LAT-2,Q48435_KLEPN,8.22,,IC50,Inhibition of Klebsiella pneumoniae HP205 cephalosporinase CMY-36 by UV spectrophotometer in presence of 100 uM of cephalothin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL158,,,,,,,Klebsiella pneumoniae
185971,2806,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,5.33,,Ki,"Inhibition constant against Angiotensin II receptor, type 1 was determined",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1069,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1069,ANTAGONIST,,Tclin,,,Homo sapiens
185972,2806,1731,Type-1B angiotensin II receptor,GPCR,P29089,Agtr1b,AGTRB_RAT,8.72,,IC50,"Binding affinity for rat angiotensin II receptor, type 1",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1069,,,,,,,Rattus norvegicus
185973,2806,2071,Type-1A angiotensin II receptor,GPCR,P25095,Agtr1,AGTRA_RAT,8.47,,IC50,"Displacement of [125I]Sar1,Ile8-Ang2 from AT1 receptor in Wistar rat hepatic membrane",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1069,,,,,,,Rattus norvegicus
185974,2806,2881,Angiotensin II receptor (AT-1) type-1,GPCR,P25095|P29089,Agtr1|Agtr1b,AGTRA_RAT|AGTRB_RAT,8.57,,IC50,"Inhibitory activity against Angiotensin II receptor, type 1 in rat aortic membrane",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1069,,,,,,,Rattus norvegicus
185975,720,168,Beta-lactamase TEM,Enzyme,P62593,bla; blaT-3; blaT-4;,BLAT_ECOLX,4.89,,Ki,Inhibition constant (Ki) for TEM-1 beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL891,,,,,,,Escherichia coli
185976,720,2139,Beta-lactamase,Enzyme,A4ZYU9,blaACC-4,A4ZYU9_ECOLX,7.59,,IC50,Inhibition of Escherichia coli beta-lactamase ACC4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL891,,,,,,,Escherichia coli
185977,720,2398,Efflux transporter; SugE,Unclassified,Q3S5C3,sugE,Q3S5C3_SALNE,8.4,,IC50,Inhibition of Salmonella enterica serotype Newport AM17274 cephalosporinase CMY-31 by UV spectrophotometer in presence of 100 uM of cephalothin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL891,,,,,,,Salmonella newport
185978,720,2399,Beta-lactamase,Enzyme,Q48435,bla LAT-2,Q48435_KLEPN,8.4,,IC50,Inhibition of Klebsiella pneumoniae HP205 cephalosporinase CMY-36 by UV spectrophotometer in presence of 100 uM of cephalothin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL891,,,,,,,Klebsiella pneumoniae
185979,720,3472,Penicillin-binding protein,Enzyme,P72355|Q53707|Q53725|Q53729|Q9XDB3,PBP2|mecA|pbp4|pbpA|pbpF,P72355_STAAU|Q53707_STAAU|Q53725_STAAU|Q53729_STAAU|Q9XDB3_STAAU,,,,Mechanism of Action; CHEMBL2363021; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL891,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL891,INHIBITOR,,,,,Staphylococcus aureus
185980,4118,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,5.72,,Kd,Binding constant for JNK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
185981,4118,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,6.42,,Kd,Binding constant for ABL1(H396P)-non phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
185982,4118,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,6.13,,Kd,Binding constant for FLT3(K663Q) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
185983,4118,2372,Phosphatidylinositol 4-kinase beta,Kinase,Q9UBF8,PI4KB,PI4KB_HUMAN,6.02,,Kd,Binding constant for PIK4CB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
185984,4118,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,7.85,,Kd,Binding constant for FLT1 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,INHIBITOR,,Tclin,,,Homo sapiens
185985,4118,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.55,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
185986,4118,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,7.85,,Kd,Binding constant for VEGFR2 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,INHIBITOR,,Tclin,,,Homo sapiens
185987,4118,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.21,,Kd,Binding constant for FGFR3(G697C) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,INHIBITOR,,Tclin,,,Homo sapiens
185988,4118,660,Calcium/calmodulin-dependent protein kinase type 1,Kinase,Q14012,CAMK1,KCC1A_HUMAN,5.68,,Kd,Binding constant for full-length CAMK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
185989,4118,2281,Fibroblast growth factor receptor 4,Kinase,P22455,FGFR4,FGFR4_HUMAN,5.55,,Kd,Binding constant for FGFR4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
185990,4118,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,8.31,,Kd,Binding constant for PDGFRA kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,INHIBITOR,,Tclin,,,Homo sapiens
185991,4118,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,5.7,,Kd,Binding constant for MET kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
185992,4118,887,Receptor-interacting serine/threonine-protein kinase 2,Kinase,O43353,RIPK2,RIPK2_HUMAN,6.24,,Kd,Binding constant for RIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
185993,4118,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,5.77,,Kd,Binding constant for JAK2(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
185994,4118,911,MAP/microtubule affinity-regulating kinase 3,Kinase,P27448,MARK3,MARK3_HUMAN,5.4,,Kd,Binding constant for full-length MARK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
216808,1741,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,6.74,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Anopheles gambiae
185996,4118,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,5.15,,Kd,Binding constant for AURKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
185997,4118,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,6.32,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
185998,4118,715,Tyrosine-protein kinase SYK,Kinase,P43405,SYK,KSYK_HUMAN,5.33,,Kd,Binding constant for SYK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
185999,4118,537,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,6.05,,Kd,Binding constant for RAF1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186000,4118,2276,"Interferon-induced, double-stranded RNA-activated protein kinase",Kinase,P19525,EIF2AK2,E2AK2_HUMAN,5.72,,Kd,Binding constant for PRKR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186001,4118,2233,Cyclin-dependent kinase 11B,Kinase,P21127,CDK11B,CD11B_HUMAN,5.68,,Kd,Binding constant for CDC2L1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186002,4118,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,6.12,,Kd,Binding constant for MAP4K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186003,4118,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,6.37,,Kd,Binding constant for BRAF(V600E) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186004,4118,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,5.8,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186005,4118,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,6.12,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186006,4118,796,Dual specificity protein kinase TTK,Kinase,P33981,TTK,TTK_HUMAN,6.82,,Kd,Binding constant for TTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186007,4118,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,7.08,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186008,4118,776,Tyrosine-protein kinase Fer,Kinase,P16591,FER,FER_HUMAN,5.57,,Kd,Binding constant for FER kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186009,4118,793,Serine/threonine-protein kinase 16,Kinase,O75716,STK16,STK16_HUMAN,6.44,,Kd,Binding constant for STK16 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186010,4118,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,6.54,,Kd,Binding constant for PLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186011,4118,741,AP2-associated protein kinase 1,Kinase,Q2M2I8,AAK1,AAK1_HUMAN,5.54,,Kd,Binding constant for AAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186012,4118,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,5.16,,Kd,Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186013,4118,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,5.3,,Kd,Binding constant for YES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186014,4118,2353,Serine/threonine-protein kinase TAO1,Kinase,Q7L7X3,TAOK1,TAOK1_HUMAN,6.62,,Kd,Binding constant for TAOK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186015,4118,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,5.24,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186016,4118,792,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.12,,Kd,Binding constant for full-length AURKC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186017,4118,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,8.7,,Kd,Binding constant for PDGFRB kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,INHIBITOR,,Tclin,,,Homo sapiens
186018,4118,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,6,,Kd,Binding constant for FGFR1 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,INHIBITOR,,Tclin,,,Homo sapiens
186019,4118,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.68,,Kd,Binding constant for FGFR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186020,4118,2239,Mitogen-activated protein kinase kinase kinase 10,Kinase,Q02779,MAP3K10,M3K10_HUMAN,5.68,,Kd,Binding constant for MLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186021,4118,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,5.52,,Kd,Binding constant for MAP4K5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186022,4118,2460,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,Kinase,Q8TBX8,PIP4K2C,PI42C_HUMAN,6.55,,Kd,Binding constant for PIP5K2C kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186023,4118,852,Serine/threonine-protein kinase 36,Kinase,Q9NRP7,STK36,STK36_HUMAN,6.33,,Kd,Binding constant for STK36 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186024,4118,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,8.74,,Kd,Binding constant for KIT(L576P) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,INHIBITOR,,Tclin,,,Homo sapiens
215154,1364,3704,Heat shock 70 kDa protein 1A,Unclassified,P0DMV8,HSPA1A,HS71A_HUMAN,4.71999979019165,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496,,,,Tchem,,,Homo sapiens
186025,4118,855,BMP-2-inducible protein kinase,Kinase,Q9NSY1,BMP2K,BMP2K_HUMAN,5.06,,Kd,Binding constant for BIKE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186026,4118,2240,Mitogen-activated protein kinase kinase kinase 11,Kinase,Q16584,MAP3K11,M3K11_HUMAN,6.13,,Kd,Binding constant for MLK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186027,4118,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,6.51,,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186028,4118,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,6.62,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186029,4118,2375,Bone morphogenetic protein receptor type-1B,Kinase,O00238,BMPR1B,BMR1B_HUMAN,6,,Kd,Binding constant for BMPR1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186030,4118,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,5.47,,Kd,Binding constant for TYK2(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186031,4118,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,5.23,,Kd,Binding constant for IRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186032,4118,2024,Protein-tyrosine kinase 6,Kinase,Q13882,PTK6,PTK6_HUMAN,5.64,,Kd,Binding constant for PTK6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186033,4118,915,Calcium/calmodulin-dependent protein kinase type 1G,Kinase,Q96NX5,CAMK1G,KCC1G_HUMAN,5.43,,Kd,Binding constant for CAMK1G kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186034,4118,2458,Serine/threonine-protein kinase TAO2,Kinase,Q9UL54,TAOK2,TAOK2_HUMAN,5.74,,Kd,Binding constant for TAOK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186035,4118,747,Serine/threonine-protein kinase Nek2,Kinase,P51955,NEK2,NEK2_HUMAN,6.01,,Kd,Binding constant for NEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186036,4118,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.05,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186037,4118,748,LIM domain kinase 1,Kinase,P53667,LIMK1,LIMK1_HUMAN,6.14,,Kd,Binding constant for full-length LIMK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186038,4118,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,5.8,,Kd,Binding constant for MAP4K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186039,4118,892,Cyclin-dependent kinase 16,Kinase,Q00536,CDK16,CDK16_HUMAN,5.92,,Kd,Binding constant for PCTK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186040,4118,2252,Serine/threonine-protein kinase Nek5,Kinase,Q6P3R8,NEK5,NEK5_HUMAN,5.14,,Kd,Binding constant for NEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tdark,,,Homo sapiens
186041,4118,2194,Interleukin-1 receptor-associated kinase 3,Kinase,Q9Y616,IRAK3,IRAK3_HUMAN,6.1,,Kd,Binding constant for IRAK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186042,4118,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,6.54,,Kd,Binding constant for MAP3K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186043,4118,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,5.52,,Kd,Binding constant for ABL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186044,4118,2200,Activin receptor type-2B,Kinase,Q13705,ACVR2B,AVR2B_HUMAN,5.62,,Kd,Binding constant for ACVR2B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186045,4118,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,5.59,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186046,4118,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,5.48,,Kd,Binding constant for TIE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186047,4118,2455,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma,Kinase,O60331,PIP5K1C,PI51C_HUMAN,5.72,,Kd,Binding constant for PIP5K1C kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186048,4118,2282,Proto-oncogene tyrosine-protein kinase ROS,Kinase,P08922,ROS1,ROS1_HUMAN,6.04,,Kd,Binding constant for ROS1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186049,4118,2466,Calcium-dependent protein kinase 1,Kinase,P62344,CPK1,CDPK1_PLAF7,6.43,,Kd,Binding constant for PFCDPK1(P.falciparum) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,,,,Plasmodium falciparum
186050,4118,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,7.09,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186051,4118,665,Mitogen-activated protein kinase 8,Kinase,P45983,MAPK8,MK08_HUMAN,5.7,,Kd,Binding constant for JNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186052,4118,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,5.14,,Kd,Binding constant for full-length SNF1LK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186053,4118,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,7.35,,Kd,Binding constant for TAOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186054,4118,2261,Tyrosine-protein kinase Srms,Kinase,Q9H3Y6,SRMS,SRMS_HUMAN,5.6,,Kd,Binding constant for SRMS kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
215156,91,3704,Heat shock 70 kDa protein 1A,Unclassified,P0DMV8,HSPA1A,HS71A_HUMAN,5.46999979019165,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14249,,,,Tchem,,,Homo sapiens
186055,4118,2369,Mitogen-activated protein kinase kinase kinase 1,Kinase,Q13233,MAP3K1,M3K1_HUMAN,5.54,,Kd,Binding constant for MAP3K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186056,4118,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.57,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186057,4118,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,8.1,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,INHIBITOR,,Tclin,,,Homo sapiens
186058,4118,543,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,7.57,,Kd,Binding constant for FLT4 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,INHIBITOR,,Tclin,,,Homo sapiens
186059,4118,2205,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,7.01,,Kd,Binding constant for DDR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186060,4118,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,6.15,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186061,4118,1604,TGF-beta receptor type-2,Kinase,P37173,TGFBR2,TGFR2_HUMAN,5.52,,Kd,Binding constant for TGFBR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186062,4118,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.57,,Kd,Binding constant for RET(M918T) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186063,4118,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,7.24,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186064,4118,2226,Mitogen-activated protein kinase kinase kinase kinase 4,Kinase,O95819,MAP4K4,M4K4_HUMAN,5.66,,Kd,Binding constant for MAP4K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186065,4118,2280,Tyrosine-protein kinase Fes/Fps,Kinase,P07332,FES,FES_HUMAN,5.85,,Kd,Binding constant for FES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186066,4118,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.92,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,INHIBITOR,,Tclin,,,Homo sapiens
186067,4118,723,"Myosin light chain kinase 2, skeletal/cardiac muscle",Kinase,Q9H1R3,MYLK2,MYLK2_HUMAN,5.7,,Kd,Binding constant for MYLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186068,4118,2238,Mitogen-activated protein kinase kinase kinase 9,Kinase,P80192,MAP3K9,M3K9_HUMAN,6.54,,Kd,Binding constant for MLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186069,4118,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,5.17,,Kd,Binding constant for LTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186070,4118,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,6.03,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186071,4118,2229,Dual specificity mitogen-activated protein kinase kinase 4,Kinase,P45985,MAP2K4,MP2K4_HUMAN,6.23,,Kd,Binding constant for MEK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186072,4118,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,5.59,,Kd,Binding constant for TXK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186073,4118,2230,Dual specificity mitogen-activated protein kinase kinase 6,Kinase,P52564,MAP2K6,MP2K6_HUMAN,5.39,,Kd,Binding constant for MEK6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186074,4118,2184,LIM domain kinase 2,Kinase,P53671,LIMK2,LIMK2_HUMAN,6.41,,Kd,Binding constant for full-length LIMK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186075,4118,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,5.66,,Kd,Binding constant for ALK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tclin,,,Homo sapiens
186076,4118,2277,Receptor-interacting serine/threonine-protein kinase 1,Kinase,Q13546,RIPK1,RIPK1_HUMAN,6.59,,Kd,Binding constant for RIPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186077,4118,2234,Cyclin-dependent kinase 11A,Kinase,Q9UQ88,CDK11A,CD11A_HUMAN,5.89,,Kd,Binding constant for CDC2L2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186078,4118,2349,Serine/threonine-protein kinase RIO2,Kinase,Q9BVS4,RIOK2,RIOK2_HUMAN,6.21,,Kd,Binding constant for RIOK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tbio,,,Homo sapiens
186079,4118,2191,Serine/threonine-protein kinase NLK,Kinase,Q9UBE8,NLK,NLK_HUMAN,5.36,,Kd,Binding constant for full-length NLK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186080,4118,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,5.57,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186081,4118,2260,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,5.66,,Kd,Binding constant for SNF1LK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186082,4118,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,5.48,,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
186083,4118,2136,Non-receptor tyrosine-protein kinase TNK1,Kinase,Q13470,TNK1,TNK1_HUMAN,6.01,,Kd,Binding constant for full-length TNK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,,,,Tchem,,,Homo sapiens
216809,56,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,7.56,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Anopheles gambiae
186084,4118,1822,Tyrosine-protein kinase ITK/TSK,Kinase,Q08881,ITK,ITK_HUMAN,,,,Mechanism of Action; CHEMBL2959; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477772,INHIBITOR,,Tclin,,,Homo sapiens
186085,1212,1634,Trypanothione reductase,Enzyme,P28593,TPR,TYTR_TRYCR,4.67,,Ki,Inhibitory activity against recombinant Trypanosoma cruzi (Trypanosoma cruzi) Trypanothione reductase (linear competitive type),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL726,,,,,,,Trypanosoma cruzi
186086,1212,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,5.77,,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL726,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
186087,1212,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.43,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL726,,,,Tclin|Tclin|Tclin,,,Homo sapiens
186088,1212,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,6.1,,Ki,Displacement of [3H]mibolerone from rat androgen receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL726,,,,,,,Rattus norvegicus
186089,1212,2862,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy2|Adcy3|Adcy4|Adcy5|Adcy6|Adcy8,ADCY2_RAT|ADCY3_RAT|ADCY4_RAT|ADCY5_RAT|ADCY6_RAT|ADCY8_RAT|D4A3N4_RAT|Q8CFM9_RAT,7.1,,IC50,The compound was tested for adenylate cyclase activity in rat corpus striatum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL726,,,,,,,Rattus norvegicus
186090,2761,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.1,,Ki,Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL187709,,,,Tclin,,,Homo sapiens
186091,2761,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,8.7,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL187709,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
186092,2761,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,7.96,,Ki,Affinity for human EMP expressed in ERG2 deficient strain of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL187709,,,,Tchem,,,Homo sapiens
186093,2340,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.08,,IC50,Compound was tested for its inhibitory potency against angiotensin I converting enzyme.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1592,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1592,INHIBITOR,,Tclin,,,Homo sapiens
186094,3236,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6.8,,IC50,Ability to induce 50% of maximal effect in rabbit vas deferens expressing Opioid receptor kappa 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL283552,,,,Tclin,,,Homo sapiens
186095,3236,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,7.92,,IC50,Ability to induce 50% of maximal effect in guinea pig ileum expressing Opioid receptor mu 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL283552,,,,,,,Cavia porcellus
186096,3236,1758,Mu-type opioid receptor,GPCR,P42866,Oprm1,OPRM_MOUSE,8.07,,IC50,Ability to induce 50% of maximal effect in mouse vas deferens expressing Opioid receptor delta 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL283552,,,,,,,Mus musculus
186097,21,1786,Dihydrofolate reductase,Enzyme,P00381,folA,DYR_LACCA,8.3,,IC50,Inhibition of dihydrofolate reductase in Lactobacillus casei,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL376180,,,,,,,Lactobacillus casei
186099,21,2102,Dihydrofolate reductase,Unclassified,B0BL08,dfrA17,B0BL08_ECOLX,7.96,,IC50,Inhibition of dihydrofolate reductase in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL376180,,,,,,,Escherichia coli
186100,21,1736,Dihydrofolate reductase,Enzyme,P00375,Dhfr,DYR_MOUSE,8.7,,IC50,Inhibitory activity against dihydrofolate reductase(DHFR) isolated from L1210 murine leukemia cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL376180,,,,,,,Mus musculus
186101,21,3610,Folylpoly-gamma-glutamate synthetase,Unclassified,P48760,Fpgs,FOLC_MOUSE,4.75,,Ki,Compound was tested for its ability to inhibit Folyl-polyglutamate synthase from mouse liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL376180,,,,,,,Mus musculus
186103,2435,2000,Alpha-1B adrenergic receptor,GPCR,P18841,ADRA1B,ADA1B_MESAU,9.48,,Ki,Displacement of [3H]prazosin (0.5 nM) from hamster Alpha-1B adrenergic receptor expressed in rat-1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,,,,Mesocricetus auratus
186104,2435,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.19,,IC50,Inhibition of human ABCB1-mediated rhodamine 123 efflux in mouse L5178 cells expressing human MDR1 after 20 mins by FACS analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,Tchem,,,Homo sapiens
186105,2435,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.48,,Ki,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,Tclin,,,Homo sapiens
186106,2435,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,9.41,,IC50,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor from rat cortical membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,,,,Rattus norvegicus
186107,2435,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.35,,Ki,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,http://www.ncbi.nlm.nih.gov/pubmed/9469684,ANTAGONIST,,Tclin,,464,Homo sapiens
186108,2435,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.68,,Ki,Binding affinity towards human Dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,Tclin,,,Homo sapiens
186109,2435,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.96,,Ki,Displacement of [3H]-YM-09151-2 (0.06 nM) from human Dopamine receptor D4 expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,Tchem,,,Homo sapiens
186110,2435,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,9.7,,Ki,Displacement of [3H]prozosin from human cloned 5HT2C receptor expressed in CHO cells,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,http://www.ncbi.nlm.nih.gov/pubmed/10991983,INVERSE AGONIST,,Tclin,,465,Homo sapiens
186111,2435,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,7.25,,Ki,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,Tclin,,,Homo sapiens
186112,2435,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.22,,Ki,Binding affinity towards Serotonin 5-hydroxytryptamine 2A receptor,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,http://www.ncbi.nlm.nih.gov/pubmed/9469684,ANTAGONIST,,Tclin,,464,Homo sapiens
186113,2435,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.29,,Ki,Displacement of [3H]prozosin from human cloned histamine H1 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,Tclin,,,Homo sapiens
186114,2435,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.59,,Ki,Ability to displace [3H]spiperone (0.3 nM) from CHO cells of human Dopamine receptor D3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,Tclin,,,Homo sapiens
186115,2435,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,7.92,,Ki,Ability to displace [3H]-SCH- 23390 (0.2 nM) from corpus striatum of rat Dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,,,,Rattus norvegicus
186116,2435,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8.57,,IC50,Inhibition of human cloned ERG expressed in CHO cells assessed as inhibition of potassium channel current by automated patch clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,Tclin,,,Homo sapiens
186117,2435,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,9.18,,Ki,Displacement of [3H]prazosin (0.3 nM) from rat Alpha-1D adrenergic receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,,,,Rattus norvegicus
186118,2435,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,9.29,,Ki,Displacement of [3H]mesulergine (0.5 nM) from rat 5-hydroxytryptamine 2C receptor expressed in SR-3T3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,,,,Rattus norvegicus
186119,2435,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,9.7,,Ki,Displacement of [3H]ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,,,,Rattus norvegicus
186120,2435,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,8.85,,Ki,Ability to displace [3H]prazosin (0.25 nM) from whole brain of rat alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,,,,Rattus norvegicus
186121,2435,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,8.3,,Ki,Displacement of [3H]5-LSD from human 5HT6 receptor expressed in human HeLa cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,Tchem,,,Homo sapiens
186122,2435,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,9.43,,Ki,Displacement of [3H]prazosin (0.3 nM) from bovine Alpha-1A adrenergic receptor expressed in BHK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,,,,Bos taurus
186123,2435,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.47,,IC50,Displacement of [3H]prazosin from Alpha-1 adrenergic receptor in whole rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,,,,Rattus norvegicus
186124,2435,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,9.35,,Ki,Displacement of [3H]spiperone (0.5 nM) from rat corpus striatum dopamine D2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12713,,,,,,,Rattus norvegicus
186125,1231,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,4.4,,Ki,Inhibitory constant of thymidylate synthase was determined in human AML cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1622,,,,Tclin,,,Homo sapiens
186126,1231,2102,Dihydrofolate reductase,Unclassified,B0BL08,dfrA17,B0BL08_ECOLX,6.09,,Kd,Thermodynamic Dissociation Constant for compound-Phe31-dihydrofolate reductase (DHFR) complex at pH 7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1622,,,,,,,Escherichia coli
186127,2767,424,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,4.26,,IC50,Inhibition of PTP1B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408,,,,Tchem,,,Homo sapiens
186128,2767,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,4.98,,Ki,Uncompetitive inhibition of human MAOA expressed in Pichia pastoris,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408,,,,Tclin,,,Homo sapiens
186129,2767,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,5.02,,Ki,Uncompetitive inhibition of human MAOB expressed in Pichia pastoris,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408,,,,Tclin,,,Homo sapiens
186130,2767,3444,UDP-glucuronosyltransferase 1-6,Enzyme,P19224,UGT1A6,UD16_HUMAN,4.7,,Ki,Inhibition of AZT glucuronidation by human recombinant UGT1A6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408,,,,Tbio,,,Homo sapiens
186131,2767,2492,"Indoleamine 2,3-dioxygenase 2",Enzyme,Q8R0V5,Ido2,I23O2_MOUSE,5.35,,IC50,Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408,,,,,,,Mus musculus
186132,2767,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,4.96,,Ki,Uncompetitive inhibition of rat MAOB expressed in Pichia pastoris,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408,,,,,,,Rattus norvegicus
186133,2767,3596,"Indoleamine 2,3-dioxygenase 1",Enzyme,P28776,Ido1,I23O1_MOUSE,4.21,,IC50,Inhibition of mouse Ido1 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408,,,,,,,Mus musculus
186134,2767,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,5.32,,Ki,Uncompetitive inhibition of rat MAOA expressed in Pichia pastoris,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408,,,,,,,Rattus norvegicus
186162,1282,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,5.72,,IC50,Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186135,942,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8.19,,Ki,Displacement of [3H]dofetilide from hERG expressed in HEK293 cells by SPA,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473,BLOCKER,,Tclin,,,Homo sapiens
186136,2352,1741,Integrase,Enzyme,Q7ZJM1,pol,Q7ZJM1_9HIV1,8,,IC50,Inhibition of HIV-1 overall integrase activity using 5'-digoxigenin-labeled GACCCTTTTAGTCAGTGTGGAAAATCTCTAGCAGT-3' as substrate after 1 hr by ELISA,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254316,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254316,INHIBITOR,,,,,Human immunodeficiency virus 1
186137,2352,2486,C-C chemokine receptor type 1,GPCR,P32246,CCR1,CCR1_HUMAN,8.3,,Ki,Binding affinity to CCR1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254316,,,,Tchem,,,Homo sapiens
186138,961,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,4.62,,IC50,Inhibition of human MMP2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1433,,,,Tchem,,,Homo sapiens
186139,961,687,Stromelysin-1,Enzyme,P08254,MMP3,MMP3_HUMAN,4.6,,IC50,Inhibition of human MMP3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1433,,,,Tchem,,,Homo sapiens
186140,961,867,Collagenase 3,Enzyme,P45452,MMP13,MMP13_HUMAN,4.4,,IC50,Inhibition of human MMP13,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1433,,INHIBITOR,,Tclin,,,Homo sapiens
186143,1821,2514,Solute carrier family 22 member 3,Transporter,O75751,SLC22A3,S22A3_HUMAN,4.22,,IC50,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58,,,,Tchem,,,Homo sapiens
186144,1821,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.36,,IC50,Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58,,,,Tchem,,,Homo sapiens
186145,1821,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.13,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58,,,,Tchem,,,Homo sapiens
186146,1821,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,6,,IC50,Inhibition of BTK (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58,,,,Tclin,,,Homo sapiens
186147,1821,605,Serine/threonine-protein kinase pim-1,Kinase,P11309,PIM1,PIM1_HUMAN,7.29,,IC50,Inhibition of recombinant PIM1 (unknown origin) expressed in Escherichia coli BL21(DE3) after 1 hr by HTRF assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58,,,,Tchem,,,Homo sapiens
186148,1821,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,6.28,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58,,,,Tchem,,,Homo sapiens
186149,1821,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,6.72,,IC50,Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58,,,,Tchem,,,Homo sapiens
186150,1821,1741,Integrase,Enzyme,Q7ZJM1,pol,Q7ZJM1_9HIV1,5.42,,IC50,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58,,,,,,,Human immunodeficiency virus 1
186151,1685,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,4.74,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL259223,,,,,,,Trypanosoma cruzi
186152,4055,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,4.11,,Ki,Binding affinity towards benzodiazepine site in GABAA receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL485818,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
186153,4055,720,Prolyl endopeptidase,Enzyme,P48147,PREP,PPCE_HUMAN,4.92,,IC50,Inhibition of human brain prolyl oligopeptidase expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL485818,,,,Tchem,,,Homo sapiens
186154,4055,595,Cyclin-dependent kinase 1,Kinase,P06493,CDK1,CDK1_HUMAN,4.84,,IC50,Inhibition of Cdk1/cyclin B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL485818,,,,Tchem,,,Homo sapiens
186155,1282,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,5.64,,Kd,Average Binding Constant for JNK3; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186156,1282,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,6.64,,Kd,Binding constant for ABL1(Q252H)-phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186157,1282,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,6,,Kd,Binding constant for FLT3(D835Y) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186158,1282,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,9.4,,Ki,Inhibition of EGFR,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,INHIBITOR,,Tclin,,,Homo sapiens
186159,1282,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,4.06,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,,,,Trypanosoma cruzi
186160,1282,2268,Tubulin alpha-1A chain,Structural,P68370,Tuba1a,TBA1A_RAT,6.39,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,,,,Rattus norvegicus
186161,1282,905,Mitogen-activated protein kinase 9,Kinase,P45984,MAPK9,MK09_HUMAN,5.85,,Kd,Average Binding Constant for JNK2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
215157,1821,3703,DNA-3-methyladenine glycosylase,Enzyme,P29372,MPG,3MG_HUMAN,5.599999904632568,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58,,,,Tchem,,,Homo sapiens
186163,1282,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,5.46,,Kd,Binding constant for MET(Y1235D) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186164,1282,837,Casein kinase I isoform epsilon,Kinase,P49674,CSNK1E,KC1E_HUMAN,6.37,,Kd,Binding constant for full-length CSNK1E,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186165,1282,887,Receptor-interacting serine/threonine-protein kinase 2,Kinase,O43353,RIPK2,RIPK2_HUMAN,6.28,,Kd,Binding constant for RIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186166,1282,922,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,5.6,,Kd,Binding constant for EPHB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186167,1282,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,8.15,,Kd,Average Binding Constant for GAK; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186168,1282,2447,Serine/threonine-protein kinase SBK1,Kinase,Q52WX2,SBK1,SBK1_HUMAN,6.25,,Kd,Binding constant for SBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tdark,,,Homo sapiens
186169,1282,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,6.22,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186170,1282,2172,Casein kinase I isoform delta,Kinase,P48730,CSNK1D,KC1D_HUMAN,5.49,,Kd,Binding constant for CSNK1D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186171,1282,2217,Serine/threonine-protein kinase pim-3,Kinase,Q86V86,PIM3,PIM3_HUMAN,5.24,,Kd,Binding constant for PIM3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186172,1282,2085,Serine/threonine-protein kinase D1,Kinase,Q15139,PRKD1,KPCD1_HUMAN,5.46,,Kd,Binding constant for PRKD1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186173,1282,2264,Ephrin type-A receptor 1,Kinase,P21709,EPHA1,EPHA1_HUMAN,5.4,,Kd,Binding constant for EPHA1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186174,1282,2188,MAP kinase-interacting serine/threonine-protein kinase 1,Kinase,Q9BUB5,MKNK1,MKNK1_HUMAN,6.54,,Kd,Binding constant for full-length MKNK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186175,1282,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,5.59,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186176,1282,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,5.7,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186177,1282,736,Ephrin type-A receptor 8,Kinase,P29322,EPHA8,EPHA8_HUMAN,5.74,,Kd,Binding constant for EPHA8 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186178,1282,853,Ephrin type-A receptor 3,Kinase,P29320,EPHA3,EPHA3_HUMAN,5.26,,Kd,Binding constant for EPHA3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186179,1282,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,6.33,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186180,1282,774,Serine/threonine-protein kinase 17B,Kinase,O94768,STK17B,ST17B_HUMAN,5.42,,Kd,Binding constant for full-length DRAK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186181,1282,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.96,,Kd,Average Binding Constant for ERBB2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186182,1282,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,5.36,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186183,1282,574,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,5.57,,Kd,Binding constant for PHKG2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186184,1282,2245,Citron Rho-interacting kinase,Kinase,O14578,CIT,CTRO_HUMAN,5.89,,Kd,Binding constant for CIT kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tbio,,,Homo sapiens
186185,1282,2336,Homeodomain-interacting protein kinase 4,Kinase,Q8NE63,HIPK4,HIPK4_HUMAN,6.51,,Kd,Binding constant for HIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186186,1282,2023,Serine/threonine-protein kinase ULK3,Kinase,Q3U3Q1,Ulk3,ULK3_MOUSE,5.85,,Kd,Average Binding Constant for ULK3 m; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,,,,Mus musculus
186187,1282,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,5.74,,Kd,Binding constant for MINK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186188,1282,2460,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,Kinase,Q8TBX8,PIP4K2C,PI42C_HUMAN,5.12,,Kd,Binding constant for PIP5K2C kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tbio,,,Homo sapiens
186189,1282,2320,Interleukin-1 receptor-associated kinase 4,Kinase,Q9NWZ3,IRAK4,IRAK4_HUMAN,6.27,,Kd,Binding constant for IRAK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186190,1282,852,Serine/threonine-protein kinase 36,Kinase,Q9NRP7,STK36,STK36_HUMAN,5.24,,Kd,Binding constant for STK36 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tbio,,,Homo sapiens
186191,1282,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,5.74,,Kd,Binding constant for KIT(A829P) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186192,1282,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,6.39,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186193,1282,822,Serine/threonine-protein kinase 17A,Kinase,Q9UEE5,STK17A,ST17A_HUMAN,5.7,,Kd,Binding constant for DRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186194,1282,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,6.23,,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186195,1282,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,5.16,,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186196,1282,2284,Ribosomal protein S6 kinase alpha-4,Kinase,O75676,RPS6KA4,KS6A4_HUMAN,5.92,,Kd,Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186197,1282,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,6.04,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186198,1282,903,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,Q9HBH9,MKNK2,MKNK2_HUMAN,6.44,,Kd,Average Binding Constant for MKNK2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186199,1282,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,7.16,,Kd,Binding constant for IRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186200,1282,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186201,1282,802,Ephrin type-A receptor 5,Kinase,P54756,EPHA5,EPHA5_HUMAN,5.82,,Kd,Binding constant for EPHA5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186202,1282,769,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",Kinase,Q16816,PHKG1,PHKG1_HUMAN,5.43,,Kd,Binding constant for full-length PHKG1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186203,1282,890,Ephrin type-B receptor 1,Kinase,P54762,EPHB1,EPHB1_HUMAN,5.89,,Kd,Binding constant for EPHB1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186204,1282,2194,Interleukin-1 receptor-associated kinase 3,Kinase,Q9Y616,IRAK3,IRAK3_HUMAN,5.82,,Kd,Binding constant for IRAK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186205,1282,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,5.48,,Kd,Binding constant for MAP3K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186206,1282,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,5.8,,Kd,Binding constant for ABL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186207,1282,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,5.92,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186208,1282,2368,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,6.1,,Kd,Binding constant for ERBB3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186209,1282,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,5.49,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186210,1282,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,5.68,,Kd,Binding constant for full-length SNF1LK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186211,1282,2084,Cyclin-dependent kinase 7,Kinase,P50613,CDK7,CDK7_HUMAN,6.21,,Kd,Binding constant for CDK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186212,1282,2270,Mitogen-activated protein kinase 4,Kinase,P31152,MAPK4,MK04_HUMAN,5.51,,Kd,Binding constant for ERK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tbio,,,Homo sapiens
186213,1282,2269,Mitogen-activated protein kinase 6,Kinase,Q16659,MAPK6,MK06_HUMAN,5.8,,Kd,Binding constant for ERK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tbio,,,Homo sapiens
186214,1282,623,Death-associated protein kinase 3,Kinase,O43293,DAPK3,DAPK3_HUMAN,5.24,,Kd,Binding constant for DAPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186215,1282,2132,Serine/threonine-protein kinase DCLK3,Kinase,Q9C098,DCLK3,DCLK3_HUMAN,5.54,,Kd,Binding constant for DCAMKL3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186216,1282,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,5.77,,IC50,Inhibition of recombinant Ret by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186217,1282,2206,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,5.16,,Kd,Binding constant for DMPK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186218,1282,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,6.2,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186219,1282,723,"Myosin light chain kinase 2, skeletal/cardiac muscle",Kinase,Q9H1R3,MYLK2,MYLK2_HUMAN,5.72,,Kd,Binding constant for MYLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tbio,,,Homo sapiens
186220,1282,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,5.26,,Kd,Binding constant for LTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tclin,,,Homo sapiens
186221,1282,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,6.62,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186222,1282,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,5.74,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186223,1282,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,5.34,,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186224,1282,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,5.96,,IC50,Inhibition of BCRP expressed in MCF7 MX cells by Hoechst 33342 staining,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186225,1282,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,5.22,,Kd,Binding constant for TXK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186226,1282,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,5.68,,Kd,Binding constant for MAP3K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186227,1282,2325,Serine/threonine-protein kinase Chk2,Kinase,O96017,CHEK2,CHK2_HUMAN,6.1,,Kd,Binding constant for CHEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186228,1282,2191,Serine/threonine-protein kinase NLK,Kinase,Q9UBE8,NLK,NLK_HUMAN,5.38,,Kd,Binding constant for NLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL939,,,,Tchem,,,Homo sapiens
186229,242,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,6.11,,IC50,Inhibition of human ABCB1-mediated rhodamine 123 efflux in mouse L5178 cells expressing human MDR1 after 20 mins by FACS analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,,,,Tchem,,,Homo sapiens
186230,242,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,9.1,,Ki,Displacement of [3H]SCH23390 from dopamine D1 receptor in CRL:CD(SD)BR-COBS rat striatum by scintillation spectrometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,,,,,,,Rattus norvegicus
186231,242,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.22,,Ki,Displacement of [3H]dofetilide from human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,,,,Tclin,,,Homo sapiens
186232,242,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.15,,Ki,Displacement of [3H]ketanserin from 5HT2A receptor in Wistar rat cortex homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,,,,,,,Rattus norvegicus
186233,242,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,5.97,,Ki,Displacement of [3H]-citalopram from SERT in rat cerebral cortex after 1 hr by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,,,,,,,Rattus norvegicus
186234,242,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,9.4,,Ki,Displacement of [3H]-8-OH-DPAT from 5HT1A receptor in Wistar rat hippocampus homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,,,,,,,Rattus norvegicus
186235,242,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,9.1,,Ki,Displacement of [3H]spiperone from dopamine D2 receptor in CRL:CD(SD)BR-COBS rat striatum by scintillation spectrometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,,,,,,,Rattus norvegicus
186236,954,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.14,,Ki,"Binding affinity against Alpha-2A adrenergic receptor, from human clones.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL707,,,,Tclin,,,Homo sapiens
186237,954,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.55,,Ki,Binding affinity against Alpha-2C adrenergic receptor from human clones.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL707,,,,Tclin,,,Homo sapiens
186238,460,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.85,,Ki,Displacement of [125I](+/-)DOI from human 5-HT2B receptor transfected in CHO cell membrane after 60 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201087,,,,Tclin,,,Homo sapiens
186239,2366,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,5.04,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1272,,,,Tchem,,,Homo sapiens
186240,918,439,Potassium voltage-gated channel subfamily A member 3,Ion channel,P22001,KCNA3,KCNA3_HUMAN,5.3,,IC50,Inhibition of Kv1.3 expressed in mouse L929 cells exposed to depolarizing step pulses from -80 mV to +40 mV by whole cell patch clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200665,,,,Tclin,,,Homo sapiens
186241,537,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1541,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1541,INHIBITOR,,,,,Escherichia coli (strain K12)
186242,1751,436,Dihydrofolate reductase,Enzyme,P16184,,DYR_PNECA,9,,IC50,Inhibition against Dihydrofolate reductase in Pneumocystis carinii,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Pneumocystis carinii
186243,1751,1786,Dihydrofolate reductase,Enzyme,P00381,folA,DYR_LACCA,8.89,,IC50,Compound was tested for the inhibition of dihydrofolate reductase in Bovine liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Lactobacillus casei
186244,1751,276,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q07422,,DRTS_TOXGO,8.85,,IC50,Inhibitory activity against Dihydrofolate reductase from Toxoplasma gondii was evaluated using 90 uM dihydrofolic acid as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Toxoplasma gondii
186245,1751,1831,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,P07382,,DRTS_LEIMA,9.89,,Ki,Inhibition of dihydrofolate reductase (DHFR) from Leishmania major,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Leishmania major
186246,1751,2153,Thymidylate synthase,Enzyme,C3SWJ7,thyA,C3SWJ7_ECOLX,5.74,,IC50,Inhibitory activity against Escherichia coli thymidylate synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Escherichia coli
186247,1751,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,6.22,,Ki,Inhibition of human TS by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,Tclin,,,Homo sapiens
186248,1751,3612,Dihydrofolate reductase,Unclassified,P00380,folA,DYR_ENTFC,8.85,,IC50,Inhibition of Streptococcus faecium dihydrofolate reductase using dihydrofolate as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Enterococcus faecium
186249,1751,2018,Thymidylate synthase,Enzyme,P00469,thyA,TYSY_LACCA,4.4,,IC50,Ability to inhibit Lactobacillus casei thymidylate synthase in vitro was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Lactobacillus casei
186250,1751,3544,Dihydrofolate reductase,Unclassified,P00376,DHFR,DYR_BOVIN,8.77,,IC50,In vitro inhibitory concentration against beef liver dihydrofolate reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Bos taurus
216810,2521,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,6.06,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Anopheles gambiae
186251,1751,1752,Dihydrofolate reductase,Enzyme,Q920D2,Dhfr,DYR_RAT,10.14,,Ki,Inhibition of rat liver DHFR by enzyme kinetics assay in presence of variable DHFA level,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Rattus norvegicus
186252,1751,3442,Dihydrofolate reductase,Enzyme,Q81R22,dfrA,Q81R22_BACAN,7.91,,IC50,Inhibition of Bacillus anthracis DHFR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Bacillus anthracis
186253,1751,2102,Dihydrofolate reductase,Unclassified,B0BL08,dfrA17,B0BL08_ECOLX,10.68,,Ki,Binding affinity against Dihydrofolate reductase of Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Escherichia coli
186254,1751,1790,Thymidylate synthase,Enzyme,P07607,Tyms,TYSY_MOUSE,4.35,,Ki,Inhibitory activity against thymidylate synthase in murine tumor cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Mus musculus
186255,1751,1736,Dihydrofolate reductase,Enzyme,P00375,Dhfr,DYR_MOUSE,5.41,,Ki,Binding affinity towards Dihydrofolate reductase derived from L1210 cells using [3H]- MTX as the radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Mus musculus
186256,1751,1956,Dihydrofolate reductase,Enzyme,P00378,DHFR,DYR_CHICK,7.72,,IC50,Compound was evaluated for the inhibition of dihydrofolate reductase (DHFR) derived from Chicken liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Gallus gallus
186257,1751,242,"Folylpolyglutamate synthase, mitochondrial",Enzyme,Q05932,FPGS,FOLC_HUMAN,5.49,,IC50,Compound was evaluated for the inhibitory activity against Folyl-polyglutamate synthase from CCRF-CEM human leukemia cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,Tchem,,,Homo sapiens
186258,1751,2289,Pteridine reductase 1,Enzyme,Q01782,PTR1,PTR1_LEIMA,7.41,,Ki,Inhibition of Leishmania major recombinant PTR1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,,,,Leishmania major
186259,1751,3613,Folate transporter 1,Unclassified,P41440,SLC19A1,S19A1_HUMAN,5.46,,Ki,Affinity towards RFC measured by the inhibition of [3H]MTX uptake,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,Tchem,,,Homo sapiens
186260,530,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1435,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1435,INHIBITOR,,,,,Escherichia coli (strain K12)
186261,2815,1827,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P15381,CACNA1C,CAC1C_RABIT,6,,IC50,Inhibition of [3H]nitrendipine binding to calcium channels in Rabbit cardiac muscle.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,,,,Oryctolagus cuniculus
186262,2815,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,6.52,,Ki,High affinity constant at binding site of human P-Glycoprotein (P-gp) in two-affinity model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,Tchem,,,Homo sapiens
186263,2815,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,5.17,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,Tchem,,,Homo sapiens
186264,2815,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,4.88,,Ki,Inhibition of MRP1 in human 2008/MRP1 cells by Lineweaver-Burke plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,Tchem,,,Homo sapiens
186265,2815,1960,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q02485,Cacna1s,CAC1S_RAT,7.24,,Ki,Inhibition of [3H]D-888 binding to L-type [Ca2+] channel of membranes from rat skeletal muscle,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,,,,Rattus norvegicus
186266,2815,1852,Translocator protein,Membrane receptor,P16257,Tspo,TSPO_RAT,8.85,,IC50,Ability to inhibit [3H]-PK 11195 binding to peripheral-type benzodiazepine receptor(PBR) in rat cerebral cortex homogenate.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,,,,Rattus norvegicus
186267,2815,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,Tclin,,,Homo sapiens
186268,2815,3556,Chloroquine resistance transporter,Unclassified,Q9N623,CRT,CRT_PLAFA,4.52,,IC50,Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]chloroquine uptake measured from 1 to 2 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,,,,Plasmodium falciparum
186269,2815,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.48,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,Tclin|Tclin|Tclin,,,Homo sapiens
186270,2815,2874,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,8.43,,IC50,Ability to inhibit [3H]nitrendipine binding to the calcium channel receptor(CCR) in rat cerebral cortex homogenate.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,,,,Rattus norvegicus
186271,2815,1853,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,7.41,,IC50,Ability to inhibit [3H]nitrendipine binding to the L-type calcium channel receptor(CCR) in rat heart homogenate.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,,,,Rattus norvegicus
186272,2815,439,Potassium voltage-gated channel subfamily A member 3,Ion channel,P22001,KCNA3,KCNA3_HUMAN,5.1,,IC50,Inhibition of Kv1.3 expressed in mouse L929 cells exposed to depolarizing step pulses from -80 mV to +40 mV by whole cell patch clamp method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,Tclin,,,Homo sapiens
186273,3548,1807,Endothelin-1 receptor,GPCR,P26684,Ednra,EDNRA_RAT,9.37,,Ki,Binding affinity towards Endothelin A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL282724,,ANTAGONIST,,,,,Rattus norvegicus
186274,3548,457,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,9.37,,Ki,Binding affinity against human Endothelin A receptor,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL282724,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3950,ANTAGONIST,,Tclin,,,Homo sapiens
217037,912,2151,Prostaglandin E2 receptor EP2 subtype,GPCR,Q62928,Ptger2,PE2R2_RAT,5.6,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
186275,3548,458,Endothelin B receptor,GPCR,P24530,EDNRB,EDNRB_HUMAN,5.01,,IC50,In vitro inhibition of endothelin binding to human Endothelin B receptor using [125I]-labeled ET-1 competition assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL282724,,ANTAGONIST,,Tclin,,,Homo sapiens
186276,546,2416,Beta-lactamase,Enzyme,B2ZTR6,,B2ZTR6_ACIBA,6.3,,Ki,Activity of Acinetobacter baumannii ADC-33 beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1010,,,,,,,Acinetobacter baumannii
186277,546,2417,Beta-lactamase,Enzyme,D6NSM8,ampC,D6NSM8_ACIBA,5.6,,Ki,Activity of Acinetobacter baumannii ADC-11 beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1010,,,,,,,Acinetobacter baumannii
186278,799,3464,Malate dehydrogenase cytoplasmic ,Enzyme,P40925,MDH1,MDHC_HUMAN,4.07,,IC50,Inhibition of malate dehydrogenase (MDH),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593,,,,Tbio,,,Homo sapiens
186279,799,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,8.1,,IC50,HIV-1 reverse transcriptase inhibitory activity against Wild Type Reverse transcriptase using (poly)rC600*(oligo)dGT as template primer.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593,INHIBITOR,,,,,Human immunodeficiency virus 1
186280,799,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,4.05,,IC50,Compound was tested for the inhibition of beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593,,,,,,,Escherichia coli (strain K12)
186281,2608,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,Mechanism of Action; CHEMBL1871; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107067,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107067,AGONIST,,Tclin,,,Homo sapiens
186282,274,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.4,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL123558,,,,Tclin,,,Homo sapiens
186283,274,2095,Potassium voltage-gated channel subfamily H member 2,Ion channel,O08703,KCNH2,KCNH2_CAVPO,6.74,,IC50,Inhibition of ERG in guinea pig ventricular myocytes assessed as blockade of rapid delayed rectifier potassium current by whole cell patch-clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL123558,,,,,,,Cavia porcellus
186284,274,2096,Potassium voltage-gated channel subfamily KQT member 1,Ion channel,O70344,KCNQ1,KCNQ1_CAVPO,6.62,,IC50,Inhibition of KVLQT1/minK in guinea pig ventricular myocytes assessed as blockade of slow delayed rectifier potassium current by whole cell patch-clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL123558,,,,,,,Cavia porcellus
186285,2353,276,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q07422,,DRTS_TOXGO,6.32,,IC50,Inhibition of Toxoplasma gondii thymidylate synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071,,,,,,,Toxoplasma gondii
186286,2353,2153,Thymidylate synthase,Enzyme,C3SWJ7,thyA,C3SWJ7_ECOLX,5.28,,IC50,The inhibitory concentration of compound was evaluated on Escherichia coli thymidylate synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071,,,,,,,Escherichia coli
186287,2353,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,6.59,,IC50,"Inhibition of human recombinant His-tagged thymidylate synthase assessed as N5,N10-methylenetetrahydrofolate oxidation to dihydrofolate after 20 mins by UV spectrophotometric analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071,,,,Tclin,,,Homo sapiens
186288,2353,2018,Thymidylate synthase,Enzyme,P00469,thyA,TYSY_LACCA,5.1,,IC50,Compound was evaluated as inhibitor of Lactobacillus casei thymidylate synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071,,,,,,,Lactobacillus casei
186289,2353,2002,Thymidylate synthase,Enzyme,P45352,Tyms,TYSY_RAT,6.05,,IC50,Inhibitory concentration against isolated rat thymidylate synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071,,,,,,,Rattus norvegicus
186290,2353,2102,Dihydrofolate reductase,Unclassified,B0BL08,dfrA17,B0BL08_ECOLX,4.64,,IC50,Inhibition of Escherichia coli DHFR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071,,,,,,,Escherichia coli
186291,2353,1790,Thymidylate synthase,Enzyme,P07607,Tyms,TYSY_MOUSE,6.38,,Ki,"Compound was evaluated for inhibition of thymidylate synthase, partially purified from L1210 mouse leukemia cells that overproduce thymidylate synthase due to amplification of TS gene",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071,,,,,,,Mus musculus
186292,3253,987,Methionine aminopeptidase 2,Enzyme,P50579,METAP2,MAP2_HUMAN,9.2,,IC50,Inhibitory activity against Methionine aminopeptidase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32838,,,,Tchem,,,Homo sapiens
186293,249,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,5.1,,Ki,"Displacement of [3H]histamine from human H4R expressed in Sf9 cells co-expressing RGS19, Galphai2 and Gbeta1gamma2 after 60 mins by liquid scintillation counting",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296419,,,,Tchem,,,Homo sapiens
186294,249,260,Somatostatin receptor type 5,GPCR,P35346,SSTR5,SSR5_HUMAN,5.39,,Ki,Displacement of [125I]11-Tyr somatostatin-14 from human SST5R expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296419,,,,Tclin,,,Homo sapiens
186295,249,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.58,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296419,,,,Tchem,,,Homo sapiens
186296,249,2826,Protein farnesyltransferase,Enzyme,P29702|P49355,FNTA|FNTB,FNTA_BOVIN|FNTB_BOVIN,8.7,,IC50,Inhibit of purified bovine Farnesyl protein transferase.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296419,,,,,,,Bos taurus
186299,2251,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.28,,IC50,BindingDB_Patents: Fluorescence Polarization Ligand Binding Assay. The glucocorticoid receptor fluorescence polarization ligand binding (GRFP) assay is used to evaluate direct binding of testing compounds to full-length glucocorticoid (GR) protein. Reagents for this assay are purchased from Invitrogen in a test kit. A fluorescent labeled GR ligand is used as a fluorescent tracer and test compounds compete with the fluorescent tracer for GR binding. The change in polarization value in the presence of test compounds is due to binding of test compounds to GR and is used to determine IC50 and relative binding affinity of test compounds for GR.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,AGONIST,,Tclin,,,Homo sapiens
215158,776,3702,Serine protease hepsin,Enzyme,P05981,HPN,HEPS_HUMAN,6.079999923706055,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,,,,Tchem,,,Homo sapiens
186300,577,1796,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P51639,Hmgcr,HMDH_RAT,8.55,,IC50,Inhibition of rat microsomal HMG-CoA reductase assessed as inhibition of cholesterol synthesis after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1477,,,,,,,Rattus norvegicus
186301,1614,558,Cholecystokinin receptor type A,GPCR,P32238,CCKAR,CCKAR_HUMAN,6.71,,IC50,Displacement of [111In]DTPA-Glu-Gly-[Tyr27(SO3H)]-CCK8 from human CCK1 receptor in A431 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206025,,,,Tclin,,,Homo sapiens
186302,277,3480,Penicillin-binding protein,Enzyme,Q07806|Q51504|Q51505|Q9X6V3|Q9X6V7|Q9X6W0,dacA|mrcA|pbpA|pbpB|pbpC|ponB,PBPA_PSEAE|Q51504_PSEAI|Q51505_PSEAI|Q9X6V3_PSEAI|Q9X6V7_PSEAI|Q9X6W0_PSEAI,,,,Mechanism of Action; CHEMBL2363020; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1537,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1537,INHIBITOR,,,,,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
186303,2172,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,9.3,,Ki,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,,,,,,,Rattus norvegicus
186304,2172,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.47,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,,,,Tchem,,,Homo sapiens
186305,2172,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,9.22,,Ki,Binding affinity of compound towards Dopamine receptor D2 using [3H]raclopride (1.2 nM) ligand in striatum bovine was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,,,,,,,Bos taurus
186306,2172,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,9.4,,IC50,Inhibition of [3H]haloperidol binding to dopamine receptors in rat striatal membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,,,,,,,Rattus norvegicus
186307,2172,204,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,7.4,,Kd,Inhibition of T-type alpha1G calcium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,,,,Tclin,,,Homo sapiens
186308,2172,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,6,,IC50,Binding affinity against opioid receptor kappa 1 by using [3H]U-69593 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,,,,Tclin,,,Homo sapiens
186309,2172,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.42,,IC50,Binding affinity against delta opiate receptor using [3H]DPDPE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,,,,Tclin,,,Homo sapiens
186310,2172,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.43,,IC50,Binding affinity against mu opioid receptor using [3H]DAMGO,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,,,,Tclin,,,Homo sapiens
186311,2172,1798,Sodium channel protein type 2 subunit alpha,Ion channel,P04775,Scn2a,SCN2A_RAT,6.47,,IC50,Inhibitory activity against type IIA sodium channel in CNaIIA-1 cell line expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,,,,,,,Rattus norvegicus
186312,384,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,,,,Mechanism of Action; CHEMBL210; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200405,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200405,AGONIST,,Tclin,,,Homo sapiens
186313,2459,2236,Cyclin-dependent kinase 8,Kinase,P49336,CDK8,CDK8_HUMAN,6.51,,Kd,Binding constant for CDK8 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186314,2459,2323,Cyclin-dependent kinase-like 2,Kinase,Q92772,CDKL2,CDKL2_HUMAN,6.89,,Kd,Binding affinity to CDKL2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tbio,,,Homo sapiens
186315,2459,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,6.89,,Kd,Average Binding Constant for ABL1; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186316,2459,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,8.35,,Kd,Binding constant for FLT3(K663Q) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,INHIBITOR,,Tclin,,,Homo sapiens
186317,2459,2244,"Muscle, skeletal receptor tyrosine-protein kinase",Kinase,O15146,MUSK,MUSK_HUMAN,6.89,,Kd,Binding constant for MUSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186318,2459,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,7.51,,Kd,Binding constant for FLT1 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,INHIBITOR,,Tclin,,,Homo sapiens
186319,2459,905,Mitogen-activated protein kinase 9,Kinase,P45984,MAPK9,MK09_HUMAN,5.44,,Kd,Average Binding Constant for JNK2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186320,2459,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.41,,IC50,Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186321,2459,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,10.68,,Ki,Inhibition of human N-terminal His-tagged non-phosphorylated VEGFR2 after 60 mins by activity based 100 fold dilution assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,INHIBITOR,,Tclin,,,Homo sapiens
186322,2459,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,5.38,,Kd,Binding constant for FGFR3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186323,2459,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,5.28,,IC50,Inhibition of recombinant INSR by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,AGONIST,,Tclin,,,Homo sapiens
186324,2459,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,7.21,,Kd,Binding constant for PDGFRA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186325,2459,2251,Myosin-IIIb,Kinase,Q8WXR4,MYO3B,MYO3B_HUMAN,5.15,,Kd,Binding constant for MYO3B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tdark,,,Homo sapiens
186326,2459,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.93,,Ki,Displacement of [3H]8-OH-DPAT from 5HT1A receptor after 1.5 hrs by scintillation counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186327,2459,1044,Cyclin-dependent kinase 15,Kinase,Q96Q40,CDK15,CDK15_HUMAN,5.54,,Kd,Binding affinity to PFTAIRE2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tdark,,,Homo sapiens
186328,2459,887,Receptor-interacting serine/threonine-protein kinase 2,Kinase,O43353,RIPK2,RIPK2_HUMAN,5.89,,Kd,Binding constant for RIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186329,2459,922,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,5.74,,Kd,Binding constant for EPHB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186330,2459,2550,Vascular endothelial growth factor receptor 2,Kinase,Q5GIT4,kdr,VGFR2_DANRE,5.59,,IC50,Inhibition of VEGFR2 in transgenic zebrafish embryo assessed as inhibition of intersegmental vessels formation measured 33 hrs post fertilization by fluorescence microscopic analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,,,,Danio rerio
186331,2459,2134,Ribosomal protein S6 kinase alpha-6,Kinase,Q9UK32,RPS6KA6,KS6A6_HUMAN,5.12,,Kd,Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186332,2459,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,5.42,,IC50,Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186333,2459,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,6.72,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186334,2459,2168,Mitogen-activated protein kinase kinase kinase MLT,Kinase,Q9NYL2,ZAK,MLTK_HUMAN,8.2,,Kd,Binding constant for ZAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186335,2459,2335,Homeodomain-interacting protein kinase 3,Kinase,Q9H422,HIPK3,HIPK3_HUMAN,6.41,,Kd,Binding affinity to HIPK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tbio,,,Homo sapiens
186336,2459,2334,Homeodomain-interacting protein kinase 2,Kinase,Q9H2X6,HIPK2,HIPK2_HUMAN,5.77,,Kd,Binding affinity to HIPK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186337,2459,537,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,8.22,,Ki,Inhibition of C-RAF,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,INHIBITOR,,Tclin,,,Homo sapiens
186338,2459,2324,Cyclin-dependent kinase-like 3,Kinase,Q8IVW4,CDKL3,CDKL3_HUMAN,6.31,,Kd,Binding affinity to CDKL3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tbio,,,Homo sapiens
186339,2459,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.38,,Ki,Displacement of [3H]LSD from 5HT2C receptor after 1.5 hrs by scintillation counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186340,2459,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.71,,Ki,Displacement of [3H]Ketanserin from 5HT2A receptor after 1.5 hrs by scintillation counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186341,2459,2264,Ephrin type-A receptor 1,Kinase,P21709,EPHA1,EPHA1_HUMAN,5.51,,Kd,Binding constant for EPHA1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186342,2459,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,5.32,,Kd,Binding constant for HPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186343,2459,2272,Mitogen-activated protein kinase 15,Kinase,Q8TD08,MAPK15,MK15_HUMAN,7.34,,Kd,Binding constant for ERK8 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186344,2459,2188,MAP kinase-interacting serine/threonine-protein kinase 1,Kinase,Q9BUB5,MKNK1,MKNK1_HUMAN,6.64,,Kd,Binding constant for full-length MKNK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186345,2459,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,7.66,,Ki,Inhibition of B-Raf,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,INHIBITOR,,Tclin,,,Homo sapiens
186346,2459,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,5.11,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186347,2459,2352,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,6.16,,Kd,Binding affinity to TAK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186348,2459,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,6.36,,Kd,Average Binding Constant for FRK; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186349,2459,870,Dual specificity protein kinase CLK1,Kinase,P49759,CLK1,CLK1_HUMAN,5.12,,Kd,Binding constant for CLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186350,2459,2359,Homeodomain-interacting protein kinase 1,Kinase,Q86Z02,HIPK1,HIPK1_HUMAN,5.96,,Kd,Binding affinity to HIPK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tbio,,,Homo sapiens
186351,2459,736,Ephrin type-A receptor 8,Kinase,P29322,EPHA8,EPHA8_HUMAN,6.02,,Kd,Average Binding Constant for EPHA8; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186352,2459,796,Dual specificity protein kinase TTK,Kinase,P33981,TTK,TTK_HUMAN,5.46,,Kd,Binding constant for TTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186353,2459,536,Ephrin type-A receptor 2,Kinase,P29317,EPHA2,EPHA2_HUMAN,5.7,,Kd,Binding constant for EPHA2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186354,2459,853,Ephrin type-A receptor 3,Kinase,P29320,EPHA3,EPHA3_HUMAN,5.72,,Kd,Binding constant for EPHA3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
217038,912,4067,Prostaglandin D2 receptor 2,Unclassified,Q9Z2J6,Ptgdr2,PD2R2_MOUSE,6.2,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Mus musculus
186355,2459,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,6.85,,Kd,Average Binding Constant for STK10; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186356,2459,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,5.47,,Kd,Average Binding Constant for STK18; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186357,2459,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,5.14,,Kd,Binding constant for JAK3(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186358,2459,2310,Tyrosine-protein kinase ABL1,Kinase,P00520,Abl1,ABL1_MOUSE,6.65,,IC50,Inhibition of mouse recombinant N-terminal His6-tagged Abl by radiometric kinase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,,,,Mus musculus
186359,2459,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,5.54,,Kd,Binding affinity to CSK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186360,2459,2353,Serine/threonine-protein kinase TAO1,Kinase,Q7L7X3,TAOK1,TAOK1_HUMAN,6.27,,Kd,Binding affinity to TAO1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tbio,,,Homo sapiens
186361,2459,2202,Serine/threonine-protein kinase TNNI3K,Kinase,Q59H18,TNNI3K,TNI3K_HUMAN,6.55,,Kd,Binding constant for full-length TNNI3K,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186362,2459,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,5.07,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186363,2459,792,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.68,,Kd,Binding constant for full-length AURKC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186364,2459,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,5.44,,Kd,Average Binding Constant for NTRK1; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186365,2459,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.43,,Kd,Binding constant for PDGFRB kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,INHIBITOR,,Tclin,,,Homo sapiens
186366,2459,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,5.6,,Kd,Average Binding Constant for FGFR1; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186367,2459,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,5.57,,Kd,Binding constant for FGFR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186368,2459,2245,Citron Rho-interacting kinase,Kinase,O14578,CIT,CTRO_HUMAN,5.21,,Kd,Binding constant for CIT kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tbio,,,Homo sapiens
186369,2459,2336,Homeodomain-interacting protein kinase 4,Kinase,Q8NE63,HIPK4,HIPK4_HUMAN,8.57,,Kd,Binding affinity to HIPK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186370,2459,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,5.8,,Kd,Binding constant for MAP4K5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186371,2459,852,Serine/threonine-protein kinase 36,Kinase,Q9NRP7,STK36,STK36_HUMAN,5.42,,Kd,Binding constant for STK36 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tbio,,,Homo sapiens
186372,2459,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.8,,Kd,Binding constant for KIT(V559D) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,INHIBITOR,,Tclin,,,Homo sapiens
186373,2459,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,6.62,,Kd,Average Binding Constant for EPHA6; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186374,2459,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,5.1,,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186375,2459,2221,Aurora kinase B,Kinase,Q96GD4,AURKB,AURKB_HUMAN,6.36,,Kd,Binding constant for AURKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186376,2459,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,6,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186377,2459,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.25,,Ki,Displacement of [3H]LSD from 5HT2B receptor after 1.5 hrs by scintillation counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186378,2459,903,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,Q9HBH9,MKNK2,MKNK2_HUMAN,6.89,,Kd,Binding constant for MKNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186379,2459,898,Ephrin type-A receptor 7,Kinase,Q15375,EPHA7,EPHA7_HUMAN,6.17,,Kd,Average Binding Constant for EPHA7; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186380,2459,2458,Serine/threonine-protein kinase TAO2,Kinase,Q9UL54,TAOK2,TAOK2_HUMAN,6.27,,Kd,Binding constant for TAOK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tbio,,,Homo sapiens
186381,2459,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,5.52,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186382,2459,802,Ephrin type-A receptor 5,Kinase,P54756,EPHA5,EPHA5_HUMAN,6.44,,Kd,Average Binding Constant for EPHA5; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186383,2459,748,LIM domain kinase 1,Kinase,P53667,LIMK1,LIMK1_HUMAN,5.8,,Kd,Binding constant for full-length LIMK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186384,2459,803,Ephrin type-A receptor 4,Kinase,P54764,EPHA4,EPHA4_HUMAN,5.89,,Kd,Average Binding Constant for EPHA4; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186385,2459,890,Ephrin type-B receptor 1,Kinase,P54762,EPHB1,EPHB1_HUMAN,5.77,,Kd,Average Binding Constant for EPHB1; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186386,2459,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,6.22,,Kd,Binding constant for TRKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186387,2459,597,Cyclin-dependent kinase 2,Kinase,P24941,CDK2,CDK2_HUMAN,5.06,,Kd,Binding constant for CDK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186388,2459,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,5.89,,Kd,Average Binding Constant for ABL2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186389,2459,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,5.68,,Kd,Binding constant for TIE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186390,2459,2466,Calcium-dependent protein kinase 1,Kinase,P62344,CPK1,CDPK1_PLAF7,6.66,,Kd,Binding constant for PFCDPK1(P.falciparum) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,,,,Plasmodium falciparum
186391,2459,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,6.62,,Kd,Binding affinity to EPHB6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186392,2459,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,5.48,,Ki,Displacement of [3H]LSD from 5HT5A receptor after 1.5 hrs by scintillation counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186393,2459,1250,Bifunctional epoxide hydrolase 2,Enzyme,P34913,EPHX2,HYES_HUMAN,7.92,,IC50,Inhibition of human recombinant soluble epoxide hydrolase assessed as cyano(6-methoxy-naphthalen-2-yl)methyl trans-[(3-phenyloxyran-2-yl)methyl] carbonate conversion to 6-methoxy-2-naphthaldehyde preincubated for 5 mins prior to substrate addition by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186394,2459,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.21,,Ki,Displacement of [3H]LSD from 5HT6 receptor after 1.5 hrs by scintillation counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186395,2459,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,5.57,,Kd,Binding affinity to TAOK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tbio,,,Homo sapiens
186396,2459,2261,Tyrosine-protein kinase Srms,Kinase,Q9H3Y6,SRMS,SRMS_HUMAN,5.01,,Kd,Binding constant for SRMS kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186397,2459,2315,Casein kinase I isoform alpha,Kinase,P48729,CSNK1A1,KC1A_HUMAN,6.6,,IC50,Inhibition of recombinant CK1 by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186398,2459,2259,Cyclin-dependent kinase 3,Kinase,Q00526,CDK3,CDK3_HUMAN,5.42,,Kd,Binding constant for CDK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186399,2459,2084,Cyclin-dependent kinase 7,Kinase,P50613,CDK7,CDK7_HUMAN,6.85,,Kd,Binding constant for full-length CDK7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186400,2459,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.08,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186401,2459,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.55,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186402,2459,543,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,7.8,,Kd,Average Binding Constant for FLT4; NA=Not Active at 10 uM,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,INHIBITOR,,Tclin,,,Homo sapiens
186403,2459,2205,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,8.18,,Kd,Binding constant for DDR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186404,2459,2160,Cyclin-dependent kinase 17,Kinase,Q00537,CDK17,CDK17_HUMAN,5.8,,Kd,Binding constant for full-length PCTK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186405,2459,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,7.17,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186406,2459,2162,Cyclin-dependent kinase 14,Kinase,O94921,CDK14,CDK14_HUMAN,5.54,,Kd,Binding constant for full-length PFTK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186407,2459,1604,TGF-beta receptor type-2,Kinase,P37173,TGFBR2,TGFR2_HUMAN,5.16,,Kd,Binding constant for TGFBR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186408,2459,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.13,,Kd,Binding constant for RET(M918T) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,INHIBITOR,,Tclin,,,Homo sapiens
186409,2459,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,8.82,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186410,2459,2226,Mitogen-activated protein kinase kinase kinase kinase 4,Kinase,O95819,MAP4K4,M4K4_HUMAN,5.32,,Kd,Binding constant for MAP4K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186411,2459,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.57,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186412,2459,2140,Mitogen-activated protein kinase 13,Kinase,O15264,MAPK13,MK13_HUMAN,5.18,,Kd,Binding affinity to p38-delta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186413,2459,723,"Myosin light chain kinase 2, skeletal/cardiac muscle",Kinase,Q9H1R3,MYLK2,MYLK2_HUMAN,5.89,,Kd,Average Binding Constant for MYLK2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tbio,,,Homo sapiens
186414,2459,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,7,,Kd,Binding affinity to YSK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186415,2459,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,5.35,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186416,2459,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,5.68,,Kd,Binding constant for TRKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186417,2459,2083,Ephrin type-B receptor 2,Kinase,P29323,EPHB2,EPHB2_HUMAN,5.72,,Kd,Binding constant for EPHB2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186418,2459,799,Mitogen-activated protein kinase 11,Kinase,Q15759,MAPK11,MK11_HUMAN,6.7,,Kd,Average Binding Constant for p38-beta; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186419,2459,2184,LIM domain kinase 2,Kinase,P53671,LIMK2,LIMK2_HUMAN,5.02,,Kd,Binding constant for LIMK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186420,2459,2463,Myosin light chain kinase 3,Kinase,Q32MK0,MYLK3,MYLK3_HUMAN,5.02,,Kd,Binding constant for MLCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186421,2459,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,5.15,,Ki,Displacement of [3H]LSD from 5HT7 receptor after 1.5 hrs by scintillation counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tclin,,,Homo sapiens
186422,2459,772,Cyclin-dependent-like kinase 5,Kinase,Q00535,CDK5,CDK5_HUMAN,5.21,,Kd,Average Binding Constant for CDK5; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186423,2459,2235,Cyclin-dependent kinase 19,Kinase,Q9BWU1,CDK19,CDK19_HUMAN,6.6,,Kd,Binding constant for CDK11 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186424,2459,2201,Serine/threonine-protein kinase 33,Kinase,Q9BYT3,STK33,STK33_HUMAN,5.62,,Kd,Binding constant for full-length STK33,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186425,2459,2191,Serine/threonine-protein kinase NLK,Kinase,Q9UBE8,NLK,NLK_HUMAN,6.19,,Kd,Binding constant for full-length NLK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186426,2459,827,Mitogen-activated protein kinase 12,Kinase,P53778,MAPK12,MK12_HUMAN,5.12,,Kd,Binding constant for full-length p38-gamma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186427,2459,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,5.44,,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186428,2459,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,6.59,,Kd,Average Binding Constant for p38-alpha; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186429,2459,2136,Non-receptor tyrosine-protein kinase TNK1,Kinase,Q13470,TNK1,TNK1_HUMAN,5.64,,Kd,Binding constant for full-length TNK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
186430,280,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1583,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1583,INHIBITOR,,,,,Escherichia coli (strain K12)
186431,660,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,7.84,,Ki,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,,,,Cavia porcellus
186432,660,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,8.21,,Ki,The ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat whole brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,,,,Rattus norvegicus
186433,660,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.64,,IC50,Binding affinity to dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,Tclin,,,Homo sapiens
186434,660,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.35,,Ki,The ability to inhibit [3H]rauwolscine binding to alpha-2 adrenergic receptor in rat cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,,,,Rattus norvegicus
186435,660,2783,Serotonin 3 (5-HT3) receptor,Ion channel,P35563|Q9JJ16,Htr3a|Htr3b,5HT3A_RAT|5HT3B_RAT,7.02,,Ki,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,,,,Rattus norvegicus
186436,660,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.77,,IC50,Binding affinity to dopamine receptor D1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,Tclin,,,Homo sapiens
186437,660,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,5.77,,Ki,The ability to inhibit [3H]-SCH- 23390 binding to Dopamine receptor D1 in rat striata,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,,,,Rattus norvegicus
186438,660,245,5-hydroxytryptamine receptor 4,GPCR,Q13639,HTR4,5HT4R_HUMAN,7.54,,Ki,Binding affinity towards Serotonin 5-hydroxytryptamine 4 receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,AGONIST,,Tclin,,,Homo sapiens
186439,660,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,8.19,,IC50,Inhibition of human ERG in MCF7 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,Tclin,,,Homo sapiens
186440,660,1833,Alpha-2A adrenergic receptor,GPCR,P22909,Adra2a,ADA2A_RAT,7.52,,Ki,Compound was evaluated for the binding affinity at Alpha adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,,,,Rattus norvegicus
186441,660,1954,5-hydroxytryptamine receptor 2A,GPCR,Q75Z89,HTR2A,5HT2A_BOVIN,8.14,,Ki,Compound was evaluated for the binding affinity at 5- HT2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,,,,Bos taurus
215159,2073,3613,Folate transporter 1,Unclassified,P41440,SLC19A1,S19A1_HUMAN,6.860000133514404,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,Tchem,,,Homo sapiens
186442,660,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.52,,Ki,The ability to inhibit [3H]prazosin binding to Alpha-1 adrenergic receptor in rat whole brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,,,,Rattus norvegicus
186443,660,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,5.35,,IC50,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,,,,Rattus norvegicus
186444,660,2818,Serotonin 3 (5-HT3) receptor,Ion channel,A5X5Y0|O95264|P46098|Q70Z44|Q8WXA8,HTR3A|HTR3B|HTR3C|HTR3D|HTR3E,5HT3A_HUMAN|5HT3B_HUMAN|5HT3C_HUMAN|5HT3D_HUMAN|5HT3E_HUMAN,6.82,,Ki,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,Tchem|Tchem|Tchem|Tchem|Tclin,,,Homo sapiens
186445,660,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.64,,Ki,Affinity towards Dopamine receptor D2 in rat striatum using [3H]spiperone as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,,,,Rattus norvegicus
186446,2474,1792,Angiotensin-converting enzyme,Enzyme,P47820,Ace,ACE_RAT,7.17,,IC50,Compound tested in vitro for inhibition of Angiotensin I converting enzyme,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431,,,,,,,Rattus norvegicus
186447,986,1786,Dihydrofolate reductase,Enzyme,P00381,folA,DYR_LACCA,8.42,,IC50,Compound was tested for the inhibition of dihydrofolate reductase in Bovine liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296373,,,,,,,Lactobacillus casei
186448,986,1736,Dihydrofolate reductase,Enzyme,P00375,Dhfr,DYR_MOUSE,6,,Ki,Binding affinity towards Dihydrofolate reductase derived from L1210 cells using [3H]- MTX as the radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296373,,,,,,,Mus musculus
186449,434,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,9.3,,Ki,Displacement of [3H]U69593 from KOR in Hartley guinea pig membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142,,,,,,,Cavia porcellus
186450,434,628,Nociceptin receptor,GPCR,P41146,OPRL1,OPRX_HUMAN,7.11,,Ki,Displacement of [3H]-N/OFQ from human nociceptin opioid receptor transfected in CHO cells after 60 mins by beta-plate liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142,,,,Tchem,,,Homo sapiens
186451,434,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.1,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142,,,,Tclin,,,Homo sapiens
186452,434,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,9.4,,Ki,Displacement of [3H]DAMGO from MOR in Hartley guinea pig membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142,,,,,,,Cavia porcellus
186453,434,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,9.32,,Ki,Displacement of [3H]diprenorphine from rat delta opioid receptor expressed in rat C6 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142,,,,,,,Rattus norvegicus
186454,434,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,9.89,,Ki,Displacement of [3H]diprenorphine from rat mu opioid receptor expressed in rat C6 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142,,,,,,,Rattus norvegicus
186455,3407,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.64,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127592,,,,Tclin|Tclin|Tclin,,,Homo sapiens
186456,741,783,G-protein coupled receptor 35,GPCR,Q9ES90,Gpr35,GPR35_MOUSE,5.32,,EC50,Agonist activity at mouse GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74,,,,,,,Mus musculus
186457,741,782,G protein-coupled receptor GPR35,GPCR,Q33BM1,Gpr35,Q33BM1_RAT,6.01,,EC50,Agonist activity at rat GPR35 expressed in CHO cells assessed as induction of beta-arrestin recruitment after 90 mins by beta-galactosidase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74,,,,,,,Rattus norvegicus
186458,741,2478,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,5.63,,Ki,Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74,,,,Tchem,,,Homo sapiens
186460,1595,843,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,Q00975,CACNA1B,CAC1B_HUMAN,5.61,,IC50,Inhibition of calcium channel Cav2.2 in IMR32 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29188,,,,Tclin,,,Homo sapiens
186461,3533,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,6.89,,Kd,Binding constant for FLT3(D835Y) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186462,3533,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.29,,Kd,Binding constant for EGFR(E746-A750del) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186463,3533,817,Protein kinase C theta type,Kinase,Q04759,PRKCQ,KPCT_HUMAN,8.6,,Kd,Binding constant for PRKCQ kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186464,3533,2197,SRSF protein kinase 1,Kinase,Q96SB4,SRPK1,SRPK1_HUMAN,5.92,,Kd,Binding constant for SRPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186465,3533,2195,Serine/threonine-protein kinase RIO3,Kinase,O14730,RIOK3,RIOK3_HUMAN,6.19,,Kd,Binding constant for RIOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186466,3533,2134,Ribosomal protein S6 kinase alpha-6,Kinase,Q9UK32,RPS6KA6,KS6A6_HUMAN,5.64,,Kd,Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186467,3533,2283,Ribosomal protein S6 kinase alpha-1,Kinase,Q15418,RPS6KA1,KS6A1_HUMAN,6.4,,Kd,Binding constant for RPS6KA1(Kin.Dom.1 - N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186468,3533,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,5.96,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186469,3533,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,5.96,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186470,3533,2335,Homeodomain-interacting protein kinase 3,Kinase,Q9H422,HIPK3,HIPK3_HUMAN,7.11,,Kd,Binding constant for HIPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186471,3533,2366,Cyclin-dependent kinase-like 5,Kinase,O76039,CDKL5,CDKL5_HUMAN,5.39,,Kd,Binding constant for CDKL5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186472,3533,2334,Homeodomain-interacting protein kinase 2,Kinase,Q9H2X6,HIPK2,HIPK2_HUMAN,6.85,,Kd,Binding constant for HIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186473,3533,2217,Serine/threonine-protein kinase pim-3,Kinase,Q86V86,PIM3,PIM3_HUMAN,7.92,,Kd,Binding constant for PIM3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186474,3533,2216,NUAK family SNF1-like kinase 1,Kinase,O60285,NUAK1,NUAK1_HUMAN,5.74,,Kd,Binding constant for ARK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186475,3533,2450,Protein kinase C iota type,Kinase,P41743,PRKCI,KPCI_HUMAN,5.85,,Kd,Binding constant for PRKCI kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186476,3533,2318,Serine/threonine-protein kinase TBK1,Kinase,Q9UHD2,TBK1,TBK1_HUMAN,6.01,,Kd,Binding constant for TBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186477,3533,2338,Serine/threonine-protein kinase ICK,Kinase,Q9UPZ9,ICK,ICK_HUMAN,6.62,,Kd,Binding constant for ICK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186478,3533,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,5.59,,Kd,Binding constant for MAP4K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186479,3533,2218,cAMP-dependent protein kinase catalytic subunit alpha,Kinase,P17612,PRKACA,KAPCA_HUMAN,5.27,,Kd,Binding constant for PKAC-alpha kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186480,3533,2272,Mitogen-activated protein kinase 15,Kinase,Q8TD08,MAPK15,MK15_HUMAN,7.06,,Kd,Binding constant for ERK8 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186481,3533,2188,MAP kinase-interacting serine/threonine-protein kinase 1,Kinase,Q9BUB5,MKNK1,MKNK1_HUMAN,5.15,,Kd,Binding constant for MKNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186482,3533,2456,Serine/threonine-protein kinase Sgk3,Kinase,Q96BR1,SGK3,SGK3_HUMAN,5.85,,Kd,Binding constant for SGK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186483,3533,726,Protein kinase C gamma type,Kinase,P05129,PRKCG,KPCG_HUMAN,6.52,,IC50,Inhibition of Protein kinase C gamma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186484,3533,871,Dual specificity protein kinase CLK2,Kinase,P49760,CLK2,CLK2_HUMAN,6.38,,Kd,Binding constant for CLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186485,3533,2333,G protein-coupled receptor kinase 7,Kinase,Q8WTQ7,GRK7,GRK7_HUMAN,6.51,,Kd,Binding constant for GRK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186486,3533,2359,Homeodomain-interacting protein kinase 1,Kinase,Q86Z02,HIPK1,HIPK1_HUMAN,6.64,,Kd,Binding constant for HIPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186487,3533,870,Dual specificity protein kinase CLK1,Kinase,P49759,CLK1,CLK1_HUMAN,6.04,,Kd,Binding constant for full-length CLK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186488,3533,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,6.55,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186489,3533,740,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Kinase,Q13555,CAMK2G,KCC2G_HUMAN,5.11,,Kd,Binding constant for CAMK2G kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186490,3533,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,6.43,,Kd,Average Binding Constant for STK18; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186491,3533,741,AP2-associated protein kinase 1,Kinase,Q2M2I8,AAK1,AAK1_HUMAN,6.05,,Kd,Binding constant for AAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186492,3533,742,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,5.64,,Kd,Average Binding Constant for MARK2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186493,3533,787,Protein kinase C epsilon type,Kinase,Q02156,PRKCE,KPCE_HUMAN,7.96,,Kd,Binding constant for PRKCE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186494,3533,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,6.38,,Kd,Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186495,3533,2181,Casein kinase II subunit alpha',Kinase,P19784,CSNK2A2,CSK22_HUMAN,5.47,,Kd,Binding constant for full-length CSNK2A2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186496,3533,899,Ribosomal protein S6 kinase alpha-5,Kinase,O75582,RPS6KA5,KS6A5_HUMAN,5.89,,Kd,Binding constant for RPS6KA5(Kin.Dom.1 - C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186497,3533,605,Serine/threonine-protein kinase pim-1,Kinase,P11309,PIM1,PIM1_HUMAN,7.3,,Kd,Competitive binding affinity to PIM1 in presence of ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186498,3533,2089,Serine/threonine-protein kinase N2,Kinase,Q16513,PKN2,PKN2_HUMAN,5.82,,Kd,Binding constant for PKN2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186499,3533,2353,Serine/threonine-protein kinase TAO1,Kinase,Q7L7X3,TAOK1,TAOK1_HUMAN,5.74,,Kd,Binding constant for TAOK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186500,3533,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,5.55,,Kd,Average Binding Constant for HCK; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186501,3533,792,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,5.52,,Kd,Average Binding Constant for Aurora3; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186502,3533,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,5.15,,Kd,Average Binding Constant for PDGFRB; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186503,3533,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,5.29,,Kd,Average Binding Constant for FGFR1; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186504,3533,2245,Citron Rho-interacting kinase,Kinase,O14578,CIT,CTRO_HUMAN,5.85,,Kd,Binding constant for CIT kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186505,3533,573,Ribosomal protein S6 kinase alpha-3,Kinase,P51812,RPS6KA3,KS6A3_HUMAN,5.66,,Kd,Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186506,3533,614,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,6.54,,Kd,Binding constant for MYLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186507,3533,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,5.08,,Kd,Average Binding Constant for MAP4K5; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186508,3533,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,6.51,,Kd,Binding constant for MINK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186509,3533,2464,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,5.01,,Kd,Binding constant for LRRK2(G2019S) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186510,3533,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,6.42,,Kd,Average Binding Constant for KIT; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186511,3533,855,BMP-2-inducible protein kinase,Kinase,Q9NSY1,BMP2K,BMP2K_HUMAN,6.37,,Kd,Binding constant for BIKE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186512,3533,856,Serine/threonine-protein kinase pim-2,Kinase,Q9P1W9,PIM2,PIM2_HUMAN,6.89,,Kd,Average Binding Constant for PIM2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186513,3533,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,5.24,,Kd,Average Binding Constant for TNIK; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186514,3533,908,Calcium/calmodulin-dependent protein kinase kinase 2,Kinase,Q96RR4,CAMKK2,KKCC2_HUMAN,5.96,,Kd,Average Binding Constant for CAMKK2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186515,3533,2284,Ribosomal protein S6 kinase alpha-4,Kinase,O75676,RPS6KA4,KS6A4_HUMAN,5.21,,Kd,Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186516,3533,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,6.4,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186517,3533,902,Dual specificity protein kinase CLK4,Kinase,Q9HAZ1,CLK4,CLK4_HUMAN,5.72,,Kd,Binding constant for CLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186518,3533,702,Death-associated protein kinase 2,Kinase,Q9UIK4,DAPK2,DAPK2_HUMAN,5.59,,Kd,Average Binding Constant for DAPK2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186519,3533,2022,Serine/threonine-protein kinase 3,Kinase,Q9JI10,Stk3,STK3_MOUSE,7.05,,Kd,Average Binding Constant for STK3_m; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,,,,Mus musculus
186520,3533,893,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,6.66,,Kd,Average Binding Constant for STK4; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186521,3533,914,Calcium/calmodulin-dependent protein kinase kinase 1,Kinase,Q8N5S9,CAMKK1,KKCC1_HUMAN,5.82,,Kd,Average Binding Constant for CAMKK1; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186522,3533,2133,Serine/threonine-protein kinase 3,Kinase,Q13188,STK3,STK3_HUMAN,6.02,,Kd,Binding constant for MST2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186523,3533,891,Calcium/calmodulin-dependent protein kinase type 1D,Kinase,Q8IU85,CAMK1D,KCC1D_HUMAN,5.59,,Kd,Average Binding Constant for CAMK1D; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186524,3533,2458,Serine/threonine-protein kinase TAO2,Kinase,Q9UL54,TAOK2,TAOK2_HUMAN,5.41,,Kd,Binding constant for TAOK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186525,3533,750,Ribosomal protein S6 kinase alpha-2,Kinase,Q15349,RPS6KA2,KS6A2_HUMAN,6.55,,Kd,Binding constant for RPS6KA2(Kin.Dom.1 - N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186526,3533,769,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",Kinase,Q16816,PHKG1,PHKG1_HUMAN,5.57,,Kd,Average Binding Constant for PHkg1; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186527,3533,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,5.08,,Kd,Binding constant for MAP4K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186528,3533,892,Cyclin-dependent kinase 16,Kinase,Q00536,CDK16,CDK16_HUMAN,5.59,,Kd,Binding constant for PCTK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186529,3533,2180,Casein kinase II subunit alpha,Kinase,P68400,CSNK2A1,CSK21_HUMAN,5.44,,Kd,Binding constant for full-length CSNK2A1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186530,3533,2208,RAC-gamma serine/threonine-protein kinase,Kinase,Q9Y243,AKT3,AKT3_HUMAN,5.85,,Kd,Binding constant for AKT3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186531,3533,2090,RAC-beta serine/threonine-protein kinase,Kinase,P31751,AKT2,AKT2_HUMAN,5.06,,Kd,Binding constant for AKT2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186532,3533,2185,Serine/threonine-protein kinase STK11,Kinase,Q15831,STK11,STK11_HUMAN,5.23,,Kd,Binding constant for LKB1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186533,3533,2331,Rhodopsin kinase,Kinase,Q15835,GRK1,RK_HUMAN,6.1,,Kd,Binding constant for GRK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186534,3533,2912,CaM kinase II,Kinase,Q13554|Q13555|Q13557|Q9UQM7,CAMK2A|CAMK2B|CAMK2D|CAMK2G,KCC2A_HUMAN|KCC2B_HUMAN|KCC2D_HUMAN|KCC2G_HUMAN,5.21,,IC50,Inhibition of purified mammalian brain [Ca(2+)]/Calmodulin dependent kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem|Tchem|Tchem|Tchem,,,Homo sapiens
186535,3533,773,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,Q9UQM7,CAMK2A,KCC2A_HUMAN,5.35,,Kd,Binding constant for CAMK2A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186536,3533,2332,G protein-coupled receptor kinase 4,Kinase,P32298,GRK4,GRK4_HUMAN,6.23,,Kd,Binding constant for GRK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186537,3533,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,6.15,,Kd,Binding constant for MAP3K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186538,3533,2211,Serine/threonine-protein kinase LATS2,Kinase,Q9NRM7,LATS2,LATS2_HUMAN,6.19,,Kd,Binding constant for LATS2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186539,3533,2182,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Kinase,Q9Y463,DYRK1B,DYR1B_HUMAN,5.27,,Kd,Binding constant for full-length DYRK1B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186540,3533,2452,Serine/threonine-protein kinase PRP4 homolog,Kinase,Q13523,PRPF4B,PRP4B_HUMAN,5.8,,Kd,Binding constant for PRP4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186541,3533,2455,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma,Kinase,O60331,PIP5K1C,PI51C_HUMAN,6.29,,Kd,Binding constant for PIP5K1C kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186542,3533,2282,Proto-oncogene tyrosine-protein kinase ROS,Kinase,P08922,ROS1,ROS1_HUMAN,5.24,,Kd,Binding constant for ROS1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186543,3533,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,7.01,,Kd,Binding constant for TAOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186544,3533,2084,Cyclin-dependent kinase 7,Kinase,P50613,CDK7,CDK7_HUMAN,5.77,,Kd,Binding constant for CDK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186545,3533,2247,Death-associated protein kinase 1,Kinase,P53355,DAPK1,DAPK1_HUMAN,6.01,,Kd,Binding constant for DAPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186546,3533,710,Protein kinase C delta type,Kinase,Q05655,PRKCD,KPCD_HUMAN,8.44,,Kd,Binding constant for PRKCD kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186547,3533,623,Death-associated protein kinase 3,Kinase,O43293,DAPK3,DAPK3_HUMAN,5.89,,Kd,Average Binding Constant for DAPK3; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186548,3533,2327,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,Q13627,DYRK1A,DYR1A_HUMAN,6.6,,Kd,Binding constant for DYRK1A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186549,3533,2206,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,6.55,,Kd,Binding constant for DMPK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186550,3533,2210,Serine/threonine-protein kinase LATS1,Kinase,O95835,LATS1,LATS1_HUMAN,5.59,,Kd,Binding constant for LATS1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186551,3533,2911,Protein kinase C (PKC),Kinase,P05696|P09215|P09216|P09217|P63319|P68403|Q64617|Q9WTQ0,Prkca|Prkcb|Prkcd|Prkce|Prkcg|Prkch|Prkcq|Prkcz,KPCA_RAT|KPCB_RAT|KPCD_RAT|KPCE_RAT|KPCG_RAT|KPCL_RAT|KPCT_RAT|KPCZ_RAT,6.49,,IC50,Inhibition of purified rat brain protein kinase C (RB-PKC),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,,,,Rattus norvegicus
186552,3533,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.89,,Kd,Average Binding Constant for LCK; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186553,3533,2238,Mitogen-activated protein kinase kinase kinase 9,Kinase,P80192,MAP3K9,M3K9_HUMAN,5.85,,Kd,Binding constant for MLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186554,3533,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,7.32,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186555,3533,2164,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,Kinase,P78356,PIP4K2B,PI42B_HUMAN,6.08,,Kd,Binding constant for full-length PIP5K2B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186556,3533,1426,3-phosphoinositide-dependent protein kinase 1,Kinase,O15530,PDPK1,PDPK1_HUMAN,6.15,,Kd,Binding constant for full-length PDPK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186557,3533,2273,Serine/threonine-protein kinase D2,Kinase,Q9BZL6,PRKD2,KPCD2_HUMAN,6.05,,Kd,Binding constant for PRKD2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186558,3533,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.49,,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186559,3533,2198,SRSF protein kinase 2,Kinase,P78362,SRPK2,SRPK2_HUMAN,5.96,,Kd,Binding constant for SRPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186560,3533,2229,Dual specificity mitogen-activated protein kinase kinase 4,Kinase,P45985,MAP2K4,MP2K4_HUMAN,6.03,,Kd,Binding constant for MEK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186561,3533,2176,Serine/threonine-protein kinase tousled-like 1,Kinase,Q9UKI8,TLK1,TLK1_HUMAN,5.68,,Kd,Binding constant for TLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186562,3533,2350,SRSF protein kinase 3,Kinase,Q9UPE1,SRPK3,SRPK3_HUMAN,5.8,,Kd,Binding constant for SRPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186563,3533,2230,Dual specificity mitogen-activated protein kinase kinase 6,Kinase,P52564,MAP2K6,MP2K6_HUMAN,5.41,,Kd,Binding constant for MEK6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186564,3533,2163,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,Kinase,Q99755,PIP5K1A,PI51A_HUMAN,6.16,,Kd,Binding constant for full-length PIP5K1A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tbio,,,Homo sapiens
186565,3533,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,6.77,,Kd,Binding constant for MAP3K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186566,3533,2170,Serine/threonine-protein kinase RIO1,Kinase,Q9BRS2,RIOK1,RIOK1_HUMAN,6.09,,Kd,Binding constant for full-length RIOK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186567,3533,2322,Cyclin-dependent kinase 4,Kinase,P11802,CDK4,CDK4_HUMAN,6.55,,Kd,Binding constant for CDK4-cyclinD1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186568,3533,2088,Ribosomal protein S6 kinase beta-1,Kinase,P23443,RPS6KB1,KS6B1_HUMAN,6.68,,Kd,Binding constant for S6K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186569,3533,2325,Serine/threonine-protein kinase Chk2,Kinase,O96017,CHEK2,CHK2_HUMAN,5.43,,Kd,Binding constant for CHEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186570,3533,2201,Serine/threonine-protein kinase 33,Kinase,Q9BYT3,STK33,STK33_HUMAN,5.59,,Kd,Binding constant for STK33 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186571,3533,884,Glycogen synthase kinase-3 beta,Kinase,P49841,GSK3B,GSK3B_HUMAN,5.59,,Kd,Binding constant for full-length GSK3B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tclin,,,Homo sapiens
186572,3533,721,Calcium/calmodulin-dependent protein kinase type II subunit delta,Kinase,Q13557,CAMK2D,KCC2D_HUMAN,5.34,,Kd,Binding constant for CAMK2D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186573,3533,2141,Serine/threonine-protein kinase Chk1,Kinase,O14757,CHEK1,CHK1_HUMAN,6.27,,Kd,Binding constant for CHEK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186574,3533,2275,cGMP-dependent protein kinase 2,Kinase,Q13237,PRKG2,KGP2_HUMAN,5.51,,Kd,Binding constant for PRKG2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186575,3533,711,cAMP-dependent protein kinase catalytic subunit beta,Kinase,P22694,PRKACB,KAPCB_HUMAN,5.49,,Kd,Binding constant for full-length PKAC-beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186576,3533,758,Protein kinase C eta type,Kinase,P24723,PRKCH,KPCL_HUMAN,5.74,,Kd,Binding constant for PRKCH kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186577,3533,815,Serine/threonine-protein kinase N1,Kinase,Q16512,PKN1,PKN1_HUMAN,6.46,,Kd,Binding constant for PKN1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186578,3533,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,6.54,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186579,3533,685,Protein kinase C beta type,Kinase,P05771,PRKCB,KPCB_HUMAN,8.33,,IC50,Inhibition of Protein kinase C beta 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,,,,Homo sapiens
186580,3533,714,Protein kinase C alpha type,Kinase,P17252,PRKCA,KPCA_HUMAN,6.44,,IC50,Inhibition of Protein kinase C alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91829,,,,Tchem,,,Homo sapiens
186581,3312,2383,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Ion channel,O88703,Hcn2,HCN2_MOUSE,5.34,,EC50,Blockade of mouse HCN2 expressed in HEK293 cells at -120 f-current amplitude by patch-clamp electrophysiological assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL471737,,,,,,,Mus musculus
186582,3312,1674,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,Q9Y3Q4,HCN4,HCN4_HUMAN,5.37,,EC50,Blockade of human HCN4 expressed in HEK293 cells at -120 f-current amplitude by patch-clamp electrophysiological assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL471737,,,,Tclin,,,Homo sapiens
186583,3312,2382,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Ion channel,O88704,Hcn1,HCN1_MOUSE,5.35,,EC50,Blockade of mouse HCN1 expressed in HEK293 cells at -120 f-current amplitude by patch-clamp electrophysiological assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL471737,,,,,,,Mus musculus
186584,977,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.82,,IC50,Inhibition of human ABCB1-mediated rhodamine 123 efflux in mouse L5178 cells expressing human MDR1 after 20 mins by FACS analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305660,,,,Tchem,,,Homo sapiens
186585,977,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,7.35,,IC50,Compound is evaluated for in vitro receptor binding affinity against H1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305660,,,,,,,Cavia porcellus
186586,977,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.33,,IC50,Compound is evaluated for in vitro receptor binding affinity against 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305660,,,,Tclin,,,Homo sapiens
186587,977,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.96,,IC50,Compound is evaluated for in vitro receptor binding affinity against Muscarinic acetylcholine receptor M1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305660,,,,Tclin,,,Homo sapiens
186588,977,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.21,,IC50,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305660,,,,Tclin,,,Homo sapiens
186589,1890,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,6.24,,Ki,Inhibition of [3H]- NE reuptake into rat hippocampal synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL623,,,,,,,Rattus norvegicus
186590,1890,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.62,,Ki,Inhibition of [3H]- DA reuptake into rat striatal synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL623,,,,,,,Rattus norvegicus
186591,1890,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,6.86,,Ki,Inhibition of [3H]5-HT reuptake into rat frontal cortex synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL623,,,,,,,Rattus norvegicus
186593,3137,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,6.02,,Ki,compound was tested for inhibitory activity against Thrombin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30044,,,,Tclin,,,Homo sapiens
186594,3137,88,Urokinase-type plasminogen activator,Enzyme,P00749,PLAU,UROK_HUMAN,5.8,,Ki,compound was tested for inhibitory activity against Urokinase-type plasminogen activator (microPa),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30044,,,,Tchem,,,Homo sapiens
186595,3137,3586,Acrosin,Unclassified,P08001,ACR,ACRO_PIG,5.77,,Ki,Reversible competitive inhibition of boar spermatozoa acrosin using BzArgOEt as substrate by Dixon plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30044,,,,,,,Sus scrofa
186596,3137,683,Suppressor of tumorigenicity 14 protein,Enzyme,Q9Y5Y6,ST14,ST14_HUMAN,6.27,,Ki,compound was tested for inhibitory activity against Matriptase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30044,,,,Tchem,,,Homo sapiens
186597,866,3472,Penicillin-binding protein,Enzyme,P72355|Q53707|Q53725|Q53729|Q9XDB3,PBP2|mecA|pbp4|pbpA|pbpF,P72355_STAAU|Q53707_STAAU|Q53725_STAAU|Q53729_STAAU|Q9XDB3_STAAU,,,,Mechanism of Action; CHEMBL2362972; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL893,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL893,INHIBITOR,,,,,Staphylococcus aureus
186598,3178,424,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,4.34,,IC50,Inhibition of recombinant PTP1B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL230006,,,,Tchem,,,Homo sapiens
186599,3178,896,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,P28845,HSD11B1,DHI1_HUMAN,8.07,,IC50,"Inhibition of human 11beta HSD1 expressed in HEK293 cells assessed as assessed as inhibition of [1,2-(n)3H]cortisone to [3H]-cortisol after 60 mins by scintillation proximity assay",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL230006,,,,Tclin,,,Homo sapiens
186600,3178,2301,Corticosteroid 11-beta-dehydrogenase isozyme 2,Enzyme,P50233,Hsd11b2,DHI2_RAT,6.44,,IC50,Inhibition of rat renal 11beta-HSD2 in rat liver assessed as inhibition of cortisone production,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL230006,,,,,,,Rattus norvegicus
186601,3178,2300,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,P16232,Hsd11b1,DHI1_RAT,7.05,,IC50,Inhibition of 11beta-HSD1 in rat liver assessed as cortisone level,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL230006,,,,,,,Rattus norvegicus
186602,3178,1476,"Glycogen phosphorylase, muscle form",Enzyme,P00489,PYGM,PYGM_RABIT,4.18,,IC50,Inhibition of rabbit muscle glycogen phosphorylase A assessed as phosphate release from glucose-1-phosphate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL230006,,,,,,,Oryctolagus cuniculus
186603,3178,2070,Aldo-keto reductase family 1 member B10,Enzyme,O60218,AKR1B10,AK1BA_HUMAN,5.31,,IC50,Inhibition of reductase activity of N-terminal 6His-tagged human AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as pyridine-3-aldehyde reduction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL230006,,,,Tchem,,,Homo sapiens
186604,3178,2058,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,P50172,Hsd11b1,DHI1_MOUSE,8.7,,IC50,Inhibition of mouse 11beta-HSD1 expressed in HEK293 cell microsomes assessed as inhibition of [3H]cortisone conversion to [3H]cortisol by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL230006,,,,,,,Mus musculus
186605,3178,811,Corticosteroid 11-beta-dehydrogenase isozyme 2,Enzyme,P80365,HSD11B2,DHI2_HUMAN,8.91,,IC50,Inhibition of human 11beta-HSD2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL230006,,,,Tchem,,,Homo sapiens
186606,3178,3481,Protein-tyrosine phosphatase 1C,Enzyme,P29350,PTPN6,PTN6_HUMAN,4.18,,IC50,Inhibition of recombinant SHP1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL230006,,,,Tchem,,,Homo sapiens
186607,3178,2404,Tyrosine-protein phosphatase non-receptor type 11,Enzyme,Q06124,PTPN11,PTN11_HUMAN,5.02,,IC50,Inhibition of recombinant SHP2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL230006,,,,Tchem,,,Homo sapiens
186608,3178,758,Protein kinase C eta type,Kinase,P24723,PRKCH,KPCL_HUMAN,6.6,,Kd,Binding affinity to recombinant human PKCeta in after 2 hrs by microequilibrium dialysis assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL230006,,,,Tchem,,,Homo sapiens
186609,539,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201118,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201118,INHIBITOR,,,,,Escherichia coli (strain K12)
186610,2600,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,7.45,,Kd,Dissociation constant was determined against H1 receptor of guinea pig lung membranes using radioligand binding assays.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17157,,,,,,,Cavia porcellus
186611,2600,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.54,,IC50,Compound is evaluated for in vitro receptor binding affinity against Muscarinic acetylcholine receptor M1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17157,,,,Tclin,,,Homo sapiens
186612,2600,3571,Transcriptional activator protein luxR,Unclassified,P12746,luxR,LUXR_ALIFS,4.04,,IC50,Inhibition of LuxR-dependent quorum sensing in Vibrio fischeri assessed as reduction of 3-oxo-C6-HSL-induced bioluminescence intensity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17157,,,,,,,Aliivibrio fischeri
186613,2600,754,Cytochrome P450 2J2,Enzyme,P51589,CYP2J2,CP2J2_HUMAN,5.09,,IC50,Inhibition of human recombinant CYP2J2 expressed in baculovirus-infected Sf9 insect cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17157,,,,Tchem,,,Homo sapiens
186614,2600,2856,Adrenergic receptor alpha-1,GPCR,P25100|P35348|P35368,ADRA1A|ADRA1B|ADRA1D,ADA1A_HUMAN|ADA1B_HUMAN|ADA1D_HUMAN,5.63,,IC50,Compound is evaluated for in vitro receptor binding affinity against Alpha-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17157,,,,Tclin|Tclin|Tclin,,,Homo sapiens
186615,3920,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.3,,IC50,Agonist activity at glucocorticoid receptor in HFF assessed as inhibition of IL-1-induced IL-6 production after 24 hrs,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,AGONIST,,Tclin,,,Homo sapiens
186616,692,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,5.22,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1292,,,,,,,Trypanosoma cruzi
186617,1232,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,5.63,,Ki,Tested for the inhibition of [14C]-DDATHF influx in CCRF-CEM cells of human leukemic lymphoblast,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1679,,,,Tclin,,,Homo sapiens
186618,2351,1439,Phospholipase D2,Enzyme,O14939,PLD2,PLD2_HUMAN,5.47,,IC50,Inhibition of human PLD2 assessed as release of methyl-[3H]choline from choline-methyl-[3H]dipalmitoylphosphatidylcholine after 30 mins by exogenous substrate assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,Tchem,,,Homo sapiens
186619,2351,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,4.48,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,,,,Trypanosoma cruzi
186620,2351,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,4.93,,EC50,Agonist activity at PXR (unknown origin) expressed in human HepG2 cells assessed as induction of CYP3A4 transactivation after 16 hrs by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,Tchem,,,Homo sapiens
186621,2351,2883,Estrogen receptor,Transcription factor,P06211|Q62986,Esr1|Esr2,ESR1_RAT|ESR2_RAT,8.73,,IC50,Inhibition of estradiol binding to estrogen receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,,,,Rattus norvegicus
186622,2351,1990,Estrogen receptor,Transcription factor,P06211,Esr1,ESR1_RAT,9.43,,Ki,Binding affinity for rat estrogen receptor alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,,,,Rattus norvegicus
186623,2351,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.42,,Ki,Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,Tclin,,,Homo sapiens
186624,2351,1438,Phospholipase D1,Enzyme,Q13393,PLD1,PLD1_HUMAN,5.4,,IC50,Inhibition of human PLD1b,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,Tchem,,,Homo sapiens
186625,2351,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.16,,Ki,Displacement of [3H]LSD from human cloned 5HT2B receptor expressed in CHO cells by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,Tclin,,,Homo sapiens
186626,2351,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,7.18,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
186627,2351,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,4.94,,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,Tclin,,,Homo sapiens
186628,2351,1991,Estrogen receptor beta,Transcription factor,Q62986,Esr2,ESR2_RAT,8.56,,Ki,Binding affinity for rat estrogen receptor beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,,,,Rattus norvegicus
186629,1771,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201081,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201081,AGONIST,,Tclin,,,Homo sapiens
186630,2441,1913,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O54735,Pde5a,PDE5A_RAT,8.74,,Ki,Inhibition of phosphodiesterase 5 in rat fetal lung fibroblast (RFL-6) cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Rattus norvegicus
186631,2441,696,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",Enzyme,Q13946,PDE7A,PDE7A_HUMAN,5.33,,IC50,Inhibition of human recombinant PDE7A1 at 1 uM by [3H]cGMP based tritium scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tclin,,,Homo sapiens
186632,2441,794,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",Enzyme,O76083,PDE9A,PDE9A_HUMAN,5.47,,IC50,Inhibition of Phosphodiesterase 9,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tchem,,,Homo sapiens
186633,2441,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,5.11,,IC50,Inhibition of human recombinant PDE4 (Phosphodiesterase 4),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
186634,2441,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.48,,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tclin,,,Homo sapiens
186635,2441,1914,Uncharacterized protein,Enzyme,E1BN64,PDE3B,E1BN64_BOVIN,5.04,,IC50,Inhibition of bovine aorta PDE3 (Phosphodiesterase 3),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Bos taurus
186636,2441,2549,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O77746,PDE5A,PDE5A_CANFA,9,,IC50,Inhibitory activity against phosphodiesterase 5 (PDE5) isolated from canine lung,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Canis familiaris
186637,2441,2907,Phosphodiesterase 1,Enzyme,Q01066|Q63421|Q9EPR9,Pde1a|Pde1b|Pde1c,PDE1B_RAT|PDE1C_RAT|Q9EPR9_RAT,6.59,,IC50,Inhibition of Phosphodiesterase 1 from rat liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Rattus norvegicus
186638,2441,559,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,Q08499,PDE4D,PDE4D_HUMAN,4.7,,IC50,Inhibition of human PDE4D,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tclin,,,Homo sapiens
186639,2441,210,Multidrug resistance-associated protein 5,Transporter,O15440,ABCC5,MRP5_HUMAN,5.92,,Ki,Inhibition of ABCC5 in human erythrocytes assessed as inhibition of ATP-mediated [3H]cGMP uptake in inside-out vesicles after 60 mins by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tchem,,,Homo sapiens
186640,2441,2492,"Indoleamine 2,3-dioxygenase 2",Enzyme,Q8R0V5,Ido2,I23O2_MOUSE,5.35,,IC50,Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Mus musculus
186641,2441,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,6.7,,Ki,Displacement of [3H]ZM241385 from human AA2AR expressed in HEK293T cells after 2 hrs by liquid scintillation counter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tclin,,,Homo sapiens
186642,2441,770,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",Enzyme,P51160,PDE6C,PDE6C_HUMAN,7.41,,IC50,Inhibition of human recombinant PDE6C at 1 uM by [3H]cGMP based tritium scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tclin,,,Homo sapiens
186643,2441,2299,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",Enzyme,P11541,PDE6A,PDE6A_BOVIN,6.85,,IC50,Inhibition of bovine retina PDE6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Bos taurus
186644,2441,2904,Phosphodiesterase 1,Enzyme,P14100|Q01061,PDE1A|PDE1B,PDE1A_BOVIN|PDE1B_BOVIN,6.4,,IC50,Inhibition of Phosphodiesterase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Bos taurus
186645,2441,2906,Phosphodiesterase 6,Enzyme,P04972|P11541|P16586|P22571|P23439|Q95142,PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H,CNCG_BOVIN|CNRG_BOVIN|PDE6A_BOVIN|PDE6B_BOVIN|PDE6C_BOVIN|PDE6D_BOVIN,7.7,,IC50,Inhibition of phosphodiesterase 6 from bovine retina,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Bos taurus
186646,2441,2903,Phosphodiesterase 1,Enzyme,P54750|Q01064|Q14123,PDE1A|PDE1B|PDE1C,PDE1A_HUMAN|PDE1B_HUMAN|PDE1C_HUMAN,6.57,,IC50,Inhibitory activity against phosphodiesterase-1 (PDE1) isolated from canine lung,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tclin|Tclin|Tclin,,,Homo sapiens
186647,2441,3614,Phosphodiesterase 2A,Unclassified,P14099,PDE2A,PDE2A_BOVIN,4.37,,IC50,Inhibitory activity against phosphodiesterase-2 (PDE2) isolated from bovine adrenal gland,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Bos taurus
186648,2441,2864,Phosphodiesterase 4,Enzyme,P14270|P14644|P14646|P54748,Pde4a|Pde4b|Pde4c|Pde4d,PDE4A_RAT|PDE4B_RAT|PDE4C_RAT|PDE4D_RAT,5.34,,IC50,Inhibitory concentration against phosphodiesterase 4 (PDE4) from rat kidney,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Rattus norvegicus
186649,2441,2032,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",Enzyme,P16586,PDE6C,PDE6C_BOVIN,7.48,,IC50,Inhibition of bovine cone PDE6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Bos taurus
186650,2441,1926,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,Q28156,PDE5A,PDE5A_BOVIN,8.22,,IC50,Inhibition of bovine aorta PDE5 (Phosphodiesterase 5),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,,,,Bos taurus
186651,2441,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,5.15,,IC50,Inhibitory concentration against phosphodiesterase 3 from human platelet,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tclin|Tclin,,,Homo sapiens
186652,2441,418,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,Q9HCR9,PDE11A,PDE11_HUMAN,5.64,,IC50,Inhibition of human phosphodiesterase 11,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tchem,,,Homo sapiens
186653,2441,446,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,Q9Y233,PDE10A,PDE10_HUMAN,5.51,,IC50,Inhibitory concentration against human phosphodiesterase 10,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tclin,,,Homo sapiens
186654,1222,628,Nociceptin receptor,GPCR,P41146,OPRL1,OPRX_HUMAN,6.3,,Ki,Displacement of [125I]nociceptin from human NOP expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46516,,,,Tchem,,,Homo sapiens
186655,1222,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.64,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46516,,,,Tclin,,,Homo sapiens
186656,1222,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.82,,Ki,Displacement of [3H]LSD from human cloned 5HT2B receptor expressed in CHO cells by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46516,,,,Tclin,,,Homo sapiens
186657,1222,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.93,,Ki,Displacement of [3H]LSD from human 5HT6 receptor expressed in HEK293 cells after 1.5 hrs by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46516,,,,Tchem,,,Homo sapiens
186658,1387,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200635,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200635,AGONIST,,Tclin,,,Homo sapiens
186659,354,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1497,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1497,AGONIST,,Tclin,,,Homo sapiens
186660,1599,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.63,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL841,,,,Tchem,,,Homo sapiens
186661,1599,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,5.23,,Kd,Binding affinity to human recombinant Tie2 by SPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL841,,,,Tclin,,,Homo sapiens
186715,785,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,8.48,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186662,1599,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,6.57,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL841,,,,Tclin|Tclin|Tclin,,,Homo sapiens
186663,1599,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,7.3,,Ki,Binding affinity for delta opioid receptor of rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL841,,,,,,,Rattus norvegicus
186664,1599,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,9.8,,Ki,Binding affinity for Mu opioid receptor of rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL841,,,,,,,Rattus norvegicus
186665,2727,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200449,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200449,AGONIST,,Tclin,,,Homo sapiens
186666,624,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,4,,IC50,Inhibition of PAD4 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404520,,,,Tclin,,,Homo sapiens
186667,624,1411,Protein-arginine deiminase type-4,Enzyme,Q9UM07,PADI4,PADI4_HUMAN,4,,IC50,Inhibition of PAD4 by ABPP-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404520,,,,Tchem,,,Homo sapiens
186668,1909,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.32,,IC50,Inhibition of P-glycoprotein expressed in A2780/ADR cells by calcein AM assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,Tchem,,,Homo sapiens
186669,1909,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,5.85,,IC50,Alpha-2-adrenolytic activity was assessed from the ability to inhibit [3H]yohimbine binding to rat cerebral cortex preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,,,,Rattus norvegicus
186670,1909,3464,Malate dehydrogenase cytoplasmic ,Enzyme,P40925,MDH1,MDHC_HUMAN,4.3,,IC50,Inhibition of malate dehydrogenase (MDH),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,Tbio,,,Homo sapiens
186671,1909,1975,Equilibrative nucleoside transporter 1,Transporter,O54698,Slc29a1,S29A1_RAT,5.27,,Ki,Ability to displace radioligand from Na+ independent Adenosine transporter in rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,,,,Rattus norvegicus
186672,1909,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.49,,Ki,Displacement of [125]AB-MECA binding to human Adenosine A3 receptor expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,Tchem,,,Homo sapiens
186673,1909,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,4.7,,IC50,Compound was tested for the inhibition of beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,,,,Escherichia coli (strain K12)
186674,1909,1938,Adenosine receptor A3,GPCR,P28647,Adora3,AA3R_RAT,4.96,,Ki,Binding affinity against rat Adenosine A3 receptor from CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,,,,Rattus norvegicus
186675,1909,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.44,,IC50,Alpha-1-adrenolytic activity was assessed from the ability to inhibit [3H]prazosin binding to rat cerebral cortex preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,,,,Rattus norvegicus
186676,1909,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,4.2,,Ki,Displacement of [3H]-CGS- 21680 binding to Adenosine A2A receptor in rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,,,,Rattus norvegicus
186677,1909,2874,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,9.08,,Ki,Inhibition of [3H]nitrendipine binding to L-type calcium channel from rat brain cortex homogenate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,,,,Rattus norvegicus
186678,1909,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,4.71,,Ki,Displacement of [3H](R)-PIA binding to Adenosine A1 receptor in rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,,,,Rattus norvegicus
186679,1909,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,4.78,,IC50,Inhibition of ABCG2 in human mitoxantrone-resistant MCF7 cells by Hoechst 33342 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,,,,Tchem,,,Homo sapiens
186681,1001,2305,Putative hydrolase RBBP9,Enzyme,O75884,RBBP9,RBBP9_HUMAN,5.11,,IC50,Displacement of fluorophosphate-rhodamine from RBBP9 transfected in human HEK293T cells proteomes after 30 mins by SDS-PAGE gel fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50588,,,,Tchem,,,Homo sapiens
186682,2237,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,5.15,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21333,,,,,,,Trypanosoma cruzi
186683,2237,1726,Cysteinyl leukotriene receptor 1,GPCR,Q2NNR5,CYSLTR1,CLTR1_CAVPO,9.1,,Ki,In vitro binding of Cysteinyl leukotriene receptor 1 to guinea pig lung membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21333,,,,,,,Cavia porcellus
186684,2237,3088,Uracil nucleotide/cysteinyl leukotriene receptor,GPCR,Q13304,GPR17,GPR17_HUMAN,5.39,,Ki,Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes after 60 mins by heterologous competition binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21333,,,,Tchem,,,Homo sapiens
186685,3553,596,DNA topoisomerase 1,Enzyme,P11387,TOP1,TOP1_HUMAN,5.57,,IC50,Inhibit supercoil relaxation property of topoisomerase I.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11252,,,,Tclin,,,Homo sapiens
186686,3553,2876,Estrogen receptor,Nuclear hormone receptor,P03372|Q92731,ESR1|ESR2,ESR1_HUMAN|ESR2_HUMAN,7.7,,IC50,Tested for 50% inhibition of generation of Human estrogen receptor polymerase chain reaction(PCR) products,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11252,,,,Tclin|Tclin,,,Homo sapiens
186687,3553,612,GTPase HRas,Cytosolic other,P01112,HRAS,RASH_HUMAN,6.7,,IC50,Tested for 50% inhibition of generation of Human Ha-ras polymerase chain reaction(PCR) products,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11252,,,,Tchem,,,Homo sapiens
186716,785,2168,Mitogen-activated protein kinase kinase kinase MLT,Kinase,Q9NYL2,ZAK,MLTK_HUMAN,7.35,,Kd,Binding constant for ZAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186688,2406,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,9.05,,Ki,Inhibitory constant against HMG-CoA reductase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1496,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1496,INHIBITOR,,Tclin,,,Homo sapiens
186689,2406,1796,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P51639,Hmgcr,HMDH_RAT,8.68,,IC50,Inhibition of HMG-CoA reductase in rat liver microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1496,,,,,,,Rattus norvegicus
186690,2406,3482,Phosphodiesterase 6D,Enzyme,O43924,PDE6D,PDE6D_HUMAN,5.9,,Kd,Binding affinity to His6-tagged PDE-delta (unknown origin) measured every 3 mins by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1496,,,,Tclin,,,Homo sapiens
186691,535,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL186,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL186,INHIBITOR,,,,,Escherichia coli (strain K12)
186692,1275,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.44,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51149,,,,Tclin|Tclin|Tclin,,,Homo sapiens
186693,1349,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200908,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200908,AGONIST,,Tclin,,,Homo sapiens
186694,1390,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1549,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1549,AGONIST,,Tclin,,,Homo sapiens
186695,785,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,6,,Kd,Binding constant for full-length MEK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186696,785,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,5.49,,Kd,Binding constant for FLT3(K663Q) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186697,785,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,7.1,,Kd,Binding constant for EGFR(G719S) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186698,785,2268,Tubulin alpha-1A chain,Structural,P68370,Tuba1a,TBA1A_RAT,7.26,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,,,,Rattus norvegicus
186699,785,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,5.3,,Kd,Binding constant for FLT1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186700,785,441,Serine/threonine-protein kinase mTOR,Kinase,P42345,MTOR,MTOR_HUMAN,4.46,,IC50,Inhibition of recombinant mTOR by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186701,785,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,5.54,,Kd,Binding constant for VEGFR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186702,785,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,9.68,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,INHIBITOR,,Tclin,,,Homo sapiens
186703,785,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,5.41,,Kd,Binding constant for FGFR3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186704,785,2144,Proto-oncogene tyrosine-protein kinase Src,Kinase,P00523,SRC,SRC_CHICK,7.96,,Kd,Activity of wild type chicken c N-terminal His-tagged Src expressed in Escherichia coli BL21 (DE3),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,,,,Gallus gallus
186705,785,2364,Serine/threonine-protein kinase 35,Kinase,Q8TDR2,STK35,STK35_HUMAN,6.11,,Kd,Binding constant for STK35 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186706,785,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,9.33,,Kd,Binding constant for PDGFRA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186707,785,837,Casein kinase I isoform epsilon,Kinase,P49674,CSNK1E,KC1E_HUMAN,5.82,,Kd,Binding constant for full-length CSNK1E,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186708,785,887,Receptor-interacting serine/threonine-protein kinase 2,Kinase,O43353,RIPK2,RIPK2_HUMAN,7.51,,Kd,Binding constant for RIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186709,785,3483,Myelin transcription factor 1,Unclassified,Q01538,MYT1,MYT1_HUMAN,7.2,,IC50,Binding affinity to human full-length His-tagged Myt1 kinase expressed in HEK293 cells by TR-FRET based binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186710,785,922,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,9.47,,Kd,Binding constant for EPHB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186711,785,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,6,,Kd,Binding constant for JAK2(Kin.Dom.2/JH1 - catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186712,785,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,8.59,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186713,785,2447,Serine/threonine-protein kinase SBK1,Kinase,Q52WX2,SBK1,SBK1_HUMAN,5.92,,Kd,Binding constant for SBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tdark,,,Homo sapiens
186714,785,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,5.03,,Kd,Binding constant for AURKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186717,785,2871,MAP kinase p38,Kinase,O15264|P53778|Q15759|Q16539,MAPK11|MAPK12|MAPK13|MAPK14,MK11_HUMAN|MK12_HUMAN|MK13_HUMAN|MK14_HUMAN,7,,IC50,Inhibition of p38 kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem|Tchem|Tchem|Tchem,,,Homo sapiens
186718,785,715,Tyrosine-protein kinase SYK,Kinase,P43405,SYK,KSYK_HUMAN,5.54,,Kd,Binding constant for SYK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186719,785,2166,Wee1-like protein kinase,Kinase,P30291,WEE1,WEE1_HUMAN,5.15,,Kd,Binding constant for WEE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186720,785,537,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,6.24,,Kd,Binding constant for RAF1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186721,785,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,8.85,,Kd,Binding constant for full-length BTK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186722,785,2341,Mitogen-activated protein kinase kinase kinase 13,Kinase,O43283,MAP3K13,M3K13_HUMAN,5.28,,Kd,Binding constant for LZK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186723,785,2264,Ephrin type-A receptor 1,Kinase,P21709,EPHA1,EPHA1_HUMAN,8.39,,Kd,Binding constant for EPHA1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186724,785,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,6.01,,Kd,Binding constant for MAP4K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186725,785,2462,Serine/threonine-protein kinase Nek11,Kinase,Q8NG66,NEK11,NEK11_HUMAN,6.33,,Kd,Binding constant for NEK11 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186726,785,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,6.3,,Kd,Binding constant for BRAF kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186727,785,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,9.3,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,INHIBITOR,,Tchem,,,Homo sapiens
186728,785,2241,Serine/threonine-protein kinase MRCK alpha,Kinase,Q5VT25,CDC42BPA,MRCKA_HUMAN,5.7,,Kd,Binding constant for MRCKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186729,785,2352,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,5.43,,Kd,Binding constant for TAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186730,785,2319,Tyrosine-protein kinase Blk,Kinase,P16277,Blk,BLK_MOUSE,8.1,,IC50,Inhibition of mouse BLK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,,,,Mus musculus
186731,785,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,9.51,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,INHIBITOR,,Tchem,,,Homo sapiens
186732,785,736,Ephrin type-A receptor 8,Kinase,P29322,EPHA8,EPHA8_HUMAN,9.62,,Kd,Binding constant for EPHA8 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186733,785,536,Ephrin type-A receptor 2,Kinase,P29317,EPHA2,EPHA2_HUMAN,9.07,,Kd,Binding constant for EPHA2 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,INHIBITOR,,Tclin,,,Homo sapiens
186734,785,853,Ephrin type-A receptor 3,Kinase,P29320,EPHA3,EPHA3_HUMAN,10.03,,Kd,Binding constant for EPHA3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186735,785,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,5.92,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186736,785,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,6.19,,Kd,Binding constant for JAK3(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186737,785,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,9.52,,Kd,Binding constant for YES kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,INHIBITOR,,Tclin,,,Homo sapiens
186738,785,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,9,,Kd,Binding constant for full-length CSK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186739,785,2202,Serine/threonine-protein kinase TNNI3K,Kinase,Q59H18,TNNI3K,TNI3K_HUMAN,7.96,,Kd,Binding constant for full-length TNNI3K,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186740,785,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.85,,Kd,Binding constant for ERBB2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186741,785,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,9.46,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,INHIBITOR,,Tclin,,,Homo sapiens
186742,785,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,9.2,,Kd,Binding constant for PDGFRB kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,INHIBITOR,,Tclin,,,Homo sapiens
186743,785,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,5.43,,Kd,Binding constant for FGFR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186744,785,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,5.85,,Kd,Binding constant for FGFR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186745,785,2207,"Chaperone activity of bc1 complex-like, mitochondrial",Kinase,Q8NI60,COQ8A,COQ8A_HUMAN,6.72,,Kd,Binding constant for ADCK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186746,785,2167,Serine/threonine-protein kinase 25,Kinase,O00506,STK25,STK25_HUMAN,5.47,,Kd,Binding constant for YSK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186747,785,876,Mitogen-activated protein kinase kinase kinase 4,Kinase,Q9Y6R4,MAP3K4,M3K4_HUMAN,6.51,,Kd,Binding constant for MAP3K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186748,785,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,7.35,,Kd,Binding constant for MAP4K5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186749,785,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,6.37,,Kd,Binding constant for MINK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186750,785,852,Serine/threonine-protein kinase 36,Kinase,Q9NRP7,STK36,STK36_HUMAN,6.68,,Kd,Binding constant for STK36 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186751,785,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,9.24,,Kd,Binding constant for KIT(L576P) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,INHIBITOR,,Tclin,,,Homo sapiens
186752,785,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,7.26,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186753,785,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,5.68,,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186754,785,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,5.7,,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186755,785,2036,Proto-oncogene tyrosine-protein kinase LCK,Kinase,P06240,Lck,LCK_MOUSE,10.19,,Ki,Inhibition of murine Lck in presence of ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,,,,Mus musculus
186756,785,2219,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,Kinase,Q99640,PKMYT1,PMYT1_HUMAN,6.89,,Kd,Binding constant for PKMYT1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186757,785,2221,Aurora kinase B,Kinase,Q96GD4,AURKB,AURKB_HUMAN,5.19,,IC50,Inhibition of AurB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186758,785,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,6.14,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186759,785,2375,Bone morphogenetic protein receptor type-1B,Kinase,O00238,BMPR1B,BMR1B_HUMAN,7.28,,Kd,Binding constant for BMPR1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186760,785,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,6.96,,Kd,Binding constant for TYK2(JH2domain-pseudokinase) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186761,785,893,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,5.42,,Kd,Binding constant for MST1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186762,785,2024,Protein-tyrosine kinase 6,Kinase,Q13882,PTK6,PTK6_HUMAN,8.11,,Kd,Binding constant for PTK6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186763,785,2458,Serine/threonine-protein kinase TAO2,Kinase,Q9UL54,TAOK2,TAOK2_HUMAN,5.27,,Kd,Binding constant for TAOK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186764,785,747,Serine/threonine-protein kinase Nek2,Kinase,P51955,NEK2,NEK2_HUMAN,5.19,,Kd,Binding constant for NEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186765,785,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,9.24,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,INHIBITOR,,Tclin,,,Homo sapiens
186766,785,746,Cytoplasmic tyrosine-protein kinase BMX,Kinase,P51813,BMX,BMX_HUMAN,8.85,,Kd,Binding constant for full-length BMX,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186767,785,802,Ephrin type-A receptor 5,Kinase,P54756,EPHA5,EPHA5_HUMAN,9.62,,Kd,Binding constant for EPHA5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186768,785,748,LIM domain kinase 1,Kinase,P53667,LIMK1,LIMK1_HUMAN,6.24,,Kd,Binding constant for full-length LIMK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186769,785,803,Ephrin type-A receptor 4,Kinase,P54764,EPHA4,EPHA4_HUMAN,8.92,,Kd,Binding constant for EPHA4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186770,785,890,Ephrin type-B receptor 1,Kinase,P54762,EPHB1,EPHB1_HUMAN,9.35,,Kd,Binding constant for EPHB1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186771,785,2142,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,P42336,PIK3CA,PK3CA_HUMAN,4.42,,IC50,Inhibition of recombinant PI3Kalpha by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186772,785,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,8.25,,Kd,Binding constant for TNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186773,785,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,6.19,,Kd,Binding constant for MAP4K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186774,785,2262,Dual specificity testis-specific protein kinase 1,Kinase,Q15569,TESK1,TESK1_HUMAN,7.48,,Kd,Binding constant for TESK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186775,785,966,Activin receptor type-1,Kinase,Q04771,ACVR1,ACVR1_HUMAN,6.21,,Kd,Binding constant for ACVR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186776,785,2209,Serine/threonine-protein kinase MRCK gamma,Kinase,Q6DT37,CDC42BPG,MRCKG_HUMAN,5.92,,Kd,Binding constant for DMPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186777,785,2242,Serine/threonine-protein kinase MRCK beta,Kinase,Q9Y5S2,CDC42BPB,MRCKB_HUMAN,5.68,,Kd,Binding constant for MRCKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186778,785,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,6.85,,Kd,Binding constant for MAP3K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186779,785,2357,Serine/threonine-protein kinase ULK3,Kinase,Q6PHR2,ULK3,ULK3_HUMAN,5.34,,Kd,Binding constant for ULK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186780,785,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,9.77,,Kd,Binding constant for ABL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186781,785,2189,Serine/threonine-protein kinase 26,Kinase,Q9P289,STK26,STK26_HUMAN,5.72,,Kd,Binding constant for full-length MST4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186782,785,2200,Activin receptor type-2B,Kinase,Q13705,ACVR2B,AVR2B_HUMAN,6.24,,Kd,Binding constant for ACVR2B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186783,785,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,9.68,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,INHIBITOR,,Tchem,,,Homo sapiens
186784,785,2368,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,7.74,,Kd,Binding constant for ERBB3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186785,785,2466,Calcium-dependent protein kinase 1,Kinase,P62344,CPK1,CDPK1_PLAF7,6.19,,Kd,Binding constant for PFCDPK1(P.falciparum) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,,,,Plasmodium falciparum
186786,785,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,10.41,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186787,785,704,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,4.52,,IC50,Inhibition of recombinant PI3Kdelta by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186788,785,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,8.19,,Kd,Binding constant for full-length SNF1LK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186789,785,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,5.64,,Kd,Binding constant for TAOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186790,785,2261,Tyrosine-protein kinase Srms,Kinase,Q9H3Y6,SRMS,SRMS_HUMAN,7.89,,Kd,Binding constant for SRMS kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,INHIBITOR,,Tchem,,,Homo sapiens
186791,785,2373,Serine/threonine-protein kinase SIK3,Kinase,Q9Y2K2,SIK3,SIK3_HUMAN,7.55,,Kd,Binding constant for QSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186792,785,2872,Dual specificity mitogen-activated protein kinase kinase; MEK1/2,Kinase,P36507|Q02750,MAP2K1|MAP2K2,MP2K1_HUMAN|MP2K2_HUMAN,5.77,,IC50,Inhibition of MEK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin|Tclin,,,Homo sapiens
186793,785,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,9.1,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,INHIBITOR,,Tclin,,,Homo sapiens
186794,785,2374,Wee1-like protein kinase 2,Kinase,P0C1S8,WEE2,WEE2_HUMAN,6.7,,Kd,Binding constant for WEE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186795,785,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,9.24,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186796,785,2205,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,8.52,,Kd,Binding affinity to wild type DDR2 (unknown origin) by FLiK assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186797,785,965,Serine/threonine-protein kinase receptor R3,Kinase,P37023,ACVRL1,ACVL1_HUMAN,6.34,,Kd,Binding constant for ACVRL1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186798,785,964,Activin receptor type-1B,Kinase,P36896,ACVR1B,ACV1B_HUMAN,6.48,,Kd,Binding constant for ACVR1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186799,785,2223,Bone morphogenetic protein receptor type-1A,Kinase,P36894,BMPR1A,BMR1A_HUMAN,5.15,,Kd,Binding constant for BMPR1A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186800,785,2263,TGF-beta receptor type-1,Kinase,P36897,TGFBR1,TGFR1_HUMAN,6.64,,Kd,Binding constant for TGFBR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186801,785,1604,TGF-beta receptor type-2,Kinase,P37173,TGFBR2,TGFR2_HUMAN,5.54,,Kd,Binding constant for TGFBR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186802,785,2192,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,Q9P2K8,EIF2AK4,E2AK4_HUMAN,5.8,,Kd,"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186803,785,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.41,,Kd,Binding constant for RET(M918T) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186804,785,2206,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,5.89,,Kd,Binding constant for DMPK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186805,785,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,9.16,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186806,785,2226,Mitogen-activated protein kinase kinase kinase kinase 4,Kinase,O95819,MAP4K4,M4K4_HUMAN,5.51,,Kd,Binding constant for MAP4K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186807,785,2199,Activin receptor type-2A,Kinase,P27037,ACVR2A,AVR2A_HUMAN,6.68,,Kd,Binding constant for ACVR2A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186808,785,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,9.7,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,INHIBITOR,,Tclin,,,Homo sapiens
186809,785,723,"Myosin light chain kinase 2, skeletal/cardiac muscle",Kinase,Q9H1R3,MYLK2,MYLK2_HUMAN,5.46,,Kd,Binding constant for MYLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186810,785,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,7.1,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186811,785,2083,Ephrin type-B receptor 2,Kinase,P29323,EPHB2,EPHB2_HUMAN,9.41,,Kd,Binding constant for EPHB2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186812,785,799,Mitogen-activated protein kinase 11,Kinase,Q15759,MAPK11,MK11_HUMAN,6.39,,Kd,Binding constant for full-length p38-beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186813,785,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,5.85,,Kd,Binding constant for full-length MEK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin,,,Homo sapiens
186814,785,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,8.68,,Kd,Binding constant for TXK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186815,785,2453,Serine/threonine-protein kinase VRK2,Kinase,Q86Y07,VRK2,VRK2_HUMAN,5.49,,Kd,Binding constant for VRK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tbio,,,Homo sapiens
186816,785,2184,LIM domain kinase 2,Kinase,P53671,LIMK2,LIMK2_HUMAN,7.07,,Kd,Binding constant for full-length LIMK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186817,785,2267,Ephrin type-B receptor 3,Kinase,P54753,EPHB3,EPHB3_HUMAN,8.16,,Kd,Binding constant for EPHB3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186818,785,2069,Tyrosine-protein kinase Tec,Kinase,P42680,TEC,TEC_HUMAN,7.89,,Kd,Binding constant for TEC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186819,785,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,6.55,,Kd,Binding constant for MAP3K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186820,785,2191,Serine/threonine-protein kinase NLK,Kinase,Q9UBE8,NLK,NLK_HUMAN,6.59,,Kd,Binding constant for full-length NLK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186821,785,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,5.89,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186822,785,2260,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,8.41,,Kd,Binding constant for SNF1LK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186823,785,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,7.57,,Kd,Binding constant for full-length p38-alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tchem,,,Homo sapiens
186824,2243,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200386,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200386,AGONIST,,Tclin,,,Homo sapiens
186825,2809,794,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",Enzyme,O76083,PDE9A,PDE9A_HUMAN,6.34,,IC50,Inhibition of Phosphodiesterase 9,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1339,,,,Tchem,,,Homo sapiens
186826,2809,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,5.35,,IC50,Inhibition of human phosphodiesterase 4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1339,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
186827,2809,2904,Phosphodiesterase 1,Enzyme,P14100|Q01061,PDE1A|PDE1B,PDE1A_BOVIN|PDE1B_BOVIN,6.74,,IC50,Inhibition of Phosphodiesterase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1339,,,,,,,Bos taurus
186828,2809,693,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Enzyme,O00408,PDE2A,PDE2A_HUMAN,5.51,,IC50,Inhibition of PDE2 (unknown origin) using FAM-cGMP and FAM-cAMP as substrate after 60 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1339,,,,Tclin,,,Homo sapiens
186829,2809,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,5.68,,IC50,Inhibition of human phosphodiesterase 3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1339,,,,Tclin|Tclin,,,Homo sapiens
186830,2809,418,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,Q9HCR9,PDE11A,PDE11_HUMAN,6.89,,IC50,Inhibition of human phosphodiesterase 11,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1339,,,,Tchem,,,Homo sapiens
186831,2809,446,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,Q9Y233,PDE10A,PDE10_HUMAN,6.1,,IC50,Inhibitory concentration against human phosphodiesterase 10,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1339,,,,Tclin,,,Homo sapiens
186837,528,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1618,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1618,INHIBITOR,,,,,Escherichia coli (strain K12)
186838,1580,548,Equilibrative nucleoside transporter 1,Transporter,Q99808,SLC29A1,S29A1_HUMAN,6.55,,Ki,Inhibition of ENT1 in human K562 cells by flow cytometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL92870,,,,Tclin,,,Homo sapiens
186839,1580,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.8,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL92870,,,,Tclin,,,Homo sapiens
186840,1580,2875,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P04774|P04775|P08104,Scn1a|Scn2a|Scn3a,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,7.11,,Ki,Inhibition of [3H]- batrachotoxin binding to sodium channel in rat neocortical membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL92870,,,,,,,Rattus norvegicus
186841,1423,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,5.51,,Kd,Binding constant for JNK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186842,1423,2514,Solute carrier family 22 member 3,Transporter,O75751,SLC22A3,S22A3_HUMAN,4.59,,IC50,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186843,1423,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,5.2,,Kd,Binding constant for FLT3(ITD) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186844,1423,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8.96,,Kd,Binding constant for ABL1-non phosphorylated kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,INHIBITOR,,Tclin,,,Homo sapiens
186845,1423,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.12,,Kd,"Binding constant for EGFR(L747-E749del, A750P) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186846,1423,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.52,,Ki,Inhibition of human carbonic anhydrase 2 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186847,1423,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,5.13,,Ki,Inhibition of mouse carbonic anhydrase 13 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,,,,Mus musculus
186848,1423,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.14,,IC50,Inhibition of P-glycoprotein expressed in A2780/ADR cells by calcein AM assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186849,1423,905,Mitogen-activated protein kinase 9,Kinase,P45984,MAPK9,MK09_HUMAN,5.28,,Kd,Average Binding Constant for JNK2; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186850,1423,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,4.59,,IC50,Inhibition of VEGFR2 by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186851,1423,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,4.51,,Ki,Inhibition of recombinant human c-Src,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186852,1423,2144,Proto-oncogene tyrosine-protein kinase Src,Kinase,P00523,SRC,SRC_CHICK,5.56,,IC50,Inhibition of chicken wild-type cSRC (251 to 533)-mediated phosphorylation of biotinylated poly-Glu-Tyr expressed in Escherichia coli BL21(DE3) preincubated for 30 to 60 mins prior to substrate addition by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,,,,Gallus gallus
186853,1423,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,7.51,,Kd,Binding constant for PDGFRA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186854,1423,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.38,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186855,1423,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,6,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186856,1423,2168,Mitogen-activated protein kinase kinase kinase MLT,Kinase,Q9NYL2,ZAK,MLTK_HUMAN,5.59,,Kd,Binding constant for ZAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186857,1423,2187,Maternal embryonic leucine zipper kinase,Kinase,Q14680,MELK,MELK_HUMAN,5.72,,Kd,Binding constant for full-length MELK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186858,1423,715,Tyrosine-protein kinase SYK,Kinase,P43405,SYK,KSYK_HUMAN,5.3,,IC50,Inhibition of recombinant Syk,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186859,1423,537,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,5.77,,Kd,Binding constant for RAF1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186860,1423,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,5.48,,Kd,Binding constant for BRAF(V600E) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186861,1423,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,5.62,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186862,1423,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,5.82,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186863,1423,870,Dual specificity protein kinase CLK1,Kinase,P49759,CLK1,CLK1_HUMAN,5.35,,Kd,Average Binding Constant for CLK1; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186864,1423,736,Ephrin type-A receptor 8,Kinase,P29322,EPHA8,EPHA8_HUMAN,5.85,,Kd,Binding constant for EPHA8 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186865,1423,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,5.11,,Kd,Binding constant for PLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186866,1423,2310,Tyrosine-protein kinase ABL1,Kinase,P00520,Abl1,ABL1_MOUSE,7.97,,IC50,Inhibition of mouse recombinant N-terminal His6-tagged Abl by radiometric kinase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,,,,Mus musculus
186867,1423,2202,Serine/threonine-protein kinase TNNI3K,Kinase,Q59H18,TNNI3K,TNI3K_HUMAN,5.37,,Kd,Binding constant for full-length TNNI3K,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186971,239,1896,Prothrombin,Enzyme,P00735,F2,THRB_BOVIN,8.02,,Ki,Inhibitory activity against thrombin.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1166,,,,,,,Bos taurus
186868,1423,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.85,,Kd,Binding constant for PDGFRB kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,INHIBITOR,,Tclin,,,Homo sapiens
186869,1423,2336,Homeodomain-interacting protein kinase 4,Kinase,Q8NE63,HIPK4,HIPK4_HUMAN,6.02,,Kd,Binding constant for HIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186870,1423,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,6.46,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186871,1423,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,7.4,,IC50,Inhibition of human MATE1-mediated [14]-metformin uptake expressed in polarized MDCK2 cells after 5 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186872,1423,2460,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,Kinase,Q8TBX8,PIP4K2C,PI42C_HUMAN,6.42,,Kd,Binding constant for PIP5K2C kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tbio,,,Homo sapiens
186873,1423,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.89,,Kd,Binding constant for KIT kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,INHIBITOR,,Tclin,,,Homo sapiens
186874,1423,822,Serine/threonine-protein kinase 17A,Kinase,Q9UEE5,STK17A,ST17A_HUMAN,5.55,,Kd,Average Binding Constant for STK17A; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186875,1423,902,Dual specificity protein kinase CLK4,Kinase,Q9HAZ1,CLK4,CLK4_HUMAN,5.68,,Kd,Binding constant for CLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186876,1423,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,5.06,,Kd,Binding constant for TYK2(JH2domain-pseudokinase) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186877,1423,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,5.92,,Kd,Binding constant for IRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186878,1423,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.05,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186879,1423,1583,Lysine--tRNA ligase,Enzyme,Q15046,KARS,SYK_HUMAN,5.3,,Ki,Inhibition of SYK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186880,1423,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,6.01,,Ki,Inhibition of human carbonic anhydrase 12 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186881,1423,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,8.22,,Kd,Binding affinity to human active site of N-terminal hexahistidine-tagged ABL2 expressed in Trichoplusia ni infected Sf9 cells by isothermal titration calorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186882,1423,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.34,,Ki,Inhibition of human carbonic anhydrase 4 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186883,1423,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,6.28,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186884,1423,665,Mitogen-activated protein kinase 8,Kinase,P45983,MAPK8,MK08_HUMAN,5.49,,Kd,Average Binding Constant for JNK1; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186885,1423,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.51,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186886,1423,2890,Tyrosine-protein kinase ABL,Kinase,P00519|P42684,ABL1|ABL2,ABL1_HUMAN|ABL2_HUMAN,7.4,,IC50,Inhibition of Abl tyrosine kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem|Tclin,,,Homo sapiens
186887,1423,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.96,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186888,1423,2205,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,7.82,,Kd,Binding constant for DDR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186889,1423,297,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,P16083,NQO2,NQO2_HUMAN,6.4,,IC50,Competitive inhibition of human recombinant NQO2-mediated mitomycin C metabolism using NADH as cosubstrate incubated for 5 mins prior to NADH addition measured after 30 mins by Michaelis-Menten plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186890,1423,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,9.15,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186891,1423,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,7.4,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186892,1423,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,6.28,,Ki,Inhibition of human carbonic anhydrase 3 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186893,1423,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,4.69,,Ki,Inhibition of human carbonic anhydrase 5A by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186894,1423,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,5.47,,IC50,Inhibition of BCRP expressed in MDCK cells by pheophorbide A assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186895,1423,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,6.33,,Ki,Inhibition of human carbonic anhydrase 14 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186896,1423,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,6.96,,Ki,Inhibition of human carbonic anhydrase 7 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186897,1423,2930,Bcr/Abl fusion protein,Kinase,P00519|P11274,ABL1|BCR,ABL1_HUMAN|BCR_HUMAN,7.85,,Ki,Inhibition of Bcr-Abl,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin|Tclin,,,Homo sapiens
186898,1423,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.12,,Ki,Inhibition of human carbonic anhydrase 9 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186899,1423,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.11,,Ki,Inhibition of mouse carbonic anhydrase 15 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,,,,Mus musculus
186900,1423,2235,Cyclin-dependent kinase 19,Kinase,Q9BWU1,CDK19,CDK19_HUMAN,5.26,,Kd,Binding constant for CDK11 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186901,1423,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,7.5,,Ki,Inhibition of human carbonic anhydrase 1 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186902,1423,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,4.77,,Ki,Inhibition of human carbonic anhydrase 5B by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186903,1423,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,6.41,,Ki,Inhibition of human carbonic anhydrase 6 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin,,,Homo sapiens
186904,1423,2814,Platelet-derived growth factor receptor,Kinase,P09619|P16234,PDGFRA|PDGFRB,PGFRA_HUMAN|PGFRB_HUMAN,7.3,,IC50,Inhibition of the platelet-derived growth factor receptor.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tclin|Tclin,,,Homo sapiens
186905,1423,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,4.86,,IC50,Inhibition of p38alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL941,,,,Tchem,,,Homo sapiens
186906,1314,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.13,,IC50,Inhibition of human ERG potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL472,,,,Tclin,,,Homo sapiens
186907,508,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1596,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1596,INHIBITOR,,,,,Escherichia coli (strain K12)
186908,1797,270,Voltage-dependent T-type calcium channel subunit alpha-1I,Ion channel,Q9P0X4,CACNA1I,CAC1I_HUMAN,6.9,,IC50,Inhibition of T-type calcium channel alpha1I by FLIPR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45816,,,,Tclin,,,Homo sapiens
186909,1797,204,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,6.7,,IC50,Inhibition of human Cav3.1 alpha1G expressed in HEK293 cells assessed as inhibition of calcium influx by FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45816,,,,Tclin,,,Homo sapiens
186910,1797,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.72,,Ki,Binding affinity at hERG expressed in HEK293 cells by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45816,,,,Tclin,,,Homo sapiens
186911,1797,843,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,Q00975,CACNA1B,CAC1B_HUMAN,5.87,,IC50,Inhibition of N-type calcium channel Alpha-1B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45816,,,,Tclin,,,Homo sapiens
186912,1996,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,5.6,,Ki,Displacement of [3H]CP-55940 from human recombinant CB1 receptor expressed in HEK293 cells by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247,,,,Tclin,,,Homo sapiens
186913,1996,1976,Fatty-acid amide hydrolase 1,Enzyme,P97612,Faah,FAAH1_RAT,8,,IC50,Inhibition of rat histidine tagged FAAH expressed in Escherichia coli by coumarin ester substrate fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247,,,,,,,Rattus norvegicus
186914,1996,2128,Monoacylglycerol lipase ABHD12,Enzyme,Q8N2K0,ABHD12,ABD12_HUMAN,7.1,,IC50,Inhibition of recombinant ABHD12 transfected in HEK293T cells by SDS-PAGE using rhodamine-tagged FP probe,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247,,,,Tchem,,,Homo sapiens
186915,1996,2126,Sn1-specific diacylglycerol lipase beta,Enzyme,Q8NCG7,DAGLB,DGLB_HUMAN,7.22,,IC50,Inhibition of human recombinant DAGLbeta overexpressed in african green monkey COS7 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247,,,,Tchem,,,Homo sapiens
186916,1996,834,Sn1-specific diacylglycerol lipase alpha,Enzyme,Q9Y4D2,DAGLA,DGLA_HUMAN,8,,IC50,Inhibition of human DAGLalpha expressed in HEK293T cell membrane using [14C]SAG substrate in detergent free solution by FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247,,,,Tchem,,,Homo sapiens
186917,1996,2423,Pancreatic triacylglycerol lipase,Enzyme,P00591,PNLIP,LIPP_PIG,6.66,,IC50,Inhibition of porcine pancreatic lipase using micellar solution of triolein as substrate preincubated for 5 mins before substrate addition measured after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247,,,,,,,Sus scrofa
186918,1996,2127,Abhydrolase domain-containing protein 16A,Enzyme,O95870,ABHD16A,ABHGA_HUMAN,7.52,,IC50,Inhibition of recombinant BAT5 transfected in HEK293T cells by SDS-PAGE using rhodamine-tagged FP probe,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247,,,,Tchem,,,Homo sapiens
186919,1996,2129,Platelet-activating factor acetylhydrolase,Enzyme,Q13093,PLA2G7,PAFA_HUMAN,7.3,,IC50,Inhibition of recombinant PLA2g7 transfected in HEK293T cells by SDS-PAGE using rhodamine-tagged FP probe,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247,,,,Tchem,,,Homo sapiens
186920,1996,2632,Gastric triacylglycerol lipase,Enzyme,P07098,LIPF,LIPG_HUMAN,,,,Mechanism of Action; CHEMBL1796; SINGLE PROTEIN,CHEMBL,,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175247,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020766s035lbl.pdf,INHIBITOR,,Tclin,,502,Homo sapiens
186922,351,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200376,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200376,AGONIST,,Tclin,,,Homo sapiens
186923,1827,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.59,,IC50,Inhibitory activity against angiotensin I converting enzyme (ACE),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1165,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1165,INHIBITOR,,Tclin,,,Homo sapiens
186924,1350,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.12,,Ki,Inhibition of human ERG expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1107,,,,Tclin,,,Homo sapiens
186925,1225,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,9.12,,EC50,Transactivation activity at glucocorticoid receptor in rat H4II-E cells assessed as induction of tyrosine amino transferase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1473,,,,,,,Rattus norvegicus
186926,1857,675,"Isoleucine--tRNA ligase, cytoplasmic",Enzyme,P41252,IARS,SYIC_HUMAN,9.1,,IC50,Compound was evaluated for inhibitory activity against Isoleucyl-tRNA synthetase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL719,,,,Tchem,,,Homo sapiens
186927,1857,2543,Isoleucine--tRNA ligase,Enzyme,Q99YW3,ileS,SYI_STRP1,,,,Mechanism of Action; CHEMBL2364671; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL719,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL719,INHIBITOR,,,,,Streptococcus pyogenes serotype M1
186928,88,652,Protein P,Polyprotein,Q9IF40,P,Q9IF40_HBV,,,,Mechanism of Action; CHEMBL2362994; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL484,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL484,INHIBITOR,,,,,Hepatitis B virus
186929,1170,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.67,,IC50,Inhibition of human ERG in MCF7 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL914,,,,Tclin,,,Homo sapiens
186930,150,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200732,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200732,AGONIST,,Tclin,,,Homo sapiens
186931,1365,2007,Butyrylcholinesterase,Enzyme,Q9N1N9,BCHE,Q9N1N9_HORSE,6.47,,Ki,Reversible mixed-type inhibition of horse serum butyrylcholinesterase using acetylcholine bromide as substrate assessed as free enzyme-inhibitor complex by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200933,,,,,,,Equus caballus
186932,1365,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,5.89,,Ki,Reversible mixed-type inhibition of electric eel acetylcholinesterase using acetylcholine bromide as substrate assessed as free enzyme-inhibitor complex by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200933,,,,,,,Electrophorus electricus
186933,1365,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,,,,Mechanism of Action; CHEMBL220; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200933,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200933,INHIBITOR,,Tclin,,,Homo sapiens
186934,353,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,8.28,,IC50,Competitive displacement of [3H]dexamethasone from glucocorticoid receptor of rat liver cytosol,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200384,,,,,,,Rattus norvegicus
186935,353,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200384,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200384,AGONIST,,Tclin,,,Homo sapiens
186936,924,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,6.28,,IC50,Inhibitory activity against cyclic GMP-phosphodiesterase (PDE V) isolated from porcine aorta.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin,,,Homo sapiens
186937,924,1891,Cyclic AMP-specific phosphodiesterase SSPDE4A1A,Enzyme,O77823,PDE4A,O77823_PIG,5.28,,IC50,"Inhibition of phosphodiesterase 4 (PDE4) from porcine liver, range 0.058-7.78",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,,,,,,,Sus scrofa
186938,924,3484,Protein prune homolog,Enzyme,Q86TP1,PRUNE,PRUNE_HUMAN,6.11,,IC50,Inhibition of human prune assessed as reduction of cAMP-phosphodiesterase activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,,,,Tchem,,,Homo sapiens
186939,924,548,Equilibrative nucleoside transporter 1,Transporter,Q99808,SLC29A1,S29A1_HUMAN,8.5,,Ki,GRAC: human ENT1 selective inhibitor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin,,,Homo sapiens
186940,924,2878,Phosphodiesterase 6,Enzyme,O43924|P16499|P18545|P35913|P51160|Q13956,PDE6A|PDE6B|PDE6C|PDE6D|PDE6G|PDE6H,CNCG_HUMAN|CNRG_HUMAN|PDE6A_HUMAN|PDE6B_HUMAN|PDE6C_HUMAN|PDE6D_HUMAN,6.9,,Ki,Inhibition of human phosphodiesterase 6,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
186941,924,831,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",Enzyme,Q9NP56,PDE7B,PDE7B_HUMAN,6,,IC50,GRAC: human PDE7B selective inhibitor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin,,,Homo sapiens
186942,924,2877,Phosphodiesterase 7,Enzyme,Q13946|Q9NP56,PDE7A|PDE7B,PDE7A_HUMAN|PDE7B_HUMAN,6.22,,Ki,Inhibition of human phosphodiesterase 7,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
186943,924,2903,Phosphodiesterase 1,Enzyme,P54750|Q01064|Q14123,PDE1A|PDE1B|PDE1C,PDE1A_HUMAN|PDE1B_HUMAN|PDE1C_HUMAN,4.35,,IC50,Inhibition of [Ca(2+)]/calmodulin dependent phosphodiesterase PDE 1 of guinea pig ventricle,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin|Tclin|Tclin,,,Homo sapiens
186944,924,693,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Enzyme,O00408,PDE2A,PDE2A_HUMAN,5.49,,IC50,"Inhibition of phosphodiesterase 2 (PDE2) from porcine platelets, range 2.54-4.14",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin,,,Homo sapiens
186945,924,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,4.37,,IC50,Inhibition of low Km cyclic cAMP phosphodiesterase PDE III of guinea pig ventricle,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
186946,924,1890,Cyclic nucleotide phosphodiesterase PDE3A,Enzyme,Q9XSW7,,Q9XSW7_PIG,4.36,,IC50,"Inhibition of phosphodiesterase 3 (PDE3) from porcine platelets, range 31.8-60.7",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,,,,,,,Sus scrofa
186947,924,418,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,Q9HCR9,PDE11A,PDE11_HUMAN,6.4,,Ki,Inhibition of human phosphodiesterase 11,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,,,,Tchem,,,Homo sapiens
186948,924,446,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,Q9Y233,PDE10A,PDE10_HUMAN,6,,Ki,Inhibitory activity against phosphodiesterase 10,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin,,,Homo sapiens
186949,924,845,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",Enzyme,O60658,PDE8A,PDE8A_HUMAN,5.1,,IC50,GRAC: human PDE8A selective inhibitor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,INHIBITOR,,Tclin,,,Homo sapiens
186950,597,2514,Solute carrier family 22 member 3,Transporter,O75751,SLC22A3,S22A3_HUMAN,6.39,,IC50,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790,,,,Tchem,,,Homo sapiens
186951,597,1634,Trypanothione reductase,Enzyme,P28593,TPR,TYTR_TRYCR,5.7,,Ki,"Inhibitory constant against recombinant Trypanosoma cruzi trypanothione reductase was determined photometrically at 25 degree C in TR assay buffer (40 mM Hepes, 1 mM EDTA, pH 7.5)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790,,,,,,,Trypanosoma cruzi
186952,597,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,6.68,,IC50,Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790,,,,Tchem,,,Homo sapiens
186953,597,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,6.4,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790,,,,Tchem,,,Homo sapiens
186954,597,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,5.12,,IC50,Inhibition of human neutrophils gelatinase B after 30 mins by fluorescence plate reader,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790,,,,Tchem,,,Homo sapiens
186955,597,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,6.3,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790,,,,Tchem,,,Homo sapiens
186956,597,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,6.15,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790,,,,Tchem,,,Homo sapiens
186957,597,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,5.12,,IC50,Inhibition of human rheumatoid synovial fibroblasts gelatinase A after 30 mins by fluorescence plate reader,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790,,,,Tchem,,,Homo sapiens
186958,200,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,10.4,,Ki,Inhibition of HIV protease,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL116,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL116,INHIBITOR,,,,,Human immunodeficiency virus 1
186959,200,730,Cathepsin D,Enzyme,P07339,CTSD,CATD_HUMAN,4.82,,IC50,Inhibition of human cathepsin D,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL116,,,,Tchem,,,Homo sapiens
186960,91,47,P2Y purinoceptor 1,GPCR,P49652,P2RY1,P2RY1_MELGA,5.55,,EC50,Activation of Purinoceptor P2Y1-mediated phospholipase C in turkey erythrocyte membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14249,,,,,,,Meleagris gallopavo
186961,91,2033,Endoplasmin,Membrane other,P41148,HSP90B1,ENPL_CANFA,5.49,,IC50,"Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from dog Grp94 after 24 hrs by fluorescence polarization assay",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14249,,,,,,,Canis familiaris
186962,91,3485,"Heat shock protein 75 kDa, mitochondrial",Unclassified,Q12931,TRAP1,TRAP1_HUMAN,4.5,,IC50,"Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from recombinant human Trap-1 after 24 hrs by fluorescence polarization assay",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14249,,,,Tchem,,,Homo sapiens
186963,91,904,P2Y purinoceptor 11,GPCR,Q96G91,P2RY11,P2Y11_HUMAN,5.17,,EC50,Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14249,,,,Tbio,,,Homo sapiens
186964,91,2043,MAP kinase-activated protein kinase 2,Kinase,P49137,MAPKAPK2,MAPK2_HUMAN,5.55,,IC50,Inhibition of human recombinant phospho-MK2 (36-400) by HTRF assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14249,,,,Tchem,,,Homo sapiens
186965,91,3598,Adenylate kinase 2,Unclassified,P29410,Ak2,KAD2_RAT,4.05,,Ki,"Inhibitory activity against rat adenylate kinase II was determined in the presence of ATP, non competitive inhibition",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14249,,,,,,,Rattus norvegicus
186966,91,600,P2Y purinoceptor 4,GPCR,P51582,P2RY4,P2RY4_HUMAN,6.2,,Ki,GRAC: human P2Y4 selective antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14249,,,,Tchem,,,Homo sapiens
186967,91,832,P2Y purinoceptor 1,GPCR,P47900,P2RY1,P2RY1_HUMAN,6.07,,EC50,Agonist activity at human GFP-tagged P2Y1R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14249,,,,Tchem,,,Homo sapiens
186968,3142,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201749,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201749,AGONIST,,Tclin,,,Homo sapiens
186969,239,662,Tissue-type plasminogen activator,Enzyme,P00750,PLAT,TPA_HUMAN,4.06,,Ki,Inhibition of human t-PA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1166,,,,Tclin,,,Homo sapiens
186970,239,1626,Cationic trypsin,Enzyme,P00760,,TRY1_BOVIN,5.54,,Ki,Inhibition of bovine trypsin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1166,,,,,,,Bos taurus
186973,566,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095930,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095930,INHIBITOR,,,,,Escherichia coli (strain K12)
186978,538,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201224,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201224,INHIBITOR,,,,,Escherichia coli (strain K12)
186979,62,703,Estradiol 17-beta-dehydrogenase 1,Enzyme,P14061,HSD17B1,DHB1_HUMAN,4.73,,IC50,Inhibition of human recombinant 17betaHSD1 expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL207413,,,,Tchem,,,Homo sapiens
186980,62,896,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,P28845,HSD11B1,DHI1_HUMAN,6.1,,IC50,Inhibition of human recombinant 11-beta-HSD1 expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL207413,,,,Tclin,,,Homo sapiens
186981,62,811,Corticosteroid 11-beta-dehydrogenase isozyme 2,Enzyme,P80365,HSD11B2,DHI2_HUMAN,6.7,,IC50,Inhibition of human recombinant 11-beta-HSD2 expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL207413,,,,Tchem,,,Homo sapiens
186982,62,707,Estradiol 17-beta-dehydrogenase 2,Enzyme,P37059,HSD17B2,DHB2_HUMAN,5.42,,IC50,Inhibition of human recombinant 17-beta-HSD2 expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL207413,,,,Tchem,,,Homo sapiens
186983,1635,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.76,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201187,,,,Tchem,,,Homo sapiens
186984,1635,510,C-C chemokine receptor type 5,GPCR,P51681,CCR5,CCR5_HUMAN,7.6,,Kd,Binding affinity to CCR5,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201187,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201187,ANTAGONIST,,Tclin,,,Homo sapiens
186985,1635,3616,C-C chemokine receptor type 5,GPCR,P61813,CCR5,CCR5_MACMU,9.62,,Ki,Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201187,,,,,,,Macaca mulatta
186986,2583,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,5.22,,Ki,Inhibition of ACE (unknown origin) assessed as 3-Hydroxybutyril-glycil-glycil-glycine conversion to 3-hydroxybutyric acid after 60 mins by WST assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1017,,,,Tclin,,,Homo sapiens
186987,2583,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.31,,IC50,"Displacement of [125I]Tyr4-Sar1,Ile8-Angiotensin II from human Angiotensin 1 receptor after 60 mins by scintillation counting",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1017,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1017,ANTAGONIST,,Tclin,,,Homo sapiens
186988,2583,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,5.82,,EC50,Partial agonist activity at human PPARgamma-LBD/Gal4 DNA binding domain by transactivation assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1017,,,,Tclin,,,Homo sapiens
186989,2583,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.75,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1017,,,,Tchem,,,Homo sapiens
186990,2583,1731,Type-1B angiotensin II receptor,GPCR,P29089,Agtr1b,AGTRB_RAT,8.52,,IC50,Inhibition of specific binding of [125I]angiotensin-II to angiotensin 1 receptor in rat lung membrane preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1017,,,,,,,Rattus norvegicus
186991,2583,862,Type-2 angiotensin II receptor,GPCR,P50052,AGTR2,AGTR2_HUMAN,9.48,,IC50,Displacement of [125I]Sar1 Ile8-Ang 2 from angiotensin 2 AT2 receptor after 180 mins by gamma counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1017,,,,Tchem,,,Homo sapiens
186992,2583,2071,Type-1A angiotensin II receptor,GPCR,P25095,Agtr1,AGTRA_RAT,9.64,,Ki,Displacement of [125I]SI-Ang2 from AT1 receptor in Sprague-Dawley rat liver membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1017,,,,,,,Rattus norvegicus
186999,2269,680,Arachidonate 15-lipoxygenase,Enzyme,P16050,ALOX15,LOX15_HUMAN,4.85,,IC50,Inhibition of 15-lipoxygenase by LMB assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608,,,,Tchem,,,Homo sapiens
187000,2269,945,ATP-binding cassette sub-family A member 1,Transporter,O95477,ABCA1,ABCA1_HUMAN,,,,Mechanism of Action; CHEMBL2362986; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608,INHIBITOR,,Tclin,,,Homo sapiens
187001,2187,2100,Beta-lactamase,Enzyme,A2RP81,blaPER-2,A2RP81_CITFR,6.7,,Ki,Inhibition of Citrobacter freundii PER2 beta lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL702,,,,,,,Citrobacter freundii
187002,2187,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL702,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL702,INHIBITOR,,,,,Escherichia coli (strain K12)
187003,321,2049,Baculoviral IAP repeat-containing protein 5,Unclassified,O15392,BIRC5,BIRC5_HUMAN,5.1,,Kd,Binding affinity to human survivin expressed in Escherichia coli BL21 cells after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL232201,,,,Tchem,,,Homo sapiens
187004,1328,861,Bcl-2-like protein 1,Cytosolic other,Q07817,BCL2L1,B2CL1_HUMAN,6.32,,Ki,Displacement of FAM-Bak from human Bcl-xL by FP assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,Tchem,,,Homo sapiens
187005,1328,3487,Kinesin-like protein 1,Unclassified,P52732,KIF11,KIF11_HUMAN,4.97,,IC50,Inhibition of human recombinant Eg5 ATPase activity expressed in Escherichia coli after 30 mins by malachite green-based spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,Tchem,,,Homo sapiens
187006,1328,1302,"Malate dehydrogenase, mitochondrial",Enzyme,P00346,MDH2,MDHM_PIG,5.55,,IC50,Inhibition of pig heart mitochondrial MDH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,,,,Sus scrofa
187007,1328,525,Apoptosis regulator Bcl-2,Cytosolic other,P10415,BCL2,BCL2_HUMAN,6.77,,Ki,Displacement of FAM-Bim peptide from human Bcl2 by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,Tclin,,,Homo sapiens
187008,1328,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,6.3,,Ki,The compound was tested for inhibitory activity against Aldose reductase from human placenta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,Tclin,,,Homo sapiens
187009,1328,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,4.34,,IC50,Inhibition of Escherichia coli AmpC beta lactamase using relaxed assay conditions in presence of 0.00001% Triton X-100 detergent,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,,,,Escherichia coli (strain K12)
187010,1328,2047,"Malate dehydrogenase, cytoplasmic",Enzyme,P11708,MDH1,MDHC_PIG,5.24,,IC50,Inhibition of pig cytosolic MDH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,,,,Sus scrofa
187011,1328,2046,Malate dehydrogenase,Enzyme,Q6VVP7,,Q6VVP7_PLAFA,5.69,,IC50,Inhibition of Plasmodium falciparum MDH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,,,,Plasmodium falciparum
187012,1328,2045,Lactate dehydrogenase,Enzyme,Q0PJ46,LDH,Q0PJ46_PLAFA,5.58,,IC50,Inhibition of Plasmodium falciparum LDH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,,,,Plasmodium falciparum
187013,1328,3486,Apoptosis regulator Bcl-W,Cytosolic other,Q92843,BCL2L2,B2CL2_HUMAN,4.75,,Ki,Displacement of Flu-Bak peptide from recombinant antiapoptotic Bcl-w protein by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,Tchem,,,Homo sapiens
187014,1328,859,Induced myeloid leukemia cell differentiation protein Mcl-1,Cytosolic other,Q07820,MCL1,MCL1_HUMAN,6.74,,Ki,Displacement of FAM-Bid from human Mcl1 by FP assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,Tchem,,,Homo sapiens
187015,2593,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,,,,Mechanism of Action; CHEMBL247; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1486,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1486,INHIBITOR,,,,,Human immunodeficiency virus 1
187016,544,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201046,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201046,INHIBITOR,,,,,Escherichia coli (strain K12)
187017,1066,424,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,4.2,,IC50,Inhibition of recombinant PTP1B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1756,,,,Tchem,,,Homo sapiens
187018,1066,3481,Protein-tyrosine phosphatase 1C,Enzyme,P29350,PTPN6,PTN6_HUMAN,4.39,,IC50,Inhibition of recombinant SHP1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1756,,,,Tchem,,,Homo sapiens
187019,1066,2404,Tyrosine-protein phosphatase non-receptor type 11,Enzyme,Q06124,PTPN11,PTN11_HUMAN,5.08,,Kd,Binding affinity to recombinant SHP2 by surface plasmon response,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1756,,,,Tchem,,,Homo sapiens
187020,1066,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,,,,Mechanism of Action; CHEMBL242; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1756,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1756,MODULATOR,,Tclin,,,Homo sapiens
187021,2080,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,7.21,,IC50,Inhibition of [3H]spiroperidol (0.5 nM) binding to dopamine receptor from rat striatal membrane.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL47050,,,,,,,Rattus norvegicus
187022,548,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1296,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1296,INHIBITOR,,,,,Escherichia coli (strain K12)
187023,786,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,5.72,,IC50,Inhibitory concentration against Clostridium histolyticum Collagenase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL178,,,,Tchem,,,Homo sapiens
187024,1617,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.09,,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38827,,,,Tclin,,,Homo sapiens
187025,1932,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,5.7,,Kd,Binding constant for JNK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187026,1932,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,4.4,,Kd,Binding affinity to human FLT3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187027,1932,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8.44,,Kd,Binding affinity to human ABL1,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,INHIBITOR,,Tclin,,,Homo sapiens
187028,1932,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,8.39,,Ki,Inhibition of human carbonic anhydrase 2 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187029,1932,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,5.33,,Ki,Inhibition of mouse carbonic anhydrase 13 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,,,,Mus musculus
187030,1932,905,Mitogen-activated protein kinase 9,Kinase,P45984,MAPK9,MK09_HUMAN,5.24,,Kd,Binding constant for JNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187031,1932,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.72,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187032,1932,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,7.13,,Kd,Binding affinity to human PDGFRalpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187033,1932,922,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,6.14,,Kd,Binding constant for EPHB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187034,1932,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,6.72,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187035,1932,2168,Mitogen-activated protein kinase kinase kinase MLT,Kinase,Q9NYL2,ZAK,MLTK_HUMAN,7.96,,Kd,Binding constant for ZAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187036,1932,537,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,5.41,,Kd,Binding constant for RAF1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187037,1932,2264,Ephrin type-A receptor 1,Kinase,P21709,EPHA1,EPHA1_HUMAN,6.23,,Kd,Binding constant for EPHA1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187038,1932,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,6.05,,Kd,Binding constant for HPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187039,1932,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,6.24,,Kd,Binding constant for BRAF(V600E) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187040,1932,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,6.49,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187041,1932,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,7.07,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187042,1932,870,Dual specificity protein kinase CLK1,Kinase,P49759,CLK1,CLK1_HUMAN,5.68,,Kd,Binding constant for CLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187043,1932,736,Ephrin type-A receptor 8,Kinase,P29322,EPHA8,EPHA8_HUMAN,7.43,,Kd,Binding constant for EPHA8 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187044,1932,536,Ephrin type-A receptor 2,Kinase,P29317,EPHA2,EPHA2_HUMAN,6.64,,Kd,Binding constant for EPHA2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187045,1932,853,Ephrin type-A receptor 3,Kinase,P29320,EPHA3,EPHA3_HUMAN,6.96,,Kd,Binding constant for EPHA3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187046,1932,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,5.17,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187047,1932,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,5.96,,Kd,Binding constant for YES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187048,1932,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,5.62,,Kd,Binding constant for CSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187049,1932,2353,Serine/threonine-protein kinase TAO1,Kinase,Q7L7X3,TAOK1,TAOK1_HUMAN,5.33,,Kd,Binding constant for TAOK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tbio,,,Homo sapiens
187050,1932,2202,Serine/threonine-protein kinase TNNI3K,Kinase,Q59H18,TNNI3K,TNI3K_HUMAN,6.44,,Kd,Binding constant for TNNI3K kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187051,1932,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,6.41,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187052,1932,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.8,,Kd,Binding affinity to human PDGFRbeata,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187053,1932,2460,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,Kinase,Q8TBX8,PIP4K2C,PI42C_HUMAN,5.06,,Kd,Binding constant for PIP5K2C kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tbio,,,Homo sapiens
187054,1932,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.77,,Kd,Binding affinity to human c-Kit,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187055,1932,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,6.19,,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187056,1932,902,Dual specificity protein kinase CLK4,Kinase,Q9HAZ1,CLK4,CLK4_HUMAN,5.15,,Kd,Binding constant for CLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187057,1932,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,7,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187058,1932,802,Ephrin type-A receptor 5,Kinase,P54756,EPHA5,EPHA5_HUMAN,5.72,,Kd,Binding constant for EPHA5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187059,1932,803,Ephrin type-A receptor 4,Kinase,P54764,EPHA4,EPHA4_HUMAN,6.48,,Kd,Binding constant for EPHA4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187060,1932,890,Ephrin type-B receptor 1,Kinase,P54762,EPHB1,EPHB1_HUMAN,5.89,,Kd,Binding constant for EPHB1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187061,1932,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,6.22,,Kd,Binding constant for TRKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187062,1932,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,6.52,,Ki,Inhibition of human carbonic anhydrase 12 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187063,1932,2242,Serine/threonine-protein kinase MRCK beta,Kinase,Q9Y5S2,CDC42BPB,MRCKB_HUMAN,6.04,,Kd,Binding constant for MRCKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tbio,,,Homo sapiens
187064,1932,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,7.59,,Kd,Binding constant for ABL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187065,1932,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.35,,Ki,Inhibition of human carbonic anhydrase 4 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187066,1932,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,6.3,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187067,1932,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,6,,Kd,Binding constant for TIE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187068,1932,2466,Calcium-dependent protein kinase 1,Kinase,P62344,CPK1,CDPK1_PLAF7,6.1,,Kd,Binding constant for PFCDPK1(P.falciparum) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,,,,Plasmodium falciparum
187069,1932,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,6.3,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187070,1932,665,Mitogen-activated protein kinase 8,Kinase,P45983,MAPK8,MK08_HUMAN,6.35,,Kd,Binding constant for JNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187071,1932,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,5.77,,Kd,Binding constant for TAOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tbio,,,Homo sapiens
187072,1932,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.8,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187073,1932,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.35,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187074,1932,2205,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,8.22,,Kd,Binding affinity to wild type DDR2 (unknown origin) by FLiK assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187075,1932,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,6,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187076,1932,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.06,,Kd,Binding constant for RET kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187077,1932,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,8.96,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187078,1932,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,7.33,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187079,1932,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,6.35,,Ki,Inhibition of human carbonic anhydrase 3 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187080,1932,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,6.31,,Kd,Binding constant for TRKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187081,1932,2083,Ephrin type-B receptor 2,Kinase,P29323,EPHB2,EPHB2_HUMAN,6.19,,Kd,Binding constant for EPHB2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187082,1932,799,Mitogen-activated protein kinase 11,Kinase,Q15759,MAPK11,MK11_HUMAN,7.44,,Kd,Binding constant for p38-beta kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187083,1932,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,5.26,,Ki,Inhibition of human carbonic anhydrase 5A by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187084,1932,2267,Ephrin type-B receptor 3,Kinase,P54753,EPHB3,EPHB3_HUMAN,6,,Kd,Binding constant for EPHB3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187085,1932,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,6.65,,Ki,Inhibition of human carbonic anhydrase 14 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187086,1932,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,7,,Ki,Inhibition of human carbonic anhydrase 7 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187087,1932,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,7.38,,Ki,Inhibition of human carbonic anhydrase 9 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187088,1932,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,7.1,,Ki,Inhibition of mouse carbonic anhydrase 15 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,,,,Mus musculus
187089,1932,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,7.53,,Ki,Inhibition of human carbonic anhydrase 1 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187090,1932,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,4.83,,Ki,Inhibition of human carbonic anhydrase 5B by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187091,1932,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,6.34,,Ki,Inhibition of human carbonic anhydrase 6 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin,,,Homo sapiens
187092,1932,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,6.34,,Kd,Binding constant for p38-alpha kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tchem,,,Homo sapiens
187093,1527,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,6.4,,Ki,Inhibition of human recombinant aromatase assessed as conversion of O-dibenzylfluorescein benzyl ester substrate to fluorescein byproduct by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,Tclin,,,Homo sapiens
187731,4187,536,Ephrin type-A receptor 2,Kinase,P29317,EPHA2,EPHA2_HUMAN,7,,Kd,Binding constant for EPHA2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187094,1527,3617,Cytochrome P450 11A1,Enzyme,P14137,Cyp11a1,CP11A_RAT,5.91,,IC50,Inhibition of cholesterol side chain cleavage cytochrome P450,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,,,,Rattus norvegicus
187095,1527,3618,Cytochrome P450 24A1,Enzyme,Q09128,Cyp24a1,CP24A_RAT,4.7,,IC50,Inhibitory activity against 25-hydroxyvitamin D3 24-hydroxylase of rat kidney mitochondria,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,,,,Rattus norvegicus
187096,1527,1962,Gonadotropin-releasing hormone receptor,GPCR,P30969,Gnrhr,GNRHR_RAT,9.66,,Kd,"Dissociation constant was determined in vitro using rat pituitary membranes and [125I]-leuprolide as radioligand, at concentration 3.16*10e-6 M",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,,,,Rattus norvegicus
187097,1527,3619,Cytochrome P450 7A1,Enzyme,P18125,Cyp7a1,CP7A1_RAT,6.71,,IC50,Inhibition of cytochrome P450 Cholesterol 7-alpha-hydroxylase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,,,,Rattus norvegicus
187098,1527,3620,Cytochrome P450 51,Enzyme,Q64654,Cyp51a1,CP51A_RAT,7.19,,Ki,Inhibition of lanosterol 14-alpha-demethylase of rat hepatic microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,,,,Rattus norvegicus
187099,1527,3549,Cytochrome P450 11B1,Unclassified,P15150,CYP11B1,C11B1_BOVIN,6.82,,IC50,Inhibition of Corticoid 11-beta-hydroxylase cytochrome P450,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,,,,Bos taurus
187100,1527,3488,Cytochrome P450 21,Enzyme,P08686,CYP21A2,CP21A_HUMAN,5.05,,IC50,Inhibition of Progesterone 21-hydroxylase cytochrome P450 21,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,Tbio,,,Homo sapiens
187101,1527,3621,Cytochrome P450 17A1,Enzyme,P11715,Cyp17a1,CP17A_RAT,6.69,,IC50,"Inhibition of 17,20-lyase activity of rat testicular microsomal P450-17alpha",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,,,,Rattus norvegicus
187102,2599,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,5.52,,IC50,Inhibition of human CYP51 expressed in Topp 3 cells by lanosterol demethylase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1306,,,,Tchem,,,Homo sapiens
187103,230,932,Neuromedin-K receptor,GPCR,P29371,TACR3,NK3R_HUMAN,6.34,,Ki,Displacement of [3H]osanetant from wild type human NK3 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1471,,,,Tchem,,,Homo sapiens
187104,230,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,10.7,,Ki,GRAC: human NK1 selective antagonist,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1471,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1471,ANTAGONIST,,Tclin,,,Homo sapiens
187105,146,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,9.92,,IC50,Inhibition of bovine AChE by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1652,,,,,,,Bos taurus
187106,146,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,4.34,,Kd,Binding affinity to mouse AChE by equilibrium binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1652,,,,,,,Mus musculus
187107,146,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,,,,Mechanism of Action; CHEMBL220; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1652,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1652,INHIBITOR,,Tclin,,,Homo sapiens
187108,1795,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1731,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1731,INHIBITOR,,,,,Escherichia coli (strain K12)
187109,4119,3622,Histone deacetylase 6,Unclassified,Q9Z2V5,Hdac6,HDAC6_MOUSE,6.41,,IC50,Inhibition of mouse HDAC6 using Ac-KGLGK(Ac)-MCA as substrate after 30 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL343448,,,,,,,Mus musculus
187110,542,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1601,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1601,INHIBITOR,,,,,Escherichia coli (strain K12)
187111,1030,1988,NS3,Enzyme,A3EZI9,NS3,A3EZI9_9HEPC,6.12,,IC50,Inhibitory concentration against hepatitis C virus helicase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL417,,,,,,,Hepatitis C virus
187112,960,728,Telomerase reverse transcriptase,Enzyme,O14746,TERT,TERT_HUMAN,4.14,,IC50,Inhibition of telomerase from human COLO201 cell,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,,,,Tchem,,,Homo sapiens
187113,960,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,6,,IC50,Inhibition human placenta topoisomerase 2 assessed as conversion of supercoiled pBR322 DNA to relaxed form,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,INHIBITOR,,Tclin,,,Homo sapiens
187114,960,596,DNA topoisomerase 1,Enzyme,P11387,TOP1,TOP1_HUMAN,4.7,,IC50,Inhibition of human topoisomerase 1 assessed as decrease in pBR322 mobility on agarose gel by electrophoresis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,,,,Tclin,,,Homo sapiens
187115,960,3623,Type-2 restriction enzyme HindIII,Unclassified,P43870,hindIIIR,T2D3_HAEIN,4.02,,IC50,Inhibition of Haemophilus influenzae Hind 3 assessed as undigested supercoiled pBR322 DNA concentration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,,,,,,,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)
187116,960,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,7.4,,IC50,Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,,,,Tchem,,,Homo sapiens
187117,960,3624,Type-2 restriction enzyme ScaI,Unclassified,O52691,scaIR,T2S1_STRCS,4.6,,IC50,Inhibition of Streptomyces caespitosus Sca 1 assessed as undigested supercoiled pBR322 DNA concentration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,,,,,,,Streptomyces caespitosus
187118,960,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,5.96,,IC50,Inhibitory concentration against Clostridium histolyticum Collagenase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,,,,Tchem,,,Homo sapiens
187119,960,1507,Ribonuclease pancreatic,Enzyme,P61823,RNASE1,RNAS1_BOVIN,4.6,,IC50,Inhibition of bovine pancreas RNase A assessed as undigested supercoiled pBR322 DNA concentration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,,,,,,,Bos taurus
187120,960,1741,Integrase,Enzyme,Q7ZJM1,pol,Q7ZJM1_9HIV1,6.05,,IC50,"Inhibition of HIV-1 integrase, under 1 uM for the 3''-preprocessing",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,,,,,,,Human immunodeficiency virus 1
187121,392,1807,Endothelin-1 receptor,GPCR,P26684,Ednra,EDNRA_RAT,8.19,,Ki,Binding affinity towards Endothelin A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL957,,,,,,,Rattus norvegicus
187122,392,1844,Endothelin-1 receptor,GPCR,Q29010,EDNRA,EDNRA_PIG,8.12,,IC50,In vitro inhibition of [125 I]ET-1 binding to Endothelin A receptor in porcine aortic membrane.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL957,,,,,,,Sus scrofa
187123,392,457,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,8.19,,Ki,Ability to displace endothelin ([125I]ET1) from human Endothelin A receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL957,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL957,ANTAGONIST,,Tclin,,,Homo sapiens
187124,392,458,Endothelin B receptor,GPCR,P24530,EDNRB,EDNRB_HUMAN,7.1,,Ki,Inhibitory activity against human endothelin B receptor expressed in CHO cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL957,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL957,ANTAGONIST,,Tclin,,,Homo sapiens
187125,119,778,Renin,Enzyme,Q9TSZ1,REN,RENI_CALJA,8.7,,IC50,Inhibition of renin in marmoset plasma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1639,,,,,,,Callithrix jacchus
187126,119,2396,Renin,Enzyme,Q7M3D2,,Q7M3D2_RABIT,7.96,,IC50,Inhibition of rabbit renin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1639,,,,,,,Oryctolagus cuniculus
187127,119,779,Renin,Enzyme,Q6DLS0,REN,RENI_MACFA,8.1,,IC50,Inhibition of cynomolgus monkey plasma renin activity after 60 mins by competitive RIA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1639,,,,,,,Macaca fascicularis
187128,119,2395,Renin-1,Enzyme,P06281,Ren1,RENI1_MOUSE,8.35,,IC50,Inhibition of mouse renin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1639,,,,,,,Mus musculus
187129,119,2394,Renin,Enzyme,P08424,Ren1,RENI_RAT,7.1,,IC50,Inhibition of rat renin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1639,,,,,,,Rattus norvegicus
187130,2811,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.46,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200629,,,,Tchem,,,Homo sapiens
187131,2811,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.6,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200629,,,,Tchem,,,Homo sapiens
187132,2811,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.72,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200629,,,,Tchem,,,Homo sapiens
187133,102,2749,Topoisomerase IV,Enzyme,P0AFI2|P20083,parC|parE,PARC_ECOLI|PARE_ECOLI,,,,Mechanism of Action; CHEMBL2363076; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200498,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200498,INHIBITOR,,,,,Escherichia coli (strain K12)
187134,102,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,,,,Mechanism of Action; CHEMBL2311224; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200498,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200498,INHIBITOR,,,,,Escherichia coli (strain K12)
187135,257,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.29,,IC50,Inhibition of CYP3A4 in human liver microsome,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1487,,,,Tclin,,,Homo sapiens
187136,257,630,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,4.84,,IC50,Inhibition of recombinant HDAC6 (unknown origin) after 10 mins by fluorimetric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1487,,,,Tclin,,,Homo sapiens
187137,257,606,Histone deacetylase 1,Enzyme,Q13547,HDAC1,HDAC1_HUMAN,4.93,,IC50,Inhibition of recombinant HDAC1 (unknown origin) after 10 mins by fluorimetric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1487,,,,Tclin,,,Homo sapiens
187138,257,598,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,4.65,,IC50,Inhibition of recombinant HDAC2 (unknown origin) after 10 mins by fluorimetric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1487,,,,Tclin,,,Homo sapiens
187139,257,1796,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P51639,Hmgcr,HMDH_RAT,8.42,,IC50,Inhibition of rat microsomal HMGCoA reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1487,,,,,,,Rattus norvegicus
187140,792,2390,Hypoxia-inducible factor 1-alpha,Transcription factor,Q16665,HIF1A,HIF1A_HUMAN,4.75,,EC50,Activation of human HIF1alpha expressed in DFX-induced human U2OS cells incubated for 30 mins prior to DFX-induction measured after overnight incubation by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL556,,,,Tchem,,,Homo sapiens
187141,1245,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,9,,IC50,Inhibitory activity against angiotensin I converting enzyme (ACE),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL581,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL581,INHIBITOR,,Tclin,,,Homo sapiens
187142,1893,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.7,,IC50,Inhibition of human MDR1-dependent accumulation of calcein-AM expressed in MDCK2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL584,,,,Tchem,,,Homo sapiens
187143,1893,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,11,,Ki,Inhibition of HIV protease,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL584,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL584,INHIBITOR,,,,,Human immunodeficiency virus 1
187144,493,896,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,P28845,HSD11B1,DHI1_HUMAN,7.08,,IC50,Ability to convert [3H]cortisol to the tritium labeled cortisone in the presence of human 11 beta hydroxysteroid dehydrogenase type 2,CHEMBL,=,1,KEGG DRUG,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499915,http://www.kegg.jp/entry/D01899,INHIBITOR,,Tclin,,,Homo sapiens
187145,493,2086,Corticosteroid 11-beta-dehydrogenase isozyme 2,Enzyme,P51661,Hsd11b2,DHI2_MOUSE,7.09,,IC50,Inhibition of mouse microsomal 11beta-HSD2 expressed in HEK293 cells assessed as conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499915,,,,,,,Mus musculus
187146,493,2058,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,P50172,Hsd11b1,DHI1_MOUSE,6.97,,IC50,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499915,,,,,,,Mus musculus
187147,547,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL474579,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL474579,INHIBITOR,,,,,Escherichia coli (strain K12)
187148,2855,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.01,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL603,,,,Tchem,,,Homo sapiens
187149,2855,1726,Cysteinyl leukotriene receptor 1,GPCR,Q2NNR5,CYSLTR1,CLTR1_CAVPO,9.52,,Ki,Displacement of [3H]LTD4 on guinea pig lung parenchymal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL603,,,,,,,Cavia porcellus
187150,2855,343,Cysteinyl leukotriene receptor 1,GPCR,Q9Y271,CYSLTR1,CLTR1_HUMAN,9.5,,Ki,GRAC: human CysLT1 selective antagonist,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL603,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL603,ANTAGONIST,,Tclin,,,Homo sapiens
187151,2855,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,5.12,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL603,,,,Tchem,,,Homo sapiens
187152,2855,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.89,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL603,,,,Tchem,,,Homo sapiens
187153,2855,377,Cytosolic phospholipase A2,Enzyme,P47712,PLA2G4A,PA24A_HUMAN,4.07,,IC50,In vitro inhibition of cystolic phospholipase A2 alpha.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL603,,,,Tchem,,,Homo sapiens
187154,810,320,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,,,,Mechanism of Action; CHEMBL1893; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200515,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200515,INHIBITOR,,Tclin,,,Homo sapiens
187155,1548,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,4.64,,IC50,Inhibition of ABL1 by flash plate based radioactive enzyme assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tclin,,,Homo sapiens
187156,1548,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,9.04,,Kd,Binding constant for EGFR(G719C) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,INHIBITOR,,Tclin,,,Homo sapiens
187157,1548,2268,Tubulin alpha-1A chain,Structural,P68370,Tuba1a,TBA1A_RAT,7.27,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,,,,Rattus norvegicus
187158,1548,2372,Phosphatidylinositol 4-kinase beta,Kinase,Q9UBF8,PI4KB,PI4KB_HUMAN,6.03,,Kd,Binding constant for PIK4CB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tchem,,,Homo sapiens
187159,1548,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,4.77,,IC50,Inhibition of INSR by flash plate based radioactive enzyme assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,AGONIST,,Tclin,,,Homo sapiens
187160,1548,887,Receptor-interacting serine/threonine-protein kinase 2,Kinase,O43353,RIPK2,RIPK2_HUMAN,5.44,,Kd,Binding constant for RIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tchem,,,Homo sapiens
187161,1548,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,5.96,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tchem,,,Homo sapiens
187162,1548,2371,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma,Kinase,O75747,PIK3C2G,P3C2G_HUMAN,5.12,,Kd,Binding constant for PIK3C2G kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tbio,,,Homo sapiens
187163,1548,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,5.59,,Kd,Average Binding Constant for STK10; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tchem,,,Homo sapiens
187164,1548,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,8.15,,Kd,Binding constant for ERBB2 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,INHIBITOR,,Tclin,,,Homo sapiens
187165,1548,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,5.07,,IC50,Inhibition of PDGFRbeta by flash plate based radioactive enzyme assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tclin,,,Homo sapiens
187166,1548,2370,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,Kinase,O00750,PIK3C2B,P3C2B_HUMAN,6.17,,Kd,Binding constant for PIK3C2B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tchem,,,Homo sapiens
187167,1548,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,7.27,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tclin,,,Homo sapiens
187168,1548,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,5.48,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tchem,,,Homo sapiens
187169,1548,597,Cyclin-dependent kinase 2,Kinase,P24941,CDK2,CDK2_HUMAN,4.96,,IC50,Inhibition of CDK2 by flash plate based radioactive enzyme assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tchem,,,Homo sapiens
187170,1548,1317,Dual specificity mitogen-activated protein kinase kinase 7,Kinase,O14733,MAP2K7,MP2K7_HUMAN,5.36,,Kd,Binding constant for MKK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tbio,,,Homo sapiens
187171,1548,2368,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,5.26,,Kd,Binding constant for ERBB3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554,,,,Tchem,,,Homo sapiens
187732,4187,853,Ephrin type-A receptor 3,Kinase,P29320,EPHA3,EPHA3_HUMAN,6.15,,Kd,Binding constant for EPHA3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187172,1043,3489,Cholecystokinin A receptor,GPCR,O08786,Cckar,CCKAR_MOUSE,4.47,,IC50,Concentration of compound required to inhibit binding of [125I]J-BH-CCK-8 radioligand to CCKA in mouse pancreatic membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442,,,,,,,Mus musculus
187173,1043,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,8.68,,Ki,Displacement of [3H]carboxytryptamine from recombinant human 5-HT1B receptor expressed in HEK cells by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442,,,,Tclin,,,Homo sapiens
187174,1043,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,9.1,,Ki,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1D receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442,AGONIST,,Tclin,,,Homo sapiens
187175,1043,3625,Adenylate cyclase,Unclassified,O32393,cyaC,O32393_ARTPT,4.15,,IC50,Inhibition of Spirulina platensis adenylyl cyclase assessed as cAMP level by cAMP immunogenic assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442,,,,,,,Arthrospira platensis
187176,1043,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,7.85,,Ki,Displacement of [3H]LSD from 5-HT5A receptor after 1.5 hrs by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442,,,,Tchem,,,Homo sapiens
187177,1043,1848,Gastrin/cholecystokinin type B receptor,GPCR,P56481,Cckbr,GASR_MOUSE,4.77,,IC50,Concentration of compound required to inhibit binding of [125I]J-BH-CCK-8 radioligand to CCKB in mouse fore brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442,,,,,,,Mus musculus
187178,888,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.3,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1732,,,,Tchem,,,Homo sapiens
187179,888,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.43,,IC50,Inhibition of specific [3H]clonidine binding (0.4 nM) to rat brain membranes alpha-2 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1732,,,,,,,Rattus norvegicus
187180,888,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.9,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1732,,,,Tchem,,,Homo sapiens
187181,888,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.55,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1732,,,,Tchem,,,Homo sapiens
187182,888,1848,Gastrin/cholecystokinin type B receptor,GPCR,P56481,Cckbr,GASR_MOUSE,4.64,,IC50,Concentration of compound required to inhibit binding of [125I]J-BH-CCK-8 radioligand to CCKB in mouse fore brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1732,,,,,,,Mus musculus
187183,1240,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,,,,Mechanism of Action; CHEMBL243; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1664,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1664,INHIBITOR,,,,,Human immunodeficiency virus 1
187184,1836,1726,Cysteinyl leukotriene receptor 1,GPCR,Q2NNR5,CYSLTR1,CLTR1_CAVPO,9.3,,Ki,Binding affinity towards Cysteinyl leukotriene D4 receptor (cysLT1) was measured by the displacement of [3H]LTD4 radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL787,,,,,,,Cavia porcellus
187185,1836,3088,Uracil nucleotide/cysteinyl leukotriene receptor,GPCR,Q13304,GPR17,GPR17_HUMAN,5.18,,Ki,Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes after 60 mins by heterologous competition binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL787,,,,Tchem,,,Homo sapiens
187186,1836,343,Cysteinyl leukotriene receptor 1,GPCR,Q9Y271,CYSLTR1,CLTR1_HUMAN,9.3,,Ki,GRAC: human CysLT1 selective antagonist,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL787,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL787,ANTAGONIST,,Tclin,,,Homo sapiens
187188,1482,2514,Solute carrier family 22 member 3,Transporter,O75751,SLC22A3,S22A3_HUMAN,4.13,,IC50,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL481,,,,Tchem,,,Homo sapiens
187189,1482,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.68,,IC50,Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL481,,,,Tchem,,,Homo sapiens
187190,1482,955,Acetylcholinesterase,Enzyme,P04058,ache,ACES_TORCA,7.58,,Ki,Inhibition of Torpedo californica AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL481,,,,,,,Torpedo californica
187191,1482,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.57,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL481,,,,Tchem,,,Homo sapiens
187192,1482,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,7.3,,Ki,Inhibition of human AChE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL481,,,,Tclin,,,Homo sapiens
187193,1482,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,5.1,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL481,,,,Tchem,,,Homo sapiens
187194,1482,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.68,,IC50,Inhibition of human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells after 1.5 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL481,,,,Tchem,,,Homo sapiens
187195,1213,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,,,,Mechanism of Action; CHEMBL217; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200854,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200854,ANTAGONIST,,Tclin,,,Homo sapiens
187196,1370,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.85,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127300,,,,Tclin|Tclin|Tclin,,,Homo sapiens
187197,3520,2744,Muscle-type nicotinic acetylcholine receptor,Ion channel,P02708|P07510|P11230|Q04844|Q07001,CHRNA1|CHRNB1|CHRND|CHRNE|CHRNG,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN|ACHE_HUMAN|ACHG_HUMAN,,,,Mechanism of Action; CHEMBL2362997; PROTEIN COMPLEX GROUP,CHEMBL,,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200549,http://www.ncbi.nlm.nih.gov/pubmed/8680742,ANTAGONIST,,Tclin|Tclin|Tclin|Tclin|Tclin,,497,Homo sapiens
187198,3609,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,7.52,,IC50,Tested for inhibition of HIV protease,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222559,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222559,INHIBITOR,,,,,Human immunodeficiency virus 1
187199,3609,730,Cathepsin D,Enzyme,P07339,CTSD,CATD_HUMAN,4.82,,Ki,Compound was tested for inhibition human Cathepsin D,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222559,,,,Tchem,,,Homo sapiens
187200,3609,2565,Pepsin A-5,Enzyme,P0DJD9,PGA5,PEPA5_HUMAN,5.7,,Ki,Inhibition of human pepsin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222559,,,,Tclin,,,Homo sapiens
187201,3609,2502,Cathepsin E,Enzyme,P14091,CTSE,CATE_HUMAN,5.05,,Ki,Compound was tested for inhibition human Cathepsin E,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222559,,,,Tchem,,,Homo sapiens
187202,3609,2067,CAAX prenyl protease 1 homolog,Enzyme,Q80W54,Zmpste24,FACE1_MOUSE,5.92,,IC50,Inhibition of mouse ZMPSTE24 expressed n delta ste24 delta rce1 yeast,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222559,,,,,,,Mus musculus
187206,893,548,Equilibrative nucleoside transporter 1,Transporter,Q99808,SLC29A1,S29A1_HUMAN,9,,Ki,GRAC: human ENT1 selective inhibitor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL126075,,,,Tclin,,,Homo sapiens
187207,893,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,6.22,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL126075,,,,Tclin|Tclin|Tclin,,,Homo sapiens
187209,1255,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,5.71,,EC50,Agonist activity at PXR (unknown origin) expressed in human HepG2 cells assessed as induction of CYP3A4 transactivation after 16 hrs by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358,,,,Tchem,,,Homo sapiens
187210,1255,1990,Estrogen receptor,Transcription factor,P06211,Esr1,ESR1_RAT,8.23,,IC50,Displacement of [3H]estradiol from rat uterine cytosolic estrogen receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358,,,,,,,Rattus norvegicus
187211,1255,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,6.1,,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358,,,,Tclin,,,Homo sapiens
187212,1255,1250,Bifunctional epoxide hydrolase 2,Enzyme,P34913,EPHX2,HYES_HUMAN,7.59,,Ki,Competitive inhibition of human recombinant soluble epoxide hydrolase using [3H]-tDPPO as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358,,,,Tchem,,,Homo sapiens
187213,1255,752,Steroid hormone receptor ERR1,Nuclear hormone receptor,P11474,ESRRA,ERR1_HUMAN,8.7,,IC50,Antagonist activity at ERalpha receptor in human MCF7 cells assessed as inhibition of cell growth after 6 days by crystal violet staining method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358,,,,Tchem,,,Homo sapiens
187214,2370,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,7,,Ki,Concentration giving half of the maximal ATPase activity calculated for the high-affinity binding site of the CHO P-Glycoprotein (P-gp) in two-affinity model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL772,,,,Tchem,,,Homo sapiens
187215,2370,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.8,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL772,,,,Tclin|Tclin|Tclin,,,Homo sapiens
187216,2370,2440,Quinolone resistance protein NorA,Transporter,P0A0J7,norA,NORA_STAAU,5.15,,IC50,Inhibition of NorA in Staphylococcus aureus 1199B assessed as inhibition of ethidium bromide efflux dose response curve based fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL772,,,,,,,Staphylococcus aureus
187217,2370,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,4.58,,IC50,Inhibition of ABCG2 in human mitoxantrone-resistant MCF7 cells by Hoechst 33342 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL772,,,,Tchem,,,Homo sapiens
187218,2370,2057,Synaptic vesicular amine transporter,Transporter,Q27963,SLC18A2,VMAT2_BOVIN,9,,Ki,Inhibition of dopamine uptake at VMAT in bovine chromaffin granule ghosts,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL772,,,,,,,Bos taurus
187219,837,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.05,,Ki,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,Tclin,,,Homo sapiens
187220,837,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.77,,Ki,Ability to displace [3H]prazosin from cloned human Alpha-1D adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,Tclin,,,Homo sapiens
187221,837,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,10,,Ki,GRAC: human a1A selective antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,Tclin,,,Homo sapiens
187222,837,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,7.25,,Ki,Ability to displace [3H]prazosin from cloned human Alpha-1B adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,Tclin,,,Homo sapiens
187223,837,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.18,,Ki,Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,Tclin,,,Homo sapiens
187224,837,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.35,,Ki,Ability to displace [3H]rauwolscine from cloned human Alpha-2C adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,Tclin,,,Homo sapiens
187225,837,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.72,,Ki,Displacement of [125 I]AB-MECA from human Adenosine A3 receptor expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,Tchem,,,Homo sapiens
187226,837,2874,Voltage-gated L-type calcium channel,Ion channel,P22002|P27732|Q02485,Cacna1c|Cacna1d|Cacna1s,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,7.22,,Ki,Inhibition of [3H]-isradipine binding to L-type [Ca2+] channel of rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,,,,Rattus norvegicus
187227,837,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,4.38,,Ki,Displacement of [3H]R-PIA from Adenosine A1 receptor of rat brain membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,,,,Rattus norvegicus
187229,2781,1928,Small conductance calcium-activated potassium channel protein 3,Ion channel,P70605,Kcnn3,KCNN3_RAT,5.04,,Ki,Displacement of [I125]apamine from Wistar rat recombinant SK3 channel expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,,,,Rattus norvegicus
187230,2781,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.1,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,Tchem,,,Homo sapiens
187231,2781,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,4.24,,IC50,Displacement of [3H]GABA from gamma-aminobutyric-acid A (GABA-A) receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
187232,2781,2583,Acetylcholine receptor subunit alpha,Ion channel,P02710,CHRNA1,ACHA_TORCA,5.22,,IC50,Displacement of [3H]PCP from nAChR in Torpedo nobiliana electric organs membranes in presence of 100 uM carbachol by scintillation counting method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,,,,Torpedo californica
187233,2781,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.26,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,Tchem,,,Homo sapiens
187234,2781,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.03,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,Tchem,,,Homo sapiens
187235,2781,1929,Zinc-activated ligand-gated ion channel,Ion channel,Q401N2,ZACN,ZACN_HUMAN,5.2,,IC50,GRAC: human ZAC selective agonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,Tchem,,,Homo sapiens
187236,2781,1783,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,Q05941,Chrna7,ACHA7_RAT,5.32,,Ki,Binding affinity nicotinic acetylcholine receptor alpha-7 was evaluated by its ability to inhibit [3H]methyllycaconitine ([3H]-MLA) binding to rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,,,,Rattus norvegicus
187237,2781,2727,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P09483|P12390,Chrna4|Chrnb2,ACHA4_RAT|ACHB2_RAT,5.01,,Ki,Binding affinity for nicotinic acetylcholine receptor alpha4-beta2 was evaluated by its ability to inhibit [3H]NIC binding to rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,,,,Rattus norvegicus
187238,2781,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,5.51,,IC50,GRAC: human AChR-alpha7 commonly used antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,Tchem,,,Homo sapiens
187239,2781,2602,Nicotinic acetylcholine receptor alpha 5 subunit,Ion channel,A9XFY4,nAChRalpha5,A9XFY4_MUSDO,5.73,,Ki,Displacement of [3H]alpha-bungarotoxin from nAChR in Musca domestica (house fly) head membrane after 60 min by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,,,,Musca domestica
187240,3535,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,5.03,,Ki,Binding affinity to adrenergic alpha2A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226335,,,,Tclin,,,Homo sapiens
187241,3535,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,7.92,,IC50,Inhibition of AChE (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226335,,,,Tclin,,,Homo sapiens
187242,3535,304,Xanthine dehydrogenase/oxidase,Enzyme,P47989,XDH,XDH_HUMAN,4.28,,IC50,Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226335,,,,Tclin,,,Homo sapiens
187243,3535,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,5.02,,Ki,Binding affinity to adrenergic alpha2c receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226335,,,,Tclin,,,Homo sapiens
187244,3535,2064,Serum albumin,Secreted,P02769,ALB,ALBU_BOVIN,4.38,,IC50,Inhibition of glycation of bovine serum albumin assessed as advanced glycated end product measured after 7 days by spectrofluorimeter in presence of glucose anhydrous,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226335,,,,,,,Bos taurus
187245,3535,1250,Bifunctional epoxide hydrolase 2,Enzyme,P34913,EPHX2,HYES_HUMAN,4.61,,IC50,Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis after 1 hr by fluorescence method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226335,,,,Tchem,,,Homo sapiens
187246,3535,2298,Sialidase,Enzyme,P10481,nanH,NANH_CLOPF,4.51,,IC50,Inhibition of Clostridium perfringens neuraminidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226335,,,,,,,Clostridium perfringens
187247,3535,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,4.89,,IC50,Inhibition of aldose reductase in rat lens homogenates by fluorophotometer,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226335,,,,,,,Rattus norvegicus
187248,475,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,4.38,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,,,,Trypanosoma cruzi
187249,1974,2297,ParE,Enzyme,Q7X1P7,parE,Q7X1P7_STREE,5.69,,IC50,Inhibition of Streptococcus pneumoniae SP-3 parE after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36506,,,,,,,Streptococcus pneumoniae
187250,1974,2296,DNA gyrase subunit B,Enzyme,P0A4L9,gyrB,GYRB_STRPN,7.43,,IC50,Inhibition of Streptococcus pneumoniae SP-3 gyrB by enzyme coupled phosphate assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36506,,,,,,,Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)
187251,1974,1237,DNA gyrase subunit B,Enzyme,P0AES6,gyrB,GYRB_ECOLI,6.81,,IC50,Inhibition of Escherichia coli JM109 DNA gyrase subunit B assessed as ATP hydrolysis by ATPase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36506,,,,,,,Escherichia coli (strain K12)
187252,1974,3626,DNA gyrase subunit B,Unclassified,P0C559,gyrB,GYRB_MYCSM,6.7,,IC50,Inhibition of Mycobacterium smegmatis GyrB ATPase activity expressed in Escherichia coli BL21 (DE3) after 2 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36506,,,,,,,Mycobacterium smegmatis
187253,1974,2485,DNA gyrase subunit B,Enzyme,C3SLN2,gyrB,C3SLN2_ECOLX,7.55,,Kd,Binding affinity to Escherichia coli GyrB,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36506,,,,,,,Escherichia coli
187254,1974,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,7,,IC50,Inhibition of reconstituted Escherichia coli DNA gyrase subunit AB assessed as reduction of DNA supercoiling activity using pBR322 DNA substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36506,,,,,,,Escherichia coli (strain K12)
187255,1974,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,4.18,,IC50,Inhibition of ABCG2 in human mitoxantrone-resistant MCF7 cells by Hoechst 33342 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36506,,,,Tchem,,,Homo sapiens
187256,1974,2922,DNA gyrase,Enzyme,Q5HK03|Q5HK04,gyrA|gyrB,GYRA_STAEQ|GYRB_STAEQ,,,,Mechanism of Action; CHEMBL2331040; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36506,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36506,INHIBITOR,,,,,Staphylococcus epidermidis (strain ATCC 35984 / RP62A)
187257,552,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200672,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200672,INHIBITOR,,,,,Escherichia coli (strain K12)
187258,1437,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,10.15,,Ki,Inhibition of HIV-1 Protease activity,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL115,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL115,INHIBITOR,,,,,Human immunodeficiency virus 1
187259,1437,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,5.11,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL115,,,,Tchem,,,Homo sapiens
187260,1437,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.77,,IC50,Inhibition of human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells after 1.5 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL115,,,,Tchem,,,Homo sapiens
187261,1437,1888,Protease,Enzyme,Q4U254,protease,Q4U254_9ENTO,8.48,,Ki,Binding affinity against HIV-2 protease enzyme.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL115,,,,,,,Human rhinovirus sp
187262,534,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL454446,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL454446,INHIBITOR,,,,,Escherichia coli (strain K12)
187263,3611,1951,Proliferating cell nuclear antigen,Unclassified,P12004,PCNA,PCNA_HUMAN,4.6,,IC50,Inhibition of human recombinant PCNA interaction with PIP box protein N-5-carboxyfluorescein-SAVLQKKITDYFHPKK after 30 mins by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41632,,,,Tchem,,,Homo sapiens
187264,3611,92,Thyroid hormone receptor alpha,Nuclear hormone receptor,P10827,THRA,THA_HUMAN,9.85,,IC50,Concentration required to inhibit 50% of I-T3 binding to hTR1 (Thyroid hormone receptor alpha) was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41632,,,,Tclin,,,Homo sapiens
187265,3611,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,4.46,,IC50,Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41632,,,,Tclin,,,Homo sapiens
187266,3611,93,Thyroid hormone receptor beta,Nuclear hormone receptor,P10828,THRB,THB_HUMAN,10.39,,IC50,Inhibition of thyroid hormone receptor beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41632,,,,Tclin,,,Homo sapiens
187267,3611,1861,Thyroid hormone receptor beta,Transcription factor,P18113,Thrb,THB_RAT,9.82,,IC50,In vitro inhibition of the bound [125I]L-T3 rat liver nuclear L-triiodothyronine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41632,,,,,,,Rattus norvegicus
187268,776,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,8.35,,Ki,Binding affinity to human thrombin,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,INHIBITOR,,Tclin,,,Homo sapiens
187269,1601,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.99,,IC50,Inhibition of human MDR1-dependent accumulation of calcein-AM expressed in MDCK2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL729,,,,Tchem,,,Homo sapiens
187270,1601,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.07,,IC50,Inhibition of human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL729,,,,Tclin,,,Homo sapiens
187271,1601,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,10.4,,Ki,Inhibition of HIV1 protease D30N/L63P/N88D mutant,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL729,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL729,INHIBITOR,,,,,Human immunodeficiency virus 1
187272,1601,2067,CAAX prenyl protease 1 homolog,Enzyme,Q80W54,Zmpste24,FACE1_MOUSE,4.74,,IC50,Inhibition of mouse ZMPSTE24 expressed n delta ste24 delta rce1 yeast,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL729,,,,,,,Mus musculus
187273,1601,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,7.6,,IC50,Inhibition of wild type C-South African Human immunodeficiency virus 1 protease using chromogenic peptide H-1048 as substrate by UV spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL729,,,,,,,Human immunodeficiency virus 1
187274,2369,320,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,,,,Mechanism of Action; CHEMBL1893; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1668,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1668,INHIBITOR,,Tclin,,,Homo sapiens
187275,3604,1951,Proliferating cell nuclear antigen,Unclassified,P12004,PCNA,PCNA_HUMAN,4.77,,IC50,Inhibition of human recombinant PCNA interaction with PIP box protein N-5-carboxyfluorescein-SAVLQKKITDYFHPKK after 30 mins by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL291053,,,,Tchem,,,Homo sapiens
187276,3604,92,Thyroid hormone receptor alpha,Nuclear hormone receptor,P10827,THRA,THA_HUMAN,10.39,,IC50,Concentration required to inhibit 50% of I-T3 binding to hTR1 (Thyroid hormone receptor alpha) was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL291053,,,,Tclin,,,Homo sapiens
187277,3604,93,Thyroid hormone receptor beta,Nuclear hormone receptor,P10828,THRB,THB_HUMAN,10.72,,IC50,Concentration required to inhibit 50% of I-T3 binding to hTR1 (Thyroid hormone receptor beta) was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL291053,,,,Tclin,,,Homo sapiens
187280,176,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,5.4,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL633,,,,,,,Trypanosoma cruzi
187281,176,1283,Lethal factor,Enzyme,P15917,lef,LEF_BACAN,5.46,,IC50,Protection against Bacillus anthracis lethal toxin-mediated cytotoxicity in mouse RAW264.7 cells assessed as change in viability after 24 hrs by WST1 dye reduction assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL633,,,,,,,Bacillus anthracis
187282,176,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,7.21,,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL633,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
187283,176,477,Squalene monooxygenase,Enzyme,Q14534,SQLE,ERG1_HUMAN,4.92,,IC50,Inhibitory activity against Trypanosoma cruzi microsomal squalene synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL633,,,,Tchem,,,Homo sapiens
187284,176,709,Squalene synthase,Enzyme,P37268,FDFT1,FDFT_HUMAN,5.1,,IC50,Inhibitory activity against Trypanosoma cruzi glycosomal squalene synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL633,,,,Tchem,,,Homo sapiens
187285,39,731,Lysosomal alpha-glucosidase,Enzyme,P10253,GAA,LYAG_HUMAN,5.3,,IC50,Inhibition of maltase in human Caco-2 cell model system after 2 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1566,,,,Tclin,,,Homo sapiens
187286,39,3627,"Oligo-1,6-glucosidase",Unclassified,P53051,IMA1,MALX3_YEAST,4.42,,IC50,Inhibition of Saccharomyces cerevisiae alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 10 mins measured after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1566,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
180614,2646,92,Thyroid hormone receptor alpha,Nuclear hormone receptor,P10827,THRA,THA_HUMAN,,,,,UNKNOWN,,1,IUPHAR,,,AGONIST,,Tclin,,,Homo sapiens
180616,362,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,,,,,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2907502,http://www.ncbi.nlm.nih.gov/pubmed/2907502,INHIBITOR,,Tclin,88,88,Homo sapiens
180618,1710,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,,,,,UNKNOWN,,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2700,AGONIST,,Tclin,,,Homo sapiens
180619,4633,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000773/WC500045832.pdf,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000773/WC500045832.pdf,ALKYLATING AGENT,,,198,198,
180620,1879,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,,UNKNOWN,,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6949,AGONIST,,Tclin,,,Homo sapiens
180621,4304,51,Sodium/glucose cotransporter 2,Transporter,P31639,SLC5A2,SC5A2_HUMAN,9.3,,IC50,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4594,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4594,INHIBITOR,,Tclin,,,Homo sapiens
180622,4949,1611,Tumor necrosis factor ligand superfamily member 13B,Cytokine,Q9Y275,TNFSF13B,TN13B_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125370s053lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125370s053lbl.pdf,ANTIBODY BINDING,,Tclin,199,199,Homo sapiens
180623,4950,2730,Integrin alpha-IIb/beta-3,Adhesion,P05106|P08514,ITGA2B|ITGB3,ITA2B_HUMAN|ITB3_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103575s5126lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103575s5126lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin,200,200,Homo sapiens
180624,4951,3502,B-lymphocyte antigen CD20,Surface antigen,P11836,MS4A1,CD20_HUMAN,9.92,,Kd,Binding affinity for clone 2F2 ((HuMax-CD20).,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6778,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125326s060lbl.pdf,ANTIBODY BINDING,,Tclin,201,201,Homo sapiens
180625,4952,3503,Interleukin-1 beta,Cytokine,P01584,IL1B,IL1B_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125319s081lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125319s081lbl.pdf,ANTIBODY BINDING,,Tclin,202,202,Homo sapiens
180626,4953,2993,Interleukin-2 receptor,Membrane receptor,P01589|P14784|P31785,IL2RA|IL2RB|IL2RG,IL2RA_HUMAN|IL2RB_HUMAN|IL2RG_HUMAN,8,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6880,http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/103749s5059lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin|Tclin,203,203,Homo sapiens
180627,4954,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,9.41,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6882,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125084s063lbl.pdf,ANTIBODY BINDING,,Tclin,204,204,Homo sapiens
180628,1130,3504,Nuclear receptor subfamily 2 group E member 1,Nuclear hormone receptor,Q9Y466,NR2E1,NR2E1_HUMAN,5.180456161499023,,Kd,orthogonal direct binding assay,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24936658,,,,Tbio,205,,Homo sapiens
180629,975,3504,Nuclear receptor subfamily 2 group E member 1,Nuclear hormone receptor,Q9Y466,NR2E1,NR2E1_HUMAN,4.560667514801025,,Kd,orthogonal direct binding assay,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/24936658,,,,Tbio,205,,Homo sapiens
187356,2581,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.4,,IC50,Inhibition of human ERG by patch-clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1136,,,,Tclin,,,Homo sapiens
180630,4955,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,10.3,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6883,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125147s200lbl.pdf,AGONIST,,Tclin,215,215,Homo sapiens
180631,4956,1643,Vascular endothelial growth factor A,Secreted,P15692,VEGFA,VEGFA_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125085s305lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125085s305lbl.pdf,ANTIBODY BINDING,,Tclin,216,216,Homo sapiens
180632,4957,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125409s104lbl.pdf,ANTIBODY BINDING,,Tclin,,217,Homo sapiens
180633,4958,3505,Cytotoxic T-lymphocyte protein 4,Surface antigen,P16410,CTLA4,CTLA4_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125377s055lbl.pdf,ANTIBODY BINDING,,Tclin,,218,Homo sapiens
180634,4959,3478,Leukocyte adhesion glycoprotein LFA-1 alpha,Adhesion,P20701,ITGAL,ITAL_HUMAN,11.4,,Kd,Binding of humanized MHM24 to human CD11a on Jurkat cells.,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6593,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125075s130lbl.pdf,ANTIBODY BINDING,,Tclin,219,219,Homo sapiens
180635,4960,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002498/WC500138940.pdf,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002498/WC500138940.pdf,AGONIST,,Tclin,220,220,Homo sapiens
180636,4961,3506,Protective antigen,Secreted,P13423,pagA,PAG_BACAN,8.555954933166504,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125349s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125349s000lbl.pdf,ANTIBODY BINDING,,,221,221,Bacillus anthracis
180637,4907,3508,Poly [ADP-ribose] polymerase 3,Enzyme,Q9Y6F1,PARP3,PARP3_HUMAN,7.34,,IC50,Inhibition of PARP3 (unknown origin) using activated DNA as substrate after 1 hr by streptavidin-horseradish peroxidase-based luminescence assay,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL521686,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf,INHIBITOR,,Tclin,223,223,Homo sapiens
180639,4964,3509,Tumor necrosis factor receptor superfamily member 8,Membrane receptor,P28908,TNFRSF8,TNR8_HUMAN,,,,antibody binding to CD30-expressing cells,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125388_S056S078lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125388_S056S078lbl.pdf,BINDING AGENT,,Tclin,226,226,Homo sapiens
180641,4965,3511,Tumor necrosis factor ligand superfamily member 11,Cytokine,O14788,TNFSF11,TNF11_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125320s170lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125320s170lbl.pdf,ANTIBODY BINDING,,Tclin,227,227,Homo sapiens
180642,4966,3512,Interleukin-12,Cytokine,P29459|P29460,IL12A|IL12B,IL12A_HUMAN|IL12B_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125261s114lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125261s114lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin,228,228,Homo sapiens
180643,4966,3513,Interleukin-23,Cytokine,P29460|Q9NPF7,IL12B|IL23A,IL12B_HUMAN|IL23A_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125261s114lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125261s114lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin,228,228,Homo sapiens
180644,4967,503,Tumor necrosis factor,Cytokine,P01375,TNF,TNFA_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125289s094lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125289s094lbl.pdf,ANTIBODY BINDING,,Tclin,229,229,Homo sapiens
180645,4968,503,Tumor necrosis factor,Cytokine,P01375,TNF,TNFA_HUMAN,10.045757293701172,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125160s215lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125160s215lbl.pdf,ANTIBODY BINDING,,Tclin,230,230,Homo sapiens
180646,4969,3515,Complement C5,Secreted,P01031,C5,CO5_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125166s368s380lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125166s368s380lbl.pdf,ANTIBODY BINDING,,Tclin,231,231,Homo sapiens
180649,4970,3018,Integrin alpha-4/beta-1,Adhesion,P05556|P13612,ITGA4|ITGB1,ITA4_HUMAN|ITB1_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125104s840s847s889lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125104s840s847s889lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin,234,234,Homo sapiens
180650,4970,3019,Integrin alpha-4/beta-7,Adhesion,P13612|P26010,ITGA4|ITGB7,ITA4_HUMAN|ITB7_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125104s840s847s889lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125104s840s847s889lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin,234,234,Homo sapiens
180651,4971,1643,Vascular endothelial growth factor A,Secreted,P15692,VEGFA,VEGFA_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125156s106lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125156s106lbl.pdf,ANTIBODY BINDING,,Tclin,237,237,Homo sapiens
180652,4972,3517,Ig epsilon chain C region,Antibody,P01854,IGHE,IGHE_HUMAN,8.16,,Kd,<i>In vitro</i> binding affinity,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6890,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103976s5161lbl.pdf,ANTIBODY BINDING,,Tclin,238,238,Homo sapiens
180683,4975,3502,B-lymphocyte antigen CD20,Surface antigen,P11836,MS4A1,CD20_HUMAN,8.51,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6780,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103705s5432lbl.pdf,ANTIBODY BINDING,,Tclin,248,248,Homo sapiens
187287,39,2122,Lysosomal alpha-glucosidase,Enzyme,Q6P7A9,Gaa,LYAG_RAT,5.46,,Ki,Competitive inhibition of rat alpha-glucosidase assessed as production of chromogenic p-Nitrphenol measured after 3 mins by HPLC and Michaelis-Menten equation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1566,,,,,,,Rattus norvegicus
187288,39,2431,Alpha-amylase,Enzyme,P94451,,P94451_GEOSE,6.47,,Ki,Competitive inhibition of Bacillus stearothermophilus alpha-glucosidase assessed as production of chromogenic p-Nitrphenol measured after 3 mins by HPLC and Michaelis-Menten equation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1566,,,,,,,Geobacillus stearothermophilus
187289,39,1898,"Sucrase-isomaltase, intestinal",Enzyme,P23739,Si,SUIS_RAT,6.4,,IC50,Inhibition of rat intestinal sucrase using sucrose as substrate assessed as D-glucose release from substrate preincubated for 15 mins measured after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1566,,,,,,,Rattus norvegicus
187290,39,626,Alpha-amylase 1,Enzyme,P04745,AMY1A,AMY1_HUMAN,6,,IC50,Inhibition of human salivary alpha-amylase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1566,,,,Tchem,,,Homo sapiens
187291,39,3628,Pancreatic alpha-amylase,Unclassified,P00690,AMY2,AMYP_PIG,4.45,,IC50,Inhibition of porcine pancreatic alpha amylase using starch as substrate by Bernfeld method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1566,,,,,,,Sus scrofa
187292,39,496,Pancreatic alpha-amylase,Enzyme,P04746,AMY2A,AMYP_HUMAN,,,,Mechanism of Action; CHEMBL2045; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1566,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1566,INHIBITOR,,Tclin,,,Homo sapiens
187293,543,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL507674,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL507674,INHIBITOR,,,,,Escherichia coli (strain K12)
187294,1585,1951,Proliferating cell nuclear antigen,Unclassified,P12004,PCNA,PCNA_HUMAN,5.44,,IC50,Inhibition of human recombinant PCNA interaction with PIP box protein N-5-carboxyfluorescein-SAVLQKKITDYFHPKK after 30 mins by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1544,,,,Tchem,,,Homo sapiens
187295,1585,92,Thyroid hormone receptor alpha,Nuclear hormone receptor,P10827,THRA,THA_HUMAN,10.24,,Kd,Displacement of [125I]T3 from human TRalpha receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1544,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1544,AGONIST,,Tclin,,,Homo sapiens
187296,1585,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,4.64,,IC50,Direct channel-gating action blocked by picrotoxin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1544,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
187297,1585,93,Thyroid hormone receptor beta,Nuclear hormone receptor,P10828,THRB,THB_HUMAN,10.1,,Ki,Inhibitory activity against [125I]T3 binding to human TRbeta1 receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1544,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1544,AGONIST,,Tclin,,,Homo sapiens
187298,1585,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,5.15,,EC50,Non-competitive inhibitory activity against recombinant Gamma-aminobutyric acid A (GABA-A) receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1544,,,,,,,Rattus norvegicus
187299,1585,1861,Thyroid hormone receptor beta,Transcription factor,P18113,Thrb,THB_RAT,8.74,,IC50,In vitro inhibition of the bound [125I]L-T3 rat liver nuclear L-triiodothyronine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1544,,,,,,,Rattus norvegicus
187300,403,2852,Dopamine receptor,GPCR,P18901|P19020|P25115|P30729|P61169,Drd1|Drd2|Drd3|Drd4|Drd5,DRD1_RAT|DRD2_RAT|DRD3_RAT|DRD4_RAT|DRD5_RAT,7.55,,IC50,In vitro affinity for dopamine receptor by displacement of [3H]- apomorphine in rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL493,,,,,,,Rattus norvegicus
187301,403,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,6.29,,IC50,Alpha-2 adrenergic receptor activity assessed in vitro for displacement of [3H]clonidine from specific binding sites on rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL493,,,,,,,Rattus norvegicus
187302,403,2859,Cerebral cortex alpha adrenergic receptor,GPCR,P18130|Q28838,ADRA1A|ADRA2A,ADA1A_BOVIN|ADA2A_BOVIN,6.29,,IC50,In vitro affinity for alpha adrenergic receptor by displacement of 3[H]clonidine in calf cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL493,,,,,,,Bos taurus
187303,403,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.4,,Kd,In vitro affinity at mutant D2 receptor (S197A) in C6 (glioma) cell membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL493,,,,,,,Rattus norvegicus
187304,3944,189,DNA topoisomerase 2-alpha,Enzyme,P11388,TOP2A,TOP2A_HUMAN,,,,Mechanism of Action; CHEMBL1806; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200645,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200645,INHIBITOR,,Tclin,,,Homo sapiens
187305,2422,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,10.4,,Ki,Inhibition of HIV protease,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL114,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL114,INHIBITOR,,,,,Human immunodeficiency virus 1
187306,2422,3556,Chloroquine resistance transporter,Unclassified,Q9N623,CRT,CRT_PLAFA,4.89,,IC50,Inhibition of chloroquine-resistant Plasmodium falciparum Dd2 CRT expressed in Xenopus laevis oocyte assessed as inhibition of [3H]chloroquine uptake measured from 1 to 2 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL114,,,,,,,Plasmodium falciparum
187307,2422,1888,Protease,Enzyme,Q4U254,protease,Q4U254_9ENTO,9.3,,IC50,Compound was evaluated for inhibitory activity against HIV-2 protease,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL114,,,,,,,Human rhinovirus sp
187308,3483,2422,14-alpha sterol demethylase,Enzyme,Q96W81,cyp51B,Q96W81_ASPFM,7.14,,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme B expressed in Escherichia coli assessed as tight binding affinity constant,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1397,,,,,,,Neosartorya fumigata
187309,3483,2421,14-alpha sterol demethylase Cyp51A,Enzyme,Q4WNT5,,Q4WNT5_ASPFU,5.57,,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme A expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1397,,,,,,,Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100)
187310,254,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.17,,IC50,Inhibition of human MDR1-dependent accumulation of calcein-AM expressed in MDCK2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1163,,,,Tchem,,,Homo sapiens
187311,254,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,9.62,,Ki,Inhibition constant for human immunodeficiency virus type 1 protease,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1163,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1163,INHIBITOR,,,,,Human immunodeficiency virus 1
187312,254,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,7.59,,IC50,The percent reduction of the reverse transcriptase (RT) activity in HIV-1/MN-infected MT-2 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1163,,,,,,,Human immunodeficiency virus 1
187313,254,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,8.4,,IC50,Inhibition of wild type C-South African Human immunodeficiency virus 1 protease using chromogenic peptide H-1048 as substrate by UV spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1163,,,,,,,Human immunodeficiency virus 1
187314,1513,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,5.52,,IC50,Inhibition of Trypanosoma cruzi cruzaine preincubated for 5 mins before substrate addition by fluorescence assay in absence of Triton X-100,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711,,,,,,,Trypanosoma cruzi
187315,1513,392,Vasopressin V2 receptor,GPCR,P30518,AVPR2,V2R_HUMAN,6.1,,IC50,Inhibition of vasopressin-stimulated vasopressin V2 receptor in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711,,,,Tclin,,,Homo sapiens
187316,1513,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,5.44,,IC50,Inhibition of human CYP51 expressed in Topp 3 cells by lanosterol demethylase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711,,,,Tchem,,,Homo sapiens
187317,1513,2422,14-alpha sterol demethylase,Enzyme,Q96W81,cyp51B,Q96W81_ASPFM,7.51,,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme B expressed in Escherichia coli assessed as tight binding affinity constant,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711,,,,,,,Neosartorya fumigata
187318,1513,2421,14-alpha sterol demethylase Cyp51A,Enzyme,Q4WNT5,,Q4WNT5_ASPFU,6,,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme A expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711,,,,,,,Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100)
187319,1513,1720,C-C chemokine receptor type 4,GPCR,P51679,CCR4,CCR4_HUMAN,6.7,,IC50,Inverse agonist activity at CCR4 in human HTLA cells assessed as depression of basal activity incubated for 20 mins by beta arrestin-recruitment mediated luciferase reporter gene assay in absence of CCL22,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711,,,,Tclin,,,Homo sapiens
187320,1513,2155,C-X-C chemokine receptor type 1,GPCR,P25024,CXCR1,CXCR1_HUMAN,7,,IC50,Inhibition of CX3CL1-stimulated CX3CR1 in human HTLA cells pre-incubated for 20 mins measured on day 4 by beta arrestin-recruitment mediated luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711,,,,Tchem,,,Homo sapiens
187321,2391,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.47,,IC50,Inhibition of human OCT1-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL163,,,,Tchem,,,Homo sapiens
187322,2391,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.61,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL163,,,,Tchem,,,Homo sapiens
187323,2391,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,10.82,,Ki,Inhibition constant of ritonavir towards HIV protease was determined,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL163,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL163,INHIBITOR,,,,,Human immunodeficiency virus 1
187324,2391,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,5.36,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells up to 500 uM after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL163,,,,Tchem,,,Homo sapiens
187325,2391,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,7.1,,IC50,Inhibition of human MATE1-mediated [14]-metformin uptake expressed in HEK293 cells after 1.5 mins by scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL163,,,,Tchem,,,Homo sapiens
187326,1048,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.41,,IC50,Inhibition of human ERG expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL532,,,,Tclin,,,Homo sapiens
187327,1048,622,Motilin receptor,GPCR,O43193,MLNR,MTLR_HUMAN,4.43,,Ki,In vitro binding affinity towards human motilin receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL532,,,,Tchem,,,Homo sapiens
187328,881,1903,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P50997,ATP1A1,AT1A1_CANFA,8.1,,IC50,Inhibition of [3H]ouabain binding to Digitalis receptor in dog heart microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254219,,,,,,,Canis familiaris
187329,2088,1767,Gastrin/cholecystokinin type B receptor,GPCR,P30553,Cckbr,GASR_RAT,8.17,,IC50,Inhibition of the specific binding of [125I](BH)-CCK-8 to Cholecystokinin type B receptor in rat brain cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1328,,,,,,,Rattus norvegicus
187330,2088,1766,Cholecystokinin receptor type A,GPCR,P30551,Cckar,CCKAR_RAT,6.22,,IC50,Evaluated for inhibition of cholecystokinin type A receptor by displacing [125I]bolton hunter CCK-8 radioligand in the rat pancreas,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1328,,,,,,,Rattus norvegicus
187331,2088,607,Gastrin/cholecystokinin type B receptor,GPCR,P32239,CCKBR,GASR_HUMAN,7.84,,Ki,Inhibition of binding of [125I]-PD 142308 to CCK-B receptor was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1328,,,,Tclin,,,Homo sapiens
187332,2088,1848,Gastrin/cholecystokinin type B receptor,GPCR,P56481,Cckbr,GASR_MOUSE,9.1,,IC50,Evaluated for inhibition of cholecystokinin type B receptor by displacing [125I]-Bolton hunter CCK-8 radioligand in the mouse cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1328,,,,,,,Mus musculus
215161,2353,3613,Folate transporter 1,Unclassified,P41440,SLC19A1,S19A1_HUMAN,8.199999809265137,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071,,,,Tchem,,,Homo sapiens
187333,2646,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,4.98,,IC50,Inhibition of TTR mediated fibrillogenesis assessed as acid-induced protein aggregation turbidity after 1.5 hrs by turbidimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL559,,,,Tclin,,,Homo sapiens
187334,2646,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,5.1,,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL559,,,,Tclin,,,Homo sapiens
187335,846,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,6.48,,IC50,Ability to displace [3H]L-689560 from NMDA receptor glycine site in rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL559,,,,,,,Rattus norvegicus
187336,846,1861,Thyroid hormone receptor beta,Transcription factor,P18113,Thrb,THB_RAT,7.46,,IC50,In vitro inhibition of the bound [125I]L-T3 rat liver nuclear L-triiodothyronine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL559,,,,,,,Rattus norvegicus
187337,846,2753,Thyroid hormone receptor,Nuclear hormone receptor,P10827|P10828,THRA|THRB,THA_HUMAN|THB_HUMAN,,,,Mechanism of Action; CHEMBL2111462; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL559,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL559,AGONIST,,Tclin|Tclin,,,Homo sapiens
187338,882,1903,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P50997,ATP1A1,AT1A1_CANFA,6.3,,IC50,Inhibition of Na+/K+ ATPase from dog kidney,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1751,,,,,,,Canis familiaris
187339,882,1696,Nuclear receptor ROR-gamma,Nuclear hormone receptor,P51449,RORC,RORG_HUMAN,5.7,,IC50,Antagonist activity at transactivation domain of RORgammat (unknown origin) expressed in Drosophila Schneider cells co-expressing Gal4-DNA binding domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1751,,,,Tchem,,,Homo sapiens
187340,882,3629,Nuclear receptor ROR-gamma,Unclassified,P51450,Rorc,RORG_MOUSE,5.7,,IC50,Inhibition of mouse Gal4 DNA binding domain-fused ROR gamma expressed in Drosophila S2 cells assessed as inhibition of transcriptional activity by luciferase reporter assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1751,,,,,,,Mus musculus
187341,882,2792,Sodium/potassium-transporting ATPase,Transporter,P05023|P05026|P13637|P14415|P50993|P54709|P54710|Q13733,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,AT1A1_HUMAN|AT1A2_HUMAN|AT1A3_HUMAN|AT1A4_HUMAN|AT1B1_HUMAN|AT1B2_HUMAN|AT1B3_HUMAN|ATNG_HUMAN,6.4,,IC50,Inhibitory activity against Na+/K+ ATPase was determined,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1751,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1751,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
187342,3482,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,Mechanism of Action; CHEMBL206; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201477,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201477,AGONIST,,Tclin,,,Homo sapiens
187343,2379,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,5.66,,EC50,Transactivation of human PXR expressed in HepG2 cells after 18 hrs by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1617,,,,Tchem,,,Homo sapiens
187344,2379,2923,Bacterial DNA-directed RNA polymerase,Enzyme,P0A7Z4|P0A800|P0A8T7|P0A8V2,rpoA|rpoB|rpoC|rpoZ,RPOA_ECOLI|RPOB_ECOLI|RPOC_ECOLI|RPOZ_ECOLI,,,,Mechanism of Action; CHEMBL2364672; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1617,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1617,INHIBITOR,,,,,Escherichia coli (strain K12)
187345,1062,1990,Estrogen receptor,Transcription factor,P06211,Esr1,ESR1_RAT,5.52,,Kd,Displacement of radiolabeled estradiol from estradiol receptor in rat uterine cytosol,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1697793,,,,,,,Rattus norvegicus
187346,2531,1246,Hematopoietic prostaglandin D synthase,Enzyme,O60760,HPGDS,HPGDS_HUMAN,4.57,,IC50,Inhibition of human H-PGDS expressed in Escherichia coli BL21 assessed as rate of glutathione-chloro-dinitro benzene conjugation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL453904,,,,Tchem,,,Homo sapiens
187347,2552,441,Serine/threonine-protein kinase mTOR,Kinase,P42345,MTOR,MTOR_HUMAN,9.02,,IC50,Inhibitory activity against macrophilin (FKBP-12),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732,,,,Tclin,,,Homo sapiens
187348,2552,2613,Splicing factor 3B subunit 3,Unclassified,Q15393,SF3B3,SF3B3_HUMAN,7.96,,IC50,Inhibition of SAP130 mediated cell growth in human WiDr cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732,,,,Tchem,,,Homo sapiens
187349,2552,1725,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,Enzyme,Q08209,PPP3CA,PP2BA_HUMAN,7.7,,Kd,"Binding affinity to protein phosphatase, calcineurin (CN) was determined",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732,,,,Tchem,,,Homo sapiens
187350,2552,2480,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,Q13451,FKBP5,FKBP5_HUMAN,7.1,,Ki,Binding affinity to human FKBP51 by competitive fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732,,,,Tchem,,,Homo sapiens
187351,67,2792,Sodium/potassium-transporting ATPase,Transporter,P05023|P05026|P13637|P14415|P50993|P54709|P54710|Q13733,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,AT1A1_HUMAN|AT1A2_HUMAN|AT1A3_HUMAN|AT1A4_HUMAN|AT1B1_HUMAN|AT1B2_HUMAN|AT1B3_HUMAN|ATNG_HUMAN,,,,Mechanism of Action; CHEMBL2095186; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545057,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545057,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
187352,939,2585,Growth hormone-releasing hormone receptor,GPCR,Q02643,GHRHR,GHRHR_HUMAN,9.85,,IC50,Displacement of [125I]JV1-42 from GHRH receptor expressed in human MX1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL92,,,,Tclin,,,Homo sapiens
187353,2823,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,7,,Ki,High affinity constant at binding site of human P-Glycoprotein (P-gp) in two-affinity model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL159,,,,Tchem,,,Homo sapiens
187354,2823,1902,Amine oxidase [flavin-containing] B,Enzyme,P56560,MAOB,AOFB_BOVIN,4.11,,Ki,Inhibitory activity against Monoamine oxidase B isolated from beef liver mitochondria was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL159,,,,,,,Bos taurus
187355,80,567,72 kDa type IV collagenase,Enzyme,P08253,MMP2,MMP2_HUMAN,5,,IC50,Concentration inhibiting Clostridium histolyticum collagenase.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502620,,,,Tchem,,,Homo sapiens
187357,1325,896,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,P28845,HSD11B1,DHI1_HUMAN,8.22,,IC50,Inhibition of human 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone into [3H]cortisol by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL441687,,,,Tclin,,,Homo sapiens
187358,1325,2058,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,P50172,Hsd11b1,DHI1_MOUSE,8.52,,IC50,Inhibition of mouse 11beta-HSD1 expressed in HEK293 cells assessed as conversion of [3H]cortisone into [3H]cortisol by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL441687,,,,,,,Mus musculus
187359,1325,811,Corticosteroid 11-beta-dehydrogenase isozyme 2,Enzyme,P80365,HSD11B2,DHI2_HUMAN,9.4,,IC50,Inhibition of human 11beta-HSD2 expressed in HEK293 cells assessed as conversion of [3H]cortisone into [3H]cortisol by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL441687,,,,Tchem,,,Homo sapiens
187360,2377,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,5.64,,EC50,Activation of PXR in human DPX2 cells after 24 hrs by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL374478,,,,Tchem,,,Homo sapiens
187361,2377,762,Lanosterol 14-alpha demethylase,Enzyme,Q16850,CYP51A1,CP51A_HUMAN,4.52,,IC50,Inhibition of human CYP51 expressed in Topp 3 cells by lanosterol demethylase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL374478,,,,Tchem,,,Homo sapiens
187362,2825,2868,Tubulin,Structural,Q6B856|Q862F3|Q862L2,TUBB2B,Q862F3_BOVIN|Q862L2_BOVIN|TBB2B_BOVIN,5.74,,IC50,In vitro inhibition of tubulin polymerization measured as turbidity formed by centrifugation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90555,,,,,,,Bos taurus
187363,2376,2923,Bacterial DNA-directed RNA polymerase,Enzyme,P0A7Z4|P0A800|P0A8T7|P0A8V2,rpoA|rpoB|rpoC|rpoZ,RPOA_ECOLI|RPOB_ECOLI|RPOC_ECOLI|RPOZ_ECOLI,,,,Mechanism of Action; CHEMBL2364672; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL444633,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL444633,INHIBITOR,,,,,Escherichia coli (strain K12)
187364,2044,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,5.59,,IC50,Inhibition of MDR1 (unknown origin) transfected in human SKOV3 cells assessed as growth inhibition after 48 hrs by SRB assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL428647,,,,Tchem,,,Homo sapiens
187365,2044,1957,Botulinum neurotoxin type A,Enzyme,P10845,botA,BXA1_CLOBO,5.28,,IC50,Inhibition of Clostridium botulinum recombinant neurotoxin A light chain using SNAPtide as substrate after 1 hr by FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL428647,,,,,,,Clostridium botulinum
187366,3217,424,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,5.89,,IC50,Inhibition of human PTPase 1B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1015,,,,Tchem,,,Homo sapiens
187367,3217,1932,Tyrosine-protein phosphatase 1,Enzyme,P25044,PTP1,PTP1_YEAST,5.92,,IC50,Inhibitory activity against Saccharomyces cerevisiae Tyrosine phosphatase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1015,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
187368,3217,1934,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Enzyme,Q13822,ENPP2,ENPP2_HUMAN,6.08,,Ki,Competitive inhibition of human recombinant C-terminal FLAG-tagged autotaxin expressed in baculovirus-infected Sf9 cells assessed as FS-3 hydrolysis by Michaelis-Menten method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1015,,,,Tchem,,,Homo sapiens
187369,3217,1933,Vesicular glutamate transporter 3,Unclassified,Q7TSF2,Slc17a8,VGLU3_RAT,7.4,,Ki,"Evaluated for competitive inhibition against Vesicular glutamate transporter (VGLUT), and Ki value was reported.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1015,,,,,,,Rattus norvegicus
187370,3972,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,6.59,,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200633,,,,Tclin,,,Homo sapiens
187371,3972,3630,Glutamate-gated chloride channel,Ion channel,P91730,,GLUCB_HAECO,,,,Mechanism of Action; CHEMBL2363050; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200633,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200633,MODULATOR,,,,,Haemonchus contortus
187372,3972,3631,Glutamate-gated chloride channel,Ion channel,Q25634,GluClX,Q25634_ONCVO,,,,Mechanism of Action; CHEMBL2363051; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200633,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200633,MODULATOR,,,,,Onchocerca volvulus
187373,2378,2923,Bacterial DNA-directed RNA polymerase,Enzyme,P0A7Z4|P0A800|P0A8T7|P0A8V2,rpoA|rpoB|rpoC|rpoZ,RPOA_ECOLI|RPOB_ECOLI|RPOC_ECOLI|RPOZ_ECOLI,,,,Mechanism of Action; CHEMBL2364672; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1660,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1660,INHIBITOR,,,,,Escherichia coli (strain K12)
187374,3542,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.77,,Ki,Binding affinity to human AT1 receptor by radioligand displacement assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL938,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL938,ANTAGONIST,,Tclin,,,Homo sapiens
187375,3542,1731,Type-1B angiotensin II receptor,GPCR,P29089,Agtr1b,AGTRB_RAT,8.62,,IC50,"Binding affinity for Angiotensin II receptor, type 1 measured by ability to displace [125I]- A II from its specific binding site in rat liver membrane",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL938,,,,,,,Rattus norvegicus
187376,3542,862,Type-2 angiotensin II receptor,GPCR,P50052,AGTR2,AGTR2_HUMAN,9.82,,Ki,Displacement of radiolabeled saralasin from human AT2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL938,,,,Tchem,,,Homo sapiens
187377,3542,2881,Angiotensin II receptor (AT-1) type-1,GPCR,P25095|P29089,Agtr1|Agtr1b,AGTRA_RAT|AGTRB_RAT,8.77,,IC50,"In vitro binding affinity to the angiotensin II receptor, type 1 in rat liver",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL938,,,,,,,Rattus norvegicus
187378,2446,441,Serine/threonine-protein kinase mTOR,Kinase,P42345,MTOR,MTOR_HUMAN,10,,IC50,Inhibition of mTOR kinase expressed in human HEK293 cells by Western blot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413,,,,Tclin,,,Homo sapiens
187379,2446,2541,Eukaryotic translation initiation factor 4E,Nuclear other,P06730,EIF4E,IF4E_HUMAN,9.3,,Kd,Binding affinity to purified elF4E,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413,,,,Tchem,,,Homo sapiens
187411,817,1862,Oxytocin receptor,GPCR,P70536,Oxtr,OXYR_RAT,9.01,,Ki,Displacement of [3H]AVP from rat OT receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1429,,,,,,,Rattus norvegicus
187380,2446,2540,Programmed cell death protein 4,Unclassified,Q53EL6,PDCD4,PDCD4_HUMAN,7.3,,EC50,Inhibition of TPA-induced degradation of Pdcd4 (amino acid 39-91) expressed in human HEK293 cells assessed as minimum compound concentration required for 50% recovery of Pdcd4-luciferase signal incubated for 8 hrs by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413,,,,Tchem,,,Homo sapiens
187381,2446,2480,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,Q13451,FKBP5,FKBP5_HUMAN,8.52,,Ki,Binding affinity to human FKBP51 by competitive fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413,,,,Tchem,,,Homo sapiens
187382,259,1928,Small conductance calcium-activated potassium channel protein 3,Ion channel,P70605,Kcnn3,KCNN3_RAT,5.23,,Ki,Displacement of [I125]apamine from Wistar rat recombinant SK3 channel expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1360,,,,,,,Rattus norvegicus
187383,813,2792,Sodium/potassium-transporting ATPase,Transporter,P05023|P05026|P13637|P14415|P50993|P54709|P54710|Q13733,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,AT1A1_HUMAN|AT1A2_HUMAN|AT1A3_HUMAN|AT1A4_HUMAN|AT1B1_HUMAN|AT1B2_HUMAN|AT1B3_HUMAN|ATNG_HUMAN,,,,Mechanism of Action; CHEMBL2095186; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1614,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1614,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
187384,4106,2565,Pepsin A-5,Enzyme,P0DJD9,PGA5,PEPA5_HUMAN,,,,Mechanism of Action; CHEMBL3295; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2367706,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2367706,INHIBITOR,,Tclin,,,Homo sapiens
187385,3008,434,Oxytocin receptor,GPCR,P30559,OXTR,OXYR_HUMAN,7.96,,Ki,Binding affinity to human oxytocin receptor,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL382301,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000253/WC500040495.pdf,ANTAGONIST,,Tclin,,622,Homo sapiens
187386,3008,392,Vasopressin V2 receptor,GPCR,P30518,AVPR2,V2R_HUMAN,6.48,,Ki,Binding affinity to human vasopressin V2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL382301,,,,Tclin,,,Homo sapiens
187387,3008,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,9.82,,Ki,Binding affinity to human vasopressin V1a receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL382301,,,,Tclin,,,Homo sapiens
187388,3008,391,Vasopressin V1b receptor,GPCR,P47901,AVPR1B,V1BR_HUMAN,7.36,,Ki,Binding affinity to human vasopressin V1b receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL382301,,,,Tclin,,,Homo sapiens
187389,2042,1863,Vasopressin V2 receptor,GPCR,Q00788,Avpr2,V2R_RAT,7.21,,Ki,Binding affinity against Vasopressin receptor in rat liver,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395429,,,,,,,Rattus norvegicus
187390,2042,434,Oxytocin receptor,GPCR,P30559,OXTR,OXYR_HUMAN,9.1,,Ki,Binding affinity for human oxytocin receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395429,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395429,AGONIST,,Tclin,,,Homo sapiens
187391,2042,1862,Oxytocin receptor,GPCR,P70536,Oxtr,OXYR_RAT,9.05,,Ki,Binding affinity against oxytocin receptor in rat uterus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395429,,,,,,,Rattus norvegicus
187392,3126,1862,Oxytocin receptor,GPCR,P70536,Oxtr,OXYR_RAT,9.05,,Ki,Binding affinity against Oxytocin receptor was determined in rat uterine membrane using radioligand [3H]oxytocin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL435716,,,,,,,Rattus norvegicus
187393,1980,1887,Somatostatin receptor type 5,GPCR,P30938,Sstr5,SSR5_RAT,8.98,,IC50,Tested for inhibition of radioligand binding to cloned somatostatin receptor rSSTR5,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680,,,,,,,Rattus norvegicus
187394,1980,1980,Somatostatin receptor type 1,GPCR,P30872,SSTR1,SSR1_HUMAN,6.65,,Ki,Displacement of [125I]-somatostatin from human sst1 receptor after 2 hrs by beta scintillation counting analysis,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680,AGONIST,,Tclin,,,Homo sapiens
187395,1980,1885,Somatostatin receptor type 3,GPCR,P30935,Sstr3,SSR3_MOUSE,8.52,,IC50,Tested for inhibition of radioligand binding to cloned somatostatin receptor mSSTR3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680,,,,,,,Mus musculus
187396,1980,1884,Somatostatin receptor type 2,GPCR,P30875,Sstr2,SSR2_MOUSE,9.55,,IC50,Tested for inhibition of radioligand binding to cloned somatostatin receptor mSSTR2b,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680,,,,,,,Mus musculus
187397,1980,1886,Somatostatin receptor type 4,GPCR,P31391,SSTR4,SSR4_HUMAN,6.4,,Ki,Displacement of [125I]-somatostatin from human sst4 receptor after 2 hrs by beta scintillation counting analysis,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1680,AGONIST,,Tclin,,,Homo sapiens
187405,817,1863,Vasopressin V2 receptor,GPCR,Q00788,Avpr2,V2R_RAT,9.1,,Ki,Displacement of [3H]AVP from vasopressin V2 receptor in rat kidney membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1429,,,,,,,Rattus norvegicus
187406,817,392,Vasopressin V2 receptor,GPCR,P30518,AVPR2,V2R_HUMAN,8.3,,Ki,Binding affinity against human vasopressin V2 receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1429,http://www.ncbi.nlm.nih.gov/pubmed/9792651,AGONIST,,Tclin,,350,Homo sapiens
187407,817,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,8.42,,Ki,Binding affinity against human vasopressin V1a receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1429,,,,Tclin,,,Homo sapiens
187408,817,391,Vasopressin V1b receptor,GPCR,P47901,AVPR1B,V1BR_HUMAN,9.43,,Ki,Binding affinity against human vasopressin V1b receptor was determined by using plasma membranes from CHO cells stably transfected with VP/OT receptors,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1429,,,,Tclin,,,Homo sapiens
187409,817,2038,Vasopressin V1b receptor,GPCR,P48974,Avpr1b,V1BR_RAT,9.7,,Ki,Displacement of [3H]AVP from rat vasopressin V1b receptor expressed in At-T20 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1429,,,,,,,Rattus norvegicus
187410,817,1971,Vasopressin V1a receptor,GPCR,P30560,Avpr1a,V1AR_RAT,7.97,,Ki,Displacement of [3H]AVP from vasopressin V1a receptor in rat liver membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1429,,,,,,,Rattus norvegicus
217039,913,4068,Prostaglandin E2 receptor EP3 subtype,Unclassified,P34980,Ptger3,PE2R3_RAT,9.39,,EC50,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
187412,2810,1778,Vasopressin V2 receptor,GPCR,P32307,AVPR2,V2R_PIG,8.48,,IC50,Tested for the inhibition to V2 subtype receptor using [3H]- (VS2) as radioligand at 3 nM and arginine-vasopressin at 2 uM in LLCPKI cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,,,,,,,Sus scrofa
187413,2810,1863,Vasopressin V2 receptor,GPCR,Q00788,Avpr2,V2R_RAT,9.35,,Ki,Displacement of [3H]AVP from vasopressin V2 receptor in rat kidney membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,,,,,,,Rattus norvegicus
187414,2810,434,Oxytocin receptor,GPCR,P30559,OXTR,OXYR_HUMAN,8.78,,Ki,Displacement of [3H]-AVP from human oxytocin receptor expressed in CHO cells after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,,,,Tclin,,,Homo sapiens
187415,2810,392,Vasopressin V2 receptor,GPCR,P30518,AVPR2,V2R_HUMAN,8.92,,Ki,Displacement of [3H]AVP from human vasopressin V2 receptor expressed CHO cells after 60 mins,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,AGONIST,,Tclin,,,Homo sapiens
187416,2810,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,9.59,,Ki,Inhibition of human vasopressin V1a receptor expressed in CHO cells by polarisation binding assay using 96-well plate membranes,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,AGONIST,,Tclin,,,Homo sapiens
187417,2810,391,Vasopressin V1b receptor,GPCR,P47901,AVPR1B,V1BR_HUMAN,9.31,,Ki,Displacement of [3H]-AVP from human vasopressin V1b receptor expressed in CHO cells after 30 mins,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,AGONIST,,Tclin,,,Homo sapiens
187418,2810,1965,Vasopressin V2 receptor,GPCR,P48044,AVPR2,V2R_BOVIN,8.82,,Kd,Inhibition of radioligand [3H]AVP binding to V2 receptor in bovine kidney inner medulla membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,,,,,,,Bos taurus
187419,2810,2038,Vasopressin V1b receptor,GPCR,P48974,Avpr1b,V1BR_RAT,9.54,,Ki,Displacement of [3H]AVP from rat vasopressin V1b receptor expressed in At-T20 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,,,,,,,Rattus norvegicus
187420,2810,1971,Vasopressin V1a receptor,GPCR,P30560,Avpr1a,V1AR_RAT,9.19,,Kd,Binding potency against V1 receptor in rat liver cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,,,,,,,Rattus norvegicus
187421,2810,2908,Vasopressin V1 receptor,GPCR,P30560|P48974,Avpr1a|Avpr1b,V1AR_RAT|V1BR_RAT,9.19,,Kd,Compound was evaluated for its dissociation constant (Kd) to rat liver Vasopressin V1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,,,,,,,Rattus norvegicus
187422,2810,1862,Oxytocin receptor,GPCR,P70536,Oxtr,OXYR_RAT,8.93,,Ki,Displacement of [3H]AVP from rat OT receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373742,,,,,,,Rattus norvegicus
187423,2959,3490,Vasopressin receptor,GPCR,P30518|P37288|P47901,AVPR1A|AVPR1B|AVPR2,V1AR_HUMAN|V1BR_HUMAN|V2R_HUMAN,,,,Mechanism of Action; CHEMBL2363078; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200690,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200690,AGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
187424,2977,2641,"1,3-beta-glucan synthase catalytic subunit FksP",Enzyme,Q4WLT4,,Q4WLT4_ASPFU,,,,Mechanism of Action; CHEMBL2364674; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499808,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499808,INHIBITOR,,,,,Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100)
187425,2958,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,8,,IC50,The Compound was tested for the concentration to inhibit 50% of [125 I ]leuprorelin binding to the cloned human Leutinizing releasing hormone receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1007,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1007,AGONIST,,Tclin,,,Homo sapiens
187426,2958,1962,Gonadotropin-releasing hormone receptor,GPCR,P30969,Gnrhr,GNRHR_RAT,8.7,,IC50,Concentration of the peptide which displaces 50% of 125 I-[D-Lys6] gonadotropin-releasing hormone bound to rat pituitary membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1007,,,,,,,Rattus norvegicus
187427,2955,932,Neuromedin-K receptor,GPCR,P29371,TACR3,NK3R_HUMAN,9.66,,EC50,Agonist activity at NK3R (unknown origin) transfected in CHO cells assessed as calcium influx at 10 mM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL373569,,,,Tchem,,,Homo sapiens
187428,760,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,4.87,,IC50,Inhibition of human MRP2 expressed in dog MDCK2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,,,,Tbio,,,Homo sapiens
187429,760,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,5.57,,IC50,Inhibition of MRP1 in human 2008 cells assessed as Calcein AM accumulation treated 30 mins before Calcein AM addition measured up to 90 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,,,,Tchem,,,Homo sapiens
187430,760,1725,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,Enzyme,Q08209,PPP3CA,PP2BA_HUMAN,8.4,,Kd,"Binding affinity to protein phosphatase, calcineurin (CN) was determined",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,,,,Tchem,,,Homo sapiens
187431,760,2425,Peptidyl-prolyl cis-trans isomerase D,Enzyme,Q08752,PPID,PPID_HUMAN,8.15,,Ki,Inhibition of fluorescein labeled cyclosporin binding to Cyp40 by fluorescence polarization competition assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,,,,Tchem,,,Homo sapiens
187432,760,1452,Peptidyl-prolyl cis-trans isomerase B,Enzyme,P23284,PPIB,PPIB_HUMAN,8.01,,Kd,Binding affinity to human Cyclophilin B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,,,,Tchem,,,Homo sapiens
187433,760,2278,Peptidyl-prolyl cis-trans isomerase FKBP1B,Enzyme,P68106,FKBP1B,FKB1B_HUMAN,8.22,,Ki,The compound was tested for inhibition of Peptidyl-propyl isomerase (PPIase).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,,,,Tchem,,,Homo sapiens
187434,760,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,6.34,,IC50,In vitro inhibitory activity against HIV-1 RT in CEM4 cell line,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,,,,,,,Human immunodeficiency virus 1
187435,760,768,Peptidyl-prolyl cis-trans isomerase FKBP4,Enzyme,Q02790,FKBP4,FKBP4_HUMAN,7.8,,IC50,50% inhibitory concentration of competitive binding against hCyp-18 PPIase activity using uncoupled assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,,,,Tchem,,,Homo sapiens
187554,4173,2378,Cathepsin S,Enzyme,P25774,CTSS,CATS_HUMAN,6.52,,IC50,Inhibition of human Cathepsin S,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813,,,,Tchem,,,Homo sapiens
187436,760,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,4.2,,IC50,Inhibition of ABCG2 in human mitoxantrone-resistant MCF7 cells by Hoechst 33342 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,,,,Tchem,,,Homo sapiens
187437,1559,1962,Gonadotropin-releasing hormone receptor,GPCR,P30969,Gnrhr,GNRHR_RAT,9.3,,IC50,The compound was tested for the concentration to inhibit 50% of [125 I]leuprorelin binding to Leutinizing releasing hormone receptor in the membrane fractions of the rat pituitary,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200775,,,,,,,Rattus norvegicus
187438,774,1846,Growth factor receptor-bound protein 2,Cytosolic other,P62993,GRB2,GRB2_HUMAN,5.3,,IC50,Inhibition of GST-Grb2 Tyrosine kinase SH2 domain binding to [3H]labeled-phosphopeptide (Ac-SpYVNK-NH-C(O)-CH2CH2H3),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1554,,,,Tchem,,,Homo sapiens
187439,774,2279,Growth factor receptor-bound protein 2,Cytosolic other,Q60631,Grb2,GRB2_MOUSE,5.3,,IC50,In vitro binding assay of Shc-derived phosphopeptide to Growth factor receptor bound protein 2 SH2 in B104-1-1 cells was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1554,,,,,,,Mus musculus
187440,1327,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,,,,Mechanism of Action; CHEMBL1855; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200501,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200501,AGONIST,,Tclin,,,Homo sapiens
187441,1798,2532,"Beta-1,3-glucan synthase catalytic subunit 1",Enzyme,O13428,GSC1,O13428_CANAX,,,,Mechanism of Action; CHEMBL2364673; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL457547,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL457547,INHIBITOR,,,,,Candida albicans
187442,2966,3632,Nucleoside triphosphate diphosphohydrolase 3,Unclassified,Q80Z26,Entpd3,Q80Z26_RAT,4.9,,Ki,Inhibition of rat recombinant NTPDase3 expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502,,,,,,,Rattus norvegicus
187443,2966,2616,ATP-dependent 6-phosphofructokinase,Kinase,O15648,pfk,PFKA_TRYBB,5.52,,IC50,Inhibition of Trypanosoma brucei PFK-mediated ADP production using ATP/fructose-6-phosphate as substrate by luciferase based luminescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502,,,,,,,Trypanosoma brucei brucei
187444,2966,2887,Protein kinase C (PKC),Kinase,O94806|P05129|P05771|P17252|P24723|P41743|Q02156|Q04759|Q05513|Q05655|Q15139,PRKCA|PRKCB|PRKCD|PRKCE|PRKCG|PRKCH|PRKCI|PRKCQ|PRKCZ|PRKD1|PRKD3,KPCA_HUMAN|KPCB_HUMAN|KPCD1_HUMAN|KPCD3_HUMAN|KPCD_HUMAN|KPCE_HUMAN|KPCG_HUMAN|KPCI_HUMAN|KPCL_HUMAN|KPCT_HUMAN|KPCZ_HUMAN,4.54,,IC50,Inhibition of Protein kinase C (PKC),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502,,,,Tbio|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tclin,,,Homo sapiens
187445,2966,2040,RmtA,Enzyme,Q5VLE3,rmtA,Q5VLE3_EMEND,5.23,,IC50,Inhibition of Aspergillus nidulans recombinant GST-RmtA expressed in BL21 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502,,,,,,,Emericella nidulans
187446,2966,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,5.03,,IC50,Inhibition of purified HIV-1 reverse transcriptase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502,,,,,,,Human immunodeficiency virus 1
187447,2966,1984,DNA-dependent protein kinase catalytic subunit,Kinase,P78527,PRKDC,PRKDC_HUMAN,5.77,,IC50,Inhibitory activity against DNA-DNA dependent protein kinase (DNA-PK),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502,,,,Tchem,,,Homo sapiens
187448,2966,3633,Ectonucleoside triphosphate diphosphohydrolase 2,Unclassified,O35795,Entpd2,ENTP2_RAT,4.18,,Ki,Inhibition of rat recombinant NTPDase2 expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502,,,,,,,Rattus norvegicus
187449,2966,3418,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",Enzyme,Q9NXA8,SIRT5,SIR5_HUMAN,4.85,,IC50,Inhibition of human Sirt5 deacetylation activity using FKRGVL-acetylLys-EYGVKV as substrate after 60 mins by glutamate dehydrogenase-coupled assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502,,,,Tbio,,,Homo sapiens
187450,2966,912,Protein arginine N-methyltransferase 1,Enzyme,Q99873,PRMT1,ANM1_HUMAN,5.27,,IC50,Inhibition of His6x-tagged PRMT1-mediated protein arginine methylation expressed in Escherichia coli BL21 (DE3) using H4(1-20) and [14C]-SAM by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502,,,,Tchem,,,Homo sapiens
187451,2966,842,NAD-dependent protein deacetylase sirtuin-2,Enzyme,Q8IXJ6,SIRT2,SIR2_HUMAN,5.96,,IC50,Inhibition of recombinant SIRT2 using ZMAL substrate after 4 hrs by homogeneous fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502,,,,Tchem,,,Homo sapiens
187452,2966,826,NAD-dependent protein deacetylase sirtuin-1,Enzyme,Q96EB6,SIRT1,SIR1_HUMAN,6.52,,IC50,Inhibition of recombinant SIRT1 using ZMAL substrate after 4 hrs by homogeneous fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL265502,,,,Tchem,,,Homo sapiens
187453,2975,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,,,,Mechanism of Action; CHEMBL1855; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200509,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200509,AGONIST,,Tclin,,,Homo sapiens
187454,583,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,8.8,,Ki,GRAC: human GnRH1 selective antagonist,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200490,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200490,ANTAGONIST,,Tclin,,,Homo sapiens
187455,2807,3634,D-alanyl-D-alanine dipeptidase,Unclassified,Q06241,vanX,VANX_ENTFC,4.21,,Ki,"Inhibition of D,D-dipeptidase activity Van X in Enterococcus faecium ATCC 51559 using D-alanyl-(R)-phenylthioglycine substrate",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL262777,,,,,,,Enterococcus faecium
187456,1236,492,Antithrombin-III,Secreted,P01008,SERPINC1,ANT3_HUMAN,7.49,,Kd,Catalyses the inactivation of coagulation proteases by activated antithrombin-III,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6819,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200644,ACTIVATOR,,Tclin,,,Homo sapiens
187457,1279,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,,,,Mechanism of Action; CHEMBL1855; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1251,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1251,ANTAGONIST,,Tclin,,,Homo sapiens
187458,2997,258,Somatostatin receptor type 2,GPCR,P30874,SSTR2,SSR2_HUMAN,10.46,,Ki,Inhibition of [125 I -Tyr]SRIF-14 binding to membranes isolated from CHO-K1 cells expressing cloned human SRIF receptor (sst-2) subtype,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2019,AGONIST,,Tclin,,361,Homo sapiens
187459,2997,1887,Somatostatin receptor type 5,GPCR,P30938,Sstr5,SSR5_RAT,9.07,,IC50,Tested for inhibition of radioligand binding to cloned somatostatin receptor rSSTR5,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,,,,,,,Rattus norvegicus
187460,2997,1980,Somatostatin receptor type 1,GPCR,P30872,SSTR1,SSR1_HUMAN,9.54,,Ki,Inhibition of [125 I -Tyr]SRIF-14 binding to membranes isolated from CHO-K1 cells expressing cloned human SRIF receptor (sst-1) subtype,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2019,AGONIST,,Tclin,,361,Homo sapiens
187461,2997,260,Somatostatin receptor type 5,GPCR,P35346,SSTR5,SSR5_HUMAN,9.85,,Ki,Inhibition of human sst5 receptor expressed in CHO cells,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2019,AGONIST,,Tclin,,361,Homo sapiens
187462,2997,1885,Somatostatin receptor type 3,GPCR,P30935,Sstr3,SSR3_MOUSE,10.1,,IC50,Tested for inhibition of radioligand binding to cloned somatostatin receptor mSSTR3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,,,,,,,Mus musculus
187463,2997,259,Somatostatin receptor type 3,GPCR,P32745,SSTR3,SSR3_HUMAN,10,,Ki,Inhibition of [125 I -Tyr]SRIF-14 binding to membranes isolated from CHO-K1 cells expressing cloned human SRIF receptor (sst-3) subtype,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2019,AGONIST,,Tclin,,361,Homo sapiens
187464,2997,2910,Somatostatin receptor,GPCR,P28646|P30680|P30936|P30937|P30938,Sstr1|Sstr2|Sstr3|Sstr4|Sstr5,SSR1_RAT|SSR2_RAT|SSR3_RAT|SSR4_RAT|SSR5_RAT,9.7,,IC50,Compound was tested for its potency to displace 3-[125I]- - Tyr11-SRIF-14 from somatostatin receptor on membranes of rat cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,,,,,,,Rattus norvegicus
187466,2997,2909,Somatostatin receptor,GPCR,O08858|P30873|P30875|P30935|P49660,Sstr1|Sstr2|Sstr3|Sstr4|Sstr5,SSR1_MOUSE|SSR2_MOUSE|SSR3_MOUSE|SSR4_MOUSE|SSR5_MOUSE,5.89,,IC50,Compound was tested for its binding affinity against somatostatin receptors on AtT-20 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,,,,,,,Mus musculus
187467,2997,1884,Somatostatin receptor type 2,GPCR,P30875,Sstr2,SSR2_MOUSE,9.55,,IC50,Tested for inhibition of radioligand binding to cloned somatostatin receptor mSSTR2b,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,,,,,,,Mus musculus
187468,2997,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,5.7,,IC50,Inhibition of [3H]-DPDPE binding to Opioid receptor delta 1 of rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,,,,,,,Rattus norvegicus
187469,2997,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,8.22,,IC50,Inhibition of binding of [3H]-naloxone to Opioid receptor mu 1 of rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,,,,,,,Rattus norvegicus
187470,2997,1886,Somatostatin receptor type 4,GPCR,P31391,SSTR4,SSR4_HUMAN,9.23,,Ki,Inhibition of human sst4 receptor expressed in CHO cells,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823872,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2019,AGONIST,,Tclin,,361,Homo sapiens
187471,2994,1908,Glucagon receptor,GPCR,P30082,Gcgr,GLR_RAT,8.82,,IC50,Compound was tested for its ability to displace [125I]glucagon from the glucagon receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266481,,,,,,,Rattus norvegicus
187472,2994,2862,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy2|Adcy3|Adcy4|Adcy5|Adcy6|Adcy8,ADCY2_RAT|ADCY3_RAT|ADCY4_RAT|ADCY5_RAT|ADCY6_RAT|ADCY8_RAT|D4A3N4_RAT|Q8CFM9_RAT,8.23,,EC50,Adenylate cyclase activity measured as 50% inhibitory concentration,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266481,,,,,,,Rattus norvegicus
187473,1123,2306,Glucagon-like peptide 1 receptor,GPCR,P32301,Glp1r,GLP1R_RAT,9.85,,IC50,Displacement of [125I]exendin-4 from GLP1 receptor in rat RINm5F cells after 2 hrs by gamma counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL414357,,,,,,,Rattus norvegicus
187474,1123,1700,Glucagon-like peptide 1 receptor,GPCR,P43220,GLP1R,GLP1R_HUMAN,9.18,,IC50,Displacement of [125I]GLP1 from human GLP1R expressed in CHOK1 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL414357,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL414357,AGONIST,,Tclin,,,Homo sapiens
187475,1010,1360,Transmembrane glycoprotein gp41,Membrane other,O40239,env,O40239_9PLVG,,,,Mechanism of Action; CHEMBL2362987; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL525076,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL525076,INHIBITOR,,,,,Human immunodeficiency virus
187476,4120,1995,Metabotropic glutamate receptor 4,GPCR,P31423,Grm4,GRM4_RAT,5.4,,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR4a in rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284377,,,,,,,Rattus norvegicus
187477,4120,697,Metabotropic glutamate receptor 4,GPCR,Q14833,GRM4,GRM4_HUMAN,6,,EC50,Agonistic activity at Metabotropic glutamate receptor 4 expressed in mammalian cells by GTPgammaS binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284377,,,,Tchem,,,Homo sapiens
187478,4120,1996,Metabotropic glutamate receptor 6,GPCR,P35349,Grm6,GRM6_RAT,5.57,,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR6 in rat,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284377,,,,,,,Rattus norvegicus
187479,4124,2828,Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2),Transcription factor,O15379|Q9Y618,HDAC3|NCOR2,HDAC3_HUMAN|NCOR2_HUMAN,8.7,,Ki,"Displacement of fluorescent 5-(3-(3-(4-((4-((7-(hydroxyamino)-7-oxoheptyl)carbamoyl)phenylamino)methyl)-1H-1,2,3-triazol-1-yl)propyl)thioureido)-2-(3-hydroxy-6-oxo-6H-xanthen-9-yl)benzoic acid from human HDAC3/NcoR2 by fluorescence polarization assay",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tchem|Tclin,,,Homo sapiens
187480,4124,2149,Histone deacetylase-like amidohydrolase,Enzyme,Q70I53,hdaH,HDAH_ALCSD,6.52,,Kd,Inhibition of Bordetella FB188 HDAH using Boc-L-Lys(acetyl)-MCA as substrate by fluorogenic enzymatic assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,,,,Alcaligenes sp. (strain DSM 11172)
187481,4124,917,Histone deacetylase 10,Enzyme,Q969S8,HDAC10,HDA10_HUMAN,7.3,,Ki,Inhibition of HDAC10,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tclin,,,Homo sapiens
187482,4124,2035,Histone deacetylase,Enzyme,Q9ZTP8,hd1b,Q9ZTP8_MAIZE,7.55,,IC50,Inhibition of maize HD1B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,,,,Zea mays
187555,4173,749,Cathepsin L1,Enzyme,P07711,CTSL,CATL1_HUMAN,5.46,,IC50,Inhibition of human Cathepsin L,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813,,,,Tclin,,,Homo sapiens
187483,4124,2307,Histone deacetylase 11,Enzyme,Q96DB2,HDAC11,HDA11_HUMAN,7.89,,Ki,Inhibition of recombinant human HDAC11 enzyme using Ac-LeuGlyLys(Ac)-AMC as substrate after 15 to 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tclin,,,Homo sapiens
187484,4124,2916,Histone deacetylase,Enzyme,O15379|P56524|Q13547|Q8WUI4|Q92769|Q969S8|Q96DB2|Q9BY41|Q9UBN7|Q9UKV0|Q9UQL6,HDAC1|HDAC10|HDAC11|HDAC2|HDAC3|HDAC4|HDAC5|HDAC6|HDAC7|HDAC8|HDAC9,HDA10_HUMAN|HDA11_HUMAN|HDAC1_HUMAN|HDAC2_HUMAN|HDAC3_HUMAN|HDAC4_HUMAN|HDAC5_HUMAN|HDAC6_HUMAN|HDAC7_HUMAN|HDAC8_HUMAN|HDAC9_HUMAN,8,,IC50,Inhibitory activity against Histone deacetylase (HDAC) in K 562 erythroleukemia cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
187485,4124,717,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,6.76,,Ki,Competitive inhibition of HDAC8 using KI-104 as substrate by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tclin,,,Homo sapiens
187486,4124,2917,Histone deacetylase 1/3/5/8,Enzyme,O15379|Q13547|Q9BY41|Q9UQL6,HDAC1|HDAC3|HDAC5|HDAC8,HDAC1_HUMAN|HDAC3_HUMAN|HDAC5_HUMAN|HDAC8_HUMAN,6.96,,IC50,Inhibition of HDAC1/3/5/8 in human HeLa cell extract using Boc-Lys-(acetyl)-AMC as substrate incubated for 5 mins prior to substrate addition measured after 30 mins by fluorometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
187487,4124,2829,Histone deacetylase 3/NCoR1,Transcription factor,O15379|O75376,HDAC3|NCOR1,HDAC3_HUMAN|NCOR1_HUMAN,7.92,,Ki,Inhibition of GST-tagged recombinant human HDAC3/NcoR1 enzyme using flurogenic Ac-LeuGlyLys (Ac)-AMC as substrate after 15 to 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tchem|Tclin,,,Homo sapiens
187488,4124,2435,Lysine-specific demethylase 4E,Enzyme,B2RXH2,KDM4E,KDM4E_HUMAN,4.85,,IC50,Inhibition of JMJD2E pre-incubated for 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tchem,,,Homo sapiens
187489,4124,2400,Histone deacetylase,Enzyme,Q7K6A1,PfHDAC1,Q7K6A1_PLAF7,7,,IC50,Inhibition of Plasmodium falciparum 3D7 histone deacetylase infected in human erythrocytes assessed as alteration of histone H3 acetylation after 3.5 hrs by SDS-PAGE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,,,,Plasmodium falciparum
187490,4124,810,Histone deacetylase 9,Enzyme,Q9UKV0,HDAC9,HDAC9_HUMAN,7.31,,Ki,Competitive inhibition of HDAC9 using KI-104 as substrate by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tclin,,,Homo sapiens
187491,4124,630,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,9,,Ki,"Displacement of fluorescent 5-(3-(3-(4-((4-((7-(hydroxyamino)-7-oxoheptyl)carbamoyl)phenylamino)methyl)-1H-1,2,3-triazol-1-yl)propyl)thioureido)-2-(3-hydroxy-6-oxo-6H-xanthen-9-yl)benzoic acid from human HDAC6 by fluorescence polarization assay",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,INHIBITOR,,Tclin,,,Homo sapiens
187492,4124,606,Histone deacetylase 1,Enzyme,Q13547,HDAC1,HDAC1_HUMAN,8.89,,Ki,Inhibition of human HDAC1,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,INHIBITOR,,Tclin,,,Homo sapiens
187493,4124,766,Histone deacetylase 4,Enzyme,P56524,HDAC4,HDAC4_HUMAN,7.8,,Ki,Inhibition of HDAC4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tclin,,,Homo sapiens
187494,4124,619,Histone deacetylase 3,Enzyme,O15379,HDAC3,HDAC3_HUMAN,8.3,,Ki,Inhibition of human HDAC3,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,INHIBITOR,,Tclin,,,Homo sapiens
187495,4124,1818,Histone deacetylase 1,Enzyme,O09106,Hdac1,HDAC1_MOUSE,6.95,,IC50,In vitro for anti-HDAC1 (Histone deacetylase 1) activity in mouse A20 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,,,,Mus musculus
187496,4124,598,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,8.8,,Ki,Inhibition of human HDAC2,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,INHIBITOR,,Tclin,,,Homo sapiens
187497,4124,2109,Histone deacetylase,Enzyme,Q9XYC7,HDAC1,Q9XYC7_PLAFA,7.23,,IC50,Inhibition of Plasmodium falciparum HDAC1 expressed in Drosophila melanogaster S2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,,,,Plasmodium falciparum
187498,4124,575,Histone deacetylase 5,Enzyme,Q9UQL6,HDAC5,HDAC5_HUMAN,7.48,,Ki,Inhibition of HDAC5,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tclin,,,Homo sapiens
187499,4124,2918,Histone deacetylase (HDAC1 and HDAC2),Enzyme,Q13547|Q92769,HDAC1|HDAC2,HDAC1_HUMAN|HDAC2_HUMAN,8,,IC50,Inhibition of human histone deacetylase (mixture of HDAC1 and HDAC2) prepared from K562 erythroleukemia cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tclin|Tclin,,,Homo sapiens
187500,4124,1812,HD2 type histone deacetylase HDA106; Histone deacetylase 2b; Uncharacterized protein,Enzyme,Q94F81,hda106,Q94F81_MAIZE,7.3,,IC50,In vitro for anti-HD2 (Histone deacetylase 2) activity in maize,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,,,,Zea mays
187501,4124,2919,Histone deacetylase,Enzyme,B1WBY8|Q4QQW4|Q5RJZ2|Q6P6W3|Q99P96|Q99P97|Q99P99,Hdac1|Hdac2|Hdac3|Hdac4|Hdac5|Hdac6|Hdac7,B1WBY8_RAT|HDAC1_RAT|HDAC3_RAT|HDAC4_RAT|HDAC7_RAT|Q5RJZ2_RAT|Q99P97_RAT,6.78,,IC50,Inhibitory concentration against rat liver Histone deacetylase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,,,,Rattus norvegicus
187502,4124,668,Histone deacetylase 7,Enzyme,Q8WUI4,HDAC7,HDAC7_HUMAN,6.89,,Ki,Competitive inhibition of HDAC7 using KI-104 as substrate by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL98,,,,Tclin,,,Homo sapiens
187503,4125,1372,"Glutamate receptor ionotropic, NMDA 1",Ion channel,P35439,Grin1,NMDZ1_RAT,4.76,,IC50,Inhibitory concentration required to inhibit [3H]strychnine binding to N-methyl-D-aspartate glutamate receptor 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54922,,,,,,,Rattus norvegicus
187504,4127,3635,Gamma-glutamyltranspeptidase 1,Unclassified,P07314,Ggt1,GGT1_RAT,4.3,,Ki,Inhibition of Rattus norvegicus Wistar (rat) rat Gamma-glutamyltranspeptidase using L-gamma-glutamyl-p-nitroanilide as substrate incubated for 15 min prior to substrate addition by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11298,,,,,,,Rattus norvegicus
187505,4134,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,4.52,,Ki,Tested for its ability to inhibit rabbit liver aldehyde oxidase catalyzed oxidation of N-methyl-nicotinamide (NMN),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL102970,,,,Tbio,,,Homo sapiens
217040,913,2108,Prostaglandin F2-alpha receptor,GPCR,P43117,Ptgfr,PF2R_MOUSE,7,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Mus musculus
187506,4135,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,Mechanism of Action; CHEMBL222; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201178,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201178,RELEASING AGENT,,Tclin,,,Homo sapiens
187507,4135,320,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,,,,Mechanism of Action; CHEMBL1893; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201178,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201178,INHIBITOR,,Tclin,,,Homo sapiens
187508,4137,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.89,,IC50,Inhibition of human ERG channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1621,,,,Tclin,,,Homo sapiens
187509,4142,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,4.68,,IC50,Inhibition of aurora kinase A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439,,,,Tchem,,,Homo sapiens
187510,4142,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439,INHIBITOR,,,,,Escherichia coli (strain K12)
187511,4143,1730,Pol polyprotein,Enzyme,Q72874,pol,Q72874_9HIV1,10.85,,Ki,Inhibition of HIV1 protease,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1323,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1323,INHIBITOR,,,,,Human immunodeficiency virus 1
187512,4146,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.6,,Ki,Displacement of [3H]DHT from human androgen receptor in MDA453 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1170,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1170,AGONIST,,Tclin,,,Homo sapiens
187513,4146,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.72,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1170,,,,,,,Rattus norvegicus
187514,4146,425,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,7.25,,IC50,"In vitro cytochrome P450 17A1 inhibition was assayed using the rapid acetic acid releasing assay (AARA), utilizing intact P450c17-expressing Escherichia coli or P450c17-LNCaP cells as the enzyme source.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1170,,,,Tclin,,,Homo sapiens
187515,4149,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL491571,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL491571,INHIBITOR,,,,,Escherichia coli (strain K12)
187516,4151,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,10.44,,Ki,Binding constant measured against Alpha-1A adrenergic receptor in human prostate; +++:highly active,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24778,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24778,ANTAGONIST,,Tclin,,,Homo sapiens
187517,4152,2643,Sodium channel protein,Ion channel,Q2VKV7,vssc,Q2VKV7_SARSC,,,,Mechanism of Action; CHEMBL2362985; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1525,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1525,BLOCKER,,,,,Sarcoptes scabiei type hominis
187518,4150,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,9.72,,Ki,Antagonist activity against human CB1 receptor expressed in CHO-K1 cells by [35S]GTPgamma binding assay,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000666/WC500021287.pdf,ANTAGONIST,,Tclin,,233,Homo sapiens
187519,4150,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.6,,IC50,Inhibition of human recombinant AChE expressed in HEK293 cells by photometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111,,,,Tclin,,,Homo sapiens
187520,4150,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.55,,IC50,Inhibition of human ERG expressed in HEK293 cells assessed as inhibition of potassium channel current after 5 mins by patch clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111,,,,Tclin,,,Homo sapiens
187521,4150,1910,Cannabinoid receptor 2,GPCR,P47936,Cnr2,CNR2_MOUSE,6.43,,Ki,Displacement of [3H]CP55940 from CB2 receptor in CD1 mouse spleen membrane by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111,,,,,,,Mus musculus
187522,4150,2568,G-protein coupled receptor 55,GPCR,Q9Y2T6,GPR55,GPR55_HUMAN,5.7,,EC50,Agonist activity at GPR55 (unknown origin) expressed in CHO cells assessed as inhibition of LPI-induced beta-arrestin translocation after 90 mins by luminescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111,,,,Tclin,,,Homo sapiens
187523,4150,608,Cannabinoid receptor 2,GPCR,P34972,CNR2,CNR2_HUMAN,8.96,,Ki,Displacement of [3H]-CP-55940 from human CB2 receptor expressed in HEK293T cell membranes by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111,,,,Tchem,,,Homo sapiens
187524,4150,1195,N-arachidonyl glycine receptor,GPCR,Q14330,GPR18,GPR18_HUMAN,5,,IC50,Antagonist activity at human GPR18 transfected in CHO cells assessed as delta9-THC-induced beta-arrestin recruitment incubated 60 mins prior to delta9-THC addition by beta-arrestin translocation assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111,,,,Tbio,,,Homo sapiens
187525,4150,1955,Cannabinoid receptor 1,GPCR,P47746,Cnr1,CNR1_MOUSE,8.82,,Ki,Displacement of [3H]CP55940 from CB1 receptor in CD1 mouse brain membrane without cerebellum by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111,,,,,,,Mus musculus
187526,4150,1811,Cannabinoid receptor 1,GPCR,P20272,Cnr1,CNR1_RAT,9.51,,Ki,Antagonist activity at rat CB1 receptor in SF9 cells assessed as inhibition of CP-55940-stimulated GTPgammaS binding,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111,,,,,,,Rattus norvegicus
187527,4161,441,Serine/threonine-protein kinase mTOR,Kinase,P42345,MTOR,MTOR_HUMAN,5.75,,IC50,Inhibition of FKBP12-independent human recombinant mTOR expressed in HEK293 cells using His6-S6K1 as a substrate by DELFIA assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201182,,,,Tclin,,,Homo sapiens
187528,4161,178,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,P62942,FKBP1A,FKB1A_HUMAN,,,,Mechanism of Action; CHEMBL1902; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201182,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201182,INHIBITOR,,Tclin,,,Homo sapiens
187529,4162,2752,Potassium-transporting ATPase,Transporter,P20648|P51164,ATP4A|ATP4B,ATP4A_HUMAN|ATP4B_HUMAN,,,,Mechanism of Action; CHEMBL2095173; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201863,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201863,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
187530,4163,3412,Voltage-gated potassium channel,Ion channel,O43525|O43526|O95259|P16389|P17658|P22001|P22459|P22460|P48547|P51787|P56696|Q03721|Q09470|Q12809|Q14003|Q14721|Q16322|Q6PIU1|Q8NCM2|Q8TAE7|Q8TDN1|Q8TDN2|Q92953|Q96KK3|Q96L42|Q96PR1|Q96RP8|Q9BQ31|Q9H252|Q9H3M0|Q9NR82|Q9NS40|Q9NSA2|Q9NZV8|Q9UIX4|Q9UJ96|Q9UK17|Q9ULD8|Q9ULS6|Q9UQ05,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,KCA10_HUMAN|KCNA1_HUMAN|KCNA2_HUMAN|KCNA3_HUMAN|KCNA4_HUMAN|KCNA5_HUMAN|KCNA6_HUMAN|KCNA7_HUMAN|KCNB1_HUMAN|KCNB2_HUMAN|KCNC1_HUMAN|KCNC2_HUMAN|KCNC3_HUMAN|KCNC4_HUMAN|KCND1_HUMAN|KCND2_HUMAN|KCND3_HUMAN|KCNF1_HUMAN|KCNG1_HUMAN|KCNG2_HUMAN|KCNG3_HUMAN|KCNG4_HUMAN|KCNH1_HUMAN|KCNH2_HUMAN|KCNH3_HUMAN|KCNH4_HUMAN|KCNH5_HUMAN|KCNH6_HUMAN|KCNH7_HUMAN|KCNH8_HUMAN|KCNQ1_HUMAN|KCNQ2_HUMAN|KCNQ3_HUMAN|KCNQ4_HUMAN|KCNQ5_HUMAN|KCNS1_HUMAN|KCNS2_HUMAN|KCNS3_HUMAN|KCNV1_HUMAN|KCNV2_HUMAN,,,,Mechanism of Action; CHEMBL2362996; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284348,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284348,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
187531,4165,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action; CHEMBL231; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201747,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201747,ANTAGONIST,,Tclin,,,Homo sapiens
187532,4167,2626,Sphingosine 1-phosphate receptor 3,GPCR,Q99500,S1PR3,S1PR3_HUMAN,8.52,,EC50,Agonist activity at S1P3 receptor (unknown origin),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL314854,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL314854,AGONIST,,Tclin,,,Homo sapiens
187533,4167,2016,Sphingosine 1-phosphate receptor 5,GPCR,Q9H228,S1PR5,S1PR5_HUMAN,9.52,,EC50,Agonist activity at S1P5 receptor (unknown origin),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL314854,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL314854,AGONIST,,Tclin,,,Homo sapiens
187534,4167,1548,Sphingosine-1-phosphate lyase 1,Enzyme,O95470,SGPL1,SGPL1_HUMAN,4.77,,IC50,Inhibition of human recombinant S1PL (62 to 568) expressed in Sf9 insect cells using S1P as substrate after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL314854,,,,Tchem,,,Homo sapiens
187535,4167,2625,Sphingosine 1-phosphate receptor 4,GPCR,O95977,S1PR4,S1PR4_HUMAN,9.52,,EC50,Agonist activity at S1P4 receptor (unknown origin),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL314854,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL314854,AGONIST,,Tclin,,,Homo sapiens
187536,4167,2015,Sphingosine 1-phosphate receptor 1,GPCR,P21453,S1PR1,S1PR1_HUMAN,9.52,,EC50,Agonist activity at S1P1 receptor (unknown origin),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL314854,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL314854,AGONIST,,Tclin,,,Homo sapiens
187537,4169,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501122,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501122,INHIBITOR,,,,,Escherichia coli (strain K12)
187538,4172,2379,Cathepsin F,Enzyme,Q9UBX1,CTSF,CATF_HUMAN,5.96,,IC50,Inhibition of human Cathepsin F,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394,,,,Tchem,,,Homo sapiens
187539,4172,2377,Cathepsin K,Enzyme,P43235,CTSK,CATK_HUMAN,7.4,,IC50,Inhibition of human Cathepsin K,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394,,,,Tchem,,,Homo sapiens
187540,4172,733,Cathepsin B,Enzyme,P07858,CTSB,CATB_HUMAN,5.21,,IC50,Inhibition of human CatB after 60 mins fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394,,,,Tchem,,,Homo sapiens
187541,4172,2376,Cathepsin L2,Enzyme,O60911,CTSV,CATL2_HUMAN,7.12,,IC50,Inhibition of human Cathepsin V,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394,,,,Tchem,,,Homo sapiens
187542,4172,663,Neutrophil elastase,Enzyme,P08246,ELANE,ELNE_HUMAN,4.77,,IC50,Inhibition of human leukocyte elastase after 60 mins fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394,,,,Tclin,,,Homo sapiens
187543,4172,756,Chymase,Enzyme,P23946,CMA1,CMA1_HUMAN,7.49,,IC50,Inhibition of human Chymase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394,,,,Tchem,,,Homo sapiens
187545,4172,2378,Cathepsin S,Enzyme,P25774,CTSS,CATS_HUMAN,6.92,,IC50,Inhibition of human Cathepsin S,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394,,,,Tchem,,,Homo sapiens
187546,4172,749,Cathepsin L1,Enzyme,P07711,CTSL,CATL1_HUMAN,6.12,,IC50,Inhibition of human Cathepsin L,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394,,,,Tclin,,,Homo sapiens
187547,4173,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,5.06,,IC50,Inhibition of human plasmin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813,,,,Tclin,,,Homo sapiens
187548,4173,2377,Cathepsin K,Enzyme,P43235,CTSK,CATK_HUMAN,6.2,,IC50,Inhibition of human Cathepsin K,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813,,,,Tchem,,,Homo sapiens
187549,4173,733,Cathepsin B,Enzyme,P07858,CTSB,CATB_HUMAN,6.68,,IC50,Inhibition of cathepsin B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813,,,,Tchem,,,Homo sapiens
187550,4173,2376,Cathepsin L2,Enzyme,O60911,CTSV,CATL2_HUMAN,5.87,,IC50,Inhibition of human Cathepsin V,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813,,,,Tchem,,,Homo sapiens
187551,4173,688,Chymotrypsin-like elastase family member 1,Enzyme,Q9UNI1,CELA1,CELA1_HUMAN,7.52,,IC50,Inhibition of human Pancreatic elastase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813,,,,Tchem,,,Homo sapiens
187552,4173,663,Neutrophil elastase,Enzyme,P08246,ELANE,ELNE_HUMAN,6.17,,IC50,Inhibition of human leukocyte elastase after 60 mins fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813,,,,Tclin,,,Homo sapiens
187553,4173,756,Chymase,Enzyme,P23946,CMA1,CMA1_HUMAN,7.59,,IC50,Inhibition of human Chymase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813,,,,Tchem,,,Homo sapiens
187556,4173,2926,"Hepatitis C virus serine protease, NS3/NS4A",Enzyme,A3EZI9|D2K2A8,NS3|NS4A,A3EZI9_9HEPC|D2K2A8_9HEPC,,,,Mechanism of Action; CHEMBL2095231; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231813,INHIBITOR,,,,,Hepatitis C virus
187557,4174,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,,,,Mechanism of Action; CHEMBL247; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175691,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175691,INHIBITOR,,,,,Human immunodeficiency virus 1
187558,4175,829,Prolyl endopeptidase FAP,Enzyme,Q12884,FAP,SEPR_HUMAN,7.05,,IC50,Inhibition of FAPalpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL237500,,,,Tchem,,,Homo sapiens
187559,4175,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.53,,IC50,Displacement of [N-methyl-3H]scopolamine from human recombinant muscarinic M1 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL237500,,,,Tclin,,,Homo sapiens
187560,4175,2476,Prolyl endopeptidase FAP,Enzyme,P97321,Fap,SEPR_MOUSE,6.43,,IC50,Inhibition of mouse recombinant FAP expressed in HEK293 cells using Ala-Pro-p-nitroanilide as substrate incubated for 15 mins prior to substrate addition,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL237500,,,,,,,Mus musculus
187561,4175,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,10,,IC50,Inhibition of human C-terminal step-tagged DPP4 expressed using baculovirus system,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL237500,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL237500,INHIBITOR,,Tclin,,,Homo sapiens
187562,4176,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.57,,IC50,Inhibition of CYP3A4 expressed in baculovirus infected insect microsomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254328,,,,Tclin,,,Homo sapiens
187563,4176,443,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,5.79,,IC50,Inhibition of human CYP11B1 expressed in hamster V79MZh11B1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254328,,,,Tclin,,,Homo sapiens
187564,4176,673,"Cytochrome P450 11B2, mitochondrial",Enzyme,P19099,CYP11B2,C11B2_HUMAN,5.76,,IC50,Inhibition of human CYP11B2 expressed in hamster V79MZh11B2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254328,,,,Tchem,,,Homo sapiens
187565,4176,425,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,8.54,,IC50,"Ability to inhibit the C17,20-lyase enzyme by 50% using 17-alpha-hydroxyprogesterone as substrate.",CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254328,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9288,INHIBITOR,,Tclin,,,Homo sapiens
187566,4176,3621,Cytochrome P450 17A1,Enzyme,P11715,Cyp17a1,CP17A_RAT,7.9,,IC50,"Inhibition of Wistar rat testicular C17,20-lyase using [3H]17-hydroxyprogesterone as substrate preincubated for 20 mins",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254328,,,,,,,Rattus norvegicus
187567,4178,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,5.74,,Kd,Binding constant for full-length MEK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187568,4178,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,6.72,,Kd,Binding constant for FLT3(K663Q) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187569,4178,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8.05,,Kd,Binding constant for ABL1(Y253F)-phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187570,4178,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,8.32,,Kd,Binding constant for EGFR(E746-A750del) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,INHIBITOR,,Tclin,,,Homo sapiens
187571,4178,2268,Tubulin alpha-1A chain,Structural,P68370,Tuba1a,TBA1A_RAT,6.32,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,,,,Rattus norvegicus
187572,4178,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,6.59,,Kd,Binding constant for FLT1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tclin,,,Homo sapiens
187573,4178,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7.15,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tclin,,,Homo sapiens
187574,4178,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,6.33,,Kd,Average Binding Constant for VEGFR2; NA=Not Active at 10 uM,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,INHIBITOR,,Tclin,,,Homo sapiens
187575,4178,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.62,,Kd,Average Binding Constant for FGFR3; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187576,4178,2364,Serine/threonine-protein kinase 35,Kinase,Q8TDR2,STK35,STK35_HUMAN,7.25,,Kd,Binding constant for STK35 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187577,4178,2281,Fibroblast growth factor receptor 4,Kinase,P22455,FGFR4,FGFR4_HUMAN,5.64,,Kd,Binding constant for FGFR4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187578,4178,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,6.64,,Kd,Binding constant for PDGFRA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187579,4178,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,5.39,,Kd,Binding constant for MET(Y1235D) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187580,4178,837,Casein kinase I isoform epsilon,Kinase,P49674,CSNK1E,KC1E_HUMAN,5.82,,Kd,Average Binding Constant for CSNK1E; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187581,4178,887,Receptor-interacting serine/threonine-protein kinase 2,Kinase,O43353,RIPK2,RIPK2_HUMAN,8.34,,Kd,Binding constant for RIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187582,4178,922,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,6.28,,Kd,Binding constant for EPHB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187583,4178,2134,Ribosomal protein S6 kinase alpha-6,Kinase,Q9UK32,RPS6KA6,KS6A6_HUMAN,6.62,,Kd,Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187584,4178,2283,Ribosomal protein S6 kinase alpha-1,Kinase,Q15418,RPS6KA1,KS6A1_HUMAN,6.4,,Kd,Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187585,4178,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,7.07,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187586,4178,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,7.31,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187587,4178,2168,Mitogen-activated protein kinase kinase kinase MLT,Kinase,Q9NYL2,ZAK,MLTK_HUMAN,5.29,,Kd,Binding constant for ZAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187588,4178,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,5.77,,Kd,Binding constant for BTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187589,4178,2264,Ephrin type-A receptor 1,Kinase,P21709,EPHA1,EPHA1_HUMAN,6.64,,Kd,Binding constant for EPHA1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187590,4178,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,5.26,,Kd,Binding constant for HPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187591,4178,2257,AarF domain-containing protein kinase 4,Kinase,Q96D53,COQ8B,COQ8B_HUMAN,5.77,,Kd,Binding constant for full-length ADCK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tbio,,,Homo sapiens
187592,4178,2188,MAP kinase-interacting serine/threonine-protein kinase 1,Kinase,Q9BUB5,MKNK1,MKNK1_HUMAN,6.44,,Kd,Binding constant for full-length MKNK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187593,4178,2241,Serine/threonine-protein kinase MRCK alpha,Kinase,Q5VT25,CDC42BPA,MRCKA_HUMAN,5.59,,Kd,Binding constant for MRCKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187594,4178,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,6.57,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187595,4178,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,6.77,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187596,4178,736,Ephrin type-A receptor 8,Kinase,P29322,EPHA8,EPHA8_HUMAN,7.04,,Kd,Binding constant for EPHA8 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187597,4178,536,Ephrin type-A receptor 2,Kinase,P29317,EPHA2,EPHA2_HUMAN,5.96,,Kd,Binding constant for EPHA2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tclin,,,Homo sapiens
187598,4178,853,Ephrin type-A receptor 3,Kinase,P29320,EPHA3,EPHA3_HUMAN,5.74,,Kd,Average Binding Constant for EPHA3; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187599,4178,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,7.09,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187600,4178,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,6.21,,Kd,Binding constant for PLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187601,4178,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,6.92,,Kd,Binding constant for YES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187602,4178,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,5.6,,Kd,Binding constant for full-length CSK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187603,4178,2202,Serine/threonine-protein kinase TNNI3K,Kinase,Q59H18,TNNI3K,TNI3K_HUMAN,5.55,,Kd,Binding constant for full-length TNNI3K,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187604,4178,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.59,,Kd,Binding constant for ERBB2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tclin,,,Homo sapiens
187605,4178,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,6.44,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187606,4178,792,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,5.82,,Kd,Binding constant for full-length AURKC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187607,4178,574,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,5.1,,Kd,Binding constant for PHKG2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187608,4178,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.06,,Kd,Binding constant for PDGFRB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187609,4178,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,6.25,,Kd,Binding constant for FGFR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187610,4178,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,5.96,,Kd,Binding constant for FGFR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187611,4178,2245,Citron Rho-interacting kinase,Kinase,O14578,CIT,CTRO_HUMAN,5.74,,Kd,Binding constant for CIT kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tbio,,,Homo sapiens
187612,4178,2207,"Chaperone activity of bc1 complex-like, mitochondrial",Kinase,Q8NI60,COQ8A,COQ8A_HUMAN,5.35,,Kd,Binding constant for ADCK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tbio,,,Homo sapiens
187700,4187,2197,SRSF protein kinase 1,Kinase,Q96SB4,SRPK1,SRPK1_HUMAN,5.74,,Kd,Binding constant for SRPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187613,4178,876,Mitogen-activated protein kinase kinase kinase 4,Kinase,Q9Y6R4,MAP3K4,M3K4_HUMAN,5.52,,Kd,Binding constant for MAP3K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tbio,,,Homo sapiens
187614,4178,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,6.35,,Kd,Binding constant for MAP4K5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187615,4178,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,5.47,,Kd,Binding constant for MINK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187616,4178,2320,Interleukin-1 receptor-associated kinase 4,Kinase,Q9NWZ3,IRAK4,IRAK4_HUMAN,7.12,,Kd,Binding constant for IRAK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187617,4178,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.47,,Kd,Binding constant for KIT(A829P) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187618,4178,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,6.32,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tclin,,,Homo sapiens
187619,4178,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,7.3,,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187620,4178,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,5.64,,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187621,4178,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,7.02,,Kd,Average Binding Constant for SLK; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187622,4178,903,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,Q9HBH9,MKNK2,MKNK2_HUMAN,5.77,,Kd,Binding constant for MKNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187623,4178,2375,Bone morphogenetic protein receptor type-1B,Kinase,O00238,BMPR1B,BMR1B_HUMAN,6.62,,Kd,Binding constant for BMPR1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tbio,,,Homo sapiens
187624,4178,53,Macrophage-stimulating protein receptor,Kinase,Q04912,MST1R,RON_HUMAN,5.47,,IC50,In vitro inhibition of Met proto-oncogene tyrosine kinase (c-Met) expressed in baculovirus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187625,4178,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,5.92,,Kd,Binding constant for IRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187626,4178,898,Ephrin type-A receptor 7,Kinase,Q15375,EPHA7,EPHA7_HUMAN,5.62,,Kd,Binding constant for EPHA7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187627,4178,2024,Protein-tyrosine kinase 6,Kinase,Q13882,PTK6,PTK6_HUMAN,7.48,,Kd,Average Binding Constant for PTK6; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187628,4178,755,5'-AMP-activated protein kinase catalytic subunit alpha-1,Kinase,Q13131,PRKAA1,AAPK1_HUMAN,5.52,,Kd,Binding constant for AMPK-alpha1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187629,4178,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.96,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187630,4178,802,Ephrin type-A receptor 5,Kinase,P54756,EPHA5,EPHA5_HUMAN,6.62,,Kd,Binding constant for EPHA5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187631,4178,803,Ephrin type-A receptor 4,Kinase,P54764,EPHA4,EPHA4_HUMAN,5.8,,Kd,Binding constant for EPHA4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187632,4178,769,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",Kinase,Q16816,PHKG1,PHKG1_HUMAN,5.96,,Kd,Binding constant for full-length PHKG1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187633,4178,890,Ephrin type-B receptor 1,Kinase,P54762,EPHB1,EPHB1_HUMAN,6.54,,Kd,Binding constant for EPHB1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187634,4178,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,5.82,,Kd,Binding constant for MAP4K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187635,4178,2262,Dual specificity testis-specific protein kinase 1,Kinase,Q15569,TESK1,TESK1_HUMAN,5.43,,Kd,Binding constant for TESK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tbio,,,Homo sapiens
187636,4178,966,Activin receptor type-1,Kinase,Q04771,ACVR1,ACVR1_HUMAN,6.82,,Kd,Binding constant for ACVR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187637,4178,2209,Serine/threonine-protein kinase MRCK gamma,Kinase,Q6DT37,CDC42BPG,MRCKG_HUMAN,5.66,,Kd,Binding constant for DMPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tbio,,,Homo sapiens
187638,4178,2242,Serine/threonine-protein kinase MRCK beta,Kinase,Q9Y5S2,CDC42BPB,MRCKB_HUMAN,5.6,,Kd,Binding constant for MRCKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tbio,,,Homo sapiens
187639,4178,2357,Serine/threonine-protein kinase ULK3,Kinase,Q6PHR2,ULK3,ULK3_HUMAN,5.19,,Kd,Binding constant for ULK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187640,4178,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,7.16,,Kd,Binding constant for ABL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187641,4178,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,7.18,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187642,4178,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,6,,Kd,Binding constant for TIE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tclin,,,Homo sapiens
187643,4178,2368,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,6.8,,Kd,Binding constant for ERBB3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187644,4178,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,7.12,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187645,4178,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,6.37,,Kd,Binding constant for full-length SNF1LK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187646,4178,2261,Tyrosine-protein kinase Srms,Kinase,Q9H3Y6,SRMS,SRMS_HUMAN,5.72,,Kd,Binding constant for SRMS kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187647,4178,2084,Cyclin-dependent kinase 7,Kinase,P50613,CDK7,CDK7_HUMAN,5.39,,Kd,Binding constant for CDK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187648,4178,2448,Serine/threonine-protein kinase 32A,Kinase,Q8WU08,STK32A,ST32A_HUMAN,5.3,,Kd,Binding constant for YANK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tdark,,,Homo sapiens
187649,4178,2373,Serine/threonine-protein kinase SIK3,Kinase,Q9Y2K2,SIK3,SIK3_HUMAN,5.41,,Kd,Binding constant for QSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187650,4178,713,Rho-associated protein kinase 2,Kinase,O75116,ROCK2,ROCK2_HUMAN,5.44,,Kd,Binding constant for ROCK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187651,4178,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.44,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187652,4178,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,5.92,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187653,4178,543,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,6.52,,Kd,Average Binding Constant for FLT4; NA=Not Active at 10 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tclin,,,Homo sapiens
187654,4178,2337,Hormonally up-regulated neu tumor-associated kinase,Kinase,P57058,HUNK,HUNK_HUMAN,5.39,,Kd,Binding constant for HUNK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tbio,,,Homo sapiens
187655,4178,2205,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,6.49,,Kd,Binding constant for DDR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187656,4178,2269,Mitogen-activated protein kinase 6,Kinase,Q16659,MAPK6,MK06_HUMAN,5.82,,Kd,Binding constant for ERK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tbio,,,Homo sapiens
187657,4178,965,Serine/threonine-protein kinase receptor R3,Kinase,P37023,ACVRL1,ACVL1_HUMAN,6.33,,Kd,Binding constant for ACVRL1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187658,4178,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,5.82,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187659,4178,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7.85,,Kd,Binding constant for RET(M918T) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,INHIBITOR,,Tclin,,,Homo sapiens
187660,4178,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,7.96,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187661,4178,2226,Mitogen-activated protein kinase kinase kinase kinase 4,Kinase,O95819,MAP4K4,M4K4_HUMAN,5.85,,Kd,Binding constant for MAP4K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187662,4178,2082,Tyrosine-protein kinase receptor TYRO3,Kinase,Q06418,TYRO3,TYRO3_HUMAN,7.03,,Kd,Binding constant for TYRO3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187663,4178,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,7.77,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187664,4178,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,6.26,,Kd,Binding constant for LTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187665,4178,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,6.01,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187666,4178,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,6.6,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187667,4178,2083,Ephrin type-B receptor 2,Kinase,P29323,EPHB2,EPHB2_HUMAN,6.36,,Kd,Binding constant for EPHB2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,INHIBITOR,,Tchem,,,Homo sapiens
187668,4178,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,5.96,,Kd,Binding constant for full-length MEK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187669,4178,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,5.43,,Kd,Binding constant for TXK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187670,4178,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,5.68,,Kd,Binding constant for ALK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tclin,,,Homo sapiens
187671,4178,2088,Ribosomal protein S6 kinase beta-1,Kinase,P23443,RPS6KB1,KS6B1_HUMAN,5.8,,Kd,Binding constant for S6K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187672,4178,2201,Serine/threonine-protein kinase 33,Kinase,Q9BYT3,STK33,STK33_HUMAN,5.85,,Kd,Binding constant for full-length STK33,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187673,4178,2362,Receptor-interacting serine/threonine-protein kinase 4,Kinase,P57078,RIPK4,RIPK4_HUMAN,6.21,,Kd,Binding constant for RIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187674,4178,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,5.8,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187675,4178,2260,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,5.72,,Kd,Binding constant for SNF1LK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187676,4178,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,5.85,,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24828,,,,Tchem,,,Homo sapiens
187677,4180,2928,DNA-directed RNA polymerase,Enzyme,Q182S6|Q18CF1|Q18CF3|Q18CI5,rpoA|rpoB|rpoC|rpoZ,RPOA_PEPD6|RPOB_PEPD6|RPOC_PEPD6|RPOZ_PEPD6,,,,Mechanism of Action; CHEMBL2363852; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445546,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445546,INHIBITOR,,,,,Peptoclostridium difficile (strain 630)
187678,4181,1813,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,Q9Z351,Kcnq2,KCNQ2_MOUSE,5.89,,EC50,Induction of mouse KCNQ2 expressed in HEK293 cells at -40 mV holding potential by whole-cell patch clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41355,,,,,,,Mus musculus
187679,4182,631,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,9.4,,Ki,Inhibition of Factor 10a,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL198362,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL198362,INHIBITOR,,Tclin,,,Homo sapiens
187680,4183,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.8,,Ki,Binding affinity to human beta2-adrenoceptor by radioligand binding assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095777,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095777,AGONIST,,Tclin,,,Homo sapiens
187681,4183,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,7.04,,Ki,Displacement of [3H]CGP12177 from human beta-1 adrenoceptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095777,,,,Tclin,,,Homo sapiens
187682,4183,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,4.6,,IC50,Binding affinity to dopamine 2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095777,,,,Tclin,,,Homo sapiens
187683,4184,327,P2Y purinoceptor 12,GPCR,Q9H244,P2RY12,P2Y12_HUMAN,7.85,,Ki,Displacement of [33P]2-MeS-ADP from human recombinant P2Y12 receptor expressed in CHO cell membranes by scintillation counting method,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL398435,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL398435,NEGATIVE ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
187684,4185,537,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,7.32,,IC50,Inhibition of C-Raf in presence of 100 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1229517,,,,Tclin,,,Homo sapiens
187685,4185,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,7.68,,IC50,Inhibition of wild type BRAF (unknown origin),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1229517,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1229517,INHIBITOR,,Tclin,,,Homo sapiens
187686,4186,1764,B2 bradykinin receptor,GPCR,P25023,Bdkrb2,BKRB2_RAT,10.11,,Ki,Binding affinity against rat bradykinin B2 receptors expressed in CHO cells using [3H]bradykinin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2028850,,,,,,,Rattus norvegicus
187687,4186,2569,B2 bradykinin receptor,GPCR,O70526,BDKRB2,BKRB2_CAVPO,9.96,,Ki,In vitro binding affinity against bradykinin receptor B2 from guinea pig ileum.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2028850,,,,,,,Cavia porcellus
187688,4186,1715,B2 bradykinin receptor,GPCR,P30411,BDKRB2,BKRB2_HUMAN,10.22,,Ki,Binding affinity towards human cloned Bradykinin receptor B2 expressed in CHO cells by [3H]bradykinin displacement.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2028850,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2028850,ANTAGONIST,,Tclin,,,Homo sapiens
187689,4187,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,6.68,,Kd,Binding constant for FLT3(D835Y) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187690,4187,2323,Cyclin-dependent kinase-like 2,Kinase,Q92772,CDKL2,CDKL2_HUMAN,5.68,,Kd,Binding constant for CDKL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187691,4187,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8,,Kd,Binding constant for ABL1(T315I)-phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187692,4187,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.57,,Kd,Binding constant for EGFR(G719C) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187693,4187,2248,Serine/threonine-protein kinase DCLK1,Kinase,O15075,DCLK1,DCLK1_HUMAN,6.48,,Kd,Binding constant for DCAMKL1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187694,4187,2244,"Muscle, skeletal receptor tyrosine-protein kinase",Kinase,O15146,MUSK,MUSK_HUMAN,6.64,,Kd,Binding constant for MUSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187695,4187,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,5.64,,Kd,Binding constant for FLT1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187696,4187,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.25,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187697,4187,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,5.57,,Kd,Binding constant for FGFR3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187698,4187,2364,Serine/threonine-protein kinase 35,Kinase,Q8TDR2,STK35,STK35_HUMAN,6.21,,Kd,Binding constant for STK35 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187699,4187,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,6.47,,Kd,Binding constant for INSR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,AGONIST,,Tclin,,,Homo sapiens
187701,4187,2328,Dual specificity tyrosine-phosphorylation-regulated kinase 2,Kinase,Q92630,DYRK2,DYRK2_HUMAN,5.4,,Kd,Binding constant for DYRK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187702,4187,2195,Serine/threonine-protein kinase RIO3,Kinase,O14730,RIOK3,RIOK3_HUMAN,5.4,,Kd,Binding constant for RIOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187703,4187,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,9.26,,Kd,Binding constant for MET(M1250T) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,INHIBITOR,,Tclin,,,Homo sapiens
187704,4187,2186,Dual specificity mitogen-activated protein kinase kinase 3,Kinase,P46734,MAP2K3,MP2K3_HUMAN,5.48,,Kd,Binding constant for MEK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187705,4187,887,Receptor-interacting serine/threonine-protein kinase 2,Kinase,O43353,RIPK2,RIPK2_HUMAN,6.05,,Kd,Binding constant for RIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187706,4187,922,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,6.24,,Kd,Binding constant for EPHB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187707,4187,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,6.54,,Kd,Binding constant for JAK2(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187708,4187,2346,Serine/threonine-protein kinase NIM1,Kinase,Q8IY84,NIM1K,NIM1_HUMAN,5.34,,Kd,Binding constant for NIM1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187709,4187,2447,Serine/threonine-protein kinase SBK1,Kinase,Q52WX2,SBK1,SBK1_HUMAN,5.89,,Kd,Binding constant for SBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tdark,,,Homo sapiens
187710,4187,2360,Mitogen-activated protein kinase kinase kinase 15,Kinase,Q6ZN16,MAP3K15,M3K15_HUMAN,5.55,,Kd,Binding constant for MAP3K15 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187711,4187,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,6.59,,Kd,Binding constant for AURKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187712,4187,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,6.48,,Kd,Binding constant for JAK1(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187713,4187,1822,Tyrosine-protein kinase ITK/TSK,Kinase,Q08881,ITK,ITK_HUMAN,5.7,,Kd,Binding constant for ITK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187714,4187,715,Tyrosine-protein kinase SYK,Kinase,P43405,SYK,KSYK_HUMAN,5.6,,Kd,Binding constant for SYK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187715,4187,2276,"Interferon-induced, double-stranded RNA-activated protein kinase",Kinase,P19525,EIF2AK2,E2AK2_HUMAN,5.96,,Kd,Binding constant for PRKR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187716,4187,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,5.11,,Kd,Binding constant for BTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187717,4187,2233,Cyclin-dependent kinase 11B,Kinase,P21127,CDK11B,CD11B_HUMAN,6.12,,Kd,Binding constant for CDC2L1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187718,4187,2085,Serine/threonine-protein kinase D1,Kinase,Q15139,PRKD1,KPCD1_HUMAN,6,,Kd,Binding constant for PRKD1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187719,4187,2341,Mitogen-activated protein kinase kinase kinase 13,Kinase,O43283,MAP3K13,M3K13_HUMAN,6.64,,Kd,Binding constant for LZK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187720,4187,2318,Serine/threonine-protein kinase TBK1,Kinase,Q9UHD2,TBK1,TBK1_HUMAN,6.16,,Kd,Binding constant for TBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187721,4187,2264,Ephrin type-A receptor 1,Kinase,P21709,EPHA1,EPHA1_HUMAN,6.85,,Kd,Binding constant for EPHA1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187722,4187,2190,Serine/threonine-protein kinase Nek7,Kinase,Q8TDX7,NEK7,NEK7_HUMAN,5.24,,Kd,Binding constant for NEK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187723,4187,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,7.41,,Kd,Binding constant for HPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187724,4187,2257,AarF domain-containing protein kinase 4,Kinase,Q96D53,COQ8B,COQ8B_HUMAN,5.96,,Kd,Binding constant for ADCK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187725,4187,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,6.17,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187726,4187,2274,Serine/threonine-protein kinase D3,Kinase,O94806,PRKD3,KPCD3_HUMAN,6.29,,Kd,Binding constant for PRKD3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187727,4187,2445,Angiopoietin-1 receptor,Kinase,Q02858,Tek,TIE2_MOUSE,6.35,,IC50,Inhibition of TIE2 in mouse 3T3-E cells assessed growth factor-induced autophosphorylation by sandwich ELISA method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,,,,Mus musculus
187728,4187,2352,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,5.74,,Kd,Binding constant for TAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187729,4187,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,5.54,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187730,4187,736,Ephrin type-A receptor 8,Kinase,P29322,EPHA8,EPHA8_HUMAN,6.55,,Kd,Binding constant for EPHA8 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187733,4187,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,7.36,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187734,4187,776,Tyrosine-protein kinase Fer,Kinase,P16591,FER,FER_HUMAN,6.57,,Kd,Binding constant for FER kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187735,4187,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,7.22,,Kd,Binding constant for PLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187736,4187,741,AP2-associated protein kinase 1,Kinase,Q2M2I8,AAK1,AAK1_HUMAN,5.64,,Kd,Binding constant for AAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187737,4187,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,6.7,,Kd,Binding constant for JAK3(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187738,4187,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,6.11,,Kd,Binding constant for YES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187739,4187,2310,Tyrosine-protein kinase ABL1,Kinase,P00520,Abl1,ABL1_MOUSE,5.94,,IC50,Inhibition of ABL in mouse BaF3-BCL cells assessed as growth factor-induced autophosphorylation by sandwich ELISA method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,,,,Mus musculus
187740,4187,2353,Serine/threonine-protein kinase TAO1,Kinase,Q7L7X3,TAOK1,TAOK1_HUMAN,5.92,,Kd,Binding constant for TAOK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187741,4187,2202,Serine/threonine-protein kinase TNNI3K,Kinase,Q59H18,TNNI3K,TNI3K_HUMAN,6.96,,Kd,Binding constant for TNNI3K kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187742,4187,792,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,5.37,,Kd,Binding constant for AURKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187743,4187,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,7.02,,Kd,Binding constant for TRKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187744,4187,670,Rho-associated protein kinase 1,Kinase,Q13464,ROCK1,ROCK1_HUMAN,5.43,,Kd,Binding constant for ROCK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187745,4187,2204,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,Q8NFD2,ANKK1,ANKK1_HUMAN,6.11,,Kd,Binding constant for ANKK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187746,4187,2336,Homeodomain-interacting protein kinase 4,Kinase,Q8NE63,HIPK4,HIPK4_HUMAN,5.44,,Kd,Binding constant for HIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187747,4187,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,7.1,,Kd,Binding constant for MAP4K5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187748,4187,2249,Serine/threonine-protein kinase DCLK2,Kinase,Q8N568,DCLK2,DCLK2_HUMAN,6.43,,Kd,Binding constant for DCAMKL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187749,4187,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,5.36,,Kd,Binding constant for MINK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187750,4187,2320,Interleukin-1 receptor-associated kinase 4,Kinase,Q9NWZ3,IRAK4,IRAK4_HUMAN,5.44,,Kd,Binding constant for IRAK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187751,4187,2193,Insulin receptor-related protein,Kinase,P14616,INSRR,INSRR_HUMAN,6.22,,Kd,Binding constant for INSRR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187752,4187,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,6.1,,Kd,"Binding constant for KIT(V559D,T670I) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187753,4187,855,BMP-2-inducible protein kinase,Kinase,Q9NSY1,BMP2K,BMP2K_HUMAN,6.13,,Kd,Binding constant for BIKE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187754,4187,609,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,6.11,,Kd,Binding constant for IGF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187755,4187,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,7.19,,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187756,4187,908,Calcium/calmodulin-dependent protein kinase kinase 2,Kinase,Q96RR4,CAMKK2,KKCC2_HUMAN,5.82,,Kd,Binding constant for CAMKK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187757,4187,2221,Aurora kinase B,Kinase,Q96GD4,AURKB,AURKB_HUMAN,7.12,,Kd,Binding constant for AURKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187758,4187,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,7.74,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187759,4187,2375,Bone morphogenetic protein receptor type-1B,Kinase,O00238,BMPR1B,BMR1B_HUMAN,6.64,,Kd,Binding constant for BMPR1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187760,4187,53,Macrophage-stimulating protein receptor,Kinase,Q04912,MST1R,RON_HUMAN,7.6,,Kd,Binding constant for MST1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187761,4187,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,6.68,,Kd,Binding constant for TYK2(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187762,4187,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,7.31,,Kd,Binding constant for IRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187763,4187,893,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,6.24,,Kd,Binding constant for MST1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187764,4187,898,Ephrin type-A receptor 7,Kinase,Q15375,EPHA7,EPHA7_HUMAN,6.33,,Kd,Binding constant for EPHA7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187765,4187,2133,Serine/threonine-protein kinase 3,Kinase,Q13188,STK3,STK3_HUMAN,6,,Kd,Binding constant for MST2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187766,4187,1253,Inhibitor of nuclear factor kappa-B kinase subunit beta,Kinase,O14920,IKBKB,IKKB_HUMAN,5.26,,Kd,Binding constant for IKK-beta kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187767,4187,2253,Serine/threonine-protein kinase Nek9,Kinase,Q8TD19,NEK9,NEK9_HUMAN,6.1,,Kd,Binding constant for NEK9 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187768,4187,2458,Serine/threonine-protein kinase TAO2,Kinase,Q9UL54,TAOK2,TAOK2_HUMAN,6.05,,Kd,Binding constant for TAOK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187769,4187,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.03,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187770,4187,755,5'-AMP-activated protein kinase catalytic subunit alpha-1,Kinase,Q13131,PRKAA1,AAPK1_HUMAN,5.62,,Kd,Binding constant for AMPK-alpha1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187771,4187,746,Cytoplasmic tyrosine-protein kinase BMX,Kinase,P51813,BMX,BMX_HUMAN,5.44,,Kd,Binding constant for BMX kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187772,4187,802,Ephrin type-A receptor 5,Kinase,P54756,EPHA5,EPHA5_HUMAN,6,,Kd,Binding constant for EPHA5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187773,4187,748,LIM domain kinase 1,Kinase,P53667,LIMK1,LIMK1_HUMAN,6.08,,Kd,Binding constant for LIMK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187774,4187,2833,NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor),Kinase,P06748|Q9UM73,ALK|NPM1,ALK_HUMAN|NPM_HUMAN,7.29,,IC50,Inhibition of NPM/ALK (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by [3H]-thymidine incorporation assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio|Tclin,,,Homo sapiens
187775,4187,2356,Serine/threonine-protein kinase ULK2,Kinase,Q8IYT8,ULK2,ULK2_HUMAN,5.8,,Kd,Binding constant for ULK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187776,4187,803,Ephrin type-A receptor 4,Kinase,P54764,EPHA4,EPHA4_HUMAN,6.44,,Kd,Binding constant for EPHA4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187777,4187,890,Ephrin type-B receptor 1,Kinase,P54762,EPHB1,EPHB1_HUMAN,6.92,,Kd,Binding constant for EPHB1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187778,4187,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,6.12,,Kd,Binding constant for TNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187779,4187,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,7.12,,Kd,Binding constant for MAP4K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187780,4187,2262,Dual specificity testis-specific protein kinase 1,Kinase,Q15569,TESK1,TESK1_HUMAN,6.42,,Kd,Binding constant for TESK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187781,4187,672,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.51,,Kd,Binding constant for FAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187782,4187,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,7.09,,Kd,Binding constant for TRKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187783,4187,1823,Tyrosine-protein kinase ZAP-70,Kinase,P43403,ZAP70,ZAP70_HUMAN,5.38,,Kd,Binding constant for ZAP70 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187784,4187,966,Activin receptor type-1,Kinase,Q04771,ACVR1,ACVR1_HUMAN,6.36,,Kd,Binding constant for ACVR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187785,4187,2194,Interleukin-1 receptor-associated kinase 3,Kinase,Q9Y616,IRAK3,IRAK3_HUMAN,7.51,,Kd,Binding constant for IRAK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187786,4187,2332,G protein-coupled receptor kinase 4,Kinase,P32298,GRK4,GRK4_HUMAN,5.38,,Kd,Binding constant for GRK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187787,4187,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,7.14,,Kd,Binding constant for MAP3K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187788,4187,2357,Serine/threonine-protein kinase ULK3,Kinase,Q6PHR2,ULK3,ULK3_HUMAN,5.17,,Kd,Binding constant for ULK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187789,4187,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,6.34,,Kd,Binding constant for ABL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187790,4187,2189,Serine/threonine-protein kinase 26,Kinase,Q9P289,STK26,STK26_HUMAN,5.55,,Kd,Binding constant for MST4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187791,4187,2169,Protein-tyrosine kinase 2-beta,Kinase,Q14289,PTK2B,FAK2_HUMAN,6.72,,Kd,Binding constant for PYK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187792,4187,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,6.96,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187793,4187,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,6.57,,Kd,Binding constant for TIE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187794,4187,2183,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,Q14164,IKBKE,IKKE_HUMAN,6.15,,Kd,Binding constant for IKK-epsilon kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187795,4187,2451,Peripheral plasma membrane protein CASK,Kinase,O14936,CASK,CSKP_HUMAN,6.85,,Kd,Binding constant for CASK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187796,4187,2465,Dual serine/threonine and tyrosine protein kinase,Kinase,Q6XUX3,DSTYK,DUSTY_HUMAN,6.35,,Kd,Binding constant for RIPK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187797,4187,2282,Proto-oncogene tyrosine-protein kinase ROS,Kinase,P08922,ROS1,ROS1_HUMAN,8.39,,Kd,Binding constant for ROS1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187798,4187,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,8.22,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187799,4187,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,6.7,,Kd,Binding constant for SIK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187800,4187,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,6.31,,Kd,Binding constant for TAOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187801,4187,2369,Mitogen-activated protein kinase kinase kinase 1,Kinase,Q13233,MAP3K1,M3K1_HUMAN,5.96,,Kd,Binding constant for MAP3K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187802,4187,2084,Cyclin-dependent kinase 7,Kinase,P50613,CDK7,CDK7_HUMAN,6.48,,Kd,Binding constant for CDK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187803,4187,713,Rho-associated protein kinase 2,Kinase,O75116,ROCK2,ROCK2_HUMAN,5.48,,Kd,Binding constant for ROCK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187804,4187,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.89,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187805,4187,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,6.68,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187806,4187,2363,Uncharacterized serine/threonine-protein kinase SBK3,Kinase,P0C264,SBK3,SBK3_HUMAN,6.62,,Kd,Binding constant for SgK110 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tdark,,,Homo sapiens
187807,4187,2444,Macrophage-stimulating protein receptor,Kinase,Q62190,Mst1r,RON_MOUSE,7.1,,IC50,Inhibition of RON in mouse 3T3 cells assessed as growth factor-induced autophosphorylation by sandwich ELISA method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,,,,Mus musculus
187808,4187,964,Activin receptor type-1B,Kinase,P36896,ACVR1B,ACV1B_HUMAN,6.07,,Kd,Binding constant for ACVR1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187809,4187,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,6.96,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187810,4187,2263,TGF-beta receptor type-1,Kinase,P36897,TGFBR1,TGFR1_HUMAN,6,,Kd,Binding constant for TGFBR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187811,4187,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,5.89,,Kd,Binding constant for RET(M918T) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187812,4187,2206,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,5.85,,Kd,Binding constant for DMPK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187813,4187,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,6.29,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187814,4187,2082,Tyrosine-protein kinase receptor TYRO3,Kinase,Q06418,TYRO3,TYRO3_HUMAN,6.1,,Kd,Binding constant for TYRO3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187815,4187,2280,Tyrosine-protein kinase Fes/Fps,Kinase,P07332,FES,FES_HUMAN,6.35,,Kd,Binding constant for FES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187816,4187,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,7.52,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187817,4187,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,7.92,,Kd,Binding constant for LTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187818,4187,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,6.01,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187819,4187,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,8.11,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187820,4187,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,7.43,,Kd,Binding constant for TRKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tclin,,,Homo sapiens
187821,4187,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.92,,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187822,4187,2350,SRSF protein kinase 3,Kinase,Q9UPE1,SRPK3,SRPK3_HUMAN,5.09,,Kd,Binding constant for SRPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187823,4187,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,6.07,,Kd,Binding constant for TXK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187824,4187,2184,LIM domain kinase 2,Kinase,P53671,LIMK2,LIMK2_HUMAN,6.16,,Kd,Binding constant for LIMK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187825,4187,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,9.13,,Ki,Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,INHIBITOR,,Tclin,,,Homo sapiens
187826,4187,2454,Mitogen-activated protein kinase kinase kinase 12,Kinase,Q12852,MAP3K12,M3K12_HUMAN,6.77,,Kd,Binding constant for DLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187827,4187,2277,Receptor-interacting serine/threonine-protein kinase 1,Kinase,Q13546,RIPK1,RIPK1_HUMAN,5.8,,Kd,Binding constant for RIPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187828,4187,2163,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,Kinase,Q99755,PIP5K1A,PI51A_HUMAN,5.49,,Kd,Binding constant for PIP5K1A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187829,4187,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,6.96,,Kd,Binding constant for MAP3K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187830,4187,2234,Cyclin-dependent kinase 11A,Kinase,Q9UQ88,CDK11A,CD11A_HUMAN,6.38,,Kd,Binding constant for CDC2L2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187831,4187,2170,Serine/threonine-protein kinase RIO1,Kinase,Q9BRS2,RIOK1,RIOK1_HUMAN,5.21,,Kd,Binding constant for RIOK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187832,4187,2088,Ribosomal protein S6 kinase beta-1,Kinase,P23443,RPS6KB1,KS6B1_HUMAN,6.19,,Kd,Binding constant for S6K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187833,4187,2355,Serine/threonine-protein kinase ULK1,Kinase,O75385,ULK1,ULK1_HUMAN,6,,Kd,Binding constant for ULK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187834,4187,2362,Receptor-interacting serine/threonine-protein kinase 4,Kinase,P57078,RIPK4,RIPK4_HUMAN,5.68,,Kd,Binding constant for RIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187835,4187,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,7.1,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187836,4187,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,8.44,,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187837,4187,2271,Mitogen-activated protein kinase 7,Kinase,Q13164,MAPK7,MK07_HUMAN,6.29,,Kd,Binding constant for ERK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tbio,,,Homo sapiens
187838,4187,2136,Non-receptor tyrosine-protein kinase TNK1,Kinase,Q13470,TNK1,TNK1_HUMAN,6.49,,Kd,Binding constant for TNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601719,,,,Tchem,,,Homo sapiens
187839,4189,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,7,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1062,,,,Tchem,,,Homo sapiens
187840,4190,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,5.72,,Kd,Binding constant for MEK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187841,4190,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,5.96,,Kd,Binding constant for ABL1(H396P)-non phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187842,4190,2372,Phosphatidylinositol 4-kinase beta,Kinase,Q9UBF8,PI4KB,PI4KB_HUMAN,5.47,,Kd,Binding constant for PIK4CB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187843,4190,2248,Serine/threonine-protein kinase DCLK1,Kinase,O15075,DCLK1,DCLK1_HUMAN,7.17,,Kd,Binding constant for DCAMKL1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187844,4190,660,Calcium/calmodulin-dependent protein kinase type 1,Kinase,Q14012,CAMK1,KCC1A_HUMAN,6.33,,Kd,Binding constant for CAMK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187845,4190,2197,SRSF protein kinase 1,Kinase,Q96SB4,SRPK1,SRPK1_HUMAN,5.68,,Kd,Binding constant for SRPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187846,4190,2328,Dual specificity tyrosine-phosphorylation-regulated kinase 2,Kinase,Q92630,DYRK2,DYRK2_HUMAN,5.43,,Kd,Binding constant for DYRK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187847,4190,2195,Serine/threonine-protein kinase RIO3,Kinase,O14730,RIOK3,RIOK3_HUMAN,5.7,,Kd,Binding constant for RIOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187848,4190,2449,Serine/threonine-protein kinase Nek3,Kinase,P51956,NEK3,NEK3_HUMAN,5.96,,Kd,Binding constant for NEK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187849,4190,2186,Dual specificity mitogen-activated protein kinase kinase 3,Kinase,P46734,MAP2K3,MP2K3_HUMAN,6.33,,Kd,Binding constant for MEK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187850,4190,757,Calcium/calmodulin-dependent protein kinase type II subunit beta,Kinase,Q13554,CAMK2B,KCC2B_HUMAN,6.51,,Kd,Binding constant for CAMK2B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187908,4190,702,Death-associated protein kinase 2,Kinase,Q9UIK4,DAPK2,DAPK2_HUMAN,7.01,,Kd,Binding constant for DAPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187851,4190,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,10.44,,Kd,Binding constant for JAK2(JH1domain-catalytic) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,INHIBITOR,,Tclin,,,Homo sapiens
187852,4190,2134,Ribosomal protein S6 kinase alpha-6,Kinase,Q9UK32,RPS6KA6,KS6A6_HUMAN,6.82,,Kd,Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187853,4190,2283,Ribosomal protein S6 kinase alpha-1,Kinase,Q15418,RPS6KA1,KS6A1_HUMAN,6.92,,Kd,Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187854,4190,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,7,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187855,4190,2447,Serine/threonine-protein kinase SBK1,Kinase,Q52WX2,SBK1,SBK1_HUMAN,5.89,,Kd,Binding constant for SBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tdark,,,Homo sapiens
187856,4190,2360,Mitogen-activated protein kinase kinase kinase 15,Kinase,Q6ZN16,MAP3K15,M3K15_HUMAN,5.96,,Kd,Binding constant for MAP3K15 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187857,4190,2344,Microtubule-associated serine/threonine-protein kinase 1,Kinase,Q9Y2H9,MAST1,MAST1_HUMAN,6.28,,Kd,Binding constant for MAST1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187858,4190,3493,JAK2/TYK2,Kinase,O60674|P29597,JAK2|TYK2,JAK2_HUMAN|TYK2_HUMAN,6.09,,IC50,Inhibition of JAK2/TYK2 in human whole blood assessed as inhibition of IL-23-induced STAT-3 phosphorylation preincubated for 45 mins followed by IL-23 addition measured after 15 mins by FACS analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin|Tclin,,,Homo sapiens
187859,4190,3492,JAK1/JAK2/TYK2,Kinase,O60674|P23458|P29597,JAK1|JAK2|TYK2,JAK1_HUMAN|JAK2_HUMAN|TYK2_HUMAN,6.53,,IC50,Inhibition of JAK1/JAK2/TYK2 in human whole blood assessed as inhibition of IL-6-induced STAT-1 phosphorylation preincubated for 45 mins followed by IL-6 addition measured after 15 mins by FACS analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin|Tclin|Tclin,,,Homo sapiens
187860,4190,3491,JAK1/TYK2,Kinase,P23458|P29597,JAK1|TYK2,JAK1_HUMAN|TYK2_HUMAN,6.71,,IC50,Inhibition of JAK1/TYK2 in human whole blood assessed as inhibition of IFN-alpha-induced STAT-3 phosphorylation preincubated for 45 mins followed by IFN-alpha addition measured after 15 mins by FACS analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin|Tclin,,,Homo sapiens
187861,4190,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,10.05,,Ki,Inhibition of purified JAK1 incubated for 30 mins,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,INHIBITOR,,Tclin,,,Homo sapiens
187862,4190,2335,Homeodomain-interacting protein kinase 3,Kinase,Q9H422,HIPK3,HIPK3_HUMAN,5.92,,Kd,Binding constant for HIPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187863,4190,2334,Homeodomain-interacting protein kinase 2,Kinase,Q9H2X6,HIPK2,HIPK2_HUMAN,6,,Kd,Binding constant for HIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187864,4190,2187,Maternal embryonic leucine zipper kinase,Kinase,Q14680,MELK,MELK_HUMAN,5.66,,Kd,Binding constant for MELK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187865,4190,689,Serine/threonine-protein kinase PLK1,Kinase,P53350,PLK1,PLK1_HUMAN,6.89,,Kd,Binding constant for PLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187866,4190,2318,Serine/threonine-protein kinase TBK1,Kinase,Q9UHD2,TBK1,TBK1_HUMAN,5.77,,Kd,Binding constant for TBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187867,4190,2190,Serine/threonine-protein kinase Nek7,Kinase,Q8TDX7,NEK7,NEK7_HUMAN,5.31,,Kd,Binding constant for NEK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187868,4190,2330,Serine/threonine-protein kinase/endoribonuclease IRE1,Kinase,O75460,ERN1,ERN1_HUMAN,5.6,,Kd,Binding constant for ERN1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187869,4190,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,5.66,,Kd,Binding constant for BRAF kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187870,4190,2347,Serine/threonine-protein kinase OSR1,Kinase,O95747,OXSR1,OXSR1_HUMAN,5.57,,Kd,Binding constant for OSR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187871,4190,2351,STE20/SPS1-related proline-alanine-rich protein kinase,Kinase,Q9UEW8,STK39,STK39_HUMAN,5.72,,Kd,Binding constant for STK39 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187872,4190,2352,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,6.14,,Kd,Binding constant for TAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187873,4190,871,Dual specificity protein kinase CLK2,Kinase,P49760,CLK2,CLK2_HUMAN,6.34,,Kd,Binding constant for CLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187874,4190,2333,G protein-coupled receptor kinase 7,Kinase,Q8WTQ7,GRK7,GRK7_HUMAN,6.27,,Kd,Binding constant for GRK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187875,4190,2359,Homeodomain-interacting protein kinase 1,Kinase,Q86Z02,HIPK1,HIPK1_HUMAN,5.92,,Kd,Binding constant for HIPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187876,4190,2832,JAK3/JAK1,Kinase,P23458|P52333,JAK1|JAK3,JAK1_HUMAN|JAK3_HUMAN,7.64,,IC50,Inhibition of JAK3/1 in human T cells expressing CD3 assessed as inhibition of IL2-stimulated STAT5a phosphorylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin|Tclin,,,Homo sapiens
187877,4190,796,Dual specificity protein kinase TTK,Kinase,P33981,TTK,TTK_HUMAN,6.32,,Kd,Binding constant for TTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187878,4190,2831,JAK2/JAK1,Kinase,O60674|P23458,JAK1|JAK2,JAK1_HUMAN|JAK2_HUMAN,7.51,,IC50,Inhibition of JAK2/1 in human T cells expressing CD3 assessed as inhibition of IFNgamma-stimulated STAT1 phosphorylation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin|Tclin,,,Homo sapiens
187879,4190,853,Ephrin type-A receptor 3,Kinase,P29320,EPHA3,EPHA3_HUMAN,5.21,,Kd,Binding constant for EPHA3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187880,4190,793,Serine/threonine-protein kinase 16,Kinase,O75716,STK16,STK16_HUMAN,6.31,,Kd,Binding constant for STK16 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187881,4190,774,Serine/threonine-protein kinase 17B,Kinase,O94768,STK17B,ST17B_HUMAN,5.46,,Kd,Binding constant for DRAK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187882,4190,740,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Kinase,Q13555,CAMK2G,KCC2G_HUMAN,7,,Kd,Binding constant for CAMK2G kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187883,4190,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,6.7,,Kd,Binding constant for PLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187884,4190,741,AP2-associated protein kinase 1,Kinase,Q2M2I8,AAK1,AAK1_HUMAN,6.92,,Kd,Binding constant for AAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187885,4190,742,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,6.18,,Kd,Binding constant for MARK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187886,4190,787,Protein kinase C epsilon type,Kinase,Q02156,PRKCE,KPCE_HUMAN,6.28,,Kd,Binding constant for PRKCE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187887,4190,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,8.7,,Kd,Binding constant for JAK3(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187888,4190,899,Ribosomal protein S6 kinase alpha-5,Kinase,O75582,RPS6KA5,KS6A5_HUMAN,6.85,,Kd,Binding constant for RPS6KA5(Kin.Dom.2-C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187889,4190,2181,Casein kinase II subunit alpha',Kinase,P19784,CSNK2A2,CSK22_HUMAN,5.48,,Kd,Binding constant for CSNK2A2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187890,4190,2353,Serine/threonine-protein kinase TAO1,Kinase,Q7L7X3,TAOK1,TAOK1_HUMAN,5.89,,Kd,Binding constant for TAOK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187891,4190,792,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,5.06,,Kd,Binding constant for AURKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187892,4190,574,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,6,,Kd,Binding constant for PHKG2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187893,4190,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,5.82,,Kd,Binding constant for TRKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187894,4190,670,Rho-associated protein kinase 1,Kinase,Q13464,ROCK1,ROCK1_HUMAN,7.22,,Kd,Binding constant for ROCK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187895,4190,2204,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,Q8NFD2,ANKK1,ANKK1_HUMAN,6.41,,Kd,Binding constant for ANKK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187896,4190,2167,Serine/threonine-protein kinase 25,Kinase,O00506,STK25,STK25_HUMAN,5.2,,Kd,Binding constant for YSK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187897,4190,614,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,6.44,,Kd,Binding constant for MYLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187898,4190,2249,Serine/threonine-protein kinase DCLK2,Kinase,Q8N568,DCLK2,DCLK2_HUMAN,6.12,,Kd,Binding constant for DCAMKL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187899,4190,2464,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,7.05,,Kd,Binding constant for LRRK2(G2019S) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187900,4190,2214,Serine/threonine-protein kinase PAK 6,Kinase,Q9NQU5,PAK6,PAK6_HUMAN,5.54,,Kd,Binding constant for PAK6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187901,4190,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,5.2,,Kd,Binding constant for KIT(A829P) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187902,4190,855,BMP-2-inducible protein kinase,Kinase,Q9NSY1,BMP2K,BMP2K_HUMAN,6.68,,Kd,Binding constant for BIKE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187903,4190,2215,Serine/threonine-protein kinase PAK 7,Kinase,Q9P286,PAK5,PAK5_HUMAN,5.89,,Kd,Binding constant for PAK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187904,4190,822,Serine/threonine-protein kinase 17A,Kinase,Q9UEE5,STK17A,ST17A_HUMAN,5.21,,Kd,Binding constant for DRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187905,4190,2284,Ribosomal protein S6 kinase alpha-4,Kinase,O75676,RPS6KA4,KS6A4_HUMAN,6.47,,Kd,Binding constant for RPS6KA4(Kin.Dom.2-C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187906,4190,902,Dual specificity protein kinase CLK4,Kinase,Q9HAZ1,CLK4,CLK4_HUMAN,5.77,,Kd,Binding constant for CLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187907,4190,903,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,Q9HBH9,MKNK2,MKNK2_HUMAN,6.7,,Kd,Binding constant for MKNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187909,4190,2375,Bone morphogenetic protein receptor type-1B,Kinase,O00238,BMPR1B,BMR1B_HUMAN,5.74,,Kd,Binding constant for BMPR1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187910,4190,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,9.3,,Ki,Inhibition of TYK2 kinase domain using N-terminal 5-carboxyfluorescein-tagged Val-Ala-Leu-Val-Asp-Gly-Tyr-Phe-Arg-Leu-Thr-Thr as substrate after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187911,4190,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,6.54,,Kd,Binding constant for IRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187912,4190,891,Calcium/calmodulin-dependent protein kinase type 1D,Kinase,Q8IU85,CAMK1D,KCC1D_HUMAN,6.92,,Kd,Binding constant for CAMK1D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187913,4190,915,Calcium/calmodulin-dependent protein kinase type 1G,Kinase,Q96NX5,CAMK1G,KCC1G_HUMAN,5.66,,Kd,Binding constant for CAMK1G kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187914,4190,1253,Inhibitor of nuclear factor kappa-B kinase subunit beta,Kinase,O14920,IKBKB,IKKB_HUMAN,5.64,,Kd,Binding constant for IKK-beta kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187915,4190,2458,Serine/threonine-protein kinase TAO2,Kinase,Q9UL54,TAOK2,TAOK2_HUMAN,6.51,,Kd,Binding constant for TAOK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187916,4190,750,Ribosomal protein S6 kinase alpha-2,Kinase,Q15349,RPS6KA2,KS6A2_HUMAN,6.82,,Kd,Binding constant for RSK3(Kin.Dom.2-C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187917,4190,2356,Serine/threonine-protein kinase ULK2,Kinase,Q8IYT8,ULK2,ULK2_HUMAN,6.72,,Kd,Binding constant for ULK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187918,4190,769,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",Kinase,Q16816,PHKG1,PHKG1_HUMAN,5.24,,Kd,Binding constant for PHKG1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187919,4190,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,5.59,,Kd,Binding constant for TNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187920,4190,2180,Casein kinase II subunit alpha,Kinase,P68400,CSNK2A1,CSK21_HUMAN,5.38,,Kd,Binding constant for CSNK2A1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187921,4190,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,6.48,,Kd,Binding constant for TRKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187922,4190,2331,Rhodopsin kinase,Kinase,Q15835,GRK1,RK_HUMAN,6.14,,Kd,Binding constant for GRK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187923,4190,773,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,Q9UQM7,CAMK2A,KCC2A_HUMAN,7.34,,Kd,Binding constant for CAMK2A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187924,4190,2332,G protein-coupled receptor kinase 4,Kinase,P32298,GRK4,GRK4_HUMAN,5.21,,Kd,Binding constant for GRK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187925,4190,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,7.39,,Kd,Binding constant for MAP3K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187926,4190,2357,Serine/threonine-protein kinase ULK3,Kinase,Q6PHR2,ULK3,ULK3_HUMAN,5.62,,Kd,Binding constant for ULK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187927,4190,2189,Serine/threonine-protein kinase 26,Kinase,Q9P289,STK26,STK26_HUMAN,5.51,,Kd,Binding constant for MST4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187928,4190,2361,Serine/threonine-protein kinase PLK2,Kinase,Q9NYY3,PLK2,PLK2_HUMAN,5.82,,Kd,Binding constant for PLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187929,4190,2224,Bone morphogenetic protein receptor type-2,Kinase,Q13873,BMPR2,BMPR2_HUMAN,6.03,,Kd,Binding constant for BMPR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187930,4190,2183,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,Q14164,IKBKE,IKKE_HUMAN,5.92,,Kd,Binding constant for IKK-epsilon kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187931,4190,2451,Peripheral plasma membrane protein CASK,Kinase,O14936,CASK,CSKP_HUMAN,5.82,,Kd,Binding constant for CASK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187932,4190,2612,Serine/threonine-protein kinase PknB,Kinase,P9WI81,pknB,PKNB_MYCTU,5.38,,Kd,Binding constant for PKNB(M.tuberculosis) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
187933,4190,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,5.51,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187934,4190,665,Mitogen-activated protein kinase 8,Kinase,P45983,MAPK8,MK08_HUMAN,5.32,,Kd,Binding constant for JNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187935,4190,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,6.23,,Kd,Binding constant for TAOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187936,4190,2315,Casein kinase I isoform alpha,Kinase,P48729,CSNK1A1,KC1A_HUMAN,5.74,,Kd,Binding constant for CSNK1A1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187937,4190,2369,Mitogen-activated protein kinase kinase kinase 1,Kinase,Q13233,MAP3K1,M3K1_HUMAN,5.38,,Kd,Binding constant for MAP3K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
217041,913,4093,Prostaglandin E2 receptor EP1 subtype,Unclassified,P70597,Ptger1,PE2R1_RAT,7.7,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
187938,4190,2084,Cyclin-dependent kinase 7,Kinase,P50613,CDK7,CDK7_HUMAN,5.48,,Kd,Binding constant for CDK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187939,4190,2373,Serine/threonine-protein kinase SIK3,Kinase,Q9Y2K2,SIK3,SIK3_HUMAN,5.89,,Kd,Binding constant for QSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187940,4190,713,Rho-associated protein kinase 2,Kinase,O75116,ROCK2,ROCK2_HUMAN,7.28,,Kd,Binding constant for ROCK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187941,4190,2247,Death-associated protein kinase 1,Kinase,P53355,DAPK1,DAPK1_HUMAN,7.14,,Kd,Binding constant for DAPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187942,4190,2363,Uncharacterized serine/threonine-protein kinase SBK3,Kinase,P0C264,SBK3,SBK3_HUMAN,5.24,,Kd,Binding constant for SgK110 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tdark,,,Homo sapiens
187943,4190,623,Death-associated protein kinase 3,Kinase,O43293,DAPK3,DAPK3_HUMAN,7.05,,Kd,Binding constant for DAPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187944,4190,2256,Serine/threonine-protein kinase PAK 4,Kinase,O96013,PAK4,PAK4_HUMAN,5.8,,Kd,Binding constant for PAK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187945,4190,2132,Serine/threonine-protein kinase DCLK3,Kinase,Q9C098,DCLK3,DCLK3_HUMAN,6.59,,Kd,Binding constant for DCAMKL3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187946,4190,2327,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,Q13627,DYRK1A,DYR1A_HUMAN,6.04,,Kd,Binding constant for DYRK1A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187947,4190,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.72,,Kd,Binding constant for RET(V804M) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187948,4190,2206,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,5.46,,Kd,Binding constant for DMPK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187949,4190,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,6.36,,Kd,Binding constant for LTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187950,4190,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,6.57,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187951,4190,2266,Serine/threonine-protein kinase PLK3,Kinase,Q9H4B4,PLK3,PLK3_HUMAN,6.15,,Kd,Binding constant for PLK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187952,4190,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,6.44,,Kd,Binding constant for TRKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187953,4190,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.49,,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187954,4190,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,5.4,,Kd,Binding constant for MEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187955,4190,2229,Dual specificity mitogen-activated protein kinase kinase 4,Kinase,P45985,MAP2K4,MP2K4_HUMAN,5.74,,Kd,Binding constant for MEK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187956,4190,2350,SRSF protein kinase 3,Kinase,Q9UPE1,SRPK3,SRPK3_HUMAN,5.48,,Kd,Binding constant for SRPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187957,4190,2453,Serine/threonine-protein kinase VRK2,Kinase,Q86Y07,VRK2,VRK2_HUMAN,5.4,,Kd,Binding constant for VRK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187958,4190,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,5.82,,Kd,Binding constant for ALK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tclin,,,Homo sapiens
187959,4190,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,6.82,,Kd,Binding constant for MAP3K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187960,4190,2170,Serine/threonine-protein kinase RIO1,Kinase,Q9BRS2,RIOK1,RIOK1_HUMAN,5.6,,Kd,Binding constant for RIOK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187961,4190,2349,Serine/threonine-protein kinase RIO2,Kinase,Q9BVS4,RIOK2,RIOK2_HUMAN,5.92,,Kd,Binding constant for RIOK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tbio,,,Homo sapiens
187962,4190,2355,Serine/threonine-protein kinase ULK1,Kinase,O75385,ULK1,ULK1_HUMAN,6.52,,Kd,Binding constant for ULK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187963,4190,721,Calcium/calmodulin-dependent protein kinase type II subunit delta,Kinase,Q13557,CAMK2D,KCC2D_HUMAN,7.05,,Kd,Binding constant for CAMK2D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187964,4190,2275,cGMP-dependent protein kinase 2,Kinase,Q13237,PRKG2,KGP2_HUMAN,6.16,,Kd,Binding constant for PRKG2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187965,4190,2362,Receptor-interacting serine/threonine-protein kinase 4,Kinase,P57078,RIPK4,RIPK4_HUMAN,5.68,,Kd,Binding constant for RIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187966,4190,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,5.7,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789941,,,,Tchem,,,Homo sapiens
187967,4199,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,4.05,,Ki,Inhibition of human carbonic anhydrase 4 by Lineweaver-Burk curves,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200731,,,,Tclin,,,Homo sapiens
187968,4203,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,4.97,,Ki,Inhibition of human cytosolic carbonic anhydrase 1 by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1354,,,,Tclin,,,Homo sapiens
187969,4203,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,4.44,,Ki,Inhibition of Candida albicans Nce103,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1354,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
187970,4207,3494,Inositol-1(or 4)-monophosphatase 1,Enzyme,P29218,IMPA1,IMPA1_HUMAN,,,,Mechanism of Action; CHEMBL1786; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200826,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200826,INHIBITOR,,Tclin,,,Homo sapiens
187971,4207,2886,Glycogen synthase kinase-3,Kinase,P49840|P49841,GSK3A|GSK3B,GSK3A_HUMAN|GSK3B_HUMAN,,,,Mechanism of Action; CHEMBL2095188; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200826,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200826,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
187972,4209,2000,Alpha-1B adrenergic receptor,GPCR,P18841,ADRA1B,ADA1B_MESAU,9.08,,Ki,Displacement of [3H]prazosin (0.5 nM) from hamster Alpha-1B adrenergic receptor expressed in rat-1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Mesocricetus auratus
187973,4209,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,5,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tchem,,,Homo sapiens
187974,4209,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.87,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tchem,,,Homo sapiens
187975,4209,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.68,,Ki,Ability to displace [3H]rauwolscine from cloned human Alpha-2A adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tclin,,,Homo sapiens
187976,4209,2860,Serotonin 2 (5-HT2) receptor,GPCR,P08909|P14842|P30994,Htr2a|Htr2b|Htr2c,5HT2A_RAT|5HT2B_RAT|5HT2C_RAT,4.38,,IC50,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
187977,4209,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,9.4,,Ki,Binding affinity against alpha-2 adrenergic receptor was determined by the displacement of [3H]prazosin from rat brain cortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
187978,4209,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.08,,Ki,Displacement of [3H]-YM-09151-2 (0.06 nM) from human Dopamine receptor D4 expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tchem,,,Homo sapiens
187979,4209,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,9.7,,Ki,Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1D adrenergic receptor,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=503,INVERSE AGONIST,,Tclin,,,Homo sapiens
187980,4209,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,9.48,,Ki,Binding affinity was determined for the alpha-1D adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tclin,,,Homo sapiens
187981,4209,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,10.4,,Ki,Displacement of [3H]prazosin from human recombinant alpha1A adrenoceptor expressed in CHO cells,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=503,INVERSE AGONIST,,Tclin,,,Homo sapiens
187982,4209,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,9.68,,Ki,Ability to displace [3H]prazosin from cloned human Alpha-1B adrenergic receptor,CHEMBL,=,1,IUPHAR,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=503,INVERSE AGONIST,,Tclin,,,Homo sapiens
187983,4209,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.8,,IC50,Inhibitory concentration against potassium channel HERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tclin,,,Homo sapiens
187984,4209,1833,Alpha-2A adrenergic receptor,GPCR,P22909,Adra2a,ADA2A_RAT,5.78,,Ki,"The compound was tested for binding affinity against alpha-2d-adrenoceptor, from rat clones.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
187985,4209,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,9.7,,Ki,Displacement of [3H]prazosin (0.3 nM) from rat Alpha-1D adrenergic receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
187986,4209,1864,Alpha-2A adrenergic receptor,GPCR,P18871,ADRA2A,ADA2A_PIG,5.39,,Ki,Compound was evaluated for inhibition of binding of [3H]-RX 821002 to Alpha-2 adrenergic receptor in porcine alpha2-clone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Sus scrofa
187987,4209,2902,Alpha-2 adrenergic receptor,GPCR,P30545|Q01337|Q01338,Adra2a|Adra2b|Adra2c,ADA2A_MOUSE|ADA2B_MOUSE|ADA2C_MOUSE,7.89,,Ki,Compound was evaluated for inhibition of binding of [3H]-MK-91 to Alpha-2 adrenergic receptor in mouse NG-108 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Mus musculus
187988,4209,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.89,,Ki,Ability to displace [3H]rauwolscine from cloned human Alpha-2B adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tclin,,,Homo sapiens
187989,4209,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.62,,Ki,Ability to displace [3H]rauwolscine from cloned human Alpha-2C adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tclin,,,Homo sapiens
187990,4209,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.42,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tchem,,,Homo sapiens
187991,4209,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.8,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tchem,,,Homo sapiens
215162,5110,3499,Beta-galactosidase,Enzyme,P16278,GLB1,BGAL_HUMAN,4.050000190734863,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,Tchem,,,Homo sapiens
187992,4209,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,5.82,,Ki,Displacement of [3H]ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
187993,4209,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,9.07,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tchem,,,Homo sapiens
187994,4209,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,10.99,,Kd,Alpha-1-adrenolytic activity was assessed in vitro from the ability to inhibit clonidine binding to rat aorta preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
187995,4209,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tclin|Tclin|Tclin,,,Homo sapiens
187996,4209,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,9.77,,Ki,Binding affinity against Alpha-1A adrenergic receptor from bovine clone,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Bos taurus
187997,4209,1868,Alpha-2A adrenergic receptor,GPCR,Q28838,ADRA2A,ADA2A_BOVIN,6.97,,Ki,Compound was evaluated for inhibition of binding of [3H]MK-91 to Alpha-2 adrenergic receptor in bovine pineal,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Bos taurus
187998,4209,297,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,P16083,NQO2,NQO2_HUMAN,8.11,,IC50,Binding affinity to low affinity melatonin (MT3) site of quinone reductase 2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,Tchem,,,Homo sapiens
187999,4209,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,10.15,,Ki,Inhibition of [3H]- prazosin binding against Alpha-1A adrenergic receptor from rat submaxillary gland,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
188000,4209,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.63,,Ki,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
188003,4209,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,10,,Ki,Displacement of [3H]prazosin from adrenergic alpha-1B receptor in rat liver membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
188004,4209,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,4.96,,IC50,Inhibition of [3H]spiperone binding to Dopamine receptor D2 from rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
188005,4209,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,9.7,,Ki,Compound was evaluated for binding affinity towards mu-specific opiate receptor from combinatorial peptoid library,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
188006,4211,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.05,,Kd,Dissociation constant for binding to SH2 domain of Fyn protein kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL539,,,,Tclin,,,Homo sapiens
188007,4211,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,6.19,,Kd,Dissociation constant for binding to SH2 domain of p56 lck tyrosine kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL539,,,,Tclin,,,Homo sapiens
188008,4213,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1091,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1091,AGONIST,,Tclin,,,Homo sapiens
188009,4218,2855,Adrenergic receptor alpha-2,GPCR,P08913|P18089|P18825,ADRA2A|ADRA2B|ADRA2C,ADA2A_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN,,,,Mechanism of Action; CHEMBL2095158; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200432,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200432,AGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
188010,4219,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.01,,Ki,Inhibition constant of anion against human carbonic anhydrase isozyme hCA IV,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1060,,,,Tclin,,,Homo sapiens
188012,4221,432,Tyrosinase,Enzyme,P14679,TYR,TYRO_HUMAN,,,,Mechanism of Action; CHEMBL1973; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL544,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL544,INHIBITOR,,Tclin,,,Homo sapiens
188018,4223,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,5.52,,IC50,Inhibition of rat hydroxytryptamine 7 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188019,4223,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,7.15,,IC50,Inhibition of rat dopamine D3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188020,4223,2783,Serotonin 3 (5-HT3) receptor,Ion channel,P35563|Q9JJ16,Htr3a|Htr3b,5HT3A_RAT|5HT3B_RAT,5.37,,IC50,Inhibition against rat hydroxytryptamine 3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188021,4223,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,5.7,,IC50,Inhibition of rat hydroxytryptamine 2C receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188022,4223,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,5.82,,IC50,Inhibition of rat hydroxytryptamine 2A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188023,4223,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,9.3,,IC50,Inhibition of [3H]5-HT re-uptake in rat synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188024,4223,1878,D(4) dopamine receptor,GPCR,P30729,Drd4,DRD4_RAT,5.47,,IC50,Inhibition of rat dopamine D4 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188025,4223,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,5.52,,IC50,Inhibition of rat hydroxytryptamine 6 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188026,4223,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,5.3,,IC50,Inhibition of rat hydroxytryptamine 1B receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188027,4223,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,9.52,,IC50,Inhibition of 8-OH DPAT binding to rat hydroxytryptamine 1A receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188028,4223,1872,5-hydroxytryptamine receptor 1D,GPCR,P28565,Htr1d,5HT1D_RAT,5.4,,IC50,Inhibition of rat hydroxytryptamine 1D receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188029,4223,2855,Adrenergic receptor alpha-2,GPCR,P08913|P18089|P18825,ADRA2A|ADRA2B|ADRA2C,ADA2A_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN,5.22,,IC50,Inhibition of alpha-2-adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,Tclin|Tclin|Tclin,,,Homo sapiens
188030,4223,2856,Adrenergic receptor alpha-1,GPCR,P25100|P35348|P35368,ADRA1A|ADRA1B|ADRA1D,ADA1A_HUMAN|ADA1B_HUMAN|ADA1D_HUMAN,5.7,,IC50,Inhibition of alpha-1-adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,Tclin|Tclin|Tclin,,,Homo sapiens
188031,4223,1855,5-hydroxytryptamine receptor 4,GPCR,Q62758,Htr4,5HT4R_RAT,6.6,,IC50,Inhibition of rat hydroxytryptamine 4 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188032,4223,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.18,,IC50,Displacement of [3H]spiperone from dopamine D2 receptor of rat striatal membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL439849,,,,,,,Rattus norvegicus
188033,4225,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,5.96,,Kd,Binding constant for JNK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188034,4225,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,5.57,,Kd,Binding constant for MEK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188035,4225,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8.82,,Kd,Binding constant for ABL1(T315I)-phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188036,4225,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,7.51,,Kd,Binding constant for FLT3(K663Q) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188037,4225,2323,Cyclin-dependent kinase-like 2,Kinase,Q92772,CDKL2,CDKL2_HUMAN,6.28,,Kd,Binding constant for CDKL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tbio,,,Homo sapiens
188038,4225,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.64,,Kd,Binding constant for EGFR(G719C) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188039,4225,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,8.24,,Kd,Binding constant for FLT1 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,INHIBITOR,,Tclin,,,Homo sapiens
188040,4225,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,8.23,,Kd,Binding constant for VEGFR2 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,INHIBITOR,,Tclin,,,Homo sapiens
188041,4225,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.68,,Kd,Binding constant for FGFR3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188042,4225,2197,SRSF protein kinase 1,Kinase,Q96SB4,SRPK1,SRPK1_HUMAN,5.74,,Kd,Binding constant for SRPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188043,4225,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,9.29,,Kd,Binding constant for PDGFRA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188044,4225,2195,Serine/threonine-protein kinase RIO3,Kinase,O14730,RIOK3,RIOK3_HUMAN,6,,Kd,Binding constant for RIOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188045,4225,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,6.09,,Kd,Binding constant for MET kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188046,4225,887,Receptor-interacting serine/threonine-protein kinase 2,Kinase,O43353,RIPK2,RIPK2_HUMAN,5,,Kd,Binding constant for RIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188047,4225,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,5.48,,Kd,Binding constant for JAK2(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188048,4225,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,5.57,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188049,4225,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,7.14,,Kd,Binding constant for AURKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188050,4225,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,6.85,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188051,4225,1822,Tyrosine-protein kinase ITK/TSK,Kinase,Q08881,ITK,ITK_HUMAN,5.92,,Kd,Binding constant for ITK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188052,4225,2168,Mitogen-activated protein kinase kinase kinase MLT,Kinase,Q9NYL2,ZAK,MLTK_HUMAN,5.59,,Kd,Binding constant for ZAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188053,4225,2276,"Interferon-induced, double-stranded RNA-activated protein kinase",Kinase,P19525,EIF2AK2,E2AK2_HUMAN,5.13,,Kd,Binding constant for PRKR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tbio,,,Homo sapiens
188054,4225,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,6.48,,Kd,Binding constant for HPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188055,4225,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,5.74,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188056,4225,796,Dual specificity protein kinase TTK,Kinase,P33981,TTK,TTK_HUMAN,5.41,,Kd,Binding constant for TTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188057,4225,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,5.92,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188058,4225,793,Serine/threonine-protein kinase 16,Kinase,O75716,STK16,STK16_HUMAN,6.43,,Kd,Binding constant for STK16 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188059,4225,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,8.38,,Ki,Inhibition of human PLK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188060,4225,741,AP2-associated protein kinase 1,Kinase,Q2M2I8,AAK1,AAK1_HUMAN,5.92,,Kd,Binding constant for AAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188061,4225,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,5.51,,Kd,Binding constant for JAK3(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188062,4225,2181,Casein kinase II subunit alpha',Kinase,P19784,CSNK2A2,CSK22_HUMAN,5.55,,Kd,Binding constant for CSNK2A2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188063,4225,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,5.57,,Kd,Binding constant for YES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188064,4225,2089,Serine/threonine-protein kinase N2,Kinase,Q16513,PKN2,PKN2_HUMAN,5.57,,Kd,Binding constant for PKN2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188065,4225,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,5.96,,Kd,Binding constant for CSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188066,4225,792,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,8.89,,Kd,Binding constant for AURKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188067,4225,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,5.74,,Kd,Binding constant for TRKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188068,4225,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,9.24,,Kd,Binding constant for PDGFRB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188069,4225,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,6.42,,Kd,Binding constant for FGFR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188070,4225,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.96,,Kd,Binding constant for FGFR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188071,4225,2250,Myosin-IIIa,Kinase,Q8NEV4,MYO3A,MYO3A_HUMAN,5.72,,Kd,Binding constant for MYO3A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tbio,,,Homo sapiens
188072,4225,2204,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,Q8NFD2,ANKK1,ANKK1_HUMAN,5.44,,Kd,Binding constant for ANKK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tbio,,,Homo sapiens
188073,4225,876,Mitogen-activated protein kinase kinase kinase 4,Kinase,Q9Y6R4,MAP3K4,M3K4_HUMAN,5.25,,Kd,Binding constant for MAP3K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tbio,,,Homo sapiens
188074,4225,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,6.26,,Kd,Binding constant for MAP4K5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188075,4225,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,6.25,,Kd,Binding constant for MINK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188076,4225,2464,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,6.04,,Kd,Binding constant for LRRK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188077,4225,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,9.31,,Kd,Binding constant for KIT(V559D) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188078,4225,855,BMP-2-inducible protein kinase,Kinase,Q9NSY1,BMP2K,BMP2K_HUMAN,6,,Kd,Binding constant for BIKE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188079,4225,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,6.74,,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188080,4225,908,Calcium/calmodulin-dependent protein kinase kinase 2,Kinase,Q96RR4,CAMKK2,KKCC2_HUMAN,5.82,,Kd,Binding constant for CAMKK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188081,4225,2221,Aurora kinase B,Kinase,Q96GD4,AURKB,AURKB_HUMAN,7.96,,Kd,Binding constant for AURKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188082,4225,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,6,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188083,4225,2375,Bone morphogenetic protein receptor type-1B,Kinase,O00238,BMPR1B,BMR1B_HUMAN,5.54,,Kd,Binding constant for BMPR1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tbio,,,Homo sapiens
188084,4225,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,5.44,,Kd,Binding constant for TYK2(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188085,4225,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,5.51,,Kd,Binding constant for IRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
215163,5110,3430,Lactase-phlorizin hydrolase,Enzyme,P09848,LCT,LPH_HUMAN,4.300000190734863,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,Tbio,,,Homo sapiens
188086,4225,893,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,5.85,,Kd,Binding constant for MST1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188087,4225,914,Calcium/calmodulin-dependent protein kinase kinase 1,Kinase,Q8N5S9,CAMKK1,KKCC1_HUMAN,5.85,,Kd,Binding constant for CAMKK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188088,4225,2133,Serine/threonine-protein kinase 3,Kinase,Q13188,STK3,STK3_HUMAN,5.66,,Kd,Binding constant for MST2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188089,4225,2356,Serine/threonine-protein kinase ULK2,Kinase,Q8IYT8,ULK2,ULK2_HUMAN,5,,Kd,Binding constant for ULK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188090,4225,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,5.22,,Kd,Binding constant for TNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188091,4225,892,Cyclin-dependent kinase 16,Kinase,Q00536,CDK16,CDK16_HUMAN,5.28,,Kd,Binding constant for PCTK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188092,4225,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,5.92,,Kd,Binding constant for MAP4K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188093,4225,2262,Dual specificity testis-specific protein kinase 1,Kinase,Q15569,TESK1,TESK1_HUMAN,5.37,,Kd,Binding constant for TESK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tbio,,,Homo sapiens
188094,4225,2242,Serine/threonine-protein kinase MRCK beta,Kinase,Q9Y5S2,CDC42BPB,MRCKB_HUMAN,5.32,,Kd,Binding constant for MRCKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tbio,,,Homo sapiens
188095,4225,2332,G protein-coupled receptor kinase 4,Kinase,P32298,GRK4,GRK4_HUMAN,5.64,,Kd,Binding constant for GRK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188096,4225,2357,Serine/threonine-protein kinase ULK3,Kinase,Q6PHR2,ULK3,ULK3_HUMAN,6.17,,Kd,Binding constant for ULK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188097,4225,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,7.15,,Kd,Binding constant for ABL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188098,4225,2200,Activin receptor type-2B,Kinase,Q13705,ACVR2B,AVR2B_HUMAN,5.28,,Kd,Binding constant for ACVR2B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188099,4225,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,5.51,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188100,4225,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,6.51,,Kd,Binding constant for TIE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188101,4225,2282,Proto-oncogene tyrosine-protein kinase ROS,Kinase,P08922,ROS1,ROS1_HUMAN,5.49,,Kd,Binding constant for ROS1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188102,4225,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,6.44,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188103,4225,665,Mitogen-activated protein kinase 8,Kinase,P45983,MAPK8,MK08_HUMAN,5.41,,Kd,Binding constant for JNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188104,4225,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.68,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188105,4225,543,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,6.77,,Kd,Binding constant for FLT4 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,INHIBITOR,,Tclin,,,Homo sapiens
188106,4225,2337,Hormonally up-regulated neu tumor-associated kinase,Kinase,P57058,HUNK,HUNK_HUMAN,5.82,,Kd,Binding constant for HUNK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tbio,,,Homo sapiens
188107,4225,2205,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,5.28,,Kd,Binding constant for DDR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188108,4225,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,7.01,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188109,4225,2256,Serine/threonine-protein kinase PAK 4,Kinase,O96013,PAK4,PAK4_HUMAN,5.35,,Kd,Binding constant for PAK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188110,4225,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7,,Kd,Binding constant for RET(M918T) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188111,4225,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,6.47,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188112,4225,2226,Mitogen-activated protein kinase kinase kinase kinase 4,Kinase,O95819,MAP4K4,M4K4_HUMAN,6.46,,Kd,Binding constant for MAP4K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188113,4225,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,5.57,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188114,4225,723,"Myosin light chain kinase 2, skeletal/cardiac muscle",Kinase,Q9H1R3,MYLK2,MYLK2_HUMAN,5.89,,Kd,Binding constant for MYLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tbio,,,Homo sapiens
188115,4225,2238,Mitogen-activated protein kinase kinase kinase 9,Kinase,P80192,MAP3K9,M3K9_HUMAN,5.52,,Kd,Binding constant for MLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188116,4225,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,6.57,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188117,4225,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,6.38,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188118,4225,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,5.89,,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188119,4225,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,5.59,,Kd,Binding constant for MEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tclin,,,Homo sapiens
188120,4225,2350,SRSF protein kinase 3,Kinase,Q9UPE1,SRPK3,SRPK3_HUMAN,5.64,,Kd,Binding constant for SRPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188121,4225,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,5.62,,Kd,Binding constant for TXK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188122,4225,2454,Mitogen-activated protein kinase kinase kinase 12,Kinase,Q12852,MAP3K12,M3K12_HUMAN,5.77,,Kd,Binding constant for DLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188123,4225,2463,Myosin light chain kinase 3,Kinase,Q32MK0,MYLK3,MYLK3_HUMAN,5.77,,Kd,Binding constant for MLCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188124,4225,2277,Receptor-interacting serine/threonine-protein kinase 1,Kinase,Q13546,RIPK1,RIPK1_HUMAN,5.6,,Kd,Binding constant for RIPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188125,4225,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,5.55,,Kd,Binding constant for MAP3K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188126,4225,2170,Serine/threonine-protein kinase RIO1,Kinase,Q9BRS2,RIOK1,RIOK1_HUMAN,5.92,,Kd,Binding constant for RIOK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188127,4225,2362,Receptor-interacting serine/threonine-protein kinase 4,Kinase,P57078,RIPK4,RIPK4_HUMAN,5.85,,Kd,Binding constant for RIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188128,4225,2260,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,5.68,,Kd,Binding constant for SIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188129,4225,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,5.89,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188130,4225,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,5.49,,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188131,4225,2136,Non-receptor tyrosine-protein kinase TNK1,Kinase,Q13470,TNK1,TNK1_HUMAN,6.8,,Kd,Binding constant for TNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1289926,,,,Tchem,,,Homo sapiens
188132,4227,2294,Sonic hedgehog protein,Enzyme,Q15465,SHH,SHH_HUMAN,7.82,,IC50,Inhibition of human SHH pathway in mouse S12 cells assessed as GLI-mediated transcriptional activity after 48 hrs by luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473417,,,,Tchem,,,Homo sapiens
188133,4227,2120,Sonic hedgehog protein,Enzyme,Q62226,Shh,SHH_MOUSE,8.52,,IC50,Inhibition of SHH in mouse Shh Light2 cells by GLI-responsive firefly luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473417,,,,,,,Mus musculus
188134,4227,2477,Smoothened homolog,GPCR,Q99835,SMO,SMO_HUMAN,7.79,,Ki,Displacement of [3H]cyclopamine from wild type Smo expressed in U2OS cells after 2 hrs by scintillation counting,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473417,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473417,INHIBITOR,,Tclin,,,Homo sapiens
188135,4227,2479,Smoothened homolog,GPCR,P56726,Smo,SMO_MOUSE,8.3,,IC50,Inhibition of Smo in mouse C3H10T1/2 cells using human recombinant SHH assessed as effect on SMO/SHH transient transcriptional activation after 20 hrs by Gli-luciferase reporter assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL473417,,,,,,,Mus musculus
188136,4228,1047,Cystic fibrosis transmembrane conductance regulator,Ion channel,P13569,CFTR,CFTR_HUMAN,8.52,,EC50,Potentiation of human CFTR F508del mutant expressed in mouse NIH-3T3 cells after 30 mins by fluorescent voltage sensing optical assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2010601,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2010601,POSITIVE MODULATOR,,Tclin,,,Homo sapiens
188137,4229,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,,,,Mechanism of Action; CHEMBL1987; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1963683,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1963683,AGONIST,,Tclin,,,Homo sapiens
188138,4242,432,Tyrosinase,Enzyme,P14679,TYR,TYRO_HUMAN,,,,Mechanism of Action; CHEMBL1973; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200522,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200522,INHIBITOR,,Tclin,,,Homo sapiens
188139,4247,1283,Lethal factor,Enzyme,P15917,lef,LEF_BACAN,6.3,,Ki,Inhibition of anthrax lethal factor metalloprotease,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1275977,,,,,,,Bacillus anthracis
188140,4247,57,Transient receptor potential cation channel subfamily V member 1,Ion channel,Q8NER1,TRPV1,TRPV1_HUMAN,6.4,,IC50,Inhibition of TRPV1-mediated membrane currents in human DRG neurons,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1275977,,,,Tclin,,,Homo sapiens
188141,4247,3636,Menin,Unclassified,O00255,MEN1,MEN1_HUMAN,4.81,,Kd,Binding affinity to menin (unknown origin) by isothermal titration calorimetry analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1275977,,,,Tchem,,,Homo sapiens
188142,4247,1287,Lecithin retinol acyltransferase,Enzyme,O95237,LRAT,LRAT_HUMAN,4.83,,IC50,Compound tested in vitro for inhibition of translation using highly active Escherichia coli S30 and a plasmid containing a gene expressing truncated lecithin retinol acyltransferase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1275977,,,,Tbio,,,Homo sapiens
188143,4248,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.27,,Ki,Inhibition of human recombinant carbonic anhydrase 12 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200471,,,,Tclin,,,Homo sapiens
188144,4248,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.21,,Ki,Inhibition of human recombinant carbonic anhydrase 4 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200471,,,,Tclin,,,Homo sapiens
188145,4248,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,5.38,,Ki,Inhibition of human recombinant carbonic anhydrase 13 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200471,,,,Tclin,,,Homo sapiens
188146,4248,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.79,,Ki,Inhibition of human recombinant carbonic anhydrase 3 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200471,,,,Tclin,,,Homo sapiens
188147,4248,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,5.29,,Ki,Inhibition of human recombinant carbonic anhydrase 5A preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200471,,,,Tclin,,,Homo sapiens
188148,4248,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.54,,Ki,Inhibition of human recombinant carbonic anhydrase 14 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200471,,,,Tclin,,,Homo sapiens
188149,4248,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,5.11,,Ki,Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200471,,,,Tclin,,,Homo sapiens
188150,4248,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.76,,Ki,Inhibition of human recombinant carbonic anhydrase 9 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200471,,,,Tclin,,,Homo sapiens
188151,4248,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.45,,Ki,Inhibition of human recombinant carbonic anhydrase 5B preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200471,,,,Tclin,,,Homo sapiens
188152,4248,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,5.62,,Ki,Inhibition of human recombinant carbonic anhydrase 6 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200471,,,,Tclin,,,Homo sapiens
188153,4257,2891,Cyclooxygenase,Enzyme,P23219|P35354,PTGS1|PTGS2,PGH1_HUMAN|PGH2_HUMAN,,,,Mechanism of Action; CHEMBL2094253; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1120,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1120,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
188154,4258,3637,Transient receptor potential cation channel subfamily M member 8,Unclassified,Q8R455,Trpm8,TRPM8_RAT,4.28,,EC50,Activation of rat TRPM8 expressed in HEK293 cells assessed as stimulation of intracellular Ca2+ levels,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29411,,,,,,,Rattus norvegicus
188155,4258,1683,Transient receptor potential cation channel subfamily A member 1,Ion channel,O75762,TRPA1,TRPA1_HUMAN,5.22,,EC50,Activation of human TRPA1 assessed as stimulation of intracellular Ca2+ levels,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29411,,,,Tclin,,,Homo sapiens
188156,4265,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,4.74,,IC50,Inhibition of human DHFR after 2 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039594,,,,Tclin,,,Homo sapiens
188157,4265,3544,Dihydrofolate reductase,Unclassified,P00376,DHFR,DYR_BOVIN,4.6,,IC50,Inhibition of bovine DHFR after 2 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039594,,,,,,,Bos taurus
188158,4266,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.26,,Ki,Inhibition of human CA2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,Tclin,,,Homo sapiens
188159,4266,1292,Endolysin,Enzyme,P00720,E,ENLYS_BPT4,4.04,,Kd,Dissociation constant against T4 lysozyme mutant L99A/M102Q,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,,,,Enterobacteria phage T4
188160,4266,2428,Carbonic anhydrase 2,Unclassified,Q3I4V7,CAN2,Q3I4V7_CRYNV,4.59,,Ki,Inhibition of Cryptococcus neoformans recombinant Can2 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,,,,Cryptococcus neoformans var. grubii
188161,4266,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.04,,Ki,Inhibition of human CA12 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,Tclin,,,Homo sapiens
188162,4266,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.02,,Ki,Inhibition of human CA4 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,Tclin,,,Homo sapiens
188163,4266,2436,Carbonic anhydrase,Unclassified,Q2PCB5,ca,Q2PCB5_DICLA,4.86,,Ki,Inhibition of Dicentrarchus labrax CA using 4-nitrophenylacetate substrate by esterase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,,,,Dicentrarchus labrax
188164,4266,2143,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878,,P96878_MYCTU,4.1,,Ki,Inhibition of Mycobacterium tuberculosis recombinant Rv3273 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
188165,4266,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.57,,Ki,Inhibition of human CA3 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,Tclin,,,Homo sapiens
188166,4266,2578,Beta-carbonic anhydrase 1,Enzyme,P9WPJ7,mtcA1,MTCA1_MYCTU,4.19,,Ki,Inhibition of Mycobacterium tuberculosis recombinant Rv1284 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
188167,4266,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,4.94,,Ki,Inhibition of human CA14 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,Tclin,,,Homo sapiens
188168,4266,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.06,,Ki,Inhibition of human CA9 by stopped-flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,Tclin,,,Homo sapiens
188169,4266,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,4.98,,Ki,Inhibition of mouse recombinant carbonic anhydrase 15 by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,,,,Mus musculus
188170,4266,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5,,Ki,Inhibition of human recombinant alpha-carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,Tclin,,,Homo sapiens
188171,4266,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,4.76,,Ki,Inhibition of Candida albicans recombinant Nce103 beta-carbonic anhydrase after 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14060,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
188172,4267,432,Tyrosinase,Enzyme,P14679,TYR,TYRO_HUMAN,4.52,,IC50,Inhibition of tyrosinase in Melan-a cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL232202,,,,Tclin,,,Homo sapiens
188173,4267,3526,Tyrosinase,Unclassified,P11344,Tyr,TYRO_MOUSE,4.52,,IC50,Inhibition of tyrosinase in mouse Melan-a cells by ELISA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL232202,,,,,,,Mus musculus
188174,4276,3495,Cytochrome P450,Enzyme,E0V9R7|E0VAD1|E0VBK5|E0VCA5|E0VCW8|E0VCW9|E0VDM3|E0VDR0|E0VED4|E0VGV6|E0VHL8|E0VHZ1|E0VJJ0|E0VM29|E0VMV6|E0VMV7|E0VMW9|E0VQ45|E0VQ46|E0VQ47|E0VRD2|E0VSD4|E0VSD5|E0VUR0|E0VUR1|E0VV39|E0VV52|E0VV70|E0VV72|E0VXT9|E0VZW4|E0W115|E0W2B1|E0W389|E0W4F7,,E0V9R7_PEDHC|E0VAD1_PEDHC|E0VBK5_PEDHC|E0VCA5_PEDHC|E0VCW8_PEDHC|E0VCW9_PEDHC|E0VDM3_PEDHC|E0VDR0_PEDHC|E0VED4_PEDHC|E0VGV6_PEDHC|E0VHL8_PEDHC|E0VHZ1_PEDHC|E0VJJ0_PEDHC|E0VM29_PEDHC|E0VMV6_PEDHC|E0VMV7_PEDHC|E0VMW9_PEDHC|E0VQ45_PEDHC|E0VQ46_PEDHC|E0VQ47_PEDHC|E0VRD2_PEDHC|E0VSD4_PEDHC|E0VSD5_PEDHC|E0VUR0_PEDHC|E0VUR1_PEDHC|E0VV39_PEDHC|E0VV52_PEDHC|E0VV70_PEDHC|E0VV72_PEDHC|E0VXT9_PEDHC|E0VZW4_PEDHC|E0W115_PEDHC|E0W2B1_PEDHC|E0W389_PEDHC|E0W4F7_PEDHC,,,,Mechanism of Action; CHEMBL2364702; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201131,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201131,INHIBITOR,,,,,Pediculus humanus subsp. corporis
188175,4289,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,4.48,,IC50,Inhibition of aromatase in human placental microsomes by radiometric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL367149,,,,Tclin,,,Homo sapiens
188176,4289,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,5.01,,IC50,Inhibition of sheep COX2-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL367149,,,,,,,Ovis aries
188177,4289,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,4.82,,IC50,Inhibition of bovine COX1-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL367149,,,,,,,Bos taurus
188178,4289,2621,Oxoeicosanoid receptor 1,GPCR,Q8TDS5,OXER1,OXER1_HUMAN,5.7,,IC50,Antagonist activity at human OXE receptor fused with G-alphai assessed as inhibition of 5-oxo-ETE-induced GTPgammaS binding after 60 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL367149,,,,Tchem,,,Homo sapiens
188179,4296,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,4.1,,Ki,Inhibition of human carbonic anhydrase 4 by Lineweaver-Burk curves,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1141,,,,Tclin,,,Homo sapiens
188180,4298,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,5.51,,Ki,Inhibition of human thrombin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231779,,,,Tclin,,,Homo sapiens
188181,4298,2050,Coagulation factor X,Enzyme,O19045,F10,FA10_RABIT,9.77,,Ki,Binding affinity to rabbit F10a,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231779,,,,,,,Oryctolagus cuniculus
188182,4298,631,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,10.1,,Ki,Inhibition of human factor 10a,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231779,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL231779,INHIBITOR,,Tclin,,,Homo sapiens
188184,4300,1741,Integrase,Enzyme,Q7ZJM1,pol,Q7ZJM1_9HIV1,8.14,,IC50,Inhibition of recombinant HIV1 integrase strand transfer activity,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL204656,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL204656,INHIBITOR,,,,,Human immunodeficiency virus 1
188185,4303,3429,Sodium channel alpha subunit,Ion channel,P35498|P35499|Q01118|Q14524|Q15858|Q99250|Q9NY46|Q9UI33|Q9UQD0|Q9Y5Y9,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN|SCN4A_HUMAN|SCN5A_HUMAN|SCN7A_HUMAN|SCN8A_HUMAN|SCN9A_HUMAN|SCNAA_HUMAN|SCNBA_HUMAN,,,,Mechanism of Action; CHEMBL2331043; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87992,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87992,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
188186,4304,2434,Low affinity sodium-glucose cotransporter,Transporter,Q9NY91,SLC5A4,SC5A4_HUMAN,8.87,,IC50,Inhibition of human SGLT2 expressed in CHO cells using methyl-alpha-D-glucopyranoside by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429910,,,,Tchem,,,Homo sapiens
188187,4304,2059,Sodium/glucose cotransporter 1,Transporter,P13866,SLC5A1,SC5A1_HUMAN,8.49,,IC50,Inhibition of human SGLT2 expressed in african green monkey COS7 cells assessed as inhibition of [14C]-methyl-alpha-D-glucopyranoside uptake after 2 hrs by scintillation counting in presence of 25 % human plasma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429910,,,,Tclin,,,Homo sapiens
188188,4304,2432,Sodium/myo-inositol cotransporter 2,Transporter,Q8WWX8,SLC5A11,SC5AB_HUMAN,6.42,,IC50,Inhibition of SGLT6 expressed in CHO cells assessed as inhibition of [14C]-alpha-methyl-D-glucopyranoside transport after 60 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429910,,,,Tchem,,,Homo sapiens
188189,4304,2060,Sodium/glucose cotransporter 2,Transporter,P53792,Slc5a2,SC5A2_RAT,8.52,,EC50,Inhibition of rat SGLT2 expressed in CHO cells assessed as inhibition of [14C]AMG accumulation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429910,,,,,,,Rattus norvegicus
188190,4308,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,8.89,,IC50,Binding affinity for human estrogen receptor alpha,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328190,http://www.ncbi.nlm.nih.gov/pubmed/12825935,AGONIST,,Tclin,,327,Homo sapiens
188191,4308,2883,Estrogen receptor,Transcription factor,P06211|Q62986,Esr1|Esr2,ESR1_RAT|ESR2_RAT,7.95,,IC50,Inhibition of estradiol binding to estrogen receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328190,,,,,,,Rattus norvegicus
188192,4308,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.74,,IC50,Binding affinity for human estrogen receptor beta,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328190,http://www.ncbi.nlm.nih.gov/pubmed/12825935,AGONIST,,Tclin,,327,Homo sapiens
188193,4310,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.48,,Ki,Inhibition of human recombinant CA2 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188194,4310,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,6.74,,IC50,Binding affinity to human inactivated voltage-gated Na channel 1.7 expressed in HEK293 cells by patch-clamp technique,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,BLOCKER,,Tclin,,,Homo sapiens
188195,4310,3536,Sodium channel protein type X alpha subunit,Unclassified,Q62968,Scn10a,SCNAA_RAT,4.8,,IC50,Binding affinity to voltage-gated Na channel 1.8 in Sprague-Dawley rat L4/L5 DRG neurons by patch-clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,,,,Rattus norvegicus
188196,4310,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.43,,Ki,Inhibition of human recombinant CA12 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188197,4310,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.28,,Ki,Inhibition of human recombinant CA4 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188198,4310,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,5.92,,Ki,Inhibition of human recombinant CA13 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188199,4310,2570,Sodium channel protein type 3 subunit alpha,Ion channel,P08104,Scn3a,SCN3A_RAT,6.38,,IC50,Binding affinity to rat inactivated voltage-gated Na channel 1.3 expressed in human HEK293 cells by patch-clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,,,,Rattus norvegicus
188200,4310,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,6.43,,Ki,Inhibition of human recombinant CA3 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188201,4310,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,5.34,,Ki,Inhibition of human recombinant CA5A by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188202,4310,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,6.33,,Ki,Inhibition of human recombinant CA14 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188203,4310,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,5.35,,Ki,Inhibition of human recombinant CA7 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188204,4310,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,6.45,,Ki,Inhibition of human recombinant CA9 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188205,4310,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,6.34,,Ki,Inhibition of mouse recombinant CA15 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,,,,Mus musculus
188206,4310,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.44,,Ki,Inhibition of human recombinant CA1 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188207,4310,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,6.47,,Ki,Inhibition of human recombinant CA5B by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188208,4310,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,6.39,,Ki,Inhibition of human recombinant CA6 by stopped flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323,,,,Tclin,,,Homo sapiens
188209,4314,2838,Muscarinic acetylcholine receptor,GPCR,P08482|P08483|P08485|P08911|P10980,Chrm1|Chrm2|Chrm3|Chrm4|Chrm5,ACM1_RAT|ACM2_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT,5.08,,Ki,"Binding affinity against muscarinic acetylcholine receptor from rat brain crude membrane, using [3H]-NMS (N-Methylscopolamine) as the radioligand.",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20835,,,,,,,Rattus norvegicus
188210,4314,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,6.92,,IC50,Binding affinity for muscarinic acetylcholine receptor M1 using [3H]oxotremorine-M (Oxo-M) radioligand in rat hippocampus membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20835,,,,,,,Rattus norvegicus
188212,4318,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,5.7,,Kd,Binding constant for JNK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188213,4318,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,6.64,,Kd,Binding constant for ABL1(F317L)-phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tclin,,,Homo sapiens
188214,4318,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,5.85,,Kd,Binding constant for FLT3(D835Y) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tclin,,,Homo sapiens
188215,4318,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,10,,Kd,Binding constant for EGFR(G719C) kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,INHIBITOR,,Tclin,,,Homo sapiens
188216,4318,905,Mitogen-activated protein kinase 9,Kinase,P45984,MAPK9,MK09_HUMAN,5.68,,Kd,Binding constant for JNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188217,4318,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.55,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tclin,,,Homo sapiens
188218,4318,2328,Dual specificity tyrosine-phosphorylation-regulated kinase 2,Kinase,Q92630,DYRK2,DYRK2_HUMAN,5.74,,Kd,Binding constant for DYRK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188219,4318,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,5.66,,Kd,Binding constant for MET kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tclin,,,Homo sapiens
188220,4318,837,Casein kinase I isoform epsilon,Kinase,P49674,CSNK1E,KC1E_HUMAN,5.89,,Kd,Binding constant for CSNK1E kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188221,4318,887,Receptor-interacting serine/threonine-protein kinase 2,Kinase,O43353,RIPK2,RIPK2_HUMAN,5.57,,Kd,Binding constant for RIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188222,4318,2134,Ribosomal protein S6 kinase alpha-6,Kinase,Q9UK32,RPS6KA6,KS6A6_HUMAN,5.51,,Kd,Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188223,4318,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,7.1,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188224,4318,2447,Serine/threonine-protein kinase SBK1,Kinase,Q52WX2,SBK1,SBK1_HUMAN,5.32,,Kd,Binding constant for SBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tdark,,,Homo sapiens
188225,4318,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,5.89,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188226,4318,2188,MAP kinase-interacting serine/threonine-protein kinase 1,Kinase,Q9BUB5,MKNK1,MKNK1_HUMAN,5.74,,Kd,Binding constant for MKNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188227,4318,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,5.85,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188228,4318,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,5.37,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188229,4318,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,8.3,,Kd,Binding constant for ERBB2 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,INHIBITOR,,Tclin,,,Homo sapiens
188230,4318,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,5.66,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tclin,,,Homo sapiens
188231,4318,574,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,6.33,,Kd,Binding constant for PHKG2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188232,4318,2245,Citron Rho-interacting kinase,Kinase,O14578,CIT,CTRO_HUMAN,5.54,,Kd,Binding constant for CIT kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tbio,,,Homo sapiens
188233,4318,2336,Homeodomain-interacting protein kinase 4,Kinase,Q8NE63,HIPK4,HIPK4_HUMAN,6.44,,Kd,Binding constant for HIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188234,4318,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,8.2,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,INHIBITOR,,Tclin,,,Homo sapiens
188235,4318,822,Serine/threonine-protein kinase 17A,Kinase,Q9UEE5,STK17A,ST17A_HUMAN,5.64,,Kd,Binding constant for DRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188236,4318,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,6.47,,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188237,4318,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,5.43,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188238,4318,903,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,Q9HBH9,MKNK2,MKNK2_HUMAN,5.8,,Kd,Binding constant for MKNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188239,4318,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,6.62,,Kd,Binding constant for IRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188240,4318,769,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",Kinase,Q16816,PHKG1,PHKG1_HUMAN,5.89,,Kd,Binding constant for PHKG1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188241,4318,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,6.66,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188242,4318,2182,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Kinase,Q9Y463,DYRK1B,DYR1B_HUMAN,5.55,,Kd,Binding constant for DYRK1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188243,4318,2368,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,5.35,,Kd,Binding constant for ERBB3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188244,4318,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,5.51,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188245,4318,2327,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,Q13627,DYRK1A,DYR1A_HUMAN,6.01,,Kd,Binding constant for DYRK1A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188246,4318,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,6.24,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tclin,,,Homo sapiens
188247,4318,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,5.28,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
216333,1535,3899,Galectin-3,Unclassified,P17931,LGALS3,LEG3_HUMAN,4.03,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL417016,,,,,,,Homo sapiens
188248,4318,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,5.51,,Kd,Binding constant for TXK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188249,4318,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,5.89,,Kd,Binding constant for p38-alpha kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1173655,,,,Tchem,,,Homo sapiens
188250,4326,527,Prostaglandin D2 receptor,GPCR,Q13258,PTGDR,PD2R_HUMAN,10.52,,Kd,Binding affinity to human DP receptor expressed in HEK293 cells,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426559,http://www.ncbi.nlm.nih.gov/pubmed/17300164,ANTAGONIST,,Tclin,,338,Homo sapiens
188251,4326,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,5,,Ki,Binding affinity to human FP receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426559,,,,Tclin,,,Homo sapiens
188252,4326,341,Prostacyclin receptor,GPCR,P43119,PTGIR,PI2R_HUMAN,5.18,,Ki,Binding affinity to human IP receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426559,,,,Tclin,,,Homo sapiens
188253,4326,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,6.87,,Ki,Binding affinity to human EP2 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426559,,,,Tclin,,,Homo sapiens
188254,4326,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,6.05,,Ki,Binding affinity to human EP3 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426559,,,,Tclin,,,Homo sapiens
188255,4326,228,Prostaglandin D2 receptor 2,GPCR,Q9Y5Y4,PTGDR2,PD2R2_HUMAN,6.13,,Ki,Activity at CRTH2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426559,,,,Tchem,,,Homo sapiens
188256,4326,393,Thromboxane A2 receptor,GPCR,P21731,TBXA2R,TA2R_HUMAN,8.53,,Ki,Binding affinity to human TP receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426559,,,,Tclin,,,Homo sapiens
188257,4326,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,5.94,,Ki,Binding affinity to human EP1 receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426559,,,,Tclin,,,Homo sapiens
188258,4334,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.22,,IC50,Inhibition of binding to recombinant human ERalpha by scintillation proximity assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46740,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46740,MODULATOR,,Tclin,,,Homo sapiens
188259,4334,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.42,,IC50,Inhibition of binding to recombinant human ERbeta by scintillation proximity assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46740,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46740,MODULATOR,,Tclin,,,Homo sapiens
188260,4340,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,9,,IC50,Inhibition of DPP4 in human plasma assessed as formation of 7-amino-4-methylcoumarin from glycyl-L-proline 4-methylcoumaryl-7-amide by fluorescence assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL227529,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL227529,INHIBITOR,,Tclin,,,Homo sapiens
188261,4347,168,Beta-lactamase TEM,Enzyme,P62593,bla; blaT-3; blaT-4;,BLAT_ECOLX,4.7,,Ki,Inhibition constant (Ki) for TEM-1 beta-lactamase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200651,,,,,,,Escherichia coli
188262,4347,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,dacA|dacB|dacC|ftsI|mrcA|mrcB|mrdA,DACA_ECOLI|DACB_ECOLI|DACC_ECOLI|FTSI_ECOLI|PBP2_ECOLI|PBPA_ECOLI|PBPB_ECOLI,,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200651,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200651,INHIBITOR,,,,,Escherichia coli (strain K12)
188263,4357,2532,"Beta-1,3-glucan synthase catalytic subunit 1",Enzyme,O13428,GSC1,O13428_CANAX,7.75,,IC50,In vitro inhibitory activity against Beta glucan synthase,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL264241,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL264241,INHIBITOR,,,,,Candida albicans
188264,4358,328,"Nitric oxide synthase, inducible",Enzyme,P35228,NOS2,NOS2_HUMAN,5.15,,Kd,Binding affinity to truncated iNOS construct (1-490) by spectral assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104514,,,,Tchem,,,Homo sapiens
188265,4359,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,7.72,,Kd,Binding constant for MEK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188266,4359,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,6,,Kd,Binding constant for FLT3(D835H) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188267,4359,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,10.54,,Kd,Binding constant for ABL1(F317L)-phosphorylated kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,INHIBITOR,,Tclin,,,Homo sapiens
188268,4359,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,7.74,,Kd,Binding constant for EGFR(E746-A750del) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188269,4359,817,Protein kinase C theta type,Kinase,Q04759,PRKCQ,KPCT_HUMAN,6.04,,Kd,Binding constant for PRKCQ kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188270,4359,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,9,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,INHIBITOR,,Tclin,,,Homo sapiens
188271,4359,2364,Serine/threonine-protein kinase 35,Kinase,Q8TDR2,STK35,STK35_HUMAN,8.7,,Kd,Binding constant for STK35 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188272,4359,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,5.29,,Kd,Binding constant for PDGFRA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188273,4359,2195,Serine/threonine-protein kinase RIO3,Kinase,O14730,RIOK3,RIOK3_HUMAN,5.8,,Kd,Binding constant for RIOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188274,4359,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,5.66,,Kd,Binding constant for MET kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188275,4359,837,Casein kinase I isoform epsilon,Kinase,P49674,CSNK1E,KC1E_HUMAN,6.96,,Kd,Binding constant for CSNK1E kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188276,4359,2251,Myosin-IIIb,Kinase,Q8WXR4,MYO3B,MYO3B_HUMAN,5.64,,Kd,Binding constant for MYO3B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tdark,,,Homo sapiens
188277,4359,2186,Dual specificity mitogen-activated protein kinase kinase 3,Kinase,P46734,MAP2K3,MP2K3_HUMAN,5.59,,Kd,Binding constant for MEK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188278,4359,2159,Serine/threonine-protein kinase PAK 3,Kinase,O75914,PAK3,PAK3_HUMAN,5.24,,Kd,Binding constant for PAK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188279,4359,1044,Cyclin-dependent kinase 15,Kinase,Q96Q40,CDK15,CDK15_HUMAN,5.8,,Kd,Binding constant for PFTAIRE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tdark,,,Homo sapiens
188280,4359,887,Receptor-interacting serine/threonine-protein kinase 2,Kinase,O43353,RIPK2,RIPK2_HUMAN,5.43,,Kd,Binding constant for RIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188281,4359,922,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,8.04,,Kd,Binding constant for EPHB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188282,4359,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,5.96,,Kd,Binding constant for JAK2(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188283,4359,2134,Ribosomal protein S6 kinase alpha-6,Kinase,Q9UK32,RPS6KA6,KS6A6_HUMAN,5.57,,Kd,Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188284,4359,2346,Serine/threonine-protein kinase NIM1,Kinase,Q8IY84,NIM1K,NIM1_HUMAN,5.82,,Kd,Binding constant for NIM1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188285,4359,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,8.89,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188286,4359,2344,Microtubule-associated serine/threonine-protein kinase 1,Kinase,Q9Y2H9,MAST1,MAST1_HUMAN,6.46,,Kd,Binding constant for MAST1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188287,4359,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,8.09,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188288,4359,2172,Casein kinase I isoform delta,Kinase,P48730,CSNK1D,KC1D_HUMAN,6.62,,Kd,Binding constant for CSNK1D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188289,4359,1822,Tyrosine-protein kinase ITK/TSK,Kinase,Q08881,ITK,ITK_HUMAN,5.77,,Kd,Binding constant for ITK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188290,4359,2168,Mitogen-activated protein kinase kinase kinase MLT,Kinase,Q9NYL2,ZAK,MLTK_HUMAN,7.1,,Kd,Binding constant for ZAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188291,4359,2335,Homeodomain-interacting protein kinase 3,Kinase,Q9H422,HIPK3,HIPK3_HUMAN,5.49,,Kd,Binding constant for HIPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188292,4359,2334,Homeodomain-interacting protein kinase 2,Kinase,Q9H2X6,HIPK2,HIPK2_HUMAN,5.72,,Kd,Binding constant for HIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188293,4359,715,Tyrosine-protein kinase SYK,Kinase,P43405,SYK,KSYK_HUMAN,6.54,,Kd,Binding constant for SYK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188294,4359,689,Serine/threonine-protein kinase PLK1,Kinase,P53350,PLK1,PLK1_HUMAN,5.74,,Kd,Binding constant for PLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188295,4359,2166,Wee1-like protein kinase,Kinase,P30291,WEE1,WEE1_HUMAN,6.29,,Kd,Binding constant for WEE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188296,4359,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,8.32,,Kd,Binding constant for BTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188297,4359,2216,NUAK family SNF1-like kinase 1,Kinase,O60285,NUAK1,NUAK1_HUMAN,5.23,,Kd,Binding constant for ARK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188298,4359,2341,Mitogen-activated protein kinase kinase kinase 13,Kinase,O43283,MAP3K13,M3K13_HUMAN,6.32,,Kd,Binding constant for LZK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188299,4359,2318,Serine/threonine-protein kinase TBK1,Kinase,Q9UHD2,TBK1,TBK1_HUMAN,6.6,,Kd,Binding constant for TBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188300,4359,2264,Ephrin type-A receptor 1,Kinase,P21709,EPHA1,EPHA1_HUMAN,5.64,,Kd,Binding constant for EPHA1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188301,4359,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,7.82,,Kd,Binding constant for HPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188302,4359,2462,Serine/threonine-protein kinase Nek11,Kinase,Q8NG66,NEK11,NEK11_HUMAN,6.19,,Kd,Binding constant for NEK11 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188303,4359,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,8.2,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188304,4359,2274,Serine/threonine-protein kinase D3,Kinase,O94806,PRKD3,KPCD3_HUMAN,5.34,,Kd,Binding constant for PRKD3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188305,4359,2351,STE20/SPS1-related proline-alanine-rich protein kinase,Kinase,Q9UEW8,STK39,STK39_HUMAN,5.43,,Kd,Binding constant for STK39 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188306,4359,2352,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,7,,Kd,Binding constant for TAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188307,4359,871,Dual specificity protein kinase CLK2,Kinase,P49760,CLK2,CLK2_HUMAN,5.77,,Kd,Binding constant for CLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188308,4359,872,Dual specificity protein kinase CLK3,Kinase,P49761,CLK3,CLK3_HUMAN,6.52,,Kd,Binding constant for CLK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188309,4359,2319,Tyrosine-protein kinase Blk,Kinase,P16277,Blk,BLK_MOUSE,8.14,,IC50,Inhibition of mouse BLK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,,,,Mus musculus
188310,4359,2333,G protein-coupled receptor kinase 7,Kinase,Q8WTQ7,GRK7,GRK7_HUMAN,5.77,,Kd,Binding constant for GRK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188311,4359,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,8.85,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188312,4359,2359,Homeodomain-interacting protein kinase 1,Kinase,Q86Z02,HIPK1,HIPK1_HUMAN,6.28,,Kd,Binding constant for HIPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188313,4359,870,Dual specificity protein kinase CLK1,Kinase,P49759,CLK1,CLK1_HUMAN,6.22,,Kd,Binding constant for CLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188314,4359,736,Ephrin type-A receptor 8,Kinase,P29322,EPHA8,EPHA8_HUMAN,8.05,,Kd,Binding constant for EPHA8 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188315,4359,536,Ephrin type-A receptor 2,Kinase,P29317,EPHA2,EPHA2_HUMAN,7.74,,Kd,Binding constant for EPHA2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188316,4359,853,Ephrin type-A receptor 3,Kinase,P29320,EPHA3,EPHA3_HUMAN,8.24,,Kd,Binding constant for EPHA3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188317,4359,2177,Serine/threonine-protein kinase tousled-like 2,Kinase,Q86UE8,TLK2,TLK2_HUMAN,5.68,,Kd,Binding constant for TLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188318,4359,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,8.15,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188319,4359,776,Tyrosine-protein kinase Fer,Kinase,P16591,FER,FER_HUMAN,6.44,,Kd,Binding constant for FER kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188320,4359,740,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Kinase,Q13555,CAMK2G,KCC2G_HUMAN,5.44,,Kd,Binding constant for CAMK2G kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188321,4359,741,AP2-associated protein kinase 1,Kinase,Q2M2I8,AAK1,AAK1_HUMAN,5.64,,Kd,Binding constant for AAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188322,4359,787,Protein kinase C epsilon type,Kinase,Q02156,PRKCE,KPCE_HUMAN,5.62,,Kd,Binding constant for PRKCE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188323,4359,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,5.92,,Kd,Binding constant for JAK3(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188324,4359,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,8.4,,Kd,Binding constant for YES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188325,4359,2089,Serine/threonine-protein kinase N2,Kinase,Q16513,PKN2,PKN2_HUMAN,5.49,,Kd,Binding constant for PKN2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188326,4359,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,7.49,,Kd,Binding constant for CSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188327,4359,2353,Serine/threonine-protein kinase TAO1,Kinase,Q7L7X3,TAOK1,TAOK1_HUMAN,5.89,,Kd,Binding constant for TAOK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188328,4359,2202,Serine/threonine-protein kinase TNNI3K,Kinase,Q59H18,TNNI3K,TNI3K_HUMAN,6.77,,Kd,Binding constant for TNNI3K kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188329,4359,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.6,,Kd,Binding constant for ERBB2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188330,4359,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,8.47,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,INHIBITOR,,Tclin,,,Homo sapiens
188331,4359,574,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,5.89,,Kd,Binding constant for PHKG2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188332,4359,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,5.51,,Kd,Binding constant for TRKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188333,4359,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,6.7,,Kd,Binding constant for PDGFRB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188334,4359,670,Rho-associated protein kinase 1,Kinase,Q13464,ROCK1,ROCK1_HUMAN,6.06,,Kd,Binding constant for ROCK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
216545,621,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,7.3,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Cavia porcellus
188335,4359,2245,Citron Rho-interacting kinase,Kinase,O14578,CIT,CTRO_HUMAN,5.62,,Kd,Binding constant for CIT kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188336,4359,573,Ribosomal protein S6 kinase alpha-3,Kinase,P51812,RPS6KA3,KS6A3_HUMAN,5.92,,Kd,Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188337,4359,2250,Myosin-IIIa,Kinase,Q8NEV4,MYO3A,MYO3A_HUMAN,5.21,,Kd,Binding constant for MYO3A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188338,4359,2204,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,Q8NFD2,ANKK1,ANKK1_HUMAN,5.68,,Kd,Binding constant for ANKK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188339,4359,2336,Homeodomain-interacting protein kinase 4,Kinase,Q8NE63,HIPK4,HIPK4_HUMAN,6.89,,Kd,Binding constant for HIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188340,4359,2167,Serine/threonine-protein kinase 25,Kinase,O00506,STK25,STK25_HUMAN,6.05,,Kd,Binding constant for YSK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188341,4359,614,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,6.31,,Kd,Binding constant for MYLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188342,4359,876,Mitogen-activated protein kinase kinase kinase 4,Kinase,Q9Y6R4,MAP3K4,M3K4_HUMAN,6.96,,Kd,Binding constant for MAP3K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188343,4359,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,9.3,,Kd,Binding constant for MAP4K5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188344,4359,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,8.49,,Kd,Binding constant for MINK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188345,4359,2171,Casein kinase I isoform alpha-like,Kinase,Q8N752,CSNK1A1L,KC1AL_HUMAN,5.59,,Kd,Binding constant for CSNK1A1L kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tdark,,,Homo sapiens
188346,4359,2464,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,6.3,,Kd,Binding constant for LRRK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188347,4359,852,Serine/threonine-protein kinase 36,Kinase,Q9NRP7,STK36,STK36_HUMAN,6.24,,Kd,Binding constant for STK36 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188348,4359,2320,Interleukin-1 receptor-associated kinase 4,Kinase,Q9NWZ3,IRAK4,IRAK4_HUMAN,6.44,,Kd,Binding constant for IRAK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188349,4359,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.14,,Kd,Binding constant for KIT(D816V) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188350,4359,855,BMP-2-inducible protein kinase,Kinase,Q9NSY1,BMP2K,BMP2K_HUMAN,6.46,,Kd,Binding constant for BIKE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188351,4359,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,7.59,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188352,4359,2240,Mitogen-activated protein kinase kinase kinase 11,Kinase,Q16584,MAP3K11,M3K11_HUMAN,5.57,,Kd,Binding constant for MLK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188353,4359,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,5.96,,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188354,4359,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,7.51,,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188355,4359,2367,Megakaryocyte-associated tyrosine-protein kinase,Kinase,P42679,MATK,MATK_HUMAN,5.24,,Kd,Binding constant for CTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188356,4359,908,Calcium/calmodulin-dependent protein kinase kinase 2,Kinase,Q96RR4,CAMKK2,KKCC2_HUMAN,6.11,,Kd,Binding constant for CAMKK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188357,4359,2219,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,Kinase,Q99640,PKMYT1,PMYT1_HUMAN,6.46,,Kd,Binding constant for PKMYT1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188358,4359,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,8.33,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188359,4359,902,Dual specificity protein kinase CLK4,Kinase,Q9HAZ1,CLK4,CLK4_HUMAN,5.49,,Kd,Binding constant for CLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188360,4359,53,Macrophage-stimulating protein receptor,Kinase,Q04912,MST1R,RON_HUMAN,5.2,,Kd,Binding constant for MST1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188361,4359,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,5.35,,Kd,Binding constant for TYK2(JH2domain-pseudokinase) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188362,4359,2254,Serine/threonine-protein kinase PAK 1,Kinase,Q13153,PAK1,PAK1_HUMAN,5.64,,Kd,Binding constant for PAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188363,4359,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,6.22,,Kd,Binding constant for IRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188364,4359,893,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,6.72,,Kd,Binding constant for MST1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188365,4359,2133,Serine/threonine-protein kinase 3,Kinase,Q13188,STK3,STK3_HUMAN,6.43,,Kd,Binding constant for MST2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188366,4359,891,Calcium/calmodulin-dependent protein kinase type 1D,Kinase,Q8IU85,CAMK1D,KCC1D_HUMAN,6.26,,Kd,Binding constant for CAMK1D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188367,4359,2458,Serine/threonine-protein kinase TAO2,Kinase,Q9UL54,TAOK2,TAOK2_HUMAN,5.72,,Kd,Binding constant for TAOK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188368,4359,747,Serine/threonine-protein kinase Nek2,Kinase,P51955,NEK2,NEK2_HUMAN,5.8,,Kd,Binding constant for NEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188369,4359,755,5'-AMP-activated protein kinase catalytic subunit alpha-1,Kinase,Q13131,PRKAA1,AAPK1_HUMAN,5.41,,Kd,Binding constant for AMPK-alpha1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188370,4359,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,8.38,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,INHIBITOR,,Tclin,,,Homo sapiens
188371,4359,750,Ribosomal protein S6 kinase alpha-2,Kinase,Q15349,RPS6KA2,KS6A2_HUMAN,5.49,,Kd,Binding constant for RSK3(Kin.Dom.1-N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188372,4359,746,Cytoplasmic tyrosine-protein kinase BMX,Kinase,P51813,BMX,BMX_HUMAN,6.7,,Kd,Binding constant for BMX kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188373,4359,802,Ephrin type-A receptor 5,Kinase,P54756,EPHA5,EPHA5_HUMAN,7.57,,Kd,Binding constant for EPHA5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188374,4359,2356,Serine/threonine-protein kinase ULK2,Kinase,Q8IYT8,ULK2,ULK2_HUMAN,6.35,,Kd,Binding constant for ULK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188375,4359,803,Ephrin type-A receptor 4,Kinase,P54764,EPHA4,EPHA4_HUMAN,7.74,,Kd,Binding constant for EPHA4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188376,4359,2833,NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor),Kinase,P06748|Q9UM73,ALK|NPM1,ALK_HUMAN|NPM_HUMAN,6.82,,IC50,Inhibition of NPM/ALK L256T mutant kinase activity in BaF3 cells by radioenzymatic assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio|Tclin,,,Homo sapiens
188377,4359,769,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",Kinase,Q16816,PHKG1,PHKG1_HUMAN,6.47,,Kd,Binding constant for PHKG1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188378,4359,890,Ephrin type-B receptor 1,Kinase,P54762,EPHB1,EPHB1_HUMAN,7.48,,Kd,Binding constant for EPHB1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188379,4359,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,7.54,,Kd,Binding constant for TNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188380,4359,892,Cyclin-dependent kinase 16,Kinase,Q00536,CDK16,CDK16_HUMAN,5.62,,Kd,Binding constant for PCTK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188381,4359,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,8.29,,Kd,Binding constant for MAP4K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188382,4359,672,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.24,,Kd,Binding constant for FAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188383,4359,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,5.47,,Kd,Binding constant for TRKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188384,4359,1823,Tyrosine-protein kinase ZAP-70,Kinase,P43403,ZAP70,ZAP70_HUMAN,5.8,,Kd,Binding constant for ZAP70 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188385,4359,773,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,Q9UQM7,CAMK2A,KCC2A_HUMAN,5.35,,Kd,Binding constant for CAMK2A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188386,4359,2332,G protein-coupled receptor kinase 4,Kinase,P32298,GRK4,GRK4_HUMAN,5.31,,Kd,Binding constant for GRK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188387,4359,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,7.52,,Kd,Binding constant for MAP3K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188388,4359,2357,Serine/threonine-protein kinase ULK3,Kinase,Q6PHR2,ULK3,ULK3_HUMAN,6.34,,Kd,Binding constant for ULK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188389,4359,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,8.82,,Kd,Binding constant for ABL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188390,4359,2457,Eukaryotic translation initiation factor 2-alpha kinase 1,Kinase,Q9BQI3,EIF2AK1,E2AK1_HUMAN,6.2,,Kd,Binding constant for EIF2AK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188391,4359,2189,Serine/threonine-protein kinase 26,Kinase,Q9P289,STK26,STK26_HUMAN,7.43,,Kd,Binding constant for MST4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188392,4359,2361,Serine/threonine-protein kinase PLK2,Kinase,Q9NYY3,PLK2,PLK2_HUMAN,6.02,,Kd,Binding constant for PLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188393,4359,2224,Bone morphogenetic protein receptor type-2,Kinase,Q13873,BMPR2,BMPR2_HUMAN,6.24,,Kd,Binding constant for BMPR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188394,4359,2169,Protein-tyrosine kinase 2-beta,Kinase,Q14289,PTK2B,FAK2_HUMAN,6.41,,Kd,Binding constant for PYK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188395,4359,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,8.48,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188396,4359,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,5.41,,Kd,Binding constant for TIE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188397,4359,2183,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,Q14164,IKBKE,IKKE_HUMAN,7.28,,Kd,Binding constant for IKK-epsilon kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188398,4359,1317,Dual specificity mitogen-activated protein kinase kinase 7,Kinase,O14733,MAP2K7,MP2K7_HUMAN,5.28,,Kd,Binding constant for MKK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188399,4359,2451,Peripheral plasma membrane protein CASK,Kinase,O14936,CASK,CSKP_HUMAN,6.08,,Kd,Binding constant for CASK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188400,4359,2465,Dual serine/threonine and tyrosine protein kinase,Kinase,Q6XUX3,DSTYK,DUSTY_HUMAN,6.42,,Kd,Binding constant for RIPK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188401,4359,2612,Serine/threonine-protein kinase PknB,Kinase,P9WI81,pknB,PKNB_MYCTU,5.26,,Kd,Binding constant for PKNB(M.tuberculosis) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
188402,4359,2368,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,9.11,,Kd,Binding constant for ERBB3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188403,4359,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,5.52,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188404,4359,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,7.54,,Kd,Binding constant for SIK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188405,4359,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,6.47,,Kd,Binding constant for TAOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188406,4359,2261,Tyrosine-protein kinase Srms,Kinase,Q9H3Y6,SRMS,SRMS_HUMAN,7,,Kd,Binding constant for SRMS kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188407,4359,2315,Casein kinase I isoform alpha,Kinase,P48729,CSNK1A1,KC1A_HUMAN,6.55,,Kd,Binding constant for CSNK1A1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188408,4359,2369,Mitogen-activated protein kinase kinase kinase 1,Kinase,Q13233,MAP3K1,M3K1_HUMAN,5.36,,Kd,Binding constant for MAP3K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188409,4359,2084,Cyclin-dependent kinase 7,Kinase,P50613,CDK7,CDK7_HUMAN,5.92,,Kd,Binding constant for CDK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188410,4359,2448,Serine/threonine-protein kinase 32A,Kinase,Q8WU08,STK32A,ST32A_HUMAN,5.74,,Kd,Binding constant for YANK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tdark,,,Homo sapiens
188411,4359,2373,Serine/threonine-protein kinase SIK3,Kinase,Q9Y2K2,SIK3,SIK3_HUMAN,7.19,,Kd,Binding constant for QSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188412,4359,713,Rho-associated protein kinase 2,Kinase,O75116,ROCK2,ROCK2_HUMAN,6.44,,Kd,Binding constant for ROCK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188413,4359,2243,Serine/threonine-protein kinase 24,Kinase,Q9Y6E0,STK24,STK24_HUMAN,6.42,,Kd,Binding constant for MST3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188414,4359,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,7.96,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188415,4359,2890,Tyrosine-protein kinase ABL,Kinase,P00519|P42684,ABL1|ABL2,ABL1_HUMAN|ABL2_HUMAN,8.96,,IC50,Inhibition of Abl kinase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem|Tclin,,,Homo sapiens
188416,4359,2374,Wee1-like protein kinase 2,Kinase,P0C1S8,WEE2,WEE2_HUMAN,7.03,,Kd,Binding constant for WEE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188417,4359,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,6.42,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188418,4359,2337,Hormonally up-regulated neu tumor-associated kinase,Kinase,P57058,HUNK,HUNK_HUMAN,5.3,,Kd,Binding constant for HUNK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188419,4359,2205,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,6.85,,Kd,Binding constant for DDR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188420,4359,710,Protein kinase C delta type,Kinase,Q05655,PRKCD,KPCD_HUMAN,5.8,,Kd,Binding constant for PRKCD kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188421,4359,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,5.54,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188422,4359,2132,Serine/threonine-protein kinase DCLK3,Kinase,Q9C098,DCLK3,DCLK3_HUMAN,5.27,,Kd,Binding constant for DCAMKL3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188423,4359,2162,Cyclin-dependent kinase 14,Kinase,O94921,CDK14,CDK14_HUMAN,5.85,,Kd,Binding constant for PFTK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188424,4359,2192,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,Q9P2K8,EIF2AK4,E2AK4_HUMAN,6.57,,Kd,"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188425,4359,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,5.42,,Kd,Binding constant for RET(M918T) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188426,4359,2206,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,7.04,,Kd,Binding constant for DMPK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188427,4359,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,6.92,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188428,4359,2226,Mitogen-activated protein kinase kinase kinase kinase 4,Kinase,O95819,MAP4K4,M4K4_HUMAN,8.09,,Kd,Binding constant for MAP4K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188429,4359,2255,Serine/threonine-protein kinase PAK 2,Kinase,Q13177,PAK2,PAK2_HUMAN,5.72,,Kd,Binding constant for PAK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188430,4359,2082,Tyrosine-protein kinase receptor TYRO3,Kinase,Q06418,TYRO3,TYRO3_HUMAN,7.21,,Kd,Binding constant for TYRO3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188431,4359,2280,Tyrosine-protein kinase Fes/Fps,Kinase,P07332,FES,FES_HUMAN,6.48,,Kd,Binding constant for FES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188432,4359,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,9.23,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188433,4359,2238,Mitogen-activated protein kinase kinase kinase 9,Kinase,P80192,MAP3K9,M3K9_HUMAN,5.57,,Kd,Binding constant for MLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188434,4359,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,5.52,,Kd,Binding constant for LTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188435,4359,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,7.8,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188436,4359,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,7.28,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188437,4359,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,5.92,,Kd,Binding constant for TRKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188438,4359,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.66,,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188439,4359,2083,Ephrin type-B receptor 2,Kinase,P29323,EPHB2,EPHB2_HUMAN,8.08,,Kd,Binding constant for EPHB2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188440,4359,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,8,,Kd,Binding constant for MEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188441,4359,2229,Dual specificity mitogen-activated protein kinase kinase 4,Kinase,P45985,MAP2K4,MP2K4_HUMAN,5.59,,Kd,Binding constant for MEK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188442,4359,2176,Serine/threonine-protein kinase tousled-like 1,Kinase,Q9UKI8,TLK1,TLK1_HUMAN,6.24,,Kd,Binding constant for TLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188443,4359,2350,SRSF protein kinase 3,Kinase,Q9UPE1,SRPK3,SRPK3_HUMAN,5.41,,Kd,Binding constant for SRPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188444,4359,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,7.14,,Kd,Binding constant for TXK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188445,4359,2453,Serine/threonine-protein kinase VRK2,Kinase,Q86Y07,VRK2,VRK2_HUMAN,6.15,,Kd,Binding constant for VRK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188446,4359,2230,Dual specificity mitogen-activated protein kinase kinase 6,Kinase,P52564,MAP2K6,MP2K6_HUMAN,5.89,,Kd,Binding constant for MEK6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188447,4359,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,6.16,,Kd,Binding constant for ALK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin,,,Homo sapiens
188448,4359,2267,Ephrin type-B receptor 3,Kinase,P54753,EPHB3,EPHB3_HUMAN,6.68,,Kd,Binding constant for EPHB3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188449,4359,2454,Mitogen-activated protein kinase kinase kinase 12,Kinase,Q12852,MAP3K12,M3K12_HUMAN,6.17,,Kd,Binding constant for DLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188450,4359,2069,Tyrosine-protein kinase Tec,Kinase,P42680,TEC,TEC_HUMAN,5.49,,Kd,Binding constant for TEC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188451,4359,2163,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,Kinase,Q99755,PIP5K1A,PI51A_HUMAN,5.48,,Kd,Binding constant for PIP5K1A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188452,4359,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,7.27,,Kd,Binding constant for MAP3K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188453,4359,2930,Bcr/Abl fusion protein,Kinase,P00519|P11274,ABL1|BCR,ABL1_HUMAN|BCR_HUMAN,7.7,,IC50,Inhibition of Bcr-Abl fusion protein,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tclin|Tclin,,,Homo sapiens
188454,4359,2170,Serine/threonine-protein kinase RIO1,Kinase,Q9BRS2,RIOK1,RIOK1_HUMAN,5.66,,Kd,Binding constant for RIOK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188455,4359,2088,Ribosomal protein S6 kinase beta-1,Kinase,P23443,RPS6KB1,KS6B1_HUMAN,6.18,,Kd,Binding constant for S6K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188456,4359,2355,Serine/threonine-protein kinase ULK1,Kinase,O75385,ULK1,ULK1_HUMAN,5.92,,Kd,Binding constant for ULK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188457,4359,2201,Serine/threonine-protein kinase 33,Kinase,Q9BYT3,STK33,STK33_HUMAN,7.43,,Kd,Binding constant for STK33 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188458,4359,2325,Serine/threonine-protein kinase Chk2,Kinase,O96017,CHEK2,CHK2_HUMAN,6.92,,Kd,Binding constant for CHEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188459,4359,925,Testis-specific serine/threonine-protein kinase 1,Kinase,Q9BXA7,TSSK1B,TSSK1_HUMAN,5.34,,Kd,Binding constant for TSSK1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188460,4359,2191,Serine/threonine-protein kinase NLK,Kinase,Q9UBE8,NLK,NLK_HUMAN,5.66,,Kd,Binding constant for NLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188461,4359,2141,Serine/threonine-protein kinase Chk1,Kinase,O14757,CHEK1,CHK1_HUMAN,5.52,,Kd,Binding constant for CHEK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188462,4359,815,Serine/threonine-protein kinase N1,Kinase,Q16512,PKN1,PKN1_HUMAN,5.54,,Kd,Binding constant for PKN1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188463,4359,2260,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,7.52,,Kd,Binding constant for SIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188464,4359,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,8.51,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188465,4359,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,6.96,,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tchem,,,Homo sapiens
188466,4359,2271,Mitogen-activated protein kinase 7,Kinase,Q13164,MAPK7,MK07_HUMAN,5.64,,Kd,Binding constant for ERK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL288441,,,,Tbio,,,Homo sapiens
188467,4360,1931,Dynamin-1,Structural,Q05193,DNM1,DYN1_HUMAN,5.24,,IC50,Concentration required against dynamin-1 GTPase activity of sheep brain.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113150,,,,Tbio,,,Homo sapiens
188468,4361,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,5.47,,EC50,Ligand dependent recruitment of SRC1(676-700) peptide to human Farnesoid X-activated receptor by fluorescence resonance energy transfer assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL240597,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL240597,AGONIST,,Tclin,,,Homo sapiens
188469,4362,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,5.15,,IC50,Inhibition of Sprague-Dawley rat liver COMT after 10 mins using 0.05 uCi [14CH3]-SAM as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1788402,,,,,,,Rattus norvegicus
188470,4373,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,4.52,,Ki,Binding affinity against human cytosolic Carbonic anhydrase II,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356,,,,Tclin,,,Homo sapiens
188471,4373,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,4.13,,Ki,Binding affinity against human cytosolic Carbonic anhydrase IV,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356,,,,Tclin,,,Homo sapiens
188472,4373,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,4.61,,Ki,Inhibition of Candida albicans Nce103,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
188475,4374,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.58,,Ki,Displacement of [3H]citalopram from SERT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL360328,,,,Tclin,,,Homo sapiens
188477,4376,1928,Small conductance calcium-activated potassium channel protein 3,Ion channel,P70605,Kcnn3,KCNN3_RAT,6.85,,Ki,Displacement of [I125]apamine from Wistar rat recombinant SK3 channel expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121663,,,,,,,Rattus norvegicus
188478,4376,795,Small conductance calcium-activated potassium channel protein 3,Ion channel,Q9UGI6,KCNN3,KCNN3_HUMAN,5.89,,IC50,Inhibition of Kca2.3 channel expressed in HEK293 cells by thallium flux assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121663,,,,Tchem,,,Homo sapiens
188479,4376,714,Protein kinase C alpha type,Kinase,P17252,PRKCA,KPCA_HUMAN,4.96,,IC50,Inhibition of human recombinant PKCalpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121663,,,,Tchem,,,Homo sapiens
188480,4380,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.22,,IC50,Inhibition of binding of [3H]imipramine to imipramine receptor in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1118,,,,,,,Rattus norvegicus
188481,4390,3537,Adenosine A2a receptor,Unclassified,P46616,ADORA2A,AA2AR_CAVPO,4.89,,Ki,Antagonist binding of N6-cyclohexyl-[3H]-adenosine to guinea pig brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,,,,Cavia porcellus
188482,4390,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,4.25,,Ki,Inhibition of c-AMP phosphodiesterase activity in guinea pig tracheal muscle,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,INHIBITOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
188483,4390,2839,Adenosine A2 receptor,GPCR,P29276|P30543,Adora2a|Adora2b,AA2AR_RAT|AA2BR_RAT,5.88,,Ki,Binding of Adenosine A2 receptor in whole rat brain membrane using [3H]CHA as a Radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,,,,Rattus norvegicus
188484,4390,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,9.22,,Ki,Binding affinity for adenosine A1 receptor by using as [3H]CPX iradioligand n membranes from Chinese hamster ovary cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,ANTAGONIST,,Tclin,,,Homo sapiens
216546,1982,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,8.2,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Cavia porcellus
188485,4390,1914,Uncharacterized protein,Enzyme,E1BN64,PDE3B,E1BN64_BOVIN,4.11,,Ki,Inhibition of bovine heart phosphodiesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,,,,Bos taurus
188486,4390,1959,Adenosine receptor A1,GPCR,P47745,ADORA1,AA1R_CAVPO,5.01,,Ki,Affinity against adenosine A1 receptor in the brain membranes by the displacement of [3H]CPX.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,,,,Cavia porcellus
188487,4390,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,9.22,,Ki,Binding affinity for adenosine A2a receptor by using as [3H]ZM-241385 radioligand in membranes from HEK-A2A cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,ANTAGONIST,,Tclin,,,Homo sapiens
188488,4390,3425,Adenosine receptor,GPCR,P25099|P28647|P29276|P30543,Adora1|Adora2a|Adora2b|Adora3,AA1R_RAT|AA2AR_RAT|AA2BR_RAT|AA3R_RAT,4.7,,Ki,Antagonist binding of N6-cyclohexyl-[3H]-adenosine to rat testes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,,,,Rattus norvegicus
188489,4390,147,Adenosine receptor A2b,GPCR,P29275,ADORA2B,AA2BR_HUMAN,5.57,,Ki,Displacement of [3H]DPCPX from human recombinant adenosine A2B receptor expressed in HEK293 cell membrane,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,ANTAGONIST,,Tclin,,,Homo sapiens
188490,4390,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,7.85,,Ki,Binding affinity for adenosine A3 receptor by displacement of specific binding of [125I]AB-MECA in membranes from CHO-A3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,ANTAGONIST,,Tchem,,,Homo sapiens
188491,4390,1938,Adenosine receptor A3,GPCR,P28647,Adora3,AA3R_RAT,4.07,,Ki,Binding affinity to rat adenosine A3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,,,,Rattus norvegicus
188492,4390,491,"Alkaline phosphatase, tissue-nonspecific isozyme",Enzyme,P05186,ALPL,PPBT_HUMAN,4.09,,Ki,Inhibition of TNSALP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,Tchem,,,Homo sapiens
188493,4390,704,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,4.12,,IC50,Inhibition of PI3Kdelta (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,Tclin,,,Homo sapiens
188494,4390,1958,Adenosine receptor A1,GPCR,P28190,ADORA1,AA1R_BOVIN,5.42,,Ki,Binding affinity towards adenosine A1 receptor of bovine brain membrane using [3H]-CHA at 20 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,,,,Bos taurus
188495,4390,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,5.17,,Ki,Binding affinity at rat Adenosine A2A receptor by [3H]-CGS- 21680 displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,,,,Rattus norvegicus
188496,4390,3427,Heart phosphodiesterase,Enzyme,E1BN64|P14100|Q01061,PDE1A|PDE1B|PDE3B,E1BN64_BOVIN|PDE1A_BOVIN|PDE1B_BOVIN,4.04,,IC50,Inhibition of bovine heart phosphodiesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,,,,Bos taurus
188497,4390,3424,Adenosine A2b receptor,GPCR,P29276,Adora2b,AA2BR_RAT,4.82,,Ki,Inhibition of [125I]-APOBX binding to rat Adenosine A2B receptor expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,,,,Rattus norvegicus
188498,4390,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,6.15,,Ki,Inhibition of [3H]-CHA binding to rat brain membrane Adenosine A1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,,,,,,,Rattus norvegicus
188499,4390,3426,Adenosine A2 receptor,GPCR,P29274|P29275,ADORA2A|ADORA2B,AA2AR_HUMAN|AA2BR_HUMAN,4.85,,Ki,Inhibition of the stimulation by 5'-(N-ethylcarbamoyl) adenosine of adenyl cyclase via adenosine A2 receptor in human platelet membranes.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,ANTAGONIST,,Tclin|Tclin,,,Homo sapiens
188500,4390,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,,,,Mechanism of Action; CHEMBL2094125; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
188501,4396,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.74,,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL416898,,,,,,,Rattus norvegicus
188503,4401,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.53,,Ki,Binding affinity to sigma 1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1672054,,,,Tclin,,,Homo sapiens
188504,4401,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,9.9,,Ki,Displacement of [3H]GR205171 from human NK1 receptor in cortex homogenate by liquid scintillation counting,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1672054,http://www.ncbi.nlm.nih.gov/pubmed/19536319,ANTAGONIST,,Tclin,,357,Homo sapiens
188505,4410,599,C-X-C chemokine receptor type 4,GPCR,P61073,CXCR4,CXCR4_HUMAN,6.05,,Ki,Displacement of [125I]12G5 antibody from human wild type CXCR4 expressed in COS7 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18442,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18442,PARTIAL AGONIST,,Tclin,,,Homo sapiens
188506,4410,2125,C-X-C chemokine receptor type 4,GPCR,O08565,Cxcr4,CXCR4_RAT,6.97,,IC50,Displacement of [125I]CXCL12 from CXCR4 in rat IR983F cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18442,,,,,,,Rattus norvegicus
188507,4410,798,C-C chemokine receptor type 2,GPCR,P41597,CCR2,CCR2_HUMAN,10.4,,IC50,Displacement of [125I]SDF1alpha from CCR2/CXCR4 expressed in CHOK1 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18442,,,,Tchem,,,Homo sapiens
188508,4426,3537,Adenosine A2a receptor,Unclassified,P46616,ADORA2A,AA2AR_CAVPO,4.89,,Ki,Antagonist binding of N6-cyclohexyl-[3H]-adenosine to guinea pig brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,,,,Cavia porcellus
188509,4426,2863,Phosphodiesterase 4,Enzyme,P27815|Q07343|Q08493|Q08499,PDE4A|PDE4B|PDE4C|PDE4D,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,4.25,,Ki,Inhibition of c-AMP phosphodiesterase activity in guinea pig tracheal muscle,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,INHIBITOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
188510,4426,2839,Adenosine A2 receptor,GPCR,P29276|P30543,Adora2a|Adora2b,AA2AR_RAT|AA2BR_RAT,5.88,,Ki,Binding of Adenosine A2 receptor in whole rat brain membrane using [3H]CHA as a Radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,,,,Rattus norvegicus
188511,4426,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,9.22,,Ki,Binding affinity for adenosine A1 receptor by using as [3H]CPX iradioligand n membranes from Chinese hamster ovary cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,ANTAGONIST,,Tclin,,,Homo sapiens
188512,4426,1914,Uncharacterized protein,Enzyme,E1BN64,PDE3B,E1BN64_BOVIN,4.11,,Ki,Inhibition of bovine heart phosphodiesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,,,,Bos taurus
188513,4426,1959,Adenosine receptor A1,GPCR,P47745,ADORA1,AA1R_CAVPO,5.01,,Ki,Affinity against adenosine A1 receptor in the brain membranes by the displacement of [3H]CPX.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,,,,Cavia porcellus
188514,4426,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,9.22,,Ki,Binding affinity for adenosine A2a receptor by using as [3H]ZM-241385 radioligand in membranes from HEK-A2A cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,ANTAGONIST,,Tclin,,,Homo sapiens
188515,4426,3425,Adenosine receptor,GPCR,P25099|P28647|P29276|P30543,Adora1|Adora2a|Adora2b|Adora3,AA1R_RAT|AA2AR_RAT|AA2BR_RAT|AA3R_RAT,4.7,,Ki,Antagonist binding of N6-cyclohexyl-[3H]-adenosine to rat testes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,,,,Rattus norvegicus
188516,4426,147,Adenosine receptor A2b,GPCR,P29275,ADORA2B,AA2BR_HUMAN,5.57,,Ki,Displacement of [3H]DPCPX from human recombinant adenosine A2B receptor expressed in HEK293 cell membrane,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,ANTAGONIST,,Tclin,,,Homo sapiens
188517,4426,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,7.85,,Ki,Binding affinity for adenosine A3 receptor by displacement of specific binding of [125I]AB-MECA in membranes from CHO-A3 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,ANTAGONIST,,Tchem,,,Homo sapiens
188518,4426,1938,Adenosine receptor A3,GPCR,P28647,Adora3,AA3R_RAT,4.07,,Ki,Binding affinity to rat adenosine A3 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,,,,Rattus norvegicus
188519,4426,491,"Alkaline phosphatase, tissue-nonspecific isozyme",Enzyme,P05186,ALPL,PPBT_HUMAN,4.09,,Ki,Inhibition of TNSALP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,Tchem,,,Homo sapiens
188520,4426,704,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,4.12,,IC50,Inhibition of PI3Kdelta (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,Tclin,,,Homo sapiens
188521,4426,1958,Adenosine receptor A1,GPCR,P28190,ADORA1,AA1R_BOVIN,5.42,,Ki,Binding affinity towards adenosine A1 receptor of bovine brain membrane using [3H]-CHA at 20 uM,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,,,,Bos taurus
188522,4426,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,5.17,,Ki,Binding affinity at rat Adenosine A2A receptor by [3H]-CGS- 21680 displacement.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,,,,Rattus norvegicus
188523,4426,3427,Heart phosphodiesterase,Enzyme,E1BN64|P14100|Q01061,PDE1A|PDE1B|PDE3B,E1BN64_BOVIN|PDE1A_BOVIN|PDE1B_BOVIN,4.04,,IC50,Inhibition of bovine heart phosphodiesterase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,,,,Bos taurus
188524,4426,3424,Adenosine A2b receptor,GPCR,P29276,Adora2b,AA2BR_RAT,4.82,,Ki,Inhibition of [125I]-APOBX binding to rat Adenosine A2B receptor expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,,,,Rattus norvegicus
188525,4426,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,6.15,,Ki,Inhibition of [3H]-CHA binding to rat brain membrane Adenosine A1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,,,,,,,Rattus norvegicus
188526,4426,3426,Adenosine A2 receptor,GPCR,P29274|P29275,ADORA2A|ADORA2B,AA2AR_HUMAN|AA2BR_HUMAN,4.85,,Ki,Inhibition of the stimulation by 5'-(N-ethylcarbamoyl) adenosine of adenyl cyclase via adenosine A2 receptor in human platelet membranes.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,ANTAGONIST,,Tclin|Tclin,,,Homo sapiens
188527,4426,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,,,,Mechanism of Action; CHEMBL2094125; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104089,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
188529,4454,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,Mechanism of Action; CHEMBL1871; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201101,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201101,AGONIST,,Tclin,,,Homo sapiens
188530,4456,2019,Glucocorticoid receptor,Transcription factor,P06537,Nr3c1,GCR_MOUSE,6.72,,Kd,"Displacement of 1 x 10'-8 M of [1,2,3-3H]-triamcinolone acetonide from glucocorticoid receptor in soluble fraction of mouse L929 cells after 20 hrs",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL977,,,,,,,Mus musculus
188531,4456,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL977,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL977,AGONIST,,Tclin,,,Homo sapiens
188532,4458,350,Dihydropteroate synthase,Enzyme,P0AC13,folP,DHPS_ECOLI,,,,Mechanism of Action; CHEMBL2364668; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL453,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL453,INHIBITOR,,,,,Escherichia coli (strain K12)
188533,4466,2040,RmtA,Enzyme,Q5VLE3,rmtA,Q5VLE3_EMEND,4.74,,IC50,Inhibition of Aspergillus nidulans RmtA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408917,,,,,,,Emericella nidulans
188534,4477,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,7,,Ki,Binding affinity against human cytosolic Carbonic anhydrase IV,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1355,,,,Tclin,,,Homo sapiens
188535,4477,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,4.41,,Ki,Inhibition of Candida albicans Nce103,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1355,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
188536,4480,3638,Intestinal alkaline phosphatase,Unclassified,P19111,ALPI,PPBI_BOVIN,5.62,,IC50,Inhibition of calf intestinal alkaline phosphatase using p-nitrophenyl phosphate as substrate preincubated for 10 mins before substrate addition after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200925,,,,,,,Bos taurus
216547,2337,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,7.4,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,,,,,Cavia porcellus
188537,4482,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,6.69,,Ki,Alpha-2 adrenergic receptor binding affinity was tested against membrane preparations of rat brain.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL677,,,,,,,Rattus norvegicus
188538,4482,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.44,,Ki,Compound was evaluated for inhibition of [3H]prazosin binding to Alpha-1 adrenergic receptor in rat forebrain homogenate.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL677,,,,,,,Rattus norvegicus
188539,4482,2855,Adrenergic receptor alpha-2,GPCR,P08913|P18089|P18825,ADRA2A|ADRA2B|ADRA2C,ADA2A_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN,,,,Mechanism of Action; CHEMBL2095158; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL677,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL677,AGONIST,,Tclin|Tclin|Tclin,,,Homo sapiens
188540,4483,733,Cathepsin B,Enzyme,P07858,CTSB,CATB_HUMAN,4.96,,IC50,Inhibition of recombinant cathepsin B (unknown origin) using Z-Leu-Arg-AMC as substrate by spectrofluorometer analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451887,,,,Tchem,,,Homo sapiens
188541,4483,928,Proteasome subunit beta type-8,Enzyme,P28062,PSMB8,PSB8_HUMAN,7.85,,IC50,Inhibition of chymotrypsin-like activity of LMP7 immunoproteasome by proteasome active site ELISA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451887,,,,Tclin,,,Homo sapiens
188542,4484,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,10.1,,Ki,Binding affinity to muscarinic M2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL551466,,,,Tclin,,,Homo sapiens
188543,4484,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,10.1,,Ki,Binding affinity to muscarinic M1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL551466,,,,Tclin,,,Homo sapiens
188544,4484,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,10.15,,Ki,Binding affinity to muscarinic M3 receptor,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL551466,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL551466,ANTAGONIST,,Tclin,,,Homo sapiens
188545,4484,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,9.7,,IC50,Displacement of [3H]NMS from human muscarinic M4 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL551466,,,,Tclin,,,Homo sapiens
188546,4484,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,9.8,,IC50,Displacement of [3H]NMS from human muscarinic M5 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL551466,,,,Tclin,,,Homo sapiens
188547,4493,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200989,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200989,AGONIST,,Tclin,,,Homo sapiens
188550,4497,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,,Mechanism of Action; CHEMBL206; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200430,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200430,AGONIST,,Tclin,,,Homo sapiens
188551,4498,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.89,,IC50,Inhibition of human ERG channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107360,,,,Tclin,,,Homo sapiens
188552,4501,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.49,,Ki,Displacement of [3H]WIN35428 from DAT in Sprague-Dawley rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201192,,,,,,,Rattus norvegicus
188553,4504,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200562,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200562,AGONIST,,Tclin,,,Homo sapiens
188554,4505,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,4.46,,Ki,Binding affinity towards peroxisome proliferator activated receptor alpha (PPAR alpha),CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL981,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL981,AGONIST,,Tclin,,,Homo sapiens
188555,4505,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,7.03,,Kd,Binding affinity to rat recombinant L-FABP high affinity site expressed in Escherichia coli BL21(DE3) at 5 deg C by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL981,,,,,,,Rattus norvegicus
188556,4505,869,"Fatty acid-binding protein, intestinal",Cytosolic other,P12104,FABP2,FABPI_HUMAN,6,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from I-FABP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL981,,,,Tchem,,,Homo sapiens
188557,4512,3494,Inositol-1(or 4)-monophosphatase 1,Enzyme,P29218,IMPA1,IMPA1_HUMAN,,,,Mechanism of Action; CHEMBL1786; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200826,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200826,INHIBITOR,,Tclin,,,Homo sapiens
188558,4512,2886,Glycogen synthase kinase-3,Kinase,P49840|P49841,GSK3A|GSK3B,GSK3A_HUMAN|GSK3B_HUMAN,,,,Mechanism of Action; CHEMBL2095188; PROTEIN FAMILY,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200826,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200826,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
188559,4516,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,9.19,,EC50,Agonist activity at wild type human melanocortin-4 receptor expressed in HEK293 cells co-transfected with CRE/beta-galactosidase reporter gene assessed as stimulatory response after 6 hrs,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103784,,,,Tclin,,,Homo sapiens
188560,4523,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.92,,Ki,High affinity constant at binding site of human P-Glycoprotein (P-gp) in two-affinity model,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL170,,,,Tchem,,,Homo sapiens
188561,4523,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.29,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL170,,,,Tchem,,,Homo sapiens
188586,4611,577,"Fatty acid-binding protein, adipocyte",Cytosolic other,P15090,FABP4,FABP4_HUMAN,4.1,,Kd,Binding affinity against Adipocyte lipid binding protein,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46403,,,,Tchem,,,Homo sapiens
188562,4523,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,5.36,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL170,,,,Tclin|Tclin|Tclin,,,Homo sapiens
188563,4554,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,10.12,,IC50,Transrepression activity at glucocorticoid receptor in human H292 cells assessed as inhibition of TNF-stimulated IL-6 cytokine synthesis,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1473,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1473,AGONIST,,Tclin,,,Homo sapiens
188564,4562,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,7.89,,Ki,Displacement of [3H]8-OH-DPAT from human 5HT1A receptor in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284092,,AGONIST,,Tclin,,,Homo sapiens
188565,4562,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.24,,Ki,Binding affinity to D2 receptor by radioligand binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284092,,,,Tclin,,,Homo sapiens
188566,4562,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1a|Adra1b|Adra1d,ADA1A_RAT|ADA1B_RAT|ADA1D_RAT,5.62,,Ki,Displacement of [3H]prazosin from adrenergic alpha-1 receptor in rat cerebral cortex cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284092,,,,,,,Rattus norvegicus
188567,4562,2847,Serotonin 1 (5-HT1) receptor,GPCR,P19327|P28564|P28565|P30940,Htr1a|Htr1b|Htr1d|Htr1f,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,6.17,,IC50,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]5-HT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284092,,,,,,,Rattus norvegicus
188568,4562,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,7.5,,Ki,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284092,,,,,,,Rattus norvegicus
188569,4566,3639,Gamma-hydroxybutyrate receptor,Unclassified,Q6RY99,Tspan17,Q6RY99_RAT,5.18,,IC50,Binding affinity towards [3H]GHB binding site,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1342,,,,,,,Rattus norvegicus
188570,4566,2776,GABA-B receptor,GPCR,O75899|Q9UBS5,GABBR1|GABBR2,GABR1_HUMAN|GABR2_HUMAN,,,,Mechanism of Action; CHEMBL2111463; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1342,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1342,AGONIST,,Tclin|Tclin,,,Homo sapiens
188571,4569,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200953,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200953,AGONIST,,Tclin,,,Homo sapiens
188572,4573,436,Dihydrofolate reductase,Enzyme,P16184,,DYR_PNECA,5.62,,IC50,Inhibition of Pneumocystis carinii dihydrofolate reductase (DHFR) enzyme by trimethoprim (TMP),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134561,,,,,,,Pneumocystis carinii
188573,4573,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,6.11,,Ki,Inhibition of human DHFR assessed as oxidation of NADPH using dihydrofolate as substrate pre-incubated for 10 mins before substrate addition by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134561,,,,Tclin,,,Homo sapiens
188574,4573,2102,Dihydrofolate reductase,Unclassified,B0BL08,dfrA17,B0BL08_ECOLX,8.15,,IC50,Inhibition of Escherichia coli dihydrofolate reductase (DHFR) enzyme by trimethoprim (TMP),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134561,,,,,,,Escherichia coli
188575,4573,2420,Dihydrofolate reductase,Enzyme,P0A017,folA,DYR_STAAU,10.1,,Ki,Inhibition of Staphylococcus aureus DHFR using dihydrofolate as substrate preincubated for 10 mins followed by substrate addition by spectrophotometric analysis in presence of NADPH,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134561,,,,,,,Staphylococcus aureus
188576,4586,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprk1|Oprm1|Sigmar1,OPRD_RAT|OPRK_RAT|OPRM_RAT|SGMR1_RAT,8.7,,Ki,Inhibition of [3H]- naloxone binding to Opioid receptors in rat brain membrane in the absence of Na,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL159659,,,,,,,Rattus norvegicus
188577,4601,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,5.52,,IC50,Inhibition of MRP1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90568,,,,Tchem,,,Homo sapiens
188578,4601,2534,Cytochrome P450 1B1,Enzyme,Q16678,CYP1B1,CP1B1_HUMAN,7.54,,IC50,Inhibition of human CYP1B1 by EROD assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90568,,,,Tchem,,,Homo sapiens
188579,4606,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200975,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200975,AGONIST,,Tclin,,,Homo sapiens
188580,4608,424,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,5.41,,IC50,Inhibition of human PTPase 1B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1640,,,,Tchem,,,Homo sapiens
188581,4608,1932,Tyrosine-protein phosphatase 1,Enzyme,P25044,PTP1,PTP1_YEAST,5.13,,IC50,Inhibitory activity against Saccharomyces cerevisiae Tyrosine phosphatase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1640,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
188582,4609,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,Mechanism of Action; CHEMBL1871; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200335,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200335,AGONIST,,Tclin,,,Homo sapiens
188583,4611,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,4.52,,IC50,Displacement of [3H]BRL49653 from Homo sapiens (human) PPARgamma receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46403,,,,Tclin,,,Homo sapiens
188584,4611,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,5.96,,IC50,Displacement of [3H]GW2331 from Homo sapiens (human) PPARalpha receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46403,,,,Tclin,,,Homo sapiens
188585,4611,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,5.22,,IC50,Displacement of [3H]GW2433 from Homo sapiens (human) PPARdelta receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46403,,,,Tchem,,,Homo sapiens
188587,4616,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,6.05,,Ki,Displacement of [3H]naltrindole from human delta opioid receptor expressed in CHO cells after 3 hrs by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1186579,,,,Tclin,,,Homo sapiens
188588,4618,722,"Fatty acid-binding protein, heart",Cytosolic other,P05413,FABP3,FABPH_HUMAN,8.56,,Kd,Binding affinity to human FABP3 expressed in Escherichia coli BL21 (DE3) in DMPC liposomes by surface plasmon resonance analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8739,,,,Tchem,,,Homo sapiens
188589,4618,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,4.35,,IC50,Inhibition of aromatase in human placental microsomes by radiometric method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8739,,,,Tclin,,,Homo sapiens
188590,4618,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,4.92,,IC50,Inhibition of sheep COX2-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8739,,,,,,,Ovis aries
188591,4618,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.4,,Ki,Inhibition of COX-1 (unknown origin) using arachidonic acid as substrate assessed as formation of prostanoid products preincubated for 10 mins prior to substrate addition measured after 2 mins by Ellman's method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8739,,,,Tclin,,,Homo sapiens
188592,4618,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,5.7,,Kd,Binding affinity to PPARgamma,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8739,,,,Tclin,,,Homo sapiens
188593,4618,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,8.1,,Kd,Binding affinity to PPAR-alpha (unknown origin) by fluorescence-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8739,,,,Tclin,,,Homo sapiens
188594,4618,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,4.03,,IC50,Inhibition of bovine COX1-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8739,,,,,,,Bos taurus
188595,4618,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,4.8,,IC50,Displacement of [3H]GW2433 from Homo sapiens (human) PPARdelta receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8739,,,,Tchem,,,Homo sapiens
188596,4618,1940,Tissue factor,Membrane receptor,P13726,F3,TF_HUMAN,4.52,,IC50,Inhibition of amidolytic activity of human tissue factor/human factor 7a,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8739,,,,Tchem,,,Homo sapiens
188597,4623,3640,Nicotinic acetylcholine receptor,Ion channel,E0VB18|E0VB20|E0VDF4|E0VDF5|E0VDF7|E0VP62,,E0VB18_PEDHC|E0VB20_PEDHC|E0VDF4_PEDHC|E0VDF5_PEDHC|E0VDF7_PEDHC|E0VP62_PEDHC,,,,Mechanism of Action; CHEMBL2364023; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2040681,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2040681,AGONIST,,,,,Pediculus humanus subsp. corporis
188598,4624,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,4.02,,IC50,Inhibition of aldose reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1044,,,,Tclin,,,Homo sapiens
188599,4627,558,Cholecystokinin receptor type A,GPCR,P32238,CCKAR,CCKAR_HUMAN,9.55,,Ki,Displacement of radiolabeled CCK-8s from human CCK1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1121,,,,Tclin,,,Homo sapiens
188600,4627,1978,Cholecystokinin receptor type A,GPCR,Q63931,CCKAR,CCKAR_CAVPO,9.55,,Ki,Inhibition of [3H]pCCK-8 binding to Cholecystokinin type A receptor of Guinea pig pancreatic membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1121,,,,,,,Cavia porcellus
188601,4627,1767,Gastrin/cholecystokinin type B receptor,GPCR,P30553,Cckbr,GASR_RAT,9.39,,Ki,Binding affinity for Cholecystokinin type B receptor using [125I]-BH-CCK-8 in rat cortex synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1121,,,,,,,Rattus norvegicus
188602,4627,2920,Cholecystokinin receptor,GPCR,O08786|P56481,Cckar|Cckbr,CCKAR_MOUSE|GASR_MOUSE,9.52,,Ki,Potency in displacing [3H]propionyl-Cholecystokinin from mouse brain membranes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1121,,,,,,,Mus musculus
188603,4627,1766,Cholecystokinin receptor type A,GPCR,P30551,Cckar,CCKAR_RAT,10.05,,Ki,Binding affinity for Cholecystokinin type A receptor using [125I]BH-CCK-8 in rat pancreatic tissue,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1121,,,,,,,Rattus norvegicus
188604,4627,607,Gastrin/cholecystokinin type B receptor,GPCR,P32239,CCKBR,GASR_HUMAN,9.55,,Ki,Tested for the inhibition of [3H]pCCK-8 binding to Cholecystokinin type B receptor in guinea pig brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1121,,,,Tclin,,,Homo sapiens
188605,4627,1848,Gastrin/cholecystokinin type B receptor,GPCR,P56481,Cckbr,GASR_MOUSE,9.52,,IC50,Evaluated for inhibition of cholecystokinin type B receptor by displacing [125I]-Bolton hunter CCK-8 radioligand in the mouse cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1121,,,,,,,Mus musculus
188606,4628,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.31,,EC50,Displacement of [3H]R1881 from AR in human MDA-MB-453 cells,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1082407,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1082407,ANTAGONIST,,Tclin,,,Homo sapiens
188607,4630,344,Farnesyl pyrophosphate synthase,Enzyme,P14324,FDPS,FPPS_HUMAN,4.53,,Ki,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL450079,,,,Tclin,,,Homo sapiens
188608,4631,2827,Soluble guanylate cyclase,Enzyme,O75343|P33402|Q02108|Q02153,GUCY1A2|GUCY1A3|GUCY1B2|GUCY1B3,GCYA2_HUMAN|GCYA3_HUMAN|GCYB1_HUMAN|GCYB2_HUMAN,,,,Mechanism of Action; CHEMBL2111348; PROTEIN COMPLEX GROUP,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL136478,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL136478,ACTIVATOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
188609,4633,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.68,,IC50,Inhibition of Src,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL297812,,,,Tclin,,,Homo sapiens
188610,4634,179,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q02127,DHODH,PYRD_HUMAN,7.52,,Ki,Inhibition of human recombinant DHODH,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL973,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL973,INHIBITOR,,Tclin,,,Homo sapiens
188611,4634,1480,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q63707,Dhodh,PYRD_RAT,8.05,,IC50,Inhibitory activity against rat dihydroorotate dehydrogenase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL973,,,,,,,Rattus norvegicus
188612,4634,3641,Dihydroorotate dehydrogenase,Unclassified,Q54A96,dhod,Q54A96_PLAFA,4.66,,Ki,Inhibition of ubiquinone binding site of Plasmodium falciparum dihydroorotate dehydrogenase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL973,,,,,,,Plasmodium falciparum
188613,4634,1761,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,O35435,Dhodh,PYRD_MOUSE,7.16,,IC50,Inhibitory concentration tested on enzyme dihydroorotate dehydrogenase in mouse,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL973,,,,,,,Mus musculus
188614,4635,1961,High affinity choline transporter 1,Unclassified,Q8BGY9,Slc5a7,SC5A7_MOUSE,6.17,,Ki,Inhibition of [3H]choline uptake at choline transporter 1 in mouse brain synaptosome,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2095207,,,,,,,Mus musculus
188615,4637,2381,Vesicular acetylcholine transporter,Transporter,Q62666,Slc18a3,VACHT_RAT,5.01,,IC50,Inhibition of VACHT in rat synaptic vesicles assessed as [3H]HT uptake pretreated for 30 mins measured after 10 mins by scintillation spectrophotometer analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1160160,,,,,,,Rattus norvegicus
188616,4637,250,Beta-lactamase,Enzyme,P00811,ampC,AMPC_ECOLI,6.33,,IC50,Inhibitory activity against beta-lactamase in the presence of 5 mM KPi concentration of buffer,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1160160,,,,,,,Escherichia coli (strain K12)
188617,4637,3498,Chymotrypsin C,Enzyme,Q99895,CTRC,CTRC_HUMAN,4.3,,IC50,Inhibitory activity against chymotrypsinogen,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1160160,,,,Tchem,,,Homo sapiens
188618,4637,3499,Beta-galactosidase,Enzyme,P16278,GLB1,BGAL_HUMAN,4.1,,IC50,Inhibition of Beta-galactosidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1160160,,,,Tchem,,,Homo sapiens
188619,4641,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,5.48,,EC50,"Activation of C-terminal HA epitope tagged human TAAR1 expressed in RD-HGA16 cells co-expressing Gq protein, Galpha16 by cAMP accumulation assay",CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1927030,http://www.ncbi.nlm.nih.gov/pubmed/22037049,AGONIST,,Tclin,,409,Homo sapiens
188620,4641,2469,Trace amine-associated receptor 1,GPCR,Q8HZ64,TAAR1,TAAR1_MACMU,5.6,,EC50,Activation of rhesus monkey TAAR1 expressed in RD-HGA16 cells co-expressing Gq protein assessed as cAMP accumulation by fluorescence plate reader,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1927030,,,,,,,Macaca mulatta
188621,4641,2470,Trace amine-associated receptor 1,GPCR,Q923Y9,Taar1,TAAR1_RAT,6.63,,EC50,Activation of rat wild type TAAR1 expressed in HEK293 cells assessed as stimulation of cAMP production after 1 hr by chemiluminescent assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1927030,,,,,,,Rattus norvegicus
188622,4641,2471,Trace amine-associated receptor 1,GPCR,Q923Y8,Taar1,TAAR1_MOUSE,6.07,,EC50,Activation of mouse wild type TAAR1 expressed in HEK293 cells assessed as stimulation of cAMP production after 1 hr by chemiluminescent assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1927030,,,,,,,Mus musculus
188623,4642,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,4.52,,IC50,Displacement of [3H]BRL49653 from Homo sapiens (human) PPARgamma receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108766,,,,Tclin,,,Homo sapiens
188624,4642,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,4.52,,IC50,Displacement of [3H]GW2331 from Homo sapiens (human) PPARalpha receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108766,,,,Tclin,,,Homo sapiens
188625,4642,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,4.52,,IC50,Displacement of [3H]GW2433 from Homo sapiens (human) PPARdelta receptor by scintillation proximity assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108766,,,,Tchem,,,Homo sapiens
188641,4648,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.96,,IC50,Inhibition of COX1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42710,,,,Tclin,,,Homo sapiens
188642,4654,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,7.55,,IC50,Inhibition of wild-type B-Raf,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1946170,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1946170,INHIBITOR,,Tclin,,,Homo sapiens
188643,4654,1250,Bifunctional epoxide hydrolase 2,Enzyme,P34913,EPHX2,HYES_HUMAN,9.3,,IC50,Inhibition of human recombinant soluble epoxide hydrolase assessed as cyano(6-methoxy-naphthalen-2-yl)methyl trans-[(3-phenyloxyran-2-yl)methyl] carbonate conversion to 6-methoxy-2-naphthaldehyde preincubated for 5 mins prior to substrate addition by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1946170,,INHIBITOR,,Tchem,,,Homo sapiens
188655,4660,1845,Muscarinic acetylcholine receptor M3,GPCR,P08483,Chrm3,ACM3_RAT,8.59,,Kd,In vitro receptor binding against Muscarinic acetylcholine receptor M3 in rat submandibular gland was determined using [3H]pirenzepine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516476,,,,,,,Rattus norvegicus
188656,4660,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.6,,Kd,In vitro receptor binding against Muscarinic acetylcholine receptor M1 in rat cerebral cortex was determined using [3H]pirenzepine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516476,,,,,,,Rattus norvegicus
188657,4660,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,8.57,,Kd,In vitro receptor binding against Muscarinic acetylcholine receptor M2 in rat heart was determined using [3H]pirenzepine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516476,,,,,,,Rattus norvegicus
188658,4663,2017,Cocaine esterase,Enzyme,O00748,CES2,EST2_HUMAN,5.65,,Ki,Inhibition constant against human intestinal carboxylesterase (hiCE) expressed in Sf21 cells using 3 mM o-NPA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190677,,,,Tchem,,,Homo sapiens
188659,4663,661,Liver carboxylesterase 1,Enzyme,P23141,CES1,EST1_HUMAN,5.14,,Ki,Inhibition constant against human liver carboxylesterase (hCE1) expressed in Sf21 cells using 3 mM o-NPA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190677,,,,Tchem,,,Homo sapiens
188660,4664,2079,Solute carrier family 22 member 20,Transporter,Q80UJ1,Slc22a20,S22AK_MOUSE,4.86,,Ki,Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL541,,,,,,,Mus musculus
188661,4664,2567,D-amino-acid oxidase,Enzyme,P14920,DAO,OXDA_HUMAN,5.7,,Ki,Competitive inhibition of human recombinant DAAO by Michaelis-Menten plot analysis in presence of D-serine,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL541,,,,Tchem,,,Homo sapiens
188662,4673,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,9.75,,Ki,Displacement of [3H]U69593 from kappa opioid receptor in guinea pig cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267495,,,,,,,Cavia porcellus
188663,4673,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,9.64,,Ki,Binding affinity to kappa opioid receptor,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267495,http://www.ncbi.nlm.nih.gov/pubmed/16251241,AGONIST,,Tclin,,455,Homo sapiens
188664,4673,1760,Delta-type opioid receptor,GPCR,P32300,Oprd1,OPRD_MOUSE,7.29,,Ki,Displacement of [3H]DPDPE from delta opioid receptor in mouse whole brain membranes without cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267495,,,,,,,Mus musculus
188665,4673,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,9.24,,Ki,Displacement of [3H]DAMGO from mu opioid receptor in guinea pig forebrain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267495,,,,,,,Cavia porcellus
188666,4673,1758,Mu-type opioid receptor,GPCR,P42866,Oprm1,OPRM_MOUSE,9.37,,Ki,Displacement of [3H]DAMGO from mu opioid receptor in mouse whole brain without cerebellum,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267495,,,,,,,Mus musculus
188667,4676,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,4.67,,Kd,Binding affinity to sarin-inhibited hemoglobin free human erythrocyte ghost acetylcholinesterase using acetylthiocholineiodide as substrate measured up to 1 hr by Ellman method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL291233,,,,Tclin,,,Homo sapiens
188668,4682,917,Histone deacetylase 10,Enzyme,Q969S8,HDAC10,HDA10_HUMAN,7.51,,Ki,Competitive inhibition of HDAC10 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,,Tclin,,177,Homo sapiens
188669,4682,2307,Histone deacetylase 11,Enzyme,Q96DB2,HDAC11,HDA11_HUMAN,8.46,,Ki,Competitive inhibition of HDAC11 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,,Tclin,,177,Homo sapiens
188670,4682,717,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,7.66,,Ki,Competitive inhibition of HDAC8 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,,Tclin,,177,Homo sapiens
188671,4682,810,Histone deacetylase 9,Enzyme,Q9UKV0,HDAC9,HDAC9_HUMAN,8.92,,Ki,Competitive inhibition of HDAC9 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,,Tclin,,177,Homo sapiens
188672,4682,630,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,9.15,,Ki,Competitive inhibition of HDAC6 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,,Tclin,,177,Homo sapiens
188673,4682,606,Histone deacetylase 1,Enzyme,Q13547,HDAC1,HDAC1_HUMAN,9,,Ki,Inhibition of human HDAC1,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,,Tclin,,177,Homo sapiens
188674,4682,766,Histone deacetylase 4,Enzyme,P56524,HDAC4,HDAC4_HUMAN,9.22,,Ki,Competitive inhibition of HDAC4 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,,Tclin,,177,Homo sapiens
188675,4682,619,Histone deacetylase 3,Enzyme,O15379,HDAC3,HDAC3_HUMAN,8.96,,Ki,Inhibition of human HDAC3,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,,Tclin,,177,Homo sapiens
188676,4682,598,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,9.19,,Ki,Inhibition of human HDAC2,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,,Tclin,,177,Homo sapiens
188677,4682,2109,Histone deacetylase,Enzyme,Q9XYC7,HDAC1,Q9XYC7_PLAFA,8.74,,IC50,Inhibition of Plasmodium falciparum HDAC1 expressed in Drosophila melanogaster S2 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,,,,,,,Plasmodium falciparum
188678,4682,575,Histone deacetylase 5,Enzyme,Q9UQL6,HDAC5,HDAC5_HUMAN,9.15,,Ki,Competitive inhibition of HDAC5 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,,Tclin,,177,Homo sapiens
188679,4682,668,Histone deacetylase 7,Enzyme,Q8WUI4,HDAC7,HDAC7_HUMAN,8.64,,Ki,Competitive inhibition of HDAC7 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483254,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/205353s000lbl.pdf,INHIBITOR,,Tclin,,177,Homo sapiens
188680,4683,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.23,,IC50,Inhibition of esterase activity of human carbonic anhydrase 2 by CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23838,,,,Tclin,,,Homo sapiens
188681,4683,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,5.99,,IC50,Inhibition of esterase activity of mouse carbonic anhydrase 13 by CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23838,,,,,,,Mus musculus
188682,4683,2130,Monoglyceride lipase,Enzyme,O35678,Mgll,MGLL_MOUSE,5.92,,IC50,Displacement of 2-arachidonylglycerol from MAGL in Swiss Webster mouse brain after 5 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23838,,,,,,,Mus musculus
188683,4683,2131,Fatty-acid amide hydrolase 1,Enzyme,O08914,Faah,FAAH1_MOUSE,6.27,,IC50,Inhibition of FAAH-mediated [3H]anandamide hydrolysis in mouse brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23838,,,,,,,Mus musculus
188684,4683,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,7.89,,IC50,Displacement of acetylcholine from AChE in Swiss Webster mouse brain after 5 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23838,,,,,,,Mus musculus
188685,4683,1955,Cannabinoid receptor 1,GPCR,P47746,Cnr1,CNR1_MOUSE,5.92,,IC50,Displacement of [3H]CP-55940 from CB1 receptor in mouse brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23838,,,,,,,Mus musculus
188686,4683,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.47,,IC50,Inhibition of esterase activity of human carbonic anhydrase 1 by CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23838,,,,Tclin,,,Homo sapiens
188687,4684,2925,Glutamate receptor ionotropic AMPA,Ion channel,P42261|P42262|P42263|P48058,GRIA1|GRIA2|GRIA3|GRIA4,GRIA1_HUMAN|GRIA2_HUMAN|GRIA3_HUMAN|GRIA4_HUMAN,6.61,,IC50,Antagonist activity at human iGluA1 receptor flop isoform expressed in CHO-S cells coexpressing TARP gamma-3 assessed as inhibition of glutamate-induced increase in intracellular calcium levels after 2 mins followed by cyclothiazide/glutamate addition by fluorescence imaging plate reader method,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1214124,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1214124,ANTAGONIST,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
188688,4690,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,6.6,,EC50,Activation of human PXR expressed in african green monkey CV1 cells transfected with pSG5-hPXRDATG and (ER6)3-tk-CAT reporter,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29609,,,,Tchem,,,Homo sapiens
188689,4690,1888,Protease,Enzyme,Q4U254,protease,Q4U254_9ENTO,7.24,,EC50,Inhibition of HRV Protease 3CP (serotype 14).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29609,,,,,,,Human rhinovirus sp
188690,4706,749,Cathepsin L1,Enzyme,P07711,CTSL,CATL1_HUMAN,4.05,,IC50,Inhibitory concentration against human liver cathepsin L,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL306043,,,,Tclin,,,Homo sapiens
188691,4713,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,5.66,,Kd,Binding constant for ABL1(T315I)-phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tclin,,,Homo sapiens
188692,4713,2248,Serine/threonine-protein kinase DCLK1,Kinase,O15075,DCLK1,DCLK1_HUMAN,5.17,,Kd,Binding constant for DCAMKL1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188693,4713,660,Calcium/calmodulin-dependent protein kinase type 1,Kinase,Q14012,CAMK1,KCC1A_HUMAN,5.92,,Kd,Binding constant for CAMK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188694,4713,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,9.24,,Kd,Binding constant for JAK2(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,INHIBITOR,,Tclin,,,Homo sapiens
188695,4713,2134,Ribosomal protein S6 kinase alpha-6,Kinase,Q9UK32,RPS6KA6,KS6A6_HUMAN,6.27,,Kd,Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188696,4713,2283,Ribosomal protein S6 kinase alpha-1,Kinase,Q15418,RPS6KA1,KS6A1_HUMAN,5.85,,Kd,Binding constant for RSK1(Kin.Dom.2-C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188697,4713,3493,JAK2/TYK2,Kinase,O60674|P29597,JAK2|TYK2,JAK2_HUMAN|TYK2_HUMAN,6.64,,IC50,Inhibition of JAK2/TYK2 in human whole blood assessed as inhibition of IL-23-induced STAT-3 phosphorylation preincubated for 45 mins followed by IL-23 addition measured after 15 mins by FACS analysis,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
188698,4713,3492,JAK1/JAK2/TYK2,Kinase,O60674|P23458|P29597,JAK1|JAK2|TYK2,JAK1_HUMAN|JAK2_HUMAN|TYK2_HUMAN,7.12,,IC50,Inhibition of JAK1/JAK2/TYK2 in human whole blood assessed as inhibition of IL-6-induced STAT-1 phosphorylation preincubated for 45 mins followed by IL-6 addition measured after 15 mins by FACS analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,INHIBITOR,,Tclin|Tclin|Tclin,,,Homo sapiens
188699,4713,3491,JAK1/TYK2,Kinase,P23458|P29597,JAK1|TYK2,JAK1_HUMAN|TYK2_HUMAN,7.46,,IC50,Inhibition of JAK1/TYK2 in human whole blood assessed as inhibition of IFN-alpha-induced STAT-3 phosphorylation preincubated for 45 mins followed by IFN-alpha addition measured after 15 mins by FACS analysis,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,INHIBITOR,,Tclin|Tclin,,,Homo sapiens
188700,4713,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,9.17,,Ki,Inhibition of human recombinant GST-tagged JAK1 using 5-FAM-KKSRGDYMTMQIG as substrate by peptide mobility shift assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,INHIBITOR,,Tclin,,,Homo sapiens
188701,4713,2333,G protein-coupled receptor kinase 7,Kinase,Q8WTQ7,GRK7,GRK7_HUMAN,5.37,,Kd,Binding constant for GRK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188703,4713,2089,Serine/threonine-protein kinase N2,Kinase,Q16513,PKN2,PKN2_HUMAN,5.92,,Kd,Binding constant for PKN2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188704,4713,670,Rho-associated protein kinase 1,Kinase,Q13464,ROCK1,ROCK1_HUMAN,6.33,,Kd,Binding constant for ROCK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tclin,,,Homo sapiens
188705,4713,2464,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,6.26,,Kd,Binding constant for LRRK2(G2019S) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188706,4713,855,BMP-2-inducible protein kinase,Kinase,Q9NSY1,BMP2K,BMP2K_HUMAN,5.15,,Kd,Binding constant for BIKE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188707,4713,903,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,Q9HBH9,MKNK2,MKNK2_HUMAN,5.8,,Kd,Binding constant for MKNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188708,4713,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,8.36,,Ki,Inhibition of human recombinant GST-tagged TYK2 using 5-FAM-KKSRGDYMTMQIG as substrate by peptide mobility shift assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,INHIBITOR,,Tclin,,,Homo sapiens
188709,4713,891,Calcium/calmodulin-dependent protein kinase type 1D,Kinase,Q8IU85,CAMK1D,KCC1D_HUMAN,5.8,,Kd,Binding constant for CAMK1D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188710,4713,2133,Serine/threonine-protein kinase 3,Kinase,Q13188,STK3,STK3_HUMAN,5.37,,Kd,Binding affinity to MST2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188711,4713,750,Ribosomal protein S6 kinase alpha-2,Kinase,Q15349,RPS6KA2,KS6A2_HUMAN,6.22,,Kd,Binding constant for RSK3(Kin.Dom.2-C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188712,4713,773,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,Q9UQM7,CAMK2A,KCC2A_HUMAN,5.46,,Kd,Binding constant for CAMK2A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188713,4713,2357,Serine/threonine-protein kinase ULK3,Kinase,Q6PHR2,ULK3,ULK3_HUMAN,5.19,,Kd,Binding constant for ULK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188714,4713,2612,Serine/threonine-protein kinase PknB,Kinase,P9WI81,pknB,PKNB_MYCTU,5.7,,Kd,Binding constant for PKNB(M.tuberculosis) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
188715,4713,713,Rho-associated protein kinase 2,Kinase,O75116,ROCK2,ROCK2_HUMAN,6.38,,Kd,Binding constant for ROCK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tclin,,,Homo sapiens
188716,4713,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.96,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tclin,,,Homo sapiens
188717,4713,710,Protein kinase C delta type,Kinase,Q05655,PRKCD,KPCD_HUMAN,5.7,,Kd,Binding constant for PRKCD kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tclin,,,Homo sapiens
188718,4713,2408,Tyrosine-protein kinase JAK3,Kinase,Q62137,Jak3,JAK3_MOUSE,7.32,,IC50,Inhibition of Jak3-mediated IL2-induced Stat5 phosphorylation in mouse CTLL cells by cell-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,,,,Mus musculus
188719,4713,2132,Serine/threonine-protein kinase DCLK3,Kinase,Q9C098,DCLK3,DCLK3_HUMAN,8.35,,Kd,Binding affinity to DCamkL3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188720,4713,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,5.48,,Kd,Binding constant for RET(M918T) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tclin,,,Homo sapiens
188721,4713,2206,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,5.92,,Kd,Binding constant for DMPK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188722,4713,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,6.34,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tclin,,,Homo sapiens
188723,4713,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.62,,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188724,4713,2571,Tyrosine-protein kinase JAK2,Kinase,Q62120,Jak2,JAK2_MOUSE,5.69,,IC50,Inhibition of JAK2 in C57BL/6 mouse whole blood assessed as inhibition of GM-CSF-stimulated STAT5a phosphorylation after 30 mins by flow cytometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,,,,Mus musculus
188725,4713,721,Calcium/calmodulin-dependent protein kinase type II subunit delta,Kinase,Q13557,CAMK2D,KCC2D_HUMAN,5.57,,Kd,Binding constant for CAMK2D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188726,4713,815,Serine/threonine-protein kinase N1,Kinase,Q16512,PKN1,PKN1_HUMAN,6.77,,Kd,Binding constant for PKN1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188727,4713,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,5.32,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188728,4713,2136,Non-receptor tyrosine-protein kinase TNK1,Kinase,Q13470,TNK1,TNK1_HUMAN,6.92,,Kd,Binding constant for TNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL221959,,,,Tchem,,,Homo sapiens
188729,4716,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,9.52,,IC50,Inhibition of FLT3 in human MV4-11 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1171837,,,,Tclin,,,Homo sapiens
188730,4716,2144,Proto-oncogene tyrosine-protein kinase Src,Kinase,P00523,SRC,SRC_CHICK,9.05,,IC50,Inhibition of chicken wild-type cSRC (251 to 533)-mediated phosphorylation of biotinylated poly-Glu-Tyr expressed in Escherichia coli BL21(DE3) preincubated for 30 to 60 mins prior to substrate addition by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1171837,,,,,,,Gallus gallus
188731,4716,531,Breakpoint cluster region protein,Kinase,P11274,BCR,BCR_HUMAN,,,,Mechanism of Action; CHEMBL5146; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1171837,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1171837,INHIBITOR,,Tclin,,,Homo sapiens
188732,4718,2686,Glucagon-like peptide 2 receptor,GPCR,O95838,GLP2R,GLP2R_HUMAN,10.05,,EC50,Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104987,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104987,AGONIST,,Tclin,,,Homo sapiens
188733,4728,2572,Prostaglandin G/H synthase 1,Enzyme,O97554,PTGS1,PGH1_RABIT,5.59,,IC50,Inhibition of COX-1 in rabbit peripheral venous blood assessed as formation of 12-hydroxyheptadecatrienoic acid after 24 hrs by HPLC in presence of calcium ionophore A23187,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908355,,,,,,,Oryctolagus cuniculus
188734,4728,2573,Prostaglandin G/H synthase 2,Enzyme,O02768,PTGS2,PGH2_RABIT,5.08,,IC50,Inhibition of COX-2 in rabbit peripheral venous blood assessed as formation of 12-hydroxyheptadecatrienoic acid after 24 hrs in by HPLC presence of calcium ionophore A23188 and lipopolysaccharide,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908355,,,,,,,Oryctolagus cuniculus
188735,4728,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,5.05,,IC50,In vitro inhibition of 5-lipoxygenase pathway in rat basophilic leukemia (RBL-1) cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908355,,,,,,,Rattus norvegicus
188736,4728,2845,Cyclooxygenase,Enzyme,P35355|Q63921,Ptgs1|Ptgs2,PGH1_RAT|PGH2_RAT,8,,IC50,In vitro inhibition of Prostaglandin G/H synthase pathway in rat basophilic leukemia (RBL-1) cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908355,,,,,,,Rattus norvegicus
188761,4796,2094,Carbonic anhydrase,Enzyme,Q5AJ71,NCE103,CAN_CANAL,4.29,,Ki,Inhibition of Candida albicans Nce103,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500826,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
188762,4797,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,1.2,,Ki,Inhibitory activity against human carbonic anhydrase II expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93268,,,,Tclin,,,Homo sapiens
188737,4731,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabra1|Gabra2|Gabra3|Gabra4|Gabra5|Gabra6|Gabrb1|Gabrb2|Gabrb3|Gabrd|Gabre|Gabrg1|Gabrg2|Gabrg3|Gabrp|Gabrq,GBRA1_RAT|GBRA2_RAT|GBRA3_RAT|GBRA4_RAT|GBRA5_RAT|GBRA6_RAT|GBRB1_RAT|GBRB2_RAT|GBRB3_RAT|GBRD_RAT|GBRE_RAT|GBRG1_RAT|GBRG2_RAT|GBRG3_RAT|GBRP_RAT|Q91ZM7_RAT,5.72,,IC50,Displacement of [3H]muscimol from GABA-A receptor in Sprague-Dawley rat spinal cord,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1705373,,,,,,,Rattus norvegicus
188738,4732,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,9,,IC50,Inhibition of human AchE,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33864,,,,Tclin,,,Homo sapiens
188739,4733,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.16,,Ki,Inhibition of human recombinant carbonic anhydrase 12 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508338,,,,Tclin,,,Homo sapiens
188740,4733,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.25,,Ki,Inhibition of human recombinant carbonic anhydrase 4 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508338,,,,Tclin,,,Homo sapiens
188741,4733,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,5.16,,Ki,Inhibition of human recombinant carbonic anhydrase 13 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508338,,,,Tclin,,,Homo sapiens
188742,4733,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.2,,Ki,Inhibition of human recombinant carbonic anhydrase 3 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508338,,,,Tclin,,,Homo sapiens
188743,4733,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,5.14,,Ki,Inhibition of human recombinant carbonic anhydrase 5A preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508338,,,,Tclin,,,Homo sapiens
188744,4733,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.18,,Ki,Inhibition of human recombinant carbonic anhydrase 14 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508338,,,,Tclin,,,Homo sapiens
188745,4733,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,4.96,,Ki,Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508338,,,,Tclin,,,Homo sapiens
188746,4733,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.23,,Ki,Inhibition of human recombinant carbonic anhydrase 5B preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508338,,,,Tclin,,,Homo sapiens
188747,4733,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,5.29,,Ki,Inhibition of human recombinant carbonic anhydrase 6 preincubated for 15 mins to 72 hrs measured after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508338,,,,Tclin,,,Homo sapiens
188748,4741,2929,ATP synthase,Enzyme,P9WPS1|P9WPU5|P9WPU7|P9WPU9|P9WPV1|P9WPV3|P9WPV5|P9WPV7,atpA|atpB|atpC|atpD|atpE|atpF|atpFH|atpG,ATP6_MYCTU|ATPA_MYCTU|ATPB_MYCTU|ATPE_MYCTU|ATPFD_MYCTU|ATPF_MYCTU|ATPG_MYCTU|ATPL_MYCTU,,,,Mechanism of Action; CHEMBL2364166; PROTEIN COMPLEX,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL376488,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL376488,INHIBITOR,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
188750,4752,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,9.1,,Ki,,IUPHAR,=,1,CHEMBL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8035,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200837,ANTAGONIST,,Tclin,,,Homo sapiens
188751,4757,2687,Kelch-like ECH-associated protein 1,Cytosolic other,Q14145,KEAP1,KEAP1_HUMAN,,,,Mechanism of Action; CHEMBL2069156; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL589586,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL589586,INHIBITOR,,Tclin,,,Homo sapiens
188752,4758,2059,Sodium/glucose cotransporter 1,Transporter,P13866,SLC5A1,SC5A1_HUMAN,5.72,,IC50,Inhibition of human SGLT1 expressed in CHO-K1 cells by [14C]AMG uptake assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2048484,,,,Tclin,,,Homo sapiens
188753,4773,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.32,,Ki,Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15841,,,,Tclin,,,Homo sapiens
188754,4773,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,4.42,,EC50,Agonist activity at human estrogen receptor-alpha by yeast two-hybrid assay in presence of SRC1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15841,,,,Tclin,,,Homo sapiens
188755,4773,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,5.73,,EC50,Agonist activity at human estrogen receptor-beta by yeast two-hybrid assay in presence of SRC1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15841,,,,Tclin,,,Homo sapiens
188756,4773,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.07,,Ki,Inhibition of human carbonic anhydrase 12 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15841,,,,Tclin,,,Homo sapiens
188757,4773,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,5.11,,Ki,Inhibition of human carbonic anhydrase 14 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15841,,,,Tclin,,,Homo sapiens
188758,4773,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,5.06,,Ki,Inhibition of human carbonic anhydrase 7 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15841,,,,Tclin,,,Homo sapiens
188759,4773,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.09,,Ki,Inhibition of human carbonic anhydrase 9 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15841,,,,Tclin,,,Homo sapiens
188760,4773,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.1,,Ki,Inhibition of human carbonic anhydrase 1 preincubated for 15 mins by CO2 hydration stopped-flow assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15841,,,,Tclin,,,Homo sapiens
188763,4797,1746,Carbonic anhydrase 13,Enzyme,Q9D6N1,Ca13,CAH13_MOUSE,1.9,,Ki,Inhibitory activity against mouse carbonic anhydrase XIII expressed in Escherichia coli TOP 10,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93268,,,,,,,Mus musculus
188764,4797,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,2.08,,Ki,Inhibitory activity against human carbonic anhydrase I expressed in Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93268,,,,Tclin,,,Homo sapiens
188765,4801,2263,TGF-beta receptor type-1,Kinase,P36897,TGFBR1,TGFR1_HUMAN,5.43,,IC50,Inhibition of Alk5 in TGF-beta-stimulated human HepG2 cells assessed as decrease in Smad2 phosphorylation treated for 45 mins prior to TGF-beta stimulation measured after 60 mins by odyssey blot scanner analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2028663,,,,Tchem,,,Homo sapiens
188767,4806,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.25,,Ki,Binding affinity to human beta 2 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104993,,,,Tclin,,,Homo sapiens
188768,4806,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,7.34,,Ki,Binding affinity to human beta 1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104993,,,,Tclin,,,Homo sapiens
188769,4806,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,6.05,,IC50,Inhibition of DAT-mediated [3H]DA in rat synaptosomes by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104993,,,,,,,Rattus norvegicus
188770,4806,1856,5-hydroxytryptamine receptor 3A,Ion channel,P35563,Htr3a,5HT3A_RAT,6.64,,Ki,Binding affinity to rat 5HT3A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104993,,,,,,,Rattus norvegicus
188771,4806,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,6.74,,Ki,Binding affinity to human histamine H2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104993,,,,Tclin,,,Homo sapiens
188772,4806,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.74,,Ki,Binding affinity to human 5HT2C receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104993,,,,Tclin,,,Homo sapiens
188773,4806,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.74,,Ki,Binding affinity to human 5HT2A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104993,,,,Tclin,,,Homo sapiens
188774,4806,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,6.74,,Ki,Binding affinity to human histamine H1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104993,,,,Tclin,,,Homo sapiens
188775,4806,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,8.28,,IC50,Inhibition of SERT-mediated [3H]5HT uptake in rat synaptosomes by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104993,,,,,,,Rattus norvegicus
188776,4806,284,5-hydroxytryptamine receptor 5A,GPCR,P47898,HTR5A,5HT5A_HUMAN,6.66,,Ki,Binding affinity to human 5HT5A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104993,,,,Tchem,,,Homo sapiens
188777,4806,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.48,,Ki,Binding affinity to human 5HT6 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104993,,,,Tchem,,,Homo sapiens
188778,4808,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,6.18,,IC50,In vitro inhibition of acetylcholinesterase isolated from human erythrocytes.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL130880,,,,Tclin,,,Homo sapiens
188779,4810,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,8.25,,IC50,Inhibition of ErbB1 relative to control,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1873475,,,,Tclin,,,Homo sapiens
188780,4810,746,Cytoplasmic tyrosine-protein kinase BMX,Kinase,P51813,BMX,BMX_HUMAN,9.1,,IC50,Inhibition of BMX,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1873475,,,,Tchem,,,Homo sapiens
188782,4810,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7.43,,IC50,Inhibition of RET,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1873475,,,,Tclin,,,Homo sapiens
188783,4811,2637,NS5B protein,Enzyme,Q8JXU8,NS5B,Q8JXU8_9HEPC,,,,Mechanism of Action; CHEMBL5375; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1259059,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1259059,INHIBITOR,,,,,Hepatitis C virus
188784,4812,2378,Cathepsin S,Enzyme,P25774,CTSS,CATS_HUMAN,6.1,,IC50,Inhibition of human cathepsin S in human JY cells assessed as p10 accumulation by fluorescence-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501849,,,,Tchem,,,Homo sapiens
188785,4812,2926,"Hepatitis C virus serine protease, NS3/NS4A",Enzyme,A3EZI9|D2K2A8,NS3|NS4A,A3EZI9_9HEPC|D2K2A8_9HEPC,9.3,,Ki,"BindingDB_Patents: Inhibition Assay. The inhibition of full-length hepatitis C NS3 protease enzyme was measured essentially as described in Poliakov, 2002 Prot Expression & Purification 25 363 371. Briefly, the hydrolysis of a depsipeptide substrate, Ac-DED(Edans)EEAbu[COO]ASK(Dabcyl)-NH2 (AnaSpec, San Jose, USA), was measured spectrofluorometrically in the presence of a peptide cofactor, KKGSVVIVGRIVLSGK (Ake Engstrom, Department of Medical Biochemistry and Microbiology, Uppsala University, Sweden). [Landro, 1997 #Biochem 36 9340-9348]. The enzyme (1 nM) was incubated in 50 mM HEPES, pH 7.5, 10 mM DTT, 40% glycerol, 0.1% n-octyl-D-glucoside, with 25 µM NS4A cofactor and inhibitor at 30 C. for 10 min, whereupon the reaction was initiated by addition of 0.5 µM substrate. Inhibitors were dissolved in DMSO, sonicated for 30 sec. and vortexed.",CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501849,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501849,INHIBITOR,,,,,Hepatitis C virus
188786,4813,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,Mechanism of Action; CHEMBL1780; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105689,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105689,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
188787,3203,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2a|Adra2b|Adra2c,ADA2A_RAT|ADA2B_RAT|ADA2C_RAT,8.11,,Ki,Displacement of [3H]clonidine from Alpha-2 adrenergic receptor of rat brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL677,,,,,,,Rattus norvegicus
188788,4822,3458,Neuraminidase,Enzyme,Q194T1,,Q194T1_9INFA,5.51,,IC50,Inhibition of Influenza A virus (A/RI/5+/1957(H2N2)) recombinant neuraminidase using MUNANA as substrate after 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL466246,,,,,,,Influenza A virus (A/RI/5+/1957(H2N2))
188819,4866,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.59,,IC50,Inhibition of FGFR2 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188789,4823,1794,Neuraminidase,Enzyme,P03468,NA,NRAM_I34A1,8.85,,IC50,inhibitory concentration required to inhibit neuraminidase enzyme from different strains of influenza A virus,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139367,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206426lbl.pdf,INHIBITOR,,,,352,Influenza A virus (strain A/Puerto Rico/8/1934 H1N1)
188790,4823,1795,Neuraminidase,Enzyme,P03474,NA,NRAM_INBLE,8.3,,IC50,Inhibitory activity against influenza B neuraminidase,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139367,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206426lbl.pdf,INHIBITOR,,,,352,Influenza B virus (strain B/Lee/1940)
188791,4823,2574,Neuraminidase,Enzyme,Q9IGQ6,NA,NRAM_I18A0,9.08,,Ki,Inhibition of Influenza A virus (A/Brevig Mission/1/1918(H1N1)) recombinant soluble neuraminidase using 2'-4(methylumbelliferyl)-alpha-D-N-acetylneuraminic acid substrate by fluorimetric assay,CHEMBL,=,1,DRUG LABEL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139367,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206426lbl.pdf,INHIBITOR,,,,352,Influenza A virus (strain A/Brevig Mission/1/1918 H1N1)
188792,4839,1935,Plasma kallikrein,Enzyme,P03952,KLKB1,KLKB1_HUMAN,,,,Mechanism of Action; CHEMBL2000; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201619,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201619,INHIBITOR,,Tclin,,,Homo sapiens
188797,4857,500,Steryl-sulfatase,Enzyme,P08842,STS,STS_HUMAN,4.22,,Ki,Inhibitory activity against steroid sulfatase (STS) desulfation of 4-MUS,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL494753,,,,Tchem,,,Homo sapiens
188798,4857,2079,Solute carrier family 22 member 20,Transporter,Q80UJ1,Slc22a20,S22AK_MOUSE,4.24,,Ki,Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL494753,,,,,,,Mus musculus
188799,4864,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.49,,IC50,Inhibition of human DAT,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL99946,,,,Tclin,,,Homo sapiens
188800,4864,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,8.07,,Ki,Inhibition of [3H]-paroxetine binding on serotonin transporter of rat cerebral cortical synaptic membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL99946,,,,,,,Rattus norvegicus
188801,4864,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,5.2,,IC50,Binding affinity for N-methyl-D-aspartate glutamate receptor of cerebral cortical synaptic membranes from rats using [3H]MK-801 as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL99946,,,,,,,Rattus norvegicus
188802,4866,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,5.9,,IC50,Inhibition of ABL (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188803,4866,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,7.22,,IC50,Inhibition of FLT3 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188804,4866,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,6.05,,IC50,Inhibition of EGFR (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188805,4866,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.77,,IC50,Inhibition of TEL-fused SRC (unknown origin) by cell-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188806,4866,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,5.38,,IC50,Inhibition of TEL-fused KDR (unknown origin) by cell-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188807,4866,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.37,,IC50,Inhibition of FGFR3 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188808,4866,2281,Fibroblast growth factor receptor 4,Kinase,P22455,FGFR4,FGFR4_HUMAN,6.02,,IC50,Inhibition of FGFR4 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188809,4866,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,5.94,,IC50,Inhibition of PDGFRalpha (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188810,4866,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,5.87,,IC50,Inhibition of TEL-fused MET (unknown origin) by cell-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188811,4866,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,6.21,,IC50,Inhibition of JAK2 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188812,4866,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,5.43,,IC50,Inhibition of JAK1 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188813,4866,715,Tyrosine-protein kinase SYK,Kinase,P43405,SYK,KSYK_HUMAN,5.52,,IC50,Inhibition of SYK (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188814,4866,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,5.47,,IC50,Inhibition of BTK (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188815,4866,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,5.71,,IC50,Inhibition of TEL-fused FGR (unknown origin) by cell-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tchem,,,Homo sapiens
188816,4866,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,5.1,,IC50,Inhibition of JAK3 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188817,4866,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.9,,IC50,Inhibition of human ERG by dofetilide binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188818,4866,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,5.56,,IC50,Inhibition of TEL-fused TRKA (unknown origin) by cell-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188820,4866,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,5.89,,IC50,Inhibition of cKIT (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188821,4866,903,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,Q9HBH9,MKNK2,MKNK2_HUMAN,5.65,,IC50,Inhibition of MKNK2 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tchem,,,Homo sapiens
188822,4866,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.08,,IC50,Inhibition of LYN (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188823,4866,1823,Tyrosine-protein kinase ZAP-70,Kinase,P43403,ZAP70,ZAP70_HUMAN,5.01,,IC50,Inhibition of ZAP70 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tchem,,,Homo sapiens
188824,4866,597,Cyclin-dependent kinase 2,Kinase,P24941,CDK2,CDK2_HUMAN,5.4,,IC50,Inhibition of CDK2 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tchem,,,Homo sapiens
188825,4866,2282,Proto-oncogene tyrosine-protein kinase ROS,Kinase,P08922,ROS1,ROS1_HUMAN,6.85,,IC50,Inhibition of TEL-fused ROS (unknown origin) by cell-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188826,4866,713,Rho-associated protein kinase 2,Kinase,O75116,ROCK2,ROCK2_HUMAN,5.9,,IC50,Inhibition of ROCK2 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188827,4866,2627,Transcription factor ETV6,Transcription factor,P41212,ETV6,ETV6_HUMAN,5.49,,IC50,Inhibition of wild-type TEL (unknown origin) by cell-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tbio,,,Homo sapiens
188828,4866,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.4,,IC50,Inhibition of RET (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188829,4866,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,6.25,,IC50,Inhibition of LCK (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188830,4866,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,5.74,,IC50,Inhibition of TEL-fused TRKB (unknown origin) by cell-based assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188831,4866,2322,Cyclin-dependent kinase 4,Kinase,P11802,CDK4,CDK4_HUMAN,5.33,,IC50,Inhibition of CDK4 (unknown origin) after 60 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2403108,,,,Tclin,,,Homo sapiens
188832,4874,3642,Lanosterol 14-alpha demethylase,Enzyme,F2SHH3,,F2SHH3_TRIRC,,,,Mechanism of Action; CHEMBL3307221; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103877,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103877,INHIBITOR,,,,,Trichophyton rubrum (strain ATCC MYA-4607 / CBS 118892)
188833,4875,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.53,,IC50,Inhibition of human ERG by whole cell patch clamp assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2023898,,,,Tclin,,,Homo sapiens
188834,4876,917,Histone deacetylase 10,Enzyme,Q969S8,HDAC10,HDA10_HUMAN,7.23,,Ki,Competitive inhibition of HDAC10 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,INHIBITOR,,Tclin,,,Homo sapiens
188835,4876,2307,Histone deacetylase 11,Enzyme,Q96DB2,HDAC11,HDA11_HUMAN,7.57,,Ki,Competitive inhibition of HDAC11 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,INHIBITOR,,Tclin,,,Homo sapiens
188836,4876,717,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,7.66,,Ki,Competitive inhibition of HDAC8 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,INHIBITOR,,Tclin,,,Homo sapiens
188837,4876,810,Histone deacetylase 9,Enzyme,Q9UKV0,HDAC9,HDAC9_HUMAN,7.62,,Ki,Competitive inhibition of HDAC9 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,INHIBITOR,,Tclin,,,Homo sapiens
188838,4876,630,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,8.8,,Ki,Inhibition of human HDAC6,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,INHIBITOR,,Tclin,,,Homo sapiens
188839,4876,606,Histone deacetylase 1,Enzyme,Q13547,HDAC1,HDAC1_HUMAN,9.07,,Ki,Inhibition of human HDAC1,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,INHIBITOR,,Tclin,,,Homo sapiens
188840,4876,619,Histone deacetylase 3,Enzyme,O15379,HDAC3,HDAC3_HUMAN,8.82,,Ki,Inhibition of human HDAC3,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,INHIBITOR,,Tclin,,,Homo sapiens
188841,4876,598,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,9.07,,Ki,Inhibition of human HDAC2,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,INHIBITOR,,Tclin,,,Homo sapiens
188842,4876,575,Histone deacetylase 5,Enzyme,Q9UQL6,HDAC5,HDAC5_HUMAN,7.6,,Ki,Competitive inhibition of HDAC5 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,INHIBITOR,,Tclin,,,Homo sapiens
188843,4876,668,Histone deacetylase 7,Enzyme,Q8WUI4,HDAC7,HDAC7_HUMAN,7.29,,Ki,Competitive inhibition of HDAC7 using KI-104 as substrate by fluorescence assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408513,INHIBITOR,,Tclin,,,Homo sapiens
188844,4877,2628,"Leucine--tRNA ligase, cytoplasmic",Enzyme,P26637,CDC60,SYLC_YEAST,5.73,,Ki,Inhibition of Saccharomyces cerevisiae cytoplasmic leucyl-tRNA synthetase after 20 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL443052,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
188845,4877,3643,Leucine-tRNA ligase,Enzyme,F2SF18,,F2SF18_TRIRC,,,,Mechanism of Action; CHEMBL3307222; SINGLE PROTEIN,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL443052,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL443052,INHIBITOR,,,,,Trichophyton rubrum (strain ATCC MYA-4607 / CBS 118892)
188846,4881,2630,Orexin receptor type 1,GPCR,P58307,Hcrtr1,OX1R_MOUSE,8.77,,Ki,Antagonist activity at mouse OX1 receptor expressed in CHO cells assessed as inhibition of orexin A-induced Ca2+ accumulation after 1 hr by Fluo-4-AM staining-based FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1083659,,,,,,,Mus musculus
188847,4881,2629,Orexin receptor type 2,GPCR,P58308,Hcrtr2,OX2R_MOUSE,8.06,,Ki,Antagonist activity at mouse OX2 receptor expressed in HEK cells assessed as inhibition of orexin A-induced Ca2+ accumulation after 1 hr by Fluo-4-AM staining-based FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1083659,,,,,,,Mus musculus
188848,4882,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,6.08,,Ki,Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells after 90 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770,,,,Tclin,,,Homo sapiens
188849,4882,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,8.66,,Ki,Binding affinity towards human Adenosine A2a receptor expressed in HEK293 cells using 6 nM [3H]CGS-21680,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770,http://www.ncbi.nlm.nih.gov/pubmed/16004599,ANTAGONIST,,Tclin,,424,Homo sapiens
188850,4882,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.35,,Ki,Displacement of [3H]PSB-11 from human recombinant adenosine A3 receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770,,,,Tchem,,,Homo sapiens
188851,4882,1826,Adenosine receptor A2a,GPCR,P30543,Adora2a,AA2AR_RAT,8.7,,Ki,Displacement of [3H]ZM241385 from rat recombinant adenosine A2A receptor expressed in CHO cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770,,,,,,,Rattus norvegicus
188852,4882,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,6.82,,Ki,Displacement of [3H]CHA from Adenosine A1 receptor of rat forebrain membranes (shielded from light),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770,,,,,,,Rattus norvegicus
188853,4893,32,Thymidine phosphorylase,Enzyme,P07650,deoA,TYPH_ECOLI,7.7,,IC50,Inhibition of Thymidine phosphorylase from Escherichia coli,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL65375,,,,,,,Escherichia coli (strain K12)
188854,4895,33,Dipeptidyl peptidase 4,Enzyme,P14740,Dpp4,DPP4_RAT,9.54,,IC50,Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2147777,,,,,,,Rattus norvegicus
188855,4896,829,Prolyl endopeptidase FAP,Enzyme,Q12884,FAP,SEPR_HUMAN,4.14,,IC50,Inhibition of human recombinant FAP expressed in baculovirus-infected Sf9 insect cells using H-Ala-Pro-AFC as substrate after 60 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1929387,,,,Tchem,,,Homo sapiens
188857,4903,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,6.57,,Kd,Binding constant for JNK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188858,4903,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,8,,Kd,Binding constant for MEK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188859,4903,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8,,Kd,Binding constant for ABL1(T315I)-phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188860,4903,2323,Cyclin-dependent kinase-like 2,Kinase,Q92772,CDKL2,CDKL2_HUMAN,5.89,,Kd,Binding constant for CDKL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
188861,4903,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,9.38,,Kd,Binding constant for FLT3(D835Y) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188862,4903,817,Protein kinase C theta type,Kinase,Q04759,PRKCQ,KPCT_HUMAN,5.26,,Kd,Binding constant for PRKCQ kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188863,4903,2248,Serine/threonine-protein kinase DCLK1,Kinase,O15075,DCLK1,DCLK1_HUMAN,6.27,,Kd,Binding constant for DCAMKL1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188864,4903,2244,"Muscle, skeletal receptor tyrosine-protein kinase",Kinase,O15146,MUSK,MUSK_HUMAN,6.23,,Kd,Binding constant for MUSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188865,4903,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.24,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188866,4903,660,Calcium/calmodulin-dependent protein kinase type 1,Kinase,Q14012,CAMK1,KCC1A_HUMAN,5.23,,Kd,Binding constant for CAMK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188867,4903,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,7.03,,Kd,Binding constant for FGFR3 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,INHIBITOR,,Tclin,,,Homo sapiens
188868,4903,2364,Serine/threonine-protein kinase 35,Kinase,Q8TDR2,STK35,STK35_HUMAN,6.09,,Kd,Binding constant for STK35 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188869,4903,2232,Calcium/calmodulin-dependent protein kinase type IV,Kinase,Q16566,CAMK4,KCC4_HUMAN,5.43,,Kd,Binding constant for CAMK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
188870,4903,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,7.62,,Kd,Binding constant for INSR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,AGONIST,,Tclin,,,Homo sapiens
188871,4903,2281,Fibroblast growth factor receptor 4,Kinase,P22455,FGFR4,FGFR4_HUMAN,5.74,,Kd,Binding constant for FGFR4 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,INHIBITOR,,Tclin,,,Homo sapiens
188872,4903,2197,SRSF protein kinase 1,Kinase,Q96SB4,SRPK1,SRPK1_HUMAN,7.43,,Kd,Binding constant for SRPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188873,4903,2195,Serine/threonine-protein kinase RIO3,Kinase,O14730,RIOK3,RIOK3_HUMAN,7.44,,Kd,Binding constant for RIOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188874,4903,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,6.7,,Kd,Binding constant for MET kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188875,4903,837,Casein kinase I isoform epsilon,Kinase,P49674,CSNK1E,KC1E_HUMAN,6.64,,Kd,Binding constant for CSNK1E kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188876,4903,2251,Myosin-IIIb,Kinase,Q8WXR4,MYO3B,MYO3B_HUMAN,5.57,,Kd,Binding constant for MYO3B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tdark,,,Homo sapiens
188877,4903,2186,Dual specificity mitogen-activated protein kinase kinase 3,Kinase,P46734,MAP2K3,MP2K3_HUMAN,5.68,,Kd,Binding constant for MEK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188878,4903,2159,Serine/threonine-protein kinase PAK 3,Kinase,O75914,PAK3,PAK3_HUMAN,6.68,,Kd,Binding constant for PAK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188879,4903,922,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,5.96,,Kd,Binding constant for EPHB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188880,4903,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,7.85,,Kd,Binding constant for JAK2(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188881,4903,2134,Ribosomal protein S6 kinase alpha-6,Kinase,Q9UK32,RPS6KA6,KS6A6_HUMAN,6.64,,Kd,Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188882,4903,911,MAP/microtubule affinity-regulating kinase 3,Kinase,P27448,MARK3,MARK3_HUMAN,6.11,,Kd,Binding constant for MARK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188883,4903,2283,Ribosomal protein S6 kinase alpha-1,Kinase,Q15418,RPS6KA1,KS6A1_HUMAN,6.74,,Kd,Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188884,4903,2447,Serine/threonine-protein kinase SBK1,Kinase,Q52WX2,SBK1,SBK1_HUMAN,6.96,,Kd,Binding constant for SBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tdark,,,Homo sapiens
188885,4903,2360,Mitogen-activated protein kinase kinase kinase 15,Kinase,Q6ZN16,MAP3K15,M3K15_HUMAN,5.85,,Kd,Binding constant for MAP3K15 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188886,4903,2344,Microtubule-associated serine/threonine-protein kinase 1,Kinase,Q9Y2H9,MAST1,MAST1_HUMAN,5.34,,Kd,Binding constant for MAST1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188887,4903,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,8.74,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188888,4903,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,8.32,,Kd,Binding constant for JAK1(JH2domain-pseudokinase) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188889,4903,2172,Casein kinase I isoform delta,Kinase,P48730,CSNK1D,KC1D_HUMAN,5.89,,Kd,Binding constant for CSNK1D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188890,4903,1822,Tyrosine-protein kinase ITK/TSK,Kinase,Q08881,ITK,ITK_HUMAN,6.68,,Kd,Binding constant for ITK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188891,4903,2335,Homeodomain-interacting protein kinase 3,Kinase,Q9H422,HIPK3,HIPK3_HUMAN,6.07,,Kd,Binding constant for HIPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
188892,4903,2334,Homeodomain-interacting protein kinase 2,Kinase,Q9H2X6,HIPK2,HIPK2_HUMAN,6.1,,Kd,Binding constant for HIPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188893,4903,2187,Maternal embryonic leucine zipper kinase,Kinase,Q14680,MELK,MELK_HUMAN,8.31,,Kd,Binding constant for MELK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188894,4903,2166,Wee1-like protein kinase,Kinase,P30291,WEE1,WEE1_HUMAN,5.54,,Kd,Binding constant for WEE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188895,4903,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,6.51,,Kd,Binding constant for BTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188896,4903,2216,NUAK family SNF1-like kinase 1,Kinase,O60285,NUAK1,NUAK1_HUMAN,6.8,,Kd,Binding constant for ARK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188897,4903,2085,Serine/threonine-protein kinase D1,Kinase,Q15139,PRKD1,KPCD1_HUMAN,6,,Kd,Binding constant for PRKD1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188898,4903,2341,Mitogen-activated protein kinase kinase kinase 13,Kinase,O43283,MAP3K13,M3K13_HUMAN,6.85,,Kd,Binding constant for LZK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
188899,4903,2318,Serine/threonine-protein kinase TBK1,Kinase,Q9UHD2,TBK1,TBK1_HUMAN,6.82,,Kd,Binding constant for TBK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188900,4903,2338,Serine/threonine-protein kinase ICK,Kinase,Q9UPZ9,ICK,ICK_HUMAN,5.77,,Kd,Binding constant for ICK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188901,4903,2264,Ephrin type-A receptor 1,Kinase,P21709,EPHA1,EPHA1_HUMAN,5.92,,Kd,Binding constant for EPHA1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188902,4903,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,7.46,,Kd,Binding constant for HPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188903,4903,2330,Serine/threonine-protein kinase/endoribonuclease IRE1,Kinase,O75460,ERN1,ERN1_HUMAN,5.7,,Kd,Binding constant for ERN1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188904,4903,2228,MAP/microtubule affinity-regulating kinase 4,Kinase,Q96L34,MARK4,MARK4_HUMAN,5.7,,Kd,Binding constant for MARK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188905,4903,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,6.52,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188906,4903,2347,Serine/threonine-protein kinase OSR1,Kinase,O95747,OXSR1,OXSR1_HUMAN,5.89,,Kd,Binding constant for OSR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
188907,4903,2274,Serine/threonine-protein kinase D3,Kinase,O94806,PRKD3,KPCD3_HUMAN,6.19,,Kd,Binding constant for PRKD3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188908,4903,2456,Serine/threonine-protein kinase Sgk3,Kinase,Q96BR1,SGK3,SGK3_HUMAN,6,,Kd,Binding constant for SGK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
188909,4903,2351,STE20/SPS1-related proline-alanine-rich protein kinase,Kinase,Q9UEW8,STK39,STK39_HUMAN,6.28,,Kd,Binding constant for STK39 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
188910,4903,2352,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,8.39,,Kd,Binding constant for TAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188911,4903,871,Dual specificity protein kinase CLK2,Kinase,P49760,CLK2,CLK2_HUMAN,6.12,,Kd,Binding constant for CLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188912,4903,2333,G protein-coupled receptor kinase 7,Kinase,Q8WTQ7,GRK7,GRK7_HUMAN,5.92,,Kd,Binding constant for GRK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188913,4903,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,5.57,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188914,4903,2165,Myosin light chain kinase family member 4,Kinase,Q86YV6,MYLK4,MYLK4_HUMAN,6.36,,Kd,Binding constant for MYLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188915,4903,2359,Homeodomain-interacting protein kinase 1,Kinase,Q86Z02,HIPK1,HIPK1_HUMAN,5.89,,Kd,Binding constant for HIPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
188916,4903,870,Dual specificity protein kinase CLK1,Kinase,P49759,CLK1,CLK1_HUMAN,8.06,,Kd,Binding constant for CLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188917,4903,796,Dual specificity protein kinase TTK,Kinase,P33981,TTK,TTK_HUMAN,7.66,,Kd,Binding constant for TTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188918,4903,536,Ephrin type-A receptor 2,Kinase,P29317,EPHA2,EPHA2_HUMAN,5.54,,Kd,Binding constant for EPHA2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188919,4903,853,Ephrin type-A receptor 3,Kinase,P29320,EPHA3,EPHA3_HUMAN,5.07,,Kd,Binding constant for EPHA3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188920,4903,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,7.06,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188921,4903,776,Tyrosine-protein kinase Fer,Kinase,P16591,FER,FER_HUMAN,7.14,,Kd,Binding constant for FER kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188922,4903,793,Serine/threonine-protein kinase 16,Kinase,O75716,STK16,STK16_HUMAN,7.74,,Kd,Binding constant for STK16 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188923,4903,774,Serine/threonine-protein kinase 17B,Kinase,O94768,STK17B,ST17B_HUMAN,6.17,,Kd,Binding constant for DRAK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188924,4903,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,7.28,,Kd,Binding constant for PLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188925,4903,741,AP2-associated protein kinase 1,Kinase,Q2M2I8,AAK1,AAK1_HUMAN,7.2,,Kd,Binding constant for AAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188926,4903,742,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,5.85,,Kd,Binding constant for MARK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188927,4903,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,8.09,,Kd,Binding constant for JAK3(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188928,4903,899,Ribosomal protein S6 kinase alpha-5,Kinase,O75582,RPS6KA5,KS6A5_HUMAN,6.7,,Kd,Binding constant for RPS6KA5(Kin.Dom.1-N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188929,4903,2181,Casein kinase II subunit alpha',Kinase,P19784,CSNK2A2,CSK22_HUMAN,6.05,,Kd,Binding constant for CSNK2A2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188930,4903,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,7.1,,Kd,Binding constant for YES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188931,4903,2089,Serine/threonine-protein kinase N2,Kinase,Q16513,PKN2,PKN2_HUMAN,5.85,,Kd,Binding constant for PKN2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188932,4903,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,5.28,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188933,4903,792,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.72,,Kd,Binding constant for AURKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188934,4903,574,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,6.59,,Kd,Binding constant for PHKG2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188935,4903,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,8.35,,Kd,Binding constant for TRKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188936,4903,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.82,,Kd,Binding constant for PDGFRB kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,INHIBITOR,,Tclin,,,Homo sapiens
188937,4903,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.46,,Kd,Binding constant for FGFR2 kinase domain,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,INHIBITOR,,Tclin,,,Homo sapiens
188938,4903,573,Ribosomal protein S6 kinase alpha-3,Kinase,P51812,RPS6KA3,KS6A3_HUMAN,7.19,,Kd,Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188939,4903,2336,Homeodomain-interacting protein kinase 4,Kinase,Q8NE63,HIPK4,HIPK4_HUMAN,5.92,,Kd,Binding constant for HIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188940,4903,614,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,6.54,,Kd,Binding constant for MYLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188941,4903,2239,Mitogen-activated protein kinase kinase kinase 10,Kinase,Q02779,MAP3K10,M3K10_HUMAN,5.64,,Kd,Binding constant for MLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188942,4903,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,6.41,,Kd,Binding constant for MAP4K5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188943,4903,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,7.09,,Kd,Binding constant for MINK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188944,4903,2464,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,7.43,,Kd,Binding constant for LRRK2(G2019S) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188945,4903,2320,Interleukin-1 receptor-associated kinase 4,Kinase,Q9NWZ3,IRAK4,IRAK4_HUMAN,6.09,,Kd,Binding constant for IRAK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188946,4903,2193,Insulin receptor-related protein,Kinase,P14616,INSRR,INSRR_HUMAN,7.68,,Kd,Binding constant for INSRR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188947,4903,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,8.57,,Kd,Binding constant for KIT(L576P) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188948,4903,855,BMP-2-inducible protein kinase,Kinase,Q9NSY1,BMP2K,BMP2K_HUMAN,8.66,,Kd,Binding constant for BIKE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188949,4903,2215,Serine/threonine-protein kinase PAK 7,Kinase,Q9P286,PAK5,PAK5_HUMAN,5.89,,Kd,Binding constant for PAK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188950,4903,822,Serine/threonine-protein kinase 17A,Kinase,Q9UEE5,STK17A,ST17A_HUMAN,6.96,,Kd,Binding constant for DRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188951,4903,2240,Mitogen-activated protein kinase kinase kinase 11,Kinase,Q16584,MAP3K11,M3K11_HUMAN,6.15,,Kd,Binding constant for MLK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188952,4903,609,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,7.21,,Kd,Binding constant for IGF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188953,4903,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,6.03,,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188954,4903,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,7.28,,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188955,4903,908,Calcium/calmodulin-dependent protein kinase kinase 2,Kinase,Q96RR4,CAMKK2,KKCC2_HUMAN,6.04,,Kd,Binding constant for CAMKK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188956,4903,2284,Ribosomal protein S6 kinase alpha-4,Kinase,O75676,RPS6KA4,KS6A4_HUMAN,6.21,,Kd,Binding constant for RPS6KA4(Kin.Dom.1-N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188957,4903,2221,Aurora kinase B,Kinase,Q96GD4,AURKB,AURKB_HUMAN,6.38,,Kd,Binding constant for AURKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188958,4903,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,7.29,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188959,4903,902,Dual specificity protein kinase CLK4,Kinase,Q9HAZ1,CLK4,CLK4_HUMAN,7.74,,Kd,Binding constant for CLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188960,4903,702,Death-associated protein kinase 2,Kinase,Q9UIK4,DAPK2,DAPK2_HUMAN,5.49,,Kd,Binding constant for DAPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188961,4903,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,7.43,,Kd,Binding constant for TYK2(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188962,4903,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,6.92,,Kd,Binding constant for IRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188963,4903,893,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,8.05,,Kd,Binding constant for MST1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
216548,1375,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,6.7,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,,,,Cavia porcellus
188964,4903,914,Calcium/calmodulin-dependent protein kinase kinase 1,Kinase,Q8N5S9,CAMKK1,KKCC1_HUMAN,6.2,,Kd,Binding constant for CAMKK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188965,4903,891,Calcium/calmodulin-dependent protein kinase type 1D,Kinase,Q8IU85,CAMK1D,KCC1D_HUMAN,5.66,,Kd,Binding constant for CAMK1D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188966,4903,2133,Serine/threonine-protein kinase 3,Kinase,Q13188,STK3,STK3_HUMAN,7.42,,Kd,Binding constant for MST2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188967,4903,915,Calcium/calmodulin-dependent protein kinase type 1G,Kinase,Q96NX5,CAMK1G,KCC1G_HUMAN,6.59,,Kd,Binding constant for CAMK1G kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188968,4903,755,5'-AMP-activated protein kinase catalytic subunit alpha-1,Kinase,Q13131,PRKAA1,AAPK1_HUMAN,7.06,,Kd,Binding constant for AMPK-alpha1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188969,4903,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.03,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188970,4903,750,Ribosomal protein S6 kinase alpha-2,Kinase,Q15349,RPS6KA2,KS6A2_HUMAN,7.24,,Kd,Binding constant for RSK3(Kin.Dom.1-N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188971,4903,2356,Serine/threonine-protein kinase ULK2,Kinase,Q8IYT8,ULK2,ULK2_HUMAN,6.42,,Kd,Binding constant for ULK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188972,4903,769,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",Kinase,Q16816,PHKG1,PHKG1_HUMAN,6.85,,Kd,Binding constant for PHKG1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188973,4903,890,Ephrin type-B receptor 1,Kinase,P54762,EPHB1,EPHB1_HUMAN,6.26,,Kd,Binding constant for EPHB1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188974,4903,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,5.8,,Kd,Binding constant for TNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188975,4903,892,Cyclin-dependent kinase 16,Kinase,Q00536,CDK16,CDK16_HUMAN,7.68,,Kd,Binding constant for PCTK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188976,4903,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,6.54,,Kd,Binding constant for MAP4K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188977,4903,672,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,6.68,,Kd,Binding constant for FAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188978,4903,2180,Casein kinase II subunit alpha,Kinase,P68400,CSNK2A1,CSK21_HUMAN,5.12,,Kd,Binding constant for CSNK2A1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188979,4903,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,7.49,,Kd,Binding constant for TRKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188980,4903,2185,Serine/threonine-protein kinase STK11,Kinase,Q15831,STK11,STK11_HUMAN,7.74,,Kd,Binding constant for LKB1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188981,4903,2331,Rhodopsin kinase,Kinase,Q15835,GRK1,RK_HUMAN,6,,Kd,Binding constant for GRK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188982,4903,1823,Tyrosine-protein kinase ZAP-70,Kinase,P43403,ZAP70,ZAP70_HUMAN,5.46,,Kd,Binding constant for ZAP70 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188983,4903,966,Activin receptor type-1,Kinase,Q04771,ACVR1,ACVR1_HUMAN,6.22,,Kd,Binding constant for ACVR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188984,4903,2194,Interleukin-1 receptor-associated kinase 3,Kinase,Q9Y616,IRAK3,IRAK3_HUMAN,5.28,,Kd,Binding constant for IRAK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188985,4903,773,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,Q9UQM7,CAMK2A,KCC2A_HUMAN,5.44,,Kd,Binding constant for CAMK2A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188986,4903,2332,G protein-coupled receptor kinase 4,Kinase,P32298,GRK4,GRK4_HUMAN,7.77,,Kd,Binding constant for GRK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188987,4903,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,8.03,,Kd,Binding constant for MAP3K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188988,4903,597,Cyclin-dependent kinase 2,Kinase,P24941,CDK2,CDK2_HUMAN,5.85,,Kd,Binding constant for CDK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188989,4903,2357,Serine/threonine-protein kinase ULK3,Kinase,Q6PHR2,ULK3,ULK3_HUMAN,7.22,,Kd,Binding constant for ULK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188990,4903,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,5.7,,Kd,Binding constant for ABL2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188991,4903,2227,Serine/threonine-protein kinase MARK1,Kinase,Q9P0L2,MARK1,MARK1_HUMAN,5.85,,Kd,Binding constant for MARK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188992,4903,2189,Serine/threonine-protein kinase 26,Kinase,Q9P289,STK26,STK26_HUMAN,7.31,,Kd,Binding constant for MST4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
188993,4903,2224,Bone morphogenetic protein receptor type-2,Kinase,Q13873,BMPR2,BMPR2_HUMAN,7.25,,Kd,Binding constant for BMPR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188994,4903,2169,Protein-tyrosine kinase 2-beta,Kinase,Q14289,PTK2B,FAK2_HUMAN,7.09,,Kd,Binding constant for PYK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188995,4903,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,6.42,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188996,4903,2211,Serine/threonine-protein kinase LATS2,Kinase,Q9NRM7,LATS2,LATS2_HUMAN,6.42,,Kd,Binding constant for LATS2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188997,4903,2339,Inhibitor of nuclear factor kappa-B kinase subunit alpha,Kinase,O15111,CHUK,IKKA_HUMAN,5.35,,Kd,Binding constant for IKK-alpha kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
188998,4903,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,5.85,,Kd,Binding constant for TIE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
188999,4903,2183,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,Q14164,IKBKE,IKKE_HUMAN,6.77,,Kd,Binding constant for IKK-epsilon kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189000,4903,2182,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Kinase,Q9Y463,DYRK1B,DYR1B_HUMAN,5.8,,Kd,Binding constant for DYRK1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189001,4903,2452,Serine/threonine-protein kinase PRP4 homolog,Kinase,Q13523,PRPF4B,PRP4B_HUMAN,8.08,,Kd,Binding constant for PRP4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189002,4903,2612,Serine/threonine-protein kinase PknB,Kinase,P9WI81,pknB,PKNB_MYCTU,8.44,,Kd,Binding constant for PKNB(M.tuberculosis) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
189003,4903,2282,Proto-oncogene tyrosine-protein kinase ROS,Kinase,P08922,ROS1,ROS1_HUMAN,5.43,,Kd,Binding constant for ROS1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189004,4903,2466,Calcium-dependent protein kinase 1,Kinase,P62344,CPK1,CDPK1_PLAF7,5.92,,Kd,Binding constant for PFCDPK1(P.falciparum) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,,,,Plasmodium falciparum
189005,4903,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,6.85,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189006,4903,665,Mitogen-activated protein kinase 8,Kinase,P45983,MAPK8,MK08_HUMAN,6.2,,Kd,Binding constant for JNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189007,4903,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,6.55,,Kd,Binding constant for SIK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189008,4903,2084,Cyclin-dependent kinase 7,Kinase,P50613,CDK7,CDK7_HUMAN,6.52,,Kd,Binding constant for CDK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189009,4903,2243,Serine/threonine-protein kinase 24,Kinase,Q9Y6E0,STK24,STK24_HUMAN,6.96,,Kd,Binding constant for MST3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189010,4903,2203,5'-AMP-activated protein kinase catalytic subunit alpha-2,Kinase,P54646,PRKAA2,AAPK2_HUMAN,7.08,,Kd,Binding constant for AMPK-alpha2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189011,4903,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.2,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189012,4903,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.32,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189013,4903,2363,Uncharacterized serine/threonine-protein kinase SBK3,Kinase,P0C264,SBK3,SBK3_HUMAN,5.7,,Kd,Binding constant for SgK110 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tdark,,,Homo sapiens
189014,4903,2205,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,7.38,,Kd,Binding constant for DDR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189015,4903,2160,Cyclin-dependent kinase 17,Kinase,Q00537,CDK17,CDK17_HUMAN,7.03,,Kd,Binding constant for PCTK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189016,4903,623,Death-associated protein kinase 3,Kinase,O43293,DAPK3,DAPK3_HUMAN,5.68,,Kd,Binding constant for DAPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189017,4903,965,Serine/threonine-protein kinase receptor R3,Kinase,P37023,ACVRL1,ACVL1_HUMAN,5.38,,Kd,Binding constant for ACVRL1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189018,4903,964,Activin receptor type-1B,Kinase,P36896,ACVR1B,ACV1B_HUMAN,5.31,,Kd,Binding constant for ACVR1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189019,4903,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,5.66,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189020,4903,2263,TGF-beta receptor type-1,Kinase,P36897,TGFBR1,TGFR1_HUMAN,5.38,,Kd,Binding constant for TGFBR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189021,4903,2256,Serine/threonine-protein kinase PAK 4,Kinase,O96013,PAK4,PAK4_HUMAN,5.52,,Kd,Binding constant for PAK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189022,4903,2132,Serine/threonine-protein kinase DCLK3,Kinase,Q9C098,DCLK3,DCLK3_HUMAN,6.11,,Kd,Binding constant for DCAMKL3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189023,4903,2162,Cyclin-dependent kinase 14,Kinase,O94921,CDK14,CDK14_HUMAN,6.33,,Kd,Binding constant for PFTK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189024,4903,2192,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,Q9P2K8,EIF2AK4,E2AK4_HUMAN,5.7,,Kd,"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189025,4903,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.02,,Kd,Binding constant for RET(V804M) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189026,4903,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,7.92,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189027,4903,2226,Mitogen-activated protein kinase kinase kinase kinase 4,Kinase,O95819,MAP4K4,M4K4_HUMAN,6.82,,Kd,Binding constant for MAP4K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189028,4903,2161,Cyclin-dependent kinase 18,Kinase,Q07002,CDK18,CDK18_HUMAN,6.29,,Kd,Binding constant for PCTK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
189029,4903,2210,Serine/threonine-protein kinase LATS1,Kinase,O95835,LATS1,LATS1_HUMAN,6.38,,Kd,Binding constant for LATS1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
189030,4903,2255,Serine/threonine-protein kinase PAK 2,Kinase,Q13177,PAK2,PAK2_HUMAN,5.48,,Kd,Binding constant for PAK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189031,4903,2082,Tyrosine-protein kinase receptor TYRO3,Kinase,Q06418,TYRO3,TYRO3_HUMAN,5.31,,Kd,Binding constant for TYRO3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189032,4903,2280,Tyrosine-protein kinase Fes/Fps,Kinase,P07332,FES,FES_HUMAN,5.92,,Kd,Binding constant for FES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189033,4903,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,8.21,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189034,4903,723,"Myosin light chain kinase 2, skeletal/cardiac muscle",Kinase,Q9H1R3,MYLK2,MYLK2_HUMAN,5.4,,Kd,Binding constant for MYLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
189035,4903,2238,Mitogen-activated protein kinase kinase kinase 9,Kinase,P80192,MAP3K9,M3K9_HUMAN,6.66,,Kd,Binding constant for MLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189036,4903,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,6.82,,Kd,Binding constant for LTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189037,4903,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,8.28,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189038,4903,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,7.92,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189039,4903,2164,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,Kinase,P78356,PIP4K2B,PI42B_HUMAN,7.77,,Kd,Binding constant for PIP5K2B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189040,4903,1426,3-phosphoinositide-dependent protein kinase 1,Kinase,O15530,PDPK1,PDPK1_HUMAN,5.55,,Kd,Binding constant for PDPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189041,4903,2273,Serine/threonine-protein kinase D2,Kinase,Q9BZL6,PRKD2,KPCD2_HUMAN,6.14,,Kd,Binding constant for PRKD2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189042,4903,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,7.72,,Kd,Binding constant for TRKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189043,4903,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,7.68,,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189044,4903,2198,SRSF protein kinase 2,Kinase,P78362,SRPK2,SRPK2_HUMAN,7.44,,Kd,Binding constant for SRPK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
189045,4903,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,7.38,,Kd,Binding constant for MEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189046,4903,2229,Dual specificity mitogen-activated protein kinase kinase 4,Kinase,P45985,MAP2K4,MP2K4_HUMAN,5.43,,Kd,Binding constant for MEK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189047,4903,2350,SRSF protein kinase 3,Kinase,Q9UPE1,SRPK3,SRPK3_HUMAN,7.92,,Kd,Binding constant for SRPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189048,4903,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,6.07,,Kd,Binding constant for TXK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189049,4903,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,7.51,,Kd,Binding constant for ALK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189050,4903,2454,Mitogen-activated protein kinase kinase kinase 12,Kinase,Q12852,MAP3K12,M3K12_HUMAN,6.85,,Kd,Binding constant for DLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189051,4903,2463,Myosin light chain kinase 3,Kinase,Q32MK0,MYLK3,MYLK3_HUMAN,6.96,,Kd,Binding constant for MLCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189052,4903,2277,Receptor-interacting serine/threonine-protein kinase 1,Kinase,Q13546,RIPK1,RIPK1_HUMAN,6.62,,Kd,Binding constant for RIPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189053,4903,2163,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,Kinase,Q99755,PIP5K1A,PI51A_HUMAN,7.31,,Kd,Binding constant for PIP5K1A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
189054,4903,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,7.47,,Kd,Binding constant for MAP3K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189055,4903,2170,Serine/threonine-protein kinase RIO1,Kinase,Q9BRS2,RIOK1,RIOK1_HUMAN,7.64,,Kd,Binding constant for RIOK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189056,4903,2542,Vascular endothelial growth factor receptor 2,Kinase,P35918,Kdr,VGFR2_MOUSE,7.89,,IC50,Inhibition of mouse GST-fused VEGFR2 expressed in Sf9 insect cells after 20 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,,,,Mus musculus
189057,4903,2322,Cyclin-dependent kinase 4,Kinase,P11802,CDK4,CDK4_HUMAN,6.8,,Kd,Binding constant for CDK4-cyclinD1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189058,4903,2088,Ribosomal protein S6 kinase beta-1,Kinase,P23443,RPS6KB1,KS6B1_HUMAN,6.72,,Kd,Binding constant for S6K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189059,4903,2355,Serine/threonine-protein kinase ULK1,Kinase,O75385,ULK1,ULK1_HUMAN,6.47,,Kd,Binding constant for ULK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189060,4903,2201,Serine/threonine-protein kinase 33,Kinase,Q9BYT3,STK33,STK33_HUMAN,5.96,,Kd,Binding constant for STK33 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189061,4903,925,Testis-specific serine/threonine-protein kinase 1,Kinase,Q9BXA7,TSSK1B,TSSK1_HUMAN,5.21,,Kd,Binding constant for TSSK1B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189062,4903,884,Glycogen synthase kinase-3 beta,Kinase,P49841,GSK3B,GSK3B_HUMAN,7.08,,Kd,Binding constant for GSK3B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189063,4903,2141,Serine/threonine-protein kinase Chk1,Kinase,O14757,CHEK1,CHK1_HUMAN,6.54,,Kd,Binding constant for CHEK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189064,4903,1945,Glycogen synthase kinase-3 alpha,Kinase,P49840,GSK3A,GSK3A_HUMAN,6.37,,Kd,Binding constant for GSK3A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tclin,,,Homo sapiens
189065,4903,2968,cGMP-dependent protein kinase 1,Kinase,Q13976,PRKG1,KGP1_HUMAN,7.85,,Kd,Binding constant for PRKG1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189066,4903,2362,Receptor-interacting serine/threonine-protein kinase 4,Kinase,P57078,RIPK4,RIPK4_HUMAN,6.36,,Kd,Binding constant for RIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189067,4903,815,Serine/threonine-protein kinase N1,Kinase,Q16512,PKN1,PKN1_HUMAN,6.13,,Kd,Binding constant for PKN1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189068,4903,2260,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,6.17,,Kd,Binding constant for SIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189069,4903,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,6.54,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189070,4903,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,8.07,,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189071,4903,2271,Mitogen-activated protein kinase 7,Kinase,Q13164,MAPK7,MK07_HUMAN,5.6,,Kd,Binding constant for ERK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tbio,,,Homo sapiens
189072,4903,2136,Non-receptor tyrosine-protein kinase TNK1,Kinase,Q13470,TNK1,TNK1_HUMAN,6.68,,Kd,Binding constant for TNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502835,,,,Tchem,,,Homo sapiens
189073,4921,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,4.48,,IC50,Inhibition of tetrodotoxin-sensitive Na+ channel at -50 mV membrane holding potential by patch-clamp electrophysiology,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48582,,,,Tclin,,,Homo sapiens
189074,4921,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,7.59,,IC50,Inhibition of MAO-B in mitochondria-enriched Sprague-Dawley rat liver fractions using p-tyramine as substrate incubated for 30 mins prior to substrate addition measured for 45 mins by amplex red reagent-based microplate fluorescence reader analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48582,,,,,,,Rattus norvegicus
189075,4921,2875,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P04774|P04775|P08104,Scn1a|Scn2a|Scn3a,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,5.09,,IC50,Binding of [3H]batrachotoxin (BTX) to rat brain sodium channel,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48582,,,,,,,Rattus norvegicus
189076,4921,1770,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q9R0C9,Sigmar1,SGMR1_RAT,7.71,,IC50,Inhibition of [3H]pentazocine binding to Opioid receptor sigma 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48582,,,,,,,Rattus norvegicus
189078,4937,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,5.85,,IC50,Inhibition of KDR using Bio-Gastrintide as substrate by TR-FRET assay in presence of 50 uM of ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1738797,,,,Tclin,,,Homo sapiens
189079,4939,2378,Cathepsin S,Enzyme,P25774,CTSS,CATS_HUMAN,4.11,,IC50,Inhibition of human cathepsin S,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL599872,,,,Tchem,,,Homo sapiens
189080,4941,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,5.46,,IC50,Inhibition of GST-fused human FLT3 cytoplasmic domain (amino acids 564 to 993) using Ulight-JAK1 as substrate after 1 hr by TR-FRET assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189963,,,,Tclin,,,Homo sapiens
189081,4941,3411,CDK2/Cyclin A,Kinase,P20248|P24941,CCNA2|CDK2,CCNA2_HUMAN|CDK2_HUMAN,6.64,,IC50,Inhibition of CDK2/cyclinA (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189963,,,,Tchem|Tchem,,,Homo sapiens
189082,4941,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,7.2,,IC50,Inhibition of JAK3 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189963,,,,Tclin,,,Homo sapiens
189083,4941,1944,Cyclin-dependent kinase 9,Kinase,P50750,CDK9,CDK9_HUMAN,6.1,,IC50,Inhibition of CDK9 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189963,,,,,,,Homo sapiens
189084,4943,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,9.9,,EC50,Agonist activity at guinea pig trachea beta2-adrenergic receptor assessed as relaxation of histamine-induced tracheal ring contraction,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1363,,,,,,,Cavia porcellus
189085,4943,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,7.6,,EC50,Agonist activity at human beta3 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1363,,,,Tclin,,,Homo sapiens
189087,4713,2831,JAK2/JAK1,Kinase,O60674|P23458,JAK1|JAK2,JAK1_HUMAN|JAK2_HUMAN,6.391473770141602,,IC50,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203214s007lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203214s007lbl.pdf,INHIBITOR,,Tclin|Tclin,255,255,Homo sapiens
189088,4713,2832,JAK3/JAK1,Kinase,P23458|P52333,JAK1|JAK3,JAK1_HUMAN|JAK3_HUMAN,7.251811981201172,,IC50,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203214s007lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203214s007lbl.pdf,INHIBITOR,,Tclin|Tclin,255,255,Homo sapiens
189089,2272,6,DNA,DNA,,,,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1321,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1321,OTHER,,,,,
189090,758,6,DNA,DNA,,,,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL88,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL88,OTHER,,,,,
189091,1647,6,DNA,DNA,,,,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL427,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL427,OTHER,,,,,
189092,4392,6,DNA,DNA,,,,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1386,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1386,OTHER,,,,,
189093,4210,6,DNA,DNA,,,,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL414804,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL414804,OTHER,,,,,
189095,588,6,DNA,DNA,,,,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL515,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL515,ALKYLATING AGENT,,,,,
189096,2795,6,DNA,DNA,,,,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1488,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1488,OTHER,,,,,
189097,2638,6,DNA,DNA,,,,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL671,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL671,OTHER,,,,,
189099,4977,372,Interleukin-6,Cytokine,P05231,IL6,IL6_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125496s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125496s000lbl.pdf,ANTIBODY BINDING,,Tclin,256,256,Homo sapiens
189100,4978,503,Tumor necrosis factor,Cytokine,P01375,TNF,TNFA_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103795s5548lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103795s5548lbl.pdf,INHIBITOR,,Tclin,257,257,Homo sapiens
189102,4979,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103792s5311lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/103792s5311lbl.pdf,ANTIBODY BINDING,,Tclin,258,258,Homo sapiens
189103,1909,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1484,BLOCKER,,Tclin|Tclin,,,Homo sapiens
189104,4980,3647,Myeloid cell surface antigen CD33,Surface antigen,P20138,CD33,CD33_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021174s020lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021174s020lbl.pdf,ANTIBODY BINDING,,Tclin,260,260,Homo sapiens
189105,4980,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021174s020lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021174s020lbl.pdf,OTHER,,,260,260,
189107,4981,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020986s059s081lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020986s059s081lbl.pdf,AGONIST,,Tclin,261,261,Homo sapiens
189109,4983,3502,B-lymphocyte antigen CD20,Surface antigen,P11836,MS4A1,CD20_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125486_s008lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125486_s008lbl.pdf,ANTIBODY BINDING,,Tclin,263,263,Homo sapiens
189110,4984,3502,B-lymphocyte antigen CD20,Surface antigen,P11836,MS4A1,CD20_HUMAN,7.853871822357178,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125019s210s213lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/125019s210s213lbl.pdf,ANTIBODY BINDING,,Tclin,264,264,Homo sapiens
189111,4985,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021536s031s051lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021536s031s051lbl.pdf,AGONIST,,Tclin,266,266,Homo sapiens
189149,5000,3654,Proprotein convertase subtilisin/kexin type 9,Enzyme,Q8NBP7,PCSK9,PCSK9_HUMAN,9.72,,Kd,"Dissociation equilibrium constant for wild-type hPCSK9, measured using proprietary BIACore&reg; technology.",IUPHAR,=,1,SCIENTIFIC LITERATURE,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7343,http://www.ncbi.nlm.nih.gov/pubmed/23083772,INHIBITOR,,Tclin,333,333,Homo sapiens
189151,2281,607,Gastrin/cholecystokinin type B receptor,GPCR,P32239,CCKBR,GASR_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/2863192,http://www.ncbi.nlm.nih.gov/pubmed/2863192,ANTAGONIST,,Tclin,336,336,Homo sapiens
189152,4659,1683,Transient receptor potential cation channel subfamily A member 1,Ion channel,O75762,TRPA1,TRPA1_HUMAN,4.040958404541016,,IC50,inhibition of calcium response evoked by the TRPA1 agonist AITC (10uM) in IMR90,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/25765567,http://www.ncbi.nlm.nih.gov/pubmed/25765567,BLOCKER,,Tclin,339,339,Homo sapiens
189153,2309,1683,Transient receptor potential cation channel subfamily A member 1,Ion channel,O75762,TRPA1,TRPA1_HUMAN,4.481485843658447,,IC50,inhibition of calcium response evoked by the TRPA1 agonist AITC (10uM) in IMR90,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/25765567,http://www.ncbi.nlm.nih.gov/pubmed/25765567,BLOCKER,,Tclin,339,339,Homo sapiens
189156,861,1683,Transient receptor potential cation channel subfamily A member 1,Ion channel,O75762,TRPA1,TRPA1_HUMAN,3.0809218883514404,,IC50,inhibition of calcium response evoked by the TRPA1 agonist AITC (10uM) in IMR90,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/25765567,http://www.ncbi.nlm.nih.gov/pubmed/25765567,BLOCKER,,Tclin,339,339,Homo sapiens
189155,5004,3656,"laminin, fibronectin and collagen",Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125422s025lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125422s025lbl.pdf,HYDROLYTIC ENZYME,,,341,341,
189157,3525,2752,Potassium-transporting ATPase,Transporter,P20648|P51164,ATP4A|ATP4B,ATP4A_HUMAN|ATP4B_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/14681344,INHIBITOR,,Tclin|Tclin,,343,Homo sapiens
189162,346,788,Histamine H3 receptor,GPCR,Q9Y5N1,HRH3,HRH3_HUMAN,9.522878646850586,,EC50,[125I]Iodoproxyfan binding to H3 receptors in CHO cells,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20530654,http://www.ncbi.nlm.nih.gov/pubmed/20530654,INVERSE AGONIST,,Tclin,353,353,Homo sapiens
189163,4858,3184,Corticotropin-releasing factor receptor 1,GPCR,P34998,CRHR1,CRFR1_HUMAN,8.481486320495605,,Kd,COS cells binding human CRF,SCIENTIFIC LITERATURE,=,1,IUPHAR,http://www.ncbi.nlm.nih.gov/pubmed/7692441,,AGONIST,,Tclin,354,355,Homo sapiens
189165,4778,441,Serine/threonine-protein kinase mTOR,Kinase,P42345,MTOR,MTOR_HUMAN,9.698969841003418,,IC50,"Measured as dose-dependent inhibition of phosphorylation of ribosomal protein S6, a signaling protein downstream of mTOR",SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21482695,http://www.ncbi.nlm.nih.gov/pubmed/21482695,INHIBITOR,,Tclin,356,356,Homo sapiens
189166,4336,3412,Voltage-gated potassium channel,Ion channel,O43525|O43526|O95259|P16389|P17658|P22001|P22459|P22460|P48547|P51787|P56696|Q03721|Q09470|Q12809|Q14003|Q14721|Q16322|Q6PIU1|Q8NCM2|Q8TAE7|Q8TDN1|Q8TDN2|Q92953|Q96KK3|Q96L42|Q96PR1|Q96RP8|Q9BQ31|Q9H252|Q9H3M0|Q9NR82|Q9NS40|Q9NSA2|Q9NZV8|Q9UIX4|Q9UJ96|Q9UK17|Q9ULD8|Q9ULS6|Q9UQ05,KCNA1|KCNA10|KCNA2|KCNA3|KCNA4|KCNA5|KCNA6|KCNA7|KCNB1|KCNB2|KCNC1|KCNC2|KCNC3|KCNC4|KCND1|KCND2|KCND3|KCNF1|KCNG1|KCNG2|KCNG3|KCNG4|KCNH1|KCNH2|KCNH3|KCNH4|KCNH5|KCNH6|KCNH7|KCNH8|KCNQ1|KCNQ2|KCNQ3|KCNQ4|KCNQ5|KCNS1|KCNS2|KCNS3|KCNV1|KCNV2,KCA10_HUMAN|KCNA1_HUMAN|KCNA2_HUMAN|KCNA3_HUMAN|KCNA4_HUMAN|KCNA5_HUMAN|KCNA6_HUMAN|KCNA7_HUMAN|KCNB1_HUMAN|KCNB2_HUMAN|KCNC1_HUMAN|KCNC2_HUMAN|KCNC3_HUMAN|KCNC4_HUMAN|KCND1_HUMAN|KCND2_HUMAN|KCND3_HUMAN|KCNF1_HUMAN|KCNG1_HUMAN|KCNG2_HUMAN|KCNG3_HUMAN|KCNG4_HUMAN|KCNH1_HUMAN|KCNH2_HUMAN|KCNH3_HUMAN|KCNH4_HUMAN|KCNH5_HUMAN|KCNH6_HUMAN|KCNH7_HUMAN|KCNH8_HUMAN|KCNQ1_HUMAN|KCNQ2_HUMAN|KCNQ3_HUMAN|KCNQ4_HUMAN|KCNQ5_HUMAN|KCNS1_HUMAN|KCNS2_HUMAN|KCNS3_HUMAN|KCNV1_HUMAN|KCNV2_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/22805230,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,358,Homo sapiens
189168,4153,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/23337758,INHIBITOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,360,Homo sapiens
189169,2223,6,DNA,DNA,,,,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/1828228,OTHER,,,,362,
189170,4108,6,DNA,DNA,,,,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/7527033,OTHER,,,,363,
189171,5006,327,P2Y purinoceptor 12,GPCR,Q9H244,P2RY12,P2Y12_HUMAN,8.627087593078613,,IC50,cAMP accumulation in HORK3-expressing cells,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/11502873,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204958lbl.pdf,ANTAGONIST,,Tclin,364,365,Homo sapiens
189172,5006,1689,P2Y purinoceptor 13,GPCR,Q9BPV8,P2RY13,P2Y13_HUMAN,8.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1776,,ANTAGONIST,,Tchem,,,Homo sapiens
189175,4113,327,P2Y purinoceptor 12,GPCR,Q9H244,P2RY12,P2Y12_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201772,ANTAGONIST,,Tclin,,,Homo sapiens
189176,5007,3397,Erythropoietin receptor,Membrane receptor,P19235,EPOR,EPOR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001033/WC500043300.pdf,AGONIST,,Tclin,,366,Homo sapiens
189177,1596,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/017588s040lbl.pdf,OTHER,,,,369,
189178,2150,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/28684,ANTAGONIST,,Tclin,,370,Homo sapiens
189179,1040,2730,Integrin alpha-IIb/beta-3,Adhesion,P05106|P08514,ITGA2B|ITGB3,ITA2B_HUMAN|ITB3_HUMAN,6.2441253662109375,,IC50,platelet aggregation inhibition in plasma anticoagulated PPACK,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/9315536,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020718s037lbl.pdf,INHIBITOR,,Tclin|Tclin,372,371,Homo sapiens
189180,2680,2730,Integrin alpha-IIb/beta-3,Adhesion,P05106|P08514,ITGA2B|ITGB3,ITA2B_HUMAN|ITB3_HUMAN,7.958607196807861,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/1469694,"http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020912s021,020913s018lbl.pdf",INHIBITOR,,Tclin|Tclin,374,373,Homo sapiens
189181,5008,2477,Smoothened homolog,GPCR,Q99835,SMO,SMO_HUMAN,8.221848487854004,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23063522,http://www.ncbi.nlm.nih.gov/pubmed/22042473,ANTAGONIST,,Tclin,375,376,Homo sapiens
189182,723,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,,,,,UNKNOWN,,1,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2286,INHIBITOR,,Tclin,,,Homo sapiens
189183,5009,609,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,8.30980396270752,,IC50,human placental type 1 IGF receptor,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/2472386,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021839s016lbl.pdf,AGONIST,,Tclin,378,379,Homo sapiens
189184,5009,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,5.853871822357178,,IC50,human placental insulin receptor,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/2472386,,,,Tclin,378,,Homo sapiens
189185,5010,1047,Cystic fibrosis transmembrane conductance regulator,Ion channel,P13569,CFTR,CFTR_HUMAN,6.455932140350342,,EC50,human bronchial epithelial (HBE) cells with CF homozygous for the F508del CFTR mutation,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/21976485,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206038Orig1s000lbl.pdf,PHARMACOLOGICAL CHAPERONE,,Tclin,380,381,Homo sapiens
189186,5011,2993,Interleukin-2 receptor,Membrane receptor,P01589|P14784|P31785,IL2RA|IL2RB|IL2RG,IL2RA_HUMAN|IL2RB_HUMAN|IL2RG_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103293s5130lbl.pdf,AGONIST,,Tclin|Tclin|Tclin,,382,Homo sapiens
189160,5005,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,9.468521118164062,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://dx.doi.org/10.1002/jlcr.1116,http://www.ncbi.nlm.nih.gov/pubmed/18638004,INHIBITOR,,Tclin,345,344,Homo sapiens
189253,1739,2931,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,P18507|P31644|P47870,GABRA5|GABRB2|GABRG2,GBRA5_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,4.559999942779541,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26056160,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,438,,Homo sapiens
189254,1739,3665,GABA-A receptor alpha-6/beta-2,Ion channel,P47870|Q16445,GABRA6|GABRB2,GBRA6_HUMAN|GBRB2_HUMAN,4.130000114440918,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26056160,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin,438,,Homo sapiens
189255,1739,3666,GABA-A receptor alpha-6/beta-2/delta,Ion channel,O14764|P47870|Q16445,GABRA6|GABRB2|GABRD,GBRA6_HUMAN|GBRB2_HUMAN|GBRD_HUMAN,4.440000057220459,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26056160,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,438,,Homo sapiens
189257,1739,3667,GABA-A receptor alpha-6/beta-3/delta,Ion channel,O14764|P28472|Q16445,GABRA6|GABRB3|GABRD,GBRA6_HUMAN|GBRB3_HUMAN|GBRD_HUMAN,4.5,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26056160,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,438,,Homo sapiens
189259,5037,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,10.069999694824219,,Ki,"CHO cells, [3H]Spiperone (0.7nM)",SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20093397,,PARTIAL AGONIST,,Tclin,439,,Homo sapiens
189260,5037,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.3100004196167,,Ki,"CHO cells, [3H]Spiperone (0.16nM)",SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/20093397,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204370lbl.pdf,PARTIAL AGONIST,,Tclin,439,440,Homo sapiens
189261,5037,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.59000015258789,,Ki,"CHO cells, [3H]8-OH-DPAT (1.5nM)",SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/20093397,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204370lbl.pdf,PARTIAL AGONIST,,Tclin,439,440,Homo sapiens
189262,5037,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.730000019073486,,Ki,"CHO-K1 cells, [3H]Ketanserine (0.5nM)",SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/20093397,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204370lbl.pdf,ANTAGONIST,,Tclin,439,440,Homo sapiens
189263,5037,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,9.239999771118164,,Ki,"CHO-K1 cells, [3H]LSD (1.2nM)",SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20093397,,ANTAGONIST,,Tclin,439,,Homo sapiens
189265,5037,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.869999885559082,,Ki,"CHO-K1 cells, [3H]Mesulergine (1.0nM)",SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20093397,,ANTAGONIST,,Tclin,439,,Homo sapiens
189267,5037,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.949999809265137,,Ki,"CHO cells, [3H]LSD (1.5nM)",SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20093397,,,,Tclin,439,,Homo sapiens
189268,5037,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.630000114440918,,Ki,"CHO-1 cells, [3H]Pyrilamine (1.5nM)",SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20093397,,ANTAGONIST,,Tclin,439,,Homo sapiens
189269,5037,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.679999828338623,,Ki,"HEK-293 cells, [3H]Prazosin (0.6nM)",SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/20093397,,,,Tclin,439,,Homo sapiens
189271,5042,2710,Growth hormone receptor,GPCR,P10912,GHR,GHR_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/6285914,AGONIST,,Tclin,,441,Homo sapiens
189272,5044,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/8891469,ACTIVATOR,,Tclin,,443,Homo sapiens
214964,5059,2683,Thrombopoietin receptor,Membrane receptor,P40238,MPL,TPOR_HUMAN,7.0757207139,,EC50,Mechanism of Action; cell proliferation; recombinant human TPO,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/29274361,http://dx.doi.org/10.1016/S0168-8278(14)61094-1,AGONIST,,Tclin,2525,468,Homo sapiens
214965,5061,133,Interleukin-5,Cytokine,P05113,IL5,IL5_HUMAN,10,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125526Orig1s000Lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125526Orig1s000Lbl.pdf,ANTIBODY BINDING,,Tclin,469,469,Homo sapiens
214966,1438,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,8.739928245544434,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19967488,http://www.ncbi.nlm.nih.gov/pubmed/19967488,ANTAGONIST,,Tclin,471,471,Homo sapiens
214967,267,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,9.267605781555176,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19967488,http://www.ncbi.nlm.nih.gov/pubmed/19967488,ANTAGONIST,,Tclin,471,471,Homo sapiens
214968,3931,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,7.698318958282471,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/1397053,http://www.ncbi.nlm.nih.gov/pubmed/1397053,ANTAGONIST,,Tclin,472,472,Homo sapiens
214969,5062,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,7.823908805847168,,IC50,Inhibition of EGFR phosphorylation in double mutant cell line H1975,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25271963,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208065s000lbl.pdf,INHIBITOR,,Tclin,473,474,Homo sapiens
214970,862,3686,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",Kinase,Q15118,PDK1,PDK1_HUMAN,3,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9405293,,INHIBITOR,,Tchem,476,,Homo sapiens
214971,862,3687,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial",Kinase,Q15119,PDK2,PDK2_HUMAN,3.698970079421997,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9405293,,INHIBITOR,,Tbio,476,,Homo sapiens
214972,862,3688,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial",Kinase,Q15120,PDK3,PDK3_HUMAN,2.096909999847412,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9405293,,INHIBITOR,,Tbio,476,,Homo sapiens
214973,862,3689,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial",Kinase,Q16654,PDK4,PDK4_HUMAN,3.301029920578003,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/9405293,,INHIBITOR,,Tbio,476,,Homo sapiens
214974,2270,3429,Sodium channel alpha subunit,Ion channel,P35498|P35499|Q01118|Q14524|Q15858|Q99250|Q9NY46|Q9UI33|Q9UQD0|Q9Y5Y9,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN|SCN4A_HUMAN|SCN5A_HUMAN|SCN7A_HUMAN|SCN8A_HUMAN|SCN9A_HUMAN|SCNAA_HUMAN|SCNBA_HUMAN,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
214975,2686,3429,Sodium channel alpha subunit,Ion channel,P35498|P35499|Q01118|Q14524|Q15858|Q99250|Q9NY46|Q9UI33|Q9UQD0|Q9Y5Y9,SCN10A|SCN11A|SCN1A|SCN2A|SCN3A|SCN4A|SCN5A|SCN7A|SCN8A|SCN9A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN|SCN4A_HUMAN|SCN5A_HUMAN|SCN7A_HUMAN|SCN8A_HUMAN|SCN9A_HUMAN|SCNAA_HUMAN|SCNBA_HUMAN,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1762,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1762,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
189488,1757,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,10.010000228881836,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL376897,,,,Tclin,,,Homo sapiens
189559,1067,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,9.899999618530273,,EC50,Agonist activity at ER-beta (unknown origin) transfected in HEK293T cells after 24 hrs by Steady-Glo luciferase reporter gene assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482,,,,Tclin,,,Homo sapiens
189605,1757,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,9.819999694824219,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL376897,,,,Tclin,,,Homo sapiens
189613,4119,2829,Histone deacetylase 3/NCoR1,Transcription factor,O15379|O75376,HDAC3|NCOR1,HDAC3_HUMAN|NCOR1_HUMAN,9.819999694824219,,Ki,Inhibition of GST-tagged recombinant human HDAC3/NcoR1 enzyme using flurogenic Ac-LeuGlyLys (Ac)-AMC as substrate after 15 to 30 mins,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL343448,,,,Tchem|Tclin,,,Homo sapiens
189766,1757,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,9.680000305175781,,Ki,Displacement of [3H]N-methylscopolamine from human muscarinic M5 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL376897,,,,Tclin,,,Homo sapiens
189982,1932,2930,Bcr/Abl fusion protein,Kinase,P00519|P11274,ABL1|BCR,ABL1_HUMAN|BCR_HUMAN,9.479999542236328,,IC50,Inhibition of Bcr-Abl kinase (unknown origin) after 30 mins by HTRF assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255863,,,,Tclin|Tclin,,,Homo sapiens
190063,3616,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,9.420000076293945,,Kd,Binding affinity to beta-1 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL67096,,,,Tclin,,,Homo sapiens
190232,1067,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.319999694824219,,Ki,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482,,,,Tclin,,,Homo sapiens
190297,4716,2930,Bcr/Abl fusion protein,Kinase,P00519|P11274,ABL1|BCR,ABL1_HUMAN|BCR_HUMAN,9.300000190734863,,IC50,Inhibition of BCR/ABL (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1171837,,,,Tclin|Tclin,,,Homo sapiens
190299,1195,80,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,P31644,GABRA5,GBRA5_HUMAN,9.300000190734863,,Kd,Binding affinity to GABAA alpha-5-beta-2-gamma-2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,,,,Tclin,,,Homo sapiens
190699,785,2930,Bcr/Abl fusion protein,Kinase,P00519|P11274,ABL1|BCR,ABL1_HUMAN|BCR_HUMAN,9.100000381469727,,IC50,Inhibition of wild type Bcr-Abl,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1421,,,,Tclin|Tclin,,,Homo sapiens
190794,703,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,9.069999694824219,,Ki,Displacement of [3H]flumazenil from bovine benzodiazepine receptor GABA-A channel of brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL452,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
190868,1195,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,9.050000190734863,,Ki,Displacement of [3H]flumazenil from bovine benzodiazepine receptor GABA-A channel of brain membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
191009,2561,2823,Anti-estrogen binding site (AEBS),Enzyme,Q15125|Q9UBM7,DHCR7|EBP,DHCR7_HUMAN|EBP_HUMAN,9,,Kd,Binding affinity towards antiestrogen binding site AEBS,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,,,,Tchem|Tchem,,,Homo sapiens
191142,660,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.960000038146973,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,Tclin,,,Homo sapiens
191231,3616,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,8.920000076293945,,Kd,Binding affinity to beta2 adrenergic receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL67096,,,,Tclin,,,Homo sapiens
213291,734,2825,Protein farnesyltransferase,Enzyme,P49354|P49356,FNTA|FNTB,FNTA_HUMAN|FNTB_HUMAN,4.849999904632568,,IC50,inhibitory activity against human Farnesyltransferase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1650,,,,,,,Homo sapiens
191797,4941,2812,Cyclin-dependent kinase 4/cyclin D1,Kinase,P11802|P24385,CCND1|CDK4,CCND1_HUMAN|CDK4_HUMAN,8.699999809265137,,IC50,Inhibition of CDK4/cyclin D1 (unknown origin) using Rb as substrate after 60 mins by scintillation counting analysis in presence of [r-33P]ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189963,,,,Tchem|Tclin,,,Homo sapiens
191801,1195,75,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P14867,GABRA1,GBRA1_HUMAN,8.699999809265137,,Kd,Binding affinity to GABAA alpha-1-beta-2-gamma-2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,,,,Tclin,,,Homo sapiens
192302,2800,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.5600004196167,,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107687,,,,Tclin,,,Homo sapiens
192312,800,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,8.550000190734863,,IC50,In vitro displacement of [3H]-diazepam from GABA-A Benzodiazepine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL268254,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
192876,2800,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.4399995803833,,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107687,,,,Tclin,,,Homo sapiens
192943,4941,3671,CDK6/cyclin D1,Kinase,P24385|Q00534,CCND1|CDK6,CCND1_HUMAN|CDK6_HUMAN,8.420000076293945,,IC50,Inhibition of CDK6/cyclinD1 (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189963,,,,Tchem|Tclin,,,Homo sapiens
193561,1920,2799,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,P17787|Q15822,CHRNA2|CHRNB2,ACHA2_HUMAN|ACHB2_HUMAN,8.260000228881836,,Ki,Displacement of [3H]epibatidine from alpha2beta2 nAChR after 4 hrs by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,Tchem|Tclin,,,Homo sapiens
193579,2800,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.25,,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107687,,,,Tclin,,,Homo sapiens
193605,1195,77,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,8.239999771118164,,Ki,Displacement of [3H]Ro-151788 from benzodiazepine binding site of GABAA alpha-2-beta-2-gamma-2 receptor expressed in HEK293T cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,,,,Tclin,,,Homo sapiens
194114,2044,2509,Tubulin beta-3 chain,Structural,Q13509,TUBB3,TBB3_HUMAN,8.109999656677246,,IC50,Inhibition of beta3 tubulin overexpressed in human HeLa cells after 48 hrs by SRB assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL428647,,,,Tclin,,,Homo sapiens
194182,881,2792,Sodium/potassium-transporting ATPase,Transporter,P05023|P05026|P13637|P14415|P50993|P54709|P54710|Q13733,ATP1A1|ATP1A2|ATP1A3|ATP1A4|ATP1B1|ATP1B2|ATP1B3|FXYD2,AT1A1_HUMAN|AT1A2_HUMAN|AT1A3_HUMAN|AT1A4_HUMAN|AT1B1_HUMAN|AT1B2_HUMAN|AT1B3_HUMAN|ATNG_HUMAN,8.100000381469727,,IC50,Inhibition of [3H]- ouabain binding to digitalis receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254219,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
194336,1195,79,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,P34903,GABRA3,GBRA3_HUMAN,8.09000015258789,,Ki,Displacement of [3H]Ro-151788 from benzodiazepine binding site of GABAA alpha-3-beta-2-gamma-2 receptor expressed in HEK293T cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407,,,,Tclin,,,Homo sapiens
196283,4119,2828,Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2),Transcription factor,O15379|Q9Y618,HDAC3|NCOR2,HDAC3_HUMAN|NCOR2_HUMAN,7.739999771118164,,IC50,Inhibition of recombinant human HDAC3/NCOR2 using Boc-L-Lys(epsilon-trifluoroacetyl)-AMC as substrate by two-step fluorogenic assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL343448,,,,Tchem|Tclin,,,Homo sapiens
196415,2800,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.71999979019165,,Ki,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107687,,,,Tclin,,,Homo sapiens
196750,5039,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,7.659999847412109,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tclin,,,Homo sapiens
196881,852,80,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,P31644,GABRA5,GBRA5_HUMAN,7.639999866485596,,Kd,Binding affinity to GABAA alpha-5-beta-2-gamma-2 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12,,,,Tclin,,,Homo sapiens
196908,1920,2803,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P30926|P43681,CHRNA4|CHRNB4,ACHA4_HUMAN|ACHB4_HUMAN,7.639999866485596,,Ki,Displacement of [3H]epibatidine from alpha4beta4 nAChR after 4 hrs by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,Tclin|Tclin,,,Homo sapiens
196962,2800,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.619999885559082,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107687,,,,Tclin,,,Homo sapiens
198584,729,307,Adenylate cyclase type 1,Enzyme,Q08828,ADCY1,ADCY1_HUMAN,7.389999866485596,,IC50,Inhibition of [125 I]6-IHPP-forskolin binding to adenylate cyclase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52606,,,,Tchem,,,Homo sapiens
198838,1920,3384,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,P32297,CHRNA3,ACHA3_HUMAN,7.349999904632568,,IC50,Inhibition of [3H]nicotine binding to alpha3 nicotinic acetylcholine receptor in Homo sapiens (human) SH-SY5Y cells co-expressing beta2beta4alpha5 Nicotinic acetylcholine receptor subunits,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,Tclin,,,Homo sapiens
199077,1407,1255,Interleukin-8,Cytokine,P10145,CXCL8,IL8_HUMAN,7.300000190734863,,IC50,Inhibition of CXCL8-induced chemotaxis in human polymorphonuclear leukocyte pretreated for 15 mins measured after 4 hrs by cell migration assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,Tchem,,,Homo sapiens
199087,2366,160,ATP-binding cassette sub-family C member 8,Ion channel,Q09428,ABCC8,ABCC8_HUMAN,7.300000190734863,,Kd,Displacement of [3H]glibenclamide from COS-1 cells expressing Sulfonylurea receptor 1 (SUR-1),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1272,,,,Tclin,,,Homo sapiens
216550,1605,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,7.14,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL998,,,,,,,Cavia porcellus
199098,1782,2818,Serotonin 3 (5-HT3) receptor,Ion channel,A5X5Y0|O95264|P46098|Q70Z44|Q8WXA8,HTR3A|HTR3B|HTR3C|HTR3D|HTR3E,5HT3A_HUMAN|5HT3B_HUMAN|5HT3C_HUMAN|5HT3D_HUMAN|5HT3E_HUMAN,7.300000190734863,,Kd,Potency at neuronal 5-hydroxytryptamine 3 receptors in the rabbit heart,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL86,,,,Tchem|Tchem|Tchem|Tchem|Tclin,,,Homo sapiens
199101,1068,75,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P14867,GABRA1,GBRA1_HUMAN,7.300000190734863,,Ki,Displacement of [3H]Ro15-1788 from benzodiazepine binding site of GABAA alpha-1-beta-2-gamma-2 receptor expressed in HEK293T cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,,,,Tclin,,,Homo sapiens
199239,776,2870,Trypsin,Enzyme,P07477|P07478|P35030,PRSS1|PRSS2|PRSS3,TRY1_HUMAN|TRY2_HUMAN|TRY3_HUMAN,7.300000190734863,,Ki,Inhibitory constant (Ki) was determined against human trypsin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,,,,Tchem|Tchem|Tclin,,,Homo sapiens
199261,1310,1128,Excitatory amino acid transporter 3,Transporter,P43005,SLC1A1,EAA3_HUMAN,7.289999961853027,,Ki,Inhibition of [3H]D-Asp uptake at human EAAT3 in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tchem,,,Homo sapiens
199665,802,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,7.210000038146973,,IC50,"PUBCHEM_BIOASSAY: Estrogen Receptor-beta Coactivator Binding Inhibitors ELISA Secondary Assay. (Class of assay: confirmatory) [Related pubchem assays: 633 (Primary screen preceding this ELISA dose response confirmation assay.), 733 (Primary dose response assay preceding this ELISA dose response confirmation assay.)]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1591,,,,Tclin,,,Homo sapiens
199927,558,998,Beta-adrenergic receptor kinase 1,Kinase,P25098,GRK2,ARBK1_HUMAN,7.150000095367432,,EC50,"PUBCHEM_BIOASSAY: Dose Response of inhibitors of GRK2 binding with RNA aptamer, Cherry Pick 1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488855]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1343544,,,,Tbio,,,Homo sapiens
199973,660,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.150000095367432,,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1729,,,,Tclin,,,Homo sapiens
199988,1920,2736,Neuronal acetylcholine receptor; alpha2/beta4,Ion channel,P30926|Q15822,CHRNA2|CHRNB4,ACHA2_HUMAN|ACHB4_HUMAN,7.150000095367432,,Ki,Displacement of [3H]epibatidine from alpha2beta4 nAChR after 4 hrs by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,Tchem|Tclin,,,Homo sapiens
200205,5039,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,7.099999904632568,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tclin,,,Homo sapiens
200268,2052,2819,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNB1|CHRND|CHRNG,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN|ACHG_HUMAN,7.090000152587891,,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL185073,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
200269,2396,2819,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNB1|CHRND|CHRNG,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN|ACHG_HUMAN,7.090000152587891,,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200648,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
200270,2781,2819,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNB1|CHRND|CHRNG,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN|ACHG_HUMAN,7.090000152587891,,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
200271,2811,2819,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNB1|CHRND|CHRNG,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN|ACHG_HUMAN,7.090000152587891,,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200629,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
200355,1920,2820,Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3,Ion channel,P17787|P32297|Q05901|Q15825,CHRNA3|CHRNA6|CHRNB2|CHRNB3,ACHA3_HUMAN|ACHA6_HUMAN|ACHB2_HUMAN|ACHB3_HUMAN,7.070000171661377,,IC50,Antagonist activity at human alpha6/alpha3beta2beta3 nAChR expressed in human SHEP1 cells assessed as inhibition of carbamylcholine-induced 86Rb+ ion efflux preincubated for 10 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3,,,,Tchem|Tchem|Tclin|Tclin,,,Homo sapiens
200606,1688,3679,FAD-linked sulfhydryl oxidase ALR,Enzyme,P55789,GFER,ALR_HUMAN,7.010000228881836,,AC50,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395110,,,,Tchem,,,Homo sapiens
200614,1364,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,7.010000228881836,,IC50,"PUBCHEM_BIOASSAY: Estrogen Receptor-beta Coactivator Binding Inhibitors ELISA Secondary Assay. (Class of assay: confirmatory) [Related pubchem assays: 633 (Primary screen preceding this ELISA dose response confirmation assay.), 733 (Primary dose response assay preceding this ELISA dose response confirmation assay.)]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496,,,,Tclin,,,Homo sapiens
201000,2808,2803,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P30926|P43681,CHRNA4|CHRNB4,ACHA4_HUMAN|ACHB4_HUMAN,6.960000038146973,,Ki,Binding affinity to alpha4beta4 nAChR,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1396,,,,Tclin|Tclin,,,Homo sapiens
201196,1665,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,6.909999847412109,,Ki,Binding affinity to human adenosine A2A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL416956,,,,Tclin,,,Homo sapiens
201729,1068,79,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,P34903,GABRA3,GBRA3_HUMAN,6.789999961853027,,Ki,Displacement of [3H]Ro-151788 from benzodiazepine binding site of GABAA alpha-3-beta-2-gamma-2 receptor expressed in HEK293T cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522,,,,Tclin,,,Homo sapiens
201956,2372,465,Retinol-binding protein 4,Secreted,P02753,RBP4,RET4_HUMAN,6.739999771118164,,Kd,Binding affinity to His-tagged recombinant human sRBP expressed in Escherichia coli BL21(DE3) assessed as apparent dissociation constant after 5 mins by fluorescence spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL986,,,,Tchem,,,Homo sapiens
205402,1310,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.210000038146973,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tchem,,,Homo sapiens
201987,4757,361,Hydroxycarboxylic acid receptor 2,GPCR,Q8TDS4,HCAR2,HCAR2_HUMAN,6.739999771118164,,Ki,Displacement of [3H]nicotinic acid from human GPR109a receptor expressed in human HEK293T cells by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL589586,,,,Tclin,,,Homo sapiens
202005,5039,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.730000019073486,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tchem,,,Homo sapiens
202265,2800,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.699999809265137,,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107687,,,,Tclin,,,Homo sapiens
202572,1067,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,6.630000114440918,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482,,,,Tchem,,,Homo sapiens
202597,2715,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,6.619999885559082,,IC50,Inhibition of human recombinant MAO-A assessed as kynuramine oxidation to 4-hydroxyquinoline after 40 mins by LC-MS/MS analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1179,,,,Tclin,,,Homo sapiens
202725,2800,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.599999904632568,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107687,,,,Tclin,,,Homo sapiens
202984,1310,521,Metabotropic glutamate receptor 1,GPCR,Q13255,GRM1,GRM1_HUMAN,6.599999904632568,,Ki,Displacement of [3H]quisqualate from mGluR1 receptor expressed in BHK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tchem,,,Homo sapiens
203091,1262,2596,Gamma-aminobutyric acid receptor subunit rho-1,Ion channel,P24046,GABRR1,GBRR1_HUMAN,6.570000171661377,,EC50,Agonist activity at human GABAA rho1 receptor expressed in TSA201 cells after 1 min by FLIPR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,Tchem,,,Homo sapiens
203208,1646,2802,Neuronal acetylcholine receptor; alpha3/beta2,Ion channel,P17787|P32297,CHRNA3|CHRNB2,ACHA3_HUMAN|ACHB2_HUMAN,6.550000190734863,,IC50,Inhibitory concentration against Nicotinic acetylcholine receptor alpha3-beta2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267936,,,,Tclin|Tclin,,,Homo sapiens
203261,1310,918,Metabotropic glutamate receptor 2,GPCR,Q14416,GRM2,GRM2_HUMAN,6.539999961853027,,EC50,Compound was tested for the inhibition of metabotropic glutamate receptor 2 (mGluR2).,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tchem,,,Homo sapiens
203652,5039,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.489999771118164,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tchem,,,Homo sapiens
203908,2286,3679,FAD-linked sulfhydryl oxidase ALR,Enzyme,P55789,GFER,ALR_HUMAN,6.440000057220459,,AC50,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643,,,,Tchem,,,Homo sapiens
203977,1982,3679,FAD-linked sulfhydryl oxidase ALR,Enzyme,P55789,GFER,ALR_HUMAN,6.429999828338623,,AC50,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,Tchem,,,Homo sapiens
203995,5039,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,6.429999828338623,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tchem,,,Homo sapiens
204168,1310,694,Metabotropic glutamate receptor 5,GPCR,P41594,GRM5,GRM5_HUMAN,6.409999847412109,,Ki,Binding affinity to mGluR5 receptor expressed in BHK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tchem,,,Homo sapiens
204290,2171,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3A|PDE3B,PDE3A_HUMAN|PDE3B_HUMAN,6.389999866485596,,IC50,Inhibition of phosphodiesterase 3,CHEMBL,=,1,SCIENTIFIC LITERATURE,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24646,http://www.ncbi.nlm.nih.gov/pubmed/11855658,INHIBITOR,,Tclin|Tclin,,466,Homo sapiens
204306,2870,77,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,6.389999866485596,,Ki,Displacement of [3H]Ro-151788 from benzodiazepine binding site of GABAA alpha-2-beta-2-gamma-2 receptor expressed in HEK293T cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,Tclin,,,Homo sapiens
204368,1523,2778,Glutamate [NMDA] receptor,Ion channel,O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,NMD3A_HUMAN|NMD3B_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMDE4_HUMAN|NMDZ1_HUMAN,6.380000114440918,,Ki,The compound was tested for its ability to block PCP N-methyl-D-aspartate glutamate receptor at the PCP (phencyclidine) binding site in postmortem human frontal cortex.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL742,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL742,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
204426,3508,3679,FAD-linked sulfhydryl oxidase ALR,Enzyme,P55789,GFER,ALR_HUMAN,6.360000133514404,,AC50,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356238,,,,Tchem,,,Homo sapiens
204456,1547,1435,Phosphoethanolamine/phosphocholine phosphatase,Enzyme,Q8TCT1,PHOSPHO1,PHOP1_HUMAN,6.360000133514404,,IC50,"PUBCHEM_BIOASSAY: SAR assay for compounds that inhibit PHOSPHO1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1545, AID1565, AID1574]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL480,,,,Tchem,,,Homo sapiens
204546,629,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,6.349999904632568,,Ki,Inhibition of human carbonic anhydrase 7 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
205190,594,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRB3|GABRG2,GBRA1_HUMAN|GBRB3_HUMAN|GBRG2_HUMAN,6.25,,Ki,Inhibition of [3H]Ro-151788 binding to human GABA A receptor (alpha-1-beta-3-gamma-2) stably expressed in L(tk-) cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451,,,,Tclin|Tclin|Tclin,,,Homo sapiens
205605,1100,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.179999828338623,,Ki,Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL276443,,,,Tclin,,,Homo sapiens
205721,475,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,6.159999847412109,,Ki,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,Tchem,,,Homo sapiens
205754,881,2426,Signal transducer and activator of transcription 3,Transcription factor,P40763,STAT3,STAT3_HUMAN,6.150000095367432,,IC50,"PUBCHEM_BIOASSAY: Dose response cell-based assay to measure STAT3 inhibition. (Class of assay: confirmatory) [Related pubchem assays: 920, 1317, 1265, 1308, 862 ]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254219,,,,Tchem,,,Homo sapiens
205795,1310,482,"Glutamate receptor ionotropic, kainate 1",Ion channel,P39086,GRIK1,GRIK1_HUMAN,6.150000095367432,,Ki,Binding affinity against human ionotropic glutamate receptor kainate 1 in HK293 cells using [3H]kainate as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tclin,,,Homo sapiens
205797,1310,691,"Glutamate receptor ionotropic, kainate 5",Ion channel,Q16478,GRIK5,GRIK5_HUMAN,6.150000095367432,,Ki,Displacement of [3H]kainate from human Ionotropic glutamate receptor ionotropic kainate 1 expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tclin,,,Homo sapiens
206163,1310,739,"Glutamate receptor ionotropic, kainate 3",Ion channel,Q13003,GRIK3,GRIK3_HUMAN,6.099999904632568,,Ki,Ability to bind to Ionotropic glutamate receptor ionotropic kainate 3 was evaluated,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tclin,,,Homo sapiens
206380,1310,716,Glutamate receptor 4,Ion channel,P48058,GRIA4,GRIA4_HUMAN,6.059999942779541,,Ki,Compound was tested for binding affinity against human Ionotropic glutamate receptor AMPA 4 in HEK293 cells using [3H]AMPA as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tclin,,,Homo sapiens
206507,5039,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,6.039999961853027,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tchem,,,Homo sapiens
206586,1310,520,Glutamate receptor 2,Ion channel,P42262,GRIA2,GRIA2_HUMAN,6.03000020980835,,Ki,Compound was tested for binding affinity against human Ionotropic glutamate receptor AMPA 2 in HK293 cells using [3H]AMPA as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tclin,,,Homo sapiens
206699,2870,79,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,P34903,GABRA3,GBRA3_HUMAN,6.010000228881836,,Ki,Displacement of [3H]Ro-151788 from benzodiazepine binding site of GABAA alpha-3-beta-2-gamma-2 receptor expressed in HEK293T cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,Tclin,,,Homo sapiens
206790,367,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL409,,,,Tchem,,,Homo sapiens
206932,621,3679,FAD-linked sulfhydryl oxidase ALR,Enzyme,P55789,GFER,ALR_HUMAN,5.989999771118164,,AC50,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,Tchem,,,Homo sapiens
207024,2630,3679,FAD-linked sulfhydryl oxidase ALR,Enzyme,P55789,GFER,ALR_HUMAN,5.960000038146973,,AC50,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1378,,,,Tchem,,,Homo sapiens
207193,1310,738,"Glutamate receptor ionotropic, kainate 2",Ion channel,Q13002,GRIK2,GRIK2_HUMAN,5.960000038146973,,Ki,Binding affinity against human GluR6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tclin,,,Homo sapiens
207224,4392,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.949999809265137,,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1386,,,,Tclin,,,Homo sapiens
207243,2004,2426,Signal transducer and activator of transcription 3,Transcription factor,P40763,STAT3,STAT3_HUMAN,5.940000057220459,,IC50,"PUBCHEM_BIOASSAY: Dose response cell-based assay to measure STAT3 inhibition. (Class of assay: confirmatory) [Related pubchem assays: 920, 1317, 1265, 1308, 862 ]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL222863,,,,Tchem,,,Homo sapiens
207250,5048,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,5.940000057220459,,Ki,Displacement of [3H]pyrilamine from human H1 receptor expressed in CHO cell membrane after 120 mins by liquid scintillation counting analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL462605,,,,Tclin,,,Homo sapiens
207555,1665,146,Adenosine receptor A1,GPCR,P30542,ADORA1,AA1R_HUMAN,5.909999847412109,,Ki,Binding affinity to human adenosine A1 receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL416956,,,,Tclin,,,Homo sapiens
207557,2749,3679,FAD-linked sulfhydryl oxidase ALR,Enzyme,P55789,GFER,ALR_HUMAN,5.900000095367432,,AC50,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL829,,,,Tchem,,,Homo sapiens
207592,2284,3679,FAD-linked sulfhydryl oxidase ALR,Enzyme,P55789,GFER,ALR_HUMAN,5.889999866485596,,AC50,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,,,,Tchem,,,Homo sapiens
207629,2852,857,Vitamin K-dependent protein C,Enzyme,P04070,PROC,PROC_HUMAN,5.889999866485596,,IC50,Inhibition of human APC using S-2366 as substrate preincubated for 300 seconds followed by substrate addition measured after 40 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266349,,,,Tchem,,,Homo sapiens
207795,1310,408,Glutamate receptor 1,Ion channel,P42261,GRIA1,GRIA1_HUMAN,5.869999885559082,,Ki,Compound was tested for binding affinity against human Ionotropic glutamate receptor AMPA 1 in HEK293 cells using [3H]-AMPA as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tclin,,,Homo sapiens
207802,1153,3679,FAD-linked sulfhydryl oxidase ALR,Enzyme,P55789,GFER,ALR_HUMAN,5.860000133514404,,AC50,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL588,,,,Tchem,,,Homo sapiens
207841,947,3679,FAD-linked sulfhydryl oxidase ALR,Enzyme,P55789,GFER,ALR_HUMAN,5.849999904632568,,AC50,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,Tchem,,,Homo sapiens
207976,1310,697,Metabotropic glutamate receptor 4,GPCR,Q14833,GRM4,GRM4_HUMAN,5.849999904632568,,Ki,Displacement of [3H]Quisqualate from human mGluR4 receptor expressed in BHK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tchem,,,Homo sapiens
208154,2852,662,Tissue-type plasminogen activator,Enzyme,P00750,PLAT,TPA_HUMAN,5.820000171661377,,Ki,Inhibition of human t-PA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266349,,,,Tclin,,,Homo sapiens
208157,1132,2218,cAMP-dependent protein kinase catalytic subunit alpha,Kinase,P17612,PRKACA,KAPCA_HUMAN,5.809999942779541,,AC50,PUBCHEM_BIOASSAY: Protein Kinase A Activity Assay Measured in Biochemical System Using Plate Reader - 2052-04_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2689],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38380,,,,Tchem,,,Homo sapiens
208464,776,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,5.769999980926514,,Ki,Inhibitory constant (Ki) was determined against human plasmin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,,,,Tclin,,,Homo sapiens
208493,475,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.760000228881836,,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,Tclin,,,Homo sapiens
208621,629,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.739999771118164,,Ki,Inhibition of human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
208627,2852,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,5.739999771118164,,Ki,Inhibition of human plasmin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266349,,,,Tclin,,,Homo sapiens
208655,882,2426,Signal transducer and activator of transcription 3,Transcription factor,P40763,STAT3,STAT3_HUMAN,5.730000019073486,,IC50,"PUBCHEM_BIOASSAY: Dose response cell-based assay to measure STAT3 inhibition. (Class of assay: confirmatory) [Related pubchem assays: 920, 1317, 1265, 1308, 862 ]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1751,,,,Tchem,,,Homo sapiens
208824,133,2760,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,P18507|P47869|P47870,GABRA2|GABRB2|GABRG2,GBRA2_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,5.699999809265137,,EC50,Effective concentration against GABA-evoked chloride currents mediated by human Gamma-aminobutyric acid GABA-A receptor alpha2-beta2-gamma2L expressed in Xenopus oocytes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190279,,,,Tclin|Tclin|Tclin,,,Homo sapiens
208882,294,804,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,5.699999809265137,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370,,,,Tchem,,,Homo sapiens
208895,2781,2801,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,P30926|P32297,CHRNA3|CHRNB4,ACHA3_HUMAN|ACHB4_HUMAN,5.699999809265137,,IC50,Inhibitory activity against nicotinic acetylcholine receptor alpha3-beta4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687,,,,Tclin|Tclin,,,Homo sapiens
209097,5037,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,5.679999828338623,,Ki,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2024517,,,,Tclin,,,Homo sapiens
209125,1364,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,5.670000076293945,,IC50,PUBCHEM_BIOASSAY: Estrogen Receptor-alpha Coactivator Binding Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 629 (Primary screen preceding this dose response confirmation assay.)],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496,,,,Tclin,,,Homo sapiens
209461,629,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.619999885559082,,Ki,Inhibition of human carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
209497,373,3673,Insulin-degrading enzyme,Enzyme,P14735,IDE,IDE_HUMAN,5.599999904632568,,EC50,"PUBCHEM_BIOASSAY: Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay for activators of recombinant IDE. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588439, AID588440, AID588442]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL857,,,,Tchem,,,Homo sapiens
209596,1328,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,5.590000152587891,,IC50,PUBCHEM_BIOASSAY: Estrogen Receptor-alpha Coactivator Binding Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 629 (Primary screen preceding this dose response confirmation assay.)],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,Tclin,,,Homo sapiens
210055,475,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.519999980926514,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,Tchem,,,Homo sapiens
210058,314,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,5.519999980926514,,IC50,"PUBCHEM_BIOASSAY: Estrogen Receptor-beta Coactivator Binding Inhibitors ELISA Secondary Assay. (Class of assay: confirmatory) [Related pubchem assays: 633 (Primary screen preceding this ELISA dose response confirmation assay.), 733 (Primary dose response assay preceding this ELISA dose response confirmation assay.)]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096979,,,,Tclin,,,Homo sapiens
210115,475,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.519999980926514,,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,Tclin,,,Homo sapiens
210161,475,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.510000228881836,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,Tchem,,,Homo sapiens
210167,1646,2736,Neuronal acetylcholine receptor; alpha2/beta4,Ion channel,P30926|Q15822,CHRNA2|CHRNB4,ACHA2_HUMAN|ACHB4_HUMAN,5.510000228881836,,IC50,Inhibitory concentration against Nicotinic acetylcholine receptor alpha2-beta4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267936,,,,Tchem|Tclin,,,Homo sapiens
210242,5039,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,5.5,,IC50,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tclin,,,Homo sapiens
210335,475,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,5.489999771118164,,Ki,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,Tclin,,,Homo sapiens
210376,475,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.480000019073486,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,Tclin,,,Homo sapiens
210380,2852,807,Coagulation factor VII,Enzyme,P08709,F7,FA7_HUMAN,5.480000019073486,,IC50,Inhibition of human coagulation factor 7a using spectrozyme as substrate preincubated for 300 seconds followed by substrate addition measured after 40 mins by spectrophotometric analysis in presence of tissue factor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266349,,,,Tchem,,,Homo sapiens
210485,1109,2760,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,P18507|P47869|P47870,GABRA2|GABRB2|GABRG2,GBRA2_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,5.460000038146973,,EC50,Effective concentration against GABA-evoked chloride currents mediated by human Gamma-aminobutyric acid GABA-A receptor alpha2-beta2-gamma2L expressed in Xenopus oocytes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681,,,,Tclin|Tclin|Tclin,,,Homo sapiens
210568,629,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.449999809265137,,Ki,Inhibition of human carbonic anhydrase 3 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
210710,2852,631,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,5.429999828338623,,Ki,Inhibition of human factor 10a,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266349,,,,Tclin,,,Homo sapiens
210769,776,631,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,5.420000076293945,,Ki,Inhibitory constant (Ki) was determined against human Coagulation factor Xa (fXa),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,,,,Tclin,,,Homo sapiens
210866,3032,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,5.400000095367432,,IC50,PUBCHEM_BIOASSAY: Estrogen Receptor-alpha Coactivator Binding Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 629 (Primary screen preceding this dose response confirmation assay.)],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290106,,,,Tclin,,,Homo sapiens
210917,629,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.400000095367432,,Ki,Inhibition of human carbonic anhydrase 5b after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
210943,5039,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.389999866485596,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tchem,,,Homo sapiens
211031,629,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,5.380000114440918,,Ki,Inhibition of human carbonic anhydrase 5a after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
211077,4392,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.369999885559082,,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1386,,,,Tclin,,,Homo sapiens
211206,5039,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.340000152587891,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tchem,,,Homo sapiens
211248,5039,411,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O76074,PDE5A,PDE5A_HUMAN,5.329999923706055,,IC50,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tclin,,,Homo sapiens
211254,776,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,5.329999923706055,,IC50,Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,,,,Tchem,,,Homo sapiens
211276,629,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.329999923706055,,Ki,Inhibition of human carbonic anhydrase 12 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
211301,4732,3670,SUMO-activating enzyme,Enzyme,Q9UBE0|Q9UBT2,SAE1|UBA2,SAE1_HUMAN|SAE2_HUMAN,5.320000171661377,,IC50,"PUBCHEM_BIOASSAY: uHTS HTRF assay for identification of inhibitors of SUMOylation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2011, AID2018, AID2069, AID2614, AID2658]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33864,,,,Tbio|Tbio,,,Homo sapiens
211334,1310,897,Metabotropic glutamate receptor 6,GPCR,O15303,GRM6,GRM6_HUMAN,5.309999942779541,,EC50,Compound was tested for the inhibition of Metabotropic glutamate receptor 6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tbio,,,Homo sapiens
211358,629,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.309999942779541,,Ki,Inhibition of human carbonic anhydrase 4 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
211368,629,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,5.309999942779541,,Ki,Inhibition of human carbonic anhydrase 6 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
211384,1262,174,Sodium- and chloride-dependent GABA transporter 1,Transporter,P30531,SLC6A1,SC6A1_HUMAN,5.300000190734863,,IC50,Inhibitory activity against human GABA transporter-1 (hGAT1),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,Tclin,,,Homo sapiens
211439,729,3676,"Solute carrier family 2, facilitated glucose transporter member 1",Transporter,P11166,SLC2A1,GTR1_HUMAN,5.300000190734863,,Kd,Inhibition of [125I]7-IHPP-Fsk binding to glucose transporter of human erythrocyte membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52606,,,,Tchem,,,Homo sapiens
211447,629,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,5.300000190734863,,Ki,Inhibition of human carbonic anhydrase 9 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
211615,1364,2721,Transitional endoplasmic reticulum ATPase,Enzyme,P55072,VCP,TERA_HUMAN,5.260000228881836,,IC50,"PUBCHEM_BIOASSAY: Dose response biochemical high throughput screening assay for inhibitors of the p97 ATPase. (Class of assay: confirmatory) [Related pubchem assays: 1481, 1517 ]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496,,,,Tchem,,,Homo sapiens
211635,1067,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.260000228881836,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482,,,,Tclin,,,Homo sapiens
211754,475,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.230000019073486,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,Tclin,,,Homo sapiens
211832,1999,2778,Glutamate [NMDA] receptor,Ion channel,O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,NMD3A_HUMAN|NMD3B_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMDE4_HUMAN|NMDZ1_HUMAN,5.21999979019165,,Ki,The compound was tested for its ability to block PCP N-methyl-D-aspartate glutamate receptor at the PCP (phencyclidine) binding site in postmortem human frontal cortex.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
211851,113,649,Toll-like receptor 9,Membrane receptor,Q9NR96,TLR9,TLR9_HUMAN,5.210000038146973,,IC50,"PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for inhibitors of TLR9-MyD88 binding. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504734, AID504750, AID540250, AID540251]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554041,,,,Tclin,,,Homo sapiens
211922,4733,649,Toll-like receptor 9,Membrane receptor,Q9NR96,TLR9,TLR9_HUMAN,5.199999809265137,,IC50,"PUBCHEM_BIOASSAY: Fluorescence-based cell-based high throughput dose response assay for inhibitors of TLR9-MyD88 binding. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504734, AID504750, AID540250, AID540251]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508338,,,,Tclin,,,Homo sapiens
212172,1262,3677,Sodium- and chloride-dependent GABA transporter 3,Transporter,P48066,SLC6A11,S6A11_HUMAN,5.150000095367432,,IC50,Inhibitory activity against human sodium and chloride dependent GABA transporter 3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,Tbio,,,Homo sapiens
212296,2123,3679,FAD-linked sulfhydryl oxidase ALR,Enzyme,P55789,GFER,ALR_HUMAN,5.119999885559082,,AC50,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089,,,,Tchem,,,Homo sapiens
212410,849,571,Caspase-3,Enzyme,P42574,CASP3,CASP3_HUMAN,5.099999904632568,,EC50,"PUBCHEM_BIOASSAY: Absorbance-based biochemical high throughput dose response assay for activators of procaspase-3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463141, AID463197, AID463210, AID488941, AID488954, AID493114, AID493115, AID504328, AID504330]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41286,,,,Tchem,,,Homo sapiens
212483,3032,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,5.090000152587891,,IC50,PUBCHEM_BIOASSAY: Estrogen Receptor-beta Coactivator Binding Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 633 (Primary screen preceding this dose response confirmation assay.)],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290106,,,,Tclin,,,Homo sapiens
212488,776,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,5.090000152587891,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,,,,Tchem,,,Homo sapiens
212623,475,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.050000190734863,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,Tclin,,,Homo sapiens
212646,875,343,Cysteinyl leukotriene receptor 1,GPCR,Q9Y271,CYSLTR1,CLTR1_HUMAN,5.050000190734863,,Ki,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL411,,,,Tclin,,,Homo sapiens
212932,629,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,4.980000019073486,,Ki,Inhibition of human carbonic anhydrase 13 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
212933,144,2778,Glutamate [NMDA] receptor,Ion channel,O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN2D|GRIN3A|GRIN3B,NMD3A_HUMAN|NMD3B_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMDE4_HUMAN|NMDZ1_HUMAN,4.980000019073486,,Ki,The compound was tested for its ability to block PCP N-methyl-D-aspartate glutamate receptor at the PCP (phencyclidine) binding site in postmortem human frontal cortex.,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL660,BLOCKER,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
212957,1109,75,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P14867,GABRA1,GBRA1_HUMAN,4.960000038146973,,EC50,Activity at human GABAA alpha-1-beta-2-gamma-2s receptor expressed in HEK293 cells assessed as effect on GABA-induced current at 3 uM by whole cell patch-clamp technique,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681,,,,Tclin,,,Homo sapiens
212973,776,297,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,P16083,NQO2,NQO2_HUMAN,4.960000038146973,,IC50,"Displacement of (S)-N4-(4-(3-(2-((4-carbamimidoylphenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanamido)butyl)-N1-(15-oxo-19-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-4,7,10-trioxa-14-azanonadecyl)-2-(4-(3-(trifluoromethyl)-3H-diazirin-3-yl)benzamido)succinamide from human recombinant NQO2 after 1 hr by densitometric analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,,,,Tchem,,,Homo sapiens
212986,1646,2820,Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3,Ion channel,P17787|P32297|Q05901|Q15825,CHRNA3|CHRNA6|CHRNB2|CHRNB3,ACHA3_HUMAN|ACHA6_HUMAN|ACHB2_HUMAN|ACHB3_HUMAN,4.960000038146973,,IC50,GRAC: human AChR-alpha6-alpha3-beta2-beta3 [chimera] commonly used antagonist,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267936,,,,Tchem|Tchem|Tclin|Tclin,,,Homo sapiens
213041,629,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,4.940000057220459,,Ki,Inhibition of human carbonic anhydrase 14 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tclin,,,Homo sapiens
213315,228,3681,Mannose-6-phosphate isomerase,Enzyme,P34949,MPI,MPI_HUMAN,4.840000152587891,,IC50,PUBCHEM_BIOASSAY: HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate. (Class of assay: confirmatory) [Related pubchem assays: 1209 ],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,Tchem,,,Homo sapiens
213322,849,3678,Caspase-7,Enzyme,P55210,CASP7,CASP7_HUMAN,4.829999923706055,,EC50,"PUBCHEM_BIOASSAY: Counterscreen for procaspase-3 activators: absorbance-based biochemical high throughput dose response assay for activators of procaspase-7. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463141, AID463197, AID463210, AID488941, AID488954, AID493114, AID493115, AID504328, AID504330]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41286,,,,Tchem,,,Homo sapiens
213434,719,343,Cysteinyl leukotriene receptor 1,GPCR,Q9Y271,CYSLTR1,CLTR1_HUMAN,4.78000020980835,,Ki,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,Tclin,,,Homo sapiens
213483,91,3674,Heat shock cognate 71 kDa protein,Unclassified,P11142,HSPA8,HSP7C_HUMAN,4.760000228881836,,IC50,PUBCHEM_BIOASSAY: In Vitro Hsc70 Dose Response Fluorescence Polarization Assay. (Class of assay: confirmatory) [Related pubchem assays: 1072 ],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14249,,,,Tchem,,,Homo sapiens
213502,1067,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,4.75,,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482,,,,Tclin,,,Homo sapiens
213504,5039,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,4.75,,Ki,Inhibition of human CA6 using 4-nitrophenylacetate substrate by esterase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tclin,,,Homo sapiens
213524,5003,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,4.739999771118164,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201539,,,,Tclin,,,Homo sapiens
213627,2852,3672,Coagulation factor XI,Enzyme,P03951,F11,FA11_HUMAN,4.699999809265137,,IC50,Inhibition of human coagulation factor 11a using S-2366 as substrate preincubated for 300 seconds followed by substrate addition measured after 40 mins by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266349,,,,Tchem,,,Homo sapiens
213649,1775,859,Induced myeloid leukemia cell differentiation protein Mcl-1,Cytosolic other,Q07820,MCL1,MCL1_HUMAN,4.690000057220459,,IC50,"PUBCHEM_BIOASSAY: Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. (Class of assay: confirmatory) [Related pubchem assays: 2090 (Summary AID.), 2057 (Screening assay (MCL1 inhibitors).), 2168 (Screening assay (MCL1 inhibitors).)]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1065,,,,Tchem,,,Homo sapiens
213695,776,857,Vitamin K-dependent protein C,Enzyme,P04070,PROC,PROC_HUMAN,4.679999828338623,,Ki,Inhibitory constant (Ki) was determined against human Activated protein C,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,,,,Tchem,,,Homo sapiens
213735,1637,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,4.650000095367432,,IC50,PUBCHEM_BIOASSAY: Estrogen Receptor-alpha Coactivator Binding Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 629 (Primary screen preceding this dose response confirmation assay.)],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,Tclin,,,Homo sapiens
213738,1775,861,Bcl-2-like protein 1,Cytosolic other,Q07817,BCL2L1,B2CL1_HUMAN,4.650000095367432,,IC50,"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of MCL1: fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of BCL2-related protein, long isoform (BCLXL). (Class of assay: confirmatory) [Related pubchem assays: 2129 (Screening assay (BCLXL inhibitors).), 2057 (Screening assay (MCL-1 inhibitors).), 2144 (Summary AID.), 2166 (Screening assay (BCLXL inhibitors).)]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1065,,,,Tchem,,,Homo sapiens
213775,1535,3463,Galectin-9,Unclassified,O00182,LGALS9,LEG9_HUMAN,4.639999866485596,,Kd,Binding affinity to galectin 9N terminal domain at 0 degC by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL417016,,,,Tchem,,,Homo sapiens
213779,854,2810,"Sulfonylurea receptor 1, Kir6.2",Ion channel,Q09428|Q14654,ABCC8|KCNJ11,ABCC8_HUMAN|KCJ11_HUMAN,4.630000114440918,,EC50,Activation of human recombinant SUR1/Kir6.2 channel expressed in HEK293 cells assessed as increase in ionic current by whole cell patch clamp assay,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL181,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL181,OPENER,,Tclin|Tclin,,,Homo sapiens
213795,314,3670,SUMO-activating enzyme,Enzyme,Q9UBE0|Q9UBT2,SAE1|UBA2,SAE1_HUMAN|SAE2_HUMAN,4.630000114440918,,IC50,"PUBCHEM_BIOASSAY: uHTS HTRF assay for identification of inhibitors of SUMOylation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2011, AID2018, AID2069, AID2614, AID2658]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096979,,,,Tbio|Tbio,,,Homo sapiens
213857,776,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.599999904632568,,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,,,,Tchem,,,Homo sapiens
213971,2451,2716,DNA polymerase beta,Enzyme,P06746,POLB,DPOLB_HUMAN,4.579999923706055,,IC50,Inhibition of DNA polymerase beta lyase activity by deoxyribose phosphate excision assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53569,,,,Tchem,,,Homo sapiens
213982,294,133,Interleukin-5,Cytokine,P05113,IL5,IL5_HUMAN,4.570000171661377,,IC50,Inhibition of interleukin-5,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370,,,,Tclin,,,Homo sapiens
214005,1364,3674,Heat shock cognate 71 kDa protein,Unclassified,P11142,HSPA8,HSP7C_HUMAN,4.559999942779541,,IC50,PUBCHEM_BIOASSAY: High Throughput Screening Assay for Hsc70 Inhibitors. (Class of assay: confirmatory) ,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496,,,,Tchem,,,Homo sapiens
214062,2451,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,4.539999961853027,,IC50,Inhibition of human DPP4 using H-Gly-Pro-AMC peptide substrate assessed as increase in fluorescence for 20 mins by fluorimetric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53569,,,,Tclin,,,Homo sapiens
214065,1366,2800,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P17787|P43681,CHRNA4|CHRNB2,ACHA4_HUMAN|ACHB2_HUMAN,4.539999961853027,,IC50,GRAC: human AChR-alpha4-beta2 channel blocker,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL100622,,,,Tclin|Tclin,,,Homo sapiens
214112,629,882,Beta-secretase 1,Enzyme,P56817,BACE1,BACE1_HUMAN,4.519999980926514,,IC50,Inhibition of human Beta-secretase 1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,Tchem,,,Homo sapiens
214182,5039,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,4.480000019073486,,Ki,Inhibition of human CA2 using 4-nitrophenylacetate substrate by esterase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tclin,,,Homo sapiens
214215,911,987,Methionine aminopeptidase 2,Enzyme,P50579,METAP2,MAP2_HUMAN,4.460000038146973,,IC50,Inhibition of human MetAP2 expressed in baculovirus infected Sf9 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1170610,,,,Tchem,,,Homo sapiens
214220,2715,3683,Lysine-specific histone demethylase 1B,Enzyme,Q8NB78,KDM1B,KDM1B_HUMAN,4.460000038146973,,IC50,Inhibition of recombinant LSD2 (22 to 822 aa) (unknown origin) expressed in Escherichia coli BL21(DE) by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1179,,,,Tbio,,,Homo sapiens
214224,1310,1126,Excitatory amino acid transporter 1,Transporter,P43003,SLC1A3,EAA1_HUMAN,4.460000038146973,,Ki,Inhibition of [3H]D-Asp uptake at EAAT1 in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tchem,,,Homo sapiens
214245,1262,3684,Sodium- and chloride-dependent betaine transporter,Transporter,P48065,SLC6A12,S6A12_HUMAN,4.440000057220459,,IC50,Inhibition of human GABA transporter (hBGT-1) activity.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,Tchem,,,Homo sapiens
214290,2056,1411,Protein-arginine deiminase type-4,Enzyme,Q9UM07,PADI4,PADI4_HUMAN,4.409999847412109,,IC50,"PUBCHEM_BIOASSAY: Fluorescence-based biochemical dose response assay to identify inhibitors of Protein Arginine Deaminase 4 (PAD4). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463073, AID463083, AID485272, AID488796]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19224,,,,Tchem,,,Homo sapiens
214318,2278,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRA1|GABRA2|GABRA3|GABRA4|GABRA5|GABRA6|GABRB1|GABRB2|GABRB3|GABRD|GABRE|GABRG1|GABRG2|GABRG3|GABRP|GABRQ,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA4_HUMAN|GBRA5_HUMAN|GBRA6_HUMAN|GBRB1_HUMAN|GBRB2_HUMAN|GBRB3_HUMAN|GBRD_HUMAN|GBRE_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN|GBRP_HUMAN|GBRT_HUMAN,4.400000095367432,,Ki,Displacement of [3H]gamma-amino butyric acid from Gamma-aminobutyric acid (GABA-A) receptor of human cerebellar cortex preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL287631,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
214319,1569,3675,CAAX prenyl protease 2,Enzyme,Q9Y256,RCE1,FACE2_HUMAN,4.389999866485596,,AC50,PUBCHEM_BIOASSAY: Human Ras-Converting Enzyme Inhibition Assay Measured in Biochemical System Using Plate Reader - 2034-04_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2618],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33,,,,Tchem,,,Homo sapiens
214341,911,2309,Methionine aminopeptidase 1,Enzyme,P53582,METAP1,MAP11_HUMAN,4.369999885559082,,IC50,Inhibition of human MetAP1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1170610,,,,Tchem,,,Homo sapiens
214345,1310,152,"Glutathione reductase, mitochondrial",Enzyme,P00390,GSR,GSHR_HUMAN,4.369999885559082,,Ki,Competitive inhibition of human erythrocyte Glutathione reductase using GSSG substrate by Lineweaver-Burk plot analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tclin,,,Homo sapiens
214404,776,662,Tissue-type plasminogen activator,Enzyme,P00750,PLAT,TPA_HUMAN,4.340000152587891,,Ki,Inhibitory constant (Ki) was determined against human Tissue plasminogen activator (tissue plasminogen activator),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48361,,,,Tclin,,,Homo sapiens
214453,2095,2760,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,P18507|P47869|P47870,GABRA2|GABRB2|GABRG2,GBRA2_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,4.300000190734863,,EC50,Effective concentration against GABA-evoked chloride currents mediated by human Gamma-aminobutyric acid GABA-A receptor alpha2-beta2-gamma2L expressed in Xenopus oocytes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448,,,,Tclin|Tclin|Tclin,,,Homo sapiens
214590,4605,3673,Insulin-degrading enzyme,Enzyme,P14735,IDE,IDE_HUMAN,4.269999980926514,,EC50,"PUBCHEM_BIOASSAY: Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay for activators of recombinant IDE. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588439, AID588440, AID588442]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200883,,,,Tchem,,,Homo sapiens
214597,2265,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.269999980926514,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194,BLOCKER,,Tclin|Tclin|Tclin,,,Homo sapiens
214662,769,354,Cystine/glutamate transporter,Transporter,Q9UPY5,SLC7A11,XCT_HUMAN,4.230000019073486,,Ki,Competitive inhibition of [3H]L-glutamate uptake at amino acid transport system xc- in human SNB19 cells by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL863,,,,Tbio,,,Homo sapiens
214664,2495,491,"Alkaline phosphatase, tissue-nonspecific isozyme",Enzyme,P05186,ALPL,PPBT_HUMAN,4.21999979019165,,EC50,"PUBCHEM_BIOASSAY: uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay. (Class of assay: confirmatory) [Related pubchem assays: 813, 518, 1548, 1450 ]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1221,,,,Tchem,,,Homo sapiens
214671,729,2858,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P35498|Q99250|Q9NY46,SCN1A|SCN2A|SCN3A,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,4.21999979019165,,IC50,Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52606,,,,Tclin|Tclin|Tclin,,,Homo sapiens
214688,1535,3462,Galectin-8,Unclassified,O00214,LGALS8,LEG8_HUMAN,4.210000038146973,,Kd,Binding affinity to galectin 8N terminal domain at 20 degC by fluorescence polarization assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL417016,,,,Tchem,,,Homo sapiens
214692,1310,1127,Excitatory amino acid transporter 2,Transporter,P43004,SLC1A2,EAA2_HUMAN,4.210000038146973,,Ki,Inhibition of [3H]D-Asp uptake at human EAAT2 in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,Tchem,,,Homo sapiens
215068,773,6,DNA,DNA,,,,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL476,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL476,OTHER,,,,,
214775,1200,3675,CAAX prenyl protease 2,Enzyme,Q9Y256,RCE1,FACE2_HUMAN,4.150000095367432,,AC50,PUBCHEM_BIOASSAY: Human Ras-Converting Enzyme Inhibition Assay Measured in Biochemical System Using Plate Reader - 2034-04_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2618],CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,,,,Tchem,,,Homo sapiens
214777,1800,491,"Alkaline phosphatase, tissue-nonspecific isozyme",Enzyme,P05186,ALPL,PPBT_HUMAN,4.150000095367432,,EC50,"PUBCHEM_BIOASSAY: uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay. (Class of assay: confirmatory) [Related pubchem assays: 813, 518, 1548, 1450 ]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,Tchem,,,Homo sapiens
214812,5039,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,4.119999885559082,,Ki,Inhibition of human CA1 using 4-nitrophenylacetate substrate by esterase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,Tclin,,,Homo sapiens
214874,4125,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,4.070000171661377,,Ki,Inhibition of ACE (unknown origin) assessed as 3-Hydroxybutyril-glycil-glycil-glycine conversion to 3-hydroxybutyric acid after 60 mins by WST assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54922,,,,Tclin,,,Homo sapiens
214908,1366,2803,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,P30926|P43681,CHRNA4|CHRNB4,ACHA4_HUMAN|ACHB4_HUMAN,4.039999961853027,,IC50,GRAC: human AChR-alpha4-beta4 channel blocker,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL100622,,,,Tclin|Tclin,,,Homo sapiens
214920,24,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,4.019999980926514,,IC50,Inhibition of aldose reductase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1044,,,,Tclin,,,Homo sapiens
215004,5075,2066,Solute carrier family 22 member 12,Transporter,Q96S37,SLC22A12,S22AC_HUMAN,5.136677265167236,,IC50,,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf,INHIBITOR,,Tclin,508,508,Homo sapiens
215005,5075,1529,Solute carrier family 22 member 11,Transporter,Q9NSA0,SLC22A11,S22AB_HUMAN,5.431798458099365,,IC50,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207988lbl.pdf,,INHIBITOR,,Tclin,508,,Homo sapiens
215007,1532,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/17276408,BLOCKER,,Tclin|Tclin,,509,Homo sapiens
215009,6,187,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/17276408,BLOCKER,,Tclin,,509,Homo sapiens
215011,3880,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/17276408,BLOCKER,,Tclin|Tclin,,509,Homo sapiens
215012,5078,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,7.744727611541748,,EC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/22047812,http://www.ncbi.nlm.nih.gov/pubmed/22047812,AGONIST,,Tclin,512,512,Homo sapiens
215013,5078,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,7.698969841003418,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/22047812,,AGONIST,,Tclin,512,,Homo sapiens
215015,779,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,,UNKNOWN,,1,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1479,AGONIST,,Tclin,,,Homo sapiens
215016,3529,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D05732,http://www.kegg.jp/entry/D05732,AGONIST,,Tclin,,,Homo sapiens
215017,47,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D01582,http://www.kegg.jp/entry/D01582,INHIBITOR,,Tclin,,,Homo sapiens
215018,47,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D01582,http://www.kegg.jp/entry/D01582,INHIBITOR,,Tclin,,,Homo sapiens
215019,478,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,6.522878646850586,,IC50,inhibitION the aldosterone-induced MR activity,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/15716462,http://www.ncbi.nlm.nih.gov/pubmed/21771637,ANTAGONIST,,Tclin,514,515,Homo sapiens
215021,5079,23,Streptococcus pneumoniae,Bacteria,,,,6.7917256355285645,,MIC90,invasive S. pneumoniae isolates,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/19833635,,MINIMUM INHIBITORY CONCENTRATION,,,516,,
215022,5079,25,Staphylococcus aureus subsp. aureus,Bacteria,,,,7.0927557945251465,,MIC90,methicillin-susceptible S. aureus (MSSA),SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/19833635,,MINIMUM INHIBITORY CONCENTRATION,,,516,,
215023,78,427,Retinoic acid receptor gamma,Nuclear hormone receptor,P13631,RARG,RARG_HUMAN,,,,Mechanism of Action,CHEMBL,,1,CHEMBL,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1131,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1131,AGONIST,,Tclin,,,Homo sapiens
215026,1030,6,DNA,DNA,,,,,,,forms a complex with DNA by intercalation between base pairs resulting in inhibition of DNA and RNA synthesis,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050778s021lbl.pdf,OTHER,,,,521,
215027,4373,3693,glycine,Amino acid,,,,,,,alternatives to urea for the excretion of waste nitrogen,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020645s008lbl.pdf,OTHER,,,,522,
215028,4664,3693,glycine,Amino acid,,,,,,,alternatives to urea for the excretion of waste nitrogen,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020645s008lbl.pdf,OTHER,,,,522,
215029,495,434,Oxytocin receptor,GPCR,P30559,OXTR,OXYR_HUMAN,8.148741722106934,,Ki,oxytocin receptors expressed in COS-7 cells,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/15740719,https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2015-PI-01665-1,AGONIST,,Tclin,528,529,Homo sapiens
215030,495,392,Vasopressin V2 receptor,GPCR,P30518,AVPR2,V2R_HUMAN,5.232102394104004,,Ki,vasopressin V2 receptors expressed in COS-7 cells,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/15740719,,,,Tclin,528,,Homo sapiens
215066,4157,2921,Voltage-gated L-type calcium channel,Ion channel,Q01668|Q13936,CACNA1C|CACNA1D,CAC1C_HUMAN|CAC1D_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/8821512,http://www.ncbi.nlm.nih.gov/pubmed/8821512,BLOCKER,,Tclin|Tclin,553,553,Homo sapiens
215069,1141,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D01675,http://www.kegg.jp/entry/D01675,INHIBITOR,,Tclin,,,Homo sapiens
215070,3341,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D01533,http://www.kegg.jp/entry/D01533,AGONIST,,Tclin,,,Homo sapiens
215073,1178,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.958607196807861,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23755755,http://www.ncbi.nlm.nih.gov/pubmed/23755755,INHIBITOR,,Tclin,569,569,Homo sapiens
215074,1178,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.267606258392334,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/23755755,http://www.ncbi.nlm.nih.gov/pubmed/23755755,INHIBITOR,,Tclin,569,569,Homo sapiens
215075,5087,2993,Interleukin-2 receptor,Membrane receptor,P01589|P14784|P31785,IL2RA|IL2RB|IL2RG,IL2RA_HUMAN|IL2RB_HUMAN|IL2RG_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103767s5119lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin|Tclin,,570,Homo sapiens
215076,5088,3697,T-cell surface antigen CD2,Surface antigen,P06729,CD2,CD2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/125036s0144lbl.pdf,INHIBITOR,,Tclin,,571,Homo sapiens
215077,5089,3698,T-lymphocyte activation antigen CD80,Surface antigen,P33681,CD80,CD80_HUMAN,7.92,,Kd,Measuring binding of <sup>125</sup>I-labeled B7Ig fusion protein to immobilized abatacept.,IUPHAR,~,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6891,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125118s179lbl.pdf,INHIBITOR,,Tclin,,572,Homo sapiens
215078,5089,3699,T-lymphocyte activation antigen CD86,Surface antigen,P42081,CD86,CD86_HUMAN,7.92,,Kd,Measuring binding of <sup>125</sup>I-labeled B7Ig fusion protein to immobilized abatacept.,IUPHAR,~,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6891,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125118s179lbl.pdf,INHIBITOR,,Tclin,,572,Homo sapiens
215081,5091,3698,T-lymphocyte activation antigen CD80,Surface antigen,P33681,CD80,CD80_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125288s062lbl.pdf,INHIBITOR,,Tclin,,575,Homo sapiens
215082,5091,3699,T-lymphocyte activation antigen CD86,Surface antigen,P42081,CD86,CD86_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125288s062lbl.pdf,INHIBITOR,,Tclin,,575,Homo sapiens
215084,4974,503,Tumor necrosis factor,Cytokine,P01375,TNF,TNFA_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103772s5370lbl.pdf,ANTIBODY BINDING,,Tclin,,247,Homo sapiens
215086,4982,3019,Integrin alpha-4/beta-7,Adhesion,P13612|P26010,ITGA4|ITGB7,ITA4_HUMAN|ITB7_HUMAN,8.300000190734863,,IC50,Mechanism of Action,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7437,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125476s000lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin,,262,Homo sapiens
215079,736,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D03594,http://www.kegg.jp/entry/D03594,AGONIST,,Tclin,,,Homo sapiens
215080,1678,6,DNA,DNA,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207155s000lbl.pdf,CROSS-LINKING AGENT,,,,573,
215088,5083,3405,Interleukin-17A,Cytokine,Q16552,IL17A,IL17_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125521s000lbl.pdf,ANTIBODY BINDING,,Tclin,,576,Homo sapiens
215090,5094,3506,Protective antigen,Secreted,P13423,pagA,PAG_BACAN,9.481486320495605,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125509lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125509lbl.pdf,ANTIBODY BINDING,,,577,577,Bacillus anthracis
215091,5093,133,Interleukin-5,Cytokine,P05113,IL5,IL5_HUMAN,10.091514587402344,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761033lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761033lbl.pdf,ANTIBODY BINDING,,Tclin,578,578,Homo sapiens
215092,5105,3503,Interleukin-1 beta,Cytokine,P01584,IL1B,IL1B_HUMAN,12.301030158996582,,Kd,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125249lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125249lbl.pdf,INHIBITOR,,Tclin,579,579,Homo sapiens
215093,5105,3700,Interleukin-1 alpha,Cytokine,P01583,IL1A,IL1A_HUMAN,11.853872299194336,,Kd,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125249lbl.pdf,,INHIBITOR,,Tchem,579,,Homo sapiens
215094,5105,3701,Interleukin-1 receptor antagonist protein,Unclassified,P18510,IL1RN,IL1RA_HUMAN,11.214670181274414,,Kd,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/125249lbl.pdf,,INHIBITOR,,Tchem,579,,Homo sapiens
215095,5109,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021846s101lbl.pdf,ACTIVATOR,,Tclin,,580,Homo sapiens
215096,5121,14,phosphate,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205109s001lbl.pdf,SEQUESTERING AGENT,,,,581,
215097,5129,3404,glucocerebroside,Metabolite,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020057s034lbl.pdf,HYDROLYTIC ENZYME,,,,582,
215146,1751,3711,Folate receptor alpha,Membrane receptor,P15328,FOLR1,FOLR1_HUMAN,6.940000057220459,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,Tchem,,,Homo sapiens
215147,1605,3710,Sodium-dependent neutral amino acid transporter B(0)AT2,Transporter,Q9H2J7,SLC6A15,S6A15_HUMAN,5.400000095367432,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL998,,,,Tbio,,,Homo sapiens
215148,1328,3703,DNA-3-methyladenine glycosylase,Enzyme,P29372,MPG,3MG_HUMAN,5.519999980926514,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL51483,,,,Tchem,,,Homo sapiens
215149,471,3708,Hepatocyte growth factor activator,Enzyme,Q04756,HGFAC,HGFA_HUMAN,4.489999771118164,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL590799,,,,Tchem,,,Homo sapiens
215150,256,3707,Krueppel-like factor 10,Unclassified,Q13118,KLF10,KLF10_HUMAN,4,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL641,,,,Tbio,,,Homo sapiens
215151,249,3706,Polycomb protein EED,Unclassified,O75530,EED,EED_HUMAN,4.03000020980835,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296419,,,,Tbio,,,Homo sapiens
215164,3535,3207,Neuromedin-U receptor 2,GPCR,Q9GZQ4,NMUR2,NMUR2_HUMAN,5.920000076293945,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226335,,,,Tchem,,,Homo sapiens
215165,3577,3207,Neuromedin-U receptor 2,GPCR,Q9GZQ4,NMUR2,NMUR2_HUMAN,5.179999828338623,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33720,,,,Tchem,,,Homo sapiens
215166,4344,3102,G-protein coupled receptor 39,GPCR,O43194,GPR39,GPR39_HUMAN,8.4399995803833,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200679,,,,Tchem,,,Homo sapiens
215169,1018,2478,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,5.25,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL953,,,,Tchem,,,Homo sapiens
215171,2697,2478,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,5.130000114440918,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1324,,,,Tchem,,,Homo sapiens
215177,947,2435,Lysine-specific demethylase 4E,Enzyme,B2RXH2,KDM4E,KDM4E_HUMAN,5.519999980926514,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,Tchem,,,Homo sapiens
215178,1762,2435,Lysine-specific demethylase 4E,Enzyme,B2RXH2,KDM4E,KDM4E_HUMAN,5.519999980926514,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL459,,,,Tchem,,,Homo sapiens
215197,3514,2314,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Kinase,P48736,PIK3CG,PK3CG_HUMAN,4.860000133514404,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
215198,5110,2303,Glycogen debranching enzyme,Enzyme,P35573,AGL,GDE_HUMAN,5,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,Tbio,,,Homo sapiens
215199,5110,2302,"Sucrase-isomaltase, intestinal",Enzyme,P14410,SI,SUIS_HUMAN,6.590000152587891,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,Tchem,,,Homo sapiens
215200,5110,2288,Non-lysosomal glucosylceramidase,Enzyme,Q9HCG7,GBA2,GBA2_HUMAN,4,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,Tchem,,,Homo sapiens
215204,2446,2278,Peptidyl-prolyl cis-trans isomerase FKBP1B,Enzyme,P68106,FKBP1B,FKB1B_HUMAN,9.699999809265137,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL413,,,,Tchem,,,Homo sapiens
215205,2552,2278,Peptidyl-prolyl cis-trans isomerase FKBP1B,Enzyme,P68106,FKBP1B,FKB1B_HUMAN,9.399999618530273,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL269732,,,,Tchem,,,Homo sapiens
215223,774,2205,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,5.050000190734863,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1554,,,,Tchem,,,Homo sapiens
215248,865,2070,Aldo-keto reductase family 1 member B10,Enzyme,O60218,AKR1B10,AK1BA_HUMAN,5.71999979019165,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,Tchem,,,Homo sapiens
215249,1193,2070,Aldo-keto reductase family 1 member B10,Enzyme,O60218,AKR1B10,AK1BA_HUMAN,6.119999885559082,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL23588,,,,Tchem,,,Homo sapiens
215250,1663,2070,Aldo-keto reductase family 1 member B10,Enzyme,O60218,AKR1B10,AK1BA_HUMAN,5.800000190734863,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686,,,,Tchem,,,Homo sapiens
215253,4878,1984,DNA-dependent protein kinase catalytic subunit,Kinase,P78527,PRKDC,PRKDC_HUMAN,5.170000076293945,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2216870,,,,Tchem,,,Homo sapiens
215256,2722,1696,Nuclear receptor ROR-gamma,Nuclear hormone receptor,P51449,RORC,RORG_HUMAN,6.699999809265137,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,Tchem,,,Homo sapiens
215258,3514,1475,"Glycogen phosphorylase, liver form",Enzyme,P06737,PYGL,PYGL_HUMAN,5.320000171661377,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
215259,1751,1422,Proton-coupled folate transporter,Transporter,Q96NT5,SLC46A1,PCFT_HUMAN,6.920000076293945,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,Tchem,,,Homo sapiens
215260,2353,1422,Proton-coupled folate transporter,Transporter,Q96NT5,SLC46A1,PCFT_HUMAN,7,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071,,,,Tchem,,,Homo sapiens
215261,578,1138,Coagulation factor XIII A chain,Enzyme,P00488,F13A1,F13A_HUMAN,5.400000095367432,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL45627,,,,Tchem,,,Homo sapiens
215271,3601,1026,Gamma-butyrobetaine dioxygenase,Enzyme,O75936,BBOX1,BODG_HUMAN,5.239999771118164,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120563,,,,Tchem,,,Homo sapiens
215278,1616,993,DNA-(apurinic or apyrimidinic site) lyase,Enzyme,P27695,APEX1,APEX1_HUMAN,5.300000190734863,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279014,,,,Tchem,,,Homo sapiens
215281,2797,924,G-protein coupled bile acid receptor 1,GPCR,Q8TDU6,GPBAR1,GPBAR_HUMAN,5.619999885559082,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1551,,,,Tchem,,,Homo sapiens
215284,4466,912,Protein arginine N-methyltransferase 1,Enzyme,Q99873,PRMT1,ANM1_HUMAN,6,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408917,,,,Tchem,,,Homo sapiens
215293,1751,888,Folate receptor beta,Membrane receptor,P14207,FOLR2,FOLR2_HUMAN,6.96999979019165,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426,,,,Tchem,,,Homo sapiens
215295,2073,888,Folate receptor beta,Membrane receptor,P14207,FOLR2,FOLR2_HUMAN,7.21999979019165,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225072,,,,Tchem,,,Homo sapiens
215297,2353,888,Folate receptor beta,Membrane receptor,P14207,FOLR2,FOLR2_HUMAN,7.659999847412109,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL225071,,,,Tchem,,,Homo sapiens
215310,2441,845,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",Enzyme,O60658,PDE8A,PDE8A_HUMAN,4,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tclin,,,Homo sapiens
215313,370,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,4.639999866485596,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL277535,,,,Tchem,,,Homo sapiens
215314,983,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,5.090000152587891,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,,,,Tchem,,,Homo sapiens
215315,1527,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,4.599999904632568,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,Tchem,,,Homo sapiens
215317,1800,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,5.420000076293945,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,Tchem,,,Homo sapiens
215319,2123,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,4.849999904632568,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1089,,,,Tchem,,,Homo sapiens
215320,2434,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,5.079999923706055,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200725,,,,Tchem,,,Homo sapiens
215321,2495,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,5.190000057220459,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1221,,,,Tchem,,,Homo sapiens
215322,3177,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,4.639999866485596,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL356918,,,,Tchem,,,Homo sapiens
215323,3309,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,4.639999866485596,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1571863,,,,Tchem,,,Homo sapiens
215324,3408,833,"Indoleamine 2,3-dioxygenase 1",Enzyme,P14902,IDO1,I23O1_HUMAN,4.550000190734863,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1262,,,,Tchem,,,Homo sapiens
215325,2448,829,Prolyl endopeptidase FAP,Enzyme,Q12884,FAP,SEPR_HUMAN,5.230000019073486,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1422,,,,Tchem,,,Homo sapiens
215333,1547,806,Fatty acid synthase,Enzyme,P49327,FASN,FAS_HUMAN,5.28000020980835,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL480,,,,Tchem,,,Homo sapiens
215336,1990,806,Fatty acid synthase,Enzyme,P49327,FASN,FAS_HUMAN,5.46999979019165,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1503,,,,Tchem,,,Homo sapiens
215338,2054,806,Fatty acid synthase,Enzyme,P49327,FASN,FAS_HUMAN,5.389999866485596,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1502,,,,Tchem,,,Homo sapiens
215340,2350,806,Fatty acid synthase,Enzyme,P49327,FASN,FAS_HUMAN,5.230000019073486,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1219,,,,Tchem,,,Homo sapiens
215360,5110,731,Lysosomal alpha-glucosidase,Enzyme,P10253,GAA,LYAG_HUMAN,5.21999979019165,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,Tclin,,,Homo sapiens
215361,3400,728,Telomerase reverse transcriptase,Enzyme,O14746,TERT,TERT_HUMAN,5.070000171661377,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8659,,,,Tchem,,,Homo sapiens
215363,3514,715,Tyrosine-protein kinase SYK,Kinase,P43405,SYK,KSYK_HUMAN,4.699999809265137,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tclin,,,Homo sapiens
215366,180,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,4.21999979019165,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,Tclin,,,Homo sapiens
215369,2441,693,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Enzyme,O00408,PDE2A,PDE2A_HUMAN,4.199999809265137,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL192,,,,Tclin,,,Homo sapiens
215370,1867,683,Suppressor of tumorigenicity 14 protein,Enzyme,Q9Y5Y6,ST14,ST14_HUMAN,10.699999809265137,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273264,,,,Tchem,,,Homo sapiens
215372,4182,683,Suppressor of tumorigenicity 14 protein,Enzyme,Q9Y5Y6,ST14,ST14_HUMAN,5.46999979019165,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL198362,,,,Tchem,,,Homo sapiens
215376,5062,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,6.039999961853027,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3353410,,,,Tclin,,,Homo sapiens
215377,5144,615,Glucosylceramidase,Enzyme,P04062,GBA,GLCM_HUMAN,4.519999980926514,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200829,,,,Tclin,,,Homo sapiens
215383,4716,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7.590000152587891,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1171837,,,,Tclin,,,Homo sapiens
215396,5118,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.760000228881836,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200528,,,,Tclin,,,Homo sapiens
215400,4716,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,8.520000457763672,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1171837,,,,Tclin,,,Homo sapiens
215402,5110,495,"Maltase-glucoamylase, intestinal",Enzyme,O43451,MGAM,MGA_HUMAN,5.820000171661377,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,Tclin,,,Homo sapiens
215403,4072,432,Tyrosinase,Enzyme,P14679,TYR,TYRO_HUMAN,4.489999771118164,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL196,,,,Tclin,,,Homo sapiens
215404,495,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,7.389999866485596,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3301668,,,,Tclin,,,Homo sapiens
215405,5118,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,5.53000020980835,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200528,,,,Tclin,,,Homo sapiens
215436,2722,380,Nuclear receptor ROR-alpha,Nuclear hormone receptor,P35398,RORA,RORA_HUMAN,6.699999809265137,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL38,,,,Tchem,,,Homo sapiens
215437,2268,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.900000095367432,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897,,,,Tclin,,,Homo sapiens
215438,2268,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,6.440000057220459,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897,,,,Tclin,,,Homo sapiens
215439,1663,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,4.110000133514404,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686,,,,Tclin,,,Homo sapiens
215440,1943,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,5.090000152587891,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1401,,,,Tclin,,,Homo sapiens
215441,1763,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,7.150000095367432,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191083,,,,Tclin,,,Homo sapiens
215442,4921,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,4.349999904632568,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48582,,,,Tclin,,,Homo sapiens
215443,1763,286,Amine oxidase [flavin-containing] B,Enzyme,P27338,MAOB,AOFB_HUMAN,5.360000133514404,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191083,,,,Tclin,,,Homo sapiens
215444,760,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,6.300000190734863,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,,,,Tchem,,,Homo sapiens
215445,1048,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,5.389999866485596,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL532,,,,Tchem,,,Homo sapiens
215446,1314,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,5.28000020980835,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL472,,,,Tchem,,,Homo sapiens
215447,78,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,4.739999771118164,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1131,,,,Tchem,,,Homo sapiens
215448,134,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,5.039999961853027,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54349,,,,Tchem,,,Homo sapiens
215449,392,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,4.420000076293945,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL957,,,,Tchem,,,Homo sapiens
215450,866,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,4.159999847412109,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL893,,,,Tchem,,,Homo sapiens
215451,1261,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,4.940000057220459,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL374975,,,,Tchem,,,Homo sapiens
215452,1297,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,4.650000095367432,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL146095,,,,Tchem,,,Homo sapiens
215453,1890,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,5.380000114440918,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL623,,,,Tchem,,,Homo sapiens
215454,1922,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,4.510000228881836,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,Tchem,,,Homo sapiens
215455,2179,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,6.519999980926514,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595,,,,Tchem,,,Homo sapiens
215456,2241,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,4.010000228881836,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL976,,,,Tchem,,,Homo sapiens
215457,2377,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,4.949999809265137,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL374478,,,,Tchem,,,Homo sapiens
215458,2405,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,5.190000057220459,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,,,,Tchem,,,Homo sapiens
215459,2657,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,4.130000114440918,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL833,,,,Tchem,,,Homo sapiens
215460,2767,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,5.570000171661377,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408,,,,Tchem,,,Homo sapiens
215461,4452,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,5.070000171661377,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1159650,,,,Tchem,,,Homo sapiens
215462,4817,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,5.199999809265137,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL437765,,,,Tchem,,,Homo sapiens
215463,4673,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,7.130000114440918,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267495,,,,Tclin,,,Homo sapiens
215464,2840,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,6.400000095367432,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1042,,,,Tclin,,,Homo sapiens
215465,87,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.889999866485596,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1265,,,,Tclin,,,Homo sapiens
215466,249,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.380000114440918,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296419,,,,Tclin,,,Homo sapiens
215467,647,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,6.489999771118164,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200776,,,,Tclin,,,Homo sapiens
215468,973,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,6.480000019073486,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200969,,,,Tclin,,,Homo sapiens
215469,1222,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.920000076293945,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL46516,,,,Tclin,,,Homo sapiens
215470,1665,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.599999904632568,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL416956,,,,Tclin,,,Homo sapiens
215471,2172,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.769999980926514,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423,,,,Tclin,,,Homo sapiens
215472,2389,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,6.489999771118164,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85,,,,Tclin,,,Homo sapiens
215473,2534,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,6.420000076293945,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15770,,,,Tclin,,,Homo sapiens
215474,2583,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.489999771118164,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1017,,,,Tclin,,,Homo sapiens
215475,4109,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.889999866485596,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465,,,,Tclin,,,Homo sapiens
215476,4654,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.739999771118164,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1946170,,,,Tclin,,,Homo sapiens
215477,2815,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,4.429999828338623,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,Tchem,,,Homo sapiens
215478,1637,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,5.139999866485596,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,Tclin,,,Homo sapiens
215481,2268,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.369999885559082,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL897,,,,Tclin,,,Homo sapiens
215482,4496,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,8.239999771118164,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986,,,,Tchem,,,Homo sapiens
215483,1239,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.789999961853027,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256786,,,,Tclin,,,Homo sapiens
215484,2419,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.980000019073486,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1263,,,,Tclin,,,Homo sapiens
215485,4183,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.980000019073486,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095777,,,,Tclin,,,Homo sapiens
215486,4496,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.460000038146973,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986,,,,Tclin,,,Homo sapiens
215487,4006,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,8.670000076293945,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL350221,,,,Tclin,,,Homo sapiens
215488,4006,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,9.039999961853027,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL350221,,,,Tclin,,,Homo sapiens
215489,946,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.460000038146973,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL502,,,,Tchem,,,Homo sapiens
215490,1571,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.659999847412109,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1514,,,,Tclin,,,Homo sapiens
215491,5062,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.789999961853027,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3353410,,,,Tclin,,,Homo sapiens
215492,4673,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,9.140000343322754,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267495,,,,Tclin,,,Homo sapiens
215493,5060,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,6.039999961853027,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL435298,,,,Tclin,,,Homo sapiens
215500,979,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/8736619,ANTAGONIST,,Tclin,,601,Homo sapiens
215502,311,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D03080,http://www.kegg.jp/entry/D03080,INHIBITOR,,Tclin,,,Homo sapiens
215503,383,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D07532,http://www.kegg.jp/entry/D07532,ANTAGONIST,,Tclin,,,Homo sapiens
215505,4314,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5,,EC50,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
215506,4314,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.7,,EC50,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
215507,4314,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.1,,EC50,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
215508,4314,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.1,,EC50,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
215509,4314,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,4.8,,EC50,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
215510,288,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D07197,http://www.kegg.jp/entry/D07197,ANTAGONIST,,Tclin,,,Homo sapiens
215513,3187,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,8.67,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2821,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2821,AGONIST,,Tclin,,,Homo sapiens
215514,3187,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2821,,AGONIST,,Tclin,,,Homo sapiens
215515,5157,3397,Erythropoietin receptor,Membrane receptor,P19235,EPOR,EPOR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103951s5363lbl.pdf,AGONIST,,Tclin,,604,Homo sapiens
215516,5158,3024,Interferon alpha/beta receptor,Membrane receptor,P17181|P48551,IFNAR1|IFNAR2,INAR1_HUMAN|INAR2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103964s5264lbl.pdf,AGONIST,,Tclin|Tclin,,605,Homo sapiens
215517,5160,3397,Erythropoietin receptor,Membrane receptor,P19235,EPOR,EPOR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000116/WC500024979.pdf,AGONIST,,Tclin,,606,Homo sapiens
215518,5164,3024,Interferon alpha/beta receptor,Membrane receptor,P17181|P48551,IFNAR1|IFNAR2,INAR1_HUMAN|INAR2_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/103949s5299lbl.pdf,AGONIST,,Tclin|Tclin,,607,Homo sapiens
215519,5165,3397,Erythropoietin receptor,Membrane receptor,P19235,EPOR,EPOR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125164s071s072s073lbl.pdf,AGONIST,,Tclin,,608,Homo sapiens
215520,5167,3648,Granulocyte colony-stimulating factor receptor,Membrane receptor,Q99062,CSF3R,CSF3R_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/10776839,ACTIVATOR,,Tclin,,609,Homo sapiens
215521,5169,429,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,,,,,UNKNOWN,,1,KEGG DRUG,,http://www.kegg.jp/entry/D07578,AGONIST,,Tclin,,,Homo sapiens
215522,5170,3397,Erythropoietin receptor,Membrane receptor,P19235,EPOR,EPOR_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000872/WC500054377.pdf,AGONIST,,Tclin,,610,Homo sapiens
215524,4381,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.95,,IC50,Inhibition of the reuptake of [<sup>3</sup>H]5-HT,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7901,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7901,INHIBITOR,,Tclin,,,Homo sapiens
215525,296,596,DNA topoisomerase 1,Enzyme,P11387,TOP1,TOP1_HUMAN,6.561441898345947,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/9875499,http://www.ncbi.nlm.nih.gov/pubmed/9875499,INHIBITOR,,Tclin,612,612,Homo sapiens
215526,5154,2544,Genome polyprotein,Polyprotein,P27958,,POLG_HCVH,10.853872299194336,,EC50,,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,INHIBITOR,,,613,613,Hepatitis C virus genotype 1a (isolate H)
215527,5154,2536,Genome polyprotein,Polyprotein,P26663,,POLG_HCVBK,10.795880317687988,,EC50,,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,INHIBITOR,,,613,613,Hepatitis C virus genotype 1b (isolate BK)
215529,5154,3407,Genome polyprotein,Polyprotein,Q99IB8,,POLG_HCVJF,10.97881031036377,,EC50,,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,INHIBITOR,,,613,613,Hepatitis C virus genotype 2a (isolate JFH-1)
216551,1375,1860,Histamine H1 receptor,GPCR,P31390,Hrh1,HRH1_RAT,5.35,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,,,,Rattus norvegicus
215531,5154,3694,Genome polyprotein,Polyprotein,O39929,,POLG_HCVED,11.045757293701172,,EC50,,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,INHIBITOR,,,613,613,Hepatitis C virus genotype 4a (isolate ED43)
215532,5154,3720,Genome polyprotein,Polyprotein,Q81495,,POLG_HCVK3,11.397939682006836,,EC50,,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,INHIBITOR,,,613,613,Hepatitis C virus genotype 3a (isolate k3a) (HCV)
215533,5154,3721,Genome polyprotein,Polyprotein,Q9DHD6,,POLG_HCVJP,11.397939682006836,,EC50,,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,INHIBITOR,,,613,613,Hepatitis C virus genotype 2b (isolate JPUT971017) (HCV)
215534,5154,3722,Genome polyprotein,Polyprotein,O91936,,POLG_HCVSA,10.425969123840332,,EC50,,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,INHIBITOR,,,613,613,Hepatitis C virus genotype 5a (isolate SA13) (HCV)
215535,5154,3723,Genome polyprotein,Polyprotein,Q5I2N3,,POLG_HCV6A,11.09691047668457,,EC50,,DRUG LABEL,=,1,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,INHIBITOR,,,613,613,Hepatitis C virus genotype 6a (isolate 6a33) (HCV)
215537,1054,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.9,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7178,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7178,ANTAGONIST,,Tclin,,,Homo sapiens
215497,1354,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,Mechanism of Action,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D01743,http://www.kegg.jp/entry/D01743,AGONIST,,Tclin,,,Homo sapiens
215499,5155,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,7.004364967346191,,EC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/12166927,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207999s000lbl.pdf,AGONIST,,Tclin,599,600,Homo sapiens
215802,3294,607,Gastrin/cholecystokinin type B receptor,GPCR,P32239,CCKBR,GASR_HUMAN,5.029978734,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215803,1817,529,Prostaglandin F2-alpha receptor,GPCR,P43088,PTGFR,PF2R_HUMAN,5.027704571,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215804,2863,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.026872146,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215805,435,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,4.795880017,,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
215856,5181,505,Extracellular calcium-sensing receptor,GPCR,P41180,CASR,CASR_HUMAN,4.6,,EC50,Measuring ligand induced IP<sub>1</sub> accumulation.,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8375,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003995/WC500217100.pdf,AGONIST,,Tclin,,627,Homo sapiens
215902,5214,1616,Tryptophan 5-hydroxylase 1,Enzyme,P17752,TPH1,TPH1_HUMAN,7.79587984085083,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/28041831,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208794s000lbl.pdf,INHIBITOR,,Tclin,642,644,Homo sapiens
215903,5216,3690,aspargine,Amino acid,,,,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125359s088lbl.pdf,HYDROLYTIC ENZYME,,,,643,
215904,3911,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,,,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D01273,http://www.kegg.jp/entry/D01273,AGONIST,,Tclin,,,Homo sapiens
215905,4172,3871,Nonstructural protein NS3-4A,Unclassified,A0A0K1CY61,,A0A0K1CY61_9HEPC,7.85,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218394,,,,,,,Hepatitis C virus
215906,4812,3871,Nonstructural protein NS3-4A,Unclassified,A0A0K1CY61,,A0A0K1CY61_9HEPC,9.44,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL501849,,,,,,,Hepatitis C virus
215907,4939,3871,Nonstructural protein NS3-4A,Unclassified,A0A0K1CY61,,A0A0K1CY61_9HEPC,10.3,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL599872,,,,,,,Hepatitis C virus
215908,4344,3883,G protein-coupled receptor 39-1b,Unclassified,A6QR73,Gpr39,A6QR73_RAT,5.39,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200679,,,,,,,Rattus norvegicus
215909,5039,3855,Leukotriene C4 synthase,Unclassified,A6XA80,LTC4S,LTC4S_CAVPO,5.57,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,,,,Cavia porcellus
215910,398,2102,Dihydrofolate reductase,Unclassified,B0BL08,dfrA17,B0BL08_ECOLX,8.53,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31891,,,,,,,Escherichia coli
215911,2723,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,6.76,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL299175,,,,,,,Cavia porcellus
215913,1520,2594,3-oxoacyl-[acyl-carrier-protein] synthase 3,Enzyme,C3TDZ2,fabH,C3TDZ2_ECOLX,5.2,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL176,,,,,,,Escherichia coli
215914,5110,3900,Beta-galactosidase,Unclassified,D3ZUM4,Glb1,D3ZUM4_RAT,4.62,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,,,,Rattus norvegicus
215915,1775,3891,Cytoplasmic zinc-finger protein,Unclassified,G5EF15,pos-1,G5EF15_CAEEL,4.99,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1065,,,,,,,Caenorhabditis elegans
215917,314,3891,Cytoplasmic zinc-finger protein,Unclassified,G5EF15,pos-1,G5EF15_CAEEL,4.43,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096979,,,,,,,Caenorhabditis elegans
215918,228,3891,Cytoplasmic zinc-finger protein,Unclassified,G5EF15,pos-1,G5EF15_CAEEL,4.77,,EC50,Inconclusive,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Caenorhabditis elegans
215919,3500,3891,Cytoplasmic zinc-finger protein,Unclassified,G5EF15,pos-1,G5EF15_CAEEL,5,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267548,,,,,,,Caenorhabditis elegans
215920,1364,3891,Cytoplasmic zinc-finger protein,Unclassified,G5EF15,pos-1,G5EF15_CAEEL,4.34,,EC50,Inconclusive,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496,,,,,,,Caenorhabditis elegans
215921,1637,3891,Cytoplasmic zinc-finger protein,Unclassified,G5EF15,pos-1,G5EF15_CAEEL,4.58,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,,,,Caenorhabditis elegans
215922,533,3891,Cytoplasmic zinc-finger protein,Unclassified,G5EF15,pos-1,G5EF15_CAEEL,4.3,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL927,,,,,,,Caenorhabditis elegans
215923,2144,2029,Voltage-dependent calcium channel subunit alpha-2/delta-1,Ion channel,O08532,Cacna2d1,CA2D1_MOUSE,6.01,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL301523,,,,,,,Mus musculus
215925,302,619,Histone deacetylase 3,Enzyme,O15379,HDAC3,HDAC3_HUMAN,7.6,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL487253,,,,Tclin,,,Homo sapiens
215926,4182,2050,Coagulation factor X,Enzyme,O19045,F10,FA10_RABIT,6.29,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL198362,,,,,,,Oryctolagus cuniculus
215928,1527,3842,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",Unclassified,O35084,Cyp27b1,CP27B_MOUSE,6.44,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,,,,Mus musculus
215932,92,3876,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,Unclassified,O35820,Dnph1,DNPH1_RAT,4.4,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL752,,,,,,,Rattus norvegicus
215933,786,3877,ORF 73,Unclassified,O40947,,O40947_HHV8,5.63,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL178,,,,,,,Human herpesvirus 8
215934,2707,3877,ORF 73,Unclassified,O40947,,O40947_HHV8,5.67,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84,,,,,,,Human herpesvirus 8
215935,4317,3877,ORF 73,Unclassified,O40947,,O40947_HHV8,6.38,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL354349,,,,,,,Human herpesvirus 8
215936,960,3877,ORF 73,Unclassified,O40947,,O40947_HHV8,5.84,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,,,,,,,Human herpesvirus 8
215937,924,3877,ORF 73,Unclassified,O40947,,O40947_HHV8,5.05,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932,,,,,,,Human herpesvirus 8
215938,4127,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,7.82,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11298,,,,,,,Electrophorus electricus
215939,4808,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,6.77,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL130880,,,,,,,Electrophorus electricus
215940,1811,2031,Polyphenol oxidase 2,Enzyme,O42713,PPO2,PPO2_AGABI,5.43,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL245416,,,,,,,Agaricus bisporus
215942,1362,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,6.34,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL399121,,,,Tclin,,,Homo sapiens
215943,893,3856,Equilibrative nucleoside transporter 2,Unclassified,O54699,Slc29a2,S29A2_RAT,5.06,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL126075,,,,,,,Rattus norvegicus
215944,215,3834,Testosterone 17-beta-dehydrogenase 3,Unclassified,O54939,Hsd17b3,DHB3_RAT,6.77,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274826,,,,,,,Rattus norvegicus
215945,78,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.71,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1131,,,,,,,Rattus norvegicus
215946,4452,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.46,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1159650,,,,,,,Rattus norvegicus
215947,2405,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.4,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,,,,,,,Rattus norvegicus
215948,2697,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.33,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1324,,,,,,,Rattus norvegicus
215949,1297,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.49,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL146095,,,,,,,Rattus norvegicus
215950,2534,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.06,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15770,,,,,,,Rattus norvegicus
215951,760,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,6.22,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL160,,,,,,,Rattus norvegicus
215952,1922,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.34,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,,,,Rattus norvegicus
215953,1052,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.94,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218877,,,,,,,Rattus norvegicus
215954,311,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL340978,,,,,,,Rattus norvegicus
215955,2377,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.46,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL374478,,,,,,,Rattus norvegicus
215956,1261,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.76,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL374975,,,,,,,Rattus norvegicus
215957,2767,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.97,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408,,,,,,,Rattus norvegicus
215958,4817,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,5.51,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL437765,,,,,,,Rattus norvegicus
215959,1314,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,5.55,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL472,,,,,,,Rattus norvegicus
215960,134,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.64,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54349,,,,,,,Rattus norvegicus
215961,2179,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,5.7,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL595,,,,,,,Rattus norvegicus
215962,1890,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.76,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL623,,,,,,,Rattus norvegicus
215963,1223,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.1,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL806,,,,,,,Rattus norvegicus
215964,2657,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.31,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL833,,,,,,,Rattus norvegicus
215965,392,3832,Bile salt export pump,Unclassified,O70127,Abcb11,ABCBB_RAT,4.51,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL957,,,,,,,Rattus norvegicus
215966,875,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,4.84,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL411,,,,Tchem,,,Homo sapiens
215967,4305,2549,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O77746,PDE5A,PDE5A_CANFA,8.28,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1963681,,,,,,,Canis familiaris
215968,1052,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,5.39,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218877,,,,Tchem,,,Homo sapiens
215969,4072,3885,Pancreatic alpha-amylase,Unclassified,P00689,Amy2,AMYP_RAT,4.58,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL196,,,,,,,Rattus norvegicus
215971,2852,1626,Cationic trypsin,Enzyme,P00760,,TRY1_BOVIN,7.95,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266349,,,,,,,Bos taurus
215972,1398,3886,Trypsin,Unclassified,P00761,,TRYP_PIG,5.5,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1301,,,,,,,Sus scrofa
215973,4853,3886,Trypsin,Unclassified,P00761,,TRYP_PIG,5.15,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1569545,,,,,,,Sus scrofa
215974,1981,3886,Trypsin,Unclassified,P00761,,TRYP_PIG,5.03,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL4,,,,,,,Sus scrofa
215975,60,3880,Thermolysin,Unclassified,P00800,npr,THER_BACTH,5.02,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10247,,,,,,,Bacillus thermoproteolyticus
215977,4260,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,6.22,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105487,,,,Tclin,,,Homo sapiens
215978,4260,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,4.4,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105487,,,,Tclin,,,Homo sapiens
215979,4209,3887,Beta-casein,Unclassified,P02665,Csn2,CASB_RAT,9.44,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2,,,,,,,Rattus norvegicus
215980,2470,3887,Beta-casein,Unclassified,P02665,Csn2,CASB_RAT,8.81,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
215981,828,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,4.66,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Rattus norvegicus
215982,829,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,4.66,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Rattus norvegicus
215985,1646,2583,Acetylcholine receptor subunit alpha,Ion channel,P02710,CHRNA1,ACHA_TORCA,6.22,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267936,,,,,,,Torpedo californica
215987,4197,465,Retinol-binding protein 4,Secreted,P02753,RBP4,RET4_HUMAN,6.74,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL986,,,,Tchem,,,Homo sapiens
215988,2372,2291,Beta-lactoglobulin,Unclassified,P02754,LGB,LACB_BOVIN,7.44,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL986,,,,,,,Bos taurus
215989,4197,2291,Beta-lactoglobulin,Unclassified,P02754,LGB,LACB_BOVIN,7.44,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL986,,,,,,,Bos taurus
215990,2698,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,4.4,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121626,,,,Tclin,,,Homo sapiens
215992,865,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,6,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139,,,,Tclin,,,Homo sapiens
215993,1285,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,7,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL457,,,,Tclin,,,Homo sapiens
215994,1650,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,4.3,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL509,,,,Tclin,,,Homo sapiens
215996,1925,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,6.59,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL63323,,,,Tclin,,,Homo sapiens
215998,43,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,5.92,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93645,,,,Tclin,,,Homo sapiens
215999,2001,3818,Neuraminidase,Unclassified,P03469,NA,NRAM_I77AB,8.86,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,,,,,,,Influenza A virus (strain A/USSR/90/1977 H1N1)
216003,3535,3818,Neuraminidase,Unclassified,P03469,NA,NRAM_I77AB,4.02,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226335,,,,,,,Influenza A virus (strain A/USSR/90/1977 H1N1)
216008,2001,2489,Neuraminidase,Enzyme,P03470,NA,NRAM_I33A0,6.32,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,,,,,,,Influenza A virus (strain A/Wilson-Smith/1933 H1N1)
216011,4801,537,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,6.82,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2028663,,,,Tclin,,,Homo sapiens
216012,3186,955,Acetylcholinesterase,Enzyme,P04058,ache,ACES_TORCA,5.76,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL123248,,,,,,,Torpedo californica
216013,828,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.26,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
216014,829,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.26,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
216926,1581,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,,,,,KEGG DRUG,,1,KEGG DRUG,http://www.kegg.jp/entry/D02722,http://www.kegg.jp/entry/D02722,AGONIST,,Tclin,,,Homo sapiens
216928,3224,554,Plasminogen activator inhibitor 1,Secreted,P05121,SERPINE1,PAI1_HUMAN,4.823908805847168,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/12152654,,INHIBITOR,,Tchem,646,,Homo sapiens
216930,1523,2925,Glutamate receptor ionotropic AMPA,Ion channel,P42261|P42262|P42263|P48058,GRIA1|GRIA2|GRIA3|GRIA4,GRIA1_HUMAN|GRIA2_HUMAN|GRIA3_HUMAN|GRIA4_HUMAN,,,,"antidepressant action of (2R,6R)-HNK metabolite",SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/27144355,http://www.ncbi.nlm.nih.gov/pubmed/27144355,OPENER,,Tclin|Tclin|Tclin|Tclin,649,649,Homo sapiens
216931,5218,2322,Cyclin-dependent kinase 4,Kinase,P11802,CDK4,CDK4_HUMAN,8,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25941111,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209092s000lbl.pdf,INHIBITOR,,Tclin,651,650,Homo sapiens
216932,5218,1950,Cyclin-dependent kinase 6,Kinase,Q00534,CDK6,CDK6_HUMAN,7.408935546875,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25941111,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209092s000lbl.pdf,INHIBITOR,,Tclin,651,650,Homo sapiens
216933,5221,3714,Programmed cell death 1 ligand 1,CD molecules,Q9NZQ7,CD274,PD1L1_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761049s000lbl.pdf,ANTIBODY BINDING,,Tclin,,654,Homo sapiens
216934,5222,699,Poly [ADP-ribose] polymerase 1,Enzyme,P09874,PARP1,PARP1_HUMAN,8.42,,IC50,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8275,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208447lbl.pdf,INHIBITOR,,Tclin,,653,Homo sapiens
216935,5222,34,Poly [ADP-ribose] polymerase 2,Enzyme,Q9UGN5,PARP2,PARP2_HUMAN,8.68,,IC50,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8275,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208447lbl.pdf,INHIBITOR,,Tclin,,653,Homo sapiens
216936,5220,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208854s000lbl.pdf,ANTAGONIST,,Tclin,,652,Homo sapiens
216937,5223,3502,B-lymphocyte antigen CD20,Surface antigen,P11836,MS4A1,CD20_HUMAN,9.08,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7580,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761053lbl.pdf,ANTIBODY BINDING,,Tclin,,655,Homo sapiens
216938,5224,3910,Interleukin-4 receptor subunit alpha,Membrane receptor,P24394,IL4R,IL4RA_HUMAN,11.06,,IC50,Value derived from an ELISA-based solution competition assay.,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7574,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761055lbl.pdf,ANTIBODY BINDING,,Tclin,,656,Homo sapiens
216939,5226,320,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208082s000lbl.pdf,INHIBITOR,,Tclin,,657,Homo sapiens
216940,5227,320,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,8.522878646850586,,Ki,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209241lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209241lbl.pdf,INHIBITOR,,Tclin,658,658,Homo sapiens
216220,5039,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,6.46,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,,,,Rattus norvegicus
216221,1971,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,5.82,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445,,,,Tclin,,,Homo sapiens
216223,181,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,5,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL627,,,,Tclin,,,Homo sapiens
216224,180,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,Tclin,,,Homo sapiens
216225,751,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.52,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL669,,,,Tclin,,,Homo sapiens
216226,60,3830,Neprilysin,Unclassified,P08049,MME,NEP_RABIT,8.4,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10247,,,,,,,Oryctolagus cuniculus
216231,903,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.35,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22108,,,,Tclin,,,Homo sapiens
216232,903,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.39,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22108,,,,Tclin,,,Homo sapiens
216233,1440,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,4.49,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6,,,,Tchem,,,Homo sapiens
216235,2279,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,7.38,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL103,,,,Tbio,,,Homo sapiens
216236,4189,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,7.74,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1062,,,,Tbio,,,Homo sapiens
216237,4213,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,7.55,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1091,,,,Tbio,,,Homo sapiens
216238,734,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,6.89,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1650,,,,Tbio,,,Homo sapiens
216239,2245,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,7.51,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,Tbio,,,Homo sapiens
216240,1057,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL135,,,,Tbio,,,Homo sapiens
216241,3188,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1405,,,,Tbio,,,Homo sapiens
216242,820,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,7.65,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1498,,,,Tbio,,,Homo sapiens
216243,1067,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482,,,,Tbio,,,Homo sapiens
216244,3187,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482,,,,Tbio,,,Homo sapiens
216245,2256,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,5.23,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL253363,,,,Tbio,,,Homo sapiens
216246,111,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,6.28,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL273453,,,,Tbio,,,Homo sapiens
216247,215,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,5.76,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL274826,,,,Tbio,,,Homo sapiens
216248,3927,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,5.92,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27769,,,,Tbio,,,Homo sapiens
216249,2607,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,6.72,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL386630,,,,Tbio,,,Homo sapiens
216250,214,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440283,,,,Tbio,,,Homo sapiens
216251,1879,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,6.14,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757,,,,Tbio,,,Homo sapiens
216252,795,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90593,,,,Tbio,,,Homo sapiens
216253,828,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,7.48,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
216254,829,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,7.48,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
216167,4285,3861,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,8.54,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL578378,,,,,,,Homo sapiens
216168,1763,3861,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,6.26,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL191083,,,,,,,Homo sapiens
216169,4818,3861,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,8.65,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL566752,,,,,,,Homo sapiens
216170,522,3861,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,4.52,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723,,,,,,,Homo sapiens
216171,2308,566,Myeloperoxidase,Enzyme,P05164,MPO,PERM_HUMAN,5.55,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1518,,,,Tchem,,,Homo sapiens
216173,2245,372,Interleukin-6,Cytokine,P05231,IL6,IL6_HUMAN,8.38,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,Tclin,,,Homo sapiens
216174,5174,3906,Intercellular adhesion molecule 1,Unclassified,P05362,ICAM1,ICAM1_HUMAN,8.53,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2048028,,,,,,,Homo sapiens
216175,1829,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,8.85,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL259972,,,,,,,Ovis aries
216176,1528,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,6.1,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL571,,,,,,,Ovis aries
216177,109,2051,Muscarinic acetylcholine receptor M2,GPCR,P06199,CHRM2,ACM2_PIG,8.7,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120476,,,,,,,Sus scrofa
216178,2815,2051,Muscarinic acetylcholine receptor M2,GPCR,P06199,CHRM2,ACM2_PIG,4.51,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,,,,Sus scrofa
216179,1255,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.68,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358,,,,Tclin,,,Homo sapiens
216180,828,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.25,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
216181,829,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.25,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
216184,2561,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.89,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,,,,Tclin,,,Homo sapiens
216185,4452,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,8.5,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1159650,,,,,,,Rattus norvegicus
216186,4554,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,8.3,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1473,,,,,,,Rattus norvegicus
216188,828,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,7.66,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Rattus norvegicus
216189,829,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,7.66,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Rattus norvegicus
216192,3972,3888,Sodium/potassium-transporting ATPase subunit alpha-1,Unclassified,P06685,Atp1a1,AT1A1_RAT,5.08,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200633,,,,,,,Rattus norvegicus
216193,2332,3831,Beta-hexosaminidase subunit alpha,Unclassified,P06865,HEXA,HEXA_HUMAN,5.51,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36,,,,,,,Homo sapiens
216198,3630,3884,Epoxide hydrolase 1,Unclassified,P07099,EPHX1,HYEP_HUMAN,6.92,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1076347,,,,,,,Homo sapiens
216199,4988,3864,Steroid Delta-isomerase,Unclassified,P07445,ksi,SDIS_PSEPU,4.8,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL406393,,,,,,,Pseudomonas putida
216201,784,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.21,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1346,,,,Tclin,,,Homo sapiens
216203,2332,3862,Beta-hexosaminidase subunit beta,Unclassified,P07686,HEXB,HEXB_HUMAN,5.35,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36,,,,,,,Homo sapiens
216205,60,1894,Neprilysin,Enzyme,P07861,Mme,NEP_RAT,8.32,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10247,,,,,,,Rattus norvegicus
216271,784,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.5,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1346,,,,Tclin,,,Homo sapiens
216273,1187,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,5.1,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106,,,,Tclin,,,Homo sapiens
216274,2846,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.89,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL638,,,,Tclin,,,Homo sapiens
216275,242,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,7.59,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,,,,,,,Rattus norvegicus
216276,903,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.1,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22108,,,,Tclin,,,Homo sapiens
216277,2807,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.3,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL262777,,,,Tclin,,,Homo sapiens
216278,1209,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8.2,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41,,,,Tclin,,,Homo sapiens
216279,1561,3903,"Alkaline phosphatase, tissue-nonspecific isozyme",Unclassified,P09487,ALPL,PPBT_BOVIN,4.72,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1454,,,,,,,Bos taurus
216281,1974,3857,DNA gyrase subunit B,Unclassified,P0A0K8,gyrB,GYRB_STAAU,6.9,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL36506,,,,,,,Staphylococcus aureus
216282,1519,3826,3-oxoacyl-[acyl-carrier-protein] synthase 3,Unclassified,P0A6R0,fabH,FABH_ECOLI,5.17,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1384,,,,,,,Escherichia coli (strain K12)
216283,1286,164,DNA topoisomerase 4 subunit A,Enzyme,P0C1U9,parC,PARC_STAAU,6.52,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL430,,,,,,,Staphylococcus aureus
216284,828,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,5.85,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
216285,829,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,5.85,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
216286,4185,3824,Serine/threonine-protein kinase A-Raf,Kinase,P10398,ARAF,ARAF_HUMAN,6.02,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1229517,,,,,,,Homo sapiens
216287,4801,3824,Serine/threonine-protein kinase A-Raf,Kinase,P10398,ARAF,ARAF_HUMAN,7.59,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2028663,,,,,,,Homo sapiens
216288,903,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.58,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22108,,,,Tclin,,,Homo sapiens
216289,3972,3865,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,Unclassified,P11507,Atp2a2,AT2A2_RAT,5.17,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200633,,,,,,,Rattus norvegicus
216290,1187,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.54,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106,,,,Tchem,,,Homo sapiens
216291,2846,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.85,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL638,,,,Tchem,,,Homo sapiens
216292,1067,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.06,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482,,,,,,,Oryctolagus cuniculus
216293,5039,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,6.57,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,,,,Oryctolagus cuniculus
216294,60,125,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,6.5,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10247,,,,Tclin,,,Homo sapiens
216296,60,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,6.38,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10247,,,,,,,Oryctolagus cuniculus
216297,2866,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,9.4,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16332,,,,,,,Oryctolagus cuniculus
216298,1005,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,6.1,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL578,,,,,,,Oryctolagus cuniculus
216304,1245,1710,Angiotensin-converting enzyme,Enzyme,P12822,ACE,ACE_RABIT,8.82,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL581,,,,,,,Oryctolagus cuniculus
216305,784,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,4.6,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1346,,,,Tclin,,,Homo sapiens
216306,717,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.31,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL304902,,,,Tclin,,,Homo sapiens
216307,1374,432,Tyrosinase,Enzyme,P14679,TYR,TYRO_HUMAN,6.25,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL443605,,,,Tclin,,,Homo sapiens
216308,3883,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,7.62,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL136711,,,,,,,Rattus norvegicus
216309,1830,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,5.85,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460,,,,,,,Rattus norvegicus
216311,2865,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,9.38,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL708,,,,,,,Rattus norvegicus
216312,564,2567,D-amino-acid oxidase,Enzyme,P14920,DAO,OXDA_HUMAN,5,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL161,,,,Tchem,,,Homo sapiens
216313,5003,3822,Insulin receptor,Unclassified,P15127,Insr,INSR_RAT,8.71,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201539,,,,,,,Rattus norvegicus
216315,766,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.74,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139835,,,,,,,Rattus norvegicus
216319,5065,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,8.58,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL197309,,,,,,,Rattus norvegicus
216320,828,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.09,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Rattus norvegicus
216321,829,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.09,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Rattus norvegicus
216326,1791,3881,"Cytochrome P450 11B1, mitochondrial",Unclassified,P15393,Cyp11b1,C11B1_RAT,5.34,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL934,,,,,,,Rattus norvegicus
216327,1126,3838,"Cytochrome P450 11B2, mitochondrial",Unclassified,P15539,Cyp11b2,C11B2_MOUSE,6.72,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9298,,,,,,,Mus musculus
216328,2803,1756,Aldose reductase,Enzyme,P16116,AKR1B1,ALDR_BOVIN,4.24,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109,,,,,,,Bos taurus
216329,2958,3846,Lutropin-choriogonadotropic hormone receptor,Unclassified,P16235,Lhcgr,LSHR_RAT,8.9,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1007,,,,,,,Rattus norvegicus
216330,4660,2608,Muscarinic acetylcholine receptor DM1,GPCR,P16395,mAChR-A,ACM1_DROME,8.62,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516476,,,,,,,Drosophila melanogaster
216332,2807,3848,UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase,Unclassified,P17443,murG,MURG_ECOLI,5,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL262777,,,,,,,Escherichia coli (strain K12)
216334,1499,1803,Beta-1 adrenergic receptor,GPCR,P18090,Adrb1,ADRB1_RAT,6.22,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL434,,,,,,,Rattus norvegicus
216338,2146,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,6.03,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215,,,,,,,Bos taurus
216339,1960,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,6.35,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Bos taurus
216340,2470,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,7.87,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Bos taurus
216341,2032,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,7.88,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,,,,Bos taurus
216342,2562,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,9.9,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL836,,,,,,,Bos taurus
216343,2146,2000,Alpha-1B adrenergic receptor,GPCR,P18841,ADRA1B,ADA1B_MESAU,5.9,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215,,,,,,,Mesocricetus auratus
216344,1960,2000,Alpha-1B adrenergic receptor,GPCR,P18841,ADRA1B,ADA1B_MESAU,6.58,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1437,,,,,,,Mesocricetus auratus
216345,2032,2000,Alpha-1B adrenergic receptor,GPCR,P18841,ADRA1B,ADA1B_MESAU,6.69,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,,,,Mesocricetus auratus
216346,3883,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,6.37,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL136711,,,,,,,Rattus norvegicus
216347,1830,1810,D(1A) dopamine receptor,GPCR,P18901,Drd1,DRD1_RAT,5.8,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460,,,,,,,Rattus norvegicus
216348,242,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,7.42,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,,,,,,,Rattus norvegicus
216349,2715,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,4.89,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1179,,,,,,,Rattus norvegicus
216350,5037,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,8.8,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2024517,,,,,,,Rattus norvegicus
216351,2144,3638,Intestinal alkaline phosphatase,Unclassified,P19111,ALPI,PPBI_BOVIN,4.1,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL301523,,,,,,,Bos taurus
216352,719,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,4.75,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,,,,Rattus norvegicus
216354,1775,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,7.27,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1065,,,,,,,Rattus norvegicus
216356,966,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.62,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108,,,,,,,Rattus norvegicus
216358,2422,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.37,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL114,,,,,,,Rattus norvegicus
216360,1042,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.09,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119443,,,,,,,Rattus norvegicus
216362,781,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.69,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201044,,,,,,,Rattus norvegicus
216364,431,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.54,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177,,,,,,,Rattus norvegicus
216366,1764,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.39,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200843,,,,,,,Rattus norvegicus
216368,887,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,9.14,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601773,,,,,,,Rattus norvegicus
216370,3408,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.25,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1262,,,,,,,Rattus norvegicus
216372,2078,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.62,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1290,,,,,,,Rattus norvegicus
216373,1786,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL13,,,,,,,Rattus norvegicus
216374,704,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.27,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134,,,,,,,Rattus norvegicus
216376,885,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.58,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1403281,,,,,,,Rattus norvegicus
216378,3659,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.9,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Rattus norvegicus
216380,1588,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,9.33,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157138,,,,,,,Rattus norvegicus
216382,888,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,9.18,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1732,,,,,,,Rattus norvegicus
216384,2180,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.75,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1909072,,,,,,,Rattus norvegicus
216386,1856,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.15,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19236,,,,,,,Rattus norvegicus
216388,255,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24,,,,,,,Rattus norvegicus
216389,832,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.47,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL248702,,,,,,,Rattus norvegicus
216391,137,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.93,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266195,,,,,,,Rattus norvegicus
216392,894,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.53,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27193,,,,,,,Rattus norvegicus
216393,569,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.05,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL27810,,,,,,,Rattus norvegicus
216394,3032,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.26,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290106,,,,,,,Rattus norvegicus
216396,249,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.12,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296419,,,,,,,Rattus norvegicus
216398,1200,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.37,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,,,,,,,Rattus norvegicus
216400,389,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.57,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL357995,,,,,,,Rattus norvegicus
216402,3952,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.68,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL420,,,,,,,Rattus norvegicus
216404,1531,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.41,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429,,,,,,,Rattus norvegicus
216406,654,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.97,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL43064,,,,,,,Rattus norvegicus
216408,1043,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,9.11,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442,,,,,,,Rattus norvegicus
216410,1971,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.73,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445,,,,,,,Rattus norvegicus
216412,673,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.58,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL49080,,,,,,,Rattus norvegicus
216414,403,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.25,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL493,,,,,,,Rattus norvegicus
216416,4061,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.21,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499,,,,,,,Rattus norvegicus
216419,765,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.91,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Rattus norvegicus
216421,2105,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,7.82,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL531,,,,,,,Rattus norvegicus
216423,1530,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.6,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL534,,,,,,,Rattus norvegicus
216425,2027,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,7.03,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL546,,,,,,,Rattus norvegicus
216426,663,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,4.3,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL549,,,,,,,Rattus norvegicus
216427,2284,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.29,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,,,,,,,Rattus norvegicus
216429,2536,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.26,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL404849,,,,,,,Rattus norvegicus
216431,2717,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.65,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL621,,,,,,,Rattus norvegicus
216434,180,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.7,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL629,,,,,,,Rattus norvegicus
216436,2291,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.79,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL631,,,,,,,Rattus norvegicus
216438,40,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL642,,,,,,,Rattus norvegicus
216439,2286,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.59,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643,,,,,,,Rattus norvegicus
216441,2815,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.52,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,,,,Rattus norvegicus
216443,522,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723,,,,,,,Rattus norvegicus
216446,1212,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.78,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL726,,,,,,,Rattus norvegicus
216448,2274,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.02,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL728,,,,,,,Rattus norvegicus
216450,2032,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.25,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,,,,Rattus norvegicus
216452,983,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,4.79,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,,,,,,,Rattus norvegicus
216454,2561,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,4.92,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,,,,,,,Rattus norvegicus
216456,395,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.59,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL844,,,,,,,Rattus norvegicus
216458,1800,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,4.94,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL91,,,,,,,Rattus norvegicus
216460,2149,1733,Alpha-2B adrenergic receptor,GPCR,P19328,Adra2b,ADA2B_RAT,6.58,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL61006,,,,,,,Rattus norvegicus
216461,1310,2104,Glutamate receptor 1,Ion channel,P19490,Gria1,GRIA1_RAT,4.46,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216464,1310,1204,Glutamate receptor 2,Ion channel,P19491,Gria2,GRIA2_RAT,6.55,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216467,1310,2105,Glutamate receptor 3,Ion channel,P19492,Gria3,GRIA3_RAT,4,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216471,1310,2106,Glutamate receptor 4,Ion channel,P19493,Gria4,GRIA4_RAT,4.77,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216474,60,3843,Neprilysin,Unclassified,P19621,MME,NEP_PIG,8.21,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10247,,,,,,,Sus scrofa
216475,4671,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,5.83,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266155,,,,,,,Rattus norvegicus
216476,729,3873,Adenylate cyclase type 1,Unclassified,P19754,ADCY1,ADCY1_BOVIN,7.54,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52606,,,,,,,Bos taurus
216477,1862,1811,Cannabinoid receptor 1,GPCR,P20272,Cnr1,CNR1_RAT,8.66,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL947,,,,,,,Rattus norvegicus
216478,903,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.72,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22108,,,,Tclin,,,Homo sapiens
216479,4671,1817,Amine oxidase [flavin-containing] A,Enzyme,P21396,Maoa,AOFA_RAT,4.86,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266155,,,,,,,Rattus norvegicus
216480,392,3858,Endothelin B receptor,Unclassified,P21451,Ednrb,EDNRB_RAT,7.02,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL957,,,,,,,Rattus norvegicus
216481,2402,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,4.49,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL589,,,,Tclin,,,Homo sapiens
216482,4810,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.55,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1873475,,,,Tclin,,,Homo sapiens
216483,2402,109,D(1B) dopamine receptor,GPCR,P21918,DRD5,DRD5_HUMAN,4.38,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL589,,,,Tchem,,,Homo sapiens
216484,1362,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.99,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL399121,,,,Tclin,,,Homo sapiens
216485,1310,1987,"Glutamate receptor ionotropic, kainate 1",Ion channel,P22756,Grik1,GRIK1_RAT,6.85,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216490,1310,3895,Metabotropic glutamate receptor 1,Unclassified,P23385,Grm1,GRM1_RAT,5,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216498,1262,3909,Gamma-aminobutyric acid receptor subunit gamma-1,Ion channel,P23574,Gabrg1,GBRG1_RAT,7.48,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,,,,Rattus norvegicus
216499,1262,2146,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P23576,Gabra2,GBRA2_RAT,7.66,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,,,,Rattus norvegicus
216500,2470,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,7.66,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267930,,,,,,,Rattus norvegicus
216501,2032,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,6.48,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,,,,Rattus norvegicus
216502,1117,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,6.63,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1412355,,,,,,,Rattus norvegicus
216503,1262,1937,Sodium- and chloride-dependent GABA transporter 1,Transporter,P23978,Slc6a1,SC6A1_RAT,5.59,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,,,,Rattus norvegicus
216517,766,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,8.3,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139835,,,,,,,Rattus norvegicus
216521,475,1815,Type-1 angiotensin II receptor,GPCR,P25104,AGTR1,AGTR1_BOVIN,6.96,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,,,,Bos taurus
216524,1985,1815,Type-1 angiotensin II receptor,GPCR,P25104,AGTR1,AGTR1_BOVIN,8.09,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1516,,,,,,,Bos taurus
216527,4322,1815,Type-1 angiotensin II receptor,GPCR,P25104,AGTR1,AGTR1_BOVIN,6.38,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL57242,,,,,,,Bos taurus
216528,1631,2293,Cruzipain,Enzyme,P25779,,CYSP_TRYCR,5.22,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1085699,,,,,,,Trypanosoma cruzi
216529,2459,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,7.74,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
216530,4006,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,6.89,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL350221,,,,Tclin,,,Homo sapiens
216531,2459,1712,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.96,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,Tchem,,,Homo sapiens
216532,787,3519,Creatine transporter,Unclassified,P28570,Slc6a8,SC6A8_RAT,4.68,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1135,,,,,,,Rattus norvegicus
216533,5054,785,Dipeptidyl peptidase 4,Enzyme,P28843,Dpp4,DPP4_MOUSE,7.36,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105762,,,,,,,Mus musculus
216534,1153,3424,Adenosine A2b receptor,GPCR,P29276,Adora2b,AA2BR_RAT,7.45,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL588,,,,,,,Rattus norvegicus
216535,947,3424,Adenosine A2b receptor,GPCR,P29276,Adora2b,AA2BR_RAT,6.01,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Rattus norvegicus
216536,558,3481,Protein-tyrosine phosphatase 1C,Enzyme,P29350,PTPN6,PTN6_HUMAN,4.68,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1343544,,,,Tchem,,,Homo sapiens
216537,1982,1878,D(4) dopamine receptor,GPCR,P30729,Drd4,DRD4_RAT,7.3,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
216538,1276,206,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,P31213,SRD5A2,S5A2_HUMAN,4.85,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL464982,,,,Tclin,,,Homo sapiens
216539,242,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,7,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112,,,,,,,Cavia porcellus
216540,1707,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,8,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL73451,,,,,,,Cavia porcellus
216542,1353,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,6.4,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54,,,,,,,Cavia porcellus
216543,1796,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,9.07,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6437,,,,,,,Cavia porcellus
216544,2865,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,7.8,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL708,,,,,,,Cavia porcellus
216552,1310,3896,Metabotropic glutamate receptor 2,Unclassified,P31421,Grm2,GRM2_RAT,5.4,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216556,1310,3898,Metabotropic glutamate receptor 3,Unclassified,P31422,Grm3,GRM3_RAT,5.52,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216557,1310,1995,Metabotropic glutamate receptor 4,GPCR,P31423,Grm4,GRM4_RAT,4.92,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216563,1310,3892,Metabotropic glutamate receptor 5,Unclassified,P31424,Grm5,GRM5_RAT,5.36,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216569,1262,3835,Sodium- and chloride-dependent GABA transporter 2,Unclassified,P31646,Slc6a13,S6A13_RAT,5.3,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,,,,Rattus norvegicus
216570,1262,2054,Sodium- and chloride-dependent GABA transporter 1,Transporter,P31648,Slc6a1,SC6A1_MOUSE,5.14,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,,,,Mus musculus
216574,1262,3836,Sodium- and chloride-dependent GABA transporter 2,Unclassified,P31649,Slc6a13,S6A13_MOUSE,4.56,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,,,,Mus musculus
216576,1262,3821,Sodium- and chloride-dependent GABA transporter 3,Unclassified,P31650,Slc6a11,S6A11_MOUSE,5.09,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,,,,Mus musculus
216578,1117,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,7.63,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1412355,,,,,,,Rattus norvegicus
216579,1187,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.09,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL106,,,,Tchem,,,Homo sapiens
216580,2846,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,4.82,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL638,,,,Tchem,,,Homo sapiens
216581,5001,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,8.89,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2159122,,,,,,,Rattus norvegicus
216582,4673,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,9.43,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267495,,,,,,,Rattus norvegicus
216583,4673,1857,Kappa-type opioid receptor,GPCR,P33534,Oprk1,OPRK_MOUSE,9.75,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267495,,,,,,,Mus musculus
216584,5001,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,9.05,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2159122,,,,,,,Rattus norvegicus
216585,475,2419,Type-1 angiotensin II receptor,GPCR,P34976,AGTR1,AGTR1_RABIT,9.19,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1014,,,,,,,Oryctolagus cuniculus
216587,2381,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.05,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL289480,,,,Tclin,,,Homo sapiens
216589,395,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.55,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL844,,,,Tclin,,,Homo sapiens
216590,1310,1996,Metabotropic glutamate receptor 6,GPCR,P35349,Grm6,GRM6_RAT,4.8,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216593,903,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.16,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22108,,,,Tclin,,,Homo sapiens
216594,395,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,5.27,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL844,,,,Tclin,,,Homo sapiens
216595,1310,1372,"Glutamate receptor ionotropic, NMDA 1",Ion channel,P35439,Grin1,NMDZ1_RAT,5.54,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216599,1794,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,4.96,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,,,,Tclin,,,Homo sapiens
216600,4185,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,6.44,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1229517,,,,Tclin,,,Homo sapiens
216601,2405,1900,Peroxisome proliferator-activated receptor gamma,Transcription factor,P37238,Pparg,PPARG_MOUSE,7.52,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL121,,,,,,,Mus musculus
216602,701,3859,Trypanothione reductase,Unclassified,P39051,TPR,TYTR_TRYBB,5.47,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL415,,,,,,,Trypanosoma brucei brucei
216603,1310,1789,"Glutamate receptor ionotropic, kainate 2",Ion channel,P42260,Grik2,GRIK2_RAT,5.48,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216612,1310,2114,"Glutamate receptor ionotropic, kainate 3",Ion channel,P42264,Grik3,GRIK3_RAT,6.31,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216616,1164,1758,Mu-type opioid receptor,GPCR,P42866,Oprm1,OPRM_MOUSE,8.23,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596,,,,,,,Mus musculus
216617,60,3860,Endothelin-converting enzyme 1,Unclassified,P42892,ECE1,ECE1_HUMAN,8.1,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10247,,,,,,,Homo sapiens
216618,719,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,4.58,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL104,,,,,,,Rattus norvegicus
216620,966,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.78,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108,,,,,,,Rattus norvegicus
216622,191,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.45,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113,,,,,,,Rattus norvegicus
216624,333,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.85,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200383,,,,,,,Rattus norvegicus
216626,781,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.02,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201044,,,,,,,Rattus norvegicus
216628,887,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.79,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL601773,,,,,,,Rattus norvegicus
216630,2599,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,4.88,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1306,,,,,,,Rattus norvegicus
216632,885,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.96,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1403281,,,,,,,Rattus norvegicus
216634,3659,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.91,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15245,,,,,,,Rattus norvegicus
216636,1588,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.64,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157138,,,,,,,Rattus norvegicus
216638,671,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.28,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1626,,,,,,,Rattus norvegicus
216640,888,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.3,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1732,,,,,,,Rattus norvegicus
216642,2180,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.29,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1909072,,,,,,,Rattus norvegicus
216644,1723,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.02,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19215,,,,,,,Rattus norvegicus
216646,1634,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.25,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21731,,,,,,,Rattus norvegicus
216648,945,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.55,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL219916,,,,,,,Rattus norvegicus
216650,1527,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,4.45,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL157101,,,,,,,Rattus norvegicus
216652,249,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.62,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296419,,,,,,,Rattus norvegicus
216654,1200,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.96,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,,,,,,,Rattus norvegicus
216656,977,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.58,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL305660,,,,,,,Rattus norvegicus
216658,1688,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.84,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395110,,,,,,,Rattus norvegicus
216660,875,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,4.71,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL411,,,,,,,Rattus norvegicus
216662,3952,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.41,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL420,,,,,,,Rattus norvegicus
216664,1531,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.24,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429,,,,,,,Rattus norvegicus
216666,654,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.72,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL43064,,,,,,,Rattus norvegicus
216668,1043,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.09,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL442,,,,,,,Rattus norvegicus
216670,2637,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.29,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479,,,,,,,Rattus norvegicus
216672,403,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.16,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL493,,,,,,,Rattus norvegicus
216674,1001,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.19,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50588,,,,,,,Rattus norvegicus
216676,765,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.62,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Rattus norvegicus
216678,2105,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.71,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL531,,,,,,,Rattus norvegicus
216680,663,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.76,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL549,,,,,,,Rattus norvegicus
216682,2090,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.92,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL55,,,,,,,Rattus norvegicus
216684,2284,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.03,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL564,,,,,,,Rattus norvegicus
216686,2142,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.96,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL597,,,,,,,Rattus norvegicus
216688,2717,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.93,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL621,,,,,,,Rattus norvegicus
216690,2291,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.21,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL631,,,,,,,Rattus norvegicus
216692,2286,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.1,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL643,,,,,,,Rattus norvegicus
216694,1028,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.2,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,,,,,,,Rattus norvegicus
216696,2815,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.68,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280,,,,,,,Rattus norvegicus
216698,954,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.81,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL707,,,,,,,Rattus norvegicus
216700,621,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.07,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71,,,,,,,Rattus norvegicus
216702,1982,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.19,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,,,,,,,Rattus norvegicus
216705,2337,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.06,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL716,,,,,,,Rattus norvegicus
216707,522,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.11,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723,,,,,,,Rattus norvegicus
216709,1212,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.62,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL726,,,,,,,Rattus norvegicus
216711,2274,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.49,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL728,,,,,,,Rattus norvegicus
216713,2032,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.19,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL762,,,,,,,Rattus norvegicus
216716,983,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,4.67,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL808,,,,,,,Rattus norvegicus
216718,2351,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.66,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL81,,,,,,,Rattus norvegicus
216720,2561,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,4.66,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL83,,,,,,,Rattus norvegicus
216722,1599,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.21,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL841,,,,,,,Rattus norvegicus
216724,1343,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.87,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL862,,,,,,,Rattus norvegicus
216726,937,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,6.96,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,,,,,,,Rattus norvegicus
216728,2551,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.56,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL95,,,,,,,Rattus norvegicus
216730,1362,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,8.48,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL399121,,,,Tclin,,,Homo sapiens
216731,4349,171,5-hydroxytryptamine receptor 3A,Ion channel,P46098,HTR3A,5HT3A_HUMAN,10.5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1189679,,,,Tclin,,,Homo sapiens
216734,1531,3837,CAAX prenyl protease 1,Unclassified,P47154,STE24,STE24_YEAST,5.11,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
216735,1981,3837,CAAX prenyl protease 1,Unclassified,P47154,STE24,STE24_YEAST,5.71,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL4,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
216736,1310,3854,Metabotropic glutamate receptor 8,Unclassified,P47743,Grm8,GRM8_MOUSE,7.66,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Mus musculus
216737,2866,1792,Angiotensin-converting enzyme,Enzyme,P47820,Ace,ACE_RAT,8.1,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16332,,,,,,,Rattus norvegicus
216738,1005,1792,Angiotensin-converting enzyme,Enzyme,P47820,Ace,ACE_RAT,6.85,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL578,,,,,,,Rattus norvegicus
216739,1862,1910,Cannabinoid receptor 2,GPCR,P47936,Cnr2,CNR2_MOUSE,8.74,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL947,,,,,,,Mus musculus
216740,2862,2598,Arachidonate 5-lipoxygenase,Enzyme,P48999,Alox5,LOX5_MOUSE,6.72,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93,,,,,,,Mus musculus
216741,4496,2034,D(1A) dopamine receptor,GPCR,P50130,DRD1,DRD1_PIG,6.85,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986,,,,,,,Sus scrofa
216742,5202,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,6.1,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105759,,,,Tclin,,,Homo sapiens
216743,3514,2247,Death-associated protein kinase 1,Kinase,P53355,DAPK1,DAPK1_HUMAN,5.05,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,Tchem,,,Homo sapiens
216744,5201,420,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",Enzyme,P54750,PDE1A,PDE1A_HUMAN,5.21,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL484785,,,,Tclin,,,Homo sapiens
216745,1499,1824,Beta-2 adrenergic receptor,GPCR,P54833,ADRB2,ADRB2_CANFA,6,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL434,,,,,,,Canis familiaris
216746,3883,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,7.88,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL136711,,,,,,,Rattus norvegicus
216747,5037,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,7.8,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2024517,,,,,,,Rattus norvegicus
216748,1830,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,7.48,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460,,,,,,,Rattus norvegicus
216750,1262,2145,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P62813,Gabra1,GBRA1_RAT,5,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL96,,,,,,,Rattus norvegicus
216751,3008,1862,Oxytocin receptor,GPCR,P70536,Oxtr,OXYR_RAT,7.4,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL382301,,,,,,,Rattus norvegicus
216752,1310,3845,Metabotropic glutamate receptor 8,Unclassified,P70579,Grm8,GRM8_RAT,5.47,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Rattus norvegicus
216755,2245,3833,Disintegrin and metalloproteinase domain-containing protein 17,Unclassified,P78536,ADAM17,ADA17_HUMAN,7.83,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,,,,Homo sapiens
216756,1829,1969,Prostaglandin G/H synthase 2,Enzyme,P79208,PTGS2,PGH2_SHEEP,6.36,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL259972,,,,,,,Ovis aries
216757,4127,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,7.8,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL11298,,,,,,,Equus caballus
216758,4808,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,7.15,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL130880,,,,,,,Equus caballus
216759,2377,230,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,P9WGR1,inhA,INHA_MYCTU,7.52,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL374478,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
216760,2707,3902,UDP-galactopyranose mutase,Unclassified,P9WIQ1,glf,GLF_MYCTU,5.16,,AC50,active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL84,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
216761,960,3902,UDP-galactopyranose mutase,Unclassified,P9WIQ1,glf,GLF_MYCTU,4.49,,AC50,active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
216762,3601,3840,Bifunctional protein GlmU,Unclassified,P9WMN3,glmU,GLMU_MYCTU,4.05,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL120563,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
216763,4732,3840,Bifunctional protein GlmU,Unclassified,P9WMN3,glmU,GLMU_MYCTU,5.41,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL33864,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
216764,928,3840,Bifunctional protein GlmU,Unclassified,P9WMN3,glmU,GLMU_MYCTU,4.07,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL964,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
216765,1067,2119,Lanosterol 14-alpha demethylase,Enzyme,P9WPP9,cyp51,CP51_MYCTU,4,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193482,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
216766,3290,2556,Bacterial leucyl aminopeptidase,Enzyme,Q01693,,AMPX_VIBPR,6.8,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL310555,,,,,,,Vibrio proteolyticus
216767,5110,3851,Lactase-phlorizin hydrolase,Unclassified,Q02401,Lct,LPH_RAT,4.14,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,,,,Rattus norvegicus
216768,1310,3828,Glutamate racemase,Unclassified,Q03469,murI,MURI_LACFE,4.55,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Lactobacillus fermentum
216769,1531,3872,CAAX prenyl protease 2,Unclassified,Q03530,RCE1,RCE1_YEAST,4.82,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
216770,2870,3872,CAAX prenyl protease 2,Unclassified,Q03530,RCE1,RCE1_YEAST,4.77,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL911,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
216771,1200,3872,CAAX prenyl protease 2,Unclassified,Q03530,RCE1,RCE1_YEAST,5.46,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30008,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
216772,597,3872,CAAX prenyl protease 2,Unclassified,Q03530,RCE1,RCE1_YEAST,5.24,,AC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL790,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
216773,558,2404,Tyrosine-protein phosphatase non-receptor type 11,Enzyme,Q06124,PTPN11,PTN11_HUMAN,4.77,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1343544,,,,Tchem,,,Homo sapiens
216775,5215,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.61,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3126842,,,,Tclin,,,Homo sapiens
216777,302,606,Histone deacetylase 1,Enzyme,Q13547,HDAC1,HDAC1_HUMAN,7.77,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL487253,,,,Tclin,,,Homo sapiens
216778,5201,696,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",Enzyme,Q13946,PDE7A,PDE7A_HUMAN,6.14,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL484785,,,,Tclin,,,Homo sapiens
216779,1922,614,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,5.69,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193,,,,Tchem,,,Homo sapiens
216780,849,3869,Female germline-specific tumor suppressor gld-1,Unclassified,Q17339,gld-1,GLD1_CAEEL,5.14,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41286,,,,,,,Caenorhabditis elegans
216781,257,3874,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,Q1W675,HMGCR,HMDH_PIG,4.49,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1487,,,,,,,Sus scrofa
216782,2001,2488,Neuraminidase,Enzyme,Q20MD3,NA,Q20MD3_9INFA,8.54,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,,,,,,,Influenza A virus (A/udorn/1972(H3N2))
216783,1499,1757,Beta-2 adrenergic receptor,GPCR,Q28044,ADRB2,ADRB2_BOVIN,6.48,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL434,,,,,,,Bos taurus
216786,5039,2436,Carbonic anhydrase,Unclassified,Q2PCB5,ca,Q2PCB5_DICLA,5.03,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL506247,,,,,,,Dicentrarchus labrax
216787,345,3889,Core protein,Unclassified,Q2Q167,,Q2Q167_9HEPC,4.53,,IC50,Not Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1293,,,,,,,Hepatitis C virus
216788,1637,3820,Lipoxygenase,Unclassified,Q39829,,Q39829_SOYBN,4.29,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,,,,Glycine max
216791,864,2428,Carbonic anhydrase 2,Unclassified,Q3I4V7,CAN2,Q3I4V7_CRYNV,5.92,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Cryptococcus neoformans var. grubii
216792,2452,3901,Neutrophil elastase,Unclassified,Q3UP87,Elane,ELNE_MOUSE,6.84,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76688,,,,,,,Mus musculus
216793,5110,3868,Alpha-galactosidase,Unclassified,Q42656,,AGAL_COFAR,8.52,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,,,,Coffea arabica
216795,1856,2116,Nischarin,Unclassified,Q4G017,Nisch,NISCH_RAT,7.11,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19236,,,,,,,Rattus norvegicus
216796,4671,2116,Nischarin,Unclassified,Q4G017,Nisch,NISCH_RAT,8.89,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266155,,,,,,,Rattus norvegicus
216797,1806,3823,Beta-galactosidase,Unclassified,Q58D55,GLB1,BGAL_BOVIN,4,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1561,,,,,,,Bos taurus
216798,5110,3817,Beta-galactosidase,Unclassified,Q59750,lacZ,BGAL_RHIML,4.9,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,,,,Rhizobium meliloti
216799,558,3815,tRNA 2'-phosphotransferase,Unclassified,Q5A7N4,TPT1,Q5A7N4_CANAL,5.77,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1343544,,,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
216800,230,3870,Substance-P receptor,Unclassified,Q5DUB1,TACR1,NK1R_MERUN,10.05,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1471,,,,,,,Meriones unguiculatus
216801,2803,3879,Aldose reductase-related protein 1,Unclassified,Q5RJP0,Akr1b7,ALD1_RAT,4.25,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109,,,,,,,Rattus norvegicus
216802,4741,3890,ATP synthase subunit c,Unclassified,Q5TIX5,atpE,Q5TIX5_MYCSM,8.6,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL376488,,,,,,,Mycobacterium smegmatis
216805,568,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,6.76,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Anopheles gambiae
216806,864,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,6.2,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Anopheles gambiae
216807,1089,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,6.73,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Anopheles gambiae
216811,949,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,6.56,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Anopheles gambiae
216812,396,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,7.5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Anopheles gambiae
216813,2537,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,7.53,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Anopheles gambiae
216814,2540,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,6.58,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL328560,,,,,,,Anopheles gambiae
216815,1624,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,4.87,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Anopheles gambiae
216816,1385,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,7.5,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL435,,,,,,,Anopheles gambiae
216817,2872,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,6.58,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Anopheles gambiae
216818,2799,3841,Carbonic anhydrase,Unclassified,Q5TU56,,Q5TU56_ANOGA,6.79,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Anopheles gambiae
216819,4805,2048,Sigma non-opioid intracellular receptor 1,Membrane other,Q60492,SIGMAR1,SGMR1_CAVPO,7.15,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1213165,,,,,,,Cavia porcellus
216820,1794,3816,Sodium channel protein type 9 subunit alpha,Unclassified,Q62205,Scn9a,SCN9A_MOUSE,4.96,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL558,,,,,,,Mus musculus
216821,5008,2120,Sonic hedgehog protein,Enzyme,Q62226,Shh,SHH_MOUSE,8.26,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105737,,,,,,,Mus musculus
216822,2144,3581,L-type amino acid transporter 1,Unclassified,Q63016,Slc7a5,LAT1_RAT,4.26,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL301523,,,,,,,Rattus norvegicus
216823,4605,3852,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Unclassified,Q63470,Dyrk1a,DYR1A_RAT,5.03,,AC50,active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200883,,,,,,,Rattus norvegicus
216824,1821,3852,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Unclassified,Q63470,Dyrk1a,DYR1A_RAT,5.02,,AC50,active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58,,,,,,,Rattus norvegicus
216825,3021,3852,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Unclassified,Q63470,Dyrk1a,DYR1A_RAT,5.83,,AC50,active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24171,,,,,,,Rattus norvegicus
216827,5060,1893,Prostaglandin G/H synthase 1,Enzyme,Q63921,Ptgs1,PGH1_RAT,7.52,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL435298,,,,,,,Rattus norvegicus
216828,3972,3897,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,Unclassified,Q64578,Atp2a1,AT2A1_RAT,4.77,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200633,,,,,,,Rattus norvegicus
216829,828,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,4.63,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Bos taurus
216830,829,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,4.63,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Bos taurus
216833,1400,3908,Envelope glycoprotein gp160,Unclassified,Q6QLK5,env,Q6QLK5_9HIV1,5.2,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL896,,,,,,,Human immunodeficiency virus 1
216834,3032,3908,Envelope glycoprotein gp160,Unclassified,Q6QLK5,env,Q6QLK5_9HIV1,5.21,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290106,,,,,,,Human immunodeficiency virus 1
216835,318,3908,Envelope glycoprotein gp160,Unclassified,Q6QLK5,env,Q6QLK5_9HIV1,4.89,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL388590,,,,,,,Human immunodeficiency virus 1
216836,1364,3908,Envelope glycoprotein gp160,Unclassified,Q6QLK5,env,Q6QLK5_9HIV1,5.14,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496,,,,,,,Human immunodeficiency virus 1
216837,1010,3867,GP41,Unclassified,Q76270,HIV1 ENV,Q76270_9HIV1,8,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL525076,,,,,,,Human immunodeficiency virus 1
216841,2352,3905,Integrase,Enzyme,Q76353,,Q76353_9HIV1,5.74,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL254316,,,,,,,Human immunodeficiency virus 1
216843,4402,3839,MecA,Unclassified,Q7DHH4,mecA,Q7DHH4_STAAU,5.49,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL520642,,,,,,,Staphylococcus aureus
216846,902,3878,Apical membrane antigen 1,Unclassified,Q7KQK5,AMA1,Q7KQK5_PLAF7,4.55,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1328913,,,,,,,Plasmodium falciparum (isolate 3D7)
216847,403,1933,Vesicular glutamate transporter 3,Unclassified,Q7TSF2,Slc17a8,VGLU3_RAT,4.66,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL493,,,,,,,Rattus norvegicus
216848,3124,1741,Integrase,Enzyme,Q7ZJM1,pol,Q7ZJM1_9HIV1,5.8,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL487258,,,,,,,Human immunodeficiency virus 1
216849,4175,880,Dipeptidyl peptidase 9,Enzyme,Q86TI2,DPP9,DPP9_HUMAN,4,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL237500,,,,Tchem,,,Homo sapiens
216850,787,1961,High affinity choline transporter 1,Unclassified,Q8BGY9,Slc5a7,SC5A7_MOUSE,4.25,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1135,,,,,,,Mus musculus
216851,1028,3827,M18 aspartyl aminopeptidase,Unclassified,Q8I2J3,,Q8I2J3_PLAF7,5.52,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,,,,,,,Plasmodium falciparum (isolate 3D7)
216852,947,3827,M18 aspartyl aminopeptidase,Unclassified,Q8I2J3,,Q8I2J3_PLAF7,5.7,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL59,,,,,,,Plasmodium falciparum (isolate 3D7)
216853,2797,3819,M1-family alanyl aminopeptidase,Unclassified,Q8IEK1,,Q8IEK1_PLAF7,5.59,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1551,,,,,,,Plasmodium falciparum (isolate 3D7)
216854,3032,3819,M1-family alanyl aminopeptidase,Unclassified,Q8IEK1,,Q8IEK1_PLAF7,4.37,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL290106,,,,,,,Plasmodium falciparum (isolate 3D7)
216855,318,3819,M1-family alanyl aminopeptidase,Unclassified,Q8IEK1,,Q8IEK1_PLAF7,4.2,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL388590,,,,,,,Plasmodium falciparum (isolate 3D7)
216856,1364,3819,M1-family alanyl aminopeptidase,Unclassified,Q8IEK1,,Q8IEK1_PLAF7,4.24,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496,,,,,,,Plasmodium falciparum (isolate 3D7)
216857,3047,3819,M1-family alanyl aminopeptidase,Unclassified,Q8IEK1,,Q8IEK1_PLAF7,4.09,,IC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94394,,,,,,,Plasmodium falciparum (isolate 3D7)
216858,4183,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,8.1,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095777,,,,,,,Cavia porcellus
216859,2723,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,7.58,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL299175,,,,,,,Cavia porcellus
216861,1499,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,7.54,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL434,,,,,,,Cavia porcellus
216866,2543,3850,5-hydroxytryptamine 1D receptor,Unclassified,Q8MI13,5htr1d,Q8MI13_BOVIN,7.23,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128,,,,,,,Bos taurus
216867,2459,3863,Purine nucleoside phosphorylase,Unclassified,Q8T9Z7,PNP,Q8T9Z7_PLAFA,7.9,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,,,,,,,Plasmodium falciparum
216868,5155,924,G-protein coupled bile acid receptor 1,GPCR,Q8TDU6,GPBAR1,GPBAR_HUMAN,7,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL566315,,,,Tchem,,,Homo sapiens
216869,765,3825,Histone-lysine N-methyltransferase SETD7,Unclassified,Q8WTS6,SETD7,SETD7_HUMAN,4.7,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL516,,,,,,,Homo sapiens
216870,2755,3893,Dihydrofolate reductase,Unclassified,Q8Z9J9,folA,Q8Z9J9_SALTI,8.08,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL22,,,,,,,Salmonella typhi
216872,398,3893,Dihydrofolate reductase,Unclassified,Q8Z9J9,folA,Q8Z9J9_SALTI,8.18,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL31891,,,,,,,Salmonella typhi
216873,2615,3893,Dihydrofolate reductase,Unclassified,Q8Z9J9,folA,Q8Z9J9_SALTI,8.35,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL32039,,,,,,,Salmonella typhi
216874,1375,3904,Histamine H4 receptor,Unclassified,Q91ZY3,HRH4,Q91ZY3_CAVPO,8.22,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,,,,Cavia porcellus
216875,302,598,Histone deacetylase 2,Enzyme,Q92769,HDAC2,HDAC2_HUMAN,8.05,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL487253,,,,Tclin,,,Homo sapiens
216876,4733,3882,Beta-lactamase,Unclassified,Q932Y6,bla(tem-2),Q932Y6_PSEAI,4.77,,IC50,inactive,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL508338,,,,,,,Pseudomonas aeruginosa
216877,1612,3907,Acyl-CoA:cholesterol acyltransferase,Unclassified,Q95214,ACAT,Q95214_RABIT,4.77,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503,,,,,,,Oryctolagus cuniculus
216878,302,917,Histone deacetylase 10,Enzyme,Q969S8,HDAC10,HDA10_HUMAN,7.14,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL487253,,,,Tclin,,,Homo sapiens
216879,1845,3853,Mu opioid receptor-like OR2,Unclassified,Q98UH1,oprm1,Q98UH1_DANRE,6.73,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70,,,,,,,Danio rerio
216880,629,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,5.11,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL206452,,,,,,,Mus musculus
216881,302,717,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,6.97,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL487253,,,,Tclin,,,Homo sapiens
216882,3630,3894,Epoxide hydrolase 1,Unclassified,Q9D379,Ephx1,HYEP_MOUSE,6.44,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1076347,,,,,,,Mus musculus
216883,4184,3849,P2Y purinoceptor 12,Unclassified,Q9EPX4,P2ry12,P2Y12_RAT,5.38,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL398435,,,,,,,Rattus norvegicus
216884,2316,3844,Thyrotropin-releasing hormone receptor 2,Unclassified,Q9ERT1,TRH-R2,Q9ERT1_MOUSE,8.15,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1472,,,,,,,Mus musculus
216886,2111,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,5.32,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL340801,,,,Tchem,,,Homo sapiens
216887,56,3847,Carbonic anhydrase,Unclassified,Q9HVB9,,Q9HVB9_PSEAE,7.12,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20,,,,,,,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)
216888,1375,3829,Histamine H3 receptor,Unclassified,Q9JI35,HRH3,HRH3_CAVPO,9.84,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,,,,Cavia porcellus
216890,1709,3875,Beta-lactamase class B VIM-2,Unclassified,Q9K2N0,blaVIM-2,Q9K2N0_PSEAI,4.92,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127,,,,,,,Pseudomonas aeruginosa
216891,484,3875,Beta-lactamase class B VIM-2,Unclassified,Q9K2N0,blaVIM-2,Q9K2N0_PSEAI,6.22,,Kd,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1560,,,,,,,Pseudomonas aeruginosa
216893,5048,1966,Histamine H3 receptor,GPCR,Q9QYN8,Hrh3,HRH3_RAT,7.77,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL462605,,,,,,,Rattus norvegicus
216894,659,1966,Histamine H3 receptor,GPCR,Q9QYN8,Hrh3,HRH3_RAT,9.18,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL8,,,,,,,Rattus norvegicus
216895,1375,1966,Histamine H3 receptor,GPCR,Q9QYN8,Hrh3,HRH3_RAT,8.2,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL90,,,,,,,Rattus norvegicus
216896,302,630,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,8.22,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL487253,,,,Tclin,,,Homo sapiens
216897,5110,3866,Alpha-galactosidase C,Unclassified,Q9UUZ4,aglC,AGALC_ASPNG,5.74,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,,,,Aspergillus niger
216898,2861,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,4.74,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL129,,,,,,,Human immunodeficiency virus 1
216899,1115,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,8,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL308954,,,,,,,Human immunodeficiency virus 1
216907,1241,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,5.6,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL666,,,,,,,Human immunodeficiency virus 1
216911,1117,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,6.19,,EC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1412355,,,,,,,Rattus norvegicus
216912,1775,2516,Zinc finger protein mex-5,Cytosolic other,Q9XUB2,mex-5,MEX5_CAEEL,4.91,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1065,,,,,,,Caenorhabditis elegans
216914,314,2516,Zinc finger protein mex-5,Cytosolic other,Q9XUB2,mex-5,MEX5_CAEEL,6.95,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096979,,,,,,,Caenorhabditis elegans
216915,228,2516,Zinc finger protein mex-5,Cytosolic other,Q9XUB2,mex-5,MEX5_CAEEL,5.35,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53,,,,,,,Caenorhabditis elegans
216916,2701,2516,Zinc finger protein mex-5,Cytosolic other,Q9XUB2,mex-5,MEX5_CAEEL,4.45,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1197206,,,,,,,Caenorhabditis elegans
216917,3500,2516,Zinc finger protein mex-5,Cytosolic other,Q9XUB2,mex-5,MEX5_CAEEL,5.05,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL267548,,,,,,,Caenorhabditis elegans
216918,1364,2516,Zinc finger protein mex-5,Cytosolic other,Q9XUB2,mex-5,MEX5_CAEEL,4.72,,EC50,Inconclusive,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL496,,,,,,,Caenorhabditis elegans
216919,1637,2516,Zinc finger protein mex-5,Cytosolic other,Q9XUB2,mex-5,MEX5_CAEEL,5.06,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL52,,,,,,,Caenorhabditis elegans
216920,533,2516,Zinc finger protein mex-5,Cytosolic other,Q9XUB2,mex-5,MEX5_CAEEL,4.48,,EC50,Active,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL927,,,,,,,Caenorhabditis elegans
216921,3225,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,8.7,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14012,,,,Tclin,,,Homo sapiens
216922,4671,821,Nischarin,Membrane receptor,Q9Y2I1,NISCH,NISCH_HUMAN,9.2,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL266155,,,,Tclin,,,Homo sapiens
216923,1437,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,9.27,,Ki,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL115,,,,,,,Human immunodeficiency virus 1
216925,4143,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,10.21,,IC50,,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1323,,,,,,,Human immunodeficiency virus 1
216982,343,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,6.17,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1967,,AGONIST,,Tclin,,,Homo sapiens
216983,343,3975,Prostacyclin receptor,Unclassified,P43252,Ptgir,PI2R_MOUSE,7.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1967,,AGONIST,,,,,Mus musculus
216984,343,3978,Prostacyclin receptor,Unclassified,P43253,Ptgir,PI2R_RAT,7.72,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1967,,AGONIST,,,,,Rattus norvegicus
216985,361,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,5.52,,IC50,Measured using a TR-FRET competitive displacement assay.,IUPHAR,~,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2807,,ANTAGONIST,,Tclin,,,Homo sapiens
216986,403,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,7.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=35,,AGONIST,,,,,Rattus norvegicus
216987,431,3989,Beta-3 adrenergic receptor,Unclassified,P26255,Adrb3,ADRB3_RAT,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=570,,ANTAGONIST,,,,,Rattus norvegicus
216988,432,4055,Potassium voltage-gated channel subfamily D member 3,Unclassified,Q9Z0V1,Kcnd3,KCND3_MOUSE,4.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2397,,BLOCKER,,,,,Mus musculus
216989,437,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=36,,ANTAGONIST,,,,,Mus musculus
216990,437,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=36,,AGONIST,,,,,Rattus norvegicus
216991,463,3991,Adenosine receptor A2b,Unclassified,Q60614,Adora2b,AA2BR_MOUSE,4.89,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=407,,ANTAGONIST,,,,,Mus musculus
216992,470,3917,Transient receptor potential cation channel subfamily A member 1,Unclassified,Q8BLA8,Trpa1,TRPA1_MOUSE,4.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2422,,GATING INHIBITOR,,,,,Mus musculus
216993,487,3933,Beta-3 adrenergic receptor,Unclassified,P25962,Adrb3,ADRB3_MOUSE,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=569,,AGONIST,,,,,Mus musculus
216994,487,3989,Beta-3 adrenergic receptor,Unclassified,P26255,Adrb3,ADRB3_RAT,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=569,,AGONIST,,,,,Rattus norvegicus
216995,594,2547,Thyrotropin-releasing hormone receptor,GPCR,P21761,Trhr,TRFR_MOUSE,4.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3370,,ANTAGONIST,,,,,Mus musculus
216996,594,1967,Thyrotropin-releasing hormone receptor,GPCR,Q01717,Trhr,TRFR_RAT,4.82,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3370,,ANTAGONIST,,,,,Rattus norvegicus
216997,621,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=83,,ANTAGONIST,,,,,Rattus norvegicus
216998,621,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,5.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=83,,ANTAGONIST,,,,,Mus musculus
216999,631,1924,Prostaglandin E2 receptor EP3 subtype,GPCR,P30557,Ptger3,PE2R3_MOUSE,6.77,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1917,,AGONIST,,,,,Mus musculus
217000,631,3975,Prostacyclin receptor,Unclassified,P43252,Ptgir,PI2R_MOUSE,8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1917,,AGONIST,,,,,Mus musculus
217001,631,1923,Prostaglandin E2 receptor EP2 subtype,GPCR,Q62053,Ptger2,PE2R2_MOUSE,5.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1917,,AGONIST,,,,,Mus musculus
217002,642,3945,Voltage-dependent N-type calcium channel subunit alpha-1B,Unclassified,Q02294,Cacna1b,CAC1B_RAT,6.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7767,,BLOCKER,,,,,Rattus norvegicus
217003,645,3593,Histamine H2 receptor,Unclassified,P25102,Hrh2,HRH2_RAT,5.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1231,,ANTAGONIST,,,,,Rattus norvegicus
217004,660,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,5.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=240,,AGONIST,,,,,Mus musculus
217005,660,3960,5-hydroxytryptamine receptor 4,Unclassified,P97288,Htr4,5HT4R_MOUSE,7.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=240,,AGONIST,,,,,Mus musculus
217006,666,3955,Transient receptor potential cation channel subfamily V member 4,Unclassified,Q9EPK8,Trpv4,TRPV4_MOUSE,5.6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2478,,ACTIVATOR,,,,,Mus musculus
217007,701,3990,G protein-activated inward rectifier potassium channel 2,Ion channel,P48542,Kcnj6,KCNJ6_MOUSE,4.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2398,,BLOCKER,,,,,Mus musculus
217008,704,4005,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Unclassified,O70507,Hcn4,HCN4_MOUSE,5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=516,,BLOCKER,,,,,Mus musculus
217009,704,2383,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Ion channel,O88703,Hcn2,HCN2_MOUSE,5.1,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=516,,BLOCKER,,,,,Mus musculus
217010,704,2382,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Ion channel,O88704,Hcn1,HCN1_MOUSE,4.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=516,,BLOCKER,,,,,Mus musculus
217011,704,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,6.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=516,,AGONIST,,,,,Rattus norvegicus
217012,722,4017,5-hydroxytryptamine receptor 5A,Unclassified,P30966,Htr5a,5HT5A_MOUSE,5.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,,ANTAGONIST,,,,,Mus musculus
217013,722,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,,ANTAGONIST,,,,,Mus musculus
217014,722,2403,Histamine H4 receptor,GPCR,Q91ZY1,Hrh4,HRH4_RAT,5.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,,ANTAGONIST,,,,,Rattus norvegicus
217015,722,2402,Histamine H4 receptor,GPCR,Q91ZY2,Hrh4,HRH4_MOUSE,5.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,,ANTAGONIST,,,,,Mus musculus
217016,722,1966,Histamine H3 receptor,GPCR,Q9QYN8,Hrh3,HRH3_RAT,5.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=38,,ANTAGONIST,,,,,Rattus norvegicus
217017,760,547,Solute carrier organic anion transporter family member 1B1,Transporter,Q9Y6L6,SLCO1B1,SO1B1_HUMAN,7.29,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1024,,INHIBITOR,,Tchem,,,Homo sapiens
217018,765,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,6.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=277,,ANTAGONIST,,,,,Rattus norvegicus
217019,812,3990,G protein-activated inward rectifier potassium channel 2,Ion channel,P48542,Kcnj6,KCNJ6_MOUSE,4.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2399,,BLOCKER,,,,,Mus musculus
217020,812,3976,G protein-activated inward rectifier potassium channel 4,Unclassified,P48545,Kcnj5,KCNJ5_MOUSE,4.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2399,,BLOCKER,,,,,Mus musculus
217021,812,3395,Equilibrative nucleoside transporter 4,Transporter,Q7RTT9,SLC29A4,S29A4_HUMAN,4.49,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2399,,INHIBITOR,,Tbio,,,Homo sapiens
217022,824,4101,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O54915,Nr1i2,NR1I2_MOUSE,6.1,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2768,,AGONIST,,,,,Mus musculus
217023,831,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,8.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=354,,ANTAGONIST,,,,,Rattus norvegicus
217024,842,316,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,Q14957,GRIN2C,NMDE3_HUMAN,6.33,,IC50,"Measured <i>vs.</i> exogenously expressed zeta1/epsilon3 (<i>GRIN1/GRIN2C</i>) subunits, at pH 6.9",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6953,,BLOCKER,,Tclin,,,Homo sapiens
217025,852,1967,Thyrotropin-releasing hormone receptor,GPCR,Q01717,Trhr,TRFR_RAT,5.15,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3364,,ANTAGONIST,,,,,Rattus norvegicus
217026,854,4084,ATP-sensitive inward rectifier potassium channel 11,Unclassified,Q61743,Kcnj11,KCJ11_MOUSE,4.2,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2409,,ACTIVATOR,,,,,Mus musculus
217027,887,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=278,,ANTAGONIST,,,,,Rattus norvegicus
217028,888,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=121,,ANTAGONIST,,,,,Rattus norvegicus
217029,897,3946,Potassium voltage-gated channel subfamily C member 1,Unclassified,P15388,Kcnc1,KCNC1_MOUSE,4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2298,,BLOCKER,,,,,Mus musculus
217030,897,3986,Potassium voltage-gated channel subfamily A member 7,Unclassified,Q17ST2,Kcna7,KCNA7_MOUSE,4.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2298,,BLOCKER,,,,,Mus musculus
217031,897,4051,Voltage-dependent L-type calcium channel subunit alpha-1F,Unclassified,Q9JIS7,Cacna1f,CAC1F_MOUSE,4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2298,,BLOCKER,,,,,Mus musculus
217032,912,1924,Prostaglandin E2 receptor EP3 subtype,GPCR,P30557,Ptger3,PE2R3_MOUSE,7.12,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Mus musculus
217033,912,4068,Prostaglandin E2 receptor EP3 subtype,Unclassified,P34980,Ptger3,PE2R3_RAT,8.38,,EC50,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
217034,912,1922,Prostaglandin E2 receptor EP1 subtype,GPCR,P35375,Ptger1,PE2R1_MOUSE,5.9,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Mus musculus
217035,912,2152,Prostaglandin E2 receptor EP4 subtype,GPCR,P43114,Ptger4,PE2R4_RAT,6.2,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
217036,912,4093,Prostaglandin E2 receptor EP1 subtype,Unclassified,P70597,Ptger1,PE2R1_RAT,6.4,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
217042,913,3273,Cation channel sperm-associated protein 4,Ion channel,Q7RTX7,CATSPER4,CTSR4_HUMAN,6.3,,EC50,Patch clamp electrophysiology.,IUPHAR,=,,,,,ACTIVATOR,,Tchem,,,Homo sapiens
217043,913,3272,Cation channel sperm-associated protein 3,Ion channel,Q86XQ3,CATSPER3,CTSR3_HUMAN,6.3,,EC50,Patch clamp electrophysiology.,IUPHAR,=,,,,,ACTIVATOR,,Tchem,,,Homo sapiens
217044,913,3270,Cation channel sperm-associated protein 1,Ion channel,Q8NEC5,CATSPER1,CTSR1_HUMAN,6.3,,EC50,Patch clamp electrophysiology,IUPHAR,=,,,,,ACTIVATOR,,Tchem,,,Homo sapiens
217045,913,3271,Cation channel sperm-associated protein 2,Ion channel,Q96P56,CATSPER2,CTSR2_HUMAN,6.3,,EC50,Patch clamp electrophysiology.,IUPHAR,=,,,,,ACTIVATOR,,Tchem,,,Homo sapiens
217046,913,4067,Prostaglandin D2 receptor 2,Unclassified,Q9Z2J6,Ptgdr2,PD2R2_MOUSE,5.5,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Mus musculus
217047,924,3395,Equilibrative nucleoside transporter 4,Transporter,Q7RTT9,SLC29A4,S29A4_HUMAN,5.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4807,,INHIBITOR,,Tbio,,,Homo sapiens
217048,934,3917,Transient receptor potential cation channel subfamily A member 1,Unclassified,Q8BLA8,Trpa1,TRPA1_MOUSE,4.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2430,,GATING INHIBITOR,,,,,Mus musculus
217049,961,3985,Matrilysin,Unclassified,P09237,MMP7,MMP7_HUMAN,4.14,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6464,,INHIBITOR,,,,,Homo sapiens
217050,1016,4068,Prostaglandin E2 receptor EP3 subtype,Unclassified,P34980,Ptger3,PE2R3_RAT,7.13,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1918,,AGONIST,,,,,Rattus norvegicus
217051,1016,4093,Prostaglandin E2 receptor EP1 subtype,Unclassified,P70597,Ptger1,PE2R1_RAT,6.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1918,,AGONIST,,,,,Rattus norvegicus
217052,1042,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=148,,AGONIST,,,,,Rattus norvegicus
217053,1043,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,7.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,AGONIST,,,,,Rattus norvegicus
217054,1043,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,AGONIST,,,,,Rattus norvegicus
217055,1043,4060,5-hydroxytryptamine receptor 1F,Unclassified,P30940,Htr1f,5HT1F_RAT,7.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,AGONIST,,,,,Rattus norvegicus
217056,1043,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,ANTAGONIST,,,,,Mus musculus
217057,1043,3973,5-hydroxytryptamine receptor 5A,Unclassified,P35364,Htr5a,5HT5A_RAT,8.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=149,,ANTAGONIST,,,,,Rattus norvegicus
217058,1045,4053,Solute carrier organic anion transporter family member 2B1,Unclassified,O94956,SLCO2B1,SO2B1_HUMAN,6.28,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4920,,INHIBITOR,,,,,Homo sapiens
217059,1086,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.51,,Ki,Displacement of [<sup<3</sup>H]QNB binding in rat forebrain brain homogenate.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7181,,ANTAGONIST,,,,,Rattus norvegicus
217060,1086,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,8.14,,Ki,Displacement of [<sup<3</sup>H]QNB binding in rat hindbrain brain homogenate.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7181,,ANTAGONIST,,,,,Rattus norvegicus
217061,1097,1798,Sodium channel protein type 2 subunit alpha,Ion channel,P04775,Scn2a,SCN2A_RAT,6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2621,,BLOCKER,,,,,Rattus norvegicus
217062,1176,3946,Potassium voltage-gated channel subfamily C member 1,Unclassified,P15388,Kcnc1,KCNC1_MOUSE,4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2560,,BLOCKER,,,,,Mus musculus
217063,1193,1670,Potassium channel subfamily T member 2,Ion channel,Q6UVM3,KCNT2,KCNT2_HUMAN,8.85,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2447,,ACTIVATOR,,Tbio,,,Homo sapiens
217064,1193,3915,Transient receptor potential cation channel subfamily M member 4,Unclassified,Q7TN37,Trpm4,TRPM4_MOUSE,5.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2447,,GATING INHIBITOR,,,,,Mus musculus
217065,1209,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=203,,ANTAGONIST,,,,,Rattus norvegicus
217066,1209,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,5.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=203,,ANTAGONIST,,,,,Rattus norvegicus
217067,1209,3395,Equilibrative nucleoside transporter 4,Transporter,Q7RTT9,SLC29A4,S29A4_HUMAN,4.64,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=203,,INHIBITOR,,Tbio,,,Homo sapiens
217068,1212,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,7.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=204,,ANTAGONIST,,,,,Rattus norvegicus
217069,1212,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,8.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=204,,ANTAGONIST,,,,,Rattus norvegicus
217070,1230,1751,Sodium-dependent serotonin transporter,Transporter,P31652,Slc6a4,SC6A4_RAT,8.19,,Ki,Inhibition of [<sup>3</sup>]5-HT uptake into rat astrocyte cultures.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7189,,INHIBITOR,,,,,Rattus norvegicus
217071,1273,3383,Acetylcholine receptor subunit alpha,Ion channel,P02708,CHRNA1,ACHA_HUMAN,6,,IC50,,IUPHAR,~,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=356,,BLOCKER,,Tclin,,,Homo sapiens
217072,1273,1744,Muscarinic acetylcholine receptor M2,GPCR,P10980,Chrm2,ACM2_RAT,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=356,,ALLOSTERIC MODULATOR,,,,,Rattus norvegicus
217073,1314,4084,ATP-sensitive inward rectifier potassium channel 11,Unclassified,Q61743,Kcnj11,KCJ11_MOUSE,5.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2414,,BLOCKER,,,,,Mus musculus
217074,1353,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,6.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=86,,ANTAGONIST,,,,,Mus musculus
217075,1353,3990,G protein-activated inward rectifier potassium channel 2,Ion channel,P48542,Kcnj6,KCNJ6_MOUSE,4.1,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=86,,GATING INHIBITOR,,,,,Mus musculus
217076,1371,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=323,,ANTAGONIST,,,,,Rattus norvegicus
217077,1404,4015,Farnesyl pyrophosphate synthase,Unclassified,P05369,Fdps,FPPS_RAT,5.13,,IC50,in vitro using kidney cell lines,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3059,,INHIBITOR,,,,,Rattus norvegicus
217078,1422,1924,Prostaglandin E2 receptor EP3 subtype,GPCR,P30557,Ptger3,PE2R3_MOUSE,7.66,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,,,,Mus musculus
217079,1422,1925,Prostaglandin E2 receptor EP4 subtype,GPCR,P32240,Ptger4,PE2R4_MOUSE,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,,,,Mus musculus
217080,1422,4068,Prostaglandin E2 receptor EP3 subtype,Unclassified,P34980,Ptger3,PE2R3_RAT,9.2,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,,,,Rattus norvegicus
217081,1422,1922,Prostaglandin E2 receptor EP1 subtype,GPCR,P35375,Ptger1,PE2R1_MOUSE,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,,,,Mus musculus
217082,1422,3975,Prostacyclin receptor,Unclassified,P43252,Ptgir,PI2R_MOUSE,8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,,,,Mus musculus
217083,1422,4093,Prostaglandin E2 receptor EP1 subtype,Unclassified,P70597,Ptger1,PE2R1_RAT,7.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,,,,Rattus norvegicus
217084,1422,1923,Prostaglandin E2 receptor EP2 subtype,GPCR,Q62053,Ptger2,PE2R2_MOUSE,5.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,,,,Mus musculus
217085,1422,2151,Prostaglandin E2 receptor EP2 subtype,GPCR,Q62928,Ptger2,PE2R2_RAT,5.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1895,,AGONIST,,,,,Rattus norvegicus
217086,1427,3990,G protein-activated inward rectifier potassium channel 2,Ion channel,P48542,Kcnj6,KCNJ6_MOUSE,4.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=357,,BLOCKER,,,,,Mus musculus
217087,1427,3976,G protein-activated inward rectifier potassium channel 4,Unclassified,P48545,Kcnj5,KCNJ5_MOUSE,4.5,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=357,,BLOCKER,,,,,Mus musculus
217088,1499,3989,Beta-3 adrenergic receptor,Unclassified,P26255,Adrb3,ADRB3_RAT,5.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=536,,AGONIST,,,,,Rattus norvegicus
217089,1511,4102,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q01815,Cacna1c,CAC1C_MOUSE,7.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4488,,GATING INHIBITOR,,,,,Mus musculus
217090,1511,4051,Voltage-dependent L-type calcium channel subunit alpha-1F,Unclassified,Q9JIS7,Cacna1f,CAC1F_MOUSE,6.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4488,,GATING INHIBITOR,,,,,Mus musculus
217091,1524,3934,5-hydroxytryptamine receptor 1B,Unclassified,P28334,Htr1b,5HT1B_MOUSE,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,,,,Mus musculus
217092,1524,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,6.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=88,,ANTAGONIST,,,,,Mus musculus
217093,1546,4019,Somatostatin receptor type 2,Unclassified,P30680,Sstr2,SSR2_RAT,8.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2031,,AGONIST,,,,,Rattus norvegicus
217094,1546,1885,Somatostatin receptor type 3,GPCR,P30935,Sstr3,SSR3_MOUSE,8.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2031,,AGONIST,,,,,Mus musculus
217095,1546,4088,Somatostatin receptor type 3,Unclassified,P30936,Sstr3,SSR3_RAT,6.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2031,,AGONIST,,,,,Rattus norvegicus
217096,1546,1887,Somatostatin receptor type 5,GPCR,P30938,Sstr5,SSR5_RAT,7.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2031,,AGONIST,,,,,Rattus norvegicus
217097,1563,3965,Synaptic vesicle glycoprotein 2A,Unclassified,Q02563,Sv2a,SV2A_RAT,6.1,,IC50,"<i>In vitro</i> inhibitory activity against [<sup>3</sup>H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding site, in rat brain homogenate",IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6826,,INHIBITOR,,,,,Rattus norvegicus
217098,1579,4072,Sodium channel protein type 5 subunit alpha,Unclassified,P15389,Scn5a,SCN5A_RAT,4.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2623,,BLOCKER,,,,,Rattus norvegicus
217099,1579,3536,Sodium channel protein type X alpha subunit,Unclassified,Q62968,Scn10a,SCNAA_RAT,4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2623,,BLOCKER,,,,,Rattus norvegicus
217100,1613,1669,Potassium channel subfamily T member 1,Ion channel,Q5JUK3,KCNT1,KCNT1_HUMAN,5.36,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=205,,ACTIVATOR,,Tchem,,,Homo sapiens
217101,1614,1766,Cholecystokinin receptor type A,GPCR,P30551,Cckar,CCKAR_RAT,6.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=892,,ANTAGONIST,,,,,Rattus norvegicus
217102,1634,3990,G protein-activated inward rectifier potassium channel 2,Ion channel,P48542,Kcnj6,KCNJ6_MOUSE,4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2402,,BLOCKER,,,,,Mus musculus
217103,1638,1804,Vitamin D3 receptor,Transcription factor,P13053,Vdr,VDR_RAT,8.21,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2784,,AGONIST,,,,,Rattus norvegicus
217104,1649,3566,Constitutive androstane receptor,Unclassified,O35627,Nr1i3,NR1I3_MOUSE,7.6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2757,,AGONIST,,,,,Mus musculus
217105,1712,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.98,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7227,,ANTAGONIST,,Tclin,,,Homo sapiens
217106,1712,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,6.99,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7227,,ANTAGONIST,,Tclin,,,Homo sapiens
217107,1723,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,7.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=133,,ANTAGONIST,,,,,Mus musculus
217108,1726,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,6.4,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7438,,AGONIST,,,,,Rattus norvegicus
217109,1726,1845,Muscarinic acetylcholine receptor M3,GPCR,P08483,Chrm3,ACM3_RAT,6.92,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7438,,AGONIST,,,,,Rattus norvegicus
217110,1753,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,4.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=483,,AGONIST,,,,,Rattus norvegicus
217111,1764,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,7.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=150,,AGONIST,,,,,Rattus norvegicus
217112,1764,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,7.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=150,,AGONIST,,,,,Rattus norvegicus
217113,1775,4060,5-hydroxytryptamine receptor 1F,Unclassified,P30940,Htr1f,5HT1F_RAT,7.8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,,,,Rattus norvegicus
217114,1775,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,7.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,,,,Mus musculus
217115,1775,3973,5-hydroxytryptamine receptor 5A,Unclassified,P35364,Htr5a,5HT5A_RAT,6.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=134,,ANTAGONIST,,,,,Rattus norvegicus
217116,1782,1841,D(2) dopamine receptor,GPCR,P61168,Drd2,DRD2_MOUSE,7.54,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=241,,ANTAGONIST,,,,,Mus musculus
217117,1782,3960,5-hydroxytryptamine receptor 4,Unclassified,P97288,Htr4,5HT4R_MOUSE,6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=241,,AGONIST,,,,,Mus musculus
217118,1796,3934,5-hydroxytryptamine receptor 1B,Unclassified,P28334,Htr1b,5HT1B_MOUSE,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,,ANTAGONIST,,,,,Mus musculus
217119,1796,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=135,,ANTAGONIST,,,,,Mus musculus
217120,1797,4077,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Unclassified,P54282,Cacna1a,CAC1A_RAT,6.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2522,,GATING INHIBITOR,,,,,Rattus norvegicus
217121,1797,4071,Voltage-dependent R-type calcium channel subunit alpha-1E,Unclassified,Q07652,Cacna1e,CAC1E_RAT,6.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2522,,GATING INHIBITOR,,,,,Rattus norvegicus
217122,1802,1967,Thyrotropin-releasing hormone receptor,GPCR,Q01717,Trhr,TRFR_RAT,5.49,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3342,,ANTAGONIST,,,,,Rattus norvegicus
217123,1836,4038,Uracil nucleotide/cysteinyl leukotriene receptor,Unclassified,Q6NS65,Gpr17,GPR17_MOUSE,7.21,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3340,,ANTAGONIST,,,,,Mus musculus
217124,1874,1857,Kappa-type opioid receptor,GPCR,P33534,Oprk1,OPRK_MOUSE,7.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1663,,AGONIST,,,,,Mus musculus
217125,1878,1857,Kappa-type opioid receptor,GPCR,P33534,Oprk1,OPRK_MOUSE,8.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1638,,ANTAGONIST,,,,,Mus musculus
217126,1878,1758,Mu-type opioid receptor,GPCR,P42866,Oprm1,OPRM_MOUSE,9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1638,,ANTAGONIST,,,,,Mus musculus
217127,1890,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7247,,INHIBITOR,,Tclin,,,Homo sapiens
217128,1896,3938,Extracellular calcium-sensing receptor,Unclassified,P48442,Casr,CASR_RAT,4,,Kd,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
217129,1909,3947,Potassium voltage-gated channel subfamily A member 4,Unclassified,P15385,Kcna4,KCNA4_RAT,6.1,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2559,,BLOCKER,,,,,Rattus norvegicus
217130,1920,3935,Potassium voltage-gated channel subfamily D member 3,Unclassified,Q62897,Kcnd3,KCND3_RAT,7.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2585,,BLOCKER,,,,,Rattus norvegicus
217131,1922,4025,Potassium voltage-gated channel subfamily A member 1,Unclassified,P16388,Kcna1,KCNA1_MOUSE,4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2514,,BLOCKER,,,,,Mus musculus
217132,1922,4076,Potassium voltage-gated channel subfamily A member 2,Unclassified,P63142,Kcna2,KCNA2_RAT,4.7,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2514,,BLOCKER,,,,,Rattus norvegicus
217133,1922,3986,Potassium voltage-gated channel subfamily A member 7,Unclassified,Q17ST2,Kcna7,KCNA7_MOUSE,4.9,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2514,,BLOCKER,,,,,Mus musculus
217134,1925,1670,Potassium channel subfamily T member 2,Ion channel,Q6UVM3,KCNT2,KCNT2_HUMAN,8.68,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2439,,ACTIVATOR,,Tbio,,,Homo sapiens
217135,1935,4014,Sodium-dependent neutral amino acid transporter B(0)AT1,Unclassified,Q2A865,Slc6a19,S6A19_RAT,4.64,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7401,,INHIBITOR,,,,,Rattus norvegicus
217136,1937,907,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,O60840,CACNA1F,CAC1F_HUMAN,6,,IC50,,IUPHAR,~,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2523,,GATING INHIBITOR,,Tclin,,,Homo sapiens
217137,1937,1853,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,6.8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2523,,GATING INHIBITOR,,,,,Rattus norvegicus
217138,1937,437,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q13698,CACNA1S,CAC1S_HUMAN,6,,IC50,,IUPHAR,~,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2523,,GATING INHIBITOR,,Tclin,,,Homo sapiens
217139,1947,907,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,O60840,CACNA1F,CAC1F_HUMAN,6,,IC50,,IUPHAR,~,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334,,GATING INHIBITOR,,Tclin,,,Homo sapiens
217140,1947,1853,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,P22002,Cacna1c,CAC1C_RAT,6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334,,GATING INHIBITOR,,,,,Rattus norvegicus
217141,1947,1960,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q02485,Cacna1s,CAC1S_RAT,6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2334,,GATING INHIBITOR,,,,,Rattus norvegicus
217142,1980,4019,Somatostatin receptor type 2,Unclassified,P30680,Sstr2,SSR2_RAT,8.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2055,,AGONIST,,,,,Rattus norvegicus
217143,1980,4088,Somatostatin receptor type 3,Unclassified,P30936,Sstr3,SSR3_RAT,7.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2055,,AGONIST,,,,,Rattus norvegicus
217145,2042,1971,Vasopressin V1a receptor,GPCR,P30560,Avpr1a,V1AR_RAT,6.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2174,,AGONIST,,,,,Rattus norvegicus
217146,2045,2568,G-protein coupled receptor 55,GPCR,Q9Y2T6,GPR55,GPR55_HUMAN,8.4,,EC50,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
217147,2073,4087,Trifunctional purine biosynthetic protein adenosine-3,Unclassified,Q64737,Gart,PUR2_MOUSE,5.03,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6837,,INHIBITOR,,,,,Mus musculus
217148,2105,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,7.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=48,,AGONIST,,,,,Rattus norvegicus
217149,2112,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,4.74,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7556,,ANTAGONIST,,,,,Rattus norvegicus
217150,2113,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,7.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=209,,ANTAGONIST,,,,,Rattus norvegicus
217151,2113,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=209,,ANTAGONIST,,,,,Rattus norvegicus
217152,2123,216,Cytochrome P450 2C8,Enzyme,P10632,CYP2C8,CP2C8_HUMAN,5.14,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7266,,INHIBITOR,,Tbio,,,Homo sapiens
217153,2144,4075,Probable G-protein coupled receptor 139,Unclassified,Q6DWJ6,GPR139,GP139_HUMAN,4.51,,IC50,Measured using a GTP&gamma;S assay in transfected COS7 cells.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3313,,AGONIST,,,,,Homo sapiens
217154,2168,3940,Peptidyl-prolyl cis-trans isomerase FKBP1A,Unclassified,Q62658,Fkbp1a,FKB1A_RAT,8.22,,IC50,Indirect measurement of primary target inhibition via rotamase inhibition,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6783,,INHIBITOR,,,,,Rattus norvegicus
217155,2172,4054,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O54898,Cacna1g,CAC1G_RAT,7.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=90,,BLOCKER,,,,,Rattus norvegicus
217156,2172,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=90,,ANTAGONIST,,,,,Rattus norvegicus
217157,2172,3990,G protein-activated inward rectifier potassium channel 2,Ion channel,P48542,Kcnj6,KCNJ6_MOUSE,5.5,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=90,,GATING INHIBITOR,,,,,Mus musculus
217158,2172,3923,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,Q9EQ60,Cacna1h,CAC1H_RAT,7.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=90,,BLOCKER,,,,,Rattus norvegicus
217159,2232,3967,Growth hormone secretagogue receptor type 1,Unclassified,O08725,Ghsr,GHSR_RAT,9.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1092,,AGONIST,,,,,Rattus norvegicus
217160,2268,3969,Transient receptor potential cation channel subfamily V member 2,Unclassified,Q9WUD2,Trpv2,TRPV2_RAT,4.5,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4357,,ACTIVATOR,,,,,Rattus norvegicus
217161,2302,2382,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Ion channel,O88704,Hcn1,HCN1_MOUSE,5.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5464,,BLOCKER,,,,,Mus musculus
217162,2332,4032,Multidrug and toxin extrusion protein 2,Unclassified,Q3V050,Slc47a2,S47A2_MOUSE,6.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4800,,INHIBITOR,,,,,Mus musculus
217163,2346,3962,Potassium channel subfamily T member 1,Unclassified,Q9Z258,Kcnt1,KCNT1_RAT,4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2342,,BLOCKER,,,,,Rattus norvegicus
217164,2354,4011,Prostaglandin D2 receptor 2,Unclassified,Q6XKD3,Ptgdr2,PD2R2_RAT,7.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1911,,ANTAGONIST,,,,,Rattus norvegicus
217165,2354,4067,Prostaglandin D2 receptor 2,Unclassified,Q9Z2J6,Ptgdr2,PD2R2_MOUSE,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1911,,ANTAGONIST,,,,,Mus musculus
217166,2358,3593,Histamine H2 receptor,Unclassified,P25102,Hrh2,HRH2_RAT,6.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1234,,ANTAGONIST,,,,,Rattus norvegicus
217167,2360,1766,Cholecystokinin receptor type A,GPCR,P30551,Cckar,CCKAR_RAT,4.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=871,,AGONIST,,,,,Rattus norvegicus
217168,2377,2703,Solute carrier organic anion transporter family member 1A2,Unclassified,P46721,SLCO1A2,SO1A2_HUMAN,4.29,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2765,,INHIBITOR,,Tbio,,,Homo sapiens
217169,2377,547,Solute carrier organic anion transporter family member 1B1,Transporter,Q9Y6L6,SLCO1B1,SO1B1_HUMAN,5.96,,Ki,Inhibition of atorvastatin transport by OATP1B1.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2765,,INHIBITOR,,Tchem,,,Homo sapiens
217170,2382,3968,Small conductance calcium-activated potassium channel protein 2,Unclassified,P70604,Kcnn2,KCNN2_RAT,4.89,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2326,,ACTIVATOR,,,,,Rattus norvegicus
217171,2382,3268,Small conductance calcium-activated potassium channel protein 1,Ion channel,Q92952,KCNN1,KCNN1_HUMAN,4.68,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2326,,ACTIVATOR,,Tchem,,,Homo sapiens
217172,2440,3935,Potassium voltage-gated channel subfamily D member 3,Unclassified,Q62897,Kcnd3,KCND3_RAT,4.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2586,,BLOCKER,,,,,Rattus norvegicus
217173,2457,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7483,,ANTAGONIST,,Tclin,,,Homo sapiens
217174,2457,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7483,,ANTAGONIST,,Tclin,,,Homo sapiens
217175,2459,4058,Platelet-derived growth factor receptor beta,Unclassified,P05622,Pdgfrb,PGFRB_MOUSE,7.24,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5711,,INHIBITOR,,,,,Mus musculus
217176,2459,3961,Vascular endothelial growth factor receptor 3,Unclassified,P35917,Flt4,VGFR3_MOUSE,7.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5711,,INHIBITOR,,,,,Mus musculus
217177,2470,3934,5-hydroxytryptamine receptor 1B,Unclassified,P28334,Htr1b,5HT1B_MOUSE,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99,,ANTAGONIST,,,,,Mus musculus
217178,2470,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,5.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=99,,ANTAGONIST,,,,,Rattus norvegicus
217179,2538,1924,Prostaglandin E2 receptor EP3 subtype,GPCR,P30557,Ptger3,PE2R3_MOUSE,9.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1919,,AGONIST,,,,,Mus musculus
217180,2538,4068,Prostaglandin E2 receptor EP3 subtype,Unclassified,P34980,Ptger3,PE2R3_RAT,9.38,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1919,,AGONIST,,,,,Rattus norvegicus
217181,2538,1922,Prostaglandin E2 receptor EP1 subtype,GPCR,P35375,Ptger1,PE2R1_MOUSE,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1919,,AGONIST,,,,,Mus musculus
217182,2538,4093,Prostaglandin E2 receptor EP1 subtype,Unclassified,P70597,Ptger1,PE2R1_RAT,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1919,,AGONIST,,,,,Rattus norvegicus
217183,2543,4017,5-hydroxytryptamine receptor 5A,Unclassified,P30966,Htr5a,5HT5A_MOUSE,4.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=54,,AGONIST,,,,,Mus musculus
217184,2543,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,5.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=54,,ANTAGONIST,,,,,Rattus norvegicus
217185,2605,3933,Beta-3 adrenergic receptor,Unclassified,P25962,Adrb3,ADRB3_MOUSE,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=571,,ANTAGONIST,,,,,Mus musculus
217186,2605,3989,Beta-3 adrenergic receptor,Unclassified,P26255,Adrb3,ADRB3_RAT,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=571,,ANTAGONIST,,,,,Rattus norvegicus
217187,2620,3991,Adenosine receptor A2b,Unclassified,Q60614,Adora2b,AA2BR_MOUSE,5.25,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=413,,ANTAGONIST,,,,,Mus musculus
217188,2633,3916,Potassium voltage-gated channel subfamily C member 4,Unclassified,Q63734,Kcnc4,KCNC4_RAT,4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2579,,GATING INHIBITOR,,,,,Rattus norvegicus
217189,2637,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,8.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100,,ANTAGONIST,,,,,Rattus norvegicus
217190,2637,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100,,ANTAGONIST,,,,,Rattus norvegicus
217191,2637,3990,G protein-activated inward rectifier potassium channel 2,Ion channel,P48542,Kcnj6,KCNJ6_MOUSE,4.2,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=100,,GATING INHIBITOR,,,,,Mus musculus
217192,2657,848,Cytochrome P450 2B6,Enzyme,P20813,CYP2B6,CP2B6_HUMAN,6.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7307,,INHIBITOR,,Tbio,,,Homo sapiens
217193,2696,4084,ATP-sensitive inward rectifier potassium channel 11,Unclassified,Q61743,Kcnj11,KCJ11_MOUSE,4.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6848,,BLOCKER,,,,,Mus musculus
217194,2720,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,6.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5820,,AGONIST,,Tclin,,,Homo sapiens
217195,2720,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5820,,AGONIST,,Tclin,,,Homo sapiens
217196,2720,527,Prostaglandin D2 receptor,GPCR,Q13258,PTGDR,PD2R_HUMAN,8.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5820,,AGONIST,,Tclin,,,Homo sapiens
217197,2722,3980,Nuclear receptor subfamily 2 group C member 2,Unclassified,P49116,NR2C2,NR2C2_HUMAN,4.62,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2644,,AGONIST,,,,,Homo sapiens
217198,2775,3960,5-hydroxytryptamine receptor 4,Unclassified,P97288,Htr4,5HT4R_MOUSE,7.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=260,,ANTAGONIST,,,,,Mus musculus
217199,2780,4075,Probable G-protein coupled receptor 139,Unclassified,Q6DWJ6,GPR139,GP139_HUMAN,4.59,,IC50,Measured using a GTP&gamma;S assay in transfected COS7 cells.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=717,,AGONIST,,,,,Homo sapiens
217200,2784,2471,Trace amine-associated receptor 1,GPCR,Q923Y8,Taar1,TAAR1_MOUSE,7.1,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2150,,AGONIST,,,,,Mus musculus
217201,2784,2470,Trace amine-associated receptor 1,GPCR,Q923Y9,Taar1,TAAR1_RAT,7.2,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2150,,AGONIST,,,,,Rattus norvegicus
217202,2815,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.22,,Ki,Inhibition of testosterone 6&beta;-hydroxylation.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2406,,INHIBITOR,,Tclin,,,Homo sapiens
217203,2815,3954,Potassium voltage-gated channel subfamily C member 2,Unclassified,P22462,Kcnc2,KCNC2_RAT,4.9,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2406,,BLOCKER,,,,,Rattus norvegicus
217204,2815,4073,Two pore calcium channel protein 2,Unclassified,Q8NHX9,TPCN2,TPC2_HUMAN,5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2406,,BLOCKER,,,,,Homo sapiens
217205,2815,3984,Two pore calcium channel protein 1,Unclassified,Q9ULQ1,TPCN1,TPC1_HUMAN,4.64,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2406,,BLOCKER,,,,,Homo sapiens
217206,2824,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,4.2,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=345,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
217207,2824,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,4.6,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=345,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
217208,2824,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.1,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=345,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
217209,2824,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.2,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=345,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
217210,2831,3980,Nuclear receptor subfamily 2 group C member 2,Unclassified,P49116,NR2C2,NR2C2_HUMAN,4.71,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4053,,AGONIST,,,,,Homo sapiens
217211,2868,4015,Farnesyl pyrophosphate synthase,Unclassified,P05369,Fdps,FPPS_RAT,6.3,,IC50,in vitro using kidney cell lines,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3177,,INHIBITOR,,,,,Rattus norvegicus
217212,2875,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,8.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103,,ANTAGONIST,,,,,Rattus norvegicus
217213,2875,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,8.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=103,,ANTAGONIST,,,,,Rattus norvegicus
217214,2878,4077,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Unclassified,P54282,Cacna1a,CAC1A_RAT,6.3,,IC50,,IUPHAR,=,,,,,BLOCKER,,,,,Rattus norvegicus
217215,2949,178,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,P62942,FKBP1A,FKB1A_HUMAN,8.55,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7974,,INHIBITOR,,Tclin,,,Homo sapiens
217216,2966,4056,P2X purinoceptor 1,Unclassified,P47824,P2rx1,P2RX1_RAT,6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728,,ANTAGONIST,,,,,Rattus norvegicus
217217,2966,3939,P2X purinoceptor 2,Unclassified,P49653,P2rx2,P2RX2_RAT,4.98,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728,,ANTAGONIST,,,,,Rattus norvegicus
217218,2966,3931,P2X purinoceptor 3,Unclassified,P49654,P2rx3,P2RX3_RAT,5.52,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728,,ANTAGONIST,,,,,Rattus norvegicus
217219,2966,4096,P2X purinoceptor 5,Unclassified,P51578,P2rx5,P2RX5_RAT,5.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728,,ANTAGONIST,,,,,Rattus norvegicus
217220,2966,830,P2Y purinoceptor 6,GPCR,Q15077,P2RY6,P2RY6_HUMAN,4,,Kb,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1728,,ANTAGONIST,,Tchem,,,Homo sapiens
217221,3064,4025,Potassium voltage-gated channel subfamily A member 1,Unclassified,P16388,Kcna1,KCNA1_MOUSE,4.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2486,,BLOCKER,,,,,Mus musculus
217222,3064,4076,Potassium voltage-gated channel subfamily A member 2,Unclassified,P63142,Kcna2,KCNA2_RAT,4.4,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2486,,BLOCKER,,,,,Rattus norvegicus
217223,3064,3986,Potassium voltage-gated channel subfamily A member 7,Unclassified,Q17ST2,Kcna7,KCNA7_MOUSE,4.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2486,,BLOCKER,,,,,Mus musculus
217224,3064,3971,Transient receptor potential cation channel subfamily V member 1,Unclassified,Q704Y3,Trpv1,TRPV1_MOUSE,8,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2486,,ACTIVATOR,,,,,Mus musculus
217225,3165,3958,Thromboxane A2 receptor,Unclassified,P30987,Tbxa2r,TA2R_MOUSE,9.2,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1979,,ANTAGONIST,,,,,Mus musculus
217226,3294,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=87,,ANTAGONIST,,,,,Rattus norvegicus
217227,3294,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,7.4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=87,,ANTAGONIST,,,,,Rattus norvegicus
217228,3294,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=87,,ANTAGONIST,,,,,Rattus norvegicus
217229,3396,2470,Trace amine-associated receptor 1,GPCR,Q923Y9,Taar1,TAAR1_RAT,5.9,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2149,,AGONIST,,,,,Rattus norvegicus
217230,3542,1805,Type-2 angiotensin II receptor,GPCR,P35351,Agtr2,AGTR2_RAT,9,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=598,,ANTAGONIST,,,,,Rattus norvegicus
217231,3580,426,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,6.63,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2648,,AGONIST,,Tclin,,,Homo sapiens
217232,3580,427,Retinoic acid receptor gamma,Nuclear hormone receptor,P13631,RARG,RARG_HUMAN,6.23,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2648,,AGONIST,,Tclin,,,Homo sapiens
217233,3639,3997,P2Y purinoceptor 4,Unclassified,O35811,P2ry4,P2RY4_RAT,5.6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1734,,AGONIST,,,,,Rattus norvegicus
217234,3659,3934,5-hydroxytryptamine receptor 1B,Unclassified,P28334,Htr1b,5HT1B_MOUSE,8.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,,,,Mus musculus
217235,3659,4060,5-hydroxytryptamine receptor 1F,Unclassified,P30940,Htr1f,5HT1F_RAT,6.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,,,,Rattus norvegicus
217236,3659,1835,5-hydroxytryptamine receptor 2B,GPCR,P30994,Htr2b,5HT2B_RAT,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=102,,ANTAGONIST,,,,,Rattus norvegicus
217238,3972,4094,P2X purinoceptor 4,Unclassified,P51577,P2rx4,P2RX4_RAT,6.6,,EC50,,IUPHAR,~,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2373,,ALLOSTERIC MODULATOR,,,,,Rattus norvegicus
217239,4109,3969,Transient receptor potential cation channel subfamily V member 2,Unclassified,Q9WUD2,Trpv2,TRPV2_RAT,4.85,,EC50,,IUPHAR,=,,,,,ACTIVATOR,,,,,Rattus norvegicus
217240,4110,1971,Vasopressin V1a receptor,GPCR,P30560,Avpr1a,V1AR_RAT,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2226,,ANTAGONIST,,,,,Rattus norvegicus
217241,4110,1863,Vasopressin V2 receptor,GPCR,Q00788,Avpr2,V2R_RAT,8.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2226,,ANTAGONIST,,,,,Rattus norvegicus
217242,4163,3946,Potassium voltage-gated channel subfamily C member 1,Unclassified,P15388,Kcnc1,KCNC1_MOUSE,4.5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2416,,BLOCKER,,,,,Mus musculus
217243,4163,3954,Potassium voltage-gated channel subfamily C member 2,Unclassified,P22462,Kcnc2,KCNC2_RAT,4.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2416,,BLOCKER,,,,,Rattus norvegicus
217244,4167,3959,Transient receptor potential cation channel subfamily M member 7,Unclassified,Q923J1,Trpm7,TRPM7_MOUSE,6.14,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2407,,BLOCKER,,,,,Mus musculus
217245,4168,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,8.69,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7461,,ANTAGONIST,,,,,Rattus norvegicus
217246,4168,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.17,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7461,,AGONIST,,,,,Rattus norvegicus
217247,4168,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.77,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7461,,ANTAGONIST,,,,,Rattus norvegicus
217248,4184,548,Equilibrative nucleoside transporter 1,Transporter,Q99808,SLC29A1,S29A1_HUMAN,7.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1765,,INHIBITOR,,Tclin,,,Homo sapiens
217249,4186,4044,B2 bradykinin receptor,Unclassified,P32299,Bdkrb2,BKRB2_MOUSE,9.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=667,,ANTAGONIST,,,,,Mus musculus
217250,4247,3938,Extracellular calcium-sensing receptor,Unclassified,P48442,Casr,CASR_RAT,4,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=709,,AGONIST,,,,,Rattus norvegicus
217251,4265,3917,Transient receptor potential cation channel subfamily A member 1,Unclassified,Q8BLA8,Trpa1,TRPA1_MOUSE,5.2,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2427,,GATING INHIBITOR,,,,,Mus musculus
217252,4289,4047,Transient receptor potential cation channel subfamily A member 1,Unclassified,Q6RI86,Trpa1,TRPA1_RAT,4.4,,EC50,Patch clamp,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1051,,ACTIVATOR,,,,,Rattus norvegicus
217253,4310,1798,Sodium channel protein type 2 subunit alpha,Ion channel,P04775,Scn2a,SCN2A_RAT,4.52,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7472,,BLOCKER,,,,,Rattus norvegicus
217254,4329,4019,Somatostatin receptor type 2,Unclassified,P30680,Sstr2,SSR2_RAT,9.07,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2018,,AGONIST,,,,,Rattus norvegicus
217255,4376,4016,cGMP-gated cation channel alpha-1,Unclassified,P29973,CNGA1,CNGA1_HUMAN,6.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2313,,BLOCKER,,,,,Homo sapiens
217256,4376,4050,Cyclic nucleotide-gated olfactory channel,Unclassified,Q16280,CNGA2,CNGA2_HUMAN,5.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2313,,BLOCKER,,,,,Homo sapiens
217257,4420,1787,5-hydroxytryptamine receptor 7,GPCR,P32304,Htr7,5HT7R_MOUSE,7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=282,,ANTAGONIST,,,,,Mus musculus
217258,4420,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,6.5,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=282,,ANTAGONIST,,,,,Rattus norvegicus
217259,4420,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.48,,Ki,Biased for &beta;-arrestin signalling.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=282,,AGONIST,,Tclin,,,Homo sapiens
217260,4482,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=508,,AGONIST,,Tclin,,,Homo sapiens
217261,4508,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
217262,4508,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
217263,4508,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,5.1,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
217264,4514,3993,Parathyroid hormone 2 receptor,Unclassified,P70555,Pth2r,PTH2R_RAT,6.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4448,,AGONIST,,,,,Rattus norvegicus
217265,4588,3999,Potassium voltage-gated channel subfamily KQT member 3,Unclassified,O88944,Kcnq3,KCNQ3_RAT,5.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2599,,INHIBITOR,,,,,Rattus norvegicus
217266,4588,4091,Potassium voltage-gated channel subfamily KQT member 1,Unclassified,P97414,Kcnq1,KCNQ1_MOUSE,4.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2599,,INHIBITOR,,,,,Mus musculus
217267,4622,4006,Heat-stable enterotoxin receptor,Unclassified,P23897,Gucy2c,GUC2C_RAT,8.38,,Ki,Competitive-inhibition of [<sup>125</sup>I]-STa binding to rat intestinal mucosa,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5017,,AGONIST,,,,,Rattus norvegicus
217268,4633,4101,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O54915,Nr1i2,NR1I2_MOUSE,8.52,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2774,,ANTAGONIST,,,,,Mus musculus
217269,4655,3986,Potassium voltage-gated channel subfamily A member 7,Unclassified,Q17ST2,Kcna7,KCNA7_MOUSE,4.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2567,,BLOCKER,,,,,Mus musculus
217270,4710,2499,Vasoactive intestinal polypeptide receptor 1,GPCR,P32241,VIPR1,VIPR1_HUMAN,6.2,,Ki,inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor,IUPHAR,=,,,,,AGONIST,,Tbio,,,Homo sapiens
217271,4716,2236,Cyclin-dependent kinase 8,Kinase,P49336,CDK8,CDK8_HUMAN,8.17,,Kd,CDK8/cyclin C.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5890,,INHIBITOR,,Tchem,,,Homo sapiens
217272,4716,2235,Cyclin-dependent kinase 19,Kinase,Q9BWU1,CDK19,CDK19_HUMAN,7.92,,Kd,CDK19/cyclin C.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5890,,INHIBITOR,,Tchem,,,Homo sapiens
217273,4752,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,7.49,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8035,,ANTAGONIST,,Tclin,,,Homo sapiens
217274,4806,1872,5-hydroxytryptamine receptor 1D,GPCR,P28565,Htr1d,5HT1D_RAT,5.4,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7351,,ANTAGONIST,,,,,Rattus norvegicus
217275,4816,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,10.3,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7354,,ANTAGONIST,,Tclin,,,Homo sapiens
217276,4816,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,9.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7354,,ANTAGONIST,,Tclin,,,Homo sapiens
217277,4817,2703,Solute carrier organic anion transporter family member 1A2,Unclassified,P46721,SLCO1A2,SO1A2_HUMAN,4.96,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4570,,INHIBITOR,,Tbio,,,Homo sapiens
217278,4817,547,Solute carrier organic anion transporter family member 1B1,Transporter,Q9Y6L6,SLCO1B1,SO1B1_HUMAN,5.7,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4570,,INHIBITOR,,Tchem,,,Homo sapiens
217279,4829,474,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,P27815,PDE4A,PDE4A_HUMAN,7.85,,IC50,Potency against recombinant human PDE4A1A isoform in a TR-FRET assay.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7372,,INHIBITOR,,Tclin,,,Homo sapiens
217280,4829,825,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",Enzyme,Q08493,PDE4C,PDE4C_HUMAN,6.93,,IC50,Potency against recombinant human PDE4C1 isoform in a TR-FRET assay.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7372,,INHIBITOR,,Tclin,,,Homo sapiens
217281,4858,3956,Corticotropin-releasing factor receptor 2,Unclassified,P47866,Crhr2,CRFR2_RAT,7.9,,Kd,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
217282,4858,3929,Corticotropin-releasing factor receptor 2,Unclassified,Q60748,Crhr2,CRFR2_MOUSE,7.8,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Mus musculus
217283,4927,2306,Glucagon-like peptide 1 receptor,GPCR,P32301,Glp1r,GLP1R_RAT,7.7,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7386,,AGONIST,,,,,Rattus norvegicus
217284,4945,1766,Cholecystokinin receptor type A,GPCR,P30551,Cckar,CCKAR_RAT,9.3,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3551,,AGONIST,,,,,Rattus norvegicus
217285,4988,263,fMet-Leu-Phe receptor,GPCR,P21462,FPR1,FPR1_HUMAN,4,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=610,,ANTAGONIST,,Tchem,,,Homo sapiens
217286,4988,924,G-protein coupled bile acid receptor 1,GPCR,Q8TDU6,GPBAR1,GPBAR_HUMAN,6.2,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=610,,AGONIST,,Tchem,,,Homo sapiens
217287,5006,4038,Uracil nucleotide/cysteinyl leukotriene receptor,Unclassified,Q6NS65,Gpr17,GPR17_MOUSE,8.92,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1776,,ANTAGONIST,,,,,Mus musculus
217288,5046,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,6.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7626,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
217289,5052,1763,5-hydroxytryptamine receptor 2A,GPCR,P14842,Htr2a,5HT2A_RAT,7.7,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
217290,5052,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.2,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
217291,5052,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.1,,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
217292,5052,1878,D(4) dopamine receptor,GPCR,P30729,Drd4,DRD4_RAT,7.3,,Ki,,IUPHAR,=,,,,,ANTAGONIST,,,,,Rattus norvegicus
217293,5052,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,6.8,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
217294,5052,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.8,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
217295,5052,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,9.7,,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
217296,5077,3978,Prostacyclin receptor,Unclassified,P43253,Ptgir,PI2R_RAT,5.68,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7552,,AGONIST,,,,,Rattus norvegicus
217297,5143,4100,Catechol O-methyltransferase,Enzyme,O88587,Comt,COMT_MOUSE,8.82,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8988,,INHIBITOR,,,,,Mus musculus
217298,5143,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,8.82,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8988,,INHIBITOR,,,,,Rattus norvegicus
217299,5169,1804,Vitamin D3 receptor,Transcription factor,P13053,Vdr,VDR_RAT,8,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2783,,AGONIST,,,,,Rattus norvegicus
217300,5211,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,6.28,,IC50,Assay used apatinib mesylate (YN968D1),IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7648,,INHIBITOR,,Tchem,,,Homo sapiens
217301,5227,2286,Synaptic vesicular amine transporter,Transporter,Q01827,Slc18a2,VMAT2_RAT,6.73,,Ki,Displacement binding assay using rat brain homogenate.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8694,,INHIBITOR,,,,,Rattus norvegicus
217302,5229,386,Purine nucleoside phosphorylase,Enzyme,P00491,PNP,PNPH_HUMAN,10.142667770385742,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/9628722,http://www.ncbi.nlm.nih.gov/pubmed/17897085,INHIBITOR,,Tclin,660,661,Homo sapiens
217303,5231,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,7.96,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5702,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207997Orig1Orig2s000lbl.pdf,INHIBITOR,,Tclin,,662,Homo sapiens
217304,5232,2684,Parathyroid hormone/parathyroid hormone-related peptide receptor,GPCR,Q03431,PTH1R,PTH1R_HUMAN,9.699999809265137,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26562265,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208743lbl.pdf,AGONIST,,Tclin,664,663,Homo sapiens
217305,5233,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,9.221848487854004,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/27780853,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208772lbl.pdf,INHIBITOR,,Tclin,666,665,Homo sapiens
217306,5233,2282,Proto-oncogene tyrosine-protein kinase ROS,Kinase,P08922,ROS1,ROS1_HUMAN,8.721246719360352,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/27780853,,INHIBITOR,,Tclin,666,,Homo sapiens
217307,5233,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,8.677781105041504,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/27780853,,INHIBITOR,,Tclin,666,,Homo sapiens
217309,5233,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,7.173925399780273,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/27780853,,INHIBITOR,,Tclin,666,,Homo sapiens
217310,5233,609,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,7.136677265167236,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/27780853,,INHIBITOR,,Tclin,666,,Homo sapiens
217312,5233,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,6.79587984085083,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/27780853,,INHIBITOR,,Tclin,666,,Homo sapiens
217313,5234,3714,Programmed cell death 1 ligand 1,CD molecules,Q9NZQ7,CD274,PD1L1_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761069s000lbl.pdf,ANTIBODY BINDING,,Tclin,,667,Homo sapiens
217314,5230,4103,Peptide,Unclassified,,,,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761052lbl.pdf,PROTEOLYTIC ENZYME,,,,668,
217315,4794,4104,Bacterial cell membrane,Cell membrane,,,,,,,,UNKNOWN,,1,DRUG LABEL,,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b7aa0bae-255b-4792-a963-6606370a175f,MEMBRANE PERMEABILIZER,,,,669,
217316,197,4105,Ergosterol,Metabolite,,,,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050740s021lbl.pdf,SEQUESTERING AGENT,,,,670,
217317,5237,3004,Interleukin-6 receptor,Membrane receptor,P08887|P40189,IL6R|IL6ST,IL6RA_HUMAN|IL6RB_HUMAN,11.100000381469727,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7999,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761037s000lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin,,671,Homo sapiens
217319,2402,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,8.14,,Ki,,IUPHAR,=,1,IUPHAR,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7295,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7295,AGONIST,,Tclin,,,Homo sapiens
217320,5240,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,8.080851554870605,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/14761182,http://www.ncbi.nlm.nih.gov/pubmed/22278334,INHIBITOR,,Tclin,672,675,Homo sapiens
217321,5240,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,6.080851078033447,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/14761182,,INHIBITOR,,Tclin,672,,Homo sapiens
217322,5239,550,Dipeptidyl peptidase 4,Enzyme,P27487,DPP4,DPP4_HUMAN,9.045757293701172,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/21570283,http://www.ncbi.nlm.nih.gov/pubmed/21093089,INHIBITOR,,Tclin,673,674,Homo sapiens
217323,5241,631,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,8.823908805847168,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/19297154,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208383s000lbl.pdf,INHIBITOR,,Tclin,676,677,Homo sapiens
217324,5245,3195,Follicle-stimulating hormone receptor,GPCR,P23945,FSHR,FSHR_HUMAN,,,,,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/1446593,AGONIST,,Tclin,,678,Homo sapiens
217325,5246,3513,Interleukin-23,Cytokine,P29460|Q9NPF7,IL12B|IL23A,IL12B_HUMAN|IL23A_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761061s000lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin,,679,Homo sapiens
217327,5247,4106,B-cell receptor CD22,Membrane receptor,P20273,CD22,CD22_HUMAN,9.7,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8266,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004119/WC500231261.pdf,ANTIBODY BINDING,,Tclin,,680,Homo sapiens
217328,5247,6,DNA,DNA,,,,,,,,UNKNOWN,,1,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004119/WC500231261.pdf,DNA STRAND BREAK,,,,680,
217329,5248,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,9,,EC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/17553678,http://www.ncbi.nlm.nih.gov/pubmed/17553678,AGONIST,,Tclin,681,681,Homo sapiens
217330,5248,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,5.958607196807861,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/17553678,,AGONIST,,Tclin,681,,Homo sapiens
217331,5248,771,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,Q03181,PPARD,PPARD_HUMAN,5.801342964172363,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/17553678,,AGONIST,,Tchem,681,,Homo sapiens
217332,5250,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,7.823908805847168,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,"Bai AP, Guo ZR, Hu WH, Shen F, Cheng GF., Design, synthesis and in vitro evaluation of a new class of novel cyclooxygenase-2 inhibitors: 3,4-diaryl-3-pyrrolin-2-ones., Chin Chem Lett, 2001, 12, 9, 775–8",http://www.ncbi.nlm.nih.gov/pubmed/15210067,INHIBITOR,,Tclin,682,688,Homo sapiens
217333,5242,2536,Genome polyprotein,Polyprotein,P26663,,POLG_HCVBK,10.42021656036377,,Ki,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209195s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209195s000lbl.pdf,INHIBITOR,,,683,683,Hepatitis C virus genotype 1b (isolate BK)
217334,5242,3720,Genome polyprotein,Polyprotein,Q81495,,POLG_HCVK3,10.180456161499023,,Ki,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209195s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209195s000lbl.pdf,INHIBITOR,,,683,683,Hepatitis C virus genotype 3a (isolate k3a) (HCV)
217335,5251,4107,"Isocitrate dehydrogenase [NADP], mitochondrial",Enzyme,P48735,IDH2,IDHP_HUMAN,7,,IC50,inhibition of 2HG production by the IDH2(R140Q) homodimer,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/28193778,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209606s000lbl.pdf,INHIBITOR,,Tclin,684,685,Homo sapiens
217336,5252,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,7.036211967468262,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/15715478,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208051s000lbl.pdf,INHIBITOR,,Tclin,686,687,Homo sapiens
217337,5252,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,7.229147911071777,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/15715478,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208051s000lbl.pdf,INHIBITOR,,Tclin,686,687,Homo sapiens
217338,5252,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,8.619789123535156,,Kd,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/22037378,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208051s000lbl.pdf,INHIBITOR,,Tclin,104,687,Homo sapiens
217339,5235,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004209/WC500232105.pdf,AGONIST,,Tclin,,689,Homo sapiens
217340,5235,4108,Tumor necrosis factor receptor superfamily member 16,Membrane receptor,P08138,NGFR,TNR16_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004209/WC500232105.pdf,AGONIST,,Tclin,,689,Homo sapiens
217383,4810,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,10,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tchem,1198,,Homo sapiens
217384,4810,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,8.481486,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tchem,1198,,Homo sapiens
217385,4810,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,7.537602,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tclin,1198,,Homo sapiens
217387,4810,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,7.537602,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tclin,1198,,Homo sapiens
217389,4810,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,8.200659,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tclin,1198,,Homo sapiens
217390,4810,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7.721246,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tclin,1198,,Homo sapiens
217391,4810,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,8.387216,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tclin,1198,,Homo sapiens
217392,4810,1822,Tyrosine-protein kinase ITK/TSK,Kinase,Q08881,ITK,ITK_HUMAN,8.309804,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tclin,1198,,Homo sapiens
217393,4810,2069,Tyrosine-protein kinase Tec,Kinase,P42680,TEC,TEC_HUMAN,8.154902,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tchem,1198,,Homo sapiens
217394,4810,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,8.69897,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tchem,1198,,Homo sapiens
217395,4810,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,8.19382,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tclin,1198,,Homo sapiens
217396,4810,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,8.468521,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tclin,1198,,Homo sapiens
217397,4810,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,7.49485,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tclin,1198,,Homo sapiens
217398,5260,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,8.29243,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26641137,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/210259s000lbl.pdf,INHIBITOR,,Tclin,1198,1298,Homo sapiens
217399,5260,746,Cytoplasmic tyrosine-protein kinase BMX,Kinase,P51813,BMX,BMX_HUMAN,7.337242,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tchem,1198,,Homo sapiens
217400,5260,2069,Tyrosine-protein kinase Tec,Kinase,P42680,TEC,TEC_HUMAN,7.031517,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tchem,1198,,Homo sapiens
217401,5260,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,6.434152,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tchem,1198,,Homo sapiens
217402,5260,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,7.79588,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26641137,,INHIBITOR,,Tclin,1198,,Homo sapiens
217403,5258,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,9.677781,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/16982756,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004131/WC500239033.pdf,INHIBITOR,,Tclin,1300,1299,Homo sapiens
217404,5258,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,9.79588,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/16982756,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004131/WC500239033.pdf,INHIBITOR,,Tclin,1300,1299,Homo sapiens
217405,5258,543,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,9.619789,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/16982756,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004131/WC500239033.pdf,INHIBITOR,,Tclin,1300,1299,Homo sapiens
217406,5258,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,8.787812,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/16982756,,INHIBITOR,,Tclin,1300,,Homo sapiens
217407,5258,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,8.764472,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/16982756,,INHIBITOR,,Tclin,1300,,Homo sapiens
217408,5258,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,6.374688,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/16982756,,INHIBITOR,,Tclin,1300,,Homo sapiens
217409,5258,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,6.524329,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/16982756,,INHIBITOR,,Tclin,1300,,Homo sapiens
217410,5258,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,5.866461,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/16982756,,INHIBITOR,,Tclin,1300,,Homo sapiens
217412,2989,2708,Calcitonin receptor,GPCR,P30988,CALCR,CALCR_HUMAN,11.08566,,EC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/14623894,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017808s036lbl.pdf,AGONIST,,Tclin,1400,305,Homo sapiens
217413,2989,2980,Amylin receptor AMY1,GPCR,O60894|P30988,CALCR|RAMP1,CALCR_HUMAN|RAMP1_HUMAN,9.649752,,IC50,IC50 values for peptides in competition for 125I-labeled salmon CT binding to COS-7 cells cotransfected with 100 ng of hCTR and 100 ng of RAMP.,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/10385705,,AGONIST,,Tclin|Tclin,1500,,Homo sapiens
217414,2989,2981,Amylin receptor AMY2,GPCR,O60895|P30988,CALCR|RAMP2,CALCR_HUMAN|RAMP2_HUMAN,9.872895,,IC50,IC50 values for peptides in competition for 125I-labeled salmon CT binding to COS-7 cells cotransfected with 100 ng of hCTR and 100 ng of RAMP.,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/10385705,,AGONIST,,Tchem|Tclin,1500,,Homo sapiens
217415,2989,2982,Amylin receptor AMY3,GPCR,O60896|P30988,CALCR|RAMP3,CALCR_HUMAN|RAMP3_HUMAN,9.498941,,IC50,IC50 values for peptides in competition for 125I-labeled salmon CT binding to COS-7 cells cotransfected with 100 ng of hCTR and 100 ng of RAMP.,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/10385705,,AGONIST,,Tclin|Tclin,1500,,Homo sapiens
217418,4427,2708,Calcitonin receptor,GPCR,P30988,CALCR,CALCR_HUMAN,7.809668,,IC50,IC50 values for peptides in competition for 125I-labeled salmon CT binding to COS-7 cells cotransfected with 100 ng of hCTR and 100 ng of RAMP.,SCIENTIFIC LITERATURE,=,1,CHEMBL,http://www.ncbi.nlm.nih.gov/pubmed/10385705,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201614,AGONIST,,Tclin,1500,,Homo sapiens
217419,4427,2980,Amylin receptor AMY1,GPCR,O60894|P30988,CALCR|RAMP1,CALCR_HUMAN|RAMP1_HUMAN,7.530178,,IC50,IC50 values for peptides in competition for 125I-labeled salmon CT binding to COS-7 cells cotransfected with 100 ng of hCTR and 100 ng of RAMP.,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/10385705,,AGONIST,,Tclin|Tclin,1500,,Homo sapiens
217420,4427,2981,Amylin receptor AMY2,GPCR,O60895|P30988,CALCR|RAMP2,CALCR_HUMAN|RAMP2_HUMAN,8.082494,,IC50,IC50 values for peptides in competition for 125I-labeled salmon CT binding to COS-7 cells cotransfected with 100 ng of hCTR and 100 ng of RAMP.,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/10385705,,AGONIST,,Tchem|Tclin,1500,,Homo sapiens
217421,4427,2982,Amylin receptor AMY3,GPCR,O60896|P30988,CALCR|RAMP3,CALCR_HUMAN|RAMP3_HUMAN,7.705534,,IC50,IC50 values for peptides in competition for 125I-labeled salmon CT binding to COS-7 cells cotransfected with 100 ng of hCTR and 100 ng of RAMP.,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/10385705,,AGONIST,,Tclin|Tclin,1500,,Homo sapiens
217423,5270,51,Sodium/glucose cotransporter 2,Transporter,P31639,SLC5A2,SC5A2_HUMAN,9.057,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/21449606,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209803s000lbl.pdf,INHIBITOR,,Tclin,1700,1800,Homo sapiens
217424,5270,2059,Sodium/glucose cotransporter 1,Transporter,P13866,SLC5A1,SC5A1_HUMAN,5.707744,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/21449606,,INHIBITOR,,Tclin,1700,,Homo sapiens
217425,5272,385,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.3,,IC50,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2504,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209360s000lbl.pdf,AGONIST,,Tclin,,1901,Homo sapiens
217426,5272,862,Type-2 angiotensin II receptor,GPCR,P50052,AGTR2,AGTR2_HUMAN,10.2,,Kd,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2504,,AGONIST,,Tchem,,,Homo sapiens
217427,5278,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.79588,,IC50,equilibrium-binding affinity of ARN-509 for AR measured in competition with 16b-[18F]fluoro-5a-DHT,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/22266222,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210951s000lbl.pdf,INHIBITOR,,Tclin,1903,2003,Homo sapiens
217532,4858,4114,Corticotropin-releasing factor receptor 2,GPCR,Q13324,CRHR2,CRFR2_HUMAN,7.4,,Kd,,IUPHAR,=,,,,,AGONIST,,,,,Homo sapiens
217533,1440,4067,Prostaglandin D2 receptor 2,Unclassified,Q9Z2J6,Ptgdr2,PD2R2_MOUSE,6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1909,,AGONIST,,,,,Mus musculus
217536,875,4118,Steroid hormone receptor ERR1,Nuclear hormone receptor,O08580,Esrra,ERR1_MOUSE,5.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2801,,ANTAGONIST,,,,,Mus musculus
217537,4211,4115,Free fatty acid receptor 2,GPCR,O15552,FFAR2,FFAR2_HUMAN,4.6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1058,,AGONIST,,,,,Homo sapiens
217539,436,4119,Gonadotropin-releasing hormone receptor,GPCR,Q01776,Gnrhr,GNRHR_MOUSE,10.05,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3860,,AGONIST,,,,,Mus musculus
217540,2968,1962,Gonadotropin-releasing hormone receptor,GPCR,P30969,Gnrhr,GNRHR_RAT,8.8,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1177,,AGONIST,,,,,Rattus norvegicus
217541,4812,4120,Polyprotein,Polyprotein,Q6GYR8,,Q6GYR8_9HEPC,9.44,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7367,,INHIBITOR,,,,,Hepacivirus C
217543,182,2183,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,Q14164,IKBKE,IKKE_HUMAN,6,,IC50,Inhibition of substrate phosphorylation.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7113,,INHIBITOR,,Tchem,,,Homo sapiens
217545,626,3968,Small conductance calcium-activated potassium channel protein 2,Unclassified,P70604,Kcnn2,KCNN2_RAT,4.1,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2322,,ACTIVATOR,,,,,Rattus norvegicus
217546,4376,3968,Small conductance calcium-activated potassium channel protein 2,Unclassified,P70604,Kcnn2,KCNN2_RAT,6.8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2313,,BLOCKER,,,,,Rattus norvegicus
217547,2781,3968,Small conductance calcium-activated potassium channel protein 2,Unclassified,P70604,Kcnn2,KCNN2_RAT,5.6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2294,,BLOCKER,,,,,Rattus norvegicus
217548,1209,3990,G protein-activated inward rectifier potassium channel 2,Ion channel,P48542,Kcnj6,KCNJ6_MOUSE,4.8,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=203,,GATING INHIBITOR,,,,,Mus musculus
217549,3032,3962,Potassium channel subfamily T member 1,Unclassified,Q9Z258,Kcnt1,KCNT1_RAT,6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2338,,ACTIVATOR,,,,,Rattus norvegicus
217550,342,3962,Potassium channel subfamily T member 1,Unclassified,Q9Z258,Kcnt1,KCNT1_RAT,6,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2337,,GATING INHIBITOR,,,,,Rattus norvegicus
217552,5260,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8912,,INHIBITOR,,Tclin,,,Homo sapiens
217556,419,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,7.85,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7434,,AGONIST,,Tclin,,,Homo sapiens
217557,1388,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,9.95,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2868,,AGONIST,,Tclin,,,Homo sapiens
217558,1225,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,6.83,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7080,,AGONIST,,Tclin,,,Homo sapiens
217560,432,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,5.66,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2397,,BLOCKER,,Tclin,,,Homo sapiens
217561,2346,4072,Sodium channel protein type 5 subunit alpha,Unclassified,P15389,Scn5a,SCN5A_RAT,5,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2342,,BLOCKER,,,,,Rattus norvegicus
217562,1564,4121,Neurotensin receptor type 2,GPCR,P70310,Ntsr2,NTR2_MOUSE,8.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1586,,AGONIST,,,,,Mus musculus
217563,91,3997,P2Y purinoceptor 4,Unclassified,O35811,P2ry4,P2RY4_RAT,6.3,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1713,,AGONIST,,,,,Rattus norvegicus
217564,4829,149,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,Q07343,PDE4B,PDE4B_HUMAN,7.57,,IC50,Potency against recombinant human PDE4B1 and B2 isoforms in a TR-FRET assay.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7372,,INHIBITOR,,Tclin,,,Homo sapiens
217565,419,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,7.55,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7434,,AGONIST,,Tclin,,,Homo sapiens
217566,4514,4122,Parathyroid hormone/parathyroid hormone-related peptide receptor,GPCR,P25961,Pth1r,PTH1R_RAT,8.7,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4448,,AGONIST,,,,,Rattus norvegicus
217567,4890,4123,Sodium/glucose cotransporter 1,Transporter,Q8C3K6,Slc5a1,SC5A1_MOUSE,5.86,,IC50,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing mSGLT1.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9394,,INHIBITOR,,,,,Mus musculus
217568,4890,4124,Sodium/glucose cotransporter 1,Transporter,P53790,Slc5a1,SC5A1_RAT,5.93,,IC50,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing rSGLT1.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9394,,INHIBITOR,,,,,Rattus norvegicus
217569,4890,4125,Sodium/glucose cotransporter 2,Transporter,Q923I7,Slc5a2,SC5A2_MOUSE,8.25,,IC50,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing mSGLT2.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9394,,INHIBITOR,,,,,Mus musculus
217570,4890,2060,Sodium/glucose cotransporter 2,Transporter,P53792,Slc5a2,SC5A2_RAT,8.2,,IC50,Measuring inhibition of sodium-dependent [<sup>14</sup>C]AMG-uptake in CHO cells expressing rSGLT2.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9394,,INHIBITOR,,,,,Rattus norvegicus
217571,158,4126,Sodium/hydrogen exchanger 1,Transporter,P26431,Slc9a1,SL9A1_RAT,6,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2421,,INHIBITOR,,,,,Rattus norvegicus
217574,1546,1884,Somatostatin receptor type 2,GPCR,P30875,Sstr2,SSR2_MOUSE,9.1,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2031,,AGONIST,,,,,Mus musculus
217575,1980,4112,Somatostatin receptor type 5,GPCR,O08858,Sstr5,SSR5_MOUSE,9.9,,Ki,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2055,,AGONIST,,,,,Mus musculus
217576,2487,4113,Succinate receptor 1,GPCR,Q9BXA5,SUCNR1,SUCR1_HUMAN,4.7,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3637,,AGONIST,,,,,Homo sapiens
217577,182,2318,Serine/threonine-protein kinase TBK1,Kinase,Q9UHD2,TBK1,TBK1_HUMAN,6,,IC50,Inhibition of substrate phosphorylation.,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7113,,INHIBITOR,,Tchem,,,Homo sapiens
217578,3396,2471,Trace amine-associated receptor 1,GPCR,Q923Y8,Taar1,TAAR1_MOUSE,5.8,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2149,,AGONIST,,,,,Mus musculus
217579,934,3637,Transient receptor potential cation channel subfamily M member 8,Unclassified,Q8R455,Trpm8,TRPM8_RAT,4.2,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2430,,ACTIVATOR,,,,,Rattus norvegicus
217580,934,3583,Transient receptor potential cation channel subfamily M member 8,Unclassified,Q8R4D5,Trpm8,TRPM8_MOUSE,5.4,,EC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2430,,ACTIVATOR,,,,,Mus musculus
217632,4945,1767,Gastrin/cholecystokinin type B receptor,GPCR,P30553,Cckbr,GASR_RAT,9.39,,Ki,Binding affinity for Cholecystokinin type B receptor using [125I]-BH-CCK-8 in rat cortex synaptosomes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1121,,,,,,,Rattus norvegicus
217633,4945,1978,Cholecystokinin receptor type A,GPCR,Q63931,CCKAR,CCKAR_CAVPO,9.55,,Ki,Inhibition of [3H]pCCK-8 binding to Cholecystokinin type A receptor of Guinea pig pancreatic membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1121,,,,,,,Cavia porcellus
217634,5217,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,5.85,,Ki,Binding affinity to human Nicotinic acetylcholine receptor alpha7 expressed in IMR32 cells using [3H]alpha-bungarotoxin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL497939,,,,Tchem,,,Homo sapiens
217635,5217,1772,Acetylcholine receptor subunit delta,Ion channel,P02718,chrnd,ACHD_TORCA,4,,EC50,Compound was evaluated for functional potencies and efficacies at human Nicotinic acetylcholine receptor subtype TE671 (muscle),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL497939,,,,,,,Torpedo californica
217636,4458,1807,Endothelin-1 receptor,GPCR,P26684,Ednra,EDNRA_RAT,6.11,,IC50,Antagonism of [125 I]ET-1 binding to the rat endothelin receptor in vascular smooth muscle VSM-A10 cells.,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL453,,,,,,,Rattus norvegicus
217637,2251,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,5.6,,Ki,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,Tclin,,,Homo sapiens
217638,4458,457,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,6.11,,IC50,Inhibitory concentration against Endothelin A receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL453,,,,Tclin,,,Homo sapiens
217639,4458,458,Endothelin B receptor,GPCR,P24530,EDNRB,EDNRB_HUMAN,4.62,,IC50,Binding affinity against human Endothelin B receptor in transfected COS 7 cell membrane preparation,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL453,,,,Tclin,,,Homo sapiens
217640,4945,1848,Gastrin/cholecystokinin type B receptor,GPCR,P56481,Cckbr,GASR_MOUSE,9.52,,IC50,Evaluated for inhibition of cholecystokinin type B receptor by displacing [125I]-Bolton hunter CCK-8 radioligand in the mouse cerebral cortex,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1121,,,,,,,Mus musculus
217641,2646,1861,Thyroid hormone receptor beta,Transcription factor,P18113,Thrb,THB_RAT,7.46,,IC50,In vitro inhibition of the bound [125I]L-T3 rat liver nuclear L-triiodothyronine receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL559,,,,,,,Rattus norvegicus
217642,5229,4145,Purine nucleoside phosphorylase,Unclassified,P55859,PNP,PNPH_BOVIN,10.64,,Ki,Inhibitory activity of compound against bovine purine nucleoside phosphorylase (PNP),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218291,,,,,,,Bos taurus
217643,2251,1176,Glutamine synthetase,Enzyme,P15104,GLUL,GLNA_HUMAN,7.5,,EC50,Ability to induce human glutamine synthetase in skeletal muscle cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,Tchem,,,Homo sapiens
217644,4702,2110,Beta-1 adrenergic receptor,GPCR,B0FL73,ADRB1,B0FL73_CAVPO,7.62,,Kd,In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24,,,,,,,Cavia porcellus
217645,4702,1750,Beta-2 adrenergic receptor,GPCR,Q8K4Z4,Adrb2,ADRB2_CAVPO,5.93,,Kd,In vitro beta-2 adrenergic receptor activity was determined by measuring inhibition of the isoproterenol induced relaxation in isolated guinea pig tracheal chains contracted with PGF2-alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24,,,,,,,Cavia porcellus
217646,5272,1731,Type-1B angiotensin II receptor,GPCR,P29089,Agtr1b,AGTRB_RAT,9.51,,Ki,"In vitro binding affinity at rat liver Angiotensin II receptor, type 1 was determined based on displacement of [125I]-Ang II",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408403,,,,,,,Rattus norvegicus
217647,837,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.2,,Ki,Binding affinity towards Alpha-1A adrenergic receptor in rat hippocampal membranes using [3H]prazosin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,,,,Rattus norvegicus
217648,837,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.42,,Ki,Binding affinity towards Alpha-1B adrenergic receptor in rat liver using [3H]prazosin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,,,,Rattus norvegicus
217649,837,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,6.53,,Ki,Binding affinity towards Dopamine receptor D2 in rat striatum using [3H]spiperone as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,,,,Rattus norvegicus
217650,837,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,9.42,,Ki,Binding affinity towards Alpha-1A adrenergic receptor in bovine brain using [3H]prazosin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,,,,Bos taurus
217651,837,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,7.08,,Ki,Binding affinity towards Alpha-1D adrenergic receptor in rat brain using [3H]prazosin as radioligand,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL405355,,,,,,,Rattus norvegicus
217652,1211,1801,D(1A) dopamine receptor,GPCR,Q95136,DRD1,DRD1_BOVIN,7.75,,Ki,Binding affinity of compound towards Dopamine receptor D1 using [3H]SCH-23390 (0.5 nM) ligand in striatum bovine was determined,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42055,,,,,,,Bos taurus
217653,1431,1964,Farnesyl pyrophosphate synthase,Enzyme,Q0GKD7,,Q0GKD7_LEIDO,6.8,,IC50,Inhibitory activity against Leishmania major Farnesyl diphosphate synthase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53950,,,,,,,Leishmania donovani
217654,5272,1815,Type-1 angiotensin II receptor,GPCR,P25104,AGTR1,AGTR1_BOVIN,8.24,,Kd,Dissociation constant for [125 I] Ang binding to type 1 Angiotensin II receptor of bovine adrenocortical membranes,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408403,,,,,,,Bos taurus
217655,5217,1783,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,Q05941,Chrna7,ACHA7_RAT,9.05,,Ki,In vitro binding affinity towards Nicotinic acetylcholine receptor alpha7 using [125I]-alpha-Bungarotoxin in rat brain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL497939,,,,,,,Rattus norvegicus
217656,3875,622,Motilin receptor,GPCR,O43193,MLNR,MTLR_HUMAN,7.36,,IC50,Compound was tested for in vitro motilin receptor binding affinity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL532,,,,Tchem,,,Homo sapiens
217657,2443,3607,P-glycoprotein 3,Unclassified,P21447,Abcb1a,MDR1A_MOUSE,5.17,,Kd,Compound was tested for the binding affinity towards recombinant NBD2 C-terminal cytotoxic nucleotide-binding domain of mouse P-Glycoprotein,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,,,,Mus musculus
217658,4702,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5,,Ki,Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24,,,,,,,Rattus norvegicus
217659,1881,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,6.14,,Ki,Binding affinity to human CBG receptor (corticosteroid-binding globulins),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757,,,,Tbio,,,Homo sapiens
217660,2251,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,7.51,,Ki,Binding affinity to human CBG receptor (corticosteroid-binding globulins),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,Tbio,,,Homo sapiens
217716,5231,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,6.92,,Kd,Binding constant for TNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217661,2251,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,9.54,,Ki,Displacement of [3H]-aldosterone from human mineralocorticoid receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,Tclin,,,Homo sapiens
217662,294,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,8.54,,IC50,Steroid binding against the rat thymus glucocorticoid receptor,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370,,,,,,,Rattus norvegicus
217663,3875,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.41,,IC50,Inhibition of human ERG expressed in HEK cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL532,,,,Tclin,,,Homo sapiens
217664,2251,2019,Glucocorticoid receptor,Transcription factor,P06537,Nr3c1,GCR_MOUSE,8.47,,EC50,Inhibition of mouse glutamine synthetase by GR-mediated transactivation in C2C12 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,,,,Mus musculus
217665,3920,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.79,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Rattus norvegicus
217666,4702,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,8.75,,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24,,,,Tchem,,,Homo sapiens
217667,3920,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,9.44,,Ki,Displacement of [3H]-aldosterone from human mineralocorticoid receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
217668,2592,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,6.42,,IC50,Inhibition of HIV1 reverse transcriptase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL483,,,,,,,Human immunodeficiency virus 1
217669,2478,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,7.22,,IC50,Inhibition of HIV1 reverse transcriptase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL991,,,,,,,Human immunodeficiency virus 1
217670,5252,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,6.07,,IC50,Inhibition of human VEGFR2 in presence of 1 uM ATP,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217671,2001,2150,Neuraminidase,Enzyme,B4URF0,NA,B4URF0_9INFA,10.22,,IC50,Inhibition of Influenza Virus A/Horneburg/IDT7489/08 (H1N1) neuraminidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL674,,,,,,,Influenza A virus (A/WSN/1933(H1N1))
217672,2399,3905,Integrase,Enzyme,Q76353,,Q76353_9HIV1,4.55,,IC50,Inhibition of HIV1 recombinant integrase 3'-processing activity,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237046,,,,,,,Human immunodeficiency virus 1
217673,4300,3905,Integrase,Enzyme,Q76353,,Q76353_9HIV1,8.75,,IC50,Inhibition of HIV1 integrase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL204656,,,,,,,Human immunodeficiency virus 1
217674,200,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,10.44,,Ki,Inhibition of HIV1 protease,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL116,,,,,,,Human immunodeficiency virus 1
217675,1893,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,10.15,,Ki,Inhibition of wild-type HIV1 BH10 protease expressed in Escherichia coli by spectrophotometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL584,,,,,,,Human immunodeficiency virus 1
217676,2391,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,10.47,,Ki,Inhibition of HIV1 protease,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL163,,,,,,,Human immunodeficiency virus 1
217677,2422,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,10.4,,Ki,Inhibition of wild-type HIV1 BH10 protease expressed in Escherichia coli by spectrophotometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL114,,,,,,,Human immunodeficiency virus 1
217678,1310,4146,Glutamate racemase,Unclassified,P56068,murI,MURI_HELPY,5.24,,Ki,Inhibition of Helicobacter pylori glutamate racemase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76232,,,,,,,Helicobacter pylori (strain ATCC 700392 / 26695)
217679,5208,503,Tumor necrosis factor,Cytokine,P01375,TNF,TNFA_HUMAN,8.42,,Kd,Binding affinity to TNF-alpha (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL255489,,,,Tclin,,,Homo sapiens
217680,5272,2071,Type-1A angiotensin II receptor,GPCR,P25095,Agtr1,AGTRA_RAT,9.4,,IC50,"Displacement of [125I]Sar1,Ile8-Ang2 from AT1 receptor in Wistar rat hepatic membrane",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408403,,,,,,,Rattus norvegicus
217681,1881,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,6.3,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757,,,,Tchem,,,Homo sapiens
217682,1963,501,Sex hormone-binding globulin,Secreted,P04278,SHBG,SHBG_HUMAN,7.97,,Kd,Displacement of [3H]5alpha dihydrotestosterone from human sex hormone binding globulin,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162,,,,Tchem,,,Homo sapiens
217683,4823,2150,Neuraminidase,Enzyme,B4URF0,NA,B4URF0_9INFA,10.15,,IC50,Inhibition of oseltamivir-resistant Influenza A virus A/WSN/1933(H1N1) recombinant wild type neuraminidase transfected in HEK293 cells using MUNANA as substrate assessed as release of 4-methylumbelliferone preincubated for 10 mins followed by substrate addition measured after 15 mins by fluorometric assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139367,,,,,,,Influenza A virus (A/WSN/1933(H1N1))
217684,5217,1779,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,P09483,Chrna4,ACHA4_RAT,9.47,,Ki,Displacement of [3H]cytisine from alpha4beta2 nicotinic acetylcholine receptor in rat brain cortex membrane homogenates,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL497939,,,,,,,Rattus norvegicus
217685,1881,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.46,,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757,,,,Tchem,,,Homo sapiens
217686,5261,1819,Prostaglandin F2-alpha receptor,GPCR,P37289,PTGFR,PF2R_BOVIN,7.01,,Ki,Displacement of [3H]PGF2 alpha from FP receptor in bovine corpus luteum membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1050,,,,,,,Bos taurus
217687,1551,1819,Prostaglandin F2-alpha receptor,GPCR,P37289,PTGFR,PF2R_BOVIN,7.01,,Ki,Displacement of [3H]PGF2 alpha from FP receptor in bovine corpus luteum membrane,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1050,,,,,,,Bos taurus
217688,4702,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,6.82,,Ki,Binding affinity to human adrenergic beta1 receptor by radioligand displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24,,,,Tclin,,,Homo sapiens
217689,5250,1738,Prostaglandin G/H synthase 2,Enzyme,Q05769,Ptgs2,PGH2_MOUSE,7.75,,IC50,Inhibition of COX2 in mouse peritoneal macrophages,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL504535,,,,,,,Mus musculus
217690,5250,1739,Prostaglandin G/H synthase 1,Enzyme,P22437,Ptgs1,PGH1_MOUSE,6.94,,IC50,Inhibition of COX1 in mouse peritoneal macrophages,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL504535,,,,,,,Mus musculus
217691,2251,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,5.58,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL131,,,,,,,Rattus norvegicus
217692,3920,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,4.66,,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Rattus norvegicus
217693,5241,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.75,,Ki,Binding affinity to human ERG,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL512351,,,,Tclin,,,Homo sapiens
217694,3535,2150,Neuraminidase,Enzyme,B4URF0,NA,B4URF0_9INFA,4.47,,Ki,Noncompetitive inhibition of recombinant influenza A virus rvH1N1 A/Bervig_Mission/1/18 neuraminidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL226335,,,,,,,Influenza A virus (A/WSN/1933(H1N1))
217695,3514,2150,Neuraminidase,Enzyme,B4URF0,NA,B4URF0_9INFA,5.66,,IC50,Noncompetitive inhibition of recombinant influenza A virus rvH1N1 A/Bervig_Mission/1/18 neuraminidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL50,,,,,,,Influenza A virus (A/WSN/1933(H1N1))
217696,5231,543,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,6.17,,Kd,Binding constant for FLT4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217697,5231,2159,Serine/threonine-protein kinase PAK 3,Kinase,O75914,PAK3,PAK3_HUMAN,6.75,,Kd,Binding constant for full-length PAK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217698,5231,1426,3-phosphoinositide-dependent protein kinase 1,Kinase,O15530,PDPK1,PDPK1_HUMAN,6.96,,Kd,Binding affinity to PDPK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217699,5231,769,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",Kinase,Q16816,PHKG1,PHKG1_HUMAN,6.72,,Kd,Binding affinity to PHKG1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217700,5231,2163,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,Kinase,Q99755,PIP5K1A,PI51A_HUMAN,6.51,,Kd,Binding constant for full-length PIP5K1A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217701,5231,2134,Ribosomal protein S6 kinase alpha-6,Kinase,Q9UK32,RPS6KA6,KS6A6_HUMAN,5.82,,Kd,Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217702,5231,2165,Myosin light chain kinase family member 4,Kinase,Q86YV6,MYLK4,MYLK4_HUMAN,6.19,,Kd,Binding constant for SgK085 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217703,5231,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,6.6,,IC50,Inhibition of recombinant GST-tagged VEGFR2 kinase domain (V789 to V1356) (unknown origin) expressed in insect Sf9 cells using polyGlu4:Tyr peptide as substrate after 120 mins by Kinase-Glo assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217704,5231,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,6.02,,Kd,Binding constant for YES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217705,5231,2167,Serine/threonine-protein kinase 25,Kinase,O00506,STK25,STK25_HUMAN,5.75,,Kd,Binding constant for YSK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217706,5231,1823,Tyrosine-protein kinase ZAP-70,Kinase,P43403,ZAP70,ZAP70_HUMAN,5.59,,Kd,Binding constant for ZAP70 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217707,5231,2164,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,Kinase,P78356,PIP4K2B,PI42B_HUMAN,6.57,,Kd,Binding constant for full-length PIP5K2B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217708,5231,711,cAMP-dependent protein kinase catalytic subunit beta,Kinase,P22694,PRKACB,KAPCB_HUMAN,6.62,,Kd,Binding constant for full-length PKAC-beta,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217709,5231,4148,cAMP-dependent protein kinase catalytic subunit PRKX,Unclassified,P51817,PRKX,PRKX_HUMAN,6.02,,Kd,Binding constant for full-length PRKX,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,,,,Homo sapiens
217710,5231,2169,Protein-tyrosine kinase 2-beta,Kinase,Q14289,PTK2B,FAK2_HUMAN,6.18,,Kd,Binding constant for full-length PTK2B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217711,5231,870,Dual specificity protein kinase CLK1,Kinase,P49759,CLK1,CLK1_HUMAN,6.46,,Kd,Binding constant for full-length CLK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217712,5231,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,5.06,,Kd,Binding constant for full-length CSK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217713,5231,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,5.85,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217714,5231,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,5.72,,Kd,Binding constant for TIE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217715,5231,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,5.8,,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217717,5231,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,6.42,,Kd,Binding constant for TRKA kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217718,5231,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,6.51,,Kd,Binding constant for TRKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217719,5231,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,5.77,,Kd,Binding constant for TRKC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217720,5231,796,Dual specificity protein kinase TTK,Kinase,P33981,TTK,TTK_HUMAN,6.46,,Kd,Binding constant for TTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217721,5231,2180,Casein kinase II subunit alpha,Kinase,P68400,CSNK2A1,CSK21_HUMAN,6.6,,Kd,Binding constant for full-length CSNK2A1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217722,5231,702,Death-associated protein kinase 2,Kinase,Q9UIK4,DAPK2,DAPK2_HUMAN,6.05,,Kd,Binding constant for full-length DAPK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217723,5231,774,Serine/threonine-protein kinase 17B,Kinase,O94768,STK17B,ST17B_HUMAN,5.33,,Kd,Binding constant for full-length DRAK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217724,5231,2182,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Kinase,Q9Y463,DYRK1B,DYR1B_HUMAN,6.48,,Kd,Binding constant for full-length DYRK1B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217725,5231,1945,Glycogen synthase kinase-3 alpha,Kinase,P49840,GSK3A,GSK3A_HUMAN,5.6,,Kd,Binding constant for full-length GSK3A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217726,5231,884,Glycogen synthase kinase-3 beta,Kinase,P49841,GSK3B,GSK3B_HUMAN,5.75,,Kd,Binding constant for full-length GSK3B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217727,5231,2183,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,Q14164,IKBKE,IKKE_HUMAN,6.8,,Kd,Binding constant for full-length IKK-epsilon,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217728,5231,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,6.6,,Kd,Binding constant for TYK2(Kin.Dom.2/JH1 - catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217729,5231,665,Mitogen-activated protein kinase 8,Kinase,P45983,MAPK8,MK08_HUMAN,5.36,,Kd,Binding constant for full-length JNK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217730,5231,2185,Serine/threonine-protein kinase STK11,Kinase,Q15831,STK11,STK11_HUMAN,6.46,,Kd,Binding constant for full-length LKB1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217731,5231,911,MAP/microtubule affinity-regulating kinase 3,Kinase,P27448,MARK3,MARK3_HUMAN,7.68,,Kd,Binding constant for full-length MARK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217732,5231,2186,Dual specificity mitogen-activated protein kinase kinase 3,Kinase,P46734,MAP2K3,MP2K3_HUMAN,5.28,,Kd,Binding constant for full-length MEK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217733,5231,2187,Maternal embryonic leucine zipper kinase,Kinase,Q14680,MELK,MELK_HUMAN,6.55,,Kd,Binding constant for full-length MELK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217734,5231,741,AP2-associated protein kinase 1,Kinase,Q2M2I8,AAK1,AAK1_HUMAN,7.32,,Kd,Binding constant for AAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217735,5231,893,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,7.77,,Kd,Binding affinity to MST1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217736,5231,2192,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,Q9P2K8,EIF2AK4,E2AK4_HUMAN,7.41,,Kd,"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217737,5231,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,6.14,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217738,5231,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,6.1,,Kd,Binding constant for ABL1(T315I)-phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217739,5231,2194,Interleukin-1 receptor-associated kinase 3,Kinase,Q9Y616,IRAK3,IRAK3_HUMAN,6.75,,Kd,Binding constant for IRAK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217740,5231,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,7.03,,Kd,Binding constant for JAK2(Kin.Dom.2/JH1 - catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217741,5231,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,7.92,,Kd,Binding constant for JAK3(Kin.Dom.2/JH1 - catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217742,5231,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,5.44,,Kd,Binding constant for JNK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217743,5231,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,8.11,,Kd,Binding constant for KIT(D816V) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217744,5231,2170,Serine/threonine-protein kinase RIO1,Kinase,Q9BRS2,RIOK1,RIOK1_HUMAN,5.92,,Kd,Binding constant for full-length RIOK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217745,5231,2195,Serine/threonine-protein kinase RIO3,Kinase,O14730,RIOK3,RIOK3_HUMAN,6.38,,Kd,Binding constant for full-length RIOK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217746,5231,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,6.25,,Kd,Binding constant for full-length SNF1LK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217747,5231,2197,SRSF protein kinase 1,Kinase,Q96SB4,SRPK1,SRPK1_HUMAN,7.38,,Kd,Binding constant for full-length SRPK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217748,5231,2198,SRSF protein kinase 2,Kinase,P78362,SRPK2,SRPK2_HUMAN,6.48,,Kd,Binding constant for full-length SRPK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217749,5231,2136,Non-receptor tyrosine-protein kinase TNK1,Kinase,Q13470,TNK1,TNK1_HUMAN,7.08,,Kd,Binding constant for full-length TNK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217750,5231,925,Testis-specific serine/threonine-protein kinase 1,Kinase,Q9BXA7,TSSK1B,TSSK1_HUMAN,5.32,,Kd,Binding constant for full-length TSSK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217751,5231,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.68,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217752,5231,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,6.42,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217753,5231,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,6.57,,Kd,Binding constant for ALK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217754,5231,755,5'-AMP-activated protein kinase catalytic subunit alpha-1,Kinase,Q13131,PRKAA1,AAPK1_HUMAN,6.75,,Kd,Binding constant for AMPK-alpha1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217755,5231,2203,5'-AMP-activated protein kinase catalytic subunit alpha-2,Kinase,P54646,PRKAA2,AAPK2_HUMAN,6.34,,Kd,Binding constant for AMPK-alpha2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217756,5231,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,5.14,,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217757,5231,2206,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,5.42,,Kd,Binding constant for DMPK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217758,5231,850,RAC-alpha serine/threonine-protein kinase,Kinase,P31749,AKT1,AKT1_HUMAN,6.02,,Kd,Binding constant for AKT1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217759,5231,2090,RAC-beta serine/threonine-protein kinase,Kinase,P31751,AKT2,AKT2_HUMAN,6.11,,Kd,Binding constant for AKT2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217760,5231,2210,Serine/threonine-protein kinase LATS1,Kinase,O95835,LATS1,LATS1_HUMAN,5.96,,Kd,Binding constant for LATS1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217761,5231,2211,Serine/threonine-protein kinase LATS2,Kinase,Q9NRM7,LATS2,LATS2_HUMAN,5.66,,Kd,Binding constant for LATS2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217762,5231,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,6.55,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217763,5231,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,6.23,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217764,5231,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,5.52,,Kd,Binding constant for LTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217765,5231,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,5.38,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217766,5231,822,Serine/threonine-protein kinase 17A,Kinase,Q9UEE5,STK17A,ST17A_HUMAN,5.72,,Kd,Binding constant for DRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217767,5231,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,8.06,,Kd,"Binding constant for EGFR(L858R,T790M) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217768,5231,2216,NUAK family SNF1-like kinase 1,Kinase,O60285,NUAK1,NUAK1_HUMAN,7.39,,Kd,Binding constant for ARK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217769,5231,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,7.1,,IC50,Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217770,5231,545,Platelet-derived growth factor receptor alpha,Kinase,P16234,PDGFRA,PGFRA_HUMAN,6.75,,Kd,Binding affinity to PDGFRA,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217771,5231,381,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,6.96,,Kd,Binding constant for PDGFRB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217772,5231,574,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,6.05,,Kd,Binding affinity to PHKG2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217773,5231,605,Serine/threonine-protein kinase pim-1,Kinase,P11309,PIM1,PIM1_HUMAN,6.25,,Kd,Binding constant for PIM1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217774,5231,2217,Serine/threonine-protein kinase pim-3,Kinase,Q86V86,PIM3,PIM3_HUMAN,6.25,,Kd,Binding constant for PIM3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217775,5231,2218,cAMP-dependent protein kinase catalytic subunit alpha,Kinase,P17612,PRKACA,KAPCA_HUMAN,6.14,,Kd,Binding constant for PKAC-alpha kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217776,5231,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,5.68,,Kd,Binding constant for MAP4K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217777,5231,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,6.92,,Kd,Binding constant for MAP4K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217778,5231,2221,Aurora kinase B,Kinase,Q96GD4,AURKB,AURKB_HUMAN,7.21,,Kd,Binding constant for AURKB kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217779,5231,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,6.21,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217780,5231,855,BMP-2-inducible protein kinase,Kinase,Q9NSY1,BMP2K,BMP2K_HUMAN,6.66,,Kd,Binding constant for BIKE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217781,5231,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,6.3,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217782,5231,2225,Serine/threonine-protein kinase BRSK1,Kinase,Q8TDC3,BRSK1,BRSK1_HUMAN,5.92,,Kd,Binding constant for BRSK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217783,5231,891,Calcium/calmodulin-dependent protein kinase type 1D,Kinase,Q8IU85,CAMK1D,KCC1D_HUMAN,6.17,,Kd,Binding constant for CAMK1D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217784,5231,915,Calcium/calmodulin-dependent protein kinase type 1G,Kinase,Q96NX5,CAMK1G,KCC1G_HUMAN,5.75,,Kd,Binding constant for CAMK1G kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217785,5231,2226,Mitogen-activated protein kinase kinase kinase kinase 4,Kinase,O95819,MAP4K4,M4K4_HUMAN,6.19,,Kd,Binding constant for MAP4K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217786,5231,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,5.96,,Kd,Binding constant for MAP4K5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217787,5231,2227,Serine/threonine-protein kinase MARK1,Kinase,Q9P0L2,MARK1,MARK1_HUMAN,6.77,,Kd,Binding constant for MARK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217788,5231,742,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,7,,Kd,Binding constant for MARK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217789,5231,2228,MAP/microtubule affinity-regulating kinase 4,Kinase,Q96L34,MARK4,MARK4_HUMAN,6.43,,Kd,Binding constant for MARK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217790,5231,2229,Dual specificity mitogen-activated protein kinase kinase 4,Kinase,P45985,MAP2K4,MP2K4_HUMAN,5.32,,Kd,Binding constant for MEK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217791,5231,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,5.54,,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217792,5231,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,6.25,,Kd,Binding constant for MET(Y1235D) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217793,5231,773,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,Q9UQM7,CAMK2A,KCC2A_HUMAN,7.7,,Kd,Binding constant for CAMK2A kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217794,5231,757,Calcium/calmodulin-dependent protein kinase type II subunit beta,Kinase,Q13554,CAMK2B,KCC2B_HUMAN,6.68,,Kd,Binding constant for CAMK2B kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217795,5231,721,Calcium/calmodulin-dependent protein kinase type II subunit delta,Kinase,Q13557,CAMK2D,KCC2D_HUMAN,7.44,,Kd,Binding constant for CAMK2D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217796,5231,740,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Kinase,Q13555,CAMK2G,KCC2G_HUMAN,6.85,,Kd,Binding constant for CAMK2G kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217797,5231,914,Calcium/calmodulin-dependent protein kinase kinase 1,Kinase,Q8N5S9,CAMKK1,KKCC1_HUMAN,6.89,,Kd,Binding constant for CAMKK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217798,5231,908,Calcium/calmodulin-dependent protein kinase kinase 2,Kinase,Q96RR4,CAMKK2,KKCC2_HUMAN,7.14,,Kd,Binding constant for CAMKK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217799,5231,2235,Cyclin-dependent kinase 19,Kinase,Q9BWU1,CDK19,CDK19_HUMAN,5.14,,Kd,Binding constant for CDK11 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217800,5231,903,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,Q9HBH9,MKNK2,MKNK2_HUMAN,6.02,,Kd,Binding constant for MKNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217801,5231,2238,Mitogen-activated protein kinase kinase kinase 9,Kinase,P80192,MAP3K9,M3K9_HUMAN,7.82,,Kd,Binding constant for MLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217802,5231,2239,Mitogen-activated protein kinase kinase kinase 10,Kinase,Q02779,MAP3K10,M3K10_HUMAN,6.1,,Kd,Binding constant for MLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217803,5231,2240,Mitogen-activated protein kinase kinase kinase 11,Kinase,Q16584,MAP3K11,M3K11_HUMAN,7.77,,Kd,Binding constant for MLK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217804,5231,2133,Serine/threonine-protein kinase 3,Kinase,Q13188,STK3,STK3_HUMAN,7.4,,Kd,Binding affinity to MST2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217805,5231,614,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,6.66,,Kd,Binding affinity to MYLK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217806,5231,2141,Serine/threonine-protein kinase Chk1,Kinase,O14757,CHEK1,CHK1_HUMAN,5.89,,Kd,Binding constant for CHEK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217807,5231,871,Dual specificity protein kinase CLK2,Kinase,P49760,CLK2,CLK2_HUMAN,6.07,,Kd,Binding constant for CLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217808,5231,902,Dual specificity protein kinase CLK4,Kinase,Q9HAZ1,CLK4,CLK4_HUMAN,6.39,,Kd,Binding constant for CLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217809,5231,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,6.85,,IC50,Inhibition of human FMS expressed in growth factor dependent mouse FDC-P1 cells assessed as inhibition of FMS-mediated cell proliferation in presence human CSF1 after 48 hrs by resazurin dye reduction assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217810,5231,2247,Death-associated protein kinase 1,Kinase,P53355,DAPK1,DAPK1_HUMAN,5.33,,Kd,Binding constant for DAPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217811,5231,623,Death-associated protein kinase 3,Kinase,O43293,DAPK3,DAPK3_HUMAN,5.75,,Kd,Binding constant for DAPK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217812,5231,2254,Serine/threonine-protein kinase PAK 1,Kinase,Q13153,PAK1,PAK1_HUMAN,5.7,,Kd,Binding affinity to PAK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217813,5231,2255,Serine/threonine-protein kinase PAK 2,Kinase,Q13177,PAK2,PAK2_HUMAN,5.68,,Kd,Binding affinity to PAK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217814,5231,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,5.62,,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217815,5231,792,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.77,,Kd,Binding constant for full-length AURKC,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217816,5231,2258,Serine/threonine-protein kinase BRSK2,Kinase,Q8IWQ3,BRSK2,BRSK2_HUMAN,6.19,,Kd,Binding constant for full-length BRSK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217817,5231,660,Calcium/calmodulin-dependent protein kinase type 1,Kinase,Q14012,CAMK1,KCC1A_HUMAN,5.7,,Kd,Binding constant for full-length CAMK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217818,5231,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,6.66,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217819,5231,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,7.2,,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217820,5231,2260,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,6.8,,Kd,Binding constant for SNF1LK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217821,5231,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.92,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217822,5231,793,Serine/threonine-protein kinase 16,Kinase,O75716,STK16,STK16_HUMAN,6.55,,Kd,Binding constant for STK16 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217823,5231,715,Tyrosine-protein kinase SYK,Kinase,P43405,SYK,KSYK_HUMAN,7.06,,Kd,Binding constant for SYK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217824,5231,815,Serine/threonine-protein kinase N1,Kinase,Q16512,PKN1,PKN1_HUMAN,8.03,,Kd,Binding constant for PKN1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217825,5231,2089,Serine/threonine-protein kinase N2,Kinase,Q16513,PKN2,PKN2_HUMAN,7.82,,Kd,Binding constant for PKN2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217826,5231,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,7.18,,Kd,Binding constant for PLK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217827,5231,710,Protein kinase C delta type,Kinase,Q05655,PRKCD,KPCD_HUMAN,6.5,,Kd,Binding constant for PRKCD kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217828,5231,787,Protein kinase C epsilon type,Kinase,Q02156,PRKCE,KPCE_HUMAN,6.27,,Kd,Binding constant for PRKCE kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217829,5231,758,Protein kinase C eta type,Kinase,P24723,PRKCH,KPCL_HUMAN,6.54,,Kd,Binding constant for PRKCH kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217830,5231,817,Protein kinase C theta type,Kinase,Q04759,PRKCQ,KPCT_HUMAN,6.04,,Kd,Binding constant for PRKCQ kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217831,5231,2268,Tubulin alpha-1A chain,Structural,P68370,Tuba1a,TBA1A_RAT,5.51,,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,,,,Rattus norvegicus
217832,5231,776,Tyrosine-protein kinase Fer,Kinase,P16591,FER,FER_HUMAN,5.92,,Kd,Binding constant for FER kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217833,5231,2273,Serine/threonine-protein kinase D2,Kinase,Q9BZL6,PRKD2,KPCD2_HUMAN,5.2,,Kd,Binding constant for PRKD2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217834,5231,2274,Serine/threonine-protein kinase D3,Kinase,O94806,PRKD3,KPCD3_HUMAN,5.5,,Kd,Binding constant for PRKD3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217835,5231,2968,cGMP-dependent protein kinase 1,Kinase,Q13976,PRKG1,KGP1_HUMAN,6.6,,Kd,Binding constant for PRKG1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217836,5231,2275,cGMP-dependent protein kinase 2,Kinase,Q13237,PRKG2,KGP2_HUMAN,7.13,,Kd,Binding constant for PRKG2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217837,5231,2276,"Interferon-induced, double-stranded RNA-activated protein kinase",Kinase,P19525,EIF2AK2,E2AK2_HUMAN,5.16,,Kd,Binding constant for PRKR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217838,5231,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7.7,,Kd,Binding constant for RET(V804M) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217839,5231,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,5.8,,Kd,Binding constant for FGFR1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217840,5231,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,5.62,,Kd,Binding constant for FGFR2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217841,5231,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,5.77,,Kd,Binding constant for FGFR3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217842,5231,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,6.14,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217843,5231,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,6.35,,Kd,Binding constant for FLT1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217844,5231,2282,Proto-oncogene tyrosine-protein kinase ROS,Kinase,P08922,ROS1,ROS1_HUMAN,6.37,,Kd,Binding constant for ROS1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217845,5231,2283,Ribosomal protein S6 kinase alpha-1,Kinase,Q15418,RPS6KA1,KS6A1_HUMAN,6.59,,Kd,Binding affinity to RPS6KA4(Kin.Dom.1-N-terminal),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217846,5231,750,Ribosomal protein S6 kinase alpha-2,Kinase,Q15349,RPS6KA2,KS6A2_HUMAN,6.62,,Kd,Binding affinity to RPS6KA5(Kin.Dom.1-N-terminal),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217847,5231,573,Ribosomal protein S6 kinase alpha-3,Kinase,P51812,RPS6KA3,KS6A3_HUMAN,6.13,,Kd,Binding constant for RPS6KA3(Kin.Dom.1 - N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217848,5231,2284,Ribosomal protein S6 kinase alpha-4,Kinase,O75676,RPS6KA4,KS6A4_HUMAN,6.59,,Kd,Binding constant for RPS6KA4(Kin.Dom.1 - C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217849,5231,899,Ribosomal protein S6 kinase alpha-5,Kinase,O75582,RPS6KA5,KS6A5_HUMAN,6.62,,Kd,Binding constant for RPS6KA5(Kin.Dom.1 - C-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217850,2443,2295,Xanthine dehydrogenase/oxidase,Enzyme,P22985,Xdh,XDH_RAT,4.1,,IC50,Inhibition of rat liver xanthine oxidase after 2 hrs by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,,,,Rattus norvegicus
217851,5222,2537,Tankyrase-1,Enzyme,O95271,TNKS,TNKS1_HUMAN,6.24,,IC50,Inhibition of human TANK1 C-terminal domain by trichloroacetic acid precipitation assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094636,,,,Tchem,,,Homo sapiens
217852,5222,3727,Poly [ADP-ribose] polymerase 4,Enzyme,Q9UKK3,PARP4,PARP4_HUMAN,6.48,,IC50,Inhibition of human v-PARP catalytic domain by trichloroacetic acid precipitation assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094636,,,,,,,Homo sapiens
217853,5222,3508,Poly [ADP-ribose] polymerase 3,Enzyme,Q9Y6F1,PARP3,PARP3_HUMAN,5.89,,IC50,Inhibition of human PARP3 by trichloroacetic acid precipitation assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094636,,,,Tclin,,,Homo sapiens
217854,294,3609,Interleukin-5,Unclassified,P04401,Il5,IL5_MOUSE,4.58,,IC50,Inhibition of IL5-mediated proliferation of mouse Y16 cells by WST1 assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370,,,,,,,Mus musculus
217855,5110,4128,Beta-galactosidase,Unclassified,Q8VNN2,lacZ,BGAL_ECOLX,4.89,,Ki,Inhibition of Escherichia coli beta-galactosidase,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL110458,,,,,,,Escherichia coli
217856,2443,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,5.83,,Ki,Inhibition of human carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217857,2443,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.6,,Ki,Inhibition of human carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217858,2443,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,5.19,,Ki,Inhibition of human carbonic anhydrase 3 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217859,2443,220,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,5.05,,Ki,Inhibition of human carbonic anhydrase 4 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217860,2443,398,"Carbonic anhydrase 5A, mitochondrial",Enzyme,P35218,CA5A,CAH5A_HUMAN,5.39,,Ki,Inhibition of human carbonic anhydrase 5a after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217861,2443,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.34,,Ki,Inhibition of human carbonic anhydrase 5b after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217862,2443,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,5.01,,Ki,Inhibition of human carbonic anhydrase 6 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217863,2443,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,5.33,,Ki,Inhibition of human carbonic anhydrase 7 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217895,5231,2350,SRSF protein kinase 3,Kinase,Q9UPE1,SRPK3,SRPK3_HUMAN,7.1,,Kd,Binding affinity to SRPK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217864,2443,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,4.99,,Ki,Inhibition of human carbonic anhydrase 9 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217865,2443,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,5.04,,Ki,Inhibition of human carbonic anhydrase 12 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217866,2443,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,5.32,,Ki,Inhibition of human carbonic anhydrase 13 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217867,2443,751,Carbonic anhydrase 14,Enzyme,Q9ULX7,CA14,CAH14_HUMAN,4.93,,Ki,Inhibition of human carbonic anhydrase 14 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
217868,2443,2073,Carbonic anhydrase 15,Enzyme,Q99N23,Ca15,CAH15_MOUSE,6.19,,Ki,Inhibition of mouse carbonic anhydrase 15 after 15 mins by stopped flow CO2 hydration method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,,,,Mus musculus
217869,5231,2327,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,Q13627,DYRK1A,DYR1A_HUMAN,7,,Kd,Binding affinity to DYRK1A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217870,5231,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,5.51,,Kd,Binding affinity to EPHB6,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217871,5231,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,5.51,,Kd,Binding affinity to ERBB4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217872,5231,2330,Serine/threonine-protein kinase/endoribonuclease IRE1,Kinase,O75460,ERN1,ERN1_HUMAN,5.64,,Kd,Binding affinity to ERN1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217873,5231,2331,Rhodopsin kinase,Kinase,Q15835,GRK1,RK_HUMAN,7.07,,Kd,Binding affinity to GRK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217874,5231,2332,G protein-coupled receptor kinase 4,Kinase,P32298,GRK4,GRK4_HUMAN,6.96,,Kd,Binding affinity to GRK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217875,5231,2333,G protein-coupled receptor kinase 7,Kinase,Q8WTQ7,GRK7,GRK7_HUMAN,7.32,,Kd,Binding affinity to GRK7,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217876,5231,2334,Homeodomain-interacting protein kinase 2,Kinase,Q9H2X6,HIPK2,HIPK2_HUMAN,5.51,,Kd,Binding affinity to HIPK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217877,5231,2335,Homeodomain-interacting protein kinase 3,Kinase,Q9H422,HIPK3,HIPK3_HUMAN,5.64,,Kd,Binding affinity to HIPK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217878,5231,2336,Homeodomain-interacting protein kinase 4,Kinase,Q8NE63,HIPK4,HIPK4_HUMAN,6.02,,Kd,Binding affinity to HIPK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217879,5231,2337,Hormonally up-regulated neu tumor-associated kinase,Kinase,P57058,HUNK,HUNK_HUMAN,6.62,,Kd,Binding affinity to HUNK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217880,5231,2339,Inhibitor of nuclear factor kappa-B kinase subunit alpha,Kinase,O15111,CHUK,IKKA_HUMAN,5.42,,Kd,Binding affinity to IKK-alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217881,5231,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,6.17,,Kd,Binding affinity to JH1 catalytic domain JAK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217882,5231,2341,Mitogen-activated protein kinase kinase kinase 13,Kinase,O43283,MAP3K13,M3K13_HUMAN,5.55,,Kd,Binding affinity to LZK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217883,5231,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,6.85,,Kd,Binding affinity to MAP3K2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217884,5231,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,6.68,,Kd,Binding affinity to MAP3K3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217885,5231,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,5.6,,Kd,Binding affinity to MAP4K2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217886,5231,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,6.77,,Kd,Binding affinity to MINK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217887,5231,2370,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,Kinase,O00750,PIK3C2B,P3C2B_HUMAN,5.85,,Kd,Binding affinity to PIK3C2B,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217888,5231,2371,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma,Kinase,O75747,PIK3C2G,P3C2G_HUMAN,6.24,,Kd,Binding affinity to PIK3C2G,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217889,5231,714,Protein kinase C alpha type,Kinase,P17252,PRKCA,KPCA_HUMAN,6.14,,Kd,Binding affinity to PKAC-alpha,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217890,5231,2348,U4/U6 small nuclear ribonucleoprotein Prp4,Unclassified,O43172,PRPF4,PRP4_HUMAN,7.26,,Kd,Binding affinity to PRP4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217891,5231,2373,Serine/threonine-protein kinase SIK3,Kinase,Q9Y2K2,SIK3,SIK3_HUMAN,7.01,,Kd,Binding affinity to QSK,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217892,5231,2349,Serine/threonine-protein kinase RIO2,Kinase,Q9BVS4,RIOK2,RIOK2_HUMAN,7.01,,Kd,Binding affinity to RIOK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217893,5231,670,Rho-associated protein kinase 1,Kinase,Q13464,ROCK1,ROCK1_HUMAN,5.11,,Kd,Binding affinity to ROCK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217894,5231,713,Rho-associated protein kinase 2,Kinase,O75116,ROCK2,ROCK2_HUMAN,5.64,,Kd,Binding affinity to ROCK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217896,5231,2352,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,6.89,,Kd,Binding affinity to TAK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217897,5231,2318,Serine/threonine-protein kinase TBK1,Kinase,Q9UHD2,TBK1,TBK1_HUMAN,8.03,,Kd,Binding affinity to TBK1,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217898,5231,2365,Tankyrase-2,Enzyme,Q9H2K2,TNKS2,TNKS2_HUMAN,6.92,,Kd,Binding affinity to TNK2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217899,5231,2357,Serine/threonine-protein kinase ULK3,Kinase,Q6PHR2,ULK3,ULK3_HUMAN,5.89,,Kd,Binding affinity to ULK3,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217900,5231,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,7.82,,Kd,Binding affinity to YSK4,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217901,4174,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,7.82,,IC50,Inhibition of wild-type HIV-1 reverse transcriptase by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175691,,,,,,,Human immunodeficiency virus 1
217902,1967,165,DNA gyrase subunit A,Enzyme,P9WG47,gyrA,GYRA_MYCTU,4.28,,IC50,Inhibition of DNA supercoiling activity of wild type Mycobacterium tuberculosis DNA gyrase A,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
217903,5229,3863,Purine nucleoside phosphorylase,Unclassified,Q8T9Z7,PNP,Q8T9Z7_PLAFA,9.07,,Ki,Inhibition of Plasmodium falciparum PNP expressed in Escherichia coli BL21(DE3) cells by spectrophotometry,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218291,,,,,,,Plasmodium falciparum
217904,4822,2150,Neuraminidase,Enzyme,B4URF0,NA,B4URF0_9INFA,8.89,,IC50,Inhibition of Influenza A virus (A/Yamagata/83/2006(H1N1)) neuraminidase after 30 mins by fluorescence analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL466246,,,,,,,Influenza A virus (A/WSN/1933(H1N1))
217905,3920,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,7.66,,IC50,Displacement of [3H]dexamethasone from Sprague-Dawley rat GR by liquid scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Rattus norvegicus
217907,5270,2434,Low affinity sodium-glucose cotransporter,Transporter,Q9NY91,SLC5A4,SC5A4_HUMAN,9.06,,IC50,Inhibition of human SGLT2 expressed in CHO cells assessed as inhibition of methyl alpha-D-glucopyranoside uptake after 1 hr,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1770248,,,,Tchem,,,Homo sapiens
217908,5270,2060,Sodium/glucose cotransporter 2,Transporter,P53792,Slc5a2,SC5A2_RAT,8.94,,IC50,Inhibition of rat SGLT2,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1770248,,,,,,,Rattus norvegicus
217909,113,3882,Beta-lactamase,Unclassified,Q932Y6,bla(tem-2),Q932Y6_PSEAI,5.28,,IC50,"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of TLR9-MyD88 binding: fluorescence-based cell-based high throughput dose response assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504734, AID504750, AID540250, AID540251]",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL554041,,,,,,,Pseudomonas aeruginosa
217910,5252,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,5.22,,Kd,Binding constant for ABL1(Q252H)-phosphorylated kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217911,5252,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,6.17,,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217912,5252,776,Tyrosine-protein kinase Fer,Kinase,P16591,FER,FER_HUMAN,6.29,,Kd,Binding constant for FER kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217913,5252,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,5.72,,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217914,5252,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,6.6,,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217915,5252,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,6.92,,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217916,5252,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,5.39,,Kd,Binding constant for SRC kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217917,5252,2175,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,6.41,,Kd,Binding constant for TIE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217918,5252,534,Tyrosine-protein kinase Yes,Kinase,P07947,YES1,YES_HUMAN,6.62,,Kd,Binding constant for YES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217919,5252,2274,Serine/threonine-protein kinase D3,Kinase,O94806,PRKD3,KPCD3_HUMAN,5.62,,Kd,Binding constant for PRKD3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217920,5252,876,Mitogen-activated protein kinase kinase kinase 4,Kinase,Q9Y6R4,MAP3K4,M3K4_HUMAN,7.41,,Kd,Binding constant for MAP3K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tbio,,,Homo sapiens
217921,5252,775,Serine/threonine-protein kinase 10,Kinase,O94804,STK10,STK10_HUMAN,7.89,,Kd,Binding constant for LOK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217922,5252,892,Cyclin-dependent kinase 16,Kinase,Q00536,CDK16,CDK16_HUMAN,5.64,,Kd,Binding constant for PCTK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217923,5252,2133,Serine/threonine-protein kinase 3,Kinase,Q13188,STK3,STK3_HUMAN,7.24,,Kd,Binding constant for MST2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217924,5252,893,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,6.57,,Kd,Binding constant for MST1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217955,5252,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.19,,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217925,5252,2454,Mitogen-activated protein kinase kinase kinase 12,Kinase,Q12852,MAP3K12,M3K12_HUMAN,6.43,,Kd,Binding constant for DLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217926,5252,2167,Serine/threonine-protein kinase 25,Kinase,O00506,STK25,STK25_HUMAN,7.92,,Kd,Binding constant for YSK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tbio,,,Homo sapiens
217927,5252,875,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,Q9Y4K4,MAP4K5,M4K5_HUMAN,9.19,,Kd,Binding constant for MAP4K5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217928,5252,2342,Mitogen-activated protein kinase kinase kinase 2,Kinase,Q9Y2U5,MAP3K2,M3K2_HUMAN,6.35,,Kd,Binding constant for MAP3K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217929,5252,2193,Insulin receptor-related protein,Kinase,P14616,INSRR,INSRR_HUMAN,5.34,,Kd,Binding constant for INSRR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217930,5252,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,7.18,,Kd,Binding constant for SLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217931,5252,2187,Maternal embryonic leucine zipper kinase,Kinase,Q14680,MELK,MELK_HUMAN,5.8,,Kd,Binding constant for MELK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217932,5252,2216,NUAK family SNF1-like kinase 1,Kinase,O60285,NUAK1,NUAK1_HUMAN,5.82,,Kd,Binding constant for ARK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217933,5252,2344,Microtubule-associated serine/threonine-protein kinase 1,Kinase,Q9Y2H9,MAST1,MAST1_HUMAN,5.26,,Kd,Binding constant for MAST1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217934,5252,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,6.85,,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217935,5252,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,5.48,,Kd,Binding constant for SIK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217936,5252,852,Serine/threonine-protein kinase 36,Kinase,Q9NRP7,STK36,STK36_HUMAN,5.28,,Kd,Binding constant for STK36 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tbio,,,Homo sapiens
217937,5252,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,5.38,,Kd,Binding constant for TAOK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tbio,,,Homo sapiens
217938,5252,2273,Serine/threonine-protein kinase D2,Kinase,Q9BZL6,PRKD2,KPCD2_HUMAN,5.96,,Kd,Binding constant for PRKD2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217939,5252,2189,Serine/threonine-protein kinase 26,Kinase,Q9P289,STK26,STK26_HUMAN,8.13,,Kd,Binding constant for MST4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tbio,,,Homo sapiens
217940,5252,4149,Serine/threonine-protein kinase 32B,Unclassified,Q9NY57,STK32B,ST32B_HUMAN,5.19,,Kd,Binding constant for YANK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,,,,Homo sapiens
217941,5252,2214,Serine/threonine-protein kinase PAK 6,Kinase,Q9NQU5,PAK6,PAK6_HUMAN,5.13,,Kd,Binding constant for PAK6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217942,5252,891,Calcium/calmodulin-dependent protein kinase type 1D,Kinase,Q8IU85,CAMK1D,KCC1D_HUMAN,5.25,,Kd,Binding constant for CAMK1D kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217943,5252,750,Ribosomal protein S6 kinase alpha-2,Kinase,Q15349,RPS6KA2,KS6A2_HUMAN,5.39,,Kd,Binding constant for RSK3(Kin.Dom.1-N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217944,5252,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,7.8,,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217945,5252,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,7.59,,Kd,Binding constant for MEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217946,5252,2201,Serine/threonine-protein kinase 33,Kinase,Q9BYT3,STK33,STK33_HUMAN,6.03,,Kd,Binding constant for STK33 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217947,5252,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.85,,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217948,5252,2238,Mitogen-activated protein kinase kinase kinase 9,Kinase,P80192,MAP3K9,M3K9_HUMAN,5.27,,Kd,Binding constant for MLK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217949,5252,2364,Serine/threonine-protein kinase 35,Kinase,Q8TDR2,STK35,STK35_HUMAN,5.35,,Kd,Binding constant for STK35 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217950,5252,2168,Mitogen-activated protein kinase kinase kinase MLT,Kinase,Q9NYL2,ZAK,MLTK_HUMAN,5.82,,Kd,Binding constant for ZAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217951,5252,2336,Homeodomain-interacting protein kinase 4,Kinase,Q8NE63,HIPK4,HIPK4_HUMAN,5.82,,Kd,Binding constant for HIPK4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217952,5252,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,7.2,,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217953,5252,1317,Dual specificity mitogen-activated protein kinase kinase 7,Kinase,O14733,MAP2K7,MP2K7_HUMAN,6.28,,Kd,Binding constant for MKK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tbio,,,Homo sapiens
217954,5252,2226,Mitogen-activated protein kinase kinase kinase kinase 4,Kinase,O95819,MAP4K4,M4K4_HUMAN,6.48,,Kd,Binding constant for MAP4K4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217956,5252,672,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,5.72,,Kd,Binding constant for FAK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217957,5252,2169,Protein-tyrosine kinase 2-beta,Kinase,Q14289,PTK2B,FAK2_HUMAN,5.1,,Kd,Binding constant for PYK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217958,5252,2260,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,6.66,,Kd,Binding constant for SIK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217959,5252,2374,Wee1-like protein kinase 2,Kinase,P0C1S8,WEE2,WEE2_HUMAN,5.89,,Kd,Binding constant for WEE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tbio,,,Homo sapiens
217960,5252,2465,Dual serine/threonine and tyrosine protein kinase,Kinase,Q6XUX3,DSTYK,DUSTY_HUMAN,5.19,,Kd,Binding constant for RIPK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tbio,,,Homo sapiens
217961,5231,2448,Serine/threonine-protein kinase 32A,Kinase,Q8WU08,STK32A,ST32A_HUMAN,5.62,,Kd,Binding constant for YANK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tdark,,,Homo sapiens
217962,5231,1253,Inhibitor of nuclear factor kappa-B kinase subunit beta,Kinase,O14920,IKBKB,IKKB_HUMAN,5.2,,Kd,Binding constant for IKK-beta kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217963,5231,2230,Dual specificity mitogen-activated protein kinase kinase 6,Kinase,P52564,MAP2K6,MP2K6_HUMAN,5.19,,Kd,Binding constant for MEK6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217964,5231,2088,Ribosomal protein S6 kinase beta-1,Kinase,P23443,RPS6KB1,KS6B1_HUMAN,5.89,,Kd,Binding constant for S6K1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217965,5231,2166,Wee1-like protein kinase,Kinase,P30291,WEE1,WEE1_HUMAN,5.34,,Kd,Binding constant for WEE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217966,5231,2452,Serine/threonine-protein kinase PRP4 homolog,Kinase,Q13523,PRPF4B,PRP4B_HUMAN,7.26,,Kd,Binding constant for PRP4 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217967,5231,872,Dual specificity protein kinase CLK3,Kinase,P49761,CLK3,CLK3_HUMAN,5.44,,Kd,Binding constant for CLK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217968,5231,2208,RAC-gamma serine/threonine-protein kinase,Kinase,Q9Y243,AKT3,AKT3_HUMAN,5.36,,Kd,Binding constant for AKT3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217969,5231,2142,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,P42336,PIK3CA,PK3CA_HUMAN,5.96,,Kd,Binding constant for PIK3CA(H1047L) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tclin,,,Homo sapiens
217970,5231,856,Serine/threonine-protein kinase pim-2,Kinase,Q9P1W9,PIM2,PIM2_HUMAN,5.51,,Kd,Binding constant for PIM2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217971,5231,2456,Serine/threonine-protein kinase Sgk3,Kinase,Q96BR1,SGK3,SGK3_HUMAN,5.85,,Kd,Binding constant for SGK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217972,5231,2338,Serine/threonine-protein kinase ICK,Kinase,Q9UPZ9,ICK,ICK_HUMAN,5.23,,Kd,Binding constant for ICK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217973,5231,2344,Microtubule-associated serine/threonine-protein kinase 1,Kinase,Q9Y2H9,MAST1,MAST1_HUMAN,6.72,,Kd,Binding constant for MAST1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217974,5231,2201,Serine/threonine-protein kinase 33,Kinase,Q9BYT3,STK33,STK33_HUMAN,6.72,,Kd,Binding constant for STK33 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217975,5231,905,Mitogen-activated protein kinase 9,Kinase,P45984,MAPK9,MK09_HUMAN,5.3,,Kd,Binding constant for JNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217976,5231,2463,Myosin light chain kinase 3,Kinase,Q32MK0,MYLK3,MYLK3_HUMAN,5.64,,Kd,Binding constant for MLCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217977,5231,2464,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,6.75,,Kd,Binding constant for LRRK2(G2019S) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tchem,,,Homo sapiens
217978,5231,2465,Dual serine/threonine and tyrosine protein kinase,Kinase,Q6XUX3,DSTYK,DUSTY_HUMAN,5.33,,Kd,Binding constant for RIPK5 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,Tbio,,,Homo sapiens
217979,5231,2466,Calcium-dependent protein kinase 1,Kinase,P62344,CPK1,CDPK1_PLAF7,6.02,,Kd,Binding constant for PFCDPK1(P.falciparum) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL608533,,,,,,,Plasmodium falciparum
217980,5252,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,6.4,,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217981,5252,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,6.8,,Kd,Binding constant for BTK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217982,5252,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,5.52,,Kd,Binding constant for INSR kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217983,5252,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,5.7,,Kd,Binding constant for JAK3(JH1domain-catalytic) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217984,5252,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,5.4,,Kd,Binding constant for MET kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217985,5252,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,5.52,,Kd,Binding constant for TIE2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217986,5252,2325,Serine/threonine-protein kinase Chk2,Kinase,O96017,CHEK2,CHK2_HUMAN,6.07,,Kd,Binding constant for CHEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217987,5252,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,6.17,,Kd,Binding constant for TNK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
217988,5252,2192,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,Q9P2K8,EIF2AK4,E2AK4_HUMAN,7.02,,Kd,"Binding constant for GCN2(Kin.Dom.2,S808G) kinase domain",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217989,5252,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,7.54,,Kd,Binding constant for MINK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217990,5252,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,7.03,,Kd,Binding constant for HPK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217991,5252,2141,Serine/threonine-protein kinase Chk1,Kinase,O14757,CHEK1,CHK1_HUMAN,5.24,,Kd,Binding constant for CHEK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217992,5252,2173,Casein kinase I isoform gamma-2,Kinase,P78368,CSNK1G2,KC1G2_HUMAN,5.18,,Kd,Binding constant for CSNK1G2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217993,5252,2340,Interleukin-1 receptor-associated kinase 1,Kinase,P51617,IRAK1,IRAK1_HUMAN,5.64,,Kd,Binding constant for IRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217994,5252,2080,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,6.72,,Kd,Binding constant for AXL kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217995,5252,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,7.07,,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217996,5252,2084,Cyclin-dependent kinase 7,Kinase,P50613,CDK7,CDK7_HUMAN,5.29,,Kd,Binding constant for CDK7 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217997,5252,837,Casein kinase I isoform epsilon,Kinase,P49674,CSNK1E,KC1E_HUMAN,6.54,,Kd,Binding constant for CSNK1E kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217998,5252,2368,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,8.11,,Kd,Binding constant for ERBB3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
217999,5252,2280,Tyrosine-protein kinase Fes/Fps,Kinase,P07332,FES,FES_HUMAN,6.23,,Kd,Binding constant for FES kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
218000,5252,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,6.31,,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
218001,5252,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.09,,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
218002,5252,2343,Mitogen-activated protein kinase kinase kinase 3,Kinase,Q99759,MAP3K3,M3K3_HUMAN,6.89,,Kd,Binding constant for MAP3K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218003,5252,2240,Mitogen-activated protein kinase kinase kinase 11,Kinase,Q16584,MAP3K11,M3K11_HUMAN,5.24,,Kd,Binding constant for MLK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218004,5252,2239,Mitogen-activated protein kinase kinase kinase 10,Kinase,Q02779,MAP3K10,M3K10_HUMAN,5.34,,Kd,Binding constant for MLK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218005,5252,53,Macrophage-stimulating protein receptor,Kinase,Q04912,MST1R,RON_HUMAN,5.08,,Kd,Binding constant for MST1R kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218006,5252,747,Serine/threonine-protein kinase Nek2,Kinase,P51955,NEK2,NEK2_HUMAN,6.6,,Kd,Binding constant for NEK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218007,5252,2449,Serine/threonine-protein kinase Nek3,Kinase,P51956,NEK3,NEK3_HUMAN,5.62,,Kd,Binding constant for NEK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tbio,,,Homo sapiens
218008,5252,2254,Serine/threonine-protein kinase PAK 1,Kinase,Q13153,PAK1,PAK1_HUMAN,6.68,,Kd,Binding constant for PAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218009,5252,2255,Serine/threonine-protein kinase PAK 2,Kinase,Q13177,PAK2,PAK2_HUMAN,7.1,,Kd,Binding constant for PAK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218010,5252,2085,Serine/threonine-protein kinase D1,Kinase,Q15139,PRKD1,KPCD1_HUMAN,6.09,,Kd,Binding constant for PRKD1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218011,5252,665,Mitogen-activated protein kinase 8,Kinase,P45983,MAPK8,MK08_HUMAN,5.48,,Kd,Binding constant for JNK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218012,5252,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,5.6,,Kd,Binding constant for JNK3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218013,5252,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,7.85,,Kd,Binding constant for MEK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
218014,5252,2283,Ribosomal protein S6 kinase alpha-1,Kinase,Q15418,RPS6KA1,KS6A1_HUMAN,5.13,,Kd,Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218015,5252,715,Tyrosine-protein kinase SYK,Kinase,P43405,SYK,KSYK_HUMAN,5.29,,Kd,Binding constant for SYK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
218016,5252,2179,Tyrosine-protein kinase TXK,Kinase,P42681,TXK,TXK_HUMAN,5.32,,Kd,Binding constant for TXK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218017,5252,2166,Wee1-like protein kinase,Kinase,P30291,WEE1,WEE1_HUMAN,5.39,,Kd,Binding constant for WEE1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218018,5252,2243,Serine/threonine-protein kinase 24,Kinase,Q9Y6E0,STK24,STK24_HUMAN,8.19,,Kd,Binding constant for MST3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218019,5252,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,8.11,,Kd,Binding constant for MAP4K3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218020,5252,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,5.51,,Kd,Binding constant for FLT3(D835Y) kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tclin,,,Homo sapiens
218021,5252,774,Serine/threonine-protein kinase 17B,Kinase,O94768,STK17B,ST17B_HUMAN,5.96,,Kd,Binding constant for DRAK2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218022,5252,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,6.26,,Kd,Binding constant for CSK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218023,5252,2174,Casein kinase I isoform gamma-3,Kinase,Q9Y6M4,CSNK1G3,KC1G3_HUMAN,5.11,,Kd,Binding constant for CSNK1G3 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tbio,,,Homo sapiens
218024,5252,2329,Ephrin type-B receptor 6,Kinase,O15197,EPHB6,EPHB6_HUMAN,5.55,,Kd,Binding constant for EPHB6 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218025,5252,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,6.66,,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218026,5252,2341,Mitogen-activated protein kinase kinase kinase 13,Kinase,O43283,MAP3K13,M3K13_HUMAN,6.13,,Kd,Binding constant for LZK kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tbio,,,Homo sapiens
218027,5252,822,Serine/threonine-protein kinase 17A,Kinase,Q9UEE5,STK17A,ST17A_HUMAN,6.47,,Kd,Binding constant for DRAK1 kinase domain,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL180022,,,,Tchem,,,Homo sapiens
218028,4702,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,5,,Ki,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24,,,,Tclin,,,Homo sapiens
218029,294,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.57,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370,,,,,,,Bos taurus
218030,294,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,5.96,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370,,,,,,,Rattus norvegicus
218031,3920,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.52,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,,,,Bos taurus
218032,1963,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.64,,Ki,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162,,,,Tclin,,,Homo sapiens
218033,1963,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.62,,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1162,,,,Tclin,,,Homo sapiens
218034,1881,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,7.65,,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757,,,,,,,Bos taurus
218035,1881,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,8.68,,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL757,,,,,,,Rattus norvegicus
218036,1513,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.3,,Ki,Displacement of [3H]-DHA from recombinant human beta2 adrenoceptor expressed in HEK293T cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711,,,,Tclin,,,Homo sapiens
218037,4758,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,6.2,,Ki,Inhibition of HIV1 recombinant protease using Lys-Ala-Arg-Val-Nle-Nph-Glu-Ala-Nle-NH2 as substrate by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2048484,,,,,,,Human immunodeficiency virus 1
218038,119,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,7.12,,Ki,Inhibition of HIV1 recombinant protease using Lys-Ala-Arg-Val-Nle-Nph-Glu-Ala-Nle-NH2 as substrate by spectrophotometric analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1639,,,,,,,Human immunodeficiency virus 1
218039,3194,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,4.7,,IC50,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL94007,,,,,,,Human immunodeficiency virus 1
218040,960,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,4.28,,IC50,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL53463,,,,,,,Human immunodeficiency virus 1
218041,1407,346,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,4.37,,IC50,"Inhibition of human recombinant N-terminal His6-tagged AKR1C2 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL175,,,,Tchem,,,Homo sapiens
218042,5217,2602,Nicotinic acetylcholine receptor alpha 5 subunit,Ion channel,A9XFY4,nAChRalpha5,A9XFY4_MUSDO,5.91,,Ki,Displacement of [3H]alpha-bungarotoxin from nAChR in Musca domestica (house fly) head membrane after 60 min by scintillation counting,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL497939,,,,,,,Musca domestica
218043,5217,2583,Acetylcholine receptor subunit alpha,Ion channel,P02710,CHRNA1,ACHA_TORCA,5.45,,IC50,Displacement of [3H]alpha-BGT from nAChR in Torpedo nobiliana electric organs membranes by scintillation counting method,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL497939,,,,,,,Torpedo californica
218044,1967,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.75,,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL9,,,,Tchem,,,Homo sapiens
218045,258,3641,Dihydroorotate dehydrogenase,Unclassified,Q54A96,dhod,Q54A96_PLAFA,4.57,,Ki,Inhibition of plasmodium falciparum DHODH assessed as inhibition of [14C]bicarbonate incorporation into pyrimidine nucleotide by HPLC analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1450,,,,,,,Plasmodium falciparum
218046,2799,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,7.01,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218047,568,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,6.94,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218048,2872,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,6.94,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218049,2537,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,6.95,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL26,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218050,2706,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,6.96,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218051,396,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,5.36,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218052,949,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,5.18,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218490,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218053,864,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,6.95,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218054,1089,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,5.51,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218055,1741,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,6.93,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218056,1624,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,6.06,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL419,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218057,2521,2158,Carbonic anhydrase,Enzyme,Q6FTL6,,Q6FTL6_CANGA,5.1,,Ki,Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL21,,,,,,,Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65)
218058,681,3861,Amyloid beta A4 protein,Unclassified,P05067,APP,A4_HUMAN,4,,IC50,Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL497,,,,,,,Homo sapiens
218059,2977,4129,"1,3-beta-D-glucan synthase catalytic subunit",Unclassified,O13383,CaFKS1,O13383_CANAX,9.62,,IC50,"Inhibition of wild type Candida albicans MY1055 1,3-beta-D-glucan synthase using UDP[6,3H]-glucose as substrate after 60 mins by liquid scintillation counting analysis",CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499808,,,,,,,Candida albicans
218060,2443,88,Urokinase-type plasminogen activator,Enzyme,P00749,PLAU,UROK_HUMAN,4.68,,IC50,Inhibition of urokinase amidolytic activity (unknown origin),CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tchem,,,Homo sapiens
218061,2443,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,4.73,,Kd,Inhibition of human thrombin assessed as equilibrium dissociation constant at 50 to 1000 uM by BIAcore analysis,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431701,,,,Tclin,,,Homo sapiens
218062,3920,237,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.25,,Ki,Displacement of [3H]-methyltrienolone from human progesterone receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
218063,3920,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,5.85,,Ki,Displacement of [3H]-methyltrienolone from human androgen receptor expressed in HEK293 cells,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL384467,,,,Tclin,,,Homo sapiens
218064,799,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,5.92,,IC50,Inhibition of HIV1 wild type reverse transcriptase using poly rC.dG and [3H]dGTP as substrate,CHEMBL,=,,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593,,,,,,,Human immunodeficiency virus 1
218132,4805,1741,Integrase,Enzyme,Q7ZJM1,pol,Q7ZJM1_9HIV1,8.130768,,IC50,HIV-1 integrase catalyzed strand transfer,SCIENTIFIC LITERATURE,=,1,CHEMBL,http://www.ncbi.nlm.nih.gov/pubmed/27645238,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1213165,INHIBITOR,,,2108,,Human immunodeficiency virus 1
218133,5274,1741,Integrase,Enzyme,Q7ZJM1,pol,Q7ZJM1_9HIV1,8.124939,,IC50,HIV-1 integrase catalyzed strand transfer,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/27645238,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209360s000lbl.pdf,INHIBITOR,,,2108,1902,Human immunodeficiency virus 1
218134,5279,4228,T-cell surface glycoprotein CD4,Membrane receptor,P01730,CD4,CD4_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761065s001lbl.pdf,ANTIBODY BINDING,,Tclin,,2309,Homo sapiens
218135,5280,715,Tyrosine-protein kinase SYK,Kinase,P43405,SYK,KSYK_HUMAN,7.387216143,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/16946104,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209299lbl.pdf,INHIBITOR,,Tclin,2311,2310,Homo sapiens
218136,5280,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,7.091514981,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/16946104,,INHIBITOR,,Tchem,2311,,Homo sapiens
218138,5282,4229,Fibroblast growth factor 23,Secreted,Q9GZV9,FGF23,FGF23_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761068s000lbl.pdf,ANTIBODY BINDING,,Tclin,,2313,Homo sapiens
218139,5283,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,9.022275924682617,,Ki,displacement of [3H]-labelled substance P from cloned human receptor expressed in CHO cells,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/16332435,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210493s000lbl.pdf/drugsatfda_docs/label/2014/125477s007lbl.pdf,ANTAGONIST,,Tclin,47,2314,Homo sapiens
218141,5285,2683,Thrombopoietin receptor,Membrane receptor,P40238,MPL,TPOR_HUMAN,8.481486,,EC50,,SCIENTIFIC LITERATURE,-,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/19183407,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210238s000lbl.pdf,AGONIST,,Tclin,2316,2416,Homo sapiens
218142,5289,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,9.327902,,IC50,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210496lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210496lbl.pdf,INHIBITOR,,Tclin,2417,2417,Homo sapiens
218143,5289,537,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,9.522879,,IC50,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210496lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210496lbl.pdf,INHIBITOR,,Tclin,2417,2417,Homo sapiens
218144,5290,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,7.9,,IC50,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7921,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210498lbl.pdf,INHIBITOR,,Tclin,,2418,Homo sapiens
218145,5290,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,7.9,,IC50,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7921,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210498lbl.pdf,INHIBITOR,,Tclin,,2418,Homo sapiens
218146,5284,4230,Calcitonin-gene-related peptide receptor,GPCR,O60894|Q16602,CALCRL|RAMP1,CALRL_HUMAN|RAMP1_HUMAN,10.69897,,Ki,,SCIENTIFIC LITERATURE,,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26559125,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761077s000lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin,2419,2315,Homo sapiens
218147,5281,3513,Interleukin-23,Cytokine,P29460|Q9NPF7,IL12B|IL23A,IL12B_HUMAN|IL23A_HUMAN,9.5,,Kd,,IUPHAR,,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8093,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf,ANTIBODY BINDING,,Tclin|Tclin,,2312,Homo sapiens
218148,5291,4231,Envelope protein F13,Viral envelope protein,P33815,C17L,F13_VAR67,7.381951903,,EC50,activity in cell culture assays,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208627s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208627s000lbl.pdf,INHIBITOR,,Tclin,2519,2519,Variola virus (isolate Human/India/Ind3/1967)
218149,5292,4232,Isocitrate dehydrogenase [NADP] cytoplasmic,Enzyme,O75874,IDH1,IDHC_HUMAN,7.1487416513,,IC50,The enzyme and compound were preincubated for 1h,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29670690,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211192s000lbl.pdf,INHIBITOR,,Tclin,2521,2522,Homo sapiens
218152,5293,342,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,8.823908741,,IC50,"determined by competition for [125I-Tyr5,DLeu6,NMeLeu7,Pro9-NEt-]GnRH from human GnRH receptor",SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/19006286,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210450s000lbl.pdf,ANTAGONIST,,Tclin,2523,2524,Homo sapiens
218156,5294,4233,30S ribosomal protein S10,Ribosomal protein,,,,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211109lbl.pdf,,,,,2526,
218158,5295,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,7.920818754,,EC50,cellular activity; wild type ,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210806s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210806s000lbl.pdf,INHIBITOR,,,2527,2527,Human immunodeficiency virus 1
218159,5296,704,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,10.63827216,,Kd,Enzymatic assay at 3mM ATP (nM),SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24211136,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211155s000lbl.pdf,INHIBITOR,,Tclin,2529,2528,Homo sapiens
218160,5296,2314,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Kinase,P48736,PIK3CG,PK3CG_HUMAN,9.619788758,,Kd,Enzymatic assay at 3mM ATP (nM),SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24211136,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211155s000lbl.pdf,INHIBITOR,,Tclin,2529,2528,Homo sapiens
218161,5297,387,Epidermal growth factor receptor,Kinase,P00533,EGFR,EGFR_HUMAN,8.22184875,,IC50,ELISA-Based erbB Kinase Assay with 20 uM [ATP],SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/30506139,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211288s000lbl.pdf,INHIBITOR,,Tclin,2530,2531,Homo sapiens
218162,5297,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,7.3400838,,IC50,ELISA-Based erbB Kinase Assay with 20 uM [ATP],SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/30506139,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211288s000lbl.pdf,INHIBITOR,,Tclin,2530,2531,Homo sapiens
218163,5297,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,7.132532512,,IC50,ELISA-Based erbB Kinase Assay with 20 uM [ATP],SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/30506139,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211288s000lbl.pdf,INHIBITOR,,Tclin,2530,2531,Homo sapiens
218165,5300,699,Poly [ADP-ribose] polymerase 1,Enzyme,P09874,PARP1,PARP1_HUMAN,8.920818754,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26652717,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211651s000lbl.pdf,INHIBITOR,,Tclin,2534,2533,Homo sapiens
218166,5300,34,Poly [ADP-ribose] polymerase 2,Enzyme,Q9UGN5,PARP2,PARP2_HUMAN,9.060480747,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26652717,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211651s000lbl.pdf,INHIBITOR,,Tclin,2534,2533,Homo sapiens
218169,5302,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,9.9586073148,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26144315,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2536,2535,Homo sapiens
218170,5302,2282,Proto-oncogene tyrosine-protein kinase ROS,Kinase,P08922,ROS1,ROS1_HUMAN,9.3010299957,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/27401242,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2537,2535,Homo sapiens
218171,5302,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,8.568636236,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2538,2535,Homo sapiens
218172,5302,776,Tyrosine-protein kinase Fer,Kinase,P16591,FER,FER_HUMAN,8.48148606,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2538,2535,Homo sapiens
218173,5302,2280,Tyrosine-protein kinase Fes/Fps,Kinase,P07332,FES,FES_HUMAN,8.2218487496,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2538,2535,Homo sapiens
218174,5302,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,7.619788758,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2538,2535,Homo sapiens
218175,5302,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,7.638272164,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2538,2535,Homo sapiens
218176,5302,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,7.337242168,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2538,2535,Homo sapiens
218177,5302,672,Focal adhesion kinase 1,Kinase,Q05397,PTK2,FAK1_HUMAN,7.769551079,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2538,2535,Homo sapiens
218178,5302,2169,Protein-tyrosine kinase 2-beta,Kinase,Q14289,PTK2B,FAK2_HUMAN,7.853871964,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2538,2535,Homo sapiens
218179,5302,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,7.769551079,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2538,2535,Homo sapiens
218180,5303,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,9.38,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29736245,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210598s000lbl.pdf,ANTAGONIST,,Tclin,2540,2539,Homo sapiens
218181,5303,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,9.52,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29736245,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210598s000lbl.pdf,ANTAGONIST,,Tclin,2540,2539,Homo sapiens
218182,5303,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.75,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29736245,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210598s000lbl.pdf,ANTAGONIST,,Tclin,2540,2539,Homo sapiens
218183,5303,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,9.26,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29736245,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210598s000lbl.pdf,ANTAGONIST,,Tclin,2540,2539,Homo sapiens
218184,5303,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.2,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29736245,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210598s000lbl.pdf,ANTAGONIST,,Tclin,2540,2539,Homo sapiens
218185,5304,2477,Smoothened homolog,GPCR,Q99835,SMO,SMO_HUMAN,8.301029996,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24900436,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210656s000lbl.pdf,ANTAGONIST,,Tclin,2542,2541,Homo sapiens
218186,5305,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,8.187086643,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/21138586,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210861s000lbl.pdf,INHIBITOR,,Tclin,2544,2543,Homo sapiens
218187,5305,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,8.091514981,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/21138586,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210861s000lbl.pdf,INHIBITOR,,Tclin,2544,2543,Homo sapiens
218188,5305,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,7.974694135,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/21138586,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210861s000lbl.pdf,INHIBITOR,,Tclin,2544,2543,Homo sapiens
218189,5306,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,8.301029996,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/27908881,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211349s000lbl.pdf,INHIBITOR,,Tclin,2546,2545,Homo sapiens
218190,5307,505,Extracellular calcium-sensing receptor,GPCR,P41180,CASR,CASR_HUMAN,7.031517051,,EC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/29724589,http://www.ncbi.nlm.nih.gov/pubmed/29724589,AGONIST,,Tclin,2547,2547,Homo sapiens
218192,5309,1935,Plasma kallikrein,Enzyme,P03952,KLKB1,KLKB1_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/30267321,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761090s000lbl.pdf,INHIBITOR,,Tclin,2548,2549,Homo sapiens
218193,5311,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,8.958607315,,EC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/30411311,http://www.ncbi.nlm.nih.gov/pubmed/30411311,AGONIST,,Tclin,2550,2550,Homo sapiens
218194,5312,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,8.080921908,,EC50,activity measured for the active metabolite (omidenepag),SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/30465134,http://www.ncbi.nlm.nih.gov/pubmed/30465134,AGONIST,,Tclin,2551,2551,Homo sapiens
218195,5308,4234,von Willebrand factor,Unclassified,P04275,VWF,VWF_HUMAN,8.508638306,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9123,,ANTIBODY BINDING,,Tclin,,2552,Homo sapiens
218196,5314,4106,B-cell receptor CD22,Membrane receptor,P20273,CD22,CD22_HUMAN,8.2,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7675,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761104s000lbl.pdf,BINDING AGENT,,Tclin,,2553,Homo sapiens
218198,5315,4235,Calcitonin gene-related peptide 1,GPCR,P06881,CALCA,CALCA_HUMAN,10.3,,Kd,,IUPHAR,>,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9208,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761089s000lbl.pdf,ANTIBODY BINDING,,Tclin,,2554,Homo sapiens
218199,5316,4235,Calcitonin gene-related peptide 1,GPCR,P06881,CALCA,CALCA_HUMAN,8.7,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8967,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761063s000lbl.pdf,ANTIBODY BINDING,,Tclin,,2555,Homo sapiens
218200,5317,3394,Programmed cell death protein 1,Membrane receptor,Q15116,PDCD1,PDCD1_HUMAN,7.102372909,,Kd,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/28265006,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761097s000lbl.pdf,ANTIBODY BINDING,,Tclin,2557,2556,Homo sapiens
218201,5320,134,Interferon gamma,Cytokine,P01579,IFNG,IFNG_HUMAN,9.1,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9295,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761107s000lbl.pdf,ANTIBODY BINDING,,Tclin,,2558,Homo sapiens
218202,5322,3515,Complement C5,Secreted,P01031,C5,CO5_HUMAN,9.356547324,,Kd,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29649283,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761108s000lbl.pdf,ANTIBODY BINDING,,Tclin,2560,2559,Homo sapiens
218204,5323,4236,Interleukin-3 receptor,Membrane receptor,P26951|P32927,CSF2RB|IL3RA,IL3RA_HUMAN|IL3RB_HUMAN,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761116s000lbl.pdf,BINDING AGENT,,Tclin,,2563,Homo sapiens
218205,5301,4237,Polymerase acidic protein,Enzyme,P03433,PA,PA_I34A1,8.853872,,IC50,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210854s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210854s000lbl.pdf,INHIBITOR,,Tclin,2564,2564,Influenza A virus (strain A/Puerto Rico/8/1934 H1N1)
218207,5225,4238,Potassium,Inorganic material,,,,,,,,UNKNOWN,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/25531770,BINDING AGENT,,,,2565,
218208,5286,3631,Glutamate-gated chloride channel,Ion channel,Q25634,GluClX,Q25634_ONCVO,,,,,UNKNOWN,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/25651699,INHIBITOR,,,,2566,Onchocerca volvulus
218209,5288,2568,G-protein coupled receptor 55,GPCR,Q9Y2T6,GPR55,GPR55_HUMAN,,,,,UNKNOWN,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/23108553,ANTAGONIST,,Tclin,,2567,Homo sapiens
218210,5288,57,Transient receptor potential cation channel subfamily V member 1,Ion channel,Q8NER1,TRPV1,TRPV1_HUMAN,,,,,UNKNOWN,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/23108553,INHIBITOR,,Tclin,,2567,Homo sapiens
218211,5287,4240,30S ribosomal protein,Ribosomal protein,,,,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210303Orig1s000lbl.pdf,INHIBITOR,,,,2568,
218212,3578,4243,Plasmodium vivax,Bacteria,,,,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210795s000lbl.pdf,INHIBITOR,,,,2569,
218215,5298,4244,70S ribosomal protein,Ribosomal protein,,,,,,,,UNKNOWN,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/24002361,INHIBITOR,,,,2572,
218216,5299,4240,30S ribosomal protein,Ribosomal protein,,,,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209816_209817lbl.pdf,INHIBITOR,,,,2532,
218217,5318,4245,adenosine,Unclassified,,,,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761092s000lbl.pdf,OTHER,,,,2575,
218218,5321,4246,L-asparagine,Amino acid,,,,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761102s000lbl.pdf,OTHER,,,,2576,
218219,4817,1510,DNA-directed RNA polymerase subunit beta,Enzyme,P0A8V2,rpoB,RPOB_ECOLI,,,,,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210910s000lbl.pdf,INHIBITOR,,,,2577,Escherichia coli (strain K12)
218221,2734,4248,Fasciola species,Parasite,,,,,,,active against the immature and mature worms of Fasciola hepatica and Fasciola gigantica,DRUG LABEL,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208711s000lbl.pdf,OTHER,,,,2578,
218222,4192,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,5.9355,,IC50,,DRUG LABEL,=,,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002294/WC500117862.pdf,,INHIBITOR,,Tchem,184,,Homo sapiens
218223,4192,556,Solute carrier family 22 member 6,Transporter,Q4U2R8,SLC22A6,S22A6_HUMAN,5.5376,,IC50,,DRUG LABEL,=,,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002294/WC500117862.pdf,,INHIBITOR,,Tclin,184,,Homo sapiens
218224,4192,557,Solute carrier family 22 member 8,Transporter,Q8TCC7,SLC22A8,S22A8_HUMAN,5.6271,,IC50,,DRUG LABEL,=,,,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002294/WC500117862.pdf,,INHIBITOR,,Tclin,184,,Homo sapiens
218226,5324,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRB2|GABRG2,GBRA1_HUMAN|GBRB2_HUMAN|GBRG2_HUMAN,7.2218,,EC50,Possible target. Activity determined against recombinant Ltk cells,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211371Orig1s000MultidisciplineR.pdf,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,2584,,Homo sapiens
218228,5324,3664,GABA A receptor alpha-4/beta-3/delta,Ion channel,O14764|P28472|P48169,GABRA4|GABRB3|GABRD,GBRA4_HUMAN|GBRB3_HUMAN|GBRD_HUMAN,7.0969,,EC50,Possible target. Activity determined against recombinant CHO cells,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211371Orig1s000MultidisciplineR.pdf,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,2584,,Homo sapiens
218229,5324,4249,GABA-A receptor alpha-6/beta-3/delta,Ion channel,O14764|P28472|Q16445,GABRA6|GABRB3|GABRD,GBRA6_HUMAN|GBRB3_HUMAN|GBRD_HUMAN,6.8097,,EC50,Possible target. Activity determined against recombinant CHO cells,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211371Orig1s000MultidisciplineR.pdf,,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin,2584,,Homo sapiens
218231,5325,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,4.8477,,Ki,Binding affinity,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211230s000lbl.pdf,,INHIBITOR,,Tclin,2585,,Homo sapiens
218232,5325,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.4318,,Ki,Binding affinity,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211230s000lbl.pdf,,INHIBITOR,,Tclin,2585,,Homo sapiens
218233,5325,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,4.088,,Ki,Binding affinity,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211230s000lbl.pdf,,INHIBITOR,,Tclin,2585,,Homo sapiens
218235,5326,2015,Sphingosine 1-phosphate receptor 1,GPCR,P21453,S1PR1,S1PR1_HUMAN,9.4089,,EC50,Possible mechanism of action,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/31144287,http://www.ncbi.nlm.nih.gov/pubmed/31144287,MODULATOR,,Tclin,2586,2586,Homo sapiens
218236,5326,2016,Sphingosine 1-phosphate receptor 5,GPCR,Q9H228,S1PR5,S1PR5_HUMAN,9.0088,,EC50,Possible mechanism of action,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/31144287,http://www.ncbi.nlm.nih.gov/pubmed/31144287,MODULATOR,,Tclin,2586,2586,Homo sapiens
218237,5326,4250,Sphingosine 1-phosphate receptor 2,GPCR,O95136,S1PR2,S1PR2_HUMAN,4,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/31144287,,MODULATOR,,Tchem,2586,,Homo sapiens
218239,5326,2626,Sphingosine 1-phosphate receptor 3,GPCR,Q99500,S1PR3,S1PR3_HUMAN,3,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/31144287,,MODULATOR,,Tclin,2586,,Homo sapiens
218240,5326,2625,Sphingosine 1-phosphate receptor 4,GPCR,O95977,S1PR4,S1PR4_HUMAN,6.1249,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/31144287,,MODULATOR,,Tclin,2586,,Homo sapiens
218241,5327,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,8.9208,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/31161538,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf,INHIBITOR,,Tclin,2588,2587,Homo sapiens
218244,5327,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,8.6021,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/31161538,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf,INHIBITOR,,Tclin,2588,2587,Homo sapiens
218245,5327,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,8.5229,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/31161538,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf,INHIBITOR,,Tclin,2588,2587,Homo sapiens
218246,5327,2281,Fibroblast growth factor receptor 4,Kinase,P22455,FGFR4,FGFR4_HUMAN,8.2441,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/31161538,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf,INHIBITOR,,Tclin,2588,2587,Homo sapiens
218247,5327,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,7.4342,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/31161538,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf,INHIBITOR,,Tclin,2588,2587,Homo sapiens
218248,5328,2142,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,P42336,PIK3CA,PK3CA_HUMAN,8.3372,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/31256368,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212526s000lbl.pdf,INHIBITOR,,Tclin,2590,2589,Homo sapiens
218249,5329,2523,Melanocyte-stimulating hormone receptor,GPCR,Q01726,MC1R,MSHR_HUMAN,,,,,DRUG LABEL,,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf,,AGONIST,,Tclin,2591,,Homo sapiens
218251,5329,1718,Melanocortin receptor 3,GPCR,P41968,MC3R,MC3R_HUMAN,,,,,DRUG LABEL,,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf,,AGONIST,,Tchem,2591,,Homo sapiens
218252,5329,1717,Melanocortin receptor 5,GPCR,P33032,MC5R,MC5R_HUMAN,,,,,DRUG LABEL,,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf,,AGONIST,,Tchem,2591,,Homo sapiens
218253,5329,2685,Adrenocorticotropic hormone receptor,GPCR,Q01718,MC2R,ACTHR_HUMAN,,,,,DRUG LABEL,,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf,,AGONIST,,Tclin,2591,,Homo sapiens
218256,5333,4253,B-cell antigen receptor complex-associated protein beta chain,Tumour-associated antigen,P40259,CD79B,CD79B_HUMAN,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761121s000lbl.pdf,ANTIBODY BINDING,,Tclin,,2593,Homo sapiens
218257,5334,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.187,,IC50,Competitively inhibits androgen binding,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26137992,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212099Orig1s000lbl.pdf,INHIBITOR,,Tclin,2595,2594,Homo sapiens
218258,5334,4254,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,,,,,DRUG LABEL,,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212099Orig1s000lbl.pdf,,ANTAGONIST,,Tclin,2594,,Homo sapiens
218355,5337,4256,Interleukin-23 subunit alpha,Cytokine,Q9NPF7,IL23A,IL23A_HUMAN,11,,Kd,selectively binds to the p19 subunit of human IL-23,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/25905918,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761105s000lbl.pdf,INHIBITOR,,Tclin,2693,2692,Homo sapiens
218356,5338,3024,Interferon alpha/beta receptor,Membrane receptor,P17181|P48551,IFNAR1|IFNAR2,INAR1_HUMAN|INAR2_HUMAN,,,,Patients showed a statistically significant difference in the JAK2V617F allele burden (19.7%) and JAK2V617F allele change from baseline (-22.9%),DRUG LABEL,,1,DRUG LABEL,,https://www.ema.europa.eu/en/documents/product-information/besremi-epar-product-information_en.pdf,BINDING AGENT,,Tclin|Tclin,,2694,Homo sapiens
218357,5339,2059,Sodium/glucose cotransporter 1,Transporter,P13866,SLC5A1,SC5A1_HUMAN,7.4436,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/22739142,https://www.ema.europa.eu/en/documents/product-information/zynquista-epar-product-information_en.pdf,INHIBITOR,,Tclin,2696,2695,Homo sapiens
218358,5339,51,Sodium/glucose cotransporter 2,Transporter,P31639,SLC5A2,SC5A2_HUMAN,8.7447,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/22739142,https://www.ema.europa.eu/en/documents/product-information/zynquista-epar-product-information_en.pdf,INHIBITOR,,Tclin,2696,2695,Homo sapiens
218359,5340,4351,phenylalanine,Amino acid,,,,,,,,DRUG LABEL,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761079s000lbl.pdf,PROTEOLYTIC ENZYME,,,,2698,
218360,5341,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,8.796,,Kd,FLT3 binding affinity in biochemical assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19754199,http://www.ncbi.nlm.nih.gov/pubmed/19654408,INHIBITOR,,Tclin,2699,2700,Homo sapiens
218362,5330,4251,Exportin-1,Nuclear other,O14980,XPO1,XPO1_HUMAN,7.7,,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,https://clinicaltrials.gov/ProvidedDocs/61/NCT02215161/Prot_SAP_000.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212306s000lbl.pdf,INHIBITOR,,Tclin,2701,2592,Homo sapiens
218363,4468,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3a|Grin3b,NMD3A_RAT|NMD3B_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMDZ1_RAT,6.1611,,Ki,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/23183107,,ANTAGONIST,,,2702,,Rattus norvegicus
218365,5336,4352,rivaroxaban,Drug,,,,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.fda.gov/media/113279/download,BINDING AGENT,,,,2703,
218366,5336,4353,apixaban,Drug,,,,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.fda.gov/media/113279/download,BINDING AGENT,,,,2703,
218368,5329,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,8,,Kd,Functional evaluation of PT‐141 at the MC4R was performed by measuring the accumulation of intracellular cAMP in HEK‐293 cells expressing MC4R,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/12851303,http://www.ncbi.nlm.nih.gov/pubmed/12851303,AGONIST,,Tclin,2704,2704,Homo sapiens
218370,5331,4354,Synaptosomal-associated protein 25,Cytosolic other,P60880,SNAP25,SNP25_HUMAN,,,,Mechanism of Action,DRUG LABEL,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761085s000lbl.pdf,BLOCKER,,Tclin,,2705,Homo sapiens
218371,5342,4357,Beta-lactamase,Enzyme,Q2PUH3,blaCTX-M-15,Q2PUH3_KLEPN,6.4,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/31383664,http://www.ncbi.nlm.nih.gov/pubmed/31383664,INHIBITOR,,,2706,2706,Klebsiella pneumoniae
218372,5342,4358,Beta-lactamase,Enzyme,Q9X5A7,L2camp,Q9X5A7_STEMA,6.33,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/31383664,http://www.ncbi.nlm.nih.gov/pubmed/31383664,INHIBITOR,,,2706,2706,Stenotrophomonas maltophilia
218373,5342,4359,Beta-lactamase,Enzyme,Q93LQ9,KPC-2,Q93LQ9_KLEPN,6.64,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/31383664,http://www.ncbi.nlm.nih.gov/pubmed/31383664,INHIBITOR,,,2706,2706,Klebsiella pneumoniae
218374,5342,4360,Beta-lactamase,Enzyme,Q93DC4,bla,Q93DC4_KLEPN,6.59,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/31383664,http://www.ncbi.nlm.nih.gov/pubmed/31383664,INHIBITOR,,,2706,2706,Klebsiella pneumoniae
218375,5342,4361,Beta-lactamase,Enzyme,B1PL86,blaKPC-4,B1PL86_KLEPN,6.04,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/31383664,http://www.ncbi.nlm.nih.gov/pubmed/31383664,INHIBITOR,,,2706,2706,Klebsiella pneumoniae
218380,5343,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.88,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/26222558,http://www.ncbi.nlm.nih.gov/pubmed/26222558,INHIBITOR,,Tclin,2707,2707,Homo sapiens
218381,5343,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.56,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/26222558,http://www.ncbi.nlm.nih.gov/pubmed/26222558,INHIBITOR,,Tclin,2707,2707,Homo sapiens
218384,5345,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,9,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf,,INHIBITOR,,Tclin,2709,2710,Homo sapiens
218385,5345,2081,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,8.52,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf,,INHIBITOR,,Tclin,2709,2710,Homo sapiens
218386,5345,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,8.3,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf,,INHIBITOR,,Tclin,2709,2710,Homo sapiens
218387,5345,2282,Proto-oncogene tyrosine-protein kinase ROS,Kinase,P08922,ROS1,ROS1_HUMAN,8.15,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf,,INHIBITOR,,Tclin,2709,2710,Homo sapiens
218388,5345,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,7.92,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf,,INHIBITOR,,Tclin,2709,2710,Homo sapiens
218389,5345,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,7.4,,IC50,,SCIENTIFIC LITERATURE,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf,,INHIBITOR,,Tclin,2709,,Homo sapiens
218390,5345,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,7.15,,IC50,,SCIENTIFIC LITERATURE,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf,,INHIBITOR,,Tclin,2709,,Homo sapiens
218391,5346,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,7.33,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/30886973,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211675s000lbl.pdf,INHIBITOR,,Tclin,2712,2711,Homo sapiens
218392,5346,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,6.92,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/30886973,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211675s000lbl.pdf,INHIBITOR,,Tclin,2712,2711,Homo sapiens
218393,5346,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,5.63,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/30886973,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211675s000lbl.pdf,INHIBITOR,,Tclin,2712,2711,Homo sapiens
218394,5343,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,6.79,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/26222558,http://www.ncbi.nlm.nih.gov/pubmed/26222558,INHIBITOR,,Tclin,2707,2707,Homo sapiens
218395,5347,712,Tyrosine-protein kinase JAK2,Kinase,O60674,JAK2,JAK2_HUMAN,8.52,,IC50,wild type JAK2,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/18394554,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf,INHIBITOR,,Tclin,2714,2713,Homo sapiens
218396,5347,539,Receptor-type tyrosine-protein kinase FLT3,Kinase,P36888,FLT3,FLT3_HUMAN,7.82,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/18394554,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf,INHIBITOR,,Tclin,2714,2713,Homo sapiens
218397,5347,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,5.99,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/18394554,,INHIBITOR,,Tclin,2714,,Homo sapiens
218398,5347,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,6.97,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/18394554,,INHIBITOR,,Tclin,2714,,Homo sapiens
218399,5347,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,6.39,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/18394554,,INHIBITOR,,Tclin,2714,,Homo sapiens
218400,5185,258,Somatostatin receptor type 2,GPCR,P30874,SSTR2,SSR2_HUMAN,8.6,,Ki,Mechanism of Action,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210828s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210828s000lbl.pdf,ANTAGONIST,,Tclin,2715,2715,Homo sapiens
218401,5349,4363,Sodium/hydrogen exchanger 3,Transporter,P48764,SLC9A3,SL9A3_HUMAN,9.06,,IC50,wild type,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/28495802,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211801s000lbl.pdf,INHIBITOR,,Tclin,2716,2717,Homo sapiens
218402,5350,427,Retinoic acid receptor gamma,Nuclear hormone receptor,P13631,RARG,RARG_HUMAN,8.11,,EC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/29706423,http://www.ncbi.nlm.nih.gov/pubmed/29706423,AGONIST,,Tclin,2718,2718,Homo sapiens
218403,5350,231,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,6.3,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/29706423,,AGONIST,,Tclin,2718,,Homo sapiens
218404,5350,426,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,6.9,,EC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/29706423,,AGONIST,,Tclin,2718,,Homo sapiens
218405,5351,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,8.65,,Ki,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/20855361,http://www.ncbi.nlm.nih.gov/pubmed/20855361,AGONIST,,Tclin,2719,2719,Homo sapiens
218406,5353,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,9.52,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/31381333,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213217s000lbl.pdf,INHIBITOR,,Tclin,2721,2720,Homo sapiens
218408,5356,4368,hemoglobin subunit alpha,Transporter,P69905,HBA1,HBA_HUMAN,5.09,,EC50,Hemoglobin S differs from hemoglobin A only by a single amino acid substitution: a valine replaces a glutamine in the 6th position of the beta chain of globin; forms a reversible covalent bond with the N‐terminal valine of the α chain of HbS.,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/27378309,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213137s000lbl.pdf,INHIBITOR,,Tclin,2724,2723,Homo sapiens
218442,5352,1417,Penicillin-binding protein 1A,Enzyme,P02918,mrcA,PBPA_ECOLI,5.48,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Escherichia coli (strain K12)
218443,5352,659,Penicillin-binding protein 1A,Enzyme,Q07806,mrcA,PBPA_PSEAE,6.07,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
218444,5352,4378,Penicillin-binding protein 1A,Enzyme,G1C775,ponA,G1C775_ACIBA,5.98,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Acinetobacter baumannii
218445,5352,1418,Penicillin-binding protein 1B,Enzyme,P02919,mrcB,PBPB_ECOLI,5.47,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Escherichia coli (strain K12)
218446,5352,4379,Penicillin-binding protein 1B,Enzyme,A6T4V3,mrcB,A6T4V3_KLEP7,5.46,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Klebsiella pneumoniae subsp. pneumoniae (strain ATCC 700721 / MGH 78578)
218447,5352,4380,"Peptidoglycan D,D-transpeptidase MrdA",Enzyme,H4I819,mrdA,H4I819_ECOLX,5.66,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Escherichia coli DEC1B
218448,5352,4381,"Peptidoglycan D,D-transpeptidase MrdA",Enzyme,A0A0W8ASI8,mrdA,A0A0W8ASI8_KLEPN,7.2,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Klebsiella pneumoniae
218449,5352,310,Peptidoglycan synthase FtsI,Enzyme,P0AD68,ftsI,FTSI_ECOLI,7.4,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Escherichia coli (strain K12)
218439,5371,930,Egl nine homolog 1,Enzyme,Q9GZT9,EGLN1,EGLN1_HUMAN,4.54,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/29856623,http://www.ncbi.nlm.nih.gov/pubmed/30805897,INHIBITOR,,Tclin,2743,2741,Homo sapiens
218450,5352,4382,"Peptidoglycan D,D-transpeptidase FtsI",Enzyme,A6T4M7,ftsI,A6T4M7_KLEP7,7.21,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Klebsiella pneumoniae subsp. pneumoniae (strain ATCC 700721 / MGH 78578)
218451,5352,4383,"Peptidoglycan D,D-transpeptidase FtsI",Enzyme,G3XD46,ftsI,FTSI_PSEAE,7.22,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1)
218452,5352,4384,"Peptidoglycan D,D-transpeptidase FtsI",Enzyme,D0CCM7,ftsI,D0CCM7_ACIB2,6.17,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / CIP 70.34 / JCM 6841 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81)
218453,5352,4385,Penicillin-binding protein 4,Enzyme,A0A5E6DR09,pbpD_1,A0A5E6DR09_KLEPN,5.44,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/29061741,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209445s000lbl.pdf,INHIBITOR,,,2745,2746,Klebsiella pneumoniae
218454,5365,4372,P-selectin,Adhesion,P16109,SELP,LYAM3_HUMAN,5.59,,IC50,ex-vivo determination published in FDA's Multi-Discipline Review of BLA 761128,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761128s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761128s000lbl.pdf,INHIBITOR,,Tclin,2734,2734,Homo sapiens
218455,5367,596,DNA topoisomerase 1,Enzyme,P11387,TOP1,TOP1_HUMAN,7.51,,IC50,cell-free DNA topoisomerase I inhibitory activity of DXd component,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/27026201,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf,INHIBITOR,,Tclin,2738,2737,Homo sapiens
218459,5357,4386,exon 53 of dystrophin pre-mRNA,RNA,P11532,DMD,DMD_HUMAN,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211970s000lbl.pdf,ANTISENSE INHIBITOR,,Tclin,,2725,Homo sapiens
218410,5358,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.26,,Ki,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209500s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209500s000lbl.pdf,ANTAGONIST,,Tclin,2726,2726,Homo sapiens
218411,5358,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.49,,Ki,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209500s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209500s000lbl.pdf,ANTAGONIST,,Tclin,2726,2726,Homo sapiens
218412,5358,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.48,,Ki,,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209500s000lbl.pdf,,,,Tclin,2726,,Homo sapiens
218413,5358,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.38,,Ki,,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209500s000lbl.pdf,,ANTAGONIST,,Tclin,2726,,Homo sapiens
218418,5360,38,Orexin receptor type 1,GPCR,O43613,HCRTR1,OX1R_HUMAN,8.22,,Ki,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212028s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212028s000lbl.pdf,ANTAGONIST,,Tclin,2727,2727,Homo sapiens
218419,5360,2577,Orexin receptor type 2,GPCR,O43614,HCRTR2,OX2R_HUMAN,8.52,,Ki,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212028s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212028s000lbl.pdf,ANTAGONIST,,Tclin,2727,2727,Homo sapiens
218421,5362,4369,Sclerostin,Glycoprotein,Q9BQB4,SOST,SOST_HUMAN,11.7,,Kd,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8092,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf,BINDING AGENT,,Tclin,,2729,Homo sapiens
218422,5363,1643,Vascular endothelial growth factor A,Secreted,P15692,VEGFA,VEGFA_HUMAN,8.8,,Kd,binds to the three major isoforms of VEGF-A,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8713,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761125s000lbl.pdf,INHIBITOR,,Tclin,,2730,Homo sapiens
218423,5364,4370,Growth/differentiation factor 11,Cytokine,O95390,GDF11,GDF11_HUMAN,10.13,,Kd,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24658078,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761136lbl.pdf,BINDING AGENT,,Tclin,2732,2731,Homo sapiens
218424,5364,4371,Growth/differentiation factor 8,Cytokine,O14793,MSTN,GDF8_HUMAN,9.69,,Kd,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24658078,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761136lbl.pdf,BINDING AGENT,,Tclin,2732,2731,Homo sapiens
218426,5366,4373,Nectin-4,Tumour-associated antigen,Q96NY8,NECTIN4,NECT4_HUMAN,10.24,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/27013195,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761137s000lbl.pdf,BINDING AGENT,,Tclin,2736,2735,Homo sapiens
218427,5367,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,8.13,,Kd,HER2-specific cell growth inhibition,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/27026201,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf,BINDING AGENT,,Tclin,2738,2737,Homo sapiens
218431,5151,3714,Programmed cell death 1 ligand 1,CD molecules,Q9NZQ7,CD274,PD1L1_HUMAN,9.39,,Kd,Mechanism of Action,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/27412122,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761034s000lbl.pdf,ANTIBODY BINDING,,Tclin,2740,593,Homo sapiens
218436,5372,1047,Cystic fibrosis transmembrane conductance regulator,Ion channel,P13569,CFTR,CFTR_HUMAN,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212273s000lbl.pdf,,,Tclin,,2742,Homo sapiens
218437,5361,4376,Calcitonin gene-related peptide type 1 receptor,GPCR,Q16602,CALCRL,CALRL_HUMAN,10.2,,Ki,,IUPHAR,=,1,DRUG LABEL,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10176,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211765s000lbl.pdf,ANTAGONIST,,Tclin,,2728,Homo sapiens
218438,5371,4374,Egl nine homolog 2,Enzyme,Q96KS0,EGLN2,EGLN2_HUMAN,5.24,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/29856623,http://www.ncbi.nlm.nih.gov/pubmed/30805897,INHIBITOR,,Tclin,2743,2741,Homo sapiens
218440,5371,4375,Egl nine homolog 3,Enzyme,Q9H6Z9,EGLN3,EGLN3_HUMAN,5.18,,IC50,,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/29856623,http://www.ncbi.nlm.nih.gov/pubmed/30805897,INHIBITOR,,Tclin,2743,2741,Homo sapiens
218441,5348,4377,50S ribosomal protein,Ribosomal protein,,,,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211672s000,211673s000lbl.pdf",INHIBITOR,,,,2744,
218460,5182,4387,exon 51 of dystrophin pre-mRNA,RNA,P11532,DMD,DMD_HUMAN,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206488lbl.pdf,BINDING AGENT,,Tclin,,2747,Homo sapiens
218461,5313,4388,transthyretin (TTR) mRNA,RNA,P02766,TTR,TTHY_HUMAN,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210922s000lbl.pdf,ANTISENSE INHIBITOR,,Tclin,,2570,Homo sapiens
218462,5319,4388,transthyretin (TTR) mRNA,RNA,P02766,TTR,TTHY_HUMAN,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211172lbl.pdf,ANTISENSE INHIBITOR,,Tclin,,2571,Homo sapiens
218463,5354,4389,aminolevulinate synthase1 (ALAS1) mRNA,RNA,P13196,ALAS1,HEM1_HUMAN,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/0212194s000lbl.pdf,ANTISENSE INHIBITOR,,Tclin,,2722,Homo sapiens
218464,5335,4390,apolipoprotein C-III (apoC-III) mRNA,RNA,P02656,APOC3,APOC3_HUMAN,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.ema.europa.eu/en/documents/assessment-report/waylivra-epar-public-assessment-report_en.pdf,ANTISENSE INHIBITOR,,Tclin,,2599,Homo sapiens
218465,5368,4354,Synaptosomal-associated protein 25,Cytosolic other,P60880,SNAP25,SNP25_HUMAN,,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1,SCIENTIFIC LITERATURE,,http://www.ncbi.nlm.nih.gov/pubmed/8103915,BLOCKER,,Tclin,,2748,Homo sapiens
218466,5333,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761121s000lbl.pdf,BINDING AGENT,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,2593,Homo sapiens
218467,5366,3518,Tubulin beta,Tumour-associated antigen,P04350|P07437|P68371|Q13509|Q13885|Q3ZCM7|Q9BUF5|Q9BVA1|Q9H4B7,TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8,TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB5_HUMAN|TBB6_HUMAN|TBB8_HUMAN,,,,Mechanism of Action,UNKNOWN,,1,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761137s000lbl.pdf,BINDING AGENT,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,2735,Homo sapiens
218468,1922,437,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q13698,CACNA1S,CAC1S_HUMAN,6.3,,IC50,,IUPHAR,=,,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2514,,INHIBITOR,,Tclin,,,Homo sapiens
218470,4887,19,H1N1 subtype,Virus,,,,6.13,,EC50,Antiviral activity (EC50) as determined by plaque reduction assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19428599,http://www.ncbi.nlm.nih.gov/pubmed/19428599,,,,6,6,
218471,4887,20,H2N2 subtype,Virus,,,,6,,EC50,Antiviral activity (EC50) as determined by plaque reduction assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19428599,http://www.ncbi.nlm.nih.gov/pubmed/19428599,,,,6,6,
218472,4887,21,H3N2 subtype,Virus,,,,5.74,,EC50,Antiviral activity (EC50) as determined by plaque reduction assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19428599,http://www.ncbi.nlm.nih.gov/pubmed/19428599,,,,6,6,
218473,4887,22,H1N5 subtype,Virus,,,,5.35,,EC50,Antiviral activity (EC50) as determined by plaque reduction assay,SCIENTIFIC LITERATURE,=,1,SCIENTIFIC LITERATURE,http://www.ncbi.nlm.nih.gov/pubmed/19428599,http://www.ncbi.nlm.nih.gov/pubmed/19428599,,,,6,6,
218500,5380,4398,Histone-lysine N-methyltransferase EZH1,Enzyme,Q92800,EZH1,EZH1_HUMAN,6.41,,IC50,,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211723s000lbl.pdf,,INHIBITOR,,Tchem,2766,,Homo sapiens
218502,5381,4376,Calcitonin gene-related peptide type 1 receptor,GPCR,Q16602,CALCRL,CALRL_HUMAN,10.56,,Ki,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/23153230,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212728s000lbl.pdf,ANTAGONIST,,Tclin,2768,2767,Homo sapiens
218503,5382,4399,ATP-citrate synthase,Enzyme,P53396,ACLY,ACLY_HUMAN,5.69,,Ki,Inhibition of ACL by ETC-1002-CoA,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/27892461,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211616s000lbl.pdf,INHIBITOR,,Tclin,2770,2769,Homo sapiens
218504,5383,2015,Sphingosine 1-phosphate receptor 1,GPCR,P21453,S1PR1,S1PR1_HUMAN,9.39,,EC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26990079,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209899s000lbl.pdf,AGONIST,,Tclin,2772,2771,Homo sapiens
218505,5383,2016,Sphingosine 1-phosphate receptor 5,GPCR,Q9H228,S1PR5,S1PR5_HUMAN,7.96,,EC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/26990079,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209899s000lbl.pdf,AGONIST,,Tclin,2772,2771,Homo sapiens
218506,5384,443,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,8.6,,IC50,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212801s000lbl.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212801s000lbl.pdf,INHIBITOR,,Tclin,2773,2773,Homo sapiens
218507,5384,673,"Cytochrome P450 11B2, mitochondrial",Enzyme,P19099,CYP11B2,C11B2_HUMAN,9.15,,IC50,,SCIENTIFIC LITERATURE,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212801s000lbl.pdf,,INHIBITOR,,Tchem,2773,,Homo sapiens
218508,5385,3575,Lymphocyte differentiation antigen CD38,Tumour-associated antigen,P28907,CD38,CD38_HUMAN,9.7,,Kd,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/24987056,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761113s000lbl.pdf,BINDING AGENT,,Tclin,2776,2775,Homo sapiens
218509,5386,4235,Calcitonin gene-related peptide 1,GPCR,P06881,CALCA,CALCA_HUMAN,10.82,,Kd,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/761119Orig1s000OtherR.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761119s000lbl.pdf,BINDING AGENT,,Tclin,2778,2777,Homo sapiens
218510,5386,4400,Calcitonin gene-related peptide 2,GPCR,P10092,CALCB,CALCB_HUMAN,10.24,,Kd,,DRUG LABEL,=,1,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/761119Orig1s000OtherR.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761119s000lbl.pdf,BINDING AGENT,,Tclin,2778,2777,Homo sapiens
218511,5387,609,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,9,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/20847162,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761143s000lbl.pdf,ANTAGONIST,,Tclin,2780,2779,Homo sapiens
218512,5388,1728,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,7.85,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/17332304,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213756s000lbl.pdf,INHIBITOR,,Tclin,2781,2782,Homo sapiens
218513,5388,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,7.85,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/17332304,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213756s000lbl.pdf,INHIBITOR,,Tclin,2781,2782,Homo sapiens
218514,5389,4401,ERBB2/ERBB3,Kinase,P04626|P21860,ERBB2|ERBB3,ERBB2_HUMAN|ERBB3_HUMAN,8.16,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/32241871,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213411s000lbl.pdf,INHIBITOR,,Tclin|Tclin,2784,2783,Homo sapiens
218515,5389,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,6.5,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/32241871,,INHIBITOR,,Tclin,2784,,Homo sapiens
218516,5390,759,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,9.4,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/32315352,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf,INHIBITOR,,Tclin,2785,2786,Homo sapiens
218517,5390,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,9.3,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/32315352,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf,INHIBITOR,,Tclin,2785,2786,Homo sapiens
218518,5390,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,9,,IC50,,SCIENTIFIC LITERATURE,=,1,DRUG LABEL,http://www.ncbi.nlm.nih.gov/pubmed/32315352,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf,INHIBITOR,,Tclin,2785,2786,Homo sapiens
218519,5390,2281,Fibroblast growth factor receptor 4,Kinase,P22455,FGFR4,FGFR4_HUMAN,7.52,,IC50,,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/32315352,,INHIBITOR,,Tclin,2785,,Homo sapiens
218614,5378,699,Poly [ADP-ribose] polymerase 1,Enzyme,P09874,PARP1,PARP1_HUMAN,8.49,,IC50,biotinylated [NAD+]-based luminescence assays,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/27926532,,INHIBITOR,,Tclin,2883,,Homo sapiens
218615,5378,34,Poly [ADP-ribose] polymerase 2,Enzyme,Q9UGN5,PARP2,PARP2_HUMAN,8.72,,IC50,biotinylated [NAD+]-based luminescence assays,SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/27926532,,INHIBITOR,,Tclin,2883,,Homo sapiens
218616,5376,4501,Ebola virus (EBOV),Virus,,,,7.06,,EC50,human microvascular endothelial cells (HMVEC-TERT),SCIENTIFIC LITERATURE,=,,,http://www.ncbi.nlm.nih.gov/pubmed/26934220,,INHIBITOR,,,2884,,
